<!DOCTYPE html>

<html xmlns="http://www.w3.org/1999/xhtml">

<head>

<meta charset="utf-8" />
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />


<meta name="author" content="Gary Koplik, Matt Tribby" />


<title>Rare Diseases in the Duke Medical System</title>

<script src="data:application/x-javascript;base64,/*! jQuery v1.11.3 | (c) 2005, 2015 jQuery Foundation, Inc. | jquery.org/license */
!function(a,b){"object"==typeof module&&"object"==typeof module.exports?module.exports=a.document?b(a,!0):function(a){if(!a.document)throw new Error("jQuery requires a window with a document");return b(a)}:b(a)}("undefined"!=typeof window?window:this,function(a,b){var c=[],d=c.slice,e=c.concat,f=c.push,g=c.indexOf,h={},i=h.toString,j=h.hasOwnProperty,k={},l="1.11.3",m=function(a,b){return new m.fn.init(a,b)},n=/^[\s\uFEFF\xA0]+|[\s\uFEFF\xA0]+$/g,o=/^-ms-/,p=/-([\da-z])/gi,q=function(a,b){return b.toUpperCase()};m.fn=m.prototype={jquery:l,constructor:m,selector:"",length:0,toArray:function(){return d.call(this)},get:function(a){return null!=a?0>a?this[a+this.length]:this[a]:d.call(this)},pushStack:function(a){var b=m.merge(this.constructor(),a);return b.prevObject=this,b.context=this.context,b},each:function(a,b){return m.each(this,a,b)},map:function(a){return this.pushStack(m.map(this,function(b,c){return a.call(b,c,b)}))},slice:function(){return this.pushStack(d.apply(this,arguments))},first:function(){return this.eq(0)},last:function(){return this.eq(-1)},eq:function(a){var b=this.length,c=+a+(0>a?b:0);return this.pushStack(c>=0&&b>c?[this[c]]:[])},end:function(){return this.prevObject||this.constructor(null)},push:f,sort:c.sort,splice:c.splice},m.extend=m.fn.extend=function(){var a,b,c,d,e,f,g=arguments[0]||{},h=1,i=arguments.length,j=!1;for("boolean"==typeof g&&(j=g,g=arguments[h]||{},h++),"object"==typeof g||m.isFunction(g)||(g={}),h===i&&(g=this,h--);i>h;h++)if(null!=(e=arguments[h]))for(d in e)a=g[d],c=e[d],g!==c&&(j&&c&&(m.isPlainObject(c)||(b=m.isArray(c)))?(b?(b=!1,f=a&&m.isArray(a)?a:[]):f=a&&m.isPlainObject(a)?a:{},g[d]=m.extend(j,f,c)):void 0!==c&&(g[d]=c));return g},m.extend({expando:"jQuery"+(l+Math.random()).replace(/\D/g,""),isReady:!0,error:function(a){throw new Error(a)},noop:function(){},isFunction:function(a){return"function"===m.type(a)},isArray:Array.isArray||function(a){return"array"===m.type(a)},isWindow:function(a){return null!=a&&a==a.window},isNumeric:function(a){return!m.isArray(a)&&a-parseFloat(a)+1>=0},isEmptyObject:function(a){var b;for(b in a)return!1;return!0},isPlainObject:function(a){var b;if(!a||"object"!==m.type(a)||a.nodeType||m.isWindow(a))return!1;try{if(a.constructor&&!j.call(a,"constructor")&&!j.call(a.constructor.prototype,"isPrototypeOf"))return!1}catch(c){return!1}if(k.ownLast)for(b in a)return j.call(a,b);for(b in a);return void 0===b||j.call(a,b)},type:function(a){return null==a?a+"":"object"==typeof a||"function"==typeof a?h[i.call(a)]||"object":typeof a},globalEval:function(b){b&&m.trim(b)&&(a.execScript||function(b){a.eval.call(a,b)})(b)},camelCase:function(a){return a.replace(o,"ms-").replace(p,q)},nodeName:function(a,b){return a.nodeName&&a.nodeName.toLowerCase()===b.toLowerCase()},each:function(a,b,c){var d,e=0,f=a.length,g=r(a);if(c){if(g){for(;f>e;e++)if(d=b.apply(a[e],c),d===!1)break}else for(e in a)if(d=b.apply(a[e],c),d===!1)break}else if(g){for(;f>e;e++)if(d=b.call(a[e],e,a[e]),d===!1)break}else for(e in a)if(d=b.call(a[e],e,a[e]),d===!1)break;return a},trim:function(a){return null==a?"":(a+"").replace(n,"")},makeArray:function(a,b){var c=b||[];return null!=a&&(r(Object(a))?m.merge(c,"string"==typeof a?[a]:a):f.call(c,a)),c},inArray:function(a,b,c){var d;if(b){if(g)return g.call(b,a,c);for(d=b.length,c=c?0>c?Math.max(0,d+c):c:0;d>c;c++)if(c in b&&b[c]===a)return c}return-1},merge:function(a,b){var c=+b.length,d=0,e=a.length;while(c>d)a[e++]=b[d++];if(c!==c)while(void 0!==b[d])a[e++]=b[d++];return a.length=e,a},grep:function(a,b,c){for(var d,e=[],f=0,g=a.length,h=!c;g>f;f++)d=!b(a[f],f),d!==h&&e.push(a[f]);return e},map:function(a,b,c){var d,f=0,g=a.length,h=r(a),i=[];if(h)for(;g>f;f++)d=b(a[f],f,c),null!=d&&i.push(d);else for(f in a)d=b(a[f],f,c),null!=d&&i.push(d);return e.apply([],i)},guid:1,proxy:function(a,b){var c,e,f;return"string"==typeof b&&(f=a[b],b=a,a=f),m.isFunction(a)?(c=d.call(arguments,2),e=function(){return a.apply(b||this,c.concat(d.call(arguments)))},e.guid=a.guid=a.guid||m.guid++,e):void 0},now:function(){return+new Date},support:k}),m.each("Boolean Number String Function Array Date RegExp Object Error".split(" "),function(a,b){h["[object "+b+"]"]=b.toLowerCase()});function r(a){var b="length"in a&&a.length,c=m.type(a);return"function"===c||m.isWindow(a)?!1:1===a.nodeType&&b?!0:"array"===c||0===b||"number"==typeof b&&b>0&&b-1 in a}var s=function(a){var b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u="sizzle"+1*new Date,v=a.document,w=0,x=0,y=ha(),z=ha(),A=ha(),B=function(a,b){return a===b&&(l=!0),0},C=1<<31,D={}.hasOwnProperty,E=[],F=E.pop,G=E.push,H=E.push,I=E.slice,J=function(a,b){for(var c=0,d=a.length;d>c;c++)if(a[c]===b)return c;return-1},K="checked|selected|async|autofocus|autoplay|controls|defer|disabled|hidden|ismap|loop|multiple|open|readonly|required|scoped",L="[\\x20\\t\\r\\n\\f]",M="(?:\\\\.|[\\w-]|[^\\x00-\\xa0])+",N=M.replace("w","w#"),O="\\["+L+"*("+M+")(?:"+L+"*([*^$|!~]?=)"+L+"*(?:'((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\"|("+N+"))|)"+L+"*\\]",P=":("+M+")(?:\\((('((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\")|((?:\\\\.|[^\\\\()[\\]]|"+O+")*)|.*)\\)|)",Q=new RegExp(L+"+","g"),R=new RegExp("^"+L+"+|((?:^|[^\\\\])(?:\\\\.)*)"+L+"+$","g"),S=new RegExp("^"+L+"*,"+L+"*"),T=new RegExp("^"+L+"*([>+~]|"+L+")"+L+"*"),U=new RegExp("="+L+"*([^\\]'\"]*?)"+L+"*\\]","g"),V=new RegExp(P),W=new RegExp("^"+N+"$"),X={ID:new RegExp("^#("+M+")"),CLASS:new RegExp("^\\.("+M+")"),TAG:new RegExp("^("+M.replace("w","w*")+")"),ATTR:new RegExp("^"+O),PSEUDO:new RegExp("^"+P),CHILD:new RegExp("^:(only|first|last|nth|nth-last)-(child|of-type)(?:\\("+L+"*(even|odd|(([+-]|)(\\d*)n|)"+L+"*(?:([+-]|)"+L+"*(\\d+)|))"+L+"*\\)|)","i"),bool:new RegExp("^(?:"+K+")$","i"),needsContext:new RegExp("^"+L+"*[>+~]|:(even|odd|eq|gt|lt|nth|first|last)(?:\\("+L+"*((?:-\\d)?\\d*)"+L+"*\\)|)(?=[^-]|$)","i")},Y=/^(?:input|select|textarea|button)$/i,Z=/^h\d$/i,$=/^[^{]+\{\s*\[native \w/,_=/^(?:#([\w-]+)|(\w+)|\.([\w-]+))$/,aa=/[+~]/,ba=/'|\\/g,ca=new RegExp("\\\\([\\da-f]{1,6}"+L+"?|("+L+")|.)","ig"),da=function(a,b,c){var d="0x"+b-65536;return d!==d||c?b:0>d?String.fromCharCode(d+65536):String.fromCharCode(d>>10|55296,1023&d|56320)},ea=function(){m()};try{H.apply(E=I.call(v.childNodes),v.childNodes),E[v.childNodes.length].nodeType}catch(fa){H={apply:E.length?function(a,b){G.apply(a,I.call(b))}:function(a,b){var c=a.length,d=0;while(a[c++]=b[d++]);a.length=c-1}}}function ga(a,b,d,e){var f,h,j,k,l,o,r,s,w,x;if((b?b.ownerDocument||b:v)!==n&&m(b),b=b||n,d=d||[],k=b.nodeType,"string"!=typeof a||!a||1!==k&&9!==k&&11!==k)return d;if(!e&&p){if(11!==k&&(f=_.exec(a)))if(j=f[1]){if(9===k){if(h=b.getElementById(j),!h||!h.parentNode)return d;if(h.id===j)return d.push(h),d}else if(b.ownerDocument&&(h=b.ownerDocument.getElementById(j))&&t(b,h)&&h.id===j)return d.push(h),d}else{if(f[2])return H.apply(d,b.getElementsByTagName(a)),d;if((j=f[3])&&c.getElementsByClassName)return H.apply(d,b.getElementsByClassName(j)),d}if(c.qsa&&(!q||!q.test(a))){if(s=r=u,w=b,x=1!==k&&a,1===k&&"object"!==b.nodeName.toLowerCase()){o=g(a),(r=b.getAttribute("id"))?s=r.replace(ba,"\\$&"):b.setAttribute("id",s),s="[id='"+s+"'] ",l=o.length;while(l--)o[l]=s+ra(o[l]);w=aa.test(a)&&pa(b.parentNode)||b,x=o.join(",")}if(x)try{return H.apply(d,w.querySelectorAll(x)),d}catch(y){}finally{r||b.removeAttribute("id")}}}return i(a.replace(R,"$1"),b,d,e)}function ha(){var a=[];function b(c,e){return a.push(c+" ")>d.cacheLength&&delete b[a.shift()],b[c+" "]=e}return b}function ia(a){return a[u]=!0,a}function ja(a){var b=n.createElement("div");try{return!!a(b)}catch(c){return!1}finally{b.parentNode&&b.parentNode.removeChild(b),b=null}}function ka(a,b){var c=a.split("|"),e=a.length;while(e--)d.attrHandle[c[e]]=b}function la(a,b){var c=b&&a,d=c&&1===a.nodeType&&1===b.nodeType&&(~b.sourceIndex||C)-(~a.sourceIndex||C);if(d)return d;if(c)while(c=c.nextSibling)if(c===b)return-1;return a?1:-1}function ma(a){return function(b){var c=b.nodeName.toLowerCase();return"input"===c&&b.type===a}}function na(a){return function(b){var c=b.nodeName.toLowerCase();return("input"===c||"button"===c)&&b.type===a}}function oa(a){return ia(function(b){return b=+b,ia(function(c,d){var e,f=a([],c.length,b),g=f.length;while(g--)c[e=f[g]]&&(c[e]=!(d[e]=c[e]))})})}function pa(a){return a&&"undefined"!=typeof a.getElementsByTagName&&a}c=ga.support={},f=ga.isXML=function(a){var b=a&&(a.ownerDocument||a).documentElement;return b?"HTML"!==b.nodeName:!1},m=ga.setDocument=function(a){var b,e,g=a?a.ownerDocument||a:v;return g!==n&&9===g.nodeType&&g.documentElement?(n=g,o=g.documentElement,e=g.defaultView,e&&e!==e.top&&(e.addEventListener?e.addEventListener("unload",ea,!1):e.attachEvent&&e.attachEvent("onunload",ea)),p=!f(g),c.attributes=ja(function(a){return a.className="i",!a.getAttribute("className")}),c.getElementsByTagName=ja(function(a){return a.appendChild(g.createComment("")),!a.getElementsByTagName("*").length}),c.getElementsByClassName=$.test(g.getElementsByClassName),c.getById=ja(function(a){return o.appendChild(a).id=u,!g.getElementsByName||!g.getElementsByName(u).length}),c.getById?(d.find.ID=function(a,b){if("undefined"!=typeof b.getElementById&&p){var c=b.getElementById(a);return c&&c.parentNode?[c]:[]}},d.filter.ID=function(a){var b=a.replace(ca,da);return function(a){return a.getAttribute("id")===b}}):(delete d.find.ID,d.filter.ID=function(a){var b=a.replace(ca,da);return function(a){var c="undefined"!=typeof a.getAttributeNode&&a.getAttributeNode("id");return c&&c.value===b}}),d.find.TAG=c.getElementsByTagName?function(a,b){return"undefined"!=typeof b.getElementsByTagName?b.getElementsByTagName(a):c.qsa?b.querySelectorAll(a):void 0}:function(a,b){var c,d=[],e=0,f=b.getElementsByTagName(a);if("*"===a){while(c=f[e++])1===c.nodeType&&d.push(c);return d}return f},d.find.CLASS=c.getElementsByClassName&&function(a,b){return p?b.getElementsByClassName(a):void 0},r=[],q=[],(c.qsa=$.test(g.querySelectorAll))&&(ja(function(a){o.appendChild(a).innerHTML="<a id='"+u+"'></a><select id='"+u+"-\f]' msallowcapture=''><option selected=''></option></select>",a.querySelectorAll("[msallowcapture^='']").length&&q.push("[*^$]="+L+"*(?:''|\"\")"),a.querySelectorAll("[selected]").length||q.push("\\["+L+"*(?:value|"+K+")"),a.querySelectorAll("[id~="+u+"-]").length||q.push("~="),a.querySelectorAll(":checked").length||q.push(":checked"),a.querySelectorAll("a#"+u+"+*").length||q.push(".#.+[+~]")}),ja(function(a){var b=g.createElement("input");b.setAttribute("type","hidden"),a.appendChild(b).setAttribute("name","D"),a.querySelectorAll("[name=d]").length&&q.push("name"+L+"*[*^$|!~]?="),a.querySelectorAll(":enabled").length||q.push(":enabled",":disabled"),a.querySelectorAll("*,:x"),q.push(",.*:")})),(c.matchesSelector=$.test(s=o.matches||o.webkitMatchesSelector||o.mozMatchesSelector||o.oMatchesSelector||o.msMatchesSelector))&&ja(function(a){c.disconnectedMatch=s.call(a,"div"),s.call(a,"[s!='']:x"),r.push("!=",P)}),q=q.length&&new RegExp(q.join("|")),r=r.length&&new RegExp(r.join("|")),b=$.test(o.compareDocumentPosition),t=b||$.test(o.contains)?function(a,b){var c=9===a.nodeType?a.documentElement:a,d=b&&b.parentNode;return a===d||!(!d||1!==d.nodeType||!(c.contains?c.contains(d):a.compareDocumentPosition&&16&a.compareDocumentPosition(d)))}:function(a,b){if(b)while(b=b.parentNode)if(b===a)return!0;return!1},B=b?function(a,b){if(a===b)return l=!0,0;var d=!a.compareDocumentPosition-!b.compareDocumentPosition;return d?d:(d=(a.ownerDocument||a)===(b.ownerDocument||b)?a.compareDocumentPosition(b):1,1&d||!c.sortDetached&&b.compareDocumentPosition(a)===d?a===g||a.ownerDocument===v&&t(v,a)?-1:b===g||b.ownerDocument===v&&t(v,b)?1:k?J(k,a)-J(k,b):0:4&d?-1:1)}:function(a,b){if(a===b)return l=!0,0;var c,d=0,e=a.parentNode,f=b.parentNode,h=[a],i=[b];if(!e||!f)return a===g?-1:b===g?1:e?-1:f?1:k?J(k,a)-J(k,b):0;if(e===f)return la(a,b);c=a;while(c=c.parentNode)h.unshift(c);c=b;while(c=c.parentNode)i.unshift(c);while(h[d]===i[d])d++;return d?la(h[d],i[d]):h[d]===v?-1:i[d]===v?1:0},g):n},ga.matches=function(a,b){return ga(a,null,null,b)},ga.matchesSelector=function(a,b){if((a.ownerDocument||a)!==n&&m(a),b=b.replace(U,"='$1']"),!(!c.matchesSelector||!p||r&&r.test(b)||q&&q.test(b)))try{var d=s.call(a,b);if(d||c.disconnectedMatch||a.document&&11!==a.document.nodeType)return d}catch(e){}return ga(b,n,null,[a]).length>0},ga.contains=function(a,b){return(a.ownerDocument||a)!==n&&m(a),t(a,b)},ga.attr=function(a,b){(a.ownerDocument||a)!==n&&m(a);var e=d.attrHandle[b.toLowerCase()],f=e&&D.call(d.attrHandle,b.toLowerCase())?e(a,b,!p):void 0;return void 0!==f?f:c.attributes||!p?a.getAttribute(b):(f=a.getAttributeNode(b))&&f.specified?f.value:null},ga.error=function(a){throw new Error("Syntax error, unrecognized expression: "+a)},ga.uniqueSort=function(a){var b,d=[],e=0,f=0;if(l=!c.detectDuplicates,k=!c.sortStable&&a.slice(0),a.sort(B),l){while(b=a[f++])b===a[f]&&(e=d.push(f));while(e--)a.splice(d[e],1)}return k=null,a},e=ga.getText=function(a){var b,c="",d=0,f=a.nodeType;if(f){if(1===f||9===f||11===f){if("string"==typeof a.textContent)return a.textContent;for(a=a.firstChild;a;a=a.nextSibling)c+=e(a)}else if(3===f||4===f)return a.nodeValue}else while(b=a[d++])c+=e(b);return c},d=ga.selectors={cacheLength:50,createPseudo:ia,match:X,attrHandle:{},find:{},relative:{">":{dir:"parentNode",first:!0}," ":{dir:"parentNode"},"+":{dir:"previousSibling",first:!0},"~":{dir:"previousSibling"}},preFilter:{ATTR:function(a){return a[1]=a[1].replace(ca,da),a[3]=(a[3]||a[4]||a[5]||"").replace(ca,da),"~="===a[2]&&(a[3]=" "+a[3]+" "),a.slice(0,4)},CHILD:function(a){return a[1]=a[1].toLowerCase(),"nth"===a[1].slice(0,3)?(a[3]||ga.error(a[0]),a[4]=+(a[4]?a[5]+(a[6]||1):2*("even"===a[3]||"odd"===a[3])),a[5]=+(a[7]+a[8]||"odd"===a[3])):a[3]&&ga.error(a[0]),a},PSEUDO:function(a){var b,c=!a[6]&&a[2];return X.CHILD.test(a[0])?null:(a[3]?a[2]=a[4]||a[5]||"":c&&V.test(c)&&(b=g(c,!0))&&(b=c.indexOf(")",c.length-b)-c.length)&&(a[0]=a[0].slice(0,b),a[2]=c.slice(0,b)),a.slice(0,3))}},filter:{TAG:function(a){var b=a.replace(ca,da).toLowerCase();return"*"===a?function(){return!0}:function(a){return a.nodeName&&a.nodeName.toLowerCase()===b}},CLASS:function(a){var b=y[a+" "];return b||(b=new RegExp("(^|"+L+")"+a+"("+L+"|$)"))&&y(a,function(a){return b.test("string"==typeof a.className&&a.className||"undefined"!=typeof a.getAttribute&&a.getAttribute("class")||"")})},ATTR:function(a,b,c){return function(d){var e=ga.attr(d,a);return null==e?"!="===b:b?(e+="","="===b?e===c:"!="===b?e!==c:"^="===b?c&&0===e.indexOf(c):"*="===b?c&&e.indexOf(c)>-1:"$="===b?c&&e.slice(-c.length)===c:"~="===b?(" "+e.replace(Q," ")+" ").indexOf(c)>-1:"|="===b?e===c||e.slice(0,c.length+1)===c+"-":!1):!0}},CHILD:function(a,b,c,d,e){var f="nth"!==a.slice(0,3),g="last"!==a.slice(-4),h="of-type"===b;return 1===d&&0===e?function(a){return!!a.parentNode}:function(b,c,i){var j,k,l,m,n,o,p=f!==g?"nextSibling":"previousSibling",q=b.parentNode,r=h&&b.nodeName.toLowerCase(),s=!i&&!h;if(q){if(f){while(p){l=b;while(l=l[p])if(h?l.nodeName.toLowerCase()===r:1===l.nodeType)return!1;o=p="only"===a&&!o&&"nextSibling"}return!0}if(o=[g?q.firstChild:q.lastChild],g&&s){k=q[u]||(q[u]={}),j=k[a]||[],n=j[0]===w&&j[1],m=j[0]===w&&j[2],l=n&&q.childNodes[n];while(l=++n&&l&&l[p]||(m=n=0)||o.pop())if(1===l.nodeType&&++m&&l===b){k[a]=[w,n,m];break}}else if(s&&(j=(b[u]||(b[u]={}))[a])&&j[0]===w)m=j[1];else while(l=++n&&l&&l[p]||(m=n=0)||o.pop())if((h?l.nodeName.toLowerCase()===r:1===l.nodeType)&&++m&&(s&&((l[u]||(l[u]={}))[a]=[w,m]),l===b))break;return m-=e,m===d||m%d===0&&m/d>=0}}},PSEUDO:function(a,b){var c,e=d.pseudos[a]||d.setFilters[a.toLowerCase()]||ga.error("unsupported pseudo: "+a);return e[u]?e(b):e.length>1?(c=[a,a,"",b],d.setFilters.hasOwnProperty(a.toLowerCase())?ia(function(a,c){var d,f=e(a,b),g=f.length;while(g--)d=J(a,f[g]),a[d]=!(c[d]=f[g])}):function(a){return e(a,0,c)}):e}},pseudos:{not:ia(function(a){var b=[],c=[],d=h(a.replace(R,"$1"));return d[u]?ia(function(a,b,c,e){var f,g=d(a,null,e,[]),h=a.length;while(h--)(f=g[h])&&(a[h]=!(b[h]=f))}):function(a,e,f){return b[0]=a,d(b,null,f,c),b[0]=null,!c.pop()}}),has:ia(function(a){return function(b){return ga(a,b).length>0}}),contains:ia(function(a){return a=a.replace(ca,da),function(b){return(b.textContent||b.innerText||e(b)).indexOf(a)>-1}}),lang:ia(function(a){return W.test(a||"")||ga.error("unsupported lang: "+a),a=a.replace(ca,da).toLowerCase(),function(b){var c;do if(c=p?b.lang:b.getAttribute("xml:lang")||b.getAttribute("lang"))return c=c.toLowerCase(),c===a||0===c.indexOf(a+"-");while((b=b.parentNode)&&1===b.nodeType);return!1}}),target:function(b){var c=a.location&&a.location.hash;return c&&c.slice(1)===b.id},root:function(a){return a===o},focus:function(a){return a===n.activeElement&&(!n.hasFocus||n.hasFocus())&&!!(a.type||a.href||~a.tabIndex)},enabled:function(a){return a.disabled===!1},disabled:function(a){return a.disabled===!0},checked:function(a){var b=a.nodeName.toLowerCase();return"input"===b&&!!a.checked||"option"===b&&!!a.selected},selected:function(a){return a.parentNode&&a.parentNode.selectedIndex,a.selected===!0},empty:function(a){for(a=a.firstChild;a;a=a.nextSibling)if(a.nodeType<6)return!1;return!0},parent:function(a){return!d.pseudos.empty(a)},header:function(a){return Z.test(a.nodeName)},input:function(a){return Y.test(a.nodeName)},button:function(a){var b=a.nodeName.toLowerCase();return"input"===b&&"button"===a.type||"button"===b},text:function(a){var b;return"input"===a.nodeName.toLowerCase()&&"text"===a.type&&(null==(b=a.getAttribute("type"))||"text"===b.toLowerCase())},first:oa(function(){return[0]}),last:oa(function(a,b){return[b-1]}),eq:oa(function(a,b,c){return[0>c?c+b:c]}),even:oa(function(a,b){for(var c=0;b>c;c+=2)a.push(c);return a}),odd:oa(function(a,b){for(var c=1;b>c;c+=2)a.push(c);return a}),lt:oa(function(a,b,c){for(var d=0>c?c+b:c;--d>=0;)a.push(d);return a}),gt:oa(function(a,b,c){for(var d=0>c?c+b:c;++d<b;)a.push(d);return a})}},d.pseudos.nth=d.pseudos.eq;for(b in{radio:!0,checkbox:!0,file:!0,password:!0,image:!0})d.pseudos[b]=ma(b);for(b in{submit:!0,reset:!0})d.pseudos[b]=na(b);function qa(){}qa.prototype=d.filters=d.pseudos,d.setFilters=new qa,g=ga.tokenize=function(a,b){var c,e,f,g,h,i,j,k=z[a+" "];if(k)return b?0:k.slice(0);h=a,i=[],j=d.preFilter;while(h){(!c||(e=S.exec(h)))&&(e&&(h=h.slice(e[0].length)||h),i.push(f=[])),c=!1,(e=T.exec(h))&&(c=e.shift(),f.push({value:c,type:e[0].replace(R," ")}),h=h.slice(c.length));for(g in d.filter)!(e=X[g].exec(h))||j[g]&&!(e=j[g](e))||(c=e.shift(),f.push({value:c,type:g,matches:e}),h=h.slice(c.length));if(!c)break}return b?h.length:h?ga.error(a):z(a,i).slice(0)};function ra(a){for(var b=0,c=a.length,d="";c>b;b++)d+=a[b].value;return d}function sa(a,b,c){var d=b.dir,e=c&&"parentNode"===d,f=x++;return b.first?function(b,c,f){while(b=b[d])if(1===b.nodeType||e)return a(b,c,f)}:function(b,c,g){var h,i,j=[w,f];if(g){while(b=b[d])if((1===b.nodeType||e)&&a(b,c,g))return!0}else while(b=b[d])if(1===b.nodeType||e){if(i=b[u]||(b[u]={}),(h=i[d])&&h[0]===w&&h[1]===f)return j[2]=h[2];if(i[d]=j,j[2]=a(b,c,g))return!0}}}function ta(a){return a.length>1?function(b,c,d){var e=a.length;while(e--)if(!a[e](b,c,d))return!1;return!0}:a[0]}function ua(a,b,c){for(var d=0,e=b.length;e>d;d++)ga(a,b[d],c);return c}function va(a,b,c,d,e){for(var f,g=[],h=0,i=a.length,j=null!=b;i>h;h++)(f=a[h])&&(!c||c(f,d,e))&&(g.push(f),j&&b.push(h));return g}function wa(a,b,c,d,e,f){return d&&!d[u]&&(d=wa(d)),e&&!e[u]&&(e=wa(e,f)),ia(function(f,g,h,i){var j,k,l,m=[],n=[],o=g.length,p=f||ua(b||"*",h.nodeType?[h]:h,[]),q=!a||!f&&b?p:va(p,m,a,h,i),r=c?e||(f?a:o||d)?[]:g:q;if(c&&c(q,r,h,i),d){j=va(r,n),d(j,[],h,i),k=j.length;while(k--)(l=j[k])&&(r[n[k]]=!(q[n[k]]=l))}if(f){if(e||a){if(e){j=[],k=r.length;while(k--)(l=r[k])&&j.push(q[k]=l);e(null,r=[],j,i)}k=r.length;while(k--)(l=r[k])&&(j=e?J(f,l):m[k])>-1&&(f[j]=!(g[j]=l))}}else r=va(r===g?r.splice(o,r.length):r),e?e(null,g,r,i):H.apply(g,r)})}function xa(a){for(var b,c,e,f=a.length,g=d.relative[a[0].type],h=g||d.relative[" "],i=g?1:0,k=sa(function(a){return a===b},h,!0),l=sa(function(a){return J(b,a)>-1},h,!0),m=[function(a,c,d){var e=!g&&(d||c!==j)||((b=c).nodeType?k(a,c,d):l(a,c,d));return b=null,e}];f>i;i++)if(c=d.relative[a[i].type])m=[sa(ta(m),c)];else{if(c=d.filter[a[i].type].apply(null,a[i].matches),c[u]){for(e=++i;f>e;e++)if(d.relative[a[e].type])break;return wa(i>1&&ta(m),i>1&&ra(a.slice(0,i-1).concat({value:" "===a[i-2].type?"*":""})).replace(R,"$1"),c,e>i&&xa(a.slice(i,e)),f>e&&xa(a=a.slice(e)),f>e&&ra(a))}m.push(c)}return ta(m)}function ya(a,b){var c=b.length>0,e=a.length>0,f=function(f,g,h,i,k){var l,m,o,p=0,q="0",r=f&&[],s=[],t=j,u=f||e&&d.find.TAG("*",k),v=w+=null==t?1:Math.random()||.1,x=u.length;for(k&&(j=g!==n&&g);q!==x&&null!=(l=u[q]);q++){if(e&&l){m=0;while(o=a[m++])if(o(l,g,h)){i.push(l);break}k&&(w=v)}c&&((l=!o&&l)&&p--,f&&r.push(l))}if(p+=q,c&&q!==p){m=0;while(o=b[m++])o(r,s,g,h);if(f){if(p>0)while(q--)r[q]||s[q]||(s[q]=F.call(i));s=va(s)}H.apply(i,s),k&&!f&&s.length>0&&p+b.length>1&&ga.uniqueSort(i)}return k&&(w=v,j=t),r};return c?ia(f):f}return h=ga.compile=function(a,b){var c,d=[],e=[],f=A[a+" "];if(!f){b||(b=g(a)),c=b.length;while(c--)f=xa(b[c]),f[u]?d.push(f):e.push(f);f=A(a,ya(e,d)),f.selector=a}return f},i=ga.select=function(a,b,e,f){var i,j,k,l,m,n="function"==typeof a&&a,o=!f&&g(a=n.selector||a);if(e=e||[],1===o.length){if(j=o[0]=o[0].slice(0),j.length>2&&"ID"===(k=j[0]).type&&c.getById&&9===b.nodeType&&p&&d.relative[j[1].type]){if(b=(d.find.ID(k.matches[0].replace(ca,da),b)||[])[0],!b)return e;n&&(b=b.parentNode),a=a.slice(j.shift().value.length)}i=X.needsContext.test(a)?0:j.length;while(i--){if(k=j[i],d.relative[l=k.type])break;if((m=d.find[l])&&(f=m(k.matches[0].replace(ca,da),aa.test(j[0].type)&&pa(b.parentNode)||b))){if(j.splice(i,1),a=f.length&&ra(j),!a)return H.apply(e,f),e;break}}}return(n||h(a,o))(f,b,!p,e,aa.test(a)&&pa(b.parentNode)||b),e},c.sortStable=u.split("").sort(B).join("")===u,c.detectDuplicates=!!l,m(),c.sortDetached=ja(function(a){return 1&a.compareDocumentPosition(n.createElement("div"))}),ja(function(a){return a.innerHTML="<a href='#'></a>","#"===a.firstChild.getAttribute("href")})||ka("type|href|height|width",function(a,b,c){return c?void 0:a.getAttribute(b,"type"===b.toLowerCase()?1:2)}),c.attributes&&ja(function(a){return a.innerHTML="<input/>",a.firstChild.setAttribute("value",""),""===a.firstChild.getAttribute("value")})||ka("value",function(a,b,c){return c||"input"!==a.nodeName.toLowerCase()?void 0:a.defaultValue}),ja(function(a){return null==a.getAttribute("disabled")})||ka(K,function(a,b,c){var d;return c?void 0:a[b]===!0?b.toLowerCase():(d=a.getAttributeNode(b))&&d.specified?d.value:null}),ga}(a);m.find=s,m.expr=s.selectors,m.expr[":"]=m.expr.pseudos,m.unique=s.uniqueSort,m.text=s.getText,m.isXMLDoc=s.isXML,m.contains=s.contains;var t=m.expr.match.needsContext,u=/^<(\w+)\s*\/?>(?:<\/\1>|)$/,v=/^.[^:#\[\.,]*$/;function w(a,b,c){if(m.isFunction(b))return m.grep(a,function(a,d){return!!b.call(a,d,a)!==c});if(b.nodeType)return m.grep(a,function(a){return a===b!==c});if("string"==typeof b){if(v.test(b))return m.filter(b,a,c);b=m.filter(b,a)}return m.grep(a,function(a){return m.inArray(a,b)>=0!==c})}m.filter=function(a,b,c){var d=b[0];return c&&(a=":not("+a+")"),1===b.length&&1===d.nodeType?m.find.matchesSelector(d,a)?[d]:[]:m.find.matches(a,m.grep(b,function(a){return 1===a.nodeType}))},m.fn.extend({find:function(a){var b,c=[],d=this,e=d.length;if("string"!=typeof a)return this.pushStack(m(a).filter(function(){for(b=0;e>b;b++)if(m.contains(d[b],this))return!0}));for(b=0;e>b;b++)m.find(a,d[b],c);return c=this.pushStack(e>1?m.unique(c):c),c.selector=this.selector?this.selector+" "+a:a,c},filter:function(a){return this.pushStack(w(this,a||[],!1))},not:function(a){return this.pushStack(w(this,a||[],!0))},is:function(a){return!!w(this,"string"==typeof a&&t.test(a)?m(a):a||[],!1).length}});var x,y=a.document,z=/^(?:\s*(<[\w\W]+>)[^>]*|#([\w-]*))$/,A=m.fn.init=function(a,b){var c,d;if(!a)return this;if("string"==typeof a){if(c="<"===a.charAt(0)&&">"===a.charAt(a.length-1)&&a.length>=3?[null,a,null]:z.exec(a),!c||!c[1]&&b)return!b||b.jquery?(b||x).find(a):this.constructor(b).find(a);if(c[1]){if(b=b instanceof m?b[0]:b,m.merge(this,m.parseHTML(c[1],b&&b.nodeType?b.ownerDocument||b:y,!0)),u.test(c[1])&&m.isPlainObject(b))for(c in b)m.isFunction(this[c])?this[c](b[c]):this.attr(c,b[c]);return this}if(d=y.getElementById(c[2]),d&&d.parentNode){if(d.id!==c[2])return x.find(a);this.length=1,this[0]=d}return this.context=y,this.selector=a,this}return a.nodeType?(this.context=this[0]=a,this.length=1,this):m.isFunction(a)?"undefined"!=typeof x.ready?x.ready(a):a(m):(void 0!==a.selector&&(this.selector=a.selector,this.context=a.context),m.makeArray(a,this))};A.prototype=m.fn,x=m(y);var B=/^(?:parents|prev(?:Until|All))/,C={children:!0,contents:!0,next:!0,prev:!0};m.extend({dir:function(a,b,c){var d=[],e=a[b];while(e&&9!==e.nodeType&&(void 0===c||1!==e.nodeType||!m(e).is(c)))1===e.nodeType&&d.push(e),e=e[b];return d},sibling:function(a,b){for(var c=[];a;a=a.nextSibling)1===a.nodeType&&a!==b&&c.push(a);return c}}),m.fn.extend({has:function(a){var b,c=m(a,this),d=c.length;return this.filter(function(){for(b=0;d>b;b++)if(m.contains(this,c[b]))return!0})},closest:function(a,b){for(var c,d=0,e=this.length,f=[],g=t.test(a)||"string"!=typeof a?m(a,b||this.context):0;e>d;d++)for(c=this[d];c&&c!==b;c=c.parentNode)if(c.nodeType<11&&(g?g.index(c)>-1:1===c.nodeType&&m.find.matchesSelector(c,a))){f.push(c);break}return this.pushStack(f.length>1?m.unique(f):f)},index:function(a){return a?"string"==typeof a?m.inArray(this[0],m(a)):m.inArray(a.jquery?a[0]:a,this):this[0]&&this[0].parentNode?this.first().prevAll().length:-1},add:function(a,b){return this.pushStack(m.unique(m.merge(this.get(),m(a,b))))},addBack:function(a){return this.add(null==a?this.prevObject:this.prevObject.filter(a))}});function D(a,b){do a=a[b];while(a&&1!==a.nodeType);return a}m.each({parent:function(a){var b=a.parentNode;return b&&11!==b.nodeType?b:null},parents:function(a){return m.dir(a,"parentNode")},parentsUntil:function(a,b,c){return m.dir(a,"parentNode",c)},next:function(a){return D(a,"nextSibling")},prev:function(a){return D(a,"previousSibling")},nextAll:function(a){return m.dir(a,"nextSibling")},prevAll:function(a){return m.dir(a,"previousSibling")},nextUntil:function(a,b,c){return m.dir(a,"nextSibling",c)},prevUntil:function(a,b,c){return m.dir(a,"previousSibling",c)},siblings:function(a){return m.sibling((a.parentNode||{}).firstChild,a)},children:function(a){return m.sibling(a.firstChild)},contents:function(a){return m.nodeName(a,"iframe")?a.contentDocument||a.contentWindow.document:m.merge([],a.childNodes)}},function(a,b){m.fn[a]=function(c,d){var e=m.map(this,b,c);return"Until"!==a.slice(-5)&&(d=c),d&&"string"==typeof d&&(e=m.filter(d,e)),this.length>1&&(C[a]||(e=m.unique(e)),B.test(a)&&(e=e.reverse())),this.pushStack(e)}});var E=/\S+/g,F={};function G(a){var b=F[a]={};return m.each(a.match(E)||[],function(a,c){b[c]=!0}),b}m.Callbacks=function(a){a="string"==typeof a?F[a]||G(a):m.extend({},a);var b,c,d,e,f,g,h=[],i=!a.once&&[],j=function(l){for(c=a.memory&&l,d=!0,f=g||0,g=0,e=h.length,b=!0;h&&e>f;f++)if(h[f].apply(l[0],l[1])===!1&&a.stopOnFalse){c=!1;break}b=!1,h&&(i?i.length&&j(i.shift()):c?h=[]:k.disable())},k={add:function(){if(h){var d=h.length;!function f(b){m.each(b,function(b,c){var d=m.type(c);"function"===d?a.unique&&k.has(c)||h.push(c):c&&c.length&&"string"!==d&&f(c)})}(arguments),b?e=h.length:c&&(g=d,j(c))}return this},remove:function(){return h&&m.each(arguments,function(a,c){var d;while((d=m.inArray(c,h,d))>-1)h.splice(d,1),b&&(e>=d&&e--,f>=d&&f--)}),this},has:function(a){return a?m.inArray(a,h)>-1:!(!h||!h.length)},empty:function(){return h=[],e=0,this},disable:function(){return h=i=c=void 0,this},disabled:function(){return!h},lock:function(){return i=void 0,c||k.disable(),this},locked:function(){return!i},fireWith:function(a,c){return!h||d&&!i||(c=c||[],c=[a,c.slice?c.slice():c],b?i.push(c):j(c)),this},fire:function(){return k.fireWith(this,arguments),this},fired:function(){return!!d}};return k},m.extend({Deferred:function(a){var b=[["resolve","done",m.Callbacks("once memory"),"resolved"],["reject","fail",m.Callbacks("once memory"),"rejected"],["notify","progress",m.Callbacks("memory")]],c="pending",d={state:function(){return c},always:function(){return e.done(arguments).fail(arguments),this},then:function(){var a=arguments;return m.Deferred(function(c){m.each(b,function(b,f){var g=m.isFunction(a[b])&&a[b];e[f[1]](function(){var a=g&&g.apply(this,arguments);a&&m.isFunction(a.promise)?a.promise().done(c.resolve).fail(c.reject).progress(c.notify):c[f[0]+"With"](this===d?c.promise():this,g?[a]:arguments)})}),a=null}).promise()},promise:function(a){return null!=a?m.extend(a,d):d}},e={};return d.pipe=d.then,m.each(b,function(a,f){var g=f[2],h=f[3];d[f[1]]=g.add,h&&g.add(function(){c=h},b[1^a][2].disable,b[2][2].lock),e[f[0]]=function(){return e[f[0]+"With"](this===e?d:this,arguments),this},e[f[0]+"With"]=g.fireWith}),d.promise(e),a&&a.call(e,e),e},when:function(a){var b=0,c=d.call(arguments),e=c.length,f=1!==e||a&&m.isFunction(a.promise)?e:0,g=1===f?a:m.Deferred(),h=function(a,b,c){return function(e){b[a]=this,c[a]=arguments.length>1?d.call(arguments):e,c===i?g.notifyWith(b,c):--f||g.resolveWith(b,c)}},i,j,k;if(e>1)for(i=new Array(e),j=new Array(e),k=new Array(e);e>b;b++)c[b]&&m.isFunction(c[b].promise)?c[b].promise().done(h(b,k,c)).fail(g.reject).progress(h(b,j,i)):--f;return f||g.resolveWith(k,c),g.promise()}});var H;m.fn.ready=function(a){return m.ready.promise().done(a),this},m.extend({isReady:!1,readyWait:1,holdReady:function(a){a?m.readyWait++:m.ready(!0)},ready:function(a){if(a===!0?!--m.readyWait:!m.isReady){if(!y.body)return setTimeout(m.ready);m.isReady=!0,a!==!0&&--m.readyWait>0||(H.resolveWith(y,[m]),m.fn.triggerHandler&&(m(y).triggerHandler("ready"),m(y).off("ready")))}}});function I(){y.addEventListener?(y.removeEventListener("DOMContentLoaded",J,!1),a.removeEventListener("load",J,!1)):(y.detachEvent("onreadystatechange",J),a.detachEvent("onload",J))}function J(){(y.addEventListener||"load"===event.type||"complete"===y.readyState)&&(I(),m.ready())}m.ready.promise=function(b){if(!H)if(H=m.Deferred(),"complete"===y.readyState)setTimeout(m.ready);else if(y.addEventListener)y.addEventListener("DOMContentLoaded",J,!1),a.addEventListener("load",J,!1);else{y.attachEvent("onreadystatechange",J),a.attachEvent("onload",J);var c=!1;try{c=null==a.frameElement&&y.documentElement}catch(d){}c&&c.doScroll&&!function e(){if(!m.isReady){try{c.doScroll("left")}catch(a){return setTimeout(e,50)}I(),m.ready()}}()}return H.promise(b)};var K="undefined",L;for(L in m(k))break;k.ownLast="0"!==L,k.inlineBlockNeedsLayout=!1,m(function(){var a,b,c,d;c=y.getElementsByTagName("body")[0],c&&c.style&&(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),typeof b.style.zoom!==K&&(b.style.cssText="display:inline;margin:0;border:0;padding:1px;width:1px;zoom:1",k.inlineBlockNeedsLayout=a=3===b.offsetWidth,a&&(c.style.zoom=1)),c.removeChild(d))}),function(){var a=y.createElement("div");if(null==k.deleteExpando){k.deleteExpando=!0;try{delete a.test}catch(b){k.deleteExpando=!1}}a=null}(),m.acceptData=function(a){var b=m.noData[(a.nodeName+" ").toLowerCase()],c=+a.nodeType||1;return 1!==c&&9!==c?!1:!b||b!==!0&&a.getAttribute("classid")===b};var M=/^(?:\{[\w\W]*\}|\[[\w\W]*\])$/,N=/([A-Z])/g;function O(a,b,c){if(void 0===c&&1===a.nodeType){var d="data-"+b.replace(N,"-$1").toLowerCase();if(c=a.getAttribute(d),"string"==typeof c){try{c="true"===c?!0:"false"===c?!1:"null"===c?null:+c+""===c?+c:M.test(c)?m.parseJSON(c):c}catch(e){}m.data(a,b,c)}else c=void 0}return c}function P(a){var b;for(b in a)if(("data"!==b||!m.isEmptyObject(a[b]))&&"toJSON"!==b)return!1;

return!0}function Q(a,b,d,e){if(m.acceptData(a)){var f,g,h=m.expando,i=a.nodeType,j=i?m.cache:a,k=i?a[h]:a[h]&&h;if(k&&j[k]&&(e||j[k].data)||void 0!==d||"string"!=typeof b)return k||(k=i?a[h]=c.pop()||m.guid++:h),j[k]||(j[k]=i?{}:{toJSON:m.noop}),("object"==typeof b||"function"==typeof b)&&(e?j[k]=m.extend(j[k],b):j[k].data=m.extend(j[k].data,b)),g=j[k],e||(g.data||(g.data={}),g=g.data),void 0!==d&&(g[m.camelCase(b)]=d),"string"==typeof b?(f=g[b],null==f&&(f=g[m.camelCase(b)])):f=g,f}}function R(a,b,c){if(m.acceptData(a)){var d,e,f=a.nodeType,g=f?m.cache:a,h=f?a[m.expando]:m.expando;if(g[h]){if(b&&(d=c?g[h]:g[h].data)){m.isArray(b)?b=b.concat(m.map(b,m.camelCase)):b in d?b=[b]:(b=m.camelCase(b),b=b in d?[b]:b.split(" ")),e=b.length;while(e--)delete d[b[e]];if(c?!P(d):!m.isEmptyObject(d))return}(c||(delete g[h].data,P(g[h])))&&(f?m.cleanData([a],!0):k.deleteExpando||g!=g.window?delete g[h]:g[h]=null)}}}m.extend({cache:{},noData:{"applet ":!0,"embed ":!0,"object ":"clsid:D27CDB6E-AE6D-11cf-96B8-444553540000"},hasData:function(a){return a=a.nodeType?m.cache[a[m.expando]]:a[m.expando],!!a&&!P(a)},data:function(a,b,c){return Q(a,b,c)},removeData:function(a,b){return R(a,b)},_data:function(a,b,c){return Q(a,b,c,!0)},_removeData:function(a,b){return R(a,b,!0)}}),m.fn.extend({data:function(a,b){var c,d,e,f=this[0],g=f&&f.attributes;if(void 0===a){if(this.length&&(e=m.data(f),1===f.nodeType&&!m._data(f,"parsedAttrs"))){c=g.length;while(c--)g[c]&&(d=g[c].name,0===d.indexOf("data-")&&(d=m.camelCase(d.slice(5)),O(f,d,e[d])));m._data(f,"parsedAttrs",!0)}return e}return"object"==typeof a?this.each(function(){m.data(this,a)}):arguments.length>1?this.each(function(){m.data(this,a,b)}):f?O(f,a,m.data(f,a)):void 0},removeData:function(a){return this.each(function(){m.removeData(this,a)})}}),m.extend({queue:function(a,b,c){var d;return a?(b=(b||"fx")+"queue",d=m._data(a,b),c&&(!d||m.isArray(c)?d=m._data(a,b,m.makeArray(c)):d.push(c)),d||[]):void 0},dequeue:function(a,b){b=b||"fx";var c=m.queue(a,b),d=c.length,e=c.shift(),f=m._queueHooks(a,b),g=function(){m.dequeue(a,b)};"inprogress"===e&&(e=c.shift(),d--),e&&("fx"===b&&c.unshift("inprogress"),delete f.stop,e.call(a,g,f)),!d&&f&&f.empty.fire()},_queueHooks:function(a,b){var c=b+"queueHooks";return m._data(a,c)||m._data(a,c,{empty:m.Callbacks("once memory").add(function(){m._removeData(a,b+"queue"),m._removeData(a,c)})})}}),m.fn.extend({queue:function(a,b){var c=2;return"string"!=typeof a&&(b=a,a="fx",c--),arguments.length<c?m.queue(this[0],a):void 0===b?this:this.each(function(){var c=m.queue(this,a,b);m._queueHooks(this,a),"fx"===a&&"inprogress"!==c[0]&&m.dequeue(this,a)})},dequeue:function(a){return this.each(function(){m.dequeue(this,a)})},clearQueue:function(a){return this.queue(a||"fx",[])},promise:function(a,b){var c,d=1,e=m.Deferred(),f=this,g=this.length,h=function(){--d||e.resolveWith(f,[f])};"string"!=typeof a&&(b=a,a=void 0),a=a||"fx";while(g--)c=m._data(f[g],a+"queueHooks"),c&&c.empty&&(d++,c.empty.add(h));return h(),e.promise(b)}});var S=/[+-]?(?:\d*\.|)\d+(?:[eE][+-]?\d+|)/.source,T=["Top","Right","Bottom","Left"],U=function(a,b){return a=b||a,"none"===m.css(a,"display")||!m.contains(a.ownerDocument,a)},V=m.access=function(a,b,c,d,e,f,g){var h=0,i=a.length,j=null==c;if("object"===m.type(c)){e=!0;for(h in c)m.access(a,b,h,c[h],!0,f,g)}else if(void 0!==d&&(e=!0,m.isFunction(d)||(g=!0),j&&(g?(b.call(a,d),b=null):(j=b,b=function(a,b,c){return j.call(m(a),c)})),b))for(;i>h;h++)b(a[h],c,g?d:d.call(a[h],h,b(a[h],c)));return e?a:j?b.call(a):i?b(a[0],c):f},W=/^(?:checkbox|radio)$/i;!function(){var a=y.createElement("input"),b=y.createElement("div"),c=y.createDocumentFragment();if(b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",k.leadingWhitespace=3===b.firstChild.nodeType,k.tbody=!b.getElementsByTagName("tbody").length,k.htmlSerialize=!!b.getElementsByTagName("link").length,k.html5Clone="<:nav></:nav>"!==y.createElement("nav").cloneNode(!0).outerHTML,a.type="checkbox",a.checked=!0,c.appendChild(a),k.appendChecked=a.checked,b.innerHTML="<textarea>x</textarea>",k.noCloneChecked=!!b.cloneNode(!0).lastChild.defaultValue,c.appendChild(b),b.innerHTML="<input type='radio' checked='checked' name='t'/>",k.checkClone=b.cloneNode(!0).cloneNode(!0).lastChild.checked,k.noCloneEvent=!0,b.attachEvent&&(b.attachEvent("onclick",function(){k.noCloneEvent=!1}),b.cloneNode(!0).click()),null==k.deleteExpando){k.deleteExpando=!0;try{delete b.test}catch(d){k.deleteExpando=!1}}}(),function(){var b,c,d=y.createElement("div");for(b in{submit:!0,change:!0,focusin:!0})c="on"+b,(k[b+"Bubbles"]=c in a)||(d.setAttribute(c,"t"),k[b+"Bubbles"]=d.attributes[c].expando===!1);d=null}();var X=/^(?:input|select|textarea)$/i,Y=/^key/,Z=/^(?:mouse|pointer|contextmenu)|click/,$=/^(?:focusinfocus|focusoutblur)$/,_=/^([^.]*)(?:\.(.+)|)$/;function aa(){return!0}function ba(){return!1}function ca(){try{return y.activeElement}catch(a){}}m.event={global:{},add:function(a,b,c,d,e){var f,g,h,i,j,k,l,n,o,p,q,r=m._data(a);if(r){c.handler&&(i=c,c=i.handler,e=i.selector),c.guid||(c.guid=m.guid++),(g=r.events)||(g=r.events={}),(k=r.handle)||(k=r.handle=function(a){return typeof m===K||a&&m.event.triggered===a.type?void 0:m.event.dispatch.apply(k.elem,arguments)},k.elem=a),b=(b||"").match(E)||[""],h=b.length;while(h--)f=_.exec(b[h])||[],o=q=f[1],p=(f[2]||"").split(".").sort(),o&&(j=m.event.special[o]||{},o=(e?j.delegateType:j.bindType)||o,j=m.event.special[o]||{},l=m.extend({type:o,origType:q,data:d,handler:c,guid:c.guid,selector:e,needsContext:e&&m.expr.match.needsContext.test(e),namespace:p.join(".")},i),(n=g[o])||(n=g[o]=[],n.delegateCount=0,j.setup&&j.setup.call(a,d,p,k)!==!1||(a.addEventListener?a.addEventListener(o,k,!1):a.attachEvent&&a.attachEvent("on"+o,k))),j.add&&(j.add.call(a,l),l.handler.guid||(l.handler.guid=c.guid)),e?n.splice(n.delegateCount++,0,l):n.push(l),m.event.global[o]=!0);a=null}},remove:function(a,b,c,d,e){var f,g,h,i,j,k,l,n,o,p,q,r=m.hasData(a)&&m._data(a);if(r&&(k=r.events)){b=(b||"").match(E)||[""],j=b.length;while(j--)if(h=_.exec(b[j])||[],o=q=h[1],p=(h[2]||"").split(".").sort(),o){l=m.event.special[o]||{},o=(d?l.delegateType:l.bindType)||o,n=k[o]||[],h=h[2]&&new RegExp("(^|\\.)"+p.join("\\.(?:.*\\.|)")+"(\\.|$)"),i=f=n.length;while(f--)g=n[f],!e&&q!==g.origType||c&&c.guid!==g.guid||h&&!h.test(g.namespace)||d&&d!==g.selector&&("**"!==d||!g.selector)||(n.splice(f,1),g.selector&&n.delegateCount--,l.remove&&l.remove.call(a,g));i&&!n.length&&(l.teardown&&l.teardown.call(a,p,r.handle)!==!1||m.removeEvent(a,o,r.handle),delete k[o])}else for(o in k)m.event.remove(a,o+b[j],c,d,!0);m.isEmptyObject(k)&&(delete r.handle,m._removeData(a,"events"))}},trigger:function(b,c,d,e){var f,g,h,i,k,l,n,o=[d||y],p=j.call(b,"type")?b.type:b,q=j.call(b,"namespace")?b.namespace.split("."):[];if(h=l=d=d||y,3!==d.nodeType&&8!==d.nodeType&&!$.test(p+m.event.triggered)&&(p.indexOf(".")>=0&&(q=p.split("."),p=q.shift(),q.sort()),g=p.indexOf(":")<0&&"on"+p,b=b[m.expando]?b:new m.Event(p,"object"==typeof b&&b),b.isTrigger=e?2:3,b.namespace=q.join("."),b.namespace_re=b.namespace?new RegExp("(^|\\.)"+q.join("\\.(?:.*\\.|)")+"(\\.|$)"):null,b.result=void 0,b.target||(b.target=d),c=null==c?[b]:m.makeArray(c,[b]),k=m.event.special[p]||{},e||!k.trigger||k.trigger.apply(d,c)!==!1)){if(!e&&!k.noBubble&&!m.isWindow(d)){for(i=k.delegateType||p,$.test(i+p)||(h=h.parentNode);h;h=h.parentNode)o.push(h),l=h;l===(d.ownerDocument||y)&&o.push(l.defaultView||l.parentWindow||a)}n=0;while((h=o[n++])&&!b.isPropagationStopped())b.type=n>1?i:k.bindType||p,f=(m._data(h,"events")||{})[b.type]&&m._data(h,"handle"),f&&f.apply(h,c),f=g&&h[g],f&&f.apply&&m.acceptData(h)&&(b.result=f.apply(h,c),b.result===!1&&b.preventDefault());if(b.type=p,!e&&!b.isDefaultPrevented()&&(!k._default||k._default.apply(o.pop(),c)===!1)&&m.acceptData(d)&&g&&d[p]&&!m.isWindow(d)){l=d[g],l&&(d[g]=null),m.event.triggered=p;try{d[p]()}catch(r){}m.event.triggered=void 0,l&&(d[g]=l)}return b.result}},dispatch:function(a){a=m.event.fix(a);var b,c,e,f,g,h=[],i=d.call(arguments),j=(m._data(this,"events")||{})[a.type]||[],k=m.event.special[a.type]||{};if(i[0]=a,a.delegateTarget=this,!k.preDispatch||k.preDispatch.call(this,a)!==!1){h=m.event.handlers.call(this,a,j),b=0;while((f=h[b++])&&!a.isPropagationStopped()){a.currentTarget=f.elem,g=0;while((e=f.handlers[g++])&&!a.isImmediatePropagationStopped())(!a.namespace_re||a.namespace_re.test(e.namespace))&&(a.handleObj=e,a.data=e.data,c=((m.event.special[e.origType]||{}).handle||e.handler).apply(f.elem,i),void 0!==c&&(a.result=c)===!1&&(a.preventDefault(),a.stopPropagation()))}return k.postDispatch&&k.postDispatch.call(this,a),a.result}},handlers:function(a,b){var c,d,e,f,g=[],h=b.delegateCount,i=a.target;if(h&&i.nodeType&&(!a.button||"click"!==a.type))for(;i!=this;i=i.parentNode||this)if(1===i.nodeType&&(i.disabled!==!0||"click"!==a.type)){for(e=[],f=0;h>f;f++)d=b[f],c=d.selector+" ",void 0===e[c]&&(e[c]=d.needsContext?m(c,this).index(i)>=0:m.find(c,this,null,[i]).length),e[c]&&e.push(d);e.length&&g.push({elem:i,handlers:e})}return h<b.length&&g.push({elem:this,handlers:b.slice(h)}),g},fix:function(a){if(a[m.expando])return a;var b,c,d,e=a.type,f=a,g=this.fixHooks[e];g||(this.fixHooks[e]=g=Z.test(e)?this.mouseHooks:Y.test(e)?this.keyHooks:{}),d=g.props?this.props.concat(g.props):this.props,a=new m.Event(f),b=d.length;while(b--)c=d[b],a[c]=f[c];return a.target||(a.target=f.srcElement||y),3===a.target.nodeType&&(a.target=a.target.parentNode),a.metaKey=!!a.metaKey,g.filter?g.filter(a,f):a},props:"altKey bubbles cancelable ctrlKey currentTarget eventPhase metaKey relatedTarget shiftKey target timeStamp view which".split(" "),fixHooks:{},keyHooks:{props:"char charCode key keyCode".split(" "),filter:function(a,b){return null==a.which&&(a.which=null!=b.charCode?b.charCode:b.keyCode),a}},mouseHooks:{props:"button buttons clientX clientY fromElement offsetX offsetY pageX pageY screenX screenY toElement".split(" "),filter:function(a,b){var c,d,e,f=b.button,g=b.fromElement;return null==a.pageX&&null!=b.clientX&&(d=a.target.ownerDocument||y,e=d.documentElement,c=d.body,a.pageX=b.clientX+(e&&e.scrollLeft||c&&c.scrollLeft||0)-(e&&e.clientLeft||c&&c.clientLeft||0),a.pageY=b.clientY+(e&&e.scrollTop||c&&c.scrollTop||0)-(e&&e.clientTop||c&&c.clientTop||0)),!a.relatedTarget&&g&&(a.relatedTarget=g===a.target?b.toElement:g),a.which||void 0===f||(a.which=1&f?1:2&f?3:4&f?2:0),a}},special:{load:{noBubble:!0},focus:{trigger:function(){if(this!==ca()&&this.focus)try{return this.focus(),!1}catch(a){}},delegateType:"focusin"},blur:{trigger:function(){return this===ca()&&this.blur?(this.blur(),!1):void 0},delegateType:"focusout"},click:{trigger:function(){return m.nodeName(this,"input")&&"checkbox"===this.type&&this.click?(this.click(),!1):void 0},_default:function(a){return m.nodeName(a.target,"a")}},beforeunload:{postDispatch:function(a){void 0!==a.result&&a.originalEvent&&(a.originalEvent.returnValue=a.result)}}},simulate:function(a,b,c,d){var e=m.extend(new m.Event,c,{type:a,isSimulated:!0,originalEvent:{}});d?m.event.trigger(e,null,b):m.event.dispatch.call(b,e),e.isDefaultPrevented()&&c.preventDefault()}},m.removeEvent=y.removeEventListener?function(a,b,c){a.removeEventListener&&a.removeEventListener(b,c,!1)}:function(a,b,c){var d="on"+b;a.detachEvent&&(typeof a[d]===K&&(a[d]=null),a.detachEvent(d,c))},m.Event=function(a,b){return this instanceof m.Event?(a&&a.type?(this.originalEvent=a,this.type=a.type,this.isDefaultPrevented=a.defaultPrevented||void 0===a.defaultPrevented&&a.returnValue===!1?aa:ba):this.type=a,b&&m.extend(this,b),this.timeStamp=a&&a.timeStamp||m.now(),void(this[m.expando]=!0)):new m.Event(a,b)},m.Event.prototype={isDefaultPrevented:ba,isPropagationStopped:ba,isImmediatePropagationStopped:ba,preventDefault:function(){var a=this.originalEvent;this.isDefaultPrevented=aa,a&&(a.preventDefault?a.preventDefault():a.returnValue=!1)},stopPropagation:function(){var a=this.originalEvent;this.isPropagationStopped=aa,a&&(a.stopPropagation&&a.stopPropagation(),a.cancelBubble=!0)},stopImmediatePropagation:function(){var a=this.originalEvent;this.isImmediatePropagationStopped=aa,a&&a.stopImmediatePropagation&&a.stopImmediatePropagation(),this.stopPropagation()}},m.each({mouseenter:"mouseover",mouseleave:"mouseout",pointerenter:"pointerover",pointerleave:"pointerout"},function(a,b){m.event.special[a]={delegateType:b,bindType:b,handle:function(a){var c,d=this,e=a.relatedTarget,f=a.handleObj;return(!e||e!==d&&!m.contains(d,e))&&(a.type=f.origType,c=f.handler.apply(this,arguments),a.type=b),c}}}),k.submitBubbles||(m.event.special.submit={setup:function(){return m.nodeName(this,"form")?!1:void m.event.add(this,"click._submit keypress._submit",function(a){var b=a.target,c=m.nodeName(b,"input")||m.nodeName(b,"button")?b.form:void 0;c&&!m._data(c,"submitBubbles")&&(m.event.add(c,"submit._submit",function(a){a._submit_bubble=!0}),m._data(c,"submitBubbles",!0))})},postDispatch:function(a){a._submit_bubble&&(delete a._submit_bubble,this.parentNode&&!a.isTrigger&&m.event.simulate("submit",this.parentNode,a,!0))},teardown:function(){return m.nodeName(this,"form")?!1:void m.event.remove(this,"._submit")}}),k.changeBubbles||(m.event.special.change={setup:function(){return X.test(this.nodeName)?(("checkbox"===this.type||"radio"===this.type)&&(m.event.add(this,"propertychange._change",function(a){"checked"===a.originalEvent.propertyName&&(this._just_changed=!0)}),m.event.add(this,"click._change",function(a){this._just_changed&&!a.isTrigger&&(this._just_changed=!1),m.event.simulate("change",this,a,!0)})),!1):void m.event.add(this,"beforeactivate._change",function(a){var b=a.target;X.test(b.nodeName)&&!m._data(b,"changeBubbles")&&(m.event.add(b,"change._change",function(a){!this.parentNode||a.isSimulated||a.isTrigger||m.event.simulate("change",this.parentNode,a,!0)}),m._data(b,"changeBubbles",!0))})},handle:function(a){var b=a.target;return this!==b||a.isSimulated||a.isTrigger||"radio"!==b.type&&"checkbox"!==b.type?a.handleObj.handler.apply(this,arguments):void 0},teardown:function(){return m.event.remove(this,"._change"),!X.test(this.nodeName)}}),k.focusinBubbles||m.each({focus:"focusin",blur:"focusout"},function(a,b){var c=function(a){m.event.simulate(b,a.target,m.event.fix(a),!0)};m.event.special[b]={setup:function(){var d=this.ownerDocument||this,e=m._data(d,b);e||d.addEventListener(a,c,!0),m._data(d,b,(e||0)+1)},teardown:function(){var d=this.ownerDocument||this,e=m._data(d,b)-1;e?m._data(d,b,e):(d.removeEventListener(a,c,!0),m._removeData(d,b))}}}),m.fn.extend({on:function(a,b,c,d,e){var f,g;if("object"==typeof a){"string"!=typeof b&&(c=c||b,b=void 0);for(f in a)this.on(f,b,c,a[f],e);return this}if(null==c&&null==d?(d=b,c=b=void 0):null==d&&("string"==typeof b?(d=c,c=void 0):(d=c,c=b,b=void 0)),d===!1)d=ba;else if(!d)return this;return 1===e&&(g=d,d=function(a){return m().off(a),g.apply(this,arguments)},d.guid=g.guid||(g.guid=m.guid++)),this.each(function(){m.event.add(this,a,d,c,b)})},one:function(a,b,c,d){return this.on(a,b,c,d,1)},off:function(a,b,c){var d,e;if(a&&a.preventDefault&&a.handleObj)return d=a.handleObj,m(a.delegateTarget).off(d.namespace?d.origType+"."+d.namespace:d.origType,d.selector,d.handler),this;if("object"==typeof a){for(e in a)this.off(e,b,a[e]);return this}return(b===!1||"function"==typeof b)&&(c=b,b=void 0),c===!1&&(c=ba),this.each(function(){m.event.remove(this,a,c,b)})},trigger:function(a,b){return this.each(function(){m.event.trigger(a,b,this)})},triggerHandler:function(a,b){var c=this[0];return c?m.event.trigger(a,b,c,!0):void 0}});function da(a){var b=ea.split("|"),c=a.createDocumentFragment();if(c.createElement)while(b.length)c.createElement(b.pop());return c}var ea="abbr|article|aside|audio|bdi|canvas|data|datalist|details|figcaption|figure|footer|header|hgroup|mark|meter|nav|output|progress|section|summary|time|video",fa=/ jQuery\d+="(?:null|\d+)"/g,ga=new RegExp("<(?:"+ea+")[\\s/>]","i"),ha=/^\s+/,ia=/<(?!area|br|col|embed|hr|img|input|link|meta|param)(([\w:]+)[^>]*)\/>/gi,ja=/<([\w:]+)/,ka=/<tbody/i,la=/<|&#?\w+;/,ma=/<(?:script|style|link)/i,na=/checked\s*(?:[^=]|=\s*.checked.)/i,oa=/^$|\/(?:java|ecma)script/i,pa=/^true\/(.*)/,qa=/^\s*<!(?:\[CDATA\[|--)|(?:\]\]|--)>\s*$/g,ra={option:[1,"<select multiple='multiple'>","</select>"],legend:[1,"<fieldset>","</fieldset>"],area:[1,"<map>","</map>"],param:[1,"<object>","</object>"],thead:[1,"<table>","</table>"],tr:[2,"<table><tbody>","</tbody></table>"],col:[2,"<table><tbody></tbody><colgroup>","</colgroup></table>"],td:[3,"<table><tbody><tr>","</tr></tbody></table>"],_default:k.htmlSerialize?[0,"",""]:[1,"X<div>","</div>"]},sa=da(y),ta=sa.appendChild(y.createElement("div"));ra.optgroup=ra.option,ra.tbody=ra.tfoot=ra.colgroup=ra.caption=ra.thead,ra.th=ra.td;function ua(a,b){var c,d,e=0,f=typeof a.getElementsByTagName!==K?a.getElementsByTagName(b||"*"):typeof a.querySelectorAll!==K?a.querySelectorAll(b||"*"):void 0;if(!f)for(f=[],c=a.childNodes||a;null!=(d=c[e]);e++)!b||m.nodeName(d,b)?f.push(d):m.merge(f,ua(d,b));return void 0===b||b&&m.nodeName(a,b)?m.merge([a],f):f}function va(a){W.test(a.type)&&(a.defaultChecked=a.checked)}function wa(a,b){return m.nodeName(a,"table")&&m.nodeName(11!==b.nodeType?b:b.firstChild,"tr")?a.getElementsByTagName("tbody")[0]||a.appendChild(a.ownerDocument.createElement("tbody")):a}function xa(a){return a.type=(null!==m.find.attr(a,"type"))+"/"+a.type,a}function ya(a){var b=pa.exec(a.type);return b?a.type=b[1]:a.removeAttribute("type"),a}function za(a,b){for(var c,d=0;null!=(c=a[d]);d++)m._data(c,"globalEval",!b||m._data(b[d],"globalEval"))}function Aa(a,b){if(1===b.nodeType&&m.hasData(a)){var c,d,e,f=m._data(a),g=m._data(b,f),h=f.events;if(h){delete g.handle,g.events={};for(c in h)for(d=0,e=h[c].length;e>d;d++)m.event.add(b,c,h[c][d])}g.data&&(g.data=m.extend({},g.data))}}function Ba(a,b){var c,d,e;if(1===b.nodeType){if(c=b.nodeName.toLowerCase(),!k.noCloneEvent&&b[m.expando]){e=m._data(b);for(d in e.events)m.removeEvent(b,d,e.handle);b.removeAttribute(m.expando)}"script"===c&&b.text!==a.text?(xa(b).text=a.text,ya(b)):"object"===c?(b.parentNode&&(b.outerHTML=a.outerHTML),k.html5Clone&&a.innerHTML&&!m.trim(b.innerHTML)&&(b.innerHTML=a.innerHTML)):"input"===c&&W.test(a.type)?(b.defaultChecked=b.checked=a.checked,b.value!==a.value&&(b.value=a.value)):"option"===c?b.defaultSelected=b.selected=a.defaultSelected:("input"===c||"textarea"===c)&&(b.defaultValue=a.defaultValue)}}m.extend({clone:function(a,b,c){var d,e,f,g,h,i=m.contains(a.ownerDocument,a);if(k.html5Clone||m.isXMLDoc(a)||!ga.test("<"+a.nodeName+">")?f=a.cloneNode(!0):(ta.innerHTML=a.outerHTML,ta.removeChild(f=ta.firstChild)),!(k.noCloneEvent&&k.noCloneChecked||1!==a.nodeType&&11!==a.nodeType||m.isXMLDoc(a)))for(d=ua(f),h=ua(a),g=0;null!=(e=h[g]);++g)d[g]&&Ba(e,d[g]);if(b)if(c)for(h=h||ua(a),d=d||ua(f),g=0;null!=(e=h[g]);g++)Aa(e,d[g]);else Aa(a,f);return d=ua(f,"script"),d.length>0&&za(d,!i&&ua(a,"script")),d=h=e=null,f},buildFragment:function(a,b,c,d){for(var e,f,g,h,i,j,l,n=a.length,o=da(b),p=[],q=0;n>q;q++)if(f=a[q],f||0===f)if("object"===m.type(f))m.merge(p,f.nodeType?[f]:f);else if(la.test(f)){h=h||o.appendChild(b.createElement("div")),i=(ja.exec(f)||["",""])[1].toLowerCase(),l=ra[i]||ra._default,h.innerHTML=l[1]+f.replace(ia,"<$1></$2>")+l[2],e=l[0];while(e--)h=h.lastChild;if(!k.leadingWhitespace&&ha.test(f)&&p.push(b.createTextNode(ha.exec(f)[0])),!k.tbody){f="table"!==i||ka.test(f)?"<table>"!==l[1]||ka.test(f)?0:h:h.firstChild,e=f&&f.childNodes.length;while(e--)m.nodeName(j=f.childNodes[e],"tbody")&&!j.childNodes.length&&f.removeChild(j)}m.merge(p,h.childNodes),h.textContent="";while(h.firstChild)h.removeChild(h.firstChild);h=o.lastChild}else p.push(b.createTextNode(f));h&&o.removeChild(h),k.appendChecked||m.grep(ua(p,"input"),va),q=0;while(f=p[q++])if((!d||-1===m.inArray(f,d))&&(g=m.contains(f.ownerDocument,f),h=ua(o.appendChild(f),"script"),g&&za(h),c)){e=0;while(f=h[e++])oa.test(f.type||"")&&c.push(f)}return h=null,o},cleanData:function(a,b){for(var d,e,f,g,h=0,i=m.expando,j=m.cache,l=k.deleteExpando,n=m.event.special;null!=(d=a[h]);h++)if((b||m.acceptData(d))&&(f=d[i],g=f&&j[f])){if(g.events)for(e in g.events)n[e]?m.event.remove(d,e):m.removeEvent(d,e,g.handle);j[f]&&(delete j[f],l?delete d[i]:typeof d.removeAttribute!==K?d.removeAttribute(i):d[i]=null,c.push(f))}}}),m.fn.extend({text:function(a){return V(this,function(a){return void 0===a?m.text(this):this.empty().append((this[0]&&this[0].ownerDocument||y).createTextNode(a))},null,a,arguments.length)},append:function(){return this.domManip(arguments,function(a){if(1===this.nodeType||11===this.nodeType||9===this.nodeType){var b=wa(this,a);b.appendChild(a)}})},prepend:function(){return this.domManip(arguments,function(a){if(1===this.nodeType||11===this.nodeType||9===this.nodeType){var b=wa(this,a);b.insertBefore(a,b.firstChild)}})},before:function(){return this.domManip(arguments,function(a){this.parentNode&&this.parentNode.insertBefore(a,this)})},after:function(){return this.domManip(arguments,function(a){this.parentNode&&this.parentNode.insertBefore(a,this.nextSibling)})},remove:function(a,b){for(var c,d=a?m.filter(a,this):this,e=0;null!=(c=d[e]);e++)b||1!==c.nodeType||m.cleanData(ua(c)),c.parentNode&&(b&&m.contains(c.ownerDocument,c)&&za(ua(c,"script")),c.parentNode.removeChild(c));return this},empty:function(){for(var a,b=0;null!=(a=this[b]);b++){1===a.nodeType&&m.cleanData(ua(a,!1));while(a.firstChild)a.removeChild(a.firstChild);a.options&&m.nodeName(a,"select")&&(a.options.length=0)}return this},clone:function(a,b){return a=null==a?!1:a,b=null==b?a:b,this.map(function(){return m.clone(this,a,b)})},html:function(a){return V(this,function(a){var b=this[0]||{},c=0,d=this.length;if(void 0===a)return 1===b.nodeType?b.innerHTML.replace(fa,""):void 0;if(!("string"!=typeof a||ma.test(a)||!k.htmlSerialize&&ga.test(a)||!k.leadingWhitespace&&ha.test(a)||ra[(ja.exec(a)||["",""])[1].toLowerCase()])){a=a.replace(ia,"<$1></$2>");try{for(;d>c;c++)b=this[c]||{},1===b.nodeType&&(m.cleanData(ua(b,!1)),b.innerHTML=a);b=0}catch(e){}}b&&this.empty().append(a)},null,a,arguments.length)},replaceWith:function(){var a=arguments[0];return this.domManip(arguments,function(b){a=this.parentNode,m.cleanData(ua(this)),a&&a.replaceChild(b,this)}),a&&(a.length||a.nodeType)?this:this.remove()},detach:function(a){return this.remove(a,!0)},domManip:function(a,b){a=e.apply([],a);var c,d,f,g,h,i,j=0,l=this.length,n=this,o=l-1,p=a[0],q=m.isFunction(p);if(q||l>1&&"string"==typeof p&&!k.checkClone&&na.test(p))return this.each(function(c){var d=n.eq(c);q&&(a[0]=p.call(this,c,d.html())),d.domManip(a,b)});if(l&&(i=m.buildFragment(a,this[0].ownerDocument,!1,this),c=i.firstChild,1===i.childNodes.length&&(i=c),c)){for(g=m.map(ua(i,"script"),xa),f=g.length;l>j;j++)d=i,j!==o&&(d=m.clone(d,!0,!0),f&&m.merge(g,ua(d,"script"))),b.call(this[j],d,j);if(f)for(h=g[g.length-1].ownerDocument,m.map(g,ya),j=0;f>j;j++)d=g[j],oa.test(d.type||"")&&!m._data(d,"globalEval")&&m.contains(h,d)&&(d.src?m._evalUrl&&m._evalUrl(d.src):m.globalEval((d.text||d.textContent||d.innerHTML||"").replace(qa,"")));i=c=null}return this}}),m.each({appendTo:"append",prependTo:"prepend",insertBefore:"before",insertAfter:"after",replaceAll:"replaceWith"},function(a,b){m.fn[a]=function(a){for(var c,d=0,e=[],g=m(a),h=g.length-1;h>=d;d++)c=d===h?this:this.clone(!0),m(g[d])[b](c),f.apply(e,c.get());return this.pushStack(e)}});var Ca,Da={};function Ea(b,c){var d,e=m(c.createElement(b)).appendTo(c.body),f=a.getDefaultComputedStyle&&(d=a.getDefaultComputedStyle(e[0]))?d.display:m.css(e[0],"display");return e.detach(),f}function Fa(a){var b=y,c=Da[a];return c||(c=Ea(a,b),"none"!==c&&c||(Ca=(Ca||m("<iframe frameborder='0' width='0' height='0'/>")).appendTo(b.documentElement),b=(Ca[0].contentWindow||Ca[0].contentDocument).document,b.write(),b.close(),c=Ea(a,b),Ca.detach()),Da[a]=c),c}!function(){var a;k.shrinkWrapBlocks=function(){if(null!=a)return a;a=!1;var b,c,d;return c=y.getElementsByTagName("body")[0],c&&c.style?(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),typeof b.style.zoom!==K&&(b.style.cssText="-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;display:block;margin:0;border:0;padding:1px;width:1px;zoom:1",b.appendChild(y.createElement("div")).style.width="5px",a=3!==b.offsetWidth),c.removeChild(d),a):void 0}}();var Ga=/^margin/,Ha=new RegExp("^("+S+")(?!px)[a-z%]+$","i"),Ia,Ja,Ka=/^(top|right|bottom|left)$/;a.getComputedStyle?(Ia=function(b){return b.ownerDocument.defaultView.opener?b.ownerDocument.defaultView.getComputedStyle(b,null):a.getComputedStyle(b,null)},Ja=function(a,b,c){var d,e,f,g,h=a.style;return c=c||Ia(a),g=c?c.getPropertyValue(b)||c[b]:void 0,c&&(""!==g||m.contains(a.ownerDocument,a)||(g=m.style(a,b)),Ha.test(g)&&Ga.test(b)&&(d=h.width,e=h.minWidth,f=h.maxWidth,h.minWidth=h.maxWidth=h.width=g,g=c.width,h.width=d,h.minWidth=e,h.maxWidth=f)),void 0===g?g:g+""}):y.documentElement.currentStyle&&(Ia=function(a){return a.currentStyle},Ja=function(a,b,c){var d,e,f,g,h=a.style;return c=c||Ia(a),g=c?c[b]:void 0,null==g&&h&&h[b]&&(g=h[b]),Ha.test(g)&&!Ka.test(b)&&(d=h.left,e=a.runtimeStyle,f=e&&e.left,f&&(e.left=a.currentStyle.left),h.left="fontSize"===b?"1em":g,g=h.pixelLeft+"px",h.left=d,f&&(e.left=f)),void 0===g?g:g+""||"auto"});function La(a,b){return{get:function(){var c=a();if(null!=c)return c?void delete this.get:(this.get=b).apply(this,arguments)}}}!function(){var b,c,d,e,f,g,h;if(b=y.createElement("div"),b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",d=b.getElementsByTagName("a")[0],c=d&&d.style){c.cssText="float:left;opacity:.5",k.opacity="0.5"===c.opacity,k.cssFloat=!!c.cssFloat,b.style.backgroundClip="content-box",b.cloneNode(!0).style.backgroundClip="",k.clearCloneStyle="content-box"===b.style.backgroundClip,k.boxSizing=""===c.boxSizing||""===c.MozBoxSizing||""===c.WebkitBoxSizing,m.extend(k,{reliableHiddenOffsets:function(){return null==g&&i(),g},boxSizingReliable:function(){return null==f&&i(),f},pixelPosition:function(){return null==e&&i(),e},reliableMarginRight:function(){return null==h&&i(),h}});function i(){var b,c,d,i;c=y.getElementsByTagName("body")[0],c&&c.style&&(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),b.style.cssText="-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box;display:block;margin-top:1%;top:1%;border:1px;padding:1px;width:4px;position:absolute",e=f=!1,h=!0,a.getComputedStyle&&(e="1%"!==(a.getComputedStyle(b,null)||{}).top,f="4px"===(a.getComputedStyle(b,null)||{width:"4px"}).width,i=b.appendChild(y.createElement("div")),i.style.cssText=b.style.cssText="-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;display:block;margin:0;border:0;padding:0",i.style.marginRight=i.style.width="0",b.style.width="1px",h=!parseFloat((a.getComputedStyle(i,null)||{}).marginRight),b.removeChild(i)),b.innerHTML="<table><tr><td></td><td>t</td></tr></table>",i=b.getElementsByTagName("td"),i[0].style.cssText="margin:0;border:0;padding:0;display:none",g=0===i[0].offsetHeight,g&&(i[0].style.display="",i[1].style.display="none",g=0===i[0].offsetHeight),c.removeChild(d))}}}(),m.swap=function(a,b,c,d){var e,f,g={};for(f in b)g[f]=a.style[f],a.style[f]=b[f];e=c.apply(a,d||[]);for(f in b)a.style[f]=g[f];return e};var Ma=/alpha\([^)]*\)/i,Na=/opacity\s*=\s*([^)]*)/,Oa=/^(none|table(?!-c[ea]).+)/,Pa=new RegExp("^("+S+")(.*)$","i"),Qa=new RegExp("^([+-])=("+S+")","i"),Ra={position:"absolute",visibility:"hidden",display:"block"},Sa={letterSpacing:"0",fontWeight:"400"},Ta=["Webkit","O","Moz","ms"];function Ua(a,b){if(b in a)return b;var c=b.charAt(0).toUpperCase()+b.slice(1),d=b,e=Ta.length;while(e--)if(b=Ta[e]+c,b in a)return b;return d}function Va(a,b){for(var c,d,e,f=[],g=0,h=a.length;h>g;g++)d=a[g],d.style&&(f[g]=m._data(d,"olddisplay"),c=d.style.display,b?(f[g]||"none"!==c||(d.style.display=""),""===d.style.display&&U(d)&&(f[g]=m._data(d,"olddisplay",Fa(d.nodeName)))):(e=U(d),(c&&"none"!==c||!e)&&m._data(d,"olddisplay",e?c:m.css(d,"display"))));for(g=0;h>g;g++)d=a[g],d.style&&(b&&"none"!==d.style.display&&""!==d.style.display||(d.style.display=b?f[g]||"":"none"));return a}function Wa(a,b,c){var d=Pa.exec(b);return d?Math.max(0,d[1]-(c||0))+(d[2]||"px"):b}function Xa(a,b,c,d,e){for(var f=c===(d?"border":"content")?4:"width"===b?1:0,g=0;4>f;f+=2)"margin"===c&&(g+=m.css(a,c+T[f],!0,e)),d?("content"===c&&(g-=m.css(a,"padding"+T[f],!0,e)),"margin"!==c&&(g-=m.css(a,"border"+T[f]+"Width",!0,e))):(g+=m.css(a,"padding"+T[f],!0,e),"padding"!==c&&(g+=m.css(a,"border"+T[f]+"Width",!0,e)));return g}function Ya(a,b,c){var d=!0,e="width"===b?a.offsetWidth:a.offsetHeight,f=Ia(a),g=k.boxSizing&&"border-box"===m.css(a,"boxSizing",!1,f);if(0>=e||null==e){if(e=Ja(a,b,f),(0>e||null==e)&&(e=a.style[b]),Ha.test(e))return e;d=g&&(k.boxSizingReliable()||e===a.style[b]),e=parseFloat(e)||0}return e+Xa(a,b,c||(g?"border":"content"),d,f)+"px"}m.extend({cssHooks:{opacity:{get:function(a,b){if(b){var c=Ja(a,"opacity");return""===c?"1":c}}}},cssNumber:{columnCount:!0,fillOpacity:!0,flexGrow:!0,flexShrink:!0,fontWeight:!0,lineHeight:!0,opacity:!0,order:!0,orphans:!0,widows:!0,zIndex:!0,zoom:!0},cssProps:{"float":k.cssFloat?"cssFloat":"styleFloat"},style:function(a,b,c,d){if(a&&3!==a.nodeType&&8!==a.nodeType&&a.style){var e,f,g,h=m.camelCase(b),i=a.style;if(b=m.cssProps[h]||(m.cssProps[h]=Ua(i,h)),g=m.cssHooks[b]||m.cssHooks[h],void 0===c)return g&&"get"in g&&void 0!==(e=g.get(a,!1,d))?e:i[b];if(f=typeof c,"string"===f&&(e=Qa.exec(c))&&(c=(e[1]+1)*e[2]+parseFloat(m.css(a,b)),f="number"),null!=c&&c===c&&("number"!==f||m.cssNumber[h]||(c+="px"),k.clearCloneStyle||""!==c||0!==b.indexOf("background")||(i[b]="inherit"),!(g&&"set"in g&&void 0===(c=g.set(a,c,d)))))try{i[b]=c}catch(j){}}},css:function(a,b,c,d){var e,f,g,h=m.camelCase(b);return b=m.cssProps[h]||(m.cssProps[h]=Ua(a.style,h)),g=m.cssHooks[b]||m.cssHooks[h],g&&"get"in g&&(f=g.get(a,!0,c)),void 0===f&&(f=Ja(a,b,d)),"normal"===f&&b in Sa&&(f=Sa[b]),""===c||c?(e=parseFloat(f),c===!0||m.isNumeric(e)?e||0:f):f}}),m.each(["height","width"],function(a,b){m.cssHooks[b]={get:function(a,c,d){return c?Oa.test(m.css(a,"display"))&&0===a.offsetWidth?m.swap(a,Ra,function(){return Ya(a,b,d)}):Ya(a,b,d):void 0},set:function(a,c,d){var e=d&&Ia(a);return Wa(a,c,d?Xa(a,b,d,k.boxSizing&&"border-box"===m.css(a,"boxSizing",!1,e),e):0)}}}),k.opacity||(m.cssHooks.opacity={get:function(a,b){return Na.test((b&&a.currentStyle?a.currentStyle.filter:a.style.filter)||"")?.01*parseFloat(RegExp.$1)+"":b?"1":""},set:function(a,b){var c=a.style,d=a.currentStyle,e=m.isNumeric(b)?"alpha(opacity="+100*b+")":"",f=d&&d.filter||c.filter||"";c.zoom=1,(b>=1||""===b)&&""===m.trim(f.replace(Ma,""))&&c.removeAttribute&&(c.removeAttribute("filter"),""===b||d&&!d.filter)||(c.filter=Ma.test(f)?f.replace(Ma,e):f+" "+e)}}),m.cssHooks.marginRight=La(k.reliableMarginRight,function(a,b){return b?m.swap(a,{display:"inline-block"},Ja,[a,"marginRight"]):void 0}),m.each({margin:"",padding:"",border:"Width"},function(a,b){m.cssHooks[a+b]={expand:function(c){for(var d=0,e={},f="string"==typeof c?c.split(" "):[c];4>d;d++)e[a+T[d]+b]=f[d]||f[d-2]||f[0];return e}},Ga.test(a)||(m.cssHooks[a+b].set=Wa)}),m.fn.extend({css:function(a,b){return V(this,function(a,b,c){var d,e,f={},g=0;if(m.isArray(b)){for(d=Ia(a),e=b.length;e>g;g++)f[b[g]]=m.css(a,b[g],!1,d);return f}return void 0!==c?m.style(a,b,c):m.css(a,b)},a,b,arguments.length>1)},show:function(){return Va(this,!0)},hide:function(){return Va(this)},toggle:function(a){return"boolean"==typeof a?a?this.show():this.hide():this.each(function(){U(this)?m(this).show():m(this).hide()})}});function Za(a,b,c,d,e){
return new Za.prototype.init(a,b,c,d,e)}m.Tween=Za,Za.prototype={constructor:Za,init:function(a,b,c,d,e,f){this.elem=a,this.prop=c,this.easing=e||"swing",this.options=b,this.start=this.now=this.cur(),this.end=d,this.unit=f||(m.cssNumber[c]?"":"px")},cur:function(){var a=Za.propHooks[this.prop];return a&&a.get?a.get(this):Za.propHooks._default.get(this)},run:function(a){var b,c=Za.propHooks[this.prop];return this.options.duration?this.pos=b=m.easing[this.easing](a,this.options.duration*a,0,1,this.options.duration):this.pos=b=a,this.now=(this.end-this.start)*b+this.start,this.options.step&&this.options.step.call(this.elem,this.now,this),c&&c.set?c.set(this):Za.propHooks._default.set(this),this}},Za.prototype.init.prototype=Za.prototype,Za.propHooks={_default:{get:function(a){var b;return null==a.elem[a.prop]||a.elem.style&&null!=a.elem.style[a.prop]?(b=m.css(a.elem,a.prop,""),b&&"auto"!==b?b:0):a.elem[a.prop]},set:function(a){m.fx.step[a.prop]?m.fx.step[a.prop](a):a.elem.style&&(null!=a.elem.style[m.cssProps[a.prop]]||m.cssHooks[a.prop])?m.style(a.elem,a.prop,a.now+a.unit):a.elem[a.prop]=a.now}}},Za.propHooks.scrollTop=Za.propHooks.scrollLeft={set:function(a){a.elem.nodeType&&a.elem.parentNode&&(a.elem[a.prop]=a.now)}},m.easing={linear:function(a){return a},swing:function(a){return.5-Math.cos(a*Math.PI)/2}},m.fx=Za.prototype.init,m.fx.step={};var $a,_a,ab=/^(?:toggle|show|hide)$/,bb=new RegExp("^(?:([+-])=|)("+S+")([a-z%]*)$","i"),cb=/queueHooks$/,db=[ib],eb={"*":[function(a,b){var c=this.createTween(a,b),d=c.cur(),e=bb.exec(b),f=e&&e[3]||(m.cssNumber[a]?"":"px"),g=(m.cssNumber[a]||"px"!==f&&+d)&&bb.exec(m.css(c.elem,a)),h=1,i=20;if(g&&g[3]!==f){f=f||g[3],e=e||[],g=+d||1;do h=h||".5",g/=h,m.style(c.elem,a,g+f);while(h!==(h=c.cur()/d)&&1!==h&&--i)}return e&&(g=c.start=+g||+d||0,c.unit=f,c.end=e[1]?g+(e[1]+1)*e[2]:+e[2]),c}]};function fb(){return setTimeout(function(){$a=void 0}),$a=m.now()}function gb(a,b){var c,d={height:a},e=0;for(b=b?1:0;4>e;e+=2-b)c=T[e],d["margin"+c]=d["padding"+c]=a;return b&&(d.opacity=d.width=a),d}function hb(a,b,c){for(var d,e=(eb[b]||[]).concat(eb["*"]),f=0,g=e.length;g>f;f++)if(d=e[f].call(c,b,a))return d}function ib(a,b,c){var d,e,f,g,h,i,j,l,n=this,o={},p=a.style,q=a.nodeType&&U(a),r=m._data(a,"fxshow");c.queue||(h=m._queueHooks(a,"fx"),null==h.unqueued&&(h.unqueued=0,i=h.empty.fire,h.empty.fire=function(){h.unqueued||i()}),h.unqueued++,n.always(function(){n.always(function(){h.unqueued--,m.queue(a,"fx").length||h.empty.fire()})})),1===a.nodeType&&("height"in b||"width"in b)&&(c.overflow=[p.overflow,p.overflowX,p.overflowY],j=m.css(a,"display"),l="none"===j?m._data(a,"olddisplay")||Fa(a.nodeName):j,"inline"===l&&"none"===m.css(a,"float")&&(k.inlineBlockNeedsLayout&&"inline"!==Fa(a.nodeName)?p.zoom=1:p.display="inline-block")),c.overflow&&(p.overflow="hidden",k.shrinkWrapBlocks()||n.always(function(){p.overflow=c.overflow[0],p.overflowX=c.overflow[1],p.overflowY=c.overflow[2]}));for(d in b)if(e=b[d],ab.exec(e)){if(delete b[d],f=f||"toggle"===e,e===(q?"hide":"show")){if("show"!==e||!r||void 0===r[d])continue;q=!0}o[d]=r&&r[d]||m.style(a,d)}else j=void 0;if(m.isEmptyObject(o))"inline"===("none"===j?Fa(a.nodeName):j)&&(p.display=j);else{r?"hidden"in r&&(q=r.hidden):r=m._data(a,"fxshow",{}),f&&(r.hidden=!q),q?m(a).show():n.done(function(){m(a).hide()}),n.done(function(){var b;m._removeData(a,"fxshow");for(b in o)m.style(a,b,o[b])});for(d in o)g=hb(q?r[d]:0,d,n),d in r||(r[d]=g.start,q&&(g.end=g.start,g.start="width"===d||"height"===d?1:0))}}function jb(a,b){var c,d,e,f,g;for(c in a)if(d=m.camelCase(c),e=b[d],f=a[c],m.isArray(f)&&(e=f[1],f=a[c]=f[0]),c!==d&&(a[d]=f,delete a[c]),g=m.cssHooks[d],g&&"expand"in g){f=g.expand(f),delete a[d];for(c in f)c in a||(a[c]=f[c],b[c]=e)}else b[d]=e}function kb(a,b,c){var d,e,f=0,g=db.length,h=m.Deferred().always(function(){delete i.elem}),i=function(){if(e)return!1;for(var b=$a||fb(),c=Math.max(0,j.startTime+j.duration-b),d=c/j.duration||0,f=1-d,g=0,i=j.tweens.length;i>g;g++)j.tweens[g].run(f);return h.notifyWith(a,[j,f,c]),1>f&&i?c:(h.resolveWith(a,[j]),!1)},j=h.promise({elem:a,props:m.extend({},b),opts:m.extend(!0,{specialEasing:{}},c),originalProperties:b,originalOptions:c,startTime:$a||fb(),duration:c.duration,tweens:[],createTween:function(b,c){var d=m.Tween(a,j.opts,b,c,j.opts.specialEasing[b]||j.opts.easing);return j.tweens.push(d),d},stop:function(b){var c=0,d=b?j.tweens.length:0;if(e)return this;for(e=!0;d>c;c++)j.tweens[c].run(1);return b?h.resolveWith(a,[j,b]):h.rejectWith(a,[j,b]),this}}),k=j.props;for(jb(k,j.opts.specialEasing);g>f;f++)if(d=db[f].call(j,a,k,j.opts))return d;return m.map(k,hb,j),m.isFunction(j.opts.start)&&j.opts.start.call(a,j),m.fx.timer(m.extend(i,{elem:a,anim:j,queue:j.opts.queue})),j.progress(j.opts.progress).done(j.opts.done,j.opts.complete).fail(j.opts.fail).always(j.opts.always)}m.Animation=m.extend(kb,{tweener:function(a,b){m.isFunction(a)?(b=a,a=["*"]):a=a.split(" ");for(var c,d=0,e=a.length;e>d;d++)c=a[d],eb[c]=eb[c]||[],eb[c].unshift(b)},prefilter:function(a,b){b?db.unshift(a):db.push(a)}}),m.speed=function(a,b,c){var d=a&&"object"==typeof a?m.extend({},a):{complete:c||!c&&b||m.isFunction(a)&&a,duration:a,easing:c&&b||b&&!m.isFunction(b)&&b};return d.duration=m.fx.off?0:"number"==typeof d.duration?d.duration:d.duration in m.fx.speeds?m.fx.speeds[d.duration]:m.fx.speeds._default,(null==d.queue||d.queue===!0)&&(d.queue="fx"),d.old=d.complete,d.complete=function(){m.isFunction(d.old)&&d.old.call(this),d.queue&&m.dequeue(this,d.queue)},d},m.fn.extend({fadeTo:function(a,b,c,d){return this.filter(U).css("opacity",0).show().end().animate({opacity:b},a,c,d)},animate:function(a,b,c,d){var e=m.isEmptyObject(a),f=m.speed(b,c,d),g=function(){var b=kb(this,m.extend({},a),f);(e||m._data(this,"finish"))&&b.stop(!0)};return g.finish=g,e||f.queue===!1?this.each(g):this.queue(f.queue,g)},stop:function(a,b,c){var d=function(a){var b=a.stop;delete a.stop,b(c)};return"string"!=typeof a&&(c=b,b=a,a=void 0),b&&a!==!1&&this.queue(a||"fx",[]),this.each(function(){var b=!0,e=null!=a&&a+"queueHooks",f=m.timers,g=m._data(this);if(e)g[e]&&g[e].stop&&d(g[e]);else for(e in g)g[e]&&g[e].stop&&cb.test(e)&&d(g[e]);for(e=f.length;e--;)f[e].elem!==this||null!=a&&f[e].queue!==a||(f[e].anim.stop(c),b=!1,f.splice(e,1));(b||!c)&&m.dequeue(this,a)})},finish:function(a){return a!==!1&&(a=a||"fx"),this.each(function(){var b,c=m._data(this),d=c[a+"queue"],e=c[a+"queueHooks"],f=m.timers,g=d?d.length:0;for(c.finish=!0,m.queue(this,a,[]),e&&e.stop&&e.stop.call(this,!0),b=f.length;b--;)f[b].elem===this&&f[b].queue===a&&(f[b].anim.stop(!0),f.splice(b,1));for(b=0;g>b;b++)d[b]&&d[b].finish&&d[b].finish.call(this);delete c.finish})}}),m.each(["toggle","show","hide"],function(a,b){var c=m.fn[b];m.fn[b]=function(a,d,e){return null==a||"boolean"==typeof a?c.apply(this,arguments):this.animate(gb(b,!0),a,d,e)}}),m.each({slideDown:gb("show"),slideUp:gb("hide"),slideToggle:gb("toggle"),fadeIn:{opacity:"show"},fadeOut:{opacity:"hide"},fadeToggle:{opacity:"toggle"}},function(a,b){m.fn[a]=function(a,c,d){return this.animate(b,a,c,d)}}),m.timers=[],m.fx.tick=function(){var a,b=m.timers,c=0;for($a=m.now();c<b.length;c++)a=b[c],a()||b[c]!==a||b.splice(c--,1);b.length||m.fx.stop(),$a=void 0},m.fx.timer=function(a){m.timers.push(a),a()?m.fx.start():m.timers.pop()},m.fx.interval=13,m.fx.start=function(){_a||(_a=setInterval(m.fx.tick,m.fx.interval))},m.fx.stop=function(){clearInterval(_a),_a=null},m.fx.speeds={slow:600,fast:200,_default:400},m.fn.delay=function(a,b){return a=m.fx?m.fx.speeds[a]||a:a,b=b||"fx",this.queue(b,function(b,c){var d=setTimeout(b,a);c.stop=function(){clearTimeout(d)}})},function(){var a,b,c,d,e;b=y.createElement("div"),b.setAttribute("className","t"),b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",d=b.getElementsByTagName("a")[0],c=y.createElement("select"),e=c.appendChild(y.createElement("option")),a=b.getElementsByTagName("input")[0],d.style.cssText="top:1px",k.getSetAttribute="t"!==b.className,k.style=/top/.test(d.getAttribute("style")),k.hrefNormalized="/a"===d.getAttribute("href"),k.checkOn=!!a.value,k.optSelected=e.selected,k.enctype=!!y.createElement("form").enctype,c.disabled=!0,k.optDisabled=!e.disabled,a=y.createElement("input"),a.setAttribute("value",""),k.input=""===a.getAttribute("value"),a.value="t",a.setAttribute("type","radio"),k.radioValue="t"===a.value}();var lb=/\r/g;m.fn.extend({val:function(a){var b,c,d,e=this[0];{if(arguments.length)return d=m.isFunction(a),this.each(function(c){var e;1===this.nodeType&&(e=d?a.call(this,c,m(this).val()):a,null==e?e="":"number"==typeof e?e+="":m.isArray(e)&&(e=m.map(e,function(a){return null==a?"":a+""})),b=m.valHooks[this.type]||m.valHooks[this.nodeName.toLowerCase()],b&&"set"in b&&void 0!==b.set(this,e,"value")||(this.value=e))});if(e)return b=m.valHooks[e.type]||m.valHooks[e.nodeName.toLowerCase()],b&&"get"in b&&void 0!==(c=b.get(e,"value"))?c:(c=e.value,"string"==typeof c?c.replace(lb,""):null==c?"":c)}}}),m.extend({valHooks:{option:{get:function(a){var b=m.find.attr(a,"value");return null!=b?b:m.trim(m.text(a))}},select:{get:function(a){for(var b,c,d=a.options,e=a.selectedIndex,f="select-one"===a.type||0>e,g=f?null:[],h=f?e+1:d.length,i=0>e?h:f?e:0;h>i;i++)if(c=d[i],!(!c.selected&&i!==e||(k.optDisabled?c.disabled:null!==c.getAttribute("disabled"))||c.parentNode.disabled&&m.nodeName(c.parentNode,"optgroup"))){if(b=m(c).val(),f)return b;g.push(b)}return g},set:function(a,b){var c,d,e=a.options,f=m.makeArray(b),g=e.length;while(g--)if(d=e[g],m.inArray(m.valHooks.option.get(d),f)>=0)try{d.selected=c=!0}catch(h){d.scrollHeight}else d.selected=!1;return c||(a.selectedIndex=-1),e}}}}),m.each(["radio","checkbox"],function(){m.valHooks[this]={set:function(a,b){return m.isArray(b)?a.checked=m.inArray(m(a).val(),b)>=0:void 0}},k.checkOn||(m.valHooks[this].get=function(a){return null===a.getAttribute("value")?"on":a.value})});var mb,nb,ob=m.expr.attrHandle,pb=/^(?:checked|selected)$/i,qb=k.getSetAttribute,rb=k.input;m.fn.extend({attr:function(a,b){return V(this,m.attr,a,b,arguments.length>1)},removeAttr:function(a){return this.each(function(){m.removeAttr(this,a)})}}),m.extend({attr:function(a,b,c){var d,e,f=a.nodeType;if(a&&3!==f&&8!==f&&2!==f)return typeof a.getAttribute===K?m.prop(a,b,c):(1===f&&m.isXMLDoc(a)||(b=b.toLowerCase(),d=m.attrHooks[b]||(m.expr.match.bool.test(b)?nb:mb)),void 0===c?d&&"get"in d&&null!==(e=d.get(a,b))?e:(e=m.find.attr(a,b),null==e?void 0:e):null!==c?d&&"set"in d&&void 0!==(e=d.set(a,c,b))?e:(a.setAttribute(b,c+""),c):void m.removeAttr(a,b))},removeAttr:function(a,b){var c,d,e=0,f=b&&b.match(E);if(f&&1===a.nodeType)while(c=f[e++])d=m.propFix[c]||c,m.expr.match.bool.test(c)?rb&&qb||!pb.test(c)?a[d]=!1:a[m.camelCase("default-"+c)]=a[d]=!1:m.attr(a,c,""),a.removeAttribute(qb?c:d)},attrHooks:{type:{set:function(a,b){if(!k.radioValue&&"radio"===b&&m.nodeName(a,"input")){var c=a.value;return a.setAttribute("type",b),c&&(a.value=c),b}}}}}),nb={set:function(a,b,c){return b===!1?m.removeAttr(a,c):rb&&qb||!pb.test(c)?a.setAttribute(!qb&&m.propFix[c]||c,c):a[m.camelCase("default-"+c)]=a[c]=!0,c}},m.each(m.expr.match.bool.source.match(/\w+/g),function(a,b){var c=ob[b]||m.find.attr;ob[b]=rb&&qb||!pb.test(b)?function(a,b,d){var e,f;return d||(f=ob[b],ob[b]=e,e=null!=c(a,b,d)?b.toLowerCase():null,ob[b]=f),e}:function(a,b,c){return c?void 0:a[m.camelCase("default-"+b)]?b.toLowerCase():null}}),rb&&qb||(m.attrHooks.value={set:function(a,b,c){return m.nodeName(a,"input")?void(a.defaultValue=b):mb&&mb.set(a,b,c)}}),qb||(mb={set:function(a,b,c){var d=a.getAttributeNode(c);return d||a.setAttributeNode(d=a.ownerDocument.createAttribute(c)),d.value=b+="","value"===c||b===a.getAttribute(c)?b:void 0}},ob.id=ob.name=ob.coords=function(a,b,c){var d;return c?void 0:(d=a.getAttributeNode(b))&&""!==d.value?d.value:null},m.valHooks.button={get:function(a,b){var c=a.getAttributeNode(b);return c&&c.specified?c.value:void 0},set:mb.set},m.attrHooks.contenteditable={set:function(a,b,c){mb.set(a,""===b?!1:b,c)}},m.each(["width","height"],function(a,b){m.attrHooks[b]={set:function(a,c){return""===c?(a.setAttribute(b,"auto"),c):void 0}}})),k.style||(m.attrHooks.style={get:function(a){return a.style.cssText||void 0},set:function(a,b){return a.style.cssText=b+""}});var sb=/^(?:input|select|textarea|button|object)$/i,tb=/^(?:a|area)$/i;m.fn.extend({prop:function(a,b){return V(this,m.prop,a,b,arguments.length>1)},removeProp:function(a){return a=m.propFix[a]||a,this.each(function(){try{this[a]=void 0,delete this[a]}catch(b){}})}}),m.extend({propFix:{"for":"htmlFor","class":"className"},prop:function(a,b,c){var d,e,f,g=a.nodeType;if(a&&3!==g&&8!==g&&2!==g)return f=1!==g||!m.isXMLDoc(a),f&&(b=m.propFix[b]||b,e=m.propHooks[b]),void 0!==c?e&&"set"in e&&void 0!==(d=e.set(a,c,b))?d:a[b]=c:e&&"get"in e&&null!==(d=e.get(a,b))?d:a[b]},propHooks:{tabIndex:{get:function(a){var b=m.find.attr(a,"tabindex");return b?parseInt(b,10):sb.test(a.nodeName)||tb.test(a.nodeName)&&a.href?0:-1}}}}),k.hrefNormalized||m.each(["href","src"],function(a,b){m.propHooks[b]={get:function(a){return a.getAttribute(b,4)}}}),k.optSelected||(m.propHooks.selected={get:function(a){var b=a.parentNode;return b&&(b.selectedIndex,b.parentNode&&b.parentNode.selectedIndex),null}}),m.each(["tabIndex","readOnly","maxLength","cellSpacing","cellPadding","rowSpan","colSpan","useMap","frameBorder","contentEditable"],function(){m.propFix[this.toLowerCase()]=this}),k.enctype||(m.propFix.enctype="encoding");var ub=/[\t\r\n\f]/g;m.fn.extend({addClass:function(a){var b,c,d,e,f,g,h=0,i=this.length,j="string"==typeof a&&a;if(m.isFunction(a))return this.each(function(b){m(this).addClass(a.call(this,b,this.className))});if(j)for(b=(a||"").match(E)||[];i>h;h++)if(c=this[h],d=1===c.nodeType&&(c.className?(" "+c.className+" ").replace(ub," "):" ")){f=0;while(e=b[f++])d.indexOf(" "+e+" ")<0&&(d+=e+" ");g=m.trim(d),c.className!==g&&(c.className=g)}return this},removeClass:function(a){var b,c,d,e,f,g,h=0,i=this.length,j=0===arguments.length||"string"==typeof a&&a;if(m.isFunction(a))return this.each(function(b){m(this).removeClass(a.call(this,b,this.className))});if(j)for(b=(a||"").match(E)||[];i>h;h++)if(c=this[h],d=1===c.nodeType&&(c.className?(" "+c.className+" ").replace(ub," "):"")){f=0;while(e=b[f++])while(d.indexOf(" "+e+" ")>=0)d=d.replace(" "+e+" "," ");g=a?m.trim(d):"",c.className!==g&&(c.className=g)}return this},toggleClass:function(a,b){var c=typeof a;return"boolean"==typeof b&&"string"===c?b?this.addClass(a):this.removeClass(a):this.each(m.isFunction(a)?function(c){m(this).toggleClass(a.call(this,c,this.className,b),b)}:function(){if("string"===c){var b,d=0,e=m(this),f=a.match(E)||[];while(b=f[d++])e.hasClass(b)?e.removeClass(b):e.addClass(b)}else(c===K||"boolean"===c)&&(this.className&&m._data(this,"__className__",this.className),this.className=this.className||a===!1?"":m._data(this,"__className__")||"")})},hasClass:function(a){for(var b=" "+a+" ",c=0,d=this.length;d>c;c++)if(1===this[c].nodeType&&(" "+this[c].className+" ").replace(ub," ").indexOf(b)>=0)return!0;return!1}}),m.each("blur focus focusin focusout load resize scroll unload click dblclick mousedown mouseup mousemove mouseover mouseout mouseenter mouseleave change select submit keydown keypress keyup error contextmenu".split(" "),function(a,b){m.fn[b]=function(a,c){return arguments.length>0?this.on(b,null,a,c):this.trigger(b)}}),m.fn.extend({hover:function(a,b){return this.mouseenter(a).mouseleave(b||a)},bind:function(a,b,c){return this.on(a,null,b,c)},unbind:function(a,b){return this.off(a,null,b)},delegate:function(a,b,c,d){return this.on(b,a,c,d)},undelegate:function(a,b,c){return 1===arguments.length?this.off(a,"**"):this.off(b,a||"**",c)}});var vb=m.now(),wb=/\?/,xb=/(,)|(\[|{)|(}|])|"(?:[^"\\\r\n]|\\["\\\/bfnrt]|\\u[\da-fA-F]{4})*"\s*:?|true|false|null|-?(?!0\d)\d+(?:\.\d+|)(?:[eE][+-]?\d+|)/g;m.parseJSON=function(b){if(a.JSON&&a.JSON.parse)return a.JSON.parse(b+"");var c,d=null,e=m.trim(b+"");return e&&!m.trim(e.replace(xb,function(a,b,e,f){return c&&b&&(d=0),0===d?a:(c=e||b,d+=!f-!e,"")}))?Function("return "+e)():m.error("Invalid JSON: "+b)},m.parseXML=function(b){var c,d;if(!b||"string"!=typeof b)return null;try{a.DOMParser?(d=new DOMParser,c=d.parseFromString(b,"text/xml")):(c=new ActiveXObject("Microsoft.XMLDOM"),c.async="false",c.loadXML(b))}catch(e){c=void 0}return c&&c.documentElement&&!c.getElementsByTagName("parsererror").length||m.error("Invalid XML: "+b),c};var yb,zb,Ab=/#.*$/,Bb=/([?&])_=[^&]*/,Cb=/^(.*?):[ \t]*([^\r\n]*)\r?$/gm,Db=/^(?:about|app|app-storage|.+-extension|file|res|widget):$/,Eb=/^(?:GET|HEAD)$/,Fb=/^\/\//,Gb=/^([\w.+-]+:)(?:\/\/(?:[^\/?#]*@|)([^\/?#:]*)(?::(\d+)|)|)/,Hb={},Ib={},Jb="*/".concat("*");try{zb=location.href}catch(Kb){zb=y.createElement("a"),zb.href="",zb=zb.href}yb=Gb.exec(zb.toLowerCase())||[];function Lb(a){return function(b,c){"string"!=typeof b&&(c=b,b="*");var d,e=0,f=b.toLowerCase().match(E)||[];if(m.isFunction(c))while(d=f[e++])"+"===d.charAt(0)?(d=d.slice(1)||"*",(a[d]=a[d]||[]).unshift(c)):(a[d]=a[d]||[]).push(c)}}function Mb(a,b,c,d){var e={},f=a===Ib;function g(h){var i;return e[h]=!0,m.each(a[h]||[],function(a,h){var j=h(b,c,d);return"string"!=typeof j||f||e[j]?f?!(i=j):void 0:(b.dataTypes.unshift(j),g(j),!1)}),i}return g(b.dataTypes[0])||!e["*"]&&g("*")}function Nb(a,b){var c,d,e=m.ajaxSettings.flatOptions||{};for(d in b)void 0!==b[d]&&((e[d]?a:c||(c={}))[d]=b[d]);return c&&m.extend(!0,a,c),a}function Ob(a,b,c){var d,e,f,g,h=a.contents,i=a.dataTypes;while("*"===i[0])i.shift(),void 0===e&&(e=a.mimeType||b.getResponseHeader("Content-Type"));if(e)for(g in h)if(h[g]&&h[g].test(e)){i.unshift(g);break}if(i[0]in c)f=i[0];else{for(g in c){if(!i[0]||a.converters[g+" "+i[0]]){f=g;break}d||(d=g)}f=f||d}return f?(f!==i[0]&&i.unshift(f),c[f]):void 0}function Pb(a,b,c,d){var e,f,g,h,i,j={},k=a.dataTypes.slice();if(k[1])for(g in a.converters)j[g.toLowerCase()]=a.converters[g];f=k.shift();while(f)if(a.responseFields[f]&&(c[a.responseFields[f]]=b),!i&&d&&a.dataFilter&&(b=a.dataFilter(b,a.dataType)),i=f,f=k.shift())if("*"===f)f=i;else if("*"!==i&&i!==f){if(g=j[i+" "+f]||j["* "+f],!g)for(e in j)if(h=e.split(" "),h[1]===f&&(g=j[i+" "+h[0]]||j["* "+h[0]])){g===!0?g=j[e]:j[e]!==!0&&(f=h[0],k.unshift(h[1]));break}if(g!==!0)if(g&&a["throws"])b=g(b);else try{b=g(b)}catch(l){return{state:"parsererror",error:g?l:"No conversion from "+i+" to "+f}}}return{state:"success",data:b}}m.extend({active:0,lastModified:{},etag:{},ajaxSettings:{url:zb,type:"GET",isLocal:Db.test(yb[1]),global:!0,processData:!0,async:!0,contentType:"application/x-www-form-urlencoded; charset=UTF-8",accepts:{"*":Jb,text:"text/plain",html:"text/html",xml:"application/xml, text/xml",json:"application/json, text/javascript"},contents:{xml:/xml/,html:/html/,json:/json/},responseFields:{xml:"responseXML",text:"responseText",json:"responseJSON"},converters:{"* text":String,"text html":!0,"text json":m.parseJSON,"text xml":m.parseXML},flatOptions:{url:!0,context:!0}},ajaxSetup:function(a,b){return b?Nb(Nb(a,m.ajaxSettings),b):Nb(m.ajaxSettings,a)},ajaxPrefilter:Lb(Hb),ajaxTransport:Lb(Ib),ajax:function(a,b){"object"==typeof a&&(b=a,a=void 0),b=b||{};var c,d,e,f,g,h,i,j,k=m.ajaxSetup({},b),l=k.context||k,n=k.context&&(l.nodeType||l.jquery)?m(l):m.event,o=m.Deferred(),p=m.Callbacks("once memory"),q=k.statusCode||{},r={},s={},t=0,u="canceled",v={readyState:0,getResponseHeader:function(a){var b;if(2===t){if(!j){j={};while(b=Cb.exec(f))j[b[1].toLowerCase()]=b[2]}b=j[a.toLowerCase()]}return null==b?null:b},getAllResponseHeaders:function(){return 2===t?f:null},setRequestHeader:function(a,b){var c=a.toLowerCase();return t||(a=s[c]=s[c]||a,r[a]=b),this},overrideMimeType:function(a){return t||(k.mimeType=a),this},statusCode:function(a){var b;if(a)if(2>t)for(b in a)q[b]=[q[b],a[b]];else v.always(a[v.status]);return this},abort:function(a){var b=a||u;return i&&i.abort(b),x(0,b),this}};if(o.promise(v).complete=p.add,v.success=v.done,v.error=v.fail,k.url=((a||k.url||zb)+"").replace(Ab,"").replace(Fb,yb[1]+"//"),k.type=b.method||b.type||k.method||k.type,k.dataTypes=m.trim(k.dataType||"*").toLowerCase().match(E)||[""],null==k.crossDomain&&(c=Gb.exec(k.url.toLowerCase()),k.crossDomain=!(!c||c[1]===yb[1]&&c[2]===yb[2]&&(c[3]||("http:"===c[1]?"80":"443"))===(yb[3]||("http:"===yb[1]?"80":"443")))),k.data&&k.processData&&"string"!=typeof k.data&&(k.data=m.param(k.data,k.traditional)),Mb(Hb,k,b,v),2===t)return v;h=m.event&&k.global,h&&0===m.active++&&m.event.trigger("ajaxStart"),k.type=k.type.toUpperCase(),k.hasContent=!Eb.test(k.type),e=k.url,k.hasContent||(k.data&&(e=k.url+=(wb.test(e)?"&":"?")+k.data,delete k.data),k.cache===!1&&(k.url=Bb.test(e)?e.replace(Bb,"$1_="+vb++):e+(wb.test(e)?"&":"?")+"_="+vb++)),k.ifModified&&(m.lastModified[e]&&v.setRequestHeader("If-Modified-Since",m.lastModified[e]),m.etag[e]&&v.setRequestHeader("If-None-Match",m.etag[e])),(k.data&&k.hasContent&&k.contentType!==!1||b.contentType)&&v.setRequestHeader("Content-Type",k.contentType),v.setRequestHeader("Accept",k.dataTypes[0]&&k.accepts[k.dataTypes[0]]?k.accepts[k.dataTypes[0]]+("*"!==k.dataTypes[0]?", "+Jb+"; q=0.01":""):k.accepts["*"]);for(d in k.headers)v.setRequestHeader(d,k.headers[d]);if(k.beforeSend&&(k.beforeSend.call(l,v,k)===!1||2===t))return v.abort();u="abort";for(d in{success:1,error:1,complete:1})v[d](k[d]);if(i=Mb(Ib,k,b,v)){v.readyState=1,h&&n.trigger("ajaxSend",[v,k]),k.async&&k.timeout>0&&(g=setTimeout(function(){v.abort("timeout")},k.timeout));try{t=1,i.send(r,x)}catch(w){if(!(2>t))throw w;x(-1,w)}}else x(-1,"No Transport");function x(a,b,c,d){var j,r,s,u,w,x=b;2!==t&&(t=2,g&&clearTimeout(g),i=void 0,f=d||"",v.readyState=a>0?4:0,j=a>=200&&300>a||304===a,c&&(u=Ob(k,v,c)),u=Pb(k,u,v,j),j?(k.ifModified&&(w=v.getResponseHeader("Last-Modified"),w&&(m.lastModified[e]=w),w=v.getResponseHeader("etag"),w&&(m.etag[e]=w)),204===a||"HEAD"===k.type?x="nocontent":304===a?x="notmodified":(x=u.state,r=u.data,s=u.error,j=!s)):(s=x,(a||!x)&&(x="error",0>a&&(a=0))),v.status=a,v.statusText=(b||x)+"",j?o.resolveWith(l,[r,x,v]):o.rejectWith(l,[v,x,s]),v.statusCode(q),q=void 0,h&&n.trigger(j?"ajaxSuccess":"ajaxError",[v,k,j?r:s]),p.fireWith(l,[v,x]),h&&(n.trigger("ajaxComplete",[v,k]),--m.active||m.event.trigger("ajaxStop")))}return v},getJSON:function(a,b,c){return m.get(a,b,c,"json")},getScript:function(a,b){return m.get(a,void 0,b,"script")}}),m.each(["get","post"],function(a,b){m[b]=function(a,c,d,e){return m.isFunction(c)&&(e=e||d,d=c,c=void 0),m.ajax({url:a,type:b,dataType:e,data:c,success:d})}}),m._evalUrl=function(a){return m.ajax({url:a,type:"GET",dataType:"script",async:!1,global:!1,"throws":!0})},m.fn.extend({wrapAll:function(a){if(m.isFunction(a))return this.each(function(b){m(this).wrapAll(a.call(this,b))});if(this[0]){var b=m(a,this[0].ownerDocument).eq(0).clone(!0);this[0].parentNode&&b.insertBefore(this[0]),b.map(function(){var a=this;while(a.firstChild&&1===a.firstChild.nodeType)a=a.firstChild;return a}).append(this)}return this},wrapInner:function(a){return this.each(m.isFunction(a)?function(b){m(this).wrapInner(a.call(this,b))}:function(){var b=m(this),c=b.contents();c.length?c.wrapAll(a):b.append(a)})},wrap:function(a){var b=m.isFunction(a);return this.each(function(c){m(this).wrapAll(b?a.call(this,c):a)})},unwrap:function(){return this.parent().each(function(){m.nodeName(this,"body")||m(this).replaceWith(this.childNodes)}).end()}}),m.expr.filters.hidden=function(a){return a.offsetWidth<=0&&a.offsetHeight<=0||!k.reliableHiddenOffsets()&&"none"===(a.style&&a.style.display||m.css(a,"display"))},m.expr.filters.visible=function(a){return!m.expr.filters.hidden(a)};var Qb=/%20/g,Rb=/\[\]$/,Sb=/\r?\n/g,Tb=/^(?:submit|button|image|reset|file)$/i,Ub=/^(?:input|select|textarea|keygen)/i;function Vb(a,b,c,d){var e;if(m.isArray(b))m.each(b,function(b,e){c||Rb.test(a)?d(a,e):Vb(a+"["+("object"==typeof e?b:"")+"]",e,c,d)});else if(c||"object"!==m.type(b))d(a,b);else for(e in b)Vb(a+"["+e+"]",b[e],c,d)}m.param=function(a,b){var c,d=[],e=function(a,b){b=m.isFunction(b)?b():null==b?"":b,d[d.length]=encodeURIComponent(a)+"="+encodeURIComponent(b)};if(void 0===b&&(b=m.ajaxSettings&&m.ajaxSettings.traditional),m.isArray(a)||a.jquery&&!m.isPlainObject(a))m.each(a,function(){e(this.name,this.value)});else for(c in a)Vb(c,a[c],b,e);return d.join("&").replace(Qb,"+")},m.fn.extend({serialize:function(){return m.param(this.serializeArray())},serializeArray:function(){return this.map(function(){var a=m.prop(this,"elements");return a?m.makeArray(a):this}).filter(function(){var a=this.type;return this.name&&!m(this).is(":disabled")&&Ub.test(this.nodeName)&&!Tb.test(a)&&(this.checked||!W.test(a))}).map(function(a,b){var c=m(this).val();return null==c?null:m.isArray(c)?m.map(c,function(a){return{name:b.name,value:a.replace(Sb,"\r\n")}}):{name:b.name,value:c.replace(Sb,"\r\n")}}).get()}}),m.ajaxSettings.xhr=void 0!==a.ActiveXObject?function(){return!this.isLocal&&/^(get|post|head|put|delete|options)$/i.test(this.type)&&Zb()||$b()}:Zb;var Wb=0,Xb={},Yb=m.ajaxSettings.xhr();a.attachEvent&&a.attachEvent("onunload",function(){for(var a in Xb)Xb[a](void 0,!0)}),k.cors=!!Yb&&"withCredentials"in Yb,Yb=k.ajax=!!Yb,Yb&&m.ajaxTransport(function(a){if(!a.crossDomain||k.cors){var b;return{send:function(c,d){var e,f=a.xhr(),g=++Wb;if(f.open(a.type,a.url,a.async,a.username,a.password),a.xhrFields)for(e in a.xhrFields)f[e]=a.xhrFields[e];a.mimeType&&f.overrideMimeType&&f.overrideMimeType(a.mimeType),a.crossDomain||c["X-Requested-With"]||(c["X-Requested-With"]="XMLHttpRequest");for(e in c)void 0!==c[e]&&f.setRequestHeader(e,c[e]+"");f.send(a.hasContent&&a.data||null),b=function(c,e){var h,i,j;if(b&&(e||4===f.readyState))if(delete Xb[g],b=void 0,f.onreadystatechange=m.noop,e)4!==f.readyState&&f.abort();else{j={},h=f.status,"string"==typeof f.responseText&&(j.text=f.responseText);try{i=f.statusText}catch(k){i=""}h||!a.isLocal||a.crossDomain?1223===h&&(h=204):h=j.text?200:404}j&&d(h,i,j,f.getAllResponseHeaders())},a.async?4===f.readyState?setTimeout(b):f.onreadystatechange=Xb[g]=b:b()},abort:function(){b&&b(void 0,!0)}}}});function Zb(){try{return new a.XMLHttpRequest}catch(b){}}function $b(){try{return new a.ActiveXObject("Microsoft.XMLHTTP")}catch(b){}}m.ajaxSetup({accepts:{script:"text/javascript, application/javascript, application/ecmascript, application/x-ecmascript"},contents:{script:/(?:java|ecma)script/},converters:{"text script":function(a){return m.globalEval(a),a}}}),m.ajaxPrefilter("script",function(a){void 0===a.cache&&(a.cache=!1),a.crossDomain&&(a.type="GET",a.global=!1)}),m.ajaxTransport("script",function(a){if(a.crossDomain){var b,c=y.head||m("head")[0]||y.documentElement;return{send:function(d,e){b=y.createElement("script"),b.async=!0,a.scriptCharset&&(b.charset=a.scriptCharset),b.src=a.url,b.onload=b.onreadystatechange=function(a,c){(c||!b.readyState||/loaded|complete/.test(b.readyState))&&(b.onload=b.onreadystatechange=null,b.parentNode&&b.parentNode.removeChild(b),b=null,c||e(200,"success"))},c.insertBefore(b,c.firstChild)},abort:function(){b&&b.onload(void 0,!0)}}}});var _b=[],ac=/(=)\?(?=&|$)|\?\?/;m.ajaxSetup({jsonp:"callback",jsonpCallback:function(){var a=_b.pop()||m.expando+"_"+vb++;return this[a]=!0,a}}),m.ajaxPrefilter("json jsonp",function(b,c,d){var e,f,g,h=b.jsonp!==!1&&(ac.test(b.url)?"url":"string"==typeof b.data&&!(b.contentType||"").indexOf("application/x-www-form-urlencoded")&&ac.test(b.data)&&"data");return h||"jsonp"===b.dataTypes[0]?(e=b.jsonpCallback=m.isFunction(b.jsonpCallback)?b.jsonpCallback():b.jsonpCallback,h?b[h]=b[h].replace(ac,"$1"+e):b.jsonp!==!1&&(b.url+=(wb.test(b.url)?"&":"?")+b.jsonp+"="+e),b.converters["script json"]=function(){return g||m.error(e+" was not called"),g[0]},b.dataTypes[0]="json",f=a[e],a[e]=function(){g=arguments},d.always(function(){a[e]=f,b[e]&&(b.jsonpCallback=c.jsonpCallback,_b.push(e)),g&&m.isFunction(f)&&f(g[0]),g=f=void 0}),"script"):void 0}),m.parseHTML=function(a,b,c){if(!a||"string"!=typeof a)return null;"boolean"==typeof b&&(c=b,b=!1),b=b||y;var d=u.exec(a),e=!c&&[];return d?[b.createElement(d[1])]:(d=m.buildFragment([a],b,e),e&&e.length&&m(e).remove(),m.merge([],d.childNodes))};var bc=m.fn.load;m.fn.load=function(a,b,c){if("string"!=typeof a&&bc)return bc.apply(this,arguments);var d,e,f,g=this,h=a.indexOf(" ");return h>=0&&(d=m.trim(a.slice(h,a.length)),a=a.slice(0,h)),m.isFunction(b)?(c=b,b=void 0):b&&"object"==typeof b&&(f="POST"),g.length>0&&m.ajax({url:a,type:f,dataType:"html",data:b}).done(function(a){e=arguments,g.html(d?m("<div>").append(m.parseHTML(a)).find(d):a)}).complete(c&&function(a,b){g.each(c,e||[a.responseText,b,a])}),this},m.each(["ajaxStart","ajaxStop","ajaxComplete","ajaxError","ajaxSuccess","ajaxSend"],function(a,b){m.fn[b]=function(a){return this.on(b,a)}}),m.expr.filters.animated=function(a){return m.grep(m.timers,function(b){return a===b.elem}).length};var cc=a.document.documentElement;function dc(a){return m.isWindow(a)?a:9===a.nodeType?a.defaultView||a.parentWindow:!1}m.offset={setOffset:function(a,b,c){var d,e,f,g,h,i,j,k=m.css(a,"position"),l=m(a),n={};"static"===k&&(a.style.position="relative"),h=l.offset(),f=m.css(a,"top"),i=m.css(a,"left"),j=("absolute"===k||"fixed"===k)&&m.inArray("auto",[f,i])>-1,j?(d=l.position(),g=d.top,e=d.left):(g=parseFloat(f)||0,e=parseFloat(i)||0),m.isFunction(b)&&(b=b.call(a,c,h)),null!=b.top&&(n.top=b.top-h.top+g),null!=b.left&&(n.left=b.left-h.left+e),"using"in b?b.using.call(a,n):l.css(n)}},m.fn.extend({offset:function(a){if(arguments.length)return void 0===a?this:this.each(function(b){m.offset.setOffset(this,a,b)});var b,c,d={top:0,left:0},e=this[0],f=e&&e.ownerDocument;if(f)return b=f.documentElement,m.contains(b,e)?(typeof e.getBoundingClientRect!==K&&(d=e.getBoundingClientRect()),c=dc(f),{top:d.top+(c.pageYOffset||b.scrollTop)-(b.clientTop||0),left:d.left+(c.pageXOffset||b.scrollLeft)-(b.clientLeft||0)}):d},position:function(){if(this[0]){var a,b,c={top:0,left:0},d=this[0];return"fixed"===m.css(d,"position")?b=d.getBoundingClientRect():(a=this.offsetParent(),b=this.offset(),m.nodeName(a[0],"html")||(c=a.offset()),c.top+=m.css(a[0],"borderTopWidth",!0),c.left+=m.css(a[0],"borderLeftWidth",!0)),{top:b.top-c.top-m.css(d,"marginTop",!0),left:b.left-c.left-m.css(d,"marginLeft",!0)}}},offsetParent:function(){return this.map(function(){var a=this.offsetParent||cc;while(a&&!m.nodeName(a,"html")&&"static"===m.css(a,"position"))a=a.offsetParent;return a||cc})}}),m.each({scrollLeft:"pageXOffset",scrollTop:"pageYOffset"},function(a,b){var c=/Y/.test(b);m.fn[a]=function(d){return V(this,function(a,d,e){var f=dc(a);return void 0===e?f?b in f?f[b]:f.document.documentElement[d]:a[d]:void(f?f.scrollTo(c?m(f).scrollLeft():e,c?e:m(f).scrollTop()):a[d]=e)},a,d,arguments.length,null)}}),m.each(["top","left"],function(a,b){m.cssHooks[b]=La(k.pixelPosition,function(a,c){return c?(c=Ja(a,b),Ha.test(c)?m(a).position()[b]+"px":c):void 0})}),m.each({Height:"height",Width:"width"},function(a,b){m.each({padding:"inner"+a,content:b,"":"outer"+a},function(c,d){m.fn[d]=function(d,e){var f=arguments.length&&(c||"boolean"!=typeof d),g=c||(d===!0||e===!0?"margin":"border");return V(this,function(b,c,d){var e;return m.isWindow(b)?b.document.documentElement["client"+a]:9===b.nodeType?(e=b.documentElement,Math.max(b.body["scroll"+a],e["scroll"+a],b.body["offset"+a],e["offset"+a],e["client"+a])):void 0===d?m.css(b,c,g):m.style(b,c,d,g)},b,f?d:void 0,f,null)}})}),m.fn.size=function(){return this.length},m.fn.andSelf=m.fn.addBack,"function"==typeof define&&define.amd&&define("jquery",[],function(){return m});var ec=a.jQuery,fc=a.$;return m.noConflict=function(b){return a.$===m&&(a.$=fc),b&&a.jQuery===m&&(a.jQuery=ec),m},typeof b===K&&(a.jQuery=a.$=m),m});
"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="data:text/css;charset=utf-8,html%7Bfont%2Dfamily%3Asans%2Dserif%3B%2Dwebkit%2Dtext%2Dsize%2Dadjust%3A100%25%3B%2Dms%2Dtext%2Dsize%2Dadjust%3A100%25%7Dbody%7Bmargin%3A0%7Darticle%2Caside%2Cdetails%2Cfigcaption%2Cfigure%2Cfooter%2Cheader%2Chgroup%2Cmain%2Cmenu%2Cnav%2Csection%2Csummary%7Bdisplay%3Ablock%7Daudio%2Ccanvas%2Cprogress%2Cvideo%7Bdisplay%3Ainline%2Dblock%3Bvertical%2Dalign%3Abaseline%7Daudio%3Anot%28%5Bcontrols%5D%29%7Bdisplay%3Anone%3Bheight%3A0%7D%5Bhidden%5D%2Ctemplate%7Bdisplay%3Anone%7Da%7Bbackground%2Dcolor%3Atransparent%7Da%3Aactive%2Ca%3Ahover%7Boutline%3A0%7Dabbr%5Btitle%5D%7Bborder%2Dbottom%3A1px%20dotted%7Db%2Cstrong%7Bfont%2Dweight%3A700%7Ddfn%7Bfont%2Dstyle%3Aitalic%7Dh1%7Bmargin%3A%2E67em%200%3Bfont%2Dsize%3A2em%7Dmark%7Bcolor%3A%23000%3Bbackground%3A%23ff0%7Dsmall%7Bfont%2Dsize%3A80%25%7Dsub%2Csup%7Bposition%3Arelative%3Bfont%2Dsize%3A75%25%3Bline%2Dheight%3A0%3Bvertical%2Dalign%3Abaseline%7Dsup%7Btop%3A%2D%2E5em%7Dsub%7Bbottom%3A%2D%2E25em%7Dimg%7Bborder%3A0%7Dsvg%3Anot%28%3Aroot%29%7Boverflow%3Ahidden%7Dfigure%7Bmargin%3A1em%2040px%7Dhr%7Bheight%3A0%3B%2Dwebkit%2Dbox%2Dsizing%3Acontent%2Dbox%3B%2Dmoz%2Dbox%2Dsizing%3Acontent%2Dbox%3Bbox%2Dsizing%3Acontent%2Dbox%7Dpre%7Boverflow%3Aauto%7Dcode%2Ckbd%2Cpre%2Csamp%7Bfont%2Dfamily%3Amonospace%2Cmonospace%3Bfont%2Dsize%3A1em%7Dbutton%2Cinput%2Coptgroup%2Cselect%2Ctextarea%7Bmargin%3A0%3Bfont%3Ainherit%3Bcolor%3Ainherit%7Dbutton%7Boverflow%3Avisible%7Dbutton%2Cselect%7Btext%2Dtransform%3Anone%7Dbutton%2Chtml%20input%5Btype%3Dbutton%5D%2Cinput%5Btype%3Dreset%5D%2Cinput%5Btype%3Dsubmit%5D%7B%2Dwebkit%2Dappearance%3Abutton%3Bcursor%3Apointer%7Dbutton%5Bdisabled%5D%2Chtml%20input%5Bdisabled%5D%7Bcursor%3Adefault%7Dbutton%3A%3A%2Dmoz%2Dfocus%2Dinner%2Cinput%3A%3A%2Dmoz%2Dfocus%2Dinner%7Bpadding%3A0%3Bborder%3A0%7Dinput%7Bline%2Dheight%3Anormal%7Dinput%5Btype%3Dcheckbox%5D%2Cinput%5Btype%3Dradio%5D%7B%2Dwebkit%2Dbox%2Dsizing%3Aborder%2Dbox%3B%2Dmoz%2Dbox%2Dsizing%3Aborder%2Dbox%3Bbox%2Dsizing%3Aborder%2Dbox%3Bpadding%3A0%7Dinput%5Btype%3Dnumber%5D%3A%3A%2Dwebkit%2Dinner%2Dspin%2Dbutton%2Cinput%5Btype%3Dnumber%5D%3A%3A%2Dwebkit%2Douter%2Dspin%2Dbutton%7Bheight%3Aauto%7Dinput%5Btype%3Dsearch%5D%7B%2Dwebkit%2Dbox%2Dsizing%3Acontent%2Dbox%3B%2Dmoz%2Dbox%2Dsizing%3Acontent%2Dbox%3Bbox%2Dsizing%3Acontent%2Dbox%3B%2Dwebkit%2Dappearance%3Atextfield%7Dinput%5Btype%3Dsearch%5D%3A%3A%2Dwebkit%2Dsearch%2Dcancel%2Dbutton%2Cinput%5Btype%3Dsearch%5D%3A%3A%2Dwebkit%2Dsearch%2Ddecoration%7B%2Dwebkit%2Dappearance%3Anone%7Dfieldset%7Bpadding%3A%2E35em%20%2E625em%20%2E75em%3Bmargin%3A0%202px%3Bborder%3A1px%20solid%20silver%7Dlegend%7Bpadding%3A0%3Bborder%3A0%7Dtextarea%7Boverflow%3Aauto%7Doptgroup%7Bfont%2Dweight%3A700%7Dtable%7Bborder%2Dspacing%3A0%3Bborder%2Dcollapse%3Acollapse%7Dtd%2Cth%7Bpadding%3A0%7D%40media%20print%7B%2A%2C%3Aafter%2C%3Abefore%7Bcolor%3A%23000%21important%3Btext%2Dshadow%3Anone%21important%3Bbackground%3A0%200%21important%3B%2Dwebkit%2Dbox%2Dshadow%3Anone%21important%3Bbox%2Dshadow%3Anone%21important%7Da%2Ca%3Avisited%7Btext%2Ddecoration%3Aunderline%7Da%5Bhref%5D%3Aafter%7Bcontent%3A%22%20%28%22%20attr%28href%29%20%22%29%22%7Dabbr%5Btitle%5D%3Aafter%7Bcontent%3A%22%20%28%22%20attr%28title%29%20%22%29%22%7Da%5Bhref%5E%3D%22javascript%3A%22%5D%3Aafter%2Ca%5Bhref%5E%3D%22%23%22%5D%3Aafter%7Bcontent%3A%22%22%7Dblockquote%2Cpre%7Bborder%3A1px%20solid%20%23999%3Bpage%2Dbreak%2Dinside%3Aavoid%7Dthead%7Bdisplay%3Atable%2Dheader%2Dgroup%7Dimg%2Ctr%7Bpage%2Dbreak%2Dinside%3Aavoid%7Dimg%7Bmax%2Dwidth%3A100%25%21important%7Dh2%2Ch3%2Cp%7Borphans%3A3%3Bwidows%3A3%7Dh2%2Ch3%7Bpage%2Dbreak%2Dafter%3Aavoid%7D%2Enavbar%7Bdisplay%3Anone%7D%2Ebtn%3E%2Ecaret%2C%2Edropup%3E%2Ebtn%3E%2Ecaret%7Bborder%2Dtop%2Dcolor%3A%23000%21important%7D%2Elabel%7Bborder%3A1px%20solid%20%23000%7D%2Etable%7Bborder%2Dcollapse%3Acollapse%21important%7D%2Etable%20td%2C%2Etable%20th%7Bbackground%2Dcolor%3A%23fff%21important%7D%2Etable%2Dbordered%20td%2C%2Etable%2Dbordered%20th%7Bborder%3A1px%20solid%20%23ddd%21important%7D%7D%40font%2Dface%7Bfont%2Dfamily%3A%27Glyphicons%20Halflings%27%3Bsrc%3Aurl%28data%3Aapplication%2Fvnd%2Ems%2Dfontobject%3Bbase64%2Cn04AAEFNAAACAAIABAAAAAAABQAAAAAAAAABAJABAAAEAExQAAAAAAAAAAIAAAAAAAAAAAEAAAAAAAAAJxJ%2FLAAAAAAAAAAAAAAAAAAAAAAAACgARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzAAAADgBSAGUAZwB1AGwAYQByAAAAeABWAGUAcgBzAGkAbwBuACAAMQAuADAAMAA5ADsAUABTACAAMAAwADEALgAwADAAOQA7AGgAbwB0AGMAbwBuAHYAIAAxAC4AMAAuADcAMAA7AG0AYQBrAGUAbwB0AGYALgBsAGkAYgAyAC4ANQAuADUAOAAzADIAOQAAADgARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzACAAUgBlAGcAdQBsAGEAcgAAAAAAQlNHUAAAAAAAAAAAAAAAAAAAAAADAKncAE0TAE0ZAEbuFM3pjM%2FSEdmjKHUbyow8ATBE40IvWA3vTu8LiABDQ%2BpexwUMcm1SMnNryctQSiI1K5ZnbOlXKmnVV5YvRe6RnNMFNCOs1KNVpn6yZhCJkRtVRNzEufeIq7HgSrcx4S8h%2Fv4vnrrKc6oCNxmSk2uKlZQHBii6iKFoH0746ThvkO1kJHlxjrkxs%2BLWORaDQBEtiYJIR5IB9Bi1UyL4Rmr0BNigNkMzlKQmnofBHviqVzUxwdMb3NdCn69hy%2BpRYVKGVS%2F1tnsqv4LL7wCCPZZAZPT4aCShHjHJVNuXbmMrY5LeQaGnvAkXlVrJgKRAUdFjrWEah9XebPeQMj7KS7DIBAFt8ycgC5PLGUOHSE3ErGZCiViNLL5ZARfywnCoZaKQCu6NuFX42AEeKtKUGnr%2FCm2Cy8tpFhBPMW5Fxi4Qm4TkDWh4IWFDClhU2hRWosUWqcKLlgyXB%2BlSHaWaHiWlBAR8SeSgSPCQxdVQgzUixWKSTrIQEbU94viDctkvX%2BVSjJuUmV8L4CXShI11esnp0pjWNZIyxKHS4wVQ2ime1P4RnhvGw0aDN1OLAXGERsB7buFpFGGBAre4QEQR0HOIO5oYH305G%2BKspT%2FFupEGGafCCwxSe6ZUa%2B073rXHnNdVXE6eWvibUS27XtRzkH838mYLMBmYysZTM0EM3A1fbpCBYFccN1B%2FEnCYu%2FTgCGmr7bMh8GfYL%2BBfcLvB0gRagC09w9elfldaIy%2FhNCBLRgBgtCC7jAF63wLSMAfbfAlEggYU0bUA7ACCJmTDpEmJtI78w4%2FBO7dN7JR7J7ZvbYaUbaILSQsRBiF3HGk5fEg6p9unwLvn98r%2BvnsV%2B372uf1xBLq4qU%2F45fTuqaAP%2BpssmCCCTF0mhEow8ZXZOS8D7Q85JsxZ%2BAzok7B7O%2Ff6J8AzYBySZQB%2FQHYUSA%2BEeQhEWiS6AIQzgcsDiER4MjgMBAWDV4AgQ3g1eBgIdweCQmCjJEMkJ%2BPKRWyFHHmg1Wi%2F6xzUgA0LREoKJChwnQa9B%2B5RQZRB3IlBlkAnxyQNaANwHMowzlYSMCBgnbpzvqpl0iTJNCQidDI9ZrSYNIRBhHtUa5YHMHxyGEik9hDE0AKj72AbTCaxtHPUaKZdAZSnQTyjGqGLsmBStCejApUhg4uBMU6mATujEl%2BKdDPbI6Ag4vLr%2BhjY6lbjBeoLKnZl0UZgRX8gTySOeynZVz1wOq7e1hFGYIq%2BMhrGxDLak0PrwYzSXtcuyhXEhwOYofiW%2BEcI%2Fjw8P6IY6ed%2BetAbuqKp5QIapT77LnAe505lMuqL79a0ut4rWexzFttsOsLDy7zvtQzcq3U1qabe7tB0wHWVXji%2BzDbo8x8HyIRUbXnwUcklFv51fvTymiV%2BMXLSmGH9d9%2BaXpD5X6lao41anWGig7IwIdnoBY2ht%2FpO9mClLo4NdXHAsefqWUKlXJkbqPOFhMoR4aiA1BXqhRNbB2Xwi%2B7u%2FjpAoOpKJ0UX24EsrzMfHXViakCNcKjBxuQX8BO0ZqjJ3xXzf%2B61t2VXOSgJ8xu65QKgtN6FibPmPYsXbJRHHqbgATcSZxBqGiDiU4NNNsYBsKD0MIP%2FOfKnlk%2FLkaid%2FO2NbKeuQrwOB2Gq3YHyr6ALgzym5wIBnsdC1ZkoBFZSQXChZvlesPqvK2c5oHHT3Q65jYpNxnQcGF0EHbvYqoFw60WNlXIHQF2HQB7zD6lWjZ9rVqUKBXUT6hrkZOle0RFYII0V5ZYGl1JAP0Ud1fZZMvSomBzJ710j4Me8mjQDwEre5Uv2wQfk1ifDwb5ksuJQQ3xt423lbuQjvoIQByQrNDh1JxGFkOdlJvu%2FgFtuW0wR4cgd%2BZKesSV7QkNE2kw6AV4hoIuC02LGmTomyf8PiO6CZzOTLTPQ%2BHW06H%2Btx%2BbQ8LmDYg1pTFrp2oJXgkZTyeRJZM0C8aE2LpFrNVDuhARsN543%2FFV6klQ6Tv1OoZGXLv0igKrl%2FCmJxRmX7JJbJ998VSIPQRyDBICzl4JJlYHbdql30NvYcOuZ7a10uWRrgoieOdgIm4rlq6vNOQBuqESLbXG5lzdJGHw2m0sDYmODXbYGTfSTGRKpssTO95fothJCjUGQgEL4yKoGAF%2F0SrpUDNn8CBgBcSDQByAeNkCXp4S4Ro2Xh4OeaGRgR66PVOsU8bc6TR5%2FxTcn4IVMLOkXSWiXxkZQCbvKfmoAvQaKjO3EDKwkwqHChCDEM5loQRPd5ACBki1TjF772oaQhQbQ5C0lcWXPFOzrfsDGUXGrpxasbG4iab6eByaQkQfm0VFlP0ZsDkvvqCL6QXMUwCjdMx1ZOyKhTJ7a1GWAdOUcJ8RSejxNVyGs31OKMyRyBVoZFjqIkmKlLQ5eHMeEL4MkUf23cQ%2F1SgRCJ1dk4UdBT7OoyuNgLs0oCd8RnrEIb6QdMxT2QjD4zMrJkfgx5aDMcA4orsTtKCqWb%2FVeyceqa5OGSmB28YwH4rFbkQaLoUN8OQQYnD3w2eXpI4ScQfbCUZiJ4yMOIKLyyTc7BQ4uXUw6Ee6%2FxM%2B4Y67ngNBknxIPwuppgIhFcwJyr6EIj%2BLzNj%2FmfR2vhhRlx0BILZoAYruF0caWQ7YxO66UmeguDREAFHYuC7HJviRgVO6ruJH59h%2FC%2FPkgSle8xNzZJULLWq9JMDTE2fjGE146a1Us6PZDGYle6ldWRqn%2FpdpgHKNGrGIdkRK%2BKPETT9nKT6kLyDI8xd9A1FgWmXWRAIHwZ37WyZHOVyCadJEmMVz0MadMjDrPho%2BEIochkVC2xgGiwwsQ6DMv2P7UXqT4x7CdcYGId2BJQQa85EQKmCmwcRejQ9Bm4oATENFPkxPXILHpMPUyWTI5rjNOsIlmEeMbcOCEqInpXACYQ9DDxmFo9vcmsDblcMtg4tqBerNngkIKaFJmrQAPnq1dEzsMXcwjcHdfdCibcAxxA%2Bq%2Fj9m3LM%2FO7WJka4tSidVCjsvo2lQ%2F2ewyoYyXwAYyr2PlRoR5MpgVmSUIrM3PQxXPbgjBOaDQFIyFMJvx3Pc5RSYj12ySVF9fwFPQu2e2KWVoL9q3Ayv3IzpGHUdvdPdrNUdicjsTQ2ISy7QU3DrEytIjvbzJnAkmANXjAFERA0MUoPF3%2F5KFmW14bBNOhwircYgMqoDpUMcDtCmBE82QM2YtdjVLB4kBuKho%2FbcwQdeboqfQartuU3CsCf%2BcXkgYAqp%2F0Ee3RorAZt0AvvOCSI4JICIlGlsV0bsSid%2FNIEALAAzb6HAgyWHBps6xAOwkJIGcB82CxRQq4sJf3FzA70A%2BTRqcqjEMETCoez3mkPcpnoALs0ugJY8kQwrC%2BJE5ik3w9rzrvDRjAQnqgEVvdGrNwlanR0SOKWzxOJOvLJhcd8Cl4AshACUkv9czdMkJCVQSQhp6kp7StAlpVRpK0t0SW6LHeBJnE2QchB5Ccu8kxRghZXGIgZIiSj7gEKMJDClcnX6hgoqJMwiQDigIXg3ioFLCgDgjPtYHYpsF5EiA4kcnN18MZtOrY866dEQAb0FB34OGKHGZQjwW%2FWDHA60cYFaI%2FPjpzquUqdaYGcIq%2BmLez3WLFFCtNBN2QJcrlcoELgiPku5R5dSlJFaCEqEZle1AQzAKC%2B1SotMcBNyQUFuRHRF6OlimSBgjZeTBCwLyc6A%2BP%2FoFRchXTz5ADknYJHxzrJ5pGuIKRQISU6WyKTBBjD8WozmVYWIsto1AS5rxzKlvJu4E%2FvwOiKxRtCWsDM%2BeTHUrmwrCK5BIfMzGkD%2B0Fk5LzBs0jMYXktNDblB06LMNJ09U8pzSLmo14MS0OMjcdrZ31pyQqxJJpRImlSvfYAK8inkYU52QY2FPEVsjoWewpwhRp5yAuNpkqhdb7ku9Seefl2D0B8SMTFD90xi4CSOwwZy9IKkpMtI3FmFUg3%2FkFutpQGNc3pCR7gvC4sgwbupDu3DyEN%2BW6YGLNM21jpB49irxy9BSlHrVDlnihGKHwPrbVFtc%2Bh1rVQKZduxIyojccZIIcOCmhEnC7UkY68WXKQgLi2JCDQkQWJRQuk60hZp0D3rtCTINSeY9Ej2kIKYfGxwOs4j9qMM7fYZiipzgcf7TamnehqdhsiMiCawXnz4xAbyCkLAx5EGbo3Ax1u3dUIKnTxIaxwQTHehPl3V491H0%2BbC5zgpGz7Io%2BmjdhKlPJ01EeMpM7UsRJMi1nGjmJg35i6bQBAAxjO%2FENJubU2mg3ONySEoWklCwdABETcs7ck3jgiuU9pcKKpbgn%2B3YlzV1FzIkB6pmEDOSSyDfPPlQskznctFji0kpgZjW5RZe6x9kYT4KJcXg0bNiCyif%2BpZACCyRMmYsfiKmN9tSO65F0R2OO6ytlEhY5Sj6uRKfFxw0ijJaAx%2Fk3QgnAFSq27%2F2i4GEBA%2BUvTJKK%2F9eISNvG46Em5RZfjTYLdeD8kdXHyrwId%2FDQZUaMCY4gGbke2C8vfjgV%2FY9kkRQOJIn%2FxM9INZSpiBnqX0Q9GlQPpPKAyO5y%2BW5NMPSRdBCUlmuxl40ZfMCnf2Cp044uI9WLFtCi4YVxKjuRCOBWIb4XbIsGdbo4qtMQnNOQz4XDSui7W%2FN6l54qOynCqD3DpWQ%2BmpD7C40D8BZEWGJX3tlAaZBMj1yjvDYKwCJBa201u6nBKE5UE%2B7QSEhCwrXfbRZylAaAkplhBWX50dumrElePyNMRYUrC99UmcSSNgImhFhDI4BXjMtiqkgizUGCrZ8iwFxU6fQ8GEHCFdLewwxYWxgScAYMdMLmcZR6b7rZl95eQVDGVoUKcRMM1ixXQtXNkBETZkVVPg8LoSrdetHzkuM7DjZRHP02tCxA1fmkXKF3VzfN1pc1cv%2F8lbTIkkYpqKM9VOhp65ktYk%2BQ46myFWBapDfyWUCnsnI00QTBQmuFjMZTcd0V2NQ768Fhpby04k2IzNR1wKabuGJqYWwSly6ocMFGTeeI%2BejsWDYgEvr66QgqdcIbFYDNgsm0x9UHY6SCd5%2B7tpsLpKdvhahIDyYmEJQCqMqtCF6UlrE5GXRmbu%2Bvtm3BFSxI6ND6UxIE7GsGMgWqghXxSnaRJuGFveTcK5ZVSPJyjUxe1dKgI6kNF7EZhIZs8y8FVqwEfbM0Xk2ltORVDKZZM40SD3qQoQe0orJEKwPfZwm3YPqwixhUMOndis6MhbmfvLBKjC8sKKIZKbJk8L11oNkCQzCgvjhyyEiQSuJcgCQSG4Mocfgc0Hkwcjal1UNgP0CBPikYqBIk9tONv4kLtBswH07vUCjEaHiFGlLf8MgXKzSgjp2HolRRccAOh0ILHz9qlGgIFkwAnzHJRjWFhlA7ROwINyB5HFj59PRZHFor6voq7l23EPNRwdWhgawqbivLSjRA4htEYUFkjESu67icTg5S0aW1sOkCiIysfJ9UnIWevOOLGpepcBxy1wEhd2WI3AZg7sr9WBmHWyasxMcvY%2FiOmsLtHSWNUWEGk9hScMPShasUA1AcHOtRZlqMeQ0OzYS9vQvYUjOLrzP07BUAFikcJNMi7gIxEw4pL1G54TcmmmoAQ5s7TGWErJZ2Io4yQ0ljRYhL8H5e62oDtLF8aDpnIvZ5R3GWJyAugdiiJW9hQAVTsnCBHhwu7rkBlBX6r3b7ejEY0k5GGeyKv66v%2B6dg7mcJTrWHbtMywbedYqCQ0FPwoytmSWsL8WTtChZCKKzEF7vP6De4x2BJkkniMgSdWhbeBSLtJZR9CTHetK1xb34AYIJ37OegYIoPVbXgJ%2FqDQK%2BbfCtxQRVKQu77WzOoM6SGL7MaZwCGJVk46aImai9fmam%2BWpHG%2B0BtQPWUgZ7RIAlPq6lkECUhZQ2gqWkMYKcYMYaIc4gYCDFHYa2d1nzp3%2BJ1eCBay8IYZ0wQRKGAqvCuZ%2FUgbQPyllosq%2BXtfKIZOzmeJqRazpmmoP%2F76YfkjzV2NlXTDSBYB04SVlNQsFTbGPk1t%2FI4Jktu0XSgifO2ozFOiwd%2F0SssJDn0dn4xqk4GDTTKX73%2FwQyBLdqgJ%2BWx6AQaba3BA9CKEzjtQYIfAsiYamapq80LAamYjinlKXUkxdpIDk0puXUEYzSalfRibAeDAKpNiqQ0FTwoxuGYzRnisyTotdVTclis1LHRQCy%2FqqL8oUaQzWRxilq5Mi0IJGtMY02cGLD69vGjkj3p6pGePKI8bkBv5evq8SjjyU04vJR2cQXQwSJyoinDsUJHCQ50jrFTT7yRdbdYQMB3MYCb6uBzJ9ewhXYPAIZSXfeEQBZZ3GPN3Nbhh%2FwkvAJLXnQMdi5NYYZ5GHE400GS5rXkOZSQsdZgIbzRnF9ueLnsfQ47wHAsirITnTlkCcuWWIUhJSbpM3wWhXNHvt2xUsKKMpdBSbJnBMcihkoDqAd1Zml%2FR4yrzow1Q2A5G%2Bkzo%2FRhRxQS2lCSDRV8LlYLBOOoo1bF4jwJAwKMK1tWLHlu9i0j4Ig8qVm6wE1DxXwAwQwsaBWUg2pOOol2dHxyt6npwJEdLDDVYyRc2D0HbcbLUJQj8gPevQBUBOUHXPrsAPBERICpnYESeu2OHotpXQxRGlCCtLdIsu23MhZVEoJg8Qumj%2FUMMc34IBqTKLDTp76WzL%2FdMjCxK7MjhiGjeYAC%2Fkj%2FjY%2FRde7hpSM1xChrog6yZ7OWTuD56xBJnGFE%2BpT2ElSyCnJcwVzCjkqeNLfMEJqKW0G7OFIp0G%2B9mh50I9o8k1tpCY0xYqFNIALgIfc2me4n1bmJnRZ89oepgLPT0NTMLNZsvSCZAc3TXaNB07vail36%2FdBySis4m9%2FDR8izaLJW6bWCkVgm5T%2Bius3ZXq4xI%2BGnbveLbdRwF2mNtsrE0JjYc1AXknCOrLSu7Te%2Fr4dPYMCl5qtiHNTn%2BTPbh1jCBHH%2BdMJNhwNgs3nT%2BOhQoQ0vYif56BMG6WowAcHR3DjQolxLzyVekHj00PBAaW7IIAF1EF%2BuRIWyXjQMAs2chdpaKPNaB%2BkSezYt0%2BCA04sOg5vx8Fr7Ofa9sUv87h7SLAUFSzbetCCZ9pmyLt6l6%2FTzoA1%2FZBG9bIUVHLAbi%2FkdBFgYGyGwRQGBpkqCEg2ah9UD6EedEcEL3j4y0BQQCiExEnocA3SZboh%2Bepgd3YsOkHskZwPuQ5OoyA0fTA5AXrHcUOQF%2BzkJHIA7PwCDk1gGVmGUZSSoPhNf%2BTklauz98QofOlCIQ%2FtCD4dosHYPqtPCXB3agggQQIqQJsSkB%2Bqn0rkQ1toJjON%2FOtCIB9RYv3PqRA4C4U68ZMlZn6BdgEvi2ziU%2BTQ6NIw3ej%2BAtDwMGEZk7e2IjxUWKdAxyaw9OCwSmeADTPPleyk6UhGDNXQb%2B%2BW6Uk4q6F7%2Frg6WVTo82IoCxSIsFDrav4EPHphD3u4hR53WKVvYZUwNCCeM4PMBWzK%2BEfIthZOkuAwPo5C5jgoZgn6dUdvx5rIDmd58cXXdKNfw3l%2BwM2UjgrDJeQHhbD7HW2QDoZMCujgIUkk5Fg8VCsdyjOtnGRx8wgKRPZN5dR0zPUyfGZFVihbFRniXZFOZGKPnEQzU3AnD1KfR6weHW2XS6KbPJxUkOTZsAB9vTVp3Le1F8q5l%2BDMcLiIq78jxAImD2pGFw0VHfRatScGlK6SMu8leTmhUSMy8Uhdd6xBiH3Gdman4tjQGLboJfqz6fL2WKHTmrfsKZRYX6BTDjDldKMosaSTLdQS7oDisJNqAUhw1PfTlnacCO8vl8706Km1FROgLDmudzxg%2BEWTiArtHgLsRrAXYWdB0NmToNCJdKm0KWycZQqb%2BMw76Qy29iQ5up%2FX7oyw8QZ75kP5F6iJAJz6KCmqxz8fEa%2FxnsMYcIO%2FvEkGRuMckhr4rIeLrKaXnmIzlNLxbFspOphkcnJdnz%2FChp%2FVlpj2P7jJQmQRwGnltkTV5dbF9fE3%2FfxoSqTROgq9wFUlbuYzYcasE0ouzBo%2BdDCDzxKAfhbAZYxQiHrLzV2iVexnDX%2FQnT1fsT%2Fxuhu1ui5qIytgbGmRoQkeQooO8eJNNZsf0iALur8QxZFH0nCMnjerYQqG1pIfjyVZWxhVRznmmfLG00BcBWJE6hzQWRyFknuJnXuk8A5FRDCulwrWASSNoBtR%2BCtGdkPwYN2o7DOw%2FVGlCZPusRBFXODQdUM5zeHDIVuAJBLqbO%2Ff9Qua%2BpDqEPk230Sob9lEZ8BHiCorjVghuI0lI4JDgHGRDD%2FprQ84B1pVGkIpVUAHCG%2Biz3Bn3qm2AVrYcYWhock4jso5%2BJ7HfHVj4WMIQdGctq3psBCVVzupQOEioBGA2Bk%2BUILT7%2BVoX5mdxxA5fS42gISQVi%2FHTzrgMxu0fY6hE1ocUwwbsbWcezrY2n6S8%2F6cxXkOH4prpmPuFoikTzY7T85C4T2XYlbxLglSv2uLCgFv8Quk%2FwdesUdWPeHYIH0R729JIisN9Apdd4eB10aqwXrPt%2BSu9mA8k8n1sjMwnfsfF2j3jMUzXepSHmZ%2FBfqXvzgUNQQWOXO8YEuFBh4QTYCkOAPxywpYu1VxiDyJmKVcmJPGWk%2Fgc3Pov02StyYDahwmzw3E1gYC9wkupyWfDqDSUMpCTH5e5N8B%2F%2FlHiMuIkTNw4USHrJU67bjXGqNav6PBuQSoqTxc8avHoGmvqNtXzIaoyMIQIiiUHIM64cXieouplhNYln7qgc4wBVAYR104kO%2BCvKqsg4yIUlFNThVUAKZxZt1XA34h3TCUUiXVkZ0w8Hh2R0Z5L0b4LZvPd%2Fp1gi%2F07h8qfwHrByuSxglc9cI4QIg2oqvC%2Fqm0i7tjPLTgDhoWTAKDO2ONW5oe%2B%2FeKB9vZB8K6C25yCZ9RFVMnb6NRdRjyVK57CHHSkJBfnM2%2Fj4ODUwRkqrtBBCrDsDpt8jhZdXoy%2F1BCqw3sSGhgGGy0a5Jw6BP%2FTExoCmNFYjZl248A0osgPyGEmRA%2BfAsqPVaNAfytu0vuQJ7rk3J4kTDTR2AlCHJ5cls26opZM4w3jMULh2YXKpcqGBtuleAlOZnaZGbD6DHzMd6i2oFeJ8z9XYmalg1Szd%2FocZDc1C7Y6vcALJz2lYnTXiWEr2wawtoR4g3jvWUU2Ngjd1cewtFzEvM1NiHZPeLlIXFbBPawxNgMwwAlyNSuGF3zizVeOoC9bag1qRAQKQE%2FEZBWC2J8mnXAN2aTBboZ7HewnObE8CwROudZHmUM5oZ%2FUgd%2FJZQK8lvAm43uDRAbyW8gZ%2BZGq0EVerVGUKUSm%2FIdn8AQHdR4m7bue88WBwft9mSCeMOt1ncBwziOmJYI2ZR7ewNMPiCugmSsE4EyQ%2BQATJG6qORMGd4snEzc6B4shPIo4G1T7PgSm8PY5eUkPdF8JZ0VBtadbHXoJgnEhZQaODPj2gpODKJY5Yp4DOsLBFxWbvXN755KWylJm%2BoOd4zEL9Hpubuy2gyyfxh8oEfFutnYWdfB8PdESLWYvSqbElP9qo3u6KTmkhoacDauMNNjj0oy40DFV7Ql0aZj77xfGl7TJNHnIwgqOkenruYYNo6h724%2BzUQ7%2BvkCpZB%2BpGA562hYQiDxHVWOq0oDQl%2FQsoiY%2BcuI7iWq%2FZIBtHcXJ7kks%2Bh2fCNUPA82BzjnqktNts%2BRLdk1VSu%2BtqEn7QZCCsvEqk6FkfiOYkrsw092J8jsfIuEKypNjLxrKA9kiA19mxBD2suxQKCzwXGws7kEJvlhUiV9tArLIdZW0IORcxEzdzKmjtFhsjKy%2F44XYXdI5noQoRcvjZ1RMPACRqYg2V1%2BOwOepcOknRLLFdYgTkT5UApt%2FJhLM3jeFYprZV%2BZow2g8fP%2BU68hkKFWJj2yBbKqsrp25xkZX1DAjUw52IMYWaOhab8Kp05VrdNftqwRrymWF4OQSjbdfzmRZirK8FMJELEgER2PHjEAN9pGfLhCUiTJFbd5LBkOBMaxLr%2FA1SY9dXFz4RjzoU9ExfJCmx%2FI9FKEGT3n2cmzl2X42L3Jh%2BAbQq6sA%2BSs1kitoa4TAYgKHaoybHUDJ51oETdeI%2F9ThSmjWGkyLi5QAGWhL0BG1UsTyRGRJOldKBrYJeB8ljLJHfATWTEQBXBDnQexOHTB%2BUn44zExFE4vLytcu5NwpWrUxO%2F0ZICUGM7hGABXym0V6ZvDST0E370St9MIWQOTWngeoQHUTdCJUP04spMBMS8LSker9cReVQkULFDIZDFPrhTzBl6sed9wcZQTbL%2BBDqMyaN3RJPh%2Fanbx%2BIv%2BqgQdAa3M9Z5JmvYlh4qop%2BHo1F1W5gbOE9YKLgAnWytXElU4G8GtW47lhgFE6gaSs%2Bgs37sFvi0PPVvA5dnCBgILTwoKd%2F%2BDoL9F6inlM7H4rOTzD79KJgKlZO%2FZgt22UsKhrAaXU5ZcLrAglTVKJEmNJvORGN1vqrcfSMizfpsgbIe9zno%2BgBoKVXgIL%2FVI8dB1O5o%2FR3Suez%2FgD7M781ShjKpIIORM%2FnxG%2BjjhhgPwsn2IoXsPGPqYHXA63zJ07M2GPEykQwJBYLK808qYxuIew4frk52nhCsnCYmXiR6CuapvE1IwRB4%2FQftDbEn%2BAucIr1oxrLabRj9q4ae0%2BfXkHnteAJwXRbVkR0mctVSwEbqhJiMSZUp9DNbEDMmjX22m3ABpkrPQQTP3S1sib5pD2VRKRd%2BeNAjLYyT0hGrdjWJZy24OYXRoWQAIhGBZRxuBFMjjZQhpgrWo8SiFYbojcHO8V5DyscJpLTHyx9Fimassyo5U6WNtquUMYgccaHY5amgR3PQzq3ToNM5ABnoB9kuxsebqmYZm0R9qxJbFXCQ1UPyFIbxoUraTJFDpCk0Wk9GaYJKz%2F6oHwEP0Q14lMtlddQsOAU9zlYdMVHiT7RQP3XCmWYDcHCGbVRHGnHuwzScA0BaSBOGkz3lM8CArjrBsyEoV6Ys4qgDK3ykQQPZ3hCRGNXQTNNXbEb6tDiTDLKOyMzRhCFT%2BmAUmiYbV3YQVqFVp9dorv%2BTsLeCykS2b5yyu8AV7IS9cxcL8z4Kfwp%2BxJyYLv1OsxQCZwTB4a8BZ%2F5EdxTBJthApqyfd9u3ifr%2FWILTqq5VqgwMT9SOxbSGWLQJUUWCVi4k9tho9nEsbUh7U6NUsLmkYFXOhZ0kmamaJLRNJzSj%2Fqn4Mso6zb6iLLBXoaZ6AqeWCjHQm2lztnejYYM2eubnpBdKVLORZhudH3JF1waBJKA9%2BW8EhMj3Kzf0L4vi4k6RoHh3Z5YgmSZmk6ns4fjScjAoL8GoOECgqgYEBYUGFVO4FUv4%2FYtowhEmTs0vrvlD%2FCrisnoBNDAcUi%2FteY7OctFlmARQzjOItrrlKuPO6E2Ox93L4O%2F4DcgV%2FdZ7qR3VBwVQxP1GCieA4RIpweYJ5FoYrHxqRBdJjnqbsikA2Ictbb8vE1GYIo9dacK0REgDX4smy6GAkxlH1yCGGsk%2BtgiDhNKuKu3yNrMdxafmKTF632F8Vx4BNK57GvlFisrkjN9WDAtjsWA0ENT2e2nETUb%2Fn7qwhvGnrHuf5bX6Vh%2Fn3xffU3PeHdR%2BFA92i6ufT3AlyAREoNDh6chiMWTvjKjHDeRhOa9YkOQRq1vQXEMppAQVwHCuIcV2g5rBn6GmZZpTR7vnSD6ZmhdSl176gqKTXu5E%2BYbfL0adwNtHP7dT7t7b46DVZIkzaRJOM%2BS6KcrzYVg%2BT3wSRFRQashjfU18NutrKa%2F7PXbtuJvpIjbgPeqd%2BpjmRw6YKpnANFSQcpzTZgpSNJ6J7uiagAbir%2F8tNXJ%2FOsOnRh6iuIexxrmkIneAgz8QoLmiaJ8sLQrELVK2yn3wOHp57BAZJhDZjTBzyoRAuuZ4eoxHruY1pSb7qq79cIeAdOwin4GdgMeIMHeG%2BFZWYaiUQQyC5b50zKjYw97dFjAeY2I4Bnl105Iku1y0lMA1ZHolLx19uZnRdILcXKlZGQx%2FGdEqSsMRU1BIrFqRcV1qQOOHyxOLXEGcbRtAEsuAC2V4K3p5mFJ22IDWaEkk9ttf5Izb2LkD1MnrSwztXmmD%2FQi%2FEmVEFBfiKGmftsPwVaIoZanlKndMZsIBOskFYpDOq3QUs9aSbAAtL5Dbokus2G4%2FasthNMK5UQKCOhU97oaOYNGsTah%2BjfCKsZnTRn5TbhFX8ghg8CBYt%2FBjeYYYUrtUZ5jVij%2Fop7V5SsbA4mYTOwZ46hqdpbB6Qvq3AS2HHNkC15pTDIcDNGsMPXaBidXYPHc6PJAkRh29Vx8KcgX46LoUQBhRM%2B3SW6Opll%2FwgxxsPgKJKzr5QCmwkUxNbeg6Wj34SUnEzOemSuvS2OetRCO8Tyy%2BQbSKVJcqkia%2BGvDefFwMOmgnD7h81TUtMn%2BmRpyJJ349HhAnoWFTejhpYTL9G8N2nVg1qkXBeoS9Nw2fB27t7trm7d%2FQK7Cr4uoCeOQ7%2F8JfKT77KiDzLImESHw%2F0wf73QeHu74hxv7uihi4fTX%2BXEwAyQG3264dwv17aJ5N335Vt9sdrAXhPOAv8JFvzqyYXwfx8WYJaef1gMl98JRFyl5Mv5Uo%2FoVH5ww5OzLFsiTPDns7fS6EURSSWd%2F92BxMYQ8sBaH%2Bj%2BwthQPdVgDGpTfi%2BJQIWMD8xKqULliRH01rTeyF8x8q%2FGBEEEBrAJMPf25UQwi0b8tmqRXY7kIvNkzrkvRWLnxoGYEJsz8u4oOyMp8cHyaybb1HdMCaLApUE%2B%2F7xLIZGP6H9xuSEXp1zLIdjk5nBaMuV%2FyTDRRP8Y2ww5RO6d2D94o%2B6ucWIqUAvgHIHXhZsmDhjVLczmZ3ca0Cb3PpKwt2UtHVQ0BgFJsqqTsnzZPlKahRUkEu4qmkJt%2Bkqdae76ViWe3STan69yaF9%2BfESD2lcQshLHWVu4ovItXxO69bqC5p1nZLvI8NdQB9s9UNaJGlQ5mG947ipdDA0eTIw%2FA1zEdjWquIsQXXGIVEH0thC5M%2BW9pZe7IhAVnPJkYCCXN5a32HjN6nsvokEqRS44tGIs7s2LVTvcrHAF%2BRVmI8L4HUYk4x%2B67AxSMJKqCg8zrGOgvK9kNMdDrNiUtSWuHFpC8%2Fp5qIQrEo%2FH%2B1l%2F0cAwQ2nKmpWxKcMIuHY44Y6DlkpO48tRuUGBWT0FyHwSKO72Ud%2BtJUfdaZ4CWNijzZtlRa8%2BCkmO%2FEwHYfPZFU%2FhzjFWH7vnzHRMo%2BaF9u8qHSAiEkA2HjoNQPEwHsDKOt6hOoK3Ce%2F%2B%2F9boMWDa44I6FrQhdgS7OnNaSzwxWKZMcyHi6LN4WC6sSj0qm2PSOGBTvDs%2FGWJS6SwEN%2FULwpb4LQo9fYjUfSXRwZkynUazlSpvX9e%2BG2zor8l%2BYaMxSEomDdLHGcD6YVQPegTaA74H8%2BV4WvJkFUrjMLGLlvSZQWvi8%2FQA7yzQ8GPno%2F%2F5SJHRP%2FOqKObPCo81s%2F%2B6WgLqykYpGAgQZhVDEBPXWgU%2FWzFZjKUhSFInufPRiMAUULC6T11yL45ZrRoB4DzOyJShKXaAJIBS9wzLYIoCEcJKQW8GVCx4fihqJ6mshBUXSw3wWVj3grrHQlGNGhIDNNzsxQ3M%2BGWn6ASobIWC%2BLbYOC6UpahVO13Zs2zOzZC8z7FmA05JhUGyBsF4tsG0drcggIFzgg%2Fkpf3%2BCnAXKiMgIE8Jk%2FMhpkc8DUJEUzDSnWlQFme3d0sHZDrg7LavtsEX3cHwjCYA17pMTfx8Ajw9hHscN67hyo%2BRJQ4458RmPywXykkVcW688oVUrQhahpPRvTWPnuI0B%2BSkQu7dCyvLRyFYlC1LG1gRCIvn3rwQeINzZQC2KXq31FaR9UmVV2QeGVqBHjmE%2BVMd3b1fhCynD0pQNhCG6%2FWCDbKPyE7NRQzL3BzQAJ0g09aUzcQA6mUp9iZFK6Sbp%2FYbHjo%2B%2B7%2FWj8S4YNa%2BZdqAw1hDrKWFXv9%2BzaXpf8ZTDSbiqsxnwN%2FCzK5tPkOr4tRh2kY3Bn9JtalbIOI4b3F7F1vPQMfoDcdxMS8CW9m%2FNCW%2FHILTUVWQIPiD0j1A6bo8vsv6P1hCESl2abrSJWDrq5sSzUpwoxaCU9FtJyYH4QFMxDBpkkBR6kn0LMPO%2B5EJ7Z6bCiRoPedRZ%2FP0SSdii7ZnPAtVwwHUidcdyspwncz5uq6vvm4IEDbJVLUFCn%2FLvIHfooUBTkFO130FC7CmmcrKdgDJcid9mvVzsDSibOoXtIf9k6ABle3PmIxejodc4aob0QKS432srrCMndbfD454q52V01G4q913mC5HOsTzWF4h2No1av1VbcUgWAqyoZl%2B11PoFYnNv2HwAODeNRkHj%2B8SF1fcvVBu6MrehHAZK1Gm69ICcTKizykHgGFx7QdowTVAsYEF2tVc0Z6wLryz2FI1sc5By2znJAAmINndoJiB4sfPdPrTC8RnkW7KRCwxC6YvXg5ahMlQuMpoCSXjOlBy0Kij%2BbsCYPbGp8BdCBiLmLSAkEQRaieWo1SYvZIKJGj9Ur%2FeWHjiB7SOVdqMAVmpBvfRiebsFjger7DC%2B8kRFGtNrTrnnGD2GAJb8rQCWkUPYHhwXsjNBSkE6lGWUj5QNhK0DMNM2l%2BkXRZ0KLZaGsFSIdQz%2FHXDxf3%2FTE30%2BDgBKWGWdxElyLccJfEpjsnszECNoDGZpdwdRgCixeg9L4EPhH%2BRptvRMVRaahu4cySjS3P5wxAUCPkmn%2BrhyASpmiTaiDeggaIxYBmtLZDDhiWIJaBgzfCsAGUF1Q1SFZYyXDt9skCaxJsxK2Ms65dmdp5WAZyxik%2FzbrTQk5KmgxCg%2Ff45L0jywebOWUYFJQAJia7XzCV0x89rpp%2Ff3AVWhSPyTanqmik2SkD8A3Ml4NhIGLAjBXtPShwKYfi2eXtrDuKLk4QlSyTw1ftXgwqA2jUuopDl%2B5tfUWZNwBpEPXghzbBggYCw%2Fdhy0ntds2yeHCDKkF%2FYxQjNIL%2FF%2F37jLPHCKBO9ibwYCmuxImIo0ijV2Wbg3kSN2psoe8IsABv3RNFaF9uMyCtCYtqcD%2BqNOhwMlfARQUdJ2tUX%2BMNJqOwIciWalZsmEjt07tfa8ma4cji9sqz%2BQ9hWfmMoKEbIHPOQORbhQRHIsrTYlnVTNvcq1imqmmPDdVDkJgRcTgB8Sb6epCQVmFZe%2BjGDiNJQLWnfx%2BdrTKYjm0G8yH0ZAGMWzEJhUEQ4Maimgf%2Fbkvo8PLVBsZl152y5S8%2BHRDfZIMCbYZ1WDp4yrdchOJw8k6R%2B%2F2pHmydK4NIK2PHdFPHtoLmHxRDwLFb7eB%2BM4zNZcB9NrAgjVyzLM7xyYSY13ykWfIEEd2n5%2FiYp3ZdrCf7fL%2Ben%2BsIJu2W7E30MrAgZBD1rAAbZHPgeAMtKCg3NpSpYQUDWJu9bT3V7tOKv%2BNRiJc8JAKqqgCA%2FPNRBR7ChpiEulyQApMK1AyqcWnpSOmYh6yLiWkGJ2mklCSPIqN7UypWj3dGi5MvsHQ87MrB4VFgypJaFriaHivwcHIpmyi5LhNqtem4q0n8awM19Qk8BOS0EsqGscuuydYsIGsbT5GHnERUiMpKJl4ON7qjB4fEqlGN%2FhCky89232UQCiaeWpDYCJINXjT6xl4Gc7DxRCtgV0i1ma4RgWLsNtnEBRQFqZggCLiuyEydmFd7WlogpkCw5G1x4ft2psm3KAREwVwr1Gzl6RT7FDAqpVal34ewVm3VH4qn5mjGj%2BbYL1NgfLNeXDwtmYSpwzbruDKpTjOdgiIHDVQSb5%2FzBgSMbHLkxWWgghIh9QTFSDILixVwg0Eg1puooBiHAt7DzwJ7m8i8%2Fi%2BjHvKf0QDnnHVkVTIqMvIQImOrzCJwhSR7qYB5gSwL6aWL9hERHCZc4G2%2BJrpgHNB8eCCmcIWIQ6rSdyPCyftXkDlErUkHafHRlkOIjxGbAktz75bnh50dU7YHk%2BMz7wwstg6RFZb%2BTZuSOx1qqP5C66c0mptQmzIC2dlpte7vZrauAMm%2F7RfBYkGtXWGiaWTtwvAQiq2oD4YixPLXE2khB2FRaNRDTk%2B9sZ6K74Ia9VntCpN4BhJGJMT4Z5c5FhSepRCRWmBXqx%2BwhVZC4me4saDs2iNqXMuCl6iAZflH8fscC1sTsy4PHeC%2BXYuqMBMUun5YezKbRKmEPwuK%2BCLzijPEQgfhahQswBBLfg%2FGBgBiI4QwAqzJkkyYAWtjzSg2ILgMAgqxYfwERRo3zruBL9WOryUArSD8sQOcD7fvIODJxKFS615KFPsb68USBEPPj1orNzFY2xoTtNBVTyzBhPbhFH0PI5AtlJBl2aSgNPYzxYLw7XTDBDinmVoENwiGzmngrMo8OmnRP0Z0i0Zrln9DDFcnmOoBZjABaQIbPOJYZGqX%2BRCMlDDbElcjaROLDoualmUIQ88Kekk3iM4OQrADcxi3rJguS4MOIBIgKgXrjd1WkbCdqxJk%2F4efRIFsavZA7KvvJQqp3Iid5Z0NFc5aiMRzGN3vrpBzaMy4JYde3wr96PjN90AYOIbyp6T4zj8LoE66OGcX1Ef4Z3KoWLAUF4BTg7ug%2FAbkG5UNQXAMkQezujSHeir2uTThgd3gpyzDrbnEdDRH2W7U6PeRvBX1ZFMP5RM%2BZu6UUZZD8hDPHldVWntTCNk7To8IeOW9yn2wx0gmurwqC60AOde4r3ETi5pVMSDK8wxhoGAoEX9NLWHIR33VbrbMveii2jAJlrxwytTHbWNu8Y4N8vCCyZjAX%2FpcsfwXbLze2%2BD%2Bu33OGBoJyAAL3jn3RuEcdp5If8O%2Ba4NKWvxOTyDltG0IWoHhwVGe7dKkCWFT%2B%2Btm%2BhaBCikRUUMrMhYKZJKYoVuv%2FbsJzO8DwfVIInQq3g3BYypiz8baogH3r3GwqCwFtZnz4xMjAVOYnyOi5HWbFA8n0qz1OjSpHWFzpQOpvkNETZBGpxN8ybhtqV%2FDMUxd9uFZmBfKXMCn%2FSqkWJyKPnT6lq%2B4zBZni6fYRByJn6OK%2BOgPBGRAJluwGSk4wxjOOzyce%2FPKODwRlsgrVkdcsEiYrqYdXo0Er2GXi2GQZd0tNJT6c9pK1EEJG1zgDJBoTVuCXGAU8BKTvCO%2FcEQ1Wjk3Zzuy90JX4m3O5IlxVFhYkSUwuQB2up7jhvkm%2BbddRQu5F9s0XftGEJ9JSuSk%2BZachCbdU45fEqbugzTIUokwoAKvpUQF%2FCvLbWW5BNQFqFkJg2f30E%2F48StNe5QwBg8zz3YAJ82FZoXBxXSv4QDooDo79NixyglO9AembuBcx5Re3CwOKTHebOPhkmFC7wNaWtoBhFuV4AkEuJ0J%2B1pT0tLkvFVZaNzfhs%2FKd3%2BA9YsImlO4XK4vpCo%2FelHQi%2F9gkFg07xxnuXLt21unCIpDV%2BbbRxb7FC6nWYTsMFF8%2B1LUg4JFjVt3vqbuhHmDKbgQ4e%2BRGizRiO8ky05LQGMdL2IKLSNar0kNG7lHJMaXr5mLdG3nykgj6vB%2FKVijd1ARWkFEf3yiUw1v%2FWaQivVUpIDdSNrrKbjO5NPnxz6qTTGgYg03HgPhDrCFyYZTi3XQw3HXCva39mpLNFtz8AiEhxAJHpWX13gCTAwgm9YTvMeiqetdNQv6IU0hH0G%2BZManTqDLPjyrOse7WiiwOJCG%2BJ0pZYULhN8NILulmYYvmVcV2MjAfA39sGKqGdjpiPo86fecg65UPyXDIAOyOkCx5NQsLeD4gGVjTVDwOHWkbbBW0GeNjDkcSOn2Nq4cEssP54t9D749A7M1AIOBl0Fi0sSO5v3P7LCBrM6ZwFY6kp2FX6AcbGUdybnfChHPyu6WlRZ2Fwv9YM0RMI7kISRgR8HpQSJJOyTfXj%2F6gQKuihPtiUtlCQVPohUgzfezTg8o1b3n9pNZeco1QucaoXe40Fa5JYhqdTspFmxGtW9h5ezLFZs3j%2FN46f%2BS2rjYNC2JySXrnSAFhvAkz9a5L3pza8eYKHNoPrvBRESpxYPJdKVUxBE39nJ1chrAFpy4MMkf0qKgYALctGg1DQI1kIymyeS2AJNT4X240d3IFQb%2F0jQbaHJ2YRK8A%2Bls6WMhWmpCXYG5jqapGs5%2FeOJErxi2%2F2KWVHiPellTgh%2FfNl%2F2KYPKb7DUcAg%2BmCOPQFCiU9Mq%2FWLcU1xxC8aLePFZZlE%2BPCLzf7ey46INWRw2kcXySR9FDgByXzfxiNKwDFbUSMMhALPFSedyjEVM5442GZ4hTrsAEvZxIieSHGSgkwFh%2FnFNdrrFD4tBH4Il7fW6ur4J8Xaz7RW9jgtuPEXQsYk7gcMs2neu3zJwTyUerHKSh1iTBkj2YJh1SSOZL5pLuQbFFAvyO4k1Hxg2h99MTC6cTUkbONQIAnEfGsGkNFWRbuRyyaEZInM5pij73EA9rPIUfU4XoqQpHT9THZkW%2BoKFLvpyvTBMM69tN1Ydwv1LIEhHsC%2BueVG%2Bw%2BkyCPsvV3erRikcscHjZCkccx6VrBkBRusTDDd8847GA7p2Ucy0y0HdSRN6YIBciYa4vuXcAZbQAuSEmzw%2BH%2FAuOx%2BaH%2BtBL88H57D0MsqyiZxhOEQkF%2F8DR1d2hSPMj%2FsNOa5rxcUnBgH8ictv2J%2Bcb4BA4v3MCShdZ2vtK30vAwkobnEWh7rsSyhmos3WC93Gn9C4nnAd%2FPjMMtQfyDNZsOPd6XcAsnBE%2FmRHtHEyJMzJfZFLE9OvQa0i9kUmToJ0ZxknTgdl%2FXPV8xoh0K7wNHHsnBdvFH3sv52lU7UFteseLG%2FVanIvcwycVA7%2BBE1Ulyb20BvwUWZcMTKhaCcmY3ROpvonVMV4N7yBXTL7IDtHzQ4CCcqF66LjF3xUqgErKzolLyCG6Kb7irP%2FMVTCCwGRxfrPGpMMGvPLgJ881PHMNMIO09T5ig7AzZTX%2F5PLlwnJLDAPfuHynSGhV4tPqR3gJ4kg4c06c%2FF1AcjGytKm2Yb5jwMotF7vro4YDLWlnMIpmPg36NgAZsGA0W1spfLSue4xxat0Gdwd0lqDBOgIaMANykwwDKejt5YaNtJYIkrSgu0KjIg0pznY0SCd1qlC6R19g97UrWDoYJGlrvCE05J%2F5wkjpkre727p5PTRX5FGrSBIfJqhJE%2FIS876PaHFkx9pGTH3oaY3jJRvLX9Iy3Edoar7cFvJqyUlOhAEiOSAyYgVEGkzHdug%2BoRHIEOXAExMiTSKU9A6nmRC8mp8iYhwWdP2U%2F5EkFAdPrZw03YA3gSyNUtMZeh7dDCu8pF5x0VORCTgKp07ehy7NZqKTpIC4UJJ89lnboyAfy5OyXzXtuDRbtAFjZRSyGFTpFrXwkpjSLIQIG3N0Vj4BtzK3wdlkBJrO18MNsgseR4BysJilI0wI6ZahLhBFA0XBmV8d4LUzEcNVb0xbLjLTETYN8OEVqNxkt10W614dd1FlFFVTIgB7%2FBQQp1sWlNolpIu4ekxUTBV7NmxOFKEBmmN%2BnA7pvF78%2FRII5ZHA09OAiE%2F66MF6HQ%2BqVEJCHxwymukkNvzqHEh52dULPbVasfQMgTDyBZzx4007YiKdBuUauQOt27Gmy8ISclPmEUCIcuLbkb1mzQSqIa3iE0PJh7UMYQbkpe%2BhXjTJKdldyt2mVPwywoODGJtBV1lJTgMsuSQBlDMwhEKIfrvsxGQjHPCEfNfMAY2oxvyKcKPUbQySkKG6tj9AQyEW3Q5rpaDJ5Sns9ScLKeizPRbvWYAw4bXkrZdmB7CQopCH8NAmqbuciZChHN8lVGaDbCnmddnqO1PQ4ieMYfcSiBE5zzMz%2BJV%2F4eyzrzTEShvqSGzgWimkNxLvUj86iAwcZuIkqdB0VaIB7wncLRmzHkiUQpPBIXbDDLHBlq7vp9xwuC9AiNkIptAYlG7Biyuk8ILdynuUM1cHWJgeB%2BK3wBP%2FineogxkvBNNQ4AkW0hvpBOQGFfeptF2YTR75MexYDUy7Q%2F9uocGsx41O4IZhViw%2F2FvAEuGO5g2kyXBUijAggWM08bRhXg5ijgMwDJy40QeY%2FcQpUDZiIzmvskQpO5G1zyGZA8WByjIQU4jRoFJt56behxtHUUE%2Fom7Rj2psYXGmq3llVOCgGYKNMo4pzwntITtapDqjvQtqpjaJwjHmDzSVGLxMt12gEXAdLi%2FcaHSM3FPRGRf7dB7YC%2BcD2ho6oL2zGDCkjlf%2FDFoQVl8GS%2F56wur3rdV6ggtzZW60MRB3g%2BU1W8o8cvqIpMkctiGVMzXUFI7FacFLrgtdz4mTEr4aRAaQ2AFQaNeG7GX0yOJgMRYFziXdJf24kg%2FgBQIZMG%2FYcPEllRTVNoDYR6oSJ8wQNLuihfw81UpiKPm714bZX1KYjcXJdfclCUOOpvTxr9AAJevTY4HK%2FG7F3mUc3GOAKqh60zM0v34v%2BELyhJZqhkaMA8UMMOU90f8RKEJFj7EqepBVwsRiLbwMo1J2zrE2UYJnsgIAscDmjPjnzI8a719Wxp757wqmSJBjXowhc46QN4RwKIxqEE6E5218OeK7RfcpGjWG1jD7qND%2B%2FGTk6M56Ig4yMsU6LUW1EWE%2BfIYycVV1thldSlbP6ltdC01y3KUfkobkt2q01YYMmxpKRvh1Z48uNKzP%2FIoRIZ%2FF6buOymSnW8gICitpJjKWBscSb9JJKaWkvEkqinAJ2kowKoqkqZftRqfRQlLtKoqvTRDi2vg%2FRrPD%2Fd3a09J8JhGZlEkOM6znTsoMCsuvTmywxTCDhw5dd0GJOHCMPbsj3QLkTE3MInsZsimDQ3HkvthT7U9VA4s6G07sID0FW4SHJmRGwCl%2BMu4xf0ezqeXD2PtPDnwMPo86sbwDV%2B9PWcgFcARUVYm3hrFQrHcgMElFGbSM2A1zUYA3baWfheJp2AINmTJLuoyYD%2FOwA4a6V0ChBN97E8YtDBerUECv0u0TlxR5yhJCXvJxgyM73Bb6pyq0jTFJDZ4p1Am1SA6sh8nADd1hAcGBMfq4d%2FUfwnmBqe0Jun1n1LzrgKuZMAnxA3NtCN7Klf4BH%2B14B7ibBmgt0TGUafVzI4uKlpF7v8NmgNjg90D6QE3tbx8AjSAC%2BOA1YJvclyPKgT27QpIEgVYpbPYGBsnyCNrGz9XUsCHkW1QAHgL2STZk12QGqmvAB0NFteERkvBIH7INDsNW9KKaAYyDMdBEMzJiWaJHZALqDxQDWRntumSDPcplyFiI1oDpT8wbwe01AHhW6%2BvAUUBoGhY3CT2tgwehdPqU%2F4Q7ZLYvhRl%2FogOvR9O2%2BwkkPKW5vCTjD2fHRYXONCoIl4Jh1bZY0ZE1O94mMGn%2FdFSWBWzQ%2FVYk%2BGezi46RgiDv3EshoTmMSlioUK6MQEN8qeyK6FRninyX8ZPeUWjjbMJChn0n%2FyJvrq5bh5UcCAcBYSafTFg7p0jDgrXo2QWLb3WpSOET%2FHh4oSadBTvyDo10IufLzxiMLAnbZ1vcUmj3w7BQuIXjEZXifwukVxrGa9j%2BDXfpi12m1RbzYLg9J2wFergEwOxFyD0%2FJstNK06ZN2XdZSGWxcJODpQHOq4iKqjqkJUmPu1VczL5xTGUfCgLEYyNBCCbMBFT%2FcUP6pE%2FmujnHsSDeWxMbhrNilS5MyYR0nJyzanWXBeVcEQrRIhQeJA6Xt4f2eQESNeLwmC10WJVHqwx8SSyrtAAjpGjidcj1E2FYN0LObUcFQhafUKTiGmHWRHGsFCB%2BHEXgrzJEB5bp0QiF8ZHh11nFX8AboTD0PS4O1LqF8XBks2MpjsQnwKHF6HgaKCVLJtcr0XjqFMRGfKv8tmmykhLRzu%2BvqQ02%2BKpJBjaLt9ye1Ab%2BBbEBhy4EVdIJDrL2naV0o4wU8YZ2Lq04FG1mWCKC%2BUwkXOoAjneU%2FxHplMQo2cXUlrVNqJYczgYlaOEczVCs%2FOCgkyvLmTmdaBJc1iBLuKwmr6qtRnhowngsDxhzKFAi02tf8bmET8BO27ovJKF1plJwm3b0JpMh38%2BxsrXXg7U74QUM8ZCIMOpXujHntKdaRtsgyEZl5MClMVMMMZkZLNxH9%2Bb8fH6%2Bb8Lev30A9TuEVj9CqAdmwAAHBPbfOBFEATAPZ2CS0OH1Pj%2F0Q7PFUcC8hDrxESWdfgFRm%2B7vvWbkEppHB4T%2F1ApWnlTIqQwjcPl0VgS1yHSmD0OdsCVST8CQVwuiew1Y%2Bg3QGFjNMzwRB2DSsAk26cmA8lp2wIU4p93AUBiUHFGOxOajAqD7Gm6NezNDjYzwLOaSXRBYcWipTSONHjUDXCY4mMI8XoVCR%2FRrs%2FJLKXgEx%2BqkmeDlFOD1%2FyTQNDClRuiUyKYCllfMiQiyFkmuTz2vLsBNyRW%2Bxz%2B5FElFxWB28VjYIGZ0Yd%2B5wIjkcoMaggxswbT0pCmckRAErbRlIlcOGdBo4djTNO8FAgQ%2BlT6vPS60BwTRSUAM3ddkEAZiwtEyArrkiDRnS7LJ%2B2hwbzd2YDQagSgACpsovmjil5wfPuXq3GuH0CyE7FK3M4FgRaFoIkaodORrPx1%2BJpI9psyNYIFuJogZa0%2F1AhOWdlHQxdAgbwacsHqPZo8u%2FngAH2GmaTdhYnBfSDbBfh8CHq6Bx5bttP2%2BRdM%2BMAaYaZ0Y%2FADkbNCZuAyAVQa2OcXOeICmDn9Q%2FeFkDeFQg5MgHEDXq%2FtVjj%2Bjtd26nhaaolWxs1ixSUgOBwrDhRIGOLyOVk2%2FBc0UxvseQCO2pQ2i%2BKrfhu%2FWeBovNb5dJxQtJRUDv2mCwYVpNl2efQM9xQHnK0JwLYt%2FU0Wf%2BphiA4uw8G91slC832pmOTCAoZXohg1fewCZqLBhkOUBofBWpMPsqg7XEXgPfAlDo2U5WXjtFdS87PIqClCK5nW6adCeXPkUiTGx0emOIDQqw1yFYGHEVx20xKjJVYe0O8iLmnQr3FA9nSIQilUKtJ4ZAdcTm7%2BExseJauyqo30hs%2B1qSW211A1SFAOUgDlCGq7eTIcMAeyZkV1SQJ4j%2Fe1Smbq4HcjqgFbLAGLyKxlMDMgZavK5NAYH19Olz3la%2FQCTiVelFnU6O%2FGCvykqS%2FwZJDhKN9gBtSOp%2F1SP5VRgJcoVj%2Bkmf2wBgv4gjrgARBWiURYx8xENV3bEVUAAWWD3dYDKAIWk5opaCFCMR5ZjJExiCAw7gYiSZ2rkyTce4eNMY3lfGn%2B8p6%2BvBckGlKEXnA6Eota69OxDO9oOsJoy28BXOR0UoXNRaJD5ceKdlWMJlOFzDdZNpc05tkMGQtqeNF2lttZqNco1VtwXgRstLSQ6tSPChgqtGV5h2DcDReIQadaNRR6AsAYKL5gSFsCJMgfsaZ7DpKh8mg8Wz8V7H%2BgDnLuMxaWEIUPevIbClgap4dqmVWSrPgVYCzAoZHIa5z2Ocx1D%2FGvDOEqMOKLrMefWIbSWHZ6jbgA8qVBhYNHpx0P%2BjAgN5TB3haSifDcApp6yymEi6Ij%2FGsEpDYUgcHATJUYDUAmC1SCkJ4cuZXSAP2DEpQsGUjQmKJfJOvlC2x%2FpChkOyLW7KEoMYc5FDC4v2FGqSoRWiLsbPCiyg1U5yiHZVm1XLkHMMZL11%2Fyxyw0UnGig3MFdZklN5FI%2FqiT65T%2BjOXOdO7XbgWurOAZR6Cv9uu1cm5LjkXX4xi6mWn5r5NjBS0gTliHhMZI2WNqSiSphEtiCAwnafS11JhseDGHYQ5%2BbqWiAYiAv6Jsf79%2FVUs4cIl%2Bn6%2BWOjcgB%2F2l5TreoAV2717JzZbQIR0W1cl%2FdEqCy5kJ3ZSIHuU0vBoHooEpiHeQWVkkkOqRX27eD1FWw4BfO9CJDdKoSogQi3hAAwsPRFrN5RbX7bqLdBJ9JYMohWrgJKHSjVl1sy2xAG0E3sNyO0oCbSGOxCNBRRXTXenYKuwAoDLfnDcQaCwehUOIDiHAu5m5hMpKeKM4sIo3vxACakIxKoH2YWF2QM84e6F5C5hJU4g8uxuFOlAYnqtwxmHyNEawLW%2FPhoawJDrGAP0JYWHgAVUByo%2FbGdiv2T2EMg8gsS14%2FrAdzlOYazFE7w4OzxeKiWdm3nSOnQRRKXSlVo8HEAbBfyJMKqoq%2BSCcTSx5NDtbFwNlh8VhjGGDu7JG5%2FTAGAvniQSSUog0pNzTim8Owc6QTuSKSTXlQqwV3eiEnklS3LeSXYPXGK2VgeZBqNcHG6tZHvA3vTINhV0ELuQdp3t1y9%2BogD8Kk%2FW7QoRN1UWPqM4%2BxdygkFDPLoTaumKReKiLWoPHOfY54m3qPx4c%2B4pgY3MRKKbljG8w4wvz8pxk3AqKsy4GMAkAtmRjRMsCxbb4Q2Ds0Ia9ci8cMT6DmsJG00XaHCIS%2Bo3F8YVVeikw13w%2BOEDaCYYhC0ZE54kA4jpjruBr5STWeqQG6M74HHL6TZ3lXrd99ZX%2B%2B7LhNatQaZosuxEf5yRA15S9gPeHskBIq3Gcw81AGb9%2FO53DYi%2F5CsQ51EmEh8Rkg4vOciClpy4d04eYsfr6fyQkBmtD%2BP8sNh6e%2BXYHJXT%2FlkXxT4KXU5F2sGxYyzfniMMQkb9OjDN2C8tRRgTyL7GwozH14PrEUZc6oz05Emne3Ts5EG7WolDmU8OB1LDG3VrpQxp%2BpT0KYV5dGtknU64JhabdqcVQbGZiAxQAnvN1u70y1AnmvOSPgLI6uB4AuDGhmAu3ATkJSw7OtS%2F2ToPjqkaq62%2F7WFG8advGlRRqxB9diP07JrXowKR9tpRa%2BjGJ91zxNTT1h8I2PcSfoUPtd7NejVoH03EUcqSBuFZPkMZhegHyo2ZAITovmm3zAIdGFWxoNNORiMRShgwdYwFzkPw5PA4a5MIIQpmq%2Bnsp3YMuXt%2FGkXxLx%2FP6%2BZJS0lFyz4MunC3eWSGE8xlCQrKvhKUPXr0hjpAN9ZK4PfEDrPMfMbGNWcHDzjA7ngMxTPnT7GMHar%2BgMQQ3NwHCv4zH4BIMYvzsdiERi6gebRmerTsVwZJTRsL8dkZgxgRxmpbgRcud%2BYlCIRpPwHShlUSwuipZnx9QCsEWziVazdDeKSYU5CF7UVPAhLer3CgJOQXl%2Fzh575R5rsrmRnKAzq4POFdgbYBuEviM4%2BLVC15ssLNFghbTtHWerS1hDt5s4qkLUha%2FqpZXhWh1C6lTQAqCNQnaDjS7UGFBC6wTu8yFnKJnExCnAs3Ok9yj5KpfZESQ4lTy5pTGTnkAUpxI%2ByjEldJfSo4y0QhG4i4IwkRFGcjWY8%2BEzgYYJUK7BXQksLxAww%2FYYWBMhJILB9e8ePEJ4OP7z%2B4%2FwOQDl64iOYDp26DaONPxpKtBxq%2FaTzRGarm3VkPYTLJKx6Z%2FMw2YbBGseJhPMwhhNswrIkyvV2BYzrvZbxLpKwcWJhYmFtVZ%2BlPEq91FzVp1HlQY1bZVLqeNR9SAUn6n0E28k%2FUuGkNpP1DBI5ch%2FEehZfjUQ9aE41NhETExoPT2gGQz0IhWJbEOvTQ4wgcXCHHFBhewYUiFHuhRSAUVmEHeCRQHQkXGFwkAgyzREJCVN7TRnTon36Zw3tPhx4EALwNdwDv%2BJ41YSP4B2CQqz0EFgARZ4ESgBHQgROwAVn9GTI%2BHYexTUevLUeta4%2FDqKrbMVS%2BYqb8hUwYCrlgKtmAq1YCrFgKrd4qpXiqZcKn1oqdWipjYKpWwVPVYqW6xUpVipKqFR3QKjagVEtAqHpxUMTitsnFaJOKx2cVhswq35RVpyiq9lFVNIKnOQVMkgqtYxVNxiqQjFS7GKlSIVIsQqPIhUWwioigFQ%2B%2BKkN8VHr49HDw9Ebo9EDo9DTo9Crg9BDg9%2FWx7gWx7YWwlobYrOGxWPNisAaAHEyALpkAVDIAeWAArsABVXACYuAD5cAF6wAKFQAQqgAbVAAsoAAlQAUaYAfkwAvogBWQACOgAD9AAHSAAKT4GUdMiOvFngBTwCn2AZ7Dv6B6k%2F90B8%2ByRnkV144AIBoAMTQATGgAjNAA4YABgwABZgB%2FmQCwyAVlwCguASlwCEuAQFwB4uAMlwBYuAJlQAUVAAhUD2KgdpUDaJgaRMDFJgX5MC1JgWJEAokQCWRAHxEAWkQBMRADpEAMkQAYROAEecC484DRpwBDTnwNOdw05tjTmiNOYwtswhYFwLA7BYG4LA2BYGOLAwRYFuLAsxYFQJAohIEyJAMwkAwiQC0JAJgkAeiQBkJAFokAPCQA0JABwcD4Dgc4cDdDgaYcDIDgYgUC6CgWgUClCgUYUAVBQBOFAEYMALgwAgDA9QYAdIn8AZzeBB2L5EcWrenUT1KXienEsuJJ7x5U8XlTjc1NVzUyXFTGb1LlpUtWlTDIjqwE4LsagowoCi2gJLKAkpoBgJQNpAIhNqaEoneI6kiiqQ6Go%2Fn6j0cS%2Ba2gEU8gIHJ%2BBwfgZX4GL%2BBd%2FgW34FZ%2BBS%2FgUH4FN6BTegTvoEv6BJegRnYEF2A79gOvYDl2BdEjCkqkGtwXp0LNToIskOTXzh%2FF062yJ7AAAAEDAWAAABWhJ%2BKPEIJgBFxMVP7w2QJBGHASQnOBKXKFIdUK4igKA9IEaYJg%29%3Bsrc%3Aurl%28data%3Aapplication%2Fvnd%2Ems%2Dfontobject%3Bbase64%2Cn04AAEFNAAACAAIABAAAAAAABQAAAAAAAAABAJABAAAEAExQAAAAAAAAAAIAAAAAAAAAAAEAAAAAAAAAJxJ%2FLAAAAAAAAAAAAAAAAAAAAAAAACgARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzAAAADgBSAGUAZwB1AGwAYQByAAAAeABWAGUAcgBzAGkAbwBuACAAMQAuADAAMAA5ADsAUABTACAAMAAwADEALgAwADAAOQA7AGgAbwB0AGMAbwBuAHYAIAAxAC4AMAAuADcAMAA7AG0AYQBrAGUAbwB0AGYALgBsAGkAYgAyAC4ANQAuADUAOAAzADIAOQAAADgARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzACAAUgBlAGcAdQBsAGEAcgAAAAAAQlNHUAAAAAAAAAAAAAAAAAAAAAADAKncAE0TAE0ZAEbuFM3pjM%2FSEdmjKHUbyow8ATBE40IvWA3vTu8LiABDQ%2BpexwUMcm1SMnNryctQSiI1K5ZnbOlXKmnVV5YvRe6RnNMFNCOs1KNVpn6yZhCJkRtVRNzEufeIq7HgSrcx4S8h%2Fv4vnrrKc6oCNxmSk2uKlZQHBii6iKFoH0746ThvkO1kJHlxjrkxs%2BLWORaDQBEtiYJIR5IB9Bi1UyL4Rmr0BNigNkMzlKQmnofBHviqVzUxwdMb3NdCn69hy%2BpRYVKGVS%2F1tnsqv4LL7wCCPZZAZPT4aCShHjHJVNuXbmMrY5LeQaGnvAkXlVrJgKRAUdFjrWEah9XebPeQMj7KS7DIBAFt8ycgC5PLGUOHSE3ErGZCiViNLL5ZARfywnCoZaKQCu6NuFX42AEeKtKUGnr%2FCm2Cy8tpFhBPMW5Fxi4Qm4TkDWh4IWFDClhU2hRWosUWqcKLlgyXB%2BlSHaWaHiWlBAR8SeSgSPCQxdVQgzUixWKSTrIQEbU94viDctkvX%2BVSjJuUmV8L4CXShI11esnp0pjWNZIyxKHS4wVQ2ime1P4RnhvGw0aDN1OLAXGERsB7buFpFGGBAre4QEQR0HOIO5oYH305G%2BKspT%2FFupEGGafCCwxSe6ZUa%2B073rXHnNdVXE6eWvibUS27XtRzkH838mYLMBmYysZTM0EM3A1fbpCBYFccN1B%2FEnCYu%2FTgCGmr7bMh8GfYL%2BBfcLvB0gRagC09w9elfldaIy%2FhNCBLRgBgtCC7jAF63wLSMAfbfAlEggYU0bUA7ACCJmTDpEmJtI78w4%2FBO7dN7JR7J7ZvbYaUbaILSQsRBiF3HGk5fEg6p9unwLvn98r%2BvnsV%2B372uf1xBLq4qU%2F45fTuqaAP%2BpssmCCCTF0mhEow8ZXZOS8D7Q85JsxZ%2BAzok7B7O%2Ff6J8AzYBySZQB%2FQHYUSA%2BEeQhEWiS6AIQzgcsDiER4MjgMBAWDV4AgQ3g1eBgIdweCQmCjJEMkJ%2BPKRWyFHHmg1Wi%2F6xzUgA0LREoKJChwnQa9B%2B5RQZRB3IlBlkAnxyQNaANwHMowzlYSMCBgnbpzvqpl0iTJNCQidDI9ZrSYNIRBhHtUa5YHMHxyGEik9hDE0AKj72AbTCaxtHPUaKZdAZSnQTyjGqGLsmBStCejApUhg4uBMU6mATujEl%2BKdDPbI6Ag4vLr%2BhjY6lbjBeoLKnZl0UZgRX8gTySOeynZVz1wOq7e1hFGYIq%2BMhrGxDLak0PrwYzSXtcuyhXEhwOYofiW%2BEcI%2Fjw8P6IY6ed%2BetAbuqKp5QIapT77LnAe505lMuqL79a0ut4rWexzFttsOsLDy7zvtQzcq3U1qabe7tB0wHWVXji%2BzDbo8x8HyIRUbXnwUcklFv51fvTymiV%2BMXLSmGH9d9%2BaXpD5X6lao41anWGig7IwIdnoBY2ht%2FpO9mClLo4NdXHAsefqWUKlXJkbqPOFhMoR4aiA1BXqhRNbB2Xwi%2B7u%2FjpAoOpKJ0UX24EsrzMfHXViakCNcKjBxuQX8BO0ZqjJ3xXzf%2B61t2VXOSgJ8xu65QKgtN6FibPmPYsXbJRHHqbgATcSZxBqGiDiU4NNNsYBsKD0MIP%2FOfKnlk%2FLkaid%2FO2NbKeuQrwOB2Gq3YHyr6ALgzym5wIBnsdC1ZkoBFZSQXChZvlesPqvK2c5oHHT3Q65jYpNxnQcGF0EHbvYqoFw60WNlXIHQF2HQB7zD6lWjZ9rVqUKBXUT6hrkZOle0RFYII0V5ZYGl1JAP0Ud1fZZMvSomBzJ710j4Me8mjQDwEre5Uv2wQfk1ifDwb5ksuJQQ3xt423lbuQjvoIQByQrNDh1JxGFkOdlJvu%2FgFtuW0wR4cgd%2BZKesSV7QkNE2kw6AV4hoIuC02LGmTomyf8PiO6CZzOTLTPQ%2BHW06H%2Btx%2BbQ8LmDYg1pTFrp2oJXgkZTyeRJZM0C8aE2LpFrNVDuhARsN543%2FFV6klQ6Tv1OoZGXLv0igKrl%2FCmJxRmX7JJbJ998VSIPQRyDBICzl4JJlYHbdql30NvYcOuZ7a10uWRrgoieOdgIm4rlq6vNOQBuqESLbXG5lzdJGHw2m0sDYmODXbYGTfSTGRKpssTO95fothJCjUGQgEL4yKoGAF%2F0SrpUDNn8CBgBcSDQByAeNkCXp4S4Ro2Xh4OeaGRgR66PVOsU8bc6TR5%2FxTcn4IVMLOkXSWiXxkZQCbvKfmoAvQaKjO3EDKwkwqHChCDEM5loQRPd5ACBki1TjF772oaQhQbQ5C0lcWXPFOzrfsDGUXGrpxasbG4iab6eByaQkQfm0VFlP0ZsDkvvqCL6QXMUwCjdMx1ZOyKhTJ7a1GWAdOUcJ8RSejxNVyGs31OKMyRyBVoZFjqIkmKlLQ5eHMeEL4MkUf23cQ%2F1SgRCJ1dk4UdBT7OoyuNgLs0oCd8RnrEIb6QdMxT2QjD4zMrJkfgx5aDMcA4orsTtKCqWb%2FVeyceqa5OGSmB28YwH4rFbkQaLoUN8OQQYnD3w2eXpI4ScQfbCUZiJ4yMOIKLyyTc7BQ4uXUw6Ee6%2FxM%2B4Y67ngNBknxIPwuppgIhFcwJyr6EIj%2BLzNj%2FmfR2vhhRlx0BILZoAYruF0caWQ7YxO66UmeguDREAFHYuC7HJviRgVO6ruJH59h%2FC%2FPkgSle8xNzZJULLWq9JMDTE2fjGE146a1Us6PZDGYle6ldWRqn%2FpdpgHKNGrGIdkRK%2BKPETT9nKT6kLyDI8xd9A1FgWmXWRAIHwZ37WyZHOVyCadJEmMVz0MadMjDrPho%2BEIochkVC2xgGiwwsQ6DMv2P7UXqT4x7CdcYGId2BJQQa85EQKmCmwcRejQ9Bm4oATENFPkxPXILHpMPUyWTI5rjNOsIlmEeMbcOCEqInpXACYQ9DDxmFo9vcmsDblcMtg4tqBerNngkIKaFJmrQAPnq1dEzsMXcwjcHdfdCibcAxxA%2Bq%2Fj9m3LM%2FO7WJka4tSidVCjsvo2lQ%2F2ewyoYyXwAYyr2PlRoR5MpgVmSUIrM3PQxXPbgjBOaDQFIyFMJvx3Pc5RSYj12ySVF9fwFPQu2e2KWVoL9q3Ayv3IzpGHUdvdPdrNUdicjsTQ2ISy7QU3DrEytIjvbzJnAkmANXjAFERA0MUoPF3%2F5KFmW14bBNOhwircYgMqoDpUMcDtCmBE82QM2YtdjVLB4kBuKho%2FbcwQdeboqfQartuU3CsCf%2BcXkgYAqp%2F0Ee3RorAZt0AvvOCSI4JICIlGlsV0bsSid%2FNIEALAAzb6HAgyWHBps6xAOwkJIGcB82CxRQq4sJf3FzA70A%2BTRqcqjEMETCoez3mkPcpnoALs0ugJY8kQwrC%2BJE5ik3w9rzrvDRjAQnqgEVvdGrNwlanR0SOKWzxOJOvLJhcd8Cl4AshACUkv9czdMkJCVQSQhp6kp7StAlpVRpK0t0SW6LHeBJnE2QchB5Ccu8kxRghZXGIgZIiSj7gEKMJDClcnX6hgoqJMwiQDigIXg3ioFLCgDgjPtYHYpsF5EiA4kcnN18MZtOrY866dEQAb0FB34OGKHGZQjwW%2FWDHA60cYFaI%2FPjpzquUqdaYGcIq%2BmLez3WLFFCtNBN2QJcrlcoELgiPku5R5dSlJFaCEqEZle1AQzAKC%2B1SotMcBNyQUFuRHRF6OlimSBgjZeTBCwLyc6A%2BP%2FoFRchXTz5ADknYJHxzrJ5pGuIKRQISU6WyKTBBjD8WozmVYWIsto1AS5rxzKlvJu4E%2FvwOiKxRtCWsDM%2BeTHUrmwrCK5BIfMzGkD%2B0Fk5LzBs0jMYXktNDblB06LMNJ09U8pzSLmo14MS0OMjcdrZ31pyQqxJJpRImlSvfYAK8inkYU52QY2FPEVsjoWewpwhRp5yAuNpkqhdb7ku9Seefl2D0B8SMTFD90xi4CSOwwZy9IKkpMtI3FmFUg3%2FkFutpQGNc3pCR7gvC4sgwbupDu3DyEN%2BW6YGLNM21jpB49irxy9BSlHrVDlnihGKHwPrbVFtc%2Bh1rVQKZduxIyojccZIIcOCmhEnC7UkY68WXKQgLi2JCDQkQWJRQuk60hZp0D3rtCTINSeY9Ej2kIKYfGxwOs4j9qMM7fYZiipzgcf7TamnehqdhsiMiCawXnz4xAbyCkLAx5EGbo3Ax1u3dUIKnTxIaxwQTHehPl3V491H0%2BbC5zgpGz7Io%2BmjdhKlPJ01EeMpM7UsRJMi1nGjmJg35i6bQBAAxjO%2FENJubU2mg3ONySEoWklCwdABETcs7ck3jgiuU9pcKKpbgn%2B3YlzV1FzIkB6pmEDOSSyDfPPlQskznctFji0kpgZjW5RZe6x9kYT4KJcXg0bNiCyif%2BpZACCyRMmYsfiKmN9tSO65F0R2OO6ytlEhY5Sj6uRKfFxw0ijJaAx%2Fk3QgnAFSq27%2F2i4GEBA%2BUvTJKK%2F9eISNvG46Em5RZfjTYLdeD8kdXHyrwId%2FDQZUaMCY4gGbke2C8vfjgV%2FY9kkRQOJIn%2FxM9INZSpiBnqX0Q9GlQPpPKAyO5y%2BW5NMPSRdBCUlmuxl40ZfMCnf2Cp044uI9WLFtCi4YVxKjuRCOBWIb4XbIsGdbo4qtMQnNOQz4XDSui7W%2FN6l54qOynCqD3DpWQ%2BmpD7C40D8BZEWGJX3tlAaZBMj1yjvDYKwCJBa201u6nBKE5UE%2B7QSEhCwrXfbRZylAaAkplhBWX50dumrElePyNMRYUrC99UmcSSNgImhFhDI4BXjMtiqkgizUGCrZ8iwFxU6fQ8GEHCFdLewwxYWxgScAYMdMLmcZR6b7rZl95eQVDGVoUKcRMM1ixXQtXNkBETZkVVPg8LoSrdetHzkuM7DjZRHP02tCxA1fmkXKF3VzfN1pc1cv%2F8lbTIkkYpqKM9VOhp65ktYk%2BQ46myFWBapDfyWUCnsnI00QTBQmuFjMZTcd0V2NQ768Fhpby04k2IzNR1wKabuGJqYWwSly6ocMFGTeeI%2BejsWDYgEvr66QgqdcIbFYDNgsm0x9UHY6SCd5%2B7tpsLpKdvhahIDyYmEJQCqMqtCF6UlrE5GXRmbu%2Bvtm3BFSxI6ND6UxIE7GsGMgWqghXxSnaRJuGFveTcK5ZVSPJyjUxe1dKgI6kNF7EZhIZs8y8FVqwEfbM0Xk2ltORVDKZZM40SD3qQoQe0orJEKwPfZwm3YPqwixhUMOndis6MhbmfvLBKjC8sKKIZKbJk8L11oNkCQzCgvjhyyEiQSuJcgCQSG4Mocfgc0Hkwcjal1UNgP0CBPikYqBIk9tONv4kLtBswH07vUCjEaHiFGlLf8MgXKzSgjp2HolRRccAOh0ILHz9qlGgIFkwAnzHJRjWFhlA7ROwINyB5HFj59PRZHFor6voq7l23EPNRwdWhgawqbivLSjRA4htEYUFkjESu67icTg5S0aW1sOkCiIysfJ9UnIWevOOLGpepcBxy1wEhd2WI3AZg7sr9WBmHWyasxMcvY%2FiOmsLtHSWNUWEGk9hScMPShasUA1AcHOtRZlqMeQ0OzYS9vQvYUjOLrzP07BUAFikcJNMi7gIxEw4pL1G54TcmmmoAQ5s7TGWErJZ2Io4yQ0ljRYhL8H5e62oDtLF8aDpnIvZ5R3GWJyAugdiiJW9hQAVTsnCBHhwu7rkBlBX6r3b7ejEY0k5GGeyKv66v%2B6dg7mcJTrWHbtMywbedYqCQ0FPwoytmSWsL8WTtChZCKKzEF7vP6De4x2BJkkniMgSdWhbeBSLtJZR9CTHetK1xb34AYIJ37OegYIoPVbXgJ%2FqDQK%2BbfCtxQRVKQu77WzOoM6SGL7MaZwCGJVk46aImai9fmam%2BWpHG%2B0BtQPWUgZ7RIAlPq6lkECUhZQ2gqWkMYKcYMYaIc4gYCDFHYa2d1nzp3%2BJ1eCBay8IYZ0wQRKGAqvCuZ%2FUgbQPyllosq%2BXtfKIZOzmeJqRazpmmoP%2F76YfkjzV2NlXTDSBYB04SVlNQsFTbGPk1t%2FI4Jktu0XSgifO2ozFOiwd%2F0SssJDn0dn4xqk4GDTTKX73%2FwQyBLdqgJ%2BWx6AQaba3BA9CKEzjtQYIfAsiYamapq80LAamYjinlKXUkxdpIDk0puXUEYzSalfRibAeDAKpNiqQ0FTwoxuGYzRnisyTotdVTclis1LHRQCy%2FqqL8oUaQzWRxilq5Mi0IJGtMY02cGLD69vGjkj3p6pGePKI8bkBv5evq8SjjyU04vJR2cQXQwSJyoinDsUJHCQ50jrFTT7yRdbdYQMB3MYCb6uBzJ9ewhXYPAIZSXfeEQBZZ3GPN3Nbhh%2FwkvAJLXnQMdi5NYYZ5GHE400GS5rXkOZSQsdZgIbzRnF9ueLnsfQ47wHAsirITnTlkCcuWWIUhJSbpM3wWhXNHvt2xUsKKMpdBSbJnBMcihkoDqAd1Zml%2FR4yrzow1Q2A5G%2Bkzo%2FRhRxQS2lCSDRV8LlYLBOOoo1bF4jwJAwKMK1tWLHlu9i0j4Ig8qVm6wE1DxXwAwQwsaBWUg2pOOol2dHxyt6npwJEdLDDVYyRc2D0HbcbLUJQj8gPevQBUBOUHXPrsAPBERICpnYESeu2OHotpXQxRGlCCtLdIsu23MhZVEoJg8Qumj%2FUMMc34IBqTKLDTp76WzL%2FdMjCxK7MjhiGjeYAC%2Fkj%2FjY%2FRde7hpSM1xChrog6yZ7OWTuD56xBJnGFE%2BpT2ElSyCnJcwVzCjkqeNLfMEJqKW0G7OFIp0G%2B9mh50I9o8k1tpCY0xYqFNIALgIfc2me4n1bmJnRZ89oepgLPT0NTMLNZsvSCZAc3TXaNB07vail36%2FdBySis4m9%2FDR8izaLJW6bWCkVgm5T%2Bius3ZXq4xI%2BGnbveLbdRwF2mNtsrE0JjYc1AXknCOrLSu7Te%2Fr4dPYMCl5qtiHNTn%2BTPbh1jCBHH%2BdMJNhwNgs3nT%2BOhQoQ0vYif56BMG6WowAcHR3DjQolxLzyVekHj00PBAaW7IIAF1EF%2BuRIWyXjQMAs2chdpaKPNaB%2BkSezYt0%2BCA04sOg5vx8Fr7Ofa9sUv87h7SLAUFSzbetCCZ9pmyLt6l6%2FTzoA1%2FZBG9bIUVHLAbi%2FkdBFgYGyGwRQGBpkqCEg2ah9UD6EedEcEL3j4y0BQQCiExEnocA3SZboh%2Bepgd3YsOkHskZwPuQ5OoyA0fTA5AXrHcUOQF%2BzkJHIA7PwCDk1gGVmGUZSSoPhNf%2BTklauz98QofOlCIQ%2FtCD4dosHYPqtPCXB3agggQQIqQJsSkB%2Bqn0rkQ1toJjON%2FOtCIB9RYv3PqRA4C4U68ZMlZn6BdgEvi2ziU%2BTQ6NIw3ej%2BAtDwMGEZk7e2IjxUWKdAxyaw9OCwSmeADTPPleyk6UhGDNXQb%2B%2BW6Uk4q6F7%2Frg6WVTo82IoCxSIsFDrav4EPHphD3u4hR53WKVvYZUwNCCeM4PMBWzK%2BEfIthZOkuAwPo5C5jgoZgn6dUdvx5rIDmd58cXXdKNfw3l%2BwM2UjgrDJeQHhbD7HW2QDoZMCujgIUkk5Fg8VCsdyjOtnGRx8wgKRPZN5dR0zPUyfGZFVihbFRniXZFOZGKPnEQzU3AnD1KfR6weHW2XS6KbPJxUkOTZsAB9vTVp3Le1F8q5l%2BDMcLiIq78jxAImD2pGFw0VHfRatScGlK6SMu8leTmhUSMy8Uhdd6xBiH3Gdman4tjQGLboJfqz6fL2WKHTmrfsKZRYX6BTDjDldKMosaSTLdQS7oDisJNqAUhw1PfTlnacCO8vl8706Km1FROgLDmudzxg%2BEWTiArtHgLsRrAXYWdB0NmToNCJdKm0KWycZQqb%2BMw76Qy29iQ5up%2FX7oyw8QZ75kP5F6iJAJz6KCmqxz8fEa%2FxnsMYcIO%2FvEkGRuMckhr4rIeLrKaXnmIzlNLxbFspOphkcnJdnz%2FChp%2FVlpj2P7jJQmQRwGnltkTV5dbF9fE3%2FfxoSqTROgq9wFUlbuYzYcasE0ouzBo%2BdDCDzxKAfhbAZYxQiHrLzV2iVexnDX%2FQnT1fsT%2Fxuhu1ui5qIytgbGmRoQkeQooO8eJNNZsf0iALur8QxZFH0nCMnjerYQqG1pIfjyVZWxhVRznmmfLG00BcBWJE6hzQWRyFknuJnXuk8A5FRDCulwrWASSNoBtR%2BCtGdkPwYN2o7DOw%2FVGlCZPusRBFXODQdUM5zeHDIVuAJBLqbO%2Ff9Qua%2BpDqEPk230Sob9lEZ8BHiCorjVghuI0lI4JDgHGRDD%2FprQ84B1pVGkIpVUAHCG%2Biz3Bn3qm2AVrYcYWhock4jso5%2BJ7HfHVj4WMIQdGctq3psBCVVzupQOEioBGA2Bk%2BUILT7%2BVoX5mdxxA5fS42gISQVi%2FHTzrgMxu0fY6hE1ocUwwbsbWcezrY2n6S8%2F6cxXkOH4prpmPuFoikTzY7T85C4T2XYlbxLglSv2uLCgFv8Quk%2FwdesUdWPeHYIH0R729JIisN9Apdd4eB10aqwXrPt%2BSu9mA8k8n1sjMwnfsfF2j3jMUzXepSHmZ%2FBfqXvzgUNQQWOXO8YEuFBh4QTYCkOAPxywpYu1VxiDyJmKVcmJPGWk%2Fgc3Pov02StyYDahwmzw3E1gYC9wkupyWfDqDSUMpCTH5e5N8B%2F%2FlHiMuIkTNw4USHrJU67bjXGqNav6PBuQSoqTxc8avHoGmvqNtXzIaoyMIQIiiUHIM64cXieouplhNYln7qgc4wBVAYR104kO%2BCvKqsg4yIUlFNThVUAKZxZt1XA34h3TCUUiXVkZ0w8Hh2R0Z5L0b4LZvPd%2Fp1gi%2F07h8qfwHrByuSxglc9cI4QIg2oqvC%2Fqm0i7tjPLTgDhoWTAKDO2ONW5oe%2B%2FeKB9vZB8K6C25yCZ9RFVMnb6NRdRjyVK57CHHSkJBfnM2%2Fj4ODUwRkqrtBBCrDsDpt8jhZdXoy%2F1BCqw3sSGhgGGy0a5Jw6BP%2FTExoCmNFYjZl248A0osgPyGEmRA%2BfAsqPVaNAfytu0vuQJ7rk3J4kTDTR2AlCHJ5cls26opZM4w3jMULh2YXKpcqGBtuleAlOZnaZGbD6DHzMd6i2oFeJ8z9XYmalg1Szd%2FocZDc1C7Y6vcALJz2lYnTXiWEr2wawtoR4g3jvWUU2Ngjd1cewtFzEvM1NiHZPeLlIXFbBPawxNgMwwAlyNSuGF3zizVeOoC9bag1qRAQKQE%2FEZBWC2J8mnXAN2aTBboZ7HewnObE8CwROudZHmUM5oZ%2FUgd%2FJZQK8lvAm43uDRAbyW8gZ%2BZGq0EVerVGUKUSm%2FIdn8AQHdR4m7bue88WBwft9mSCeMOt1ncBwziOmJYI2ZR7ewNMPiCugmSsE4EyQ%2BQATJG6qORMGd4snEzc6B4shPIo4G1T7PgSm8PY5eUkPdF8JZ0VBtadbHXoJgnEhZQaODPj2gpODKJY5Yp4DOsLBFxWbvXN755KWylJm%2BoOd4zEL9Hpubuy2gyyfxh8oEfFutnYWdfB8PdESLWYvSqbElP9qo3u6KTmkhoacDauMNNjj0oy40DFV7Ql0aZj77xfGl7TJNHnIwgqOkenruYYNo6h724%2BzUQ7%2BvkCpZB%2BpGA562hYQiDxHVWOq0oDQl%2FQsoiY%2BcuI7iWq%2FZIBtHcXJ7kks%2Bh2fCNUPA82BzjnqktNts%2BRLdk1VSu%2BtqEn7QZCCsvEqk6FkfiOYkrsw092J8jsfIuEKypNjLxrKA9kiA19mxBD2suxQKCzwXGws7kEJvlhUiV9tArLIdZW0IORcxEzdzKmjtFhsjKy%2F44XYXdI5noQoRcvjZ1RMPACRqYg2V1%2BOwOepcOknRLLFdYgTkT5UApt%2FJhLM3jeFYprZV%2BZow2g8fP%2BU68hkKFWJj2yBbKqsrp25xkZX1DAjUw52IMYWaOhab8Kp05VrdNftqwRrymWF4OQSjbdfzmRZirK8FMJELEgER2PHjEAN9pGfLhCUiTJFbd5LBkOBMaxLr%2FA1SY9dXFz4RjzoU9ExfJCmx%2FI9FKEGT3n2cmzl2X42L3Jh%2BAbQq6sA%2BSs1kitoa4TAYgKHaoybHUDJ51oETdeI%2F9ThSmjWGkyLi5QAGWhL0BG1UsTyRGRJOldKBrYJeB8ljLJHfATWTEQBXBDnQexOHTB%2BUn44zExFE4vLytcu5NwpWrUxO%2F0ZICUGM7hGABXym0V6ZvDST0E370St9MIWQOTWngeoQHUTdCJUP04spMBMS8LSker9cReVQkULFDIZDFPrhTzBl6sed9wcZQTbL%2BBDqMyaN3RJPh%2Fanbx%2BIv%2BqgQdAa3M9Z5JmvYlh4qop%2BHo1F1W5gbOE9YKLgAnWytXElU4G8GtW47lhgFE6gaSs%2Bgs37sFvi0PPVvA5dnCBgILTwoKd%2F%2BDoL9F6inlM7H4rOTzD79KJgKlZO%2FZgt22UsKhrAaXU5ZcLrAglTVKJEmNJvORGN1vqrcfSMizfpsgbIe9zno%2BgBoKVXgIL%2FVI8dB1O5o%2FR3Suez%2FgD7M781ShjKpIIORM%2FnxG%2BjjhhgPwsn2IoXsPGPqYHXA63zJ07M2GPEykQwJBYLK808qYxuIew4frk52nhCsnCYmXiR6CuapvE1IwRB4%2FQftDbEn%2BAucIr1oxrLabRj9q4ae0%2BfXkHnteAJwXRbVkR0mctVSwEbqhJiMSZUp9DNbEDMmjX22m3ABpkrPQQTP3S1sib5pD2VRKRd%2BeNAjLYyT0hGrdjWJZy24OYXRoWQAIhGBZRxuBFMjjZQhpgrWo8SiFYbojcHO8V5DyscJpLTHyx9Fimassyo5U6WNtquUMYgccaHY5amgR3PQzq3ToNM5ABnoB9kuxsebqmYZm0R9qxJbFXCQ1UPyFIbxoUraTJFDpCk0Wk9GaYJKz%2F6oHwEP0Q14lMtlddQsOAU9zlYdMVHiT7RQP3XCmWYDcHCGbVRHGnHuwzScA0BaSBOGkz3lM8CArjrBsyEoV6Ys4qgDK3ykQQPZ3hCRGNXQTNNXbEb6tDiTDLKOyMzRhCFT%2BmAUmiYbV3YQVqFVp9dorv%2BTsLeCykS2b5yyu8AV7IS9cxcL8z4Kfwp%2BxJyYLv1OsxQCZwTB4a8BZ%2F5EdxTBJthApqyfd9u3ifr%2FWILTqq5VqgwMT9SOxbSGWLQJUUWCVi4k9tho9nEsbUh7U6NUsLmkYFXOhZ0kmamaJLRNJzSj%2Fqn4Mso6zb6iLLBXoaZ6AqeWCjHQm2lztnejYYM2eubnpBdKVLORZhudH3JF1waBJKA9%2BW8EhMj3Kzf0L4vi4k6RoHh3Z5YgmSZmk6ns4fjScjAoL8GoOECgqgYEBYUGFVO4FUv4%2FYtowhEmTs0vrvlD%2FCrisnoBNDAcUi%2FteY7OctFlmARQzjOItrrlKuPO6E2Ox93L4O%2F4DcgV%2FdZ7qR3VBwVQxP1GCieA4RIpweYJ5FoYrHxqRBdJjnqbsikA2Ictbb8vE1GYIo9dacK0REgDX4smy6GAkxlH1yCGGsk%2BtgiDhNKuKu3yNrMdxafmKTF632F8Vx4BNK57GvlFisrkjN9WDAtjsWA0ENT2e2nETUb%2Fn7qwhvGnrHuf5bX6Vh%2Fn3xffU3PeHdR%2BFA92i6ufT3AlyAREoNDh6chiMWTvjKjHDeRhOa9YkOQRq1vQXEMppAQVwHCuIcV2g5rBn6GmZZpTR7vnSD6ZmhdSl176gqKTXu5E%2BYbfL0adwNtHP7dT7t7b46DVZIkzaRJOM%2BS6KcrzYVg%2BT3wSRFRQashjfU18NutrKa%2F7PXbtuJvpIjbgPeqd%2BpjmRw6YKpnANFSQcpzTZgpSNJ6J7uiagAbir%2F8tNXJ%2FOsOnRh6iuIexxrmkIneAgz8QoLmiaJ8sLQrELVK2yn3wOHp57BAZJhDZjTBzyoRAuuZ4eoxHruY1pSb7qq79cIeAdOwin4GdgMeIMHeG%2BFZWYaiUQQyC5b50zKjYw97dFjAeY2I4Bnl105Iku1y0lMA1ZHolLx19uZnRdILcXKlZGQx%2FGdEqSsMRU1BIrFqRcV1qQOOHyxOLXEGcbRtAEsuAC2V4K3p5mFJ22IDWaEkk9ttf5Izb2LkD1MnrSwztXmmD%2FQi%2FEmVEFBfiKGmftsPwVaIoZanlKndMZsIBOskFYpDOq3QUs9aSbAAtL5Dbokus2G4%2FasthNMK5UQKCOhU97oaOYNGsTah%2BjfCKsZnTRn5TbhFX8ghg8CBYt%2FBjeYYYUrtUZ5jVij%2Fop7V5SsbA4mYTOwZ46hqdpbB6Qvq3AS2HHNkC15pTDIcDNGsMPXaBidXYPHc6PJAkRh29Vx8KcgX46LoUQBhRM%2B3SW6Opll%2FwgxxsPgKJKzr5QCmwkUxNbeg6Wj34SUnEzOemSuvS2OetRCO8Tyy%2BQbSKVJcqkia%2BGvDefFwMOmgnD7h81TUtMn%2BmRpyJJ349HhAnoWFTejhpYTL9G8N2nVg1qkXBeoS9Nw2fB27t7trm7d%2FQK7Cr4uoCeOQ7%2F8JfKT77KiDzLImESHw%2F0wf73QeHu74hxv7uihi4fTX%2BXEwAyQG3264dwv17aJ5N335Vt9sdrAXhPOAv8JFvzqyYXwfx8WYJaef1gMl98JRFyl5Mv5Uo%2FoVH5ww5OzLFsiTPDns7fS6EURSSWd%2F92BxMYQ8sBaH%2Bj%2BwthQPdVgDGpTfi%2BJQIWMD8xKqULliRH01rTeyF8x8q%2FGBEEEBrAJMPf25UQwi0b8tmqRXY7kIvNkzrkvRWLnxoGYEJsz8u4oOyMp8cHyaybb1HdMCaLApUE%2B%2F7xLIZGP6H9xuSEXp1zLIdjk5nBaMuV%2FyTDRRP8Y2ww5RO6d2D94o%2B6ucWIqUAvgHIHXhZsmDhjVLczmZ3ca0Cb3PpKwt2UtHVQ0BgFJsqqTsnzZPlKahRUkEu4qmkJt%2Bkqdae76ViWe3STan69yaF9%2BfESD2lcQshLHWVu4ovItXxO69bqC5p1nZLvI8NdQB9s9UNaJGlQ5mG947ipdDA0eTIw%2FA1zEdjWquIsQXXGIVEH0thC5M%2BW9pZe7IhAVnPJkYCCXN5a32HjN6nsvokEqRS44tGIs7s2LVTvcrHAF%2BRVmI8L4HUYk4x%2B67AxSMJKqCg8zrGOgvK9kNMdDrNiUtSWuHFpC8%2Fp5qIQrEo%2FH%2B1l%2F0cAwQ2nKmpWxKcMIuHY44Y6DlkpO48tRuUGBWT0FyHwSKO72Ud%2BtJUfdaZ4CWNijzZtlRa8%2BCkmO%2FEwHYfPZFU%2FhzjFWH7vnzHRMo%2BaF9u8qHSAiEkA2HjoNQPEwHsDKOt6hOoK3Ce%2F%2B%2F9boMWDa44I6FrQhdgS7OnNaSzwxWKZMcyHi6LN4WC6sSj0qm2PSOGBTvDs%2FGWJS6SwEN%2FULwpb4LQo9fYjUfSXRwZkynUazlSpvX9e%2BG2zor8l%2BYaMxSEomDdLHGcD6YVQPegTaA74H8%2BV4WvJkFUrjMLGLlvSZQWvi8%2FQA7yzQ8GPno%2F%2F5SJHRP%2FOqKObPCo81s%2F%2B6WgLqykYpGAgQZhVDEBPXWgU%2FWzFZjKUhSFInufPRiMAUULC6T11yL45ZrRoB4DzOyJShKXaAJIBS9wzLYIoCEcJKQW8GVCx4fihqJ6mshBUXSw3wWVj3grrHQlGNGhIDNNzsxQ3M%2BGWn6ASobIWC%2BLbYOC6UpahVO13Zs2zOzZC8z7FmA05JhUGyBsF4tsG0drcggIFzgg%2Fkpf3%2BCnAXKiMgIE8Jk%2FMhpkc8DUJEUzDSnWlQFme3d0sHZDrg7LavtsEX3cHwjCYA17pMTfx8Ajw9hHscN67hyo%2BRJQ4458RmPywXykkVcW688oVUrQhahpPRvTWPnuI0B%2BSkQu7dCyvLRyFYlC1LG1gRCIvn3rwQeINzZQC2KXq31FaR9UmVV2QeGVqBHjmE%2BVMd3b1fhCynD0pQNhCG6%2FWCDbKPyE7NRQzL3BzQAJ0g09aUzcQA6mUp9iZFK6Sbp%2FYbHjo%2B%2B7%2FWj8S4YNa%2BZdqAw1hDrKWFXv9%2BzaXpf8ZTDSbiqsxnwN%2FCzK5tPkOr4tRh2kY3Bn9JtalbIOI4b3F7F1vPQMfoDcdxMS8CW9m%2FNCW%2FHILTUVWQIPiD0j1A6bo8vsv6P1hCESl2abrSJWDrq5sSzUpwoxaCU9FtJyYH4QFMxDBpkkBR6kn0LMPO%2B5EJ7Z6bCiRoPedRZ%2FP0SSdii7ZnPAtVwwHUidcdyspwncz5uq6vvm4IEDbJVLUFCn%2FLvIHfooUBTkFO130FC7CmmcrKdgDJcid9mvVzsDSibOoXtIf9k6ABle3PmIxejodc4aob0QKS432srrCMndbfD454q52V01G4q913mC5HOsTzWF4h2No1av1VbcUgWAqyoZl%2B11PoFYnNv2HwAODeNRkHj%2B8SF1fcvVBu6MrehHAZK1Gm69ICcTKizykHgGFx7QdowTVAsYEF2tVc0Z6wLryz2FI1sc5By2znJAAmINndoJiB4sfPdPrTC8RnkW7KRCwxC6YvXg5ahMlQuMpoCSXjOlBy0Kij%2BbsCYPbGp8BdCBiLmLSAkEQRaieWo1SYvZIKJGj9Ur%2FeWHjiB7SOVdqMAVmpBvfRiebsFjger7DC%2B8kRFGtNrTrnnGD2GAJb8rQCWkUPYHhwXsjNBSkE6lGWUj5QNhK0DMNM2l%2BkXRZ0KLZaGsFSIdQz%2FHXDxf3%2FTE30%2BDgBKWGWdxElyLccJfEpjsnszECNoDGZpdwdRgCixeg9L4EPhH%2BRptvRMVRaahu4cySjS3P5wxAUCPkmn%2BrhyASpmiTaiDeggaIxYBmtLZDDhiWIJaBgzfCsAGUF1Q1SFZYyXDt9skCaxJsxK2Ms65dmdp5WAZyxik%2FzbrTQk5KmgxCg%2Ff45L0jywebOWUYFJQAJia7XzCV0x89rpp%2Ff3AVWhSPyTanqmik2SkD8A3Ml4NhIGLAjBXtPShwKYfi2eXtrDuKLk4QlSyTw1ftXgwqA2jUuopDl%2B5tfUWZNwBpEPXghzbBggYCw%2Fdhy0ntds2yeHCDKkF%2FYxQjNIL%2FF%2F37jLPHCKBO9ibwYCmuxImIo0ijV2Wbg3kSN2psoe8IsABv3RNFaF9uMyCtCYtqcD%2BqNOhwMlfARQUdJ2tUX%2BMNJqOwIciWalZsmEjt07tfa8ma4cji9sqz%2BQ9hWfmMoKEbIHPOQORbhQRHIsrTYlnVTNvcq1imqmmPDdVDkJgRcTgB8Sb6epCQVmFZe%2BjGDiNJQLWnfx%2BdrTKYjm0G8yH0ZAGMWzEJhUEQ4Maimgf%2Fbkvo8PLVBsZl152y5S8%2BHRDfZIMCbYZ1WDp4yrdchOJw8k6R%2B%2F2pHmydK4NIK2PHdFPHtoLmHxRDwLFb7eB%2BM4zNZcB9NrAgjVyzLM7xyYSY13ykWfIEEd2n5%2FiYp3ZdrCf7fL%2Ben%2BsIJu2W7E30MrAgZBD1rAAbZHPgeAMtKCg3NpSpYQUDWJu9bT3V7tOKv%2BNRiJc8JAKqqgCA%2FPNRBR7ChpiEulyQApMK1AyqcWnpSOmYh6yLiWkGJ2mklCSPIqN7UypWj3dGi5MvsHQ87MrB4VFgypJaFriaHivwcHIpmyi5LhNqtem4q0n8awM19Qk8BOS0EsqGscuuydYsIGsbT5GHnERUiMpKJl4ON7qjB4fEqlGN%2FhCky89232UQCiaeWpDYCJINXjT6xl4Gc7DxRCtgV0i1ma4RgWLsNtnEBRQFqZggCLiuyEydmFd7WlogpkCw5G1x4ft2psm3KAREwVwr1Gzl6RT7FDAqpVal34ewVm3VH4qn5mjGj%2BbYL1NgfLNeXDwtmYSpwzbruDKpTjOdgiIHDVQSb5%2FzBgSMbHLkxWWgghIh9QTFSDILixVwg0Eg1puooBiHAt7DzwJ7m8i8%2Fi%2BjHvKf0QDnnHVkVTIqMvIQImOrzCJwhSR7qYB5gSwL6aWL9hERHCZc4G2%2BJrpgHNB8eCCmcIWIQ6rSdyPCyftXkDlErUkHafHRlkOIjxGbAktz75bnh50dU7YHk%2BMz7wwstg6RFZb%2BTZuSOx1qqP5C66c0mptQmzIC2dlpte7vZrauAMm%2F7RfBYkGtXWGiaWTtwvAQiq2oD4YixPLXE2khB2FRaNRDTk%2B9sZ6K74Ia9VntCpN4BhJGJMT4Z5c5FhSepRCRWmBXqx%2BwhVZC4me4saDs2iNqXMuCl6iAZflH8fscC1sTsy4PHeC%2BXYuqMBMUun5YezKbRKmEPwuK%2BCLzijPEQgfhahQswBBLfg%2FGBgBiI4QwAqzJkkyYAWtjzSg2ILgMAgqxYfwERRo3zruBL9WOryUArSD8sQOcD7fvIODJxKFS615KFPsb68USBEPPj1orNzFY2xoTtNBVTyzBhPbhFH0PI5AtlJBl2aSgNPYzxYLw7XTDBDinmVoENwiGzmngrMo8OmnRP0Z0i0Zrln9DDFcnmOoBZjABaQIbPOJYZGqX%2BRCMlDDbElcjaROLDoualmUIQ88Kekk3iM4OQrADcxi3rJguS4MOIBIgKgXrjd1WkbCdqxJk%2F4efRIFsavZA7KvvJQqp3Iid5Z0NFc5aiMRzGN3vrpBzaMy4JYde3wr96PjN90AYOIbyp6T4zj8LoE66OGcX1Ef4Z3KoWLAUF4BTg7ug%2FAbkG5UNQXAMkQezujSHeir2uTThgd3gpyzDrbnEdDRH2W7U6PeRvBX1ZFMP5RM%2BZu6UUZZD8hDPHldVWntTCNk7To8IeOW9yn2wx0gmurwqC60AOde4r3ETi5pVMSDK8wxhoGAoEX9NLWHIR33VbrbMveii2jAJlrxwytTHbWNu8Y4N8vCCyZjAX%2FpcsfwXbLze2%2BD%2Bu33OGBoJyAAL3jn3RuEcdp5If8O%2Ba4NKWvxOTyDltG0IWoHhwVGe7dKkCWFT%2B%2Btm%2BhaBCikRUUMrMhYKZJKYoVuv%2FbsJzO8DwfVIInQq3g3BYypiz8baogH3r3GwqCwFtZnz4xMjAVOYnyOi5HWbFA8n0qz1OjSpHWFzpQOpvkNETZBGpxN8ybhtqV%2FDMUxd9uFZmBfKXMCn%2FSqkWJyKPnT6lq%2B4zBZni6fYRByJn6OK%2BOgPBGRAJluwGSk4wxjOOzyce%2FPKODwRlsgrVkdcsEiYrqYdXo0Er2GXi2GQZd0tNJT6c9pK1EEJG1zgDJBoTVuCXGAU8BKTvCO%2FcEQ1Wjk3Zzuy90JX4m3O5IlxVFhYkSUwuQB2up7jhvkm%2BbddRQu5F9s0XftGEJ9JSuSk%2BZachCbdU45fEqbugzTIUokwoAKvpUQF%2FCvLbWW5BNQFqFkJg2f30E%2F48StNe5QwBg8zz3YAJ82FZoXBxXSv4QDooDo79NixyglO9AembuBcx5Re3CwOKTHebOPhkmFC7wNaWtoBhFuV4AkEuJ0J%2B1pT0tLkvFVZaNzfhs%2FKd3%2BA9YsImlO4XK4vpCo%2FelHQi%2F9gkFg07xxnuXLt21unCIpDV%2BbbRxb7FC6nWYTsMFF8%2B1LUg4JFjVt3vqbuhHmDKbgQ4e%2BRGizRiO8ky05LQGMdL2IKLSNar0kNG7lHJMaXr5mLdG3nykgj6vB%2FKVijd1ARWkFEf3yiUw1v%2FWaQivVUpIDdSNrrKbjO5NPnxz6qTTGgYg03HgPhDrCFyYZTi3XQw3HXCva39mpLNFtz8AiEhxAJHpWX13gCTAwgm9YTvMeiqetdNQv6IU0hH0G%2BZManTqDLPjyrOse7WiiwOJCG%2BJ0pZYULhN8NILulmYYvmVcV2MjAfA39sGKqGdjpiPo86fecg65UPyXDIAOyOkCx5NQsLeD4gGVjTVDwOHWkbbBW0GeNjDkcSOn2Nq4cEssP54t9D749A7M1AIOBl0Fi0sSO5v3P7LCBrM6ZwFY6kp2FX6AcbGUdybnfChHPyu6WlRZ2Fwv9YM0RMI7kISRgR8HpQSJJOyTfXj%2F6gQKuihPtiUtlCQVPohUgzfezTg8o1b3n9pNZeco1QucaoXe40Fa5JYhqdTspFmxGtW9h5ezLFZs3j%2FN46f%2BS2rjYNC2JySXrnSAFhvAkz9a5L3pza8eYKHNoPrvBRESpxYPJdKVUxBE39nJ1chrAFpy4MMkf0qKgYALctGg1DQI1kIymyeS2AJNT4X240d3IFQb%2F0jQbaHJ2YRK8A%2Bls6WMhWmpCXYG5jqapGs5%2FeOJErxi2%2F2KWVHiPellTgh%2FfNl%2F2KYPKb7DUcAg%2BmCOPQFCiU9Mq%2FWLcU1xxC8aLePFZZlE%2BPCLzf7ey46INWRw2kcXySR9FDgByXzfxiNKwDFbUSMMhALPFSedyjEVM5442GZ4hTrsAEvZxIieSHGSgkwFh%2FnFNdrrFD4tBH4Il7fW6ur4J8Xaz7RW9jgtuPEXQsYk7gcMs2neu3zJwTyUerHKSh1iTBkj2YJh1SSOZL5pLuQbFFAvyO4k1Hxg2h99MTC6cTUkbONQIAnEfGsGkNFWRbuRyyaEZInM5pij73EA9rPIUfU4XoqQpHT9THZkW%2BoKFLvpyvTBMM69tN1Ydwv1LIEhHsC%2BueVG%2Bw%2BkyCPsvV3erRikcscHjZCkccx6VrBkBRusTDDd8847GA7p2Ucy0y0HdSRN6YIBciYa4vuXcAZbQAuSEmzw%2BH%2FAuOx%2BaH%2BtBL88H57D0MsqyiZxhOEQkF%2F8DR1d2hSPMj%2FsNOa5rxcUnBgH8ictv2J%2Bcb4BA4v3MCShdZ2vtK30vAwkobnEWh7rsSyhmos3WC93Gn9C4nnAd%2FPjMMtQfyDNZsOPd6XcAsnBE%2FmRHtHEyJMzJfZFLE9OvQa0i9kUmToJ0ZxknTgdl%2FXPV8xoh0K7wNHHsnBdvFH3sv52lU7UFteseLG%2FVanIvcwycVA7%2BBE1Ulyb20BvwUWZcMTKhaCcmY3ROpvonVMV4N7yBXTL7IDtHzQ4CCcqF66LjF3xUqgErKzolLyCG6Kb7irP%2FMVTCCwGRxfrPGpMMGvPLgJ881PHMNMIO09T5ig7AzZTX%2F5PLlwnJLDAPfuHynSGhV4tPqR3gJ4kg4c06c%2FF1AcjGytKm2Yb5jwMotF7vro4YDLWlnMIpmPg36NgAZsGA0W1spfLSue4xxat0Gdwd0lqDBOgIaMANykwwDKejt5YaNtJYIkrSgu0KjIg0pznY0SCd1qlC6R19g97UrWDoYJGlrvCE05J%2F5wkjpkre727p5PTRX5FGrSBIfJqhJE%2FIS876PaHFkx9pGTH3oaY3jJRvLX9Iy3Edoar7cFvJqyUlOhAEiOSAyYgVEGkzHdug%2BoRHIEOXAExMiTSKU9A6nmRC8mp8iYhwWdP2U%2F5EkFAdPrZw03YA3gSyNUtMZeh7dDCu8pF5x0VORCTgKp07ehy7NZqKTpIC4UJJ89lnboyAfy5OyXzXtuDRbtAFjZRSyGFTpFrXwkpjSLIQIG3N0Vj4BtzK3wdlkBJrO18MNsgseR4BysJilI0wI6ZahLhBFA0XBmV8d4LUzEcNVb0xbLjLTETYN8OEVqNxkt10W614dd1FlFFVTIgB7%2FBQQp1sWlNolpIu4ekxUTBV7NmxOFKEBmmN%2BnA7pvF78%2FRII5ZHA09OAiE%2F66MF6HQ%2BqVEJCHxwymukkNvzqHEh52dULPbVasfQMgTDyBZzx4007YiKdBuUauQOt27Gmy8ISclPmEUCIcuLbkb1mzQSqIa3iE0PJh7UMYQbkpe%2BhXjTJKdldyt2mVPwywoODGJtBV1lJTgMsuSQBlDMwhEKIfrvsxGQjHPCEfNfMAY2oxvyKcKPUbQySkKG6tj9AQyEW3Q5rpaDJ5Sns9ScLKeizPRbvWYAw4bXkrZdmB7CQopCH8NAmqbuciZChHN8lVGaDbCnmddnqO1PQ4ieMYfcSiBE5zzMz%2BJV%2F4eyzrzTEShvqSGzgWimkNxLvUj86iAwcZuIkqdB0VaIB7wncLRmzHkiUQpPBIXbDDLHBlq7vp9xwuC9AiNkIptAYlG7Biyuk8ILdynuUM1cHWJgeB%2BK3wBP%2FineogxkvBNNQ4AkW0hvpBOQGFfeptF2YTR75MexYDUy7Q%2F9uocGsx41O4IZhViw%2F2FvAEuGO5g2kyXBUijAggWM08bRhXg5ijgMwDJy40QeY%2FcQpUDZiIzmvskQpO5G1zyGZA8WByjIQU4jRoFJt56behxtHUUE%2Fom7Rj2psYXGmq3llVOCgGYKNMo4pzwntITtapDqjvQtqpjaJwjHmDzSVGLxMt12gEXAdLi%2FcaHSM3FPRGRf7dB7YC%2BcD2ho6oL2zGDCkjlf%2FDFoQVl8GS%2F56wur3rdV6ggtzZW60MRB3g%2BU1W8o8cvqIpMkctiGVMzXUFI7FacFLrgtdz4mTEr4aRAaQ2AFQaNeG7GX0yOJgMRYFziXdJf24kg%2FgBQIZMG%2FYcPEllRTVNoDYR6oSJ8wQNLuihfw81UpiKPm714bZX1KYjcXJdfclCUOOpvTxr9AAJevTY4HK%2FG7F3mUc3GOAKqh60zM0v34v%2BELyhJZqhkaMA8UMMOU90f8RKEJFj7EqepBVwsRiLbwMo1J2zrE2UYJnsgIAscDmjPjnzI8a719Wxp757wqmSJBjXowhc46QN4RwKIxqEE6E5218OeK7RfcpGjWG1jD7qND%2B%2FGTk6M56Ig4yMsU6LUW1EWE%2BfIYycVV1thldSlbP6ltdC01y3KUfkobkt2q01YYMmxpKRvh1Z48uNKzP%2FIoRIZ%2FF6buOymSnW8gICitpJjKWBscSb9JJKaWkvEkqinAJ2kowKoqkqZftRqfRQlLtKoqvTRDi2vg%2FRrPD%2Fd3a09J8JhGZlEkOM6znTsoMCsuvTmywxTCDhw5dd0GJOHCMPbsj3QLkTE3MInsZsimDQ3HkvthT7U9VA4s6G07sID0FW4SHJmRGwCl%2BMu4xf0ezqeXD2PtPDnwMPo86sbwDV%2B9PWcgFcARUVYm3hrFQrHcgMElFGbSM2A1zUYA3baWfheJp2AINmTJLuoyYD%2FOwA4a6V0ChBN97E8YtDBerUECv0u0TlxR5yhJCXvJxgyM73Bb6pyq0jTFJDZ4p1Am1SA6sh8nADd1hAcGBMfq4d%2FUfwnmBqe0Jun1n1LzrgKuZMAnxA3NtCN7Klf4BH%2B14B7ibBmgt0TGUafVzI4uKlpF7v8NmgNjg90D6QE3tbx8AjSAC%2BOA1YJvclyPKgT27QpIEgVYpbPYGBsnyCNrGz9XUsCHkW1QAHgL2STZk12QGqmvAB0NFteERkvBIH7INDsNW9KKaAYyDMdBEMzJiWaJHZALqDxQDWRntumSDPcplyFiI1oDpT8wbwe01AHhW6%2BvAUUBoGhY3CT2tgwehdPqU%2F4Q7ZLYvhRl%2FogOvR9O2%2BwkkPKW5vCTjD2fHRYXONCoIl4Jh1bZY0ZE1O94mMGn%2FdFSWBWzQ%2FVYk%2BGezi46RgiDv3EshoTmMSlioUK6MQEN8qeyK6FRninyX8ZPeUWjjbMJChn0n%2FyJvrq5bh5UcCAcBYSafTFg7p0jDgrXo2QWLb3WpSOET%2FHh4oSadBTvyDo10IufLzxiMLAnbZ1vcUmj3w7BQuIXjEZXifwukVxrGa9j%2BDXfpi12m1RbzYLg9J2wFergEwOxFyD0%2FJstNK06ZN2XdZSGWxcJODpQHOq4iKqjqkJUmPu1VczL5xTGUfCgLEYyNBCCbMBFT%2FcUP6pE%2FmujnHsSDeWxMbhrNilS5MyYR0nJyzanWXBeVcEQrRIhQeJA6Xt4f2eQESNeLwmC10WJVHqwx8SSyrtAAjpGjidcj1E2FYN0LObUcFQhafUKTiGmHWRHGsFCB%2BHEXgrzJEB5bp0QiF8ZHh11nFX8AboTD0PS4O1LqF8XBks2MpjsQnwKHF6HgaKCVLJtcr0XjqFMRGfKv8tmmykhLRzu%2BvqQ02%2BKpJBjaLt9ye1Ab%2BBbEBhy4EVdIJDrL2naV0o4wU8YZ2Lq04FG1mWCKC%2BUwkXOoAjneU%2FxHplMQo2cXUlrVNqJYczgYlaOEczVCs%2FOCgkyvLmTmdaBJc1iBLuKwmr6qtRnhowngsDxhzKFAi02tf8bmET8BO27ovJKF1plJwm3b0JpMh38%2BxsrXXg7U74QUM8ZCIMOpXujHntKdaRtsgyEZl5MClMVMMMZkZLNxH9%2Bb8fH6%2Bb8Lev30A9TuEVj9CqAdmwAAHBPbfOBFEATAPZ2CS0OH1Pj%2F0Q7PFUcC8hDrxESWdfgFRm%2B7vvWbkEppHB4T%2F1ApWnlTIqQwjcPl0VgS1yHSmD0OdsCVST8CQVwuiew1Y%2Bg3QGFjNMzwRB2DSsAk26cmA8lp2wIU4p93AUBiUHFGOxOajAqD7Gm6NezNDjYzwLOaSXRBYcWipTSONHjUDXCY4mMI8XoVCR%2FRrs%2FJLKXgEx%2BqkmeDlFOD1%2FyTQNDClRuiUyKYCllfMiQiyFkmuTz2vLsBNyRW%2Bxz%2B5FElFxWB28VjYIGZ0Yd%2B5wIjkcoMaggxswbT0pCmckRAErbRlIlcOGdBo4djTNO8FAgQ%2BlT6vPS60BwTRSUAM3ddkEAZiwtEyArrkiDRnS7LJ%2B2hwbzd2YDQagSgACpsovmjil5wfPuXq3GuH0CyE7FK3M4FgRaFoIkaodORrPx1%2BJpI9psyNYIFuJogZa0%2F1AhOWdlHQxdAgbwacsHqPZo8u%2FngAH2GmaTdhYnBfSDbBfh8CHq6Bx5bttP2%2BRdM%2BMAaYaZ0Y%2FADkbNCZuAyAVQa2OcXOeICmDn9Q%2FeFkDeFQg5MgHEDXq%2FtVjj%2Bjtd26nhaaolWxs1ixSUgOBwrDhRIGOLyOVk2%2FBc0UxvseQCO2pQ2i%2BKrfhu%2FWeBovNb5dJxQtJRUDv2mCwYVpNl2efQM9xQHnK0JwLYt%2FU0Wf%2BphiA4uw8G91slC832pmOTCAoZXohg1fewCZqLBhkOUBofBWpMPsqg7XEXgPfAlDo2U5WXjtFdS87PIqClCK5nW6adCeXPkUiTGx0emOIDQqw1yFYGHEVx20xKjJVYe0O8iLmnQr3FA9nSIQilUKtJ4ZAdcTm7%2BExseJauyqo30hs%2B1qSW211A1SFAOUgDlCGq7eTIcMAeyZkV1SQJ4j%2Fe1Smbq4HcjqgFbLAGLyKxlMDMgZavK5NAYH19Olz3la%2FQCTiVelFnU6O%2FGCvykqS%2FwZJDhKN9gBtSOp%2F1SP5VRgJcoVj%2Bkmf2wBgv4gjrgARBWiURYx8xENV3bEVUAAWWD3dYDKAIWk5opaCFCMR5ZjJExiCAw7gYiSZ2rkyTce4eNMY3lfGn%2B8p6%2BvBckGlKEXnA6Eota69OxDO9oOsJoy28BXOR0UoXNRaJD5ceKdlWMJlOFzDdZNpc05tkMGQtqeNF2lttZqNco1VtwXgRstLSQ6tSPChgqtGV5h2DcDReIQadaNRR6AsAYKL5gSFsCJMgfsaZ7DpKh8mg8Wz8V7H%2BgDnLuMxaWEIUPevIbClgap4dqmVWSrPgVYCzAoZHIa5z2Ocx1D%2FGvDOEqMOKLrMefWIbSWHZ6jbgA8qVBhYNHpx0P%2BjAgN5TB3haSifDcApp6yymEi6Ij%2FGsEpDYUgcHATJUYDUAmC1SCkJ4cuZXSAP2DEpQsGUjQmKJfJOvlC2x%2FpChkOyLW7KEoMYc5FDC4v2FGqSoRWiLsbPCiyg1U5yiHZVm1XLkHMMZL11%2Fyxyw0UnGig3MFdZklN5FI%2FqiT65T%2BjOXOdO7XbgWurOAZR6Cv9uu1cm5LjkXX4xi6mWn5r5NjBS0gTliHhMZI2WNqSiSphEtiCAwnafS11JhseDGHYQ5%2BbqWiAYiAv6Jsf79%2FVUs4cIl%2Bn6%2BWOjcgB%2F2l5TreoAV2717JzZbQIR0W1cl%2FdEqCy5kJ3ZSIHuU0vBoHooEpiHeQWVkkkOqRX27eD1FWw4BfO9CJDdKoSogQi3hAAwsPRFrN5RbX7bqLdBJ9JYMohWrgJKHSjVl1sy2xAG0E3sNyO0oCbSGOxCNBRRXTXenYKuwAoDLfnDcQaCwehUOIDiHAu5m5hMpKeKM4sIo3vxACakIxKoH2YWF2QM84e6F5C5hJU4g8uxuFOlAYnqtwxmHyNEawLW%2FPhoawJDrGAP0JYWHgAVUByo%2FbGdiv2T2EMg8gsS14%2FrAdzlOYazFE7w4OzxeKiWdm3nSOnQRRKXSlVo8HEAbBfyJMKqoq%2BSCcTSx5NDtbFwNlh8VhjGGDu7JG5%2FTAGAvniQSSUog0pNzTim8Owc6QTuSKSTXlQqwV3eiEnklS3LeSXYPXGK2VgeZBqNcHG6tZHvA3vTINhV0ELuQdp3t1y9%2BogD8Kk%2FW7QoRN1UWPqM4%2BxdygkFDPLoTaumKReKiLWoPHOfY54m3qPx4c%2B4pgY3MRKKbljG8w4wvz8pxk3AqKsy4GMAkAtmRjRMsCxbb4Q2Ds0Ia9ci8cMT6DmsJG00XaHCIS%2Bo3F8YVVeikw13w%2BOEDaCYYhC0ZE54kA4jpjruBr5STWeqQG6M74HHL6TZ3lXrd99ZX%2B%2B7LhNatQaZosuxEf5yRA15S9gPeHskBIq3Gcw81AGb9%2FO53DYi%2F5CsQ51EmEh8Rkg4vOciClpy4d04eYsfr6fyQkBmtD%2BP8sNh6e%2BXYHJXT%2FlkXxT4KXU5F2sGxYyzfniMMQkb9OjDN2C8tRRgTyL7GwozH14PrEUZc6oz05Emne3Ts5EG7WolDmU8OB1LDG3VrpQxp%2BpT0KYV5dGtknU64JhabdqcVQbGZiAxQAnvN1u70y1AnmvOSPgLI6uB4AuDGhmAu3ATkJSw7OtS%2F2ToPjqkaq62%2F7WFG8advGlRRqxB9diP07JrXowKR9tpRa%2BjGJ91zxNTT1h8I2PcSfoUPtd7NejVoH03EUcqSBuFZPkMZhegHyo2ZAITovmm3zAIdGFWxoNNORiMRShgwdYwFzkPw5PA4a5MIIQpmq%2Bnsp3YMuXt%2FGkXxLx%2FP6%2BZJS0lFyz4MunC3eWSGE8xlCQrKvhKUPXr0hjpAN9ZK4PfEDrPMfMbGNWcHDzjA7ngMxTPnT7GMHar%2BgMQQ3NwHCv4zH4BIMYvzsdiERi6gebRmerTsVwZJTRsL8dkZgxgRxmpbgRcud%2BYlCIRpPwHShlUSwuipZnx9QCsEWziVazdDeKSYU5CF7UVPAhLer3CgJOQXl%2Fzh575R5rsrmRnKAzq4POFdgbYBuEviM4%2BLVC15ssLNFghbTtHWerS1hDt5s4qkLUha%2FqpZXhWh1C6lTQAqCNQnaDjS7UGFBC6wTu8yFnKJnExCnAs3Ok9yj5KpfZESQ4lTy5pTGTnkAUpxI%2ByjEldJfSo4y0QhG4i4IwkRFGcjWY8%2BEzgYYJUK7BXQksLxAww%2FYYWBMhJILB9e8ePEJ4OP7z%2B4%2FwOQDl64iOYDp26DaONPxpKtBxq%2FaTzRGarm3VkPYTLJKx6Z%2FMw2YbBGseJhPMwhhNswrIkyvV2BYzrvZbxLpKwcWJhYmFtVZ%2BlPEq91FzVp1HlQY1bZVLqeNR9SAUn6n0E28k%2FUuGkNpP1DBI5ch%2FEehZfjUQ9aE41NhETExoPT2gGQz0IhWJbEOvTQ4wgcXCHHFBhewYUiFHuhRSAUVmEHeCRQHQkXGFwkAgyzREJCVN7TRnTon36Zw3tPhx4EALwNdwDv%2BJ41YSP4B2CQqz0EFgARZ4ESgBHQgROwAVn9GTI%2BHYexTUevLUeta4%2FDqKrbMVS%2BYqb8hUwYCrlgKtmAq1YCrFgKrd4qpXiqZcKn1oqdWipjYKpWwVPVYqW6xUpVipKqFR3QKjagVEtAqHpxUMTitsnFaJOKx2cVhswq35RVpyiq9lFVNIKnOQVMkgqtYxVNxiqQjFS7GKlSIVIsQqPIhUWwioigFQ%2B%2BKkN8VHr49HDw9Ebo9EDo9DTo9Crg9BDg9%2FWx7gWx7YWwlobYrOGxWPNisAaAHEyALpkAVDIAeWAArsABVXACYuAD5cAF6wAKFQAQqgAbVAAsoAAlQAUaYAfkwAvogBWQACOgAD9AAHSAAKT4GUdMiOvFngBTwCn2AZ7Dv6B6k%2F90B8%2ByRnkV144AIBoAMTQATGgAjNAA4YABgwABZgB%2FmQCwyAVlwCguASlwCEuAQFwB4uAMlwBYuAJlQAUVAAhUD2KgdpUDaJgaRMDFJgX5MC1JgWJEAokQCWRAHxEAWkQBMRADpEAMkQAYROAEecC484DRpwBDTnwNOdw05tjTmiNOYwtswhYFwLA7BYG4LA2BYGOLAwRYFuLAsxYFQJAohIEyJAMwkAwiQC0JAJgkAeiQBkJAFokAPCQA0JABwcD4Dgc4cDdDgaYcDIDgYgUC6CgWgUClCgUYUAVBQBOFAEYMALgwAgDA9QYAdIn8AZzeBB2L5EcWrenUT1KXienEsuJJ7x5U8XlTjc1NVzUyXFTGb1LlpUtWlTDIjqwE4LsagowoCi2gJLKAkpoBgJQNpAIhNqaEoneI6kiiqQ6Go%2Fn6j0cS%2Ba2gEU8gIHJ%2BBwfgZX4GL%2BBd%2FgW34FZ%2BBS%2FgUH4FN6BTegTvoEv6BJegRnYEF2A79gOvYDl2BdEjCkqkGtwXp0LNToIskOTXzh%2FF062yJ7AAAAEDAWAAABWhJ%2BKPEIJgBFxMVP7w2QJBGHASQnOBKXKFIdUK4igKA9IEaYJg%29%20format%28%27embedded%2Dopentype%27%29%2Curl%28data%3Aapplication%2Fx%2Dfont%2Dwoff%3Bbase64%2Cd09GRgABAAAAAFuAAA8AAAAAsVwAAQAAAAAAAAAAAAAAAAAAAAAAAAAAAABGRlRNAAABWAAAABwAAAAcbSqX3EdERUYAAAF0AAAAHwAAACABRAAET1MvMgAAAZQAAABFAAAAYGe5a4ljbWFwAAAB3AAAAsAAAAZy2q3jgWN2dCAAAAScAAAABAAAAAQAKAL4Z2FzcAAABKAAAAAIAAAACP%2F%2FAANnbHlmAAAEqAAATRcAAJSkfV3Cb2hlYWQAAFHAAAAANAAAADYFTS%2FYaGhlYQAAUfQAAAAcAAAAJApEBBFobXR4AABSEAAAAU8AAAN00scgYGxvY2EAAFNgAAACJwAAAjBv%2B5XObWF4cAAAVYgAAAAgAAAAIAFqANhuYW1lAABVqAAAAZ4AAAOisyygm3Bvc3QAAFdIAAAELQAACtG6o%2BU1d2ViZgAAW3gAAAAGAAAABsMYVFAAAAABAAAAAMw9os8AAAAA0HaBdQAAAADQdnOXeNpjYGRgYOADYgkGEGBiYGRgZBQDkixgHgMABUgASgB42mNgZulmnMDAysDCzMN0gYGBIQpCMy5hMGLaAeQDpRCACYkd6h3ux%2BDAoPD%2FP%2FOB%2FwJAdSIM1UBhRiQlCgyMADGWCwwAAAB42u2UP2hTQRzHf5ekaVPExv6JjW3fvTQ0sa3QLA5xylBLgyBx0gzSWEUaXbIoBBQyCQGHLqXUqYNdtIIgIg5FHJxEtwqtpbnfaV1E1KFaSvX5vVwGEbW6OPngk8%2FvvXfv7pt3v4SImojIDw6BViKxRgIVBaZwVdSv%2BxvXA%2BIuzqcog2cOkkvDNE8Lbqs74k64i%2B5Sf3u8Z2AnIRLbyVCyTflVSEXVoEqrrMqrgiqqsqqqWQ5xlAc5zWOc5TwXucxVnuE5HdQhHdFRHdNJndZZndeFLc%2FzsKJLQ%2FWV6BcrCdWkwspVKZVROaw0qUqqoqZZcJhdTnGGxznHBS5xhad5VhNWCuturBTXKZ3RObuS98pb9c57k6ql9rp2v1as5deb1r6s9q1GV2IrHSt73T631424YXzjgPwqt%2BRn%2BVG%2BlRvyirwsS%2FKCPCfPytPypDwhj8mjctRZd9acF86y89x55jxxHjkPnXstXfbt%2FpNjj%2FnwXW%2BcHa6%2FSYvZ7yEwbDYazDcIgoUGzY3h2HtqgUcs1AFPWKgTXrRQF7xkoQhRf7uF9hPFeyzUTTSwY6EoUUJY6AC8bSGMS4Ys1Au3WaiPSGGsMtkdGH2rzJgYHAaYjxIwQqtB1CnYkEZ9BM6ALOpROAfyqI%2FDBQudgidBETXuqRIooz4DV0AV9UV4GsyivkTEyMMmw1UYGdhkuAYjA5sMGMvIwCbDDRgZeAz1TXgcmDy3YeRhk%2BcOjCxsMjyAkYFNhscwMrDJ8BQ2886gXoaRhedQvyTSkDZ7uA6HLLQBI5vGntAbGHugTc53cMxC7%2BE4SKL%2BACOzNpk3YWTWJid%2BiRo5NXIKM3fBItAPW55FdJLY3FeHBDr90606JCIU9Jk%2BMs3%2FY%2F8L8jUq3y79bJ%2F0%2F%2BROoP4v9v%2F4%2Fmj%2Bi7HBXUd0%2FelU6IHfHt8Aj9EPGAAoAvgAAAAB%2F%2F8AAnjaxb0JfBvVtTA%2BdxaN1hltI1m2ZVuSJVneLVlSHCdy9oTEWchqtrBEJRAgCYEsQNhC2EsbWmpI2dqkQBoSYgKlpaQthVL0yusrpW77aEubfq%2Fly%2BujvJampSTW5Dvnzmi1E%2Bjr%2F%2F3%2BXmbu3Llz77nnbuece865DMu0MAy5jGtiOEZkOp8lTNeUwyLP%2FDH%2BrEH41ZTDHAtB5lkOowWMPiwayNiUwwTjE46AI5xwhFrINPXYn%2F7ENY0dbWHfZAiTZbL8ID%2FInAd5xz2NpIH4STpDGonHIJNE3OP1KG4ISaSNeBuITAyRLgIxoiEUhFAnmUpEiXSRSGqAQEw0kuyFUIb0k2gnGSApyBFi0il2SI5YLGb5MdFjXCey4mNHzQ7WwLGEdZiPPgYR64we8THZHAt%2BwnT84D%2Fx8YTpGPgheKH4CMEDVF9xBOIeP3EbQgGH29BGgpGkIxCMTCW9qUTA0Zsir%2BQUP1mt%2BP2KusevwIO6Bx%2FIaj8%2FOD5O0VNrZW2EsqZBWbO1skRiEKE0DdlKKaSVO5VAuRpqk8VQJAqY7ydxaK44YJvrO2EWjOoDBoFYzQbDNkON%2BUbiKoRkywMWWf1j4bEY2iIY1AeMgvmEz%2FkVo9v4FSc%2FaMZMrFbjl4zWLL0%2BY5FlyzNlEVYDudJohg8gPUP7kcB%2Fmn%2BG6cd%2B5PV4Q72dXCgocWJADBgUuDTwiXiGSyZo14HOEQ2lE6k0XDIEusexDzZOMXwt1Dutz%2BtqmxTvlskNWXXUQIbhaurum9GrePqm9Yaeabjkiqf%2BbUvzDOvb2Y1E%2BEX2DnemcTP%2FzLcuu7xjQXdAtjR0Lo5n4%2FHs%2FGtntMlysHt%2B29NXbH6se%2F%2FWbFcyu%2Br28H0MwzI30DYeYTLMXIA2EG8QlHpAsyS0EfEToR0a3utIxFPJ3kiIHCCrZ66b0e2xEmL1dM9YN%2FMwS5p01N5jMX%2FBLKt%2F1R83l0LyC29M6%2BiYxo%2FUNg%2FEF7c2WyyW5tYl8WnhWg2%2FhyySbD5UhnDyS7OcU0dnrFw%2BDfGdI7v4QfYIIzOMq9hFtY55gmvC7jZ2FK7sEdrn6IXBuucYhjsGdQ8z0yEbWkkczjjsE5hNAIZrPx2zOLZDmKNXcXtg7EMqidAEEWg%2BSJCBBNwxvxJfc%2FbZa%2BKKf%2BxoKZybnq5vaqpPTye7CiF%2BZFjxZ8%2F7Qij0hfOG%2FcowPA1rT1l4ymWnrKmxxqfErTVrpgwPlz1kC%2BOy8NMDz6c%2BIO38K%2Fx0xkPnLW8Kx6qGAoQdL%2BTD9V9rb%2B%2Fctn%2F%2Ftrxz8dUrZrD%2Fzk%2FferF0cNt1BzctmX2FZPXt%2FjnFCQNz4Ah%2FiKllGiCMs1w5Lkg0kiEwj6VTXCDKsX9rMpnvIj9pcDecXAIXMnqn2dTUbN6w0XQ9ue6FV%2FnnXCH7S3lPWGltVcLsH75ub3ab7A8M28caNrIeOr3o5Q0yFsYL80xaa0EY%2FUEczV7icUMY5pnelAkmUAXmHYjvFWFGxuqlSaow3OM%2B%2FiYY7%2Fl%2FhVELF4EjRqNR%2FbvRbOY%2BDUGzGR%2FOh3EqmE%2FugIQQguGt%2FeMYz%2F%2BL0cimjeZfQDI3phXMbMQsqH%2BCjwVz%2Fhf4idHovgVmB8gLvjbicDcC%2FNypP536E%2F9N%2FpuMibExdohBmNwyiaZdJGoigos7GpF222xrfnZhML%2F7Z%2BylaqP63Hr%2Bm7bdUkQ6%2F2cXqdfmvwixY%2Bs2ksXFeXcE%2BiX0Z%2BIow76DBNgjJ7TOdUK18iPsPflfQD%2BDPsZG2Aj9VmKMMJ4fYRrhIaxhTDR0Elh2vA6h%2FAE6xUb29mj3sjmL72petXjejPy%2Boel60M99tFduCI59N3221xe7apOvxs6aHs7vab1IqY2tv7q2xsHeHGml%2FcV06u%2F8S%2FxTjJ%2BJYc0bWEX0ukW6YmIbGkJRMdjJ9mYIH5QIdJF4hvRGyK7cC7ctImQRcUET99fGXOoft35GYLMQu%2Bg2smnkgZUrH8AL%2F9Si217IssJ916nv14ZrJrvdxLkQvrvtBcjgPC0NXOicO8Qf4mcxPqh3hgUw3DDfdvLJXngg7N3dN2zbPJSaed3OfZnMU7dvmznp3C3bruO%2BNmue0LFsy7S%2B6265%2BfCKFYdvvuW6vmlblnUI8xCXp37CrOZv4B9gauDBlYp7adcUXB5DNCwYImlXOJJKkAdvExXxVvKEYnCo%2B3eIskP9qrrfIYs71CccBjfXRC52udTHHdaP1A1ui%2FVvH1otbrLrpNXBsGX5B89QghDyimlvNB2KfkxZ5C9%2Fem3%2Bd1%2Bd%2F%2FIfFp2%2B2Oxn%2Fs%2B9n%2F79p39S3s8idN6g0yZObwJOgKUpNB3GyU0Ls0PbRzIRq4lcarLKOJBkLRzJQD4j2090XrbA7DW8K3jNF5hlGS5e4V2D17zgss4T20egOJte5iD0bReM9yjTxnQxCRj3c5kFzGJmGbNKmwGw39IJDJcXJZGMkaAB4jyJAKw0jt5IAuIE%2BA%2BU3cVAZZrq9zhDyBrU8oosuxcGNTzCKJfla7JjNVmuSb%2F%2BtuzN2H%2BX4vlB%2BPpdfMXXmuVsNiub1T34SFbjYw5itEvVi0K0Nt9pNJUMI7SLGRhf2xipfCYf8z5OdlGKayOucFeVPeS%2Fdbo3lBrbSMmwUiQN5%2Fed7g0Ds1s17IuZC5kNzM3MZ6EWCa0DtekdJfAxz%2BR%2FOX28sND7yRMTBcf%2B%2Bs8mQCQWHya4qBv%2FufeMoWyslPA9DtMxUknxkH%2FyfTnm2CMYzs%2BCq3r7PxY%2FMXomrvTEsRpfEGHa%2BWN8E1AHjElb7d06ddA7oK%2F%2B5Mdsv9EtPms0jv0Z5kf1FqPxWdFtfFr0kHfgDX0Y%2B5PRSG7RUj0tQr7rmfX8DH4G5W28kKeJLtmQsQkuwMP1pk16EV4sl7vrMJATfyUWo%2FGwEco4rh4XFQgaiUX9qxZHrMQqKnz%2Fc2d8b9TysYrAuXpP%2FRf%2FGr8b1qwwc5a%2BeuLa6S6sneNXToG2XrEJi4R5SGs8Sq2S3d97bsfCRaTdaLwKClRHt37mkudvXbjwVrLhuYeGhh56bvfQkHpk2CwvwClqgWwuBfndC3c8dwmstj81KkagcUgbfPY8Zje0W%2F82VPWJHmSq6pP8hPWpotc%2FEexDOK3qU%2BwngPhOCiO9MJRm8TJefjelrzoKnG2Bn%2B1NCUmPE4gHFmBN9jrTigRIpsACrc9Gstg58ULkp9467%2BGf%2FeFnD5%2F31lNrt2967dhrm7bzI%2BVT5m%2BfzKhvf2MzpICEm79Bopkn07lt1762adNr127LwVqQLdJ5%2BlpQDcvHPQtVY5knhYrK6q8%2FJsiP6EuhGZdFdaNszjvpqvc%2BPI0CdjN0AXsFOC3ZfALDJwr4q2Xq%2BGF%2BGNbsxUg5NLLIEXi8otcDQcUts0D8eQ1iVDRAMBTsYiNdRIxE09EIBJO9A2xqgERTaW86BUFn0OD2xFO97FAgFhF6OoQ7prYt4XwSeUgQHiJyDbeke9IdQntciLQ1FlJMaYcUNvZBg%2BFB1ubjlnRNvl3o6IEU2w7fdNPhm%2Fhh%2BFLysUu6%2B%2BDLHkOkrSHYEjH0tEPe7WdD3uyDgvAgK%2Fm4szFFR7ch0toUgBTdWHr7EpaWru6%2B6dmbbnqWEbV2EtxAsXiZAPTtGPSbHsotI2leoM8TePEqgSQprs7AGFf8kuOkPdZPXGb55POAW1d%2FjLST9v5YflasP6v%2FCO7%2BGNAPC2BMZWmsOjp2NNbfHwMCJD%2BLPVL%2BD%2FOYlWEEI%2F9jpPddOFkB5d1GSuKZYggmCCd7JUxD7EXAzxyirYnNDLdDZoFdx14kivkvGc3579Jm36reTTvDgBnaO6vzyQ6chQmlsMoIkIQ2%2BbBDWBud1Va4pcCn8CPqxlh%2FfgtG8IPaPH8C5wk6%2FnZDv69jurV5QhtwE0x2iqOsj9Mx8B9%2F0EaUdiPfOYYDCi%2Fq9jhWRuupMDEU0%2BCtX0sDFxv07T%2FK5niBPqN9%2BtQjgEc31NGCXFeMcCEuQBIc%2FBK4CO78u7EPYvl3yaEfK3vcb6qP1R2tI7vUjVDDUdKubsSrNjYKY1qBEa2P50SJoaXiksIoLiCwnxS6EBuBde87botNfdEWwYvF%2FR0%2Fu5yCqhGeEOR2ynSeyXjt6ka7neyye8kryBSWE52y%2BRBgogrXPZ8E1yIHoHIFUM%2BAbJhE7lbMtt8ApL%2BxmZW7PwbjAO0fAVoXQOuiSP%2FksIVdFZ0aulsamKUzwPZ%2FNYDMJRBPCxsBqLzqHyneXF6Ej9HlIFo7%2Bpg%2BjUb3unRmGpstGkm6etOuDBGA5wCMefp1gTHcdZlvPBXlOslvYTp1cd8UjYLVd%2FJ5awNrIOKLnIt9MD9qdrKrWCvA6ALm3QV9VrsPm60Q7%2BRHJHP%2B2hqfugo%2FMvI2H%2Fmqr4b9tFnKSRY1Y5Ek80Nm%2FWIhr1ikKnxGz9TWXrokf9xwujfvcOTtNTWnxd0F37Y2W79tteBqZ4G5qLCuomw%2BnSr28QESCRVLTyYKILGJOPfcnaIFOsewhRdvv%2BrWa%2FWih0vlbX6Zb75T5C0qNKVFvH1QL%2FvazSWgC2s6oWXXIuUxQelKiJbowuJDQViatLmLijg9CQBMg8WiPgiw3LEeYRmm5f%2BXdnvkDnxLLjMLxtvX74C3OlwPQqx4xwIdpPx38LrlDphiyWUWHWKAzzxurS%2FxTo%2BP5wGFak62ap1PVFFN4v%2Fy%2BxuR39WnIO7lsWfwgVsK17wxrs9K8ltIKuhkw7f%2F6dhK6gQokFKhWX3urrjk%2FrnI0pgfpGMeuQIUaEM7%2BGF5q2iMkCaMQwxxOzcvU0eXbsnS9XknXvP7Gtw5dwPXlFu2ecvSHEZgNDsU6x%2FGdXBYXyOQjzZReSedeEPY6nEv9gJR4oBQJtFO6Kd0fwC6BO4LNHDeBujB6dSNcUQC9zIv2LnAzGk99bUDrdFY%2B9yGFQtEo0GQPNv6vS2drj4%2B1jHbv3aJSMUWP%2BQTZrmbNTjU8wyG%2FiXNNpskybLcJ3CiTF5Ir%2BJYzmJwE0mSVhlxbtbmvweB3ulB6Til5UuUZydpgiFVeobhU0WaBqpJ198d%2B%2FXeNRTZ9%2F1OPfG7%2B2hwzd5W3D%2BhmyjsRcUg%2F%2BCavb%2B%2BVh2ls3L7zT%2FetOnHNxeerv313vzLVqPai4nJv%2BK1FC6040%2F4udw7sAb3laSg0XCkAAs0npBO6VJabS4Elk%2FU%2BD4gTXW%2Bj0wnrMlqNamq4tMIYB87tE10i0FR3LZNhJsb7%2FR561btmes8YBCRkhYNByRtKd55mqTas9FYhJnbRGHuOh3M4QTdgQSqmgRxuzGdSvZGcbMxNQGk5C3ebLjoXIOFM4l%2BWKHmLTJwRv9E8GWJ6dYvf%2FFmEyEGr%2Bgyrr1p5zrgkz0Cw2j94Hv8Jdx7dIVegBSNtgsqGsRQEYiIBoXwD0LNvQ5d7s5Z00QzwNhqZA0b%2BtMG1tQq5nd84uq8R0zPvX35G8uRaze4jcOHzz0w1%2BQ2BIRvf6J6Kgatnrbiem%2BCFvAxfkrndzD9MFPP1GWTUHclpASUkCNAQkpCCcCgDSUDAhDZ%2BCuEkgn8J7i9nMA7pA4lISappxILKfAeSAbIcSDuN2bJcfZILqeO5rLs0MnngSHYRdrHjmaz7JEsEPw51ZqDJDmUIOZIe34WaQeegNsJn1qz8AIpT3yCjyEih%2FxELkuJ0lEMYTLVCiWpo5oYMleMH6USyYJcD%2BuOe%2BkWKpn1Qns34iyYDjkSLvgnZXcgVQNeqINXr48m3iS7cjm8tedyY0f1QvTnHHdsrKby%2F%2BSSbPY8%2FNH6vpl%2FEsq3Ae4ZU1HC44KFiI9o7CEgab%2FRqHbj7s5KAg06s39ZP%2FzxI%2FmVuF%2FTbTSy%2B3Fb8If9%2Fcv7%2Bwt91yy8RfP1QXtW5RzQn7qIiZyuFM5QfJ5E9uVnqT85TanFx0lkP3ukBAMprvsRyi%2FC8NAJL1xbIIirSvnSj4O5netb4JxmNANHPssHAcHMHsFRgEug816gDBeMbdfiuRcghqYcm0%2BXxx%2F5IAEtN3fqFF3LzAXqwoT0PN0OVTNqxo8sxMkd5Ig6k79Zk7VxxX6gMLOZFQgvpW2RrMW1D0BDihaXQ9wVRoBxPLfpknmkeMtoB%2FqM9cRc9IqmMD2XUmdZ7GSRKPUZvChf8BoykriM2MnKYbOHX8R7cLdNCxSFFVQqoYswnlWtlFS2mNkhswVpZiQW1J%2FUKFfipHGlUkM6UKBhMz1istELIHJLMSctu3ugzfaVSOjKvUgc%2FTHK4Sdg2Wscz69leKIkkrwuuWiOe9yGYKQXRumkC3qbRcMwrvhjNXgdZk3RxAUEhuSPvn3nnd%2B%2BU%2F3vlVOmrJzCD8JLxV1OHRjrZifbcFDOuRNTGqdgQm1tSNJ2OcQ04YiEXuxtII1ECSQRoQGYioEsgCfchB4ghAtw7FfJre4WZ9hkVi9MtjuWqtdNDlpMrfEG9fOT6q21okg%2Be4As38MfGquNt7oUws6Ysarj1%2FefE%2Byst86YUVNvDdts3Pv5c8m%2FaP0C%2Bf8%2FQb%2BIMnGq09BgwN01oIOAnAdagI8mBSrqk1gxTDUBOtk2ousEtBH2z4Ir2d3f6k8PXXVlt2qN9RODxRuoJT%2Fv27wm09jRYVc%2Fe%2B%2Biyx2tyzJb%2Fn3J0htXP87eSsQaf2Ly0s6Zmxela88REy1cf4273mI3iXNJ7KxrZibOm9xm6rl4fqy%2Ft27smU8tOfdW2ucBzg2UfmOIVyLIl3kpYlwphDISTXJXsctmiDtN7fNV6zelgxwnWxsVr83Aj%2FS5ki1jL%2Fa0GC6%2B2L6Um%2BaoddlNFuj%2BbJ8mH%2FiaLh8I0%2FU51NspIEfq0dohwyFXKgm4NggwQ4rRhCOUFtxxo8XnitT4cnGfT93IS8FaT85XE3H5LMY4zIEPL1hw443wz%2B1UmhTJyJGxZzw%2BwsKkKZgUiVtKOKMEb2AKHTv61FNc01PQFwKnvsZ%2F9pPA4RKTASWahmh%2B8MxwzHxKy74IRn5LGRjsPUUwTu64UYNY38caqd7HKucZ%2FtHnODtENw%2F2UfHRMaq1UUPDJQ0OKkWCeet5fYOhII1VRz8%2B%2FElg5j4Gxur3J8o2PJ4rg%2B2d08T%2FfwEzSVbyZ9XPro95T477lRKqUSRXQnauHNsISAl27oWi6Fv9z48JMv8r%2FaMMj8onCP%2FDuDZOuN%2BGPPr%2F%2Bp7bx%2B7JlbYdppcNhzKU%2F1Px5aiaGDn%2Fs1iGMaBcleKUo%2Fv9rcxkZj7DBEKOfrayytXNLYiUdBY%2BpleQXdnscKlQcpzuWluxsieeyuXIK6SdxozitWyGOV3vOHHjguyCQ6fpIYy2JwvrQEF%2FQa9Pdf%2FQqOSqCiE%2FEE1%2FXIVKTc2tzWbHnimrEd%2BVyz311Ml3P0GVTj7PD5aDnsvCvH36alEaPMePcMegXs7x8igTu4B9v7G9vTHvhCu%2FkzIdx%2BBxC0ay9zRSvoS0F2lIxI%2BX7klU63I40gLQ3w5ep5na%2BSFnba3z5D64zv%2BQtM4n4ffG3tq4aNHGRfxgrXPMim%2B5487abL7xhdseIRn1KDl%2B7aINixdv0OD%2BJSPwKf5%2BxoP6aiTeQIDVlIhMcL1H5R9PYXvprs3fv2bO7MOplCmweuiq2JRZ1zz%2B9a%2Fv2PH1Hfz9236w%2BZrPXvWfAxlj4NLLHpq3c%2FPQ3uvmvbrjG7fe%2Bo2y%2FcLdtE6VUlXi0ASb1VLUBVSUWSU4HdvAraTyS8xzM8NxvxFkXV6pUVRiJwcgC5zEeht4rwcp7ki0k41G0qlQhG1Vzlq8alEmnFi58caB5Q9vn988MLhqyVlHvLEWjtQFeupdiocF%2FtkkOGPW2ibWaBTkeZ%2FdvPWazXfOnnvL6jkRXpi85sFzZt%2B55ZptW3bl1cCCHZPD06MhySha7UFzjcjbp8fOecFCirzAG%2FyVjBX6OFIaadSjQq1nNhyIe8tVbaaSdHlXIWKacMeuZA1uxS95zILhyrxAdsXTL6m7kNQlx2P9uZf2qhufePFFbpI6%2FOU0WcP99RrCsrwseVot5mtytpf6Y0gm9sdeyKnPQ7onyK4nXlR%2Frg7H95M1upzu89DH6pgUcikoiihJ6NJKmRxV1x%2BMJiOA3YwhDRQrWU0u%2F0rvq0VYXnyCwsLeTJYBq3dAtJDavuzyoVpzZ99Z0%2Ba0uoiFH%2FxcqgDR7rUFeOrUn6Cywb8ZeNMbhLV5ugP9l0zv9UN5b5mFkjzxUcpPJCn3V402pRxtJd2GrnLdhtVk9ZSZh9W91fCSH5B7ofxPiWL%2Bj3D%2FuwhBRdyAyozeZwvQzs79soi%2BBKSnafLviZCcfrpBpLyimfLfTyJtbyruIQKD01tUwJyKEo%2FybaxkSNFUMdMkhQoJyRBQFhnUkDQSXhTM%2B3NmY0EDM7ffLIjqWEGt8lCO6mLia3PukFnghosJD5p5SIho%2FVDkzQfLE%2BIrYoJXkD19pdP7OwG%2FvoIUtagiWiZ4PAFTHHlTVhRZ7dYmPar%2BNJ%2B8JhmR6DFK5DV1foHoLNO%2FpHrvZfmWZ15RQlwvoVDKhCWNK3CCch9lfFBuAqUgpFSShmNaPj%2Bi5%2B%2BWZfKeViJfW5HnUakVL4UCNVkA4%2BETfIqx4B5xSaP2L1yn0zn2ltPn4%2BOqZGmwwEVCaCSqG53ldtL1oLGAhdMLd09MpCCF6tD6ZnAZBY9hDaYsP0jzZ0j5ZjKsF4i1UmLuhbJMCnYJPt5VwFNvmZawXjEvLJqIH8STonZjq7BZ8gKgR20C9MDFqJAX1H64QW2NEup6qgzLP8cvppL%2FNNTOBTCJABOHeWoXzLhw4Wuy7gaBtjKr9kgKq8ZlRYBS32Lpxc8vIhpNDTfyNXWybMJbn2RyQ5EmWc2QF9wmSZ0KYCE%2BcPuYO6b15Uotj2Kd4MItLS7gtFbkTdrFND6pvEZqv5Yv7jXAus7Pg7avo7KDot50NX3CPkP%2BKps8J9%2F3mGQIteY%2FLGPC%2BL7872SPR2br5fy8MtKBMHedGuM28%2FMZmPJMrGgi3Gb1S%2BSi1%2FL%2FzrZwO9XH1ce%2Fz7ZQ1WSoY%2F%2BpMb5FT4ua0Wm%2BJf%2F298nFmChEQ%2BTi71est4mq9VYI6RsymoRJKYidElT2FGnDTZvqtfhGAFTbeqEw68GqtfmbVa%2F1IFO1%2FjdWr%2F8BDRRtQh9XNjubEm4aWVpVonpTGR7PVGc%2BKJNoBIWF7kYi4gUV3r1U6723i6TxUl3n3%2FtM27aZfKb7THiHW9VzFSwHJ05VfK6Ar7kaB0XgPPE0BSkSFKsBUpaLihEWoA9wBt8qirh2VSOkZwXEwyrxZ5jyt2rJmSo9gX7cg6jsEUGJU9z9xJPOEM3uQQxKgkh35DNATnVyrmJ3mbCNyIB%2Fyox4wH1bg2DwN7q9kov4pFqny8oSm3RQbGgJ1QQTs6ZMLilOVYJ9v6Wha3HcJ9jddsXp9YhGUXLXt%2FqMDnvLpPNTXfNa60z5%2FyjXQOMq%2BlNmwh5egpYrdfZQZV9rI47xlRkuyTjpzsmCBSWNkAXVoK8sgYWqQJWbo1RLo6QH0YW6pxqfCnRgkd%2BRiFjUQUQ7poIaYoakgXxwFd9BuuI38H1xBxXSFb%2FpBDIKQFn7YB3dB36l7sG1FLaKiBdp1KxLvfswap%2F30lnVESgNnvjbUoT6w9N%2BXoio0qcYOIM%2Bheg940YimsucQVvli9NEcft2UZwGQwLuilj1fFr1i3NP94X%2BPE7Hpvtj6lBJfJ4R6NvWiaL6MgzWHxiN66DExa%2BdAdAbMYX6HVF8A%2B7rjEZIXAVbDe7PVI9rmN69JOLV1DOSvRPxWNPZBZf%2FNf%2BNy65BhYxxxV%2B77XJ2wfQ389%2FIQPgajXbwMsuAz%2F0IaQcXJavKbRqR2IqyZruXjVC2%2Bhdee%2F5vdnYOedpmVtR3NGXldxSzDSIiBVpkGb9by89UpEPKrSLZmyFDzMab%2FwXl2CNe7s%2FqCtTvWgG5kpBmCBlSzDS%2Fr8N4uwBwohRW63JTS1y32f0TQsPfXVGEHQrV8%2FNCfiOUVirYcBbIeA2%2BiF68rQIo3B%2FS628vYESr79ehzS7Q9LEL9UXmik9XVHb1yBO3Ngvt5935%2Bk1efkV51mzzrM0LL3%2F20avnwMeKuWyOUZg2TasSqZ%2BKcZQiOn1Iu2Vh497ALUVZiCKt%2Fgh6IvTIj1ZLRjWAkpHKOKovNwp00eqPROiAbiNEKieXwMLcXhVJ1%2FuzmLP4tfxaHR59cBdJVG1kTAgl9ze9QKUEQ946Hkb%2BokJ5JRDyf54Axur1D%2BWS49cLr0tTPEu7UmXrxcSr3XNvumv4yXzInXKH4F7Tc7p17Zt%2Bt%2FqW2%2B93k063X7VW6lALxTY7i1nBXMxcxmzQbabxz%2BtJo%2BwijYaIGMNS8AoSMgAPt84DdHOoMPfjXhF%2BkuH1tZvuFQrRCN07xGcXRX9MYxYchDe5BcHj%2BZ4i%2B42WyPc8Xofi7bbZJN5nJLJ5qr6IqRtzqNlM17SpFsnkEyTWoABEjz4JXOQvzWYuwdnV5LNGOwTM5v9r4RpQ8ZXsYodks3o31JBlzbYtNotisnm22MxiwGFXam5oN1n0TA%2FhRvshvTSDwHff4nNzRo9Dum6PaJbMXzDz%2Bx%2BFkj4L4bFNBb1asqsgH7Dyh4DvbkPtf5yMDKzEwyoaESMSNS9P9gJVA3%2FRTlwoMwZvxECFWxIPNw9gi01nOHjP32esZTtmXHnxvZd8ZtakqQ7ekajbXetpNa6ocTVxJtY%2BuSe69OLz77zh5bDR3xjZMzUz6fxrz1nqrZGcHQHfPVefN%2BfiK86LeXj%2BSc5lPKy%2Bk%2FvCUI%2FDaLFYCWHr6nbXuILTIsb5imNKY%2FrCm28fSMxPhkN1XbNMNZGuqwOBhtTSxWuTk6bw0ZaG86b1hKddePOKuBvmiguYBn4T%2FyOqOyGRBt7bKUI1GjioBC8aUKwF7Q319UgcmtFGIzCJGBqwQij0ynDsfdFGc3TS3BlNfJ25xmzniMkpXXTPvCaD3ZaZvyzjmZdudBostmhb0ORZNN2sJBeed1HXkrUsywueQH%2BL0eCPxmsa5ZpgRJSDZ11yDv%2Bjmbd86vxZfc1WcZJ3UkMq1BOOOVtvu%2F%2BpB%2Ben186d3GTwWAw2jheaJs09%2F%2BLNfZft37DALyrNj1wABMuUKbODyTVnT%2FKYbJ3Tpq8IrNh92dkxOj5P%2FYpZx4%2FycyiVcDYdn4JbEoKdQi9054iBKsygLW46FRGxAb0NPNCm8BSNCPjoKcj6EAus4SuP3rB%2BcV99%2FeTF6294dA8%2BTK6v74MHVpYNRt%2FI30e8QGTOOdfGWzzxcy%2B87a7bLjw37rHw1nPzp0KyyRSeZO%2BQQhInt3dYgvycjrPOv%2BT8s1rptaP84VeywdWX2T4ysr0%2F7TLIs6%2Bx9zib56ye1dM9e%2FXsZmePY3NDs9zlnNVt4%2BWgHJbbz3Livg4P9WWgviOMm4kCRT6I8vw0NbUUEnFvOuFKoxQW1gTsvFirsF5pb7qTUCx4i7VmtToveaDxvK9uOaedVvPRpVOnNz0Q6bry7uiSdQ8t7Vy4JQKVS%2BXPplV2ts4bvCwZu%2BKzgITtxepaPRzWdpv74muvv6RO0SorX6cu%2FdqKn%2FXWnrtp%2FZragz13DUCl5myiFW2Ycvb0PtsXnU%2Btx8pvLFbUspLX68mdegwmOif%2FNPDONajTGoUh6tU56HBJCTBASVvNUB5VIiKpc9kd7kludodSFz7xQbiOmMk5dOYk56gzL6uaf7N8a6MQOHm0ae6snZpFDfuT3%2FjdYzjzwkXXIVHoXNuCfQslQZqBZjTsoHMqrkE4jaYdgkGz2ATOgB3cPkSukD01DnV3ttb1wx%2B6arPqbkcNAHoFPzKUUQ%2BqL0k97pjbZv1I%2FegC9zTFbrrlFpNdmea%2BgIgfWW3wqkcis8ky5FAcRd1If5nNZrl2FFpungc8wpoCl1BpQV%2FScS%2BzjlASyUTVv%2FAJ46gkJI4bHX4lTnloctxPZE1ckS3%2BjG2fKIjkQFyzuo8jvYQG1OrGvJPSTu%2FnSp9PHNTl4z5hK%2F8gtXVKF6gEKiglgcKiRlCESsQCV5QIlKWKpr34lt%2FwkSx%2FJCmP5%2FcBKQfl%2F5gd%2BrOS%2F%2Bp91%2F%2BYCg5CXK2W4M9fu%2B%2F6xxX%2BvnelVuldIDCG0VQTpU9Dw4pRfei%2B6zWx0MLie0gPbyrkmRU7OwT16JGeyXLHqOLqAfVN1GPlBzWtFNzj0TRTCjogtP1NjIvu5habN5Aoa1k66wGpqriVetJgiGdwDZtKhnN0y4n9sXYnsqGmZfDSR15%2B5NLBlhoDaedEm7sxmpqRija6ZEEg2EAnTiAC8IrmFbGz1q08P9PSkjl%2F5bqzYqT9hMmptEXDgTqP3Wiye%2BsD4Wir4jCeoHbbp5hRfpB7BakUIppIlPCD30dR1GtslDz8OsqbXmejFC%2Fv8wu5X2myq7SJ8Avzv9DFUJySf5uNvq4%2BTi7W9D%2FOZrLChdwxmPNiBRqVjnpK%2FaGxRCDspVYKAW9AN1JANoo8wP4BJUlGqdgw6m1qPQ2QW3%2BOfU5%2FieLS%2FNuKpDU3uf8bcAXyBal5jMR2NEAbPAZt0K3hvxHBEDlUxfIGcD%2BN2gNSNx36nfqlAYow0puatNpRz0e4W2oahKzQHsjf2c16ad%2F3t2KTtPobnX6D8C8pd0MDP%2BKx7wnXqGGlLQcvikMErm6TmfsuxJXbSAxqNjOogJLQBLiKEHAE%2BJGTS3JoEhTrz8%2FCB%2B5YlupJ58aOat8Kv4JvregxwcU5Cp8GFAFm1FyOfto6GS2m1NGTS6CPNKkbsTdCBlnN9onMho55BX8IJZtEQ35lk%2BhtwN5A0V3RCPoD%2FyXAcv6pAtbZczRUA64JmcUf4q7Q89ZHLeJVZ5D1Ps%2Ft%2B0iCT3AHVtZC7JDCXfR7OSb%2FXja5H3zQbZL1B%2BULX1BMTEk3AseSpmnKEK4T9ekMIidUCRQFfcbj7z8gNLvzF7mbhQN8h6ZbRset%2BnQWdS%2FZX3k7WpS8P9sfo0iGS64wV516pOhjI6TZ2dApgI5%2BLhxywYoWxKUrykKJsIoDsR4mSrCTg0egMPnLW%2F3Q5Nn8BZEuzqEI7HK3n0%2BzFmuO3TtWQ5WJoG9YqCD6Gc32SxnbnVPfsxvrFXK2dILl7bLthDp6glhcsfp4bYvbSmj%2FmQ94uBTw0E73x2jbNRCvC6VL6GCFDwU7eWQDcC5FY5s0slieRDwtAbRsbLXbaXAuu14e2OJw1dc6jQ3ZdY8v7rv2%2FBWZLqvFWVvvcmwZkK9f5jS4muO9yR5res4kfkRxhV03L1RfPOiPtYi8pd7jNEsOpyTwxpaY%2FyCZu%2FAmd5Or9uS3DYaeqVOhH7gZN%2F8I%2Fwi1fEuLXvyNivibjuKvN%2B1Nc01HF%2F3h%2Bef%2FsOhox8MPd5SFucPjorQwXT%2BytA8EmA5mamHNFDVhBI5pjZbQpugBNkO8MvRub8KVDKST1Wag7D3xlin1ZF7LFP%2F79nbvCXFOY%2BPUjrT7%2FotsPXXZ4exdPzuhZuL5LUXVAn7k7PbhG89uz3b41X01gbjP1xwlu5rrvvf9%2Bpbs6E%2FVu7Nk642%2FPYRaAiUBdrmO6CDTBLPQFA1ur0uXoBR1INDMkypKpoTqnSMx5GiEdTEaSHLs0Alvu%2F19%2F5QW9Rv1U1ridT22i%2B53pzumbs%2BXFFXYC%2B%2BCGsTj5JUT%2FGCgRt3n78i2n71FHG4%2Fu6X%2B%2B9%2Braya7os3ZbDmgWfXun44e%2Bu2NZKuGZ0HiF8M4TlMPR%2BEU6rPKRJ8wOU2RFUFLex3egEsz3YqEAq0cqhAAW19dBZIlVzR61tuIdTnpXH7l%2BuXrbjPUyep%2B8cl6aXKWhPHpDcXl9KiTWDNr4mBQc8Tq%2BNzK%2FOKSbsfl79o9G20R%2BbrBXYvUg0rLHhtrc4TN81TTOWSZ0gL1ZVlOYH2ery%2F7XVUjFMbzYpg7UswcqJPQwBd0LKLabJ8IaCr2otcjSkIrGwootKECaUd4XH1%2BSdazRrfddkBU98t1htvWrbjqSqjaCguxrffM%2F5zDCpBALUycmajhd%2BR6ww4SWafuZ5eU%2BtPid4lgd3gt%2Bb%2FY9rQoZNmiXYPXyRHbRs8zX%2Ff4WIFjWZJtUdSD55AP3xtXH%2BZipC0EqdBGDA4CoYEU6gRLGPU11QhkLTBiEYPiqOeQgwTCl9aok1Qr5pFf71qEeNxjy%2F8F0GoqYPv75Yh9j3x4DuJ%2BuEzHRpAq2lMqb%2BqfTdiq6kGtzfOWsv0c7lSeMXDHBDe1MT%2BLUgx0Pg%2Fp87u2UicdIvqQi8DkxhcUwUXCedMpb4NQjwY3npTmgsURJavLwCRyEcN2HfWsDVGfv%2Fu9ZUWUx%2BPYFueUKwaNvbtu%2BXps3eVWbN1GcgVrdMnWJ7WmJz9SD66EBidag0NF1Ukep0t5A7sFCWdhzvYwHv6L%2FBehXuHqfaBwBEU7hfVLcXvS4VQv%2BT%2FvaSIl7cbeMc7ekv9i8S3e1L5xxpvMGcu1EYPbKyCiijjGXcDKckm43PqU2qNWlXusZMiqF82cuVzolUHN9NNR0HZPxFPV9V0wLtvq%2Bk4DqOwVWDlzuQLVdqFiP08cRX7aRlBVfR8cb55bWe5LExnlcsDp1vAP8Q9BucPMk1Ulh4GnN0SAdxcNHv3q9ohx1Ati4S%2FtkWjIDe3hQdkUGrGRaFBiUdiTSkI41UkMuuQHP%2BEaSQYlPQTFWJF03BNPpTu5KFAdkWgDukzsZKMG0Q1TAQQglScOaP%2FdsZ8%2BfP75D%2F9Uu5Gs3FY%2F2SxPld0DHOciXI9gqjcEidXjE%2B3BLosy0OcX3T7O5g65ROGyzQ2BZs7WbZVnO5ydLe32hMwTQ4wnnKXW6XW5LAa7oaXOIHoUl0FgLQLH2by8wSTWeAx2Y5PDazK3BqZbeJZwXGPaYhX87ZNszoDdaRxotXO1nNlpdvAPFWHDm8PqEE0sZxDEqGzxisFNnuCWetPcGrObN0p23tTZwMuRVodSV8%2BLTrOV3eRvzjQZiSjaLYS1WEJe0kNsJlZu9LFun7%2B%2BwW4gRDRbaxw2nrOGm%2BxOj9cmtbp9ZqeTM1m8UXfQQCSTVSQox6pvtjot%2FFpHvIUjJovFEoYvHYV9C5Y%2FxN9OfcalvII37UEhTbTg%2FAQIaPb4Vz6j5u8%2FaViycMod%2FfkDcpu8QZbZoeBi%2FvbzP3XPsZvOubMtaPHkD9jt6%2BU2O7vqU%2F9C9SMvgrXpQNG%2FE0oJxun%2BCiElUa0IKQSUwERxOntKSV7ekcuh9VBZBBo3VUcB58ofKBHCwLyf9qFosz9Ibf8dGqwaBMjRig4SGOZ2UkWI7UiO9OfUPdxOYFApUZyfpY7mgEc5rtNGGk2H1lPhAk1Hp%2FVAMqQEHEUfEYkkUQq1JMdzsX7kklRrTrUi1wMcDjmu1YYfATj7Y%2BpGpPEBXuoQIj8rR9mgCl4C9yqmF7xnVWxGVniNqtpVmXBvQ6iwni5YQ8a1jYrXtc2J13HvgkvqWxuva1sbr%2BP2S5ceKGyBwDv2DbrToe1u6BkAJV7xnVLUaq0sJB8pFqcUIPi3yuwxi4JuLr%2BP30f3OkPQ72aO0xYo3%2FEsmO3QO5qEF8S0qQH0UsKXv0brnl9%2B8M7jF174%2BDsfvPOl1au%2FRL5%2F9DsbNnwHL2pHR1NTRxMZhJtHktOOxLxErPF6YlLvpC9YP73x%2B4ofw%2B3xVdrHcDE0dQQCmCRgvt9b35xINDf1CDcRSfJ%2BpYl%2BSf8YcurfmXP5F%2Fkj6J82jNsrkWiEuhVlgFfyNkB3S5MUzLhoNiwSCYcxQ7Ui4J0Xh7fmqRbaPa1tzujxkBRlsEHy0%2FOM4pYLPb7g9O6BQJN6l9zQ0OGyCaZz0vMTbHOzXfQ7a2tsterTcqxeInODoemdktw%2B1SbVhKwtW9ffe8VKadK0OVuC3bWzyKm5LeddsWTeorWyY9IMtUFutdu5g%2BRn533qkocdvLs2HmhU75br%2FMmWtD8zA3OP2t1ea636jEzqYxJZGAwFiDEd61oTsrRuW3%2F3pYNi3bS%2BRd%2BGjOfVpAPNd6y64Gsz1GaZleWIPoYL%2Fv9mTeQBENVEguiF1aC4YeXxFETw6QyPfn0m9g8IrMFAvKM1EI11DARnbqibHk%2FIojy5rSdgCyZi06y8sS024PeuO4MfwQ5Y9yKRZCqyYaF30vzeHlmUprR21tR0t0yz8KZY66zWuGvxVQB%2F36kP%2BK38t2Hu6NQ9SFJfw0AdpqPEK2qTMpf2VCqJwqPoJezTL824b8akoL%2Bx03nhh%2BoNo5e77psxg9Q5LzebIKD%2BfsY34f2MtB9fk9v5b8PT6tYrgv4kRPwd0q9z3gdJSJ0653KjCYPwCaR5aUY63eW48O%2Fkdo33yxX9wCiMv2QTrk8eGSI6Ag6moG9t2P%2FF7GRNlDjl0gw7pJ5aOXXqyqn8SENnXBmbSwUYLyqJjv3UmY1nKr4t80no0faXsaIEiF%2FBRaIBnItSce4OUif7W6Vm9T9H1X9Vj71BEm%2BRdmIJQST%2FZfVdudUvh9S%2FqqNvqT98g9SQ3lHibZY0mRVHooyDN%2FFHmTgzjdozKw28NwQ0hwN6BCoPKaEk3YtKwNhwRLXuk076CGoZNXDQcRwZvreTZY9EZi%2Bd0s4%2Bztv8iei04JQl6ZbDD2eHV7X4uHuFVfPrOmcs6m6Kr7hssr%2B1VZFcEZ%2FPdJkn1hOs8SXS%2FNFFgqt94PIZzZ3tdaL6Q5vo6piSzdy737pwsX1VyxUrF15iJ4uNkq%2Brbyg1Z%2BO8VsNC1UmcvORPRfxtPrfRwL2p%2FoA1eZp6Z%2FaGffoewaXcA%2FxBlKlQLfhQL%2FoPgBGP3qsA7IQS8qDVNswHKRSheDUvA3Q7MZoRcJMxlEygujn1QdyzfPfq3dEp%2FbXh5e5YXW2Ngfvza0ZF6UgFL%2FE0fTq4LBlvTE2qb%2FKuuzYSXVnjTfM1osvqMHVbm9950quIZlbqaL6YP7jk3kUtA0GnX2nvq53f3WoSsvEdDRnULgo2fN7lNZJgI8%2FVWi33c3bBZnGY05%2Bdm%2B3qc7fNmj4YGKLj2nfqFP%2Bg7jdDlxEV5XsJQZP6hYrS1l0VQr4c69Xueixp90gnZPmE5OF22j%2BSYEWHlZ0K%2FHgsh%2FZtsbh6h2DNRlvv6jJh9XaJaHCZDiUDKNTMkvb8vsqCyf3ZNdSmO0fa0Y4baJTtpbKzuVzeeSI7fCKr2Z0WypapnXJ4gnoWy3PoUIlIQ1TXdqhQJIXp9Wx5fYdpeWh2TY5D%2BYVyKd0jw3iumwi%2FBC3cEy4o83QlZnW79MrCgCjbhWXBlRZVVZZv4rIKpXC01HFlHdHLoeWVl6UVc%2FJ5uGm6CViW5mulYMk%2BHqNYr0AyUPivLg2oMs2MPqtuhHyRyiwvNJej1Br%2BfcLyoAyu8D9B7bgmzUqfFobF5nKnK4%2Bt8MPJkI%2FxHUNWk117jugWF%2BxazTAALQn6%2BUE9lhoI5ApGA%2FiuJOsrlNP28SVVuBVajXmircLel46w2bJS1Q0Ft0KDuikDFL%2F3pYrid1Q4FvofwRIo4R9h2ftSwc6jHAMqLcCql8YPHtlzGoByNXYN6v8hXnRaOhUvx0sVLCexwupGDR4NOYC7PePa5keIPACnuAdD7dEadRuTIiS6Lb7uskb381My5yjzF8lGCjBRqdwrWJCagfB3yCy7XT1i92hbcZ5Ci1FJkgYMDf6n%2BjspIsHFjJrTOdzSMuOa9DbDcj%2FnH9N9bIoGVgzHPWIQuFuYtaMRaq8eCKI0gEF6lPOZjBz3EEvaaxwSUT9U%2F8JbJZPJJLBLolH1La%2FRbF9AbC8JJjv%2FmMnssKjLRBJyqj9QXxNko0Ux%2FX79epfiXkm6fmKwF%2Fen1HLc6LxloXWKvGa5rVCVL83VuiPcDEX%2FK5pTXOxHfx6HHB0t2FI0qI2rCZFTrvPWU67zVuS%2FkTsLnc7IKhFg30e4FOkqNSfH5PtkmUy6Cpiv%2F36k2sbqCeCFNa%2BURpoY0sZoYmCgCr3qgZz6s8I0gP1bYiR%2BD79H56NOz0EVWCTy2%2FfffvSCCx59W7uRV9995eqrX8GLesOXNm360iZ%2BT%2FEl3uZqL%2BFyzSZ8XxpTiI%2FG0nkT4zznFZ0t4ipMz5v4q9ssqbdKUZt6u82knPCrt6PZwsnn0XySVnyPR1ZXAn72yx48bWJsu7apnI3Hy8bygUK5Js32qcytapqgmn95uexccj205vGgJ%2BeuOeG2SORmKZr%2FqKzcx9SFctMJdwMUFZDJITs7dnOp1EKZCxg304Cevyfya%2BvlKqv6aXK1qIj3imL%2BL6hL%2ByvUlFfE0VKZ7E8gBY3M%2F8VoJCFgizH1W6VyC76nH6b7jiibYVxUmVIEspry%2FLgZIlCeP11Z4zs%2FAwvVwtGFEut5S1JY4lfyT0N%2FevOLo%2BrUEgjcqc9IkGpQbv3iW7Co5b%2BKgjvpzYdH85PLcc4X21ouwEGl%2FS4qnUAvoSlXUUhR1eKr2VWFTB%2BGMl6FsiQsVD1R3urlAAIoSn7JQkmiVVCHSpCwDH%2FqPepXQ0Db77CJOAImohB%2BRPWr31ev5g%2FkE%2BzTa4lbvZo8xdWPffQu9yJTPCNB66s%2BzXoJt%2F0L6hSoCuBIoK8fnBGG87OoRckJpLqyWe4YbpGi50g0%2B3I3UD85Oa0fzubfoXxPLbW3FDWzigmyJeM0tQkax7PqTy80%2BUxfUHPlBZIRVNQ%2Bv0xRm8REKPoLmNr0%2BUo48v9GFbXPKylqQ2IKm00QddgyWGMROCTxdLB9nCY8P7j2DjlsV%2F%2Bmfr0C0r%2FNkeXbbpPlOTBBwT0mVz1zx9S%2FwJecBF9Wgv3p032iP2v4VSgfgW2G%2BHUEdEXU6iq4CtpLJfIN9XQG8dwa1VoO8XC2SrPDDyCOQptXgbcPvlAgBfxBoGwftQKeKFrNTASPt3pGGqDt%2FQRasn2kri%2BH6L80MJRsmVYJrAKyDItpJUy3%2F15WYIJqcJ9Q5N%2FLFJ4c3dc1URpWl9hW6mu50MUIelg4ucTPf15zs5DFo1c0VSp1tKB9jkwIyuM45kb%2BIP8gHed%2B6jO3v0KbIknzLy636E8KPTdCuUpB0wLo9JKnAO6pv0vS31EtBha%2FfJemkgLVVnd8KCk4qBTpQ5m7FbifBKrPJcq0pZAFVG%2FXbOFz%2BTcq2MLrcmV28Nmi%2FOHskh82bau0k8eWCaPijQPWQ5lUvslwVCfHkXBMIehqUgtDNLeauH1huvZTbYmw%2BluPjyWoNGEuxRLR7LK5fSyXFUyK7PURQv2v8D3XOt2NJ6liBbmPGOsakw1kbeOs%2B31Wm5qpH%2BiJWSzqdPr2O7zc2TmtnrzCig6bBd%2FvgQmzOlz0STWIlmZEQfupogOZFHUZ7EkUnMn0RrpIMqAgHRJAOjIJ3yGw1I%2FMAp9q9S3Q%2FclADNm1wEeO%2Bxbwg5OIYHZLY3ehG5lJk2xhco%2B6JWybpEVz2wrR6hZyD0QXZbeDVB%2BonmlimpkWprdAs4WEZDSQppsDlcdCBJJESIYFuAtUnC4GIF2C3Uu2Kv7L1bdz6FxtqxpG4TqQOqOUNAJ2HLvPWA2GgDy4O4vaDrtyl6P%2B1fAll%2BSyFcQ28GHqh7fvvf37udylf0fNwhzgz87Y%2Bcf5x9GnF6ygHu18sAbipWeF0YPBgp2GaKeQduxxdEr3SgbH1kvH7tvqSLhedomOvZyts2dw8acu3dY%2Ff%2BucuMtCuP%2Fe4zC4XnH3OLZ8ZuxTWxy8dJfU5dhDeKPSlJy5pn%2F%2B7u3XrJhmr9C5CuleGflGQocKnlAUaRKp0BAHV0ZwUt9VCqk6zYOgRIuMfePJzdmBdpPJ7%2F6B23%2Bf%2Bsp9NMDZevovvfYHG5dGPISQq1DojqNckchVrCcCYz%2FQ0hI0m3NKDRfkgsrnamo%2Bp0CAq1FyvC3a3Nak%2Fs5VX282x9Ufy3E39VAx6o7LpCvO2wK%2Bch9jNqpJCutcIOooKnYWtDK8gTRVYygRQfwgzKM5%2BjP2jOZdx3r32Py7rQUPOzAnoRs95NvRAR0qLGU11Taqu1bUYSzMcWjMEir067JQQHfIrLBHsrgv00%2FWavd8HRLMEEYFSW3HCSNQehnrHztKqHcDyo4VfZ6gPKCR%2BgufwA8GegxUEo4A%2Bgd0BASHiH6jYMLIsUdQJTs%2FC641KN4oCHWolCMLlMfIdtWKScjx7SM5LD9HnfmhrGI0S139UWfUnxgOXdJFW%2BAMcGjKr6eHAttHF5sUoeArYKDcxMSYcKA%2FxUDhPiEOEAPafSIUFArN0r24ynI91EPARDXvIDYyvqZaWeroBOUABQA%2FE%2BDXC7PWafDLQY2oiwpUEyj4RQtVlUp1GrM7In2p2A7VuiOW6otMiGOo5Mrp05ejVuTy6dNX%2Fk%2F7mybZQ0nUmfrbx3U4KueDnlHm5wdh8FFeKnoaKKh%2FTK18StOPhwG9Xo5mqXAxvw%2F79YQwwDR%2BnAKQQ4izVXioB84qcppWB7IqjU45z4CE17OvF1Dw%2BoTFqxtz8dxwtogBnF9MjIl%2Fin%2BK8s3hM9laIn0TiCbTAXL0T798bPXqx36p3chrv0O%2BGC9Xaj48Ecv8U8UEeBvUEsDlTepiU5OvlpeNGvpnKF0RvUooWhIjnx6GeBapXCQYTw9DNg6%2FOC3gZjp76oNTj9Kz6Jqobxb9NDqc08vcKReOpcsQV2K8InXFaXW3aI6Ofr1k48rp7CX7rx%2Bv1UKPsfvzQU0Kc83i2VdILmd2%2FyX55zT9luN2%2BCu4nKfwPcK%2FCvDVU%2BpHh8%2BLaldIf1fA5h3ndT6Fln9%2FW%2F9Ce1vndfvJtnPVO2xhm3qbafHVCN1X363UXHq9xuVD8OSD29Z8pZ5cZrern9cAdGW%2Fuib%2Fud%2BVK0L9a42r6C90kL8KzxwLQw9NkIQJL0ASU8M%2BVG0KsUdgdvpgP%2F6NqqP0%2FgHZFUfGEijZLHpiIgvV5%2FBltrj8Qd7XQd5p4P%2B7tJo30NMO6VGBwahSPMYiaaBYoLY6uEnciyhhh1Z%2FvvacG%2Frjpsvnpzs0B1Id6fmX8119l88XnOxe%2FuGrzzHcdu7UtY3%2B2vmXN5zUyj3ZcPl8p1sZSs6%2FnGXtwrV7Ka0XZdz83fwjjINpZWYw85lL8BRK4nGyIir2RiOsEyipuEcIakpGjWgBjLiHWOgj0Yi34gW1kKPxHt2Na5q%2Blwg1RdRSpFDNzosb44YJXnAfoEOpZW%2F%2F6u1lhYA6leevezbI26zNHO811M2dc5HFxpk4i1jPC0s21%2FBWW5DnPQbn2X1WK43%2FaM2n18DfSoybbNHijFpamzXI31eRibGUOxSu%2FlT96YZlq1Yt20DaSBuG6knw2eusHs5EPBfNmVvHKdaQzcDfz9ZsXmLDWGXy2U5OsYSsIn8CS12jQIyD12KKqZrLPy7mSPdICmd6WGHG8NDZkkHuE4h9TU8FpmUO%2FVjC%2FEinToFyoNDz2p9XD6g78WgQdPG7Z3R0T%2FZ5dTM9lsL8Ktek7szl2L%2BgQwGgwkZHc2g5Su7NvVqwGy2Ua4KSXUwt1X4PaM5paaEu6jQ5zVFyNabxvUksVt2T%2F4VeamYPlLtffdQsk%2B2sUTY%2FzDXl%2F05W53%2FBz9UK3p7LjapZ2ZxOm%2BUlZXrL3HHGqO8%2BwVroDaCTTnTxitMxmiAAYQzVJQH%2Bnj3oIHnPaN6Zq6sNSLjBl8tKgVr2mj%2F9CWi9dnKca8rBQBsd5R1tzVlgrl5pbnPw6kZclCr2CHxMnHohLz%2B3KRQokzALyeIKFU1TNCiayJdoHvDYe7K6mZLm8S3uJ9dojuaJ62%2FqN%2FtjQxnSnhnKPw%2BLNrLi8ZKyJ3x1YhiI1aNAtP6NzCGzYv3DmaGh%2FLvQZnt0evgIhTFV0kE%2FPYxAnOHhCQUZdCWY5JWJwMzlAGl1mpNbDU7yyGnhRMILsYhH3VRAijrPcBU8%2FCj1Y9NY6cnGVW0CjTLaz7E3epvaT%2FLtTV72Rs%2B0WVVmd0dz%2FMGTI5F0OsIviaqDlbbO5X6xT3PeXbXHRtf%2Fz%2Bfdka%2BeKPr8KF7IF4vBsT9MFPuPJMBTBMq9hQxXelQ%2Bbewnf18ap4Ib%2BmSMrtDU5zqlD8QANa5MBGh%2FOwOvSDfcV2d66mfEWsbGWmIz6nsyZDWQSmqmxDneYyvjHPmRXHZxeueyRGLZzvRioKnGto9nIPkibAJA16adcOZRQr1iAP3bUyBR7T4RgAWTKxhkCYFwshq%2B7iV9r0whk50cmRcTg4fy5x4OmmNkHndIA2%2BYuMbmE9dwGYB4KFTsvnDE6Ah47r%2FfE3AYI%2BoXADpkdlENcZ8OZEEf8FFGZNxMs6ZLpG3SUFLL7Q2kcFU%2FA%2FJsw%2BvWDa%2F7emewLaoeibaF1B9qUNnuqWK3%2BUfXYVL1v%2FomD15xxeDkPnXTOKSVcCbDGtOu0YQNpGAP7U1HU58UrqGu8xIbHtkQ3LVhb7Dx46ET3Ffcm1q0YcOizNmf3bC3VjWfAcpSv3MyTlgJ23FHQgmgvk%2Bgk8pL0mcCDOn08MDAQlf%2B%2FSlTZ1z12fnqntOhbOTL9%2FZdevbAPN%2Byby1f%2FuUtC%2Fixm8ZBo59LTXEW060hGrTDplNprWd58fwB%2Fb%2FE27BdS%2Fs7U%2BrGVCeQ46nzaw9QccnmZerGZZs3Yw9aVHt%2BKh6HN4ti6lxIhT%2FwahnZtWwzlY9QHQ2c79C%2BdxzvVDKy8GqKWQERO9YAKbpsDUTLdWV5dE8PVPjvj9pqw7ah%2FPFVtkit7aj6G5xY9mfJrCz1j1e0BcnPol4UjtrCdbahIVtd2HaURujnFJR8CuOuUUfhrGhgKKgjCYNSvCc1WKlEp8wHUaAYynFNyzZn%2B2MnYv36dbMDBTonl%2FT%2Fma5IKAyEGz%2B4eRnVtaX6tss2o34u8mWorFtuFgm4A6qK%2Fyp%2FgLEBVat5WnPDdKA574ubuFJ%2FIUfZ%2FY2Nt6mN%2BZNNTSTaeI56gKwkXerTe9DDHUw8%2FH35FY3nNN7GGuBKWhrV9ep%2B0k1WjNWVaHkW1yA%2BQHWNu8rtBw2a5YXuE40rs7%2FGA%2Bj09V3hA98yRnFPOGr8ltGlsFdD%2F7tRce3LH6Trcneuiy7K7J3khKu%2B3qUaXPWaX7T6%2FKfj9BX2eZq2XAcZT79u1ClJzUtHUqfqSMWBcZS43Ena0cUGLgpkKxB1QM%2B0Fxz10wgg6r5rltnFpH05pepUq3Y2HfYqeKRntmUFNz%2BXmcOs1H31U6cC6RTVLfCg7RNBF1UF2%2FwBgu0fFQtPEU1sSg3VcNsR7dWq3af87tUFn1l3ltXpaJxpNvtcZkH2WmMst3JqRpxUH%2BWC0E1qOGtP66s1MYv%2BVLu8%2FXFXvV%2FZbunYYBeVN64ls0ur6NzpV9xzlmQwB5qC4Tq70WC0tk8dWJXeHvkD0h9zJOM0vD86%2F1NJMaIAolctvlByferCsqOKDKceOfUu1PsmoFCamV5mCrMUOCi6V6FJosMF22AcrKJgQDVhfYh6tepp%2FlYgvnCEAbJQ1L0rOpajEmRcasMiPfxhgGoVo4rwreQpV6fUJHH2e8fa1s2c13Apl1b89a58ozdoap2sjgLN9uISl7P1DrulyeIkt0zr6JjWocoPOZsaXPb6jtqBblsgsaRre2xHi4nELm0MhG1%2Bx1SXwLpFi53b%2BaHRYo%2FIrbZtuWAKu5cSEXfybnnmUCaXGTpQr0xK2O2WWY76f%2BnAjNVf7nCZHU5XqIkTnpt6VtvsFlPXg1031g%2FVRdpkkyVpD7jnmax88QwDvg%2F66NnMRdRXTcGTmQc3cuINwN5IQqi0yzb%2BYFVHuVqI5s4ADfg5oE4ybDLd28mFSFmYvRoomsWXEdLU2Wl3GJy93ZNb%2Fd5gqmNaqJZSO1l6PVRy0nZIj%2F45EetjLguh1rLqR%2BSK0hO6NrsqcNX8zoUdjQYDJ7tb4os6%2Bi%2BY0qpY2AWlnLRDWdGFTfGY1gV0zNAtJ7pdo24se0D88AwLY%2FgZmE9iuP4V5v7CSR%2FRThaHLh%2BUeBkXwU6BC7lGOevK65udTv%2BtS%2FPfW7qj3ljTcj3b9OkbV85t8xsMj7Ddj7DGpthZKwKPvso%2Fc%2F1K9aLE12fMWLV1y1D9ua8lyJdWXr%2FbG%2BnoCFutf%2FmLILe39ITUV4igr3876fpX5g2zeB52sWnIL4fXHlgeUzOx5QfIvJQyrKQE9wHUqVq%2BPEaOrz0wVvNbJZVSfsuMzxN4l9PkedFzw9V5Dj%2BnzpgoT4ZxCxJfC5RWLc74YVHxKlExCYt0JAOMatREhHBSCAtSfod6x6Ls8HCWECLwXZ9nd5Dz1T24JUdWs6fU3%2B%2BfcnT49Qe%2BkBs%2BwdsMZgPXMp3U5S958snPP%2FEE7bvkOPCuTUDTUQ%2FUzirLhML9yPahoe1D5Fj5jWsaoveyP00PehdUAHk%2FseDVWsvDWXXXsyn%2F4wfpXc2V3%2FQxli3jl%2F5hj%2F83avSCfpTNxOEKLmTjxOEKuxgNlsQn0xgct724mhynupNW1Ph6o3RYS3%2F%2B2TJrzLlkFz%2Bip3qCHKf6eqW02QJLjBYuuj4sobhCWqa%2FYHGEHpcnumuWSOhxeaL7sOakNR6vvmo%2BYcfFA8UFXEPZf9UjyudIOyNwx%2Fi90DdsujS%2FFX2UAwvWSVK4NxaMhAGw3oowp%2Fuc8CTi7D2rBgZWwb%2F60faR7SPsEbjkXy4G0XaqhXPwe2cePjxjxuHD6ssQuR1fq6PF0E%2Bo2t1nePTn8TUmxz%2FA3crMoCc7egESuoTHYc7mYdg6etORoOhR7BBGD%2BqJopELrl4S6cJNRtEAsLP%2FOdvnJq0Wo0GolY2Et9VFB2Kf%2B4bZvVyxfOMz3WdFfSIryj6DwWghre7aQbdiDrkTL3A3vNDuDpk93HqXwam%2BbWmUJZfNn5ozKV5Pmmq8PF%2FjVY%2B2Tlk2M2RzSXKjmbQ4RZcQavEYrN%2F9rlXwtIQqzxQNMzPPfHYLvuPoO9TbT8bpGw5CQPGd%2BSyX%2FCyf0Vxjd2R9NmsunnXYa8xGHzn%2BsSfM5J0y0DZEXWWxkXjcR75KBLNLHi7XvX2G8VOrf4Ykg0AMdBESIpo7MgAfyakA6rkqpI6UjNs0px7cMV%2BD5BF49Tez1VGnYmq0WIijp985m4Sn2gJR9b07riPPFo97OYbUZbxJCpot7H%2FlpZBicglCPN7WOfJkcHqc3ElWqvvz%2F1E6bIQrG%2Btz6WkM1SM9FBTR7FSs8KyBBytSmNEoquJNFN5EQyTiCrnKDx1h58yxCepPHU5nxGoxEQeeOZi2m80DxNxncVhr6BmEfUarxejw%2BWSiHhWk19bSY7aKR5MsteblJpfTLtjimBouXsm3d3djjYM%2BwEW0El9dM%2FueVRWIsXwe43R7SgbVZqrnqoJ1X%2FkuF7pcgf8duv4q6vayV5U9zMV91GxO59UUjW8rHV6u799WzKMT7umRCXbYUKM%2BfoaCcwgaoqZUtmodV3p%2BX7akb4dnU9B9La38RPFUG2SCC90tVA4XwEFhyOpZZrUCsgWYHsczLFBBVGNtstoN1bw0Z%2BO4fYIbvZVt4EUcJEKOhHeincWqONw%2Bq6w5Go%2BWGOSR7LhKV%2BKBqbBPpfUvOf9QqkpDyVhBeyyZQGMsdA5FBUqvFMtUyGq9vjnsAJU4UcrxldP1CCaofyDkSAifoP5QwWx%2BSyUGxp75BzGAvtG7uQ38LehlyEQMeh0TeE6Bm7tYdXqdkt0uOb3kfYlNwmOdDyacOq%2FqlFo1v%2BPTmTi3E%2FglC9W11b34A22zmLzvb231Q0L2Bgg60OTW4YdstO%2BYOJnO38TtpH7zy9ymokWyA79qlVSn38HtpFlImFnhu3b4boNWXklOXV0Iwo7lQ1hrZyPFcwtjwFP7iEKSHSSJw509kh8kj6pr%2BH1jR7km9vcvqN9657vffefkv%2BfKxge1X%2B7RdjYUPIESN7gTvRkB%2FRMYtEkaVkdHApmdBPpnKmz0n1xSWFOyVIuLrinZwpoCRe6kyiVZoHX088F%2BUX4%2BWKS4iBTP0IWxGtZgOdMaV4KTayqHQF%2FVihBwTbgDXTCmKoOBJeNhwJMzEVjtjIFLuU38fPR7hqNG1JS7g%2FqRCuy3vmQ3W9Vu8qbVbP%2BSzazGRJH83MzP90Ck2m31mMjP8TiLn5uwD2Ugr2PFvPQjB5BnSJvQxGQZZEB%2BLopqzGzDbMmbkAPkZVJjeO5FzOSBKCgJze2ZS4Gemc9twrwY6u9H61iUQTcRvtdT9RW3tRxAWwFs2tcuJRnI6xjmBdWjbgFNRHMHiF1uHYBfUR%2Fut5Ug2jXAaT96%2B9RH%2FFToRwIzGbKmVJ1AZQnoabSB1yyIg7ByAridHApPMjyw0OiV6RjSbCuzwLAvFizBliWJua1tsuAgvNPbmljYbpt8lkWam7b3XZiOiKJskMOtmfScnsbPW208knwjuXrXK4Q1iKIgNyYXXDVT9C2Ye%2F78GQ5BEEXfFdde2RwauOysdJNL5AzCy84ard%2FnGAVN8alecnFdgu5Gbd5DJTL%2BhHZK0vApVy3OfU8XTSJg1TlssivsPYUlIqvn66PzrVTymCc4wgF6SDNR0pDf%2B9Gp%2BVnsUH5WtpHYsuhOaey8zdwLN47V8MTbm78g687%2BP3cx6tcAeNpjYGRgYGBk8s0%2FzBIfz2%2FzlUGeZQNQhOFCWfF0GP0%2F8P8c1jusIkAuBwMTSBQAYwQM6HjaY2BkYGAV%2Bd8KJgP%2FXWG9wwAUQQGLAYqPBl942n1TvUoDQRCe1VM8kWARjNrZGIurBAsRBIuA2vkAFsJiKTYW4guIjT5ARMgTxCLoA1hcb5OgDyGHrY7f7M65e8fpLF%2B%2B2W%2FnZ2eTmGfaIJi5I0qGDlZZcD51QzTTJirZPAI9JIwVA%2BwT8L5nOdMaV0AuMJ%2BicRHq8of6LSD18fzq8ds7xjpwBnQiSI9V5QVl6NwPvgM15NXn%2FAtWZyj3W0HjEXitOc%2FdIdbetPdFTZ%2BP6t%2BX7xU0%2Fk6GJtOe1%2FB3arN0%2Fpmz1J4UZc%2BD6ExwjD7vioeGd5HvhvU%2BR%2BDZcGZ6YBPNfAi0G97iBPwFXqph2cW8%2BD7kjMfwtinHb6kLb6Wygk3cZytSEoptGrlScdHtLPeri1JKueACMZfU1ViJG1Sq5E43dIt7SZZFl1zuRhb%2FGOs44xFVDbrJzB5tYs35OmaXTrEmkv0DajnMWQB42mNgYNCCwk0MLxheMPrhgUuY2JiUmOqY2pjWMD1hdmPOY%2B5hPsLCwWLEksSyiOUOawzrLrYiti%2FsCuxJ7Kc45DiSOPZxmnG2cG7jvMelweXDNYXrEbcBdxf3KR4OngheLd443g18fHwZfFv4NfiX8T8TEBIIEZggsEpQS7BMcJsQl5CFUI3QAWEp4RLhCyJaIldEbURXiJ4RYxEzE0sQ2yD2TzxIfJkEk4SeRJbENIkNEg8k%2FklqSGZITpE8InlL8p2UmVSG1A6pb9Jx0ltkjGSmyDySlZF1kc2RnSK7R%2FaZnJ5cmdwB%2BST5SwpuCvsUjRTLFHcoOShNU9qhzKespGyhXKV8SPmBCpOKgUqcyjSVR6omqgmqe9RE1OrUnqkHqO9R%2F6FholGgsUZzgeYZLTUtL60WbS7tKh0OnQydXTpvdGV0O3S%2F6Gnopekt0ruhz6fvpl%2Bnv0n%2Fh4GdQYvBJUMhwwTDdYYvjFSM4oxmGd0zVjK2M84w3mYiYZJgssLkkqmO6TzTF2Z2ZjVmd8ylzP3MJ5lfsRCwcLJoszhhyWXpZdlhecZKxirHapbVPesF1ndsJGwCbBbZ%2FLA1sn1jZ2XXY3fFXsM%2Bz36V%2FS8HD4cGh2OOTI51ThJOK5zeOUs4OzmXOS9wPuUi4JLgss7lm2uU6zY3NrcSty1u39zN3Mvct7l%2F8xDzMPLw88jyaPM44ynkaeEZ59niucqLyUvPKwgAn3OqOQAAAQAAARcApwARAAAAAAACAAAAAQABAAAAQAAuAAAAAHjarZK9TgJBEMf%2Fd6CRaAyRhMLqCgsbL4ciglTGRPEjSiSKlnLycXJ86CEniU%2FhM9jYWPgIFkYfwd6nsDD%2Bd1mBIIUx3mZnfzs3MzszuwDCeIYG8UUwQxmAFgxxPeeuyxrmcaNYxzTuFAewi0fFQSTxqXgM11pC8TgS2oPiCUS1d8Uh8ofiSczpYcVT5LjiCPlY8Qui%2BncOr7D02y6%2FBTCrP%2Fm%2Bb5bdTrPi2I26Z9qNGtbRQBMdXMJBGRW0YOCecxEWYoiTCvxrYBunqHPdoX2bLOyrMKlZg8thDETw5K7Itci1TXlGy0124QRZZLDFU%2FexhxztMozlosTpMH6ZPge0L%2BOKGnFKjJ4WRwppHPL0PP3SI2P9jLQwFOu3GRhDfkeyDo%2F%2FG7IHgzllZQxLdquvrdCyBVvat3seJlYo06gxapUxhU2JWnFygR03sSxnEkvcpf5Y5eibGq315TDp7fKWm8zbUVl71Aqq%2FZtNnlkWmLnQtno9ycvXYbA6W2pF3aKfCayyC0Ja7Fr%2FPW70%2FHO4YM0OKxFvzf0C1MyPjwAAeNpt1VWUU2cYRuHsgxenQt1d8%2F3JOUnqAyR1d%2FcCLQVKO22pu7tQd3d3d3d3d3cXmGzumrWy3pWLs%2FNdPDMpZaWu1783l1Lpf14MnfzO6FbqVupfGkD30iR60JNe9KYP09CXfvRnAAMZxGCGMG3pW6ZjemZgKDMyEzMzC7MyG7MzB3MyF3MzD%2FMyH%2FOzAAuyEAuzCIuyGIuzBGWCRIUqOQU16jRYkqVYmmVYluVYng6GMZwRNGmxAiuyEiuzCquyGquzBmuyFmuzDuuyHuuzARuyERuzCZuyGZuzBVuyFVuzDduyHdszklGMZgd2ZAw7MZZxjGdnJrALu9LJbuzOHkxkT%2FZib%2FZhX%2FZjfw7gQA7iYA7hUA7jcI7gSI7iaI7hWI7jeE7gRE7iZE5hEqdyGqdzBmdyFmdzDudyHudzARdyERdzCZdyGZdzBVdyFVdzDddyHddzAzdyEzdzC7dyG7dzB3dyF3dzD%2FdyH%2FfzAA%2FyEA%2FzCI%2FyGI%2FzBE%2FyFE%2FzDM%2FyHM%2FzAi%2FyEi%2FzCq%2FyGq%2FzBm%2FyFm%2FzDu%2FyHu%2FzAR%2FyER%2FzCZ%2FyGZ%2FzBV%2FyFV%2FzDd%2FyHd%2FzAz%2FyEz%2FzC7%2FyG7%2FzB3%2FyF3%2FzD%2F9mpYwsy7pl3bMeWc%2BsV9Y765NNk%2FXN%2BmX9swHZwGxQNjgb0nPkmInjR0V7Uq%2FOsaPL5Y7ylE3l8tQNN7kVt%2BrmbuHW3LrbcDvam1rtzVvdm50TxrU%2FDBvRtZUY1rV5a3jXFn550Wo%2FXDNWK3dFmh7X9LimxzU9qulRTY9qelTTo5rlKLt2wk7YiaprL%2ByFvbAX9pK9ZC%2FZS%2FaSvWQv2Uv2kr1kr2KvYq9ir2KvYq9ir2KvYq9ir2Kvaq9qr2qvaq9qr2qvaq9qr2qvai%2B3l9vL7eX2cnu5vdxebi%2B3l9sr7BV2CjuFncJOYaewU9gp7NTs1LyrZq9mr2avZq9mr2avZq9mr26vbq9ur26vbq9ur26vbq9ur26vYa9hr2GvYa9hr2GvYa%2FR7oXuQ%2Feh%2B2j%2FUU7e3C3cqc%2FV3fYdof%2FQf%2Bg%2F9B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6D92H7kP3ofvQfeg%2BdB%2B6D92H7kP3ofvQfRT29B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6j6nuG3Ya7U5q%2F0hN3nCTW3Grbu4Wrs%2FrP%2Bk%2F6T%2FpP%2Bk%2F6T%2FpP%2Bk%2B6T7pPek86TzpPOk86TzpOuk66TrpOuk66TrpOlWmPu%2F36zrpOuk66TrpOuk66TrpOvl%2FPek76TvpO%2Bk76TvpO%2Bk76TvpO%2Bk76TvpO7V9t%2BqtVs%2FOaOURU6bo6PgPt6rZbwAAAAABVFDDFwAA%29%20format%28%27woff%27%29%2Curl%28data%3Aapplication%2Fx%2Dfont%2Dtruetype%3Bbase64%2CAAEAAAAPAIAAAwBwRkZUTW0ql9wAAAD8AAAAHEdERUYBRAAEAAABGAAAACBPUy8yZ7lriQAAATgAAABgY21hcNqt44EAAAGYAAAGcmN2dCAAKAL4AAAIDAAAAARnYXNw%2F%2F8AAwAACBAAAAAIZ2x5Zn1dwm8AAAgYAACUpGhlYWQFTS%2FYAACcvAAAADZoaGVhCkQEEQAAnPQAAAAkaG10eNLHIGAAAJ0YAAADdGxvY2Fv%2B5XOAACgjAAAAjBtYXhwAWoA2AAAorwAAAAgbmFtZbMsoJsAAKLcAAADonBvc3S6o%2BU1AACmgAAACtF3ZWJmwxhUUAAAsVQAAAAGAAAAAQAAAADMPaLPAAAAANB2gXUAAAAA0HZzlwABAAAADgAAABgAAAAAAAIAAQABARYAAQAEAAAAAgAAAAMEiwGQAAUABAMMAtAAAABaAwwC0AAAAaQAMgK4AAAAAAUAAAAAAAAAAAAAAAIAAAAAAAAAAAAAAFVLV04AQAAg%2F%2F8DwP8QAAAFFAB7AAAAAQAAAAAAAAAAAAAAIAABAAAABQAAAAMAAAAsAAAACgAAAdwAAQAAAAAEaAADAAEAAAAsAAMACgAAAdwABAGwAAAAaABAAAUAKAAgACsAoAClIAogLyBfIKwgvSISIxsl%2FCYBJvonCScP4APgCeAZ4CngOeBJ4FngYOBp4HngieCX4QnhGeEp4TnhRuFJ4VnhaeF54YnhleGZ4gbiCeIW4hniIeIn4jniSeJZ4mD4%2F%2F%2F%2FAAAAIAAqAKAApSAAIC8gXyCsIL0iEiMbJfwmASb6JwknD%2BAB4AXgEOAg4DDgQOBQ4GDgYuBw4IDgkOEB4RDhIOEw4UDhSOFQ4WDhcOGA4ZDhl%2BIA4gniEOIY4iHiI%2BIw4kDiUOJg%2BP%2F%2F%2F%2F%2Fj%2F9r%2FZv9i4Ajf5N%2B132nfWd4F3P3aHdoZ2SHZE9kOIB0gHCAWIBAgCiAEH%2F4f%2BB%2F3H%2FEf6x%2FlH3wfdh9wH2ofZB9jH10fVx9RH0sfRR9EHt4e3B7WHtUezh7NHsUevx65HrMIFQABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADAAAAAACjAAAAAAAAAA1AAAAIAAAACAAAAADAAAAKgAAACsAAAAEAAAAoAAAAKAAAAAGAAAApQAAAKUAAAAHAAAgAAAAIAoAAAAIAAAgLwAAIC8AAAATAAAgXwAAIF8AAAAUAAAgrAAAIKwAAAAVAAAgvQAAIL0AAAAWAAAiEgAAIhIAAAAXAAAjGwAAIxsAAAAYAAAl%2FAAAJfwAAAAZAAAmAQAAJgEAAAAaAAAm%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%2FAADiUAAA4lkAAAEJAADiYAAA4mAAAAETAAD4%2FwAA%2BP8AAAEUAAH1EQAB9REAAAEVAAH2qgAB9qoAAAEWAAYCCgAAAAABAAABAAAAAAAAAAAAAAAAAAAAAQACAAAAAAAAAAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAQAAAAAAAwAAAAAAAAAAAAAAAAAAAAAAAAAEAAUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAYAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAVAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAEUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAKAL4AAAAAf%2F%2FAAIAAgAoAAABaAMgAAMABwAusQEALzyyBwQA7TKxBgXcPLIDAgDtMgCxAwAvPLIFBADtMrIHBgH8PLIBAgDtMjMRIRElMxEjKAFA%2Fujw8AMg%2FOAoAtAAAQBkAGQETARMAFsAAAEyFh8BHgEdATc%2BAR8BFgYPATMyFhcWFRQGDwEOASsBFx4BDwEGJi8BFRQGBwYjIiYvAS4BPQEHDgEvASY2PwEjIiYnJjU0Nj8BPgE7AScuAT8BNhYfATU0Njc2AlgPJgsLCg%2BeBxYIagcCB57gChECBgMCAQIRCuCeBwIHaggWB54PCikiDyYLCwoPngcWCGoHAgee4AoRAgYDAgECEQrgngcCB2oIFgeeDwopBEwDAgECEQrgngcCB2oIFgeeDwopIg8mCwsKD54HFghqBwIHnuAKEQIGAwIBAhEK4J4HAgdqCBYHng8KKSIPJgsLCg%2BeBxYIagcCB57gChECBgAAAAABAAAAAARMBEwAIwAAATMyFhURITIWHQEUBiMhERQGKwEiJjURISImPQE0NjMhETQ2AcLIFR0BXhUdHRX%2Boh0VyBUd%2FqIVHR0VAV4dBEwdFf6iHRXIFR3%2BohUdHRUBXh0VyBUdAV4VHQAAAAABAHAAAARABEwARQAAATMyFgcBBgchMhYPAQ4BKwEVITIWDwEOASsBFRQGKwEiJj0BISImPwE%2BATsBNSEiJj8BPgE7ASYnASY2OwEyHwEWMj8BNgM5%2BgoFCP6UBgUBDAoGBngGGAp9ARMKBgZ4BhgKfQ8LlAsP%2Fu0KBgZ4BhgKff7tCgYGeAYYCnYFBv6UCAUK%2BhkSpAgUCKQSBEwKCP6UBgwMCKAIDGQMCKAIDK4LDw8LrgwIoAgMZAwIoAgMDAYBbAgKEqQICKQSAAABAGQABQSMBK4AOwAAATIXFhcjNC4DIyIOAwchByEGFSEHIR4EMzI%2BAzUzBgcGIyInLgEnIzczNjcjNzM%2BATc2AujycDwGtSM0QDkXEys4MjAPAXtk%2FtQGAZZk%2FtQJMDlCNBUWOUA0I64eYmunznYkQgzZZHABBdpkhhQ%2BH3UErr1oaS1LMCEPCx4uTzJkMjJkSnRCKw8PIjBKK6trdZ4wqndkLzVkV4UljQAAAgB7AAAETASwAD4ARwAAASEyHgUVHAEVFA4FKwEHITIWDwEOASsBFRQGKwEiJj0BISImPwE%2BATsBNSEiJj8BPgE7ARE0NhcRMzI2NTQmIwGsAV5DakIwFgwBAQwWMEJqQ7ICASAKBgZ4BhgKigsKlQoP%2FvUKBgZ4BhgKdf71CgYGeAYYCnUPtstALS1ABLAaJD8yTyokCwsLJCpQMkAlGmQMCKAIDK8LDg8KrwwIoAgMZAwIoAgMAdsKD8j%2B1EJWVEAAAAEAyAGQBEwCvAAPAAATITIWHQEUBiMhIiY9ATQ2%2BgMgFR0dFfzgFR0dArwdFcgVHR0VyBUdAAAAAgDIAAAD6ASwACUAQQAAARUUBisBFRQGBx4BHQEzMhYdASE1NDY7ATU0NjcuAT0BIyImPQEXFRQWFx4BFAYHDgEdASE1NCYnLgE0Njc%2BAT0BA%2BgdFTJjUVFjMhUd%2FOAdFTJjUVFjMhUdyEE3HCAgHDdBAZBBNxwgIBw3QQSwlhUdZFuVIyOVW5YdFZaWFR2WW5UjI5VbZB0VlshkPGMYDDI8MgwYYzyWljxjGAwyPDIMGGM8ZAAAAAEAAAAAAAAAAAAAAAAxAAAB%2F%2FIBLATCBEEAFgAAATIWFzYzMhYVFAYjISImNTQ2NyY1NDYB9261LCwueKqqeP0ST3FVQgLYBEF3YQ6teHmtclBFaw4MGZnXAAAAAgAAAGQEsASvABoAHgAAAB4BDwEBMzIWHQEhNTQ2OwEBJyY%2BARYfATc2AyEnAwL2IAkKiAHTHhQe%2B1AeFB4B1IcKCSAkCm9wCXoBebbDBLMTIxC7%2FRYlFSoqFSUC6rcQJBQJEJSWEPwecAIWAAAAAAQAAABkBLAETAALABcAIwA3AAATITIWBwEGIicBJjYXARYUBwEGJjURNDYJATYWFREUBicBJjQHARYGIyEiJjcBNjIfARYyPwE2MhkEfgoFCP3MCBQI%2FcwIBQMBCAgI%2FvgICgoDjAEICAoKCP74CFwBbAgFCvuCCgUIAWwIFAikCBQIpAgUBEwKCP3JCAgCNwgK2v74CBQI%2FvgIBQoCJgoF%2FvABCAgFCv3aCgUIAQgIFID%2BlAgKCggBbAgIpAgIpAgAAAAD%2F%2FD%2F8AS6BLoACQANABAAAAAyHwEWFA8BJzcTAScJAQUTA%2BAmDpkNDWPWXyL9mdYCZv4f%2FrNuBLoNmQ4mDlzWYP50%2FZrWAmb8anABTwAAAAEAAAAABLAEsAAPAAABETMyFh0BITU0NjsBEQEhArz6FR384B0V%2Bv4MBLACiv3aHRUyMhUdAiYCJgAAAAEADgAIBEwEnAAfAAABJTYWFREUBgcGLgE2NzYXEQURFAYHBi4BNjc2FxE0NgFwAoUnMFNGT4gkV09IQv2oWEFPiCRXT0hCHQP5ow8eIvzBN1EXGSltchkYEAIJm%2F2iKmAVGilucRoYEQJ%2FJioAAAACAAn%2F%2BAS7BKcAHQApAAAAMh4CFQcXFAcBFgYPAQYiJwEGIycHIi4CND4BBCIOARQeATI%2BATQmAZDItoNOAQFOARMXARY7GikT%2Fu13jgUCZLaDTk6DAXKwlFZWlLCUVlYEp06DtmQCBY15%2Fu4aJRg6FBQBEk0BAU6Dtsi2g1tWlLCUVlaUsJQAAQBkAFgErwREABkAAAE%2BAh4CFRQOAwcuBDU0PgIeAQKJMHt4dVg2Q3mEqD4%2Bp4V4Qzhadnh5A7VESAUtU3ZAOXmAf7JVVbJ%2FgHk5QHZTLQVIAAAAAf%2FTAF4EewSUABgAAAETNjIXEyEyFgcFExYGJyUFBiY3EyUmNjMBl4MHFQeBAaUVBhH%2BqoIHDxH%2Bqf6qEQ8Hgv6lEQYUAyABYRMT%2Fp8RDPn%2BbxQLDPb3DAsUAZD7DBEAAv%2FTAF4EewSUABgAIgAAARM2MhcTITIWBwUTFgYnJQUGJjcTJSY2MwUjFwc3Fyc3IycBl4MHFQeBAaUVBhH%2BqoIHDxH%2Bqf6qEQ8Hgv6lEQYUAfPwxUrBw0rA6k4DIAFhExP%2BnxEM%2Bf5vFAsM9vcMCxQBkPsMEWSO4ouM5YzTAAABAAAAAASwBLAAJgAAATIWHQEUBiMVFBYXBR4BHQEUBiMhIiY9ATQ2NyU%2BAT0BIiY9ATQ2Alh8sD4mDAkBZgkMDwr7ggoPDAkBZgkMJj6wBLCwfPouaEsKFwbmBRcKXQoPDwpdChcF5gYXCktoLvp8sAAAAA0AAAAABLAETAAPABMAIwAnACsALwAzADcARwBLAE8AUwBXAAATITIWFREUBiMhIiY1ETQ2FxUzNSkBIgYVERQWMyEyNjURNCYzFTM1BRUzNSEVMzUFFTM1IRUzNQchIgYVERQWMyEyNjURNCYFFTM1IRUzNQUVMzUhFTM1GQR%2BCg8PCvuCCg8PVWQCo%2F3aCg8PCgImCg8Pc2T8GGQDIGT8GGQDIGTh%2FdoKDw8KAiYKDw%2F872QDIGT8GGQDIGQETA8K%2B%2BYKDw8KBBoKD2RkZA8K%2FqIKDw8KAV4KD2RkyGRkZGTIZGRkZGQPCv6iCg8PCgFeCg9kZGRkZMhkZGRkAAAEAAAAAARMBEwADwAfAC8APwAAEyEyFhURFAYjISImNRE0NikBMhYVERQGIyEiJjURNDYBITIWFREUBiMhIiY1ETQ2KQEyFhURFAYjISImNRE0NjIBkBUdHRX%2BcBUdHQJtAZAVHR0V%2FnAVHR39vQGQFR0dFf5wFR0dAm0BkBUdHRX%2BcBUdHQRMHRX%2BcBUdHRUBkBUdHRX%2BcBUdHRUBkBUd%2FagdFf5wFR0dFQGQFR0dFf5wFR0dFQGQFR0AAAkAAAAABEwETAAPAB8ALwA%2FAE8AXwBvAH8AjwAAEzMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYhMzIWHQEUBisBIiY9ATQ2ATMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYhMzIWHQEUBisBIiY9ATQ2ATMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYhMzIWHQEUBisBIiY9ATQ2MsgVHR0VyBUdHQGlyBUdHRXIFR0dAaXIFR0dFcgVHR389cgVHR0VyBUdHQGlyBUdHRXIFR0dAaXIFR0dFcgVHR389cgVHR0VyBUdHQGlyBUdHRXIFR0dAaXIFR0dFcgVHR0ETB0VyBUdHRXIFR0dFcgVHR0VyBUdHRXIFR0dFcgVHf5wHRXIFR0dFcgVHR0VyBUdHRXIFR0dFcgVHR0VyBUd%2FnAdFcgVHR0VyBUdHRXIFR0dFcgVHR0VyBUdHRXIFR0ABgAAAAAEsARMAA8AHwAvAD8ATwBfAAATMzIWHQEUBisBIiY9ATQ2KQEyFh0BFAYjISImPQE0NgEzMhYdARQGKwEiJj0BNDYpATIWHQEUBiMhIiY9ATQ2ATMyFh0BFAYrASImPQE0NikBMhYdARQGIyEiJj0BNDYyyBUdHRXIFR0dAaUCvBUdHRX9RBUdHf6FyBUdHRXIFR0dAaUCvBUdHRX9RBUdHf6FyBUdHRXIFR0dAaUCvBUdHRX9RBUdHQRMHRXIFR0dFcgVHR0VyBUdHRXIFR3%2BcB0VyBUdHRXIFR0dFcgVHR0VyBUd%2FnAdFcgVHR0VyBUdHRXIFR0dFcgVHQAAAAABACYALAToBCAAFwAACQE2Mh8BFhQHAQYiJwEmND8BNjIfARYyAdECOwgUB7EICPzxBxUH%2FoAICLEHFAirBxYB3QI7CAixBxQI%2FPAICAGACBQHsQgIqwcAAQBuAG4EQgRCACMAAAEXFhQHCQEWFA8BBiInCQEGIi8BJjQ3CQEmND8BNjIXCQE2MgOIsggI%2FvUBCwgIsggVB%2F70%2FvQHFQiyCAgBC%2F71CAiyCBUHAQwBDAcVBDuzCBUH%2FvT%2B9AcVCLIICAEL%2FvUICLIIFQcBDAEMBxUIsggI%2FvUBDAcAAwAX%2F%2BsExQSZABkAJQBJAAAAMh4CFRQHARYUDwEGIicBBiMiLgI0PgEEIg4BFB4BMj4BNCYFMzIWHQEzMhYdARQGKwEVFAYrASImPQEjIiY9ATQ2OwE1NDYBmcSzgk1OASwICG0HFQj%2B1HeOYrSBTU2BAW%2BzmFhYmLOZWFj%2BvJYKD0sKDw8KSw8KlgoPSwoPDwpLDwSZTYKzYo15%2FtUIFQhsCAgBK01NgbTEs4JNWJmzmFhYmLOZIw8KSw8KlgoPSwoPDwpLDwqWCg9LCg8AAAMAF%2F%2FrBMUEmQAZACUANQAAADIeAhUUBwEWFA8BBiInAQYjIi4CND4BBCIOARQeATI%2BATQmBSEyFh0BFAYjISImPQE0NgGZxLOCTU4BLAgIbQcVCP7Ud45itIFNTYEBb7OYWFiYs5lYWP5YAV4KDw8K%2FqIKDw8EmU2Cs2KNef7VCBUIbAgIAStNTYG0xLOCTViZs5hYWJizmYcPCpYKDw8KlgoPAAAAAAIAFwAXBJkEsAAPAC0AAAEzMhYVERQGKwEiJjURNDYFNRYSFRQOAiIuAjU0EjcVDgEVFB4BMj4BNTQmAiZkFR0dFWQVHR0BD6fSW5vW6tabW9KnZ3xyxejFcnwEsB0V%2FnAVHR0VAZAVHeGmPv7ZuHXWm1tbm9Z1uAEnPqY3yHh0xXJyxXR4yAAEAGQAAASwBLAADwAfAC8APwAAATMyFhURFAYrASImNRE0NgEzMhYVERQGKwEiJjURNDYBMzIWFREUBisBIiY1ETQ2BTMyFh0BFAYrASImPQE0NgQBlgoPDwqWCg8P%2Ft6WCg8PCpYKDw%2F%2B3pYKDw8KlgoPD%2F7elgoPDwqWCg8PBLAPCvuCCg8PCgR%2BCg%2F%2BcA8K%2FRIKDw8KAu4KD%2F7UDwr%2BPgoPDwoBwgoPyA8K%2BgoPDwr6Cg8AAAAAAgAaABsElgSWAEcATwAAATIfAhYfATcWFwcXFh8CFhUUDwIGDwEXBgcnBwYPAgYjIi8CJi8BByYnNycmLwImNTQ%2FAjY%2FASc2Nxc3Nj8CNhIiBhQWMjY0AlghKSYFMS0Fhj0rUAMZDgGYBQWYAQ8YA1AwOIYFLDIFJisfISkmBTEtBYY8LFADGQ0ClwYGlwINGQNQLzqFBS0xBSYreLJ%2BfrJ%2BBJYFmAEOGQJQMDmGBSwxBiYrHiIoJgYxLAWGPSxRAxkOApcFBZcCDhkDUTA5hgUtMAYmKiAhKCYGMC0Fhj0sUAIZDgGYBf6ZfrF%2BfrEABwBkAAAEsAUUABMAFwAhACUAKQAtADEAAAEhMhYdASEyFh0BITU0NjMhNTQ2FxUhNQERFAYjISImNREXETMRMxEzETMRMxEzETMRAfQBLCk7ARMKD%2Fu0DwoBEzspASwBLDsp%2FUQpO2RkZGRkZGRkBRQ7KWQPCktLCg9kKTtkZGT%2B1PzgKTs7KQMgZP1EArz9RAK8%2FUQCvP1EArwAAQAMAAAFCATRAB8AABMBNjIXARYGKwERFAYrASImNREhERQGKwEiJjURIyImEgJsCBUHAmAIBQqvDwr6Cg%2F%2B1A8K%2BgoPrwoFAmoCYAcH%2FaAICv3BCg8PCgF3%2FokKDw8KAj8KAAIAZAAAA%2BgEsAARABcAAAERFBYzIREUBiMhIiY1ETQ2MwEjIiY9AQJYOykBLB0V%2FOAVHR0VA1L6FR0EsP5wKTv9dhUdHRUETBUd%2FnAdFfoAAwAXABcEmQSZAA8AGwAwAAAAMh4CFA4CIi4CND4BBCIOARQeATI%2BATQmBTMyFhURMzIWHQEUBisBIiY1ETQ2AePq1ptbW5vW6tabW1ubAb%2FoxXJyxejFcnL%2BfDIKD68KDw8K%2BgoPDwSZW5vW6tabW1ub1urWmztyxejFcnLF6MUNDwr%2B7Q8KMgoPDwoBXgoPAAAAAAL%2FnAAABRQEsAALAA8AACkBAyMDIQEzAzMDMwEDMwMFFP3mKfIp%2FeYBr9EVohTQ%2Fp4b4BsBkP5wBLD%2B1AEs%2FnD%2B1AEsAAAAAAIAZAAABLAEsAAVAC8AAAEzMhYVETMyFgcBBiInASY2OwERNDYBMzIWFREUBiMhIiY1ETQ2OwEyFh0BITU0NgImyBUdvxQLDf65DSYN%2FrkNCxS%2FHQJUMgoPDwr75goPDwoyCg8DhA8EsB0V%2Fj4XEP5wEBABkBAXAcIVHfzgDwr%2BogoPDwoBXgoPDwqvrwoPAAMAFwAXBJkEmQAPABsAMQAAADIeAhQOAiIuAjQ%2BAQQiDgEUHgEyPgE0JgUzMhYVETMyFgcDBiInAyY2OwERNDYB4%2BrWm1tbm9bq1ptbW5sBv%2BjFcnLF6MVycv58lgoPiRUKDd8NJg3fDQoViQ8EmVub1urWm1tbm9bq1ps7csXoxXJyxejFDQ8K%2Fu0XEP7tEBABExAXARMKDwAAAAMAFwAXBJkEmQAPABsAMQAAADIeAhQOAiIuAjQ%2BAQQiDgEUHgEyPgE0JiUTFgYrAREUBisBIiY1ESMiJjcTNjIB4%2BrWm1tbm9bq1ptbW5sBv%2BjFcnLF6MVycv7n3w0KFYkPCpYKD4kVCg3fDSYEmVub1urWm1tbm9bq1ps7csXoxXJyxejFAf7tEBf%2B7QoPDwoBExcQARMQAAAAAAIAAAAABLAEsAAZADkAABMhMhYXExYVERQGBwYjISImJyY1EzQ3Ez4BBSEiBgcDBhY7ATIWHwEeATsBMjY%2FAT4BOwEyNicDLgHhAu4KEwO6BwgFDBn7tAweAgYBB7kDEwKX%2FdQKEgJXAgwKlgoTAiYCEwr6ChMCJgITCpYKDAJXAhIEsA4K%2FXQYGf5XDB4CBggEDRkBqRkYAowKDsgOC%2F4%2BCw4OCpgKDg4KmAoODgsBwgsOAAMAFwAXBJkEmQAPABsAJwAAADIeAhQOAiIuAjQ%2BAQQiDgEUHgEyPgE0JgUXFhQPAQYmNRE0NgHj6tabW1ub1urWm1tbmwG%2F6MVycsXoxXJy%2Fov9ERH9EBgYBJlbm9bq1ptbW5vW6tabO3LF6MVycsXoxV2%2BDCQMvgwLFQGQFQsAAQAXABcEmQSwACgAAAE3NhYVERQGIyEiJj8BJiMiDgEUHgEyPgE1MxQOAiIuAjQ%2BAjMyA7OHBwsPCv6WCwQHhW2BdMVycsXoxXKWW5vW6tabW1ub1nXABCSHBwQL%2FpYKDwsHhUxyxejFcnLFdHXWm1tbm9bq1ptbAAAAAAIAFwABBJkEsAAaADUAAAE3NhYVERQGIyEiJj8BJiMiDgEVIzQ%2BAjMyEzMUDgIjIicHBiY1ETQ2MyEyFg8BFjMyPgEDs4cHCw8L%2FpcLBAeGboF0xXKWW5vWdcDrllub1nXAnIYHCw8LAWgKBQiFboJ0xXIEJIcHBAv%2BlwsPCweGS3LFdHXWm1v9v3XWm1t2hggFCgFoCw8LB4VMcsUAAAAKAGQAAASwBLAADwAfAC8APwBPAF8AbwB%2FAI8AnwAAEyEyFhURFAYjISImNRE0NgUhIgYVERQWMyEyNjURNCYFMzIWHQEUBisBIiY9ATQ2MyEyFh0BFAYjISImPQE0NgczMhYdARQGKwEiJj0BNDYzITIWHQEUBiMhIiY9ATQ2BzMyFh0BFAYrASImPQE0NjMhMhYdARQGIyEiJj0BNDYHMzIWHQEUBisBIiY9ATQ2MyEyFh0BFAYjISImPQE0Nn0EGgoPDwr75goPDwPA%2FK4KDw8KA1IKDw%2F9CDIKDw8KMgoPD9IBwgoPDwr%2BPgoPD74yCg8PCjIKDw%2FSAcIKDw8K%2Fj4KDw%2B%2BMgoPDwoyCg8P0gHCCg8PCv4%2BCg8PvjIKDw8KMgoPD9IBwgoPDwr%2BPgoPDwSwDwr7ggoPDwoEfgoPyA8K%2FK4KDw8KA1IKD2QPCjIKDw8KMgoPDwoyCg8PCjIKD8gPCjIKDw8KMgoPDwoyCg8PCjIKD8gPCjIKDw8KMgoPDwoyCg8PCjIKD8gPCjIKDw8KMgoPDwoyCg8PCjIKDwAAAAACAAAAAARMBLAAGQAjAAABNTQmIyEiBh0BIyIGFREUFjMhMjY1ETQmIyE1NDY7ATIWHQEDhHVT%2FtRSdmQpOzspA4QpOzsp%2FageFMgUHgMgyFN1dlLIOyn9qCk7OykCWCk7lhUdHRWWAAIAZAAABEwETAAJADcAABMzMhYVESMRNDYFMhcWFREUBw4DIyIuAScuAiMiBwYjIicmNRE%2BATc2HgMXHgIzMjc2fTIKD2QPA8AEBRADIUNAMRwaPyonKSxHHlVLBwgGBQ4WeDsXKC4TOQQpLUUdZ1AHBEwPCvvNBDMKDzACBhH%2BWwYGO1AkDQ0ODg8PDzkFAwcPAbY3VwMCAwsGFAEODg5XCAAAAwAAAAAEsASXACEAMQBBAAAAMh4CFREUBisBIiY1ETQuASAOARURFAYrASImNRE0PgEDMzIWFREUBisBIiY1ETQ2ITMyFhURFAYrASImNRE0NgHk6N6jYw8KMgoPjeT%2B%2BuSNDwoyCg9joyqgCAwMCKAIDAwCYKAIDAwIoAgMDASXY6PedP7UCg8PCgEsf9FyctF%2F%2FtQKDw8KASx03qP9wAwI%2FjQIDAwIAcwIDAwI%2FjQIDAwIAcwIDAAAAAACAAAA0wRHA90AFQA5AAABJTYWFREUBiclJisBIiY1ETQ2OwEyBTc2Mh8BFhQPARcWFA8BBiIvAQcGIi8BJjQ%2FAScmND8BNjIXAUEBAgkMDAn%2B%2FhUZ%2BgoPDwr6GQJYeAcUByIHB3h4BwciBxQHeHgHFAciBwd3dwcHIgcUBwMurAYHCv0SCgcGrA4PCgFeCg%2BEeAcHIgcUB3h4BxQHIgcHd3cHByIHFAd4eAcUByIICAAAAAACAAAA0wNyA90AFQAvAAABJTYWFREUBiclJisBIiY1ETQ2OwEyJTMWFxYVFAcGDwEiLwEuATc2NTQnJjY%2FATYBQQECCQwMCf7%2BFRn6Cg8PCvoZAdIECgZgWgYLAwkHHQcDBkhOBgMIHQcDLqwGBwr9EgoHBqwODwoBXgoPZAEJgaGafwkBAQYXBxMIZ36EaggUBxYFAAAAAAMAAADEBGID7AAbADEASwAAATMWFxYVFAYHBgcjIi8BLgE3NjU0JicmNj8BNgUlNhYVERQGJyUmKwEiJjURNDY7ATIlMxYXFhUUBwYPASIvAS4BNzY1NCcmNj8BNgPHAwsGh0RABwoDCQcqCAIGbzs3BgIJKgf9ggECCQwMCf7%2BFRn6Cg8PCvoZAdIECgZgWgYLAwkHHQcDBkhOBgMIHQcD7AEJs9lpy1QJAQYiBhQIlrJarEcJFAYhBb6sBgcK%2FRIKBwasDg8KAV4KD2QBCYGhmn8JAQEGFwcTCGd%2BhGoIFQYWBQAAAAANAAAAAASwBLAACQAVABkAHQAhACUALQA7AD8AQwBHAEsATwAAATMVIxUhFSMRIQEjFTMVIREjESM1IQURIREhESERBSM1MwUjNTMBMxEhETM1MwEzFSMVIzUjNTM1IzUhBREhEQcjNTMFIzUzASM1MwUhNSEB9GRk%2FnBkAfQCvMjI%2FtTIZAJY%2B7QBLAGQASz84GRkArxkZP1EyP4MyGQB9MhkyGRkyAEs%2FUQBLGRkZAOEZGT%2BDGRkAfT%2B1AEsA4RkZGQCWP4MZMgBLAEsyGT%2B1AEs%2FtQBLMhkZGT%2BDP4MAfRk%2FtRkZGRkyGTI%2FtQBLMhkZGT%2B1GRkZAAAAAAJAAAAAASwBLAAAwAHAAsADwATABcAGwAfACMAADcjETMTIxEzASMRMxMjETMBIxEzASE1IRcjNTMXIzUzBSM1M2RkZMhkZAGQyMjIZGQBLMjI%2FOD%2B1AEsyGRkyGRkASzIyMgD6PwYA%2Bj8GAPo%2FBgD6PwYA%2Bj7UGRkW1tbW1sAAAIAAAAKBKYEsAANABUAAAkBFhQHAQYiJwETNDYzBCYiBhQWMjYB9AKqCAj%2BMAgUCP1WAQ8KAUM7Uzs7UzsEsP1WCBQI%2FjAICAKqAdsKD807O1Q7OwAAAAADAAAACgXSBLAADQAZACEAAAkBFhQHAQYiJwETNDYzIQEWFAcBBiIvAQkBBCYiBhQWMjYB9AKqCAj%2BMAgUCP1WAQ8KAwYCqggI%2FjAIFAg4Aaj9RP7TO1M7O1M7BLD9VggUCP4wCAgCqgHbCg%2F9VggUCP4wCAg4AaoCvM07O1Q7OwAAAAABAGQAAASwBLAAJgAAASEyFREUDwEGJjURNCYjISIPAQYWMyEyFhURFAYjISImNRE0PwE2ASwDOUsSQAgKDwr9RBkSQAgFCgK8Cg8PCvyuCg8SixIEsEv8fBkSQAgFCgO2Cg8SQAgKDwr8SgoPDwoDzxkSixIAAAABAMj%2F%2FwRMBLAACgAAEyEyFhURCQERNDb6AyAVHf4%2B%2Fj4dBLAdFfuCAbz%2BQwR%2FFR0AAAAAAwAAAAAEsASwABUARQBVAAABISIGBwMGHwEeATMhMjY%2FATYnAy4BASMiBg8BDgEjISImLwEuASsBIgYVERQWOwEyNj0BNDYzITIWHQEUFjsBMjY1ETQmASEiBg8BBhYzITI2LwEuAQM2%2FkQLEAFOBw45BhcKAcIKFwY%2BDgdTARABVpYKFgROBBYK%2FdoKFgROBBYKlgoPDwqWCg8PCgLuCg8PCpYKDw%2F%2Bsf4MChMCJgILCgJYCgsCJgITBLAPCv7TGBVsCQwMCWwVGAEtCg%2F%2BcA0JnAkNDQmcCQ0PCv12Cg8PCpYKDw8KlgoPDwoCigoP%2FagOCpgKDg4KmAoOAAAAAAQAAABkBLAETAAdACEAKQAxAAABMzIeAh8BMzIWFREUBiMhIiY1ETQ2OwE%2BBAEVMzUEIgYUFjI2NCQyFhQGIiY0AfTIOF00JAcGlik7Oyn8GCk7OymWAgknM10ByGT%2Bz76Hh76H%2Fu9WPDxWPARMKTs7FRQ7Kf2oKTs7KQJYKTsIG0U1K%2F7UZGRGh76Hh74IPFY8PFYAAAAAAgA1AAAEsASvACAAIwAACQEWFx4BHwEVITUyNi8BIQYHBh4CMxUhNTY3PgE%2FAQEDIQMCqQGBFCgSJQkK%2Fl81LBFS%2Fnk6IgsJKjIe%2FpM4HAwaBwcBj6wBVKIEr%2FwaMioTFQECQkJXLd6RWSIuHAxCQhgcDCUNDQPu%2FVoByQAAAAADAGQAAAPwBLAAJwAyADsAAAEeBhUUDgMjITU%2BATURNC4EJzUFMh4CFRQOAgclMzI2NTQuAisBETMyNjU0JisBAvEFEzUwOyodN1htbDD%2BDCk7AQYLFyEaAdc5dWM%2BHy0tEP6Pi05pESpTPnbYUFJ9Xp8CgQEHGB0zOlIuQ3VONxpZBzMoAzsYFBwLEAkHRwEpSXNDM1s6KwkxYUopOzQb%2FK5lUFqBAAABAMgAAANvBLAAGQAAARcOAQcDBhYXFSE1NjcTNjQuBCcmJzUDbQJTQgeECSxK%2Fgy6Dq0DAw8MHxUXDQYEsDkTNSj8uTEoBmFhEFIDQBEaExAJCwYHAwI5AAAAAAL%2FtQAABRQEsAAlAC8AAAEjNC4FKwERFBYfARUhNTI%2BAzURIyIOBRUjESEFIxEzByczESM3BRQyCAsZEyYYGcgyGRn%2BcAQOIhoWyBkYJhMZCwgyA%2Bj7m0tLfX1LS30DhBUgFQ4IAwH8rhYZAQJkZAEFCRUOA1IBAwgOFSAVASzI%2FOCnpwMgpwACACH%2FtQSPBLAAJQAvAAABIzQuBSsBERQWHwEVITUyPgM1ESMiDgUVIxEhEwc1IRUnNxUhNQRMMggLGRMmGBnIMhkZ%2FnAEDiIaFsgZGCYTGQsIMgPoQ6f84KenAyADhBUgFQ4IAwH9dhYZAQJkZAEFCRUOAooBAwgOFSAVASz7gn1LS319S0sABAAAAAAEsARMAA8AHwAvAD8AABMhMhYdARQGIyEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2EyEyFh0BFAYjISImPQE0NhMhMhYdARQGIyEiJj0BNDYyAlgVHR0V%2FagVHR0VA%2BgVHR0V%2FBgVHR0VAyAVHR0V%2FOAVHR0VBEwVHR0V%2B7QVHR0ETB0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR0ABAAAAAAEsARMAA8AHwAvAD8AABMhMhYdARQGIyEiJj0BNDYDITIWHQEUBiMhIiY9ATQ2EyEyFh0BFAYjISImPQE0NgMhMhYdARQGIyEiJj0BNDb6ArwVHR0V%2FUQVHR2zBEwVHR0V%2B7QVHR3dArwVHR0V%2FUQVHR2zBEwVHR0V%2B7QVHR0ETB0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR0ABAAAAAAEsARMAA8AHwAvAD8AAAE1NDYzITIWHQEUBiMhIiYBNTQ2MyEyFh0BFAYjISImEzU0NjMhMhYdARQGIyEiJgE1NDYzITIWHQEUBiMhIiYB9B0VAlgVHR0V%2FagVHf5wHRUD6BUdHRX8GBUdyB0VAyAVHR0V%2FOAVHf7UHRUETBUdHRX7tBUdA7ZkFR0dFWQVHR3%2B6WQVHR0VZBUdHf7pZBUdHRVkFR0d%2FulkFR0dFWQVHR0AAAQAAAAABLAETAAPAB8ALwA%2FAAATITIWHQEUBiMhIiY9ATQ2EyEyFh0BFAYjISImPQE0NhMhMhYdARQGIyEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2MgRMFR0dFfu0FR0dFQRMFR0dFfu0FR0dFQRMFR0dFfu0FR0dFQRMFR0dFfu0FR0dBEwdFWQVHR0VZBUd%2FtQdFWQVHR0VZBUd%2FtQdFWQVHR0VZBUd%2FtQdFWQVHR0VZBUdAAgAAAAABLAETAAPAB8ALwA%2FAE8AXwBvAH8AABMzMhYdARQGKwEiJj0BNDYpATIWHQEUBiMhIiY9ATQ2ATMyFh0BFAYrASImPQE0NikBMhYdARQGIyEiJj0BNDYBMzIWHQEUBisBIiY9ATQ2KQEyFh0BFAYjISImPQE0NgEzMhYdARQGKwEiJj0BNDYpATIWHQEUBiMhIiY9ATQ2MmQVHR0VZBUdHQFBAyAVHR0V%2FOAVHR3%2B6WQVHR0VZBUdHQFBAyAVHR0V%2FOAVHR3%2B6WQVHR0VZBUdHQFBAyAVHR0V%2FOAVHR3%2B6WQVHR0VZBUdHQFBAyAVHR0V%2FOAVHR0ETB0VZBUdHRVkFR0dFWQVHR0VZBUd%2FtQdFWQVHR0VZBUdHRVkFR0dFWQVHf7UHRVkFR0dFWQVHR0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR0dFWQVHR0VZBUdAAAG%2F5wAAASwBEwAAwATACMAKgA6AEoAACEjETsCMhYdARQGKwEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2BQc1IzUzNQUhMhYdARQGIyEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2AZBkZJZkFR0dFWQVHR0VAfQVHR0V%2FgwVHR3%2B%2BqfIyAHCASwVHR0V%2FtQVHR0VAlgVHR0V%2FagVHR0ETB0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR36fUtkS68dFWQVHR0VZBUd%2FtQdFWQVHR0VZBUdAAAABgAAAAAFFARMAA8AEwAjACoAOgBKAAATMzIWHQEUBisBIiY9ATQ2ASMRMwEhMhYdARQGIyEiJj0BNDYFMxUjFSc3BSEyFh0BFAYjISImPQE0NhMhMhYdARQGIyEiJj0BNDYyZBUdHRVkFR0dA2dkZPyuAfQVHR0V%2FgwVHR0EL8jIp6f75gEsFR0dFf7UFR0dFQJYFR0dFf2oFR0dBEwdFWQVHR0VZBUd%2B7QETP7UHRVkFR0dFWQVHchkS319rx0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR0AAAAAAgAAAMgEsAPoAA8AEgAAEyEyFhURFAYjISImNRE0NgkCSwLuHywsH%2F0SHywsBIT%2B1AEsA%2BgsH%2F12HywsHwKKHyz9RAEsASwAAwAAAAAEsARMAA8AFwAfAAATITIWFREUBiMhIiY1ETQ2FxE3BScBExEEMhYUBiImNCwEWBIaGhL7qBIaGkr3ASpKASXs%2FNJwTk5wTgRMGhL8DBIaGhID9BIaZP0ftoOcAT7%2B4AH0dE5vT09vAAAAAAIA2wAFBDYEkQAWAB4AAAEyHgEVFAcOAQ8BLgQnJjU0PgIWIgYUFjI2NAKIdcZzRkWyNjYJIV5YbSk8RHOft7eCgreCBJF4ynVzj23pPz4IIWZomEiEdVijeUjDgriBgbgAAAACABcAFwSZBJkADwAXAAAAMh4CFA4CIi4CND4BAREiDgEUHgEB4%2BrWm1tbm9bq1ptbW5sBS3TFcnLFBJlbm9bq1ptbW5vW6tab%2FG8DVnLF6MVyAAACAHUAAwPfBQ8AGgA1AAABHgYVFA4DBy4DNTQ%2BBQMOAhceBBcWNj8BNiYnLgInJjc2IyYCKhVJT1dOPiUzVnB9P1SbfEokP0xXUEm8FykoAwEbITEcExUWAgYCCQkFEikMGiACCAgFD0iPdXdzdYdFR4BeRiYEBTpjl1lFh3ZzeHaQ%2Ff4hS4I6JUEnIw4IBwwQIgoYBwQQQSlZtgsBAAAAAwAAAAAEywRsAAwAKgAvAAABNz4CHgEXHgEPAiUhMhcHISIGFREUFjMhMjY9ATcRFAYjISImNRE0NgkBBzcBA%2BhsAgYUFR0OFgoFBmz9BQGQMje7%2FpApOzspAfQpO8i7o%2F5wpbm5Azj%2BlqE3AWMD9XMBAgIEDw4WKgsKc8gNuzsp%2FgwpOzsptsj%2BtKW5uaUBkKW5%2Ftf%2BljKqAWMAAgAAAAAEkwRMABsANgAAASEGByMiBhURFBYzITI2NTcVFAYjISImNRE0NgUBFhQHAQYmJzUmDgMHPgY3NT4BAV4BaaQ0wyk7OykB9Ck7yLml%2FnClubkCfwFTCAj%2BrAcLARo5ZFRYGgouOUlARioTAQsETJI2Oyn%2BDCk7OymZZ6W5uaUBkKW5G%2F7TBxUH%2Fs4GBAnLAQINFjAhO2JBNB0UBwHSCgUAAAAAAgAAAAAEnQRMAB0ANQAAASEyFwchIgYVERQWMyEyNj0BNxUUBiMhIiY1ETQ2CQE2Mh8BFhQHAQYiLwEmND8BNjIfARYyAV4BXjxDsv6jKTs7KQH0KTvIuaX%2BcKW5uQHKAYsHFQdlBwf97QcVB%2FgHB2UHFQdvCBQETBexOyn%2BDCk7OylFyNulubmlAZCluf4zAYsHB2UHFQf97AcH%2BAcVB2UHB28HAAAAAQAKAAoEpgSmADsAAAkBNjIXARYGKwEVMzU0NhcBFhQHAQYmPQEjFTMyFgcBBiInASY2OwE1IxUUBicBJjQ3ATYWHQEzNSMiJgE%2BAQgIFAgBBAcFCqrICggBCAgI%2FvgICsiqCgUH%2FvwIFAj%2B%2BAgFCq%2FICgj%2B%2BAgIAQgICsivCgUDlgEICAj%2B%2BAgKyK0KBAf%2B%2FAcVB%2F73BwQKrcgKCP74CAgBCAgKyK0KBAcBCQcVBwEEBwQKrcgKAAEAyAAAA4QETAAZAAATMzIWFREBNhYVERQGJwERFAYrASImNRE0NvpkFR0B0A8VFQ%2F%2BMB0VZBUdHQRMHRX%2BSgHFDggV%2FBgVCA4Bxf5KFR0dFQPoFR0AAAABAAAAAASwBEwAIwAAEzMyFhURATYWFREBNhYVERQGJwERFAYnAREUBisBIiY1ETQ2MmQVHQHQDxUB0A8VFQ%2F%2BMBUP%2FjAdFWQVHR0ETB0V%2FkoBxQ4IFf5KAcUOCBX8GBUIDgHF%2FkoVCA4Bxf5KFR0dFQPoFR0AAAABAJ0AGQSwBDMAFQAAAREUBicBERQGJwEmNDcBNhYVEQE2FgSwFQ%2F%2BMBUP%2FhQPDwHsDxUB0A8VBBr8GBUIDgHF%2FkoVCA4B4A4qDgHgDggV%2FkoBxQ4IAAAAAQDIABYEMwQ2AAsAABMBFhQHAQYmNRE0NvMDLhIS%2FNISGRkEMv4OCx4L%2Fg4LDhUD6BUOAAIAyABkA4QD6AAPAB8AABMzMhYVERQGKwEiJjURNDYhMzIWFREUBisBIiY1ETQ2%2BsgVHR0VyBUdHQGlyBUdHRXIFR0dA%2BgdFfzgFR0dFQMgFR0dFfzgFR0dFQMgFR0AAAEAyABkBEwD6AAPAAABERQGIyEiJjURNDYzITIWBEwdFfzgFR0dFQMgFR0DtvzgFR0dFQMgFR0dAAAAAAEAAAAZBBMEMwAVAAABETQ2FwEWFAcBBiY1EQEGJjURNDYXAfQVDwHsDw%2F%2BFA8V%2FjAPFRUPAmQBthUIDv4gDioO%2FiAOCBUBtv47DggVA%2BgVCA4AAAH%2F%2FgACBLMETwAjAAABNzIWFRMUBiMHIiY1AwEGJjUDAQYmNQM0NhcBAzQ2FwEDNDYEGGQUHgUdFWQVHQL%2BMQ4VAv4yDxUFFQ8B0gIVDwHSAh0ETgEdFfwYFR0BHRUBtf46DwkVAbX%2BOQ4JFAPoFQkP%2Fj4BthQJDv49AbYVHQAAAQEsAAAD6ARMABkAAAEzMhYVERQGKwEiJjURAQYmNRE0NhcBETQ2A1JkFR0dFWQVHf4wDxUVDwHQHQRMHRX8GBUdHRUBtv47DggVA%2BgVCA7%2BOwG2FR0AAAIAZADIBLAESAALABsAAAkBFgYjISImNwE2MgEhMhYdARQGIyEiJj0BNDYCrgH1DwkW%2B%2B4WCQ8B9Q8q%2FfcD6BUdHRX8GBUdHQQ5%2FeQPFhYPAhwP%2FUgdFWQVHR0VZBUdAAEAiP%2F8A3UESgAFAAAJAgcJAQN1%2FqABYMX92AIoA4T%2Bn%2F6fxgIoAiYAAAAAAQE7%2F%2FwEKARKAAUAAAkBJwkBNwQo%2FdnGAWH%2Bn8YCI%2F3ZxgFhAWHGAAIAFwAXBJkEmQAPADMAAAAyHgIUDgIiLgI0PgEFIyIGHQEjIgYdARQWOwEVFBY7ATI2PQEzMjY9ATQmKwE1NCYB4%2BrWm1tbm9bq1ptbW5sBfWQVHZYVHR0Vlh0VZBUdlhUdHRWWHQSZW5vW6tabW1ub1urWm7odFZYdFWQVHZYVHR0Vlh0VZBUdlhUdAAAAAAIAFwAXBJkEmQAPAB8AAAAyHgIUDgIiLgI0PgEBISIGHQEUFjMhMjY9ATQmAePq1ptbW5vW6tabW1ubAkX%2BDBUdHRUB9BUdHQSZW5vW6tabW1ub1urWm%2F5%2BHRVkFR0dFWQVHQACABcAFwSZBJkADwAzAAAAMh4CFA4CIi4CND4BBCIPAScmIg8BBhQfAQcGFB8BFjI%2FARcWMj8BNjQvATc2NC8BAePq1ptbW5vW6tabW1ubAeUZCXh4CRkJjQkJeHgJCY0JGQl4eAkZCY0JCXh4CQmNBJlbm9bq1ptbW5vW6tabrQl4eAkJjQkZCXh4CRkJjQkJeHgJCY0JGQl4eAkZCY0AAgAXABcEmQSZAA8AJAAAADIeAhQOAiIuAjQ%2BAQEnJiIPAQYUHwEWMjcBNjQvASYiBwHj6tabW1ub1urWm1tbmwEVVAcVCIsHB%2FIHFQcBdwcHiwcVBwSZW5vW6tabW1ub1urWm%2F4xVQcHiwgUCPEICAF3BxUIiwcHAAAAAAMAFwAXBJkEmQAPADsASwAAADIeAhQOAiIuAjQ%2BAQUiDgMVFDsBFjc%2BATMyFhUUBgciDgUHBhY7ATI%2BAzU0LgMTIyIGHQEUFjsBMjY9ATQmAePq1ptbW5vW6tabW1ubAT8dPEIyIRSDHgUGHR8UFw4TARkOGhITDAIBDQ6tBx4oIxgiM0Q8OpYKDw8KlgoPDwSZW5vW6tabW1ub1urWm5ELHi9PMhkFEBQQFRIXFgcIBw4UHCoZCBEQKDhcNi9IKhsJ%2FeMPCpYKDw8KlgoPAAADABcAFwSZBJkADwAfAD4AAAAyHgIUDgIiLgI0PgEFIyIGHQEUFjsBMjY9ATQmAyMiBh0BFBY7ARUjIgYdARQWMyEyNj0BNCYrARE0JgHj6tabW1ub1urWm1tbmwGWlgoPDwqWCg8PCvoKDw8KS0sKDw8KAV4KDw8KSw8EmVub1urWm1tbm9bq1ptWDwqWCg8PCpYKD%2F7UDwoyCg%2FIDwoyCg8PCjIKDwETCg8AAgAAAAAEsASwAC8AXwAAATMyFh0BHgEXMzIWHQEUBisBDgEHFRQGKwEiJj0BLgEnIyImPQE0NjsBPgE3NTQ2ExUUBisBIiY9AQ4BBzMyFh0BFAYrAR4BFzU0NjsBMhYdAT4BNyMiJj0BNDY7AS4BAg2WCg9nlxvCCg8PCsIbl2cPCpYKD2eXG8IKDw8KwhuXZw%2B5DwqWCg9EZheoCg8PCqgXZkQPCpYKD0RmF6gKDw8KqBdmBLAPCsIbl2cPCpYKD2eXG8IKDw8KwhuXZw8KlgoPZ5cbwgoP%2Fs2oCg8PCqgXZkQPCpYKD0RmF6gKDw8KqBdmRA8KlgoPRGYAAwAXABcEmQSZAA8AGwA%2FAAAAMh4CFA4CIi4CND4BBCIOARQeATI%2BATQmBxcWFA8BFxYUDwEGIi8BBwYiLwEmND8BJyY0PwE2Mh8BNzYyAePq1ptbW5vW6tabW1ubAb%2FoxXJyxejFcnKaQAcHfHwHB0AHFQd8fAcVB0AHB3x8BwdABxUHfHwHFQSZW5vW6tabW1ub1urWmztyxejFcnLF6MVaQAcVB3x8BxUHQAcHfHwHB0AHFQd8fAcVB0AHB3x8BwAAAAMAFwAXBJkEmQAPABsAMAAAADIeAhQOAiIuAjQ%2BAQQiDgEUHgEyPgE0JgcXFhQHAQYiLwEmND8BNjIfATc2MgHj6tabW1ub1urWm1tbmwG%2F6MVycsXoxXJyg2oHB%2F7ACBQIyggIagcVB0%2FFBxUEmVub1urWm1tbm9bq1ps7csXoxXJyxejFfWoHFQf%2BvwcHywcVB2oICE%2FFBwAAAAMAFwAXBJkEmQAPABgAIQAAADIeAhQOAiIuAjQ%2BAQUiDgEVFBcBJhcBFjMyPgE1NAHj6tabW1ub1urWm1tbmwFLdMVyQQJLafX9uGhzdMVyBJlbm9bq1ptbW5vW6tabO3LFdHhpAktB0P24PnLFdHMAAAAAAQAXAFMEsAP5ABUAABMBNhYVESEyFh0BFAYjIREUBicBJjQnAgoQFwImFR0dFf3aFxD99hACRgGrDQoV%2Ft0dFcgVHf7dFQoNAasNJgAAAAABAAAAUwSZA%2FkAFQAACQEWFAcBBiY1ESEiJj0BNDYzIRE0NgJ%2FAgoQEP32EBf92hUdHRUCJhcD8f5VDSYN%2FlUNChUBIx0VyBUdASMVCgAAAAEAtwAABF0EmQAVAAAJARYGIyERFAYrASImNREhIiY3ATYyAqoBqw0KFf7dHRXIFR3%2B3RUKDQGrDSYEif32EBf92hUdHRUCJhcQAgoQAAAAAQC3ABcEXQSwABUAAAEzMhYVESEyFgcBBiInASY2MyERNDYCJsgVHQEjFQoN%2FlUNJg3%2BVQ0KFQEjHQSwHRX92hcQ%2FfYQEAIKEBcCJhUdAAABAAAAtwSZBF0AFwAACQEWFAcBBiY1EQ4DBz4ENxE0NgJ%2FAgoQEP32EBdesKWBJAUsW4fHfhcEVf5VDSYN%2FlUNChUBIwIkRHVNabGdcUYHAQYVCgACAAAAAASwBLAAFQArAAABITIWFREUBi8BBwYiLwEmND8BJyY2ASEiJjURNDYfATc2Mh8BFhQPARcWBgNSASwVHRUOXvkIFAhqBwf5Xg4I%2FiH%2B1BUdFQ5e%2BQgUCGoHB%2FleDggEsB0V%2FtQVCA5e%2BQcHaggUCPleDhX7UB0VASwVCA5e%2BQcHaggUCPleDhUAAAACAEkASQRnBGcAFQArAAABFxYUDwEXFgYjISImNRE0Nh8BNzYyASEyFhURFAYvAQcGIi8BJjQ%2FAScmNgP2agcH%2BV4OCBX%2B1BUdFQ5e%2BQgU%2FQwBLBUdFQ5e%2BQgUCGoHB%2FleDggEYGoIFAj5Xg4VHRUBLBUIDl75B%2F3xHRX%2B1BUIDl75BwdqCBQI%2BV4OFQAAAAADABcAFwSZBJkADwAfAC8AAAAyHgIUDgIiLgI0PgEFIyIGFxMeATsBMjY3EzYmAyMiBh0BFBY7ATI2PQE0JgHj6tabW1ub1urWm1tbmwGz0BQYBDoEIxQ2FCMEOgQYMZYKDw8KlgoPDwSZW5vW6tabW1ub1urWm7odFP7SFB0dFAEuFB3%2BDA8KlgoPDwqWCg8AAAAABQAAAAAEsASwAEkAVQBhAGgAbwAAATIWHwEWHwEWFxY3Nj8BNjc2MzIWHwEWHwIeATsBMhYdARQGKwEiBh0BIREjESE1NCYrASImPQE0NjsBMjY1ND8BNjc%2BBAUHBhY7ATI2LwEuAQUnJgYPAQYWOwEyNhMhIiY1ESkBERQGIyERAQQJFAUFFhbEFQ8dCAsmxBYXERUXMA0NDgQZCAEPCj0KDw8KMgoP%2FnDI%2FnAPCjIKDw8KPQsOCRkFDgIGFRYfAp2mBwQK2woKAzMDEP41sQgQAzMDCgrnCwMe%2FokKDwGQAlgPCv6JBLAEAgIKDXYNCxUJDRZ2DQoHIREQFRh7LAkLDwoyCg8PCq8BLP7UrwoPDwoyCg8GBQQwgBkUAwgWEQ55ogcKDgqVCgSqnQcECo8KDgr8cg8KAXf%2BiQoPAZAAAAAAAgAAAAwErwSmACsASQAAATYWFQYCDgQuAScmByYOAQ8BBiY1NDc%2BATc%2BAScuAT4BNz4GFyYGBw4BDwEOBAcOARY2Nz4CNz4DNz4BBI0IGgItQmxhi2KORDg9EQQRMxuZGhYqCFUYEyADCQIQOjEnUmFch3vAJQgdHyaiPT44XHRZUhcYDhItIRmKcVtGYWtbKRYEBKYDEwiy%2Ft3IlVgxEQgLCwwBAQIbG5kYEyJAJghKFRE8Hzdff4U%2FM0o1JSMbL0QJGCYvcSEhHjZST2c1ODwEJygeW0AxJUBff1UyFAABAF0AHgRyBM8ATwAAAQ4BHgQXLgc%2BATceAwYHDgQHBicmNzY3PgQuAScWDgMmJy4BJyY%2BBDcGHgM3PgEuAicmPgMCjScfCic4R0IgBBsKGAoQAwEJEg5gikggBhANPkpTPhZINx8SBgsNJysiCRZOQQoVNU1bYC9QZwICBAUWITsoCAYdJzIYHw8YIiYHDyJJYlkEz0OAZVxEOSQMBzgXOB42IzElKRIqg5Gnl0o3Z0c6IAYWCwYNAwQFIDhHXGF1OWiqb0sdBxUknF0XNTQ8PEUiNWNROBYJDS5AQVUhVZloUSkAAAAAA%2F%2FcAGoE1ARGABsAPwBRAAAAMh4FFA4FIi4FND4EBSYGFxYVFAYiJjU0NzYmBwYHDgEXHgQyPgM3NiYnJgUHDgEXFhcWNj8BNiYnJicuAQIGpJ17bk85HBw6T257naKde25POhwcOU9uewIPDwYIGbD4sBcIBw5GWg0ECxYyWl%2BDiINfWjIWCwQMWv3%2FIw8JCSU4EC0OIw4DDywtCyIERi1JXGJcSSpJXGJcSS0tSVxiXEkqSVxiXEncDwYTOT58sLB8OzcTBg9FcxAxEiRGXkQxMEVeRSQSMRF1HiQPLxJEMA0EDyIPJQ8sSRIEAAAABP%2FcAAAE1ASwABQAJwA7AEwAACEjNy4ENTQ%2BBTMyFzczEzceARUUDgMHNz4BNzYmJyYlBgcOARceBBc3LgE1NDc2JhcHDgEXFhcWNj8CJyYnLgECUJQfW6l2WSwcOU9ue51SPUEglCYvbIknUGqYUi5NdiYLBAw2%2FVFGWg0ECxIqSExoNSlrjxcIB3wjDwkJJTgQLQ4MFgMsLQsieBRhdHpiGxVJXGJcSS0Pef5StVXWNBpacm5jGq0xiD8SMRFGckVzEDESHjxRQTkNmhKnbjs3EwZwJA8vEkQwDQQPC1YELEkSBAAAAAP%2FngAABRIEqwALABgAKAAAJwE2FhcBFgYjISImJSE1NDY7ATIWHQEhAQczMhYPAQ4BKwEiJi8BJjZaAoIUOBQCghUbJfryJRsBCgFZDwqWCg8BWf5DaNAUGAQ6BCMUNhQjBDoEGGQEKh8FIfvgIEdEhEsKDw8KSwLT3x0U%2FBQdHRT8FB0AAAABAGQAFQSwBLAAKAAAADIWFREBHgEdARQGJyURFh0BFAYvAQcGJj0BNDcRBQYmPQE0NjcBETQCTHxYAWsPFhgR%2FplkGhPNzRMaZP6ZERgWDwFrBLBYPv6t%2FrsOMRQpFA0M%2Bf75XRRAFRAJgIAJEBVAFF0BB%2FkMDRQpFDEOAUUBUz4AAAARAAAAAARMBLAAHQAnACsALwAzADcAOwA%2FAEMARwBLAE8AUwBXAFsAXwBjAAABMzIWHQEzMhYdASE1NDY7ATU0NjsBMhYdASE1NDYBERQGIyEiJjURFxUzNTMVMzUzFTM1MxUzNTMVMzUFFTM1MxUzNTMVMzUzFTM1MxUzNQUVMzUzFTM1MxUzNTMVMzUzFTM1A1JkFR0yFR37tB0VMh0VZBUdAfQdAQ8dFfwYFR1kZGRkZGRkZGRk%2FHxkZGRkZGRkZGT8fGRkZGRkZGRkZASwHRUyHRWWlhUdMhUdHRUyMhUd%2FnD9EhUdHRUC7shkZGRkZGRkZGRkyGRkZGRkZGRkZGTIZGRkZGRkZGRkZAAAAAMAAAAZBXcElwAZACUANwAAARcWFA8BBiY9ASMBISImPQE0NjsBATM1NDYBBycjIiY9ATQ2MyEBFxYUDwEGJj0BIyc3FzM1NDYEb%2FkPD%2FkOFZ%2F9qP7dFR0dFdECWPEV%2FamNetEVHR0VASMDGvkPD%2FkOFfG1jXqfFQSN5g4qDuYOCBWW%2FagdFWQVHQJYlhUI%2FpiNeh0VZBUd%2Fk3mDioO5g4IFZa1jXqWFQgAAAABAAAAAASwBEwAEgAAEyEyFhURFAYjIQERIyImNRE0NmQD6Ck7Oyn9rP7QZCk7OwRMOyn9qCk7%2FtQBLDspAlgpOwAAAAMAZAAABEwEsAAJABMAPwAAEzMyFh0BITU0NiEzMhYdASE1NDYBERQOBSIuBTURIRUUFRwBHgYyPgYmNTQ9AZbIFR3%2B1B0C0cgVHf7UHQEPBhgoTGacwJxmTCgYBgEsAwcNFB8nNkI2Jx8TDwUFAQSwHRX6%2BhUdHRX6%2BhUd%2FnD%2B1ClJalZcPigoPlxWakkpASz6CRIVKyclIRsWEAgJEBccISUnKhURCPoAAAAB%2F%2F8A1ARMA8IABQAAAQcJAScBBEzG%2Fp%2F%2Bn8UCJwGbxwFh%2Fp%2FHAicAAQAAAO4ETQPcAAUAAAkCNwkBBE392v3ZxgFhAWEDFf3ZAifH%2Fp8BYQAAAAAC%2F1EAZAVfA%2BgAFAApAAABITIWFREzMhYPAQYiLwEmNjsBESElFxYGKwERIRchIiY1ESMiJj8BNjIBlALqFR2WFQgO5g4qDuYOCBWW%2FoP%2BHOYOCBWWAYHX%2FRIVHZYVCA7mDioD6B0V%2FdkVDvkPD%2FkOFQGRuPkOFf5wyB0VAiYVDvkPAAABAAYAAASeBLAAMAAAEzMyFh8BITIWBwMOASMhFyEyFhQGKwEVFAYiJj0BIRUUBiImPQEjIiYvAQMjIiY0NjheERwEJgOAGB4FZAUsIf2HMAIXFR0dFTIdKh3%2B1B0qHR8SHQYFyTYUHh4EsBYQoiUY%2FiUVK8gdKh0yFR0dFTIyFR0dFTIUCQoDwR0qHQAAAAACAAAAAASwBEwACwAPAAABFSE1MzQ2MyEyFhUFIREhBLD7UMg7KQEsKTv9RASw%2B1AD6GRkKTs7Kcj84AACAAAAAAXcBEwADAAQAAATAxEzNDYzITIWFSEVBQEhAcjIyDspASwqOgH0ASz%2B1PtQASwDIP5wAlgpOzspyGT9RAK8AAEBRQAAA2sErwAbAAABFxYGKwERMzIWDwEGIi8BJjY7AREjIiY%2FATYyAnvmDggVlpYVCA7mDioO5g4IFZaWFQgO5g4qBKD5DhX9pxUO%2BQ8P%2BQ4VAlkVDvkPAAAAAQABAUQErwNrABsAAAEXFhQPAQYmPQEhFRQGLwEmND8BNhYdASE1NDYDqPkODvkPFf2oFQ%2F5Dg75DxUCWBUDYOUPKQ%2FlDwkUl5cUCQ%2FlDykP5Q8JFZWVFQkAAAAEAAAAAASwBLAACQAZAB0AIQAAAQMuASMhIgYHAwUhIgYdARQWMyEyNj0BNCYFNTMVMzUzFQSRrAUkFP1gFCQFrAQt%2FBgpOzspA%2BgpOzv%2Bq2RkZAGQAtwXLSgV%2FR1kOylkKTs7KWQpO8hkZGRkAAAAA%2F%2BcAGQEsARMAAsAIwAxAAAAMhYVERQGIiY1ETQDJSMTFgYjIisBIiYnAj0BNDU0PgE7ASUBFSIuAz0BND4CNwRpKh0dKh1k%2FV0mLwMRFQUCVBQdBDcCCwzIAqP8GAQOIhoWFR0dCwRMHRX8rhUdHRUDUhX8mcj%2B7BAIHBUBUQ76AgQQDw36%2FtT6AQsTKRwyGigUDAEAAAACAEoAAARmBLAALAA1AAABMzIWDwEeARcTFzMyFhQGBw4EIyIuBC8BLgE0NjsBNxM%2BATcnJjYDFjMyNw4BIiYCKV4UEgYSU3oPP3YRExwaEggeZGqfTzl0XFU%2BLwwLEhocExF2Pw96UxIGEyQyNDUxDDdGOASwFRMlE39N%2FrmtHSkoBwQLHBYSCg4REg4FBAgoKR2tAUdNfhQgExr7vgYGMT09AAEAFAAUBJwEnAAXAAABNwcXBxcHFycHJwcnBzcnNyc3Jxc3FzcDIOBO6rS06k7gLZubLeBO6rS06k7gLZubA7JO4C2bmy3gTuq0tOpO4C2bmy3gTuq0tAADAAAAZASwBLAAIQAtAD0AAAEzMhYdAQchMhYdARQHAw4BKwEiJi8BIyImNRE0PwI%2BARcPAREzFzMTNSE3NQEzMhYVERQGKwEiJjURNDYCijIoPBwBSCg8He4QLBf6B0YfHz0tNxSRYA0xG2SWZIjW%2Bv4%2BMv12ZBUdHRVkFR0dBLBRLJZ9USxkLR3%2BqBghMhkZJCcBkCQbxMYcKGTU1f6JZAF3feGv%2FtQdFf4MFR0dFQH0FR0AAAAAAwAAAAAEsARMACAAMAA8AAABMzIWFxMWHQEUBiMhFh0BFAYrASImLwImNRE0NjsBNgUzMhYVERQGKwEiJjURNDYhByMRHwEzNSchNQMCWPoXLBDuHTwo%2FrgcPCgyGzENYJEUNy09fP3pZBUdHRVkFR0dAl%2BIZJZkMjIBwvoETCEY%2FqgdLWQsUXYHlixRKBzGxBskAZAnJGRkHRX%2BDBUdHRUB9BUdZP6J1dSv4X0BdwADAAAAZAUOBE8AGwA3AEcAAAElNh8BHgEPASEyFhQGKwEDDgEjISImNRE0NjcXERchEz4BOwEyNiYjISoDLgQnJj8BJwUzMhYVERQGKwEiJjURNDYBZAFrHxZuDQEMVAEuVGxuVGqDBhsP%2FqoHphwOOmQBJYMGGw%2FLFRMSFv44AgoCCQMHAwUDAQwRklb9T2QVHR0VZBUdHQNp5hAWcA0mD3lMkE7%2BrRUoog0CDRElCkj%2BCVkBUxUoMjIBAgIDBQIZFrdT5B0V%2FgwVHR0VAfQVHQAAAAP%2FnABkBLAETwAdADYARgAAAQUeBBURFAYjISImJwMjIiY0NjMhJyY2PwE2BxcWBw4FKgIjIRUzMhYXEyE3ESUFMzIWFREUBisBIiY1ETQ2AdsBbgIIFBANrAf%2Bqg8bBoNqVW1sVAEuVQsBDW4WSpIRDAIDBQMHAwkDCgH%2BJd0PHAaCASZq%2FqoCUGQVHR0VZBUdHQRP5gEFEBEXC%2F3zDaIoFQFTTpBMeQ8mDXAWrrcWGQIFAwICAWQoFf6tWQH37OQdFf4MFR0dFQH0FR0AAAADAGEAAARMBQ4AGwA3AEcAAAAyFh0BBR4BFREUBiMhIiYvAQMmPwE%2BAR8BETQXNTQmBhURHAMOBAcGLwEHEyE3ESUuAQMhMhYdARQGIyEiJj0BNDYB3pBOAVMVKKIN%2FfMRJQoJ5hAWcA0mD3nGMjIBAgIDBQIZFrdT7AH3Wf6tFSiWAfQVHR0V%2FgwVHR0FDm5UaoMGGw%2F%2BqgemHA4OAWsfFm4NAQxUAS5U1ssVExIW%2FjgCCgIJAwcDBQMBDBGSVv6tZAElgwYb%2FQsdFWQVHR0VZBUdAAP%2F%2FQAGA%2BgFFAAPAC0ASQAAASEyNj0BNCYjISIGHQEUFgEVFAYiJjURBwYmLwEmNxM%2BBDMhMhYVERQGBwEDFzc2Fx4FHAIVERQWNj0BNDY3JREnAV4B9BUdHRX%2BDBUdHQEPTpBMeQ8mDXAWEOYBBRARFwsCDQ2iKBX9iexTtxYZAgUDAgIBMjIoFQFTWQRMHRVkFR0dFWQVHfzmalRubFQBLlQMAQ1uFh8BawIIEw8Mpgf%2Bqg8bBgHP%2Fq1WkhEMAQMFAwcDCQIKAv44FhITFcsPGwaDASVkAAIAFgAWBJoEmgAPACUAAAAyHgIUDgIiLgI0PgEBJSYGHQEhIgYdARQWMyEVFBY3JTY0AeLs1ptbW5vW7NabW1ubAob%2B7RAX%2Fu0KDw8KARMXEAETEASaW5vW7NabW1ub1uzWm%2F453w0KFYkPCpYKD4kVCg3fDSYAAAIAFgAWBJoEmgAPACUAAAAyHgIUDgIiLgI0PgENAQYUFwUWNj0BITI2PQE0JiMhNTQmAeLs1ptbW5vW7NabW1ubASX%2B7RAQARMQFwETCg8PCv7tFwSaW5vW7NabW1ub1uzWm%2BjfDSYN3w0KFYkPCpYKD4kVCgAAAAIAFgAWBJoEmgAPACUAAAAyHgIUDgIiLgI0PgEBAyYiBwMGFjsBERQWOwEyNjURMzI2AeLs1ptbW5vW7NabW1ubAkvfDSYN3w0KFYkPCpYKD4kVCgSaW5vW7NabW1ub1uzWm%2F5AARMQEP7tEBf%2B7QoPDwoBExcAAAIAFgAWBJoEmgAPACUAAAAyHgIUDgIiLgI0PgEFIyIGFREjIgYXExYyNxM2JisBETQmAeLs1ptbW5vW7NabW1ubAZeWCg%2BJFQoN3w0mDd8NChWJDwSaW5vW7NabW1ub1uzWm7sPCv7tFxD%2B7RAQARMQFwETCg8AAAMAGAAYBJgEmAAPAJYApgAAADIeAhQOAiIuAjQ%2BASUOAwcGJgcOAQcGFgcOAQcGFgcUFgcyHgEXHgIXHgI3Fg4BFx4CFxQGFBcWNz4CNy4BJy4BJyIOAgcGJyY2NS4BJzYuAQYHBicmNzY3HgIXHgMfAT4CJyY%2BATc%2BAzcmNzIWMjY3LgMnND4CJiceAT8BNi4CJwYHFB4BFS4CJz4BNxYyPgEB5OjVm1xcm9Xo1ZtcXJsBZA8rHDoKDz0PFD8DAxMBAzEFCRwGIgEMFhkHECIvCxU%2FOR0HFBkDDRQjEwcFaHUeISQDDTAMD0UREi4oLBAzDwQBBikEAQMLGhIXExMLBhAGKBsGBxYVEwYFAgsFAwMNFwQGCQcYFgYQCCARFwkKKiFBCwQCAQMDHzcLDAUdLDgNEiEQEgg%2FKhADGgMKEgoRBJhcm9Xo1ZtcXJvV6NWbEQwRBwkCAwYFBycPCxcHInIWInYcCUcYChQECA4QBAkuHgQPJioRFRscBAcSCgwCch0kPiAIAQcHEAsBAgsLIxcBMQENCQIPHxkCFBkdHB4QBgEBBwoMGBENBAMMJSAQEhYXDQ4qFBkKEhIDCQsXJxQiBgEOCQwHAQ0DBAUcJAwSCwRnETIoAwEJCwsLJQcKDBEAAAAAAQAAAAIErwSFABYAAAE2FwUXNxYGBw4BJwEGIi8BJjQ3ASY2AvSkjv79kfsGUE08hjv9rA8rD28PDwJYIk8EhVxliuh%2BWYcrIgsW%2FawQEG4PKxACV2XJAAYAAABgBLAErAAPABMAIwAnADcAOwAAEyEyFh0BFAYjISImPQE0NgUjFTMFITIWHQEUBiMhIiY9ATQ2BSEVIQUhMhYdARQGIyEiJj0BNDYFIRUhZAPoKTs7KfwYKTs7BBHIyPwYA%2BgpOzsp%2FBgpOzsEEf4MAfT8GAPoKTs7KfwYKTs7BBH%2B1AEsBKw7KWQpOzspZCk7ZGTIOylkKTs7KWQpO2RkyDspZCk7OylkKTtkZAAAAAIAZAAABEwEsAALABEAABMhMhYUBiMhIiY0NgERBxEBIZYDhBUdHRX8fBUdHQI7yP6iA4QEsB0qHR0qHf1E%2FtTIAfQB9AAAAAMAAABkBLAEsAAXABsAJQAAATMyFh0BITIWFREhNSMVIRE0NjMhNTQ2FxUzNQEVFAYjISImPQEB9MgpOwEsKTv%2BDMj%2BDDspASw7KcgB9Dsp%2FBgpOwSwOylkOyn%2BcGRkAZApO2QpO2RkZP1EyCk7OynIAAAABAAAAAAEsASwABUAKwBBAFcAABMhMhYPARcWFA8BBiIvAQcGJjURNDYpATIWFREUBi8BBwYiLwEmND8BJyY2ARcWFA8BFxYGIyEiJjURNDYfATc2MgU3NhYVERQGIyEiJj8BJyY0PwE2MhcyASwVCA5exwcHaggUCMdeDhUdAzUBLBUdFQ5exwgUCGoHB8deDgj%2BL2oHB8deDggV%2FtQVHRUOXscIFALLXg4VHRX%2B1BUIDl7HBwdqCBQIBLAVDl7HCBQIagcHx14OCBUBLBUdHRX%2B1BUIDl7HBwdqCBQIx14OFf0maggUCMdeDhUdFQEsFQgOXscHzl4OCBX%2B1BUdFQ5exwgUCGoHBwAAAAYAAAAABKgEqAAPABsAIwA7AEMASwAAADIeAhQOAiIuAjQ%2BAQQiDgEUHgEyPgE0JiQyFhQGIiY0JDIWFAYjIicHFhUUBiImNTQ2PwImNTQEMhYUBiImNCQyFhQGIiY0Advy3Z9fX5%2Fd8t2gXl6gAcbgv29vv%2BC%2Fb2%2F%2BLS0gIC0gAUwtICAWDg83ETNIMykfegEJ%2FoctICAtIAIdLSAgLSAEqF%2Bf3fLdoF5eoN3y3Z9Xb7%2Fgv29vv%2BC%2FBiAtISEtICAtIQqRFxwkMzMkIDEFfgEODhekIC0gIC0gIC0gIC0AAf%2FYAFoEuQS8AFsAACUBNjc2JicmIyIOAwcABw4EFx4BMzI3ATYnLgEjIgcGBwEOASY0NwA3PgEzMhceARcWBgcOBgcGIyImJyY2NwE2NzYzMhceARcWBgcBDgEnLgECIgHVWwgHdl8WGSJBMD8hIP6IDx4eLRMNBQlZN0ozAiQkEAcdEhoYDRr%2Bqw8pHA4BRyIjQS4ODyw9DQ4YIwwod26La1YOOEBGdiIwGkQB%2F0coW2tQSE5nDxE4Qv4eDyoQEAOtAdZbZWKbEQQUGjIhH%2F6JDxsdNSg3HT5CMwIkJCcQFBcMGv6uDwEcKQ4BTSIjIQEINykvYyMLKnhuiWZMBxtAOU6%2BRAH%2FSBg3ISSGV121Qv4kDwIPDyYAAAACAGQAWASvBEQAGQBEAAABPgIeAhUUDgMHLgQ1ND4CHgEFIg4DIi4DIyIGFRQeAhcWFx4EMj4DNzY3PgQ1NCYCiTB7eHVYNkN5hKg%2BPqeFeEM4WnZ4eQEjIT8yLSohJyktPyJDbxtBMjMPBw86KzEhDSIzKUAMBAgrKT8dF2oDtURIBS1TdkA5eYB%2FslVVsn%2BAeTlAdlMtBUgtJjY1JiY1NiZvTRc4SjQxDwcOPCouGBgwKEALBAkpKkQqMhNPbQACADn%2F8gR3BL4AFwAuAAAAMh8BFhUUBg8BJi8BNycBFwcvASY0NwEDNxYfARYUBwEGIi8BJjQ%2FARYfAQcXAQKru0KNQjgiHR8uEl%2F3%2FnvUaRONQkIBGxJpCgmNQkL%2B5UK6Qo1CQjcdLhJf9wGFBL5CjUJeKmsiHTUuEl%2F4%2FnvUahKNQrpCARv%2BRmkICY1CukL%2B5UJCjUK7Qjc3LxFf%2BAGFAAAAAAMAyAAAA%2BgEsAARABUAHQAAADIeAhURFAYjISImNRE0PgEHESERACIGFBYyNjQCBqqaZDo7Kf2oKTs8Zj4CWP7%2FVj09Vj0EsB4uMhX8Ryk7OykDuRUzLar9RAK8%2FRY9Vj09VgABAAAAAASwBLAAFgAACQEWFAYiLwEBEScBBRMBJyEBJyY0NjIDhgEbDx0qDiT%2B6dT%2BzP7oywEz0gEsAQsjDx0qBKH%2B5g8qHQ8j%2FvX%2B1NL%2BzcsBGAE01AEXJA4qHQAAAAADAScAEQQJBOAAMgBAAEsAAAEVHgQXIy4DJxEXHgQVFAYHFSM1JicuASczHgEXEScuBDU0PgI3NRkBDgMVFB4DFxYXET4ENC4CArwmRVI8LAKfBA0dMydAIjxQNyiym2SWVygZA4sFV0obLkJOMCAyVWg6HSoqFQ4TJhkZCWgWKTEiGBkzNwTgTgUTLD9pQiQuLBsH%2Fs0NBxMtPGQ%2Bi6oMTU8QVyhrVk1iEAFPCA4ZLzlYNkZwSCoGTf4SARIEDh02Jh0rGRQIBgPQ%2FsoCCRYgNEM0JRkAAAABAGQAZgOUBK0ASgAAATIeARUjNC4CIyIGBwYVFB4BFxYXMxUjFgYHBgc%2BATM2FjMyNxcOAyMiLgEHDgEPASc%2BBTc%2BAScjNTMmJy4CPgE3NgIxVJlemSc8OxolVBQpGxoYBgPxxQgVFS02ImIWIIwiUzUyHzY4HCAXanQmJ1YYFzcEGAcTDBEJMAwk3aYXFQcKAg4tJGEErVCLTig%2FIhIdFSw5GkowKgkFZDKCHj4yCg8BIh6TExcIASIfBAMaDAuRAxAFDQsRCjePR2QvORQrREFMIVgAAAACABn%2F%2FwSXBLAADwAfAAABMzIWDwEGIi8BJjY7AREzBRcWBisBESMRIyImPwE2MgGQlhUIDuYOKg7mDggVlsgCF%2BYOCBWWyJYVCA7mDioBLBYO%2Bg8P%2Bg4WA4QQ%2BQ4V%2FHwDhBUO%2BQ8AAAQAGf%2F%2FA%2BgEsAAHABcAGwAlAAABIzUjFSMRIQEzMhYPAQYiLwEmNjsBETMFFTM1EwczFSE1NyM1IQPoZGRkASz9qJYVCA7mDioO5g4IFZbIAZFkY8jI%2FtTIyAEsArxkZAH0%2FHwWDvoPD%2FoOFgOEZMjI%2FRL6ZJb6ZAAAAAAEABn%2F%2FwPoBLAADwAZACEAJQAAATMyFg8BBiIvASY2OwERMwUHMxUhNTcjNSERIzUjFSMRIQcVMzUBkJYVCA7mDioO5g4IFZbIAljIyP7UyMgBLGRkZAEsx2QBLBYO%2Bg8P%2Bg4WA4SW%2BmSW%2BmT7UGRkAfRkyMgAAAAEABn%2F%2FwRMBLAADwAVABsAHwAAATMyFg8BBiIvASY2OwERMwEjESM1MxMjNSMRIQcVMzUBkJYVCA7mDioO5g4IFZbIAlhkZMhkZMgBLMdkASwWDvoPD%2FoOFgOE%2FgwBkGT7UGQBkGTIyAAAAAAEABn%2F%2FwRMBLAADwAVABkAHwAAATMyFg8BBiIvASY2OwERMwEjNSMRIQcVMzUDIxEjNTMBkJYVCA7mDioO5g4IFZbIArxkyAEsx2QBZGTIASwWDvoPD%2FoOFgOE%2FgxkAZBkyMj7tAGQZAAAAAAFABn%2F%2FwSwBLAADwATABcAGwAfAAABMzIWDwEGIi8BJjY7AREzBSM1MxMhNSETITUhEyE1IQGQlhUIDuYOKg7mDggVlsgB9MjIZP7UASxk%2FnABkGT%2BDAH0ASwWDvoPD%2FoOFgOEyMj%2BDMj%2BDMj%2BDMgABQAZ%2F%2F8EsASwAA8AEwAXABsAHwAAATMyFg8BBiIvASY2OwERMwUhNSEDITUhAyE1IQMjNTMBkJYVCA7mDioO5g4IFZbIAyD%2BDAH0ZP5wAZBk%2FtQBLGTIyAEsFg76Dw%2F6DhYDhMjI%2FgzI%2FgzI%2FgzIAAIAAAAABEwETAAPAB8AAAEhMhYVERQGIyEiJjURNDYFISIGFREUFjMhMjY1ETQmAV4BkKK8u6P%2BcKW5uQJn%2FgwpOzspAfQpOzsETLuj%2FnClubmlAZClucg7Kf4MKTs7KQH0KTsAAAAAAwAAAAAETARMAA8AHwArAAABITIWFREUBiMhIiY1ETQ2BSEiBhURFBYzITI2NRE0JgUXFhQPAQYmNRE0NgFeAZClubml%2FnCju7wCZP4MKTs7KQH0KTs7%2Fm%2F9ERH9EBgYBEy5pf5wpbm5pQGQo7vIOyn%2BDCk7OykB9Ck7gr4MJAy%2BDAsVAZAVCwAAAAADAAAAAARMBEwADwAfACsAAAEhMhYVERQGIyEiJjURNDYFISIGFREUFjMhMjY1ETQmBSEyFg8BBiIvASY2AV4BkKO7uaX%2BcKW5uQJn%2FgwpOzspAfQpOzv%2BFQGQFQsMvgwkDL4MCwRMvKL%2BcKW5uaUBkKO7yDsp%2FgwpOzspAfQpO8gYEP0REf0QGAAAAAMAAAAABEwETAAPAB8AKwAAASEyFhURFAYjISImNRE0NgUhIgYVERQWMyEyNjURNCYFFxYGIyEiJj8BNjIBXgGQpbm5pf5wo7u5Amf%2BDCk7OykB9Ck7O%2F77vgwLFf5wFQsMvgwkBEy5pf5wo7u8ogGQpbnIOyn%2BDCk7OykB9Ck7z%2F0QGBgQ%2FREAAAAAAgAAAAAFFARMAB8ANQAAASEyFhURFAYjISImPQE0NjMhMjY1ETQmIyEiJj0BNDYHARYUBwEGJj0BIyImPQE0NjsBNTQ2AiYBkKW5uaX%2BcBUdHRUBwik7Oyn%2BPhUdHb8BRBAQ%2FrwQFvoVHR0V%2BhYETLml%2FnCluR0VZBUdOykB9Ck7HRVkFR3p%2FuQOJg7%2B5A4KFZYdFcgVHZYVCgAAAQDZAAID1wSeACMAAAEXFgcGAgclMhYHIggBBwYrAScmNz4BPwEhIicmNzYANjc2MwMZCQgDA5gCASwYEQ4B%2Fvf%2B8wQMDgkJCQUCUCcn%2FtIXCAoQSwENuwUJEASeCQoRC%2F5TBwEjEv7K%2FsUFDwgLFQnlbm4TFRRWAS%2FTBhAAAAACAAAAAAT%2BBEwAHwA1AAABITIWHQEUBiMhIgYVERQWMyEyFh0BFAYjISImNRE0NgUBFhQHAQYmPQEjIiY9ATQ2OwE1NDYBXgGQFR0dFf4%2BKTs7KQHCFR0dFf5wpbm5AvEBRBAQ%2FrwQFvoVHR0V%2BhYETB0VZBUdOyn%2BDCk7HRVkFR25pQGQpbnp%2FuQOJg7%2B5A4KFZYdFcgVHZYVCgACAAAAAASwBLAAFQAxAAABITIWFREUBi8BAQYiLwEmNDcBJyY2ASMiBhURFBYzITI2PQE3ERQGIyEiJjURNDYzIQLuAZAVHRUObf7IDykPjQ8PAThtDgj%2B75wpOzspAfQpO8i7o%2F5wpbm5pQEsBLAdFf5wFQgObf7IDw%2BNDykPAThtDhX%2B1Dsp%2FgwpOzsplMj%2B1qW5uaUBkKW5AAADAA4ADgSiBKIADwAbACMAAAAyHgIUDgIiLgI0PgEEIg4BFB4BMj4BNCYEMhYUBiImNAHh7tmdXV2d2e7ZnV1dnQHD5sJxccLmwnFx%2FnugcnKgcgSiXZ3Z7tmdXV2d2e7ZnUdxwubCcXHC5sJzcqBycqAAAAMAAAAABEwEsAAVAB8AIwAAATMyFhURMzIWBwEGIicBJjY7ARE0NgEhMhYdASE1NDYFFTM1AcLIFR31FAoO%2FoEOJw3%2BhQ0JFfod%2FoUD6BUd%2B7QdA2dkBLAdFf6iFg%2F%2BVg8PAaoPFgFeFR38fB0V%2BvoVHWQyMgAAAAMAAAAABEwErAAVAB8AIwAACQEWBisBFRQGKwEiJj0BIyImNwE%2BAQEhMhYdASE1NDYFFTM1AkcBeg4KFfQiFsgUGPoUCw4Bfw4n%2FfkD6BUd%2B7QdA2dkBJ7%2BTQ8g%2BhQeHRX6IQ8BrxAC%2FH8dFfr6FR1kMjIAAwAAAAAETARLABQAHgAiAAAJATYyHwEWFAcBBiInASY0PwE2MhcDITIWHQEhNTQ2BRUzNQGMAXEHFQeLBwf98wcVB%2F7cBweLCBUH1APoFR37tB0DZ2QC0wFxBweLCBUH%2FfMICAEjCBQIiwcH%2FdIdFfr6FR1kMjIABAAAAAAETASbAAkAGQAjACcAABM3NjIfAQcnJjQFNzYWFQMOASMFIiY%2FASc3ASEyFh0BITU0NgUVMzWHjg4qDk3UTQ4CFtIOFQIBHRX9qxUIDtCa1P49A%2BgVHfu0HQNnZAP%2Fjg4OTdRMDyqa0g4IFf2pFB4BFQ7Qm9T9Oh0V%2BvoVHWQyMgAAAAQAAAAABEwEsAAPABkAIwAnAAABBR4BFRMUBi8BByc3JyY2EwcGIi8BJjQ%2FAQEhMhYdASE1NDYFFTM1AV4CVxQeARUO0JvUm9IOCMNMDyoOjg4OTf76A%2BgVHfu0HQNnZASwAgEdFf2rFQgO0JrUmtIOFf1QTQ4Ojg4qDk3%2BWB0V%2BvoVHWQyMgACAAT%2F7ASwBK8ABQAIAAAlCQERIQkBFQEEsP4d%2Fsb%2BcQSs%2FTMCq2cBFP5xAacDHPz55gO5AAAAAAIAAABkBEwEsAAVABkAAAERFAYrAREhESMiJjURNDY7AREhETMHIzUzBEwdFZb9RJYVHR0V%2BgH0ZMhkZAPo%2FK4VHQGQ%2FnAdFQPoFB7%2B1AEsyMgAAAMAAABFBN0EsAAWABoALwAAAQcBJyYiDwEhESMiJjURNDY7AREhETMHIzUzARcWFAcBBiIvASY0PwE2Mh8BATYyBEwC%2FtVfCRkJlf7IlhUdHRX6AfRkyGRkAbBqBwf%2BXAgUCMoICGoHFQdPASkHFQPolf7VXwkJk%2F5wHRUD6BQe%2FtQBLMjI%2Fc5qBxUH%2FlsHB8sHFQdqCAhPASkHAAMAAAANBQcEsAAWABoAPgAAAREHJy4BBwEhESMiJjURNDY7AREhETMHIzUzARcWFA8BFxYUDwEGIi8BBwYiLwEmND8BJyY0PwE2Mh8BNzYyBExnhg8lEP72%2FreWFR0dFfoB9GTIZGQB9kYPD4ODDw9GDykPg4MPKQ9GDw%2BDgw8PRg8pD4ODDykD6P7zZ4YPAw7%2B9v5wHRUD6BQe%2FtQBLMjI%2FYxGDykPg4MPKQ9GDw%2BDgw8PRg8pD4ODDykPRg8Pg4MPAAADAAAAFQSXBLAAFQAZAC8AAAERISIGHQEhESMiJjURNDY7AREhETMHIzUzEzMyFh0BMzIWDwEGIi8BJjY7ATU0NgRM%2FqIVHf4MlhUdHRX6AfRkyGRklmQVHZYVCA7mDioO5g4IFZYdA%2Bj%2B1B0Vlv5wHRUD6BQe%2FtQBLMjI%2FagdFfoVDuYODuYOFfoVHQAAAAADAAAAAASXBLAAFQAZAC8AAAERJyYiBwEhESMiJjURNDY7AREhETMHIzUzExcWBisBFRQGKwEiJj0BIyImPwE2MgRMpQ4qDv75%2Fm6WFR0dFfoB9GTIZGTr5g4IFZYdFWQVHZYVCA7mDioD6P5wpQ8P%2Fvf%2BcB0VA%2BgUHv7UASzIyP2F5Q8V%2BhQeHhT6FQ%2FlDwADAAAAyASwBEwACQATABcAABMhMhYdASE1NDYBERQGIyEiJjURExUhNTIETBUd%2B1AdBJMdFfu0FR1kAZAETB0VlpYVHf7U%2FdoVHR0VAib%2B1MjIAAAGAAMAfQStBJcADwAZAB0ALQAxADsAAAEXFhQPAQYmPQEhNSE1NDYBIyImPQE0NjsBFyM1MwE3NhYdASEVIRUUBi8BJjQFIzU7AjIWHQEUBisBA6f4Dg74DhX%2BcAGQFf0vMhUdHRUyyGRk%2FoL3DhUBkP5wFQ73DwOBZGRkMxQdHRQzBI3mDioO5g4IFZbIlhUI%2FoUdFWQVHcjI%2FcvmDggVlsiWFQgO5g4qecgdFWQVHQAAAAACAGQAAASwBLAAFgBRAAABJTYWFREUBisBIiY1ES4ENRE0NiUyFh8BERQOAg8BERQGKwEiJjURLgQ1ETQ%2BAzMyFh8BETMRPAE%2BAjMyFh8BETMRND4DA14BFBklHRXIFR0EDiIaFiX%2B4RYZAgEVHR0LCh0VyBUdBA4iGhYBBwoTDRQZAgNkBQkVDxcZAQFkAQUJFQQxdBIUH%2FuuFR0dFQGNAQgbHzUeAWcfRJEZDA3%2BPhw%2FMSkLC%2F5BFR0dFQG%2FBA8uLkAcAcICBxENCxkMDf6iAV4CBxENCxkMDf6iAV4CBxENCwABAGQAAASwBEwAMwAAARUiDgMVERQWHwEVITUyNjURIREUFjMVITUyPgM1ETQmLwE1IRUiBhURIRE0JiM1BLAEDiIaFjIZGf5wSxn%2BDBlL%2FnAEDiIaFjIZGQGQSxkB9BlLBEw4AQUKFA78iBYZAQI4OA0lAYr%2BdiUNODgBBQoUDgN4FhkBAjg4DSX%2BdgGKJQ04AAAABgAAAAAETARMAAwAHAAgACQAKAA0AAABITIWHQEjBTUnITchBSEyFhURFAYjISImNRE0NhcVITUBBTUlBRUhNQUVFAYjIQchJyE3MwKjAXcVHWn%2B2cj%2BcGQBd%2F4lASwpOzsp%2FtQpOzspASwCvP5wAZD8GAEsArwdFf6JZP6JZAGQyGkD6B0VlmJiyGTIOyn%2BDCk7OykB9Ck7ZMjI%2FveFo4XGyMhm%2BBUdZGTIAAEAEAAQBJ8EnwAmAAATNzYWHwEWBg8BHgEXNz4BHwEeAQ8BBiIuBicuBTcRohEuDosOBhF3ZvyNdxEzE8ATBxGjAw0uMUxPZWZ4O0p3RjITCwED76IRBhPCFDERdo78ZXYRBA6IDi8RogEECBUgNUNjO0qZfHNVQBAAAAACAAAAAASwBEwAIwBBAAAAMh4EHwEVFAYvAS4BPQEmIAcVFAYPAQYmPQE%2BBRIyHgIfARUBHgEdARQGIyEiJj0BNDY3ATU0PgIB%2FLimdWQ%2FLAkJHRTKFB2N%2FsKNHRTKFB0DDTE7ZnTKcFImFgEBAW0OFR0V%2B7QVHRUOAW0CFiYETBUhKCgiCgrIFRgDIgMiFZIYGJIVIgMiAxgVyAQNJyQrIP7kExwcCgoy%2FtEPMhTUFR0dFdQUMg8BLzIEDSEZAAADAAAAAASwBLAADQAdACcAAAEHIScRMxUzNTMVMzUzASEyFhQGKwEXITcjIiY0NgMhMhYdASE1NDYETMj9qMjIyMjIyPyuArwVHR0VDIn8SokMFR0dswRMFR37UB0CvMjIAfTIyMjI%2FOAdKh1kZB0qHf7UHRUyMhUdAAAAAwBkAAAEsARMAAkAEwAdAAABIyIGFREhETQmASMiBhURIRE0JgEhETQ2OwEyFhUCvGQpOwEsOwFnZCk7ASw7%2FRv%2B1DspZCk7BEw7KfwYA%2BgpO%2F7UOyn9RAK8KTv84AGQKTs7KQAAAAAF%2F5wAAASwBEwADwATAB8AJQApAAATITIWFREUBiMhIiY1ETQ2FxEhEQUjFTMRITUzNSMRIQURByMRMwcRMxHIArx8sLB8%2FUR8sLAYA4T%2BDMjI%2FtTIyAEsAZBkyMhkZARMsHz%2BDHywsHwB9HywyP1EArzIZP7UZGQBLGT%2B1GQB9GT%2B1AEsAAAABf%2BcAAAEsARMAA8AEwAfACUAKQAAEyEyFhURFAYjISImNRE0NhcRIREBIzUjFSMRMxUzNTMFEQcjETMHETMRyAK8fLCwfP1EfLCwGAOE%2FgxkZGRkZGQBkGTIyGRkBEywfP4MfLCwfAH0fLDI%2FUQCvP2oyMgB9MjIZP7UZAH0ZP7UASwABP%2BcAAAEsARMAA8AEwAbACMAABMhMhYVERQGIyEiJjURNDYXESERBSMRMxUhESEFIxEzFSERIcgCvHywsHz9RHywsBgDhP4MyMj%2B1AEsAZDIyP7UASwETLB8%2Fgx8sLB8AfR8sMj9RAK8yP7UZAH0ZP7UZAH0AAAABP%2BcAAAEsARMAA8AEwAWABkAABMhMhYVERQGIyEiJjURNDYXESERAS0BDQERyAK8fLCwfP1EfLCwGAOE%2Fgz%2B1AEsAZD%2B1ARMsHz%2BDHywsHwB9HywyP1EArz%2BDJaWlpYBLAAAAAX%2FnAAABLAETAAPABMAFwAgACkAABMhMhYVERQGIyEiJjURNDYXESERAyERIQcjIgYVFBY7AQERMzI2NTQmI8gCvHywsHz9RHywsBgDhGT9RAK8ZIImOTYpgv4Mgik2OSYETLB8%2Fgx8sLB8AfR8sMj9RAK8%2FagB9GRWQUFUASz%2B1FRBQVYAAAAF%2F5wAAASwBEwADwATAB8AJQApAAATITIWFREUBiMhIiY1ETQ2FxEhEQUjFTMRITUzNSMRIQEjESM1MwMjNTPIArx8sLB8%2FUR8sLAYA4T%2BDMjI%2FtTIyAEsAZBkZMjIZGQETLB8%2Fgx8sLB8AfR8sMj9RAK8yGT%2B1GRkASz%2BDAGQZP4MZAAG%2F5wAAASwBEwADwATABkAHwAjACcAABMhMhYVERQGIyEiJjURNDYXESERBTMRIREzASMRIzUzBRUzNQEjNTPIArx8sLB8%2FUR8sLAYA4T9RMj%2B1GQCWGRkyP2oZAEsZGQETLB8%2Fgx8sLB8AfR8sMj9RAK8yP5wAfT%2BDAGQZMjIyP7UZAAF%2F5wAAASwBEwADwATABwAIgAmAAATITIWFREUBiMhIiY1ETQ2FxEhEQEHIzU3NSM1IQEjESM1MwMjNTPIArx8sLB8%2FUR8sLAYA4T%2BDMdkx8gBLAGQZGTIx2RkBEywfP4MfLCwfAH0fLDI%2FUQCvP5wyDLIlmT%2BDAGQZP4MZAAAAAMACQAJBKcEpwAPABsAJQAAADIeAhQOAiIuAjQ%2BAQQiDgEUHgEyPgE0JgchFSEVISc1NyEB4PDbnl5entvw255eXp4BxeTCcXHC5MJxcWz%2B1AEs%2FtRkZAEsBKdentvw255eXp7b8NueTHHC5MJxccLkwtDIZGTIZAAAAAAEAAkACQSnBKcADwAbACcAKwAAADIeAhQOAiIuAjQ%2BAQQiDgEUHgEyPgE0JgcVBxcVIycjFSMRIQcVMzUB4PDbnl5entvw255eXp4BxeTCcXHC5MJxcWwyZGRklmQBLMjIBKdentvw255eXp7b8NueTHHC5MJxccLkwtBkMmQyZGQBkGRkZAAAAv%2Fy%2F50EwgRBACAANgAAATIWFzYzMhYUBisBNTQmIyEiBh0BIyImNTQ2NyY1ND4BEzMyFhURMzIWDwEGIi8BJjY7ARE0NgH3brUsLC54qqp4gB0V%2FtQVHd5QcFZBAmKqepYKD4kVCg3fDSYN3w0KFYkPBEF3YQ6t8a36FR0dFfpzT0VrDhMSZKpi%2FbMPCv7tFxD0EBD0EBcBEwoPAAAAAAL%2F8v%2BcBMMEQQAcADMAAAEyFhc2MzIWFxQGBwEmIgcBIyImNTQ2NyY1ND4BExcWBisBERQGKwEiJjURIyImNzY3NjIB9m62LCsueaoBeFr%2Bhg0lDf6DCU9xVkECYqnm3w0KFYkPCpYKD4kVCg3HGBMZBEF3YQ%2BteGOkHAFoEBD%2Bk3NPRWsOExNkqWP9kuQQF%2F7tCg8PCgETFxDMGBMAAAABAGQAAARMBG0AGAAAJTUhATMBMwkBMwEzASEVIyIGHQEhNTQmIwK8AZD%2B8qr%2B8qr%2B1P7Uqv7yqv7yAZAyFR0BkB0VZGQBLAEsAU3%2Bs%2F7U%2FtRkHRUyMhUdAAAAAAEAeQAABDcEmwAvAAABMhYXHgEVFAYHFhUUBiMiJxUyFh0BITU0NjM1BiMiJjU0Ny4BNTQ2MzIXNCY1NDYCWF6TGll7OzIJaUo3LRUd%2FtQdFS03SmkELzlpSgUSAqMEm3FZBoNaPWcfHRpKaR77HRUyMhUd%2Bx5pShIUFVg1SmkCAhAFdKMAAAAGACcAFASJBJwAEQAqAEIASgBiAHsAAAEWEgIHDgEiJicmAhI3PgEyFgUiBw4BBwYWHwEWMzI3Njc2Nz4BLwEmJyYXIgcOAQcGFh8BFjMyNz4BNz4BLwEmJyYWJiIGFBYyNjciBw4BBw4BHwEWFxYzMjc%2BATc2Ji8BJhciBwYHBgcOAR8BFhcWMzI3PgE3NiYvASYD8m9PT29T2dzZU29PT29T2dzZ%2Fj0EBHmxIgQNDCQDBBcGG0dGYAsNAwkDCwccBAVQdRgEDA0iBAQWBhJROQwMAwkDCwf5Y4xjY4xjVhYGElE6CwwDCQMLBwgEBVB1GAQNDCIEjRcGG0dGYAsNAwkDCwcIBAR5sSIEDQwkAwPyb%2F7V%2FtVvU1dXU28BKwErb1NXVxwBIrF5DBYDCQEWYEZHGwMVDCMNBgSRAhh1UA0WAwkBFTpREgMVCyMMBwT6Y2OMY2MVFTpREQQVCyMMBwQCGHVQDRYDCQEkFmBGRxsDFQwjDQYEASKxeQwWAwkBAAAABQBkAAAD6ASwAAwADwAWABwAIgAAASERIzUhFSERNDYzIQEjNQMzByczNTMDISImNREFFRQGKwECvAEstP6s%2FoQPCgI%2FASzIZKLU1KJktP51Cg8DhA8KwwMg%2FoTIyALzCg%2F%2B1Mj84NTUyP4MDwoBi8jDCg8AAAAABQBkAAAD6ASwAAkADAATABoAIQAAASERCQERNDYzIQEjNRMjFSM1IzcDISImPQEpARUUBisBNQK8ASz%2Bov3aDwoCPwEsyD6iZKLUqv6dCg8BfAIIDwqbAyD9%2BAFe%2FdoERwoP%2FtTI%2FHzIyNT%2BZA8KNzcKD1AAAAAAAwAAAAAEsAP0AAgAGQAfAAABIxUzFyERIzcFMzIeAhUhFSEDETM0PgIBMwMhASEEiqJkZP7UotT9EsgbGiEOASz9qMhkDiEaAnPw8PzgASwB9AMgyGQBLNTUBBErJGT%2BogHCJCsRBP5w%2FnAB9AAAAAMAAAAABEwETAAZADIAOQAAATMyFh0BMzIWHQEUBiMhIiY9ATQ2OwE1NDYFNTIWFREUBiMhIic3ARE0NjMVFBYzITI2AQc1IzUzNQKKZBUdMhUdHRX%2B1BUdHRUyHQFzKTs7Kf2oARP2%2Fro7KVg%2BASw%2BWP201MjIBEwdFTIdFWQVHR0VZBUdMhUd%2BpY7KfzgKTsE9gFGAUQpO5Y%2BWFj95tSiZKIAAwBkAAAEvARMABkANgA9AAABMzIWHQEzMhYdARQGIyEiJj0BNDY7ATU0NgU1MhYVESMRMxQOAiMhIiY1ETQ2MxUUFjMhMjYBBzUjNTM1AcJkFR0yFR0dFf7UFR0dFTIdAXMpO8jIDiEaG%2F2oKTs7KVg%2BASw%2BWAGc1MjIBEwdFTIdFWQVHR0VZBUdMhUd%2BpY7Kf4M%2FtQkKxEEOykDICk7lj5YWP3m1KJkogAAAAP%2FogAABRYE1AALABsAHwAACQEWBiMhIiY3ATYyEyMiBhcTHgE7ATI2NxM2JgMVMzUCkgJ9FyAs%2BwQsIBcCfRZARNAUGAQ6BCMUNhQjBDoEGODIBK37sCY3NyYEUCf%2BTB0U%2FtIUHR0UAS4UHf4MZGQAAAAACQAAAAAETARMAA8AHwAvAD8ATwBfAG8AfwCPAAABMzIWHQEUBisBIiY9ATQ2EzMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYBMzIWHQEUBisBIiY9ATQ2ITMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYBMzIWHQEUBisBIiY9ATQ2ITMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYBqfoKDw8K%2BgoPDwr6Cg8PCvoKDw8BmvoKDw8K%2BgoPD%2Fzq%2BgoPDwr6Cg8PAZr6Cg8PCvoKDw8BmvoKDw8K%2BgoPD%2Fzq%2BgoPDwr6Cg8PAZr6Cg8PCvoKDw8BmvoKDw8K%2BgoPDwRMDwqWCg8PCpYKD%2F7UDwqWCg8PCpYKDw8KlgoPDwqWCg%2F%2B1A8KlgoPDwqWCg8PCpYKDw8KlgoPDwqWCg8PCpYKD%2F7UDwqWCg8PCpYKDw8KlgoPDwqWCg8PCpYKDw8KlgoPAAAAAwAAAAAEsAUUABkAKQAzAAABMxUjFSEyFg8BBgchJi8BJjYzITUjNTM1MwEhMhYUBisBFyE3IyImNDYDITIWHQEhNTQ2ArxkZAFePjEcQiko%2FPwoKUIcMT4BXmRkyP4%2BArwVHR0VDIn8SooNFR0dswRMFR37UB0EsMhkTzeEUzMzU4Q3T2TIZPx8HSodZGQdKh3%2B1B0VMjIVHQAABAAAAAAEsAUUAAUAGQArADUAAAAyFhUjNAchFhUUByEyFg8BIScmNjMhJjU0AyEyFhQGKwEVBSElNSMiJjQ2AyEyFh0BITU0NgIwUDnCPAE6EgMBSCkHIq%2F9WrIiCikBSAOvArwVHR0VlgET%2FEoBE5YVHR2zBEwVHftQHQUUOykpjSUmCBEhFpGRFiERCCb%2BlR0qHcjIyMgdKh39qB0VMjIVHQAEAAAAAASwBJ0ABwAUACQALgAAADIWFAYiJjQTMzIWFRQXITY1NDYzASEyFhQGKwEXITcjIiY0NgMhMhYdASE1NDYCDZZqapZqty4iKyf%2BvCcrI%2F7NArwVHR0VDYr8SokMFR0dswRMFR37UB0EnWqWamqW%2Fus5Okxra0w6Of5yHSodZGQdKh3%2B1B0VMjIVHQAEAAAAAASwBRQADwAcACwANgAAATIeARUUBiImNTQ3FzcnNhMzMhYVFBchNjU0NjMBITIWFAYrARchNyMiJjQ2AyEyFh0BITU0NgJYL1szb5xvIpBvoyIfLiIrJ%2F68Jysj%2Fs0CvBUdHRUNivxKiQwVHR2zBEwVHftQHQUUa4s2Tm9vTj5Rj2%2BjGv4KOTpMa2tMOjn%2Bch0qHWRkHSod%2FtQdFTIyFR0AAAADAAAAAASwBRIAEgAiACwAAAEFFSEUHgMXIS4BNTQ%2BAjcBITIWFAYrARchNyMiJjQ2AyEyFh0BITU0NgJYASz%2B1CU%2FP00T%2Fe48PUJtj0r%2BogK8FR0dFQ2K%2FEqJDBUdHbMETBUd%2B1AdBLChizlmUT9IGVO9VFShdksE%2FH4dKh1kZB0qHf7UHRUyMhUdAAIAyAAAA%2BgFFAAPACkAAAAyFh0BHgEdASE1NDY3NTQDITIWFyMVMxUjFTMVIxUzFAYjISImNRE0NgIvUjsuNv5wNi5kAZA2XBqsyMjIyMh1U%2F5wU3V1BRQ7KU4aXDYyMjZcGk4p%2Fkc2LmRkZGRkU3V1UwGQU3UAAAMAZP%2F%2FBEwETAAPAC8AMwAAEyEyFhURFAYjISImNRE0NgMhMhYdARQGIyEXFhQGIi8BIQcGIiY0PwEhIiY9ATQ2BQchJ5YDhBUdHRX8fBUdHQQDtgoPDwr%2B5eANGiUNWP30Vw0mGg3g%2Ft8KDw8BqmQBRGQETB0V%2FgwVHR0VAfQVHf1EDwoyCg%2FgDSUbDVhYDRslDeAPCjIKD2RkZAAAAAAEAAAAAASwBEwAGQAjAC0ANwAAEyEyFh0BIzQmKwEiBhUjNCYrASIGFSM1NDYDITIWFREhETQ2ExUUBisBIiY9ASEVFAYrASImPQHIAyBTdWQ7KfopO2Q7KfopO2R1EQPoKTv7UDvxHRVkFR0D6B0VZBUdBEx1U8gpOzspKTs7KchTdf4MOyn%2B1AEsKTv%2BDDIVHR0VMjIVHR0VMgADAAEAAASpBKwADQARABsAAAkBFhQPASEBJjQ3ATYyCQMDITIWHQEhNTQ2AeACqh8fg%2F4f%2FfsgIAEnH1n%2BrAFWAS%2F%2Bq6IDIBUd%2FHwdBI39VR9ZH4MCBh9ZHwEoH%2F5u%2FqoBMAFV%2FBsdFTIyFR0AAAAAAgCPAAAEIQSwABcALwAAAQMuASMhIgYHAwYWMyEVFBYyNj0BMzI2AyE1NDY7ATU0NjsBETMRMzIWHQEzMhYVBCG9CCcV%2FnAVJwi9CBMVAnEdKh19FROo%2Fa0dFTIdFTDILxUdMhUdAocB%2BhMcHBP%2BBhMclhUdHRWWHP2MMhUdMhUdASz%2B1B0VMh0VAAAEAAAAAASwBLAADQAQAB8AIgAAASERFAYjIREBNTQ2MyEBIzUBIREUBiMhIiY1ETQ2MyEBIzUDhAEsDwr%2Bif7UDwoBdwEsyP2oASwPCv12Cg8PCgF3ASzIAyD9wQoPAk8BLFQKD%2F7UyP4M%2FcEKDw8KA7YKD%2F7UyAAC%2F5wAZAUUBEcARgBWAAABMzIeAhcWFxY2NzYnJjc%2BARYXFgcOASsBDgEPAQ4BKwEiJj8BBisBIicHDgErASImPwEmLwEuAT0BNDY7ATY3JyY2OwE2BSMiBh0BFBY7ATI2PQE0JgHkw0uOakkMEhEfQwoKGRMKBQ8XDCkCA1Y9Pgc4HCcDIhVkFRgDDDEqwxgpCwMiFWQVGAMaVCyfExwdFXwLLW8QBxXLdAFF%2BgoPDwr6Cg8PBEdBa4pJDgYKISAiJRsQCAYIDCw9P1c3fCbqFB0dFEYOCEAUHR0UnUplNQcmFTIVHVdPXw4TZV8PCjIKDw8KMgoPAAb%2FnP%2FmBRQEfgAJACQANAA8AFIAYgAAASU2Fh8BFgYPASUzMhYfASEyFh0BFAYHBQYmJyYjISImPQE0NhcjIgYdARQ7ATI2NTQmJyYEIgYUFjI2NAE3PgEeARceAT8BFxYGDwEGJi8BJjYlBwYfAR4BPwE2Jy4BJy4BAoEBpxMuDiAOAxCL%2FCtqQ0geZgM3FR0cE%2F0fFyIJKjr%2B1D5YWLlQExIqhhALIAsSAYBALS1ALf4PmBIgHhMQHC0aPzANITNQL3wpgigJASlmHyElDR0RPRMFAhQHCxADhPcICxAmDyoNeMgiNtQdFTIVJgeEBBQPQ1g%2ByD5YrBwVODMQEAtEERzJLUAtLUD%2B24ITChESEyMgAwWzPUkrRSgJL5cvfRxYGyYrDwkLNRAhFEgJDAQAAAAAAwBkAAAEOQSwAFEAYABvAAABMzIWHQEeARcWDgIPATIeBRUUDgUjFRQGKwEiJj0BIxUUBisBIiY9ASMiJj0BNDY7AREjIiY9ATQ2OwE1NDY7ATIWHQEzNTQ2AxUhMj4CNTc0LgMjARUhMj4CNTc0LgMjAnGWCg9PaAEBIC4uEBEGEjQwOiodFyI2LUAjGg8KlgoPZA8KlgoPrwoPDwpLSwoPDwqvDwqWCg9kD9cBBxwpEwsBAQsTKRz%2B%2BQFrHCkTCwEBCxMpHASwDwptIW1KLk0tHwYGAw8UKDJOLTtdPCoVCwJLCg8PCktLCg8PCksPCpYKDwJYDwqWCg9LCg8PCktLCg%2F%2B1MgVHR0LCgQOIhoW%2FnDIFR0dCwoEDiIaFgAAAwAEAAIEsASuABcAKQAsAAATITIWFREUBg8BDgEjISImJy4CNRE0NgQiDgQPARchNy4FAyMT1AMMVnokEhIdgVL9xFKCHAgYKHoCIIx9VkcrHQYGnAIwnAIIIClJVSGdwwSuelb%2BYDO3QkJXd3ZYHFrFMwGgVnqZFyYtLSUMDPPzBQ8sKDEj%2FsIBBQACAMgAAAOEBRQADwAZAAABMzIWFREUBiMhIiY1ETQ2ARUUBisBIiY9AQHblmesVCn%2BPilUrAFINhWWFTYFFKxn%2FgwpVFQpAfRnrPwY4RU2NhXhAAACAMgAAAOEBRQADwAZAAABMxQWMxEUBiMhIiY1ETQ2ARUUBisBIiY9AQHbYLOWVCn%2BPilUrAFINhWWFTYFFJaz%2FkIpVFQpAfRnrPwY4RU2NhXhAAACAAAAFAUOBBoAFAAaAAAJASUHFRcVJwc1NzU0Jj4CPwEnCQEFJTUFJQUO%2FYL%2Bhk5klpZkAQEBBQQvkwKCAVz%2Bov6iAV4BXgL%2F%2FuWqPOCWx5SVyJb6BA0GCgYDKEEBG%2F1ipqaTpaUAAAMAZAH0BLADIAAHAA8AFwAAEjIWFAYiJjQkMhYUBiImNCQyFhQGIiY0vHxYWHxYAeh8WFh8WAHofFhYfFgDIFh8WFh8WFh8WFh8WFh8WFh8AAAAAAMBkAAAArwETAAHAA8AFwAAADIWFAYiJjQSMhYUBiImNBIyFhQGIiY0Aeh8WFh8WFh8WFh8WFh8WFh8WARMWHxYWHz%2ByFh8WFh8%2FshYfFhYfAAAAAMAZABkBEwETAAPAB8ALwAAEyEyFh0BFAYjISImPQE0NhMhMhYdARQGIyEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2fQO2Cg8PCvxKCg8PCgO2Cg8PCvxKCg8PCgO2Cg8PCvxKCg8PBEwPCpYKDw8KlgoP%2FnAPCpYKDw8KlgoP%2FnAPCpYKDw8KlgoPAAAABAAAAAAEsASwAA8AHwAvADMAAAEhMhYVERQGIyEiJjURNDYFISIGFREUFjMhMjY1ETQmBSEyFhURFAYjISImNRE0NhcVITUBXgH0ory7o%2F4Mpbm5Asv9qCk7OykCWCk7O%2F2xAfQVHR0V%2FgwVHR1HAZAEsLuj%2FgylubmlAfSlucg7Kf2oKTs7KQJYKTtkHRX%2B1BUdHRUBLBUdZMjIAAAAAAEAZABkBLAETAA7AAATITIWFAYrARUzMhYUBisBFTMyFhQGKwEVMzIWFAYjISImNDY7ATUjIiY0NjsBNSMiJjQ2OwE1IyImNDaWA%2BgVHR0VMjIVHR0VMjIVHR0VMjIVHR0V%2FBgVHR0VMjIVHR0VMjIVHR0VMjIVHR0ETB0qHcgdKh3IHSodyB0qHR0qHcgdKh3IHSodyB0qHQAAAAYBLAAFA%2BgEowAHAA0AEwAZAB8AKgAAAR4BBgcuATYBMhYVIiYlFAYjNDYBMhYVIiYlFAYjNDYDFRQGIiY9ARYzMgKKVz8%2FV1c%2FP%2F75fLB8sAK8sHyw%2FcB8sHywArywfLCwHSodKAMRBKNDsrJCQrKy%2FsCwfLB8fLB8sP7UsHywfHywfLD%2B05AVHR0VjgQAAAH%2FtQDIBJQDgQBCAAABNzYXAR4BBw4BKwEyFRQOBCsBIhE0NyYiBxYVECsBIi4DNTQzIyImJyY2NwE2HwEeAQ4BLwEHIScHBi4BNgLpRRkUASoLCAYFGg8IAQQNGyc%2FKZK4ChRUFQu4jjBJJxkHAgcPGQYGCAsBKhQaTBQVCiMUM7YDe7YsFCMKFgNuEwYS%2FtkLHw8OEw0dNkY4MhwBIBgXBAQYF%2F7gKjxTQyMNEw4PHwoBKBIHEwUjKBYGDMHBDAUWKCMAAAAAAgAAAAAEsASwACUAQwAAASM0LgUrAREUFh8BFSE1Mj4DNREjIg4FFSMRIQEjNC4DKwERFBYXMxUjNTI1ESMiDgMVIzUhBLAyCAsZEyYYGcgyGRn%2BcAQOIhoWyBkYJhMZCwgyA%2Bj9RBkIChgQEWQZDQzIMmQREBgKCBkB9AOEFSAVDggDAfyuFhkBAmRkAQUJFQ4DUgEDCA4VIBUBLP0SDxMKBQH%2BVwsNATIyGQGpAQUKEw%2BWAAAAAAMAAAAABEwErgAdACAAMAAAATUiJy4BLwEBIwEGBw4BDwEVITUiJj8BIRcWBiMVARsBARUUBiMhIiY9ATQ2MyEyFgPoGR4OFgUE%2Ft9F%2FtQSFQkfCwsBETE7EkUBJT0NISf%2B7IZ5AbEdFfwYFR0dFQPoFR0BLDIgDiIKCwLr%2FQ4jFQkTBQUyMisusKYiQTIBhwFW%2Fqr942QVHR0VZBUdHQADAAAAAASwBLAADwBHAEoAABMhMhYVERQGIyEiJjURNDYFIyIHAQYHBgcGHQEUFjMhMjY9ATQmIyInJj8BIRcWBwYjIgYdARQWMyEyNj0BNCYnIicmJyMBJhMjEzIETBUdHRX7tBUdHQJGRg0F%2FtUREhImDAsJAREIDAwINxAKCj8BCjkLEQwYCAwMCAE5CAwLCBEZGQ8B%2FuAFDsVnBLAdFfu0FR0dFQRMFR1SDP0PIBMSEAUNMggMDAgyCAwXDhmjmR8YEQwIMggMDAgyBwwBGRskAuwM%2FgUBCAAABAAAAAAEsASwAAMAEwAjACcAAAEhNSEFITIWFREUBiMhIiY1ETQ2KQEyFhURFAYjISImNRE0NhcRIREEsPtQBLD7ggGQFR0dFf5wFR0dAm0BkBUdHRX%2BcBUdHUcBLARMZMgdFfx8FR0dFQOEFR0dFf5wFR0dFQGQFR1k%2FtQBLAAEAAAAAASwBLAADwAfACMAJwAAEyEyFhURFAYjISImNRE0NgEhMhYVERQGIyEiJjURNDYXESEREyE1ITIBkBUdHRX%2BcBUdHQJtAZAVHR0V%2FnAVHR1HASzI%2B1AEsASwHRX8fBUdHRUDhBUd%2FgwdFf5wFR0dFQGQFR1k%2FtQBLP2oZAAAAAACAAAAZASwA%2BgAJwArAAATITIWFREzNTQ2MyEyFh0BMxUjFRQGIyEiJj0BIxEUBiMhIiY1ETQ2AREhETIBkBUdZB0VAZAVHWRkHRX%2BcBUdZB0V%2FnAVHR0CnwEsA%2BgdFf6ilhUdHRWWZJYVHR0Vlv6iFR0dFQMgFR3%2B1P7UASwAAAQAAAAABLAEsAADABMAFwAnAAAzIxEzFyEyFhURFAYjISImNRE0NhcRIREBITIWFREUBiMhIiY1ETQ2ZGRklgGQFR0dFf5wFR0dRwEs%2FqIDhBUdHRX8fBUdHQSwZB0V%2FnAVHR0VAZAVHWT%2B1AEs%2FgwdFf5wFR0dFQGQFR0AAAAAAgBkAAAETASwACcAKwAAATMyFhURFAYrARUhMhYVERQGIyEiJjURNDYzITUjIiY1ETQ2OwE1MwcRIRECWJYVHR0VlgHCFR0dFfx8FR0dFQFelhUdHRWWZMgBLARMHRX%2BcBUdZB0V%2FnAVHR0VAZAVHWQdFQGQFR1kyP7UASwAAAAEAAAAAASwBLAAAwATABcAJwAAISMRMwUhMhYVERQGIyEiJjURNDYXESERASEyFhURFAYjISImNRE0NgSwZGT9dgGQFR0dFf5wFR0dRwEs%2FK4DhBUdHRX8fBUdHQSwZB0V%2FnAVHR0VAZAVHWT%2B1AEs%2FgwdFf5wFR0dFQGQFR0AAAEBLAAwA28EgAAPAAAJAQYjIiY1ETQ2MzIXARYUA2H%2BEhcSDhAQDhIXAe4OAjX%2BEhcbGQPoGRsX%2FhIOKgAAAAABAUEAMgOEBH4ACwAACQE2FhURFAYnASY0AU8B7h0qKh3%2BEg4CewHuHREp%2FBgpER0B7g4qAAAAAAEAMgFBBH4DhAALAAATITIWBwEGIicBJjZkA%2BgpER3%2BEg4qDv4SHREDhCod%2FhIODgHuHSoAAAAAAQAyASwEfgNvAAsAAAkBFgYjISImNwE2MgJ7Ae4dESn8GCkRHQHuDioDYf4SHSoqHQHuDgAAAAACAAgAAASwBCgABgAKAAABFQE1LQE1ASE1IQK8%2FUwBnf5jBKj84AMgAuW2%2Fr3dwcHd%2B9jIAAAAAAIAAABkBLAEsAALADEAAAEjFTMVIREzNSM1IQEzND4FOwERFAYPARUhNSIuAzURMzIeBRUzESEEsMjI%2FtTIyAEs%2B1AyCAsZEyYYGWQyGRkBkAQOIhoWZBkYJhMZCwgy%2FOADhGRkASxkZP4MFSAVDggDAf3aFhkBAmRkAQUJFQ4CJgEDCA4VIBUBLAAAAgAAAAAETAPoACUAMQAAASM0LgUrAREUFh8BFSE1Mj4DNREjIg4FFSMRIQEjFTMVIREzNSM1IQMgMggLGRMmGBlkMhkZ%2FnAEDiIaFmQZGCYTGQsIMgMgASzIyP7UyMgBLAK8FSAVDggDAf3aFhkCAWRkAQUJFQ4CJgEDCA4VIBUBLPzgZGQBLGRkAAABAMgAZgNyBEoAEgAAATMyFgcJARYGKwEiJwEmNDcBNgK9oBAKDP4wAdAMChCgDQr%2BKQcHAdcKBEoWDP4w%2FjAMFgkB1wgUCAHXCQAAAQE%2BAGYD6ARKABIAAAEzMhcBFhQHAQYrASImNwkBJjYBU6ANCgHXBwf%2BKQoNoBAKDAHQ%2FjAMCgRKCf4pCBQI%2FikJFgwB0AHQDBYAAAEAZgDIBEoDcgASAAAAFh0BFAcBBiInASY9ATQ2FwkBBDQWCf4pCBQI%2FikJFgwB0AHQA3cKEKANCv4pBwcB1woNoBAKDP4wAdAAAAABAGYBPgRKA%2BgAEgAACQEWHQEUBicJAQYmPQE0NwE2MgJqAdcJFgz%2BMP4wDBYJAdcIFAPh%2FikKDaAQCgwB0P4wDAoQoA0KAdcHAAAAAgDZ%2F%2FkEPQSwAAUAOgAAARQGIzQ2BTMyFh8BNjc%2BAh4EBgcOBgcGIiYjIgYiJy4DLwEuAT4EHgEXJyY2A%2BiwfLD%2BVmQVJgdPBQsiKFAzRyorDwURAQQSFyozTSwNOkkLDkc3EDlfNyYHBw8GDyUqPjdGMR%2BTDA0EsHywfLDIHBPCAQIGBwcFDx81S21DBxlLR1xKQhEFBQcHGWt0bCQjP2hJNyATBwMGBcASGAAAAAACAMgAFQOEBLAAFgAaAAATITIWFREUBisBEQcGJjURIyImNRE0NhcVITX6AlgVHR0Vlv8TGpYVHR2rASwEsB0V%2FnAVHf4MsgkQFQKKHRUBkBUdZGRkAAAAAgDIABkETASwAA4AEgAAEyEyFhURBRElIREjETQ2ARU3NfoC7ic9%2FUQCWP1EZB8BDWQEsFEs%2FFt1A7Z9%2FBgEARc0%2FV1kFGQAAQAAAAECTW%2FDBF9fDzz1AB8EsAAAAADQdnOXAAAAANB2c5f%2FUf%2BcBdwFFAAAAAgAAgAAAAAAAAABAAAFFP%2BFAAAFFP9R%2FtQF3AABAAAAAAAAAAAAAAAAAAAAowG4ACgAAAAAAZAAAASwAAAEsABkBLAAAASwAAAEsABwAooAAAUUAAACigAABRQAAAGxAAABRQAAANgAAADYAAAAogAAAQQAAABIAAABBAAAAUUAAASwAGQEsAB7BLAAyASwAMgB9AAABLD%2F8gSwAAAEsAAABLD%2F8ASwAAAEsAAOBLAACQSwAGQEsP%2FTBLD%2F0wSwAAAEsAAABLAAAASwAAAEsAAABLAAJgSwAG4EsAAXBLAAFwSwABcEsABkBLAAGgSwAGQEsAAMBLAAZASwABcEsP%2BcBLAAZASwABcEsAAXBLAAAASwABcEsAAXBLAAFwSwAGQEsAAABLAAZASwAAAEsAAABLAAAASwAAAEsAAABLAAAASwAAAEsAAABLAAZASwAMgEsAAABLAAAASwADUEsABkBLAAyASw%2F7UEsAAhBLAAAASwAAAEsAAABLAAAASwAAAEsP%2BcBLAAAASwAAAEsAAABLAA2wSwABcEsAB1BLAAAASwAAAEsAAABLAACgSwAMgEsAAABLAAnQSwAMgEsADIBLAAyASwAAAEsP%2F%2BBLABLASwAGQEsACIBLABOwSwABcEsAAXBLAAFwSwABcEsAAXBLAAFwSwAAAEsAAXBLAAFwSwABcEsAAXBLAAAASwALcEsAC3BLAAAASwAAAEsABJBLAAFwSwAAAEsAAABLAAXQSw%2F9wEsP%2FcBLD%2FnwSwAGQEsAAABLAAAASwAAAEsABkBLD%2F%2FwSwAAAEsP9RBLAABgSwAAAEsAAABLABRQSwAAEEsAAABLD%2FnASwAEoEsAAUBLAAAASwAAAEsAAABLD%2FnASwAGEEsP%2F9BLAAFgSwABYEsAAWBLAAFgSwABgEsAAABMQAAASwAGQAAAAAAAD%2F2ABkADkAyAAAAScAZAAZABkAGQAZABkAGQAZAAAAAAAAAAAAAADZAAAAAAAOAAAAAAAAAAAAAAAEAAAAAAAAAAAAAAAAAAMAZABkAAAAEAAAAAAAZP%2Bc%2F5z%2FnP%2Bc%2F5z%2FnP%2Bc%2F5wACQAJ%2F%2FL%2F8gBkAHkAJwBkAGQAAAAAAGT%2FogAAAAAAAAAAAAAAAADIAGQAAAABAI8AAP%2Bc%2F5wAZAAEAMgAyAAAAGQBkABkAAAAZAEs%2F7UAAAAAAAAAAAAAAAAAAABkAAABLAFBADIAMgAIAAAAAADIAT4AZgBmANkAyADIAAAAKgAqACoAKgCyAOgA6AFOAU4BTgFOAU4BTgFOAU4BTgFOAU4BTgFOAU4BpAIGAiICfgKGAqwC5ANGA24DjAPEBAgEMgRiBKIE3AVcBboGcgb0ByAHYgfKCB4IYgi%2BCTYJhAm2Cd4KKApMCpQK4gswC4oLygwIDFgNKg1eDbAODg5oDrQPKA%2BmD%2BYQEhBUEJAQqhEqEXYRthIKEjgSfBLAExoTdBPQFCoU1BU8FagVzBYEFjYWYBawFv4XUhemGAIYLhhqGJYYsBjgGP4ZKBloGZQZxBnaGe4aNhpoGrga9hteG7QcMhyUHOIdHB1EHWwdlB28HeYeLh52HsAfYh%2FSIEYgviEyIXYhuCJAIpYiuCMOIyIjOCN6I8Ij4CQCJDAkXiSWJOIlNCVgJbwmFCZ%2BJuYnUCe8J%2FgoNChwKKwpoCnMKiYqSiqEKworeiwILGgsuizsLRwtiC30LiguZi6iLtgvDi9GL34vsi%2F4MD4whDDSMRIxYDGuMegyJDJeMpoy3jMiMz4zaDO2NBg0YDSoNNI1LDWeNeg2PjZ8Ntw3GjdON5I31DgQOEI4hjjIOQo5SjmIOcw6HDpsOpo63jugO9w8GDxQPKI8%2BD0yPew%2BOj6MPtQ%2FKD9uP6o%2F%2BkBIQIBAxkECQX5CGEKoQu5DGENCQ3ZDoEPKRBBEYESuRPZFWkW2RgZGdEa0RvZHNkd2R7ZH9kgWSDJITkhqSIZIzEkSSThJXkmESapKAkouSlIAAQAAARcApwARAAAAAAACAAAAAQABAAAAQAAuAAAAAAAAABAAxgABAAAAAAATABIAAAADAAEECQAAAGoAEgADAAEECQABACgAfAADAAEECQACAA4ApAADAAEECQADAEwAsgADAAEECQAEADgA%2FgADAAEECQAFAHgBNgADAAEECQAGADYBrgADAAEECQAIABYB5AADAAEECQAJABYB%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%2FtQAyAAAAAAAAAAAAAAAAAAAAAAAAAAABFwAAAQIBAwADAA0ADgEEAJYBBQEGAQcBCAEJAQoBCwEMAQ0BDgEPARABEQESARMA7wEUARUBFgEXARgBGQEaARsBHAEdAR4BHwEgASEBIgEjASQBJQEmAScBKAEpASoBKwEsAS0BLgEvATABMQEyATMBNAE1ATYBNwE4ATkBOgE7ATwBPQE%2BAT8BQAFBAUIBQwFEAUUBRgFHAUgBSQFKAUsBTAFNAU4BTwFQAVEBUgFTAVQBVQFWAVcBWAFZAVoBWwFcAV0BXgFfAWABYQFiAWMBZAFlAWYBZwFoAWkBagFrAWwBbQFuAW8BcAFxAXIBcwF0AXUBdgF3AXgBeQF6AXsBfAF9AX4BfwGAAYEBggGDAYQBhQGGAYcBiAGJAYoBiwGMAY0BjgGPAZABkQGSAZMBlAGVAZYBlwGYAZkBmgGbAZwBnQGeAZ8BoAGhAaIBowGkAaUBpgGnAagBqQGqAasBrAGtAa4BrwGwAbEBsgGzAbQBtQG2AbcBuAG5AboBuwG8Ab0BvgG%2FAcABwQHCAcMBxAHFAcYBxwHIAckBygHLAcwBzQHOAc8B0AHRAdIB0wHUAdUB1gHXAdgB2QHaAdsB3AHdAd4B3wHgAeEB4gHjAeQB5QHmAecB6AHpAeoB6wHsAe0B7gHvAfAB8QHyAfMB9AH1AfYB9wH4AfkB%2BgH7AfwB%2FQH%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%3D%29%20format%28%27truetype%27%29%2Curl%28data%3Aimage%2Fsvg%2Bxml%3Bbase64%2CPD94bWwgdmVyc2lvbj0iMS4wIiBzdGFuZGFsb25lPSJubyI%2FPgo8IURPQ1RZUEUgc3ZnIFBVQkxJQyAiLS8vVzNDLy9EVEQgU1ZHIDEuMS8vRU4iICJodHRwOi8vd3d3LnczLm9yZy9HcmFwaGljcy9TVkcvMS4xL0RURC9zdmcxMS5kdGQiID4KPHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPgo8bWV0YWRhdGE%2BPC9tZXRhZGF0YT4KPGRlZnM%2BCjxmb250IGlkPSJnbHlwaGljb25zX2hhbGZsaW5nc3JlZ3VsYXIiIGhvcml6LWFkdi14PSIxMjAwIiA%2BCjxmb250LWZhY2UgdW5pdHMtcGVyLWVtPSIxMjAwIiBhc2NlbnQ9Ijk2MCIgZGVzY2VudD0iLTI0MCIgLz4KPG1pc3NpbmctZ2x5cGggaG9yaXotYWR2LXg9IjUwMCIgLz4KPGdseXBoIGhvcml6LWFkdi14PSIwIiAvPgo8Z2x5cGggaG9yaXotYWR2LXg9IjQwMCIgLz4KPGdseXBoIHVuaWNvZGU9IiAiIC8%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%2BCjxnbHlwaCB1bmljb2RlPSImI3gyMDAzOyIgaG9yaXotYWR2LXg9IjEzMDAiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3gyMDA0OyIgaG9yaXotYWR2LXg9IjQzMyIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeDIwMDU7IiBob3Jpei1hZHYteD0iMzI1IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4MjAwNjsiIGhvcml6LWFkdi14PSIyMTYiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3gyMDA3OyIgaG9yaXotYWR2LXg9IjIxNiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeDIwMDg7IiBob3Jpei1hZHYteD0iMTYyIiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4MjAwOTsiIGhvcml6LWFkdi14PSIyNjAiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3gyMDBhOyIgaG9yaXotYWR2LXg9IjcyIiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4MjAyZjsiIGhvcml6LWFkdi14PSIyNjAiIC8%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3gyNmZhOyIgZD0iTTc3NCAxMTkzLjVxMTYgLTkuNSAyMC41IC0yN3QtNS41IC0zMy41bC0xMzYgLTE4N2w0NjcgLTc0NmgzMHEyMCAwIDM1IC0xOC41dDE1IC0zOS41di00MmgtMTIwMHY0MnEwIDIxIDE1IDM5LjV0MzUgMTguNWgzMGw0NjggNzQ2bC0xMzUgMTgzcS0xMCAxNiAtNS41IDM0dDIwLjUgMjh0MzQgNS41dDI4IC0yMC41bDExMSAtMTQ4bDExMiAxNTBxOSAxNiAyNyAyMC41dDM0IC01ek02MDAgMjAwaDM3N2wtMTgyIDExMmwtMTk1IDUzNHYtNjQ2eiAiIC8%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDI0OyIgZD0iTTEzMDAgMGgtNTM4bC00MSA0MDBoLTI0MmwtNDEgLTQwMGgtNTM4bDQzMSAxMjAwaDIwOWwtMjEgLTMwMGgxNjJsLTIwIDMwMGgyMDh6TTUxNSA4MDBsLTI3IC0zMDBoMjI0bC0yNyAzMDBoLTE3MHoiIC8%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%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%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDMyOyIgZD0iTTEyNSAxMjAwaDEwNTBxMTAgMCAxNy41IC03LjV0Ny41IC0xNy41di0xMTUwcTAgLTEwIC03LjUgLTE3LjV0LTE3LjUgLTcuNWgtMTA1MHEtMTAgMCAtMTcuNSA3LjV0LTcuNSAxNy41djExNTBxMCAxMCA3LjUgMTcuNXQxNy41IDcuNXpNMTA3NSAxMDAwaC04NTBxLTEwIDAgLTE3LjUgLTcuNXQtNy41IC0xNy41di04NTBxMCAtMTAgNy41IC0xNy41dDE3LjUgLTcuNWg4NTBxMTAgMCAxNy41IDcuNXQ3LjUgMTcuNXY4NTAgcTAgMTAgLTcuNSAxNy41dC0xNy41IDcuNXpNMzI1IDkwMGg1MHExMCAwIDE3LjUgLTcuNXQ3LjUgLTE3LjV2LTUwcTAgLTEwIC03LjUgLTE3LjV0LTE3LjUgLTcuNWgtNTBxLTEwIDAgLTE3LjUgNy41dC03LjUgMTcuNXY1MHEwIDEwIDcuNSAxNy41dDE3LjUgNy41ek01MjUgOTAwaDQ1MHExMCAwIDE3LjUgLTcuNXQ3LjUgLTE3LjV2LTUwcTAgLTEwIC03LjUgLTE3LjV0LTE3LjUgLTcuNWgtNDUwcS0xMCAwIC0xNy41IDcuNXQtNy41IDE3LjV2NTAgcTAgMTAgNy41IDE3LjV0MTcuNSA3LjV6TTMyNSA3MDBoNTBxMTAgMCAxNy41IC03LjV0Ny41IC0xNy41di01MHEwIC0xMCAtNy41IC0xNy41dC0xNy41IC03LjVoLTUwcS0xMCAwIC0xNy41IDcuNXQtNy41IDE3LjV2NTBxMCAxMCA3LjUgMTcuNXQxNy41IDcuNXpNNTI1IDcwMGg0NTBxMTAgMCAxNy41IC03LjV0Ny41IC0xNy41di01MHEwIC0xMCAtNy41IC0xNy41dC0xNy41IC03LjVoLTQ1MHEtMTAgMCAtMTcuNSA3LjV0LTcuNSAxNy41djUwIHEwIDEwIDcuNSAxNy41dDE3LjUgNy41ek0zMjUgNTAwaDUwcTEwIDAgMTcuNSAtNy41dDcuNSAtMTcuNXYtNTBxMCAtMTAgLTcuNSAtMTcuNXQtMTcuNSAtNy41aC01MHEtMTAgMCAtMTcuNSA3LjV0LTcuNSAxNy41djUwcTAgMTAgNy41IDE3LjV0MTcuNSA3LjV6TTUyNSA1MDBoNDUwcTEwIDAgMTcuNSAtNy41dDcuNSAtMTcuNXYtNTBxMCAtMTAgLTcuNSAtMTcuNXQtMTcuNSAtNy41aC00NTBxLTEwIDAgLTE3LjUgNy41dC03LjUgMTcuNXY1MCBxMCAxMCA3LjUgMTcuNXQxNy41IDcuNXpNMzI1IDMwMGg1MHExMCAwIDE3LjUgLTcuNXQ3LjUgLTE3LjV2LTUwcTAgLTEwIC03LjUgLTE3LjV0LTE3LjUgLTcuNWgtNTBxLTEwIDAgLTE3LjUgNy41dC03LjUgMTcuNXY1MHEwIDEwIDcuNSAxNy41dDE3LjUgNy41ek01MjUgMzAwaDQ1MHExMCAwIDE3LjUgLTcuNXQ3LjUgLTE3LjV2LTUwcTAgLTEwIC03LjUgLTE3LjV0LTE3LjUgLTcuNWgtNDUwcS0xMCAwIC0xNy41IDcuNXQtNy41IDE3LjV2NTAgcTAgMTAgNy41IDE3LjV0MTcuNSA3LjV6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTAzMzsiIGQ9Ik05MDAgODAwdjIwMHEwIDgzIC01OC41IDE0MS41dC0xNDEuNSA1OC41aC0zMDBxLTgyIDAgLTE0MSAtNTl0LTU5IC0xNDF2LTIwMGgtMTAwcS00MSAwIC03MC41IC0yOS41dC0yOS41IC03MC41di02MDBxMCAtNDEgMjkuNSAtNzAuNXQ3MC41IC0yOS41aDkwMHE0MSAwIDcwLjUgMjkuNXQyOS41IDcwLjV2NjAwcTAgNDEgLTI5LjUgNzAuNXQtNzAuNSAyOS41aC0xMDB6TTQwMCA4MDB2MTUwcTAgMjEgMTUgMzUuNXQzNSAxNC41aDIwMCBxMjAgMCAzNSAtMTQuNXQxNSAtMzUuNXYtMTUwaC0zMDB6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTAzNDsiIGQ9Ik0xMjUgMTEwMGg1MHExMCAwIDE3LjUgLTcuNXQ3LjUgLTE3LjV2LTEwNzVoLTEwMHYxMDc1cTAgMTAgNy41IDE3LjV0MTcuNSA3LjV6TTEwNzUgMTA1MnE0IDAgOSAtMnExNiAtNiAxNiAtMjN2LTQyMXEwIC02IC0zIC0xMnEtMzMgLTU5IC02Ni41IC05OXQtNjUuNSAtNTh0LTU2LjUgLTI0LjV0LTUyLjUgLTYuNXEtMjYgMCAtNTcuNSA2LjV0LTUyLjUgMTMuNXQtNjAgMjFxLTQxIDE1IC02MyAyMi41dC01Ny41IDE1dC02NS41IDcuNSBxLTg1IDAgLTE2MCAtNTdxLTcgLTUgLTE1IC01cS02IDAgLTExIDNxLTE0IDcgLTE0IDIydjQzOHEyMiA1NSA4MiA5OC41dDExOSA0Ni41cTIzIDIgNDMgMC41dDQzIC03dDMyLjUgLTguNXQzOCAtMTN0MzIuNSAtMTFxNDEgLTE0IDYzLjUgLTIxdDU3IC0xNHQ2My41IC03cTEwMyAwIDE4MyA4N3E3IDggMTggOHoiIC8%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDQyOyIgZD0iTTUwMCAxMjAwbDY4MiAtNjgycTggLTggOCAtMTh0LTggLTE4bC00NjQgLTQ2NHEtOCAtOCAtMTggLTh0LTE4IDhsLTY4MiA2ODJsMSA0NzVxMCAxMCA3LjUgMTcuNXQxNy41IDcuNWg0NzR6TTgwMCAxMjAwbDY4MiAtNjgycTggLTggOCAtMTh0LTggLTE4bC00NjQgLTQ2NHEtOCAtOCAtMTggLTh0LTE4IDhsLTU2IDU2bDQyNCA0MjZsLTcwMCA3MDBoMTUwek0zMTkuNSAxMDI0LjVxLTI5LjUgMjkuNSAtNzEgMjkuNXQtNzEgLTI5LjUgdC0yOS41IC03MS41dDI5LjUgLTcxLjV0NzEgLTI5LjV0NzEgMjkuNXQyOS41IDcxLjV0LTI5LjUgNzEuNXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDQzOyIgZD0iTTMwMCAxMjAwaDgyNXE3NSAwIDc1IC03NXYtOTAwcTAgLTI1IC0xOCAtNDNsLTY0IC02NHEtOCAtOCAtMTMgLTUuNXQtNSAxMi41djk1MHEwIDEwIC03LjUgMTcuNXQtMTcuNSA3LjVoLTcwMHEtMjUgMCAtNDMgLTE4bC02NCAtNjRxLTggLTggLTUuNSAtMTN0MTIuNSAtNWg3MDBxMTAgMCAxNy41IC03LjV0Ny41IC0xNy41di05NTBxMCAtMTAgLTcuNSAtMTcuNXQtMTcuNSAtNy41aC04NTBxLTEwIDAgLTE3LjUgNy41dC03LjUgMTcuNXY5NzUgcTAgMjUgMTggNDNsMTM5IDEzOXExOCAxOCA0MyAxOHoiIC8%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDQ5OyIgZD0iTTg3NyAxMjAwbDIgLTU3cS04MyAtMTkgLTExNiAtNDUuNXQtNDAgLTY2LjVsLTEzMiAtODM5cS05IC00OSAxMyAtNjl0OTYgLTI2di05N2gtNTAwdjk3cTE4NiAxNiAyMDAgOThsMTczIDgzMnEzIDE3IDMgMzB0LTEuNSAyMi41dC05IDE3LjV0LTEzLjUgMTIuNXQtMjEuNSAxMHQtMjYgOC41dC0zMy41IDEwcS0xMyAzIC0xOSA1djU3aDQyNXoiIC8%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%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDY3OyIgZD0iTTM1MCAxMTAwaDM1MHE2MCAwIDEyNyAtMjNsLTE3OCAtMTc3aC0zNDlxLTQxIDAgLTcwLjUgLTI5LjV0LTI5LjUgLTcwLjV2LTUwMHEwIC00MSAyOS41IC03MC41dDcwLjUgLTI5LjVoNTAwcTQxIDAgNzAuNSAyOS41dDI5LjUgNzAuNXY2OWwyMDAgMjAwdi0yMTlxMCAtMTY1IC05Mi41IC0yNTcuNXQtMjU3LjUgLTkyLjVoLTQwMHEtMTY1IDAgLTI1Ny41IDkyLjV0LTkyLjUgMjU3LjV2NDAwcTAgMTY1IDkyLjUgMjU3LjV0MjU3LjUgOTIuNXogTTY0MyA2MzlsMzk1IDM5NXE3IDcgMTcuNSA3dDE3LjUgLTdsMTAxIC0xMDFxNyAtNyA3IC0xNy41dC03IC0xNy41bC01MzEgLTUzMnEtNyAtNyAtMTcuNSAtN3QtMTcuNSA3bC0yNDggMjQ4cS03IDcgLTcgMTcuNXQ3IDE3LjVsMTAxIDEwMXE3IDcgMTcuNSA3dDE3LjUgLTdsMTExIC0xMTFxOCAtNyAxOCAtN3QxOCA3eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUwNjg7IiBkPSJNMzE4IDkxOGwyNjQgMjY0cTggOCAxOCA4dDE4IC04bDI2MCAtMjY0cTcgLTggNC41IC0xM3QtMTIuNSAtNWgtMTcwdi0yMDBoMjAwdjE3M3EwIDEwIDUgMTJ0MTMgLTVsMjY0IC0yNjBxOCAtNyA4IC0xNy41dC04IC0xNy41bC0yNjQgLTI2NXEtOCAtNyAtMTMgLTV0LTUgMTJ2MTczaC0yMDB2LTIwMGgxNzBxMTAgMCAxMi41IC01dC00LjUgLTEzbC0yNjAgLTI2NHEtOCAtOCAtMTggLTh0LTE4IDhsLTI2NCAyNjRxLTggOCAtNS41IDEzIHQxMi41IDVoMTc1djIwMGgtMjAwdi0xNzNxMCAtMTAgLTUgLTEydC0xMyA1bC0yNjQgMjY1cS04IDcgLTggMTcuNXQ4IDE3LjVsMjY0IDI2MHE4IDcgMTMgNXQ1IC0xMnYtMTczaDIwMHYyMDBoLTE3NXEtMTAgMCAtMTIuNSA1dDUuNSAxM3oiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDY5OyIgZD0iTTI1MCAxMTAwaDEwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtNDM4bDQ2NCA0NTNxMTUgMTQgMjUuNSAxMHQxMC41IC0yNXYtMTAwMHEwIC0yMSAtMTAuNSAtMjV0LTI1LjUgMTBsLTQ2NCA0NTN2LTQzOHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtMTAwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXYxMDAwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDcwOyIgZD0iTTUwIDExMDBoMTAwcTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di00MzhsNDY0IDQ1M3ExNSAxNCAyNS41IDEwdDEwLjUgLTI1di00MzhsNDY0IDQ1M3ExNSAxNCAyNS41IDEwdDEwLjUgLTI1di0xMDAwcTAgLTIxIC0xMC41IC0yNXQtMjUuNSAxMGwtNDY0IDQ1M3YtNDM4cTAgLTIxIC0xMC41IC0yNXQtMjUuNSAxMGwtNDY0IDQ1M3YtNDM4cTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC0xMDBxLTIxIDAgLTM1LjUgMTQuNSB0LTE0LjUgMzUuNXYxMDAwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDcxOyIgZD0iTTEyMDAgMTA1MHYtMTAwMHEwIC0yMSAtMTAuNSAtMjV0LTI1LjUgMTBsLTQ2NCA0NTN2LTQzOHEwIC0yMSAtMTAuNSAtMjV0LTI1LjUgMTBsLTQ5MiA0ODBxLTE1IDE0IC0xNSAzNXQxNSAzNWw0OTIgNDgwcTE1IDE0IDI1LjUgMTB0MTAuNSAtMjV2LTQzOGw0NjQgNDUzcTE1IDE0IDI1LjUgMTB0MTAuNSAtMjV6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTA3MjsiIGQ9Ik0yNDMgMTA3NGw4MTQgLTQ5OHExOCAtMTEgMTggLTI2dC0xOCAtMjZsLTgxNCAtNDk4cS0xOCAtMTEgLTMwLjUgLTR0LTEyLjUgMjh2MTAwMHEwIDIxIDEyLjUgMjh0MzAuNSAtNHoiIC8%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDc5OyIgZD0iTTg4NSA5MDBsLTM1MiAtMzUzbDM1MiAtMzUzbC0xOTcgLTE5OGwtNTUyIDU1Mmw1NTIgNTUweiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUwODA7IiBkPSJNMTA2NCA1NDdsLTU1MSAtNTUxbC0xOTggMTk4bDM1MyAzNTNsLTM1MyAzNTNsMTk4IDE5OHoiIC8%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%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%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDkxOyIgZD0iTTM5IDU4Mmw1MjIgNDI3cTE2IDEzIDI3LjUgOHQxMS41IC0yNnYtMjkxaDU1MHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMjAwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC01NTB2LTI5MXEwIC0yMSAtMTEuNSAtMjZ0LTI3LjUgOGwtNTIyIDQyN3EtMTYgMTMgLTE2IDMydDE2IDMyeiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUwOTI7IiBkPSJNNjM5IDEwMDlsNTIyIC00MjdxMTYgLTEzIDE2IC0zMnQtMTYgLTMybC01MjIgLTQyN3EtMTYgLTEzIC0yNy41IC04dC0xMS41IDI2djI5MWgtNTUwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXYyMDBxMCAyMSAxNC41IDM1LjV0MzUuNSAxNC41aDU1MHYyOTFxMCAyMSAxMS41IDI2dDI3LjUgLTh6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTA5MzsiIGQ9Ik02ODIgMTE2MWw0MjcgLTUyMnExMyAtMTYgOCAtMjcuNXQtMjYgLTExLjVoLTI5MXYtNTUwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC0yMDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djU1MGgtMjkxcS0yMSAwIC0yNiAxMS41dDggMjcuNWw0MjcgNTIycTEzIDE2IDMyIDE2dDMyIC0xNnoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDk0OyIgZD0iTTU1MCAxMjAwaDIwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtNTUwaDI5MXEyMSAwIDI2IC0xMS41dC04IC0yNy41bC00MjcgLTUyMnEtMTMgLTE2IC0zMiAtMTZ0LTMyIDE2bC00MjcgNTIycS0xMyAxNiAtOCAyNy41dDI2IDExLjVoMjkxdjU1MHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjV6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTA5NTsiIGQ9Ik02MzkgMTEwOWw1MjIgLTQyN3ExNiAtMTMgMTYgLTMydC0xNiAtMzJsLTUyMiAtNDI3cS0xNiAtMTMgLTI3LjUgLTh0LTExLjUgMjZ2MjkxcS05NCAtMiAtMTgyIC0yMHQtMTcwLjUgLTUydC0xNDcgLTkyLjV0LTEwMC41IC0xMzUuNXE1IDEwNSAyNyAxOTMuNXQ2Ny41IDE2N3QxMTMgMTM1dDE2NyA5MS41dDIyNS41IDQydjI2MnEwIDIxIDExLjUgMjZ0MjcuNSAtOHoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDk2OyIgZD0iTTg1MCAxMjAwaDMwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMzAwcTAgLTIxIC0xMC41IC0yNXQtMjQuNSAxMGwtOTQgOTRsLTI0OSAtMjQ5cS04IC03IC0xOCAtN3QtMTggN2wtMTA2IDEwNnEtNyA4IC03IDE4dDcgMThsMjQ5IDI0OWwtOTQgOTRxLTE0IDE0IC0xMCAyNC41dDI1IDEwLjV6TTM1MCAwaC0zMDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djMwMHEwIDIxIDEwLjUgMjV0MjQuNSAtMTBsOTQgLTk0bDI0OSAyNDkgcTggNyAxOCA3dDE4IC03bDEwNiAtMTA2cTcgLTggNyAtMTh0LTcgLTE4bC0yNDkgLTI0OWw5NCAtOTRxMTQgLTE0IDEwIC0yNC41dC0yNSAtMTAuNXoiIC8%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%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%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%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%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%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%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%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%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%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%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%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%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%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%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%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMTYwOyIgZD0iTTM1MCAxMTAwaDQwMHExNjUgMCAyNTcuNSAtOTIuNXQ5Mi41IC0yNTcuNXYtNDAwcTAgLTE2MyAtOTIuNSAtMjU2LjV0LTI1Ny41IC05My41aC00MDBxLTE2MyAwIC0yNTYuNSA5NHQtOTMuNSAyNTZ2NDAwcTAgMTY1IDkyLjUgMjU3LjV0MjU3LjUgOTIuNXpNODAwIDkwMGgtNTAwcS00MSAwIC03MC41IC0yOS41dC0yOS41IC03MC41di01MDBxMCAtNDEgMjkuNSAtNzAuNXQ3MC41IC0yOS41aDUwMHE0MSAwIDcwLjUgMjkuNXQyOS41IDcwLjUgdjUwMHEwIDQxIC0yOS41IDcwLjV0LTcwLjUgMjkuNXpNNTgwIDY5M2wxOTAgLTI1M3ExMiAtMTYgNi41IC0yOHQtMjYuNSAtMTJoLTQwMHEtMjEgMCAtMjYuNSAxMnQ2LjUgMjhsMTkwIDI1M3ExMiAxNyAzMCAxN3QzMCAtMTd6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTE2MTsiIGQ9Ik01NTAgMTEwMGg0MDBxMTY1IDAgMjU3LjUgLTkyLjV0OTIuNSAtMjU3LjV2LTQwMHEwIC0xNjUgLTkyLjUgLTI1Ny41dC0yNTcuNSAtOTIuNWgtNDAwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXYxMDBxMCAyMSAxNC41IDM1LjV0MzUuNSAxNC41aDQ1MHE0MSAwIDcwLjUgMjkuNXQyOS41IDcwLjV2NTAwcTAgNDEgLTI5LjUgNzAuNXQtNzAuNSAyOS41aC00NTBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djEwMCBxMCAyMSAxNC41IDM1LjV0MzUuNSAxNC41ek0zMzggODY3bDMyNCAtMjg0cTE2IC0xNCAxNiAtMzN0LTE2IC0zM2wtMzI0IC0yODRxLTE2IC0xNCAtMjcgLTl0LTExIDI2djE1MGgtMjUwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXYyMDBxMCAyMSAxNC41IDM1LjV0MzUuNSAxNC41aDI1MHYxNTBxMCAyMSAxMSAyNnQyNyAtOXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMTYyOyIgZD0iTTc5MyAxMTgybDkgLTlxOCAtMTAgNSAtMjdxLTMgLTExIC03OSAtMjI1LjV0LTc4IC0yMjEuNWwzMDAgMXEyNCAwIDMyLjUgLTE3LjV0LTUuNSAtMzUuNXEtMSAwIC0xMzMuNSAtMTU1dC0yNjcgLTMxMi41dC0xMzguNSAtMTYyLjVxLTEyIC0xNSAtMjYgLTE1aC05bC05IDhxLTkgMTEgLTQgMzJxMiA5IDQyIDEyMy41dDc5IDIyNC41bDM5IDExMGgtMzAycS0yMyAwIC0zMSAxOXEtMTAgMjEgNiA0MXE3NSA4NiAyMDkuNSAyMzcuNSB0MjI4IDI1N3Q5OC41IDExMS41cTkgMTYgMjUgMTZoOXoiIC8%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%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%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%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMTg4OyIgZD0iTTIwMCAxMTAwaDcwMHExMjQgMCAyMTIgLTg4dDg4IC0yMTJ2LTUwMHEwIC0xMjQgLTg4IC0yMTJ0LTIxMiAtODhoLTcwMHEtMTI0IDAgLTIxMiA4OHQtODggMjEydjUwMHEwIDEyNCA4OCAyMTJ0MjEyIDg4ek0xMDAgOTAwdi03MDBoOTAwdjcwMGgtOTAwek01MDAgNzAwaC0yMDB2LTMwMGgyMDB2LTEwMGgtMzAwdjUwMGgzMDB2LTEwMHpNOTAwIDcwMGgtMjAwdi0zMDBoMjAwdi0xMDBoLTMwMHY1MDBoMzAwdi0xMDB6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTE4OTsiIGQ9Ik0yMDAgMTEwMGg3MDBxMTI0IDAgMjEyIC04OHQ4OCAtMjEydi01MDBxMCAtMTI0IC04OCAtMjEydC0yMTIgLTg4aC03MDBxLTEyNCAwIC0yMTIgODh0LTg4IDIxMnY1MDBxMCAxMjQgODggMjEydDIxMiA4OHpNMTAwIDkwMHYtNzAwaDkwMHY3MDBoLTkwMHpNNTAwIDQwMGwtMzAwIDE1MGwzMDAgMTUwdi0zMDB6TTkwMCA1NTBsLTMwMCAtMTUwdjMwMHoiIC8%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%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%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%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjIxOyIgZD0iTTQ4MCAxMTY1bDY4MiAtNjgzcTMxIC0zMSAzMSAtNzUuNXQtMzEgLTc1LjVsLTEzMSAtMTMxaC00ODFsLTUxNyA1MThxLTMyIDMxIC0zMiA3NS41dDMyIDc1LjVsMjk1IDI5NnEzMSAzMSA3NS41IDMxdDc2LjUgLTMxek0xMDggNzk0bDM0MiAtMzQybDMwMyAzMDRsLTM0MSAzNDF6TTI1MCAxMDBoODAwcTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di01MGgtOTAwdjUwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXoiIC8%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%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%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%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%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%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjUwOyIgZD0iTTg2NSA1NjVsLTQ5NCAtNDk0cS0yMyAtMjMgLTQxIC0yM3EtMTQgMCAtMjIgMTMuNXQtOCAzOC41djEwMDBxMCAyNSA4IDM4LjV0MjIgMTMuNXExOCAwIDQxIC0yM2w0OTQgLTQ5NHExNCAtMTQgMTQgLTM1dC0xNCAtMzV6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTI1MTsiIGQ9Ik0zMzUgNjM1bDQ5NCA0OTRxMjkgMjkgNTAgMjAuNXQyMSAtNDkuNXYtMTAwMHEwIC00MSAtMjEgLTQ5LjV0LTUwIDIwLjVsLTQ5NCA0OTRxLTE0IDE0IC0xNCAzNXQxNCAzNXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjUyOyIgZD0iTTEwMCA5MDBoMTAwMHE0MSAwIDQ5LjUgLTIxdC0yMC41IC01MGwtNDk0IC00OTRxLTE0IC0xNCAtMzUgLTE0dC0zNSAxNGwtNDk0IDQ5NHEtMjkgMjkgLTIwLjUgNTB0NDkuNSAyMXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjUzOyIgZD0iTTYzNSA4NjVsNDk0IC00OTRxMjkgLTI5IDIwLjUgLTUwdC00OS41IC0yMWgtMTAwMHEtNDEgMCAtNDkuNSAyMXQyMC41IDUwbDQ5NCA0OTRxMTQgMTQgMzUgMTR0MzUgLTE0eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUyNTQ7IiBkPSJNNzAwIDc0MXYtMTgybC02OTIgLTMyM3YyMjFsNDEzIDE5M2wtNDEzIDE5M3YyMjF6TTEyMDAgMGgtODAwdjIwMGg4MDB2LTIwMHoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjU1OyIgZD0iTTEyMDAgOTAwaC0yMDB2LTEwMGgyMDB2LTEwMGgtMzAwdjMwMGgyMDB2MTAwaC0yMDB2MTAwaDMwMHYtMzAwek0wIDcwMGg1MHEwIDIxIDQgMzd0OS41IDI2LjV0MTggMTcuNXQyMiAxMXQyOC41IDUuNXQzMSAydDM3IDAuNWgxMDB2LTU1MHEwIC0yMiAtMjUgLTM0LjV0LTUwIC0xMy41bC0yNSAtMnYtMTAwaDQwMHYxMDBxLTQgMCAtMTEgMC41dC0yNCAzdC0zMCA3dC0yNCAxNXQtMTEgMjQuNXY1NTBoMTAwcTI1IDAgMzcgLTAuNXQzMSAtMiB0MjguNSAtNS41dDIyIC0xMXQxOCAtMTcuNXQ5LjUgLTI2LjV0NCAtMzdoNTB2MzAwaC04MDB2LTMwMHoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjU2OyIgZD0iTTgwMCA3MDBoLTUwcTAgMjEgLTQgMzd0LTkuNSAyNi41dC0xOCAxNy41dC0yMiAxMXQtMjguNSA1LjV0LTMxIDJ0LTM3IDAuNWgtMTAwdi01NTBxMCAtMjIgMjUgLTM0LjV0NTAgLTE0LjVsMjUgLTF2LTEwMGgtNDAwdjEwMHE0IDAgMTEgMC41dDI0IDN0MzAgN3QyNCAxNXQxMSAyNC41djU1MGgtMTAwcS0yNSAwIC0zNyAtMC41dC0zMSAtMnQtMjguNSAtNS41dC0yMiAtMTF0LTE4IC0xNy41dC05LjUgLTI2LjV0LTQgLTM3aC01MHYzMDAgaDgwMHYtMzAwek0xMTAwIDIwMGgtMjAwdi0xMDBoMjAwdi0xMDBoLTMwMHYzMDBoMjAwdjEwMGgtMjAwdjEwMGgzMDB2LTMwMHoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjU3OyIgZD0iTTcwMSAxMDk4aDE2MHExNiAwIDIxIC0xMXQtNyAtMjNsLTQ2NCAtNDY0bDQ2NCAtNDY0cTEyIC0xMiA3IC0yM3QtMjEgLTExaC0xNjBxLTEzIDAgLTIzIDlsLTQ3MSA0NzFxLTcgOCAtNyAxOHQ3IDE4bDQ3MSA0NzFxMTAgOSAyMyA5eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUyNTg7IiBkPSJNMzM5IDEwOThoMTYwcTEzIDAgMjMgLTlsNDcxIC00NzFxNyAtOCA3IC0xOHQtNyAtMThsLTQ3MSAtNDcxcS0xMCAtOSAtMjMgLTloLTE2MHEtMTYgMCAtMjEgMTF0NyAyM2w0NjQgNDY0bC00NjQgNDY0cS0xMiAxMiAtNyAyM3QyMSAxMXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjU5OyIgZD0iTTEwODcgODgycTExIC01IDExIC0yMXYtMTYwcTAgLTEzIC05IC0yM2wtNDcxIC00NzFxLTggLTcgLTE4IC03dC0xOCA3bC00NzEgNDcxcS05IDEwIC05IDIzdjE2MHEwIDE2IDExIDIxdDIzIC03bDQ2NCAtNDY0bDQ2NCA0NjRxMTIgMTIgMjMgN3oiIC8%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%2BCjwvZGVmcz48L3N2Zz4g%29%20format%28%27svg%27%29%7D%2Eglyphicon%7Bposition%3Arelative%3Btop%3A1px%3Bdisplay%3Ainline%2Dblock%3Bfont%2Dfamily%3A%27Glyphicons%20Halflings%27%3Bfont%2Dstyle%3Anormal%3Bfont%2Dweight%3A400%3Bline%2Dheight%3A1%3B%2Dwebkit%2Dfont%2Dsmoothing%3Aantialiased%3B%2Dmoz%2Dosx%2Dfont%2Dsmoothing%3Agrayscale%7D%2Eglyphicon%2Dasterisk%3Abefore%7Bcontent%3A%22%5C2a%22%7D%2Eglyphicon%2Dplus%3Abefore%7Bcontent%3A%22%5C2b%22%7D%2Eglyphicon%2Deur%3Abefore%2C%2Eglyphicon%2Deuro%3Abefore%7Bcontent%3A%22%5C20ac%22%7D%2Eglyphicon%2Dminus%3Abefore%7Bcontent%3A%22%5C2212%22%7D%2Eglyphicon%2Dcloud%3Abefore%7Bcontent%3A%22%5C2601%22%7D%2Eglyphicon%2Denvelope%3Abefore%7Bcontent%3A%22%5C2709%22%7D%2Eglyphicon%2Dpencil%3Abefore%7Bcontent%3A%22%5C270f%22%7D%2Eglyphicon%2Dglass%3Abefore%7Bcontent%3A%22%5Ce001%22%7D%2Eglyphicon%2Dmusic%3Abefore%7Bcontent%3A%22%5Ce002%22%7D%2Eglyphicon%2Dsearch%3Abefore%7Bcontent%3A%22%5Ce003%22%7D%2Eglyphicon%2Dheart%3Abefore%7Bcontent%3A%22%5Ce005%22%7D%2Eglyphicon%2Dstar%3Abefore%7Bcontent%3A%22%5Ce006%22%7D%2Eglyphicon%2Dstar%2Dempty%3Abefore%7Bcontent%3A%22%5Ce007%22%7D%2Eglyphicon%2Duser%3Abefore%7Bcontent%3A%22%5Ce008%22%7D%2Eglyphicon%2Dfilm%3Abefore%7Bcontent%3A%22%5Ce009%22%7D%2Eglyphicon%2Dth%2Dlarge%3Abefore%7Bcontent%3A%22%5Ce010%22%7D%2Eglyphicon%2Dth%3Abefore%7Bcontent%3A%22%5Ce011%22%7D%2Eglyphicon%2Dth%2Dlist%3Abefore%7Bcontent%3A%22%5Ce012%22%7D%2Eglyphicon%2Dok%3Abefore%7Bcontent%3A%22%5Ce013%22%7D%2Eglyphicon%2Dremove%3Abefore%7Bcontent%3A%22%5Ce014%22%7D%2Eglyphicon%2Dzoom%2Din%3Abefore%7Bcontent%3A%22%5Ce015%22%7D%2Eglyphicon%2Dzoom%2Dout%3Abefore%7Bcontent%3A%22%5Ce016%22%7D%2Eglyphicon%2Doff%3Abefore%7Bcontent%3A%22%5Ce017%22%7D%2Eglyphicon%2Dsignal%3Abefore%7Bcontent%3A%22%5Ce018%22%7D%2Eglyphicon%2Dcog%3Abefore%7Bcontent%3A%22%5Ce019%22%7D%2Eglyphicon%2Dtrash%3Abefore%7Bcontent%3A%22%5Ce020%22%7D%2Eglyphicon%2Dhome%3Abefore%7Bcontent%3A%22%5Ce021%22%7D%2Eglyphicon%2Dfile%3Abefore%7Bcontent%3A%22%5Ce022%22%7D%2Eglyphicon%2Dtime%3Abefore%7Bcontent%3A%22%5Ce023%22%7D%2Eglyphicon%2Droad%3Abefore%7Bcontent%3A%22%5Ce024%22%7D%2Eglyphicon%2Ddownload%2Dalt%3Abefore%7Bcontent%3A%22%5Ce025%22%7D%2Eglyphicon%2Ddownload%3Abefore%7Bcontent%3A%22%5Ce026%22%7D%2Eglyphicon%2Dupload%3Abefore%7Bcontent%3A%22%5Ce027%22%7D%2Eglyphicon%2Dinbox%3Abefore%7Bcontent%3A%22%5Ce028%22%7D%2Eglyphicon%2Dplay%2Dcircle%3Abefore%7Bcontent%3A%22%5Ce029%22%7D%2Eglyphicon%2Drepeat%3Abefore%7Bcontent%3A%22%5Ce030%22%7D%2Eglyphicon%2Drefresh%3Abefore%7Bcontent%3A%22%5Ce031%22%7D%2Eglyphicon%2Dlist%2Dalt%3Abefore%7Bcontent%3A%22%5Ce032%22%7D%2Eglyphicon%2Dlock%3Abefore%7Bcontent%3A%22%5Ce033%22%7D%2Eglyphicon%2Dflag%3Abefore%7Bcontent%3A%22%5Ce034%22%7D%2Eglyphicon%2Dheadphones%3Abefore%7Bcontent%3A%22%5Ce035%22%7D%2Eglyphicon%2Dvolume%2Doff%3Abefore%7Bcontent%3A%22%5Ce036%22%7D%2Eglyphicon%2Dvolume%2Ddown%3Abefore%7Bcontent%3A%22%5Ce037%22%7D%2Eglyphicon%2Dvolume%2Dup%3Abefore%7Bcontent%3A%22%5Ce038%22%7D%2Eglyphicon%2Dqrcode%3Abefore%7Bcontent%3A%22%5Ce039%22%7D%2Eglyphicon%2Dbarcode%3Abefore%7Bcontent%3A%22%5Ce040%22%7D%2Eglyphicon%2Dtag%3Abefore%7Bcontent%3A%22%5Ce041%22%7D%2Eglyphicon%2Dtags%3Abefore%7Bcontent%3A%22%5Ce042%22%7D%2Eglyphicon%2Dbook%3Abefore%7Bcontent%3A%22%5Ce043%22%7D%2Eglyphicon%2Dbookmark%3Abefore%7Bcontent%3A%22%5Ce044%22%7D%2Eglyphicon%2Dprint%3Abefore%7Bcontent%3A%22%5Ce045%22%7D%2Eglyphicon%2Dcamera%3Abefore%7Bcontent%3A%22%5Ce046%22%7D%2Eglyphicon%2Dfont%3Abefore%7Bcontent%3A%22%5Ce047%22%7D%2Eglyphicon%2Dbold%3Abefore%7Bcontent%3A%22%5Ce048%22%7D%2Eglyphicon%2Ditalic%3Abefore%7Bcontent%3A%22%5Ce049%22%7D%2Eglyphicon%2Dtext%2Dheight%3Abefore%7Bcontent%3A%22%5Ce050%22%7D%2Eglyphicon%2Dtext%2Dwidth%3Abefore%7Bcontent%3A%22%5Ce051%22%7D%2Eglyphicon%2Dalign%2Dleft%3Abefore%7Bcontent%3A%22%5Ce052%22%7D%2Eglyphicon%2Dalign%2Dcenter%3Abefore%7Bcontent%3A%22%5Ce053%22%7D%2Eglyphicon%2Dalign%2Dright%3Abefore%7Bcontent%3A%22%5Ce054%22%7D%2Eglyphicon%2Dalign%2Djustify%3Abefore%7Bcontent%3A%22%5Ce055%22%7D%2Eglyphicon%2Dlist%3Abefore%7Bcontent%3A%22%5Ce056%22%7D%2Eglyphicon%2Dindent%2Dleft%3Abefore%7Bcontent%3A%22%5Ce057%22%7D%2Eglyphicon%2Dindent%2Dright%3Abefore%7Bcontent%3A%22%5Ce058%22%7D%2Eglyphicon%2Dfacetime%2Dvideo%3Abefore%7Bcontent%3A%22%5Ce059%22%7D%2Eglyphicon%2Dpicture%3Abefore%7Bcontent%3A%22%5Ce060%22%7D%2Eglyphicon%2Dmap%2Dmarker%3Abefore%7Bcontent%3A%22%5Ce062%22%7D%2Eglyphicon%2Dadjust%3Abefore%7Bcontent%3A%22%5Ce063%22%7D%2Eglyphicon%2Dtint%3Abefore%7Bcontent%3A%22%5Ce064%22%7D%2Eglyphicon%2Dedit%3Abefore%7Bcontent%3A%22%5Ce065%22%7D%2Eglyphicon%2Dshare%3Abefore%7Bcontent%3A%22%5Ce066%22%7D%2Eglyphicon%2Dcheck%3Abefore%7Bcontent%3A%22%5Ce067%22%7D%2Eglyphicon%2Dmove%3Abefore%7Bcontent%3A%22%5Ce068%22%7D%2Eglyphicon%2Dstep%2Dbackward%3Abefore%7Bcontent%3A%22%5Ce069%22%7D%2Eglyphicon%2Dfast%2Dbackward%3Abefore%7Bcontent%3A%22%5Ce070%22%7D%2Eglyphicon%2Dbackward%3Abefore%7Bcontent%3A%22%5Ce071%22%7D%2Eglyphicon%2Dplay%3Abefore%7Bcontent%3A%22%5Ce072%22%7D%2Eglyphicon%2Dpause%3Abefore%7Bcontent%3A%22%5Ce073%22%7D%2Eglyphicon%2Dstop%3Abefore%7Bcontent%3A%22%5Ce074%22%7D%2Eglyphicon%2Dforward%3Abefore%7Bcontent%3A%22%5Ce075%22%7D%2Eglyphicon%2Dfast%2Dforward%3Abefore%7Bcontent%3A%22%5Ce076%22%7D%2Eglyphicon%2Dstep%2Dforward%3Abefore%7Bcontent%3A%22%5Ce077%22%7D%2Eglyphicon%2Deject%3Abefore%7Bcontent%3A%22%5Ce078%22%7D%2Eglyphicon%2Dchevron%2Dleft%3Abefore%7Bcontent%3A%22%5Ce079%22%7D%2Eglyphicon%2Dchevron%2Dright%3Abefore%7Bcontent%3A%22%5Ce080%22%7D%2Eglyphicon%2Dplus%2Dsign%3Abefore%7Bcontent%3A%22%5Ce081%22%7D%2Eglyphicon%2Dminus%2Dsign%3Abefore%7Bcontent%3A%22%5Ce082%22%7D%2Eglyphicon%2Dremove%2Dsign%3Abefore%7Bcontent%3A%22%5Ce083%22%7D%2Eglyphicon%2Dok%2Dsign%3Abefore%7Bcontent%3A%22%5Ce084%22%7D%2Eglyphicon%2Dquestion%2Dsign%3Abefore%7Bcontent%3A%22%5Ce085%22%7D%2Eglyphicon%2Dinfo%2Dsign%3Abefore%7Bcontent%3A%22%5Ce086%22%7D%2Eglyphicon%2Dscreenshot%3Abefore%7Bcontent%3A%22%5Ce087%22%7D%2Eglyphicon%2Dremove%2Dcircle%3Abefore%7Bcontent%3A%22%5Ce088%22%7D%2Eglyphicon%2Dok%2Dcircle%3Abefore%7Bcontent%3A%22%5Ce089%22%7D%2Eglyphicon%2Dban%2Dcircle%3Abefore%7Bcontent%3A%22%5Ce090%22%7D%2Eglyphicon%2Darrow%2Dleft%3Abefore%7Bcontent%3A%22%5Ce091%22%7D%2Eglyphicon%2Darrow%2Dright%3Abefore%7Bcontent%3A%22%5Ce092%22%7D%2Eglyphicon%2Darrow%2Dup%3Abefore%7Bcontent%3A%22%5Ce093%22%7D%2Eglyphicon%2Darrow%2Ddown%3Abefore%7Bcontent%3A%22%5Ce094%22%7D%2Eglyphicon%2Dshare%2Dalt%3Abefore%7Bcontent%3A%22%5Ce095%22%7D%2Eglyphicon%2Dresize%2Dfull%3Abefore%7Bcontent%3A%22%5Ce096%22%7D%2Eglyphicon%2Dresize%2Dsmall%3Abefore%7Bcontent%3A%22%5Ce097%22%7D%2Eglyphicon%2Dexclamation%2Dsign%3Abefore%7Bcontent%3A%22%5Ce101%22%7D%2Eglyphicon%2Dgift%3Abefore%7Bcontent%3A%22%5Ce102%22%7D%2Eglyphicon%2Dleaf%3Abefore%7Bcontent%3A%22%5Ce103%22%7D%2Eglyphicon%2Dfire%3Abefore%7Bcontent%3A%22%5Ce104%22%7D%2Eglyphicon%2Deye%2Dopen%3Abefore%7Bcontent%3A%22%5Ce105%22%7D%2Eglyphicon%2Deye%2Dclose%3Abefore%7Bcontent%3A%22%5Ce106%22%7D%2Eglyphicon%2Dwarning%2Dsign%3Abefore%7Bcontent%3A%22%5Ce107%22%7D%2Eglyphicon%2Dplane%3Abefore%7Bcontent%3A%22%5Ce108%22%7D%2Eglyphicon%2Dcalendar%3Abefore%7Bcontent%3A%22%5Ce109%22%7D%2Eglyphicon%2Drandom%3Abefore%7Bcontent%3A%22%5Ce110%22%7D%2Eglyphicon%2Dcomment%3Abefore%7Bcontent%3A%22%5Ce111%22%7D%2Eglyphicon%2Dmagnet%3Abefore%7Bcontent%3A%22%5Ce112%22%7D%2Eglyphicon%2Dchevron%2Dup%3Abefore%7Bcontent%3A%22%5Ce113%22%7D%2Eglyphicon%2Dchevron%2Ddown%3Abefore%7Bcontent%3A%22%5Ce114%22%7D%2Eglyphicon%2Dretweet%3Abefore%7Bcontent%3A%22%5Ce115%22%7D%2Eglyphicon%2Dshopping%2Dcart%3Abefore%7Bcontent%3A%22%5Ce116%22%7D%2Eglyphicon%2Dfolder%2Dclose%3Abefore%7Bcontent%3A%22%5Ce117%22%7D%2Eglyphicon%2Dfolder%2Dopen%3Abefore%7Bcontent%3A%22%5Ce118%22%7D%2Eglyphicon%2Dresize%2Dvertical%3Abefore%7Bcontent%3A%22%5Ce119%22%7D%2Eglyphicon%2Dresize%2Dhorizontal%3Abefore%7Bcontent%3A%22%5Ce120%22%7D%2Eglyphicon%2Dhdd%3Abefore%7Bcontent%3A%22%5Ce121%22%7D%2Eglyphicon%2Dbullhorn%3Abefore%7Bcontent%3A%22%5Ce122%22%7D%2Eglyphicon%2Dbell%3Abefore%7Bcontent%3A%22%5Ce123%22%7D%2Eglyphicon%2Dcertificate%3Abefore%7Bcontent%3A%22%5Ce124%22%7D%2Eglyphicon%2Dthumbs%2Dup%3Abefore%7Bcontent%3A%22%5Ce125%22%7D%2Eglyphicon%2Dthumbs%2Ddown%3Abefore%7Bcontent%3A%22%5Ce126%22%7D%2Eglyphicon%2Dhand%2Dright%3Abefore%7Bcontent%3A%22%5Ce127%22%7D%2Eglyphicon%2Dhand%2Dleft%3Abefore%7Bcontent%3A%22%5Ce128%22%7D%2Eglyphicon%2Dhand%2Dup%3Abefore%7Bcontent%3A%22%5Ce129%22%7D%2Eglyphicon%2Dhand%2Ddown%3Abefore%7Bcontent%3A%22%5Ce130%22%7D%2Eglyphicon%2Dcircle%2Darrow%2Dright%3Abefore%7Bcontent%3A%22%5Ce131%22%7D%2Eglyphicon%2Dcircle%2Darrow%2Dleft%3Abefore%7Bcontent%3A%22%5Ce132%22%7D%2Eglyphicon%2Dcircle%2Darrow%2Dup%3Abefore%7Bcontent%3A%22%5Ce133%22%7D%2Eglyphicon%2Dcircle%2Darrow%2Ddown%3Abefore%7Bcontent%3A%22%5Ce134%22%7D%2Eglyphicon%2Dglobe%3Abefore%7Bcontent%3A%22%5Ce135%22%7D%2Eglyphicon%2Dwrench%3Abefore%7Bcontent%3A%22%5Ce136%22%7D%2Eglyphicon%2Dtasks%3Abefore%7Bcontent%3A%22%5Ce137%22%7D%2Eglyphicon%2Dfilter%3Abefore%7Bcontent%3A%22%5Ce138%22%7D%2Eglyphicon%2Dbriefcase%3Abefore%7Bcontent%3A%22%5Ce139%22%7D%2Eglyphicon%2Dfullscreen%3Abefore%7Bcontent%3A%22%5Ce140%22%7D%2Eglyphicon%2Ddashboard%3Abefore%7Bcontent%3A%22%5Ce141%22%7D%2Eglyphicon%2Dpaperclip%3Abefore%7Bcontent%3A%22%5Ce142%22%7D%2Eglyphicon%2Dheart%2Dempty%3Abefore%7Bcontent%3A%22%5Ce143%22%7D%2Eglyphicon%2Dlink%3Abefore%7Bcontent%3A%22%5Ce144%22%7D%2Eglyphicon%2Dphone%3Abefore%7Bcontent%3A%22%5Ce145%22%7D%2Eglyphicon%2Dpushpin%3Abefore%7Bcontent%3A%22%5Ce146%22%7D%2Eglyphicon%2Dusd%3Abefore%7Bcontent%3A%22%5Ce148%22%7D%2Eglyphicon%2Dgbp%3Abefore%7Bcontent%3A%22%5Ce149%22%7D%2Eglyphicon%2Dsort%3Abefore%7Bcontent%3A%22%5Ce150%22%7D%2Eglyphicon%2Dsort%2Dby%2Dalphabet%3Abefore%7Bcontent%3A%22%5Ce151%22%7D%2Eglyphicon%2Dsort%2Dby%2Dalphabet%2Dalt%3Abefore%7Bcontent%3A%22%5Ce152%22%7D%2Eglyphicon%2Dsort%2Dby%2Dorder%3Abefore%7Bcontent%3A%22%5Ce153%22%7D%2Eglyphicon%2Dsort%2Dby%2Dorder%2Dalt%3Abefore%7Bcontent%3A%22%5Ce154%22%7D%2Eglyphicon%2Dsort%2Dby%2Dattributes%3Abefore%7Bcontent%3A%22%5Ce155%22%7D%2Eglyphicon%2Dsort%2Dby%2Dattributes%2Dalt%3Abefore%7Bcontent%3A%22%5Ce156%22%7D%2Eglyphicon%2Dunchecked%3Abefore%7Bcontent%3A%22%5Ce157%22%7D%2Eglyphicon%2Dexpand%3Abefore%7Bcontent%3A%22%5Ce158%22%7D%2Eglyphicon%2Dcollapse%2Ddown%3Abefore%7Bcontent%3A%22%5Ce159%22%7D%2Eglyphicon%2Dcollapse%2Dup%3Abefore%7Bcontent%3A%22%5Ce160%22%7D%2Eglyphicon%2Dlog%2Din%3Abefore%7Bcontent%3A%22%5Ce161%22%7D%2Eglyphicon%2Dflash%3Abefore%7Bcontent%3A%22%5Ce162%22%7D%2Eglyphicon%2Dlog%2Dout%3Abefore%7Bcontent%3A%22%5Ce163%22%7D%2Eglyphicon%2Dnew%2Dwindow%3Abefore%7Bcontent%3A%22%5Ce164%22%7D%2Eglyphicon%2Drecord%3Abefore%7Bcontent%3A%22%5Ce165%22%7D%2Eglyphicon%2Dsave%3Abefore%7Bcontent%3A%22%5Ce166%22%7D%2Eglyphicon%2Dopen%3Abefore%7Bcontent%3A%22%5Ce167%22%7D%2Eglyphicon%2Dsaved%3Abefore%7Bcontent%3A%22%5Ce168%22%7D%2Eglyphicon%2Dimport%3Abefore%7Bcontent%3A%22%5Ce169%22%7D%2Eglyphicon%2Dexport%3Abefore%7Bcontent%3A%22%5Ce170%22%7D%2Eglyphicon%2Dsend%3Abefore%7Bcontent%3A%22%5Ce171%22%7D%2Eglyphicon%2Dfloppy%2Ddisk%3Abefore%7Bcontent%3A%22%5Ce172%22%7D%2Eglyphicon%2Dfloppy%2Dsaved%3Abefore%7Bcontent%3A%22%5Ce173%22%7D%2Eglyphicon%2Dfloppy%2Dremove%3Abefore%7Bcontent%3A%22%5Ce174%22%7D%2Eglyphicon%2Dfloppy%2Dsave%3Abefore%7Bcontent%3A%22%5Ce175%22%7D%2Eglyphicon%2Dfloppy%2Dopen%3Abefore%7Bcontent%3A%22%5Ce176%22%7D%2Eglyphicon%2Dcredit%2Dcard%3Abefore%7Bcontent%3A%22%5Ce177%22%7D%2Eglyphicon%2Dtransfer%3Abefore%7Bcontent%3A%22%5Ce178%22%7D%2Eglyphicon%2Dcutlery%3Abefore%7Bcontent%3A%22%5Ce179%22%7D%2Eglyphicon%2Dheader%3Abefore%7Bcontent%3A%22%5Ce180%22%7D%2Eglyphicon%2Dcompressed%3Abefore%7Bcontent%3A%22%5Ce181%22%7D%2Eglyphicon%2Dearphone%3Abefore%7Bcontent%3A%22%5Ce182%22%7D%2Eglyphicon%2Dphone%2Dalt%3Abefore%7Bcontent%3A%22%5Ce183%22%7D%2Eglyphicon%2Dtower%3Abefore%7Bcontent%3A%22%5Ce184%22%7D%2Eglyphicon%2Dstats%3Abefore%7Bcontent%3A%22%5Ce185%22%7D%2Eglyphicon%2Dsd%2Dvideo%3Abefore%7Bcontent%3A%22%5Ce186%22%7D%2Eglyphicon%2Dhd%2Dvideo%3Abefore%7Bcontent%3A%22%5Ce187%22%7D%2Eglyphicon%2Dsubtitles%3Abefore%7Bcontent%3A%22%5Ce188%22%7D%2Eglyphicon%2Dsound%2Dstereo%3Abefore%7Bcontent%3A%22%5Ce189%22%7D%2Eglyphicon%2Dsound%2Ddolby%3Abefore%7Bcontent%3A%22%5Ce190%22%7D%2Eglyphicon%2Dsound%2D5%2D1%3Abefore%7Bcontent%3A%22%5Ce191%22%7D%2Eglyphicon%2Dsound%2D6%2D1%3Abefore%7Bcontent%3A%22%5Ce192%22%7D%2Eglyphicon%2Dsound%2D7%2D1%3Abefore%7Bcontent%3A%22%5Ce193%22%7D%2Eglyphicon%2Dcopyright%2Dmark%3Abefore%7Bcontent%3A%22%5Ce194%22%7D%2Eglyphicon%2Dregistration%2Dmark%3Abefore%7Bcontent%3A%22%5Ce195%22%7D%2Eglyphicon%2Dcloud%2Ddownload%3Abefore%7Bcontent%3A%22%5Ce197%22%7D%2Eglyphicon%2Dcloud%2Dupload%3Abefore%7Bcontent%3A%22%5Ce198%22%7D%2Eglyphicon%2Dtree%2Dconifer%3Abefore%7Bcontent%3A%22%5Ce199%22%7D%2Eglyphicon%2Dtree%2Ddeciduous%3Abefore%7Bcontent%3A%22%5Ce200%22%7D%2Eglyphicon%2Dcd%3Abefore%7Bcontent%3A%22%5Ce201%22%7D%2Eglyphicon%2Dsave%2Dfile%3Abefore%7Bcontent%3A%22%5Ce202%22%7D%2Eglyphicon%2Dopen%2Dfile%3Abefore%7Bcontent%3A%22%5Ce203%22%7D%2Eglyphicon%2Dlevel%2Dup%3Abefore%7Bcontent%3A%22%5Ce204%22%7D%2Eglyphicon%2Dcopy%3Abefore%7Bcontent%3A%22%5Ce205%22%7D%2Eglyphicon%2Dpaste%3Abefore%7Bcontent%3A%22%5Ce206%22%7D%2Eglyphicon%2Dalert%3Abefore%7Bcontent%3A%22%5Ce209%22%7D%2Eglyphicon%2Dequalizer%3Abefore%7Bcontent%3A%22%5Ce210%22%7D%2Eglyphicon%2Dking%3Abefore%7Bcontent%3A%22%5Ce211%22%7D%2Eglyphicon%2Dqueen%3Abefore%7Bcontent%3A%22%5Ce212%22%7D%2Eglyphicon%2Dpawn%3Abefore%7Bcontent%3A%22%5Ce213%22%7D%2Eglyphicon%2Dbishop%3Abefore%7Bcontent%3A%22%5Ce214%22%7D%2Eglyphicon%2Dknight%3Abefore%7Bcontent%3A%22%5Ce215%22%7D%2Eglyphicon%2Dbaby%2Dformula%3Abefore%7Bcontent%3A%22%5Ce216%22%7D%2Eglyphicon%2Dtent%3Abefore%7Bcontent%3A%22%5C26fa%22%7D%2Eglyphicon%2Dblackboard%3Abefore%7Bcontent%3A%22%5Ce218%22%7D%2Eglyphicon%2Dbed%3Abefore%7Bcontent%3A%22%5Ce219%22%7D%2Eglyphicon%2Dapple%3Abefore%7Bcontent%3A%22%5Cf8ff%22%7D%2Eglyphicon%2Derase%3Abefore%7Bcontent%3A%22%5Ce221%22%7D%2Eglyphicon%2Dhourglass%3Abefore%7Bcontent%3A%22%5C231b%22%7D%2Eglyphicon%2Dlamp%3Abefore%7Bcontent%3A%22%5Ce223%22%7D%2Eglyphicon%2Dduplicate%3Abefore%7Bcontent%3A%22%5Ce224%22%7D%2Eglyphicon%2Dpiggy%2Dbank%3Abefore%7Bcontent%3A%22%5Ce225%22%7D%2Eglyphicon%2Dscissors%3Abefore%7Bcontent%3A%22%5Ce226%22%7D%2Eglyphicon%2Dbitcoin%3Abefore%7Bcontent%3A%22%5Ce227%22%7D%2Eglyphicon%2Dbtc%3Abefore%7Bcontent%3A%22%5Ce227%22%7D%2Eglyphicon%2Dxbt%3Abefore%7Bcontent%3A%22%5Ce227%22%7D%2Eglyphicon%2Dyen%3Abefore%7Bcontent%3A%22%5C00a5%22%7D%2Eglyphicon%2Djpy%3Abefore%7Bcontent%3A%22%5C00a5%22%7D%2Eglyphicon%2Druble%3Abefore%7Bcontent%3A%22%5C20bd%22%7D%2Eglyphicon%2Drub%3Abefore%7Bcontent%3A%22%5C20bd%22%7D%2Eglyphicon%2Dscale%3Abefore%7Bcontent%3A%22%5Ce230%22%7D%2Eglyphicon%2Dice%2Dlolly%3Abefore%7Bcontent%3A%22%5Ce231%22%7D%2Eglyphicon%2Dice%2Dlolly%2Dtasted%3Abefore%7Bcontent%3A%22%5Ce232%22%7D%2Eglyphicon%2Deducation%3Abefore%7Bcontent%3A%22%5Ce233%22%7D%2Eglyphicon%2Doption%2Dhorizontal%3Abefore%7Bcontent%3A%22%5Ce234%22%7D%2Eglyphicon%2Doption%2Dvertical%3Abefore%7Bcontent%3A%22%5Ce235%22%7D%2Eglyphicon%2Dmenu%2Dhamburger%3Abefore%7Bcontent%3A%22%5Ce236%22%7D%2Eglyphicon%2Dmodal%2Dwindow%3Abefore%7Bcontent%3A%22%5Ce237%22%7D%2Eglyphicon%2Doil%3Abefore%7Bcontent%3A%22%5Ce238%22%7D%2Eglyphicon%2Dgrain%3Abefore%7Bcontent%3A%22%5Ce239%22%7D%2Eglyphicon%2Dsunglasses%3Abefore%7Bcontent%3A%22%5Ce240%22%7D%2Eglyphicon%2Dtext%2Dsize%3Abefore%7Bcontent%3A%22%5Ce241%22%7D%2Eglyphicon%2Dtext%2Dcolor%3Abefore%7Bcontent%3A%22%5Ce242%22%7D%2Eglyphicon%2Dtext%2Dbackground%3Abefore%7Bcontent%3A%22%5Ce243%22%7D%2Eglyphicon%2Dobject%2Dalign%2Dtop%3Abefore%7Bcontent%3A%22%5Ce244%22%7D%2Eglyphicon%2Dobject%2Dalign%2Dbottom%3Abefore%7Bcontent%3A%22%5Ce245%22%7D%2Eglyphicon%2Dobject%2Dalign%2Dhorizontal%3Abefore%7Bcontent%3A%22%5Ce246%22%7D%2Eglyphicon%2Dobject%2Dalign%2Dleft%3Abefore%7Bcontent%3A%22%5Ce247%22%7D%2Eglyphicon%2Dobject%2Dalign%2Dvertical%3Abefore%7Bcontent%3A%22%5Ce248%22%7D%2Eglyphicon%2Dobject%2Dalign%2Dright%3Abefore%7Bcontent%3A%22%5Ce249%22%7D%2Eglyphicon%2Dtriangle%2Dright%3Abefore%7Bcontent%3A%22%5Ce250%22%7D%2Eglyphicon%2Dtriangle%2Dleft%3Abefore%7Bcontent%3A%22%5Ce251%22%7D%2Eglyphicon%2Dtriangle%2Dbottom%3Abefore%7Bcontent%3A%22%5Ce252%22%7D%2Eglyphicon%2Dtriangle%2Dtop%3Abefore%7Bcontent%3A%22%5Ce253%22%7D%2Eglyphicon%2Dconsole%3Abefore%7Bcontent%3A%22%5Ce254%22%7D%2Eglyphicon%2Dsuperscript%3Abefore%7Bcontent%3A%22%5Ce255%22%7D%2Eglyphicon%2Dsubscript%3Abefore%7Bcontent%3A%22%5Ce256%22%7D%2Eglyphicon%2Dmenu%2Dleft%3Abefore%7Bcontent%3A%22%5Ce257%22%7D%2Eglyphicon%2Dmenu%2Dright%3Abefore%7Bcontent%3A%22%5Ce258%22%7D%2Eglyphicon%2Dmenu%2Ddown%3Abefore%7Bcontent%3A%22%5Ce259%22%7D%2Eglyphicon%2Dmenu%2Dup%3Abefore%7Bcontent%3A%22%5Ce260%22%7D%2A%7B%2Dwebkit%2Dbox%2Dsizing%3Aborder%2Dbox%3B%2Dmoz%2Dbox%2Dsizing%3Aborder%2Dbox%3Bbox%2Dsizing%3Aborder%2Dbox%7D%3Aafter%2C%3Abefore%7B%2Dwebkit%2Dbox%2Dsizing%3Aborder%2Dbox%3B%2Dmoz%2Dbox%2Dsizing%3Aborder%2Dbox%3Bbox%2Dsizing%3Aborder%2Dbox%7Dhtml%7Bfont%2Dsize%3A10px%3B%2Dwebkit%2Dtap%2Dhighlight%2Dcolor%3Argba%280%2C0%2C0%2C0%29%7Dbody%7Bfont%2Dfamily%3A%22Helvetica%20Neue%22%2CHelvetica%2CArial%2Csans%2Dserif%3Bfont%2Dsize%3A14px%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23333%3Bbackground%2Dcolor%3A%23fff%7Dbutton%2Cinput%2Cselect%2Ctextarea%7Bfont%2Dfamily%3Ainherit%3Bfont%2Dsize%3Ainherit%3Bline%2Dheight%3Ainherit%7Da%7Bcolor%3A%23337ab7%3Btext%2Ddecoration%3Anone%7Da%3Afocus%2Ca%3Ahover%7Bcolor%3A%2323527c%3Btext%2Ddecoration%3Aunderline%7Da%3Afocus%7Boutline%3Athin%20dotted%3Boutline%3A5px%20auto%20%2Dwebkit%2Dfocus%2Dring%2Dcolor%3Boutline%2Doffset%3A%2D2px%7Dfigure%7Bmargin%3A0%7Dimg%7Bvertical%2Dalign%3Amiddle%7D%2Ecarousel%2Dinner%3E%2Eitem%3Ea%3Eimg%2C%2Ecarousel%2Dinner%3E%2Eitem%3Eimg%2C%2Eimg%2Dresponsive%2C%2Ethumbnail%20a%3Eimg%2C%2Ethumbnail%3Eimg%7Bdisplay%3Ablock%3Bmax%2Dwidth%3A100%25%3Bheight%3Aauto%7D%2Eimg%2Drounded%7Bborder%2Dradius%3A6px%7D%2Eimg%2Dthumbnail%7Bdisplay%3Ainline%2Dblock%3Bmax%2Dwidth%3A100%25%3Bheight%3Aauto%3Bpadding%3A4px%3Bline%2Dheight%3A1%2E42857143%3Bbackground%2Dcolor%3A%23fff%3Bborder%3A1px%20solid%20%23ddd%3Bborder%2Dradius%3A4px%3B%2Dwebkit%2Dtransition%3Aall%20%2E2s%20ease%2Din%2Dout%3B%2Do%2Dtransition%3Aall%20%2E2s%20ease%2Din%2Dout%3Btransition%3Aall%20%2E2s%20ease%2Din%2Dout%7D%2Eimg%2Dcircle%7Bborder%2Dradius%3A50%25%7Dhr%7Bmargin%2Dtop%3A20px%3Bmargin%2Dbottom%3A20px%3Bborder%3A0%3Bborder%2Dtop%3A1px%20solid%20%23eee%7D%2Esr%2Donly%7Bposition%3Aabsolute%3Bwidth%3A1px%3Bheight%3A1px%3Bpadding%3A0%3Bmargin%3A%2D1px%3Boverflow%3Ahidden%3Bclip%3Arect%280%2C0%2C0%2C0%29%3Bborder%3A0%7D%2Esr%2Donly%2Dfocusable%3Aactive%2C%2Esr%2Donly%2Dfocusable%3Afocus%7Bposition%3Astatic%3Bwidth%3Aauto%3Bheight%3Aauto%3Bmargin%3A0%3Boverflow%3Avisible%3Bclip%3Aauto%7D%5Brole%3Dbutton%5D%7Bcursor%3Apointer%7D%2Eh1%2C%2Eh2%2C%2Eh3%2C%2Eh4%2C%2Eh5%2C%2Eh6%2Ch1%2Ch2%2Ch3%2Ch4%2Ch5%2Ch6%7Bfont%2Dfamily%3Ainherit%3Bfont%2Dweight%3A500%3Bline%2Dheight%3A1%2E1%3Bcolor%3Ainherit%7D%2Eh1%20%2Esmall%2C%2Eh1%20small%2C%2Eh2%20%2Esmall%2C%2Eh2%20small%2C%2Eh3%20%2Esmall%2C%2Eh3%20small%2C%2Eh4%20%2Esmall%2C%2Eh4%20small%2C%2Eh5%20%2Esmall%2C%2Eh5%20small%2C%2Eh6%20%2Esmall%2C%2Eh6%20small%2Ch1%20%2Esmall%2Ch1%20small%2Ch2%20%2Esmall%2Ch2%20small%2Ch3%20%2Esmall%2Ch3%20small%2Ch4%20%2Esmall%2Ch4%20small%2Ch5%20%2Esmall%2Ch5%20small%2Ch6%20%2Esmall%2Ch6%20small%7Bfont%2Dweight%3A400%3Bline%2Dheight%3A1%3Bcolor%3A%23777%7D%2Eh1%2C%2Eh2%2C%2Eh3%2Ch1%2Ch2%2Ch3%7Bmargin%2Dtop%3A20px%3Bmargin%2Dbottom%3A10px%7D%2Eh1%20%2Esmall%2C%2Eh1%20small%2C%2Eh2%20%2Esmall%2C%2Eh2%20small%2C%2Eh3%20%2Esmall%2C%2Eh3%20small%2Ch1%20%2Esmall%2Ch1%20small%2Ch2%20%2Esmall%2Ch2%20small%2Ch3%20%2Esmall%2Ch3%20small%7Bfont%2Dsize%3A65%25%7D%2Eh4%2C%2Eh5%2C%2Eh6%2Ch4%2Ch5%2Ch6%7Bmargin%2Dtop%3A10px%3Bmargin%2Dbottom%3A10px%7D%2Eh4%20%2Esmall%2C%2Eh4%20small%2C%2Eh5%20%2Esmall%2C%2Eh5%20small%2C%2Eh6%20%2Esmall%2C%2Eh6%20small%2Ch4%20%2Esmall%2Ch4%20small%2Ch5%20%2Esmall%2Ch5%20small%2Ch6%20%2Esmall%2Ch6%20small%7Bfont%2Dsize%3A75%25%7D%2Eh1%2Ch1%7Bfont%2Dsize%3A36px%7D%2Eh2%2Ch2%7Bfont%2Dsize%3A30px%7D%2Eh3%2Ch3%7Bfont%2Dsize%3A24px%7D%2Eh4%2Ch4%7Bfont%2Dsize%3A18px%7D%2Eh5%2Ch5%7Bfont%2Dsize%3A14px%7D%2Eh6%2Ch6%7Bfont%2Dsize%3A12px%7Dp%7Bmargin%3A0%200%2010px%7D%2Elead%7Bmargin%2Dbottom%3A20px%3Bfont%2Dsize%3A16px%3Bfont%2Dweight%3A300%3Bline%2Dheight%3A1%2E4%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Elead%7Bfont%2Dsize%3A21px%7D%7D%2Esmall%2Csmall%7Bfont%2Dsize%3A85%25%7D%2Emark%2Cmark%7Bpadding%3A%2E2em%3Bbackground%2Dcolor%3A%23fcf8e3%7D%2Etext%2Dleft%7Btext%2Dalign%3Aleft%7D%2Etext%2Dright%7Btext%2Dalign%3Aright%7D%2Etext%2Dcenter%7Btext%2Dalign%3Acenter%7D%2Etext%2Djustify%7Btext%2Dalign%3Ajustify%7D%2Etext%2Dnowrap%7Bwhite%2Dspace%3Anowrap%7D%2Etext%2Dlowercase%7Btext%2Dtransform%3Alowercase%7D%2Etext%2Duppercase%7Btext%2Dtransform%3Auppercase%7D%2Etext%2Dcapitalize%7Btext%2Dtransform%3Acapitalize%7D%2Etext%2Dmuted%7Bcolor%3A%23777%7D%2Etext%2Dprimary%7Bcolor%3A%23337ab7%7Da%2Etext%2Dprimary%3Afocus%2Ca%2Etext%2Dprimary%3Ahover%7Bcolor%3A%23286090%7D%2Etext%2Dsuccess%7Bcolor%3A%233c763d%7Da%2Etext%2Dsuccess%3Afocus%2Ca%2Etext%2Dsuccess%3Ahover%7Bcolor%3A%232b542c%7D%2Etext%2Dinfo%7Bcolor%3A%2331708f%7Da%2Etext%2Dinfo%3Afocus%2Ca%2Etext%2Dinfo%3Ahover%7Bcolor%3A%23245269%7D%2Etext%2Dwarning%7Bcolor%3A%238a6d3b%7Da%2Etext%2Dwarning%3Afocus%2Ca%2Etext%2Dwarning%3Ahover%7Bcolor%3A%2366512c%7D%2Etext%2Ddanger%7Bcolor%3A%23a94442%7Da%2Etext%2Ddanger%3Afocus%2Ca%2Etext%2Ddanger%3Ahover%7Bcolor%3A%23843534%7D%2Ebg%2Dprimary%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23337ab7%7Da%2Ebg%2Dprimary%3Afocus%2Ca%2Ebg%2Dprimary%3Ahover%7Bbackground%2Dcolor%3A%23286090%7D%2Ebg%2Dsuccess%7Bbackground%2Dcolor%3A%23dff0d8%7Da%2Ebg%2Dsuccess%3Afocus%2Ca%2Ebg%2Dsuccess%3Ahover%7Bbackground%2Dcolor%3A%23c1e2b3%7D%2Ebg%2Dinfo%7Bbackground%2Dcolor%3A%23d9edf7%7Da%2Ebg%2Dinfo%3Afocus%2Ca%2Ebg%2Dinfo%3Ahover%7Bbackground%2Dcolor%3A%23afd9ee%7D%2Ebg%2Dwarning%7Bbackground%2Dcolor%3A%23fcf8e3%7Da%2Ebg%2Dwarning%3Afocus%2Ca%2Ebg%2Dwarning%3Ahover%7Bbackground%2Dcolor%3A%23f7ecb5%7D%2Ebg%2Ddanger%7Bbackground%2Dcolor%3A%23f2dede%7Da%2Ebg%2Ddanger%3Afocus%2Ca%2Ebg%2Ddanger%3Ahover%7Bbackground%2Dcolor%3A%23e4b9b9%7D%2Epage%2Dheader%7Bpadding%2Dbottom%3A9px%3Bmargin%3A40px%200%2020px%3Bborder%2Dbottom%3A1px%20solid%20%23eee%7Dol%2Cul%7Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A10px%7Dol%20ol%2Col%20ul%2Cul%20ol%2Cul%20ul%7Bmargin%2Dbottom%3A0%7D%2Elist%2Dunstyled%7Bpadding%2Dleft%3A0%3Blist%2Dstyle%3Anone%7D%2Elist%2Dinline%7Bpadding%2Dleft%3A0%3Bmargin%2Dleft%3A%2D5px%3Blist%2Dstyle%3Anone%7D%2Elist%2Dinline%3Eli%7Bdisplay%3Ainline%2Dblock%3Bpadding%2Dright%3A5px%3Bpadding%2Dleft%3A5px%7Ddl%7Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A20px%7Ddd%2Cdt%7Bline%2Dheight%3A1%2E42857143%7Ddt%7Bfont%2Dweight%3A700%7Ddd%7Bmargin%2Dleft%3A0%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Edl%2Dhorizontal%20dt%7Bfloat%3Aleft%3Bwidth%3A160px%3Boverflow%3Ahidden%3Bclear%3Aleft%3Btext%2Dalign%3Aright%3Btext%2Doverflow%3Aellipsis%3Bwhite%2Dspace%3Anowrap%7D%2Edl%2Dhorizontal%20dd%7Bmargin%2Dleft%3A180px%7D%7Dabbr%5Bdata%2Doriginal%2Dtitle%5D%2Cabbr%5Btitle%5D%7Bcursor%3Ahelp%3Bborder%2Dbottom%3A1px%20dotted%20%23777%7D%2Einitialism%7Bfont%2Dsize%3A90%25%3Btext%2Dtransform%3Auppercase%7Dblockquote%7Bpadding%3A10px%2020px%3Bmargin%3A0%200%2020px%3Bfont%2Dsize%3A17%2E5px%3Bborder%2Dleft%3A5px%20solid%20%23eee%7Dblockquote%20ol%3Alast%2Dchild%2Cblockquote%20p%3Alast%2Dchild%2Cblockquote%20ul%3Alast%2Dchild%7Bmargin%2Dbottom%3A0%7Dblockquote%20%2Esmall%2Cblockquote%20footer%2Cblockquote%20small%7Bdisplay%3Ablock%3Bfont%2Dsize%3A80%25%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23777%7Dblockquote%20%2Esmall%3Abefore%2Cblockquote%20footer%3Abefore%2Cblockquote%20small%3Abefore%7Bcontent%3A%27%5C2014%20%5C00A0%27%7D%2Eblockquote%2Dreverse%2Cblockquote%2Epull%2Dright%7Bpadding%2Dright%3A15px%3Bpadding%2Dleft%3A0%3Btext%2Dalign%3Aright%3Bborder%2Dright%3A5px%20solid%20%23eee%3Bborder%2Dleft%3A0%7D%2Eblockquote%2Dreverse%20%2Esmall%3Abefore%2C%2Eblockquote%2Dreverse%20footer%3Abefore%2C%2Eblockquote%2Dreverse%20small%3Abefore%2Cblockquote%2Epull%2Dright%20%2Esmall%3Abefore%2Cblockquote%2Epull%2Dright%20footer%3Abefore%2Cblockquote%2Epull%2Dright%20small%3Abefore%7Bcontent%3A%27%27%7D%2Eblockquote%2Dreverse%20%2Esmall%3Aafter%2C%2Eblockquote%2Dreverse%20footer%3Aafter%2C%2Eblockquote%2Dreverse%20small%3Aafter%2Cblockquote%2Epull%2Dright%20%2Esmall%3Aafter%2Cblockquote%2Epull%2Dright%20footer%3Aafter%2Cblockquote%2Epull%2Dright%20small%3Aafter%7Bcontent%3A%27%5C00A0%20%5C2014%27%7Daddress%7Bmargin%2Dbottom%3A20px%3Bfont%2Dstyle%3Anormal%3Bline%2Dheight%3A1%2E42857143%7Dcode%2Ckbd%2Cpre%2Csamp%7Bfont%2Dfamily%3Amonospace%7Dcode%7Bpadding%3A2px%204px%3Bfont%2Dsize%3A90%25%3Bcolor%3A%23c7254e%3Bbackground%2Dcolor%3A%23f9f2f4%3Bborder%2Dradius%3A4px%7Dkbd%7Bpadding%3A2px%204px%3Bfont%2Dsize%3A90%25%3Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23333%3Bborder%2Dradius%3A3px%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%20%2D1px%200%20rgba%280%2C0%2C0%2C%2E25%29%3Bbox%2Dshadow%3Ainset%200%20%2D1px%200%20rgba%280%2C0%2C0%2C%2E25%29%7Dkbd%20kbd%7Bpadding%3A0%3Bfont%2Dsize%3A100%25%3Bfont%2Dweight%3A700%3B%2Dwebkit%2Dbox%2Dshadow%3Anone%3Bbox%2Dshadow%3Anone%7Dpre%7Bdisplay%3Ablock%3Bpadding%3A9%2E5px%3Bmargin%3A0%200%2010px%3Bfont%2Dsize%3A13px%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23333%3Bword%2Dbreak%3Abreak%2Dall%3Bword%2Dwrap%3Abreak%2Dword%3Bbackground%2Dcolor%3A%23f5f5f5%3Bborder%3A1px%20solid%20%23ccc%3Bborder%2Dradius%3A4px%7Dpre%20code%7Bpadding%3A0%3Bfont%2Dsize%3Ainherit%3Bcolor%3Ainherit%3Bwhite%2Dspace%3Apre%2Dwrap%3Bbackground%2Dcolor%3Atransparent%3Bborder%2Dradius%3A0%7D%2Epre%2Dscrollable%7Bmax%2Dheight%3A340px%3Boverflow%2Dy%3Ascroll%7D%2Econtainer%7Bpadding%2Dright%3A15px%3Bpadding%2Dleft%3A15px%3Bmargin%2Dright%3Aauto%3Bmargin%2Dleft%3Aauto%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Econtainer%7Bwidth%3A750px%7D%7D%40media%20%28min%2Dwidth%3A992px%29%7B%2Econtainer%7Bwidth%3A970px%7D%7D%40media%20%28min%2Dwidth%3A1200px%29%7B%2Econtainer%7Bwidth%3A1170px%7D%7D%2Econtainer%2Dfluid%7Bpadding%2Dright%3A15px%3Bpadding%2Dleft%3A15px%3Bmargin%2Dright%3Aauto%3Bmargin%2Dleft%3Aauto%7D%2Erow%7Bmargin%2Dright%3A%2D15px%3Bmargin%2Dleft%3A%2D15px%7D%2Ecol%2Dlg%2D1%2C%2Ecol%2Dlg%2D10%2C%2Ecol%2Dlg%2D11%2C%2Ecol%2Dlg%2D12%2C%2Ecol%2Dlg%2D2%2C%2Ecol%2Dlg%2D3%2C%2Ecol%2Dlg%2D4%2C%2Ecol%2Dlg%2D5%2C%2Ecol%2Dlg%2D6%2C%2Ecol%2Dlg%2D7%2C%2Ecol%2Dlg%2D8%2C%2Ecol%2Dlg%2D9%2C%2Ecol%2Dmd%2D1%2C%2Ecol%2Dmd%2D10%2C%2Ecol%2Dmd%2D11%2C%2Ecol%2Dmd%2D12%2C%2Ecol%2Dmd%2D2%2C%2Ecol%2Dmd%2D3%2C%2Ecol%2Dmd%2D4%2C%2Ecol%2Dmd%2D5%2C%2Ecol%2Dmd%2D6%2C%2Ecol%2Dmd%2D7%2C%2Ecol%2Dmd%2D8%2C%2Ecol%2Dmd%2D9%2C%2Ecol%2Dsm%2D1%2C%2Ecol%2Dsm%2D10%2C%2Ecol%2Dsm%2D11%2C%2Ecol%2Dsm%2D12%2C%2Ecol%2Dsm%2D2%2C%2Ecol%2Dsm%2D3%2C%2Ecol%2Dsm%2D4%2C%2Ecol%2Dsm%2D5%2C%2Ecol%2Dsm%2D6%2C%2Ecol%2Dsm%2D7%2C%2Ecol%2Dsm%2D8%2C%2Ecol%2Dsm%2D9%2C%2Ecol%2Dxs%2D1%2C%2Ecol%2Dxs%2D10%2C%2Ecol%2Dxs%2D11%2C%2Ecol%2Dxs%2D12%2C%2Ecol%2Dxs%2D2%2C%2Ecol%2Dxs%2D3%2C%2Ecol%2Dxs%2D4%2C%2Ecol%2Dxs%2D5%2C%2Ecol%2Dxs%2D6%2C%2Ecol%2Dxs%2D7%2C%2Ecol%2Dxs%2D8%2C%2Ecol%2Dxs%2D9%7Bposition%3Arelative%3Bmin%2Dheight%3A1px%3Bpadding%2Dright%3A15px%3Bpadding%2Dleft%3A15px%7D%2Ecol%2Dxs%2D1%2C%2Ecol%2Dxs%2D10%2C%2Ecol%2Dxs%2D11%2C%2Ecol%2Dxs%2D12%2C%2Ecol%2Dxs%2D2%2C%2Ecol%2Dxs%2D3%2C%2Ecol%2Dxs%2D4%2C%2Ecol%2Dxs%2D5%2C%2Ecol%2Dxs%2D6%2C%2Ecol%2Dxs%2D7%2C%2Ecol%2Dxs%2D8%2C%2Ecol%2Dxs%2D9%7Bfloat%3Aleft%7D%2Ecol%2Dxs%2D12%7Bwidth%3A100%25%7D%2Ecol%2Dxs%2D11%7Bwidth%3A91%2E66666667%25%7D%2Ecol%2Dxs%2D10%7Bwidth%3A83%2E33333333%25%7D%2Ecol%2Dxs%2D9%7Bwidth%3A75%25%7D%2Ecol%2Dxs%2D8%7Bwidth%3A66%2E66666667%25%7D%2Ecol%2Dxs%2D7%7Bwidth%3A58%2E33333333%25%7D%2Ecol%2Dxs%2D6%7Bwidth%3A50%25%7D%2Ecol%2Dxs%2D5%7Bwidth%3A41%2E66666667%25%7D%2Ecol%2Dxs%2D4%7Bwidth%3A33%2E33333333%25%7D%2Ecol%2Dxs%2D3%7Bwidth%3A25%25%7D%2Ecol%2Dxs%2D2%7Bwidth%3A16%2E66666667%25%7D%2Ecol%2Dxs%2D1%7Bwidth%3A8%2E33333333%25%7D%2Ecol%2Dxs%2Dpull%2D12%7Bright%3A100%25%7D%2Ecol%2Dxs%2Dpull%2D11%7Bright%3A91%2E66666667%25%7D%2Ecol%2Dxs%2Dpull%2D10%7Bright%3A83%2E33333333%25%7D%2Ecol%2Dxs%2Dpull%2D9%7Bright%3A75%25%7D%2Ecol%2Dxs%2Dpull%2D8%7Bright%3A66%2E66666667%25%7D%2Ecol%2Dxs%2Dpull%2D7%7Bright%3A58%2E33333333%25%7D%2Ecol%2Dxs%2Dpull%2D6%7Bright%3A50%25%7D%2Ecol%2Dxs%2Dpull%2D5%7Bright%3A41%2E66666667%25%7D%2Ecol%2Dxs%2Dpull%2D4%7Bright%3A33%2E33333333%25%7D%2Ecol%2Dxs%2Dpull%2D3%7Bright%3A25%25%7D%2Ecol%2Dxs%2Dpull%2D2%7Bright%3A16%2E66666667%25%7D%2Ecol%2Dxs%2Dpull%2D1%7Bright%3A8%2E33333333%25%7D%2Ecol%2Dxs%2Dpull%2D0%7Bright%3Aauto%7D%2Ecol%2Dxs%2Dpush%2D12%7Bleft%3A100%25%7D%2Ecol%2Dxs%2Dpush%2D11%7Bleft%3A91%2E66666667%25%7D%2Ecol%2Dxs%2Dpush%2D10%7Bleft%3A83%2E33333333%25%7D%2Ecol%2Dxs%2Dpush%2D9%7Bleft%3A75%25%7D%2Ecol%2Dxs%2Dpush%2D8%7Bleft%3A66%2E66666667%25%7D%2Ecol%2Dxs%2Dpush%2D7%7Bleft%3A58%2E33333333%25%7D%2Ecol%2Dxs%2Dpush%2D6%7Bleft%3A50%25%7D%2Ecol%2Dxs%2Dpush%2D5%7Bleft%3A41%2E66666667%25%7D%2Ecol%2Dxs%2Dpush%2D4%7Bleft%3A33%2E33333333%25%7D%2Ecol%2Dxs%2Dpush%2D3%7Bleft%3A25%25%7D%2Ecol%2Dxs%2Dpush%2D2%7Bleft%3A16%2E66666667%25%7D%2Ecol%2Dxs%2Dpush%2D1%7Bleft%3A8%2E33333333%25%7D%2Ecol%2Dxs%2Dpush%2D0%7Bleft%3Aauto%7D%2Ecol%2Dxs%2Doffset%2D12%7Bmargin%2Dleft%3A100%25%7D%2Ecol%2Dxs%2Doffset%2D11%7Bmargin%2Dleft%3A91%2E66666667%25%7D%2Ecol%2Dxs%2Doffset%2D10%7Bmargin%2Dleft%3A83%2E33333333%25%7D%2Ecol%2Dxs%2Doffset%2D9%7Bmargin%2Dleft%3A75%25%7D%2Ecol%2Dxs%2Doffset%2D8%7Bmargin%2Dleft%3A66%2E66666667%25%7D%2Ecol%2Dxs%2Doffset%2D7%7Bmargin%2Dleft%3A58%2E33333333%25%7D%2Ecol%2Dxs%2Doffset%2D6%7Bmargin%2Dleft%3A50%25%7D%2Ecol%2Dxs%2Doffset%2D5%7Bmargin%2Dleft%3A41%2E66666667%25%7D%2Ecol%2Dxs%2Doffset%2D4%7Bmargin%2Dleft%3A33%2E33333333%25%7D%2Ecol%2Dxs%2Doffset%2D3%7Bmargin%2Dleft%3A25%25%7D%2Ecol%2Dxs%2Doffset%2D2%7Bmargin%2Dleft%3A16%2E66666667%25%7D%2Ecol%2Dxs%2Doffset%2D1%7Bmargin%2Dleft%3A8%2E33333333%25%7D%2Ecol%2Dxs%2Doffset%2D0%7Bmargin%2Dleft%3A0%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Ecol%2Dsm%2D1%2C%2Ecol%2Dsm%2D10%2C%2Ecol%2Dsm%2D11%2C%2Ecol%2Dsm%2D12%2C%2Ecol%2Dsm%2D2%2C%2Ecol%2Dsm%2D3%2C%2Ecol%2Dsm%2D4%2C%2Ecol%2Dsm%2D5%2C%2Ecol%2Dsm%2D6%2C%2Ecol%2Dsm%2D7%2C%2Ecol%2Dsm%2D8%2C%2Ecol%2Dsm%2D9%7Bfloat%3Aleft%7D%2Ecol%2Dsm%2D12%7Bwidth%3A100%25%7D%2Ecol%2Dsm%2D11%7Bwidth%3A91%2E66666667%25%7D%2Ecol%2Dsm%2D10%7Bwidth%3A83%2E33333333%25%7D%2Ecol%2Dsm%2D9%7Bwidth%3A75%25%7D%2Ecol%2Dsm%2D8%7Bwidth%3A66%2E66666667%25%7D%2Ecol%2Dsm%2D7%7Bwidth%3A58%2E33333333%25%7D%2Ecol%2Dsm%2D6%7Bwidth%3A50%25%7D%2Ecol%2Dsm%2D5%7Bwidth%3A41%2E66666667%25%7D%2Ecol%2Dsm%2D4%7Bwidth%3A33%2E33333333%25%7D%2Ecol%2Dsm%2D3%7Bwidth%3A25%25%7D%2Ecol%2Dsm%2D2%7Bwidth%3A16%2E66666667%25%7D%2Ecol%2Dsm%2D1%7Bwidth%3A8%2E33333333%25%7D%2Ecol%2Dsm%2Dpull%2D12%7Bright%3A100%25%7D%2Ecol%2Dsm%2Dpull%2D11%7Bright%3A91%2E66666667%25%7D%2Ecol%2Dsm%2Dpull%2D10%7Bright%3A83%2E33333333%25%7D%2Ecol%2Dsm%2Dpull%2D9%7Bright%3A75%25%7D%2Ecol%2Dsm%2Dpull%2D8%7Bright%3A66%2E66666667%25%7D%2Ecol%2Dsm%2Dpull%2D7%7Bright%3A58%2E33333333%25%7D%2Ecol%2Dsm%2Dpull%2D6%7Bright%3A50%25%7D%2Ecol%2Dsm%2Dpull%2D5%7Bright%3A41%2E66666667%25%7D%2Ecol%2Dsm%2Dpull%2D4%7Bright%3A33%2E33333333%25%7D%2Ecol%2Dsm%2Dpull%2D3%7Bright%3A25%25%7D%2Ecol%2Dsm%2Dpull%2D2%7Bright%3A16%2E66666667%25%7D%2Ecol%2Dsm%2Dpull%2D1%7Bright%3A8%2E33333333%25%7D%2Ecol%2Dsm%2Dpull%2D0%7Bright%3Aauto%7D%2Ecol%2Dsm%2Dpush%2D12%7Bleft%3A100%25%7D%2Ecol%2Dsm%2Dpush%2D11%7Bleft%3A91%2E66666667%25%7D%2Ecol%2Dsm%2Dpush%2D10%7Bleft%3A83%2E33333333%25%7D%2Ecol%2Dsm%2Dpush%2D9%7Bleft%3A75%25%7D%2Ecol%2Dsm%2Dpush%2D8%7Bleft%3A66%2E66666667%25%7D%2Ecol%2Dsm%2Dpush%2D7%7Bleft%3A58%2E33333333%25%7D%2Ecol%2Dsm%2Dpush%2D6%7Bleft%3A50%25%7D%2Ecol%2Dsm%2Dpush%2D5%7Bleft%3A41%2E66666667%25%7D%2Ecol%2Dsm%2Dpush%2D4%7Bleft%3A33%2E33333333%25%7D%2Ecol%2Dsm%2Dpush%2D3%7Bleft%3A25%25%7D%2Ecol%2Dsm%2Dpush%2D2%7Bleft%3A16%2E66666667%25%7D%2Ecol%2Dsm%2Dpush%2D1%7Bleft%3A8%2E33333333%25%7D%2Ecol%2Dsm%2Dpush%2D0%7Bleft%3Aauto%7D%2Ecol%2Dsm%2Doffset%2D12%7Bmargin%2Dleft%3A100%25%7D%2Ecol%2Dsm%2Doffset%2D11%7Bmargin%2Dleft%3A91%2E66666667%25%7D%2Ecol%2Dsm%2Doffset%2D10%7Bmargin%2Dleft%3A83%2E33333333%25%7D%2Ecol%2Dsm%2Doffset%2D9%7Bmargin%2Dleft%3A75%25%7D%2Ecol%2Dsm%2Doffset%2D8%7Bmargin%2Dleft%3A66%2E66666667%25%7D%2Ecol%2Dsm%2Doffset%2D7%7Bmargin%2Dleft%3A58%2E33333333%25%7D%2Ecol%2Dsm%2Doffset%2D6%7Bmargin%2Dleft%3A50%25%7D%2Ecol%2Dsm%2Doffset%2D5%7Bmargin%2Dleft%3A41%2E66666667%25%7D%2Ecol%2Dsm%2Doffset%2D4%7Bmargin%2Dleft%3A33%2E33333333%25%7D%2Ecol%2Dsm%2Doffset%2D3%7Bmargin%2Dleft%3A25%25%7D%2Ecol%2Dsm%2Doffset%2D2%7Bmargin%2Dleft%3A16%2E66666667%25%7D%2Ecol%2Dsm%2Doffset%2D1%7Bmargin%2Dleft%3A8%2E33333333%25%7D%2Ecol%2Dsm%2Doffset%2D0%7Bmargin%2Dleft%3A0%7D%7D%40media%20%28min%2Dwidth%3A992px%29%7B%2Ecol%2Dmd%2D1%2C%2Ecol%2Dmd%2D10%2C%2Ecol%2Dmd%2D11%2C%2Ecol%2Dmd%2D12%2C%2Ecol%2Dmd%2D2%2C%2Ecol%2Dmd%2D3%2C%2Ecol%2Dmd%2D4%2C%2Ecol%2Dmd%2D5%2C%2Ecol%2Dmd%2D6%2C%2Ecol%2Dmd%2D7%2C%2Ecol%2Dmd%2D8%2C%2Ecol%2Dmd%2D9%7Bfloat%3Aleft%7D%2Ecol%2Dmd%2D12%7Bwidth%3A100%25%7D%2Ecol%2Dmd%2D11%7Bwidth%3A91%2E66666667%25%7D%2Ecol%2Dmd%2D10%7Bwidth%3A83%2E33333333%25%7D%2Ecol%2Dmd%2D9%7Bwidth%3A75%25%7D%2Ecol%2Dmd%2D8%7Bwidth%3A66%2E66666667%25%7D%2Ecol%2Dmd%2D7%7Bwidth%3A58%2E33333333%25%7D%2Ecol%2Dmd%2D6%7Bwidth%3A50%25%7D%2Ecol%2Dmd%2D5%7Bwidth%3A41%2E66666667%25%7D%2Ecol%2Dmd%2D4%7Bwidth%3A33%2E33333333%25%7D%2Ecol%2Dmd%2D3%7Bwidth%3A25%25%7D%2Ecol%2Dmd%2D2%7Bwidth%3A16%2E66666667%25%7D%2Ecol%2Dmd%2D1%7Bwidth%3A8%2E33333333%25%7D%2Ecol%2Dmd%2Dpull%2D12%7Bright%3A100%25%7D%2Ecol%2Dmd%2Dpull%2D11%7Bright%3A91%2E66666667%25%7D%2Ecol%2Dmd%2Dpull%2D10%7Bright%3A83%2E33333333%25%7D%2Ecol%2Dmd%2Dpull%2D9%7Bright%3A75%25%7D%2Ecol%2Dmd%2Dpull%2D8%7Bright%3A66%2E66666667%25%7D%2Ecol%2Dmd%2Dpull%2D7%7Bright%3A58%2E33333333%25%7D%2Ecol%2Dmd%2Dpull%2D6%7Bright%3A50%25%7D%2Ecol%2Dmd%2Dpull%2D5%7Bright%3A41%2E66666667%25%7D%2Ecol%2Dmd%2Dpull%2D4%7Bright%3A33%2E33333333%25%7D%2Ecol%2Dmd%2Dpull%2D3%7Bright%3A25%25%7D%2Ecol%2Dmd%2Dpull%2D2%7Bright%3A16%2E66666667%25%7D%2Ecol%2Dmd%2Dpull%2D1%7Bright%3A8%2E33333333%25%7D%2Ecol%2Dmd%2Dpull%2D0%7Bright%3Aauto%7D%2Ecol%2Dmd%2Dpush%2D12%7Bleft%3A100%25%7D%2Ecol%2Dmd%2Dpush%2D11%7Bleft%3A91%2E66666667%25%7D%2Ecol%2Dmd%2Dpush%2D10%7Bleft%3A83%2E33333333%25%7D%2Ecol%2Dmd%2Dpush%2D9%7Bleft%3A75%25%7D%2Ecol%2Dmd%2Dpush%2D8%7Bleft%3A66%2E66666667%25%7D%2Ecol%2Dmd%2Dpush%2D7%7Bleft%3A58%2E33333333%25%7D%2Ecol%2Dmd%2Dpush%2D6%7Bleft%3A50%25%7D%2Ecol%2Dmd%2Dpush%2D5%7Bleft%3A41%2E66666667%25%7D%2Ecol%2Dmd%2Dpush%2D4%7Bleft%3A33%2E33333333%25%7D%2Ecol%2Dmd%2Dpush%2D3%7Bleft%3A25%25%7D%2Ecol%2Dmd%2Dpush%2D2%7Bleft%3A16%2E66666667%25%7D%2Ecol%2Dmd%2Dpush%2D1%7Bleft%3A8%2E33333333%25%7D%2Ecol%2Dmd%2Dpush%2D0%7Bleft%3Aauto%7D%2Ecol%2Dmd%2Doffset%2D12%7Bmargin%2Dleft%3A100%25%7D%2Ecol%2Dmd%2Doffset%2D11%7Bmargin%2Dleft%3A91%2E66666667%25%7D%2Ecol%2Dmd%2Doffset%2D10%7Bmargin%2Dleft%3A83%2E33333333%25%7D%2Ecol%2Dmd%2Doffset%2D9%7Bmargin%2Dleft%3A75%25%7D%2Ecol%2Dmd%2Doffset%2D8%7Bmargin%2Dleft%3A66%2E66666667%25%7D%2Ecol%2Dmd%2Doffset%2D7%7Bmargin%2Dleft%3A58%2E33333333%25%7D%2Ecol%2Dmd%2Doffset%2D6%7Bmargin%2Dleft%3A50%25%7D%2Ecol%2Dmd%2Doffset%2D5%7Bmargin%2Dleft%3A41%2E66666667%25%7D%2Ecol%2Dmd%2Doffset%2D4%7Bmargin%2Dleft%3A33%2E33333333%25%7D%2Ecol%2Dmd%2Doffset%2D3%7Bmargin%2Dleft%3A25%25%7D%2Ecol%2Dmd%2Doffset%2D2%7Bmargin%2Dleft%3A16%2E66666667%25%7D%2Ecol%2Dmd%2Doffset%2D1%7Bmargin%2Dleft%3A8%2E33333333%25%7D%2Ecol%2Dmd%2Doffset%2D0%7Bmargin%2Dleft%3A0%7D%7D%40media%20%28min%2Dwidth%3A1200px%29%7B%2Ecol%2Dlg%2D1%2C%2Ecol%2Dlg%2D10%2C%2Ecol%2Dlg%2D11%2C%2Ecol%2Dlg%2D12%2C%2Ecol%2Dlg%2D2%2C%2Ecol%2Dlg%2D3%2C%2Ecol%2Dlg%2D4%2C%2Ecol%2Dlg%2D5%2C%2Ecol%2Dlg%2D6%2C%2Ecol%2Dlg%2D7%2C%2Ecol%2Dlg%2D8%2C%2Ecol%2Dlg%2D9%7Bfloat%3Aleft%7D%2Ecol%2Dlg%2D12%7Bwidth%3A100%25%7D%2Ecol%2Dlg%2D11%7Bwidth%3A91%2E66666667%25%7D%2Ecol%2Dlg%2D10%7Bwidth%3A83%2E33333333%25%7D%2Ecol%2Dlg%2D9%7Bwidth%3A75%25%7D%2Ecol%2Dlg%2D8%7Bwidth%3A66%2E66666667%25%7D%2Ecol%2Dlg%2D7%7Bwidth%3A58%2E33333333%25%7D%2Ecol%2Dlg%2D6%7Bwidth%3A50%25%7D%2Ecol%2Dlg%2D5%7Bwidth%3A41%2E66666667%25%7D%2Ecol%2Dlg%2D4%7Bwidth%3A33%2E33333333%25%7D%2Ecol%2Dlg%2D3%7Bwidth%3A25%25%7D%2Ecol%2Dlg%2D2%7Bwidth%3A16%2E66666667%25%7D%2Ecol%2Dlg%2D1%7Bwidth%3A8%2E33333333%25%7D%2Ecol%2Dlg%2Dpull%2D12%7Bright%3A100%25%7D%2Ecol%2Dlg%2Dpull%2D11%7Bright%3A91%2E66666667%25%7D%2Ecol%2Dlg%2Dpull%2D10%7Bright%3A83%2E33333333%25%7D%2Ecol%2Dlg%2Dpull%2D9%7Bright%3A75%25%7D%2Ecol%2Dlg%2Dpull%2D8%7Bright%3A66%2E66666667%25%7D%2Ecol%2Dlg%2Dpull%2D7%7Bright%3A58%2E33333333%25%7D%2Ecol%2Dlg%2Dpull%2D6%7Bright%3A50%25%7D%2Ecol%2Dlg%2Dpull%2D5%7Bright%3A41%2E66666667%25%7D%2Ecol%2Dlg%2Dpull%2D4%7Bright%3A33%2E33333333%25%7D%2Ecol%2Dlg%2Dpull%2D3%7Bright%3A25%25%7D%2Ecol%2Dlg%2Dpull%2D2%7Bright%3A16%2E66666667%25%7D%2Ecol%2Dlg%2Dpull%2D1%7Bright%3A8%2E33333333%25%7D%2Ecol%2Dlg%2Dpull%2D0%7Bright%3Aauto%7D%2Ecol%2Dlg%2Dpush%2D12%7Bleft%3A100%25%7D%2Ecol%2Dlg%2Dpush%2D11%7Bleft%3A91%2E66666667%25%7D%2Ecol%2Dlg%2Dpush%2D10%7Bleft%3A83%2E33333333%25%7D%2Ecol%2Dlg%2Dpush%2D9%7Bleft%3A75%25%7D%2Ecol%2Dlg%2Dpush%2D8%7Bleft%3A66%2E66666667%25%7D%2Ecol%2Dlg%2Dpush%2D7%7Bleft%3A58%2E33333333%25%7D%2Ecol%2Dlg%2Dpush%2D6%7Bleft%3A50%25%7D%2Ecol%2Dlg%2Dpush%2D5%7Bleft%3A41%2E66666667%25%7D%2Ecol%2Dlg%2Dpush%2D4%7Bleft%3A33%2E33333333%25%7D%2Ecol%2Dlg%2Dpush%2D3%7Bleft%3A25%25%7D%2Ecol%2Dlg%2Dpush%2D2%7Bleft%3A16%2E66666667%25%7D%2Ecol%2Dlg%2Dpush%2D1%7Bleft%3A8%2E33333333%25%7D%2Ecol%2Dlg%2Dpush%2D0%7Bleft%3Aauto%7D%2Ecol%2Dlg%2Doffset%2D12%7Bmargin%2Dleft%3A100%25%7D%2Ecol%2Dlg%2Doffset%2D11%7Bmargin%2Dleft%3A91%2E66666667%25%7D%2Ecol%2Dlg%2Doffset%2D10%7Bmargin%2Dleft%3A83%2E33333333%25%7D%2Ecol%2Dlg%2Doffset%2D9%7Bmargin%2Dleft%3A75%25%7D%2Ecol%2Dlg%2Doffset%2D8%7Bmargin%2Dleft%3A66%2E66666667%25%7D%2Ecol%2Dlg%2Doffset%2D7%7Bmargin%2Dleft%3A58%2E33333333%25%7D%2Ecol%2Dlg%2Doffset%2D6%7Bmargin%2Dleft%3A50%25%7D%2Ecol%2Dlg%2Doffset%2D5%7Bmargin%2Dleft%3A41%2E66666667%25%7D%2Ecol%2Dlg%2Doffset%2D4%7Bmargin%2Dleft%3A33%2E33333333%25%7D%2Ecol%2Dlg%2Doffset%2D3%7Bmargin%2Dleft%3A25%25%7D%2Ecol%2Dlg%2Doffset%2D2%7Bmargin%2Dleft%3A16%2E66666667%25%7D%2Ecol%2Dlg%2Doffset%2D1%7Bmargin%2Dleft%3A8%2E33333333%25%7D%2Ecol%2Dlg%2Doffset%2D0%7Bmargin%2Dleft%3A0%7D%7Dtable%7Bbackground%2Dcolor%3Atransparent%7Dcaption%7Bpadding%2Dtop%3A8px%3Bpadding%2Dbottom%3A8px%3Bcolor%3A%23777%3Btext%2Dalign%3Aleft%7Dth%7B%7D%2Etable%7Bwidth%3A100%25%3Bmax%2Dwidth%3A100%25%3Bmargin%2Dbottom%3A20px%7D%2Etable%3Etbody%3Etr%3Etd%2C%2Etable%3Etbody%3Etr%3Eth%2C%2Etable%3Etfoot%3Etr%3Etd%2C%2Etable%3Etfoot%3Etr%3Eth%2C%2Etable%3Ethead%3Etr%3Etd%2C%2Etable%3Ethead%3Etr%3Eth%7Bpadding%3A8px%3Bline%2Dheight%3A1%2E42857143%3Bvertical%2Dalign%3Atop%3Bborder%2Dtop%3A1px%20solid%20%23ddd%7D%2Etable%3Ethead%3Etr%3Eth%7Bvertical%2Dalign%3Abottom%3Bborder%2Dbottom%3A2px%20solid%20%23ddd%7D%2Etable%3Ecaption%2Bthead%3Etr%3Afirst%2Dchild%3Etd%2C%2Etable%3Ecaption%2Bthead%3Etr%3Afirst%2Dchild%3Eth%2C%2Etable%3Ecolgroup%2Bthead%3Etr%3Afirst%2Dchild%3Etd%2C%2Etable%3Ecolgroup%2Bthead%3Etr%3Afirst%2Dchild%3Eth%2C%2Etable%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%3Etd%2C%2Etable%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%3Eth%7Bborder%2Dtop%3A0%7D%2Etable%3Etbody%2Btbody%7Bborder%2Dtop%3A2px%20solid%20%23ddd%7D%2Etable%20%2Etable%7Bbackground%2Dcolor%3A%23fff%7D%2Etable%2Dcondensed%3Etbody%3Etr%3Etd%2C%2Etable%2Dcondensed%3Etbody%3Etr%3Eth%2C%2Etable%2Dcondensed%3Etfoot%3Etr%3Etd%2C%2Etable%2Dcondensed%3Etfoot%3Etr%3Eth%2C%2Etable%2Dcondensed%3Ethead%3Etr%3Etd%2C%2Etable%2Dcondensed%3Ethead%3Etr%3Eth%7Bpadding%3A5px%7D%2Etable%2Dbordered%7Bborder%3A1px%20solid%20%23ddd%7D%2Etable%2Dbordered%3Etbody%3Etr%3Etd%2C%2Etable%2Dbordered%3Etbody%3Etr%3Eth%2C%2Etable%2Dbordered%3Etfoot%3Etr%3Etd%2C%2Etable%2Dbordered%3Etfoot%3Etr%3Eth%2C%2Etable%2Dbordered%3Ethead%3Etr%3Etd%2C%2Etable%2Dbordered%3Ethead%3Etr%3Eth%7Bborder%3A1px%20solid%20%23ddd%7D%2Etable%2Dbordered%3Ethead%3Etr%3Etd%2C%2Etable%2Dbordered%3Ethead%3Etr%3Eth%7Bborder%2Dbottom%2Dwidth%3A2px%7D%2Etable%2Dstriped%3Etbody%3Etr%3Anth%2Dof%2Dtype%28odd%29%7Bbackground%2Dcolor%3A%23f9f9f9%7D%2Etable%2Dhover%3Etbody%3Etr%3Ahover%7Bbackground%2Dcolor%3A%23f5f5f5%7Dtable%20col%5Bclass%2A%3Dcol%2D%5D%7Bposition%3Astatic%3Bdisplay%3Atable%2Dcolumn%3Bfloat%3Anone%7Dtable%20td%5Bclass%2A%3Dcol%2D%5D%2Ctable%20th%5Bclass%2A%3Dcol%2D%5D%7Bposition%3Astatic%3Bdisplay%3Atable%2Dcell%3Bfloat%3Anone%7D%2Etable%3Etbody%3Etr%2Eactive%3Etd%2C%2Etable%3Etbody%3Etr%2Eactive%3Eth%2C%2Etable%3Etbody%3Etr%3Etd%2Eactive%2C%2Etable%3Etbody%3Etr%3Eth%2Eactive%2C%2Etable%3Etfoot%3Etr%2Eactive%3Etd%2C%2Etable%3Etfoot%3Etr%2Eactive%3Eth%2C%2Etable%3Etfoot%3Etr%3Etd%2Eactive%2C%2Etable%3Etfoot%3Etr%3Eth%2Eactive%2C%2Etable%3Ethead%3Etr%2Eactive%3Etd%2C%2Etable%3Ethead%3Etr%2Eactive%3Eth%2C%2Etable%3Ethead%3Etr%3Etd%2Eactive%2C%2Etable%3Ethead%3Etr%3Eth%2Eactive%7Bbackground%2Dcolor%3A%23f5f5f5%7D%2Etable%2Dhover%3Etbody%3Etr%2Eactive%3Ahover%3Etd%2C%2Etable%2Dhover%3Etbody%3Etr%2Eactive%3Ahover%3Eth%2C%2Etable%2Dhover%3Etbody%3Etr%3Ahover%3E%2Eactive%2C%2Etable%2Dhover%3Etbody%3Etr%3Etd%2Eactive%3Ahover%2C%2Etable%2Dhover%3Etbody%3Etr%3Eth%2Eactive%3Ahover%7Bbackground%2Dcolor%3A%23e8e8e8%7D%2Etable%3Etbody%3Etr%2Esuccess%3Etd%2C%2Etable%3Etbody%3Etr%2Esuccess%3Eth%2C%2Etable%3Etbody%3Etr%3Etd%2Esuccess%2C%2Etable%3Etbody%3Etr%3Eth%2Esuccess%2C%2Etable%3Etfoot%3Etr%2Esuccess%3Etd%2C%2Etable%3Etfoot%3Etr%2Esuccess%3Eth%2C%2Etable%3Etfoot%3Etr%3Etd%2Esuccess%2C%2Etable%3Etfoot%3Etr%3Eth%2Esuccess%2C%2Etable%3Ethead%3Etr%2Esuccess%3Etd%2C%2Etable%3Ethead%3Etr%2Esuccess%3Eth%2C%2Etable%3Ethead%3Etr%3Etd%2Esuccess%2C%2Etable%3Ethead%3Etr%3Eth%2Esuccess%7Bbackground%2Dcolor%3A%23dff0d8%7D%2Etable%2Dhover%3Etbody%3Etr%2Esuccess%3Ahover%3Etd%2C%2Etable%2Dhover%3Etbody%3Etr%2Esuccess%3Ahover%3Eth%2C%2Etable%2Dhover%3Etbody%3Etr%3Ahover%3E%2Esuccess%2C%2Etable%2Dhover%3Etbody%3Etr%3Etd%2Esuccess%3Ahover%2C%2Etable%2Dhover%3Etbody%3Etr%3Eth%2Esuccess%3Ahover%7Bbackground%2Dcolor%3A%23d0e9c6%7D%2Etable%3Etbody%3Etr%2Einfo%3Etd%2C%2Etable%3Etbody%3Etr%2Einfo%3Eth%2C%2Etable%3Etbody%3Etr%3Etd%2Einfo%2C%2Etable%3Etbody%3Etr%3Eth%2Einfo%2C%2Etable%3Etfoot%3Etr%2Einfo%3Etd%2C%2Etable%3Etfoot%3Etr%2Einfo%3Eth%2C%2Etable%3Etfoot%3Etr%3Etd%2Einfo%2C%2Etable%3Etfoot%3Etr%3Eth%2Einfo%2C%2Etable%3Ethead%3Etr%2Einfo%3Etd%2C%2Etable%3Ethead%3Etr%2Einfo%3Eth%2C%2Etable%3Ethead%3Etr%3Etd%2Einfo%2C%2Etable%3Ethead%3Etr%3Eth%2Einfo%7Bbackground%2Dcolor%3A%23d9edf7%7D%2Etable%2Dhover%3Etbody%3Etr%2Einfo%3Ahover%3Etd%2C%2Etable%2Dhover%3Etbody%3Etr%2Einfo%3Ahover%3Eth%2C%2Etable%2Dhover%3Etbody%3Etr%3Ahover%3E%2Einfo%2C%2Etable%2Dhover%3Etbody%3Etr%3Etd%2Einfo%3Ahover%2C%2Etable%2Dhover%3Etbody%3Etr%3Eth%2Einfo%3Ahover%7Bbackground%2Dcolor%3A%23c4e3f3%7D%2Etable%3Etbody%3Etr%2Ewarning%3Etd%2C%2Etable%3Etbody%3Etr%2Ewarning%3Eth%2C%2Etable%3Etbody%3Etr%3Etd%2Ewarning%2C%2Etable%3Etbody%3Etr%3Eth%2Ewarning%2C%2Etable%3Etfoot%3Etr%2Ewarning%3Etd%2C%2Etable%3Etfoot%3Etr%2Ewarning%3Eth%2C%2Etable%3Etfoot%3Etr%3Etd%2Ewarning%2C%2Etable%3Etfoot%3Etr%3Eth%2Ewarning%2C%2Etable%3Ethead%3Etr%2Ewarning%3Etd%2C%2Etable%3Ethead%3Etr%2Ewarning%3Eth%2C%2Etable%3Ethead%3Etr%3Etd%2Ewarning%2C%2Etable%3Ethead%3Etr%3Eth%2Ewarning%7Bbackground%2Dcolor%3A%23fcf8e3%7D%2Etable%2Dhover%3Etbody%3Etr%2Ewarning%3Ahover%3Etd%2C%2Etable%2Dhover%3Etbody%3Etr%2Ewarning%3Ahover%3Eth%2C%2Etable%2Dhover%3Etbody%3Etr%3Ahover%3E%2Ewarning%2C%2Etable%2Dhover%3Etbody%3Etr%3Etd%2Ewarning%3Ahover%2C%2Etable%2Dhover%3Etbody%3Etr%3Eth%2Ewarning%3Ahover%7Bbackground%2Dcolor%3A%23faf2cc%7D%2Etable%3Etbody%3Etr%2Edanger%3Etd%2C%2Etable%3Etbody%3Etr%2Edanger%3Eth%2C%2Etable%3Etbody%3Etr%3Etd%2Edanger%2C%2Etable%3Etbody%3Etr%3Eth%2Edanger%2C%2Etable%3Etfoot%3Etr%2Edanger%3Etd%2C%2Etable%3Etfoot%3Etr%2Edanger%3Eth%2C%2Etable%3Etfoot%3Etr%3Etd%2Edanger%2C%2Etable%3Etfoot%3Etr%3Eth%2Edanger%2C%2Etable%3Ethead%3Etr%2Edanger%3Etd%2C%2Etable%3Ethead%3Etr%2Edanger%3Eth%2C%2Etable%3Ethead%3Etr%3Etd%2Edanger%2C%2Etable%3Ethead%3Etr%3Eth%2Edanger%7Bbackground%2Dcolor%3A%23f2dede%7D%2Etable%2Dhover%3Etbody%3Etr%2Edanger%3Ahover%3Etd%2C%2Etable%2Dhover%3Etbody%3Etr%2Edanger%3Ahover%3Eth%2C%2Etable%2Dhover%3Etbody%3Etr%3Ahover%3E%2Edanger%2C%2Etable%2Dhover%3Etbody%3Etr%3Etd%2Edanger%3Ahover%2C%2Etable%2Dhover%3Etbody%3Etr%3Eth%2Edanger%3Ahover%7Bbackground%2Dcolor%3A%23ebcccc%7D%2Etable%2Dresponsive%7Bmin%2Dheight%3A%2E01%25%3Boverflow%2Dx%3Aauto%7D%40media%20screen%20and%20%28max%2Dwidth%3A767px%29%7B%2Etable%2Dresponsive%7Bwidth%3A100%25%3Bmargin%2Dbottom%3A15px%3Boverflow%2Dy%3Ahidden%3B%2Dms%2Doverflow%2Dstyle%3A%2Dms%2Dautohiding%2Dscrollbar%3Bborder%3A1px%20solid%20%23ddd%7D%2Etable%2Dresponsive%3E%2Etable%7Bmargin%2Dbottom%3A0%7D%2Etable%2Dresponsive%3E%2Etable%3Etbody%3Etr%3Etd%2C%2Etable%2Dresponsive%3E%2Etable%3Etbody%3Etr%3Eth%2C%2Etable%2Dresponsive%3E%2Etable%3Etfoot%3Etr%3Etd%2C%2Etable%2Dresponsive%3E%2Etable%3Etfoot%3Etr%3Eth%2C%2Etable%2Dresponsive%3E%2Etable%3Ethead%3Etr%3Etd%2C%2Etable%2Dresponsive%3E%2Etable%3Ethead%3Etr%3Eth%7Bwhite%2Dspace%3Anowrap%7D%2Etable%2Dresponsive%3E%2Etable%2Dbordered%7Bborder%3A0%7D%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Etd%3Afirst%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Eth%3Afirst%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Etd%3Afirst%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Eth%3Afirst%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Etd%3Afirst%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Eth%3Afirst%2Dchild%7Bborder%2Dleft%3A0%7D%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Etd%3Alast%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Eth%3Alast%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Etd%3Alast%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Eth%3Alast%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Etd%3Alast%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Eth%3Alast%2Dchild%7Bborder%2Dright%3A0%7D%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Alast%2Dchild%3Etd%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Alast%2Dchild%3Eth%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Alast%2Dchild%3Etd%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Alast%2Dchild%3Eth%7Bborder%2Dbottom%3A0%7D%7Dfieldset%7Bmin%2Dwidth%3A0%3Bpadding%3A0%3Bmargin%3A0%3Bborder%3A0%7Dlegend%7Bdisplay%3Ablock%3Bwidth%3A100%25%3Bpadding%3A0%3Bmargin%2Dbottom%3A20px%3Bfont%2Dsize%3A21px%3Bline%2Dheight%3Ainherit%3Bcolor%3A%23333%3Bborder%3A0%3Bborder%2Dbottom%3A1px%20solid%20%23e5e5e5%7Dlabel%7Bdisplay%3Ainline%2Dblock%3Bmax%2Dwidth%3A100%25%3Bmargin%2Dbottom%3A5px%3Bfont%2Dweight%3A700%7Dinput%5Btype%3Dsearch%5D%7B%2Dwebkit%2Dbox%2Dsizing%3Aborder%2Dbox%3B%2Dmoz%2Dbox%2Dsizing%3Aborder%2Dbox%3Bbox%2Dsizing%3Aborder%2Dbox%7Dinput%5Btype%3Dcheckbox%5D%2Cinput%5Btype%3Dradio%5D%7Bmargin%3A4px%200%200%3Bmargin%2Dtop%3A1px%5C9%3Bline%2Dheight%3Anormal%7Dinput%5Btype%3Dfile%5D%7Bdisplay%3Ablock%7Dinput%5Btype%3Drange%5D%7Bdisplay%3Ablock%3Bwidth%3A100%25%7Dselect%5Bmultiple%5D%2Cselect%5Bsize%5D%7Bheight%3Aauto%7Dinput%5Btype%3Dfile%5D%3Afocus%2Cinput%5Btype%3Dcheckbox%5D%3Afocus%2Cinput%5Btype%3Dradio%5D%3Afocus%7Boutline%3Athin%20dotted%3Boutline%3A5px%20auto%20%2Dwebkit%2Dfocus%2Dring%2Dcolor%3Boutline%2Doffset%3A%2D2px%7Doutput%7Bdisplay%3Ablock%3Bpadding%2Dtop%3A7px%3Bfont%2Dsize%3A14px%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23555%7D%2Eform%2Dcontrol%7Bdisplay%3Ablock%3Bwidth%3A100%25%3Bheight%3A34px%3Bpadding%3A6px%2012px%3Bfont%2Dsize%3A14px%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23555%3Bbackground%2Dcolor%3A%23fff%3Bbackground%2Dimage%3Anone%3Bborder%3A1px%20solid%20%23ccc%3Bborder%2Dradius%3A4px%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%3B%2Dwebkit%2Dtransition%3Aborder%2Dcolor%20ease%2Din%2Dout%20%2E15s%2C%2Dwebkit%2Dbox%2Dshadow%20ease%2Din%2Dout%20%2E15s%3B%2Do%2Dtransition%3Aborder%2Dcolor%20ease%2Din%2Dout%20%2E15s%2Cbox%2Dshadow%20ease%2Din%2Dout%20%2E15s%3Btransition%3Aborder%2Dcolor%20ease%2Din%2Dout%20%2E15s%2Cbox%2Dshadow%20ease%2Din%2Dout%20%2E15s%7D%2Eform%2Dcontrol%3Afocus%7Bborder%2Dcolor%3A%2366afe9%3Boutline%3A0%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%208px%20rgba%28102%2C175%2C233%2C%2E6%29%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%208px%20rgba%28102%2C175%2C233%2C%2E6%29%7D%2Eform%2Dcontrol%3A%3A%2Dmoz%2Dplaceholder%7Bcolor%3A%23999%3Bopacity%3A1%7D%2Eform%2Dcontrol%3A%2Dms%2Dinput%2Dplaceholder%7Bcolor%3A%23999%7D%2Eform%2Dcontrol%3A%3A%2Dwebkit%2Dinput%2Dplaceholder%7Bcolor%3A%23999%7D%2Eform%2Dcontrol%5Bdisabled%5D%2C%2Eform%2Dcontrol%5Breadonly%5D%2Cfieldset%5Bdisabled%5D%20%2Eform%2Dcontrol%7Bbackground%2Dcolor%3A%23eee%3Bopacity%3A1%7D%2Eform%2Dcontrol%5Bdisabled%5D%2Cfieldset%5Bdisabled%5D%20%2Eform%2Dcontrol%7Bcursor%3Anot%2Dallowed%7Dtextarea%2Eform%2Dcontrol%7Bheight%3Aauto%7Dinput%5Btype%3Dsearch%5D%7B%2Dwebkit%2Dappearance%3Anone%7D%40media%20screen%20and%20%28%2Dwebkit%2Dmin%2Ddevice%2Dpixel%2Dratio%3A0%29%7Binput%5Btype%3Ddate%5D%2Eform%2Dcontrol%2Cinput%5Btype%3Dtime%5D%2Eform%2Dcontrol%2Cinput%5Btype%3Ddatetime%2Dlocal%5D%2Eform%2Dcontrol%2Cinput%5Btype%3Dmonth%5D%2Eform%2Dcontrol%7Bline%2Dheight%3A34px%7D%2Einput%2Dgroup%2Dsm%20input%5Btype%3Ddate%5D%2C%2Einput%2Dgroup%2Dsm%20input%5Btype%3Dtime%5D%2C%2Einput%2Dgroup%2Dsm%20input%5Btype%3Ddatetime%2Dlocal%5D%2C%2Einput%2Dgroup%2Dsm%20input%5Btype%3Dmonth%5D%2Cinput%5Btype%3Ddate%5D%2Einput%2Dsm%2Cinput%5Btype%3Dtime%5D%2Einput%2Dsm%2Cinput%5Btype%3Ddatetime%2Dlocal%5D%2Einput%2Dsm%2Cinput%5Btype%3Dmonth%5D%2Einput%2Dsm%7Bline%2Dheight%3A30px%7D%2Einput%2Dgroup%2Dlg%20input%5Btype%3Ddate%5D%2C%2Einput%2Dgroup%2Dlg%20input%5Btype%3Dtime%5D%2C%2Einput%2Dgroup%2Dlg%20input%5Btype%3Ddatetime%2Dlocal%5D%2C%2Einput%2Dgroup%2Dlg%20input%5Btype%3Dmonth%5D%2Cinput%5Btype%3Ddate%5D%2Einput%2Dlg%2Cinput%5Btype%3Dtime%5D%2Einput%2Dlg%2Cinput%5Btype%3Ddatetime%2Dlocal%5D%2Einput%2Dlg%2Cinput%5Btype%3Dmonth%5D%2Einput%2Dlg%7Bline%2Dheight%3A46px%7D%7D%2Eform%2Dgroup%7Bmargin%2Dbottom%3A15px%7D%2Echeckbox%2C%2Eradio%7Bposition%3Arelative%3Bdisplay%3Ablock%3Bmargin%2Dtop%3A10px%3Bmargin%2Dbottom%3A10px%7D%2Echeckbox%20label%2C%2Eradio%20label%7Bmin%2Dheight%3A20px%3Bpadding%2Dleft%3A20px%3Bmargin%2Dbottom%3A0%3Bfont%2Dweight%3A400%3Bcursor%3Apointer%7D%2Echeckbox%20input%5Btype%3Dcheckbox%5D%2C%2Echeckbox%2Dinline%20input%5Btype%3Dcheckbox%5D%2C%2Eradio%20input%5Btype%3Dradio%5D%2C%2Eradio%2Dinline%20input%5Btype%3Dradio%5D%7Bposition%3Aabsolute%3Bmargin%2Dtop%3A4px%5C9%3Bmargin%2Dleft%3A%2D20px%7D%2Echeckbox%2B%2Echeckbox%2C%2Eradio%2B%2Eradio%7Bmargin%2Dtop%3A%2D5px%7D%2Echeckbox%2Dinline%2C%2Eradio%2Dinline%7Bposition%3Arelative%3Bdisplay%3Ainline%2Dblock%3Bpadding%2Dleft%3A20px%3Bmargin%2Dbottom%3A0%3Bfont%2Dweight%3A400%3Bvertical%2Dalign%3Amiddle%3Bcursor%3Apointer%7D%2Echeckbox%2Dinline%2B%2Echeckbox%2Dinline%2C%2Eradio%2Dinline%2B%2Eradio%2Dinline%7Bmargin%2Dtop%3A0%3Bmargin%2Dleft%3A10px%7Dfieldset%5Bdisabled%5D%20input%5Btype%3Dcheckbox%5D%2Cfieldset%5Bdisabled%5D%20input%5Btype%3Dradio%5D%2Cinput%5Btype%3Dcheckbox%5D%2Edisabled%2Cinput%5Btype%3Dcheckbox%5D%5Bdisabled%5D%2Cinput%5Btype%3Dradio%5D%2Edisabled%2Cinput%5Btype%3Dradio%5D%5Bdisabled%5D%7Bcursor%3Anot%2Dallowed%7D%2Echeckbox%2Dinline%2Edisabled%2C%2Eradio%2Dinline%2Edisabled%2Cfieldset%5Bdisabled%5D%20%2Echeckbox%2Dinline%2Cfieldset%5Bdisabled%5D%20%2Eradio%2Dinline%7Bcursor%3Anot%2Dallowed%7D%2Echeckbox%2Edisabled%20label%2C%2Eradio%2Edisabled%20label%2Cfieldset%5Bdisabled%5D%20%2Echeckbox%20label%2Cfieldset%5Bdisabled%5D%20%2Eradio%20label%7Bcursor%3Anot%2Dallowed%7D%2Eform%2Dcontrol%2Dstatic%7Bmin%2Dheight%3A34px%3Bpadding%2Dtop%3A7px%3Bpadding%2Dbottom%3A7px%3Bmargin%2Dbottom%3A0%7D%2Eform%2Dcontrol%2Dstatic%2Einput%2Dlg%2C%2Eform%2Dcontrol%2Dstatic%2Einput%2Dsm%7Bpadding%2Dright%3A0%3Bpadding%2Dleft%3A0%7D%2Einput%2Dsm%7Bheight%3A30px%3Bpadding%3A5px%2010px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E5%3Bborder%2Dradius%3A3px%7Dselect%2Einput%2Dsm%7Bheight%3A30px%3Bline%2Dheight%3A30px%7Dselect%5Bmultiple%5D%2Einput%2Dsm%2Ctextarea%2Einput%2Dsm%7Bheight%3Aauto%7D%2Eform%2Dgroup%2Dsm%20%2Eform%2Dcontrol%7Bheight%3A30px%3Bpadding%3A5px%2010px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E5%3Bborder%2Dradius%3A3px%7D%2Eform%2Dgroup%2Dsm%20select%2Eform%2Dcontrol%7Bheight%3A30px%3Bline%2Dheight%3A30px%7D%2Eform%2Dgroup%2Dsm%20select%5Bmultiple%5D%2Eform%2Dcontrol%2C%2Eform%2Dgroup%2Dsm%20textarea%2Eform%2Dcontrol%7Bheight%3Aauto%7D%2Eform%2Dgroup%2Dsm%20%2Eform%2Dcontrol%2Dstatic%7Bheight%3A30px%3Bmin%2Dheight%3A32px%3Bpadding%3A6px%2010px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E5%7D%2Einput%2Dlg%7Bheight%3A46px%3Bpadding%3A10px%2016px%3Bfont%2Dsize%3A18px%3Bline%2Dheight%3A1%2E3333333%3Bborder%2Dradius%3A6px%7Dselect%2Einput%2Dlg%7Bheight%3A46px%3Bline%2Dheight%3A46px%7Dselect%5Bmultiple%5D%2Einput%2Dlg%2Ctextarea%2Einput%2Dlg%7Bheight%3Aauto%7D%2Eform%2Dgroup%2Dlg%20%2Eform%2Dcontrol%7Bheight%3A46px%3Bpadding%3A10px%2016px%3Bfont%2Dsize%3A18px%3Bline%2Dheight%3A1%2E3333333%3Bborder%2Dradius%3A6px%7D%2Eform%2Dgroup%2Dlg%20select%2Eform%2Dcontrol%7Bheight%3A46px%3Bline%2Dheight%3A46px%7D%2Eform%2Dgroup%2Dlg%20select%5Bmultiple%5D%2Eform%2Dcontrol%2C%2Eform%2Dgroup%2Dlg%20textarea%2Eform%2Dcontrol%7Bheight%3Aauto%7D%2Eform%2Dgroup%2Dlg%20%2Eform%2Dcontrol%2Dstatic%7Bheight%3A46px%3Bmin%2Dheight%3A38px%3Bpadding%3A11px%2016px%3Bfont%2Dsize%3A18px%3Bline%2Dheight%3A1%2E3333333%7D%2Ehas%2Dfeedback%7Bposition%3Arelative%7D%2Ehas%2Dfeedback%20%2Eform%2Dcontrol%7Bpadding%2Dright%3A42%2E5px%7D%2Eform%2Dcontrol%2Dfeedback%7Bposition%3Aabsolute%3Btop%3A0%3Bright%3A0%3Bz%2Dindex%3A2%3Bdisplay%3Ablock%3Bwidth%3A34px%3Bheight%3A34px%3Bline%2Dheight%3A34px%3Btext%2Dalign%3Acenter%3Bpointer%2Devents%3Anone%7D%2Eform%2Dgroup%2Dlg%20%2Eform%2Dcontrol%2B%2Eform%2Dcontrol%2Dfeedback%2C%2Einput%2Dgroup%2Dlg%2B%2Eform%2Dcontrol%2Dfeedback%2C%2Einput%2Dlg%2B%2Eform%2Dcontrol%2Dfeedback%7Bwidth%3A46px%3Bheight%3A46px%3Bline%2Dheight%3A46px%7D%2Eform%2Dgroup%2Dsm%20%2Eform%2Dcontrol%2B%2Eform%2Dcontrol%2Dfeedback%2C%2Einput%2Dgroup%2Dsm%2B%2Eform%2Dcontrol%2Dfeedback%2C%2Einput%2Dsm%2B%2Eform%2Dcontrol%2Dfeedback%7Bwidth%3A30px%3Bheight%3A30px%3Bline%2Dheight%3A30px%7D%2Ehas%2Dsuccess%20%2Echeckbox%2C%2Ehas%2Dsuccess%20%2Echeckbox%2Dinline%2C%2Ehas%2Dsuccess%20%2Econtrol%2Dlabel%2C%2Ehas%2Dsuccess%20%2Ehelp%2Dblock%2C%2Ehas%2Dsuccess%20%2Eradio%2C%2Ehas%2Dsuccess%20%2Eradio%2Dinline%2C%2Ehas%2Dsuccess%2Echeckbox%20label%2C%2Ehas%2Dsuccess%2Echeckbox%2Dinline%20label%2C%2Ehas%2Dsuccess%2Eradio%20label%2C%2Ehas%2Dsuccess%2Eradio%2Dinline%20label%7Bcolor%3A%233c763d%7D%2Ehas%2Dsuccess%20%2Eform%2Dcontrol%7Bborder%2Dcolor%3A%233c763d%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%7D%2Ehas%2Dsuccess%20%2Eform%2Dcontrol%3Afocus%7Bborder%2Dcolor%3A%232b542c%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%206px%20%2367b168%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%206px%20%2367b168%7D%2Ehas%2Dsuccess%20%2Einput%2Dgroup%2Daddon%7Bcolor%3A%233c763d%3Bbackground%2Dcolor%3A%23dff0d8%3Bborder%2Dcolor%3A%233c763d%7D%2Ehas%2Dsuccess%20%2Eform%2Dcontrol%2Dfeedback%7Bcolor%3A%233c763d%7D%2Ehas%2Dwarning%20%2Echeckbox%2C%2Ehas%2Dwarning%20%2Echeckbox%2Dinline%2C%2Ehas%2Dwarning%20%2Econtrol%2Dlabel%2C%2Ehas%2Dwarning%20%2Ehelp%2Dblock%2C%2Ehas%2Dwarning%20%2Eradio%2C%2Ehas%2Dwarning%20%2Eradio%2Dinline%2C%2Ehas%2Dwarning%2Echeckbox%20label%2C%2Ehas%2Dwarning%2Echeckbox%2Dinline%20label%2C%2Ehas%2Dwarning%2Eradio%20label%2C%2Ehas%2Dwarning%2Eradio%2Dinline%20label%7Bcolor%3A%238a6d3b%7D%2Ehas%2Dwarning%20%2Eform%2Dcontrol%7Bborder%2Dcolor%3A%238a6d3b%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%7D%2Ehas%2Dwarning%20%2Eform%2Dcontrol%3Afocus%7Bborder%2Dcolor%3A%2366512c%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%206px%20%23c0a16b%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%206px%20%23c0a16b%7D%2Ehas%2Dwarning%20%2Einput%2Dgroup%2Daddon%7Bcolor%3A%238a6d3b%3Bbackground%2Dcolor%3A%23fcf8e3%3Bborder%2Dcolor%3A%238a6d3b%7D%2Ehas%2Dwarning%20%2Eform%2Dcontrol%2Dfeedback%7Bcolor%3A%238a6d3b%7D%2Ehas%2Derror%20%2Echeckbox%2C%2Ehas%2Derror%20%2Echeckbox%2Dinline%2C%2Ehas%2Derror%20%2Econtrol%2Dlabel%2C%2Ehas%2Derror%20%2Ehelp%2Dblock%2C%2Ehas%2Derror%20%2Eradio%2C%2Ehas%2Derror%20%2Eradio%2Dinline%2C%2Ehas%2Derror%2Echeckbox%20label%2C%2Ehas%2Derror%2Echeckbox%2Dinline%20label%2C%2Ehas%2Derror%2Eradio%20label%2C%2Ehas%2Derror%2Eradio%2Dinline%20label%7Bcolor%3A%23a94442%7D%2Ehas%2Derror%20%2Eform%2Dcontrol%7Bborder%2Dcolor%3A%23a94442%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%7D%2Ehas%2Derror%20%2Eform%2Dcontrol%3Afocus%7Bborder%2Dcolor%3A%23843534%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%206px%20%23ce8483%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%206px%20%23ce8483%7D%2Ehas%2Derror%20%2Einput%2Dgroup%2Daddon%7Bcolor%3A%23a94442%3Bbackground%2Dcolor%3A%23f2dede%3Bborder%2Dcolor%3A%23a94442%7D%2Ehas%2Derror%20%2Eform%2Dcontrol%2Dfeedback%7Bcolor%3A%23a94442%7D%2Ehas%2Dfeedback%20label%7E%2Eform%2Dcontrol%2Dfeedback%7Btop%3A25px%7D%2Ehas%2Dfeedback%20label%2Esr%2Donly%7E%2Eform%2Dcontrol%2Dfeedback%7Btop%3A0%7D%2Ehelp%2Dblock%7Bdisplay%3Ablock%3Bmargin%2Dtop%3A5px%3Bmargin%2Dbottom%3A10px%3Bcolor%3A%23737373%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Eform%2Dinline%20%2Eform%2Dgroup%7Bdisplay%3Ainline%2Dblock%3Bmargin%2Dbottom%3A0%3Bvertical%2Dalign%3Amiddle%7D%2Eform%2Dinline%20%2Eform%2Dcontrol%7Bdisplay%3Ainline%2Dblock%3Bwidth%3Aauto%3Bvertical%2Dalign%3Amiddle%7D%2Eform%2Dinline%20%2Eform%2Dcontrol%2Dstatic%7Bdisplay%3Ainline%2Dblock%7D%2Eform%2Dinline%20%2Einput%2Dgroup%7Bdisplay%3Ainline%2Dtable%3Bvertical%2Dalign%3Amiddle%7D%2Eform%2Dinline%20%2Einput%2Dgroup%20%2Eform%2Dcontrol%2C%2Eform%2Dinline%20%2Einput%2Dgroup%20%2Einput%2Dgroup%2Daddon%2C%2Eform%2Dinline%20%2Einput%2Dgroup%20%2Einput%2Dgroup%2Dbtn%7Bwidth%3Aauto%7D%2Eform%2Dinline%20%2Einput%2Dgroup%3E%2Eform%2Dcontrol%7Bwidth%3A100%25%7D%2Eform%2Dinline%20%2Econtrol%2Dlabel%7Bmargin%2Dbottom%3A0%3Bvertical%2Dalign%3Amiddle%7D%2Eform%2Dinline%20%2Echeckbox%2C%2Eform%2Dinline%20%2Eradio%7Bdisplay%3Ainline%2Dblock%3Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A0%3Bvertical%2Dalign%3Amiddle%7D%2Eform%2Dinline%20%2Echeckbox%20label%2C%2Eform%2Dinline%20%2Eradio%20label%7Bpadding%2Dleft%3A0%7D%2Eform%2Dinline%20%2Echeckbox%20input%5Btype%3Dcheckbox%5D%2C%2Eform%2Dinline%20%2Eradio%20input%5Btype%3Dradio%5D%7Bposition%3Arelative%3Bmargin%2Dleft%3A0%7D%2Eform%2Dinline%20%2Ehas%2Dfeedback%20%2Eform%2Dcontrol%2Dfeedback%7Btop%3A0%7D%7D%2Eform%2Dhorizontal%20%2Echeckbox%2C%2Eform%2Dhorizontal%20%2Echeckbox%2Dinline%2C%2Eform%2Dhorizontal%20%2Eradio%2C%2Eform%2Dhorizontal%20%2Eradio%2Dinline%7Bpadding%2Dtop%3A7px%3Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A0%7D%2Eform%2Dhorizontal%20%2Echeckbox%2C%2Eform%2Dhorizontal%20%2Eradio%7Bmin%2Dheight%3A27px%7D%2Eform%2Dhorizontal%20%2Eform%2Dgroup%7Bmargin%2Dright%3A%2D15px%3Bmargin%2Dleft%3A%2D15px%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Eform%2Dhorizontal%20%2Econtrol%2Dlabel%7Bpadding%2Dtop%3A7px%3Bmargin%2Dbottom%3A0%3Btext%2Dalign%3Aright%7D%7D%2Eform%2Dhorizontal%20%2Ehas%2Dfeedback%20%2Eform%2Dcontrol%2Dfeedback%7Bright%3A15px%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Eform%2Dhorizontal%20%2Eform%2Dgroup%2Dlg%20%2Econtrol%2Dlabel%7Bpadding%2Dtop%3A14%2E33px%3Bfont%2Dsize%3A18px%7D%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Eform%2Dhorizontal%20%2Eform%2Dgroup%2Dsm%20%2Econtrol%2Dlabel%7Bpadding%2Dtop%3A6px%3Bfont%2Dsize%3A12px%7D%7D%2Ebtn%7Bdisplay%3Ainline%2Dblock%3Bpadding%3A6px%2012px%3Bmargin%2Dbottom%3A0%3Bfont%2Dsize%3A14px%3Bfont%2Dweight%3A400%3Bline%2Dheight%3A1%2E42857143%3Btext%2Dalign%3Acenter%3Bwhite%2Dspace%3Anowrap%3Bvertical%2Dalign%3Amiddle%3B%2Dms%2Dtouch%2Daction%3Amanipulation%3Btouch%2Daction%3Amanipulation%3Bcursor%3Apointer%3B%2Dwebkit%2Duser%2Dselect%3Anone%3B%2Dmoz%2Duser%2Dselect%3Anone%3B%2Dms%2Duser%2Dselect%3Anone%3Buser%2Dselect%3Anone%3Bbackground%2Dimage%3Anone%3Bborder%3A1px%20solid%20transparent%3Bborder%2Dradius%3A4px%7D%2Ebtn%2Eactive%2Efocus%2C%2Ebtn%2Eactive%3Afocus%2C%2Ebtn%2Efocus%2C%2Ebtn%3Aactive%2Efocus%2C%2Ebtn%3Aactive%3Afocus%2C%2Ebtn%3Afocus%7Boutline%3Athin%20dotted%3Boutline%3A5px%20auto%20%2Dwebkit%2Dfocus%2Dring%2Dcolor%3Boutline%2Doffset%3A%2D2px%7D%2Ebtn%2Efocus%2C%2Ebtn%3Afocus%2C%2Ebtn%3Ahover%7Bcolor%3A%23333%3Btext%2Ddecoration%3Anone%7D%2Ebtn%2Eactive%2C%2Ebtn%3Aactive%7Bbackground%2Dimage%3Anone%3Boutline%3A0%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%203px%205px%20rgba%280%2C0%2C0%2C%2E125%29%3Bbox%2Dshadow%3Ainset%200%203px%205px%20rgba%280%2C0%2C0%2C%2E125%29%7D%2Ebtn%2Edisabled%2C%2Ebtn%5Bdisabled%5D%2Cfieldset%5Bdisabled%5D%20%2Ebtn%7Bcursor%3Anot%2Dallowed%3Bfilter%3Aalpha%28opacity%3D65%29%3B%2Dwebkit%2Dbox%2Dshadow%3Anone%3Bbox%2Dshadow%3Anone%3Bopacity%3A%2E65%7Da%2Ebtn%2Edisabled%2Cfieldset%5Bdisabled%5D%20a%2Ebtn%7Bpointer%2Devents%3Anone%7D%2Ebtn%2Ddefault%7Bcolor%3A%23333%3Bbackground%2Dcolor%3A%23fff%3Bborder%2Dcolor%3A%23ccc%7D%2Ebtn%2Ddefault%2Efocus%2C%2Ebtn%2Ddefault%3Afocus%7Bcolor%3A%23333%3Bbackground%2Dcolor%3A%23e6e6e6%3Bborder%2Dcolor%3A%238c8c8c%7D%2Ebtn%2Ddefault%3Ahover%7Bcolor%3A%23333%3Bbackground%2Dcolor%3A%23e6e6e6%3Bborder%2Dcolor%3A%23adadad%7D%2Ebtn%2Ddefault%2Eactive%2C%2Ebtn%2Ddefault%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddefault%7Bcolor%3A%23333%3Bbackground%2Dcolor%3A%23e6e6e6%3Bborder%2Dcolor%3A%23adadad%7D%2Ebtn%2Ddefault%2Eactive%2Efocus%2C%2Ebtn%2Ddefault%2Eactive%3Afocus%2C%2Ebtn%2Ddefault%2Eactive%3Ahover%2C%2Ebtn%2Ddefault%3Aactive%2Efocus%2C%2Ebtn%2Ddefault%3Aactive%3Afocus%2C%2Ebtn%2Ddefault%3Aactive%3Ahover%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddefault%2Efocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddefault%3Afocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddefault%3Ahover%7Bcolor%3A%23333%3Bbackground%2Dcolor%3A%23d4d4d4%3Bborder%2Dcolor%3A%238c8c8c%7D%2Ebtn%2Ddefault%2Eactive%2C%2Ebtn%2Ddefault%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddefault%7Bbackground%2Dimage%3Anone%7D%2Ebtn%2Ddefault%2Edisabled%2C%2Ebtn%2Ddefault%2Edisabled%2Eactive%2C%2Ebtn%2Ddefault%2Edisabled%2Efocus%2C%2Ebtn%2Ddefault%2Edisabled%3Aactive%2C%2Ebtn%2Ddefault%2Edisabled%3Afocus%2C%2Ebtn%2Ddefault%2Edisabled%3Ahover%2C%2Ebtn%2Ddefault%5Bdisabled%5D%2C%2Ebtn%2Ddefault%5Bdisabled%5D%2Eactive%2C%2Ebtn%2Ddefault%5Bdisabled%5D%2Efocus%2C%2Ebtn%2Ddefault%5Bdisabled%5D%3Aactive%2C%2Ebtn%2Ddefault%5Bdisabled%5D%3Afocus%2C%2Ebtn%2Ddefault%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddefault%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddefault%2Eactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddefault%2Efocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddefault%3Aactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddefault%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddefault%3Ahover%7Bbackground%2Dcolor%3A%23fff%3Bborder%2Dcolor%3A%23ccc%7D%2Ebtn%2Ddefault%20%2Ebadge%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23333%7D%2Ebtn%2Dprimary%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23337ab7%3Bborder%2Dcolor%3A%232e6da4%7D%2Ebtn%2Dprimary%2Efocus%2C%2Ebtn%2Dprimary%3Afocus%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23286090%3Bborder%2Dcolor%3A%23122b40%7D%2Ebtn%2Dprimary%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23286090%3Bborder%2Dcolor%3A%23204d74%7D%2Ebtn%2Dprimary%2Eactive%2C%2Ebtn%2Dprimary%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dprimary%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23286090%3Bborder%2Dcolor%3A%23204d74%7D%2Ebtn%2Dprimary%2Eactive%2Efocus%2C%2Ebtn%2Dprimary%2Eactive%3Afocus%2C%2Ebtn%2Dprimary%2Eactive%3Ahover%2C%2Ebtn%2Dprimary%3Aactive%2Efocus%2C%2Ebtn%2Dprimary%3Aactive%3Afocus%2C%2Ebtn%2Dprimary%3Aactive%3Ahover%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dprimary%2Efocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dprimary%3Afocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dprimary%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23204d74%3Bborder%2Dcolor%3A%23122b40%7D%2Ebtn%2Dprimary%2Eactive%2C%2Ebtn%2Dprimary%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dprimary%7Bbackground%2Dimage%3Anone%7D%2Ebtn%2Dprimary%2Edisabled%2C%2Ebtn%2Dprimary%2Edisabled%2Eactive%2C%2Ebtn%2Dprimary%2Edisabled%2Efocus%2C%2Ebtn%2Dprimary%2Edisabled%3Aactive%2C%2Ebtn%2Dprimary%2Edisabled%3Afocus%2C%2Ebtn%2Dprimary%2Edisabled%3Ahover%2C%2Ebtn%2Dprimary%5Bdisabled%5D%2C%2Ebtn%2Dprimary%5Bdisabled%5D%2Eactive%2C%2Ebtn%2Dprimary%5Bdisabled%5D%2Efocus%2C%2Ebtn%2Dprimary%5Bdisabled%5D%3Aactive%2C%2Ebtn%2Dprimary%5Bdisabled%5D%3Afocus%2C%2Ebtn%2Dprimary%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dprimary%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dprimary%2Eactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dprimary%2Efocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dprimary%3Aactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dprimary%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dprimary%3Ahover%7Bbackground%2Dcolor%3A%23337ab7%3Bborder%2Dcolor%3A%232e6da4%7D%2Ebtn%2Dprimary%20%2Ebadge%7Bcolor%3A%23337ab7%3Bbackground%2Dcolor%3A%23fff%7D%2Ebtn%2Dsuccess%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%235cb85c%3Bborder%2Dcolor%3A%234cae4c%7D%2Ebtn%2Dsuccess%2Efocus%2C%2Ebtn%2Dsuccess%3Afocus%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23449d44%3Bborder%2Dcolor%3A%23255625%7D%2Ebtn%2Dsuccess%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23449d44%3Bborder%2Dcolor%3A%23398439%7D%2Ebtn%2Dsuccess%2Eactive%2C%2Ebtn%2Dsuccess%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dsuccess%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23449d44%3Bborder%2Dcolor%3A%23398439%7D%2Ebtn%2Dsuccess%2Eactive%2Efocus%2C%2Ebtn%2Dsuccess%2Eactive%3Afocus%2C%2Ebtn%2Dsuccess%2Eactive%3Ahover%2C%2Ebtn%2Dsuccess%3Aactive%2Efocus%2C%2Ebtn%2Dsuccess%3Aactive%3Afocus%2C%2Ebtn%2Dsuccess%3Aactive%3Ahover%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dsuccess%2Efocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dsuccess%3Afocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dsuccess%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23398439%3Bborder%2Dcolor%3A%23255625%7D%2Ebtn%2Dsuccess%2Eactive%2C%2Ebtn%2Dsuccess%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dsuccess%7Bbackground%2Dimage%3Anone%7D%2Ebtn%2Dsuccess%2Edisabled%2C%2Ebtn%2Dsuccess%2Edisabled%2Eactive%2C%2Ebtn%2Dsuccess%2Edisabled%2Efocus%2C%2Ebtn%2Dsuccess%2Edisabled%3Aactive%2C%2Ebtn%2Dsuccess%2Edisabled%3Afocus%2C%2Ebtn%2Dsuccess%2Edisabled%3Ahover%2C%2Ebtn%2Dsuccess%5Bdisabled%5D%2C%2Ebtn%2Dsuccess%5Bdisabled%5D%2Eactive%2C%2Ebtn%2Dsuccess%5Bdisabled%5D%2Efocus%2C%2Ebtn%2Dsuccess%5Bdisabled%5D%3Aactive%2C%2Ebtn%2Dsuccess%5Bdisabled%5D%3Afocus%2C%2Ebtn%2Dsuccess%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dsuccess%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dsuccess%2Eactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dsuccess%2Efocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dsuccess%3Aactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dsuccess%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dsuccess%3Ahover%7Bbackground%2Dcolor%3A%235cb85c%3Bborder%2Dcolor%3A%234cae4c%7D%2Ebtn%2Dsuccess%20%2Ebadge%7Bcolor%3A%235cb85c%3Bbackground%2Dcolor%3A%23fff%7D%2Ebtn%2Dinfo%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%235bc0de%3Bborder%2Dcolor%3A%2346b8da%7D%2Ebtn%2Dinfo%2Efocus%2C%2Ebtn%2Dinfo%3Afocus%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%2331b0d5%3Bborder%2Dcolor%3A%231b6d85%7D%2Ebtn%2Dinfo%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%2331b0d5%3Bborder%2Dcolor%3A%23269abc%7D%2Ebtn%2Dinfo%2Eactive%2C%2Ebtn%2Dinfo%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dinfo%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%2331b0d5%3Bborder%2Dcolor%3A%23269abc%7D%2Ebtn%2Dinfo%2Eactive%2Efocus%2C%2Ebtn%2Dinfo%2Eactive%3Afocus%2C%2Ebtn%2Dinfo%2Eactive%3Ahover%2C%2Ebtn%2Dinfo%3Aactive%2Efocus%2C%2Ebtn%2Dinfo%3Aactive%3Afocus%2C%2Ebtn%2Dinfo%3Aactive%3Ahover%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dinfo%2Efocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dinfo%3Afocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dinfo%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23269abc%3Bborder%2Dcolor%3A%231b6d85%7D%2Ebtn%2Dinfo%2Eactive%2C%2Ebtn%2Dinfo%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dinfo%7Bbackground%2Dimage%3Anone%7D%2Ebtn%2Dinfo%2Edisabled%2C%2Ebtn%2Dinfo%2Edisabled%2Eactive%2C%2Ebtn%2Dinfo%2Edisabled%2Efocus%2C%2Ebtn%2Dinfo%2Edisabled%3Aactive%2C%2Ebtn%2Dinfo%2Edisabled%3Afocus%2C%2Ebtn%2Dinfo%2Edisabled%3Ahover%2C%2Ebtn%2Dinfo%5Bdisabled%5D%2C%2Ebtn%2Dinfo%5Bdisabled%5D%2Eactive%2C%2Ebtn%2Dinfo%5Bdisabled%5D%2Efocus%2C%2Ebtn%2Dinfo%5Bdisabled%5D%3Aactive%2C%2Ebtn%2Dinfo%5Bdisabled%5D%3Afocus%2C%2Ebtn%2Dinfo%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dinfo%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dinfo%2Eactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dinfo%2Efocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dinfo%3Aactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dinfo%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dinfo%3Ahover%7Bbackground%2Dcolor%3A%235bc0de%3Bborder%2Dcolor%3A%2346b8da%7D%2Ebtn%2Dinfo%20%2Ebadge%7Bcolor%3A%235bc0de%3Bbackground%2Dcolor%3A%23fff%7D%2Ebtn%2Dwarning%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23f0ad4e%3Bborder%2Dcolor%3A%23eea236%7D%2Ebtn%2Dwarning%2Efocus%2C%2Ebtn%2Dwarning%3Afocus%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23ec971f%3Bborder%2Dcolor%3A%23985f0d%7D%2Ebtn%2Dwarning%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23ec971f%3Bborder%2Dcolor%3A%23d58512%7D%2Ebtn%2Dwarning%2Eactive%2C%2Ebtn%2Dwarning%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dwarning%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23ec971f%3Bborder%2Dcolor%3A%23d58512%7D%2Ebtn%2Dwarning%2Eactive%2Efocus%2C%2Ebtn%2Dwarning%2Eactive%3Afocus%2C%2Ebtn%2Dwarning%2Eactive%3Ahover%2C%2Ebtn%2Dwarning%3Aactive%2Efocus%2C%2Ebtn%2Dwarning%3Aactive%3Afocus%2C%2Ebtn%2Dwarning%3Aactive%3Ahover%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dwarning%2Efocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dwarning%3Afocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dwarning%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23d58512%3Bborder%2Dcolor%3A%23985f0d%7D%2Ebtn%2Dwarning%2Eactive%2C%2Ebtn%2Dwarning%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dwarning%7Bbackground%2Dimage%3Anone%7D%2Ebtn%2Dwarning%2Edisabled%2C%2Ebtn%2Dwarning%2Edisabled%2Eactive%2C%2Ebtn%2Dwarning%2Edisabled%2Efocus%2C%2Ebtn%2Dwarning%2Edisabled%3Aactive%2C%2Ebtn%2Dwarning%2Edisabled%3Afocus%2C%2Ebtn%2Dwarning%2Edisabled%3Ahover%2C%2Ebtn%2Dwarning%5Bdisabled%5D%2C%2Ebtn%2Dwarning%5Bdisabled%5D%2Eactive%2C%2Ebtn%2Dwarning%5Bdisabled%5D%2Efocus%2C%2Ebtn%2Dwarning%5Bdisabled%5D%3Aactive%2C%2Ebtn%2Dwarning%5Bdisabled%5D%3Afocus%2C%2Ebtn%2Dwarning%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dwarning%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dwarning%2Eactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dwarning%2Efocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dwarning%3Aactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dwarning%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dwarning%3Ahover%7Bbackground%2Dcolor%3A%23f0ad4e%3Bborder%2Dcolor%3A%23eea236%7D%2Ebtn%2Dwarning%20%2Ebadge%7Bcolor%3A%23f0ad4e%3Bbackground%2Dcolor%3A%23fff%7D%2Ebtn%2Ddanger%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23d9534f%3Bborder%2Dcolor%3A%23d43f3a%7D%2Ebtn%2Ddanger%2Efocus%2C%2Ebtn%2Ddanger%3Afocus%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23c9302c%3Bborder%2Dcolor%3A%23761c19%7D%2Ebtn%2Ddanger%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23c9302c%3Bborder%2Dcolor%3A%23ac2925%7D%2Ebtn%2Ddanger%2Eactive%2C%2Ebtn%2Ddanger%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddanger%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23c9302c%3Bborder%2Dcolor%3A%23ac2925%7D%2Ebtn%2Ddanger%2Eactive%2Efocus%2C%2Ebtn%2Ddanger%2Eactive%3Afocus%2C%2Ebtn%2Ddanger%2Eactive%3Ahover%2C%2Ebtn%2Ddanger%3Aactive%2Efocus%2C%2Ebtn%2Ddanger%3Aactive%3Afocus%2C%2Ebtn%2Ddanger%3Aactive%3Ahover%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddanger%2Efocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddanger%3Afocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddanger%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23ac2925%3Bborder%2Dcolor%3A%23761c19%7D%2Ebtn%2Ddanger%2Eactive%2C%2Ebtn%2Ddanger%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddanger%7Bbackground%2Dimage%3Anone%7D%2Ebtn%2Ddanger%2Edisabled%2C%2Ebtn%2Ddanger%2Edisabled%2Eactive%2C%2Ebtn%2Ddanger%2Edisabled%2Efocus%2C%2Ebtn%2Ddanger%2Edisabled%3Aactive%2C%2Ebtn%2Ddanger%2Edisabled%3Afocus%2C%2Ebtn%2Ddanger%2Edisabled%3Ahover%2C%2Ebtn%2Ddanger%5Bdisabled%5D%2C%2Ebtn%2Ddanger%5Bdisabled%5D%2Eactive%2C%2Ebtn%2Ddanger%5Bdisabled%5D%2Efocus%2C%2Ebtn%2Ddanger%5Bdisabled%5D%3Aactive%2C%2Ebtn%2Ddanger%5Bdisabled%5D%3Afocus%2C%2Ebtn%2Ddanger%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddanger%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddanger%2Eactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddanger%2Efocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddanger%3Aactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddanger%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddanger%3Ahover%7Bbackground%2Dcolor%3A%23d9534f%3Bborder%2Dcolor%3A%23d43f3a%7D%2Ebtn%2Ddanger%20%2Ebadge%7Bcolor%3A%23d9534f%3Bbackground%2Dcolor%3A%23fff%7D%2Ebtn%2Dlink%7Bfont%2Dweight%3A400%3Bcolor%3A%23337ab7%3Bborder%2Dradius%3A0%7D%2Ebtn%2Dlink%2C%2Ebtn%2Dlink%2Eactive%2C%2Ebtn%2Dlink%3Aactive%2C%2Ebtn%2Dlink%5Bdisabled%5D%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dlink%7Bbackground%2Dcolor%3Atransparent%3B%2Dwebkit%2Dbox%2Dshadow%3Anone%3Bbox%2Dshadow%3Anone%7D%2Ebtn%2Dlink%2C%2Ebtn%2Dlink%3Aactive%2C%2Ebtn%2Dlink%3Afocus%2C%2Ebtn%2Dlink%3Ahover%7Bborder%2Dcolor%3Atransparent%7D%2Ebtn%2Dlink%3Afocus%2C%2Ebtn%2Dlink%3Ahover%7Bcolor%3A%2323527c%3Btext%2Ddecoration%3Aunderline%3Bbackground%2Dcolor%3Atransparent%7D%2Ebtn%2Dlink%5Bdisabled%5D%3Afocus%2C%2Ebtn%2Dlink%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dlink%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dlink%3Ahover%7Bcolor%3A%23777%3Btext%2Ddecoration%3Anone%7D%2Ebtn%2Dgroup%2Dlg%3E%2Ebtn%2C%2Ebtn%2Dlg%7Bpadding%3A10px%2016px%3Bfont%2Dsize%3A18px%3Bline%2Dheight%3A1%2E3333333%3Bborder%2Dradius%3A6px%7D%2Ebtn%2Dgroup%2Dsm%3E%2Ebtn%2C%2Ebtn%2Dsm%7Bpadding%3A5px%2010px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E5%3Bborder%2Dradius%3A3px%7D%2Ebtn%2Dgroup%2Dxs%3E%2Ebtn%2C%2Ebtn%2Dxs%7Bpadding%3A1px%205px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E5%3Bborder%2Dradius%3A3px%7D%2Ebtn%2Dblock%7Bdisplay%3Ablock%3Bwidth%3A100%25%7D%2Ebtn%2Dblock%2B%2Ebtn%2Dblock%7Bmargin%2Dtop%3A5px%7Dinput%5Btype%3Dbutton%5D%2Ebtn%2Dblock%2Cinput%5Btype%3Dreset%5D%2Ebtn%2Dblock%2Cinput%5Btype%3Dsubmit%5D%2Ebtn%2Dblock%7Bwidth%3A100%25%7D%2Efade%7Bopacity%3A0%3B%2Dwebkit%2Dtransition%3Aopacity%20%2E15s%20linear%3B%2Do%2Dtransition%3Aopacity%20%2E15s%20linear%3Btransition%3Aopacity%20%2E15s%20linear%7D%2Efade%2Ein%7Bopacity%3A1%7D%2Ecollapse%7Bdisplay%3Anone%7D%2Ecollapse%2Ein%7Bdisplay%3Ablock%7Dtr%2Ecollapse%2Ein%7Bdisplay%3Atable%2Drow%7Dtbody%2Ecollapse%2Ein%7Bdisplay%3Atable%2Drow%2Dgroup%7D%2Ecollapsing%7Bposition%3Arelative%3Bheight%3A0%3Boverflow%3Ahidden%3B%2Dwebkit%2Dtransition%2Dtiming%2Dfunction%3Aease%3B%2Do%2Dtransition%2Dtiming%2Dfunction%3Aease%3Btransition%2Dtiming%2Dfunction%3Aease%3B%2Dwebkit%2Dtransition%2Dduration%3A%2E35s%3B%2Do%2Dtransition%2Dduration%3A%2E35s%3Btransition%2Dduration%3A%2E35s%3B%2Dwebkit%2Dtransition%2Dproperty%3Aheight%2Cvisibility%3B%2Do%2Dtransition%2Dproperty%3Aheight%2Cvisibility%3Btransition%2Dproperty%3Aheight%2Cvisibility%7D%2Ecaret%7Bdisplay%3Ainline%2Dblock%3Bwidth%3A0%3Bheight%3A0%3Bmargin%2Dleft%3A2px%3Bvertical%2Dalign%3Amiddle%3Bborder%2Dtop%3A4px%20dashed%3Bborder%2Dtop%3A4px%20solid%5C9%3Bborder%2Dright%3A4px%20solid%20transparent%3Bborder%2Dleft%3A4px%20solid%20transparent%7D%2Edropdown%2C%2Edropup%7Bposition%3Arelative%7D%2Edropdown%2Dtoggle%3Afocus%7Boutline%3A0%7D%2Edropdown%2Dmenu%7Bposition%3Aabsolute%3Btop%3A100%25%3Bleft%3A0%3Bz%2Dindex%3A1000%3Bdisplay%3Anone%3Bfloat%3Aleft%3Bmin%2Dwidth%3A160px%3Bpadding%3A5px%200%3Bmargin%3A2px%200%200%3Bfont%2Dsize%3A14px%3Btext%2Dalign%3Aleft%3Blist%2Dstyle%3Anone%3Bbackground%2Dcolor%3A%23fff%3B%2Dwebkit%2Dbackground%2Dclip%3Apadding%2Dbox%3Bbackground%2Dclip%3Apadding%2Dbox%3Bborder%3A1px%20solid%20%23ccc%3Bborder%3A1px%20solid%20rgba%280%2C0%2C0%2C%2E15%29%3Bborder%2Dradius%3A4px%3B%2Dwebkit%2Dbox%2Dshadow%3A0%206px%2012px%20rgba%280%2C0%2C0%2C%2E175%29%3Bbox%2Dshadow%3A0%206px%2012px%20rgba%280%2C0%2C0%2C%2E175%29%7D%2Edropdown%2Dmenu%2Epull%2Dright%7Bright%3A0%3Bleft%3Aauto%7D%2Edropdown%2Dmenu%20%2Edivider%7Bheight%3A1px%3Bmargin%3A9px%200%3Boverflow%3Ahidden%3Bbackground%2Dcolor%3A%23e5e5e5%7D%2Edropdown%2Dmenu%3Eli%3Ea%7Bdisplay%3Ablock%3Bpadding%3A3px%2020px%3Bclear%3Aboth%3Bfont%2Dweight%3A400%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23333%3Bwhite%2Dspace%3Anowrap%7D%2Edropdown%2Dmenu%3Eli%3Ea%3Afocus%2C%2Edropdown%2Dmenu%3Eli%3Ea%3Ahover%7Bcolor%3A%23262626%3Btext%2Ddecoration%3Anone%3Bbackground%2Dcolor%3A%23f5f5f5%7D%2Edropdown%2Dmenu%3E%2Eactive%3Ea%2C%2Edropdown%2Dmenu%3E%2Eactive%3Ea%3Afocus%2C%2Edropdown%2Dmenu%3E%2Eactive%3Ea%3Ahover%7Bcolor%3A%23fff%3Btext%2Ddecoration%3Anone%3Bbackground%2Dcolor%3A%23337ab7%3Boutline%3A0%7D%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%2C%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Afocus%2C%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Ahover%7Bcolor%3A%23777%7D%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Afocus%2C%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Ahover%7Btext%2Ddecoration%3Anone%3Bcursor%3Anot%2Dallowed%3Bbackground%2Dcolor%3Atransparent%3Bbackground%2Dimage%3Anone%3Bfilter%3Aprogid%3ADXImageTransform%2EMicrosoft%2Egradient%28enabled%3Dfalse%29%7D%2Eopen%3E%2Edropdown%2Dmenu%7Bdisplay%3Ablock%7D%2Eopen%3Ea%7Boutline%3A0%7D%2Edropdown%2Dmenu%2Dright%7Bright%3A0%3Bleft%3Aauto%7D%2Edropdown%2Dmenu%2Dleft%7Bright%3Aauto%3Bleft%3A0%7D%2Edropdown%2Dheader%7Bdisplay%3Ablock%3Bpadding%3A3px%2020px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23777%3Bwhite%2Dspace%3Anowrap%7D%2Edropdown%2Dbackdrop%7Bposition%3Afixed%3Btop%3A0%3Bright%3A0%3Bbottom%3A0%3Bleft%3A0%3Bz%2Dindex%3A990%7D%2Epull%2Dright%3E%2Edropdown%2Dmenu%7Bright%3A0%3Bleft%3Aauto%7D%2Edropup%20%2Ecaret%2C%2Enavbar%2Dfixed%2Dbottom%20%2Edropdown%20%2Ecaret%7Bcontent%3A%22%22%3Bborder%2Dtop%3A0%3Bborder%2Dbottom%3A4px%20dashed%3Bborder%2Dbottom%3A4px%20solid%5C9%7D%2Edropup%20%2Edropdown%2Dmenu%2C%2Enavbar%2Dfixed%2Dbottom%20%2Edropdown%20%2Edropdown%2Dmenu%7Btop%3Aauto%3Bbottom%3A100%25%3Bmargin%2Dbottom%3A2px%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dright%20%2Edropdown%2Dmenu%7Bright%3A0%3Bleft%3Aauto%7D%2Enavbar%2Dright%20%2Edropdown%2Dmenu%2Dleft%7Bright%3Aauto%3Bleft%3A0%7D%7D%2Ebtn%2Dgroup%2C%2Ebtn%2Dgroup%2Dvertical%7Bposition%3Arelative%3Bdisplay%3Ainline%2Dblock%3Bvertical%2Dalign%3Amiddle%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2C%2Ebtn%2Dgroup%3E%2Ebtn%7Bposition%3Arelative%3Bfloat%3Aleft%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Eactive%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%3Aactive%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%3Afocus%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%3Ahover%2C%2Ebtn%2Dgroup%3E%2Ebtn%2Eactive%2C%2Ebtn%2Dgroup%3E%2Ebtn%3Aactive%2C%2Ebtn%2Dgroup%3E%2Ebtn%3Afocus%2C%2Ebtn%2Dgroup%3E%2Ebtn%3Ahover%7Bz%2Dindex%3A2%7D%2Ebtn%2Dgroup%20%2Ebtn%2B%2Ebtn%2C%2Ebtn%2Dgroup%20%2Ebtn%2B%2Ebtn%2Dgroup%2C%2Ebtn%2Dgroup%20%2Ebtn%2Dgroup%2B%2Ebtn%2C%2Ebtn%2Dgroup%20%2Ebtn%2Dgroup%2B%2Ebtn%2Dgroup%7Bmargin%2Dleft%3A%2D1px%7D%2Ebtn%2Dtoolbar%7Bmargin%2Dleft%3A%2D5px%7D%2Ebtn%2Dtoolbar%20%2Ebtn%2C%2Ebtn%2Dtoolbar%20%2Ebtn%2Dgroup%2C%2Ebtn%2Dtoolbar%20%2Einput%2Dgroup%7Bfloat%3Aleft%7D%2Ebtn%2Dtoolbar%3E%2Ebtn%2C%2Ebtn%2Dtoolbar%3E%2Ebtn%2Dgroup%2C%2Ebtn%2Dtoolbar%3E%2Einput%2Dgroup%7Bmargin%2Dleft%3A5px%7D%2Ebtn%2Dgroup%3E%2Ebtn%3Anot%28%3Afirst%2Dchild%29%3Anot%28%3Alast%2Dchild%29%3Anot%28%2Edropdown%2Dtoggle%29%7Bborder%2Dradius%3A0%7D%2Ebtn%2Dgroup%3E%2Ebtn%3Afirst%2Dchild%7Bmargin%2Dleft%3A0%7D%2Ebtn%2Dgroup%3E%2Ebtn%3Afirst%2Dchild%3Anot%28%3Alast%2Dchild%29%3Anot%28%2Edropdown%2Dtoggle%29%7Bborder%2Dtop%2Dright%2Dradius%3A0%3Bborder%2Dbottom%2Dright%2Dradius%3A0%7D%2Ebtn%2Dgroup%3E%2Ebtn%3Alast%2Dchild%3Anot%28%3Afirst%2Dchild%29%2C%2Ebtn%2Dgroup%3E%2Edropdown%2Dtoggle%3Anot%28%3Afirst%2Dchild%29%7Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dbottom%2Dleft%2Dradius%3A0%7D%2Ebtn%2Dgroup%3E%2Ebtn%2Dgroup%7Bfloat%3Aleft%7D%2Ebtn%2Dgroup%3E%2Ebtn%2Dgroup%3Anot%28%3Afirst%2Dchild%29%3Anot%28%3Alast%2Dchild%29%3E%2Ebtn%7Bborder%2Dradius%3A0%7D%2Ebtn%2Dgroup%3E%2Ebtn%2Dgroup%3Afirst%2Dchild%3Anot%28%3Alast%2Dchild%29%3E%2Ebtn%3Alast%2Dchild%2C%2Ebtn%2Dgroup%3E%2Ebtn%2Dgroup%3Afirst%2Dchild%3Anot%28%3Alast%2Dchild%29%3E%2Edropdown%2Dtoggle%7Bborder%2Dtop%2Dright%2Dradius%3A0%3Bborder%2Dbottom%2Dright%2Dradius%3A0%7D%2Ebtn%2Dgroup%3E%2Ebtn%2Dgroup%3Alast%2Dchild%3Anot%28%3Afirst%2Dchild%29%3E%2Ebtn%3Afirst%2Dchild%7Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dbottom%2Dleft%2Dradius%3A0%7D%2Ebtn%2Dgroup%20%2Edropdown%2Dtoggle%3Aactive%2C%2Ebtn%2Dgroup%2Eopen%20%2Edropdown%2Dtoggle%7Boutline%3A0%7D%2Ebtn%2Dgroup%3E%2Ebtn%2B%2Edropdown%2Dtoggle%7Bpadding%2Dright%3A8px%3Bpadding%2Dleft%3A8px%7D%2Ebtn%2Dgroup%3E%2Ebtn%2Dlg%2B%2Edropdown%2Dtoggle%7Bpadding%2Dright%3A12px%3Bpadding%2Dleft%3A12px%7D%2Ebtn%2Dgroup%2Eopen%20%2Edropdown%2Dtoggle%7B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%203px%205px%20rgba%280%2C0%2C0%2C%2E125%29%3Bbox%2Dshadow%3Ainset%200%203px%205px%20rgba%280%2C0%2C0%2C%2E125%29%7D%2Ebtn%2Dgroup%2Eopen%20%2Edropdown%2Dtoggle%2Ebtn%2Dlink%7B%2Dwebkit%2Dbox%2Dshadow%3Anone%3Bbox%2Dshadow%3Anone%7D%2Ebtn%20%2Ecaret%7Bmargin%2Dleft%3A0%7D%2Ebtn%2Dlg%20%2Ecaret%7Bborder%2Dwidth%3A5px%205px%200%3Bborder%2Dbottom%2Dwidth%3A0%7D%2Edropup%20%2Ebtn%2Dlg%20%2Ecaret%7Bborder%2Dwidth%3A0%205px%205px%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3E%2Ebtn%7Bdisplay%3Ablock%3Bfloat%3Anone%3Bwidth%3A100%25%3Bmax%2Dwidth%3A100%25%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3E%2Ebtn%7Bfloat%3Anone%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2B%2Ebtn%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2B%2Ebtn%2Dgroup%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%2B%2Ebtn%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%2B%2Ebtn%2Dgroup%7Bmargin%2Dtop%3A%2D1px%3Bmargin%2Dleft%3A0%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%3Anot%28%3Afirst%2Dchild%29%3Anot%28%3Alast%2Dchild%29%7Bborder%2Dradius%3A0%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%3Afirst%2Dchild%3Anot%28%3Alast%2Dchild%29%7Bborder%2Dtop%2Dright%2Dradius%3A4px%3Bborder%2Dbottom%2Dright%2Dradius%3A0%3Bborder%2Dbottom%2Dleft%2Dradius%3A0%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%3Alast%2Dchild%3Anot%28%3Afirst%2Dchild%29%7Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dtop%2Dright%2Dradius%3A0%3Bborder%2Dbottom%2Dleft%2Dradius%3A4px%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3Anot%28%3Afirst%2Dchild%29%3Anot%28%3Alast%2Dchild%29%3E%2Ebtn%7Bborder%2Dradius%3A0%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3Afirst%2Dchild%3Anot%28%3Alast%2Dchild%29%3E%2Ebtn%3Alast%2Dchild%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3Afirst%2Dchild%3Anot%28%3Alast%2Dchild%29%3E%2Edropdown%2Dtoggle%7Bborder%2Dbottom%2Dright%2Dradius%3A0%3Bborder%2Dbottom%2Dleft%2Dradius%3A0%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3Alast%2Dchild%3Anot%28%3Afirst%2Dchild%29%3E%2Ebtn%3Afirst%2Dchild%7Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dtop%2Dright%2Dradius%3A0%7D%2Ebtn%2Dgroup%2Djustified%7Bdisplay%3Atable%3Bwidth%3A100%25%3Btable%2Dlayout%3Afixed%3Bborder%2Dcollapse%3Aseparate%7D%2Ebtn%2Dgroup%2Djustified%3E%2Ebtn%2C%2Ebtn%2Dgroup%2Djustified%3E%2Ebtn%2Dgroup%7Bdisplay%3Atable%2Dcell%3Bfloat%3Anone%3Bwidth%3A1%25%7D%2Ebtn%2Dgroup%2Djustified%3E%2Ebtn%2Dgroup%20%2Ebtn%7Bwidth%3A100%25%7D%2Ebtn%2Dgroup%2Djustified%3E%2Ebtn%2Dgroup%20%2Edropdown%2Dmenu%7Bleft%3Aauto%7D%5Bdata%2Dtoggle%3Dbuttons%5D%3E%2Ebtn%20input%5Btype%3Dcheckbox%5D%2C%5Bdata%2Dtoggle%3Dbuttons%5D%3E%2Ebtn%20input%5Btype%3Dradio%5D%2C%5Bdata%2Dtoggle%3Dbuttons%5D%3E%2Ebtn%2Dgroup%3E%2Ebtn%20input%5Btype%3Dcheckbox%5D%2C%5Bdata%2Dtoggle%3Dbuttons%5D%3E%2Ebtn%2Dgroup%3E%2Ebtn%20input%5Btype%3Dradio%5D%7Bposition%3Aabsolute%3Bclip%3Arect%280%2C0%2C0%2C0%29%3Bpointer%2Devents%3Anone%7D%2Einput%2Dgroup%7Bposition%3Arelative%3Bdisplay%3Atable%3Bborder%2Dcollapse%3Aseparate%7D%2Einput%2Dgroup%5Bclass%2A%3Dcol%2D%5D%7Bfloat%3Anone%3Bpadding%2Dright%3A0%3Bpadding%2Dleft%3A0%7D%2Einput%2Dgroup%20%2Eform%2Dcontrol%7Bposition%3Arelative%3Bz%2Dindex%3A2%3Bfloat%3Aleft%3Bwidth%3A100%25%3Bmargin%2Dbottom%3A0%7D%2Einput%2Dgroup%2Dlg%3E%2Eform%2Dcontrol%2C%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Daddon%2C%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%7Bheight%3A46px%3Bpadding%3A10px%2016px%3Bfont%2Dsize%3A18px%3Bline%2Dheight%3A1%2E3333333%3Bborder%2Dradius%3A6px%7Dselect%2Einput%2Dgroup%2Dlg%3E%2Eform%2Dcontrol%2Cselect%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Daddon%2Cselect%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%7Bheight%3A46px%3Bline%2Dheight%3A46px%7Dselect%5Bmultiple%5D%2Einput%2Dgroup%2Dlg%3E%2Eform%2Dcontrol%2Cselect%5Bmultiple%5D%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Daddon%2Cselect%5Bmultiple%5D%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%2Ctextarea%2Einput%2Dgroup%2Dlg%3E%2Eform%2Dcontrol%2Ctextarea%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Daddon%2Ctextarea%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%7Bheight%3Aauto%7D%2Einput%2Dgroup%2Dsm%3E%2Eform%2Dcontrol%2C%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Daddon%2C%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%7Bheight%3A30px%3Bpadding%3A5px%2010px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E5%3Bborder%2Dradius%3A3px%7Dselect%2Einput%2Dgroup%2Dsm%3E%2Eform%2Dcontrol%2Cselect%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Daddon%2Cselect%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%7Bheight%3A30px%3Bline%2Dheight%3A30px%7Dselect%5Bmultiple%5D%2Einput%2Dgroup%2Dsm%3E%2Eform%2Dcontrol%2Cselect%5Bmultiple%5D%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Daddon%2Cselect%5Bmultiple%5D%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%2Ctextarea%2Einput%2Dgroup%2Dsm%3E%2Eform%2Dcontrol%2Ctextarea%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Daddon%2Ctextarea%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%7Bheight%3Aauto%7D%2Einput%2Dgroup%20%2Eform%2Dcontrol%2C%2Einput%2Dgroup%2Daddon%2C%2Einput%2Dgroup%2Dbtn%7Bdisplay%3Atable%2Dcell%7D%2Einput%2Dgroup%20%2Eform%2Dcontrol%3Anot%28%3Afirst%2Dchild%29%3Anot%28%3Alast%2Dchild%29%2C%2Einput%2Dgroup%2Daddon%3Anot%28%3Afirst%2Dchild%29%3Anot%28%3Alast%2Dchild%29%2C%2Einput%2Dgroup%2Dbtn%3Anot%28%3Afirst%2Dchild%29%3Anot%28%3Alast%2Dchild%29%7Bborder%2Dradius%3A0%7D%2Einput%2Dgroup%2Daddon%2C%2Einput%2Dgroup%2Dbtn%7Bwidth%3A1%25%3Bwhite%2Dspace%3Anowrap%3Bvertical%2Dalign%3Amiddle%7D%2Einput%2Dgroup%2Daddon%7Bpadding%3A6px%2012px%3Bfont%2Dsize%3A14px%3Bfont%2Dweight%3A400%3Bline%2Dheight%3A1%3Bcolor%3A%23555%3Btext%2Dalign%3Acenter%3Bbackground%2Dcolor%3A%23eee%3Bborder%3A1px%20solid%20%23ccc%3Bborder%2Dradius%3A4px%7D%2Einput%2Dgroup%2Daddon%2Einput%2Dsm%7Bpadding%3A5px%2010px%3Bfont%2Dsize%3A12px%3Bborder%2Dradius%3A3px%7D%2Einput%2Dgroup%2Daddon%2Einput%2Dlg%7Bpadding%3A10px%2016px%3Bfont%2Dsize%3A18px%3Bborder%2Dradius%3A6px%7D%2Einput%2Dgroup%2Daddon%20input%5Btype%3Dcheckbox%5D%2C%2Einput%2Dgroup%2Daddon%20input%5Btype%3Dradio%5D%7Bmargin%2Dtop%3A0%7D%2Einput%2Dgroup%20%2Eform%2Dcontrol%3Afirst%2Dchild%2C%2Einput%2Dgroup%2Daddon%3Afirst%2Dchild%2C%2Einput%2Dgroup%2Dbtn%3Afirst%2Dchild%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Afirst%2Dchild%3E%2Ebtn%2Dgroup%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Afirst%2Dchild%3E%2Edropdown%2Dtoggle%2C%2Einput%2Dgroup%2Dbtn%3Alast%2Dchild%3E%2Ebtn%2Dgroup%3Anot%28%3Alast%2Dchild%29%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Alast%2Dchild%3E%2Ebtn%3Anot%28%3Alast%2Dchild%29%3Anot%28%2Edropdown%2Dtoggle%29%7Bborder%2Dtop%2Dright%2Dradius%3A0%3Bborder%2Dbottom%2Dright%2Dradius%3A0%7D%2Einput%2Dgroup%2Daddon%3Afirst%2Dchild%7Bborder%2Dright%3A0%7D%2Einput%2Dgroup%20%2Eform%2Dcontrol%3Alast%2Dchild%2C%2Einput%2Dgroup%2Daddon%3Alast%2Dchild%2C%2Einput%2Dgroup%2Dbtn%3Afirst%2Dchild%3E%2Ebtn%2Dgroup%3Anot%28%3Afirst%2Dchild%29%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Afirst%2Dchild%3E%2Ebtn%3Anot%28%3Afirst%2Dchild%29%2C%2Einput%2Dgroup%2Dbtn%3Alast%2Dchild%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Alast%2Dchild%3E%2Ebtn%2Dgroup%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Alast%2Dchild%3E%2Edropdown%2Dtoggle%7Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dbottom%2Dleft%2Dradius%3A0%7D%2Einput%2Dgroup%2Daddon%3Alast%2Dchild%7Bborder%2Dleft%3A0%7D%2Einput%2Dgroup%2Dbtn%7Bposition%3Arelative%3Bfont%2Dsize%3A0%3Bwhite%2Dspace%3Anowrap%7D%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%7Bposition%3Arelative%7D%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%2B%2Ebtn%7Bmargin%2Dleft%3A%2D1px%7D%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%3Aactive%2C%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%3Afocus%2C%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%3Ahover%7Bz%2Dindex%3A2%7D%2Einput%2Dgroup%2Dbtn%3Afirst%2Dchild%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Afirst%2Dchild%3E%2Ebtn%2Dgroup%7Bmargin%2Dright%3A%2D1px%7D%2Einput%2Dgroup%2Dbtn%3Alast%2Dchild%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Alast%2Dchild%3E%2Ebtn%2Dgroup%7Bz%2Dindex%3A2%3Bmargin%2Dleft%3A%2D1px%7D%2Enav%7Bpadding%2Dleft%3A0%3Bmargin%2Dbottom%3A0%3Blist%2Dstyle%3Anone%7D%2Enav%3Eli%7Bposition%3Arelative%3Bdisplay%3Ablock%7D%2Enav%3Eli%3Ea%7Bposition%3Arelative%3Bdisplay%3Ablock%3Bpadding%3A10px%2015px%7D%2Enav%3Eli%3Ea%3Afocus%2C%2Enav%3Eli%3Ea%3Ahover%7Btext%2Ddecoration%3Anone%3Bbackground%2Dcolor%3A%23eee%7D%2Enav%3Eli%2Edisabled%3Ea%7Bcolor%3A%23777%7D%2Enav%3Eli%2Edisabled%3Ea%3Afocus%2C%2Enav%3Eli%2Edisabled%3Ea%3Ahover%7Bcolor%3A%23777%3Btext%2Ddecoration%3Anone%3Bcursor%3Anot%2Dallowed%3Bbackground%2Dcolor%3Atransparent%7D%2Enav%20%2Eopen%3Ea%2C%2Enav%20%2Eopen%3Ea%3Afocus%2C%2Enav%20%2Eopen%3Ea%3Ahover%7Bbackground%2Dcolor%3A%23eee%3Bborder%2Dcolor%3A%23337ab7%7D%2Enav%20%2Enav%2Ddivider%7Bheight%3A1px%3Bmargin%3A9px%200%3Boverflow%3Ahidden%3Bbackground%2Dcolor%3A%23e5e5e5%7D%2Enav%3Eli%3Ea%3Eimg%7Bmax%2Dwidth%3Anone%7D%2Enav%2Dtabs%7Bborder%2Dbottom%3A1px%20solid%20%23ddd%7D%2Enav%2Dtabs%3Eli%7Bfloat%3Aleft%3Bmargin%2Dbottom%3A%2D1px%7D%2Enav%2Dtabs%3Eli%3Ea%7Bmargin%2Dright%3A2px%3Bline%2Dheight%3A1%2E42857143%3Bborder%3A1px%20solid%20transparent%3Bborder%2Dradius%3A4px%204px%200%200%7D%2Enav%2Dtabs%3Eli%3Ea%3Ahover%7Bborder%2Dcolor%3A%23eee%20%23eee%20%23ddd%7D%2Enav%2Dtabs%3Eli%2Eactive%3Ea%2C%2Enav%2Dtabs%3Eli%2Eactive%3Ea%3Afocus%2C%2Enav%2Dtabs%3Eli%2Eactive%3Ea%3Ahover%7Bcolor%3A%23555%3Bcursor%3Adefault%3Bbackground%2Dcolor%3A%23fff%3Bborder%3A1px%20solid%20%23ddd%3Bborder%2Dbottom%2Dcolor%3Atransparent%7D%2Enav%2Dtabs%2Enav%2Djustified%7Bwidth%3A100%25%3Bborder%2Dbottom%3A0%7D%2Enav%2Dtabs%2Enav%2Djustified%3Eli%7Bfloat%3Anone%7D%2Enav%2Dtabs%2Enav%2Djustified%3Eli%3Ea%7Bmargin%2Dbottom%3A5px%3Btext%2Dalign%3Acenter%7D%2Enav%2Dtabs%2Enav%2Djustified%3E%2Edropdown%20%2Edropdown%2Dmenu%7Btop%3Aauto%3Bleft%3Aauto%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enav%2Dtabs%2Enav%2Djustified%3Eli%7Bdisplay%3Atable%2Dcell%3Bwidth%3A1%25%7D%2Enav%2Dtabs%2Enav%2Djustified%3Eli%3Ea%7Bmargin%2Dbottom%3A0%7D%7D%2Enav%2Dtabs%2Enav%2Djustified%3Eli%3Ea%7Bmargin%2Dright%3A0%3Bborder%2Dradius%3A4px%7D%2Enav%2Dtabs%2Enav%2Djustified%3E%2Eactive%3Ea%2C%2Enav%2Dtabs%2Enav%2Djustified%3E%2Eactive%3Ea%3Afocus%2C%2Enav%2Dtabs%2Enav%2Djustified%3E%2Eactive%3Ea%3Ahover%7Bborder%3A1px%20solid%20%23ddd%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enav%2Dtabs%2Enav%2Djustified%3Eli%3Ea%7Bborder%2Dbottom%3A1px%20solid%20%23ddd%3Bborder%2Dradius%3A4px%204px%200%200%7D%2Enav%2Dtabs%2Enav%2Djustified%3E%2Eactive%3Ea%2C%2Enav%2Dtabs%2Enav%2Djustified%3E%2Eactive%3Ea%3Afocus%2C%2Enav%2Dtabs%2Enav%2Djustified%3E%2Eactive%3Ea%3Ahover%7Bborder%2Dbottom%2Dcolor%3A%23fff%7D%7D%2Enav%2Dpills%3Eli%7Bfloat%3Aleft%7D%2Enav%2Dpills%3Eli%3Ea%7Bborder%2Dradius%3A4px%7D%2Enav%2Dpills%3Eli%2Bli%7Bmargin%2Dleft%3A2px%7D%2Enav%2Dpills%3Eli%2Eactive%3Ea%2C%2Enav%2Dpills%3Eli%2Eactive%3Ea%3Afocus%2C%2Enav%2Dpills%3Eli%2Eactive%3Ea%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23337ab7%7D%2Enav%2Dstacked%3Eli%7Bfloat%3Anone%7D%2Enav%2Dstacked%3Eli%2Bli%7Bmargin%2Dtop%3A2px%3Bmargin%2Dleft%3A0%7D%2Enav%2Djustified%7Bwidth%3A100%25%7D%2Enav%2Djustified%3Eli%7Bfloat%3Anone%7D%2Enav%2Djustified%3Eli%3Ea%7Bmargin%2Dbottom%3A5px%3Btext%2Dalign%3Acenter%7D%2Enav%2Djustified%3E%2Edropdown%20%2Edropdown%2Dmenu%7Btop%3Aauto%3Bleft%3Aauto%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enav%2Djustified%3Eli%7Bdisplay%3Atable%2Dcell%3Bwidth%3A1%25%7D%2Enav%2Djustified%3Eli%3Ea%7Bmargin%2Dbottom%3A0%7D%7D%2Enav%2Dtabs%2Djustified%7Bborder%2Dbottom%3A0%7D%2Enav%2Dtabs%2Djustified%3Eli%3Ea%7Bmargin%2Dright%3A0%3Bborder%2Dradius%3A4px%7D%2Enav%2Dtabs%2Djustified%3E%2Eactive%3Ea%2C%2Enav%2Dtabs%2Djustified%3E%2Eactive%3Ea%3Afocus%2C%2Enav%2Dtabs%2Djustified%3E%2Eactive%3Ea%3Ahover%7Bborder%3A1px%20solid%20%23ddd%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enav%2Dtabs%2Djustified%3Eli%3Ea%7Bborder%2Dbottom%3A1px%20solid%20%23ddd%3Bborder%2Dradius%3A4px%204px%200%200%7D%2Enav%2Dtabs%2Djustified%3E%2Eactive%3Ea%2C%2Enav%2Dtabs%2Djustified%3E%2Eactive%3Ea%3Afocus%2C%2Enav%2Dtabs%2Djustified%3E%2Eactive%3Ea%3Ahover%7Bborder%2Dbottom%2Dcolor%3A%23fff%7D%7D%2Etab%2Dcontent%3E%2Etab%2Dpane%7Bdisplay%3Anone%7D%2Etab%2Dcontent%3E%2Eactive%7Bdisplay%3Ablock%7D%2Enav%2Dtabs%20%2Edropdown%2Dmenu%7Bmargin%2Dtop%3A%2D1px%3Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dtop%2Dright%2Dradius%3A0%7D%2Enavbar%7Bposition%3Arelative%3Bmin%2Dheight%3A50px%3Bmargin%2Dbottom%3A20px%3Bborder%3A1px%20solid%20transparent%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%7Bborder%2Dradius%3A4px%7D%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dheader%7Bfloat%3Aleft%7D%7D%2Enavbar%2Dcollapse%7Bpadding%2Dright%3A15px%3Bpadding%2Dleft%3A15px%3Boverflow%2Dx%3Avisible%3B%2Dwebkit%2Doverflow%2Dscrolling%3Atouch%3Bborder%2Dtop%3A1px%20solid%20transparent%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%200%20rgba%28255%2C255%2C255%2C%2E1%29%3Bbox%2Dshadow%3Ainset%200%201px%200%20rgba%28255%2C255%2C255%2C%2E1%29%7D%2Enavbar%2Dcollapse%2Ein%7Boverflow%2Dy%3Aauto%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dcollapse%7Bwidth%3Aauto%3Bborder%2Dtop%3A0%3B%2Dwebkit%2Dbox%2Dshadow%3Anone%3Bbox%2Dshadow%3Anone%7D%2Enavbar%2Dcollapse%2Ecollapse%7Bdisplay%3Ablock%21important%3Bheight%3Aauto%21important%3Bpadding%2Dbottom%3A0%3Boverflow%3Avisible%21important%7D%2Enavbar%2Dcollapse%2Ein%7Boverflow%2Dy%3Avisible%7D%2Enavbar%2Dfixed%2Dbottom%20%2Enavbar%2Dcollapse%2C%2Enavbar%2Dfixed%2Dtop%20%2Enavbar%2Dcollapse%2C%2Enavbar%2Dstatic%2Dtop%20%2Enavbar%2Dcollapse%7Bpadding%2Dright%3A0%3Bpadding%2Dleft%3A0%7D%7D%2Enavbar%2Dfixed%2Dbottom%20%2Enavbar%2Dcollapse%2C%2Enavbar%2Dfixed%2Dtop%20%2Enavbar%2Dcollapse%7Bmax%2Dheight%3A340px%7D%40media%20%28max%2Ddevice%2Dwidth%3A480px%29%20and%20%28orientation%3Alandscape%29%7B%2Enavbar%2Dfixed%2Dbottom%20%2Enavbar%2Dcollapse%2C%2Enavbar%2Dfixed%2Dtop%20%2Enavbar%2Dcollapse%7Bmax%2Dheight%3A200px%7D%7D%2Econtainer%2Dfluid%3E%2Enavbar%2Dcollapse%2C%2Econtainer%2Dfluid%3E%2Enavbar%2Dheader%2C%2Econtainer%3E%2Enavbar%2Dcollapse%2C%2Econtainer%3E%2Enavbar%2Dheader%7Bmargin%2Dright%3A%2D15px%3Bmargin%2Dleft%3A%2D15px%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Econtainer%2Dfluid%3E%2Enavbar%2Dcollapse%2C%2Econtainer%2Dfluid%3E%2Enavbar%2Dheader%2C%2Econtainer%3E%2Enavbar%2Dcollapse%2C%2Econtainer%3E%2Enavbar%2Dheader%7Bmargin%2Dright%3A0%3Bmargin%2Dleft%3A0%7D%7D%2Enavbar%2Dstatic%2Dtop%7Bz%2Dindex%3A1000%3Bborder%2Dwidth%3A0%200%201px%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dstatic%2Dtop%7Bborder%2Dradius%3A0%7D%7D%2Enavbar%2Dfixed%2Dbottom%2C%2Enavbar%2Dfixed%2Dtop%7Bposition%3Afixed%3Bright%3A0%3Bleft%3A0%3Bz%2Dindex%3A1030%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dfixed%2Dbottom%2C%2Enavbar%2Dfixed%2Dtop%7Bborder%2Dradius%3A0%7D%7D%2Enavbar%2Dfixed%2Dtop%7Btop%3A0%3Bborder%2Dwidth%3A0%200%201px%7D%2Enavbar%2Dfixed%2Dbottom%7Bbottom%3A0%3Bmargin%2Dbottom%3A0%3Bborder%2Dwidth%3A1px%200%200%7D%2Enavbar%2Dbrand%7Bfloat%3Aleft%3Bheight%3A50px%3Bpadding%3A15px%2015px%3Bfont%2Dsize%3A18px%3Bline%2Dheight%3A20px%7D%2Enavbar%2Dbrand%3Afocus%2C%2Enavbar%2Dbrand%3Ahover%7Btext%2Ddecoration%3Anone%7D%2Enavbar%2Dbrand%3Eimg%7Bdisplay%3Ablock%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%3E%2Econtainer%20%2Enavbar%2Dbrand%2C%2Enavbar%3E%2Econtainer%2Dfluid%20%2Enavbar%2Dbrand%7Bmargin%2Dleft%3A%2D15px%7D%7D%2Enavbar%2Dtoggle%7Bposition%3Arelative%3Bfloat%3Aright%3Bpadding%3A9px%2010px%3Bmargin%2Dtop%3A8px%3Bmargin%2Dright%3A15px%3Bmargin%2Dbottom%3A8px%3Bbackground%2Dcolor%3Atransparent%3Bbackground%2Dimage%3Anone%3Bborder%3A1px%20solid%20transparent%3Bborder%2Dradius%3A4px%7D%2Enavbar%2Dtoggle%3Afocus%7Boutline%3A0%7D%2Enavbar%2Dtoggle%20%2Eicon%2Dbar%7Bdisplay%3Ablock%3Bwidth%3A22px%3Bheight%3A2px%3Bborder%2Dradius%3A1px%7D%2Enavbar%2Dtoggle%20%2Eicon%2Dbar%2B%2Eicon%2Dbar%7Bmargin%2Dtop%3A4px%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dtoggle%7Bdisplay%3Anone%7D%7D%2Enavbar%2Dnav%7Bmargin%3A7%2E5px%20%2D15px%7D%2Enavbar%2Dnav%3Eli%3Ea%7Bpadding%2Dtop%3A10px%3Bpadding%2Dbottom%3A10px%3Bline%2Dheight%3A20px%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%7Bposition%3Astatic%3Bfloat%3Anone%3Bwidth%3Aauto%3Bmargin%2Dtop%3A0%3Bbackground%2Dcolor%3Atransparent%3Bborder%3A0%3B%2Dwebkit%2Dbox%2Dshadow%3Anone%3Bbox%2Dshadow%3Anone%7D%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%20%2Edropdown%2Dheader%2C%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%7Bpadding%3A5px%2015px%205px%2025px%7D%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%7Bline%2Dheight%3A20px%7D%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%3Afocus%2C%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%3Ahover%7Bbackground%2Dimage%3Anone%7D%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dnav%7Bfloat%3Aleft%3Bmargin%3A0%7D%2Enavbar%2Dnav%3Eli%7Bfloat%3Aleft%7D%2Enavbar%2Dnav%3Eli%3Ea%7Bpadding%2Dtop%3A15px%3Bpadding%2Dbottom%3A15px%7D%7D%2Enavbar%2Dform%7Bpadding%3A10px%2015px%3Bmargin%2Dtop%3A8px%3Bmargin%2Dright%3A%2D15px%3Bmargin%2Dbottom%3A8px%3Bmargin%2Dleft%3A%2D15px%3Bborder%2Dtop%3A1px%20solid%20transparent%3Bborder%2Dbottom%3A1px%20solid%20transparent%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%200%20rgba%28255%2C255%2C255%2C%2E1%29%2C0%201px%200%20rgba%28255%2C255%2C255%2C%2E1%29%3Bbox%2Dshadow%3Ainset%200%201px%200%20rgba%28255%2C255%2C255%2C%2E1%29%2C0%201px%200%20rgba%28255%2C255%2C255%2C%2E1%29%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dform%20%2Eform%2Dgroup%7Bdisplay%3Ainline%2Dblock%3Bmargin%2Dbottom%3A0%3Bvertical%2Dalign%3Amiddle%7D%2Enavbar%2Dform%20%2Eform%2Dcontrol%7Bdisplay%3Ainline%2Dblock%3Bwidth%3Aauto%3Bvertical%2Dalign%3Amiddle%7D%2Enavbar%2Dform%20%2Eform%2Dcontrol%2Dstatic%7Bdisplay%3Ainline%2Dblock%7D%2Enavbar%2Dform%20%2Einput%2Dgroup%7Bdisplay%3Ainline%2Dtable%3Bvertical%2Dalign%3Amiddle%7D%2Enavbar%2Dform%20%2Einput%2Dgroup%20%2Eform%2Dcontrol%2C%2Enavbar%2Dform%20%2Einput%2Dgroup%20%2Einput%2Dgroup%2Daddon%2C%2Enavbar%2Dform%20%2Einput%2Dgroup%20%2Einput%2Dgroup%2Dbtn%7Bwidth%3Aauto%7D%2Enavbar%2Dform%20%2Einput%2Dgroup%3E%2Eform%2Dcontrol%7Bwidth%3A100%25%7D%2Enavbar%2Dform%20%2Econtrol%2Dlabel%7Bmargin%2Dbottom%3A0%3Bvertical%2Dalign%3Amiddle%7D%2Enavbar%2Dform%20%2Echeckbox%2C%2Enavbar%2Dform%20%2Eradio%7Bdisplay%3Ainline%2Dblock%3Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A0%3Bvertical%2Dalign%3Amiddle%7D%2Enavbar%2Dform%20%2Echeckbox%20label%2C%2Enavbar%2Dform%20%2Eradio%20label%7Bpadding%2Dleft%3A0%7D%2Enavbar%2Dform%20%2Echeckbox%20input%5Btype%3Dcheckbox%5D%2C%2Enavbar%2Dform%20%2Eradio%20input%5Btype%3Dradio%5D%7Bposition%3Arelative%3Bmargin%2Dleft%3A0%7D%2Enavbar%2Dform%20%2Ehas%2Dfeedback%20%2Eform%2Dcontrol%2Dfeedback%7Btop%3A0%7D%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Enavbar%2Dform%20%2Eform%2Dgroup%7Bmargin%2Dbottom%3A5px%7D%2Enavbar%2Dform%20%2Eform%2Dgroup%3Alast%2Dchild%7Bmargin%2Dbottom%3A0%7D%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dform%7Bwidth%3Aauto%3Bpadding%2Dtop%3A0%3Bpadding%2Dbottom%3A0%3Bmargin%2Dright%3A0%3Bmargin%2Dleft%3A0%3Bborder%3A0%3B%2Dwebkit%2Dbox%2Dshadow%3Anone%3Bbox%2Dshadow%3Anone%7D%7D%2Enavbar%2Dnav%3Eli%3E%2Edropdown%2Dmenu%7Bmargin%2Dtop%3A0%3Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dtop%2Dright%2Dradius%3A0%7D%2Enavbar%2Dfixed%2Dbottom%20%2Enavbar%2Dnav%3Eli%3E%2Edropdown%2Dmenu%7Bmargin%2Dbottom%3A0%3Bborder%2Dtop%2Dleft%2Dradius%3A4px%3Bborder%2Dtop%2Dright%2Dradius%3A4px%3Bborder%2Dbottom%2Dright%2Dradius%3A0%3Bborder%2Dbottom%2Dleft%2Dradius%3A0%7D%2Enavbar%2Dbtn%7Bmargin%2Dtop%3A8px%3Bmargin%2Dbottom%3A8px%7D%2Enavbar%2Dbtn%2Ebtn%2Dsm%7Bmargin%2Dtop%3A10px%3Bmargin%2Dbottom%3A10px%7D%2Enavbar%2Dbtn%2Ebtn%2Dxs%7Bmargin%2Dtop%3A14px%3Bmargin%2Dbottom%3A14px%7D%2Enavbar%2Dtext%7Bmargin%2Dtop%3A15px%3Bmargin%2Dbottom%3A15px%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dtext%7Bfloat%3Aleft%3Bmargin%2Dright%3A15px%3Bmargin%2Dleft%3A15px%7D%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dleft%7Bfloat%3Aleft%21important%7D%2Enavbar%2Dright%7Bfloat%3Aright%21important%3Bmargin%2Dright%3A%2D15px%7D%2Enavbar%2Dright%7E%2Enavbar%2Dright%7Bmargin%2Dright%3A0%7D%7D%2Enavbar%2Ddefault%7Bbackground%2Dcolor%3A%23f8f8f8%3Bborder%2Dcolor%3A%23e7e7e7%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dbrand%7Bcolor%3A%23777%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dbrand%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dbrand%3Ahover%7Bcolor%3A%235e5e5e%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dtext%7Bcolor%3A%23777%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3Eli%3Ea%7Bcolor%3A%23777%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3Eli%3Ea%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3Eli%3Ea%3Ahover%7Bcolor%3A%23333%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Eactive%3Ea%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Eactive%3Ea%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Eactive%3Ea%3Ahover%7Bcolor%3A%23555%3Bbackground%2Dcolor%3A%23e7e7e7%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Edisabled%3Ea%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Edisabled%3Ea%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Edisabled%3Ea%3Ahover%7Bcolor%3A%23ccc%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dtoggle%7Bborder%2Dcolor%3A%23ddd%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dtoggle%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dtoggle%3Ahover%7Bbackground%2Dcolor%3A%23ddd%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dtoggle%20%2Eicon%2Dbar%7Bbackground%2Dcolor%3A%23888%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dcollapse%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dform%7Bborder%2Dcolor%3A%23e7e7e7%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Eopen%3Ea%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Eopen%3Ea%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Eopen%3Ea%3Ahover%7Bcolor%3A%23555%3Bbackground%2Dcolor%3A%23e7e7e7%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%7Bcolor%3A%23777%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%3Ahover%7Bcolor%3A%23333%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Eactive%3Ea%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Eactive%3Ea%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Eactive%3Ea%3Ahover%7Bcolor%3A%23555%3Bbackground%2Dcolor%3A%23e7e7e7%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Ahover%7Bcolor%3A%23ccc%3Bbackground%2Dcolor%3Atransparent%7D%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dlink%7Bcolor%3A%23777%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dlink%3Ahover%7Bcolor%3A%23333%7D%2Enavbar%2Ddefault%20%2Ebtn%2Dlink%7Bcolor%3A%23777%7D%2Enavbar%2Ddefault%20%2Ebtn%2Dlink%3Afocus%2C%2Enavbar%2Ddefault%20%2Ebtn%2Dlink%3Ahover%7Bcolor%3A%23333%7D%2Enavbar%2Ddefault%20%2Ebtn%2Dlink%5Bdisabled%5D%3Afocus%2C%2Enavbar%2Ddefault%20%2Ebtn%2Dlink%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Enavbar%2Ddefault%20%2Ebtn%2Dlink%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Enavbar%2Ddefault%20%2Ebtn%2Dlink%3Ahover%7Bcolor%3A%23ccc%7D%2Enavbar%2Dinverse%7Bbackground%2Dcolor%3A%23222%3Bborder%2Dcolor%3A%23080808%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dbrand%7Bcolor%3A%239d9d9d%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dbrand%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dbrand%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dtext%7Bcolor%3A%239d9d9d%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3Eli%3Ea%7Bcolor%3A%239d9d9d%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3Eli%3Ea%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3Eli%3Ea%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Eactive%3Ea%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Eactive%3Ea%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Eactive%3Ea%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23080808%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Edisabled%3Ea%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Edisabled%3Ea%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Edisabled%3Ea%3Ahover%7Bcolor%3A%23444%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dtoggle%7Bborder%2Dcolor%3A%23333%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dtoggle%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dtoggle%3Ahover%7Bbackground%2Dcolor%3A%23333%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dtoggle%20%2Eicon%2Dbar%7Bbackground%2Dcolor%3A%23fff%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dcollapse%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dform%7Bborder%2Dcolor%3A%23101010%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Eopen%3Ea%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Eopen%3Ea%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Eopen%3Ea%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23080808%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Edropdown%2Dheader%7Bborder%2Dcolor%3A%23080808%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%20%2Edivider%7Bbackground%2Dcolor%3A%23080808%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%7Bcolor%3A%239d9d9d%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Eactive%3Ea%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Eactive%3Ea%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Eactive%3Ea%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23080808%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Ahover%7Bcolor%3A%23444%3Bbackground%2Dcolor%3Atransparent%7D%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dlink%7Bcolor%3A%239d9d9d%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dlink%3Ahover%7Bcolor%3A%23fff%7D%2Enavbar%2Dinverse%20%2Ebtn%2Dlink%7Bcolor%3A%239d9d9d%7D%2Enavbar%2Dinverse%20%2Ebtn%2Dlink%3Afocus%2C%2Enavbar%2Dinverse%20%2Ebtn%2Dlink%3Ahover%7Bcolor%3A%23fff%7D%2Enavbar%2Dinverse%20%2Ebtn%2Dlink%5Bdisabled%5D%3Afocus%2C%2Enavbar%2Dinverse%20%2Ebtn%2Dlink%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Enavbar%2Dinverse%20%2Ebtn%2Dlink%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Enavbar%2Dinverse%20%2Ebtn%2Dlink%3Ahover%7Bcolor%3A%23444%7D%2Ebreadcrumb%7Bpadding%3A8px%2015px%3Bmargin%2Dbottom%3A20px%3Blist%2Dstyle%3Anone%3Bbackground%2Dcolor%3A%23f5f5f5%3Bborder%2Dradius%3A4px%7D%2Ebreadcrumb%3Eli%7Bdisplay%3Ainline%2Dblock%7D%2Ebreadcrumb%3Eli%2Bli%3Abefore%7Bpadding%3A0%205px%3Bcolor%3A%23ccc%3Bcontent%3A%22%2F%5C00a0%22%7D%2Ebreadcrumb%3E%2Eactive%7Bcolor%3A%23777%7D%2Epagination%7Bdisplay%3Ainline%2Dblock%3Bpadding%2Dleft%3A0%3Bmargin%3A20px%200%3Bborder%2Dradius%3A4px%7D%2Epagination%3Eli%7Bdisplay%3Ainline%7D%2Epagination%3Eli%3Ea%2C%2Epagination%3Eli%3Espan%7Bposition%3Arelative%3Bfloat%3Aleft%3Bpadding%3A6px%2012px%3Bmargin%2Dleft%3A%2D1px%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23337ab7%3Btext%2Ddecoration%3Anone%3Bbackground%2Dcolor%3A%23fff%3Bborder%3A1px%20solid%20%23ddd%7D%2Epagination%3Eli%3Afirst%2Dchild%3Ea%2C%2Epagination%3Eli%3Afirst%2Dchild%3Espan%7Bmargin%2Dleft%3A0%3Bborder%2Dtop%2Dleft%2Dradius%3A4px%3Bborder%2Dbottom%2Dleft%2Dradius%3A4px%7D%2Epagination%3Eli%3Alast%2Dchild%3Ea%2C%2Epagination%3Eli%3Alast%2Dchild%3Espan%7Bborder%2Dtop%2Dright%2Dradius%3A4px%3Bborder%2Dbottom%2Dright%2Dradius%3A4px%7D%2Epagination%3Eli%3Ea%3Afocus%2C%2Epagination%3Eli%3Ea%3Ahover%2C%2Epagination%3Eli%3Espan%3Afocus%2C%2Epagination%3Eli%3Espan%3Ahover%7Bz%2Dindex%3A3%3Bcolor%3A%2323527c%3Bbackground%2Dcolor%3A%23eee%3Bborder%2Dcolor%3A%23ddd%7D%2Epagination%3E%2Eactive%3Ea%2C%2Epagination%3E%2Eactive%3Ea%3Afocus%2C%2Epagination%3E%2Eactive%3Ea%3Ahover%2C%2Epagination%3E%2Eactive%3Espan%2C%2Epagination%3E%2Eactive%3Espan%3Afocus%2C%2Epagination%3E%2Eactive%3Espan%3Ahover%7Bz%2Dindex%3A2%3Bcolor%3A%23fff%3Bcursor%3Adefault%3Bbackground%2Dcolor%3A%23337ab7%3Bborder%2Dcolor%3A%23337ab7%7D%2Epagination%3E%2Edisabled%3Ea%2C%2Epagination%3E%2Edisabled%3Ea%3Afocus%2C%2Epagination%3E%2Edisabled%3Ea%3Ahover%2C%2Epagination%3E%2Edisabled%3Espan%2C%2Epagination%3E%2Edisabled%3Espan%3Afocus%2C%2Epagination%3E%2Edisabled%3Espan%3Ahover%7Bcolor%3A%23777%3Bcursor%3Anot%2Dallowed%3Bbackground%2Dcolor%3A%23fff%3Bborder%2Dcolor%3A%23ddd%7D%2Epagination%2Dlg%3Eli%3Ea%2C%2Epagination%2Dlg%3Eli%3Espan%7Bpadding%3A10px%2016px%3Bfont%2Dsize%3A18px%3Bline%2Dheight%3A1%2E3333333%7D%2Epagination%2Dlg%3Eli%3Afirst%2Dchild%3Ea%2C%2Epagination%2Dlg%3Eli%3Afirst%2Dchild%3Espan%7Bborder%2Dtop%2Dleft%2Dradius%3A6px%3Bborder%2Dbottom%2Dleft%2Dradius%3A6px%7D%2Epagination%2Dlg%3Eli%3Alast%2Dchild%3Ea%2C%2Epagination%2Dlg%3Eli%3Alast%2Dchild%3Espan%7Bborder%2Dtop%2Dright%2Dradius%3A6px%3Bborder%2Dbottom%2Dright%2Dradius%3A6px%7D%2Epagination%2Dsm%3Eli%3Ea%2C%2Epagination%2Dsm%3Eli%3Espan%7Bpadding%3A5px%2010px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E5%7D%2Epagination%2Dsm%3Eli%3Afirst%2Dchild%3Ea%2C%2Epagination%2Dsm%3Eli%3Afirst%2Dchild%3Espan%7Bborder%2Dtop%2Dleft%2Dradius%3A3px%3Bborder%2Dbottom%2Dleft%2Dradius%3A3px%7D%2Epagination%2Dsm%3Eli%3Alast%2Dchild%3Ea%2C%2Epagination%2Dsm%3Eli%3Alast%2Dchild%3Espan%7Bborder%2Dtop%2Dright%2Dradius%3A3px%3Bborder%2Dbottom%2Dright%2Dradius%3A3px%7D%2Epager%7Bpadding%2Dleft%3A0%3Bmargin%3A20px%200%3Btext%2Dalign%3Acenter%3Blist%2Dstyle%3Anone%7D%2Epager%20li%7Bdisplay%3Ainline%7D%2Epager%20li%3Ea%2C%2Epager%20li%3Espan%7Bdisplay%3Ainline%2Dblock%3Bpadding%3A5px%2014px%3Bbackground%2Dcolor%3A%23fff%3Bborder%3A1px%20solid%20%23ddd%3Bborder%2Dradius%3A15px%7D%2Epager%20li%3Ea%3Afocus%2C%2Epager%20li%3Ea%3Ahover%7Btext%2Ddecoration%3Anone%3Bbackground%2Dcolor%3A%23eee%7D%2Epager%20%2Enext%3Ea%2C%2Epager%20%2Enext%3Espan%7Bfloat%3Aright%7D%2Epager%20%2Eprevious%3Ea%2C%2Epager%20%2Eprevious%3Espan%7Bfloat%3Aleft%7D%2Epager%20%2Edisabled%3Ea%2C%2Epager%20%2Edisabled%3Ea%3Afocus%2C%2Epager%20%2Edisabled%3Ea%3Ahover%2C%2Epager%20%2Edisabled%3Espan%7Bcolor%3A%23777%3Bcursor%3Anot%2Dallowed%3Bbackground%2Dcolor%3A%23fff%7D%2Elabel%7Bdisplay%3Ainline%3Bpadding%3A%2E2em%20%2E6em%20%2E3em%3Bfont%2Dsize%3A75%25%3Bfont%2Dweight%3A700%3Bline%2Dheight%3A1%3Bcolor%3A%23fff%3Btext%2Dalign%3Acenter%3Bwhite%2Dspace%3Anowrap%3Bvertical%2Dalign%3Abaseline%3Bborder%2Dradius%3A%2E25em%7Da%2Elabel%3Afocus%2Ca%2Elabel%3Ahover%7Bcolor%3A%23fff%3Btext%2Ddecoration%3Anone%3Bcursor%3Apointer%7D%2Elabel%3Aempty%7Bdisplay%3Anone%7D%2Ebtn%20%2Elabel%7Bposition%3Arelative%3Btop%3A%2D1px%7D%2Elabel%2Ddefault%7Bbackground%2Dcolor%3A%23777%7D%2Elabel%2Ddefault%5Bhref%5D%3Afocus%2C%2Elabel%2Ddefault%5Bhref%5D%3Ahover%7Bbackground%2Dcolor%3A%235e5e5e%7D%2Elabel%2Dprimary%7Bbackground%2Dcolor%3A%23337ab7%7D%2Elabel%2Dprimary%5Bhref%5D%3Afocus%2C%2Elabel%2Dprimary%5Bhref%5D%3Ahover%7Bbackground%2Dcolor%3A%23286090%7D%2Elabel%2Dsuccess%7Bbackground%2Dcolor%3A%235cb85c%7D%2Elabel%2Dsuccess%5Bhref%5D%3Afocus%2C%2Elabel%2Dsuccess%5Bhref%5D%3Ahover%7Bbackground%2Dcolor%3A%23449d44%7D%2Elabel%2Dinfo%7Bbackground%2Dcolor%3A%235bc0de%7D%2Elabel%2Dinfo%5Bhref%5D%3Afocus%2C%2Elabel%2Dinfo%5Bhref%5D%3Ahover%7Bbackground%2Dcolor%3A%2331b0d5%7D%2Elabel%2Dwarning%7Bbackground%2Dcolor%3A%23f0ad4e%7D%2Elabel%2Dwarning%5Bhref%5D%3Afocus%2C%2Elabel%2Dwarning%5Bhref%5D%3Ahover%7Bbackground%2Dcolor%3A%23ec971f%7D%2Elabel%2Ddanger%7Bbackground%2Dcolor%3A%23d9534f%7D%2Elabel%2Ddanger%5Bhref%5D%3Afocus%2C%2Elabel%2Ddanger%5Bhref%5D%3Ahover%7Bbackground%2Dcolor%3A%23c9302c%7D%2Ebadge%7Bdisplay%3Ainline%2Dblock%3Bmin%2Dwidth%3A10px%3Bpadding%3A3px%207px%3Bfont%2Dsize%3A12px%3Bfont%2Dweight%3A700%3Bline%2Dheight%3A1%3Bcolor%3A%23fff%3Btext%2Dalign%3Acenter%3Bwhite%2Dspace%3Anowrap%3Bvertical%2Dalign%3Amiddle%3Bbackground%2Dcolor%3A%23777%3Bborder%2Dradius%3A10px%7D%2Ebadge%3Aempty%7Bdisplay%3Anone%7D%2Ebtn%20%2Ebadge%7Bposition%3Arelative%3Btop%3A%2D1px%7D%2Ebtn%2Dgroup%2Dxs%3E%2Ebtn%20%2Ebadge%2C%2Ebtn%2Dxs%20%2Ebadge%7Btop%3A0%3Bpadding%3A1px%205px%7Da%2Ebadge%3Afocus%2Ca%2Ebadge%3Ahover%7Bcolor%3A%23fff%3Btext%2Ddecoration%3Anone%3Bcursor%3Apointer%7D%2Elist%2Dgroup%2Ditem%2Eactive%3E%2Ebadge%2C%2Enav%2Dpills%3E%2Eactive%3Ea%3E%2Ebadge%7Bcolor%3A%23337ab7%3Bbackground%2Dcolor%3A%23fff%7D%2Elist%2Dgroup%2Ditem%3E%2Ebadge%7Bfloat%3Aright%7D%2Elist%2Dgroup%2Ditem%3E%2Ebadge%2B%2Ebadge%7Bmargin%2Dright%3A5px%7D%2Enav%2Dpills%3Eli%3Ea%3E%2Ebadge%7Bmargin%2Dleft%3A3px%7D%2Ejumbotron%7Bpadding%2Dtop%3A30px%3Bpadding%2Dbottom%3A30px%3Bmargin%2Dbottom%3A30px%3Bcolor%3Ainherit%3Bbackground%2Dcolor%3A%23eee%7D%2Ejumbotron%20%2Eh1%2C%2Ejumbotron%20h1%7Bcolor%3Ainherit%7D%2Ejumbotron%20p%7Bmargin%2Dbottom%3A15px%3Bfont%2Dsize%3A21px%3Bfont%2Dweight%3A200%7D%2Ejumbotron%3Ehr%7Bborder%2Dtop%2Dcolor%3A%23d5d5d5%7D%2Econtainer%20%2Ejumbotron%2C%2Econtainer%2Dfluid%20%2Ejumbotron%7Bborder%2Dradius%3A6px%7D%2Ejumbotron%20%2Econtainer%7Bmax%2Dwidth%3A100%25%7D%40media%20screen%20and%20%28min%2Dwidth%3A768px%29%7B%2Ejumbotron%7Bpadding%2Dtop%3A48px%3Bpadding%2Dbottom%3A48px%7D%2Econtainer%20%2Ejumbotron%2C%2Econtainer%2Dfluid%20%2Ejumbotron%7Bpadding%2Dright%3A60px%3Bpadding%2Dleft%3A60px%7D%2Ejumbotron%20%2Eh1%2C%2Ejumbotron%20h1%7Bfont%2Dsize%3A63px%7D%7D%2Ethumbnail%7Bdisplay%3Ablock%3Bpadding%3A4px%3Bmargin%2Dbottom%3A20px%3Bline%2Dheight%3A1%2E42857143%3Bbackground%2Dcolor%3A%23fff%3Bborder%3A1px%20solid%20%23ddd%3Bborder%2Dradius%3A4px%3B%2Dwebkit%2Dtransition%3Aborder%20%2E2s%20ease%2Din%2Dout%3B%2Do%2Dtransition%3Aborder%20%2E2s%20ease%2Din%2Dout%3Btransition%3Aborder%20%2E2s%20ease%2Din%2Dout%7D%2Ethumbnail%20a%3Eimg%2C%2Ethumbnail%3Eimg%7Bmargin%2Dright%3Aauto%3Bmargin%2Dleft%3Aauto%7Da%2Ethumbnail%2Eactive%2Ca%2Ethumbnail%3Afocus%2Ca%2Ethumbnail%3Ahover%7Bborder%2Dcolor%3A%23337ab7%7D%2Ethumbnail%20%2Ecaption%7Bpadding%3A9px%3Bcolor%3A%23333%7D%2Ealert%7Bpadding%3A15px%3Bmargin%2Dbottom%3A20px%3Bborder%3A1px%20solid%20transparent%3Bborder%2Dradius%3A4px%7D%2Ealert%20h4%7Bmargin%2Dtop%3A0%3Bcolor%3Ainherit%7D%2Ealert%20%2Ealert%2Dlink%7Bfont%2Dweight%3A700%7D%2Ealert%3Ep%2C%2Ealert%3Eul%7Bmargin%2Dbottom%3A0%7D%2Ealert%3Ep%2Bp%7Bmargin%2Dtop%3A5px%7D%2Ealert%2Ddismissable%2C%2Ealert%2Ddismissible%7Bpadding%2Dright%3A35px%7D%2Ealert%2Ddismissable%20%2Eclose%2C%2Ealert%2Ddismissible%20%2Eclose%7Bposition%3Arelative%3Btop%3A%2D2px%3Bright%3A%2D21px%3Bcolor%3Ainherit%7D%2Ealert%2Dsuccess%7Bcolor%3A%233c763d%3Bbackground%2Dcolor%3A%23dff0d8%3Bborder%2Dcolor%3A%23d6e9c6%7D%2Ealert%2Dsuccess%20hr%7Bborder%2Dtop%2Dcolor%3A%23c9e2b3%7D%2Ealert%2Dsuccess%20%2Ealert%2Dlink%7Bcolor%3A%232b542c%7D%2Ealert%2Dinfo%7Bcolor%3A%2331708f%3Bbackground%2Dcolor%3A%23d9edf7%3Bborder%2Dcolor%3A%23bce8f1%7D%2Ealert%2Dinfo%20hr%7Bborder%2Dtop%2Dcolor%3A%23a6e1ec%7D%2Ealert%2Dinfo%20%2Ealert%2Dlink%7Bcolor%3A%23245269%7D%2Ealert%2Dwarning%7Bcolor%3A%238a6d3b%3Bbackground%2Dcolor%3A%23fcf8e3%3Bborder%2Dcolor%3A%23faebcc%7D%2Ealert%2Dwarning%20hr%7Bborder%2Dtop%2Dcolor%3A%23f7e1b5%7D%2Ealert%2Dwarning%20%2Ealert%2Dlink%7Bcolor%3A%2366512c%7D%2Ealert%2Ddanger%7Bcolor%3A%23a94442%3Bbackground%2Dcolor%3A%23f2dede%3Bborder%2Dcolor%3A%23ebccd1%7D%2Ealert%2Ddanger%20hr%7Bborder%2Dtop%2Dcolor%3A%23e4b9c0%7D%2Ealert%2Ddanger%20%2Ealert%2Dlink%7Bcolor%3A%23843534%7D%40%2Dwebkit%2Dkeyframes%20progress%2Dbar%2Dstripes%7Bfrom%7Bbackground%2Dposition%3A40px%200%7Dto%7Bbackground%2Dposition%3A0%200%7D%7D%40%2Do%2Dkeyframes%20progress%2Dbar%2Dstripes%7Bfrom%7Bbackground%2Dposition%3A40px%200%7Dto%7Bbackground%2Dposition%3A0%200%7D%7D%40keyframes%20progress%2Dbar%2Dstripes%7Bfrom%7Bbackground%2Dposition%3A40px%200%7Dto%7Bbackground%2Dposition%3A0%200%7D%7D%2Eprogress%7Bheight%3A20px%3Bmargin%2Dbottom%3A20px%3Boverflow%3Ahidden%3Bbackground%2Dcolor%3A%23f5f5f5%3Bborder%2Dradius%3A4px%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%202px%20rgba%280%2C0%2C0%2C%2E1%29%3Bbox%2Dshadow%3Ainset%200%201px%202px%20rgba%280%2C0%2C0%2C%2E1%29%7D%2Eprogress%2Dbar%7Bfloat%3Aleft%3Bwidth%3A0%3Bheight%3A100%25%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A20px%3Bcolor%3A%23fff%3Btext%2Dalign%3Acenter%3Bbackground%2Dcolor%3A%23337ab7%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%20%2D1px%200%20rgba%280%2C0%2C0%2C%2E15%29%3Bbox%2Dshadow%3Ainset%200%20%2D1px%200%20rgba%280%2C0%2C0%2C%2E15%29%3B%2Dwebkit%2Dtransition%3Awidth%20%2E6s%20ease%3B%2Do%2Dtransition%3Awidth%20%2E6s%20ease%3Btransition%3Awidth%20%2E6s%20ease%7D%2Eprogress%2Dbar%2Dstriped%2C%2Eprogress%2Dstriped%20%2Eprogress%2Dbar%7Bbackground%2Dimage%3A%2Dwebkit%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3A%2Do%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3Alinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3B%2Dwebkit%2Dbackground%2Dsize%3A40px%2040px%3Bbackground%2Dsize%3A40px%2040px%7D%2Eprogress%2Dbar%2Eactive%2C%2Eprogress%2Eactive%20%2Eprogress%2Dbar%7B%2Dwebkit%2Danimation%3Aprogress%2Dbar%2Dstripes%202s%20linear%20infinite%3B%2Do%2Danimation%3Aprogress%2Dbar%2Dstripes%202s%20linear%20infinite%3Banimation%3Aprogress%2Dbar%2Dstripes%202s%20linear%20infinite%7D%2Eprogress%2Dbar%2Dsuccess%7Bbackground%2Dcolor%3A%235cb85c%7D%2Eprogress%2Dstriped%20%2Eprogress%2Dbar%2Dsuccess%7Bbackground%2Dimage%3A%2Dwebkit%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3A%2Do%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3Alinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%7D%2Eprogress%2Dbar%2Dinfo%7Bbackground%2Dcolor%3A%235bc0de%7D%2Eprogress%2Dstriped%20%2Eprogress%2Dbar%2Dinfo%7Bbackground%2Dimage%3A%2Dwebkit%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3A%2Do%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3Alinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%7D%2Eprogress%2Dbar%2Dwarning%7Bbackground%2Dcolor%3A%23f0ad4e%7D%2Eprogress%2Dstriped%20%2Eprogress%2Dbar%2Dwarning%7Bbackground%2Dimage%3A%2Dwebkit%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3A%2Do%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3Alinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%7D%2Eprogress%2Dbar%2Ddanger%7Bbackground%2Dcolor%3A%23d9534f%7D%2Eprogress%2Dstriped%20%2Eprogress%2Dbar%2Ddanger%7Bbackground%2Dimage%3A%2Dwebkit%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3A%2Do%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3Alinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%7D%2Emedia%7Bmargin%2Dtop%3A15px%7D%2Emedia%3Afirst%2Dchild%7Bmargin%2Dtop%3A0%7D%2Emedia%2C%2Emedia%2Dbody%7Boverflow%3Ahidden%3Bzoom%3A1%7D%2Emedia%2Dbody%7Bwidth%3A10000px%7D%2Emedia%2Dobject%7Bdisplay%3Ablock%7D%2Emedia%2Dobject%2Eimg%2Dthumbnail%7Bmax%2Dwidth%3Anone%7D%2Emedia%2Dright%2C%2Emedia%3E%2Epull%2Dright%7Bpadding%2Dleft%3A10px%7D%2Emedia%2Dleft%2C%2Emedia%3E%2Epull%2Dleft%7Bpadding%2Dright%3A10px%7D%2Emedia%2Dbody%2C%2Emedia%2Dleft%2C%2Emedia%2Dright%7Bdisplay%3Atable%2Dcell%3Bvertical%2Dalign%3Atop%7D%2Emedia%2Dmiddle%7Bvertical%2Dalign%3Amiddle%7D%2Emedia%2Dbottom%7Bvertical%2Dalign%3Abottom%7D%2Emedia%2Dheading%7Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A5px%7D%2Emedia%2Dlist%7Bpadding%2Dleft%3A0%3Blist%2Dstyle%3Anone%7D%2Elist%2Dgroup%7Bpadding%2Dleft%3A0%3Bmargin%2Dbottom%3A20px%7D%2Elist%2Dgroup%2Ditem%7Bposition%3Arelative%3Bdisplay%3Ablock%3Bpadding%3A10px%2015px%3Bmargin%2Dbottom%3A%2D1px%3Bbackground%2Dcolor%3A%23fff%3Bborder%3A1px%20solid%20%23ddd%7D%2Elist%2Dgroup%2Ditem%3Afirst%2Dchild%7Bborder%2Dtop%2Dleft%2Dradius%3A4px%3Bborder%2Dtop%2Dright%2Dradius%3A4px%7D%2Elist%2Dgroup%2Ditem%3Alast%2Dchild%7Bmargin%2Dbottom%3A0%3Bborder%2Dbottom%2Dright%2Dradius%3A4px%3Bborder%2Dbottom%2Dleft%2Dradius%3A4px%7Da%2Elist%2Dgroup%2Ditem%2Cbutton%2Elist%2Dgroup%2Ditem%7Bcolor%3A%23555%7Da%2Elist%2Dgroup%2Ditem%20%2Elist%2Dgroup%2Ditem%2Dheading%2Cbutton%2Elist%2Dgroup%2Ditem%20%2Elist%2Dgroup%2Ditem%2Dheading%7Bcolor%3A%23333%7Da%2Elist%2Dgroup%2Ditem%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%3Ahover%7Bcolor%3A%23555%3Btext%2Ddecoration%3Anone%3Bbackground%2Dcolor%3A%23f5f5f5%7Dbutton%2Elist%2Dgroup%2Ditem%7Bwidth%3A100%25%3Btext%2Dalign%3Aleft%7D%2Elist%2Dgroup%2Ditem%2Edisabled%2C%2Elist%2Dgroup%2Ditem%2Edisabled%3Afocus%2C%2Elist%2Dgroup%2Ditem%2Edisabled%3Ahover%7Bcolor%3A%23777%3Bcursor%3Anot%2Dallowed%3Bbackground%2Dcolor%3A%23eee%7D%2Elist%2Dgroup%2Ditem%2Edisabled%20%2Elist%2Dgroup%2Ditem%2Dheading%2C%2Elist%2Dgroup%2Ditem%2Edisabled%3Afocus%20%2Elist%2Dgroup%2Ditem%2Dheading%2C%2Elist%2Dgroup%2Ditem%2Edisabled%3Ahover%20%2Elist%2Dgroup%2Ditem%2Dheading%7Bcolor%3Ainherit%7D%2Elist%2Dgroup%2Ditem%2Edisabled%20%2Elist%2Dgroup%2Ditem%2Dtext%2C%2Elist%2Dgroup%2Ditem%2Edisabled%3Afocus%20%2Elist%2Dgroup%2Ditem%2Dtext%2C%2Elist%2Dgroup%2Ditem%2Edisabled%3Ahover%20%2Elist%2Dgroup%2Ditem%2Dtext%7Bcolor%3A%23777%7D%2Elist%2Dgroup%2Ditem%2Eactive%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Afocus%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Ahover%7Bz%2Dindex%3A2%3Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23337ab7%3Bborder%2Dcolor%3A%23337ab7%7D%2Elist%2Dgroup%2Ditem%2Eactive%20%2Elist%2Dgroup%2Ditem%2Dheading%2C%2Elist%2Dgroup%2Ditem%2Eactive%20%2Elist%2Dgroup%2Ditem%2Dheading%3E%2Esmall%2C%2Elist%2Dgroup%2Ditem%2Eactive%20%2Elist%2Dgroup%2Ditem%2Dheading%3Esmall%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Afocus%20%2Elist%2Dgroup%2Ditem%2Dheading%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Afocus%20%2Elist%2Dgroup%2Ditem%2Dheading%3E%2Esmall%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Afocus%20%2Elist%2Dgroup%2Ditem%2Dheading%3Esmall%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Ahover%20%2Elist%2Dgroup%2Ditem%2Dheading%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Ahover%20%2Elist%2Dgroup%2Ditem%2Dheading%3E%2Esmall%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Ahover%20%2Elist%2Dgroup%2Ditem%2Dheading%3Esmall%7Bcolor%3Ainherit%7D%2Elist%2Dgroup%2Ditem%2Eactive%20%2Elist%2Dgroup%2Ditem%2Dtext%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Afocus%20%2Elist%2Dgroup%2Ditem%2Dtext%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Ahover%20%2Elist%2Dgroup%2Ditem%2Dtext%7Bcolor%3A%23c7ddef%7D%2Elist%2Dgroup%2Ditem%2Dsuccess%7Bcolor%3A%233c763d%3Bbackground%2Dcolor%3A%23dff0d8%7Da%2Elist%2Dgroup%2Ditem%2Dsuccess%2Cbutton%2Elist%2Dgroup%2Ditem%2Dsuccess%7Bcolor%3A%233c763d%7Da%2Elist%2Dgroup%2Ditem%2Dsuccess%20%2Elist%2Dgroup%2Ditem%2Dheading%2Cbutton%2Elist%2Dgroup%2Ditem%2Dsuccess%20%2Elist%2Dgroup%2Ditem%2Dheading%7Bcolor%3Ainherit%7Da%2Elist%2Dgroup%2Ditem%2Dsuccess%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Dsuccess%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Dsuccess%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Dsuccess%3Ahover%7Bcolor%3A%233c763d%3Bbackground%2Dcolor%3A%23d0e9c6%7Da%2Elist%2Dgroup%2Ditem%2Dsuccess%2Eactive%2Ca%2Elist%2Dgroup%2Ditem%2Dsuccess%2Eactive%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Dsuccess%2Eactive%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Dsuccess%2Eactive%2Cbutton%2Elist%2Dgroup%2Ditem%2Dsuccess%2Eactive%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Dsuccess%2Eactive%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%233c763d%3Bborder%2Dcolor%3A%233c763d%7D%2Elist%2Dgroup%2Ditem%2Dinfo%7Bcolor%3A%2331708f%3Bbackground%2Dcolor%3A%23d9edf7%7Da%2Elist%2Dgroup%2Ditem%2Dinfo%2Cbutton%2Elist%2Dgroup%2Ditem%2Dinfo%7Bcolor%3A%2331708f%7Da%2Elist%2Dgroup%2Ditem%2Dinfo%20%2Elist%2Dgroup%2Ditem%2Dheading%2Cbutton%2Elist%2Dgroup%2Ditem%2Dinfo%20%2Elist%2Dgroup%2Ditem%2Dheading%7Bcolor%3Ainherit%7Da%2Elist%2Dgroup%2Ditem%2Dinfo%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Dinfo%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Dinfo%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Dinfo%3Ahover%7Bcolor%3A%2331708f%3Bbackground%2Dcolor%3A%23c4e3f3%7Da%2Elist%2Dgroup%2Ditem%2Dinfo%2Eactive%2Ca%2Elist%2Dgroup%2Ditem%2Dinfo%2Eactive%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Dinfo%2Eactive%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Dinfo%2Eactive%2Cbutton%2Elist%2Dgroup%2Ditem%2Dinfo%2Eactive%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Dinfo%2Eactive%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%2331708f%3Bborder%2Dcolor%3A%2331708f%7D%2Elist%2Dgroup%2Ditem%2Dwarning%7Bcolor%3A%238a6d3b%3Bbackground%2Dcolor%3A%23fcf8e3%7Da%2Elist%2Dgroup%2Ditem%2Dwarning%2Cbutton%2Elist%2Dgroup%2Ditem%2Dwarning%7Bcolor%3A%238a6d3b%7Da%2Elist%2Dgroup%2Ditem%2Dwarning%20%2Elist%2Dgroup%2Ditem%2Dheading%2Cbutton%2Elist%2Dgroup%2Ditem%2Dwarning%20%2Elist%2Dgroup%2Ditem%2Dheading%7Bcolor%3Ainherit%7Da%2Elist%2Dgroup%2Ditem%2Dwarning%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Dwarning%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Dwarning%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Dwarning%3Ahover%7Bcolor%3A%238a6d3b%3Bbackground%2Dcolor%3A%23faf2cc%7Da%2Elist%2Dgroup%2Ditem%2Dwarning%2Eactive%2Ca%2Elist%2Dgroup%2Ditem%2Dwarning%2Eactive%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Dwarning%2Eactive%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Dwarning%2Eactive%2Cbutton%2Elist%2Dgroup%2Ditem%2Dwarning%2Eactive%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Dwarning%2Eactive%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%238a6d3b%3Bborder%2Dcolor%3A%238a6d3b%7D%2Elist%2Dgroup%2Ditem%2Ddanger%7Bcolor%3A%23a94442%3Bbackground%2Dcolor%3A%23f2dede%7Da%2Elist%2Dgroup%2Ditem%2Ddanger%2Cbutton%2Elist%2Dgroup%2Ditem%2Ddanger%7Bcolor%3A%23a94442%7Da%2Elist%2Dgroup%2Ditem%2Ddanger%20%2Elist%2Dgroup%2Ditem%2Dheading%2Cbutton%2Elist%2Dgroup%2Ditem%2Ddanger%20%2Elist%2Dgroup%2Ditem%2Dheading%7Bcolor%3Ainherit%7Da%2Elist%2Dgroup%2Ditem%2Ddanger%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Ddanger%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Ddanger%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Ddanger%3Ahover%7Bcolor%3A%23a94442%3Bbackground%2Dcolor%3A%23ebcccc%7Da%2Elist%2Dgroup%2Ditem%2Ddanger%2Eactive%2Ca%2Elist%2Dgroup%2Ditem%2Ddanger%2Eactive%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Ddanger%2Eactive%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Ddanger%2Eactive%2Cbutton%2Elist%2Dgroup%2Ditem%2Ddanger%2Eactive%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Ddanger%2Eactive%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23a94442%3Bborder%2Dcolor%3A%23a94442%7D%2Elist%2Dgroup%2Ditem%2Dheading%7Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A5px%7D%2Elist%2Dgroup%2Ditem%2Dtext%7Bmargin%2Dbottom%3A0%3Bline%2Dheight%3A1%2E3%7D%2Epanel%7Bmargin%2Dbottom%3A20px%3Bbackground%2Dcolor%3A%23fff%3Bborder%3A1px%20solid%20transparent%3Bborder%2Dradius%3A4px%3B%2Dwebkit%2Dbox%2Dshadow%3A0%201px%201px%20rgba%280%2C0%2C0%2C%2E05%29%3Bbox%2Dshadow%3A0%201px%201px%20rgba%280%2C0%2C0%2C%2E05%29%7D%2Epanel%2Dbody%7Bpadding%3A15px%7D%2Epanel%2Dheading%7Bpadding%3A10px%2015px%3Bborder%2Dbottom%3A1px%20solid%20transparent%3Bborder%2Dtop%2Dleft%2Dradius%3A3px%3Bborder%2Dtop%2Dright%2Dradius%3A3px%7D%2Epanel%2Dheading%3E%2Edropdown%20%2Edropdown%2Dtoggle%7Bcolor%3Ainherit%7D%2Epanel%2Dtitle%7Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A0%3Bfont%2Dsize%3A16px%3Bcolor%3Ainherit%7D%2Epanel%2Dtitle%3E%2Esmall%2C%2Epanel%2Dtitle%3E%2Esmall%3Ea%2C%2Epanel%2Dtitle%3Ea%2C%2Epanel%2Dtitle%3Esmall%2C%2Epanel%2Dtitle%3Esmall%3Ea%7Bcolor%3Ainherit%7D%2Epanel%2Dfooter%7Bpadding%3A10px%2015px%3Bbackground%2Dcolor%3A%23f5f5f5%3Bborder%2Dtop%3A1px%20solid%20%23ddd%3Bborder%2Dbottom%2Dright%2Dradius%3A3px%3Bborder%2Dbottom%2Dleft%2Dradius%3A3px%7D%2Epanel%3E%2Elist%2Dgroup%2C%2Epanel%3E%2Epanel%2Dcollapse%3E%2Elist%2Dgroup%7Bmargin%2Dbottom%3A0%7D%2Epanel%3E%2Elist%2Dgroup%20%2Elist%2Dgroup%2Ditem%2C%2Epanel%3E%2Epanel%2Dcollapse%3E%2Elist%2Dgroup%20%2Elist%2Dgroup%2Ditem%7Bborder%2Dwidth%3A1px%200%3Bborder%2Dradius%3A0%7D%2Epanel%3E%2Elist%2Dgroup%3Afirst%2Dchild%20%2Elist%2Dgroup%2Ditem%3Afirst%2Dchild%2C%2Epanel%3E%2Epanel%2Dcollapse%3E%2Elist%2Dgroup%3Afirst%2Dchild%20%2Elist%2Dgroup%2Ditem%3Afirst%2Dchild%7Bborder%2Dtop%3A0%3Bborder%2Dtop%2Dleft%2Dradius%3A3px%3Bborder%2Dtop%2Dright%2Dradius%3A3px%7D%2Epanel%3E%2Elist%2Dgroup%3Alast%2Dchild%20%2Elist%2Dgroup%2Ditem%3Alast%2Dchild%2C%2Epanel%3E%2Epanel%2Dcollapse%3E%2Elist%2Dgroup%3Alast%2Dchild%20%2Elist%2Dgroup%2Ditem%3Alast%2Dchild%7Bborder%2Dbottom%3A0%3Bborder%2Dbottom%2Dright%2Dradius%3A3px%3Bborder%2Dbottom%2Dleft%2Dradius%3A3px%7D%2Epanel%3E%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Elist%2Dgroup%20%2Elist%2Dgroup%2Ditem%3Afirst%2Dchild%7Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dtop%2Dright%2Dradius%3A0%7D%2Epanel%2Dheading%2B%2Elist%2Dgroup%20%2Elist%2Dgroup%2Ditem%3Afirst%2Dchild%7Bborder%2Dtop%2Dwidth%3A0%7D%2Elist%2Dgroup%2B%2Epanel%2Dfooter%7Bborder%2Dtop%2Dwidth%3A0%7D%2Epanel%3E%2Epanel%2Dcollapse%3E%2Etable%2C%2Epanel%3E%2Etable%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%7Bmargin%2Dbottom%3A0%7D%2Epanel%3E%2Epanel%2Dcollapse%3E%2Etable%20caption%2C%2Epanel%3E%2Etable%20caption%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%20caption%7Bpadding%2Dright%3A15px%3Bpadding%2Dleft%3A15px%7D%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%7Bborder%2Dtop%2Dleft%2Dradius%3A3px%3Bborder%2Dtop%2Dright%2Dradius%3A3px%7D%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%7Bborder%2Dtop%2Dleft%2Dradius%3A3px%3Bborder%2Dtop%2Dright%2Dradius%3A3px%7D%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Afirst%2Dchild%7Bborder%2Dtop%2Dleft%2Dradius%3A3px%7D%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Alast%2Dchild%7Bborder%2Dtop%2Dright%2Dradius%3A3px%7D%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%7Bborder%2Dbottom%2Dright%2Dradius%3A3px%3Bborder%2Dbottom%2Dleft%2Dradius%3A3px%7D%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%7Bborder%2Dbottom%2Dright%2Dradius%3A3px%3Bborder%2Dbottom%2Dleft%2Dradius%3A3px%7D%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Afirst%2Dchild%7Bborder%2Dbottom%2Dleft%2Dradius%3A3px%7D%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Alast%2Dchild%7Bborder%2Dbottom%2Dright%2Dradius%3A3px%7D%2Epanel%3E%2Epanel%2Dbody%2B%2Etable%2C%2Epanel%3E%2Epanel%2Dbody%2B%2Etable%2Dresponsive%2C%2Epanel%3E%2Etable%2B%2Epanel%2Dbody%2C%2Epanel%3E%2Etable%2Dresponsive%2B%2Epanel%2Dbody%7Bborder%2Dtop%3A1px%20solid%20%23ddd%7D%2Epanel%3E%2Etable%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%2C%2Epanel%3E%2Etable%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%7Bborder%2Dtop%3A0%7D%2Epanel%3E%2Etable%2Dbordered%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%7Bborder%3A0%7D%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Etd%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Eth%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Etd%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Eth%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Ethead%3Etr%3Etd%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Ethead%3Etr%3Eth%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Etd%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Eth%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Etd%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Eth%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Etd%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Eth%3Afirst%2Dchild%7Bborder%2Dleft%3A0%7D%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Etd%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Eth%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Etd%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Eth%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Ethead%3Etr%3Etd%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Ethead%3Etr%3Eth%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Etd%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Eth%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Etd%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Eth%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Etd%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Eth%3Alast%2Dchild%7Bborder%2Dright%3A0%7D%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Afirst%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Afirst%2Dchild%3Eth%2C%2Epanel%3E%2Etable%2Dbordered%3Ethead%3Etr%3Afirst%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dbordered%3Ethead%3Etr%3Afirst%2Dchild%3Eth%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Afirst%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Afirst%2Dchild%3Eth%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Afirst%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Afirst%2Dchild%3Eth%7Bborder%2Dbottom%3A0%7D%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Alast%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Alast%2Dchild%3Eth%2C%2Epanel%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Alast%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Alast%2Dchild%3Eth%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Alast%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Alast%2Dchild%3Eth%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Alast%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Alast%2Dchild%3Eth%7Bborder%2Dbottom%3A0%7D%2Epanel%3E%2Etable%2Dresponsive%7Bmargin%2Dbottom%3A0%3Bborder%3A0%7D%2Epanel%2Dgroup%7Bmargin%2Dbottom%3A20px%7D%2Epanel%2Dgroup%20%2Epanel%7Bmargin%2Dbottom%3A0%3Bborder%2Dradius%3A4px%7D%2Epanel%2Dgroup%20%2Epanel%2B%2Epanel%7Bmargin%2Dtop%3A5px%7D%2Epanel%2Dgroup%20%2Epanel%2Dheading%7Bborder%2Dbottom%3A0%7D%2Epanel%2Dgroup%20%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Elist%2Dgroup%2C%2Epanel%2Dgroup%20%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dtop%3A1px%20solid%20%23ddd%7D%2Epanel%2Dgroup%20%2Epanel%2Dfooter%7Bborder%2Dtop%3A0%7D%2Epanel%2Dgroup%20%2Epanel%2Dfooter%2B%2Epanel%2Dcollapse%20%2Epanel%2Dbody%7Bborder%2Dbottom%3A1px%20solid%20%23ddd%7D%2Epanel%2Ddefault%7Bborder%2Dcolor%3A%23ddd%7D%2Epanel%2Ddefault%3E%2Epanel%2Dheading%7Bcolor%3A%23333%3Bbackground%2Dcolor%3A%23f5f5f5%3Bborder%2Dcolor%3A%23ddd%7D%2Epanel%2Ddefault%3E%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dtop%2Dcolor%3A%23ddd%7D%2Epanel%2Ddefault%3E%2Epanel%2Dheading%20%2Ebadge%7Bcolor%3A%23f5f5f5%3Bbackground%2Dcolor%3A%23333%7D%2Epanel%2Ddefault%3E%2Epanel%2Dfooter%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dbottom%2Dcolor%3A%23ddd%7D%2Epanel%2Dprimary%7Bborder%2Dcolor%3A%23337ab7%7D%2Epanel%2Dprimary%3E%2Epanel%2Dheading%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23337ab7%3Bborder%2Dcolor%3A%23337ab7%7D%2Epanel%2Dprimary%3E%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dtop%2Dcolor%3A%23337ab7%7D%2Epanel%2Dprimary%3E%2Epanel%2Dheading%20%2Ebadge%7Bcolor%3A%23337ab7%3Bbackground%2Dcolor%3A%23fff%7D%2Epanel%2Dprimary%3E%2Epanel%2Dfooter%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dbottom%2Dcolor%3A%23337ab7%7D%2Epanel%2Dsuccess%7Bborder%2Dcolor%3A%23d6e9c6%7D%2Epanel%2Dsuccess%3E%2Epanel%2Dheading%7Bcolor%3A%233c763d%3Bbackground%2Dcolor%3A%23dff0d8%3Bborder%2Dcolor%3A%23d6e9c6%7D%2Epanel%2Dsuccess%3E%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dtop%2Dcolor%3A%23d6e9c6%7D%2Epanel%2Dsuccess%3E%2Epanel%2Dheading%20%2Ebadge%7Bcolor%3A%23dff0d8%3Bbackground%2Dcolor%3A%233c763d%7D%2Epanel%2Dsuccess%3E%2Epanel%2Dfooter%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dbottom%2Dcolor%3A%23d6e9c6%7D%2Epanel%2Dinfo%7Bborder%2Dcolor%3A%23bce8f1%7D%2Epanel%2Dinfo%3E%2Epanel%2Dheading%7Bcolor%3A%2331708f%3Bbackground%2Dcolor%3A%23d9edf7%3Bborder%2Dcolor%3A%23bce8f1%7D%2Epanel%2Dinfo%3E%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dtop%2Dcolor%3A%23bce8f1%7D%2Epanel%2Dinfo%3E%2Epanel%2Dheading%20%2Ebadge%7Bcolor%3A%23d9edf7%3Bbackground%2Dcolor%3A%2331708f%7D%2Epanel%2Dinfo%3E%2Epanel%2Dfooter%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dbottom%2Dcolor%3A%23bce8f1%7D%2Epanel%2Dwarning%7Bborder%2Dcolor%3A%23faebcc%7D%2Epanel%2Dwarning%3E%2Epanel%2Dheading%7Bcolor%3A%238a6d3b%3Bbackground%2Dcolor%3A%23fcf8e3%3Bborder%2Dcolor%3A%23faebcc%7D%2Epanel%2Dwarning%3E%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dtop%2Dcolor%3A%23faebcc%7D%2Epanel%2Dwarning%3E%2Epanel%2Dheading%20%2Ebadge%7Bcolor%3A%23fcf8e3%3Bbackground%2Dcolor%3A%238a6d3b%7D%2Epanel%2Dwarning%3E%2Epanel%2Dfooter%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dbottom%2Dcolor%3A%23faebcc%7D%2Epanel%2Ddanger%7Bborder%2Dcolor%3A%23ebccd1%7D%2Epanel%2Ddanger%3E%2Epanel%2Dheading%7Bcolor%3A%23a94442%3Bbackground%2Dcolor%3A%23f2dede%3Bborder%2Dcolor%3A%23ebccd1%7D%2Epanel%2Ddanger%3E%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dtop%2Dcolor%3A%23ebccd1%7D%2Epanel%2Ddanger%3E%2Epanel%2Dheading%20%2Ebadge%7Bcolor%3A%23f2dede%3Bbackground%2Dcolor%3A%23a94442%7D%2Epanel%2Ddanger%3E%2Epanel%2Dfooter%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dbottom%2Dcolor%3A%23ebccd1%7D%2Eembed%2Dresponsive%7Bposition%3Arelative%3Bdisplay%3Ablock%3Bheight%3A0%3Bpadding%3A0%3Boverflow%3Ahidden%7D%2Eembed%2Dresponsive%20%2Eembed%2Dresponsive%2Ditem%2C%2Eembed%2Dresponsive%20embed%2C%2Eembed%2Dresponsive%20iframe%2C%2Eembed%2Dresponsive%20object%2C%2Eembed%2Dresponsive%20video%7Bposition%3Aabsolute%3Btop%3A0%3Bbottom%3A0%3Bleft%3A0%3Bwidth%3A100%25%3Bheight%3A100%25%3Bborder%3A0%7D%2Eembed%2Dresponsive%2D16by9%7Bpadding%2Dbottom%3A56%2E25%25%7D%2Eembed%2Dresponsive%2D4by3%7Bpadding%2Dbottom%3A75%25%7D%2Ewell%7Bmin%2Dheight%3A20px%3Bpadding%3A19px%3Bmargin%2Dbottom%3A20px%3Bbackground%2Dcolor%3A%23f5f5f5%3Bborder%3A1px%20solid%20%23e3e3e3%3Bborder%2Dradius%3A4px%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E05%29%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E05%29%7D%2Ewell%20blockquote%7Bborder%2Dcolor%3A%23ddd%3Bborder%2Dcolor%3Argba%280%2C0%2C0%2C%2E15%29%7D%2Ewell%2Dlg%7Bpadding%3A24px%3Bborder%2Dradius%3A6px%7D%2Ewell%2Dsm%7Bpadding%3A9px%3Bborder%2Dradius%3A3px%7D%2Eclose%7Bfloat%3Aright%3Bfont%2Dsize%3A21px%3Bfont%2Dweight%3A700%3Bline%2Dheight%3A1%3Bcolor%3A%23000%3Btext%2Dshadow%3A0%201px%200%20%23fff%3Bfilter%3Aalpha%28opacity%3D20%29%3Bopacity%3A%2E2%7D%2Eclose%3Afocus%2C%2Eclose%3Ahover%7Bcolor%3A%23000%3Btext%2Ddecoration%3Anone%3Bcursor%3Apointer%3Bfilter%3Aalpha%28opacity%3D50%29%3Bopacity%3A%2E5%7Dbutton%2Eclose%7B%2Dwebkit%2Dappearance%3Anone%3Bpadding%3A0%3Bcursor%3Apointer%3Bbackground%3A0%200%3Bborder%3A0%7D%2Emodal%2Dopen%7Boverflow%3Ahidden%7D%2Emodal%7Bposition%3Afixed%3Btop%3A0%3Bright%3A0%3Bbottom%3A0%3Bleft%3A0%3Bz%2Dindex%3A1050%3Bdisplay%3Anone%3Boverflow%3Ahidden%3B%2Dwebkit%2Doverflow%2Dscrolling%3Atouch%3Boutline%3A0%7D%2Emodal%2Efade%20%2Emodal%2Ddialog%7B%2Dwebkit%2Dtransition%3A%2Dwebkit%2Dtransform%20%2E3s%20ease%2Dout%3B%2Do%2Dtransition%3A%2Do%2Dtransform%20%2E3s%20ease%2Dout%3Btransition%3Atransform%20%2E3s%20ease%2Dout%3B%2Dwebkit%2Dtransform%3Atranslate%280%2C%2D25%25%29%3B%2Dms%2Dtransform%3Atranslate%280%2C%2D25%25%29%3B%2Do%2Dtransform%3Atranslate%280%2C%2D25%25%29%3Btransform%3Atranslate%280%2C%2D25%25%29%7D%2Emodal%2Ein%20%2Emodal%2Ddialog%7B%2Dwebkit%2Dtransform%3Atranslate%280%2C0%29%3B%2Dms%2Dtransform%3Atranslate%280%2C0%29%3B%2Do%2Dtransform%3Atranslate%280%2C0%29%3Btransform%3Atranslate%280%2C0%29%7D%2Emodal%2Dopen%20%2Emodal%7Boverflow%2Dx%3Ahidden%3Boverflow%2Dy%3Aauto%7D%2Emodal%2Ddialog%7Bposition%3Arelative%3Bwidth%3Aauto%3Bmargin%3A10px%7D%2Emodal%2Dcontent%7Bposition%3Arelative%3Bbackground%2Dcolor%3A%23fff%3B%2Dwebkit%2Dbackground%2Dclip%3Apadding%2Dbox%3Bbackground%2Dclip%3Apadding%2Dbox%3Bborder%3A1px%20solid%20%23999%3Bborder%3A1px%20solid%20rgba%280%2C0%2C0%2C%2E2%29%3Bborder%2Dradius%3A6px%3Boutline%3A0%3B%2Dwebkit%2Dbox%2Dshadow%3A0%203px%209px%20rgba%280%2C0%2C0%2C%2E5%29%3Bbox%2Dshadow%3A0%203px%209px%20rgba%280%2C0%2C0%2C%2E5%29%7D%2Emodal%2Dbackdrop%7Bposition%3Afixed%3Btop%3A0%3Bright%3A0%3Bbottom%3A0%3Bleft%3A0%3Bz%2Dindex%3A1040%3Bbackground%2Dcolor%3A%23000%7D%2Emodal%2Dbackdrop%2Efade%7Bfilter%3Aalpha%28opacity%3D0%29%3Bopacity%3A0%7D%2Emodal%2Dbackdrop%2Ein%7Bfilter%3Aalpha%28opacity%3D50%29%3Bopacity%3A%2E5%7D%2Emodal%2Dheader%7Bmin%2Dheight%3A16%2E43px%3Bpadding%3A15px%3Bborder%2Dbottom%3A1px%20solid%20%23e5e5e5%7D%2Emodal%2Dheader%20%2Eclose%7Bmargin%2Dtop%3A%2D2px%7D%2Emodal%2Dtitle%7Bmargin%3A0%3Bline%2Dheight%3A1%2E42857143%7D%2Emodal%2Dbody%7Bposition%3Arelative%3Bpadding%3A15px%7D%2Emodal%2Dfooter%7Bpadding%3A15px%3Btext%2Dalign%3Aright%3Bborder%2Dtop%3A1px%20solid%20%23e5e5e5%7D%2Emodal%2Dfooter%20%2Ebtn%2B%2Ebtn%7Bmargin%2Dbottom%3A0%3Bmargin%2Dleft%3A5px%7D%2Emodal%2Dfooter%20%2Ebtn%2Dgroup%20%2Ebtn%2B%2Ebtn%7Bmargin%2Dleft%3A%2D1px%7D%2Emodal%2Dfooter%20%2Ebtn%2Dblock%2B%2Ebtn%2Dblock%7Bmargin%2Dleft%3A0%7D%2Emodal%2Dscrollbar%2Dmeasure%7Bposition%3Aabsolute%3Btop%3A%2D9999px%3Bwidth%3A50px%3Bheight%3A50px%3Boverflow%3Ascroll%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Emodal%2Ddialog%7Bwidth%3A600px%3Bmargin%3A30px%20auto%7D%2Emodal%2Dcontent%7B%2Dwebkit%2Dbox%2Dshadow%3A0%205px%2015px%20rgba%280%2C0%2C0%2C%2E5%29%3Bbox%2Dshadow%3A0%205px%2015px%20rgba%280%2C0%2C0%2C%2E5%29%7D%2Emodal%2Dsm%7Bwidth%3A300px%7D%7D%40media%20%28min%2Dwidth%3A992px%29%7B%2Emodal%2Dlg%7Bwidth%3A900px%7D%7D%2Etooltip%7Bposition%3Aabsolute%3Bz%2Dindex%3A1070%3Bdisplay%3Ablock%3Bfont%2Dfamily%3A%22Helvetica%20Neue%22%2CHelvetica%2CArial%2Csans%2Dserif%3Bfont%2Dsize%3A12px%3Bfont%2Dstyle%3Anormal%3Bfont%2Dweight%3A400%3Bline%2Dheight%3A1%2E42857143%3Btext%2Dalign%3Aleft%3Btext%2Dalign%3Astart%3Btext%2Ddecoration%3Anone%3Btext%2Dshadow%3Anone%3Btext%2Dtransform%3Anone%3Bletter%2Dspacing%3Anormal%3Bword%2Dbreak%3Anormal%3Bword%2Dspacing%3Anormal%3Bword%2Dwrap%3Anormal%3Bwhite%2Dspace%3Anormal%3Bfilter%3Aalpha%28opacity%3D0%29%3Bopacity%3A0%3Bline%2Dbreak%3Aauto%7D%2Etooltip%2Ein%7Bfilter%3Aalpha%28opacity%3D90%29%3Bopacity%3A%2E9%7D%2Etooltip%2Etop%7Bpadding%3A5px%200%3Bmargin%2Dtop%3A%2D3px%7D%2Etooltip%2Eright%7Bpadding%3A0%205px%3Bmargin%2Dleft%3A3px%7D%2Etooltip%2Ebottom%7Bpadding%3A5px%200%3Bmargin%2Dtop%3A3px%7D%2Etooltip%2Eleft%7Bpadding%3A0%205px%3Bmargin%2Dleft%3A%2D3px%7D%2Etooltip%2Dinner%7Bmax%2Dwidth%3A200px%3Bpadding%3A3px%208px%3Bcolor%3A%23fff%3Btext%2Dalign%3Acenter%3Bbackground%2Dcolor%3A%23000%3Bborder%2Dradius%3A4px%7D%2Etooltip%2Darrow%7Bposition%3Aabsolute%3Bwidth%3A0%3Bheight%3A0%3Bborder%2Dcolor%3Atransparent%3Bborder%2Dstyle%3Asolid%7D%2Etooltip%2Etop%20%2Etooltip%2Darrow%7Bbottom%3A0%3Bleft%3A50%25%3Bmargin%2Dleft%3A%2D5px%3Bborder%2Dwidth%3A5px%205px%200%3Bborder%2Dtop%2Dcolor%3A%23000%7D%2Etooltip%2Etop%2Dleft%20%2Etooltip%2Darrow%7Bright%3A5px%3Bbottom%3A0%3Bmargin%2Dbottom%3A%2D5px%3Bborder%2Dwidth%3A5px%205px%200%3Bborder%2Dtop%2Dcolor%3A%23000%7D%2Etooltip%2Etop%2Dright%20%2Etooltip%2Darrow%7Bbottom%3A0%3Bleft%3A5px%3Bmargin%2Dbottom%3A%2D5px%3Bborder%2Dwidth%3A5px%205px%200%3Bborder%2Dtop%2Dcolor%3A%23000%7D%2Etooltip%2Eright%20%2Etooltip%2Darrow%7Btop%3A50%25%3Bleft%3A0%3Bmargin%2Dtop%3A%2D5px%3Bborder%2Dwidth%3A5px%205px%205px%200%3Bborder%2Dright%2Dcolor%3A%23000%7D%2Etooltip%2Eleft%20%2Etooltip%2Darrow%7Btop%3A50%25%3Bright%3A0%3Bmargin%2Dtop%3A%2D5px%3Bborder%2Dwidth%3A5px%200%205px%205px%3Bborder%2Dleft%2Dcolor%3A%23000%7D%2Etooltip%2Ebottom%20%2Etooltip%2Darrow%7Btop%3A0%3Bleft%3A50%25%3Bmargin%2Dleft%3A%2D5px%3Bborder%2Dwidth%3A0%205px%205px%3Bborder%2Dbottom%2Dcolor%3A%23000%7D%2Etooltip%2Ebottom%2Dleft%20%2Etooltip%2Darrow%7Btop%3A0%3Bright%3A5px%3Bmargin%2Dtop%3A%2D5px%3Bborder%2Dwidth%3A0%205px%205px%3Bborder%2Dbottom%2Dcolor%3A%23000%7D%2Etooltip%2Ebottom%2Dright%20%2Etooltip%2Darrow%7Btop%3A0%3Bleft%3A5px%3Bmargin%2Dtop%3A%2D5px%3Bborder%2Dwidth%3A0%205px%205px%3Bborder%2Dbottom%2Dcolor%3A%23000%7D%2Epopover%7Bposition%3Aabsolute%3Btop%3A0%3Bleft%3A0%3Bz%2Dindex%3A1060%3Bdisplay%3Anone%3Bmax%2Dwidth%3A276px%3Bpadding%3A1px%3Bfont%2Dfamily%3A%22Helvetica%20Neue%22%2CHelvetica%2CArial%2Csans%2Dserif%3Bfont%2Dsize%3A14px%3Bfont%2Dstyle%3Anormal%3Bfont%2Dweight%3A400%3Bline%2Dheight%3A1%2E42857143%3Btext%2Dalign%3Aleft%3Btext%2Dalign%3Astart%3Btext%2Ddecoration%3Anone%3Btext%2Dshadow%3Anone%3Btext%2Dtransform%3Anone%3Bletter%2Dspacing%3Anormal%3Bword%2Dbreak%3Anormal%3Bword%2Dspacing%3Anormal%3Bword%2Dwrap%3Anormal%3Bwhite%2Dspace%3Anormal%3Bbackground%2Dcolor%3A%23fff%3B%2Dwebkit%2Dbackground%2Dclip%3Apadding%2Dbox%3Bbackground%2Dclip%3Apadding%2Dbox%3Bborder%3A1px%20solid%20%23ccc%3Bborder%3A1px%20solid%20rgba%280%2C0%2C0%2C%2E2%29%3Bborder%2Dradius%3A6px%3B%2Dwebkit%2Dbox%2Dshadow%3A0%205px%2010px%20rgba%280%2C0%2C0%2C%2E2%29%3Bbox%2Dshadow%3A0%205px%2010px%20rgba%280%2C0%2C0%2C%2E2%29%3Bline%2Dbreak%3Aauto%7D%2Epopover%2Etop%7Bmargin%2Dtop%3A%2D10px%7D%2Epopover%2Eright%7Bmargin%2Dleft%3A10px%7D%2Epopover%2Ebottom%7Bmargin%2Dtop%3A10px%7D%2Epopover%2Eleft%7Bmargin%2Dleft%3A%2D10px%7D%2Epopover%2Dtitle%7Bpadding%3A8px%2014px%3Bmargin%3A0%3Bfont%2Dsize%3A14px%3Bbackground%2Dcolor%3A%23f7f7f7%3Bborder%2Dbottom%3A1px%20solid%20%23ebebeb%3Bborder%2Dradius%3A5px%205px%200%200%7D%2Epopover%2Dcontent%7Bpadding%3A9px%2014px%7D%2Epopover%3E%2Earrow%2C%2Epopover%3E%2Earrow%3Aafter%7Bposition%3Aabsolute%3Bdisplay%3Ablock%3Bwidth%3A0%3Bheight%3A0%3Bborder%2Dcolor%3Atransparent%3Bborder%2Dstyle%3Asolid%7D%2Epopover%3E%2Earrow%7Bborder%2Dwidth%3A11px%7D%2Epopover%3E%2Earrow%3Aafter%7Bcontent%3A%22%22%3Bborder%2Dwidth%3A10px%7D%2Epopover%2Etop%3E%2Earrow%7Bbottom%3A%2D11px%3Bleft%3A50%25%3Bmargin%2Dleft%3A%2D11px%3Bborder%2Dtop%2Dcolor%3A%23999%3Bborder%2Dtop%2Dcolor%3Argba%280%2C0%2C0%2C%2E25%29%3Bborder%2Dbottom%2Dwidth%3A0%7D%2Epopover%2Etop%3E%2Earrow%3Aafter%7Bbottom%3A1px%3Bmargin%2Dleft%3A%2D10px%3Bcontent%3A%22%20%22%3Bborder%2Dtop%2Dcolor%3A%23fff%3Bborder%2Dbottom%2Dwidth%3A0%7D%2Epopover%2Eright%3E%2Earrow%7Btop%3A50%25%3Bleft%3A%2D11px%3Bmargin%2Dtop%3A%2D11px%3Bborder%2Dright%2Dcolor%3A%23999%3Bborder%2Dright%2Dcolor%3Argba%280%2C0%2C0%2C%2E25%29%3Bborder%2Dleft%2Dwidth%3A0%7D%2Epopover%2Eright%3E%2Earrow%3Aafter%7Bbottom%3A%2D10px%3Bleft%3A1px%3Bcontent%3A%22%20%22%3Bborder%2Dright%2Dcolor%3A%23fff%3Bborder%2Dleft%2Dwidth%3A0%7D%2Epopover%2Ebottom%3E%2Earrow%7Btop%3A%2D11px%3Bleft%3A50%25%3Bmargin%2Dleft%3A%2D11px%3Bborder%2Dtop%2Dwidth%3A0%3Bborder%2Dbottom%2Dcolor%3A%23999%3Bborder%2Dbottom%2Dcolor%3Argba%280%2C0%2C0%2C%2E25%29%7D%2Epopover%2Ebottom%3E%2Earrow%3Aafter%7Btop%3A1px%3Bmargin%2Dleft%3A%2D10px%3Bcontent%3A%22%20%22%3Bborder%2Dtop%2Dwidth%3A0%3Bborder%2Dbottom%2Dcolor%3A%23fff%7D%2Epopover%2Eleft%3E%2Earrow%7Btop%3A50%25%3Bright%3A%2D11px%3Bmargin%2Dtop%3A%2D11px%3Bborder%2Dright%2Dwidth%3A0%3Bborder%2Dleft%2Dcolor%3A%23999%3Bborder%2Dleft%2Dcolor%3Argba%280%2C0%2C0%2C%2E25%29%7D%2Epopover%2Eleft%3E%2Earrow%3Aafter%7Bright%3A1px%3Bbottom%3A%2D10px%3Bcontent%3A%22%20%22%3Bborder%2Dright%2Dwidth%3A0%3Bborder%2Dleft%2Dcolor%3A%23fff%7D%2Ecarousel%7Bposition%3Arelative%7D%2Ecarousel%2Dinner%7Bposition%3Arelative%3Bwidth%3A100%25%3Boverflow%3Ahidden%7D%2Ecarousel%2Dinner%3E%2Eitem%7Bposition%3Arelative%3Bdisplay%3Anone%3B%2Dwebkit%2Dtransition%3A%2E6s%20ease%2Din%2Dout%20left%3B%2Do%2Dtransition%3A%2E6s%20ease%2Din%2Dout%20left%3Btransition%3A%2E6s%20ease%2Din%2Dout%20left%7D%2Ecarousel%2Dinner%3E%2Eitem%3Ea%3Eimg%2C%2Ecarousel%2Dinner%3E%2Eitem%3Eimg%7Bline%2Dheight%3A1%7D%40media%20all%20and%20%28transform%2D3d%29%2C%28%2Dwebkit%2Dtransform%2D3d%29%7B%2Ecarousel%2Dinner%3E%2Eitem%7B%2Dwebkit%2Dtransition%3A%2Dwebkit%2Dtransform%20%2E6s%20ease%2Din%2Dout%3B%2Do%2Dtransition%3A%2Do%2Dtransform%20%2E6s%20ease%2Din%2Dout%3Btransition%3Atransform%20%2E6s%20ease%2Din%2Dout%3B%2Dwebkit%2Dbackface%2Dvisibility%3Ahidden%3Bbackface%2Dvisibility%3Ahidden%3B%2Dwebkit%2Dperspective%3A1000px%3Bperspective%3A1000px%7D%2Ecarousel%2Dinner%3E%2Eitem%2Eactive%2Eright%2C%2Ecarousel%2Dinner%3E%2Eitem%2Enext%7Bleft%3A0%3B%2Dwebkit%2Dtransform%3Atranslate3d%28100%25%2C0%2C0%29%3Btransform%3Atranslate3d%28100%25%2C0%2C0%29%7D%2Ecarousel%2Dinner%3E%2Eitem%2Eactive%2Eleft%2C%2Ecarousel%2Dinner%3E%2Eitem%2Eprev%7Bleft%3A0%3B%2Dwebkit%2Dtransform%3Atranslate3d%28%2D100%25%2C0%2C0%29%3Btransform%3Atranslate3d%28%2D100%25%2C0%2C0%29%7D%2Ecarousel%2Dinner%3E%2Eitem%2Eactive%2C%2Ecarousel%2Dinner%3E%2Eitem%2Enext%2Eleft%2C%2Ecarousel%2Dinner%3E%2Eitem%2Eprev%2Eright%7Bleft%3A0%3B%2Dwebkit%2Dtransform%3Atranslate3d%280%2C0%2C0%29%3Btransform%3Atranslate3d%280%2C0%2C0%29%7D%7D%2Ecarousel%2Dinner%3E%2Eactive%2C%2Ecarousel%2Dinner%3E%2Enext%2C%2Ecarousel%2Dinner%3E%2Eprev%7Bdisplay%3Ablock%7D%2Ecarousel%2Dinner%3E%2Eactive%7Bleft%3A0%7D%2Ecarousel%2Dinner%3E%2Enext%2C%2Ecarousel%2Dinner%3E%2Eprev%7Bposition%3Aabsolute%3Btop%3A0%3Bwidth%3A100%25%7D%2Ecarousel%2Dinner%3E%2Enext%7Bleft%3A100%25%7D%2Ecarousel%2Dinner%3E%2Eprev%7Bleft%3A%2D100%25%7D%2Ecarousel%2Dinner%3E%2Enext%2Eleft%2C%2Ecarousel%2Dinner%3E%2Eprev%2Eright%7Bleft%3A0%7D%2Ecarousel%2Dinner%3E%2Eactive%2Eleft%7Bleft%3A%2D100%25%7D%2Ecarousel%2Dinner%3E%2Eactive%2Eright%7Bleft%3A100%25%7D%2Ecarousel%2Dcontrol%7Bposition%3Aabsolute%3Btop%3A0%3Bbottom%3A0%3Bleft%3A0%3Bwidth%3A15%25%3Bfont%2Dsize%3A20px%3Bcolor%3A%23fff%3Btext%2Dalign%3Acenter%3Btext%2Dshadow%3A0%201px%202px%20rgba%280%2C0%2C0%2C%2E6%29%3Bfilter%3Aalpha%28opacity%3D50%29%3Bopacity%3A%2E5%7D%2Ecarousel%2Dcontrol%2Eleft%7Bbackground%2Dimage%3A%2Dwebkit%2Dlinear%2Dgradient%28left%2Crgba%280%2C0%2C0%2C%2E5%29%200%2Crgba%280%2C0%2C0%2C%2E0001%29%20100%25%29%3Bbackground%2Dimage%3A%2Do%2Dlinear%2Dgradient%28left%2Crgba%280%2C0%2C0%2C%2E5%29%200%2Crgba%280%2C0%2C0%2C%2E0001%29%20100%25%29%3Bbackground%2Dimage%3A%2Dwebkit%2Dgradient%28linear%2Cleft%20top%2Cright%20top%2Cfrom%28rgba%280%2C0%2C0%2C%2E5%29%29%2Cto%28rgba%280%2C0%2C0%2C%2E0001%29%29%29%3Bbackground%2Dimage%3Alinear%2Dgradient%28to%20right%2Crgba%280%2C0%2C0%2C%2E5%29%200%2Crgba%280%2C0%2C0%2C%2E0001%29%20100%25%29%3Bfilter%3Aprogid%3ADXImageTransform%2EMicrosoft%2Egradient%28startColorstr%3D%27%2380000000%27%2C%20endColorstr%3D%27%2300000000%27%2C%20GradientType%3D1%29%3Bbackground%2Drepeat%3Arepeat%2Dx%7D%2Ecarousel%2Dcontrol%2Eright%7Bright%3A0%3Bleft%3Aauto%3Bbackground%2Dimage%3A%2Dwebkit%2Dlinear%2Dgradient%28left%2Crgba%280%2C0%2C0%2C%2E0001%29%200%2Crgba%280%2C0%2C0%2C%2E5%29%20100%25%29%3Bbackground%2Dimage%3A%2Do%2Dlinear%2Dgradient%28left%2Crgba%280%2C0%2C0%2C%2E0001%29%200%2Crgba%280%2C0%2C0%2C%2E5%29%20100%25%29%3Bbackground%2Dimage%3A%2Dwebkit%2Dgradient%28linear%2Cleft%20top%2Cright%20top%2Cfrom%28rgba%280%2C0%2C0%2C%2E0001%29%29%2Cto%28rgba%280%2C0%2C0%2C%2E5%29%29%29%3Bbackground%2Dimage%3Alinear%2Dgradient%28to%20right%2Crgba%280%2C0%2C0%2C%2E0001%29%200%2Crgba%280%2C0%2C0%2C%2E5%29%20100%25%29%3Bfilter%3Aprogid%3ADXImageTransform%2EMicrosoft%2Egradient%28startColorstr%3D%27%2300000000%27%2C%20endColorstr%3D%27%2380000000%27%2C%20GradientType%3D1%29%3Bbackground%2Drepeat%3Arepeat%2Dx%7D%2Ecarousel%2Dcontrol%3Afocus%2C%2Ecarousel%2Dcontrol%3Ahover%7Bcolor%3A%23fff%3Btext%2Ddecoration%3Anone%3Bfilter%3Aalpha%28opacity%3D90%29%3Boutline%3A0%3Bopacity%3A%2E9%7D%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dleft%2C%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dright%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dnext%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dprev%7Bposition%3Aabsolute%3Btop%3A50%25%3Bz%2Dindex%3A5%3Bdisplay%3Ainline%2Dblock%3Bmargin%2Dtop%3A%2D10px%7D%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dleft%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dprev%7Bleft%3A50%25%3Bmargin%2Dleft%3A%2D10px%7D%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dright%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dnext%7Bright%3A50%25%3Bmargin%2Dright%3A%2D10px%7D%2Ecarousel%2Dcontrol%20%2Eicon%2Dnext%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dprev%7Bwidth%3A20px%3Bheight%3A20px%3Bfont%2Dfamily%3Aserif%3Bline%2Dheight%3A1%7D%2Ecarousel%2Dcontrol%20%2Eicon%2Dprev%3Abefore%7Bcontent%3A%27%5C2039%27%7D%2Ecarousel%2Dcontrol%20%2Eicon%2Dnext%3Abefore%7Bcontent%3A%27%5C203a%27%7D%2Ecarousel%2Dindicators%7Bposition%3Aabsolute%3Bbottom%3A10px%3Bleft%3A50%25%3Bz%2Dindex%3A15%3Bwidth%3A60%25%3Bpadding%2Dleft%3A0%3Bmargin%2Dleft%3A%2D30%25%3Btext%2Dalign%3Acenter%3Blist%2Dstyle%3Anone%7D%2Ecarousel%2Dindicators%20li%7Bdisplay%3Ainline%2Dblock%3Bwidth%3A10px%3Bheight%3A10px%3Bmargin%3A1px%3Btext%2Dindent%3A%2D999px%3Bcursor%3Apointer%3Bbackground%2Dcolor%3A%23000%5C9%3Bbackground%2Dcolor%3Argba%280%2C0%2C0%2C0%29%3Bborder%3A1px%20solid%20%23fff%3Bborder%2Dradius%3A10px%7D%2Ecarousel%2Dindicators%20%2Eactive%7Bwidth%3A12px%3Bheight%3A12px%3Bmargin%3A0%3Bbackground%2Dcolor%3A%23fff%7D%2Ecarousel%2Dcaption%7Bposition%3Aabsolute%3Bright%3A15%25%3Bbottom%3A20px%3Bleft%3A15%25%3Bz%2Dindex%3A10%3Bpadding%2Dtop%3A20px%3Bpadding%2Dbottom%3A20px%3Bcolor%3A%23fff%3Btext%2Dalign%3Acenter%3Btext%2Dshadow%3A0%201px%202px%20rgba%280%2C0%2C0%2C%2E6%29%7D%2Ecarousel%2Dcaption%20%2Ebtn%7Btext%2Dshadow%3Anone%7D%40media%20screen%20and%20%28min%2Dwidth%3A768px%29%7B%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dleft%2C%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dright%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dnext%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dprev%7Bwidth%3A30px%3Bheight%3A30px%3Bmargin%2Dtop%3A%2D15px%3Bfont%2Dsize%3A30px%7D%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dleft%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dprev%7Bmargin%2Dleft%3A%2D15px%7D%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dright%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dnext%7Bmargin%2Dright%3A%2D15px%7D%2Ecarousel%2Dcaption%7Bright%3A20%25%3Bleft%3A20%25%3Bpadding%2Dbottom%3A30px%7D%2Ecarousel%2Dindicators%7Bbottom%3A20px%7D%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3Aafter%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3Abefore%2C%2Ebtn%2Dtoolbar%3Aafter%2C%2Ebtn%2Dtoolbar%3Abefore%2C%2Eclearfix%3Aafter%2C%2Eclearfix%3Abefore%2C%2Econtainer%2Dfluid%3Aafter%2C%2Econtainer%2Dfluid%3Abefore%2C%2Econtainer%3Aafter%2C%2Econtainer%3Abefore%2C%2Edl%2Dhorizontal%20dd%3Aafter%2C%2Edl%2Dhorizontal%20dd%3Abefore%2C%2Eform%2Dhorizontal%20%2Eform%2Dgroup%3Aafter%2C%2Eform%2Dhorizontal%20%2Eform%2Dgroup%3Abefore%2C%2Emodal%2Dfooter%3Aafter%2C%2Emodal%2Dfooter%3Abefore%2C%2Enav%3Aafter%2C%2Enav%3Abefore%2C%2Enavbar%2Dcollapse%3Aafter%2C%2Enavbar%2Dcollapse%3Abefore%2C%2Enavbar%2Dheader%3Aafter%2C%2Enavbar%2Dheader%3Abefore%2C%2Enavbar%3Aafter%2C%2Enavbar%3Abefore%2C%2Epager%3Aafter%2C%2Epager%3Abefore%2C%2Epanel%2Dbody%3Aafter%2C%2Epanel%2Dbody%3Abefore%2C%2Erow%3Aafter%2C%2Erow%3Abefore%7Bdisplay%3Atable%3Bcontent%3A%22%20%22%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3Aafter%2C%2Ebtn%2Dtoolbar%3Aafter%2C%2Eclearfix%3Aafter%2C%2Econtainer%2Dfluid%3Aafter%2C%2Econtainer%3Aafter%2C%2Edl%2Dhorizontal%20dd%3Aafter%2C%2Eform%2Dhorizontal%20%2Eform%2Dgroup%3Aafter%2C%2Emodal%2Dfooter%3Aafter%2C%2Enav%3Aafter%2C%2Enavbar%2Dcollapse%3Aafter%2C%2Enavbar%2Dheader%3Aafter%2C%2Enavbar%3Aafter%2C%2Epager%3Aafter%2C%2Epanel%2Dbody%3Aafter%2C%2Erow%3Aafter%7Bclear%3Aboth%7D%2Ecenter%2Dblock%7Bdisplay%3Ablock%3Bmargin%2Dright%3Aauto%3Bmargin%2Dleft%3Aauto%7D%2Epull%2Dright%7Bfloat%3Aright%21important%7D%2Epull%2Dleft%7Bfloat%3Aleft%21important%7D%2Ehide%7Bdisplay%3Anone%21important%7D%2Eshow%7Bdisplay%3Ablock%21important%7D%2Einvisible%7Bvisibility%3Ahidden%7D%2Etext%2Dhide%7Bfont%3A0%2F0%20a%3Bcolor%3Atransparent%3Btext%2Dshadow%3Anone%3Bbackground%2Dcolor%3Atransparent%3Bborder%3A0%7D%2Ehidden%7Bdisplay%3Anone%21important%7D%2Eaffix%7Bposition%3Afixed%7D%40%2Dms%2Dviewport%7Bwidth%3Adevice%2Dwidth%7D%2Evisible%2Dlg%2C%2Evisible%2Dmd%2C%2Evisible%2Dsm%2C%2Evisible%2Dxs%7Bdisplay%3Anone%21important%7D%2Evisible%2Dlg%2Dblock%2C%2Evisible%2Dlg%2Dinline%2C%2Evisible%2Dlg%2Dinline%2Dblock%2C%2Evisible%2Dmd%2Dblock%2C%2Evisible%2Dmd%2Dinline%2C%2Evisible%2Dmd%2Dinline%2Dblock%2C%2Evisible%2Dsm%2Dblock%2C%2Evisible%2Dsm%2Dinline%2C%2Evisible%2Dsm%2Dinline%2Dblock%2C%2Evisible%2Dxs%2Dblock%2C%2Evisible%2Dxs%2Dinline%2C%2Evisible%2Dxs%2Dinline%2Dblock%7Bdisplay%3Anone%21important%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Evisible%2Dxs%7Bdisplay%3Ablock%21important%7Dtable%2Evisible%2Dxs%7Bdisplay%3Atable%21important%7Dtr%2Evisible%2Dxs%7Bdisplay%3Atable%2Drow%21important%7Dtd%2Evisible%2Dxs%2Cth%2Evisible%2Dxs%7Bdisplay%3Atable%2Dcell%21important%7D%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Evisible%2Dxs%2Dblock%7Bdisplay%3Ablock%21important%7D%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Evisible%2Dxs%2Dinline%7Bdisplay%3Ainline%21important%7D%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Evisible%2Dxs%2Dinline%2Dblock%7Bdisplay%3Ainline%2Dblock%21important%7D%7D%40media%20%28min%2Dwidth%3A768px%29%20and%20%28max%2Dwidth%3A991px%29%7B%2Evisible%2Dsm%7Bdisplay%3Ablock%21important%7Dtable%2Evisible%2Dsm%7Bdisplay%3Atable%21important%7Dtr%2Evisible%2Dsm%7Bdisplay%3Atable%2Drow%21important%7Dtd%2Evisible%2Dsm%2Cth%2Evisible%2Dsm%7Bdisplay%3Atable%2Dcell%21important%7D%7D%40media%20%28min%2Dwidth%3A768px%29%20and%20%28max%2Dwidth%3A991px%29%7B%2Evisible%2Dsm%2Dblock%7Bdisplay%3Ablock%21important%7D%7D%40media%20%28min%2Dwidth%3A768px%29%20and%20%28max%2Dwidth%3A991px%29%7B%2Evisible%2Dsm%2Dinline%7Bdisplay%3Ainline%21important%7D%7D%40media%20%28min%2Dwidth%3A768px%29%20and%20%28max%2Dwidth%3A991px%29%7B%2Evisible%2Dsm%2Dinline%2Dblock%7Bdisplay%3Ainline%2Dblock%21important%7D%7D%40media%20%28min%2Dwidth%3A992px%29%20and%20%28max%2Dwidth%3A1199px%29%7B%2Evisible%2Dmd%7Bdisplay%3Ablock%21important%7Dtable%2Evisible%2Dmd%7Bdisplay%3Atable%21important%7Dtr%2Evisible%2Dmd%7Bdisplay%3Atable%2Drow%21important%7Dtd%2Evisible%2Dmd%2Cth%2Evisible%2Dmd%7Bdisplay%3Atable%2Dcell%21important%7D%7D%40media%20%28min%2Dwidth%3A992px%29%20and%20%28max%2Dwidth%3A1199px%29%7B%2Evisible%2Dmd%2Dblock%7Bdisplay%3Ablock%21important%7D%7D%40media%20%28min%2Dwidth%3A992px%29%20and%20%28max%2Dwidth%3A1199px%29%7B%2Evisible%2Dmd%2Dinline%7Bdisplay%3Ainline%21important%7D%7D%40media%20%28min%2Dwidth%3A992px%29%20and%20%28max%2Dwidth%3A1199px%29%7B%2Evisible%2Dmd%2Dinline%2Dblock%7Bdisplay%3Ainline%2Dblock%21important%7D%7D%40media%20%28min%2Dwidth%3A1200px%29%7B%2Evisible%2Dlg%7Bdisplay%3Ablock%21important%7Dtable%2Evisible%2Dlg%7Bdisplay%3Atable%21important%7Dtr%2Evisible%2Dlg%7Bdisplay%3Atable%2Drow%21important%7Dtd%2Evisible%2Dlg%2Cth%2Evisible%2Dlg%7Bdisplay%3Atable%2Dcell%21important%7D%7D%40media%20%28min%2Dwidth%3A1200px%29%7B%2Evisible%2Dlg%2Dblock%7Bdisplay%3Ablock%21important%7D%7D%40media%20%28min%2Dwidth%3A1200px%29%7B%2Evisible%2Dlg%2Dinline%7Bdisplay%3Ainline%21important%7D%7D%40media%20%28min%2Dwidth%3A1200px%29%7B%2Evisible%2Dlg%2Dinline%2Dblock%7Bdisplay%3Ainline%2Dblock%21important%7D%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Ehidden%2Dxs%7Bdisplay%3Anone%21important%7D%7D%40media%20%28min%2Dwidth%3A768px%29%20and%20%28max%2Dwidth%3A991px%29%7B%2Ehidden%2Dsm%7Bdisplay%3Anone%21important%7D%7D%40media%20%28min%2Dwidth%3A992px%29%20and%20%28max%2Dwidth%3A1199px%29%7B%2Ehidden%2Dmd%7Bdisplay%3Anone%21important%7D%7D%40media%20%28min%2Dwidth%3A1200px%29%7B%2Ehidden%2Dlg%7Bdisplay%3Anone%21important%7D%7D%2Evisible%2Dprint%7Bdisplay%3Anone%21important%7D%40media%20print%7B%2Evisible%2Dprint%7Bdisplay%3Ablock%21important%7Dtable%2Evisible%2Dprint%7Bdisplay%3Atable%21important%7Dtr%2Evisible%2Dprint%7Bdisplay%3Atable%2Drow%21important%7Dtd%2Evisible%2Dprint%2Cth%2Evisible%2Dprint%7Bdisplay%3Atable%2Dcell%21important%7D%7D%2Evisible%2Dprint%2Dblock%7Bdisplay%3Anone%21important%7D%40media%20print%7B%2Evisible%2Dprint%2Dblock%7Bdisplay%3Ablock%21important%7D%7D%2Evisible%2Dprint%2Dinline%7Bdisplay%3Anone%21important%7D%40media%20print%7B%2Evisible%2Dprint%2Dinline%7Bdisplay%3Ainline%21important%7D%7D%2Evisible%2Dprint%2Dinline%2Dblock%7Bdisplay%3Anone%21important%7D%40media%20print%7B%2Evisible%2Dprint%2Dinline%2Dblock%7Bdisplay%3Ainline%2Dblock%21important%7D%7D%40media%20print%7B%2Ehidden%2Dprint%7Bdisplay%3Anone%21important%7D%7D%0A" rel="stylesheet" />
<script src="data:application/x-javascript;base64,/*!
 * Bootstrap v3.3.5 (http://getbootstrap.com)
 * Copyright 2011-2015 Twitter, Inc.
 * Licensed under the MIT license
 */
if("undefined"==typeof jQuery)throw new Error("Bootstrap's JavaScript requires jQuery");+function(a){"use strict";var b=a.fn.jquery.split(" ")[0].split(".");if(b[0]<2&&b[1]<9||1==b[0]&&9==b[1]&&b[2]<1)throw new Error("Bootstrap's JavaScript requires jQuery version 1.9.1 or higher")}(jQuery),+function(a){"use strict";function b(){var a=document.createElement("bootstrap"),b={WebkitTransition:"webkitTransitionEnd",MozTransition:"transitionend",OTransition:"oTransitionEnd otransitionend",transition:"transitionend"};for(var c in b)if(void 0!==a.style[c])return{end:b[c]};return!1}a.fn.emulateTransitionEnd=function(b){var c=!1,d=this;a(this).one("bsTransitionEnd",function(){c=!0});var e=function(){c||a(d).trigger(a.support.transition.end)};return setTimeout(e,b),this},a(function(){a.support.transition=b(),a.support.transition&&(a.event.special.bsTransitionEnd={bindType:a.support.transition.end,delegateType:a.support.transition.end,handle:function(b){return a(b.target).is(this)?b.handleObj.handler.apply(this,arguments):void 0}})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var c=a(this),e=c.data("bs.alert");e||c.data("bs.alert",e=new d(this)),"string"==typeof b&&e[b].call(c)})}var c='[data-dismiss="alert"]',d=function(b){a(b).on("click",c,this.close)};d.VERSION="3.3.5",d.TRANSITION_DURATION=150,d.prototype.close=function(b){function c(){g.detach().trigger("closed.bs.alert").remove()}var e=a(this),f=e.attr("data-target");f||(f=e.attr("href"),f=f&&f.replace(/.*(?=#[^\s]*$)/,""));var g=a(f);b&&b.preventDefault(),g.length||(g=e.closest(".alert")),g.trigger(b=a.Event("close.bs.alert")),b.isDefaultPrevented()||(g.removeClass("in"),a.support.transition&&g.hasClass("fade")?g.one("bsTransitionEnd",c).emulateTransitionEnd(d.TRANSITION_DURATION):c())};var e=a.fn.alert;a.fn.alert=b,a.fn.alert.Constructor=d,a.fn.alert.noConflict=function(){return a.fn.alert=e,this},a(document).on("click.bs.alert.data-api",c,d.prototype.close)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.button"),f="object"==typeof b&&b;e||d.data("bs.button",e=new c(this,f)),"toggle"==b?e.toggle():b&&e.setState(b)})}var c=function(b,d){this.$element=a(b),this.options=a.extend({},c.DEFAULTS,d),this.isLoading=!1};c.VERSION="3.3.5",c.DEFAULTS={loadingText:"loading..."},c.prototype.setState=function(b){var c="disabled",d=this.$element,e=d.is("input")?"val":"html",f=d.data();b+="Text",null==f.resetText&&d.data("resetText",d[e]()),setTimeout(a.proxy(function(){d[e](null==f[b]?this.options[b]:f[b]),"loadingText"==b?(this.isLoading=!0,d.addClass(c).attr(c,c)):this.isLoading&&(this.isLoading=!1,d.removeClass(c).removeAttr(c))},this),0)},c.prototype.toggle=function(){var a=!0,b=this.$element.closest('[data-toggle="buttons"]');if(b.length){var c=this.$element.find("input");"radio"==c.prop("type")?(c.prop("checked")&&(a=!1),b.find(".active").removeClass("active"),this.$element.addClass("active")):"checkbox"==c.prop("type")&&(c.prop("checked")!==this.$element.hasClass("active")&&(a=!1),this.$element.toggleClass("active")),c.prop("checked",this.$element.hasClass("active")),a&&c.trigger("change")}else this.$element.attr("aria-pressed",!this.$element.hasClass("active")),this.$element.toggleClass("active")};var d=a.fn.button;a.fn.button=b,a.fn.button.Constructor=c,a.fn.button.noConflict=function(){return a.fn.button=d,this},a(document).on("click.bs.button.data-api",'[data-toggle^="button"]',function(c){var d=a(c.target);d.hasClass("btn")||(d=d.closest(".btn")),b.call(d,"toggle"),a(c.target).is('input[type="radio"]')||a(c.target).is('input[type="checkbox"]')||c.preventDefault()}).on("focus.bs.button.data-api blur.bs.button.data-api",'[data-toggle^="button"]',function(b){a(b.target).closest(".btn").toggleClass("focus",/^focus(in)?$/.test(b.type))})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.carousel"),f=a.extend({},c.DEFAULTS,d.data(),"object"==typeof b&&b),g="string"==typeof b?b:f.slide;e||d.data("bs.carousel",e=new c(this,f)),"number"==typeof b?e.to(b):g?e[g]():f.interval&&e.pause().cycle()})}var c=function(b,c){this.$element=a(b),this.$indicators=this.$element.find(".carousel-indicators"),this.options=c,this.paused=null,this.sliding=null,this.interval=null,this.$active=null,this.$items=null,this.options.keyboard&&this.$element.on("keydown.bs.carousel",a.proxy(this.keydown,this)),"hover"==this.options.pause&&!("ontouchstart"in document.documentElement)&&this.$element.on("mouseenter.bs.carousel",a.proxy(this.pause,this)).on("mouseleave.bs.carousel",a.proxy(this.cycle,this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=600,c.DEFAULTS={interval:5e3,pause:"hover",wrap:!0,keyboard:!0},c.prototype.keydown=function(a){if(!/input|textarea/i.test(a.target.tagName)){switch(a.which){case 37:this.prev();break;case 39:this.next();break;default:return}a.preventDefault()}},c.prototype.cycle=function(b){return b||(this.paused=!1),this.interval&&clearInterval(this.interval),this.options.interval&&!this.paused&&(this.interval=setInterval(a.proxy(this.next,this),this.options.interval)),this},c.prototype.getItemIndex=function(a){return this.$items=a.parent().children(".item"),this.$items.index(a||this.$active)},c.prototype.getItemForDirection=function(a,b){var c=this.getItemIndex(b),d="prev"==a&&0===c||"next"==a&&c==this.$items.length-1;if(d&&!this.options.wrap)return b;var e="prev"==a?-1:1,f=(c+e)%this.$items.length;return this.$items.eq(f)},c.prototype.to=function(a){var b=this,c=this.getItemIndex(this.$active=this.$element.find(".item.active"));return a>this.$items.length-1||0>a?void 0:this.sliding?this.$element.one("slid.bs.carousel",function(){b.to(a)}):c==a?this.pause().cycle():this.slide(a>c?"next":"prev",this.$items.eq(a))},c.prototype.pause=function(b){return b||(this.paused=!0),this.$element.find(".next, .prev").length&&a.support.transition&&(this.$element.trigger(a.support.transition.end),this.cycle(!0)),this.interval=clearInterval(this.interval),this},c.prototype.next=function(){return this.sliding?void 0:this.slide("next")},c.prototype.prev=function(){return this.sliding?void 0:this.slide("prev")},c.prototype.slide=function(b,d){var e=this.$element.find(".item.active"),f=d||this.getItemForDirection(b,e),g=this.interval,h="next"==b?"left":"right",i=this;if(f.hasClass("active"))return this.sliding=!1;var j=f[0],k=a.Event("slide.bs.carousel",{relatedTarget:j,direction:h});if(this.$element.trigger(k),!k.isDefaultPrevented()){if(this.sliding=!0,g&&this.pause(),this.$indicators.length){this.$indicators.find(".active").removeClass("active");var l=a(this.$indicators.children()[this.getItemIndex(f)]);l&&l.addClass("active")}var m=a.Event("slid.bs.carousel",{relatedTarget:j,direction:h});return a.support.transition&&this.$element.hasClass("slide")?(f.addClass(b),f[0].offsetWidth,e.addClass(h),f.addClass(h),e.one("bsTransitionEnd",function(){f.removeClass([b,h].join(" ")).addClass("active"),e.removeClass(["active",h].join(" ")),i.sliding=!1,setTimeout(function(){i.$element.trigger(m)},0)}).emulateTransitionEnd(c.TRANSITION_DURATION)):(e.removeClass("active"),f.addClass("active"),this.sliding=!1,this.$element.trigger(m)),g&&this.cycle(),this}};var d=a.fn.carousel;a.fn.carousel=b,a.fn.carousel.Constructor=c,a.fn.carousel.noConflict=function(){return a.fn.carousel=d,this};var e=function(c){var d,e=a(this),f=a(e.attr("data-target")||(d=e.attr("href"))&&d.replace(/.*(?=#[^\s]+$)/,""));if(f.hasClass("carousel")){var g=a.extend({},f.data(),e.data()),h=e.attr("data-slide-to");h&&(g.interval=!1),b.call(f,g),h&&f.data("bs.carousel").to(h),c.preventDefault()}};a(document).on("click.bs.carousel.data-api","[data-slide]",e).on("click.bs.carousel.data-api","[data-slide-to]",e),a(window).on("load",function(){a('[data-ride="carousel"]').each(function(){var c=a(this);b.call(c,c.data())})})}(jQuery),+function(a){"use strict";function b(b){var c,d=b.attr("data-target")||(c=b.attr("href"))&&c.replace(/.*(?=#[^\s]+$)/,"");return a(d)}function c(b){return this.each(function(){var c=a(this),e=c.data("bs.collapse"),f=a.extend({},d.DEFAULTS,c.data(),"object"==typeof b&&b);!e&&f.toggle&&/show|hide/.test(b)&&(f.toggle=!1),e||c.data("bs.collapse",e=new d(this,f)),"string"==typeof b&&e[b]()})}var d=function(b,c){this.$element=a(b),this.options=a.extend({},d.DEFAULTS,c),this.$trigger=a('[data-toggle="collapse"][href="#'+b.id+'"],[data-toggle="collapse"][data-target="#'+b.id+'"]'),this.transitioning=null,this.options.parent?this.$parent=this.getParent():this.addAriaAndCollapsedClass(this.$element,this.$trigger),this.options.toggle&&this.toggle()};d.VERSION="3.3.5",d.TRANSITION_DURATION=350,d.DEFAULTS={toggle:!0},d.prototype.dimension=function(){var a=this.$element.hasClass("width");return a?"width":"height"},d.prototype.show=function(){if(!this.transitioning&&!this.$element.hasClass("in")){var b,e=this.$parent&&this.$parent.children(".panel").children(".in, .collapsing");if(!(e&&e.length&&(b=e.data("bs.collapse"),b&&b.transitioning))){var f=a.Event("show.bs.collapse");if(this.$element.trigger(f),!f.isDefaultPrevented()){e&&e.length&&(c.call(e,"hide"),b||e.data("bs.collapse",null));var g=this.dimension();this.$element.removeClass("collapse").addClass("collapsing")[g](0).attr("aria-expanded",!0),this.$trigger.removeClass("collapsed").attr("aria-expanded",!0),this.transitioning=1;var h=function(){this.$element.removeClass("collapsing").addClass("collapse in")[g](""),this.transitioning=0,this.$element.trigger("shown.bs.collapse")};if(!a.support.transition)return h.call(this);var i=a.camelCase(["scroll",g].join("-"));this.$element.one("bsTransitionEnd",a.proxy(h,this)).emulateTransitionEnd(d.TRANSITION_DURATION)[g](this.$element[0][i])}}}},d.prototype.hide=function(){if(!this.transitioning&&this.$element.hasClass("in")){var b=a.Event("hide.bs.collapse");if(this.$element.trigger(b),!b.isDefaultPrevented()){var c=this.dimension();this.$element[c](this.$element[c]())[0].offsetHeight,this.$element.addClass("collapsing").removeClass("collapse in").attr("aria-expanded",!1),this.$trigger.addClass("collapsed").attr("aria-expanded",!1),this.transitioning=1;var e=function(){this.transitioning=0,this.$element.removeClass("collapsing").addClass("collapse").trigger("hidden.bs.collapse")};return a.support.transition?void this.$element[c](0).one("bsTransitionEnd",a.proxy(e,this)).emulateTransitionEnd(d.TRANSITION_DURATION):e.call(this)}}},d.prototype.toggle=function(){this[this.$element.hasClass("in")?"hide":"show"]()},d.prototype.getParent=function(){return a(this.options.parent).find('[data-toggle="collapse"][data-parent="'+this.options.parent+'"]').each(a.proxy(function(c,d){var e=a(d);this.addAriaAndCollapsedClass(b(e),e)},this)).end()},d.prototype.addAriaAndCollapsedClass=function(a,b){var c=a.hasClass("in");a.attr("aria-expanded",c),b.toggleClass("collapsed",!c).attr("aria-expanded",c)};var e=a.fn.collapse;a.fn.collapse=c,a.fn.collapse.Constructor=d,a.fn.collapse.noConflict=function(){return a.fn.collapse=e,this},a(document).on("click.bs.collapse.data-api",'[data-toggle="collapse"]',function(d){var e=a(this);e.attr("data-target")||d.preventDefault();var f=b(e),g=f.data("bs.collapse"),h=g?"toggle":e.data();c.call(f,h)})}(jQuery),+function(a){"use strict";function b(b){var c=b.attr("data-target");c||(c=b.attr("href"),c=c&&/#[A-Za-z]/.test(c)&&c.replace(/.*(?=#[^\s]*$)/,""));var d=c&&a(c);return d&&d.length?d:b.parent()}function c(c){c&&3===c.which||(a(e).remove(),a(f).each(function(){var d=a(this),e=b(d),f={relatedTarget:this};e.hasClass("open")&&(c&&"click"==c.type&&/input|textarea/i.test(c.target.tagName)&&a.contains(e[0],c.target)||(e.trigger(c=a.Event("hide.bs.dropdown",f)),c.isDefaultPrevented()||(d.attr("aria-expanded","false"),e.removeClass("open").trigger("hidden.bs.dropdown",f))))}))}function d(b){return this.each(function(){var c=a(this),d=c.data("bs.dropdown");d||c.data("bs.dropdown",d=new g(this)),"string"==typeof b&&d[b].call(c)})}var e=".dropdown-backdrop",f='[data-toggle="dropdown"]',g=function(b){a(b).on("click.bs.dropdown",this.toggle)};g.VERSION="3.3.5",g.prototype.toggle=function(d){var e=a(this);if(!e.is(".disabled, :disabled")){var f=b(e),g=f.hasClass("open");if(c(),!g){"ontouchstart"in document.documentElement&&!f.closest(".navbar-nav").length&&a(document.createElement("div")).addClass("dropdown-backdrop").insertAfter(a(this)).on("click",c);var h={relatedTarget:this};if(f.trigger(d=a.Event("show.bs.dropdown",h)),d.isDefaultPrevented())return;e.trigger("focus").attr("aria-expanded","true"),f.toggleClass("open").trigger("shown.bs.dropdown",h)}return!1}},g.prototype.keydown=function(c){if(/(38|40|27|32)/.test(c.which)&&!/input|textarea/i.test(c.target.tagName)){var d=a(this);if(c.preventDefault(),c.stopPropagation(),!d.is(".disabled, :disabled")){var e=b(d),g=e.hasClass("open");if(!g&&27!=c.which||g&&27==c.which)return 27==c.which&&e.find(f).trigger("focus"),d.trigger("click");var h=" li:not(.disabled):visible a",i=e.find(".dropdown-menu"+h);if(i.length){var j=i.index(c.target);38==c.which&&j>0&&j--,40==c.which&&j<i.length-1&&j++,~j||(j=0),i.eq(j).trigger("focus")}}}};var h=a.fn.dropdown;a.fn.dropdown=d,a.fn.dropdown.Constructor=g,a.fn.dropdown.noConflict=function(){return a.fn.dropdown=h,this},a(document).on("click.bs.dropdown.data-api",c).on("click.bs.dropdown.data-api",".dropdown form",function(a){a.stopPropagation()}).on("click.bs.dropdown.data-api",f,g.prototype.toggle).on("keydown.bs.dropdown.data-api",f,g.prototype.keydown).on("keydown.bs.dropdown.data-api",".dropdown-menu",g.prototype.keydown)}(jQuery),+function(a){"use strict";function b(b,d){return this.each(function(){var e=a(this),f=e.data("bs.modal"),g=a.extend({},c.DEFAULTS,e.data(),"object"==typeof b&&b);f||e.data("bs.modal",f=new c(this,g)),"string"==typeof b?f[b](d):g.show&&f.show(d)})}var c=function(b,c){this.options=c,this.$body=a(document.body),this.$element=a(b),this.$dialog=this.$element.find(".modal-dialog"),this.$backdrop=null,this.isShown=null,this.originalBodyPad=null,this.scrollbarWidth=0,this.ignoreBackdropClick=!1,this.options.remote&&this.$element.find(".modal-content").load(this.options.remote,a.proxy(function(){this.$element.trigger("loaded.bs.modal")},this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=300,c.BACKDROP_TRANSITION_DURATION=150,c.DEFAULTS={backdrop:!0,keyboard:!0,show:!0},c.prototype.toggle=function(a){return this.isShown?this.hide():this.show(a)},c.prototype.show=function(b){var d=this,e=a.Event("show.bs.modal",{relatedTarget:b});this.$element.trigger(e),this.isShown||e.isDefaultPrevented()||(this.isShown=!0,this.checkScrollbar(),this.setScrollbar(),this.$body.addClass("modal-open"),this.escape(),this.resize(),this.$element.on("click.dismiss.bs.modal",'[data-dismiss="modal"]',a.proxy(this.hide,this)),this.$dialog.on("mousedown.dismiss.bs.modal",function(){d.$element.one("mouseup.dismiss.bs.modal",function(b){a(b.target).is(d.$element)&&(d.ignoreBackdropClick=!0)})}),this.backdrop(function(){var e=a.support.transition&&d.$element.hasClass("fade");d.$element.parent().length||d.$element.appendTo(d.$body),d.$element.show().scrollTop(0),d.adjustDialog(),e&&d.$element[0].offsetWidth,d.$element.addClass("in"),d.enforceFocus();var f=a.Event("shown.bs.modal",{relatedTarget:b});e?d.$dialog.one("bsTransitionEnd",function(){d.$element.trigger("focus").trigger(f)}).emulateTransitionEnd(c.TRANSITION_DURATION):d.$element.trigger("focus").trigger(f)}))},c.prototype.hide=function(b){b&&b.preventDefault(),b=a.Event("hide.bs.modal"),this.$element.trigger(b),this.isShown&&!b.isDefaultPrevented()&&(this.isShown=!1,this.escape(),this.resize(),a(document).off("focusin.bs.modal"),this.$element.removeClass("in").off("click.dismiss.bs.modal").off("mouseup.dismiss.bs.modal"),this.$dialog.off("mousedown.dismiss.bs.modal"),a.support.transition&&this.$element.hasClass("fade")?this.$element.one("bsTransitionEnd",a.proxy(this.hideModal,this)).emulateTransitionEnd(c.TRANSITION_DURATION):this.hideModal())},c.prototype.enforceFocus=function(){a(document).off("focusin.bs.modal").on("focusin.bs.modal",a.proxy(function(a){this.$element[0]===a.target||this.$element.has(a.target).length||this.$element.trigger("focus")},this))},c.prototype.escape=function(){this.isShown&&this.options.keyboard?this.$element.on("keydown.dismiss.bs.modal",a.proxy(function(a){27==a.which&&this.hide()},this)):this.isShown||this.$element.off("keydown.dismiss.bs.modal")},c.prototype.resize=function(){this.isShown?a(window).on("resize.bs.modal",a.proxy(this.handleUpdate,this)):a(window).off("resize.bs.modal")},c.prototype.hideModal=function(){var a=this;this.$element.hide(),this.backdrop(function(){a.$body.removeClass("modal-open"),a.resetAdjustments(),a.resetScrollbar(),a.$element.trigger("hidden.bs.modal")})},c.prototype.removeBackdrop=function(){this.$backdrop&&this.$backdrop.remove(),this.$backdrop=null},c.prototype.backdrop=function(b){var d=this,e=this.$element.hasClass("fade")?"fade":"";if(this.isShown&&this.options.backdrop){var f=a.support.transition&&e;if(this.$backdrop=a(document.createElement("div")).addClass("modal-backdrop "+e).appendTo(this.$body),this.$element.on("click.dismiss.bs.modal",a.proxy(function(a){return this.ignoreBackdropClick?void(this.ignoreBackdropClick=!1):void(a.target===a.currentTarget&&("static"==this.options.backdrop?this.$element[0].focus():this.hide()))},this)),f&&this.$backdrop[0].offsetWidth,this.$backdrop.addClass("in"),!b)return;f?this.$backdrop.one("bsTransitionEnd",b).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):b()}else if(!this.isShown&&this.$backdrop){this.$backdrop.removeClass("in");var g=function(){d.removeBackdrop(),b&&b()};a.support.transition&&this.$element.hasClass("fade")?this.$backdrop.one("bsTransitionEnd",g).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):g()}else b&&b()},c.prototype.handleUpdate=function(){this.adjustDialog()},c.prototype.adjustDialog=function(){var a=this.$element[0].scrollHeight>document.documentElement.clientHeight;this.$element.css({paddingLeft:!this.bodyIsOverflowing&&a?this.scrollbarWidth:"",paddingRight:this.bodyIsOverflowing&&!a?this.scrollbarWidth:""})},c.prototype.resetAdjustments=function(){this.$element.css({paddingLeft:"",paddingRight:""})},c.prototype.checkScrollbar=function(){var a=window.innerWidth;if(!a){var b=document.documentElement.getBoundingClientRect();a=b.right-Math.abs(b.left)}this.bodyIsOverflowing=document.body.clientWidth<a,this.scrollbarWidth=this.measureScrollbar()},c.prototype.setScrollbar=function(){var a=parseInt(this.$body.css("padding-right")||0,10);this.originalBodyPad=document.body.style.paddingRight||"",this.bodyIsOverflowing&&this.$body.css("padding-right",a+this.scrollbarWidth)},c.prototype.resetScrollbar=function(){this.$body.css("padding-right",this.originalBodyPad)},c.prototype.measureScrollbar=function(){var a=document.createElement("div");a.className="modal-scrollbar-measure",this.$body.append(a);var b=a.offsetWidth-a.clientWidth;return this.$body[0].removeChild(a),b};var d=a.fn.modal;a.fn.modal=b,a.fn.modal.Constructor=c,a.fn.modal.noConflict=function(){return a.fn.modal=d,this},a(document).on("click.bs.modal.data-api",'[data-toggle="modal"]',function(c){var d=a(this),e=d.attr("href"),f=a(d.attr("data-target")||e&&e.replace(/.*(?=#[^\s]+$)/,"")),g=f.data("bs.modal")?"toggle":a.extend({remote:!/#/.test(e)&&e},f.data(),d.data());d.is("a")&&c.preventDefault(),f.one("show.bs.modal",function(a){a.isDefaultPrevented()||f.one("hidden.bs.modal",function(){d.is(":visible")&&d.trigger("focus")})}),b.call(f,g,this)})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tooltip"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.tooltip",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.type=null,this.options=null,this.enabled=null,this.timeout=null,this.hoverState=null,this.$element=null,this.inState=null,this.init("tooltip",a,b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.DEFAULTS={animation:!0,placement:"top",selector:!1,template:'<div class="tooltip" role="tooltip"><div class="tooltip-arrow"></div><div class="tooltip-inner"></div></div>',trigger:"hover focus",title:"",delay:0,html:!1,container:!1,viewport:{selector:"body",padding:0}},c.prototype.init=function(b,c,d){if(this.enabled=!0,this.type=b,this.$element=a(c),this.options=this.getOptions(d),this.$viewport=this.options.viewport&&a(a.isFunction(this.options.viewport)?this.options.viewport.call(this,this.$element):this.options.viewport.selector||this.options.viewport),this.inState={click:!1,hover:!1,focus:!1},this.$element[0]instanceof document.constructor&&!this.options.selector)throw new Error("`selector` option must be specified when initializing "+this.type+" on the window.document object!");for(var e=this.options.trigger.split(" "),f=e.length;f--;){var g=e[f];if("click"==g)this.$element.on("click."+this.type,this.options.selector,a.proxy(this.toggle,this));else if("manual"!=g){var h="hover"==g?"mouseenter":"focusin",i="hover"==g?"mouseleave":"focusout";this.$element.on(h+"."+this.type,this.options.selector,a.proxy(this.enter,this)),this.$element.on(i+"."+this.type,this.options.selector,a.proxy(this.leave,this))}}this.options.selector?this._options=a.extend({},this.options,{trigger:"manual",selector:""}):this.fixTitle()},c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.getOptions=function(b){return b=a.extend({},this.getDefaults(),this.$element.data(),b),b.delay&&"number"==typeof b.delay&&(b.delay={show:b.delay,hide:b.delay}),b},c.prototype.getDelegateOptions=function(){var b={},c=this.getDefaults();return this._options&&a.each(this._options,function(a,d){c[a]!=d&&(b[a]=d)}),b},c.prototype.enter=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusin"==b.type?"focus":"hover"]=!0),c.tip().hasClass("in")||"in"==c.hoverState?void(c.hoverState="in"):(clearTimeout(c.timeout),c.hoverState="in",c.options.delay&&c.options.delay.show?void(c.timeout=setTimeout(function(){"in"==c.hoverState&&c.show()},c.options.delay.show)):c.show())},c.prototype.isInStateTrue=function(){for(var a in this.inState)if(this.inState[a])return!0;return!1},c.prototype.leave=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusout"==b.type?"focus":"hover"]=!1),c.isInStateTrue()?void 0:(clearTimeout(c.timeout),c.hoverState="out",c.options.delay&&c.options.delay.hide?void(c.timeout=setTimeout(function(){"out"==c.hoverState&&c.hide()},c.options.delay.hide)):c.hide())},c.prototype.show=function(){var b=a.Event("show.bs."+this.type);if(this.hasContent()&&this.enabled){this.$element.trigger(b);var d=a.contains(this.$element[0].ownerDocument.documentElement,this.$element[0]);if(b.isDefaultPrevented()||!d)return;var e=this,f=this.tip(),g=this.getUID(this.type);this.setContent(),f.attr("id",g),this.$element.attr("aria-describedby",g),this.options.animation&&f.addClass("fade");var h="function"==typeof this.options.placement?this.options.placement.call(this,f[0],this.$element[0]):this.options.placement,i=/\s?auto?\s?/i,j=i.test(h);j&&(h=h.replace(i,"")||"top"),f.detach().css({top:0,left:0,display:"block"}).addClass(h).data("bs."+this.type,this),this.options.container?f.appendTo(this.options.container):f.insertAfter(this.$element),this.$element.trigger("inserted.bs."+this.type);var k=this.getPosition(),l=f[0].offsetWidth,m=f[0].offsetHeight;if(j){var n=h,o=this.getPosition(this.$viewport);h="bottom"==h&&k.bottom+m>o.bottom?"top":"top"==h&&k.top-m<o.top?"bottom":"right"==h&&k.right+l>o.width?"left":"left"==h&&k.left-l<o.left?"right":h,f.removeClass(n).addClass(h)}var p=this.getCalculatedOffset(h,k,l,m);this.applyPlacement(p,h);var q=function(){var a=e.hoverState;e.$element.trigger("shown.bs."+e.type),e.hoverState=null,"out"==a&&e.leave(e)};a.support.transition&&this.$tip.hasClass("fade")?f.one("bsTransitionEnd",q).emulateTransitionEnd(c.TRANSITION_DURATION):q()}},c.prototype.applyPlacement=function(b,c){var d=this.tip(),e=d[0].offsetWidth,f=d[0].offsetHeight,g=parseInt(d.css("margin-top"),10),h=parseInt(d.css("margin-left"),10);isNaN(g)&&(g=0),isNaN(h)&&(h=0),b.top+=g,b.left+=h,a.offset.setOffset(d[0],a.extend({using:function(a){d.css({top:Math.round(a.top),left:Math.round(a.left)})}},b),0),d.addClass("in");var i=d[0].offsetWidth,j=d[0].offsetHeight;"top"==c&&j!=f&&(b.top=b.top+f-j);var k=this.getViewportAdjustedDelta(c,b,i,j);k.left?b.left+=k.left:b.top+=k.top;var l=/top|bottom/.test(c),m=l?2*k.left-e+i:2*k.top-f+j,n=l?"offsetWidth":"offsetHeight";d.offset(b),this.replaceArrow(m,d[0][n],l)},c.prototype.replaceArrow=function(a,b,c){this.arrow().css(c?"left":"top",50*(1-a/b)+"%").css(c?"top":"left","")},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle();a.find(".tooltip-inner")[this.options.html?"html":"text"](b),a.removeClass("fade in top bottom left right")},c.prototype.hide=function(b){function d(){"in"!=e.hoverState&&f.detach(),e.$element.removeAttr("aria-describedby").trigger("hidden.bs."+e.type),b&&b()}var e=this,f=a(this.$tip),g=a.Event("hide.bs."+this.type);return this.$element.trigger(g),g.isDefaultPrevented()?void 0:(f.removeClass("in"),a.support.transition&&f.hasClass("fade")?f.one("bsTransitionEnd",d).emulateTransitionEnd(c.TRANSITION_DURATION):d(),this.hoverState=null,this)},c.prototype.fixTitle=function(){var a=this.$element;(a.attr("title")||"string"!=typeof a.attr("data-original-title"))&&a.attr("data-original-title",a.attr("title")||"").attr("title","")},c.prototype.hasContent=function(){return this.getTitle()},c.prototype.getPosition=function(b){b=b||this.$element;var c=b[0],d="BODY"==c.tagName,e=c.getBoundingClientRect();null==e.width&&(e=a.extend({},e,{width:e.right-e.left,height:e.bottom-e.top}));var f=d?{top:0,left:0}:b.offset(),g={scroll:d?document.documentElement.scrollTop||document.body.scrollTop:b.scrollTop()},h=d?{width:a(window).width(),height:a(window).height()}:null;return a.extend({},e,g,h,f)},c.prototype.getCalculatedOffset=function(a,b,c,d){return"bottom"==a?{top:b.top+b.height,left:b.left+b.width/2-c/2}:"top"==a?{top:b.top-d,left:b.left+b.width/2-c/2}:"left"==a?{top:b.top+b.height/2-d/2,left:b.left-c}:{top:b.top+b.height/2-d/2,left:b.left+b.width}},c.prototype.getViewportAdjustedDelta=function(a,b,c,d){var e={top:0,left:0};if(!this.$viewport)return e;var f=this.options.viewport&&this.options.viewport.padding||0,g=this.getPosition(this.$viewport);if(/right|left/.test(a)){var h=b.top-f-g.scroll,i=b.top+f-g.scroll+d;h<g.top?e.top=g.top-h:i>g.top+g.height&&(e.top=g.top+g.height-i)}else{var j=b.left-f,k=b.left+f+c;j<g.left?e.left=g.left-j:k>g.right&&(e.left=g.left+g.width-k)}return e},c.prototype.getTitle=function(){var a,b=this.$element,c=this.options;return a=b.attr("data-original-title")||("function"==typeof c.title?c.title.call(b[0]):c.title)},c.prototype.getUID=function(a){do a+=~~(1e6*Math.random());while(document.getElementById(a));return a},c.prototype.tip=function(){if(!this.$tip&&(this.$tip=a(this.options.template),1!=this.$tip.length))throw new Error(this.type+" `template` option must consist of exactly 1 top-level element!");return this.$tip},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".tooltip-arrow")},c.prototype.enable=function(){this.enabled=!0},c.prototype.disable=function(){this.enabled=!1},c.prototype.toggleEnabled=function(){this.enabled=!this.enabled},c.prototype.toggle=function(b){var c=this;b&&(c=a(b.currentTarget).data("bs."+this.type),c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c))),b?(c.inState.click=!c.inState.click,c.isInStateTrue()?c.enter(c):c.leave(c)):c.tip().hasClass("in")?c.leave(c):c.enter(c)},c.prototype.destroy=function(){var a=this;clearTimeout(this.timeout),this.hide(function(){a.$element.off("."+a.type).removeData("bs."+a.type),a.$tip&&a.$tip.detach(),a.$tip=null,a.$arrow=null,a.$viewport=null})};var d=a.fn.tooltip;a.fn.tooltip=b,a.fn.tooltip.Constructor=c,a.fn.tooltip.noConflict=function(){return a.fn.tooltip=d,this}}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.popover"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.popover",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.init("popover",a,b)};if(!a.fn.tooltip)throw new Error("Popover requires tooltip.js");c.VERSION="3.3.5",c.DEFAULTS=a.extend({},a.fn.tooltip.Constructor.DEFAULTS,{placement:"right",trigger:"click",content:"",template:'<div class="popover" role="tooltip"><div class="arrow"></div><h3 class="popover-title"></h3><div class="popover-content"></div></div>'}),c.prototype=a.extend({},a.fn.tooltip.Constructor.prototype),c.prototype.constructor=c,c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle(),c=this.getContent();a.find(".popover-title")[this.options.html?"html":"text"](b),a.find(".popover-content").children().detach().end()[this.options.html?"string"==typeof c?"html":"append":"text"](c),a.removeClass("fade top bottom left right in"),a.find(".popover-title").html()||a.find(".popover-title").hide()},c.prototype.hasContent=function(){return this.getTitle()||this.getContent()},c.prototype.getContent=function(){var a=this.$element,b=this.options;return a.attr("data-content")||("function"==typeof b.content?b.content.call(a[0]):b.content)},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".arrow")};var d=a.fn.popover;a.fn.popover=b,a.fn.popover.Constructor=c,a.fn.popover.noConflict=function(){return a.fn.popover=d,this}}(jQuery),+function(a){"use strict";function b(c,d){this.$body=a(document.body),this.$scrollElement=a(a(c).is(document.body)?window:c),this.options=a.extend({},b.DEFAULTS,d),this.selector=(this.options.target||"")+" .nav li > a",this.offsets=[],this.targets=[],this.activeTarget=null,this.scrollHeight=0,this.$scrollElement.on("scroll.bs.scrollspy",a.proxy(this.process,this)),this.refresh(),this.process()}function c(c){return this.each(function(){var d=a(this),e=d.data("bs.scrollspy"),f="object"==typeof c&&c;e||d.data("bs.scrollspy",e=new b(this,f)),"string"==typeof c&&e[c]()})}b.VERSION="3.3.5",b.DEFAULTS={offset:10},b.prototype.getScrollHeight=function(){return this.$scrollElement[0].scrollHeight||Math.max(this.$body[0].scrollHeight,document.documentElement.scrollHeight)},b.prototype.refresh=function(){var b=this,c="offset",d=0;this.offsets=[],this.targets=[],this.scrollHeight=this.getScrollHeight(),a.isWindow(this.$scrollElement[0])||(c="position",d=this.$scrollElement.scrollTop()),this.$body.find(this.selector).map(function(){var b=a(this),e=b.data("target")||b.attr("href"),f=/^#./.test(e)&&a(e);return f&&f.length&&f.is(":visible")&&[[f[c]().top+d,e]]||null}).sort(function(a,b){return a[0]-b[0]}).each(function(){b.offsets.push(this[0]),b.targets.push(this[1])})},b.prototype.process=function(){var a,b=this.$scrollElement.scrollTop()+this.options.offset,c=this.getScrollHeight(),d=this.options.offset+c-this.$scrollElement.height(),e=this.offsets,f=this.targets,g=this.activeTarget;if(this.scrollHeight!=c&&this.refresh(),b>=d)return g!=(a=f[f.length-1])&&this.activate(a);if(g&&b<e[0])return this.activeTarget=null,this.clear();for(a=e.length;a--;)g!=f[a]&&b>=e[a]&&(void 0===e[a+1]||b<e[a+1])&&this.activate(f[a])},b.prototype.activate=function(b){this.activeTarget=b,this.clear();var c=this.selector+'[data-target="'+b+'"],'+this.selector+'[href="'+b+'"]',d=a(c).parents("li").addClass("active");d.parent(".dropdown-menu").length&&(d=d.closest("li.dropdown").addClass("active")),
d.trigger("activate.bs.scrollspy")},b.prototype.clear=function(){a(this.selector).parentsUntil(this.options.target,".active").removeClass("active")};var d=a.fn.scrollspy;a.fn.scrollspy=c,a.fn.scrollspy.Constructor=b,a.fn.scrollspy.noConflict=function(){return a.fn.scrollspy=d,this},a(window).on("load.bs.scrollspy.data-api",function(){a('[data-spy="scroll"]').each(function(){var b=a(this);c.call(b,b.data())})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tab");e||d.data("bs.tab",e=new c(this)),"string"==typeof b&&e[b]()})}var c=function(b){this.element=a(b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.prototype.show=function(){var b=this.element,c=b.closest("ul:not(.dropdown-menu)"),d=b.data("target");if(d||(d=b.attr("href"),d=d&&d.replace(/.*(?=#[^\s]*$)/,"")),!b.parent("li").hasClass("active")){var e=c.find(".active:last a"),f=a.Event("hide.bs.tab",{relatedTarget:b[0]}),g=a.Event("show.bs.tab",{relatedTarget:e[0]});if(e.trigger(f),b.trigger(g),!g.isDefaultPrevented()&&!f.isDefaultPrevented()){var h=a(d);this.activate(b.closest("li"),c),this.activate(h,h.parent(),function(){e.trigger({type:"hidden.bs.tab",relatedTarget:b[0]}),b.trigger({type:"shown.bs.tab",relatedTarget:e[0]})})}}},c.prototype.activate=function(b,d,e){function f(){g.removeClass("active").find("> .dropdown-menu > .active").removeClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!1),b.addClass("active").find('[data-toggle="tab"]').attr("aria-expanded",!0),h?(b[0].offsetWidth,b.addClass("in")):b.removeClass("fade"),b.parent(".dropdown-menu").length&&b.closest("li.dropdown").addClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!0),e&&e()}var g=d.find("> .active"),h=e&&a.support.transition&&(g.length&&g.hasClass("fade")||!!d.find("> .fade").length);g.length&&h?g.one("bsTransitionEnd",f).emulateTransitionEnd(c.TRANSITION_DURATION):f(),g.removeClass("in")};var d=a.fn.tab;a.fn.tab=b,a.fn.tab.Constructor=c,a.fn.tab.noConflict=function(){return a.fn.tab=d,this};var e=function(c){c.preventDefault(),b.call(a(this),"show")};a(document).on("click.bs.tab.data-api",'[data-toggle="tab"]',e).on("click.bs.tab.data-api",'[data-toggle="pill"]',e)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.affix"),f="object"==typeof b&&b;e||d.data("bs.affix",e=new c(this,f)),"string"==typeof b&&e[b]()})}var c=function(b,d){this.options=a.extend({},c.DEFAULTS,d),this.$target=a(this.options.target).on("scroll.bs.affix.data-api",a.proxy(this.checkPosition,this)).on("click.bs.affix.data-api",a.proxy(this.checkPositionWithEventLoop,this)),this.$element=a(b),this.affixed=null,this.unpin=null,this.pinnedOffset=null,this.checkPosition()};c.VERSION="3.3.5",c.RESET="affix affix-top affix-bottom",c.DEFAULTS={offset:0,target:window},c.prototype.getState=function(a,b,c,d){var e=this.$target.scrollTop(),f=this.$element.offset(),g=this.$target.height();if(null!=c&&"top"==this.affixed)return c>e?"top":!1;if("bottom"==this.affixed)return null!=c?e+this.unpin<=f.top?!1:"bottom":a-d>=e+g?!1:"bottom";var h=null==this.affixed,i=h?e:f.top,j=h?g:b;return null!=c&&c>=e?"top":null!=d&&i+j>=a-d?"bottom":!1},c.prototype.getPinnedOffset=function(){if(this.pinnedOffset)return this.pinnedOffset;this.$element.removeClass(c.RESET).addClass("affix");var a=this.$target.scrollTop(),b=this.$element.offset();return this.pinnedOffset=b.top-a},c.prototype.checkPositionWithEventLoop=function(){setTimeout(a.proxy(this.checkPosition,this),1)},c.prototype.checkPosition=function(){if(this.$element.is(":visible")){var b=this.$element.height(),d=this.options.offset,e=d.top,f=d.bottom,g=Math.max(a(document).height(),a(document.body).height());"object"!=typeof d&&(f=e=d),"function"==typeof e&&(e=d.top(this.$element)),"function"==typeof f&&(f=d.bottom(this.$element));var h=this.getState(g,b,e,f);if(this.affixed!=h){null!=this.unpin&&this.$element.css("top","");var i="affix"+(h?"-"+h:""),j=a.Event(i+".bs.affix");if(this.$element.trigger(j),j.isDefaultPrevented())return;this.affixed=h,this.unpin="bottom"==h?this.getPinnedOffset():null,this.$element.removeClass(c.RESET).addClass(i).trigger(i.replace("affix","affixed")+".bs.affix")}"bottom"==h&&this.$element.offset({top:g-b-f})}};var d=a.fn.affix;a.fn.affix=b,a.fn.affix.Constructor=c,a.fn.affix.noConflict=function(){return a.fn.affix=d,this},a(window).on("load",function(){a('[data-spy="affix"]').each(function(){var c=a(this),d=c.data();d.offset=d.offset||{},null!=d.offsetBottom&&(d.offset.bottom=d.offsetBottom),null!=d.offsetTop&&(d.offset.top=d.offsetTop),b.call(c,d)})})}(jQuery);"></script>
<script src="data:application/x-javascript;base64,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"></script>
<script src="data:application/x-javascript;base64,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"></script>
<script src="data:application/x-javascript;base64,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"></script>
<link href="data:text/css;charset=utf-8,pre%20%2Eoperator%2C%0Apre%20%2Eparen%20%7B%0Acolor%3A%20rgb%28104%2C%20118%2C%20135%29%0A%7D%0Apre%20%2Eliteral%20%7B%0Acolor%3A%20%23990073%0A%7D%0Apre%20%2Enumber%20%7B%0Acolor%3A%20%23099%3B%0A%7D%0Apre%20%2Ecomment%20%7B%0Acolor%3A%20%23998%3B%0Afont%2Dstyle%3A%20italic%0A%7D%0Apre%20%2Ekeyword%20%7B%0Acolor%3A%20%23900%3B%0Afont%2Dweight%3A%20bold%0A%7D%0Apre%20%2Eidentifier%20%7B%0Acolor%3A%20rgb%280%2C%200%2C%200%29%3B%0A%7D%0Apre%20%2Estring%20%7B%0Acolor%3A%20%23d14%3B%0A%7D%0A" rel="stylesheet" />
<script src="data:application/x-javascript;base64,var hljs=new function(){function m(p){return p.replace(/&/gm,"&amp;").replace(/</gm,"&lt;")}function f(r,q,p){return RegExp(q,"m"+(r.cI?"i":"")+(p?"g":""))}function b(r){for(var p=0;p<r.childNodes.length;p++){var q=r.childNodes[p];if(q.nodeName=="CODE"){return q}if(!(q.nodeType==3&&q.nodeValue.match(/\s+/))){break}}}function h(t,s){var p="";for(var r=0;r<t.childNodes.length;r++){if(t.childNodes[r].nodeType==3){var q=t.childNodes[r].nodeValue;if(s){q=q.replace(/\n/g,"")}p+=q}else{if(t.childNodes[r].nodeName=="BR"){p+="\n"}else{p+=h(t.childNodes[r])}}}if(/MSIE [678]/.test(navigator.userAgent)){p=p.replace(/\r/g,"\n")}return p}function a(s){var r=s.className.split(/\s+/);r=r.concat(s.parentNode.className.split(/\s+/));for(var q=0;q<r.length;q++){var p=r[q].replace(/^language-/,"");if(e[p]){return p}}}function c(q){var p=[];(function(s,t){for(var r=0;r<s.childNodes.length;r++){if(s.childNodes[r].nodeType==3){t+=s.childNodes[r].nodeValue.length}else{if(s.childNodes[r].nodeName=="BR"){t+=1}else{if(s.childNodes[r].nodeType==1){p.push({event:"start",offset:t,node:s.childNodes[r]});t=arguments.callee(s.childNodes[r],t);p.push({event:"stop",offset:t,node:s.childNodes[r]})}}}}return t})(q,0);return p}function k(y,w,x){var q=0;var z="";var s=[];function u(){if(y.length&&w.length){if(y[0].offset!=w[0].offset){return(y[0].offset<w[0].offset)?y:w}else{return w[0].event=="start"?y:w}}else{return y.length?y:w}}function t(D){var A="<"+D.nodeName.toLowerCase();for(var B=0;B<D.attributes.length;B++){var C=D.attributes[B];A+=" "+C.nodeName.toLowerCase();if(C.value!==undefined&&C.value!==false&&C.value!==null){A+='="'+m(C.value)+'"'}}return A+">"}while(y.length||w.length){var v=u().splice(0,1)[0];z+=m(x.substr(q,v.offset-q));q=v.offset;if(v.event=="start"){z+=t(v.node);s.push(v.node)}else{if(v.event=="stop"){var p,r=s.length;do{r--;p=s[r];z+=("</"+p.nodeName.toLowerCase()+">")}while(p!=v.node);s.splice(r,1);while(r<s.length){z+=t(s[r]);r++}}}}return z+m(x.substr(q))}function j(){function q(x,y,v){if(x.compiled){return}var u;var s=[];if(x.k){x.lR=f(y,x.l||hljs.IR,true);for(var w in x.k){if(!x.k.hasOwnProperty(w)){continue}if(x.k[w] instanceof Object){u=x.k[w]}else{u=x.k;w="keyword"}for(var r in u){if(!u.hasOwnProperty(r)){continue}x.k[r]=[w,u[r]];s.push(r)}}}if(!v){if(x.bWK){x.b="\\b("+s.join("|")+")\\s"}x.bR=f(y,x.b?x.b:"\\B|\\b");if(!x.e&&!x.eW){x.e="\\B|\\b"}if(x.e){x.eR=f(y,x.e)}}if(x.i){x.iR=f(y,x.i)}if(x.r===undefined){x.r=1}if(!x.c){x.c=[]}x.compiled=true;for(var t=0;t<x.c.length;t++){if(x.c[t]=="self"){x.c[t]=x}q(x.c[t],y,false)}if(x.starts){q(x.starts,y,false)}}for(var p in e){if(!e.hasOwnProperty(p)){continue}q(e[p].dM,e[p],true)}}function d(B,C){if(!j.called){j();j.called=true}function q(r,M){for(var L=0;L<M.c.length;L++){if((M.c[L].bR.exec(r)||[null])[0]==r){return M.c[L]}}}function v(L,r){if(D[L].e&&D[L].eR.test(r)){return 1}if(D[L].eW){var M=v(L-1,r);return M?M+1:0}return 0}function w(r,L){return L.i&&L.iR.test(r)}function K(N,O){var M=[];for(var L=0;L<N.c.length;L++){M.push(N.c[L].b)}var r=D.length-1;do{if(D[r].e){M.push(D[r].e)}r--}while(D[r+1].eW);if(N.i){M.push(N.i)}return f(O,M.join("|"),true)}function p(M,L){var N=D[D.length-1];if(!N.t){N.t=K(N,E)}N.t.lastIndex=L;var r=N.t.exec(M);return r?[M.substr(L,r.index-L),r[0],false]:[M.substr(L),"",true]}function z(N,r){var L=E.cI?r[0].toLowerCase():r[0];var M=N.k[L];if(M&&M instanceof Array){return M}return false}function F(L,P){L=m(L);if(!P.k){return L}var r="";var O=0;P.lR.lastIndex=0;var M=P.lR.exec(L);while(M){r+=L.substr(O,M.index-O);var N=z(P,M);if(N){x+=N[1];r+='<span class="'+N[0]+'">'+M[0]+"</span>"}else{r+=M[0]}O=P.lR.lastIndex;M=P.lR.exec(L)}return r+L.substr(O,L.length-O)}function J(L,M){if(M.sL&&e[M.sL]){var r=d(M.sL,L);x+=r.keyword_count;return r.value}else{return F(L,M)}}function I(M,r){var L=M.cN?'<span class="'+M.cN+'">':"";if(M.rB){y+=L;M.buffer=""}else{if(M.eB){y+=m(r)+L;M.buffer=""}else{y+=L;M.buffer=r}}D.push(M);A+=M.r}function G(N,M,Q){var R=D[D.length-1];if(Q){y+=J(R.buffer+N,R);return false}var P=q(M,R);if(P){y+=J(R.buffer+N,R);I(P,M);return P.rB}var L=v(D.length-1,M);if(L){var O=R.cN?"</span>":"";if(R.rE){y+=J(R.buffer+N,R)+O}else{if(R.eE){y+=J(R.buffer+N,R)+O+m(M)}else{y+=J(R.buffer+N+M,R)+O}}while(L>1){O=D[D.length-2].cN?"</span>":"";y+=O;L--;D.length--}var r=D[D.length-1];D.length--;D[D.length-1].buffer="";if(r.starts){I(r.starts,"")}return R.rE}if(w(M,R)){throw"Illegal"}}var E=e[B];var D=[E.dM];var A=0;var x=0;var y="";try{var s,u=0;E.dM.buffer="";do{s=p(C,u);var t=G(s[0],s[1],s[2]);u+=s[0].length;if(!t){u+=s[1].length}}while(!s[2]);if(D.length>1){throw"Illegal"}return{r:A,keyword_count:x,value:y}}catch(H){if(H=="Illegal"){return{r:0,keyword_count:0,value:m(C)}}else{throw H}}}function g(t){var p={keyword_count:0,r:0,value:m(t)};var r=p;for(var q in e){if(!e.hasOwnProperty(q)){continue}var s=d(q,t);s.language=q;if(s.keyword_count+s.r>r.keyword_count+r.r){r=s}if(s.keyword_count+s.r>p.keyword_count+p.r){r=p;p=s}}if(r.language){p.second_best=r}return p}function i(r,q,p){if(q){r=r.replace(/^((<[^>]+>|\t)+)/gm,function(t,w,v,u){return w.replace(/\t/g,q)})}if(p){r=r.replace(/\n/g,"<br>")}return r}function n(t,w,r){var x=h(t,r);var v=a(t);var y,s;if(v){y=d(v,x)}else{return}var q=c(t);if(q.length){s=document.createElement("pre");s.innerHTML=y.value;y.value=k(q,c(s),x)}y.value=i(y.value,w,r);var u=t.className;if(!u.match("(\\s|^)(language-)?"+v+"(\\s|$)")){u=u?(u+" "+v):v}if(/MSIE [678]/.test(navigator.userAgent)&&t.tagName=="CODE"&&t.parentNode.tagName=="PRE"){s=t.parentNode;var p=document.createElement("div");p.innerHTML="<pre><code>"+y.value+"</code></pre>";t=p.firstChild.firstChild;p.firstChild.cN=s.cN;s.parentNode.replaceChild(p.firstChild,s)}else{t.innerHTML=y.value}t.className=u;t.result={language:v,kw:y.keyword_count,re:y.r};if(y.second_best){t.second_best={language:y.second_best.language,kw:y.second_best.keyword_count,re:y.second_best.r}}}function o(){if(o.called){return}o.called=true;var r=document.getElementsByTagName("pre");for(var p=0;p<r.length;p++){var q=b(r[p]);if(q){n(q,hljs.tabReplace)}}}function l(){if(window.addEventListener){window.addEventListener("DOMContentLoaded",o,false);window.addEventListener("load",o,false)}else{if(window.attachEvent){window.attachEvent("onload",o)}else{window.onload=o}}}var e={};this.LANGUAGES=e;this.highlight=d;this.highlightAuto=g;this.fixMarkup=i;this.highlightBlock=n;this.initHighlighting=o;this.initHighlightingOnLoad=l;this.IR="[a-zA-Z][a-zA-Z0-9_]*";this.UIR="[a-zA-Z_][a-zA-Z0-9_]*";this.NR="\\b\\d+(\\.\\d+)?";this.CNR="\\b(0[xX][a-fA-F0-9]+|(\\d+(\\.\\d*)?|\\.\\d+)([eE][-+]?\\d+)?)";this.BNR="\\b(0b[01]+)";this.RSR="!|!=|!==|%|%=|&|&&|&=|\\*|\\*=|\\+|\\+=|,|\\.|-|-=|/|/=|:|;|<|<<|<<=|<=|=|==|===|>|>=|>>|>>=|>>>|>>>=|\\?|\\[|\\{|\\(|\\^|\\^=|\\||\\|=|\\|\\||~";this.ER="(?![\\s\\S])";this.BE={b:"\\\\.",r:0};this.ASM={cN:"string",b:"'",e:"'",i:"\\n",c:[this.BE],r:0};this.QSM={cN:"string",b:'"',e:'"',i:"\\n",c:[this.BE],r:0};this.CLCM={cN:"comment",b:"//",e:"$"};this.CBLCLM={cN:"comment",b:"/\\*",e:"\\*/"};this.HCM={cN:"comment",b:"#",e:"$"};this.NM={cN:"number",b:this.NR,r:0};this.CNM={cN:"number",b:this.CNR,r:0};this.BNM={cN:"number",b:this.BNR,r:0};this.inherit=function(r,s){var p={};for(var q in r){p[q]=r[q]}if(s){for(var q in s){p[q]=s[q]}}return p}}();hljs.LANGUAGES.bash=function(){var e={"true":1,"false":1};var b={cN:"variable",b:"\\$([a-zA-Z0-9_]+)\\b"};var a={cN:"variable",b:"\\$\\{(([^}])|(\\\\}))+\\}",c:[hljs.CNM]};var f={cN:"string",b:'"',e:'"',i:"\\n",c:[hljs.BE,b,a],r:0};var c={cN:"string",b:"'",e:"'",c:[{b:"''"}],r:0};var d={cN:"test_condition",b:"",e:"",c:[f,c,b,a,hljs.CNM],k:{literal:e},r:0};return{dM:{k:{keyword:{"if":1,then:1,"else":1,fi:1,"for":1,"break":1,"continue":1,"while":1,"in":1,"do":1,done:1,echo:1,exit:1,"return":1,set:1,declare:1},literal:e},c:[{cN:"shebang",b:"(#!\\/bin\\/bash)|(#!\\/bin\\/sh)",r:10},b,a,hljs.HCM,hljs.CNM,f,c,hljs.inherit(d,{b:"\\[ ",e:" \\]",r:0}),hljs.inherit(d,{b:"\\[\\[ ",e:" \\]\\]"})]}}}();hljs.LANGUAGES.cpp=function(){var a={keyword:{"false":1,"int":1,"float":1,"while":1,"private":1,"char":1,"catch":1,"export":1,virtual:1,operator:2,sizeof:2,dynamic_cast:2,typedef:2,const_cast:2,"const":1,struct:1,"for":1,static_cast:2,union:1,namespace:1,unsigned:1,"long":1,"throw":1,"volatile":2,"static":1,"protected":1,bool:1,template:1,mutable:1,"if":1,"public":1,friend:2,"do":1,"return":1,"goto":1,auto:1,"void":2,"enum":1,"else":1,"break":1,"new":1,extern:1,using:1,"true":1,"class":1,asm:1,"case":1,typeid:1,"short":1,reinterpret_cast:2,"default":1,"double":1,register:1,explicit:1,signed:1,typename:1,"try":1,"this":1,"switch":1,"continue":1,wchar_t:1,inline:1,"delete":1,alignof:1,char16_t:1,char32_t:1,constexpr:1,decltype:1,noexcept:1,nullptr:1,static_assert:1,thread_local:1,restrict:1,_Bool:1,complex:1},built_in:{std:1,string:1,cin:1,cout:1,cerr:1,clog:1,stringstream:1,istringstream:1,ostringstream:1,auto_ptr:1,deque:1,list:1,queue:1,stack:1,vector:1,map:1,set:1,bitset:1,multiset:1,multimap:1,unordered_set:1,unordered_map:1,unordered_multiset:1,unordered_multimap:1,array:1,shared_ptr:1}};return{dM:{k:a,i:"</",c:[hljs.CLCM,hljs.CBLCLM,hljs.QSM,{cN:"string",b:"'\\\\?.",e:"'",i:"."},{cN:"number",b:"\\b(\\d+(\\.\\d*)?|\\.\\d+)(u|U|l|L|ul|UL|f|F)"},hljs.CNM,{cN:"preprocessor",b:"#",e:"$"},{cN:"stl_container",b:"\\b(deque|list|queue|stack|vector|map|set|bitset|multiset|multimap|unordered_map|unordered_set|unordered_multiset|unordered_multimap|array)\\s*<",e:">",k:a,r:10,c:["self"]}]}}}();hljs.LANGUAGES.css=function(){var a={cN:"function",b:hljs.IR+"\\(",e:"\\)",c:[{eW:true,eE:true,c:[hljs.NM,hljs.ASM,hljs.QSM]}]};return{cI:true,dM:{i:"[=/|']",c:[hljs.CBLCLM,{cN:"id",b:"\\#[A-Za-z0-9_-]+"},{cN:"class",b:"\\.[A-Za-z0-9_-]+",r:0},{cN:"attr_selector",b:"\\[",e:"\\]",i:"$"},{cN:"pseudo",b:":(:)?[a-zA-Z0-9\\_\\-\\+\\(\\)\\\"\\']+"},{cN:"at_rule",b:"@(font-face|page)",l:"[a-z-]+",k:{"font-face":1,page:1}},{cN:"at_rule",b:"@",e:"[{;]",eE:true,k:{"import":1,page:1,media:1,charset:1},c:[a,hljs.ASM,hljs.QSM,hljs.NM]},{cN:"tag",b:hljs.IR,r:0},{cN:"rules",b:"{",e:"}",i:"[^\\s]",r:0,c:[hljs.CBLCLM,{cN:"rule",b:"[^\\s]",rB:true,e:";",eW:true,c:[{cN:"attribute",b:"[A-Z\\_\\.\\-]+",e:":",eE:true,i:"[^\\s]",starts:{cN:"value",eW:true,eE:true,c:[a,hljs.NM,hljs.QSM,hljs.ASM,hljs.CBLCLM,{cN:"hexcolor",b:"\\#[0-9A-F]+"},{cN:"important",b:"!important"}]}}]}]}]}}}();hljs.LANGUAGES.ini={cI:true,dM:{i:"[^\\s]",c:[{cN:"comment",b:";",e:"$"},{cN:"title",b:"^\\[",e:"\\]"},{cN:"setting",b:"^[a-z0-9_\\[\\]]+[ \\t]*=[ \\t]*",e:"$",c:[{cN:"value",eW:true,k:{on:1,off:1,"true":1,"false":1,yes:1,no:1},c:[hljs.QSM,hljs.NM]}]}]}};hljs.LANGUAGES.perl=function(){var d={getpwent:1,getservent:1,quotemeta:1,msgrcv:1,scalar:1,kill:1,dbmclose:1,undef:1,lc:1,ma:1,syswrite:1,tr:1,send:1,umask:1,sysopen:1,shmwrite:1,vec:1,qx:1,utime:1,local:1,oct:1,semctl:1,localtime:1,readpipe:1,"do":1,"return":1,format:1,read:1,sprintf:1,dbmopen:1,pop:1,getpgrp:1,not:1,getpwnam:1,rewinddir:1,qq:1,fileno:1,qw:1,endprotoent:1,wait:1,sethostent:1,bless:1,s:0,opendir:1,"continue":1,each:1,sleep:1,endgrent:1,shutdown:1,dump:1,chomp:1,connect:1,getsockname:1,die:1,socketpair:1,close:1,flock:1,exists:1,index:1,shmget:1,sub:1,"for":1,endpwent:1,redo:1,lstat:1,msgctl:1,setpgrp:1,abs:1,exit:1,select:1,print:1,ref:1,gethostbyaddr:1,unshift:1,fcntl:1,syscall:1,"goto":1,getnetbyaddr:1,join:1,gmtime:1,symlink:1,semget:1,splice:1,x:0,getpeername:1,recv:1,log:1,setsockopt:1,cos:1,last:1,reverse:1,gethostbyname:1,getgrnam:1,study:1,formline:1,endhostent:1,times:1,chop:1,length:1,gethostent:1,getnetent:1,pack:1,getprotoent:1,getservbyname:1,rand:1,mkdir:1,pos:1,chmod:1,y:0,substr:1,endnetent:1,printf:1,next:1,open:1,msgsnd:1,readdir:1,use:1,unlink:1,getsockopt:1,getpriority:1,rindex:1,wantarray:1,hex:1,system:1,getservbyport:1,endservent:1,"int":1,chr:1,untie:1,rmdir:1,prototype:1,tell:1,listen:1,fork:1,shmread:1,ucfirst:1,setprotoent:1,"else":1,sysseek:1,link:1,getgrgid:1,shmctl:1,waitpid:1,unpack:1,getnetbyname:1,reset:1,chdir:1,grep:1,split:1,require:1,caller:1,lcfirst:1,until:1,warn:1,"while":1,values:1,shift:1,telldir:1,getpwuid:1,my:1,getprotobynumber:1,"delete":1,and:1,sort:1,uc:1,defined:1,srand:1,accept:1,"package":1,seekdir:1,getprotobyname:1,semop:1,our:1,rename:1,seek:1,"if":1,q:0,chroot:1,sysread:1,setpwent:1,no:1,crypt:1,getc:1,chown:1,sqrt:1,write:1,setnetent:1,setpriority:1,foreach:1,tie:1,sin:1,msgget:1,map:1,stat:1,getlogin:1,unless:1,elsif:1,truncate:1,exec:1,keys:1,glob:1,tied:1,closedir:1,ioctl:1,socket:1,readlink:1,"eval":1,xor:1,readline:1,binmode:1,setservent:1,eof:1,ord:1,bind:1,alarm:1,pipe:1,atan2:1,getgrent:1,exp:1,time:1,push:1,setgrent:1,gt:1,lt:1,or:1,ne:1,m:0};var f={cN:"subst",b:"[$@]\\{",e:"\\}",k:d,r:10};var c={cN:"variable",b:"\\$\\d"};var b={cN:"variable",b:"[\\$\\%\\@\\*](\\^\\w\\b|#\\w+(\\:\\:\\w+)*|[^\\s\\w{]|{\\w+}|\\w+(\\:\\:\\w*)*)"};var h=[hljs.BE,f,c,b];var g={b:"->",c:[{b:hljs.IR},{b:"{",e:"}"}]};var e={cN:"comment",b:"^(__END__|__DATA__)",e:"\\n$",r:5};var a=[c,b,hljs.HCM,e,g,{cN:"string",b:"q[qwxr]?\\s*\\(",e:"\\)",c:h,r:5},{cN:"string",b:"q[qwxr]?\\s*\\[",e:"\\]",c:h,r:5},{cN:"string",b:"q[qwxr]?\\s*\\{",e:"\\}",c:h,r:5},{cN:"string",b:"q[qwxr]?\\s*\\|",e:"\\|",c:h,r:5},{cN:"string",b:"q[qwxr]?\\s*\\<",e:"\\>",c:h,r:5},{cN:"string",b:"qw\\s+q",e:"q",c:h,r:5},{cN:"string",b:"'",e:"'",c:[hljs.BE],r:0},{cN:"string",b:'"',e:'"',c:h,r:0},{cN:"string",b:"`",e:"`",c:[hljs.BE]},{cN:"string",b:"{\\w+}",r:0},{cN:"string",b:"-?\\w+\\s*\\=\\>",r:0},{cN:"number",b:"(\\b0[0-7_]+)|(\\b0x[0-9a-fA-F_]+)|(\\b[1-9][0-9_]*(\\.[0-9_]+)?)|[0_]\\b",r:0},{b:"("+hljs.RSR+"|\\b(split|return|print|reverse|grep)\\b)\\s*",k:{split:1,"return":1,print:1,reverse:1,grep:1},r:0,c:[hljs.HCM,e,{cN:"regexp",b:"(s|tr|y)/(\\\\.|[^/])*/(\\\\.|[^/])*/[a-z]*",r:10},{cN:"regexp",b:"(m|qr)?/",e:"/[a-z]*",c:[hljs.BE],r:0}]},{cN:"sub",b:"\\bsub\\b",e:"(\\s*\\(.*?\\))?[;{]",k:{sub:1},r:5},{cN:"operator",b:"-\\w\\b",r:0},{cN:"pod",b:"\\=\\w",e:"\\=cut"}];f.c=a;g.c[1].c=a;return{dM:{k:d,c:a}}}();hljs.LANGUAGES.python=function(){var b=[{cN:"string",b:"(u|b)?r?'''",e:"'''",r:10},{cN:"string",b:'(u|b)?r?"""',e:'"""',r:10},{cN:"string",b:"(u|r|ur)'",e:"'",c:[hljs.BE],r:10},{cN:"string",b:'(u|r|ur)"',e:'"',c:[hljs.BE],r:10},{cN:"string",b:"(b|br)'",e:"'",c:[hljs.BE]},{cN:"string",b:'(b|br)"',e:'"',c:[hljs.BE]}].concat([hljs.ASM,hljs.QSM]);var d={cN:"title",b:hljs.UIR};var c={cN:"params",b:"\\(",e:"\\)",c:b.concat([hljs.CNM])};var a={bWK:true,e:":",i:"[${]",c:[d,c],r:10};return{dM:{k:{keyword:{and:1,elif:1,is:1,global:1,as:1,"in":1,"if":1,from:1,raise:1,"for":1,except:1,"finally":1,print:1,"import":1,pass:1,"return":1,exec:1,"else":1,"break":1,not:1,"with":1,"class":1,assert:1,yield:1,"try":1,"while":1,"continue":1,del:1,or:1,def:1,lambda:1,nonlocal:10},built_in:{None:1,True:1,False:1,Ellipsis:1,NotImplemented:1}},i:"(</|->|\\?)",c:b.concat([hljs.HCM,hljs.inherit(a,{cN:"function",k:{def:1}}),hljs.inherit(a,{cN:"class",k:{"class":1}}),hljs.CNM,{cN:"decorator",b:"@",e:"$"}])}}}();hljs.LANGUAGES.r={dM:{c:[hljs.HCM,{cN:"number",b:"\\b0[xX][0-9a-fA-F]+[Li]?\\b",e:hljs.IMMEDIATE_RE,r:0},{cN:"number",b:"\\b\\d+(?:[eE][+\\-]?\\d*)?L\\b",e:hljs.IMMEDIATE_RE,r:0},{cN:"number",b:"\\b\\d+\\.(?!\\d)(?:i\\b)?",e:hljs.IMMEDIATE_RE,r:1},{cN:"number",b:"\\b\\d+(?:\\.\\d*)?(?:[eE][+\\-]?\\d*)?i?\\b",e:hljs.IMMEDIATE_RE,r:0},{cN:"number",b:"\\.\\d+(?:[eE][+\\-]?\\d*)?i?\\b",e:hljs.IMMEDIATE_RE,r:1},{cN:"keyword",b:"(?:tryCatch|library|setGeneric|setGroupGeneric)\\b",e:hljs.IMMEDIATE_RE,r:10},{cN:"keyword",b:"\\.\\.\\.",e:hljs.IMMEDIATE_RE,r:10},{cN:"keyword",b:"\\.\\.\\d+(?![\\w.])",e:hljs.IMMEDIATE_RE,r:10},{cN:"keyword",b:"\\b(?:function)",e:hljs.IMMEDIATE_RE,r:2},{cN:"keyword",b:"(?:if|in|break|next|repeat|else|for|return|switch|while|try|stop|warning|require|attach|detach|source|setMethod|setClass)\\b",e:hljs.IMMEDIATE_RE,r:1},{cN:"literal",b:"(?:NA|NA_integer_|NA_real_|NA_character_|NA_complex_)\\b",e:hljs.IMMEDIATE_RE,r:10},{cN:"literal",b:"(?:NULL|TRUE|FALSE|T|F|Inf|NaN)\\b",e:hljs.IMMEDIATE_RE,r:1},{cN:"identifier",b:"[a-zA-Z.][a-zA-Z0-9._]*\\b",e:hljs.IMMEDIATE_RE,r:0},{cN:"operator",b:"<\\-(?!\\s*\\d)",e:hljs.IMMEDIATE_RE,r:2},{cN:"operator",b:"\\->|<\\-",e:hljs.IMMEDIATE_RE,r:1},{cN:"operator",b:"%%|~",e:hljs.IMMEDIATE_RE},{cN:"operator",b:">=|<=|==|!=|\\|\\||&&|=|\\+|\\-|\\*|/|\\^|>|<|!|&|\\||\\$|:",e:hljs.IMMEDIATE_RE,r:0},{cN:"operator",b:"%",e:"%",i:"\\n",r:1},{cN:"identifier",b:"`",e:"`",r:0},{cN:"string",b:'"',e:'"',c:[hljs.BE],r:0},{cN:"string",b:"'",e:"'",c:[hljs.BE],r:0},{cN:"paren",b:"[[({\\])}]",e:hljs.IMMEDIATE_RE,r:0}]}};hljs.LANGUAGES.ruby=function(){var a="[a-zA-Z_][a-zA-Z0-9_]*(\\!|\\?)?";var j="[a-zA-Z_]\\w*[!?=]?|[-+~]\\@|<<|>>|=~|===?|<=>|[<>]=?|\\*\\*|[-/+%^&*~`|]|\\[\\]=?";var f={keyword:{and:1,"false":1,then:1,defined:1,module:1,"in":1,"return":1,redo:1,"if":1,BEGIN:1,retry:1,end:1,"for":1,"true":1,self:1,when:1,next:1,until:1,"do":1,begin:1,unless:1,END:1,rescue:1,nil:1,"else":1,"break":1,undef:1,not:1,"super":1,"class":1,"case":1,require:1,yield:1,alias:1,"while":1,ensure:1,elsif:1,or:1,def:1},keymethods:{__id__:1,__send__:1,abort:1,abs:1,"all?":1,allocate:1,ancestors:1,"any?":1,arity:1,assoc:1,at:1,at_exit:1,autoload:1,"autoload?":1,"between?":1,binding:1,binmode:1,"block_given?":1,call:1,callcc:1,caller:1,capitalize:1,"capitalize!":1,casecmp:1,"catch":1,ceil:1,center:1,chomp:1,"chomp!":1,chop:1,"chop!":1,chr:1,"class":1,class_eval:1,"class_variable_defined?":1,class_variables:1,clear:1,clone:1,close:1,close_read:1,close_write:1,"closed?":1,coerce:1,collect:1,"collect!":1,compact:1,"compact!":1,concat:1,"const_defined?":1,const_get:1,const_missing:1,const_set:1,constants:1,count:1,crypt:1,"default":1,default_proc:1,"delete":1,"delete!":1,delete_at:1,delete_if:1,detect:1,display:1,div:1,divmod:1,downcase:1,"downcase!":1,downto:1,dump:1,dup:1,each:1,each_byte:1,each_index:1,each_key:1,each_line:1,each_pair:1,each_value:1,each_with_index:1,"empty?":1,entries:1,eof:1,"eof?":1,"eql?":1,"equal?":1,"eval":1,exec:1,exit:1,"exit!":1,extend:1,fail:1,fcntl:1,fetch:1,fileno:1,fill:1,find:1,find_all:1,first:1,flatten:1,"flatten!":1,floor:1,flush:1,for_fd:1,foreach:1,fork:1,format:1,freeze:1,"frozen?":1,fsync:1,getc:1,gets:1,global_variables:1,grep:1,gsub:1,"gsub!":1,"has_key?":1,"has_value?":1,hash:1,hex:1,id:1,include:1,"include?":1,included_modules:1,index:1,indexes:1,indices:1,induced_from:1,inject:1,insert:1,inspect:1,instance_eval:1,instance_method:1,instance_methods:1,"instance_of?":1,"instance_variable_defined?":1,instance_variable_get:1,instance_variable_set:1,instance_variables:1,"integer?":1,intern:1,invert:1,ioctl:1,"is_a?":1,isatty:1,"iterator?":1,join:1,"key?":1,keys:1,"kind_of?":1,lambda:1,last:1,length:1,lineno:1,ljust:1,load:1,local_variables:1,loop:1,lstrip:1,"lstrip!":1,map:1,"map!":1,match:1,max:1,"member?":1,merge:1,"merge!":1,method:1,"method_defined?":1,method_missing:1,methods:1,min:1,module_eval:1,modulo:1,name:1,nesting:1,"new":1,next:1,"next!":1,"nil?":1,nitems:1,"nonzero?":1,object_id:1,oct:1,open:1,pack:1,partition:1,pid:1,pipe:1,pop:1,popen:1,pos:1,prec:1,prec_f:1,prec_i:1,print:1,printf:1,private_class_method:1,private_instance_methods:1,"private_method_defined?":1,private_methods:1,proc:1,protected_instance_methods:1,"protected_method_defined?":1,protected_methods:1,public_class_method:1,public_instance_methods:1,"public_method_defined?":1,public_methods:1,push:1,putc:1,puts:1,quo:1,raise:1,rand:1,rassoc:1,read:1,read_nonblock:1,readchar:1,readline:1,readlines:1,readpartial:1,rehash:1,reject:1,"reject!":1,remainder:1,reopen:1,replace:1,require:1,"respond_to?":1,reverse:1,"reverse!":1,reverse_each:1,rewind:1,rindex:1,rjust:1,round:1,rstrip:1,"rstrip!":1,scan:1,seek:1,select:1,send:1,set_trace_func:1,shift:1,singleton_method_added:1,singleton_methods:1,size:1,sleep:1,slice:1,"slice!":1,sort:1,"sort!":1,sort_by:1,split:1,sprintf:1,squeeze:1,"squeeze!":1,srand:1,stat:1,step:1,store:1,strip:1,"strip!":1,sub:1,"sub!":1,succ:1,"succ!":1,sum:1,superclass:1,swapcase:1,"swapcase!":1,sync:1,syscall:1,sysopen:1,sysread:1,sysseek:1,system:1,syswrite:1,taint:1,"tainted?":1,tell:1,test:1,"throw":1,times:1,to_a:1,to_ary:1,to_f:1,to_hash:1,to_i:1,to_int:1,to_io:1,to_proc:1,to_s:1,to_str:1,to_sym:1,tr:1,"tr!":1,tr_s:1,"tr_s!":1,trace_var:1,transpose:1,trap:1,truncate:1,"tty?":1,type:1,ungetc:1,uniq:1,"uniq!":1,unpack:1,unshift:1,untaint:1,untrace_var:1,upcase:1,"upcase!":1,update:1,upto:1,"value?":1,values:1,values_at:1,warn:1,write:1,write_nonblock:1,"zero?":1,zip:1}};var c={cN:"yardoctag",b:"@[A-Za-z]+"};var k=[{cN:"comment",b:"#",e:"$",c:[c]},{cN:"comment",b:"^\\=begin",e:"^\\=end",c:[c],r:10},{cN:"comment",b:"^__END__",e:"\\n$"}];var d={cN:"subst",b:"#\\{",e:"}",l:a,k:f};var i=[hljs.BE,d];var b=[{cN:"string",b:"'",e:"'",c:i,r:0},{cN:"string",b:'"',e:'"',c:i,r:0},{cN:"string",b:"%[qw]?\\(",e:"\\)",c:i,r:10},{cN:"string",b:"%[qw]?\\[",e:"\\]",c:i,r:10},{cN:"string",b:"%[qw]?{",e:"}",c:i,r:10},{cN:"string",b:"%[qw]?<",e:">",c:i,r:10},{cN:"string",b:"%[qw]?/",e:"/",c:i,r:10},{cN:"string",b:"%[qw]?%",e:"%",c:i,r:10},{cN:"string",b:"%[qw]?-",e:"-",c:i,r:10},{cN:"string",b:"%[qw]?\\|",e:"\\|",c:i,r:10}];var h={cN:"function",b:"\\bdef\\s+",e:" |$|;",l:a,k:f,c:[{cN:"title",b:j,l:a,k:f},{cN:"params",b:"\\(",e:"\\)",l:a,k:f}].concat(k)};var g={cN:"identifier",b:a,l:a,k:f,r:0};var e=k.concat(b.concat([{cN:"class",b:"\\b(class|module)\\b",e:"$|;",k:{"class":1,module:1},c:[{cN:"title",b:"[A-Za-z_]\\w*(::\\w+)*(\\?|\\!)?",r:0},{cN:"inheritance",b:"<\\s*",c:[{cN:"parent",b:"("+hljs.IR+"::)?"+hljs.IR}]}].concat(k)},h,{cN:"constant",b:"(::)?([A-Z]\\w*(::)?)+",r:0},{cN:"symbol",b:":",c:b.concat([g]),r:0},{cN:"number",b:"(\\b0[0-7_]+)|(\\b0x[0-9a-fA-F_]+)|(\\b[1-9][0-9_]*(\\.[0-9_]+)?)|[0_]\\b",r:0},{cN:"number",b:"\\?\\w"},{cN:"variable",b:"(\\$\\W)|((\\$|\\@\\@?)(\\w+))"},g,{b:"("+hljs.RSR+")\\s*",c:k.concat([{cN:"regexp",b:"/",e:"/[a-z]*",i:"\\n",c:[hljs.BE]}]),r:0}]));d.c=e;h.c[1].c=e;return{dM:{l:a,k:f,c:e}}}();hljs.LANGUAGES.scala=function(){var b={cN:"annotation",b:"@[A-Za-z]+"};var a={cN:"string",b:'u?r?"""',e:'"""',r:10};return{dM:{k:{type:1,yield:1,lazy:1,override:1,def:1,"with":1,val:1,"var":1,"false":1,"true":1,sealed:1,"abstract":1,"private":1,trait:1,object:1,"null":1,"if":1,"for":1,"while":1,"throw":1,"finally":1,"protected":1,"extends":1,"import":1,"final":1,"return":1,"else":1,"break":1,"new":1,"catch":1,"super":1,"class":1,"case":1,"package":1,"default":1,"try":1,"this":1,match:1,"continue":1,"throws":1},c:[{cN:"javadoc",b:"/\\*\\*",e:"\\*/",c:[{cN:"javadoctag",b:"@[A-Za-z]+"}],r:10},hljs.CLCM,hljs.CBLCLM,hljs.ASM,hljs.QSM,a,{cN:"class",b:"((case )?class |object |trait )",e:"({|$)",i:":",k:{"case":1,"class":1,trait:1,object:1},c:[{bWK:true,k:{"extends":1,"with":1},r:10},{cN:"title",b:hljs.UIR},{cN:"params",b:"\\(",e:"\\)",c:[hljs.ASM,hljs.QSM,a,b]}]},hljs.CNM,b]}}}();hljs.LANGUAGES.sql={cI:true,dM:{i:"[^\\s]",c:[{cN:"operator",b:"(begin|start|commit|rollback|savepoint|lock|alter|create|drop|rename|call|delete|do|handler|insert|load|replace|select|truncate|update|set|show|pragma|grant)\\b",e:";|"+hljs.ER,k:{keyword:{all:1,partial:1,global:1,month:1,current_timestamp:1,using:1,go:1,revoke:1,smallint:1,indicator:1,"end-exec":1,disconnect:1,zone:1,"with":1,character:1,assertion:1,to:1,add:1,current_user:1,usage:1,input:1,local:1,alter:1,match:1,collate:1,real:1,then:1,rollback:1,get:1,read:1,timestamp:1,session_user:1,not:1,integer:1,bit:1,unique:1,day:1,minute:1,desc:1,insert:1,execute:1,like:1,ilike:2,level:1,decimal:1,drop:1,"continue":1,isolation:1,found:1,where:1,constraints:1,domain:1,right:1,national:1,some:1,module:1,transaction:1,relative:1,second:1,connect:1,escape:1,close:1,system_user:1,"for":1,deferred:1,section:1,cast:1,current:1,sqlstate:1,allocate:1,intersect:1,deallocate:1,numeric:1,"public":1,preserve:1,full:1,"goto":1,initially:1,asc:1,no:1,key:1,output:1,collation:1,group:1,by:1,union:1,session:1,both:1,last:1,language:1,constraint:1,column:1,of:1,space:1,foreign:1,deferrable:1,prior:1,connection:1,unknown:1,action:1,commit:1,view:1,or:1,first:1,into:1,"float":1,year:1,primary:1,cascaded:1,except:1,restrict:1,set:1,references:1,names:1,table:1,outer:1,open:1,select:1,size:1,are:1,rows:1,from:1,prepare:1,distinct:1,leading:1,create:1,only:1,next:1,inner:1,authorization:1,schema:1,corresponding:1,option:1,declare:1,precision:1,immediate:1,"else":1,timezone_minute:1,external:1,varying:1,translation:1,"true":1,"case":1,exception:1,join:1,hour:1,"default":1,"double":1,scroll:1,value:1,cursor:1,descriptor:1,values:1,dec:1,fetch:1,procedure:1,"delete":1,and:1,"false":1,"int":1,is:1,describe:1,"char":1,as:1,at:1,"in":1,varchar:1,"null":1,trailing:1,any:1,absolute:1,current_time:1,end:1,grant:1,privileges:1,when:1,cross:1,check:1,write:1,current_date:1,pad:1,begin:1,temporary:1,exec:1,time:1,update:1,catalog:1,user:1,sql:1,date:1,on:1,identity:1,timezone_hour:1,natural:1,whenever:1,interval:1,work:1,order:1,cascade:1,diagnostics:1,nchar:1,having:1,left:1,call:1,"do":1,handler:1,load:1,replace:1,truncate:1,start:1,lock:1,show:1,pragma:1},aggregate:{count:1,sum:1,min:1,max:1,avg:1}},c:[{cN:"string",b:"'",e:"'",c:[hljs.BE,{b:"''"}],r:0},{cN:"string",b:'"',e:'"',c:[hljs.BE,{b:'""'}],r:0},{cN:"string",b:"`",e:"`",c:[hljs.BE]},hljs.CNM]},hljs.CBLCLM,{cN:"comment",b:"--",e:"$"}]}};hljs.LANGUAGES.stan={dM:{c:[hljs.HCM,hljs.CLCM,hljs.QSM,hljs.CNM,{cN:"operator",b:"(?:<-|~|\\|\\||&&|==|!=|<=?|>=?|\\+|-|\\.?/|\\\\|\\^|\\^|!|'|%|:|,|;|=)\\b",e:hljs.IMMEDIATE_RE,r:10},{cN:"paren",b:"[[({\\])}]",e:hljs.IMMEDIATE_RE,r:0},{cN:"function",b:"(?:Phi|Phi_approx|abs|acos|acosh|append_col|append_row|asin|asinh|atan|atan2|atanh|bernoulli_ccdf_log|bernoulli_cdf|bernoulli_cdf_log|bernoulli_log|bernoulli_logit_log|bernoulli_rng|bessel_first_kind|bessel_second_kind|beta_binomial_ccdf_log|beta_binomial_cdf|beta_binomial_cdf_log|beta_binomial_log|beta_binomial_rng|beta_ccdf_log|beta_cdf|beta_cdf_log|beta_log|beta_rng|binary_log_loss|binomial_ccdf_log|binomial_cdf|binomial_cdf_log|binomial_coefficient_log|binomial_log|binomial_logit_log|binomial_rng|block|categorical_log|categorical_logit_log|categorical_rng|cauchy_ccdf_log|cauchy_cdf|cauchy_cdf_log|cauchy_log|cauchy_rng|cbrt|ceil|chi_square_ccdf_log|chi_square_cdf|chi_square_cdf_log|chi_square_log|chi_square_rng|cholesky_decompose|col|cols|columns_dot_product|columns_dot_self|cos|cosh|crossprod|csr_extract_u|csr_extract_v|csr_extract_w|csr_matrix_times_vector|csr_to_dense_matrix|cumulative_sum|determinant|diag_matrix|diag_post_multiply|diag_pre_multiply|diagonal|digamma|dims|dirichlet_log|dirichlet_rng|distance|dot_product|dot_self|double_exponential_ccdf_log|double_exponential_cdf|double_exponential_cdf_log|double_exponential_log|double_exponential_rng|e|eigenvalues_sym|eigenvectors_sym|erf|erfc|exp|exp2|exp_mod_normal_ccdf_log|exp_mod_normal_cdf|exp_mod_normal_cdf_log|exp_mod_normal_log|exp_mod_normal_rng|expm1|exponential_ccdf_log|exponential_cdf|exponential_cdf_log|exponential_log|exponential_rng|fabs|falling_factorial|fdim|floor|fma|fmax|fmin|fmod|frechet_ccdf_log|frechet_cdf|frechet_cdf_log|frechet_log|frechet_rng|gamma_ccdf_log|gamma_cdf|gamma_cdf_log|gamma_log|gamma_p|gamma_q|gamma_rng|gaussian_dlm_obs_log|get_lp|gumbel_ccdf_log|gumbel_cdf|gumbel_cdf_log|gumbel_log|gumbel_rng|head|hypergeometric_log|hypergeometric_rng|hypot|if_else|int_step|inv|inv_chi_square_ccdf_log|inv_chi_square_cdf|inv_chi_square_cdf_log|inv_chi_square_log|inv_chi_square_rng|inv_cloglog|inv_gamma_ccdf_log|inv_gamma_cdf|inv_gamma_cdf_log|inv_gamma_log|inv_gamma_rng|inv_logit|inv_phi|inv_sqrt|inv_square|inv_wishart_log|inv_wishart_rng|inverse|inverse_spd|is_inf|is_nan|lbeta|lgamma|lkj_corr_cholesky_log|lkj_corr_cholesky_rng|lkj_corr_log|lkj_corr_rng|lmgamma|log|log10|log1m|log1m_exp|log1m_inv_logit|log1p|log1p_exp|log2|log_determinant|log_diff_exp|log_falling_factorial|log_inv_logit|log_mix|log_rising_factorial|log_softmax|log_sum_exp|logistic_ccdf_log|logistic_cdf|logistic_cdf_log|logistic_log|logistic_rng|logit|lognormal_ccdf_log|lognormal_cdf|lognormal_cdf_log|lognormal_log|lognormal_rng|machine_precision|max|mdivide_left_tri_low|mdivide_right_tri_low|mean|min|modified_bessel_first_kind|modified_bessel_second_kind|multi_gp_cholesky_log|multi_gp_log|multi_normal_cholesky_log|multi_normal_cholesky_rng|multi_normal_log|multi_normal_prec_log|multi_normal_rng|multi_student_t_log|multi_student_t_rng|multinomial_log|multinomial_rng|multiply_log|multiply_lower_tri_self_transpose|neg_binomial_2_ccdf_log|neg_binomial_2_cdf|neg_binomial_2_cdf_log|neg_binomial_2_log|neg_binomial_2_log_log|neg_binomial_2_log_rng|neg_binomial_2_rng|neg_binomial_ccdf_log|neg_binomial_cdf|neg_binomial_cdf_log|neg_binomial_log|neg_binomial_rng|negative_infinity|normal_ccdf_log|normal_cdf|normal_cdf_log|normal_log|normal_rng|not_a_number|num_elements|ordered_logistic_log|ordered_logistic_rng|owens_t|pareto_ccdf_log|pareto_cdf|pareto_cdf_log|pareto_log|pareto_rng|pareto_type_2_ccdf_log|pareto_type_2_cdf|pareto_type_2_cdf_log|pareto_type_2_log|pareto_type_2_rng|pi|poisson_ccdf_log|poisson_cdf|poisson_cdf_log|poisson_log|poisson_log_log|poisson_log_rng|poisson_rng|positive_infinity|pow|prod|qr_Q|qr_R|quad_form|quad_form_diag|quad_form_sym|rank|rayleigh_ccdf_log|rayleigh_cdf|rayleigh_cdf_log|rayleigh_log|rayleigh_rng|rep_array|rep_matrix|rep_row_vector|rep_vector|rising_factorial|round|row|rows|rows_dot_product|rows_dot_self|scaled_inv_chi_square_ccdf_log|scaled_inv_chi_square_cdf|scaled_inv_chi_square_cdf_log|scaled_inv_chi_square_log|scaled_inv_chi_square_rng|sd|segment|sin|singular_values|sinh|size|skew_normal_ccdf_log|skew_normal_cdf|skew_normal_cdf_log|skew_normal_log|skew_normal_rng|softmax|sort_asc|sort_desc|sort_indices_asc|sort_indices_desc|sqrt|sqrt2|square|squared_distance|step|student_t_ccdf_log|student_t_cdf|student_t_cdf_log|student_t_log|student_t_rng|sub_col|sub_row|sum|tail|tan|tanh|tcrossprod|tgamma|to_array_1d|to_array_2d|to_matrix|to_row_vector|to_vector|trace|trace_gen_quad_form|trace_quad_form|trigamma|trunc|uniform_ccdf_log|uniform_cdf|uniform_cdf_log|uniform_log|uniform_rng|variance|von_mises_log|von_mises_rng|weibull_ccdf_log|weibull_cdf|weibull_cdf_log|weibull_log|weibull_rng|wiener_log|wishart_log|wishart_rng)\\b",e:hljs.IMMEDIATE_RE,r:10},{cN:"function",b:"(?:bernoulli|bernoulli_logit|beta|beta_binomial|binomial|binomial_logit|categorical|categorical_logit|cauchy|chi_square|dirichlet|double_exponential|exp_mod_normal|exponential|frechet|gamma|gaussian_dlm_obs|gumbel|hypergeometric|inv_chi_square|inv_gamma|inv_wishart|lkj_corr|lkj_corr_cholesky|logistic|lognormal|multi_gp|multi_gp_cholesky|multi_normal|multi_normal_cholesky|multi_normal_prec|multi_student_t|multinomial|neg_binomial|neg_binomial_2|neg_binomial_2_log|normal|ordered_logistic|pareto|pareto_type_2|poisson|poisson_log|rayleigh|scaled_inv_chi_square|skew_normal|student_t|uniform|von_mises|weibull|wiener|wishart)\\b",e:hljs.IMMEDIATE_RE,r:10},{cN:"keyword",b:"(?:for|in|while|if|then|else|return|lower|upper|print|increment_log_prob|integrate_ode|reject)\\b",e:hljs.IMMEDIATE_RE,r:10},{cN:"keyword",b:"(?:int|real|vector|simplex|unit_vector|ordered|positive_ordered|row_vector|matrix|cholesky_factor_cov|cholesky_factor_corr|corr_matrix|cov_matrix|void)\\b",e:hljs.IMMEDIATE_RE,r:5},{cN:"keyword",b:"(?:functions|data|transformed\\s+data|parameters|transformed\\s+parameters|model|generated\\s+quantities)\\b",e:hljs.IMMEDIATE_RE,r:5}]}};hljs.LANGUAGES.xml=function(){var b="[A-Za-z0-9\\._:-]+";var a={eW:true,c:[{cN:"attribute",b:b,r:0},{b:'="',rB:true,e:'"',c:[{cN:"value",b:'"',eW:true}]},{b:"='",rB:true,e:"'",c:[{cN:"value",b:"'",eW:true}]},{b:"=",c:[{cN:"value",b:"[^\\s/>]+"}]}]};return{cI:true,dM:{c:[{cN:"pi",b:"<\\?",e:"\\?>",r:10},{cN:"doctype",b:"<!DOCTYPE",e:">",r:10,c:[{b:"\\[",e:"\\]"}]},{cN:"comment",b:"<!--",e:"-->",r:10},{cN:"cdata",b:"<\\!\\[CDATA\\[",e:"\\]\\]>",r:10},{cN:"tag",b:"<style(?=\\s|>|$)",e:">",k:{title:{style:1}},c:[a],starts:{cN:"css",e:"</style>",rE:true,sL:"css"}},{cN:"tag",b:"<script(?=\\s|>|$)",e:">",k:{title:{script:1}},c:[a],starts:{cN:"javascript",e:"<\/script>",rE:true,sL:"javascript"}},{cN:"vbscript",b:"<%",e:"%>",sL:"vbscript"},{cN:"tag",b:"</?",e:"/?>",c:[{cN:"title",b:"[^ />]+"},a]}]}}}();
hljs.initHighlightingOnLoad();

"></script>

<style type="text/css">code{white-space: pre;}</style>
<style type="text/css">
  pre:not([class]) {
    background-color: white;
  }
</style>
<script type="text/javascript">
if (window.hljs && document.readyState && document.readyState === "complete") {
   window.setTimeout(function() {
      hljs.initHighlighting();
   }, 0);
}
</script>



<style type="text/css">
h1 {
  font-size: 34px;
}
h1.title {
  font-size: 38px;
}
h2 {
  font-size: 30px;
}
h3 {
  font-size: 24px;
}
h4 {
  font-size: 18px;
}
h5 {
  font-size: 16px;
}
h6 {
  font-size: 12px;
}
.table th:not([align]) {
  text-align: left;
}
</style>


</head>

<body>

<style type="text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
code {
  color: inherit;
  background-color: rgba(0, 0, 0, 0.04);
}
img {
  max-width:100%;
  height: auto;
}
.tabbed-pane {
  padding-top: 12px;
}
button.code-folding-btn:focus {
  outline: none;
}
</style>



<div class="container-fluid main-container">

<!-- tabsets -->
<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});
</script>

<!-- code folding -->






<div class="fluid-row" id="header">



<h1 class="title toc-ignore">Rare Diseases in the Duke Medical System</h1>
<h4 class="author"><em>Gary Koplik, Matt Tribby</em></h4>

</div>

<div id="TOC">
<ul>
<li><a href="#manipulating-our-data-and-partioning-into-rare-disease-patients-non-rare-disease-patients">Manipulating our Data and Partioning into Rare Disease Patients / Non-Rare Disease Patients</a></li>
<li><a href="#summary-statistics">Summary Statistics</a></li>
<li><a href="#looking-at-prevalence-of-rare-diseases">Looking at Prevalence of Rare Diseases</a></li>
<li><a href="#graphs-using-all-rare-disease-codes">Graphs Using All Rare Disease Codes</a></li>
<li><a href="#graphs-with-only-1-rare-disease-per-code">Graphs with Only 1 Rare Disease per Code</a></li>
<li><a href="#back-to-the-diabetes-example">Back to the Diabetes Example</a></li>
<li><a href="#the-takeaway">The Takeaway</a></li>
<li><a href="#frequency-table-with-all-icd-10-codes-for-rare-diseases">Frequency Table with All ICD-10 Codes for Rare Diseases</a></li>
<li><a href="#frequency-table-of-icd-10-codes-that-each-only-map-to-exactly-1-rare-disease">Frequency Table of ICD-10 Codes that Each Only Map to Exactly 1 Rare Disease</a></li>
<li><a href="#frequency-table-with-all-icd-10-codes-for-rare-metabolic-diseases">Frequency Table with All ICD-10 Codes for Rare Metabolic Diseases</a></li>
<li><a href="#frequency-table-of-icd-10-codes-that-each-only-map-to-exactly-1-rare-metabolic-disease">Frequency Table of ICD-10 Codes that Each Only Map to Exactly 1 Rare Metabolic Disease</a></li>
</ul>
</div>

<p>This document is meant to summarize all of our work so far with the Duke Medical System data.</p>
<div id="manipulating-our-data-and-partioning-into-rare-disease-patients-non-rare-disease-patients" class="section level3">
<h3>Manipulating our Data and Partioning into Rare Disease Patients / Non-Rare Disease Patients</h3>
<p>Our data started out in a wide format. Here is some toy data as an example:</p>
<table>
<thead>
<tr class="header">
<th align="left">PATID</th>
<th align="left">VISIT</th>
<th align="left">SEX</th>
<th align="left">AGE</th>
<th align="left">ICD-9</th>
<th align="left">ICD-10</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Z111111</td>
<td align="left">OCT-2013</td>
<td align="left">M</td>
<td align="left">55</td>
<td align="left">250.00, 759.89</td>
<td align="left">E11.9, E74.02</td>
</tr>
<tr class="even">
<td align="left">Z222222</td>
<td align="left">JUL-2014</td>
<td align="left">F</td>
<td align="left">32</td>
<td align="left">315.01</td>
<td align="left">E83.01, E78.2</td>
</tr>
</tbody>
</table>
<p>We had two additional columns called <code>DX GROUP</code> and <code>LABEL</code>, but since we are unclear on what exact information these columns are specifying (it has some proprietary implications within the EPIC software system that Duke uses), we’ve chosen to disregard them for now.</p>
<p>We first converted the data from this wide format to a long format. By our data maniplulation, the toy example becomes:</p>
<table>
<thead>
<tr class="header">
<th align="left">PATID</th>
<th align="left">VISIT</th>
<th align="left">SEX</th>
<th align="left">AGE</th>
<th align="left">TERMINOLOGY</th>
<th align="left">CODE</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Z111111</td>
<td align="left">OCT-2013</td>
<td align="left">M</td>
<td align="left">55</td>
<td align="left">ICD-9</td>
<td align="left">250.00</td>
</tr>
<tr class="even">
<td align="left">Z111111</td>
<td align="left">OCT-2013</td>
<td align="left">M</td>
<td align="left">55</td>
<td align="left">ICD-9</td>
<td align="left">759.89</td>
</tr>
<tr class="odd">
<td align="left">Z111111</td>
<td align="left">OCT-2013</td>
<td align="left">M</td>
<td align="left">55</td>
<td align="left">ICD-10</td>
<td align="left">E11.9</td>
</tr>
<tr class="even">
<td align="left">Z111111</td>
<td align="left">OCT-2013</td>
<td align="left">M</td>
<td align="left">55</td>
<td align="left">ICD-10</td>
<td align="left">E74.02</td>
</tr>
<tr class="odd">
<td align="left">Z222222</td>
<td align="left">JUL-2014</td>
<td align="left">F</td>
<td align="left">32</td>
<td align="left">ICD-9</td>
<td align="left">315.01</td>
</tr>
<tr class="even">
<td align="left">Z222222</td>
<td align="left">JUL-2014</td>
<td align="left">F</td>
<td align="left">32</td>
<td align="left">ICD-10</td>
<td align="left">E83.01</td>
</tr>
<tr class="odd">
<td align="left">Z222222</td>
<td align="left">JUL-2014</td>
<td align="left">F</td>
<td align="left">32</td>
<td align="left">ICD-10</td>
<td align="left">E78.2</td>
</tr>
</tbody>
</table>
<p>Next, we partitioned our data into patients with a rare disease and patients without a rare disease. In order to be classified as a rare disease patient, the patient needed to exhibit one or more codes from our list of ICD-9 and ICD-10 codes that map to a rare disease. If a patient had at least one rare disease code, then we include <em>all</em> of that patient’s long form rows in the rare patients file. All other patients’ rows were placed in the non-rare patients file.</p>
<p><em>Note: we know this is by no means a perfect way of partitioning our data due in part to potential misdiagnoses (i.e. maybe we should require more than one instance of a rare disease code to classify patients as rare), which we have yet to explore. More significantly, many of the “rare” ICD codes map to both rare <strong>and</strong> non-rare diseases, which we will discuss further later.</em></p>
</div>
<div id="summary-statistics" class="section level3">
<h3>Summary Statistics</h3>
<p>Here, we include some summary statistics from our data set.</p>
<p><strong>Number of Unique Patients</strong>: 1245243</p>
<p><strong>Number of Unique Rare Patients</strong>: 731121</p>
<p><strong>Number of Unique Rare Patients Based Solely on ICD9</strong>: 680559</p>
<p><strong>Number of Unique Rare Patients Based Solely on ICD10</strong>: 580952</p>
<p><strong>Length of Intersection of those two</strong>: 530390</p>
<p><strong>Number of Unique Non-Rare Patients</strong>: 514122</p>
<p><strong>Unique number of rare ICD9 codes</strong>: 1401</p>
<p><strong>Unique number of rare ICD10 codes</strong>: 1585</p>
<p><strong>Proportion of Rare Codes over Total Codes ICD9</strong>: 0.2148471</p>
<p><strong>Proportion of Rare Codes over Total Codes ICD10</strong>: 0.1667331</p>
</div>
<div id="looking-at-prevalence-of-rare-diseases" class="section level3">
<h3>Looking at Prevalence of Rare Diseases</h3>
<p>Here, we started with the subset of patients that at one point were assigned at least one ICD-9 or ICD-10 code of a rare disease (from the mappings).</p>
<p>We then filtered these data to only keep the rows containing a rare disease ICD code (remember, we have restructured the data such that there is only one ICD-9 or ICD-10 code per row).</p>
<p>We finally further filtered these data such that the combination of patient ID and ICD code was unique / a primary key in this final data frame (for example, if a patient has cystic fibrosis with the specified ICD code in a visit in October of 2012 and shows the same code in October of 2013, then one of these rows will be deleted). I did this to avoid double counting patients with respect to determining prevalence of rare diseases in this data set. <em>Note, we can go back later to look <strong>only</strong> at patients who are assigned a rare disease code more than once, which is likely a more robust indication of whether a patient has a rare disease vs possibly having a rare disease</em>.</p>
</div>
<div id="graphs-using-all-rare-disease-codes" class="section level3">
<h3>Graphs Using All Rare Disease Codes</h3>
<p>These figures show the top 20 ICD-9 codes and ICD-10 codes by frequency. Here, we used all ICD codes contained in the files from the National Library of Medicine. Rather than show the ICD codes on the y-axis, we have replaced those values with the ICD code descriptions from the files from the NLM.</p>
<p><img src="data:image/png;base64,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" width="960" /><img src="data:image/png;base64,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" width="960" /></p>
<p>Given the names that are showing up here, in particular Type II Diabetes, clearly there are issues we should further explore. Since the mappings between these ICD codes are not necessarily 1 ICD code to 1 disease (some are 1 ICD code to many diseases), we will not discuss which diseases are mapping to these codes with these graphs.</p>
<p>In the next section, however, we address this discrepancy between ICD code and rare disease name by including tables of the ICD code and the unique rare disease to which it maps. Since the Diabetes issue resurfaces there, this specific example will be further discussed momentarily.</p>
</div>
<div id="graphs-with-only-1-rare-disease-per-code" class="section level3">
<h3>Graphs with Only 1 Rare Disease per Code</h3>
<p>Here, we specifically looked at only ICD codes that uniquely mapped to exactly one “rare” disease in our mapping files.</p>
<p><img src="data:image/png;base64,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" width="960" /></p>
<table>
<thead>
<tr class="header">
<th align="left">ICD-9 Code</th>
<th align="left">Rare Disease Name</th>
<th align="left">Code Description</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">268.9</td>
<td align="left">Rickets</td>
<td align="left">Unspecified vitamin D deficiency</td>
</tr>
<tr class="even">
<td align="left">780.4</td>
<td align="left">Dysequilibrium syndrome</td>
<td align="left">Dizziness and giddiness</td>
</tr>
<tr class="odd">
<td align="left">272.0</td>
<td align="left">Hyperlipoproteinemia type 2</td>
<td align="left">Pure hypercholesterolemia</td>
</tr>
<tr class="even">
<td align="left">244.9</td>
<td align="left">Thyrotropin deficiency, isolated</td>
<td align="left">Unspecified acquired hypothyroidism</td>
</tr>
<tr class="odd">
<td align="left">787.91</td>
<td align="left">Immunodysregulation, polyendocrinopathy and enteropathy X-linked</td>
<td align="left">Diarrhea</td>
</tr>
<tr class="even">
<td align="left">272.2</td>
<td align="left">Hyperlipidemia type 3</td>
<td align="left">Mixed hyperlipidemia</td>
</tr>
<tr class="odd">
<td align="left">276.8</td>
<td align="left">Gitelman syndrome</td>
<td align="left">Hypopotassemia</td>
</tr>
<tr class="even">
<td align="left">682.9</td>
<td align="left">Wells syndrome</td>
<td align="left">Cellulitis and abscess of unspecified sites</td>
</tr>
<tr class="odd">
<td align="left">278.01</td>
<td align="left">Proopiomelanocortin deficiency</td>
<td align="left">Morbid obesity</td>
</tr>
<tr class="even">
<td align="left">790.6</td>
<td align="left">Renal hypouricemia</td>
<td align="left">Other abnormal blood chemistry</td>
</tr>
<tr class="odd">
<td align="left">724.3</td>
<td align="left">Piriformis syndrome</td>
<td align="left">Sciatica</td>
</tr>
<tr class="even">
<td align="left">733.90</td>
<td align="left">Spondyloenchondrodysplasia</td>
<td align="left">Disorder of bone and cartilage, unspecified</td>
</tr>
<tr class="odd">
<td align="left">427.89</td>
<td align="left">His bundle tachycardia</td>
<td align="left">Other specified cardiac dysrhythmias</td>
</tr>
<tr class="even">
<td align="left">599.70</td>
<td align="left">Loin pain hematuria syndrome</td>
<td align="left">Hematuria, unspecified</td>
</tr>
<tr class="odd">
<td align="left">238.2</td>
<td align="left">Muir-Torre syndrome</td>
<td align="left">Neoplasm of uncertain behavior of skin</td>
</tr>
<tr class="even">
<td align="left">280.9</td>
<td align="left">Iron-refractory iron deficiency anemia</td>
<td align="left">Iron deficiency anemia, unspecified</td>
</tr>
<tr class="odd">
<td align="left">709.9</td>
<td align="left">Tight skin contracture syndrome, lethal</td>
<td align="left">Unspecified disorder of skin and subcutaneous tissue</td>
</tr>
<tr class="even">
<td align="left">174.9</td>
<td align="left">Inflammatory breast cancer</td>
<td align="left">Malignant neoplasm of breast (female), unspecified</td>
</tr>
<tr class="odd">
<td align="left">791.9</td>
<td align="left">3-Hydroxyisobutyric aciduria</td>
<td align="left">Other nonspecific findings on examination of urine</td>
</tr>
<tr class="even">
<td align="left">592.0</td>
<td align="left">Dent disease</td>
<td align="left">Calculus of kidney</td>
</tr>
</tbody>
</table>
<p><img src="data:image/png;base64,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" width="960" /></p>
<table>
<thead>
<tr class="header">
<th align="left">ICD-10 Code</th>
<th align="left">Rare Disease Name</th>
<th align="left">Code Description</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">E11.9</td>
<td align="left">Maturity-onset diabetes of the young, type 2</td>
<td align="left">Type 2 diabetes mellitus without complications</td>
</tr>
<tr class="even">
<td align="left">E55.9</td>
<td align="left">Rickets</td>
<td align="left">Vitamin D deficiency, unspecified</td>
</tr>
<tr class="odd">
<td align="left">F32.9</td>
<td align="left">Mal de debarquement</td>
<td align="left">Major depressive disorder, single episode, unspecified</td>
</tr>
<tr class="even">
<td align="left">R42</td>
<td align="left">Dysequilibrium syndrome</td>
<td align="left">Dizziness and giddiness</td>
</tr>
<tr class="odd">
<td align="left">E78.00</td>
<td align="left">Hyperlipoproteinemia type 2</td>
<td align="left">Pure hypercholesterolemia, unspecified</td>
</tr>
<tr class="even">
<td align="left">B97.89</td>
<td align="left">Togaviridae disease</td>
<td align="left">Other viral agents as the cause of diseases classified elsewhere</td>
</tr>
<tr class="odd">
<td align="left">R06.00</td>
<td align="left">Paraneoplastic Neurologic Disorders</td>
<td align="left">Dyspnea, unspecified</td>
</tr>
<tr class="even">
<td align="left">J44.9</td>
<td align="left">Bronchiolitis obliterans</td>
<td align="left">Chronic obstructive pulmonary disease, unspecified</td>
</tr>
<tr class="odd">
<td align="left">K52.9</td>
<td align="left">WDHA syndrome</td>
<td align="left">Noninfective gastroenteritis and colitis, unspecified</td>
</tr>
<tr class="even">
<td align="left">D48.5</td>
<td align="left">Dermatofibrosarcoma protuberans</td>
<td align="left">Neoplasm of uncertain behavior of skin</td>
</tr>
<tr class="odd">
<td align="left">M85.80</td>
<td align="left">Melorheostosis</td>
<td align="left">Other specified disorders of bone density and structure, unspecified site</td>
</tr>
<tr class="even">
<td align="left">E53.8</td>
<td align="left">Biotinidase deficiency</td>
<td align="left">Deficiency of other specified B group vitamins</td>
</tr>
<tr class="odd">
<td align="left">D50.9</td>
<td align="left">Iron-refractory iron deficiency anemia</td>
<td align="left">Iron deficiency anemia, unspecified</td>
</tr>
<tr class="even">
<td align="left">M62.81</td>
<td align="left">Neuropathy ataxia retinitis pigmentosa syndrome</td>
<td align="left">Muscle weakness (generalized)</td>
</tr>
<tr class="odd">
<td align="left">I63.9</td>
<td align="left">Neonatal stroke</td>
<td align="left">Cerebral infarction, unspecified</td>
</tr>
<tr class="even">
<td align="left">M72.2</td>
<td align="left">Ledderhose disease</td>
<td align="left">Plantar fascial fibromatosis</td>
</tr>
<tr class="odd">
<td align="left">E87.5</td>
<td align="left">Gordon syndrome</td>
<td align="left">Hyperkalemia</td>
</tr>
<tr class="even">
<td align="left">L08.9</td>
<td align="left">Erosive pustular dermatosis of the scalp</td>
<td align="left">Local infection of the skin and subcutaneous tissue, unspecified</td>
</tr>
<tr class="odd">
<td align="left">F98.8</td>
<td align="left">Psychosocial short stature</td>
<td align="left">Other specified behavioral and emotional disorders with onset usually occurring in childhood and adolescence</td>
</tr>
<tr class="even">
<td align="left">K58.9</td>
<td align="left">Ichthyosis bullosa of Siemens</td>
<td align="left">Irritable bowel syndrome without diarrhea</td>
</tr>
</tbody>
</table>
</div>
<div id="back-to-the-diabetes-example" class="section level3">
<h3>Back to the Diabetes Example</h3>
<p>The issue of rare vs. not rare for all of these cases goes well beyond my domain knowledge, but we do know that Type II Diabetes isn’t exactly rare.</p>
<p>Since the distinguishing factor for the rareness of diabetes is age, here we include a kernel density plot of age of patients with the ICD-10 code for Type II Diabetes (E11.9) in our rare patients data set (78,370 patients in this subset). According to <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363133">this NCBI article</a>, 63% of cases present by age 25, 79% by age 35, and 96% by age 55. Although this density plot is by no means causal proof, it appears highly unlikely that this age distribution would represent such a cohort independent of other Diabetes cases:</p>
<p><img src="data:image/png;base64,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" width="672" /></p>
</div>
<div id="the-takeaway" class="section level3">
<h3>The Takeaway</h3>
<p>As we can see from these tables, we have a recurring issue of rare diseases being grouped together with more common diseases under both ICD-9 and ICD-10, and looking at diseases that have unique mappings with respect to our rare disease data set clearly is not sufficient to guarantee that we only look at patients with true rare diseases.</p>
<p>Most notably, we need to address the question:</p>
<p><em>How useful are our mappings with respect to quantifying the burden of rare disease on the Duke Medical System, and how can we best subset the mapping relationships we have such that we can be sure to look at a <strong>true</strong> subset of rare disease patients in the Duke Medical Sytem?</em></p>
<p>It’s unclear at this point whether / how much of this issue is the result of mapping diseases to ICD codes by “walking up” the hierarchy and how much is the result of the “for billing” nature to the ICD hierarchy. For example, the Type II Diabetes issue presented here is an example of the latter problem, with the ICD-10 code <a href="www.icd10data.com/ICD10CM/Codes/E00-E89/E08-E13/E11-/E11.9">E11.9</a> incorporating other forms of Diabetes into it.</p>
<p>Regardless of the cause of the problem, we believe this is the most important issue standing between us and our goal of quantifying the burden of rare disease.</p>
</div>
<div id="frequency-table-with-all-icd-10-codes-for-rare-diseases" class="section level3">
<h3>Frequency Table with All ICD-10 Codes for Rare Diseases</h3>
<p>This table shows the frequency of all ICD-10 codes in our rare disease file (from the National Library of Medicine). We also include the ICD-10 code description as well as the name of the disease it maps to in our mapping file.</p>
<p>Number of ICD-10 Codes: <strong>3166</strong></p>
<p>Total Number of Patients: <strong>2338429</strong></p>
<table>
<thead>
<tr class="header">
<th align="left">ICD-10 Code</th>
<th align="right">Frequency</th>
<th align="left">Rare Disease Name</th>
<th align="left">ICD Code Description</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">E11.9</td>
<td align="right">78370</td>
<td align="left">Maturity-onset diabetes of the young, type 2</td>
<td align="left">Type 2 diabetes mellitus without complications</td>
</tr>
<tr class="even">
<td align="left">E55.9</td>
<td align="right">67357</td>
<td align="left">Rickets</td>
<td align="left">Vitamin D deficiency, unspecified</td>
</tr>
<tr class="odd">
<td align="left">F32.9</td>
<td align="right">63921</td>
<td align="left">Mal de debarquement</td>
<td align="left">Major depressive disorder, single episode, unspecified</td>
</tr>
<tr class="even">
<td align="left">R42</td>
<td align="right">48568</td>
<td align="left">Dysequilibrium syndrome</td>
<td align="left">Dizziness and giddiness</td>
</tr>
<tr class="odd">
<td align="left">E78.00</td>
<td align="right">46355</td>
<td align="left">Hyperlipoproteinemia type 2</td>
<td align="left">Pure hypercholesterolemia, unspecified</td>
</tr>
<tr class="even">
<td align="left">E03.9</td>
<td align="right">45959</td>
<td align="left">Kocher-Debre-Semelaigne syndrome</td>
<td align="left">Hypothyroidism, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E03.9</td>
<td align="right">45959</td>
<td align="left">Thyrotropin deficiency, isolated</td>
<td align="left">Hypothyroidism, unspecified</td>
</tr>
<tr class="even">
<td align="left">E78.2</td>
<td align="right">42956</td>
<td align="left">Hyperlipidemia type 3</td>
<td align="left">Mixed hyperlipidemia</td>
</tr>
<tr class="odd">
<td align="left">E78.2</td>
<td align="right">42956</td>
<td align="left">Xanthoma disseminatum</td>
<td align="left">Mixed hyperlipidemia</td>
</tr>
<tr class="even">
<td align="left">B97.89</td>
<td align="right">29781</td>
<td align="left">Togaviridae disease</td>
<td align="left">Other viral agents as the cause of diseases classified elsewhere</td>
</tr>
<tr class="odd">
<td align="left">R06.00</td>
<td align="right">25025</td>
<td align="left">Paraneoplastic Neurologic Disorders</td>
<td align="left">Dyspnea, unspecified</td>
</tr>
<tr class="even">
<td align="left">D22.9</td>
<td align="right">24067</td>
<td align="left">Basaloid follicular hamartoma</td>
<td align="left">Melanocytic nevi, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D22.9</td>
<td align="right">24067</td>
<td align="left">Giant congenital nevus</td>
<td align="left">Melanocytic nevi, unspecified</td>
</tr>
<tr class="even">
<td align="left">D22.9</td>
<td align="right">24067</td>
<td align="left">Becker’s nevus</td>
<td align="left">Melanocytic nevi, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D22.9</td>
<td align="right">24067</td>
<td align="left">Pseudoxanthoma elasticum</td>
<td align="left">Melanocytic nevi, unspecified</td>
</tr>
<tr class="even">
<td align="left">D22.9</td>
<td align="right">24067</td>
<td align="left">Linear nevus sebaceous syndrome</td>
<td align="left">Melanocytic nevi, unspecified</td>
</tr>
<tr class="odd">
<td align="left">J44.9</td>
<td align="right">23648</td>
<td align="left">Bronchiolitis obliterans</td>
<td align="left">Chronic obstructive pulmonary disease, unspecified</td>
</tr>
<tr class="even">
<td align="left">K52.9</td>
<td align="right">20685</td>
<td align="left">WDHA syndrome</td>
<td align="left">Noninfective gastroenteritis and colitis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D48.5</td>
<td align="right">18678</td>
<td align="left">Dermatofibrosarcoma protuberans</td>
<td align="left">Neoplasm of uncertain behavior of skin</td>
</tr>
<tr class="even">
<td align="left">M85.80</td>
<td align="right">16522</td>
<td align="left">Melorheostosis</td>
<td align="left">Other specified disorders of bone density and structure, unspecified site</td>
</tr>
<tr class="odd">
<td align="left">E53.8</td>
<td align="right">16024</td>
<td align="left">Biotinidase deficiency</td>
<td align="left">Deficiency of other specified B group vitamins</td>
</tr>
<tr class="even">
<td align="left">D50.9</td>
<td align="right">14805</td>
<td align="left">Iron-refractory iron deficiency anemia</td>
<td align="left">Iron deficiency anemia, unspecified</td>
</tr>
<tr class="odd">
<td align="left">L81.4</td>
<td align="right">12369</td>
<td align="left">Carbon baby syndrome</td>
<td align="left">Other melanin hyperpigmentation</td>
</tr>
<tr class="even">
<td align="left">L81.4</td>
<td align="right">12369</td>
<td align="left">Linear and whorled nevoid hypermelanosis</td>
<td align="left">Other melanin hyperpigmentation</td>
</tr>
<tr class="odd">
<td align="left">M62.81</td>
<td align="right">12278</td>
<td align="left">Neuropathy ataxia retinitis pigmentosa syndrome</td>
<td align="left">Muscle weakness (generalized)</td>
</tr>
<tr class="even">
<td align="left">M10.9</td>
<td align="right">12098</td>
<td align="left">Gouty nephropathy, familial</td>
<td align="left">Gout, unspecified</td>
</tr>
<tr class="odd">
<td align="left">M10.9</td>
<td align="right">12098</td>
<td align="left">Familial juvenile hyperuricaemic nephropathy</td>
<td align="left">Gout, unspecified</td>
</tr>
<tr class="even">
<td align="left">M10.9</td>
<td align="right">12098</td>
<td align="left">Autosomal dominant medullary cystic kidney disease with hyperuricemia</td>
<td align="left">Gout, unspecified</td>
</tr>
<tr class="odd">
<td align="left">I63.9</td>
<td align="right">11807</td>
<td align="left">Neonatal stroke</td>
<td align="left">Cerebral infarction, unspecified</td>
</tr>
<tr class="even">
<td align="left">M72.2</td>
<td align="right">11148</td>
<td align="left">Ledderhose disease</td>
<td align="left">Plantar fascial fibromatosis</td>
</tr>
<tr class="odd">
<td align="left">E87.5</td>
<td align="right">10605</td>
<td align="left">Gordon syndrome</td>
<td align="left">Hyperkalemia</td>
</tr>
<tr class="even">
<td align="left">L08.9</td>
<td align="right">10432</td>
<td align="left">Erosive pustular dermatosis of the scalp</td>
<td align="left">Local infection of the skin and subcutaneous tissue, unspecified</td>
</tr>
<tr class="odd">
<td align="left">F98.8</td>
<td align="right">8735</td>
<td align="left">Psychosocial short stature</td>
<td align="left">Other specified behavioral and emotional disorders with onset usually occurring in childhood and adolescence</td>
</tr>
<tr class="even">
<td align="left">H90.5</td>
<td align="right">8153</td>
<td align="left">Bjornstad syndrome</td>
<td align="left">Unspecified sensorineural hearing loss</td>
</tr>
<tr class="odd">
<td align="left">H90.5</td>
<td align="right">8153</td>
<td align="left">Mohr-Tranebjaerg syndrome</td>
<td align="left">Unspecified sensorineural hearing loss</td>
</tr>
<tr class="even">
<td align="left">H90.5</td>
<td align="right">8153</td>
<td align="left">Deafness-infertility syndrome</td>
<td align="left">Unspecified sensorineural hearing loss</td>
</tr>
<tr class="odd">
<td align="left">K58.9</td>
<td align="right">7800</td>
<td align="left">Ichthyosis bullosa of Siemens</td>
<td align="left">Irritable bowel syndrome without diarrhea</td>
</tr>
<tr class="even">
<td align="left">H53.8</td>
<td align="right">7657</td>
<td align="left">Bradyopsia</td>
<td align="left">Other visual disturbances</td>
</tr>
<tr class="odd">
<td align="left">I47.1</td>
<td align="right">7305</td>
<td align="left">His bundle tachycardia</td>
<td align="left">Supraventricular tachycardia</td>
</tr>
<tr class="even">
<td align="left">I47.1</td>
<td align="right">7305</td>
<td align="left">His bundle tachycardia</td>
<td align="left">Supraventricular tachycardia</td>
</tr>
<tr class="odd">
<td align="left">M53.3</td>
<td align="right">7125</td>
<td align="left">Coccygodynia</td>
<td align="left">Sacrococcygeal disorders, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">E78.1</td>
<td align="right">7041</td>
<td align="left">Hyperlipoproteinemia type 4</td>
<td align="left">Pure hyperglyceridemia</td>
</tr>
<tr class="odd">
<td align="left">E83.42</td>
<td align="right">6761</td>
<td align="left">Primary hypomagnesemia with secondary hypocalcemia</td>
<td align="left">Hypomagnesemia</td>
</tr>
<tr class="even">
<td align="left">I27.2</td>
<td align="right">6472</td>
<td align="left">Pulmonary edema of mountaineers</td>
<td align="left">Other secondary pulmonary hypertension</td>
</tr>
<tr class="odd">
<td align="left">I27.2</td>
<td align="right">6472</td>
<td align="left">Pulmonary venoocclusive disease</td>
<td align="left">Other secondary pulmonary hypertension</td>
</tr>
<tr class="even">
<td align="left">I27.2</td>
<td align="right">6472</td>
<td align="left">Chronic thromboembolic pulmonary hypertension</td>
<td align="left">Other secondary pulmonary hypertension</td>
</tr>
<tr class="odd">
<td align="left">R33.9</td>
<td align="right">5974</td>
<td align="left">Fowler’s syndrome</td>
<td align="left">Retention of urine, unspecified</td>
</tr>
<tr class="even">
<td align="left">L29.8</td>
<td align="right">5920</td>
<td align="left">Aquagenic pruritus</td>
<td align="left">Other pruritus</td>
</tr>
<tr class="odd">
<td align="left">D18.00</td>
<td align="right">5882</td>
<td align="left">Tufted angioma</td>
<td align="left">Hemangioma unspecified site</td>
</tr>
<tr class="even">
<td align="left">D18.00</td>
<td align="right">5882</td>
<td align="left">Glomus jugulare tumors</td>
<td align="left">Hemangioma unspecified site</td>
</tr>
<tr class="odd">
<td align="left">D18.00</td>
<td align="right">5882</td>
<td align="left">Non-involuting congenital hemangioma</td>
<td align="left">Hemangioma unspecified site</td>
</tr>
<tr class="even">
<td align="left">R06.89</td>
<td align="right">5625</td>
<td align="left">Congenital central hypoventilation syndrome</td>
<td align="left">Other abnormalities of breathing</td>
</tr>
<tr class="odd">
<td align="left">E83.52</td>
<td align="right">5433</td>
<td align="left">Familial hypocalciuric hypercalcemia</td>
<td align="left">Hypercalcemia</td>
</tr>
<tr class="even">
<td align="left">C34.90</td>
<td align="right">5271</td>
<td align="left">Lung adenocarcinoma</td>
<td align="left">Malignant neoplasm of unspecified part of unspecified bronchus or lung</td>
</tr>
<tr class="odd">
<td align="left">C34.90</td>
<td align="right">5271</td>
<td align="left">Pleuropulmonary blastoma</td>
<td align="left">Malignant neoplasm of unspecified part of unspecified bronchus or lung</td>
</tr>
<tr class="even">
<td align="left">C34.90</td>
<td align="right">5271</td>
<td align="left">Pleuropulmonary blastoma</td>
<td align="left">Malignant neoplasm of unspecified part of unspecified bronchus or lung</td>
</tr>
<tr class="odd">
<td align="left">D50.8</td>
<td align="right">5173</td>
<td align="left">Hypochromic microcytic anemia with iron overload</td>
<td align="left">Other iron deficiency anemias</td>
</tr>
<tr class="even">
<td align="left">G45.9</td>
<td align="right">5107</td>
<td align="left">Aganglionosis, total intestinal</td>
<td align="left">Transient cerebral ischemic attack, unspecified</td>
</tr>
<tr class="odd">
<td align="left">K76.0</td>
<td align="right">4828</td>
<td align="left">Visceral steatosis</td>
<td align="left">Fatty (change of) liver, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">K76.0</td>
<td align="right">4828</td>
<td align="left">Visceral steatosis</td>
<td align="left">Fatty (change of) liver, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">B37.9</td>
<td align="right">4824</td>
<td align="left">Candidiasis familial chronic mucocutaneous, autosomal recessive</td>
<td align="left">Candidiasis, unspecified</td>
</tr>
<tr class="even">
<td align="left">J98.4</td>
<td align="right">4805</td>
<td align="left">Congenital chloride diarrhea</td>
<td align="left">Other disorders of lung</td>
</tr>
<tr class="odd">
<td align="left">J98.4</td>
<td align="right">4805</td>
<td align="left">Pulmonary hyalinizing granuloma</td>
<td align="left">Other disorders of lung</td>
</tr>
<tr class="even">
<td align="left">H81.10</td>
<td align="right">4798</td>
<td align="left">Benign paroxysmal positional vertigo</td>
<td align="left">Benign paroxysmal vertigo, unspecified ear</td>
</tr>
<tr class="odd">
<td align="left">J98.8</td>
<td align="right">4762</td>
<td align="left">Ciliary dyskinesia with excessively long cilia</td>
<td align="left">Other specified respiratory disorders</td>
</tr>
<tr class="even">
<td align="left">I47.2</td>
<td align="right">4656</td>
<td align="left">Familial ventricular tachycardia</td>
<td align="left">Ventricular tachycardia</td>
</tr>
<tr class="odd">
<td align="left">I47.2</td>
<td align="right">4656</td>
<td align="left">Catecholaminergic polymorphic ventricular tachycardia</td>
<td align="left">Ventricular tachycardia</td>
</tr>
<tr class="even">
<td align="left">I47.2</td>
<td align="right">4656</td>
<td align="left">Catecholaminergic polymorphic ventricular tachycardia</td>
<td align="left">Ventricular tachycardia</td>
</tr>
<tr class="odd">
<td align="left">E10.9</td>
<td align="right">4635</td>
<td align="left">Insulin autoimmune syndrome</td>
<td align="left">Type 1 diabetes mellitus without complications</td>
</tr>
<tr class="even">
<td align="left">E03.8</td>
<td align="right">4628</td>
<td align="left">Hypothyroidism due to iodide transport defect</td>
<td align="left">Other specified hypothyroidism</td>
</tr>
<tr class="odd">
<td align="left">E03.8</td>
<td align="right">4628</td>
<td align="left">Central congenital hypothyroidism</td>
<td align="left">Other specified hypothyroidism</td>
</tr>
<tr class="even">
<td align="left">M94.0</td>
<td align="right">4624</td>
<td align="left">Tietze syndrome</td>
<td align="left">Chondrocostal junction syndrome [Tietze]</td>
</tr>
<tr class="odd">
<td align="left">D12.6</td>
<td align="right">4406</td>
<td align="left">Turcot syndrome</td>
<td align="left">Benign neoplasm of colon, unspecified</td>
</tr>
<tr class="even">
<td align="left">D12.6</td>
<td align="right">4406</td>
<td align="left">Familial adenomatous polyposis</td>
<td align="left">Benign neoplasm of colon, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D12.6</td>
<td align="right">4406</td>
<td align="left">Familial adenomatous polyposis</td>
<td align="left">Benign neoplasm of colon, unspecified</td>
</tr>
<tr class="even">
<td align="left">D12.6</td>
<td align="right">4406</td>
<td align="left">Gardner syndrome</td>
<td align="left">Benign neoplasm of colon, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D12.6</td>
<td align="right">4406</td>
<td align="left">MYH-associated polyposis</td>
<td align="left">Benign neoplasm of colon, unspecified</td>
</tr>
<tr class="even">
<td align="left">D12.6</td>
<td align="right">4406</td>
<td align="left">MYH-associated polyposis</td>
<td align="left">Benign neoplasm of colon, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q21.1</td>
<td align="right">4357</td>
<td align="left">Ostium secundum atrial septal defect</td>
<td align="left">Atrial septal defect</td>
</tr>
<tr class="even">
<td align="left">Q21.1</td>
<td align="right">4357</td>
<td align="left">Atrial septal defect sinus venosus</td>
<td align="left">Atrial septal defect</td>
</tr>
<tr class="odd">
<td align="left">Q21.1</td>
<td align="right">4357</td>
<td align="left">Double outlet right atrium</td>
<td align="left">Atrial septal defect</td>
</tr>
<tr class="even">
<td align="left">C71.9</td>
<td align="right">4292</td>
<td align="left">Glioblastoma</td>
<td align="left">Malignant neoplasm of brain, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C71.9</td>
<td align="right">4292</td>
<td align="left">Ependymoma</td>
<td align="left">Malignant neoplasm of brain, unspecified</td>
</tr>
<tr class="even">
<td align="left">C71.9</td>
<td align="right">4292</td>
<td align="left">Oligodendroglioma</td>
<td align="left">Malignant neoplasm of brain, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E88.81</td>
<td align="right">4269</td>
<td align="left">Insulin-resistance type B</td>
<td align="left">Metabolic syndrome</td>
</tr>
<tr class="even">
<td align="left">E88.81</td>
<td align="right">4269</td>
<td align="left">Abdominal obesity metabolic syndrome</td>
<td align="left">Metabolic syndrome</td>
</tr>
<tr class="odd">
<td align="left">I42.8</td>
<td align="right">4201</td>
<td align="left">Arrhythmogenic right ventricular dysplasia</td>
<td align="left">Other cardiomyopathies</td>
</tr>
<tr class="even">
<td align="left">I42.8</td>
<td align="right">4201</td>
<td align="left">Arrhythmogenic right ventricular dysplasia</td>
<td align="left">Other cardiomyopathies</td>
</tr>
<tr class="odd">
<td align="left">I42.8</td>
<td align="right">4201</td>
<td align="left">Endomyocardial fibrosis</td>
<td align="left">Other cardiomyopathies</td>
</tr>
<tr class="even">
<td align="left">D48.9</td>
<td align="right">4166</td>
<td align="left">Desmoid tumor</td>
<td align="left">Neoplasm of uncertain behavior, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D48.9</td>
<td align="right">4166</td>
<td align="left">Desmoid tumor</td>
<td align="left">Neoplasm of uncertain behavior, unspecified</td>
</tr>
<tr class="even">
<td align="left">D48.9</td>
<td align="right">4166</td>
<td align="left">Ganglioglioma</td>
<td align="left">Neoplasm of uncertain behavior, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D48.9</td>
<td align="right">4166</td>
<td align="left">Hemangioendothelioma</td>
<td align="left">Neoplasm of uncertain behavior, unspecified</td>
</tr>
<tr class="even">
<td align="left">C80.1</td>
<td align="right">4106</td>
<td align="left">Supratentorial primitive neuroectodermal tumor</td>
<td align="left">Malignant (primary) neoplasm, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C80.1</td>
<td align="right">4106</td>
<td align="left">Germ cells tumors</td>
<td align="left">Malignant (primary) neoplasm, unspecified</td>
</tr>
<tr class="even">
<td align="left">R62.50</td>
<td align="right">4040</td>
<td align="left">GRACILE syndrome</td>
<td align="left">Unspecified lack of expected normal physiological development in childhood</td>
</tr>
<tr class="odd">
<td align="left">I89.0</td>
<td align="right">3991</td>
<td align="left">Hereditary lymphedema type II</td>
<td align="left">Lymphedema, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">I89.0</td>
<td align="right">3991</td>
<td align="left">Lymphangiectasis</td>
<td align="left">Lymphedema, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">I89.0</td>
<td align="right">3991</td>
<td align="left">Primary intestinal lymphangiectasia</td>
<td align="left">Lymphedema, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">I89.0</td>
<td align="right">3991</td>
<td align="left">Intestinal lymphangiectasia</td>
<td align="left">Lymphedema, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">H35.30</td>
<td align="right">3962</td>
<td align="left">Adrenomyodystrophy</td>
<td align="left">Unspecified macular degeneration</td>
</tr>
<tr class="even">
<td align="left">H35.30</td>
<td align="right">3962</td>
<td align="left">Macular dystrophy, concentric annular</td>
<td align="left">Unspecified macular degeneration</td>
</tr>
<tr class="odd">
<td align="left">D18.01</td>
<td align="right">3917</td>
<td align="left">Tufted angioma</td>
<td align="left">Hemangioma of skin and subcutaneous tissue</td>
</tr>
<tr class="even">
<td align="left">D18.01</td>
<td align="right">3917</td>
<td align="left">Kimura disease</td>
<td align="left">Hemangioma of skin and subcutaneous tissue</td>
</tr>
<tr class="odd">
<td align="left">D18.01</td>
<td align="right">3917</td>
<td align="left">Kimura disease</td>
<td align="left">Hemangioma of skin and subcutaneous tissue</td>
</tr>
<tr class="even">
<td align="left">D18.01</td>
<td align="right">3917</td>
<td align="left">Supraumbilical midabdominal raphe and facial cavernous hemangiomas</td>
<td align="left">Hemangioma of skin and subcutaneous tissue</td>
</tr>
<tr class="odd">
<td align="left">G20</td>
<td align="right">3779</td>
<td align="left">Rapid-onset dystonia-parkinsonism</td>
<td align="left">Parkinson’s disease</td>
</tr>
<tr class="even">
<td align="left">G20</td>
<td align="right">3779</td>
<td align="left">Paralysis agitans, juvenile, of Hunt</td>
<td align="left">Parkinson’s disease</td>
</tr>
<tr class="odd">
<td align="left">G20</td>
<td align="right">3779</td>
<td align="left">Perry syndrome</td>
<td align="left">Parkinson’s disease</td>
</tr>
<tr class="even">
<td align="left">G20</td>
<td align="right">3779</td>
<td align="left">X-linked dystonia-parkinsonism/Lubag</td>
<td align="left">Parkinson’s disease</td>
</tr>
<tr class="odd">
<td align="left">N28.89</td>
<td align="right">3727</td>
<td align="left">Salcedo syndrome</td>
<td align="left">Other specified disorders of kidney and ureter</td>
</tr>
<tr class="even">
<td align="left">N28.89</td>
<td align="right">3727</td>
<td align="left">Frasier syndrome</td>
<td align="left">Other specified disorders of kidney and ureter</td>
</tr>
<tr class="odd">
<td align="left">I21.3</td>
<td align="right">3629</td>
<td align="left">Mesenteric artery ischemia</td>
<td align="left">ST elevation (STEMI) myocardial infarction of unspecified site</td>
</tr>
<tr class="even">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Progressive osseous heteroplasia</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Birt-Hogg-Dube syndrome</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Giant platelet syndrome</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Syringocystadenoma papilliferum</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Multiple familial trichoepithelioma 1</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Trichofolliculoma</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Acrospiroma</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Acrospiroma</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Acrospiroma</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Adenoid cystic carcinoma</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">TiâÂ¿che-Jadassohn nevus</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Benign eccrine spiradenoma</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Halo nevi</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Pilomatrixoma</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Familial cylindromatosis</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Familial cutaneous collagenoma</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Brooke-Spiegler syndrome</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Brooke-Spiegler syndrome</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Dermal eccrine cylindroma</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Spitz nevus</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Microcystic adnexal carcinoma</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Papillary eccrine adenoma</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Multiple familial trichoepithelioma</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Multiple familial trichoepithelioma</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Multiple familial trichoepithelioma</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D23.9</td>
<td align="right">3596</td>
<td align="left">Cylindroma</td>
<td align="left">Other benign neoplasm of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">L81.9</td>
<td align="right">3566</td>
<td align="left">Hypomelanotic disorder</td>
<td align="left">Disorder of pigmentation, unspecified</td>
</tr>
<tr class="odd">
<td align="left">I49.5</td>
<td align="right">3554</td>
<td align="left">Hypoparathyroidism-intellectual disability-dysmorphism syndrome</td>
<td align="left">Sick sinus syndrome</td>
</tr>
<tr class="even">
<td align="left">K62.89</td>
<td align="right">3542</td>
<td align="left">Cronkhite-Canada disease</td>
<td align="left">Other specified diseases of anus and rectum</td>
</tr>
<tr class="odd">
<td align="left">E80.6</td>
<td align="right">3459</td>
<td align="left">Rotor syndrome</td>
<td align="left">Other disorders of bilirubin metabolism</td>
</tr>
<tr class="even">
<td align="left">E80.6</td>
<td align="right">3459</td>
<td align="left">Dubin-Johnson syndrome</td>
<td align="left">Other disorders of bilirubin metabolism</td>
</tr>
<tr class="odd">
<td align="left">D70.9</td>
<td align="right">3451</td>
<td align="left">Acquired agranulocytosis</td>
<td align="left">Neutropenia, unspecified</td>
</tr>
<tr class="even">
<td align="left">D70.9</td>
<td align="right">3451</td>
<td align="left">Granulocytopenia</td>
<td align="left">Neutropenia, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D70.9</td>
<td align="right">3451</td>
<td align="left">Granulocytopenia</td>
<td align="left">Neutropenia, unspecified</td>
</tr>
<tr class="even">
<td align="left">D70.9</td>
<td align="right">3451</td>
<td align="left">Granulocytopenia</td>
<td align="left">Neutropenia, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E46</td>
<td align="right">3221</td>
<td align="left">Paracoccidioidomycosis</td>
<td align="left">Unspecified protein-calorie malnutrition</td>
</tr>
<tr class="even">
<td align="left">D49.6</td>
<td align="right">3208</td>
<td align="left">Acoustic neuroma</td>
<td align="left">Neoplasm of unspecified behavior of brain</td>
</tr>
<tr class="odd">
<td align="left">I71.4</td>
<td align="right">3075</td>
<td align="left">Abdominal aortic aneurysm</td>
<td align="left">Abdominal aortic aneurysm, without rupture</td>
</tr>
<tr class="even">
<td align="left">M65.9</td>
<td align="right">3032</td>
<td align="left">SAPHO syndrome</td>
<td align="left">Synovitis and tenosynovitis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">M65.9</td>
<td align="right">3032</td>
<td align="left">Synovitis</td>
<td align="left">Synovitis and tenosynovitis, unspecified</td>
</tr>
<tr class="even">
<td align="left">L50.8</td>
<td align="right">3005</td>
<td align="left">Aquagenic urticaria</td>
<td align="left">Other urticaria</td>
</tr>
<tr class="odd">
<td align="left">F80.9</td>
<td align="right">2979</td>
<td align="left">Developmental dysphasia familial</td>
<td align="left">Developmental disorder of speech and language, unspecified</td>
</tr>
<tr class="even">
<td align="left">F80.9</td>
<td align="right">2979</td>
<td align="left">Developmental dysphasia familial</td>
<td align="left">Developmental disorder of speech and language, unspecified</td>
</tr>
<tr class="odd">
<td align="left">F80.9</td>
<td align="right">2979</td>
<td align="left">Developmental dysphasia familial</td>
<td align="left">Developmental disorder of speech and language, unspecified</td>
</tr>
<tr class="even">
<td align="left">H50.00</td>
<td align="right">2913</td>
<td align="left">Esotropia</td>
<td align="left">Unspecified esotropia</td>
</tr>
<tr class="odd">
<td align="left">J38.3</td>
<td align="right">2888</td>
<td align="left">Spasmodic dysphonia</td>
<td align="left">Other diseases of vocal cords</td>
</tr>
<tr class="even">
<td align="left">B86</td>
<td align="right">2812</td>
<td align="left">Crusted scabies</td>
<td align="left">Scabies</td>
</tr>
<tr class="odd">
<td align="left">I86.8</td>
<td align="right">2758</td>
<td align="left">Orbital varix</td>
<td align="left">Varicose veins of other specified sites</td>
</tr>
<tr class="even">
<td align="left">H18.51</td>
<td align="right">2708</td>
<td align="left">Chandler’s syndrome</td>
<td align="left">Endothelial corneal dystrophy</td>
</tr>
<tr class="odd">
<td align="left">H18.51</td>
<td align="right">2708</td>
<td align="left">Cogan-Reese syndrome</td>
<td align="left">Endothelial corneal dystrophy</td>
</tr>
<tr class="even">
<td align="left">K13.79</td>
<td align="right">2676</td>
<td align="left">Palatopharyngeal incompetence</td>
<td align="left">Other lesions of oral mucosa</td>
</tr>
<tr class="odd">
<td align="left">K13.79</td>
<td align="right">2676</td>
<td align="left">Palatopharyngeal incompetence</td>
<td align="left">Other lesions of oral mucosa</td>
</tr>
<tr class="even">
<td align="left">K13.79</td>
<td align="right">2676</td>
<td align="left">Palatopharyngeal incompetence</td>
<td align="left">Other lesions of oral mucosa</td>
</tr>
<tr class="odd">
<td align="left">H20.9</td>
<td align="right">2654</td>
<td align="left">Anterior uveitis</td>
<td align="left">Unspecified iridocyclitis</td>
</tr>
<tr class="even">
<td align="left">R82.99</td>
<td align="right">2554</td>
<td align="left">Hydroxykynureninuria</td>
<td align="left">Other abnormal findings in urine</td>
</tr>
<tr class="odd">
<td align="left">D63.8</td>
<td align="right">2528</td>
<td align="left">Acrofacial dysostosis Catania type</td>
<td align="left">Anemia in other chronic diseases classified elsewhere</td>
</tr>
<tr class="even">
<td align="left">D63.8</td>
<td align="right">2528</td>
<td align="left">Acute cholinergic dysautonomia</td>
<td align="left">Anemia in other chronic diseases classified elsewhere</td>
</tr>
<tr class="odd">
<td align="left">J21.9</td>
<td align="right">2513</td>
<td align="left">Diffuse panbronchiolitis</td>
<td align="left">Acute bronchiolitis, unspecified</td>
</tr>
<tr class="even">
<td align="left">N28.1</td>
<td align="right">2461</td>
<td align="left">Maturity-onset diabetes of the young, type 5</td>
<td align="left">Cyst of kidney, acquired</td>
</tr>
<tr class="odd">
<td align="left">K56.69</td>
<td align="right">2445</td>
<td align="left">Superior mesenteric artery syndrome</td>
<td align="left">Other intestinal obstruction</td>
</tr>
<tr class="even">
<td align="left">L28.2</td>
<td align="right">2399</td>
<td align="left">Papular urticaria</td>
<td align="left">Other prurigo</td>
</tr>
<tr class="odd">
<td align="left">N62</td>
<td align="right">2392</td>
<td align="left">Gigantomastia</td>
<td align="left">Hypertrophy of breast</td>
</tr>
<tr class="even">
<td align="left">C73</td>
<td align="right">2371</td>
<td align="left">Thyroid cancer, anaplastic</td>
<td align="left">Malignant neoplasm of thyroid gland</td>
</tr>
<tr class="odd">
<td align="left">C73</td>
<td align="right">2371</td>
<td align="left">Thyroid cancer, follicular</td>
<td align="left">Malignant neoplasm of thyroid gland</td>
</tr>
<tr class="even">
<td align="left">C73</td>
<td align="right">2371</td>
<td align="left">Thyroid cancer, medullary</td>
<td align="left">Malignant neoplasm of thyroid gland</td>
</tr>
<tr class="odd">
<td align="left">C73</td>
<td align="right">2371</td>
<td align="left">Hurthle cell thyroid cancer</td>
<td align="left">Malignant neoplasm of thyroid gland</td>
</tr>
<tr class="even">
<td align="left">C73</td>
<td align="right">2371</td>
<td align="left">Papillary thyroid carcinoma</td>
<td align="left">Malignant neoplasm of thyroid gland</td>
</tr>
<tr class="odd">
<td align="left">B20</td>
<td align="right">2370</td>
<td align="left">AIDS Dementia Complex</td>
<td align="left">Human immunodeficiency virus [HIV] disease</td>
</tr>
<tr class="even">
<td align="left">C44.91</td>
<td align="right">2365</td>
<td align="left">Nevoid basal cell carcinoma syndrome</td>
<td align="left">Basal cell carcinoma of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">K12.0</td>
<td align="right">2361</td>
<td align="left">Aphthous stomatitis</td>
<td align="left">Recurrent oral aphthae</td>
</tr>
<tr class="even">
<td align="left">K12.0</td>
<td align="right">2361</td>
<td align="left">Aphthous stomatitis</td>
<td align="left">Recurrent oral aphthae</td>
</tr>
<tr class="odd">
<td align="left">K12.0</td>
<td align="right">2361</td>
<td align="left">Aphthous stomatitis</td>
<td align="left">Recurrent oral aphthae</td>
</tr>
<tr class="even">
<td align="left">K12.0</td>
<td align="right">2361</td>
<td align="left">Aphthous stomatitis</td>
<td align="left">Recurrent oral aphthae</td>
</tr>
<tr class="odd">
<td align="left">M43.6</td>
<td align="right">2346</td>
<td align="left">Sandifer syndrome</td>
<td align="left">Torticollis</td>
</tr>
<tr class="even">
<td align="left">I34.1</td>
<td align="right">2346</td>
<td align="left">Mitral valve prolapse, familial, X-linked</td>
<td align="left">Nonrheumatic mitral (valve) prolapse</td>
</tr>
<tr class="odd">
<td align="left">I34.1</td>
<td align="right">2346</td>
<td align="left">Mitral valve prolapse, familial, X-linked</td>
<td align="left">Nonrheumatic mitral (valve) prolapse</td>
</tr>
<tr class="even">
<td align="left">M62.89</td>
<td align="right">2325</td>
<td align="left">Kocher-Debre-Semelaigne syndrome</td>
<td align="left">Other specified disorders of muscle</td>
</tr>
<tr class="odd">
<td align="left">K76.89</td>
<td align="right">2324</td>
<td align="left">Nodular regenerative hyperplasia</td>
<td align="left">Other specified diseases of liver</td>
</tr>
<tr class="even">
<td align="left">K76.89</td>
<td align="right">2324</td>
<td align="left">Nodular regenerative hyperplasia</td>
<td align="left">Other specified diseases of liver</td>
</tr>
<tr class="odd">
<td align="left">K13.0</td>
<td align="right">2273</td>
<td align="left">Cheilitis glandularis</td>
<td align="left">Diseases of lips</td>
</tr>
<tr class="even">
<td align="left">M89.8X9</td>
<td align="right">2264</td>
<td align="left">Gorham’s disease</td>
<td align="left">Other specified disorders of bone, unspecified site</td>
</tr>
<tr class="odd">
<td align="left">D22.5</td>
<td align="right">2261</td>
<td align="left">Hypomelanosis of Ito</td>
<td align="left">Melanocytic nevi of trunk</td>
</tr>
<tr class="even">
<td align="left">D22.5</td>
<td align="right">2261</td>
<td align="left">TiâÂ¿che-Jadassohn nevus</td>
<td align="left">Melanocytic nevi of trunk</td>
</tr>
<tr class="odd">
<td align="left">D22.5</td>
<td align="right">2261</td>
<td align="left">Nevus of Ito</td>
<td align="left">Melanocytic nevi of trunk</td>
</tr>
<tr class="even">
<td align="left">J96.90</td>
<td align="right">2249</td>
<td align="left">Congenital central hypoventilation syndrome</td>
<td align="left">Respiratory failure, unspecified, unspecified whether with hypoxia or hypercapnia</td>
</tr>
<tr class="odd">
<td align="left">A74.9</td>
<td align="right">2239</td>
<td align="left">Psittacosis</td>
<td align="left">Chlamydial infection, unspecified</td>
</tr>
<tr class="even">
<td align="left">E06.3</td>
<td align="right">2220</td>
<td align="left">Lymphomatous thyroiditis</td>
<td align="left">Autoimmune thyroiditis</td>
</tr>
<tr class="odd">
<td align="left">L90.8</td>
<td align="right">2216</td>
<td align="left">Tight skin contracture syndrome, lethal</td>
<td align="left">Other atrophic disorders of skin</td>
</tr>
<tr class="even">
<td align="left">L90.8</td>
<td align="right">2216</td>
<td align="left">Nephrogenic Systemic Fibrosis</td>
<td align="left">Other atrophic disorders of skin</td>
</tr>
<tr class="odd">
<td align="left">L90.8</td>
<td align="right">2216</td>
<td align="left">Elastoderma</td>
<td align="left">Other atrophic disorders of skin</td>
</tr>
<tr class="even">
<td align="left">F45.8</td>
<td align="right">2214</td>
<td align="left">Gardner-Diamond syndrome</td>
<td align="left">Other somatoform disorders</td>
</tr>
<tr class="odd">
<td align="left">I44.2</td>
<td align="right">2211</td>
<td align="left">Progressive familial heart block type 1A</td>
<td align="left">Atrioventricular block, complete</td>
</tr>
<tr class="even">
<td align="left">I44.2</td>
<td align="right">2211</td>
<td align="left">Familial progressive cardiac conduction defect</td>
<td align="left">Atrioventricular block, complete</td>
</tr>
<tr class="odd">
<td align="left">C43.9</td>
<td align="right">2197</td>
<td align="left">Melanoma, familial</td>
<td align="left">Malignant melanoma of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">C43.9</td>
<td align="right">2197</td>
<td align="left">Acral lentiginous melanoma</td>
<td align="left">Malignant melanoma of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C43.9</td>
<td align="right">2197</td>
<td align="left">Superficial spreading melanoma</td>
<td align="left">Malignant melanoma of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">C43.9</td>
<td align="right">2197</td>
<td align="left">Nodular melanoma</td>
<td align="left">Malignant melanoma of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C43.9</td>
<td align="right">2197</td>
<td align="left">Lentigo maligna melanoma</td>
<td align="left">Malignant melanoma of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">C43.9</td>
<td align="right">2197</td>
<td align="left">Congenital mirror movement disorder</td>
<td align="left">Malignant melanoma of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">M35.9</td>
<td align="right">2196</td>
<td align="left">Hypereosinophilic syndrome</td>
<td align="left">Systemic involvement of connective tissue, unspecified</td>
</tr>
<tr class="even">
<td align="left">M35.9</td>
<td align="right">2196</td>
<td align="left">PANDAS</td>
<td align="left">Systemic involvement of connective tissue, unspecified</td>
</tr>
<tr class="odd">
<td align="left">K22.70</td>
<td align="right">2117</td>
<td align="left">Congenital lobar emphysema</td>
<td align="left">Barrett’s esophagus without dysplasia</td>
</tr>
<tr class="even">
<td align="left">G91.9</td>
<td align="right">2098</td>
<td align="left">Hydrocephalus</td>
<td align="left">Hydrocephalus, unspecified</td>
</tr>
<tr class="odd">
<td align="left">B35.0</td>
<td align="right">2089</td>
<td align="left">Kerion celsi</td>
<td align="left">Tinea barbae and tinea capitis</td>
</tr>
<tr class="even">
<td align="left">Q21.0</td>
<td align="right">2083</td>
<td align="left">Ventricular septal defects</td>
<td align="left">Ventricular septal defect</td>
</tr>
<tr class="odd">
<td align="left">E27.40</td>
<td align="right">2057</td>
<td align="left">Hypoaldosteronism</td>
<td align="left">Unspecified adrenocortical insufficiency</td>
</tr>
<tr class="even">
<td align="left">E27.40</td>
<td align="right">2057</td>
<td align="left">Hypoadrenalism</td>
<td align="left">Unspecified adrenocortical insufficiency</td>
</tr>
<tr class="odd">
<td align="left">C90.00</td>
<td align="right">2046</td>
<td align="left">Multiple myeloma</td>
<td align="left">Multiple myeloma not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">R27.0</td>
<td align="right">2038</td>
<td align="left">Vascular Ehlers-Danlos syndrome</td>
<td align="left">Ataxia, unspecified</td>
</tr>
<tr class="odd">
<td align="left">R27.0</td>
<td align="right">2038</td>
<td align="left">Ataxia with vitamin E deficiency</td>
<td align="left">Ataxia, unspecified</td>
</tr>
<tr class="even">
<td align="left">D47.2</td>
<td align="right">2021</td>
<td align="left">Light chain deposition disease</td>
<td align="left">Monoclonal gammopathy</td>
</tr>
<tr class="odd">
<td align="left">D47.2</td>
<td align="right">2021</td>
<td align="left">Monoclonal gammopathy of undetermined significance</td>
<td align="left">Monoclonal gammopathy</td>
</tr>
<tr class="even">
<td align="left">D47.2</td>
<td align="right">2021</td>
<td align="left">POEMS syndrome</td>
<td align="left">Monoclonal gammopathy</td>
</tr>
<tr class="odd">
<td align="left">D47.2</td>
<td align="right">2021</td>
<td align="left">Schnitzler syndrome</td>
<td align="left">Monoclonal gammopathy</td>
</tr>
<tr class="even">
<td align="left">R58</td>
<td align="right">2020</td>
<td align="left">Greenberg dysplasia</td>
<td align="left">Hemorrhage, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">E83.51</td>
<td align="right">2020</td>
<td align="left">Hypocalcemia, autosomal dominant</td>
<td align="left">Hypocalcemia</td>
</tr>
<tr class="even">
<td align="left">E13.9</td>
<td align="right">2015</td>
<td align="left">Maturity-onset diabetes of the young, type 1</td>
<td align="left">Other specified diabetes mellitus without complications</td>
</tr>
<tr class="odd">
<td align="left">E13.9</td>
<td align="right">2015</td>
<td align="left">Maturity-onset diabetes of the young, type 5</td>
<td align="left">Other specified diabetes mellitus without complications</td>
</tr>
<tr class="even">
<td align="left">E13.9</td>
<td align="right">2015</td>
<td align="left">Permanent neonatal diabetes mellitus</td>
<td align="left">Other specified diabetes mellitus without complications</td>
</tr>
<tr class="odd">
<td align="left">E13.9</td>
<td align="right">2015</td>
<td align="left">Maturity-onset diabetes of the young, type 3</td>
<td align="left">Other specified diabetes mellitus without complications</td>
</tr>
<tr class="even">
<td align="left">E13.9</td>
<td align="right">2015</td>
<td align="left">Maturity-onset diabetes of the young, type 4</td>
<td align="left">Other specified diabetes mellitus without complications</td>
</tr>
<tr class="odd">
<td align="left">E13.9</td>
<td align="right">2015</td>
<td align="left">Maturity-onset diabetes of the young, type 6</td>
<td align="left">Other specified diabetes mellitus without complications</td>
</tr>
<tr class="even">
<td align="left">E13.9</td>
<td align="right">2015</td>
<td align="left">Maturity-onset diabetes of the young, type 7</td>
<td align="left">Other specified diabetes mellitus without complications</td>
</tr>
<tr class="odd">
<td align="left">E13.9</td>
<td align="right">2015</td>
<td align="left">Maturity-onset diabetes of the young, type 8</td>
<td align="left">Other specified diabetes mellitus without complications</td>
</tr>
<tr class="even">
<td align="left">E13.9</td>
<td align="right">2015</td>
<td align="left">Maturity-onset diabetes of the young, type 9</td>
<td align="left">Other specified diabetes mellitus without complications</td>
</tr>
<tr class="odd">
<td align="left">C64.9</td>
<td align="right">2008</td>
<td align="left">Perlman syndrome</td>
<td align="left">Malignant neoplasm of unspecified kidney, except renal pelvis</td>
</tr>
<tr class="even">
<td align="left">C64.9</td>
<td align="right">2008</td>
<td align="left">Wilms’ tumor</td>
<td align="left">Malignant neoplasm of unspecified kidney, except renal pelvis</td>
</tr>
<tr class="odd">
<td align="left">C64.9</td>
<td align="right">2008</td>
<td align="left">Papillary renal cell carcinoma</td>
<td align="left">Malignant neoplasm of unspecified kidney, except renal pelvis</td>
</tr>
<tr class="even">
<td align="left">C64.9</td>
<td align="right">2008</td>
<td align="left">Clear cell renal cell carcinoma</td>
<td align="left">Malignant neoplasm of unspecified kidney, except renal pelvis</td>
</tr>
<tr class="odd">
<td align="left">C64.9</td>
<td align="right">2008</td>
<td align="left">Clear cell renal cell carcinoma</td>
<td align="left">Malignant neoplasm of unspecified kidney, except renal pelvis</td>
</tr>
<tr class="even">
<td align="left">C64.9</td>
<td align="right">2008</td>
<td align="left">Renal cell carcinoma</td>
<td align="left">Malignant neoplasm of unspecified kidney, except renal pelvis</td>
</tr>
<tr class="odd">
<td align="left">C64.9</td>
<td align="right">2008</td>
<td align="left">Renal cell carcinoma</td>
<td align="left">Malignant neoplasm of unspecified kidney, except renal pelvis</td>
</tr>
<tr class="even">
<td align="left">C64.9</td>
<td align="right">2008</td>
<td align="left">Renal cell carcinoma</td>
<td align="left">Malignant neoplasm of unspecified kidney, except renal pelvis</td>
</tr>
<tr class="odd">
<td align="left">M86.9</td>
<td align="right">1970</td>
<td align="left">Osteomyelitis</td>
<td align="left">Osteomyelitis, unspecified</td>
</tr>
<tr class="even">
<td align="left">D17.9</td>
<td align="right">1964</td>
<td align="left">Lipoblastoma</td>
<td align="left">Benign lipomatous neoplasm, unspecified</td>
</tr>
<tr class="odd">
<td align="left">I67.1</td>
<td align="right">1949</td>
<td align="left">Vein of Galen aneurysm</td>
<td align="left">Cerebral aneurysm, nonruptured</td>
</tr>
<tr class="even">
<td align="left">L85.8</td>
<td align="right">1918</td>
<td align="left">Muir-Torre syndrome</td>
<td align="left">Other specified epidermal thickening</td>
</tr>
<tr class="odd">
<td align="left">B07.8</td>
<td align="right">1873</td>
<td align="left">Epidermodysplasia verruciformis</td>
<td align="left">Other viral warts</td>
</tr>
<tr class="even">
<td align="left">D49.2</td>
<td align="right">1855</td>
<td align="left">Lymph Node Neoplasm</td>
<td align="left">Neoplasm of unspecified behavior of bone, soft tissue, and skin</td>
</tr>
<tr class="odd">
<td align="left">G51.0</td>
<td align="right">1775</td>
<td align="left">Bell’s palsy</td>
<td align="left">Bell’s palsy</td>
</tr>
<tr class="even">
<td align="left">L73.8</td>
<td align="right">1770</td>
<td align="left">Bazex-Dupre-Christol syndrome</td>
<td align="left">Other specified follicular disorders</td>
</tr>
<tr class="odd">
<td align="left">L73.8</td>
<td align="right">1770</td>
<td align="left">Trichomalacia</td>
<td align="left">Other specified follicular disorders</td>
</tr>
<tr class="even">
<td align="left">D35.2</td>
<td align="right">1767</td>
<td align="left">Prolactinoma</td>
<td align="left">Benign neoplasm of pituitary gland</td>
</tr>
<tr class="odd">
<td align="left">D35.2</td>
<td align="right">1767</td>
<td align="left">Acromegaly</td>
<td align="left">Benign neoplasm of pituitary gland</td>
</tr>
<tr class="even">
<td align="left">D35.2</td>
<td align="right">1767</td>
<td align="left">Familial isolated pituitary adenoma</td>
<td align="left">Benign neoplasm of pituitary gland</td>
</tr>
<tr class="odd">
<td align="left">E88.09</td>
<td align="right">1763</td>
<td align="left">Pseudocholinesterase deficiency</td>
<td align="left">Other disorders of plasma-protein metabolism, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">E88.09</td>
<td align="right">1763</td>
<td align="left">Pseudocholinesterase deficiency</td>
<td align="left">Other disorders of plasma-protein metabolism, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">E88.09</td>
<td align="right">1763</td>
<td align="left">Atransferrinemia</td>
<td align="left">Other disorders of plasma-protein metabolism, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">E88.09</td>
<td align="right">1763</td>
<td align="left">Congenital analbuminemia</td>
<td align="left">Other disorders of plasma-protein metabolism, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">O99.89</td>
<td align="right">1745</td>
<td align="left">Chiari-Frommel syndrome</td>
<td align="left">Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium</td>
</tr>
<tr class="even">
<td align="left">L30.8</td>
<td align="right">1736</td>
<td align="left">Acrodermatitis</td>
<td align="left">Other specified dermatitis</td>
</tr>
<tr class="odd">
<td align="left">L30.8</td>
<td align="right">1736</td>
<td align="left">Autoimmune progesterone dermatitis</td>
<td align="left">Other specified dermatitis</td>
</tr>
<tr class="even">
<td align="left">D47.3</td>
<td align="right">1735</td>
<td align="left">Essential thrombocythemia</td>
<td align="left">Essential (hemorrhagic) thrombocythemia</td>
</tr>
<tr class="odd">
<td align="left">L98.8</td>
<td align="right">1728</td>
<td align="left">Hyaline fibromatosis syndrome</td>
<td align="left">Other specified disorders of the skin and subcutaneous tissue</td>
</tr>
<tr class="even">
<td align="left">L98.8</td>
<td align="right">1728</td>
<td align="left">Pseudoainhum</td>
<td align="left">Other specified disorders of the skin and subcutaneous tissue</td>
</tr>
<tr class="odd">
<td align="left">L98.8</td>
<td align="right">1728</td>
<td align="left">Trigeminal trophic syndrome</td>
<td align="left">Other specified disorders of the skin and subcutaneous tissue</td>
</tr>
<tr class="even">
<td align="left">L98.8</td>
<td align="right">1728</td>
<td align="left">Bier spots</td>
<td align="left">Other specified disorders of the skin and subcutaneous tissue</td>
</tr>
<tr class="odd">
<td align="left">K75.81</td>
<td align="right">1710</td>
<td align="left">Visceral steatosis</td>
<td align="left">Nonalcoholic steatohepatitis (NASH)</td>
</tr>
<tr class="even">
<td align="left">E78.6</td>
<td align="right">1704</td>
<td align="left">Abetalipoproteinemia</td>
<td align="left">Lipoprotein deficiency</td>
</tr>
<tr class="odd">
<td align="left">E78.6</td>
<td align="right">1704</td>
<td align="left">Familial HDL deficiency</td>
<td align="left">Lipoprotein deficiency</td>
</tr>
<tr class="even">
<td align="left">E78.6</td>
<td align="right">1704</td>
<td align="left">Familial hypobetalipoproteinemia</td>
<td align="left">Lipoprotein deficiency</td>
</tr>
<tr class="odd">
<td align="left">E78.6</td>
<td align="right">1704</td>
<td align="left">Chorea-acanthocytosis</td>
<td align="left">Lipoprotein deficiency</td>
</tr>
<tr class="even">
<td align="left">E78.6</td>
<td align="right">1704</td>
<td align="left">Familial LCAT deficiency</td>
<td align="left">Lipoprotein deficiency</td>
</tr>
<tr class="odd">
<td align="left">E78.6</td>
<td align="right">1704</td>
<td align="left">Fish-eye disease</td>
<td align="left">Lipoprotein deficiency</td>
</tr>
<tr class="even">
<td align="left">E78.6</td>
<td align="right">1704</td>
<td align="left">Tangier disease</td>
<td align="left">Lipoprotein deficiency</td>
</tr>
<tr class="odd">
<td align="left">E78.6</td>
<td align="right">1704</td>
<td align="left">Hypolipoproteinemia</td>
<td align="left">Lipoprotein deficiency</td>
</tr>
<tr class="even">
<td align="left">E78.6</td>
<td align="right">1704</td>
<td align="left">Neuroacanthocytosis</td>
<td align="left">Lipoprotein deficiency</td>
</tr>
<tr class="odd">
<td align="left">K91.2</td>
<td align="right">1694</td>
<td align="left">Short bowel syndrome</td>
<td align="left">Postsurgical malabsorption, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">M35.00</td>
<td align="right">1693</td>
<td align="left">Acute febrile neutrophilic dermatosis</td>
<td align="left">Sicca syndrome, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C54.1</td>
<td align="right">1691</td>
<td align="left">Endometrial stromal sarcoma</td>
<td align="left">Malignant neoplasm of endometrium</td>
</tr>
<tr class="even">
<td align="left">Q65.89</td>
<td align="right">1604</td>
<td align="left">Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy</td>
<td align="left">Other specified congenital deformities of hip</td>
</tr>
<tr class="odd">
<td align="left">D75.1</td>
<td align="right">1600</td>
<td align="left">Pseudopolycythaemia</td>
<td align="left">Secondary polycythemia</td>
</tr>
<tr class="even">
<td align="left">D75.89</td>
<td align="right">1573</td>
<td align="left">Triosephosphate isomerase deficiency</td>
<td align="left">Other specified diseases of blood and blood-forming organs</td>
</tr>
<tr class="odd">
<td align="left">D75.89</td>
<td align="right">1573</td>
<td align="left">McLeod neuroacanthocytosis syndrome</td>
<td align="left">Other specified diseases of blood and blood-forming organs</td>
</tr>
<tr class="even">
<td align="left">C49.9</td>
<td align="right">1568</td>
<td align="left">Fibrosarcoma</td>
<td align="left">Malignant neoplasm of connective and soft tissue, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C49.9</td>
<td align="right">1568</td>
<td align="left">Malignant mesenchymoma</td>
<td align="left">Malignant neoplasm of connective and soft tissue, unspecified</td>
</tr>
<tr class="even">
<td align="left">C49.9</td>
<td align="right">1568</td>
<td align="left">Malignant mesenchymoma</td>
<td align="left">Malignant neoplasm of connective and soft tissue, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C49.9</td>
<td align="right">1568</td>
<td align="left">Malignant mesenchymoma</td>
<td align="left">Malignant neoplasm of connective and soft tissue, unspecified</td>
</tr>
<tr class="even">
<td align="left">C49.9</td>
<td align="right">1568</td>
<td align="left">Rhabdomyosarcoma alveolar</td>
<td align="left">Malignant neoplasm of connective and soft tissue, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C49.9</td>
<td align="right">1568</td>
<td align="left">Rhabdomyosarcoma embryonal</td>
<td align="left">Malignant neoplasm of connective and soft tissue, unspecified</td>
</tr>
<tr class="even">
<td align="left">C49.9</td>
<td align="right">1568</td>
<td align="left">Soft tissue sarcoma</td>
<td align="left">Malignant neoplasm of connective and soft tissue, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C49.9</td>
<td align="right">1568</td>
<td align="left">Soft tissue sarcoma</td>
<td align="left">Malignant neoplasm of connective and soft tissue, unspecified</td>
</tr>
<tr class="even">
<td align="left">C49.9</td>
<td align="right">1568</td>
<td align="left">Soft tissue sarcoma</td>
<td align="left">Malignant neoplasm of connective and soft tissue, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C49.9</td>
<td align="right">1568</td>
<td align="left">Alveolar soft part sarcoma</td>
<td align="left">Malignant neoplasm of connective and soft tissue, unspecified</td>
</tr>
<tr class="even">
<td align="left">C49.9</td>
<td align="right">1568</td>
<td align="left">Leiomyosarcoma</td>
<td align="left">Malignant neoplasm of connective and soft tissue, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C49.9</td>
<td align="right">1568</td>
<td align="left">Liposarcoma</td>
<td align="left">Malignant neoplasm of connective and soft tissue, unspecified</td>
</tr>
<tr class="even">
<td align="left">C49.9</td>
<td align="right">1568</td>
<td align="left">Undifferentiated pleomorphic sarcoma</td>
<td align="left">Malignant neoplasm of connective and soft tissue, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C49.9</td>
<td align="right">1568</td>
<td align="left">Myxoid liposarcoma</td>
<td align="left">Malignant neoplasm of connective and soft tissue, unspecified</td>
</tr>
<tr class="even">
<td align="left">C49.9</td>
<td align="right">1568</td>
<td align="left">Synovial sarcoma</td>
<td align="left">Malignant neoplasm of connective and soft tissue, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C49.9</td>
<td align="right">1568</td>
<td align="left">Sarcoma botryoides</td>
<td align="left">Malignant neoplasm of connective and soft tissue, unspecified</td>
</tr>
<tr class="even">
<td align="left">G80.9</td>
<td align="right">1550</td>
<td align="left">Cerebral palsy</td>
<td align="left">Cerebral palsy, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D32.9</td>
<td align="right">1536</td>
<td align="left">Meningioma</td>
<td align="left">Benign neoplasm of meninges, unspecified</td>
</tr>
<tr class="even">
<td align="left">L60.3</td>
<td align="right">1532</td>
<td align="left">Twenty-nail dystrophy</td>
<td align="left">Nail dystrophy</td>
</tr>
<tr class="odd">
<td align="left">K72.90</td>
<td align="right">1517</td>
<td align="left">Hepatic encephalopathy</td>
<td align="left">Hepatic failure, unspecified without coma</td>
</tr>
<tr class="even">
<td align="left">K72.90</td>
<td align="right">1517</td>
<td align="left">Hepatic encephalopathy</td>
<td align="left">Hepatic failure, unspecified without coma</td>
</tr>
<tr class="odd">
<td align="left">C56.9</td>
<td align="right">1467</td>
<td align="left">Ovarian carcinosarcoma</td>
<td align="left">Malignant neoplasm of unspecified ovary</td>
</tr>
<tr class="even">
<td align="left">C56.9</td>
<td align="right">1467</td>
<td align="left">Ovarian germ cell tumor</td>
<td align="left">Malignant neoplasm of unspecified ovary</td>
</tr>
<tr class="odd">
<td align="left">K83.1</td>
<td align="right">1446</td>
<td align="left">Aagenaes syndrome</td>
<td align="left">Obstruction of bile duct</td>
</tr>
<tr class="even">
<td align="left">K83.1</td>
<td align="right">1446</td>
<td align="left">Progressive familial intrahepatic cholestasis 1</td>
<td align="left">Obstruction of bile duct</td>
</tr>
<tr class="odd">
<td align="left">K83.1</td>
<td align="right">1446</td>
<td align="left">Benign recurrent intrahepatic cholestasis 1</td>
<td align="left">Obstruction of bile duct</td>
</tr>
<tr class="even">
<td align="left">K83.1</td>
<td align="right">1446</td>
<td align="left">Mirizzi syndrome</td>
<td align="left">Obstruction of bile duct</td>
</tr>
<tr class="odd">
<td align="left">C91.10</td>
<td align="right">1436</td>
<td align="left">Chronic lymphocytic leukemia</td>
<td align="left">Chronic lymphocytic leukemia of B-cell type not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">C91.10</td>
<td align="right">1436</td>
<td align="left">Leukemia, B-cell, chronic</td>
<td align="left">Chronic lymphocytic leukemia of B-cell type not having achieved remission</td>
</tr>
<tr class="odd">
<td align="left">Q24.9</td>
<td align="right">1403</td>
<td align="left">Cardiofaciocutaneous syndrome</td>
<td align="left">Congenital malformation of heart, unspecified</td>
</tr>
<tr class="even">
<td align="left">D36.9</td>
<td align="right">1397</td>
<td align="left">Cataract congenital dominant non nuclear</td>
<td align="left">Benign neoplasm, unspecified site</td>
</tr>
<tr class="odd">
<td align="left">D36.9</td>
<td align="right">1397</td>
<td align="left">Pheochromocytoma</td>
<td align="left">Benign neoplasm, unspecified site</td>
</tr>
<tr class="even">
<td align="left">G50.0</td>
<td align="right">1388</td>
<td align="left">Trigeminal neuralgia</td>
<td align="left">Trigeminal neuralgia</td>
</tr>
<tr class="odd">
<td align="left">K20.9</td>
<td align="right">1386</td>
<td align="left">Crohn’s disease of the esophagus</td>
<td align="left">Esophagitis, unspecified</td>
</tr>
<tr class="even">
<td align="left">G30.1</td>
<td align="right">1374</td>
<td align="left">Alzheimer disease type 2</td>
<td align="left">Alzheimer’s disease with late onset</td>
</tr>
<tr class="odd">
<td align="left">G30.1</td>
<td align="right">1374</td>
<td align="left">Late-Onset Familial Alzheimer Disease</td>
<td align="left">Alzheimer’s disease with late onset</td>
</tr>
<tr class="even">
<td align="left">G93.2</td>
<td align="right">1371</td>
<td align="left">Pseudotumor cerebri</td>
<td align="left">Benign intracranial hypertension</td>
</tr>
<tr class="odd">
<td align="left">F79</td>
<td align="right">1364</td>
<td align="left">Blepharophimosis intellectual disability syndromes</td>
<td align="left">Unspecified intellectual disabilities</td>
</tr>
<tr class="even">
<td align="left">B25.9</td>
<td align="right">1353</td>
<td align="left">Cytomegalic inclusion disease</td>
<td align="left">Cytomegaloviral disease, unspecified</td>
</tr>
<tr class="odd">
<td align="left">I49.1</td>
<td align="right">1346</td>
<td align="left">Gianotti Crosti syndrome</td>
<td align="left">Atrial premature depolarization</td>
</tr>
<tr class="even">
<td align="left">J84.112</td>
<td align="right">1326</td>
<td align="left">Idiopathic pulmonary fibrosis</td>
<td align="left">Idiopathic pulmonary fibrosis</td>
</tr>
<tr class="odd">
<td align="left">J84.112</td>
<td align="right">1326</td>
<td align="left">Acute interstitial pneumonia</td>
<td align="left">Idiopathic pulmonary fibrosis</td>
</tr>
<tr class="even">
<td align="left">G72.9</td>
<td align="right">1311</td>
<td align="left">Intestinal pseudo-obstruction</td>
<td align="left">Myopathy, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Meleda disease</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Acrokeratoelastoidosis of Costa</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Trichodental syndrome</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Wrinkly skin syndrome</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Beare-Stevenson cutis gyrata syndrome</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Dyschromatosis symmetrica hereditaria 1</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Hoyeraal Hreidarsson syndrome</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Bloom syndrome</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Burnett Schwartz Berberian syndrome</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Burnett Schwartz Berberian syndrome</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">LEOPARD syndrome</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Cutis laxa, autosomal recessive type 2A</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Cutis laxa, autosomal dominant</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Cutis verticis gyrata</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Dyskeratosis congenita X-linked</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Clouston syndrome</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Hypohidrotic ectodermal dysplasia autosomal recessive</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Palmoplantar keratoderma, epidermolytic</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Flynn Aird syndrome</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Insulin-resistant acanthosis nigricans, type A</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Vohwinkel syndrome</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Keratoderma palmoplantaris transgrediens</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Tylosis with esophageal cancer</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Michelin tire baby syndrome</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Naegeli syndrome</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Kindler syndrome</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Rothmund-Thomson syndrome</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Porokeratosis of Mibelli</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Punctate palmoplantar keratoderma type 2</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Unna-Thost palmoplantar keratoderma</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Ulerythema ophryogenesis</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Cutis laxa</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Cutis marmorata telangiectatica congenita</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Dyskeratosis congenita autosomal dominant</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Dyskeratosis congenita autosomal recessive</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Ectodermal dysplasia</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Focal dermal hypoplasia</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Focal dermal hypoplasia</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Hailey-Hailey disease</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Keratosis follicularis spinulosa decalvans</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Keratolytic winter erythema</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Focal facial dermal dysplasia</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Focal facial dermal dysplasia</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Focal facial dermal dysplasia</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Cutis laxa, autosomal recessive type 1</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Palmoplantar keratoderma-sclerodactyly syndrome</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Dermatopathia pigmentosa reticularis</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Hypotrichosis simplex</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Linear porokeratosis</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Tylosis</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Tylosis</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Pseudoxanthoma elasticum</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Hyperostosis-hyperphosphatemia syndrome</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Dyskeratosis congenita</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Dyskeratosis congenita</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Erythrokeratodermia variabilis et progressiva</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Cole disease</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="even">
<td align="left">Q82.8</td>
<td align="right">1282</td>
<td align="left">Acral peeling skin syndrome</td>
<td align="left">Other specified congenital malformations of skin</td>
</tr>
<tr class="odd">
<td align="left">K74.69</td>
<td align="right">1280</td>
<td align="left">Scalp ear nipple syndrome</td>
<td align="left">Other cirrhosis of liver</td>
</tr>
<tr class="even">
<td align="left">N13.5</td>
<td align="right">1271</td>
<td align="left">Retroperitoneal fibrosis</td>
<td align="left">Crossing vessel and stricture of ureter without hydronephrosis</td>
</tr>
<tr class="odd">
<td align="left">N13.5</td>
<td align="right">1271</td>
<td align="left">Retroperitoneal fibrosis</td>
<td align="left">Crossing vessel and stricture of ureter without hydronephrosis</td>
</tr>
<tr class="even">
<td align="left">M26.609</td>
<td align="right">1262</td>
<td align="left">Transient myeloproliferative syndrome</td>
<td align="left">Unspecified temporomandibular joint disorder, unspecified side</td>
</tr>
<tr class="odd">
<td align="left">D69.3</td>
<td align="right">1258</td>
<td align="left">Idiopathic thrombocytopenic purpura</td>
<td align="left">Immune thrombocytopenic purpura</td>
</tr>
<tr class="even">
<td align="left">D69.3</td>
<td align="right">1258</td>
<td align="left">Immune thrombocytopenia</td>
<td align="left">Immune thrombocytopenic purpura</td>
</tr>
<tr class="odd">
<td align="left">D69.3</td>
<td align="right">1258</td>
<td align="left">Cyclic thrombocytopenia</td>
<td align="left">Immune thrombocytopenic purpura</td>
</tr>
<tr class="even">
<td align="left">K11.20</td>
<td align="right">1255</td>
<td align="left">Sialadenitis</td>
<td align="left">Sialoadenitis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">K81.9</td>
<td align="right">1248</td>
<td align="left">Cholecystitis</td>
<td align="left">Cholecystitis, unspecified</td>
</tr>
<tr class="even">
<td align="left">K81.9</td>
<td align="right">1248</td>
<td align="left">Xanthogranulomatous cholecystitis</td>
<td align="left">Cholecystitis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D51.0</td>
<td align="right">1241</td>
<td align="left">Intrinsic factor deficiency</td>
<td align="left">Vitamin B12 deficiency anemia due to intrinsic factor deficiency</td>
</tr>
<tr class="even">
<td align="left">D51.0</td>
<td align="right">1241</td>
<td align="left">Imerslund-Grasbeck syndrome</td>
<td align="left">Vitamin B12 deficiency anemia due to intrinsic factor deficiency</td>
</tr>
<tr class="odd">
<td align="left">E21.0</td>
<td align="right">1240</td>
<td align="left">Familial isolated hyperparathyroidism</td>
<td align="left">Primary hyperparathyroidism</td>
</tr>
<tr class="even">
<td align="left">E21.0</td>
<td align="right">1240</td>
<td align="left">Primary hyperparathyroidism</td>
<td align="left">Primary hyperparathyroidism</td>
</tr>
<tr class="odd">
<td align="left">E21.0</td>
<td align="right">1240</td>
<td align="left">Hyperparathyroidism-jaw tumor syndrome</td>
<td align="left">Primary hyperparathyroidism</td>
</tr>
<tr class="even">
<td align="left">C85.89</td>
<td align="right">1210</td>
<td align="left">Primary central nervous system lymphoma</td>
<td align="left">Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites</td>
</tr>
<tr class="odd">
<td align="left">E23.0</td>
<td align="right">1192</td>
<td align="left">Isolated growth hormone deficiency type 2</td>
<td align="left">Hypopituitarism</td>
</tr>
<tr class="even">
<td align="left">E23.0</td>
<td align="right">1192</td>
<td align="left">Hypopituitarism</td>
<td align="left">Hypopituitarism</td>
</tr>
<tr class="odd">
<td align="left">E23.0</td>
<td align="right">1192</td>
<td align="left">Kallmann syndrome 3</td>
<td align="left">Hypopituitarism</td>
</tr>
<tr class="even">
<td align="left">E23.0</td>
<td align="right">1192</td>
<td align="left">Isolated growth hormone deficiency type 1B</td>
<td align="left">Hypopituitarism</td>
</tr>
<tr class="odd">
<td align="left">E23.0</td>
<td align="right">1192</td>
<td align="left">Isolated growth hormone deficiency type 1B</td>
<td align="left">Hypopituitarism</td>
</tr>
<tr class="even">
<td align="left">E23.0</td>
<td align="right">1192</td>
<td align="left">Isolated growth hormone deficiency type 3</td>
<td align="left">Hypopituitarism</td>
</tr>
<tr class="odd">
<td align="left">E23.0</td>
<td align="right">1192</td>
<td align="left">Growth hormone deficiency</td>
<td align="left">Hypopituitarism</td>
</tr>
<tr class="even">
<td align="left">E23.0</td>
<td align="right">1192</td>
<td align="left">Growth hormone deficiency</td>
<td align="left">Hypopituitarism</td>
</tr>
<tr class="odd">
<td align="left">E23.0</td>
<td align="right">1192</td>
<td align="left">Panhypopituitarism X-linked</td>
<td align="left">Hypopituitarism</td>
</tr>
<tr class="even">
<td align="left">E23.0</td>
<td align="right">1192</td>
<td align="left">Septo-optic dysplasia spectrum</td>
<td align="left">Hypopituitarism</td>
</tr>
<tr class="odd">
<td align="left">E23.0</td>
<td align="right">1192</td>
<td align="left">Sheehan syndrome</td>
<td align="left">Hypopituitarism</td>
</tr>
<tr class="even">
<td align="left">E23.0</td>
<td align="right">1192</td>
<td align="left">Fertile eunuch syndrome</td>
<td align="left">Hypopituitarism</td>
</tr>
<tr class="odd">
<td align="left">E23.0</td>
<td align="right">1192</td>
<td align="left">Lymphocytic hypophysitis</td>
<td align="left">Hypopituitarism</td>
</tr>
<tr class="even">
<td align="left">E23.0</td>
<td align="right">1192</td>
<td align="left">Pituitary dwarfism with large sella turcica</td>
<td align="left">Hypopituitarism</td>
</tr>
<tr class="odd">
<td align="left">E23.0</td>
<td align="right">1192</td>
<td align="left">Kallmann syndrome</td>
<td align="left">Hypopituitarism</td>
</tr>
<tr class="even">
<td align="left">E23.0</td>
<td align="right">1192</td>
<td align="left">Proopiomelanocortin deficiency</td>
<td align="left">Hypopituitarism</td>
</tr>
<tr class="odd">
<td align="left">E23.0</td>
<td align="right">1192</td>
<td align="left">Isolated growth hormone deficiency</td>
<td align="left">Hypopituitarism</td>
</tr>
<tr class="even">
<td align="left">M54.89</td>
<td align="right">1187</td>
<td align="left">Eagle syndrome</td>
<td align="left">Other dorsalgia</td>
</tr>
<tr class="odd">
<td align="left">F80.0</td>
<td align="right">1170</td>
<td align="left">Childhood apraxia of speech</td>
<td align="left">Phonological disorder</td>
</tr>
<tr class="even">
<td align="left">G40.309</td>
<td align="right">1168</td>
<td align="left">Convulsions, benign familial infantile, 1</td>
<td align="left">Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus</td>
</tr>
<tr class="odd">
<td align="left">G40.309</td>
<td align="right">1168</td>
<td align="left">Benign familial neonatal-infantile seizures</td>
<td align="left">Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus</td>
</tr>
<tr class="even">
<td align="left">G40.309</td>
<td align="right">1168</td>
<td align="left">Convulsions benign familial neonatal dominant form</td>
<td align="left">Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus</td>
</tr>
<tr class="odd">
<td align="left">G40.309</td>
<td align="right">1168</td>
<td align="left">Benign familial neonatal epilepsy</td>
<td align="left">Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus</td>
</tr>
<tr class="even">
<td align="left">G40.309</td>
<td align="right">1168</td>
<td align="left">Unverricht-Lundborg disease</td>
<td align="left">Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus</td>
</tr>
<tr class="odd">
<td align="left">G40.309</td>
<td align="right">1168</td>
<td align="left">Juvenile myoclonic epilepsy</td>
<td align="left">Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus</td>
</tr>
<tr class="even">
<td align="left">G40.309</td>
<td align="right">1168</td>
<td align="left">Progressive myoclonic epilepsy</td>
<td align="left">Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus</td>
</tr>
<tr class="odd">
<td align="left">G40.309</td>
<td align="right">1168</td>
<td align="left">Progressive myoclonic epilepsy</td>
<td align="left">Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus</td>
</tr>
<tr class="even">
<td align="left">G40.309</td>
<td align="right">1168</td>
<td align="left">Myoclonus epilepsy</td>
<td align="left">Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus</td>
</tr>
<tr class="odd">
<td align="left">G40.309</td>
<td align="right">1168</td>
<td align="left">Lafora disease</td>
<td align="left">Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus</td>
</tr>
<tr class="even">
<td align="left">G40.309</td>
<td align="right">1168</td>
<td align="left">Dravet syndrome</td>
<td align="left">Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus</td>
</tr>
<tr class="odd">
<td align="left">D57.1</td>
<td align="right">1167</td>
<td align="left">Subacute cerebellar degeneration</td>
<td align="left">Sickle-cell disease without crisis</td>
</tr>
<tr class="even">
<td align="left">D57.1</td>
<td align="right">1167</td>
<td align="left">Sickle cell anemia</td>
<td align="left">Sickle-cell disease without crisis</td>
</tr>
<tr class="odd">
<td align="left">D57.1</td>
<td align="right">1167</td>
<td align="left">Superior semicircular canal dehiscence syndrome</td>
<td align="left">Sickle-cell disease without crisis</td>
</tr>
<tr class="even">
<td align="left">M35.3</td>
<td align="right">1161</td>
<td align="left">Rhizomelic pseudopolyarthritis</td>
<td align="left">Polymyalgia rheumatica</td>
</tr>
<tr class="odd">
<td align="left">K86.1</td>
<td align="right">1134</td>
<td align="left">Hereditary pancreatitis</td>
<td align="left">Other chronic pancreatitis</td>
</tr>
<tr class="even">
<td align="left">L56.5</td>
<td align="right">1120</td>
<td align="left">Disseminated superficial actinic porokeratosis</td>
<td align="left">Disseminated superficial actinic porokeratosis (DSAP)</td>
</tr>
<tr class="odd">
<td align="left">I71.9</td>
<td align="right">1120</td>
<td align="left">Triple A syndrome</td>
<td align="left">Aortic aneurysm of unspecified site, without rupture</td>
</tr>
<tr class="even">
<td align="left">N39.8</td>
<td align="right">1117</td>
<td align="left">Loin pain hematuria syndrome</td>
<td align="left">Other specified disorders of urinary system</td>
</tr>
<tr class="odd">
<td align="left">G70.00</td>
<td align="right">1116</td>
<td align="left">Myasthenia gravis congenital</td>
<td align="left">Myasthenia gravis without (acute) exacerbation</td>
</tr>
<tr class="even">
<td align="left">G70.00</td>
<td align="right">1116</td>
<td align="left">Myasthenia gravis</td>
<td align="left">Myasthenia gravis without (acute) exacerbation</td>
</tr>
<tr class="odd">
<td align="left">I27.0</td>
<td align="right">1115</td>
<td align="left">Pulmonary arterial hypertension</td>
<td align="left">Primary pulmonary hypertension</td>
</tr>
<tr class="even">
<td align="left">Q25.0</td>
<td align="right">1107</td>
<td align="left">Patent ductus arteriosus</td>
<td align="left">Patent ductus arteriosus</td>
</tr>
<tr class="odd">
<td align="left">D48.1</td>
<td align="right">1073</td>
<td align="left">Hemangiopericytoma</td>
<td align="left">Neoplasm of uncertain behavior of connective and other soft tissue</td>
</tr>
<tr class="even">
<td align="left">D48.1</td>
<td align="right">1073</td>
<td align="left">Kaposiform Hemangioendothelioma</td>
<td align="left">Neoplasm of uncertain behavior of connective and other soft tissue</td>
</tr>
<tr class="odd">
<td align="left">D48.1</td>
<td align="right">1073</td>
<td align="left">Synovial Chondromatosis</td>
<td align="left">Neoplasm of uncertain behavior of connective and other soft tissue</td>
</tr>
<tr class="even">
<td align="left">D84.9</td>
<td align="right">1050</td>
<td align="left">Immunodeficiency with thymoma</td>
<td align="left">Immunodeficiency, unspecified</td>
</tr>
<tr class="odd">
<td align="left">I42.2</td>
<td align="right">1041</td>
<td align="left">Familial hypertrophic cardiomyopathy</td>
<td align="left">Other hypertrophic cardiomyopathy</td>
</tr>
<tr class="even">
<td align="left">D68.59</td>
<td align="right">1038</td>
<td align="left">Protein S deficiency</td>
<td align="left">Other primary thrombophilia</td>
</tr>
<tr class="odd">
<td align="left">D68.59</td>
<td align="right">1038</td>
<td align="left">Hereditary antithrombin deficiency</td>
<td align="left">Other primary thrombophilia</td>
</tr>
<tr class="even">
<td align="left">R16.1</td>
<td align="right">1034</td>
<td align="left">Splenomegaly</td>
<td align="left">Splenomegaly, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">L81.0</td>
<td align="right">1031</td>
<td align="left">Lichen planus pigmentosus</td>
<td align="left">Postinflammatory hyperpigmentation</td>
</tr>
<tr class="even">
<td align="left">K83.8</td>
<td align="right">1026</td>
<td align="left">Benign recurrent intrahepatic cholestasis</td>
<td align="left">Other specified diseases of biliary tract</td>
</tr>
<tr class="odd">
<td align="left">C22.0</td>
<td align="right">1020</td>
<td align="left">Fibrolamellar carcinoma</td>
<td align="left">Liver cell carcinoma</td>
</tr>
<tr class="even">
<td align="left">C22.0</td>
<td align="right">1020</td>
<td align="left">Leukoencephalopathy, cerebral calcifications, and cysts</td>
<td align="left">Liver cell carcinoma</td>
</tr>
<tr class="odd">
<td align="left">Q82.5</td>
<td align="right">1017</td>
<td align="left">Phacomatosis pigmentovascularis</td>
<td align="left">Congenital non-neoplastic nevus</td>
</tr>
<tr class="even">
<td align="left">Q82.5</td>
<td align="right">1017</td>
<td align="left">Inflammatory linear verrucous epidermal nevus</td>
<td align="left">Congenital non-neoplastic nevus</td>
</tr>
<tr class="odd">
<td align="left">Q82.5</td>
<td align="right">1017</td>
<td align="left">Nevus comedonicus</td>
<td align="left">Congenital non-neoplastic nevus</td>
</tr>
<tr class="even">
<td align="left">C15.9</td>
<td align="right">1004</td>
<td align="left">Esophageal cancer</td>
<td align="left">Malignant neoplasm of esophagus, unspecified</td>
</tr>
<tr class="odd">
<td align="left">H02.30</td>
<td align="right">980</td>
<td align="left">Ascher Syndrome</td>
<td align="left">Blepharochalasis unspecified eye, unspecified eyelid</td>
</tr>
<tr class="even">
<td align="left">N87.9</td>
<td align="right">977</td>
<td align="left">Cervical intraepithelial neoplasia</td>
<td align="left">Dysplasia of cervix uteri, unspecified</td>
</tr>
<tr class="odd">
<td align="left">R25.3</td>
<td align="right">975</td>
<td align="left">Cramp-fasciculation syndrome</td>
<td align="left">Fasciculation</td>
</tr>
<tr class="even">
<td align="left">L90.0</td>
<td align="right">970</td>
<td align="left">Lichen sclerosus</td>
<td align="left">Lichen sclerosus et atrophicus</td>
</tr>
<tr class="odd">
<td align="left">E30.1</td>
<td align="right">970</td>
<td align="left">Testotoxicosis</td>
<td align="left">Precocious puberty</td>
</tr>
<tr class="even">
<td align="left">E30.1</td>
<td align="right">970</td>
<td align="left">Precocious puberty</td>
<td align="left">Precocious puberty</td>
</tr>
<tr class="odd">
<td align="left">H18.52</td>
<td align="right">965</td>
<td align="left">Meesmann corneal dystrophy</td>
<td align="left">Epithelial (juvenile) corneal dystrophy</td>
</tr>
<tr class="even">
<td align="left">H18.52</td>
<td align="right">965</td>
<td align="left">Epithelial basement membrane corneal dystrophy</td>
<td align="left">Epithelial (juvenile) corneal dystrophy</td>
</tr>
<tr class="odd">
<td align="left">C92.00</td>
<td align="right">948</td>
<td align="left">Acute megakaryoblastic leukemia</td>
<td align="left">Acute myeloblastic leukemia, not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">C92.00</td>
<td align="right">948</td>
<td align="left">Acute non lymphoblastic leukemia</td>
<td align="left">Acute myeloblastic leukemia, not having achieved remission</td>
</tr>
<tr class="odd">
<td align="left">C92.00</td>
<td align="right">948</td>
<td align="left">Acute myeloid leukemia</td>
<td align="left">Acute myeloblastic leukemia, not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">A49.8</td>
<td align="right">946</td>
<td align="left">Vibrio vulnificus infection</td>
<td align="left">Other bacterial infections of unspecified site</td>
</tr>
<tr class="odd">
<td align="left">C83.30</td>
<td align="right">944</td>
<td align="left">Lymphoma, large-cell, immunoblastic</td>
<td align="left">Diffuse large B-cell lymphoma, unspecified site</td>
</tr>
<tr class="even">
<td align="left">C83.30</td>
<td align="right">944</td>
<td align="left">Lymphoma, large-cell</td>
<td align="left">Diffuse large B-cell lymphoma, unspecified site</td>
</tr>
<tr class="odd">
<td align="left">K63.9</td>
<td align="right">942</td>
<td align="left">Autoimmune enteropathy</td>
<td align="left">Disease of intestine, unspecified</td>
</tr>
<tr class="even">
<td align="left">E83.39</td>
<td align="right">942</td>
<td align="left">Hypophosphatasia</td>
<td align="left">Other disorders of phosphorus metabolism</td>
</tr>
<tr class="odd">
<td align="left">E83.39</td>
<td align="right">942</td>
<td align="left">Childhood hypophosphatasia</td>
<td align="left">Other disorders of phosphorus metabolism</td>
</tr>
<tr class="even">
<td align="left">I15.0</td>
<td align="right">941</td>
<td align="left">Spondylometaphyseal dysplasia with dentinogenesis imperfecta</td>
<td align="left">Renovascular hypertension</td>
</tr>
<tr class="odd">
<td align="left">D49.7</td>
<td align="right">924</td>
<td align="left">Adenoma of the adrenal gland</td>
<td align="left">Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system</td>
</tr>
<tr class="even">
<td align="left">D49.7</td>
<td align="right">924</td>
<td align="left">Adrenal medulla cancer</td>
<td align="left">Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system</td>
</tr>
<tr class="odd">
<td align="left">D49.7</td>
<td align="right">924</td>
<td align="left">Paragangliomas 1</td>
<td align="left">Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system</td>
</tr>
<tr class="even">
<td align="left">D49.7</td>
<td align="right">924</td>
<td align="left">Paragangliomas 1</td>
<td align="left">Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system</td>
</tr>
<tr class="odd">
<td align="left">D49.7</td>
<td align="right">924</td>
<td align="left">Pineocytoma</td>
<td align="left">Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system</td>
</tr>
<tr class="even">
<td align="left">D49.7</td>
<td align="right">924</td>
<td align="left">Craniopharyngioma</td>
<td align="left">Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system</td>
</tr>
<tr class="odd">
<td align="left">D49.7</td>
<td align="right">924</td>
<td align="left">Glomus jugulare tumors</td>
<td align="left">Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system</td>
</tr>
<tr class="even">
<td align="left">Q66.89</td>
<td align="right">915</td>
<td align="left">Xeroderma talipes enamel defects</td>
<td align="left">Other specified congenital deformities of feet</td>
</tr>
<tr class="odd">
<td align="left">Q66.89</td>
<td align="right">915</td>
<td align="left">Tarsal carpal coalition syndrome</td>
<td align="left">Other specified congenital deformities of feet</td>
</tr>
<tr class="even">
<td align="left">R40.20</td>
<td align="right">909</td>
<td align="left">Oculomotor apraxia Cogan type</td>
<td align="left">Unspecified coma</td>
</tr>
<tr class="odd">
<td align="left">R40.20</td>
<td align="right">909</td>
<td align="left">Laryngoonychocutaneous syndrome</td>
<td align="left">Unspecified coma</td>
</tr>
<tr class="even">
<td align="left">I42.0</td>
<td align="right">894</td>
<td align="left">Dilated cardiomyopathy</td>
<td align="left">Dilated cardiomyopathy</td>
</tr>
<tr class="odd">
<td align="left">I42.0</td>
<td align="right">894</td>
<td align="left">Familial dilated cardiomyopathy</td>
<td align="left">Dilated cardiomyopathy</td>
</tr>
<tr class="even">
<td align="left">I42.0</td>
<td align="right">894</td>
<td align="left">Diffuse cutaneous mastocytosis</td>
<td align="left">Dilated cardiomyopathy</td>
</tr>
<tr class="odd">
<td align="left">A31.0</td>
<td align="right">894</td>
<td align="left">Mycobacterium Kansasii</td>
<td align="left">Pulmonary mycobacterial infection</td>
</tr>
<tr class="even">
<td align="left">D48.0</td>
<td align="right">867</td>
<td align="left">Giant cell tumor of bone</td>
<td align="left">Neoplasm of uncertain behavior of bone and articular cartilage</td>
</tr>
<tr class="odd">
<td align="left">H46.9</td>
<td align="right">860</td>
<td align="left">Optic neuritis</td>
<td align="left">Unspecified optic neuritis</td>
</tr>
<tr class="even">
<td align="left">D46.9</td>
<td align="right">860</td>
<td align="left">Myelodysplastic syndromes</td>
<td align="left">Myelodysplastic syndrome, unspecified</td>
</tr>
<tr class="odd">
<td align="left">G54.0</td>
<td align="right">859</td>
<td align="left">Thoracic outlet syndrome</td>
<td align="left">Brachial plexus disorders</td>
</tr>
<tr class="even">
<td align="left">N94.3</td>
<td align="right">858</td>
<td align="left">Polydactyly myopia syndrome</td>
<td align="left">Premenstrual tension syndrome</td>
</tr>
<tr class="odd">
<td align="left">K14.8</td>
<td align="right">855</td>
<td align="left">Macroglossia</td>
<td align="left">Other diseases of tongue</td>
</tr>
<tr class="even">
<td align="left">G40.409</td>
<td align="right">853</td>
<td align="left">Pitt-Hopkins syndrome</td>
<td align="left">Other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus</td>
</tr>
<tr class="odd">
<td align="left">G40.409</td>
<td align="right">853</td>
<td align="left">Myoclonus epilepsy</td>
<td align="left">Other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus</td>
</tr>
<tr class="even">
<td align="left">G40.409</td>
<td align="right">853</td>
<td align="left">Early Infantile Epileptic Encephalopathy</td>
<td align="left">Other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus</td>
</tr>
<tr class="odd">
<td align="left">J39.2</td>
<td align="right">842</td>
<td align="left">Oral pharyngeal disorders</td>
<td align="left">Other diseases of pharynx</td>
</tr>
<tr class="even">
<td align="left">H33.20</td>
<td align="right">839</td>
<td align="left">Knobloch syndrome</td>
<td align="left">Serous retinal detachment, unspecified eye</td>
</tr>
<tr class="odd">
<td align="left">H33.20</td>
<td align="right">839</td>
<td align="left">Passos-Bueno syndrome</td>
<td align="left">Serous retinal detachment, unspecified eye</td>
</tr>
<tr class="even">
<td align="left">P96.89</td>
<td align="right">832</td>
<td align="left">Neonatal systemic lupus erythematosus</td>
<td align="left">Other specified conditions originating in the perinatal period</td>
</tr>
<tr class="odd">
<td align="left">K83.0</td>
<td align="right">825</td>
<td align="left">Primary sclerosing cholangitis</td>
<td align="left">Cholangitis</td>
</tr>
<tr class="even">
<td align="left">E27.49</td>
<td align="right">822</td>
<td align="left">Isolated ACTH deficiency</td>
<td align="left">Other adrenocortical insufficiency</td>
</tr>
<tr class="odd">
<td align="left">E27.49</td>
<td align="right">822</td>
<td align="left">Hyporeninemic hypoaldosteronism</td>
<td align="left">Other adrenocortical insufficiency</td>
</tr>
<tr class="even">
<td align="left">E27.49</td>
<td align="right">822</td>
<td align="left">Secondary adrenal insufficiency</td>
<td align="left">Other adrenocortical insufficiency</td>
</tr>
<tr class="odd">
<td align="left">N64.89</td>
<td align="right">818</td>
<td align="left">Galactocele</td>
<td align="left">Other specified disorders of breast</td>
</tr>
<tr class="even">
<td align="left">Q66.6</td>
<td align="right">811</td>
<td align="left">Congenital vertical talus</td>
<td align="left">Other congenital valgus deformities of feet</td>
</tr>
<tr class="odd">
<td align="left">C44.90</td>
<td align="right">798</td>
<td align="left">Muir-Torre syndrome</td>
<td align="left">Unspecified malignant neoplasm of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">G40.109</td>
<td align="right">789</td>
<td align="left">Autosomal dominant nocturnal frontal lobe epilepsy</td>
<td align="left">Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus</td>
</tr>
<tr class="odd">
<td align="left">G40.109</td>
<td align="right">789</td>
<td align="left">Malignant migrating partial seizures of infancy</td>
<td align="left">Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus</td>
</tr>
<tr class="even">
<td align="left">D58.2</td>
<td align="right">789</td>
<td align="left">Hemoglobin C disease</td>
<td align="left">Other hemoglobinopathies</td>
</tr>
<tr class="odd">
<td align="left">D58.2</td>
<td align="right">789</td>
<td align="left">Hemoglobin E disease</td>
<td align="left">Other hemoglobinopathies</td>
</tr>
<tr class="even">
<td align="left">K82.8</td>
<td align="right">782</td>
<td align="left">Rokitansky-Aschoff sinuses of the gallbladder</td>
<td align="left">Other specified diseases of gallbladder</td>
</tr>
<tr class="odd">
<td align="left">Q05.9</td>
<td align="right">780</td>
<td align="left">Meningocele</td>
<td align="left">Spina bifida, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q05.9</td>
<td align="right">780</td>
<td align="left">Meningocele</td>
<td align="left">Spina bifida, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q05.9</td>
<td align="right">780</td>
<td align="left">Meningocele</td>
<td align="left">Spina bifida, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q05.9</td>
<td align="right">780</td>
<td align="left">Myelomeningocele</td>
<td align="left">Spina bifida, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q05.9</td>
<td align="right">780</td>
<td align="left">Myelomeningocele</td>
<td align="left">Spina bifida, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q05.9</td>
<td align="right">780</td>
<td align="left">Spina bifida</td>
<td align="left">Spina bifida, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q05.9</td>
<td align="right">780</td>
<td align="left">Lipomyelomeningocele</td>
<td align="left">Spina bifida, unspecified</td>
</tr>
<tr class="even">
<td align="left">H51.8</td>
<td align="right">777</td>
<td align="left">Ocular neuromyotonia</td>
<td align="left">Other specified disorders of binocular movement</td>
</tr>
<tr class="odd">
<td align="left">M34.9</td>
<td align="right">765</td>
<td align="left">Systemic scleroderma</td>
<td align="left">Systemic sclerosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">M34.9</td>
<td align="right">765</td>
<td align="left">Limited systemic sclerosis</td>
<td align="left">Systemic sclerosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">M34.9</td>
<td align="right">765</td>
<td align="left">Diffuse cutaneous systemic sclerosis</td>
<td align="left">Systemic sclerosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">M34.9</td>
<td align="right">765</td>
<td align="left">Potocki-Shaffer syndrome</td>
<td align="left">Systemic sclerosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q67.3</td>
<td align="right">764</td>
<td align="left">Plagiocephaly</td>
<td align="left">Plagiocephaly</td>
</tr>
<tr class="even">
<td align="left">E78.89</td>
<td align="right">749</td>
<td align="left">Lipoid proteinosis of Urbach and Wiethe</td>
<td align="left">Other lipoprotein metabolism disorders</td>
</tr>
<tr class="odd">
<td align="left">E78.89</td>
<td align="right">749</td>
<td align="left">Farber’s disease</td>
<td align="left">Other lipoprotein metabolism disorders</td>
</tr>
<tr class="even">
<td align="left">E78.89</td>
<td align="right">749</td>
<td align="left">Sitosterolemia</td>
<td align="left">Other lipoprotein metabolism disorders</td>
</tr>
<tr class="odd">
<td align="left">G12.21</td>
<td align="right">748</td>
<td align="left">Amyotrophic lateral sclerosis</td>
<td align="left">Amyotrophic lateral sclerosis</td>
</tr>
<tr class="even">
<td align="left">Q99.9</td>
<td align="right">746</td>
<td align="left">Ulnar-mammary syndrome</td>
<td align="left">Chromosomal abnormality, unspecified</td>
</tr>
<tr class="odd">
<td align="left">K20.0</td>
<td align="right">745</td>
<td align="left">Eosinophilic enteropathy</td>
<td align="left">Eosinophilic esophagitis</td>
</tr>
<tr class="even">
<td align="left">H47.10</td>
<td align="right">740</td>
<td align="left">Papilledema</td>
<td align="left">Unspecified papilledema</td>
</tr>
<tr class="odd">
<td align="left">E11.39</td>
<td align="right">740</td>
<td align="left">Wolfram syndrome</td>
<td align="left">Type 2 diabetes mellitus with other diabetic ophthalmic complication</td>
</tr>
<tr class="even">
<td align="left">Z15.01</td>
<td align="right">717</td>
<td align="left">Li-Fraumeni syndrome</td>
<td align="left">Genetic susceptibility to malignant neoplasm of breast</td>
</tr>
<tr class="odd">
<td align="left">J39.8</td>
<td align="right">706</td>
<td align="left">Tracheobronchopathia osteoplastica</td>
<td align="left">Other specified diseases of upper respiratory tract</td>
</tr>
<tr class="even">
<td align="left">E22.1</td>
<td align="right">706</td>
<td align="left">Galactorrhoea-Hyperprolactinaemia</td>
<td align="left">Hyperprolactinemia</td>
</tr>
<tr class="odd">
<td align="left">I85.00</td>
<td align="right">705</td>
<td align="left">Esophageal varices</td>
<td align="left">Esophageal varices without bleeding</td>
</tr>
<tr class="even">
<td align="left">G47.31</td>
<td align="right">704</td>
<td align="left">Idiopathic alveolar hypoventilation syndrome</td>
<td align="left">Primary central sleep apnea</td>
</tr>
<tr class="odd">
<td align="left">A31.9</td>
<td align="right">700</td>
<td align="left">Atypical mycobacteriosis, familial</td>
<td align="left">Mycobacterial infection, unspecified</td>
</tr>
<tr class="even">
<td align="left">D3A.8</td>
<td align="right">695</td>
<td align="left">Carcinoid tumor</td>
<td align="left">Other benign neuroendocrine tumors</td>
</tr>
<tr class="odd">
<td align="left">I37.0</td>
<td align="right">692</td>
<td align="left">Pulmonary valve stenosis</td>
<td align="left">Nonrheumatic pulmonary valve stenosis</td>
</tr>
<tr class="even">
<td align="left">I37.0</td>
<td align="right">692</td>
<td align="left">Pulmonic stenosis</td>
<td align="left">Nonrheumatic pulmonary valve stenosis</td>
</tr>
<tr class="odd">
<td align="left">I27.89</td>
<td align="right">686</td>
<td align="left">Eisenmenger syndrome</td>
<td align="left">Other specified pulmonary heart diseases</td>
</tr>
<tr class="even">
<td align="left">K90.9</td>
<td align="right">685</td>
<td align="left">Hereditary folate malabsorption</td>
<td align="left">Intestinal malabsorption, unspecified</td>
</tr>
<tr class="odd">
<td align="left">G95.0</td>
<td align="right">684</td>
<td align="left">Syringobulbia</td>
<td align="left">Syringomyelia and syringobulbia</td>
</tr>
<tr class="even">
<td align="left">G95.0</td>
<td align="right">684</td>
<td align="left">Syringomyelia</td>
<td align="left">Syringomyelia and syringobulbia</td>
</tr>
<tr class="odd">
<td align="left">C7A.8</td>
<td align="right">683</td>
<td align="left">Neuroepithelioma</td>
<td align="left">Other malignant neuroendocrine tumors</td>
</tr>
<tr class="even">
<td align="left">C7A.8</td>
<td align="right">683</td>
<td align="left">Embryonal tumor with multilayered rosettes</td>
<td align="left">Other malignant neuroendocrine tumors</td>
</tr>
<tr class="odd">
<td align="left">C7A.8</td>
<td align="right">683</td>
<td align="left">Supratentorial primitive neuroectodermal tumor</td>
<td align="left">Other malignant neuroendocrine tumors</td>
</tr>
<tr class="even">
<td align="left">G93.0</td>
<td align="right">681</td>
<td align="left">Arachnoid cysts</td>
<td align="left">Cerebral cysts</td>
</tr>
<tr class="odd">
<td align="left">G93.0</td>
<td align="right">681</td>
<td align="left">Choroid plexus cyst</td>
<td align="left">Cerebral cysts</td>
</tr>
<tr class="even">
<td align="left">G93.0</td>
<td align="right">681</td>
<td align="left">Spinal intradural arachnoid cysts</td>
<td align="left">Cerebral cysts</td>
</tr>
<tr class="odd">
<td align="left">R77.8</td>
<td align="right">678</td>
<td align="left">Hyperferritinemia cataract syndrome</td>
<td align="left">Other specified abnormalities of plasma proteins</td>
</tr>
<tr class="even">
<td align="left">D33.3</td>
<td align="right">675</td>
<td align="left">Acoustic neuroma</td>
<td align="left">Benign neoplasm of cranial nerves</td>
</tr>
<tr class="odd">
<td align="left">L53.9</td>
<td align="right">665</td>
<td align="left">Exfoliative dermatitis</td>
<td align="left">Erythematous condition, unspecified</td>
</tr>
<tr class="even">
<td align="left">M00.9</td>
<td align="right">660</td>
<td align="left">Infectious arthritis</td>
<td align="left">Pyogenic arthritis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">K14.6</td>
<td align="right">657</td>
<td align="left">Glossodynia</td>
<td align="left">Glossodynia</td>
</tr>
<tr class="even">
<td align="left">G25.3</td>
<td align="right">653</td>
<td align="left">Herrmann syndrome</td>
<td align="left">Myoclonus</td>
</tr>
<tr class="odd">
<td align="left">G25.3</td>
<td align="right">653</td>
<td align="left">Opsoclonus-myoclonus syndrome</td>
<td align="left">Myoclonus</td>
</tr>
<tr class="even">
<td align="left">L65.8</td>
<td align="right">649</td>
<td align="left">Loose anagen hair syndrome</td>
<td align="left">Other specified nonscarring hair loss</td>
</tr>
<tr class="odd">
<td align="left">K75.4</td>
<td align="right">642</td>
<td align="left">Autoimmune hepatitis</td>
<td align="left">Autoimmune hepatitis</td>
</tr>
<tr class="even">
<td align="left">J84.89</td>
<td align="right">640</td>
<td align="left">Bronchiolitis obliterans organizing pneumonia</td>
<td align="left">Other specified interstitial pulmonary diseases</td>
</tr>
<tr class="odd">
<td align="left">J84.89</td>
<td align="right">640</td>
<td align="left">Cholesterol pneumonia</td>
<td align="left">Other specified interstitial pulmonary diseases</td>
</tr>
<tr class="even">
<td align="left">D69.2</td>
<td align="right">628</td>
<td align="left">Gardner-Diamond syndrome</td>
<td align="left">Other nonthrombocytopenic purpura</td>
</tr>
<tr class="odd">
<td align="left">D69.2</td>
<td align="right">628</td>
<td align="left">Gardner-Diamond syndrome</td>
<td align="left">Other nonthrombocytopenic purpura</td>
</tr>
<tr class="even">
<td align="left">Q27.9</td>
<td align="right">626</td>
<td align="left">Blue rubber bleb nevus syndrome</td>
<td align="left">Congenital malformation of peripheral vascular system, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q27.9</td>
<td align="right">626</td>
<td align="left">Capillary malformation-arteriovenous malformation syndrome</td>
<td align="left">Congenital malformation of peripheral vascular system, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q25.6</td>
<td align="right">625</td>
<td align="left">Pulmonary supravalvular stenosis</td>
<td align="left">Stenosis of pulmonary artery</td>
</tr>
<tr class="odd">
<td align="left">Q10.3</td>
<td align="right">620</td>
<td align="left">Ankyloblepharon filiforme adnatum cleft palate</td>
<td align="left">Other congenital malformations of eyelid</td>
</tr>
<tr class="even">
<td align="left">C16.9</td>
<td align="right">620</td>
<td align="left">Stomach cancer</td>
<td align="left">Malignant neoplasm of stomach, unspecified</td>
</tr>
<tr class="odd">
<td align="left">J38.00</td>
<td align="right">618</td>
<td align="left">Vocal cord dysfunction familial</td>
<td align="left">Paralysis of vocal cords and larynx, unspecified</td>
</tr>
<tr class="even">
<td align="left">G03.9</td>
<td align="right">618</td>
<td align="left">Arachnoiditis</td>
<td align="left">Meningitis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">G03.9</td>
<td align="right">618</td>
<td align="left">Neonatal meningitis</td>
<td align="left">Meningitis, unspecified</td>
</tr>
<tr class="even">
<td align="left">F60.3</td>
<td align="right">617</td>
<td align="left">Bronchopulmonary dysplasia</td>
<td align="left">Borderline personality disorder</td>
</tr>
<tr class="odd">
<td align="left">E27.0</td>
<td align="right">616</td>
<td align="left">Hyperadrenalism</td>
<td align="left">Other adrenocortical overactivity</td>
</tr>
<tr class="even">
<td align="left">G82.20</td>
<td align="right">614</td>
<td align="left">Spastic paraparesis</td>
<td align="left">Paraplegia, unspecified</td>
</tr>
<tr class="odd">
<td align="left">G82.20</td>
<td align="right">614</td>
<td align="left">Paraplegia</td>
<td align="left">Paraplegia, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q79.6</td>
<td align="right">610</td>
<td align="left">Brittle cornea syndrome</td>
<td align="left">Ehlers-Danlos syndrome</td>
</tr>
<tr class="odd">
<td align="left">Q79.6</td>
<td align="right">610</td>
<td align="left">Hypermobile Ehlers-Danlos syndrome</td>
<td align="left">Ehlers-Danlos syndrome</td>
</tr>
<tr class="even">
<td align="left">Q79.6</td>
<td align="right">610</td>
<td align="left">Vascular Ehlers-Danlos syndrome</td>
<td align="left">Ehlers-Danlos syndrome</td>
</tr>
<tr class="odd">
<td align="left">Q79.6</td>
<td align="right">610</td>
<td align="left">Arthrochalasia Ehlers-Danlos syndrome</td>
<td align="left">Ehlers-Danlos syndrome</td>
</tr>
<tr class="even">
<td align="left">Q79.6</td>
<td align="right">610</td>
<td align="left">Dermatosparaxis Ehlers-Danlos syndrome</td>
<td align="left">Ehlers-Danlos syndrome</td>
</tr>
<tr class="odd">
<td align="left">Q79.6</td>
<td align="right">610</td>
<td align="left">Familial joint instability syndrome</td>
<td align="left">Ehlers-Danlos syndrome</td>
</tr>
<tr class="even">
<td align="left">Q79.6</td>
<td align="right">610</td>
<td align="left">Occipital horn syndrome</td>
<td align="left">Ehlers-Danlos syndrome</td>
</tr>
<tr class="odd">
<td align="left">Q79.6</td>
<td align="right">610</td>
<td align="left">Ehlers-Danlos syndromes</td>
<td align="left">Ehlers-Danlos syndrome</td>
</tr>
<tr class="even">
<td align="left">Q79.6</td>
<td align="right">610</td>
<td align="left">Periodontal Ehlers-Danlos syndrome</td>
<td align="left">Ehlers-Danlos syndrome</td>
</tr>
<tr class="odd">
<td align="left">G81.90</td>
<td align="right">603</td>
<td align="left">Alternating hemiplegia of childhood</td>
<td align="left">Hemiplegia, unspecified affecting unspecified side</td>
</tr>
<tr class="even">
<td align="left">L21.1</td>
<td align="right">583</td>
<td align="left">Leiner disease</td>
<td align="left">Seborrheic infantile dermatitis</td>
</tr>
<tr class="odd">
<td align="left">H35.52</td>
<td align="right">582</td>
<td align="left">Late-onset retinal degeneration</td>
<td align="left">Pigmentary retinal dystrophy</td>
</tr>
<tr class="even">
<td align="left">H35.52</td>
<td align="right">582</td>
<td align="left">Retinitis pigmentosa</td>
<td align="left">Pigmentary retinal dystrophy</td>
</tr>
<tr class="odd">
<td align="left">H35.52</td>
<td align="right">582</td>
<td align="left">Cone-rod dystrophy 2</td>
<td align="left">Pigmentary retinal dystrophy</td>
</tr>
<tr class="even">
<td align="left">H35.52</td>
<td align="right">582</td>
<td align="left">Cone-rod dystrophy</td>
<td align="left">Pigmentary retinal dystrophy</td>
</tr>
<tr class="odd">
<td align="left">A49.1</td>
<td align="right">580</td>
<td align="left">Streptococcal Group A invasive disease</td>
<td align="left">Streptococcal infection, unspecified site</td>
</tr>
<tr class="even">
<td align="left">L71.8</td>
<td align="right">572</td>
<td align="left">Granulomatous rosacea</td>
<td align="left">Other rosacea</td>
</tr>
<tr class="odd">
<td align="left">L71.8</td>
<td align="right">572</td>
<td align="left">Granulomatous rosacea</td>
<td align="left">Other rosacea</td>
</tr>
<tr class="even">
<td align="left">L81.8</td>
<td align="right">569</td>
<td align="left">Acromelanosis</td>
<td align="left">Other specified disorders of pigmentation</td>
</tr>
<tr class="odd">
<td align="left">L81.8</td>
<td align="right">569</td>
<td align="left">Laugier-Hunziker syndrome</td>
<td align="left">Other specified disorders of pigmentation</td>
</tr>
<tr class="even">
<td align="left">L81.8</td>
<td align="right">569</td>
<td align="left">Dowling-Degos disease</td>
<td align="left">Other specified disorders of pigmentation</td>
</tr>
<tr class="odd">
<td align="left">L81.8</td>
<td align="right">569</td>
<td align="left">Pityriasis rotunda</td>
<td align="left">Other specified disorders of pigmentation</td>
</tr>
<tr class="even">
<td align="left">M21.869</td>
<td align="right">565</td>
<td align="left">Absence of Tibia</td>
<td align="left">Other specified acquired deformities of unspecified lower leg</td>
</tr>
<tr class="odd">
<td align="left">E23.6</td>
<td align="right">560</td>
<td align="left">Empty sella syndrome</td>
<td align="left">Other disorders of pituitary gland</td>
</tr>
<tr class="even">
<td align="left">E23.6</td>
<td align="right">560</td>
<td align="left">Froelich syndrome</td>
<td align="left">Other disorders of pituitary gland</td>
</tr>
<tr class="odd">
<td align="left">E23.6</td>
<td align="right">560</td>
<td align="left">Lymphocytic hypophysitis</td>
<td align="left">Other disorders of pituitary gland</td>
</tr>
<tr class="even">
<td align="left">C55</td>
<td align="right">559</td>
<td align="left">Uterine sarcoma</td>
<td align="left">Malignant neoplasm of uterus, part unspecified</td>
</tr>
<tr class="odd">
<td align="left">C55</td>
<td align="right">559</td>
<td align="left">Adenosarcoma of the uterus</td>
<td align="left">Malignant neoplasm of uterus, part unspecified</td>
</tr>
<tr class="even">
<td align="left">C55</td>
<td align="right">559</td>
<td align="left">Uterine Carcinosarcoma</td>
<td align="left">Malignant neoplasm of uterus, part unspecified</td>
</tr>
<tr class="odd">
<td align="left">E88.1</td>
<td align="right">558</td>
<td align="left">Familial partial lipodystrophy type 2</td>
<td align="left">Lipodystrophy, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">E88.1</td>
<td align="right">558</td>
<td align="left">Familial partial lipodystrophy type 2</td>
<td align="left">Lipodystrophy, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">E88.1</td>
<td align="right">558</td>
<td align="left">Familial partial lipodystrophy type 2</td>
<td align="left">Lipodystrophy, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">E88.1</td>
<td align="right">558</td>
<td align="left">Congenital generalized lipodystrophy type 2</td>
<td align="left">Lipodystrophy, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">E88.1</td>
<td align="right">558</td>
<td align="left">Congenital generalized lipodystrophy type 2</td>
<td align="left">Lipodystrophy, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">E88.1</td>
<td align="right">558</td>
<td align="left">Familial partial lipodystrophy</td>
<td align="left">Lipodystrophy, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">E88.1</td>
<td align="right">558</td>
<td align="left">Acquired generalized lipodystrophy</td>
<td align="left">Lipodystrophy, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">E88.1</td>
<td align="right">558</td>
<td align="left">Acquired generalized lipodystrophy</td>
<td align="left">Lipodystrophy, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q25.1</td>
<td align="right">556</td>
<td align="left">Angelman syndrome</td>
<td align="left">Coarctation of aorta</td>
</tr>
<tr class="even">
<td align="left">Q25.1</td>
<td align="right">556</td>
<td align="left">Aortic coarctation</td>
<td align="left">Coarctation of aorta</td>
</tr>
<tr class="odd">
<td align="left">Q25.1</td>
<td align="right">556</td>
<td align="left">Aortic valve stenosis</td>
<td align="left">Coarctation of aorta</td>
</tr>
<tr class="even">
<td align="left">C22.8</td>
<td align="right">555</td>
<td align="left">Primary liver cancer</td>
<td align="left">Malignant neoplasm of liver, primary, unspecified as to type</td>
</tr>
<tr class="odd">
<td align="left">J98.59</td>
<td align="right">553</td>
<td align="left">Fibrosing mediastinitis</td>
<td align="left">Other diseases of mediastinum, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">D68.0</td>
<td align="right">549</td>
<td align="left">Acquired Von Willebrand syndrome</td>
<td align="left">Von Willebrand’s disease</td>
</tr>
<tr class="odd">
<td align="left">D68.0</td>
<td align="right">549</td>
<td align="left">Pseudo-Von Willebrand disease</td>
<td align="left">Von Willebrand’s disease</td>
</tr>
<tr class="even">
<td align="left">D68.0</td>
<td align="right">549</td>
<td align="left">Pseudo-Von Willebrand disease</td>
<td align="left">Von Willebrand’s disease</td>
</tr>
<tr class="odd">
<td align="left">M47.9</td>
<td align="right">544</td>
<td align="left">Spondylarthropathy</td>
<td align="left">Spondylosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">E84.9</td>
<td align="right">541</td>
<td align="left">Cystic fibrosis</td>
<td align="left">Cystic fibrosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E03.1</td>
<td align="right">541</td>
<td align="left">Congenital hypothyroidism</td>
<td align="left">Congenital hypothyroidism without goiter</td>
</tr>
<tr class="even">
<td align="left">E03.1</td>
<td align="right">541</td>
<td align="left">Neonatal hypothyroidism</td>
<td align="left">Congenital hypothyroidism without goiter</td>
</tr>
<tr class="odd">
<td align="left">E03.1</td>
<td align="right">541</td>
<td align="left">Thyroid agenesis</td>
<td align="left">Congenital hypothyroidism without goiter</td>
</tr>
<tr class="even">
<td align="left">G24.5</td>
<td align="right">540</td>
<td align="left">Benign essential blepharospasm</td>
<td align="left">Blepharospasm</td>
</tr>
<tr class="odd">
<td align="left">D36.10</td>
<td align="right">540</td>
<td align="left">Benign schwannoma</td>
<td align="left">Benign neoplasm of peripheral nerves and autonomic nervous system, unspecified</td>
</tr>
<tr class="even">
<td align="left">D36.10</td>
<td align="right">540</td>
<td align="left">Neurofibroma</td>
<td align="left">Benign neoplasm of peripheral nerves and autonomic nervous system, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D36.10</td>
<td align="right">540</td>
<td align="left">Gangliocytoma</td>
<td align="left">Benign neoplasm of peripheral nerves and autonomic nervous system, unspecified</td>
</tr>
<tr class="even">
<td align="left">G40.901</td>
<td align="right">536</td>
<td align="left">Status epilepticus</td>
<td align="left">Epilepsy, unspecified, not intractable, with status epilepticus</td>
</tr>
<tr class="odd">
<td align="left">G24.3</td>
<td align="right">536</td>
<td align="left">Cervical dystonia</td>
<td align="left">Spasmodic torticollis</td>
</tr>
<tr class="even">
<td align="left">D72.1</td>
<td align="right">536</td>
<td align="left">Hypereosinophilic syndrome</td>
<td align="left">Eosinophilia</td>
</tr>
<tr class="odd">
<td align="left">D72.1</td>
<td align="right">536</td>
<td align="left">Familial eosinophilia</td>
<td align="left">Eosinophilia</td>
</tr>
<tr class="even">
<td align="left">E78.01</td>
<td align="right">535</td>
<td align="left">Hyperlipoproteinemia type 2</td>
<td align="left">Familial hypercholesterolemia</td>
</tr>
<tr class="odd">
<td align="left">C91.00</td>
<td align="right">533</td>
<td align="left">Acute lymphoblastic leukemia</td>
<td align="left">Acute lymphoblastic leukemia not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">I87.1</td>
<td align="right">530</td>
<td align="left">Superior vena cava syndrome</td>
<td align="left">Compression of vein</td>
</tr>
<tr class="odd">
<td align="left">I87.1</td>
<td align="right">530</td>
<td align="left">May-Thurner syndrome</td>
<td align="left">Compression of vein</td>
</tr>
<tr class="even">
<td align="left">L56.8</td>
<td align="right">521</td>
<td align="left">Actinic cheilitis</td>
<td align="left">Other specified acute skin changes due to ultraviolet radiation</td>
</tr>
<tr class="odd">
<td align="left">Q06.8</td>
<td align="right">517</td>
<td align="left">Tethered cord syndrome</td>
<td align="left">Other specified congenital malformations of spinal cord</td>
</tr>
<tr class="even">
<td align="left">Q06.8</td>
<td align="right">517</td>
<td align="left">Caudal regression syndrome</td>
<td align="left">Other specified congenital malformations of spinal cord</td>
</tr>
<tr class="odd">
<td align="left">Q06.8</td>
<td align="right">517</td>
<td align="left">Kennedy disease</td>
<td align="left">Other specified congenital malformations of spinal cord</td>
</tr>
<tr class="even">
<td align="left">C22.1</td>
<td align="right">511</td>
<td align="left">Intrahepatic cholangiocarcinoma</td>
<td align="left">Intrahepatic bile duct carcinoma</td>
</tr>
<tr class="odd">
<td align="left">C22.1</td>
<td align="right">511</td>
<td align="left">Bile duct cancer</td>
<td align="left">Intrahepatic bile duct carcinoma</td>
</tr>
<tr class="even">
<td align="left">M33.90</td>
<td align="right">510</td>
<td align="left">Dermatomyositis</td>
<td align="left">Dermatopolymyositis, unspecified, organ involvement unspecified</td>
</tr>
<tr class="odd">
<td align="left">I49.01</td>
<td align="right">506</td>
<td align="left">Paroxysmal ventricular fibrillation</td>
<td align="left">Ventricular fibrillation</td>
</tr>
<tr class="even">
<td align="left">I49.01</td>
<td align="right">506</td>
<td align="left">Ventricular fibrillation, idiopathic</td>
<td align="left">Ventricular fibrillation</td>
</tr>
<tr class="odd">
<td align="left">C44.99</td>
<td align="right">505</td>
<td align="left">Eccrine porocarcinoma</td>
<td align="left">Other specified malignant neoplasm of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">C44.99</td>
<td align="right">505</td>
<td align="left">Dermatofibrosarcoma protuberans</td>
<td align="left">Other specified malignant neoplasm of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C44.99</td>
<td align="right">505</td>
<td align="left">Bednar tumor</td>
<td align="left">Other specified malignant neoplasm of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">C44.99</td>
<td align="right">505</td>
<td align="left">Microcystic adnexal carcinoma</td>
<td align="left">Other specified malignant neoplasm of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C44.99</td>
<td align="right">505</td>
<td align="left">Hidradenocarcinoma</td>
<td align="left">Other specified malignant neoplasm of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">C44.99</td>
<td align="right">505</td>
<td align="left">Malignant cylindroma</td>
<td align="left">Other specified malignant neoplasm of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C44.99</td>
<td align="right">505</td>
<td align="left">Eccrine mucinous carcinoma</td>
<td align="left">Other specified malignant neoplasm of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">C44.99</td>
<td align="right">505</td>
<td align="left">Malignant eccrine spiradenoma</td>
<td align="left">Other specified malignant neoplasm of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C41.9</td>
<td align="right">505</td>
<td align="left">Chondrosarcoma</td>
<td align="left">Malignant neoplasm of bone and articular cartilage, unspecified</td>
</tr>
<tr class="even">
<td align="left">C41.9</td>
<td align="right">505</td>
<td align="left">Chondrosarcoma</td>
<td align="left">Malignant neoplasm of bone and articular cartilage, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C41.9</td>
<td align="right">505</td>
<td align="left">Epithelial-myoepithelial carcinoma</td>
<td align="left">Malignant neoplasm of bone and articular cartilage, unspecified</td>
</tr>
<tr class="even">
<td align="left">C41.9</td>
<td align="right">505</td>
<td align="left">Osteosarcoma</td>
<td align="left">Malignant neoplasm of bone and articular cartilage, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C41.9</td>
<td align="right">505</td>
<td align="left">Primary bone cancer</td>
<td align="left">Malignant neoplasm of bone and articular cartilage, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q21.3</td>
<td align="right">503</td>
<td align="left">Tetralogy of Fallot</td>
<td align="left">Tetralogy of Fallot</td>
</tr>
<tr class="odd">
<td align="left">M31.6</td>
<td align="right">503</td>
<td align="left">Giant cell arteritis</td>
<td align="left">Other giant cell arteritis</td>
</tr>
<tr class="even">
<td align="left">M31.6</td>
<td align="right">503</td>
<td align="left">Giant cell arteritis</td>
<td align="left">Other giant cell arteritis</td>
</tr>
<tr class="odd">
<td align="left">M60.9</td>
<td align="right">500</td>
<td align="left">Inclusion body myositis</td>
<td align="left">Myositis, unspecified</td>
</tr>
<tr class="even">
<td align="left">M60.9</td>
<td align="right">500</td>
<td align="left">Idiopathic inflammatory myopathy</td>
<td align="left">Myositis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">I33.0</td>
<td align="right">500</td>
<td align="left">Infective endocarditis</td>
<td align="left">Acute and subacute infective endocarditis</td>
</tr>
<tr class="even">
<td align="left">I33.0</td>
<td align="right">500</td>
<td align="left">Infective endocarditis</td>
<td align="left">Acute and subacute infective endocarditis</td>
</tr>
<tr class="odd">
<td align="left">Q75.3</td>
<td align="right">498</td>
<td align="left">Hemimegalencephaly</td>
<td align="left">Macrocephaly</td>
</tr>
<tr class="even">
<td align="left">Q75.3</td>
<td align="right">498</td>
<td align="left">Macrocephaly-capillary malformation</td>
<td align="left">Macrocephaly</td>
</tr>
<tr class="odd">
<td align="left">L81.3</td>
<td align="right">492</td>
<td align="left">Watson syndrome</td>
<td align="left">CafÃ© au lait spots</td>
</tr>
<tr class="even">
<td align="left">E72.53</td>
<td align="right">490</td>
<td align="left">Primary hyperoxaluria type 1</td>
<td align="left">Hyperoxaluria</td>
</tr>
<tr class="odd">
<td align="left">E72.53</td>
<td align="right">490</td>
<td align="left">Primary hyperoxaluria type 2</td>
<td align="left">Hyperoxaluria</td>
</tr>
<tr class="even">
<td align="left">C84.00</td>
<td align="right">490</td>
<td align="left">Mycosis fungoides</td>
<td align="left">Mycosis fungoides, unspecified site</td>
</tr>
<tr class="odd">
<td align="left">C78.6</td>
<td align="right">488</td>
<td align="left">Gelatinous ascites</td>
<td align="left">Secondary malignant neoplasm of retroperitoneum and peritoneum</td>
</tr>
<tr class="even">
<td align="left">C78.6</td>
<td align="right">488</td>
<td align="left">Pseudomyxoma peritonei</td>
<td align="left">Secondary malignant neoplasm of retroperitoneum and peritoneum</td>
</tr>
<tr class="odd">
<td align="left">A53.9</td>
<td align="right">486</td>
<td align="left">Treponema infection</td>
<td align="left">Syphilis, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q89.7</td>
<td align="right">484</td>
<td align="left">Ochoa syndrome</td>
<td align="left">Multiple congenital malformations, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q89.7</td>
<td align="right">484</td>
<td align="left">Facial ectodermal dysplasia</td>
<td align="left">Multiple congenital malformations, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q89.7</td>
<td align="right">484</td>
<td align="left">EEC syndrome</td>
<td align="left">Multiple congenital malformations, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q89.7</td>
<td align="right">484</td>
<td align="left">Hydronephrosis peculiar facial expression</td>
<td align="left">Multiple congenital malformations, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q89.7</td>
<td align="right">484</td>
<td align="left">Multiple pterygium syndrome lethal type</td>
<td align="left">Multiple congenital malformations, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q89.7</td>
<td align="right">484</td>
<td align="left">Pentalogy of Cantrell</td>
<td align="left">Multiple congenital malformations, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q89.7</td>
<td align="right">484</td>
<td align="left">Focal facial dermal dysplasia</td>
<td align="left">Multiple congenital malformations, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q89.7</td>
<td align="right">484</td>
<td align="left">Cantu syndrome</td>
<td align="left">Multiple congenital malformations, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">E23.2</td>
<td align="right">482</td>
<td align="left">Central diabetes insipidus</td>
<td align="left">Diabetes insipidus</td>
</tr>
<tr class="odd">
<td align="left">E23.2</td>
<td align="right">482</td>
<td align="left">Dipsogenic diabetes insipidus</td>
<td align="left">Diabetes insipidus</td>
</tr>
<tr class="even">
<td align="left">R44.1</td>
<td align="right">478</td>
<td align="left">Charles Bonnet syndrome</td>
<td align="left">Visual hallucinations</td>
</tr>
<tr class="odd">
<td align="left">G47.419</td>
<td align="right">476</td>
<td align="left">Narcolepsy</td>
<td align="left">Narcolepsy without cataplexy</td>
</tr>
<tr class="even">
<td align="left">R48.2</td>
<td align="right">473</td>
<td align="left">Apraxia</td>
<td align="left">Apraxia</td>
</tr>
<tr class="odd">
<td align="left">H18.59</td>
<td align="right">471</td>
<td align="left">Corneal endothelial dystrophy type 2</td>
<td align="left">Other hereditary corneal dystrophies</td>
</tr>
<tr class="even">
<td align="left">H18.59</td>
<td align="right">471</td>
<td align="left">Corneal dystrophy Thiel Behnke type</td>
<td align="left">Other hereditary corneal dystrophies</td>
</tr>
<tr class="odd">
<td align="left">H18.59</td>
<td align="right">471</td>
<td align="left">Corneal dystrophy of Bowman layer type 1</td>
<td align="left">Other hereditary corneal dystrophies</td>
</tr>
<tr class="even">
<td align="left">H18.59</td>
<td align="right">471</td>
<td align="left">Corneal dystrophy crystalline of Schnyder</td>
<td align="left">Other hereditary corneal dystrophies</td>
</tr>
<tr class="odd">
<td align="left">H18.59</td>
<td align="right">471</td>
<td align="left">Corneal dystrophy crystalline of Schnyder</td>
<td align="left">Other hereditary corneal dystrophies</td>
</tr>
<tr class="even">
<td align="left">H18.59</td>
<td align="right">471</td>
<td align="left">Epithelial basement membrane corneal dystrophy</td>
<td align="left">Other hereditary corneal dystrophies</td>
</tr>
<tr class="odd">
<td align="left">Q31.5</td>
<td align="right">470</td>
<td align="left">Laryngomalacia</td>
<td align="left">Congenital laryngomalacia</td>
</tr>
<tr class="even">
<td align="left">G44.52</td>
<td align="right">467</td>
<td align="left">New daily-persistent headache</td>
<td align="left">New daily persistent headache (NDPH)</td>
</tr>
<tr class="odd">
<td align="left">D3A.00</td>
<td align="right">465</td>
<td align="left">Carcinoid tumor</td>
<td align="left">Benign carcinoid tumor of unspecified site</td>
</tr>
<tr class="even">
<td align="left">G71.0</td>
<td align="right">464</td>
<td align="left">Distal myopathy with vocal cord weakness</td>
<td align="left">Muscular dystrophy</td>
</tr>
<tr class="odd">
<td align="left">G71.0</td>
<td align="right">464</td>
<td align="left">Emery-Dreifuss muscular dystrophy, X-linked</td>
<td align="left">Muscular dystrophy</td>
</tr>
<tr class="even">
<td align="left">G71.0</td>
<td align="right">464</td>
<td align="left">Limb-girdle muscular dystrophy, type 2C</td>
<td align="left">Muscular dystrophy</td>
</tr>
<tr class="odd">
<td align="left">G71.0</td>
<td align="right">464</td>
<td align="left">Walker-Warburg syndrome</td>
<td align="left">Muscular dystrophy</td>
</tr>
<tr class="even">
<td align="left">G71.0</td>
<td align="right">464</td>
<td align="left">Congenital muscular dystrophy type 1A</td>
<td align="left">Muscular dystrophy</td>
</tr>
<tr class="odd">
<td align="left">G71.0</td>
<td align="right">464</td>
<td align="left">Limb-girdle muscular dystrophy type 2H</td>
<td align="left">Muscular dystrophy</td>
</tr>
<tr class="even">
<td align="left">G71.0</td>
<td align="right">464</td>
<td align="left">Welander distal myopathy, Swedish type</td>
<td align="left">Muscular dystrophy</td>
</tr>
<tr class="odd">
<td align="left">G71.0</td>
<td align="right">464</td>
<td align="left">Becker muscular dystrophy</td>
<td align="left">Muscular dystrophy</td>
</tr>
<tr class="even">
<td align="left">G71.0</td>
<td align="right">464</td>
<td align="left">Duchenne muscular dystrophy</td>
<td align="left">Muscular dystrophy</td>
</tr>
<tr class="odd">
<td align="left">G71.0</td>
<td align="right">464</td>
<td align="left">Duchenne muscular dystrophy</td>
<td align="left">Muscular dystrophy</td>
</tr>
<tr class="even">
<td align="left">G71.0</td>
<td align="right">464</td>
<td align="left">Emery-Dreifuss muscular dystrophy</td>
<td align="left">Muscular dystrophy</td>
</tr>
<tr class="odd">
<td align="left">G71.0</td>
<td align="right">464</td>
<td align="left">Fukuyama type muscular dystrophy</td>
<td align="left">Muscular dystrophy</td>
</tr>
<tr class="even">
<td align="left">G71.0</td>
<td align="right">464</td>
<td align="left">Limb-girdle muscular dystrophy</td>
<td align="left">Muscular dystrophy</td>
</tr>
<tr class="odd">
<td align="left">G71.0</td>
<td align="right">464</td>
<td align="left">Oculopharyngeal muscular dystrophy</td>
<td align="left">Muscular dystrophy</td>
</tr>
<tr class="even">
<td align="left">G71.0</td>
<td align="right">464</td>
<td align="left">Intellectual disability-developmental delay-contractures syndrome</td>
<td align="left">Muscular dystrophy</td>
</tr>
<tr class="odd">
<td align="left">G71.0</td>
<td align="right">464</td>
<td align="left">Muscular dystrophy</td>
<td align="left">Muscular dystrophy</td>
</tr>
<tr class="even">
<td align="left">G71.0</td>
<td align="right">464</td>
<td align="left">Ocular Muscular Dystrophy</td>
<td align="left">Muscular dystrophy</td>
</tr>
<tr class="odd">
<td align="left">G71.0</td>
<td align="right">464</td>
<td align="left">Congenital muscular dystrophy</td>
<td align="left">Muscular dystrophy</td>
</tr>
<tr class="even">
<td align="left">G71.0</td>
<td align="right">464</td>
<td align="left">Facioscapulohumeral muscular dystrophy</td>
<td align="left">Muscular dystrophy</td>
</tr>
<tr class="odd">
<td align="left">G71.0</td>
<td align="right">464</td>
<td align="left">MYH7-related scapuloperoneal myopathy</td>
<td align="left">Muscular dystrophy</td>
</tr>
<tr class="even">
<td align="left">G71.0</td>
<td align="right">464</td>
<td align="left">Laing distal myopathy</td>
<td align="left">Muscular dystrophy</td>
</tr>
<tr class="odd">
<td align="left">Q24.8</td>
<td align="right">457</td>
<td align="left">Right ventricle hypoplasia</td>
<td align="left">Other specified congenital malformations of heart</td>
</tr>
<tr class="even">
<td align="left">Q24.8</td>
<td align="right">457</td>
<td align="left">Uhl anomaly</td>
<td align="left">Other specified congenital malformations of heart</td>
</tr>
<tr class="odd">
<td align="left">D56.3</td>
<td align="right">457</td>
<td align="left">Beta-thalassemia</td>
<td align="left">Thalassemia minor</td>
</tr>
<tr class="even">
<td align="left">L28.1</td>
<td align="right">454</td>
<td align="left">Prurigo nodularis</td>
<td align="left">Prurigo nodularis</td>
</tr>
<tr class="odd">
<td align="left">H35.00</td>
<td align="right">452</td>
<td align="left">Acute zonal occult outer retinopathy</td>
<td align="left">Unspecified background retinopathy</td>
</tr>
<tr class="even">
<td align="left">Q15.0</td>
<td align="right">451</td>
<td align="left">Glaucoma, congenital</td>
<td align="left">Congenital glaucoma</td>
</tr>
<tr class="odd">
<td align="left">Q15.0</td>
<td align="right">451</td>
<td align="left">Glaucoma 3 primary infantile B</td>
<td align="left">Congenital glaucoma</td>
</tr>
<tr class="even">
<td align="left">E83.19</td>
<td align="right">451</td>
<td align="left">Hemosiderosis</td>
<td align="left">Other disorders of iron metabolism</td>
</tr>
<tr class="odd">
<td align="left">E83.19</td>
<td align="right">451</td>
<td align="left">Aceruloplasminemia</td>
<td align="left">Other disorders of iron metabolism</td>
</tr>
<tr class="even">
<td align="left">I95.0</td>
<td align="right">450</td>
<td align="left">Pure autonomic failure</td>
<td align="left">Idiopathic hypotension</td>
</tr>
<tr class="odd">
<td align="left">B80</td>
<td align="right">442</td>
<td align="left">Enterobiasis</td>
<td align="left">Enterobiasis</td>
</tr>
<tr class="even">
<td align="left">B80</td>
<td align="right">442</td>
<td align="left">Strongyloidiasis</td>
<td align="left">Enterobiasis</td>
</tr>
<tr class="odd">
<td align="left">R23.1</td>
<td align="right">438</td>
<td align="left">Sneddon syndrome</td>
<td align="left">Pallor</td>
</tr>
<tr class="even">
<td align="left">J80</td>
<td align="right">438</td>
<td align="left">Acute respiratory distress syndrome</td>
<td align="left">Acute respiratory distress syndrome</td>
</tr>
<tr class="odd">
<td align="left">K29.60</td>
<td align="right">436</td>
<td align="left">Chronic erosive gastritis</td>
<td align="left">Other gastritis without bleeding</td>
</tr>
<tr class="even">
<td align="left">K29.60</td>
<td align="right">436</td>
<td align="left">Collagenous gastritis</td>
<td align="left">Other gastritis without bleeding</td>
</tr>
<tr class="odd">
<td align="left">L50.3</td>
<td align="right">435</td>
<td align="left">Familial dermographism</td>
<td align="left">Dermatographic urticaria</td>
</tr>
<tr class="even">
<td align="left">O00.90</td>
<td align="right">434</td>
<td align="left">Ectopic pregnancy</td>
<td align="left">Unspecified ectopic pregnancy without intrauterine pregnancy</td>
</tr>
<tr class="odd">
<td align="left">I71.00</td>
<td align="right">432</td>
<td align="left">Cystic medial necrosis of aorta</td>
<td align="left">Dissection of unspecified site of aorta</td>
</tr>
<tr class="even">
<td align="left">I71.00</td>
<td align="right">432</td>
<td align="left">Familial thoracic aortic aneurysm and dissection</td>
<td align="left">Dissection of unspecified site of aorta</td>
</tr>
<tr class="odd">
<td align="left">F80.81</td>
<td align="right">431</td>
<td align="left">Cluttering</td>
<td align="left">Childhood onset fluency disorder</td>
</tr>
<tr class="even">
<td align="left">D35.00</td>
<td align="right">431</td>
<td align="left">Cataract congenital dominant non nuclear</td>
<td align="left">Benign neoplasm of unspecified adrenal gland</td>
</tr>
<tr class="odd">
<td align="left">D35.00</td>
<td align="right">431</td>
<td align="left">Adenoma of the adrenal gland</td>
<td align="left">Benign neoplasm of unspecified adrenal gland</td>
</tr>
<tr class="even">
<td align="left">D35.00</td>
<td align="right">431</td>
<td align="left">Adenoma of the adrenal gland</td>
<td align="left">Benign neoplasm of unspecified adrenal gland</td>
</tr>
<tr class="odd">
<td align="left">D35.00</td>
<td align="right">431</td>
<td align="left">Pheochromocytoma</td>
<td align="left">Benign neoplasm of unspecified adrenal gland</td>
</tr>
<tr class="even">
<td align="left">D21.9</td>
<td align="right">429</td>
<td align="left">Kimura disease</td>
<td align="left">Benign neoplasm of connective and other soft tissue, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D21.9</td>
<td align="right">429</td>
<td align="left">Granular cell tumor</td>
<td align="left">Benign neoplasm of connective and other soft tissue, unspecified</td>
</tr>
<tr class="even">
<td align="left">D21.9</td>
<td align="right">429</td>
<td align="left">Intravascular papillary endothelial hyperplasia</td>
<td align="left">Benign neoplasm of connective and other soft tissue, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D89.813</td>
<td align="right">424</td>
<td align="left">Homologous wasting disease</td>
<td align="left">Graft-versus-host disease, unspecified</td>
</tr>
<tr class="even">
<td align="left">D68.61</td>
<td align="right">422</td>
<td align="left">Antiphospholipid syndrome</td>
<td align="left">Antiphospholipid syndrome</td>
</tr>
<tr class="odd">
<td align="left">D68.61</td>
<td align="right">422</td>
<td align="left">Catastrophic antiphospholipid syndrome</td>
<td align="left">Antiphospholipid syndrome</td>
</tr>
<tr class="even">
<td align="left">D16.9</td>
<td align="right">419</td>
<td align="left">Osteochondroma</td>
<td align="left">Benign neoplasm of bone and articular cartilage, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D16.9</td>
<td align="right">419</td>
<td align="left">Osteochondroma</td>
<td align="left">Benign neoplasm of bone and articular cartilage, unspecified</td>
</tr>
<tr class="even">
<td align="left">D16.9</td>
<td align="right">419</td>
<td align="left">Dupuytren subungual exostosis</td>
<td align="left">Benign neoplasm of bone and articular cartilage, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D16.9</td>
<td align="right">419</td>
<td align="left">Osteofibrous dysplasia</td>
<td align="left">Benign neoplasm of bone and articular cartilage, unspecified</td>
</tr>
<tr class="even">
<td align="left">F44.5</td>
<td align="right">417</td>
<td align="left">Dissociative seizures</td>
<td align="left">Conversion disorder with seizures or convulsions</td>
</tr>
<tr class="odd">
<td align="left">A77.0</td>
<td align="right">416</td>
<td align="left">Rocky mountain spotted fever</td>
<td align="left">Spotted fever due to Rickettsia rickettsii</td>
</tr>
<tr class="even">
<td align="left">Q85.01</td>
<td align="right">414</td>
<td align="left">Neurofibromatosis type 1</td>
<td align="left">Neurofibromatosis, type 1</td>
</tr>
<tr class="odd">
<td align="left">Q85.01</td>
<td align="right">414</td>
<td align="left">Legius syndrome</td>
<td align="left">Neurofibromatosis, type 1</td>
</tr>
<tr class="even">
<td align="left">K74.3</td>
<td align="right">412</td>
<td align="left">Primary biliary cholangitis</td>
<td align="left">Primary biliary cirrhosis</td>
</tr>
<tr class="odd">
<td align="left">I83.10</td>
<td align="right">410</td>
<td align="left">Lipodermatosclerosis</td>
<td align="left">Varicose veins of unspecified lower extremity with inflammation</td>
</tr>
<tr class="even">
<td align="left">G98.8</td>
<td align="right">410</td>
<td align="left">Allan-Herndon-Dudley syndrome</td>
<td align="left">Other disorders of nervous system</td>
</tr>
<tr class="odd">
<td align="left">R99</td>
<td align="right">409</td>
<td align="left">Sudden infant death syndrome</td>
<td align="left">Ill-defined and unknown cause of mortality</td>
</tr>
<tr class="even">
<td align="left">R99</td>
<td align="right">409</td>
<td align="left">Sudden infant death with dysgenesis of the testes syndrome</td>
<td align="left">Ill-defined and unknown cause of mortality</td>
</tr>
<tr class="odd">
<td align="left">Q75.0</td>
<td align="right">403</td>
<td align="left">Baller-Gerold syndrome</td>
<td align="left">Craniosynostosis</td>
</tr>
<tr class="even">
<td align="left">Q75.0</td>
<td align="right">403</td>
<td align="left">Kleeblattschaedel syndrome</td>
<td align="left">Craniosynostosis</td>
</tr>
<tr class="odd">
<td align="left">Q75.0</td>
<td align="right">403</td>
<td align="left">Lambdoid synostosis</td>
<td align="left">Craniosynostosis</td>
</tr>
<tr class="even">
<td align="left">Q75.0</td>
<td align="right">403</td>
<td align="left">Congenital rubella</td>
<td align="left">Craniosynostosis</td>
</tr>
<tr class="odd">
<td align="left">Q75.0</td>
<td align="right">403</td>
<td align="left">Craniosynostosis</td>
<td align="left">Craniosynostosis</td>
</tr>
<tr class="even">
<td align="left">Q75.0</td>
<td align="right">403</td>
<td align="left">Muenke Syndrome</td>
<td align="left">Craniosynostosis</td>
</tr>
<tr class="odd">
<td align="left">Q75.0</td>
<td align="right">403</td>
<td align="left">Saethre-Chotzen syndrome</td>
<td align="left">Craniosynostosis</td>
</tr>
<tr class="even">
<td align="left">Q27.30</td>
<td align="right">398</td>
<td align="left">Congenital arteriovenous shunt</td>
<td align="left">Arteriovenous malformation, site unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q27.30</td>
<td align="right">398</td>
<td align="left">Cobb syndrome</td>
<td align="left">Arteriovenous malformation, site unspecified</td>
</tr>
<tr class="even">
<td align="left">Q21.2</td>
<td align="right">393</td>
<td align="left">Atrioventricular septal defect</td>
<td align="left">Atrioventricular septal defect</td>
</tr>
<tr class="odd">
<td align="left">Q21.2</td>
<td align="right">393</td>
<td align="left">Complete atrioventricular canal</td>
<td align="left">Atrioventricular septal defect</td>
</tr>
<tr class="even">
<td align="left">Q21.2</td>
<td align="right">393</td>
<td align="left">Partial atrioventricular canal</td>
<td align="left">Atrioventricular septal defect</td>
</tr>
<tr class="odd">
<td align="left">Q21.2</td>
<td align="right">393</td>
<td align="left">Erdheim-Chester disease</td>
<td align="left">Atrioventricular septal defect</td>
</tr>
<tr class="even">
<td align="left">N04.9</td>
<td align="right">392</td>
<td align="left">MYH9 related thrombocytopenia</td>
<td align="left">Nephrotic syndrome with unspecified morphologic changes</td>
</tr>
<tr class="odd">
<td align="left">N04.9</td>
<td align="right">392</td>
<td align="left">Congenital nephrotic syndrome Finnish type</td>
<td align="left">Nephrotic syndrome with unspecified morphologic changes</td>
</tr>
<tr class="even">
<td align="left">E74.02</td>
<td align="right">392</td>
<td align="left">Adrenomyodystrophy</td>
<td align="left">Pompe disease</td>
</tr>
<tr class="odd">
<td align="left">E74.02</td>
<td align="right">392</td>
<td align="left">Glycogen storage disease type 2</td>
<td align="left">Pompe disease</td>
</tr>
<tr class="even">
<td align="left">H35.54</td>
<td align="right">388</td>
<td align="left">Best vitelliform macular dystrophy</td>
<td align="left">Dystrophies primarily involving the retinal pigment epithelium</td>
</tr>
<tr class="odd">
<td align="left">H35.54</td>
<td align="right">388</td>
<td align="left">Adult-onset vitelliform macular dystrophy</td>
<td align="left">Dystrophies primarily involving the retinal pigment epithelium</td>
</tr>
<tr class="even">
<td align="left">G60.0</td>
<td align="right">386</td>
<td align="left">Charcot-Marie-Tooth disease type 1A</td>
<td align="left">Hereditary motor and sensory neuropathy</td>
</tr>
<tr class="odd">
<td align="left">G60.0</td>
<td align="right">386</td>
<td align="left">Charcot-Marie-Tooth disease type 1B</td>
<td align="left">Hereditary motor and sensory neuropathy</td>
</tr>
<tr class="even">
<td align="left">G60.0</td>
<td align="right">386</td>
<td align="left">Charcot-Marie-Tooth disease type 1C</td>
<td align="left">Hereditary motor and sensory neuropathy</td>
</tr>
<tr class="odd">
<td align="left">G60.0</td>
<td align="right">386</td>
<td align="left">X-linked Charcot-Marie-Tooth disease type 1</td>
<td align="left">Hereditary motor and sensory neuropathy</td>
</tr>
<tr class="even">
<td align="left">G60.0</td>
<td align="right">386</td>
<td align="left">Roussy Levy syndrome</td>
<td align="left">Hereditary motor and sensory neuropathy</td>
</tr>
<tr class="odd">
<td align="left">G60.0</td>
<td align="right">386</td>
<td align="left">Hereditary neuropathy with liability to pressure palsy</td>
<td align="left">Hereditary motor and sensory neuropathy</td>
</tr>
<tr class="even">
<td align="left">G60.0</td>
<td align="right">386</td>
<td align="left">Charcot-Marie-Tooth disease</td>
<td align="left">Hereditary motor and sensory neuropathy</td>
</tr>
<tr class="odd">
<td align="left">G60.0</td>
<td align="right">386</td>
<td align="left">Hereditary sensory neuropathy type 1</td>
<td align="left">Hereditary motor and sensory neuropathy</td>
</tr>
<tr class="even">
<td align="left">G60.0</td>
<td align="right">386</td>
<td align="left">Dosage-sensitive sex reversal</td>
<td align="left">Hereditary motor and sensory neuropathy</td>
</tr>
<tr class="odd">
<td align="left">G60.0</td>
<td align="right">386</td>
<td align="left">Hypertrophic neuropathy of Dejerine-Sottas</td>
<td align="left">Hereditary motor and sensory neuropathy</td>
</tr>
<tr class="even">
<td align="left">G60.0</td>
<td align="right">386</td>
<td align="left">Charcot-Marie-Tooth disease type 2</td>
<td align="left">Hereditary motor and sensory neuropathy</td>
</tr>
<tr class="odd">
<td align="left">G60.0</td>
<td align="right">386</td>
<td align="left">Charcot-Marie-Tooth disease type 2</td>
<td align="left">Hereditary motor and sensory neuropathy</td>
</tr>
<tr class="even">
<td align="left">G60.0</td>
<td align="right">386</td>
<td align="left">Charcot-Marie-Tooth disease type 1</td>
<td align="left">Hereditary motor and sensory neuropathy</td>
</tr>
<tr class="odd">
<td align="left">G60.0</td>
<td align="right">386</td>
<td align="left">X-linked Charcot-Marie-Tooth disease</td>
<td align="left">Hereditary motor and sensory neuropathy</td>
</tr>
<tr class="even">
<td align="left">G60.0</td>
<td align="right">386</td>
<td align="left">Hereditary motor and sensory neuropathy</td>
<td align="left">Hereditary motor and sensory neuropathy</td>
</tr>
<tr class="odd">
<td align="left">R43.0</td>
<td align="right">385</td>
<td align="left">Congenital anosmia</td>
<td align="left">Anosmia</td>
</tr>
<tr class="even">
<td align="left">Q85.00</td>
<td align="right">382</td>
<td align="left">Neurofibromatosis</td>
<td align="left">Neurofibromatosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q24.5</td>
<td align="right">381</td>
<td align="left">Coronary arteries congenital malformation</td>
<td align="left">Malformation of coronary vessels</td>
</tr>
<tr class="even">
<td align="left">L43.9</td>
<td align="right">381</td>
<td align="left">Linear lichen planus</td>
<td align="left">Lichen planus, unspecified</td>
</tr>
<tr class="odd">
<td align="left">I67.89</td>
<td align="right">375</td>
<td align="left">CADASIL</td>
<td align="left">Other cerebrovascular disease</td>
</tr>
<tr class="even">
<td align="left">I67.89</td>
<td align="right">375</td>
<td align="left">Susac syndrome</td>
<td align="left">Other cerebrovascular disease</td>
</tr>
<tr class="odd">
<td align="left">I67.89</td>
<td align="right">375</td>
<td align="left">Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy</td>
<td align="left">Other cerebrovascular disease</td>
</tr>
<tr class="even">
<td align="left">G93.49</td>
<td align="right">374</td>
<td align="left">Familial encephalopathy with neuroserpin inclusion bodies</td>
<td align="left">Other encephalopathy</td>
</tr>
<tr class="odd">
<td align="left">G93.49</td>
<td align="right">374</td>
<td align="left">Hereditary diffuse leukoencephalopathy with spheroids</td>
<td align="left">Other encephalopathy</td>
</tr>
<tr class="even">
<td align="left">G93.49</td>
<td align="right">374</td>
<td align="left">Hypomyelination and congenital cataract</td>
<td align="left">Other encephalopathy</td>
</tr>
<tr class="odd">
<td align="left">K22.0</td>
<td align="right">372</td>
<td align="left">Idiopathic achalasia</td>
<td align="left">Achalasia of cardia</td>
</tr>
<tr class="even">
<td align="left">K22.0</td>
<td align="right">372</td>
<td align="left">Cardiospasm</td>
<td align="left">Achalasia of cardia</td>
</tr>
<tr class="odd">
<td align="left">Q87.40</td>
<td align="right">368</td>
<td align="left">Lujan syndrome</td>
<td align="left">Marfan’s syndrome, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q87.40</td>
<td align="right">368</td>
<td align="left">Marfan syndrome</td>
<td align="left">Marfan’s syndrome, unspecified</td>
</tr>
<tr class="odd">
<td align="left">I45.81</td>
<td align="right">368</td>
<td align="left">Jervell Lange-Nielsen syndrome</td>
<td align="left">Long QT syndrome</td>
</tr>
<tr class="even">
<td align="left">I45.81</td>
<td align="right">368</td>
<td align="left">Long QT syndrome 1</td>
<td align="left">Long QT syndrome</td>
</tr>
<tr class="odd">
<td align="left">G60.8</td>
<td align="right">368</td>
<td align="left">Congenital insensitivity to pain with anhidrosis</td>
<td align="left">Other hereditary and idiopathic neuropathies</td>
</tr>
<tr class="even">
<td align="left">G60.8</td>
<td align="right">368</td>
<td align="left">Hereditary sensory and autonomic neuropathy type 2</td>
<td align="left">Other hereditary and idiopathic neuropathies</td>
</tr>
<tr class="odd">
<td align="left">G60.8</td>
<td align="right">368</td>
<td align="left">Giant axonal neuropathy</td>
<td align="left">Other hereditary and idiopathic neuropathies</td>
</tr>
<tr class="even">
<td align="left">G60.8</td>
<td align="right">368</td>
<td align="left">Hereditary sensory neuropathy type 1</td>
<td align="left">Other hereditary and idiopathic neuropathies</td>
</tr>
<tr class="odd">
<td align="left">G60.8</td>
<td align="right">368</td>
<td align="left">Hereditary sensory and autonomic neuropathy type V</td>
<td align="left">Other hereditary and idiopathic neuropathies</td>
</tr>
<tr class="even">
<td align="left">G60.8</td>
<td align="right">368</td>
<td align="left">Hereditary sensory and autonomic neuropathy</td>
<td align="left">Other hereditary and idiopathic neuropathies</td>
</tr>
<tr class="odd">
<td align="left">D69.1</td>
<td align="right">368</td>
<td align="left">Giant platelet syndrome</td>
<td align="left">Qualitative platelet defects</td>
</tr>
<tr class="even">
<td align="left">D69.1</td>
<td align="right">368</td>
<td align="left">Giant platelet syndrome</td>
<td align="left">Qualitative platelet defects</td>
</tr>
<tr class="odd">
<td align="left">D69.1</td>
<td align="right">368</td>
<td align="left">Glanzmann thrombasthenia</td>
<td align="left">Qualitative platelet defects</td>
</tr>
<tr class="even">
<td align="left">D69.1</td>
<td align="right">368</td>
<td align="left">Gray platelet syndrome</td>
<td align="left">Qualitative platelet defects</td>
</tr>
<tr class="odd">
<td align="left">D69.1</td>
<td align="right">368</td>
<td align="left">Scott syndrome</td>
<td align="left">Qualitative platelet defects</td>
</tr>
<tr class="even">
<td align="left">D69.1</td>
<td align="right">368</td>
<td align="left">Platelet storage pool deficiency</td>
<td align="left">Qualitative platelet defects</td>
</tr>
<tr class="odd">
<td align="left">D69.1</td>
<td align="right">368</td>
<td align="left">Platelet storage pool deficiency</td>
<td align="left">Qualitative platelet defects</td>
</tr>
<tr class="even">
<td align="left">D69.1</td>
<td align="right">368</td>
<td align="left">Platelet storage pool deficiency</td>
<td align="left">Qualitative platelet defects</td>
</tr>
<tr class="odd">
<td align="left">D69.1</td>
<td align="right">368</td>
<td align="left">Platelet storage pool deficiency</td>
<td align="left">Qualitative platelet defects</td>
</tr>
<tr class="even">
<td align="left">D69.1</td>
<td align="right">368</td>
<td align="left">Thrombocytopathy asplenia miosis</td>
<td align="left">Qualitative platelet defects</td>
</tr>
<tr class="odd">
<td align="left">D69.1</td>
<td align="right">368</td>
<td align="left">Thrombasthenia</td>
<td align="left">Qualitative platelet defects</td>
</tr>
<tr class="even">
<td align="left">B44.9</td>
<td align="right">368</td>
<td align="left">Aspergillosis</td>
<td align="left">Aspergillosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">B44.9</td>
<td align="right">368</td>
<td align="left">Aspergillus niger infection</td>
<td align="left">Aspergillosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q11.1</td>
<td align="right">367</td>
<td align="left">Syndromic microphthalmia, type 3</td>
<td align="left">Other anophthalmos</td>
</tr>
<tr class="odd">
<td align="left">Q11.1</td>
<td align="right">367</td>
<td align="left">Microphthalmia</td>
<td align="left">Other anophthalmos</td>
</tr>
<tr class="even">
<td align="left">G45.3</td>
<td align="right">367</td>
<td align="left">Amaurosis fugax</td>
<td align="left">Amaurosis fugax</td>
</tr>
<tr class="odd">
<td align="left">I77.89</td>
<td align="right">366</td>
<td align="left">Cystic medial necrosis of aorta</td>
<td align="left">Other specified disorders of arteries and arterioles</td>
</tr>
<tr class="even">
<td align="left">I77.89</td>
<td align="right">366</td>
<td align="left">Degos ‘en cocarde’ erythrokeratoderma</td>
<td align="left">Other specified disorders of arteries and arterioles</td>
</tr>
<tr class="odd">
<td align="left">I77.89</td>
<td align="right">366</td>
<td align="left">Degos ‘en cocarde’ erythrokeratoderma</td>
<td align="left">Other specified disorders of arteries and arterioles</td>
</tr>
<tr class="even">
<td align="left">I77.89</td>
<td align="right">366</td>
<td align="left">Degos disease</td>
<td align="left">Other specified disorders of arteries and arterioles</td>
</tr>
<tr class="odd">
<td align="left">I77.89</td>
<td align="right">366</td>
<td align="left">Degos disease</td>
<td align="left">Other specified disorders of arteries and arterioles</td>
</tr>
<tr class="even">
<td align="left">I77.89</td>
<td align="right">366</td>
<td align="left">Cystic adventitial disease</td>
<td align="left">Other specified disorders of arteries and arterioles</td>
</tr>
<tr class="odd">
<td align="left">I77.89</td>
<td align="right">366</td>
<td align="left">STING-associated vasculopathy with onset in infancy</td>
<td align="left">Other specified disorders of arteries and arterioles</td>
</tr>
<tr class="even">
<td align="left">I99.9</td>
<td align="right">365</td>
<td align="left">Hereditary angiopathy with nephropathy, aneurysms, and muscle cramps syndrome</td>
<td align="left">Unspecified disorder of circulatory system</td>
</tr>
<tr class="odd">
<td align="left">M35.1</td>
<td align="right">364</td>
<td align="left">Mixed connective tissue disease</td>
<td align="left">Other overlap syndromes</td>
</tr>
<tr class="even">
<td align="left">N80.0</td>
<td align="right">363</td>
<td align="left">Adenomyosis</td>
<td align="left">Endometriosis of uterus</td>
</tr>
<tr class="odd">
<td align="left">K85.80</td>
<td align="right">363</td>
<td align="left">Hereditary pancreatitis</td>
<td align="left">Other acute pancreatitis without necrosis or infection</td>
</tr>
<tr class="even">
<td align="left">K85.80</td>
<td align="right">363</td>
<td align="left">Autoimmune pancreatitis</td>
<td align="left">Other acute pancreatitis without necrosis or infection</td>
</tr>
<tr class="odd">
<td align="left">D49.9</td>
<td align="right">363</td>
<td align="left">Paraneoplastic cerebellar degeneration</td>
<td align="left">Neoplasm of unspecified behavior of unspecified site</td>
</tr>
<tr class="even">
<td align="left">C32.9</td>
<td align="right">363</td>
<td align="left">Laryngeal cancer</td>
<td align="left">Malignant neoplasm of larynx, unspecified</td>
</tr>
<tr class="odd">
<td align="left">G25.89</td>
<td align="right">362</td>
<td align="left">Biotin-thiamine-responsive basal ganglia disease</td>
<td align="left">Other specified extrapyramidal and movement disorders</td>
</tr>
<tr class="even">
<td align="left">D57.20</td>
<td align="right">362</td>
<td align="left">Hemoglobin SC disease</td>
<td align="left">Sickle-cell/Hb-C disease without crisis</td>
</tr>
<tr class="odd">
<td align="left">G96.0</td>
<td align="right">360</td>
<td align="left">Cerebrospinal fluid leak</td>
<td align="left">Cerebrospinal fluid leak</td>
</tr>
<tr class="even">
<td align="left">B02.30</td>
<td align="right">359</td>
<td align="left">Herpes zoster ophthalmicus</td>
<td align="left">Zoster ocular disease, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q20.3</td>
<td align="right">358</td>
<td align="left">Transposition of the great arteries</td>
<td align="left">Discordant ventriculoarterial connection</td>
</tr>
<tr class="even">
<td align="left">P00.2</td>
<td align="right">352</td>
<td align="left">TORCH syndrome</td>
<td align="left">Newborn affected by maternal infectious and parasitic diseases</td>
</tr>
<tr class="odd">
<td align="left">D49.89</td>
<td align="right">352</td>
<td align="left">Heart tumor</td>
<td align="left">Neoplasm of unspecified behavior of other specified sites</td>
</tr>
<tr class="even">
<td align="left">E07.89</td>
<td align="right">347</td>
<td align="left">Generalized resistance to thyroid hormone</td>
<td align="left">Other specified disorders of thyroid</td>
</tr>
<tr class="odd">
<td align="left">E07.89</td>
<td align="right">347</td>
<td align="left">Generalized resistance to thyroid hormone</td>
<td align="left">Other specified disorders of thyroid</td>
</tr>
<tr class="even">
<td align="left">E07.89</td>
<td align="right">347</td>
<td align="left">Generalized resistance to thyroid hormone</td>
<td align="left">Other specified disorders of thyroid</td>
</tr>
<tr class="odd">
<td align="left">E07.89</td>
<td align="right">347</td>
<td align="left">Generalized resistance to thyroid hormone</td>
<td align="left">Other specified disorders of thyroid</td>
</tr>
<tr class="even">
<td align="left">E07.89</td>
<td align="right">347</td>
<td align="left">Familial hyperthyroidism due to mutations in TSH receptor</td>
<td align="left">Other specified disorders of thyroid</td>
</tr>
<tr class="odd">
<td align="left">E07.89</td>
<td align="right">347</td>
<td align="left">Familial hyperthyroidism due to mutations in TSH receptor</td>
<td align="left">Other specified disorders of thyroid</td>
</tr>
<tr class="even">
<td align="left">E07.89</td>
<td align="right">347</td>
<td align="left">Familial hyperthyroidism due to mutations in TSH receptor</td>
<td align="left">Other specified disorders of thyroid</td>
</tr>
<tr class="odd">
<td align="left">E07.89</td>
<td align="right">347</td>
<td align="left">Familial hyperthyroidism due to mutations in TSH receptor</td>
<td align="left">Other specified disorders of thyroid</td>
</tr>
<tr class="even">
<td align="left">D24.9</td>
<td align="right">346</td>
<td align="left">Florid papillomatosis of the nipple</td>
<td align="left">Benign neoplasm of unspecified breast</td>
</tr>
<tr class="odd">
<td align="left">E75.21</td>
<td align="right">345</td>
<td align="left">Fabry disease</td>
<td align="left">Fabry (-Anderson) disease</td>
</tr>
<tr class="even">
<td align="left">I80.8</td>
<td align="right">344</td>
<td align="left">Mondor disease</td>
<td align="left">Phlebitis and thrombophlebitis of other sites</td>
</tr>
<tr class="odd">
<td align="left">F06.30</td>
<td align="right">339</td>
<td align="left">Organic mood syndrome</td>
<td align="left">Mood disorder due to known physiological condition, unspecified</td>
</tr>
<tr class="even">
<td align="left">G61.81</td>
<td align="right">338</td>
<td align="left">Chronic inflammatory demyelinating polyneuropathy</td>
<td align="left">Chronic inflammatory demyelinating polyneuritis</td>
</tr>
<tr class="odd">
<td align="left">L92.0</td>
<td align="right">334</td>
<td align="left">Granuloma annulare</td>
<td align="left">Granuloma annulare</td>
</tr>
<tr class="even">
<td align="left">L85.9</td>
<td align="right">332</td>
<td align="left">Tylosis</td>
<td align="left">Epidermal thickening, unspecified</td>
</tr>
<tr class="odd">
<td align="left">K11.8</td>
<td align="right">332</td>
<td align="left">Mikulicz disease</td>
<td align="left">Other diseases of salivary glands</td>
</tr>
<tr class="even">
<td align="left">C21.0</td>
<td align="right">329</td>
<td align="left">Anal cancer</td>
<td align="left">Malignant neoplasm of anus, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C84.A0</td>
<td align="right">327</td>
<td align="left">Cutaneous T-cell lymphoma</td>
<td align="left">Cutaneous T-cell lymphoma, unspecified, unspecified site</td>
</tr>
<tr class="even">
<td align="left">K51.20</td>
<td align="right">326</td>
<td align="left">Ulcerative proctitis</td>
<td align="left">Ulcerative (chronic) proctitis without complications</td>
</tr>
<tr class="odd">
<td align="left">H55.01</td>
<td align="right">325</td>
<td align="left">Nystagmus 1, congenital, X- linked</td>
<td align="left">Congenital nystagmus</td>
</tr>
<tr class="even">
<td align="left">G80.1</td>
<td align="right">325</td>
<td align="left">Spastic diplegia cerebral palsy</td>
<td align="left">Spastic diplegic cerebral palsy</td>
</tr>
<tr class="odd">
<td align="left">D45</td>
<td align="right">325</td>
<td align="left">Polycythemia vera</td>
<td align="left">Polycythemia vera</td>
</tr>
<tr class="even">
<td align="left">Q12.0</td>
<td align="right">324</td>
<td align="left">Cerulean cataract</td>
<td align="left">Congenital cataract</td>
</tr>
<tr class="odd">
<td align="left">Q02</td>
<td align="right">317</td>
<td align="left">Immunodeficiency, microcephaly with normal intelligence</td>
<td align="left">Microcephaly</td>
</tr>
<tr class="even">
<td align="left">Q02</td>
<td align="right">317</td>
<td align="left">Microcephaly</td>
<td align="left">Microcephaly</td>
</tr>
<tr class="odd">
<td align="left">Q02</td>
<td align="right">317</td>
<td align="left">Nijmegen breakage syndrome</td>
<td align="left">Microcephaly</td>
</tr>
<tr class="even">
<td align="left">Q02</td>
<td align="right">317</td>
<td align="left">Microencephaly</td>
<td align="left">Microcephaly</td>
</tr>
<tr class="odd">
<td align="left">Q02</td>
<td align="right">317</td>
<td align="left">Amish lethal microcephaly</td>
<td align="left">Microcephaly</td>
</tr>
<tr class="even">
<td align="left">D49.59</td>
<td align="right">316</td>
<td align="left">Trophoblastic tumor placental site</td>
<td align="left">Neoplasm of unspecified behavior of other genitourinary organ</td>
</tr>
<tr class="odd">
<td align="left">D49.59</td>
<td align="right">316</td>
<td align="left">Ovarian sex cord tumor with annular tubules</td>
<td align="left">Neoplasm of unspecified behavior of other genitourinary organ</td>
</tr>
<tr class="even">
<td align="left">M32.14</td>
<td align="right">310</td>
<td align="left">Lupus nephritis</td>
<td align="left">Glomerular disease in systemic lupus erythematosus</td>
</tr>
<tr class="odd">
<td align="left">C85.10</td>
<td align="right">310</td>
<td align="left">B-cell lymphoma</td>
<td align="left">Unspecified B-cell lymphoma, unspecified site</td>
</tr>
<tr class="even">
<td align="left">P22.0</td>
<td align="right">307</td>
<td align="left">Respiratory distress syndrome, infant</td>
<td align="left">Respiratory distress syndrome of newborn</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Gillespie syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">De Barsy syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">De Barsy syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Neu Laxova syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Singleton Merten syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Rutherfurd syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Nicolaides-Baraitser syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Young syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Laband syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Arthrogryposis multiplex congenita pulmonary hypoplasia</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Bardet-Biedl syndrome 1</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Bardet-Biedl syndrome 2</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Biemond syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Ciliary discoordination, due to random ciliary orientation</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Costello syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Craniofacial deafness hand syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Currarino triad</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Dermochondrocorneal dystrophy of FranâÂºois</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Diaphragmatic hernia exomphalos corpus callosum agenesis</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Donnai-Barrow syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Meier-Gorlin syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Myhre syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Walker-Warburg syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Trismus-pseudocamptodactyly syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Immotile cilia syndrome, due to defective radial spokes</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Papillon Lefevre syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Popliteal pterygium syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Hennekam syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">McKusick Kaufman syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Otoonychoperoneal syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Primary ciliary dyskinesia</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Oculofaciocardiodental syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Alstrââ¢m syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Bowen-Conradi syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Cohen syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Jackson-Weiss syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Kartagener syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Bardet-Biedl syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Nance-Horan syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Nevoid basal cell carcinoma syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Oculodentodigital dysplasia</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Pallister-Hall syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Intellectual disability-developmental delay-contractures syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Feingold syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Timothy syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Andersen-Tawil syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Renpenning syndrome 1</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Acral lentiginous melanoma</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Fetal akinesia deformation sequence</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Bardet-Biedl syndrome 10</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Bardet-Biedl syndrome 11</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Bardet-Biedl syndrome 12</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Christianson syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">DICER1-related pleuropulmonary blastoma cancer predisposition syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Loeys-Dietz syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Blepharophimosis intellectual disability syndromes</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Laurence-Moon syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q87.89</td>
<td align="right">305</td>
<td align="left">Laurence-Moon syndrome</td>
<td align="left">Other specified congenital malformation syndromes, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">E72.20</td>
<td align="right">302</td>
<td align="left">Urea cycle disorders</td>
<td align="left">Disorder of urea cycle metabolism, unspecified</td>
</tr>
<tr class="even">
<td align="left">C02.9</td>
<td align="right">299</td>
<td align="left">Tongue cancer</td>
<td align="left">Malignant neoplasm of tongue, unspecified</td>
</tr>
<tr class="odd">
<td align="left">J67.9</td>
<td align="right">297</td>
<td align="left">Hypersensitivity pneumonitis</td>
<td align="left">Hypersensitivity pneumonitis due to unspecified organic dust</td>
</tr>
<tr class="even">
<td align="left">M53.9</td>
<td align="right">296</td>
<td align="left">Spondylarthropathy</td>
<td align="left">Dorsopathy, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E80.4</td>
<td align="right">296</td>
<td align="left">Congenital nonhemolytic jaundice</td>
<td align="left">Gilbert syndrome</td>
</tr>
<tr class="even">
<td align="left">D83.9</td>
<td align="right">296</td>
<td align="left">Common variable immunodeficiency</td>
<td align="left">Common variable immunodeficiency, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q15.9</td>
<td align="right">291</td>
<td align="left">Anophthalmos with limb anomalies</td>
<td align="left">Congenital malformation of eye, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q15.9</td>
<td align="right">291</td>
<td align="left">Manitoba oculotrichoanal syndrome</td>
<td align="left">Congenital malformation of eye, unspecified</td>
</tr>
<tr class="odd">
<td align="left">G57.00</td>
<td align="right">291</td>
<td align="left">Piriformis syndrome</td>
<td align="left">Lesion of sciatic nerve, unspecified lower limb</td>
</tr>
<tr class="even">
<td align="left">Q35.9</td>
<td align="right">288</td>
<td align="left">Cleft palate lateral synechia syndrome</td>
<td align="left">Cleft palate, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C62.90</td>
<td align="right">285</td>
<td align="left">Testicular seminoma</td>
<td align="left">Malignant neoplasm of unspecified testis, unspecified whether descended or undescended</td>
</tr>
<tr class="even">
<td align="left">C62.90</td>
<td align="right">285</td>
<td align="left">Testicular seminoma</td>
<td align="left">Malignant neoplasm of unspecified testis, unspecified whether descended or undescended</td>
</tr>
<tr class="odd">
<td align="left">C62.90</td>
<td align="right">285</td>
<td align="left">Testicular cancer</td>
<td align="left">Malignant neoplasm of unspecified testis, unspecified whether descended or undescended</td>
</tr>
<tr class="even">
<td align="left">C62.90</td>
<td align="right">285</td>
<td align="left">Testicular germ cell tumor</td>
<td align="left">Malignant neoplasm of unspecified testis, unspecified whether descended or undescended</td>
</tr>
<tr class="odd">
<td align="left">F44.9</td>
<td align="right">284</td>
<td align="left">Conversion disorder</td>
<td align="left">Dissociative and conversion disorder, unspecified</td>
</tr>
<tr class="even">
<td align="left">P22.9</td>
<td align="right">283</td>
<td align="left">Respiratory distress syndrome, infant</td>
<td align="left">Respiratory distress of newborn, unspecified</td>
</tr>
<tr class="odd">
<td align="left">I45.5</td>
<td align="right">283</td>
<td align="left">Progressive familial heart block type 2</td>
<td align="left">Other specified heart block</td>
</tr>
<tr class="even">
<td align="left">B08.3</td>
<td align="right">283</td>
<td align="left">Parvovirus antenatal infection</td>
<td align="left">Erythema infectiosum [fifth disease]</td>
</tr>
<tr class="odd">
<td align="left">R25.8</td>
<td align="right">282</td>
<td align="left">Athetosis</td>
<td align="left">Other abnormal involuntary movements</td>
</tr>
<tr class="even">
<td align="left">R25.8</td>
<td align="right">282</td>
<td align="left">Athetosis</td>
<td align="left">Other abnormal involuntary movements</td>
</tr>
<tr class="odd">
<td align="left">D75.82</td>
<td align="right">281</td>
<td align="left">Heparin-induced thrombocytopenia</td>
<td align="left">Heparin induced thrombocytopenia (HIT)</td>
</tr>
<tr class="even">
<td align="left">H35.53</td>
<td align="right">279</td>
<td align="left">Stargardt disease</td>
<td align="left">Other dystrophies primarily involving the sensory retina</td>
</tr>
<tr class="odd">
<td align="left">H35.53</td>
<td align="right">279</td>
<td align="left">Retinitis pigmentosa-deafness syndrome</td>
<td align="left">Other dystrophies primarily involving the sensory retina</td>
</tr>
<tr class="even">
<td align="left">H35.53</td>
<td align="right">279</td>
<td align="left">Retinitis pigmentosa-deafness syndrome</td>
<td align="left">Other dystrophies primarily involving the sensory retina</td>
</tr>
<tr class="odd">
<td align="left">H35.53</td>
<td align="right">279</td>
<td align="left">Usher syndrome, type 1</td>
<td align="left">Other dystrophies primarily involving the sensory retina</td>
</tr>
<tr class="even">
<td align="left">H35.53</td>
<td align="right">279</td>
<td align="left">Usher syndrome</td>
<td align="left">Other dystrophies primarily involving the sensory retina</td>
</tr>
<tr class="odd">
<td align="left">H35.53</td>
<td align="right">279</td>
<td align="left">Usher syndrome</td>
<td align="left">Other dystrophies primarily involving the sensory retina</td>
</tr>
<tr class="even">
<td align="left">H35.53</td>
<td align="right">279</td>
<td align="left">Fundus dystrophy, pseudoinflammatory, of Sorsby</td>
<td align="left">Other dystrophies primarily involving the sensory retina</td>
</tr>
<tr class="odd">
<td align="left">G80.0</td>
<td align="right">278</td>
<td align="left">Cerebral palsy spastic quadriplegic</td>
<td align="left">Spastic quadriplegic cerebral palsy</td>
</tr>
<tr class="even">
<td align="left">E20.9</td>
<td align="right">278</td>
<td align="left">Hypoparathyroidism</td>
<td align="left">Hypoparathyroidism, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D59.1</td>
<td align="right">277</td>
<td align="left">Autoimmune hemolytic anemia</td>
<td align="left">Other autoimmune hemolytic anemias</td>
</tr>
<tr class="even">
<td align="left">D59.1</td>
<td align="right">277</td>
<td align="left">Autoimmune hemolytic anemia</td>
<td align="left">Other autoimmune hemolytic anemias</td>
</tr>
<tr class="odd">
<td align="left">D59.1</td>
<td align="right">277</td>
<td align="left">Cold agglutinin disease</td>
<td align="left">Other autoimmune hemolytic anemias</td>
</tr>
<tr class="even">
<td align="left">D59.1</td>
<td align="right">277</td>
<td align="left">Paroxysmal cold hemoglobinuria</td>
<td align="left">Other autoimmune hemolytic anemias</td>
</tr>
<tr class="odd">
<td align="left">D59.1</td>
<td align="right">277</td>
<td align="left">Warm antibody hemolytic anemia</td>
<td align="left">Other autoimmune hemolytic anemias</td>
</tr>
<tr class="even">
<td align="left">E34.8</td>
<td align="right">275</td>
<td align="left">Rabson-Mendenhall syndrome</td>
<td align="left">Other specified endocrine disorders</td>
</tr>
<tr class="odd">
<td align="left">E34.8</td>
<td align="right">275</td>
<td align="left">Neonatal progeroid syndrome</td>
<td align="left">Other specified endocrine disorders</td>
</tr>
<tr class="even">
<td align="left">E34.8</td>
<td align="right">275</td>
<td align="left">Progeroid short stature with pigmented nevi</td>
<td align="left">Other specified endocrine disorders</td>
</tr>
<tr class="odd">
<td align="left">E34.8</td>
<td align="right">275</td>
<td align="left">Acrogeria, Gottron type</td>
<td align="left">Other specified endocrine disorders</td>
</tr>
<tr class="even">
<td align="left">E34.8</td>
<td align="right">275</td>
<td align="left">Acrogeria, Gottron type</td>
<td align="left">Other specified endocrine disorders</td>
</tr>
<tr class="odd">
<td align="left">E34.8</td>
<td align="right">275</td>
<td align="left">Leprechaunism</td>
<td align="left">Other specified endocrine disorders</td>
</tr>
<tr class="even">
<td align="left">E34.8</td>
<td align="right">275</td>
<td align="left">Progeria</td>
<td align="left">Other specified endocrine disorders</td>
</tr>
<tr class="odd">
<td align="left">E34.8</td>
<td align="right">275</td>
<td align="left">Werner’s syndrome</td>
<td align="left">Other specified endocrine disorders</td>
</tr>
<tr class="even">
<td align="left">E88.01</td>
<td align="right">272</td>
<td align="left">Alpha-1 antitrypsin deficiency</td>
<td align="left">Alpha-1-antitrypsin deficiency</td>
</tr>
<tr class="odd">
<td align="left">Q28.2</td>
<td align="right">267</td>
<td align="left">Intracranial arteriovenous malformation</td>
<td align="left">Arteriovenous malformation of cerebral vessels</td>
</tr>
<tr class="even">
<td align="left">Q28.2</td>
<td align="right">267</td>
<td align="left">Wyburn Mason’s syndrome</td>
<td align="left">Arteriovenous malformation of cerebral vessels</td>
</tr>
<tr class="odd">
<td align="left">G58.8</td>
<td align="right">265</td>
<td align="left">Pudendal Neuralgia</td>
<td align="left">Other specified mononeuropathies</td>
</tr>
<tr class="even">
<td align="left">M62.50</td>
<td align="right">263</td>
<td align="left">Muscular atrophy ataxia retinitis pigmentosa and diabetes mellitus</td>
<td align="left">Muscle wasting and atrophy, not elsewhere classified, unspecified site</td>
</tr>
<tr class="odd">
<td align="left">C71.6</td>
<td align="right">262</td>
<td align="left">Medulloblastoma</td>
<td align="left">Malignant neoplasm of cerebellum</td>
</tr>
<tr class="even">
<td align="left">Q89.8</td>
<td align="right">261</td>
<td align="left">CHARGE syndrome</td>
<td align="left">Other specified congenital malformations</td>
</tr>
<tr class="odd">
<td align="left">Q89.8</td>
<td align="right">261</td>
<td align="left">GAPO syndrome</td>
<td align="left">Other specified congenital malformations</td>
</tr>
<tr class="even">
<td align="left">Q89.8</td>
<td align="right">261</td>
<td align="left">Borjeson-Forssman-Lehmann syndrome</td>
<td align="left">Other specified congenital malformations</td>
</tr>
<tr class="odd">
<td align="left">Q89.8</td>
<td align="right">261</td>
<td align="left">Holoacardius amorphus</td>
<td align="left">Other specified congenital malformations</td>
</tr>
<tr class="even">
<td align="left">Q89.8</td>
<td align="right">261</td>
<td align="left">Infantile myofibromatosis</td>
<td align="left">Other specified congenital malformations</td>
</tr>
<tr class="odd">
<td align="left">Q89.8</td>
<td align="right">261</td>
<td align="left">Stickler syndrome type 1</td>
<td align="left">Other specified congenital malformations</td>
</tr>
<tr class="even">
<td align="left">Q89.8</td>
<td align="right">261</td>
<td align="left">Waardenburg syndrome</td>
<td align="left">Other specified congenital malformations</td>
</tr>
<tr class="odd">
<td align="left">Q89.8</td>
<td align="right">261</td>
<td align="left">Coffin-Lowry syndrome</td>
<td align="left">Other specified congenital malformations</td>
</tr>
<tr class="even">
<td align="left">Q89.8</td>
<td align="right">261</td>
<td align="left">Congenital generalized fibromatosis</td>
<td align="left">Other specified congenital malformations</td>
</tr>
<tr class="odd">
<td align="left">Q89.8</td>
<td align="right">261</td>
<td align="left">Jumping Frenchmen of Maine</td>
<td align="left">Other specified congenital malformations</td>
</tr>
<tr class="even">
<td align="left">Q89.8</td>
<td align="right">261</td>
<td align="left">Kabuki syndrome</td>
<td align="left">Other specified congenital malformations</td>
</tr>
<tr class="odd">
<td align="left">Q89.8</td>
<td align="right">261</td>
<td align="left">Persistent Mullerian duct syndrome</td>
<td align="left">Other specified congenital malformations</td>
</tr>
<tr class="even">
<td align="left">Q89.8</td>
<td align="right">261</td>
<td align="left">Hypotrichosis simplex</td>
<td align="left">Other specified congenital malformations</td>
</tr>
<tr class="odd">
<td align="left">Q89.8</td>
<td align="right">261</td>
<td align="left">Acardia</td>
<td align="left">Other specified congenital malformations</td>
</tr>
<tr class="even">
<td align="left">Q89.8</td>
<td align="right">261</td>
<td align="left">Hyperostosis-hyperphosphatemia syndrome</td>
<td align="left">Other specified congenital malformations</td>
</tr>
<tr class="odd">
<td align="left">Q89.8</td>
<td align="right">261</td>
<td align="left">Stickler syndrome</td>
<td align="left">Other specified congenital malformations</td>
</tr>
<tr class="even">
<td align="left">Q89.8</td>
<td align="right">261</td>
<td align="left">Hemihypertrophy</td>
<td align="left">Other specified congenital malformations</td>
</tr>
<tr class="odd">
<td align="left">P91.60</td>
<td align="right">261</td>
<td align="left">Hyper IgE syndrome</td>
<td align="left">Hypoxic ischemic encephalopathy [HIE], unspecified</td>
</tr>
<tr class="even">
<td align="left">G31.09</td>
<td align="right">258</td>
<td align="left">Semantic dementia</td>
<td align="left">Other frontotemporal dementia</td>
</tr>
<tr class="odd">
<td align="left">D47.1</td>
<td align="right">257</td>
<td align="left">Chronic myeloproliferative disorders</td>
<td align="left">Chronic myeloproliferative disease</td>
</tr>
<tr class="even">
<td align="left">D47.1</td>
<td align="right">257</td>
<td align="left">Campomelic dysplasia</td>
<td align="left">Chronic myeloproliferative disease</td>
</tr>
<tr class="odd">
<td align="left">D47.1</td>
<td align="right">257</td>
<td align="left">Chronic neutrophilic leukemia</td>
<td align="left">Chronic myeloproliferative disease</td>
</tr>
<tr class="even">
<td align="left">L93.2</td>
<td align="right">255</td>
<td align="left">Lupus erythematosus tumidus</td>
<td align="left">Other local lupus erythematosus</td>
</tr>
<tr class="odd">
<td align="left">L51.9</td>
<td align="right">253</td>
<td align="left">Erythema multiforme</td>
<td align="left">Erythema multiforme, unspecified</td>
</tr>
<tr class="even">
<td align="left">L51.9</td>
<td align="right">253</td>
<td align="left">Stevens-Johnson syndrome</td>
<td align="left">Erythema multiforme, unspecified</td>
</tr>
<tr class="odd">
<td align="left">L94.0</td>
<td align="right">252</td>
<td align="left">Localized scleroderma</td>
<td align="left">Localized scleroderma [morphea]</td>
</tr>
<tr class="even">
<td align="left">L94.0</td>
<td align="right">252</td>
<td align="left">Morphea</td>
<td align="left">Localized scleroderma [morphea]</td>
</tr>
<tr class="odd">
<td align="left">Q55.69</td>
<td align="right">251</td>
<td align="left">Diphallia</td>
<td align="left">Other congenital malformation of penis</td>
</tr>
<tr class="even">
<td align="left">N64.3</td>
<td align="right">250</td>
<td align="left">Ahumada Del Castillo syndrome</td>
<td align="left">Galactorrhea not associated with childbirth</td>
</tr>
<tr class="odd">
<td align="left">D03.9</td>
<td align="right">246</td>
<td align="left">Lentigo maligna melanoma</td>
<td align="left">Melanoma in situ, unspecified</td>
</tr>
<tr class="even">
<td align="left">B37.7</td>
<td align="right">244</td>
<td align="left">Systemic candidiasis</td>
<td align="left">Candidal sepsis</td>
</tr>
<tr class="odd">
<td align="left">Q61.4</td>
<td align="right">243</td>
<td align="left">Senior Loken Syndrome</td>
<td align="left">Renal dysplasia</td>
</tr>
<tr class="even">
<td align="left">Q61.4</td>
<td align="right">243</td>
<td align="left">Renal tubular dysgenesis</td>
<td align="left">Renal dysplasia</td>
</tr>
<tr class="odd">
<td align="left">Q82.2</td>
<td align="right">242</td>
<td align="left">Mastocytosis</td>
<td align="left">Mastocytosis</td>
</tr>
<tr class="even">
<td align="left">J93.83</td>
<td align="right">242</td>
<td align="left">Primary spontaneous pneumothorax</td>
<td align="left">Other pneumothorax</td>
</tr>
<tr class="odd">
<td align="left">J93.83</td>
<td align="right">242</td>
<td align="left">Catamenial pneumothorax</td>
<td align="left">Other pneumothorax</td>
</tr>
<tr class="even">
<td align="left">Q74.0</td>
<td align="right">241</td>
<td align="left">Ramer Ladda syndrome</td>
<td align="left">Other congenital malformations of upper limb(s), including shoulder girdle</td>
</tr>
<tr class="odd">
<td align="left">Q74.0</td>
<td align="right">241</td>
<td align="left">Hand foot uterus syndrome</td>
<td align="left">Other congenital malformations of upper limb(s), including shoulder girdle</td>
</tr>
<tr class="even">
<td align="left">Q74.0</td>
<td align="right">241</td>
<td align="left">Humeroradial synostosis</td>
<td align="left">Other congenital malformations of upper limb(s), including shoulder girdle</td>
</tr>
<tr class="odd">
<td align="left">Q74.0</td>
<td align="right">241</td>
<td align="left">Triphalangeal thumb non opposable</td>
<td align="left">Other congenital malformations of upper limb(s), including shoulder girdle</td>
</tr>
<tr class="even">
<td align="left">Q74.0</td>
<td align="right">241</td>
<td align="left">Central core disease</td>
<td align="left">Other congenital malformations of upper limb(s), including shoulder girdle</td>
</tr>
<tr class="odd">
<td align="left">Q74.0</td>
<td align="right">241</td>
<td align="left">Cleidocranial dysplasia</td>
<td align="left">Other congenital malformations of upper limb(s), including shoulder girdle</td>
</tr>
<tr class="even">
<td align="left">Q74.0</td>
<td align="right">241</td>
<td align="left">Sprengel deformity</td>
<td align="left">Other congenital malformations of upper limb(s), including shoulder girdle</td>
</tr>
<tr class="odd">
<td align="left">Q74.0</td>
<td align="right">241</td>
<td align="left">Macrodactyly of the hand</td>
<td align="left">Other congenital malformations of upper limb(s), including shoulder girdle</td>
</tr>
<tr class="even">
<td align="left">Q74.0</td>
<td align="right">241</td>
<td align="left">Windblown hand</td>
<td align="left">Other congenital malformations of upper limb(s), including shoulder girdle</td>
</tr>
<tr class="odd">
<td align="left">Q74.0</td>
<td align="right">241</td>
<td align="left">Congenital radio-ulnar synostosis</td>
<td align="left">Other congenital malformations of upper limb(s), including shoulder girdle</td>
</tr>
<tr class="even">
<td align="left">Q74.0</td>
<td align="right">241</td>
<td align="left">Madelung deformity</td>
<td align="left">Other congenital malformations of upper limb(s), including shoulder girdle</td>
</tr>
<tr class="odd">
<td align="left">G31.9</td>
<td align="right">241</td>
<td align="left">Cerebellar degeneration</td>
<td align="left">Degenerative disease of nervous system, unspecified</td>
</tr>
<tr class="even">
<td align="left">E72.11</td>
<td align="right">241</td>
<td align="left">Homocystinuria due to CBS deficiency</td>
<td align="left">Homocystinuria</td>
</tr>
<tr class="odd">
<td align="left">E72.11</td>
<td align="right">241</td>
<td align="left">Homocystinuria</td>
<td align="left">Homocystinuria</td>
</tr>
<tr class="even">
<td align="left">E85.4</td>
<td align="right">240</td>
<td align="left">Primary cutaneous amyloidosis</td>
<td align="left">Organ-limited amyloidosis</td>
</tr>
<tr class="odd">
<td align="left">E85.4</td>
<td align="right">240</td>
<td align="left">Primary cutaneous amyloidosis</td>
<td align="left">Organ-limited amyloidosis</td>
</tr>
<tr class="even">
<td align="left">E85.4</td>
<td align="right">240</td>
<td align="left">Primary cutaneous amyloidosis</td>
<td align="left">Organ-limited amyloidosis</td>
</tr>
<tr class="odd">
<td align="left">E85.4</td>
<td align="right">240</td>
<td align="left">Primary cutaneous amyloidosis</td>
<td align="left">Organ-limited amyloidosis</td>
</tr>
<tr class="even">
<td align="left">E85.4</td>
<td align="right">240</td>
<td align="left">Amyloidosis corneal</td>
<td align="left">Organ-limited amyloidosis</td>
</tr>
<tr class="odd">
<td align="left">D61.9</td>
<td align="right">238</td>
<td align="left">Aplastic anemia</td>
<td align="left">Aplastic anemia, unspecified</td>
</tr>
<tr class="even">
<td align="left">G90.3</td>
<td align="right">237</td>
<td align="left">Multiple system atrophy</td>
<td align="left">Multi-system degeneration of the autonomic nervous system</td>
</tr>
<tr class="odd">
<td align="left">G90.3</td>
<td align="right">237</td>
<td align="left">Multiple system atrophy</td>
<td align="left">Multi-system degeneration of the autonomic nervous system</td>
</tr>
<tr class="even">
<td align="left">N05.1</td>
<td align="right">236</td>
<td align="left">Focal segmental glomerulosclerosis</td>
<td align="left">Unspecified nephritic syndrome with focal and segmental glomerular lesions</td>
</tr>
<tr class="odd">
<td align="left">G89.0</td>
<td align="right">236</td>
<td align="left">Central pain syndrome</td>
<td align="left">Central pain syndrome</td>
</tr>
<tr class="even">
<td align="left">G45.4</td>
<td align="right">236</td>
<td align="left">Transient global amnesia</td>
<td align="left">Transient global amnesia</td>
</tr>
<tr class="odd">
<td align="left">E27.1</td>
<td align="right">236</td>
<td align="left">Addison’s disease</td>
<td align="left">Primary adrenocortical insufficiency</td>
</tr>
<tr class="even">
<td align="left">C51.9</td>
<td align="right">233</td>
<td align="left">Vulvar cancer</td>
<td align="left">Malignant neoplasm of vulva, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q76.49</td>
<td align="right">232</td>
<td align="left">Spondyloepiphyseal dysplasia Maroteaux type</td>
<td align="left">Other congenital malformations of spine, not associated with scoliosis</td>
</tr>
<tr class="even">
<td align="left">Q76.49</td>
<td align="right">232</td>
<td align="left">Caudal regression syndrome</td>
<td align="left">Other congenital malformations of spine, not associated with scoliosis</td>
</tr>
<tr class="odd">
<td align="left">Q76.49</td>
<td align="right">232</td>
<td align="left">Brachyolmia type 3</td>
<td align="left">Other congenital malformations of spine, not associated with scoliosis</td>
</tr>
<tr class="even">
<td align="left">Q76.49</td>
<td align="right">232</td>
<td align="left">Brachyolmia</td>
<td align="left">Other congenital malformations of spine, not associated with scoliosis</td>
</tr>
<tr class="odd">
<td align="left">I20.1</td>
<td align="right">231</td>
<td align="left">Prinzmetal’s variant angina</td>
<td align="left">Angina pectoris with documented spasm</td>
</tr>
<tr class="even">
<td align="left">E05.80</td>
<td align="right">231</td>
<td align="left">Focal dermal hypoplasia</td>
<td align="left">Other thyrotoxicosis without thyrotoxic crisis or storm</td>
</tr>
<tr class="odd">
<td align="left">M31.30</td>
<td align="right">230</td>
<td align="left">Granulomatosis with polyangiitis</td>
<td align="left">Wegener’s granulomatosis without renal involvement</td>
</tr>
<tr class="even">
<td align="left">I89.8</td>
<td align="right">230</td>
<td align="left">Chylous ascites</td>
<td align="left">Other specified noninfective disorders of lymphatic vessels and lymph nodes</td>
</tr>
<tr class="odd">
<td align="left">P84</td>
<td align="right">229</td>
<td align="left">Asphyxia neonatorum</td>
<td align="left">Other problems with newborn</td>
</tr>
<tr class="even">
<td align="left">M30.3</td>
<td align="right">227</td>
<td align="left">Kawasaki disease</td>
<td align="left">Mucocutaneous lymph node syndrome [Kawasaki]</td>
</tr>
<tr class="odd">
<td align="left">H81.90</td>
<td align="right">224</td>
<td align="left">Benign paroxysmal positional vertigo</td>
<td align="left">Unspecified disorder of vestibular function, unspecified ear</td>
</tr>
<tr class="even">
<td align="left">Q24.4</td>
<td align="right">223</td>
<td align="left">Subvalvular aortic stenosis</td>
<td align="left">Congenital subaortic stenosis</td>
</tr>
<tr class="odd">
<td align="left">G37.3</td>
<td align="right">223</td>
<td align="left">Transverse myelitis</td>
<td align="left">Acute transverse myelitis in demyelinating disease of central nervous system</td>
</tr>
<tr class="even">
<td align="left">G11.9</td>
<td align="right">223</td>
<td align="left">Hereditary ataxia</td>
<td align="left">Hereditary ataxia, unspecified</td>
</tr>
<tr class="odd">
<td align="left">K13.21</td>
<td align="right">221</td>
<td align="left">Leukoplakia</td>
<td align="left">Leukoplakia of oral mucosa, including tongue</td>
</tr>
<tr class="even">
<td align="left">K13.21</td>
<td align="right">221</td>
<td align="left">Oral leukoplakia</td>
<td align="left">Leukoplakia of oral mucosa, including tongue</td>
</tr>
<tr class="odd">
<td align="left">Q07.9</td>
<td align="right">220</td>
<td align="left">Muscle eye brain disease</td>
<td align="left">Congenital malformation of nervous system, unspecified</td>
</tr>
<tr class="even">
<td align="left">G47.11</td>
<td align="right">220</td>
<td align="left">Idiopathic hypersomnia</td>
<td align="left">Idiopathic hypersomnia with long sleep time</td>
</tr>
<tr class="odd">
<td align="left">E85.8</td>
<td align="right">213</td>
<td align="left">AL amyloidosis</td>
<td align="left">Other amyloidosis</td>
</tr>
<tr class="even">
<td align="left">E85.8</td>
<td align="right">213</td>
<td align="left">Amyloidosis AA</td>
<td align="left">Other amyloidosis</td>
</tr>
<tr class="odd">
<td align="left">D58.9</td>
<td align="right">213</td>
<td align="left">Congenital hemolytic anemia</td>
<td align="left">Hereditary hemolytic anemia, unspecified</td>
</tr>
<tr class="even">
<td align="left">E83.59</td>
<td align="right">212</td>
<td align="left">Calciphylaxis</td>
<td align="left">Other disorders of calcium metabolism</td>
</tr>
<tr class="odd">
<td align="left">E83.59</td>
<td align="right">212</td>
<td align="left">Nephrocalcinosis</td>
<td align="left">Other disorders of calcium metabolism</td>
</tr>
<tr class="even">
<td align="left">D43.2</td>
<td align="right">212</td>
<td align="left">Subependymal giant cell astrocytoma</td>
<td align="left">Neoplasm of uncertain behavior of brain, unspecified</td>
</tr>
<tr class="odd">
<td align="left">G51.4</td>
<td align="right">210</td>
<td align="left">Morvan’s fibrillary chorea</td>
<td align="left">Facial myokymia</td>
</tr>
<tr class="even">
<td align="left">Q14.1</td>
<td align="right">208</td>
<td align="left">Juvenile retinoschisis</td>
<td align="left">Congenital malformation of retina</td>
</tr>
<tr class="odd">
<td align="left">J94.8</td>
<td align="right">208</td>
<td align="left">Chylothorax, congenital</td>
<td align="left">Other specified pleural conditions</td>
</tr>
<tr class="even">
<td align="left">Q45.3</td>
<td align="right">205</td>
<td align="left">Accessory pancreas</td>
<td align="left">Other congenital malformations of pancreas and pancreatic duct</td>
</tr>
<tr class="odd">
<td align="left">O90.3</td>
<td align="right">204</td>
<td align="left">Peripartum cardiomyopathy</td>
<td align="left">Peripartum cardiomyopathy</td>
</tr>
<tr class="even">
<td align="left">L67.8</td>
<td align="right">204</td>
<td align="left">Crandall syndrome</td>
<td align="left">Other hair color and hair shaft abnormalities</td>
</tr>
<tr class="odd">
<td align="left">L67.8</td>
<td align="right">204</td>
<td align="left">Progressive kinking of the hair, acquired</td>
<td align="left">Other hair color and hair shaft abnormalities</td>
</tr>
<tr class="even">
<td align="left">D89.811</td>
<td align="right">203</td>
<td align="left">Chronic graft versus host disease</td>
<td align="left">Chronic graft-versus-host disease</td>
</tr>
<tr class="odd">
<td align="left">I51.81</td>
<td align="right">198</td>
<td align="left">Broken heart syndrome</td>
<td align="left">Takotsubo syndrome</td>
</tr>
<tr class="even">
<td align="left">N02.8</td>
<td align="right">195</td>
<td align="left">IgA nephropathy</td>
<td align="left">Recurrent and persistent hematuria with other morphologic changes</td>
</tr>
<tr class="odd">
<td align="left">N02.8</td>
<td align="right">195</td>
<td align="left">IgA nephropathy</td>
<td align="left">Recurrent and persistent hematuria with other morphologic changes</td>
</tr>
<tr class="even">
<td align="left">C45.9</td>
<td align="right">194</td>
<td align="left">Malignant mesothelioma</td>
<td align="left">Mesothelioma, unspecified</td>
</tr>
<tr class="odd">
<td align="left">H35.50</td>
<td align="right">193</td>
<td align="left">Leber congenital amaurosis</td>
<td align="left">Unspecified hereditary retinal dystrophy</td>
</tr>
<tr class="even">
<td align="left">H35.50</td>
<td align="right">193</td>
<td align="left">North Carolina macular dystrophy</td>
<td align="left">Unspecified hereditary retinal dystrophy</td>
</tr>
<tr class="odd">
<td align="left">H35.50</td>
<td align="right">193</td>
<td align="left">Cone dystrophy</td>
<td align="left">Unspecified hereditary retinal dystrophy</td>
</tr>
<tr class="even">
<td align="left">D89.2</td>
<td align="right">192</td>
<td align="left">Cryofibrinogenemia</td>
<td align="left">Hypergammaglobulinemia, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C18.1</td>
<td align="right">189</td>
<td align="left">Adenocarcinoma of the appendix</td>
<td align="left">Malignant neoplasm of appendix</td>
</tr>
<tr class="even">
<td align="left">C88.4</td>
<td align="right">188</td>
<td align="left">Marginal zone lymphoma</td>
<td align="left">Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]</td>
</tr>
<tr class="odd">
<td align="left">G40.802</td>
<td align="right">187</td>
<td align="left">Kohlschutter Tonz syndrome</td>
<td align="left">Other epilepsy, not intractable, without status epilepticus</td>
</tr>
<tr class="even">
<td align="left">G40.802</td>
<td align="right">187</td>
<td align="left">Photosensitive epilepsy</td>
<td align="left">Other epilepsy, not intractable, without status epilepticus</td>
</tr>
<tr class="odd">
<td align="left">C06.9</td>
<td align="right">187</td>
<td align="left">Oral cancer</td>
<td align="left">Malignant neoplasm of mouth, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q68.8</td>
<td align="right">186</td>
<td align="left">Congenital articular rigidity</td>
<td align="left">Other specified congenital musculoskeletal deformities</td>
</tr>
<tr class="odd">
<td align="left">Q68.8</td>
<td align="right">186</td>
<td align="left">Kuskokwim disease</td>
<td align="left">Other specified congenital musculoskeletal deformities</td>
</tr>
<tr class="even">
<td align="left">H93.299</td>
<td align="right">186</td>
<td align="left">Auditory neuropathy</td>
<td align="left">Other abnormal auditory perceptions, unspecified ear</td>
</tr>
<tr class="odd">
<td align="left">G61.0</td>
<td align="right">186</td>
<td align="left">Miller-Fisher syndrome</td>
<td align="left">Guillain-Barre syndrome</td>
</tr>
<tr class="even">
<td align="left">G61.0</td>
<td align="right">186</td>
<td align="left">Guillain-Barre syndrome</td>
<td align="left">Guillain-Barre syndrome</td>
</tr>
<tr class="odd">
<td align="left">G47.411</td>
<td align="right">185</td>
<td align="left">Narcolepsy</td>
<td align="left">Narcolepsy with cataplexy</td>
</tr>
<tr class="even">
<td align="left">D53.1</td>
<td align="right">185</td>
<td align="left">Thiamine responsive megaloblastic anemia syndrome</td>
<td align="left">Other megaloblastic anemias, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">D89.810</td>
<td align="right">184</td>
<td align="left">Acute graft versus host disease</td>
<td align="left">Acute graft-versus-host disease</td>
</tr>
<tr class="even">
<td align="left">D70.8</td>
<td align="right">183</td>
<td align="left">Neutropenia chronic familial</td>
<td align="left">Other neutropenia</td>
</tr>
<tr class="odd">
<td align="left">Q67.7</td>
<td align="right">181</td>
<td align="left">Pectus carinatum</td>
<td align="left">Pectus carinatum</td>
</tr>
<tr class="even">
<td align="left">Z88.8</td>
<td align="right">180</td>
<td align="left">Pseudocholinesterase deficiency</td>
<td align="left">Allergy status to other drugs, medicaments and biological substances status</td>
</tr>
<tr class="odd">
<td align="left">E78.3</td>
<td align="right">180</td>
<td align="left">Hyperlipoproteinemia type 5</td>
<td align="left">Hyperchylomicronemia</td>
</tr>
<tr class="even">
<td align="left">E78.3</td>
<td align="right">180</td>
<td align="left">Chylomicron retention disease</td>
<td align="left">Hyperchylomicronemia</td>
</tr>
<tr class="odd">
<td align="left">E78.3</td>
<td align="right">180</td>
<td align="left">Familial lipoprotein lipase deficiency</td>
<td align="left">Hyperchylomicronemia</td>
</tr>
<tr class="even">
<td align="left">D27.9</td>
<td align="right">179</td>
<td align="left">Brenner tumor of ovary</td>
<td align="left">Benign neoplasm of unspecified ovary</td>
</tr>
<tr class="odd">
<td align="left">D27.9</td>
<td align="right">179</td>
<td align="left">Sertoli-leydig cell tumors</td>
<td align="left">Benign neoplasm of unspecified ovary</td>
</tr>
<tr class="even">
<td align="left">D89.89</td>
<td align="right">176</td>
<td align="left">Nakajo Nishimura syndrome</td>
<td align="left">Other specified disorders involving the immune mechanism, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">D89.89</td>
<td align="right">176</td>
<td align="left">Nakajo syndrome</td>
<td align="left">Other specified disorders involving the immune mechanism, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">D89.89</td>
<td align="right">176</td>
<td align="left">Primary agammaglobulinemia</td>
<td align="left">Other specified disorders involving the immune mechanism, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">D89.89</td>
<td align="right">176</td>
<td align="left">Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature</td>
<td align="left">Other specified disorders involving the immune mechanism, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">D89.89</td>
<td align="right">176</td>
<td align="left">JMP syndrome</td>
<td align="left">Other specified disorders involving the immune mechanism, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q85.8</td>
<td align="right">175</td>
<td align="left">Angioma hereditary neurocutaneous</td>
<td align="left">Other phakomatoses, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q85.8</td>
<td align="right">175</td>
<td align="left">Graham Boyle Troxell syndrome</td>
<td align="left">Other phakomatoses, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q85.8</td>
<td align="right">175</td>
<td align="left">Juvenile polyposis syndrome</td>
<td align="left">Other phakomatoses, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q85.8</td>
<td align="right">175</td>
<td align="left">Cowden syndrome</td>
<td align="left">Other phakomatoses, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q85.8</td>
<td align="right">175</td>
<td align="left">Lhermitte-Duclos disease</td>
<td align="left">Other phakomatoses, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q85.8</td>
<td align="right">175</td>
<td align="left">Peutz-Jeghers syndrome</td>
<td align="left">Other phakomatoses, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q85.8</td>
<td align="right">175</td>
<td align="left">Sturge-Weber syndrome</td>
<td align="left">Other phakomatoses, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q85.8</td>
<td align="right">175</td>
<td align="left">Von Hippel-Lindau disease</td>
<td align="left">Other phakomatoses, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q85.8</td>
<td align="right">175</td>
<td align="left">Weber syndrome</td>
<td align="left">Other phakomatoses, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q85.8</td>
<td align="right">175</td>
<td align="left">Parkes Weber syndrome</td>
<td align="left">Other phakomatoses, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q85.8</td>
<td align="right">175</td>
<td align="left">Linear nevus sebaceous syndrome</td>
<td align="left">Other phakomatoses, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q85.8</td>
<td align="right">175</td>
<td align="left">Linear nevus sebaceous syndrome</td>
<td align="left">Other phakomatoses, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q85.8</td>
<td align="right">175</td>
<td align="left">Rhabdomyomatous mesenchymal hamartoma</td>
<td align="left">Other phakomatoses, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q85.8</td>
<td align="right">175</td>
<td align="left">Prosthetic joint infection</td>
<td align="left">Other phakomatoses, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q27.8</td>
<td align="right">175</td>
<td align="left">Aberrant subclavian artery</td>
<td align="left">Other specified congenital malformations of peripheral vascular system</td>
</tr>
<tr class="even">
<td align="left">Q11.2</td>
<td align="right">175</td>
<td align="left">Lenz microphthalmia syndrome</td>
<td align="left">Microphthalmos</td>
</tr>
<tr class="odd">
<td align="left">Q11.2</td>
<td align="right">175</td>
<td align="left">Cryptophthalmos</td>
<td align="left">Microphthalmos</td>
</tr>
<tr class="even">
<td align="left">Q11.2</td>
<td align="right">175</td>
<td align="left">Microphthalmia</td>
<td align="left">Microphthalmos</td>
</tr>
<tr class="odd">
<td align="left">E10.69</td>
<td align="right">175</td>
<td align="left">Immunodysregulation, polyendocrinopathy and enteropathy X-linked</td>
<td align="left">Type 1 diabetes mellitus with other specified complication</td>
</tr>
<tr class="even">
<td align="left">Q25.79</td>
<td align="right">173</td>
<td align="left">Pulmonary artery agenesis</td>
<td align="left">Other congenital malformations of pulmonary artery</td>
</tr>
<tr class="odd">
<td align="left">Q25.79</td>
<td align="right">173</td>
<td align="left">Unilateral absence of a pulmonary artery</td>
<td align="left">Other congenital malformations of pulmonary artery</td>
</tr>
<tr class="even">
<td align="left">B25.8</td>
<td align="right">173</td>
<td align="left">Cytomegalovirus retinitis</td>
<td align="left">Other cytomegaloviral diseases</td>
</tr>
<tr class="odd">
<td align="left">Q03.9</td>
<td align="right">172</td>
<td align="left">Hydrocephalus due to congenital stenosis of aqueduct of sylvius</td>
<td align="left">Congenital hydrocephalus, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q20.1</td>
<td align="right">170</td>
<td align="left">Double outlet right ventricle</td>
<td align="left">Double outlet right ventricle</td>
</tr>
<tr class="odd">
<td align="left">P90</td>
<td align="right">170</td>
<td align="left">Convulsions, benign familial infantile, 1</td>
<td align="left">Convulsions of newborn</td>
</tr>
<tr class="even">
<td align="left">P90</td>
<td align="right">170</td>
<td align="left">Benign familial neonatal-infantile seizures</td>
<td align="left">Convulsions of newborn</td>
</tr>
<tr class="odd">
<td align="left">P90</td>
<td align="right">170</td>
<td align="left">Convulsions benign familial neonatal dominant form</td>
<td align="left">Convulsions of newborn</td>
</tr>
<tr class="even">
<td align="left">P90</td>
<td align="right">170</td>
<td align="left">Benign familial neonatal epilepsy</td>
<td align="left">Convulsions of newborn</td>
</tr>
<tr class="odd">
<td align="left">D69.0</td>
<td align="right">170</td>
<td align="left">Hereditary spastic paraplegia</td>
<td align="left">Allergic purpura</td>
</tr>
<tr class="even">
<td align="left">D69.0</td>
<td align="right">170</td>
<td align="left">Hypersensitivity vasculitis</td>
<td align="left">Allergic purpura</td>
</tr>
<tr class="odd">
<td align="left">D69.0</td>
<td align="right">170</td>
<td align="left">Henoch-Schonlein purpura</td>
<td align="left">Allergic purpura</td>
</tr>
<tr class="even">
<td align="left">D75.81</td>
<td align="right">168</td>
<td align="left">Myelofibrosis</td>
<td align="left">Myelofibrosis</td>
</tr>
<tr class="odd">
<td align="left">N32.1</td>
<td align="right">167</td>
<td align="left">Enterovesical fistula</td>
<td align="left">Vesicointestinal fistula</td>
</tr>
<tr class="even">
<td align="left">N05.8</td>
<td align="right">167</td>
<td align="left">Immunotactoid glomerulopathy</td>
<td align="left">Unspecified nephritic syndrome with other morphologic changes</td>
</tr>
<tr class="odd">
<td align="left">N05.8</td>
<td align="right">167</td>
<td align="left">Fibrillary glomerulonephritis</td>
<td align="left">Unspecified nephritic syndrome with other morphologic changes</td>
</tr>
<tr class="even">
<td align="left">G51.8</td>
<td align="right">166</td>
<td align="left">Progressive hemifacial atrophy</td>
<td align="left">Other disorders of facial nerve</td>
</tr>
<tr class="odd">
<td align="left">E24.9</td>
<td align="right">165</td>
<td align="left">Cushing’s syndrome</td>
<td align="left">Cushing’s syndrome, unspecified</td>
</tr>
<tr class="even">
<td align="left">E24.9</td>
<td align="right">165</td>
<td align="left">Hyperadrenalism</td>
<td align="left">Cushing’s syndrome, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D39.10</td>
<td align="right">164</td>
<td align="left">Virilizing ovarian tumor</td>
<td align="left">Neoplasm of uncertain behavior of unspecified ovary</td>
</tr>
<tr class="even">
<td align="left">D39.10</td>
<td align="right">164</td>
<td align="left">Granulosa cell tumor of the ovary</td>
<td align="left">Neoplasm of uncertain behavior of unspecified ovary</td>
</tr>
<tr class="odd">
<td align="left">D39.10</td>
<td align="right">164</td>
<td align="left">Gynandroblastoma</td>
<td align="left">Neoplasm of uncertain behavior of unspecified ovary</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Infantile free sialic acid storage disease</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">17-alpha-hydroxylase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Gordon syndrome</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Gordon syndrome</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Tyrosinemia type 1</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Hyperphenylalaninemia due to dehydratase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Tyrosinemia type 2</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Methylmalonyl-Coenzyme A mutase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Phosphoribosylpyrophosphate synthetase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Pseudohypoaldosteronism type 2</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Pseudohypoaldosteronism type 2</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Salla disease</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">SCOT deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Sialuria, French type</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Sialuria, French type</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Mitochondrial complex II deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">17-beta hydroxysteroid dehydrogenase 3 deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">3 Methylcrotonyl-CoA carboxylase 1 deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Fumarase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Fumarase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Multiple symmetric lipomatosis</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Prolidase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Prolidase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Prolidase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Prolidase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Pseudocholinesterase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Pyruvate kinase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Rowley-Rosenberg syndrome</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Acetyl CoA acetyltransferase 2 deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Pseudoxanthoma elasticum</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Cortisone reductase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Isobutyryl-CoA dehydrogenase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Transaldolase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Cerebral folate deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Free sialic acid storage disease</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">3-methylcrotonyl-CoA carboxylase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Aromatase excess syndrome</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Hereditary folate malabsorption</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E53.1</td>
<td align="right">163</td>
<td align="left">Pyridoxine deficiency</td>
<td align="left">Pyridoxine deficiency</td>
</tr>
<tr class="odd">
<td align="left">Q13.4</td>
<td align="right">162</td>
<td align="left">Peters anomaly</td>
<td align="left">Other congenital corneal malformations</td>
</tr>
<tr class="even">
<td align="left">Q13.4</td>
<td align="right">162</td>
<td align="left">Peters plus syndrome</td>
<td align="left">Other congenital corneal malformations</td>
</tr>
<tr class="odd">
<td align="left">Q13.4</td>
<td align="right">162</td>
<td align="left">Isolated congenital megalocornea</td>
<td align="left">Other congenital corneal malformations</td>
</tr>
<tr class="even">
<td align="left">Q13.4</td>
<td align="right">162</td>
<td align="left">Isolated congenital megalocornea</td>
<td align="left">Other congenital corneal malformations</td>
</tr>
<tr class="odd">
<td align="left">G92</td>
<td align="right">162</td>
<td align="left">Neurotoxicity syndromes</td>
<td align="left">Toxic encephalopathy</td>
</tr>
<tr class="even">
<td align="left">Q89.2</td>
<td align="right">160</td>
<td align="left">Familial thyroglossal duct cyst</td>
<td align="left">Congenital malformations of other endocrine glands</td>
</tr>
<tr class="odd">
<td align="left">Q89.2</td>
<td align="right">160</td>
<td align="left">Thyroid agenesis</td>
<td align="left">Congenital malformations of other endocrine glands</td>
</tr>
<tr class="even">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">KBG syndrome</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="odd">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Mulibrey Nanism</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="even">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Robinow syndrome</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="odd">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Bangstad syndrome</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="even">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Dysostosis acral with facial and genital abnormalities</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="odd">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Spastic paraplegia 17</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="even">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Pseudo-Turner syndrome</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="odd">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Rigid spine syndrome</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="even">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Ullrich congenital muscular dystrophy</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="odd">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Aarskog syndrome</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="even">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Russell-Silver syndrome</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="odd">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Microcephalic osteodysplastic primordial dwarfism type 1</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="even">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Prader-Willi syndrome</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="odd">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Snyder-Robinson syndrome</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="even">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Cockayne syndrome</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="odd">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Diencephalic syndrome</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="even">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Dubowitz syndrome</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="odd">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Greig cephalopolysyndactyly syndrome</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="even">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Noonan syndrome 1</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="odd">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Sjogren-Larsson syndrome</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="even">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Seckel syndrome</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="odd">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Rud Syndrome</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="even">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Cornelia de Lange syndrome</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="odd">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Noonan syndrome</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="even">
<td align="left">Q87.1</td>
<td align="right">159</td>
<td align="left">Trichothiodystrophy</td>
<td align="left">Congenital malformation syndromes predominantly associated with short stature</td>
</tr>
<tr class="odd">
<td align="left">Q04.9</td>
<td align="right">159</td>
<td align="left">Cerebro-costo-mandibular syndrome</td>
<td align="left">Congenital malformation of brain, unspecified</td>
</tr>
<tr class="even">
<td align="left">K14.1</td>
<td align="right">159</td>
<td align="left">Geographic tongue</td>
<td align="left">Geographic tongue</td>
</tr>
<tr class="odd">
<td align="left">G24.8</td>
<td align="right">159</td>
<td align="left">Myoclonus-dystonia</td>
<td align="left">Other dystonia</td>
</tr>
<tr class="even">
<td align="left">G24.8</td>
<td align="right">159</td>
<td align="left">Spasmodic dysphonia</td>
<td align="left">Other dystonia</td>
</tr>
<tr class="odd">
<td align="left">G24.8</td>
<td align="right">159</td>
<td align="left">Dopa-responsive dystonia</td>
<td align="left">Other dystonia</td>
</tr>
<tr class="even">
<td align="left">P28.89</td>
<td align="right">158</td>
<td align="left">Laryngomalacia</td>
<td align="left">Other specified respiratory conditions of newborn</td>
</tr>
<tr class="odd">
<td align="left">D44.7</td>
<td align="right">157</td>
<td align="left">Paragangliomas 1</td>
<td align="left">Neoplasm of uncertain behavior of aortic body and other paraganglia</td>
</tr>
<tr class="even">
<td align="left">D44.7</td>
<td align="right">157</td>
<td align="left">Paragangliomas 1</td>
<td align="left">Neoplasm of uncertain behavior of aortic body and other paraganglia</td>
</tr>
<tr class="odd">
<td align="left">D44.7</td>
<td align="right">157</td>
<td align="left">Glomus vagale tumor</td>
<td align="left">Neoplasm of uncertain behavior of aortic body and other paraganglia</td>
</tr>
<tr class="even">
<td align="left">D44.7</td>
<td align="right">157</td>
<td align="left">Glomus tympanicum tumor</td>
<td align="left">Neoplasm of uncertain behavior of aortic body and other paraganglia</td>
</tr>
<tr class="odd">
<td align="left">F84.9</td>
<td align="right">156</td>
<td align="left">Camurati-Engelmann disease</td>
<td align="left">Pervasive developmental disorder, unspecified</td>
</tr>
<tr class="even">
<td align="left">M34.1</td>
<td align="right">155</td>
<td align="left">Limited cutaneous systemic sclerosis</td>
<td align="left">CR(E)ST syndrome</td>
</tr>
<tr class="odd">
<td align="left">M34.1</td>
<td align="right">155</td>
<td align="left">CREST syndrome</td>
<td align="left">CR(E)ST syndrome</td>
</tr>
<tr class="even">
<td align="left">B59</td>
<td align="right">154</td>
<td align="left">Pneumocystosis</td>
<td align="left">Pneumocystosis</td>
</tr>
<tr class="odd">
<td align="left">Q23.4</td>
<td align="right">153</td>
<td align="left">Hypoplastic left heart syndrome</td>
<td align="left">Hypoplastic left heart syndrome</td>
</tr>
<tr class="even">
<td align="left">M02.30</td>
<td align="right">153</td>
<td align="left">Reactive arthritis</td>
<td align="left">Reiter’s disease, unspecified site</td>
</tr>
<tr class="odd">
<td align="left">K59.8</td>
<td align="right">153</td>
<td align="left">Intestinal pseudo-obstruction</td>
<td align="left">Other specified functional intestinal disorders</td>
</tr>
<tr class="even">
<td align="left">K59.8</td>
<td align="right">153</td>
<td align="left">Ogilvie syndrome</td>
<td align="left">Other specified functional intestinal disorders</td>
</tr>
<tr class="odd">
<td align="left">G90.2</td>
<td align="right">153</td>
<td align="left">Horner’s syndrome</td>
<td align="left">Horner’s syndrome</td>
</tr>
<tr class="even">
<td align="left">G37.8</td>
<td align="right">153</td>
<td align="left">Leukoencephalopathy with vanishing white matter</td>
<td align="left">Other specified demyelinating diseases of central nervous system</td>
</tr>
<tr class="odd">
<td align="left">G37.8</td>
<td align="right">153</td>
<td align="left">Alexander disease</td>
<td align="left">Other specified demyelinating diseases of central nervous system</td>
</tr>
<tr class="even">
<td align="left">C71.0</td>
<td align="right">153</td>
<td align="left">Supratentorial primitive neuroectodermal tumor</td>
<td align="left">Malignant neoplasm of cerebrum, except lobes and ventricles</td>
</tr>
<tr class="odd">
<td align="left">C23</td>
<td align="right">153</td>
<td align="left">Gallbladder cancer</td>
<td align="left">Malignant neoplasm of gallbladder</td>
</tr>
<tr class="even">
<td align="left">G57.10</td>
<td align="right">152</td>
<td align="left">Meralgia paresthetica</td>
<td align="left">Meralgia paresthetica, unspecified lower limb</td>
</tr>
<tr class="odd">
<td align="left">G24.4</td>
<td align="right">152</td>
<td align="left">Meige syndrome</td>
<td align="left">Idiopathic orofacial dystonia</td>
</tr>
<tr class="even">
<td align="left">D82.1</td>
<td align="right">150</td>
<td align="left">22q11.2 deletion syndrome</td>
<td align="left">Di George’s syndrome</td>
</tr>
<tr class="odd">
<td align="left">D56.9</td>
<td align="right">150</td>
<td align="left">Thalassemia</td>
<td align="left">Thalassemia, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q99.8</td>
<td align="right">149</td>
<td align="left">Chromosome 18p tetrasomy</td>
<td align="left">Other specified chromosome abnormalities</td>
</tr>
<tr class="odd">
<td align="left">Q99.8</td>
<td align="right">149</td>
<td align="left">Opitz G/BBB syndrome</td>
<td align="left">Other specified chromosome abnormalities</td>
</tr>
<tr class="even">
<td align="left">Q99.8</td>
<td align="right">149</td>
<td align="left">Apparent mineralocorticoid excess</td>
<td align="left">Other specified chromosome abnormalities</td>
</tr>
<tr class="odd">
<td align="left">Q99.8</td>
<td align="right">149</td>
<td align="left">ICF syndrome</td>
<td align="left">Other specified chromosome abnormalities</td>
</tr>
<tr class="even">
<td align="left">Q99.8</td>
<td align="right">149</td>
<td align="left">Mosaic variegated aneuploidy syndrome</td>
<td align="left">Other specified chromosome abnormalities</td>
</tr>
<tr class="odd">
<td align="left">Q99.8</td>
<td align="right">149</td>
<td align="left">Weill-Marchesani syndrome</td>
<td align="left">Other specified chromosome abnormalities</td>
</tr>
<tr class="even">
<td align="left">Q99.8</td>
<td align="right">149</td>
<td align="left">Pallister-Killian mosaic syndrome</td>
<td align="left">Other specified chromosome abnormalities</td>
</tr>
<tr class="odd">
<td align="left">Q99.8</td>
<td align="right">149</td>
<td align="left">Emanuel syndrome</td>
<td align="left">Other specified chromosome abnormalities</td>
</tr>
<tr class="even">
<td align="left">Q99.8</td>
<td align="right">149</td>
<td align="left">Deafness-lymphedema-leukemia syndrome</td>
<td align="left">Other specified chromosome abnormalities</td>
</tr>
<tr class="odd">
<td align="left">F44.4</td>
<td align="right">149</td>
<td align="left">Camptocormism</td>
<td align="left">Conversion disorder with motor symptom or deficit</td>
</tr>
<tr class="even">
<td align="left">Q96.9</td>
<td align="right">148</td>
<td align="left">Genital dwarfism</td>
<td align="left">Turner’s syndrome, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q96.9</td>
<td align="right">148</td>
<td align="left">Gonadal dysgenesis</td>
<td align="left">Turner’s syndrome, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q96.9</td>
<td align="right">148</td>
<td align="left">Perrault syndrome</td>
<td align="left">Turner’s syndrome, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q96.9</td>
<td align="right">148</td>
<td align="left">Turner syndrome</td>
<td align="left">Turner’s syndrome, unspecified</td>
</tr>
<tr class="even">
<td align="left">L50.2</td>
<td align="right">148</td>
<td align="left">Cold urticaria</td>
<td align="left">Urticaria due to cold and heat</td>
</tr>
<tr class="odd">
<td align="left">L50.2</td>
<td align="right">148</td>
<td align="left">Cold urticaria</td>
<td align="left">Urticaria due to cold and heat</td>
</tr>
<tr class="even">
<td align="left">D55.0</td>
<td align="right">147</td>
<td align="left">Glucose-6-phosphate dehydrogenase deficiency</td>
<td align="left">Anemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency</td>
</tr>
<tr class="odd">
<td align="left">Q89.3</td>
<td align="right">146</td>
<td align="left">Primary ciliary dyskinesia</td>
<td align="left">Situs inversus</td>
</tr>
<tr class="even">
<td align="left">Q89.3</td>
<td align="right">146</td>
<td align="left">Situs inversus</td>
<td align="left">Situs inversus</td>
</tr>
<tr class="odd">
<td align="left">Q89.3</td>
<td align="right">146</td>
<td align="left">Dextrocardia with situs inversus</td>
<td align="left">Situs inversus</td>
</tr>
<tr class="even">
<td align="left">Q89.3</td>
<td align="right">146</td>
<td align="left">Kartagener syndrome</td>
<td align="left">Situs inversus</td>
</tr>
<tr class="odd">
<td align="left">Q89.3</td>
<td align="right">146</td>
<td align="left">Heterotaxy</td>
<td align="left">Situs inversus</td>
</tr>
<tr class="even">
<td align="left">D59.9</td>
<td align="right">146</td>
<td align="left">Hemoglobinemia</td>
<td align="left">Acquired hemolytic anemia, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q74.1</td>
<td align="right">145</td>
<td align="left">Absent patella</td>
<td align="left">Congenital malformation of knee</td>
</tr>
<tr class="even">
<td align="left">Q74.1</td>
<td align="right">145</td>
<td align="left">Congenital dislocation of the patella</td>
<td align="left">Congenital malformation of knee</td>
</tr>
<tr class="odd">
<td align="left">Q20.4</td>
<td align="right">145</td>
<td align="left">Single ventricular heart</td>
<td align="left">Double inlet ventricle</td>
</tr>
<tr class="even">
<td align="left">Q13.0</td>
<td align="right">145</td>
<td align="left">Coloboma of iris</td>
<td align="left">Coloboma of iris</td>
</tr>
<tr class="odd">
<td align="left">Q13.0</td>
<td align="right">145</td>
<td align="left">Baraitser-Winter syndrome</td>
<td align="left">Coloboma of iris</td>
</tr>
<tr class="even">
<td align="left">Q13.0</td>
<td align="right">145</td>
<td align="left">Trigonocephaly ptosis mental retardation</td>
<td align="left">Coloboma of iris</td>
</tr>
<tr class="odd">
<td align="left">G12.29</td>
<td align="right">145</td>
<td align="left">Troyer syndrome</td>
<td align="left">Other motor neuron disease</td>
</tr>
<tr class="even">
<td align="left">G12.29</td>
<td align="right">145</td>
<td align="left">Primary lateral sclerosis</td>
<td align="left">Other motor neuron disease</td>
</tr>
<tr class="odd">
<td align="left">D68.2</td>
<td align="right">145</td>
<td align="left">Dysfibrinogenemia</td>
<td align="left">Hereditary deficiency of other clotting factors</td>
</tr>
<tr class="even">
<td align="left">D68.2</td>
<td align="right">145</td>
<td align="left">Factor V deficiency</td>
<td align="left">Hereditary deficiency of other clotting factors</td>
</tr>
<tr class="odd">
<td align="left">D68.2</td>
<td align="right">145</td>
<td align="left">Factor VII deficiency</td>
<td align="left">Hereditary deficiency of other clotting factors</td>
</tr>
<tr class="even">
<td align="left">D68.2</td>
<td align="right">145</td>
<td align="left">High molecular weight kininogen deficiency</td>
<td align="left">Hereditary deficiency of other clotting factors</td>
</tr>
<tr class="odd">
<td align="left">D68.2</td>
<td align="right">145</td>
<td align="left">Afibrinogenemia</td>
<td align="left">Hereditary deficiency of other clotting factors</td>
</tr>
<tr class="even">
<td align="left">D68.2</td>
<td align="right">145</td>
<td align="left">Factor X deficiency</td>
<td align="left">Hereditary deficiency of other clotting factors</td>
</tr>
<tr class="odd">
<td align="left">D68.2</td>
<td align="right">145</td>
<td align="left">Factor X deficiency</td>
<td align="left">Hereditary deficiency of other clotting factors</td>
</tr>
<tr class="even">
<td align="left">D68.2</td>
<td align="right">145</td>
<td align="left">Factor XII deficiency</td>
<td align="left">Hereditary deficiency of other clotting factors</td>
</tr>
<tr class="odd">
<td align="left">D68.2</td>
<td align="right">145</td>
<td align="left">Factor XIII deficiency</td>
<td align="left">Hereditary deficiency of other clotting factors</td>
</tr>
<tr class="even">
<td align="left">D68.2</td>
<td align="right">145</td>
<td align="left">Factor XIII deficiency</td>
<td align="left">Hereditary deficiency of other clotting factors</td>
</tr>
<tr class="odd">
<td align="left">B54</td>
<td align="right">145</td>
<td align="left">Malaria</td>
<td align="left">Unspecified malaria</td>
</tr>
<tr class="even">
<td align="left">Q89.01</td>
<td align="right">144</td>
<td align="left">Ivemark syndrome</td>
<td align="left">Asplenia (congenital)</td>
</tr>
<tr class="odd">
<td align="left">G83.4</td>
<td align="right">144</td>
<td align="left">Cauda equina syndrome</td>
<td align="left">Cauda equina syndrome</td>
</tr>
<tr class="even">
<td align="left">Q22.0</td>
<td align="right">143</td>
<td align="left">Pulmonary atresia with ventricular septal defect</td>
<td align="left">Pulmonary valve atresia</td>
</tr>
<tr class="odd">
<td align="left">Q22.0</td>
<td align="right">143</td>
<td align="left">Pulmonary atresia with intact ventricular septum</td>
<td align="left">Pulmonary valve atresia</td>
</tr>
<tr class="even">
<td align="left">Q93.81</td>
<td align="right">142</td>
<td align="left">22q11.2 deletion syndrome</td>
<td align="left">Velo-cardio-facial syndrome</td>
</tr>
<tr class="odd">
<td align="left">M31.0</td>
<td align="right">142</td>
<td align="left">Goodpasture syndrome</td>
<td align="left">Hypersensitivity angiitis</td>
</tr>
<tr class="even">
<td align="left">M31.0</td>
<td align="right">142</td>
<td align="left">Hypersensitivity vasculitis</td>
<td align="left">Hypersensitivity angiitis</td>
</tr>
<tr class="odd">
<td align="left">K59.4</td>
<td align="right">142</td>
<td align="left">Levator syndrome</td>
<td align="left">Anal spasm</td>
</tr>
<tr class="even">
<td align="left">N15.9</td>
<td align="right">141</td>
<td align="left">BK-virus nephropathy</td>
<td align="left">Renal tubulo-interstitial disease, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q69.9</td>
<td align="right">140</td>
<td align="left">Polydactyly</td>
<td align="left">Polydactyly, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q68.0</td>
<td align="right">140</td>
<td align="left">Congenital torticollis</td>
<td align="left">Congenital deformity of sternocleidomastoid muscle</td>
</tr>
<tr class="odd">
<td align="left">Q04.8</td>
<td align="right">140</td>
<td align="left">Gillespie syndrome</td>
<td align="left">Other specified congenital malformations of brain</td>
</tr>
<tr class="even">
<td align="left">Q04.8</td>
<td align="right">140</td>
<td align="left">Exencephaly</td>
<td align="left">Other specified congenital malformations of brain</td>
</tr>
<tr class="odd">
<td align="left">Q04.8</td>
<td align="right">140</td>
<td align="left">PPM-X syndrome</td>
<td align="left">Other specified congenital malformations of brain</td>
</tr>
<tr class="even">
<td align="left">Q04.8</td>
<td align="right">140</td>
<td align="left">Subependymal nodular heterotopia</td>
<td align="left">Other specified congenital malformations of brain</td>
</tr>
<tr class="odd">
<td align="left">Q04.8</td>
<td align="right">140</td>
<td align="left">Coffin-Siris syndrome</td>
<td align="left">Other specified congenital malformations of brain</td>
</tr>
<tr class="even">
<td align="left">Q04.8</td>
<td align="right">140</td>
<td align="left">Pachygyria</td>
<td align="left">Other specified congenital malformations of brain</td>
</tr>
<tr class="odd">
<td align="left">Q04.8</td>
<td align="right">140</td>
<td align="left">Chiari malformation type 4</td>
<td align="left">Other specified congenital malformations of brain</td>
</tr>
<tr class="even">
<td align="left">Q04.8</td>
<td align="right">140</td>
<td align="left">Colpocephaly</td>
<td align="left">Other specified congenital malformations of brain</td>
</tr>
<tr class="odd">
<td align="left">J86.0</td>
<td align="right">140</td>
<td align="left">Tracheoesophageal fistula</td>
<td align="left">Pyothorax with fistula</td>
</tr>
<tr class="even">
<td align="left">H21.9</td>
<td align="right">140</td>
<td align="left">Uveal diseases</td>
<td align="left">Unspecified disorder of iris and ciliary body</td>
</tr>
<tr class="odd">
<td align="left">C88.0</td>
<td align="right">140</td>
<td align="left">Waldenstrom macroglobulinemia</td>
<td align="left">WaldenstrÃ¶m macroglobulinemia</td>
</tr>
<tr class="even">
<td align="left">C48.0</td>
<td align="right">140</td>
<td align="left">Retroperitoneal liposarcoma</td>
<td align="left">Malignant neoplasm of retroperitoneum</td>
</tr>
<tr class="odd">
<td align="left">N48.30</td>
<td align="right">139</td>
<td align="left">Priapism</td>
<td align="left">Priapism, unspecified</td>
</tr>
<tr class="even">
<td align="left">L66.1</td>
<td align="right">139</td>
<td align="left">Lichen planopilaris</td>
<td align="left">Lichen planopilaris</td>
</tr>
<tr class="odd">
<td align="left">G71.11</td>
<td align="right">139</td>
<td align="left">Myotonia atrophica</td>
<td align="left">Myotonic muscular dystrophy</td>
</tr>
<tr class="even">
<td align="left">G71.11</td>
<td align="right">139</td>
<td align="left">Myotonic dystrophy type 1</td>
<td align="left">Myotonic muscular dystrophy</td>
</tr>
<tr class="odd">
<td align="left">G71.11</td>
<td align="right">139</td>
<td align="left">Congenital myotonic dystrophy</td>
<td align="left">Myotonic muscular dystrophy</td>
</tr>
<tr class="even">
<td align="left">G71.11</td>
<td align="right">139</td>
<td align="left">Myotonic dystrophy type 2</td>
<td align="left">Myotonic muscular dystrophy</td>
</tr>
<tr class="odd">
<td align="left">G71.11</td>
<td align="right">139</td>
<td align="left">Myotonic dystrophy</td>
<td align="left">Myotonic muscular dystrophy</td>
</tr>
<tr class="even">
<td align="left">E34.0</td>
<td align="right">139</td>
<td align="left">Carcinoid syndrome</td>
<td align="left">Carcinoid syndrome</td>
</tr>
<tr class="odd">
<td align="left">Q80.9</td>
<td align="right">137</td>
<td align="left">Dykes Markes Harper syndrome</td>
<td align="left">Congenital ichthyosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q80.9</td>
<td align="right">137</td>
<td align="left">Ichthyosis lamellar 1</td>
<td align="left">Congenital ichthyosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q80.9</td>
<td align="right">137</td>
<td align="left">Ichthyosis vulgaris</td>
<td align="left">Congenital ichthyosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">L12.0</td>
<td align="right">137</td>
<td align="left">Bullous pemphigoid</td>
<td align="left">Bullous pemphigoid</td>
</tr>
<tr class="odd">
<td align="left">J61</td>
<td align="right">137</td>
<td align="left">Asbestosis</td>
<td align="left">Pneumoconiosis due to asbestos and other mineral fibers</td>
</tr>
<tr class="even">
<td align="left">J15.7</td>
<td align="right">137</td>
<td align="left">Mycoplasmal pneumonia</td>
<td align="left">Pneumonia due to Mycoplasma pneumoniae</td>
</tr>
<tr class="odd">
<td align="left">H30.90</td>
<td align="right">136</td>
<td align="left">Posterior uveitis</td>
<td align="left">Unspecified chorioretinal inflammation, unspecified eye</td>
</tr>
<tr class="even">
<td align="left">H30.90</td>
<td align="right">136</td>
<td align="left">Punctate inner choroidopathy</td>
<td align="left">Unspecified chorioretinal inflammation, unspecified eye</td>
</tr>
<tr class="odd">
<td align="left">Q43.3</td>
<td align="right">135</td>
<td align="left">Chilaiditi syndrome</td>
<td align="left">Congenital malformations of intestinal fixation</td>
</tr>
<tr class="even">
<td align="left">P05.9</td>
<td align="right">135</td>
<td align="left">IMAGe syndrome</td>
<td align="left">Newborn affected by slow intrauterine growth, unspecified</td>
</tr>
<tr class="odd">
<td align="left">M35.2</td>
<td align="right">135</td>
<td align="left">BehâÂºet disease</td>
<td align="left">BehÃ§et’s disease</td>
</tr>
<tr class="even">
<td align="left">G14</td>
<td align="right">135</td>
<td align="left">Post Polio syndrome</td>
<td align="left">Postpolio syndrome</td>
</tr>
<tr class="odd">
<td align="left">D81.9</td>
<td align="right">135</td>
<td align="left">Severe combined immunodeficiency</td>
<td align="left">Combined immunodeficiency, unspecified</td>
</tr>
<tr class="even">
<td align="left">D57.40</td>
<td align="right">135</td>
<td align="left">Sickle beta thalassemia</td>
<td align="left">Sickle-cell thalassemia without crisis</td>
</tr>
<tr class="odd">
<td align="left">D57.40</td>
<td align="right">135</td>
<td align="left">Sickle delta beta thalassemia</td>
<td align="left">Sickle-cell thalassemia without crisis</td>
</tr>
<tr class="even">
<td align="left">D18.1</td>
<td align="right">134</td>
<td align="left">Cystic hygroma</td>
<td align="left">Lymphangioma, any site</td>
</tr>
<tr class="odd">
<td align="left">D18.1</td>
<td align="right">134</td>
<td align="left">Cystic hygroma</td>
<td align="left">Lymphangioma, any site</td>
</tr>
<tr class="even">
<td align="left">D18.1</td>
<td align="right">134</td>
<td align="left">Lymphatic malformations</td>
<td align="left">Lymphangioma, any site</td>
</tr>
<tr class="odd">
<td align="left">D18.1</td>
<td align="right">134</td>
<td align="left">Lymphangiomatosis</td>
<td align="left">Lymphangioma, any site</td>
</tr>
<tr class="even">
<td align="left">C90.30</td>
<td align="right">133</td>
<td align="left">Anaplastic plasmacytoma</td>
<td align="left">Solitary plasmacytoma not having achieved remission</td>
</tr>
<tr class="odd">
<td align="left">G44.84</td>
<td align="right">132</td>
<td align="left">Exertional headache</td>
<td align="left">Primary exertional headache</td>
</tr>
<tr class="even">
<td align="left">D13.2</td>
<td align="right">132</td>
<td align="left">Paragangliomas 1</td>
<td align="left">Benign neoplasm of duodenum</td>
</tr>
<tr class="odd">
<td align="left">L12.1</td>
<td align="right">131</td>
<td align="left">Cicatricial pemphigoid</td>
<td align="left">Cicatricial pemphigoid</td>
</tr>
<tr class="even">
<td align="left">L12.1</td>
<td align="right">131</td>
<td align="left">Ocular cicatricial pemphigoid</td>
<td align="left">Cicatricial pemphigoid</td>
</tr>
<tr class="odd">
<td align="left">L12.1</td>
<td align="right">131</td>
<td align="left">Brunsting-Perry syndrome</td>
<td align="left">Cicatricial pemphigoid</td>
</tr>
<tr class="even">
<td align="left">H53.60</td>
<td align="right">129</td>
<td align="left">Keratomalacia</td>
<td align="left">Unspecified night blindness</td>
</tr>
<tr class="odd">
<td align="left">D14.1</td>
<td align="right">129</td>
<td align="left">Laryngeal papillomatosis</td>
<td align="left">Benign neoplasm of larynx</td>
</tr>
<tr class="even">
<td align="left">L43.8</td>
<td align="right">127</td>
<td align="left">Annular lichen planus</td>
<td align="left">Other lichen planus</td>
</tr>
<tr class="odd">
<td align="left">L43.8</td>
<td align="right">127</td>
<td align="left">Atrophic lichen planus</td>
<td align="left">Other lichen planus</td>
</tr>
<tr class="even">
<td align="left">L43.8</td>
<td align="right">127</td>
<td align="left">Lichen planus pemphigoides</td>
<td align="left">Other lichen planus</td>
</tr>
<tr class="odd">
<td align="left">J03.80</td>
<td align="right">127</td>
<td align="left">Lemierre syndrome</td>
<td align="left">Acute tonsillitis due to other specified organisms</td>
</tr>
<tr class="even">
<td align="left">D04.9</td>
<td align="right">127</td>
<td align="left">Bowen’s disease</td>
<td align="left">Carcinoma in situ of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q72.899</td>
<td align="right">126</td>
<td align="left">Congenital short femur</td>
<td align="left">Other reduction defects of unspecified lower limb</td>
</tr>
<tr class="even">
<td align="left">N25.89</td>
<td align="right">126</td>
<td align="left">Renal tubular acidosis with deafness</td>
<td align="left">Other disorders resulting from impaired renal tubular function</td>
</tr>
<tr class="odd">
<td align="left">N25.89</td>
<td align="right">126</td>
<td align="left">Renal tubular acidosis, distal</td>
<td align="left">Other disorders resulting from impaired renal tubular function</td>
</tr>
<tr class="even">
<td align="left">N25.89</td>
<td align="right">126</td>
<td align="left">Renal tubular acidosis, distal</td>
<td align="left">Other disorders resulting from impaired renal tubular function</td>
</tr>
<tr class="odd">
<td align="left">N25.89</td>
<td align="right">126</td>
<td align="left">Renal tubular acidosis, distal, autosomal dominant</td>
<td align="left">Other disorders resulting from impaired renal tubular function</td>
</tr>
<tr class="even">
<td align="left">N25.89</td>
<td align="right">126</td>
<td align="left">Renal tubular acidosis, distal, autosomal dominant</td>
<td align="left">Other disorders resulting from impaired renal tubular function</td>
</tr>
<tr class="odd">
<td align="left">N25.89</td>
<td align="right">126</td>
<td align="left">Hyporeninemic hypoaldosteronism</td>
<td align="left">Other disorders resulting from impaired renal tubular function</td>
</tr>
<tr class="even">
<td align="left">N25.89</td>
<td align="right">126</td>
<td align="left">Nephrocalcinosis</td>
<td align="left">Other disorders resulting from impaired renal tubular function</td>
</tr>
<tr class="odd">
<td align="left">N25.89</td>
<td align="right">126</td>
<td align="left">Renal tubular acidosis</td>
<td align="left">Other disorders resulting from impaired renal tubular function</td>
</tr>
<tr class="even">
<td align="left">N25.89</td>
<td align="right">126</td>
<td align="left">Gitelman syndrome</td>
<td align="left">Other disorders resulting from impaired renal tubular function</td>
</tr>
<tr class="odd">
<td align="left">N25.89</td>
<td align="right">126</td>
<td align="left">Renal hypouricemia</td>
<td align="left">Other disorders resulting from impaired renal tubular function</td>
</tr>
<tr class="even">
<td align="left">N25.89</td>
<td align="right">126</td>
<td align="left">SLC4A1-associated distal renal tubular acidosis</td>
<td align="left">Other disorders resulting from impaired renal tubular function</td>
</tr>
<tr class="odd">
<td align="left">N25.89</td>
<td align="right">126</td>
<td align="left">SLC4A1-associated distal renal tubular acidosis</td>
<td align="left">Other disorders resulting from impaired renal tubular function</td>
</tr>
<tr class="even">
<td align="left">I45.89</td>
<td align="right">125</td>
<td align="left">Brugada syndrome</td>
<td align="left">Other specified conduction disorders</td>
</tr>
<tr class="odd">
<td align="left">I45.89</td>
<td align="right">125</td>
<td align="left">Progressive familial heart block type 1A</td>
<td align="left">Other specified conduction disorders</td>
</tr>
<tr class="even">
<td align="left">I45.89</td>
<td align="right">125</td>
<td align="left">Progressive familial heart block type 1B</td>
<td align="left">Other specified conduction disorders</td>
</tr>
<tr class="odd">
<td align="left">I45.89</td>
<td align="right">125</td>
<td align="left">Familial progressive cardiac conduction defect</td>
<td align="left">Other specified conduction disorders</td>
</tr>
<tr class="even">
<td align="left">G10</td>
<td align="right">125</td>
<td align="left">Huntington disease</td>
<td align="left">Huntington’s disease</td>
</tr>
<tr class="odd">
<td align="left">G10</td>
<td align="right">125</td>
<td align="left">Juvenile Huntington disease</td>
<td align="left">Huntington’s disease</td>
</tr>
<tr class="even">
<td align="left">M31.1</td>
<td align="right">124</td>
<td align="left">Thrombotic thrombocytopenic purpura, acquired</td>
<td align="left">Thrombotic microangiopathy</td>
</tr>
<tr class="odd">
<td align="left">D68.4</td>
<td align="right">124</td>
<td align="left">Acquired hypoprothrombinemia</td>
<td align="left">Acquired coagulation factor deficiency</td>
</tr>
<tr class="even">
<td align="left">D68.4</td>
<td align="right">124</td>
<td align="left">Acquired hypoprothrombinemia</td>
<td align="left">Acquired coagulation factor deficiency</td>
</tr>
<tr class="odd">
<td align="left">D68.4</td>
<td align="right">124</td>
<td align="left">Acquired hemophilia A</td>
<td align="left">Acquired coagulation factor deficiency</td>
</tr>
<tr class="even">
<td align="left">G25.5</td>
<td align="right">123</td>
<td align="left">Benign hereditary chorea</td>
<td align="left">Other chorea</td>
</tr>
<tr class="odd">
<td align="left">G25.5</td>
<td align="right">123</td>
<td align="left">Chorea-acanthocytosis</td>
<td align="left">Other chorea</td>
</tr>
<tr class="even">
<td align="left">G25.5</td>
<td align="right">123</td>
<td align="left">Paroxysmal kinesigenic choreoathetosis</td>
<td align="left">Other chorea</td>
</tr>
<tr class="odd">
<td align="left">G25.5</td>
<td align="right">123</td>
<td align="left">Neuroacanthocytosis</td>
<td align="left">Other chorea</td>
</tr>
<tr class="even">
<td align="left">E83.118</td>
<td align="right">123</td>
<td align="left">Bantu siderosis</td>
<td align="left">Other hemochromatosis</td>
</tr>
<tr class="odd">
<td align="left">E83.118</td>
<td align="right">123</td>
<td align="left">Hemochromatosis type 2</td>
<td align="left">Other hemochromatosis</td>
</tr>
<tr class="even">
<td align="left">D58.0</td>
<td align="right">123</td>
<td align="left">Hereditary spherocytosis</td>
<td align="left">Hereditary spherocytosis</td>
</tr>
<tr class="odd">
<td align="left">D11.9</td>
<td align="right">123</td>
<td align="left">Warthin tumor</td>
<td align="left">Benign neoplasm of major salivary gland, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Gorlin Chaudhry Moss syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="odd">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Hanhart syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="even">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Hanhart syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="odd">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Sakati syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="even">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Summitt syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="odd">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Hallermann-Streiff syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="even">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Orofaciodigital syndrome 4</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="odd">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Char syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="even">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Charlie M syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="odd">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Frontonasal dysplasia</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="even">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Microsomia hemifacial radial defects</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="odd">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Fryns syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="even">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Orofaciodigital syndrome 2</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="odd">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Orofaciodigital syndrome 1</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="even">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Pierre Robin sequence</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="odd">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Ruvalcaba syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="even">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Weill-Marchesani syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="odd">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Sugarman brachydactyly</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="even">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Oto-palato-digital syndrome type 1</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="odd">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Wildervanck syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="even">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Oto-palato-digital syndrome type 2</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="odd">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Apert syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="even">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Fraser syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="odd">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Freeman Sheldon syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="even">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Goldenhar disease</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="odd">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Hemifacial microsomia</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="even">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Oto-Palatal-digital syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="odd">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Pfeiffer syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="even">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Miller syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="odd">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Moebius syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="even">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Dysgnathia complex</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="odd">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Auralcephalosyndactyly</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="even">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Mowat-Wilson syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="odd">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Auriculo-condylar syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="even">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Branchiootorenal syndrome</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="odd">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Orofaciodigital syndrome 3</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="even">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Orofaciodigital syndromes</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="odd">
<td align="left">Q87.0</td>
<td align="right">121</td>
<td align="left">Craniofacial microsomia</td>
<td align="left">Congenital malformation syndromes predominantly affecting facial appearance</td>
</tr>
<tr class="even">
<td align="left">Q22.5</td>
<td align="right">121</td>
<td align="left">Ebstein’s anomaly</td>
<td align="left">Ebstein’s anomaly</td>
</tr>
<tr class="odd">
<td align="left">D66</td>
<td align="right">121</td>
<td align="left">Hemophilia A</td>
<td align="left">Hereditary factor VIII deficiency</td>
</tr>
<tr class="even">
<td align="left">D66</td>
<td align="right">121</td>
<td align="left">Hemophilia</td>
<td align="left">Hereditary factor VIII deficiency</td>
</tr>
<tr class="odd">
<td align="left">M72.6</td>
<td align="right">120</td>
<td align="left">Necrotizing fasciitis</td>
<td align="left">Necrotizing fasciitis</td>
</tr>
<tr class="even">
<td align="left">C17.9</td>
<td align="right">120</td>
<td align="left">Small intestine cancer</td>
<td align="left">Malignant neoplasm of small intestine, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C17.9</td>
<td align="right">120</td>
<td align="left">Small Intestinal Adenocarcinoma</td>
<td align="left">Malignant neoplasm of small intestine, unspecified</td>
</tr>
<tr class="even">
<td align="left">L40.3</td>
<td align="right">119</td>
<td align="left">Pustulosis palmaris et plantaris</td>
<td align="left">Pustulosis palmaris et plantaris</td>
</tr>
<tr class="odd">
<td align="left">K31.819</td>
<td align="right">119</td>
<td align="left">Watermelon stomach</td>
<td align="left">Angiodysplasia of stomach and duodenum without bleeding</td>
</tr>
<tr class="even">
<td align="left">Q04.6</td>
<td align="right">118</td>
<td align="left">Schizencephaly</td>
<td align="left">Congenital cerebral cysts</td>
</tr>
<tr class="odd">
<td align="left">Q04.6</td>
<td align="right">118</td>
<td align="left">Porencephaly</td>
<td align="left">Congenital cerebral cysts</td>
</tr>
<tr class="even">
<td align="left">Q04.6</td>
<td align="right">118</td>
<td align="left">Colloid cysts of third ventricle</td>
<td align="left">Congenital cerebral cysts</td>
</tr>
<tr class="odd">
<td align="left">K31.5</td>
<td align="right">118</td>
<td align="left">Duodenal atresia</td>
<td align="left">Obstruction of duodenum</td>
</tr>
<tr class="even">
<td align="left">Q84.6</td>
<td align="right">117</td>
<td align="left">Hereditary koilonychia</td>
<td align="left">Other congenital malformations of nails</td>
</tr>
<tr class="odd">
<td align="left">D69.49</td>
<td align="right">116</td>
<td align="left">Hemangioma thrombocytopenia syndrome</td>
<td align="left">Other primary thrombocytopenia</td>
</tr>
<tr class="even">
<td align="left">D69.49</td>
<td align="right">116</td>
<td align="left">Kabuki syndrome</td>
<td align="left">Other primary thrombocytopenia</td>
</tr>
<tr class="odd">
<td align="left">D44.4</td>
<td align="right">116</td>
<td align="left">Craniopharyngioma</td>
<td align="left">Neoplasm of uncertain behavior of craniopharyngeal duct</td>
</tr>
<tr class="even">
<td align="left">B44.81</td>
<td align="right">116</td>
<td align="left">Allergic bronchopulmonary aspergillosis</td>
<td align="left">Allergic bronchopulmonary aspergillosis</td>
</tr>
<tr class="odd">
<td align="left">A46</td>
<td align="right">116</td>
<td align="left">Erysipelas</td>
<td align="left">Erysipelas</td>
</tr>
<tr class="even">
<td align="left">Q99.2</td>
<td align="right">115</td>
<td align="left">Fragile XE syndrome</td>
<td align="left">Fragile X chromosome</td>
</tr>
<tr class="odd">
<td align="left">Q99.2</td>
<td align="right">115</td>
<td align="left">Fragile X syndrome</td>
<td align="left">Fragile X chromosome</td>
</tr>
<tr class="even">
<td align="left">P29.3</td>
<td align="right">115</td>
<td align="left">Alveolar capillary dysplasia</td>
<td align="left">Persistent fetal circulation</td>
</tr>
<tr class="odd">
<td align="left">Q14.2</td>
<td align="right">114</td>
<td align="left">Coloboma of optic nerve</td>
<td align="left">Congenital malformation of optic disc</td>
</tr>
<tr class="even">
<td align="left">L11.1</td>
<td align="right">114</td>
<td align="left">Grover’s disease</td>
<td align="left">Transient acantholytic dermatosis [Grover]</td>
</tr>
<tr class="odd">
<td align="left">L98.6</td>
<td align="right">112</td>
<td align="left">Lymphocytic infiltrate of Jessner</td>
<td align="left">Other infiltrative disorders of the skin and subcutaneous tissue</td>
</tr>
<tr class="even">
<td align="left">K22.6</td>
<td align="right">112</td>
<td align="left">Mallory-Weiss syndrome</td>
<td align="left">Gastro-esophageal laceration-hemorrhage syndrome</td>
</tr>
<tr class="odd">
<td align="left">H50.89</td>
<td align="right">111</td>
<td align="left">Duane-radial ray syndrome</td>
<td align="left">Other specified strabismus</td>
</tr>
<tr class="even">
<td align="left">H50.89</td>
<td align="right">111</td>
<td align="left">Duane syndrome type 2</td>
<td align="left">Other specified strabismus</td>
</tr>
<tr class="odd">
<td align="left">H50.89</td>
<td align="right">111</td>
<td align="left">Duane syndrome type 3</td>
<td align="left">Other specified strabismus</td>
</tr>
<tr class="even">
<td align="left">H50.89</td>
<td align="right">111</td>
<td align="left">Duane syndrome type 1</td>
<td align="left">Other specified strabismus</td>
</tr>
<tr class="odd">
<td align="left">Q78.0</td>
<td align="right">110</td>
<td align="left">Osteogenesis imperfecta</td>
<td align="left">Osteogenesis imperfecta</td>
</tr>
<tr class="even">
<td align="left">Q78.0</td>
<td align="right">110</td>
<td align="left">Osteoporosis-pseudoglioma syndrome</td>
<td align="left">Osteogenesis imperfecta</td>
</tr>
<tr class="odd">
<td align="left">Q78.0</td>
<td align="right">110</td>
<td align="left">Osteogenesis imperfecta type I</td>
<td align="left">Osteogenesis imperfecta</td>
</tr>
<tr class="even">
<td align="left">Q78.0</td>
<td align="right">110</td>
<td align="left">Osteogenesis imperfecta type III</td>
<td align="left">Osteogenesis imperfecta</td>
</tr>
<tr class="odd">
<td align="left">Q78.0</td>
<td align="right">110</td>
<td align="left">Osteogenesis imperfecta type IV</td>
<td align="left">Osteogenesis imperfecta</td>
</tr>
<tr class="even">
<td align="left">Q78.0</td>
<td align="right">110</td>
<td align="left">Osteogenesis imperfecta type II</td>
<td align="left">Osteogenesis imperfecta</td>
</tr>
<tr class="odd">
<td align="left">Q78.0</td>
<td align="right">110</td>
<td align="left">Osteogenesis imperfecta type II</td>
<td align="left">Osteogenesis imperfecta</td>
</tr>
<tr class="even">
<td align="left">Q78.0</td>
<td align="right">110</td>
<td align="left">Osteogenesis imperfecta type II</td>
<td align="left">Osteogenesis imperfecta</td>
</tr>
<tr class="odd">
<td align="left">G36.0</td>
<td align="right">110</td>
<td align="left">Neuromyelitis Optica</td>
<td align="left">Neuromyelitis optica [Devic]</td>
</tr>
<tr class="even">
<td align="left">G36.0</td>
<td align="right">110</td>
<td align="left">Neuromyelitis optica spectrum disorder</td>
<td align="left">Neuromyelitis optica [Devic]</td>
</tr>
<tr class="odd">
<td align="left">D56.1</td>
<td align="right">110</td>
<td align="left">Beta-thalassemia</td>
<td align="left">Beta thalassemia</td>
</tr>
<tr class="even">
<td align="left">Q23.2</td>
<td align="right">109</td>
<td align="left">Congenital mitral stenosis</td>
<td align="left">Congenital mitral stenosis</td>
</tr>
<tr class="odd">
<td align="left">Q23.2</td>
<td align="right">109</td>
<td align="left">Mitral atresia</td>
<td align="left">Congenital mitral stenosis</td>
</tr>
<tr class="even">
<td align="left">M42.00</td>
<td align="right">108</td>
<td align="left">Scheuermann disease</td>
<td align="left">Juvenile osteochondrosis of spine, site unspecified</td>
</tr>
<tr class="odd">
<td align="left">I70.8</td>
<td align="right">108</td>
<td align="left">Retinopathy, arteriosclerotic</td>
<td align="left">Atherosclerosis of other arteries</td>
</tr>
<tr class="even">
<td align="left">C74.90</td>
<td align="right">108</td>
<td align="left">Neuroblastoma</td>
<td align="left">Malignant neoplasm of unspecified part of unspecified adrenal gland</td>
</tr>
<tr class="odd">
<td align="left">Q04.0</td>
<td align="right">106</td>
<td align="left">Adrenocortical carcinoma</td>
<td align="left">Congenital malformations of corpus callosum</td>
</tr>
<tr class="even">
<td align="left">Q04.0</td>
<td align="right">106</td>
<td align="left">Corpus callosum agenesis</td>
<td align="left">Congenital malformations of corpus callosum</td>
</tr>
<tr class="odd">
<td align="left">Q04.0</td>
<td align="right">106</td>
<td align="left">Andermann syndrome</td>
<td align="left">Congenital malformations of corpus callosum</td>
</tr>
<tr class="even">
<td align="left">E31.22</td>
<td align="right">105</td>
<td align="left">Multiple endocrine neoplasia type 2</td>
<td align="left">Multiple endocrine neoplasia [MEN] type IIA</td>
</tr>
<tr class="odd">
<td align="left">E31.22</td>
<td align="right">105</td>
<td align="left">Multiple endocrine neoplasia type 2A</td>
<td align="left">Multiple endocrine neoplasia [MEN] type IIA</td>
</tr>
<tr class="even">
<td align="left">C52</td>
<td align="right">105</td>
<td align="left">Vaginal cancer</td>
<td align="left">Malignant neoplasm of vagina</td>
</tr>
<tr class="odd">
<td align="left">C10.9</td>
<td align="right">105</td>
<td align="left">Oropharyngeal cancer, adult</td>
<td align="left">Malignant neoplasm of oropharynx, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q85.1</td>
<td align="right">104</td>
<td align="left">Bourneville syndrome</td>
<td align="left">Tuberous sclerosis</td>
</tr>
<tr class="odd">
<td align="left">Q85.1</td>
<td align="right">104</td>
<td align="left">Tuberous sclerosis</td>
<td align="left">Tuberous sclerosis</td>
</tr>
<tr class="even">
<td align="left">G00.9</td>
<td align="right">104</td>
<td align="left">Bacterial meningitis</td>
<td align="left">Bacterial meningitis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D73.5</td>
<td align="right">104</td>
<td align="left">Splenic infarcts</td>
<td align="left">Infarction of spleen</td>
</tr>
<tr class="even">
<td align="left">Q26.8</td>
<td align="right">103</td>
<td align="left">Pulmonary venous return anomaly</td>
<td align="left">Other congenital malformations of great veins</td>
</tr>
<tr class="odd">
<td align="left">G23.1</td>
<td align="right">103</td>
<td align="left">Progressive supranuclear palsy</td>
<td align="left">Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]</td>
</tr>
<tr class="even">
<td align="left">D71</td>
<td align="right">103</td>
<td align="left">Chronic granulomatous disease</td>
<td align="left">Functional disorders of polymorphonuclear neutrophils</td>
</tr>
<tr class="odd">
<td align="left">D71</td>
<td align="right">103</td>
<td align="left">Neutrophil-specific granule deficiency</td>
<td align="left">Functional disorders of polymorphonuclear neutrophils</td>
</tr>
<tr class="even">
<td align="left">K76.7</td>
<td align="right">102</td>
<td align="left">Hepatorenal syndrome</td>
<td align="left">Hepatorenal syndrome</td>
</tr>
<tr class="odd">
<td align="left">M83.9</td>
<td align="right">101</td>
<td align="left">Osteomalacia</td>
<td align="left">Adult osteomalacia, unspecified</td>
</tr>
<tr class="even">
<td align="left">G72.41</td>
<td align="right">101</td>
<td align="left">Inclusion body myositis</td>
<td align="left">Inclusion body myositis [IBM]</td>
</tr>
<tr class="odd">
<td align="left">D84.1</td>
<td align="right">101</td>
<td align="left">Properdin deficiency</td>
<td align="left">Defects in the complement system</td>
</tr>
<tr class="even">
<td align="left">D84.1</td>
<td align="right">101</td>
<td align="left">Hereditary angioedema</td>
<td align="left">Defects in the complement system</td>
</tr>
<tr class="odd">
<td align="left">D84.1</td>
<td align="right">101</td>
<td align="left">Complement component deficiency</td>
<td align="left">Defects in the complement system</td>
</tr>
<tr class="even">
<td align="left">D84.1</td>
<td align="right">101</td>
<td align="left">Complement receptor deficiency</td>
<td align="left">Defects in the complement system</td>
</tr>
<tr class="odd">
<td align="left">B83.9</td>
<td align="right">101</td>
<td align="left">Distomatosis</td>
<td align="left">Helminthiasis, unspecified</td>
</tr>
<tr class="even">
<td align="left">B83.9</td>
<td align="right">101</td>
<td align="left">Helminthiasis</td>
<td align="left">Helminthiasis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">L51.1</td>
<td align="right">100</td>
<td align="left">Erythema multiforme</td>
<td align="left">Stevens-Johnson syndrome</td>
</tr>
<tr class="even">
<td align="left">L51.1</td>
<td align="right">100</td>
<td align="left">Stevens-Johnson syndrome</td>
<td align="left">Stevens-Johnson syndrome</td>
</tr>
<tr class="odd">
<td align="left">L01.02</td>
<td align="right">100</td>
<td align="left">Eosinophilic pustular folliculitis</td>
<td align="left">Bockhart’s impetigo</td>
</tr>
<tr class="even">
<td align="left">J93.11</td>
<td align="right">100</td>
<td align="left">Primary spontaneous pneumothorax</td>
<td align="left">Primary spontaneous pneumothorax</td>
</tr>
<tr class="odd">
<td align="left">J93.11</td>
<td align="right">100</td>
<td align="left">Progressive supranuclear palsy</td>
<td align="left">Primary spontaneous pneumothorax</td>
</tr>
<tr class="even">
<td align="left">E51.9</td>
<td align="right">100</td>
<td align="left">Beriberi</td>
<td align="left">Thiamine deficiency, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D15.1</td>
<td align="right">100</td>
<td align="left">Atrial myxoma, familial</td>
<td align="left">Benign neoplasm of heart</td>
</tr>
<tr class="even">
<td align="left">D15.1</td>
<td align="right">100</td>
<td align="left">Carney complex</td>
<td align="left">Benign neoplasm of heart</td>
</tr>
<tr class="odd">
<td align="left">Q42.3</td>
<td align="right">99</td>
<td align="left">Imperforate anus</td>
<td align="left">Congenital absence, atresia and stenosis of anus without fistula</td>
</tr>
<tr class="even">
<td align="left">M04.1</td>
<td align="right">99</td>
<td align="left">Mevalonic aciduria</td>
<td align="left">Periodic fever syndromes</td>
</tr>
<tr class="odd">
<td align="left">M04.1</td>
<td align="right">99</td>
<td align="left">Familial Mediterranean fever</td>
<td align="left">Periodic fever syndromes</td>
</tr>
<tr class="even">
<td align="left">M04.1</td>
<td align="right">99</td>
<td align="left">Tumor necrosis factor receptor-associated periodic syndrome</td>
<td align="left">Periodic fever syndromes</td>
</tr>
<tr class="odd">
<td align="left">E25.0</td>
<td align="right">99</td>
<td align="left">Alternating hemiplegia of childhood</td>
<td align="left">Congenital adrenogenital disorders associated with enzyme deficiency</td>
</tr>
<tr class="even">
<td align="left">E25.0</td>
<td align="right">99</td>
<td align="left">X-linked adrenal hypoplasia congenita</td>
<td align="left">Congenital adrenogenital disorders associated with enzyme deficiency</td>
</tr>
<tr class="odd">
<td align="left">E25.0</td>
<td align="right">99</td>
<td align="left">X-linked adrenal hypoplasia congenita</td>
<td align="left">Congenital adrenogenital disorders associated with enzyme deficiency</td>
</tr>
<tr class="even">
<td align="left">E25.0</td>
<td align="right">99</td>
<td align="left">Congenital lipoid adrenal hyperplasia</td>
<td align="left">Congenital adrenogenital disorders associated with enzyme deficiency</td>
</tr>
<tr class="odd">
<td align="left">E25.0</td>
<td align="right">99</td>
<td align="left">Congenital adrenal hyperplasia</td>
<td align="left">Congenital adrenogenital disorders associated with enzyme deficiency</td>
</tr>
<tr class="even">
<td align="left">E25.0</td>
<td align="right">99</td>
<td align="left">11-beta-hydroxylase deficiency</td>
<td align="left">Congenital adrenogenital disorders associated with enzyme deficiency</td>
</tr>
<tr class="odd">
<td align="left">E25.0</td>
<td align="right">99</td>
<td align="left">18 Hydroxylase deficiency</td>
<td align="left">Congenital adrenogenital disorders associated with enzyme deficiency</td>
</tr>
<tr class="even">
<td align="left">E25.0</td>
<td align="right">99</td>
<td align="left">21-hydroxylase deficiency</td>
<td align="left">Congenital adrenogenital disorders associated with enzyme deficiency</td>
</tr>
<tr class="odd">
<td align="left">E25.0</td>
<td align="right">99</td>
<td align="left">3-beta-hydroxysteroid dehydrogenase deficiency</td>
<td align="left">Congenital adrenogenital disorders associated with enzyme deficiency</td>
</tr>
<tr class="even">
<td align="left">Q22.4</td>
<td align="right">98</td>
<td align="left">Tricuspid atresia</td>
<td align="left">Congenital tricuspid stenosis</td>
</tr>
<tr class="odd">
<td align="left">Q22.4</td>
<td align="right">98</td>
<td align="left">Tricuspid atresia</td>
<td align="left">Congenital tricuspid stenosis</td>
</tr>
<tr class="even">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">Pentosuria</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="odd">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">Diphosphoglycerate mutase deficiency of erythrocyte</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="even">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">Glucosephosphate isomerase deficiency</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="odd">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">Glyceraldehyde-3-phosphate dehydrogenase deficiency</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="even">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">Hyperglycerolemia</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="odd">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">Alpha-mannosidosis</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="even">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">Phosphoglycerate kinase deficiency</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="odd">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">Renal glycosuria</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="even">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">ALG6-CDG (CDG-Ic)</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="odd">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">ALG6-CDG (CDG-Ic)</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="even">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">ALG12-CDG (CDG-Ig)</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="odd">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">Phosphoglycerate mutase deficiency</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="even">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">Trehalase deficiency</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="odd">
<td align="left">Q30.2</td>
<td align="right">97</td>
<td align="left">Bifid nose</td>
<td align="left">Fissured, notched and cleft nose</td>
</tr>
<tr class="even">
<td align="left">M85.00</td>
<td align="right">97</td>
<td align="left">Dysplasia epiphysealis hemimelica</td>
<td align="left">Fibrous dysplasia (monostotic), unspecified site</td>
</tr>
<tr class="odd">
<td align="left">M85.00</td>
<td align="right">97</td>
<td align="left">Hyaline fibromatosis syndrome</td>
<td align="left">Fibrous dysplasia (monostotic), unspecified site</td>
</tr>
<tr class="even">
<td align="left">M35.8</td>
<td align="right">97</td>
<td align="left">Antisynthetase syndrome</td>
<td align="left">Other specified systemic involvement of connective tissue</td>
</tr>
<tr class="odd">
<td align="left">M35.8</td>
<td align="right">97</td>
<td align="left">Eosinophilia-myalgia syndrome</td>
<td align="left">Other specified systemic involvement of connective tissue</td>
</tr>
<tr class="even">
<td align="left">D76.3</td>
<td align="right">97</td>
<td align="left">Lipogranulomatosis</td>
<td align="left">Other histiocytosis syndromes</td>
</tr>
<tr class="odd">
<td align="left">D76.3</td>
<td align="right">97</td>
<td align="left">Rosai-Dorfman disease</td>
<td align="left">Other histiocytosis syndromes</td>
</tr>
<tr class="even">
<td align="left">D76.3</td>
<td align="right">97</td>
<td align="left">Non-Langerhans-Cell Histiocytosis</td>
<td align="left">Other histiocytosis syndromes</td>
</tr>
<tr class="odd">
<td align="left">D76.3</td>
<td align="right">97</td>
<td align="left">Sea-Blue histiocytosis</td>
<td align="left">Other histiocytosis syndromes</td>
</tr>
<tr class="even">
<td align="left">D76.3</td>
<td align="right">97</td>
<td align="left">Histiocytosis-lymphadenopathy plus syndrome</td>
<td align="left">Other histiocytosis syndromes</td>
</tr>
<tr class="odd">
<td align="left">D76.3</td>
<td align="right">97</td>
<td align="left">Necrobiotic xanthogranuloma</td>
<td align="left">Other histiocytosis syndromes</td>
</tr>
<tr class="even">
<td align="left">D76.3</td>
<td align="right">97</td>
<td align="left">Reticulohistiocytoma</td>
<td align="left">Other histiocytosis syndromes</td>
</tr>
<tr class="odd">
<td align="left">D56.0</td>
<td align="right">97</td>
<td align="left">Alpha-thalassemia</td>
<td align="left">Alpha thalassemia</td>
</tr>
<tr class="even">
<td align="left">P91.2</td>
<td align="right">96</td>
<td align="left">Periventricular leukomalacia</td>
<td align="left">Neonatal cerebral leukomalacia</td>
</tr>
<tr class="odd">
<td align="left">L40.4</td>
<td align="right">96</td>
<td align="left">Guttate psoriasis</td>
<td align="left">Guttate psoriasis</td>
</tr>
<tr class="even">
<td align="left">I67.5</td>
<td align="right">96</td>
<td align="left">Moyamoya disease</td>
<td align="left">Moyamoya disease</td>
</tr>
<tr class="odd">
<td align="left">G04.91</td>
<td align="right">96</td>
<td align="left">Myelitis</td>
<td align="left">Myelitis, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q79.0</td>
<td align="right">95</td>
<td align="left">Congenital diaphragmatic hernia</td>
<td align="left">Congenital diaphragmatic hernia</td>
</tr>
<tr class="odd">
<td align="left">G54.8</td>
<td align="right">95</td>
<td align="left">Tarlov cysts</td>
<td align="left">Other nerve root and plexus disorders</td>
</tr>
<tr class="even">
<td align="left">F81.2</td>
<td align="right">95</td>
<td align="left">Gerstmann syndrome</td>
<td align="left">Mathematics disorder</td>
</tr>
<tr class="odd">
<td align="left">C24.9</td>
<td align="right">95</td>
<td align="left">Biliary tract cancer</td>
<td align="left">Malignant neoplasm of biliary tract, unspecified</td>
</tr>
<tr class="even">
<td align="left">K55.30</td>
<td align="right">94</td>
<td align="left">Necrotizing enterocolitis</td>
<td align="left">Necrotizing enterocolitis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D3A.098</td>
<td align="right">94</td>
<td align="left">VIPoma</td>
<td align="left">Benign carcinoid tumors of other sites</td>
</tr>
<tr class="even">
<td align="left">D30.00</td>
<td align="right">94</td>
<td align="left">Renal oncocytoma</td>
<td align="left">Benign neoplasm of unspecified kidney</td>
</tr>
<tr class="odd">
<td align="left">C68.0</td>
<td align="right">94</td>
<td align="left">Urethral cancer</td>
<td align="left">Malignant neoplasm of urethra</td>
</tr>
<tr class="even">
<td align="left">Q20.5</td>
<td align="right">93</td>
<td align="left">Congenitally corrected transposition of the great arteries</td>
<td align="left">Discordant atrioventricular connection</td>
</tr>
<tr class="odd">
<td align="left">Q20.5</td>
<td align="right">93</td>
<td align="left">Double discordia</td>
<td align="left">Discordant atrioventricular connection</td>
</tr>
<tr class="even">
<td align="left">Q20.5</td>
<td align="right">93</td>
<td align="left">Levotransposition of the great arteries</td>
<td align="left">Discordant atrioventricular connection</td>
</tr>
<tr class="odd">
<td align="left">N85.6</td>
<td align="right">93</td>
<td align="left">Asherman’s syndrome</td>
<td align="left">Intrauterine synechiae</td>
</tr>
<tr class="even">
<td align="left">L81.5</td>
<td align="right">93</td>
<td align="left">Hypomelanotic disorder</td>
<td align="left">Leukoderma, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">K22.3</td>
<td align="right">93</td>
<td align="left">Boerhaave syndrome</td>
<td align="left">Perforation of esophagus</td>
</tr>
<tr class="even">
<td align="left">H71.90</td>
<td align="right">93</td>
<td align="left">Cholesteatoma</td>
<td align="left">Unspecified cholesteatoma, unspecified ear</td>
</tr>
<tr class="odd">
<td align="left">A41.4</td>
<td align="right">93</td>
<td align="left">Clostridium perfringens infection</td>
<td align="left">Sepsis due to anaerobes</td>
</tr>
<tr class="even">
<td align="left">Q13.1</td>
<td align="right">92</td>
<td align="left">Aniridia</td>
<td align="left">Absence of iris</td>
</tr>
<tr class="odd">
<td align="left">L13.0</td>
<td align="right">92</td>
<td align="left">Dermatitis herpetiformis</td>
<td align="left">Dermatitis herpetiformis</td>
</tr>
<tr class="even">
<td align="left">I25.41</td>
<td align="right">92</td>
<td align="left">Coronary artery aneurysm</td>
<td align="left">Coronary artery aneurysm</td>
</tr>
<tr class="odd">
<td align="left">G04.81</td>
<td align="right">92</td>
<td align="left">Rasmussen Johnsen Thomsen syndrome</td>
<td align="left">Other encephalitis and encephalomyelitis</td>
</tr>
<tr class="even">
<td align="left">G04.81</td>
<td align="right">92</td>
<td align="left">Allergic encephalomyelitis</td>
<td align="left">Other encephalitis and encephalomyelitis</td>
</tr>
<tr class="odd">
<td align="left">G04.81</td>
<td align="right">92</td>
<td align="left">Allergic encephalomyelitis</td>
<td align="left">Other encephalitis and encephalomyelitis</td>
</tr>
<tr class="even">
<td align="left">G04.81</td>
<td align="right">92</td>
<td align="left">Rasmussen encephalitis</td>
<td align="left">Other encephalitis and encephalomyelitis</td>
</tr>
<tr class="odd">
<td align="left">G04.81</td>
<td align="right">92</td>
<td align="left">Hashimoto’s encephalitis</td>
<td align="left">Other encephalitis and encephalomyelitis</td>
</tr>
<tr class="even">
<td align="left">G04.81</td>
<td align="right">92</td>
<td align="left">Autoimmune encephalitis</td>
<td align="left">Other encephalitis and encephalomyelitis</td>
</tr>
<tr class="odd">
<td align="left">D43.4</td>
<td align="right">92</td>
<td align="left">Sacrococcygeal Teratoma</td>
<td align="left">Neoplasm of uncertain behavior of spinal cord</td>
</tr>
<tr class="even">
<td align="left">I51.4</td>
<td align="right">91</td>
<td align="left">Myocarditis</td>
<td align="left">Myocarditis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">G44.53</td>
<td align="right">91</td>
<td align="left">Thunderclap headache</td>
<td align="left">Primary thunderclap headache</td>
</tr>
<tr class="even">
<td align="left">A31.8</td>
<td align="right">91</td>
<td align="left">Mycobacterium Avium Complex</td>
<td align="left">Other mycobacterial infections</td>
</tr>
<tr class="odd">
<td align="left">J82</td>
<td align="right">90</td>
<td align="left">Pneumonia, eosinophilic</td>
<td align="left">Pulmonary eosinophilia, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">H51.0</td>
<td align="right">90</td>
<td align="left">Doyne honeycomb retinal dystrophy</td>
<td align="left">Palsy (spasm) of conjugate gaze</td>
</tr>
<tr class="odd">
<td align="left">H51.0</td>
<td align="right">90</td>
<td align="left">Supranuclear ocular palsy</td>
<td align="left">Palsy (spasm) of conjugate gaze</td>
</tr>
<tr class="even">
<td align="left">H51.0</td>
<td align="right">90</td>
<td align="left">Horizontal gaze palsy with progressive scoliosis</td>
<td align="left">Palsy (spasm) of conjugate gaze</td>
</tr>
<tr class="odd">
<td align="left">D80.9</td>
<td align="right">90</td>
<td align="left">Primary agammaglobulinemia</td>
<td align="left">Immunodeficiency with predominantly antibody defects, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q80.0</td>
<td align="right">89</td>
<td align="left">Dominant ichthyosis vulgaris</td>
<td align="left">Ichthyosis vulgaris</td>
</tr>
<tr class="odd">
<td align="left">Q80.0</td>
<td align="right">89</td>
<td align="left">Ichthyosis vulgaris</td>
<td align="left">Ichthyosis vulgaris</td>
</tr>
<tr class="even">
<td align="left">G57.50</td>
<td align="right">89</td>
<td align="left">Tarsal tunnel syndrome</td>
<td align="left">Tarsal tunnel syndrome, unspecified lower limb</td>
</tr>
<tr class="odd">
<td align="left">F63.9</td>
<td align="right">89</td>
<td align="left">I cell disease</td>
<td align="left">Impulse disorder, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q55.62</td>
<td align="right">88</td>
<td align="left">Penis agenesis</td>
<td align="left">Hypoplasia of penis</td>
</tr>
<tr class="odd">
<td align="left">D14.0</td>
<td align="right">88</td>
<td align="left">Endolymphatic sac tumor</td>
<td align="left">Benign neoplasm of middle ear, nasal cavity and accessory sinuses</td>
</tr>
<tr class="even">
<td align="left">Q44.6</td>
<td align="right">87</td>
<td align="left">Polycystic liver disease</td>
<td align="left">Cystic disease of liver</td>
</tr>
<tr class="odd">
<td align="left">M33.00</td>
<td align="right">87</td>
<td align="left">Juvenile dermatomyositis</td>
<td align="left">Juvenile dermatopolymyositis, organ involvement unspecified</td>
</tr>
<tr class="even">
<td align="left">G11.8</td>
<td align="right">87</td>
<td align="left">Arts syndrome</td>
<td align="left">Other hereditary ataxias</td>
</tr>
<tr class="odd">
<td align="left">G11.8</td>
<td align="right">87</td>
<td align="left">Episodic ataxia with nystagmus</td>
<td align="left">Other hereditary ataxias</td>
</tr>
<tr class="even">
<td align="left">G11.8</td>
<td align="right">87</td>
<td align="left">Episodic ataxia</td>
<td align="left">Other hereditary ataxias</td>
</tr>
<tr class="odd">
<td align="left">C93.10</td>
<td align="right">87</td>
<td align="left">Chronic myelomonocytic leukemia</td>
<td align="left">Chronic myelomonocytic leukemia not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">A43.9</td>
<td align="right">87</td>
<td align="left">Nocardiosis</td>
<td align="left">Nocardiosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q26.2</td>
<td align="right">86</td>
<td align="left">Pulmonary venous return anomaly</td>
<td align="left">Total anomalous pulmonary venous connection</td>
</tr>
<tr class="even">
<td align="left">D61.3</td>
<td align="right">86</td>
<td align="left">Aplastic anemia</td>
<td align="left">Idiopathic aplastic anemia</td>
</tr>
<tr class="odd">
<td align="left">Q04.3</td>
<td align="right">85</td>
<td align="left">Cerebellar hypoplasia</td>
<td align="left">Other reduction deformities of brain</td>
</tr>
<tr class="even">
<td align="left">Q04.3</td>
<td align="right">85</td>
<td align="left">Lissencephaly 1</td>
<td align="left">Other reduction deformities of brain</td>
</tr>
<tr class="odd">
<td align="left">Q04.3</td>
<td align="right">85</td>
<td align="left">Aicardi syndrome</td>
<td align="left">Other reduction deformities of brain</td>
</tr>
<tr class="even">
<td align="left">Q04.3</td>
<td align="right">85</td>
<td align="left">Bilateral perisylvian polymicrogyria</td>
<td align="left">Other reduction deformities of brain</td>
</tr>
<tr class="odd">
<td align="left">Q04.3</td>
<td align="right">85</td>
<td align="left">Hydranencephaly</td>
<td align="left">Other reduction deformities of brain</td>
</tr>
<tr class="even">
<td align="left">Q04.3</td>
<td align="right">85</td>
<td align="left">Joubert syndrome</td>
<td align="left">Other reduction deformities of brain</td>
</tr>
<tr class="odd">
<td align="left">Q04.3</td>
<td align="right">85</td>
<td align="left">Pachygyria</td>
<td align="left">Other reduction deformities of brain</td>
</tr>
<tr class="even">
<td align="left">Q04.3</td>
<td align="right">85</td>
<td align="left">Pontoneocerebellar Hypoplasia</td>
<td align="left">Other reduction deformities of brain</td>
</tr>
<tr class="odd">
<td align="left">Q04.3</td>
<td align="right">85</td>
<td align="left">Pontoneocerebellar Hypoplasia</td>
<td align="left">Other reduction deformities of brain</td>
</tr>
<tr class="even">
<td align="left">Q04.3</td>
<td align="right">85</td>
<td align="left">Absence of septum pellucidum</td>
<td align="left">Other reduction deformities of brain</td>
</tr>
<tr class="odd">
<td align="left">Q04.3</td>
<td align="right">85</td>
<td align="left">Joubert syndrome with oculorenal anomalies</td>
<td align="left">Other reduction deformities of brain</td>
</tr>
<tr class="even">
<td align="left">Q04.3</td>
<td align="right">85</td>
<td align="left">Spinocerebellar ataxia 29</td>
<td align="left">Other reduction deformities of brain</td>
</tr>
<tr class="odd">
<td align="left">Q04.3</td>
<td align="right">85</td>
<td align="left">Pontocerebellar hypoplasia</td>
<td align="left">Other reduction deformities of brain</td>
</tr>
<tr class="even">
<td align="left">Q04.3</td>
<td align="right">85</td>
<td align="left">Pontocerebellar hypoplasia</td>
<td align="left">Other reduction deformities of brain</td>
</tr>
<tr class="odd">
<td align="left">Q04.3</td>
<td align="right">85</td>
<td align="left">Lissencephaly</td>
<td align="left">Other reduction deformities of brain</td>
</tr>
<tr class="even">
<td align="left">Q03.1</td>
<td align="right">85</td>
<td align="left">Dandy-Walker complex</td>
<td align="left">Atresia of foramina of Magendie and Luschka</td>
</tr>
<tr class="odd">
<td align="left">M65.20</td>
<td align="right">85</td>
<td align="left">Synovial Chondromatosis</td>
<td align="left">Calcific tendinitis, unspecified site</td>
</tr>
<tr class="even">
<td align="left">L81.6</td>
<td align="right">85</td>
<td align="left">Alezzandrini syndrome</td>
<td align="left">Other disorders of diminished melanin formation</td>
</tr>
<tr class="odd">
<td align="left">C11.9</td>
<td align="right">85</td>
<td align="left">Nasopharyngeal carcinoma</td>
<td align="left">Malignant neoplasm of nasopharynx, unspecified</td>
</tr>
<tr class="even">
<td align="left">N08</td>
<td align="right">84</td>
<td align="left">Glomerulonephritis</td>
<td align="left">Glomerular disorders in diseases classified elsewhere</td>
</tr>
<tr class="odd">
<td align="left">J60</td>
<td align="right">84</td>
<td align="left">Coal worker’s pneumoconiosis</td>
<td align="left">Coalworker’s pneumoconiosis</td>
</tr>
<tr class="even">
<td align="left">E34.3</td>
<td align="right">84</td>
<td align="left">Laron syndrome</td>
<td align="left">Short stature due to endocrine disorder</td>
</tr>
<tr class="odd">
<td align="left">E34.3</td>
<td align="right">84</td>
<td align="left">Isolated growth hormone deficiency type 1A</td>
<td align="left">Short stature due to endocrine disorder</td>
</tr>
<tr class="even">
<td align="left">C91.Z0</td>
<td align="right">84</td>
<td align="left">Large granular lymphocyte leukemia</td>
<td align="left">Other lymphoid leukemia not having achieved remission</td>
</tr>
<tr class="odd">
<td align="left">C91.Z0</td>
<td align="right">84</td>
<td align="left">Large granular lymphocyte leukemia</td>
<td align="left">Other lymphoid leukemia not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">Q61.9</td>
<td align="right">83</td>
<td align="left">Meckel syndrome</td>
<td align="left">Cystic kidney disease, unspecified</td>
</tr>
<tr class="odd">
<td align="left">F07.0</td>
<td align="right">83</td>
<td align="left">Kluver Bucy syndrome</td>
<td align="left">Personality change due to known physiological condition</td>
</tr>
<tr class="even">
<td align="left">D59.6</td>
<td align="right">83</td>
<td align="left">Paroxysmal cold hemoglobinuria</td>
<td align="left">Hemoglobinuria due to hemolysis from other external causes</td>
</tr>
<tr class="odd">
<td align="left">Q43.8</td>
<td align="right">82</td>
<td align="left">Intestinal atresia multiple</td>
<td align="left">Other specified congenital malformations of intestine</td>
</tr>
<tr class="even">
<td align="left">Q43.8</td>
<td align="right">82</td>
<td align="left">Microvillus inclusion disease</td>
<td align="left">Other specified congenital malformations of intestine</td>
</tr>
<tr class="odd">
<td align="left">Q43.8</td>
<td align="right">82</td>
<td align="left">Familial isolated pituitary adenoma</td>
<td align="left">Other specified congenital malformations of intestine</td>
</tr>
<tr class="even">
<td align="left">M08.20</td>
<td align="right">82</td>
<td align="left">Systemic onset juvenile idiopathic arthritis</td>
<td align="left">Juvenile rheumatoid arthritis with systemic onset, unspecified site</td>
</tr>
<tr class="odd">
<td align="left">C96.6</td>
<td align="right">82</td>
<td align="left">Hashimoto-Pritzker syndrome</td>
<td align="left">Unifocal Langerhans-cell histiocytosis</td>
</tr>
<tr class="even">
<td align="left">C96.6</td>
<td align="right">82</td>
<td align="left">Langerhans cell histiocytosis</td>
<td align="left">Unifocal Langerhans-cell histiocytosis</td>
</tr>
<tr class="odd">
<td align="left">Q85.9</td>
<td align="right">81</td>
<td align="left">Hypothalamic hamartomas</td>
<td align="left">Phakomatosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q85.9</td>
<td align="right">81</td>
<td align="left">Proteus syndrome</td>
<td align="left">Phakomatosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q24.0</td>
<td align="right">81</td>
<td align="left">Dextrocardia</td>
<td align="left">Dextrocardia</td>
</tr>
<tr class="even">
<td align="left">I78.0</td>
<td align="right">81</td>
<td align="left">Hereditary hemorrhagic telangiectasia</td>
<td align="left">Hereditary hemorrhagic telangiectasia</td>
</tr>
<tr class="odd">
<td align="left">B02.21</td>
<td align="right">81</td>
<td align="left">Herpes zoster oticus</td>
<td align="left">Postherpetic geniculate ganglionitis</td>
</tr>
<tr class="even">
<td align="left">Q64.4</td>
<td align="right">80</td>
<td align="left">Urachal cyst</td>
<td align="left">Malformation of urachus</td>
</tr>
<tr class="odd">
<td align="left">L88</td>
<td align="right">80</td>
<td align="left">Pyoderma gangrenosum</td>
<td align="left">Pyoderma gangrenosum</td>
</tr>
<tr class="even">
<td align="left">E55.0</td>
<td align="right">80</td>
<td align="left">Rickets</td>
<td align="left">Rickets, active</td>
</tr>
<tr class="odd">
<td align="left">M04.8</td>
<td align="right">79</td>
<td align="left">Blau syndrome</td>
<td align="left">Other autoinflammatory syndromes</td>
</tr>
<tr class="even">
<td align="left">M04.8</td>
<td align="right">79</td>
<td align="left">Majeed syndrome</td>
<td align="left">Other autoinflammatory syndromes</td>
</tr>
<tr class="odd">
<td align="left">M04.8</td>
<td align="right">79</td>
<td align="left">Deficiency of interleukin-1 receptor antagonist</td>
<td align="left">Other autoinflammatory syndromes</td>
</tr>
<tr class="even">
<td align="left">L81.7</td>
<td align="right">79</td>
<td align="left">Pigmented purpuric dermatosis</td>
<td align="left">Pigmented purpuric dermatosis</td>
</tr>
<tr class="odd">
<td align="left">L81.7</td>
<td align="right">79</td>
<td align="left">Angioma serpiginosum, X-linked</td>
<td align="left">Pigmented purpuric dermatosis</td>
</tr>
<tr class="even">
<td align="left">C91.40</td>
<td align="right">79</td>
<td align="left">Hairy cell leukemia</td>
<td align="left">Hairy cell leukemia not having achieved remission</td>
</tr>
<tr class="odd">
<td align="left">C08.9</td>
<td align="right">79</td>
<td align="left">Polymorphous low-grade adenocarcinoma</td>
<td align="left">Malignant neoplasm of major salivary gland, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">Femoral facial syndrome</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="odd">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">Nager acrofacial dysostosis</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="even">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">Chondrodysplasia, Grebe type</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="odd">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">Klippel-Trenaunay syndrome</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="even">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">Mietens-Weber syndrome</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="odd">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">Nievergelt syndrome</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="even">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">Multiple synostoses syndrome 1</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="odd">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">Rapadilino syndrome</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="even">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">TAR syndrome</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="odd">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">VACTERL association</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="even">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">Adams-Oliver syndrome</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="odd">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">CHILD syndrome</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="even">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">Holt-Oram syndrome</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="odd">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">Lacrimo-auriculo-dento-digital syndrome</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="even">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">Multiple pterygium syndrome Escobar type</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="odd">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">Nail-patella syndrome</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="even">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">Rubinstein-Taybi syndrome</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="odd">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">Sirenomelia</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="even">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">Sirenomelia</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="odd">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">Sirenomelia</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="even">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">Townes-Brocks syndrome</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="odd">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">Trichorhinophalangeal syndrome type 1</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="even">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">Weber syndrome</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="odd">
<td align="left">Q87.2</td>
<td align="right">78</td>
<td align="left">Parkes Weber syndrome</td>
<td align="left">Congenital malformation syndromes predominantly involving limbs</td>
</tr>
<tr class="even">
<td align="left">Q43.1</td>
<td align="right">78</td>
<td align="left">Hirschsprung’s disease</td>
<td align="left">Hirschsprung’s disease</td>
</tr>
<tr class="odd">
<td align="left">K65.4</td>
<td align="right">78</td>
<td align="left">Sclerosing mesenteritis</td>
<td align="left">Sclerosing mesenteritis</td>
</tr>
<tr class="even">
<td align="left">N30.80</td>
<td align="right">77</td>
<td align="left">Eosinophilic cystitis</td>
<td align="left">Other cystitis without hematuria</td>
</tr>
<tr class="odd">
<td align="left">L93.1</td>
<td align="right">77</td>
<td align="left">Cutaneous lupus erythematosus</td>
<td align="left">Subacute cutaneous lupus erythematosus</td>
</tr>
<tr class="even">
<td align="left">E24.0</td>
<td align="right">77</td>
<td align="left">ACTH-secreting pituitary adenoma</td>
<td align="left">Pituitary-dependent Cushing’s disease</td>
</tr>
<tr class="odd">
<td align="left">D59.4</td>
<td align="right">77</td>
<td align="left">Thrombotic thrombocytopenic purpura, congenital</td>
<td align="left">Other nonautoimmune hemolytic anemias</td>
</tr>
<tr class="even">
<td align="left">B45.9</td>
<td align="right">77</td>
<td align="left">Cryptococcosis</td>
<td align="left">Cryptococcosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">P24.00</td>
<td align="right">76</td>
<td align="left">McCune-Albright syndrome</td>
<td align="left">Meconium aspiration without respiratory symptoms</td>
</tr>
<tr class="even">
<td align="left">P24.00</td>
<td align="right">76</td>
<td align="left">Meconium aspiration syndrome</td>
<td align="left">Meconium aspiration without respiratory symptoms</td>
</tr>
<tr class="odd">
<td align="left">I73.81</td>
<td align="right">76</td>
<td align="left">Erythromelalgia</td>
<td align="left">Erythromelalgia</td>
</tr>
<tr class="even">
<td align="left">G54.5</td>
<td align="right">76</td>
<td align="left">Parsonage Turner syndrome</td>
<td align="left">Neuralgic amyotrophy</td>
</tr>
<tr class="odd">
<td align="left">C60.9</td>
<td align="right">76</td>
<td align="left">Penile cancer, adult</td>
<td align="left">Malignant neoplasm of penis, unspecified</td>
</tr>
<tr class="even">
<td align="left">C60.9</td>
<td align="right">76</td>
<td align="left">Buschke Lowenstein tumor</td>
<td align="left">Malignant neoplasm of penis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">G31.01</td>
<td align="right">75</td>
<td align="left">Pick’s disease</td>
<td align="left">Pick’s disease</td>
</tr>
<tr class="even">
<td align="left">G31.01</td>
<td align="right">75</td>
<td align="left">Frontotemporal dementia</td>
<td align="left">Pick’s disease</td>
</tr>
<tr class="odd">
<td align="left">G31.01</td>
<td align="right">75</td>
<td align="left">Primary progressive aphasia</td>
<td align="left">Pick’s disease</td>
</tr>
<tr class="even">
<td align="left">N46.01</td>
<td align="right">74</td>
<td align="left">Spermatogenesis arrest</td>
<td align="left">Organic azoospermia</td>
</tr>
<tr class="odd">
<td align="left">Q92.8</td>
<td align="right">72</td>
<td align="left">Cat eye syndrome</td>
<td align="left">Other specified trisomies and partial trisomies of autosomes</td>
</tr>
<tr class="even">
<td align="left">Q92.8</td>
<td align="right">72</td>
<td align="left">Chromosome 20 trisomy</td>
<td align="left">Other specified trisomies and partial trisomies of autosomes</td>
</tr>
<tr class="odd">
<td align="left">Q92.8</td>
<td align="right">72</td>
<td align="left">Trisomy 22</td>
<td align="left">Other specified trisomies and partial trisomies of autosomes</td>
</tr>
<tr class="even">
<td align="left">Q92.8</td>
<td align="right">72</td>
<td align="left">Trisomy 22</td>
<td align="left">Other specified trisomies and partial trisomies of autosomes</td>
</tr>
<tr class="odd">
<td align="left">Q92.8</td>
<td align="right">72</td>
<td align="left">MECP2 duplication syndrome</td>
<td align="left">Other specified trisomies and partial trisomies of autosomes</td>
</tr>
<tr class="even">
<td align="left">Q92.8</td>
<td align="right">72</td>
<td align="left">22q11.2 duplication syndrome</td>
<td align="left">Other specified trisomies and partial trisomies of autosomes</td>
</tr>
<tr class="odd">
<td align="left">E20.8</td>
<td align="right">72</td>
<td align="left">Hypocalcemia, autosomal dominant</td>
<td align="left">Other hypoparathyroidism</td>
</tr>
<tr class="even">
<td align="left">E20.8</td>
<td align="right">72</td>
<td align="left">Hypoparathyroidism X-linked</td>
<td align="left">Other hypoparathyroidism</td>
</tr>
<tr class="odd">
<td align="left">P24.01</td>
<td align="right">71</td>
<td align="left">McCune-Albright syndrome</td>
<td align="left">Meconium aspiration with respiratory symptoms</td>
</tr>
<tr class="even">
<td align="left">P24.01</td>
<td align="right">71</td>
<td align="left">Meconium aspiration syndrome</td>
<td align="left">Meconium aspiration with respiratory symptoms</td>
</tr>
<tr class="odd">
<td align="left">O26.86</td>
<td align="right">71</td>
<td align="left">Pruritic urticarial papules plaques of pregnancy</td>
<td align="left">Pruritic urticarial papules and plaques of pregnancy (PUPPP)</td>
</tr>
<tr class="even">
<td align="left">G52.1</td>
<td align="right">71</td>
<td align="left">Glossopharyngeal neuralgia</td>
<td align="left">Disorders of glossopharyngeal nerve</td>
</tr>
<tr class="odd">
<td align="left">Q24.6</td>
<td align="right">70</td>
<td align="left">Congenital heart block</td>
<td align="left">Congenital heart block</td>
</tr>
<tr class="even">
<td align="left">N94.810</td>
<td align="right">70</td>
<td align="left">Vulvar Vestibulitis Syndrome</td>
<td align="left">Vulvar vestibulitis</td>
</tr>
<tr class="odd">
<td align="left">D59.5</td>
<td align="right">70</td>
<td align="left">Paroxysmal nocturnal hemoglobinuria</td>
<td align="left">Paroxysmal nocturnal hemoglobinuria [Marchiafava-Micheli]</td>
</tr>
<tr class="even">
<td align="left">Q93.89</td>
<td align="right">69</td>
<td align="left">Chromosome 3p deletion</td>
<td align="left">Other deletions from the autosomes</td>
</tr>
<tr class="odd">
<td align="left">Q93.89</td>
<td align="right">69</td>
<td align="left">Johanson-Blizzard syndrome</td>
<td align="left">Other deletions from the autosomes</td>
</tr>
<tr class="even">
<td align="left">Q93.89</td>
<td align="right">69</td>
<td align="left">Jacobsen syndrome</td>
<td align="left">Other deletions from the autosomes</td>
</tr>
<tr class="odd">
<td align="left">Q93.89</td>
<td align="right">69</td>
<td align="left">Chromosome 4q deletion</td>
<td align="left">Other deletions from the autosomes</td>
</tr>
<tr class="even">
<td align="left">Q93.89</td>
<td align="right">69</td>
<td align="left">Chromosome 11q deletion</td>
<td align="left">Other deletions from the autosomes</td>
</tr>
<tr class="odd">
<td align="left">Q93.89</td>
<td align="right">69</td>
<td align="left">Chromosome 13q deletion</td>
<td align="left">Other deletions from the autosomes</td>
</tr>
<tr class="even">
<td align="left">Q93.89</td>
<td align="right">69</td>
<td align="left">Chromosome 3p- syndrome</td>
<td align="left">Other deletions from the autosomes</td>
</tr>
<tr class="odd">
<td align="left">Q93.89</td>
<td align="right">69</td>
<td align="left">Paris-Trousseau thrombocytopenia</td>
<td align="left">Other deletions from the autosomes</td>
</tr>
<tr class="even">
<td align="left">Q93.89</td>
<td align="right">69</td>
<td align="left">WAGR syndrome</td>
<td align="left">Other deletions from the autosomes</td>
</tr>
<tr class="odd">
<td align="left">Q93.89</td>
<td align="right">69</td>
<td align="left">Chromosome 1p36 deletion syndrome</td>
<td align="left">Other deletions from the autosomes</td>
</tr>
<tr class="even">
<td align="left">Q93.89</td>
<td align="right">69</td>
<td align="left">Chromosome 18p deletion</td>
<td align="left">Other deletions from the autosomes</td>
</tr>
<tr class="odd">
<td align="left">Q78.6</td>
<td align="right">69</td>
<td align="left">Hereditary multiple osteochondromas</td>
<td align="left">Multiple congenital exostoses</td>
</tr>
<tr class="even">
<td align="left">M94.1</td>
<td align="right">69</td>
<td align="left">Relapsing polychondritis</td>
<td align="left">Relapsing polychondritis</td>
</tr>
<tr class="odd">
<td align="left">C4A.9</td>
<td align="right">69</td>
<td align="left">Merkel cell carcinoma</td>
<td align="left">Merkel cell carcinoma, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q01.9</td>
<td align="right">68</td>
<td align="left">Meningoencephalocele</td>
<td align="left">Encephalocele, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q01.9</td>
<td align="right">68</td>
<td align="left">Encephalocele</td>
<td align="left">Encephalocele, unspecified</td>
</tr>
<tr class="even">
<td align="left">P08.0</td>
<td align="right">68</td>
<td align="left">Fetal macrosomia</td>
<td align="left">Exceptionally large newborn baby</td>
</tr>
<tr class="odd">
<td align="left">G43.409</td>
<td align="right">68</td>
<td align="left">Hemiplegic migraine</td>
<td align="left">Hemiplegic migraine, not intractable, without status migrainosus</td>
</tr>
<tr class="even">
<td align="left">G43.409</td>
<td align="right">68</td>
<td align="left">Familial hemiplegic migraine</td>
<td align="left">Hemiplegic migraine, not intractable, without status migrainosus</td>
</tr>
<tr class="odd">
<td align="left">C30.0</td>
<td align="right">68</td>
<td align="left">Olfactory neuroblastoma</td>
<td align="left">Malignant neoplasm of nasal cavity</td>
</tr>
<tr class="even">
<td align="left">Q79.3</td>
<td align="right">67</td>
<td align="left">Gastroschisis</td>
<td align="left">Gastroschisis</td>
</tr>
<tr class="odd">
<td align="left">Q78.9</td>
<td align="right">67</td>
<td align="left">Chondrodystrophy</td>
<td align="left">Osteochondrodysplasia, unspecified</td>
</tr>
<tr class="even">
<td align="left">L98.2</td>
<td align="right">67</td>
<td align="left">Acute febrile neutrophilic dermatosis</td>
<td align="left">Febrile neutrophilic dermatosis [Sweet]</td>
</tr>
<tr class="odd">
<td align="left">L98.2</td>
<td align="right">67</td>
<td align="left">Acromelic frontonasal dysostosis</td>
<td align="left">Febrile neutrophilic dermatosis [Sweet]</td>
</tr>
<tr class="even">
<td align="left">L10.9</td>
<td align="right">66</td>
<td align="left">Pemphigus</td>
<td align="left">Pemphigus, unspecified</td>
</tr>
<tr class="odd">
<td align="left">G12.9</td>
<td align="right">66</td>
<td align="left">Jankovic Rivera syndrome</td>
<td align="left">Spinal muscular atrophy, unspecified</td>
</tr>
<tr class="even">
<td align="left">G12.9</td>
<td align="right">66</td>
<td align="left">Myoclonus hereditary progressive distal muscular atrophy</td>
<td align="left">Spinal muscular atrophy, unspecified</td>
</tr>
<tr class="odd">
<td align="left">G12.9</td>
<td align="right">66</td>
<td align="left">Proximal spinal muscular atrophy</td>
<td align="left">Spinal muscular atrophy, unspecified</td>
</tr>
<tr class="even">
<td align="left">G12.9</td>
<td align="right">66</td>
<td align="left">Spinal muscular atrophy</td>
<td align="left">Spinal muscular atrophy, unspecified</td>
</tr>
<tr class="odd">
<td align="left">L56.4</td>
<td align="right">65</td>
<td align="left">Hydroa vacciniforme</td>
<td align="left">Polymorphous light eruption</td>
</tr>
<tr class="even">
<td align="left">I77.4</td>
<td align="right">65</td>
<td align="left">Celiac artery compression syndrome</td>
<td align="left">Celiac artery compression syndrome</td>
</tr>
<tr class="odd">
<td align="left">G72.49</td>
<td align="right">65</td>
<td align="left">Inclusion body myositis</td>
<td align="left">Other inflammatory and immune myopathies, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">G72.49</td>
<td align="right">65</td>
<td align="left">Idiopathic inflammatory myopathy</td>
<td align="left">Other inflammatory and immune myopathies, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">D80.6</td>
<td align="right">65</td>
<td align="left">Specific antibody deficiency</td>
<td align="left">Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia</td>
</tr>
<tr class="even">
<td align="left">Q87.3</td>
<td align="right">64</td>
<td align="left">Kyphoscoliotic Ehlers-Danlos syndrome</td>
<td align="left">Congenital malformation syndromes involving early overgrowth</td>
</tr>
<tr class="odd">
<td align="left">Q87.3</td>
<td align="right">64</td>
<td align="left">Beckwith-Wiedemann syndrome</td>
<td align="left">Congenital malformation syndromes involving early overgrowth</td>
</tr>
<tr class="even">
<td align="left">Q87.3</td>
<td align="right">64</td>
<td align="left">Marshall-Smith syndrome</td>
<td align="left">Congenital malformation syndromes involving early overgrowth</td>
</tr>
<tr class="odd">
<td align="left">Q87.3</td>
<td align="right">64</td>
<td align="left">Simpson-Golabi-Behmel syndrome</td>
<td align="left">Congenital malformation syndromes involving early overgrowth</td>
</tr>
<tr class="even">
<td align="left">Q87.3</td>
<td align="right">64</td>
<td align="left">Weaver syndrome</td>
<td align="left">Congenital malformation syndromes involving early overgrowth</td>
</tr>
<tr class="odd">
<td align="left">Q87.3</td>
<td align="right">64</td>
<td align="left">Williams syndrome</td>
<td align="left">Congenital malformation syndromes involving early overgrowth</td>
</tr>
<tr class="even">
<td align="left">Q87.3</td>
<td align="right">64</td>
<td align="left">Sotos syndrome</td>
<td align="left">Congenital malformation syndromes involving early overgrowth</td>
</tr>
<tr class="odd">
<td align="left">Q44.2</td>
<td align="right">64</td>
<td align="left">Ichthyosis congenita biliary atresia</td>
<td align="left">Atresia of bile ducts</td>
</tr>
<tr class="even">
<td align="left">Q44.2</td>
<td align="right">64</td>
<td align="left">Biliary atresia</td>
<td align="left">Atresia of bile ducts</td>
</tr>
<tr class="odd">
<td align="left">C24.0</td>
<td align="right">64</td>
<td align="left">Bile duct cancer</td>
<td align="left">Malignant neoplasm of extrahepatic bile duct</td>
</tr>
<tr class="even">
<td align="left">C24.0</td>
<td align="right">64</td>
<td align="left">Klatskin tumor</td>
<td align="left">Malignant neoplasm of extrahepatic bile duct</td>
</tr>
<tr class="odd">
<td align="left">Q85.02</td>
<td align="right">63</td>
<td align="left">Neurofibromatosis type 2</td>
<td align="left">Neurofibromatosis, type 2</td>
</tr>
<tr class="even">
<td align="left">Q64.2</td>
<td align="right">63</td>
<td align="left">Posterior urethral valves</td>
<td align="left">Congenital posterior urethral valves</td>
</tr>
<tr class="odd">
<td align="left">Q38.6</td>
<td align="right">63</td>
<td align="left">Hereditary mucoepithelial dysplasia</td>
<td align="left">Other congenital malformations of mouth</td>
</tr>
<tr class="even">
<td align="left">Q38.6</td>
<td align="right">63</td>
<td align="left">White sponge nevus of cannon</td>
<td align="left">Other congenital malformations of mouth</td>
</tr>
<tr class="odd">
<td align="left">Q38.0</td>
<td align="right">63</td>
<td align="left">Van der Woude syndrome</td>
<td align="left">Congenital malformations of lips, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">M30.0</td>
<td align="right">63</td>
<td align="left">Polyarteritis nodosa</td>
<td align="left">Polyarteritis nodosa</td>
</tr>
<tr class="odd">
<td align="left">M30.0</td>
<td align="right">63</td>
<td align="left">Cutaneous polyarteritis nodosa</td>
<td align="left">Polyarteritis nodosa</td>
</tr>
<tr class="even">
<td align="left">M30.0</td>
<td align="right">63</td>
<td align="left">Pediatric acute-onset neuropsychiatric syndrome</td>
<td align="left">Polyarteritis nodosa</td>
</tr>
<tr class="odd">
<td align="left">D72.89</td>
<td align="right">63</td>
<td align="left">Myeloperoxidase deficiency</td>
<td align="left">Other specified disorders of white blood cells</td>
</tr>
<tr class="even">
<td align="left">D72.89</td>
<td align="right">63</td>
<td align="left">Myeloperoxidase deficiency</td>
<td align="left">Other specified disorders of white blood cells</td>
</tr>
<tr class="odd">
<td align="left">D72.89</td>
<td align="right">63</td>
<td align="left">Glutathione synthetase deficiency</td>
<td align="left">Other specified disorders of white blood cells</td>
</tr>
<tr class="even">
<td align="left">D72.89</td>
<td align="right">63</td>
<td align="left">Neutrophil-specific granule deficiency</td>
<td align="left">Other specified disorders of white blood cells</td>
</tr>
<tr class="odd">
<td align="left">D72.89</td>
<td align="right">63</td>
<td align="left">Eosinophil peroxidase deficiency</td>
<td align="left">Other specified disorders of white blood cells</td>
</tr>
<tr class="even">
<td align="left">C49.10</td>
<td align="right">63</td>
<td align="left">Stewart Treves syndrome</td>
<td align="left">Malignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulder</td>
</tr>
<tr class="odd">
<td align="left">B48.8</td>
<td align="right">63</td>
<td align="left">Phaeohyphomycosis</td>
<td align="left">Other specified mycoses</td>
</tr>
<tr class="even">
<td align="left">A80.9</td>
<td align="right">63</td>
<td align="left">Poliomyelitis</td>
<td align="left">Acute poliomyelitis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q33.0</td>
<td align="right">62</td>
<td align="left">Bronchogenic cyst</td>
<td align="left">Congenital cystic lung</td>
</tr>
<tr class="even">
<td align="left">Q33.0</td>
<td align="right">62</td>
<td align="left">Cystic adenomatoid malformation of lung</td>
<td align="left">Congenital cystic lung</td>
</tr>
<tr class="odd">
<td align="left">G40.301</td>
<td align="right">62</td>
<td align="left">Status epilepticus</td>
<td align="left">Generalized idiopathic epilepsy and epileptic syndromes, not intractable, with status epilepticus</td>
</tr>
<tr class="even">
<td align="left">E75.29</td>
<td align="right">62</td>
<td align="left">Metachromatic leukodystrophy</td>
<td align="left">Other sphingolipidosis</td>
</tr>
<tr class="odd">
<td align="left">E75.29</td>
<td align="right">62</td>
<td align="left">Pelizaeus-Merzbacher disease</td>
<td align="left">Other sphingolipidosis</td>
</tr>
<tr class="even">
<td align="left">E75.29</td>
<td align="right">62</td>
<td align="left">Multiple sulfatase deficiency</td>
<td align="left">Other sphingolipidosis</td>
</tr>
<tr class="odd">
<td align="left">E75.29</td>
<td align="right">62</td>
<td align="left">Canavan disease</td>
<td align="left">Other sphingolipidosis</td>
</tr>
<tr class="even">
<td align="left">E75.29</td>
<td align="right">62</td>
<td align="left">Leukodystrophy</td>
<td align="left">Other sphingolipidosis</td>
</tr>
<tr class="odd">
<td align="left">E22.0</td>
<td align="right">62</td>
<td align="left">Acromegaly</td>
<td align="left">Acromegaly and pituitary gigantism</td>
</tr>
<tr class="even">
<td align="left">E22.0</td>
<td align="right">62</td>
<td align="left">Gigantism</td>
<td align="left">Acromegaly and pituitary gigantism</td>
</tr>
<tr class="odd">
<td align="left">E22.0</td>
<td align="right">62</td>
<td align="left">Gigantism</td>
<td align="left">Acromegaly and pituitary gigantism</td>
</tr>
<tr class="even">
<td align="left">C85.99</td>
<td align="right">62</td>
<td align="left">Lymphoma, gastric non Hodgkins type</td>
<td align="left">Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites</td>
</tr>
<tr class="odd">
<td align="left">C85.99</td>
<td align="right">62</td>
<td align="left">Gastric lymphoma</td>
<td align="left">Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites</td>
</tr>
<tr class="even">
<td align="left">C85.99</td>
<td align="right">62</td>
<td align="left">Primary central nervous system lymphoma</td>
<td align="left">Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites</td>
</tr>
<tr class="odd">
<td align="left">Q63.8</td>
<td align="right">61</td>
<td align="left">AREDYLD</td>
<td align="left">Other specified congenital malformations of kidney</td>
</tr>
<tr class="even">
<td align="left">Q07.8</td>
<td align="right">61</td>
<td align="left">Cerebro-oculo-facio-skeletal syndrome</td>
<td align="left">Other specified congenital malformations of nervous system</td>
</tr>
<tr class="odd">
<td align="left">Q07.8</td>
<td align="right">61</td>
<td align="left">Marcus Gunn phenomenon</td>
<td align="left">Other specified congenital malformations of nervous system</td>
</tr>
<tr class="even">
<td align="left">Q07.8</td>
<td align="right">61</td>
<td align="left">X-linked periventricular heterotopia</td>
<td align="left">Other specified congenital malformations of nervous system</td>
</tr>
<tr class="odd">
<td align="left">Q07.8</td>
<td align="right">61</td>
<td align="left">Marinesco-Sjogren syndrome</td>
<td align="left">Other specified congenital malformations of nervous system</td>
</tr>
<tr class="even">
<td align="left">Q07.8</td>
<td align="right">61</td>
<td align="left">Charcot-Marie-Tooth disease type 4E</td>
<td align="left">Other specified congenital malformations of nervous system</td>
</tr>
<tr class="odd">
<td align="left">J43.0</td>
<td align="right">61</td>
<td align="left">Swyer-James syndrome</td>
<td align="left">Unilateral pulmonary emphysema [MacLeod’s syndrome]</td>
</tr>
<tr class="even">
<td align="left">I68.0</td>
<td align="right">61</td>
<td align="left">Hereditary cerebral hemorrhage with amyloidosis</td>
<td align="left">Cerebral amyloid angiopathy</td>
</tr>
<tr class="odd">
<td align="left">H21.239</td>
<td align="right">61</td>
<td align="left">Pigment-dispersion syndrome</td>
<td align="left">Degeneration of iris (pigmentary), unspecified eye</td>
</tr>
<tr class="even">
<td align="left">D68.8</td>
<td align="right">61</td>
<td align="left">Type 1 plasminogen deficiency</td>
<td align="left">Other specified coagulation defects</td>
</tr>
<tr class="odd">
<td align="left">D68.8</td>
<td align="right">61</td>
<td align="left">Pseudo-Von Willebrand disease</td>
<td align="left">Other specified coagulation defects</td>
</tr>
<tr class="even">
<td align="left">A77.40</td>
<td align="right">61</td>
<td align="left">Ehrlichiosis</td>
<td align="left">Ehrlichiosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q79.8</td>
<td align="right">60</td>
<td align="left">Geroderma osteodysplastica</td>
<td align="left">Other congenital malformations of musculoskeletal system</td>
</tr>
<tr class="even">
<td align="left">Q79.8</td>
<td align="right">60</td>
<td align="left">Amniotic band syndrome</td>
<td align="left">Other congenital malformations of musculoskeletal system</td>
</tr>
<tr class="odd">
<td align="left">Q79.8</td>
<td align="right">60</td>
<td align="left">Poland syndrome</td>
<td align="left">Other congenital malformations of musculoskeletal system</td>
</tr>
<tr class="even">
<td align="left">Q79.8</td>
<td align="right">60</td>
<td align="left">Myostatin-related muscle hypertrophy</td>
<td align="left">Other congenital malformations of musculoskeletal system</td>
</tr>
<tr class="odd">
<td align="left">N25.0</td>
<td align="right">60</td>
<td align="left">Renal rickets</td>
<td align="left">Renal osteodystrophy</td>
</tr>
<tr class="even">
<td align="left">F48.8</td>
<td align="right">60</td>
<td align="left">Jumping Frenchmen of Maine</td>
<td align="left">Other specified nonpsychotic mental disorders</td>
</tr>
<tr class="odd">
<td align="left">F48.8</td>
<td align="right">60</td>
<td align="left">Koro</td>
<td align="left">Other specified nonpsychotic mental disorders</td>
</tr>
<tr class="even">
<td align="left">Q61.5</td>
<td align="right">59</td>
<td align="left">Nephronophthisis</td>
<td align="left">Medullary cystic kidney</td>
</tr>
<tr class="odd">
<td align="left">Q61.5</td>
<td align="right">59</td>
<td align="left">Medullary sponge kidney</td>
<td align="left">Medullary cystic kidney</td>
</tr>
<tr class="even">
<td align="left">Q61.5</td>
<td align="right">59</td>
<td align="left">Autosomal dominant medullary cystic kidney disease with hyperuricemia</td>
<td align="left">Medullary cystic kidney</td>
</tr>
<tr class="odd">
<td align="left">Q61.5</td>
<td align="right">59</td>
<td align="left">Medullary cystic kidney disease</td>
<td align="left">Medullary cystic kidney</td>
</tr>
<tr class="even">
<td align="left">Q60.2</td>
<td align="right">59</td>
<td align="left">Renal agenesis</td>
<td align="left">Renal agenesis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q32.2</td>
<td align="right">59</td>
<td align="left">Tracheobronchomalacia</td>
<td align="left">Congenital bronchomalacia</td>
</tr>
<tr class="even">
<td align="left">P59.8</td>
<td align="right">59</td>
<td align="left">Hyperbilirubinemia transient familial neonatal</td>
<td align="left">Neonatal jaundice from other specified causes</td>
</tr>
<tr class="odd">
<td align="left">P59.8</td>
<td align="right">59</td>
<td align="left">Lucey-Driscoll syndrome</td>
<td align="left">Neonatal jaundice from other specified causes</td>
</tr>
<tr class="even">
<td align="left">J84.01</td>
<td align="right">59</td>
<td align="left">Congenital pulmonary alveolar proteinosis</td>
<td align="left">Alveolar proteinosis</td>
</tr>
<tr class="odd">
<td align="left">J84.01</td>
<td align="right">59</td>
<td align="left">Autoimmune pulmonary alveolar proteinosis</td>
<td align="left">Alveolar proteinosis</td>
</tr>
<tr class="even">
<td align="left">G25.82</td>
<td align="right">59</td>
<td align="left">Hereditary hyperekplexia</td>
<td align="left">Stiff-man syndrome</td>
</tr>
<tr class="odd">
<td align="left">G25.82</td>
<td align="right">59</td>
<td align="left">Stiff person syndrome</td>
<td align="left">Stiff-man syndrome</td>
</tr>
<tr class="even">
<td align="left">D70.0</td>
<td align="right">59</td>
<td align="left">Severe congenital neutropenia autosomal recessive 3</td>
<td align="left">Congenital agranulocytosis</td>
</tr>
<tr class="odd">
<td align="left">C69.20</td>
<td align="right">59</td>
<td align="left">Melanoma-associated retinopathy</td>
<td align="left">Malignant neoplasm of unspecified retina</td>
</tr>
<tr class="even">
<td align="left">E83.31</td>
<td align="right">58</td>
<td align="left">Hypophosphatemic rickets</td>
<td align="left">Familial hypophosphatemia</td>
</tr>
<tr class="odd">
<td align="left">O26.619</td>
<td align="right">57</td>
<td align="left">Intrahepatic cholestasis of pregnancy</td>
<td align="left">Liver and biliary tract disorders in pregnancy, unspecified trimester</td>
</tr>
<tr class="even">
<td align="left">E70.329</td>
<td align="right">57</td>
<td align="left">Oculocutaneous albinism</td>
<td align="left">Oculocutaneous albinism, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C92.40</td>
<td align="right">57</td>
<td align="left">Acute promyelocytic leukemia</td>
<td align="left">Acute promyelocytic leukemia, not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">C92.40</td>
<td align="right">57</td>
<td align="left">Barraquer-Simons syndrome</td>
<td align="left">Acute promyelocytic leukemia, not having achieved remission</td>
</tr>
<tr class="odd">
<td align="left">C83.70</td>
<td align="right">57</td>
<td align="left">Burkitt lymphoma</td>
<td align="left">Burkitt lymphoma, unspecified site</td>
</tr>
<tr class="even">
<td align="left">M26.213</td>
<td align="right">56</td>
<td align="left">Prognathism mandibular</td>
<td align="left">Malocclusion, Angle’s class III</td>
</tr>
<tr class="odd">
<td align="left">D61.09</td>
<td align="right">56</td>
<td align="left">Congenital aplastic anemia</td>
<td align="left">Other constitutional aplastic anemia</td>
</tr>
<tr class="even">
<td align="left">D61.09</td>
<td align="right">56</td>
<td align="left">Fanconi anemia</td>
<td align="left">Other constitutional aplastic anemia</td>
</tr>
<tr class="odd">
<td align="left">D61.09</td>
<td align="right">56</td>
<td align="left">Fanconi syndrome</td>
<td align="left">Other constitutional aplastic anemia</td>
</tr>
<tr class="even">
<td align="left">Q38.3</td>
<td align="right">55</td>
<td align="left">Cleft tongue</td>
<td align="left">Other congenital malformations of tongue</td>
</tr>
<tr class="odd">
<td align="left">M31.4</td>
<td align="right">55</td>
<td align="left">Takayasu arteritis</td>
<td align="left">Aortic arch syndrome [Takayasu]</td>
</tr>
<tr class="even">
<td align="left">G83.89</td>
<td align="right">55</td>
<td align="left">Alternating hemiplegia of childhood</td>
<td align="left">Other specified paralytic syndromes</td>
</tr>
<tr class="odd">
<td align="left">G83.89</td>
<td align="right">55</td>
<td align="left">Alternating hemiplegia of childhood</td>
<td align="left">Other specified paralytic syndromes</td>
</tr>
<tr class="even">
<td align="left">D50.1</td>
<td align="right">55</td>
<td align="left">Plummer Vinson syndrome</td>
<td align="left">Sideropenic dysphagia</td>
</tr>
<tr class="odd">
<td align="left">K06.1</td>
<td align="right">54</td>
<td align="left">Gingival fibromatosis, 1</td>
<td align="left">Gingival enlargement</td>
</tr>
<tr class="even">
<td align="left">G23.8</td>
<td align="right">54</td>
<td align="left">Aicardi-Goutieres syndrome</td>
<td align="left">Other specified degenerative diseases of basal ganglia</td>
</tr>
<tr class="odd">
<td align="left">G23.8</td>
<td align="right">54</td>
<td align="left">Primary Familial Brain Calcification</td>
<td align="left">Other specified degenerative diseases of basal ganglia</td>
</tr>
<tr class="even">
<td align="left">G23.8</td>
<td align="right">54</td>
<td align="left">Olivopontocerebellar atrophy</td>
<td align="left">Other specified degenerative diseases of basal ganglia</td>
</tr>
<tr class="odd">
<td align="left">G23.8</td>
<td align="right">54</td>
<td align="left">Neuroferritinopathy</td>
<td align="left">Other specified degenerative diseases of basal ganglia</td>
</tr>
<tr class="even">
<td align="left">Q75.8</td>
<td align="right">53</td>
<td align="left">Frontonasal dysplasia</td>
<td align="left">Other specified congenital malformations of skull and face bones</td>
</tr>
<tr class="odd">
<td align="left">N25.1</td>
<td align="right">53</td>
<td align="left">Nephrogenic diabetes insipidus</td>
<td align="left">Nephrogenic diabetes insipidus</td>
</tr>
<tr class="even">
<td align="left">G11.4</td>
<td align="right">53</td>
<td align="left">Spastic ataxia Charlevoix-Saguenay type</td>
<td align="left">Hereditary spastic paraplegia</td>
</tr>
<tr class="odd">
<td align="left">G11.4</td>
<td align="right">53</td>
<td align="left">Infantile-onset ascending hereditary spastic paralysis</td>
<td align="left">Hereditary spastic paraplegia</td>
</tr>
<tr class="even">
<td align="left">G11.4</td>
<td align="right">53</td>
<td align="left">Spastic paraplegia 3</td>
<td align="left">Hereditary spastic paraplegia</td>
</tr>
<tr class="odd">
<td align="left">G11.4</td>
<td align="right">53</td>
<td align="left">Hereditary spastic paraplegia</td>
<td align="left">Hereditary spastic paraplegia</td>
</tr>
<tr class="even">
<td align="left">G11.4</td>
<td align="right">53</td>
<td align="left">Hereditary motor and sensory neuropathy type 5</td>
<td align="left">Hereditary spastic paraplegia</td>
</tr>
<tr class="odd">
<td align="left">G11.4</td>
<td align="right">53</td>
<td align="left">Spastic paraplegia 15</td>
<td align="left">Hereditary spastic paraplegia</td>
</tr>
<tr class="even">
<td align="left">C13.9</td>
<td align="right">53</td>
<td align="left">Hypopharyngeal cancer</td>
<td align="left">Malignant neoplasm of hypopharynx, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A35</td>
<td align="right">53</td>
<td align="left">Tetanus</td>
<td align="left">Other tetanus</td>
</tr>
<tr class="even">
<td align="left">Q93.88</td>
<td align="right">52</td>
<td align="left">Miller-Dieker syndrome</td>
<td align="left">Other microdeletions</td>
</tr>
<tr class="odd">
<td align="left">Q93.88</td>
<td align="right">52</td>
<td align="left">Stiff person syndrome</td>
<td align="left">Other microdeletions</td>
</tr>
<tr class="even">
<td align="left">Q93.88</td>
<td align="right">52</td>
<td align="left">Chromosome 17p deletion</td>
<td align="left">Other microdeletions</td>
</tr>
<tr class="odd">
<td align="left">Q93.88</td>
<td align="right">52</td>
<td align="left">Myelodysplastic syndromes</td>
<td align="left">Other microdeletions</td>
</tr>
<tr class="even">
<td align="left">Q93.88</td>
<td align="right">52</td>
<td align="left">Smith-Magenis syndrome</td>
<td align="left">Other microdeletions</td>
</tr>
<tr class="odd">
<td align="left">Q93.88</td>
<td align="right">52</td>
<td align="left">15q13.3 microdeletion syndrome</td>
<td align="left">Other microdeletions</td>
</tr>
<tr class="even">
<td align="left">Q93.88</td>
<td align="right">52</td>
<td align="left">1q21.1 microdeletion syndrome</td>
<td align="left">Other microdeletions</td>
</tr>
<tr class="odd">
<td align="left">L40.54</td>
<td align="right">52</td>
<td align="left">Psoriatic juvenile idiopathic arthritis</td>
<td align="left">Psoriatic juvenile arthropathy</td>
</tr>
<tr class="even">
<td align="left">I42.3</td>
<td align="right">52</td>
<td align="left">Endomyocardial fibrosis</td>
<td align="left">Endomyocardial (eosinophilic) disease</td>
</tr>
<tr class="odd">
<td align="left">I42.3</td>
<td align="right">52</td>
<td align="left">Endomyocardial fibrosis</td>
<td align="left">Endomyocardial (eosinophilic) disease</td>
</tr>
<tr class="even">
<td align="left">D70.4</td>
<td align="right">52</td>
<td align="left">Shwachman-Diamond syndrome</td>
<td align="left">Cyclic neutropenia</td>
</tr>
<tr class="odd">
<td align="left">D70.4</td>
<td align="right">52</td>
<td align="left">Trichohepatoenteric syndrome</td>
<td align="left">Cyclic neutropenia</td>
</tr>
<tr class="even">
<td align="left">D70.4</td>
<td align="right">52</td>
<td align="left">Cyclic neutropenia</td>
<td align="left">Cyclic neutropenia</td>
</tr>
<tr class="odd">
<td align="left">D47.4</td>
<td align="right">52</td>
<td align="left">Myelofibrosis</td>
<td align="left">Osteomyelofibrosis</td>
</tr>
<tr class="even">
<td align="left">C96.2</td>
<td align="right">52</td>
<td align="left">Miles-Carpenter x-linked mental retardation syndrome</td>
<td align="left">Malignant mast cell tumor</td>
</tr>
<tr class="odd">
<td align="left">Q93.5</td>
<td align="right">51</td>
<td align="left">Chromosome 7q deletion</td>
<td align="left">Other deletions of part of a chromosome</td>
</tr>
<tr class="even">
<td align="left">Q93.5</td>
<td align="right">51</td>
<td align="left">Angelman syndrome</td>
<td align="left">Other deletions of part of a chromosome</td>
</tr>
<tr class="odd">
<td align="left">Q93.5</td>
<td align="right">51</td>
<td align="left">22q13.3 deletion syndrome</td>
<td align="left">Other deletions of part of a chromosome</td>
</tr>
<tr class="even">
<td align="left">Q93.5</td>
<td align="right">51</td>
<td align="left">2q37 deletion syndrome</td>
<td align="left">Other deletions of part of a chromosome</td>
</tr>
<tr class="odd">
<td align="left">Q93.5</td>
<td align="right">51</td>
<td align="left">16p11.2 deletion syndrome</td>
<td align="left">Other deletions of part of a chromosome</td>
</tr>
<tr class="even">
<td align="left">Q28.8</td>
<td align="right">51</td>
<td align="left">Patent ductus venosus</td>
<td align="left">Other specified congenital malformations of circulatory system</td>
</tr>
<tr class="odd">
<td align="left">G80.3</td>
<td align="right">51</td>
<td align="left">Cerebral palsy athetoid</td>
<td align="left">Athetoid cerebral palsy</td>
</tr>
<tr class="even">
<td align="left">E75.22</td>
<td align="right">51</td>
<td align="left">Gaucher disease type 1</td>
<td align="left">Gaucher disease</td>
</tr>
<tr class="odd">
<td align="left">E75.22</td>
<td align="right">51</td>
<td align="left">Gaucher disease type 2</td>
<td align="left">Gaucher disease</td>
</tr>
<tr class="even">
<td align="left">E75.22</td>
<td align="right">51</td>
<td align="left">Gaucher disease type 3</td>
<td align="left">Gaucher disease</td>
</tr>
<tr class="odd">
<td align="left">E75.22</td>
<td align="right">51</td>
<td align="left">Gaucher disease</td>
<td align="left">Gaucher disease</td>
</tr>
<tr class="even">
<td align="left">D36.7</td>
<td align="right">51</td>
<td align="left">Perineurioma</td>
<td align="left">Benign neoplasm of other specified sites</td>
</tr>
<tr class="odd">
<td align="left">Q76.1</td>
<td align="right">50</td>
<td align="left">Klippel Feil syndrome</td>
<td align="left">Klippel-Feil syndrome</td>
</tr>
<tr class="even">
<td align="left">Q44.7</td>
<td align="right">50</td>
<td align="left">Alagille syndrome</td>
<td align="left">Other congenital malformations of liver</td>
</tr>
<tr class="odd">
<td align="left">Q44.7</td>
<td align="right">50</td>
<td align="left">Hypoplasia hepatic ductular</td>
<td align="left">Other congenital malformations of liver</td>
</tr>
<tr class="even">
<td align="left">Q44.7</td>
<td align="right">50</td>
<td align="left">Congenital hepatic fibrosis</td>
<td align="left">Other congenital malformations of liver</td>
</tr>
<tr class="odd">
<td align="left">Q14.8</td>
<td align="right">50</td>
<td align="left">Retinochoroidal coloboma</td>
<td align="left">Other congenital malformations of posterior segment of eye</td>
</tr>
<tr class="even">
<td align="left">L66.2</td>
<td align="right">50</td>
<td align="left">Quinquaud’s decalvans folliculitis</td>
<td align="left">Folliculitis decalvans</td>
</tr>
<tr class="odd">
<td align="left">D82.4</td>
<td align="right">50</td>
<td align="left">Hyper IgE syndrome</td>
<td align="left">Hyperimmunoglobulin E [IgE] syndrome</td>
</tr>
<tr class="even">
<td align="left">A52.3</td>
<td align="right">50</td>
<td align="left">Neurosyphilis</td>
<td align="left">Neurosyphilis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q87.81</td>
<td align="right">49</td>
<td align="left">MYH9 related thrombocytopenia</td>
<td align="left">Alport syndrome</td>
</tr>
<tr class="even">
<td align="left">Q87.81</td>
<td align="right">49</td>
<td align="left">Alport syndrome</td>
<td align="left">Alport syndrome</td>
</tr>
<tr class="odd">
<td align="left">Q86.0</td>
<td align="right">49</td>
<td align="left">Fetal Alcohol Spectrum Disorders</td>
<td align="left">Fetal alcohol syndrome (dysmorphic)</td>
</tr>
<tr class="even">
<td align="left">Q60.5</td>
<td align="right">49</td>
<td align="left">Oligomeganephronic renal hypoplasia</td>
<td align="left">Renal hypoplasia, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q60.5</td>
<td align="right">49</td>
<td align="left">Renal coloboma syndrome</td>
<td align="left">Renal hypoplasia, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q60.5</td>
<td align="right">49</td>
<td align="left">Maturity-onset diabetes of the young, type 5</td>
<td align="left">Renal hypoplasia, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q13.2</td>
<td align="right">49</td>
<td align="left">Microcoria, congenital</td>
<td align="left">Other congenital malformations of iris</td>
</tr>
<tr class="even">
<td align="left">Q13.2</td>
<td align="right">49</td>
<td align="left">Ectopia pupillae</td>
<td align="left">Other congenital malformations of iris</td>
</tr>
<tr class="odd">
<td align="left">N03.2</td>
<td align="right">49</td>
<td align="left">Membranous nephropathy</td>
<td align="left">Chronic nephritic syndrome with diffuse membranous glomerulonephritis</td>
</tr>
<tr class="even">
<td align="left">M92.9</td>
<td align="right">49</td>
<td align="left">Osteochondrosis</td>
<td align="left">Juvenile osteochondrosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">L10.0</td>
<td align="right">49</td>
<td align="left">Pemphigus vulgaris</td>
<td align="left">Pemphigus vulgaris</td>
</tr>
<tr class="even">
<td align="left">K55.8</td>
<td align="right">49</td>
<td align="left">Superior mesenteric artery syndrome</td>
<td align="left">Other vascular disorders of intestine</td>
</tr>
<tr class="odd">
<td align="left">I82.0</td>
<td align="right">49</td>
<td align="left">Budd-Chiari syndrome</td>
<td align="left">Budd-Chiari syndrome</td>
</tr>
<tr class="even">
<td align="left">G90.8</td>
<td align="right">49</td>
<td align="left">Crisponi syndrome</td>
<td align="left">Other disorders of autonomic nervous system</td>
</tr>
<tr class="odd">
<td align="left">E83.01</td>
<td align="right">49</td>
<td align="left">Wilson disease</td>
<td align="left">Wilson’s disease</td>
</tr>
<tr class="even">
<td align="left">E74.09</td>
<td align="right">49</td>
<td align="left">Fanconi Bickel syndrome</td>
<td align="left">Other glycogen storage disease</td>
</tr>
<tr class="odd">
<td align="left">E74.09</td>
<td align="right">49</td>
<td align="left">Glycogen storage disease type 4</td>
<td align="left">Other glycogen storage disease</td>
</tr>
<tr class="even">
<td align="left">E74.09</td>
<td align="right">49</td>
<td align="left">Lactate dehydrogenase A deficiency</td>
<td align="left">Other glycogen storage disease</td>
</tr>
<tr class="odd">
<td align="left">E74.09</td>
<td align="right">49</td>
<td align="left">Glycogen storage disease type 7</td>
<td align="left">Other glycogen storage disease</td>
</tr>
<tr class="even">
<td align="left">E74.09</td>
<td align="right">49</td>
<td align="left">Glycogen storage disease type 6</td>
<td align="left">Other glycogen storage disease</td>
</tr>
<tr class="odd">
<td align="left">E74.09</td>
<td align="right">49</td>
<td align="left">Glycogen storage disease 8</td>
<td align="left">Other glycogen storage disease</td>
</tr>
<tr class="even">
<td align="left">E74.09</td>
<td align="right">49</td>
<td align="left">Glycogen storage disease 8</td>
<td align="left">Other glycogen storage disease</td>
</tr>
<tr class="odd">
<td align="left">E74.09</td>
<td align="right">49</td>
<td align="left">Primary Fanconi syndrome</td>
<td align="left">Other glycogen storage disease</td>
</tr>
<tr class="even">
<td align="left">E74.09</td>
<td align="right">49</td>
<td align="left">Danon disease</td>
<td align="left">Other glycogen storage disease</td>
</tr>
<tr class="odd">
<td align="left">E74.09</td>
<td align="right">49</td>
<td align="left">Phosphoglycerate mutase deficiency</td>
<td align="left">Other glycogen storage disease</td>
</tr>
<tr class="even">
<td align="left">D60.9</td>
<td align="right">49</td>
<td align="left">Pure red cell aplasia</td>
<td align="left">Acquired pure red cell aplasia, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D60.9</td>
<td align="right">49</td>
<td align="left">Acquired pure red cell aplasia</td>
<td align="left">Acquired pure red cell aplasia, unspecified</td>
</tr>
<tr class="even">
<td align="left">D46.C</td>
<td align="right">49</td>
<td align="left">5q- syndrome</td>
<td align="left">Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality</td>
</tr>
<tr class="odd">
<td align="left">C86.6</td>
<td align="right">49</td>
<td align="left">Lymphomatoid papulosis</td>
<td align="left">Primary cutaneous CD30-positive T-cell proliferations</td>
</tr>
<tr class="even">
<td align="left">B00.4</td>
<td align="right">49</td>
<td align="left">Herpes simplex encephalitis</td>
<td align="left">Herpesviral encephalitis</td>
</tr>
<tr class="odd">
<td align="left">Q44.4</td>
<td align="right">48</td>
<td align="left">Bile duct cysts</td>
<td align="left">Choledochal cyst</td>
</tr>
<tr class="even">
<td align="left">Q31.8</td>
<td align="right">48</td>
<td align="left">Laryngeal cleft</td>
<td align="left">Other congenital malformations of larynx</td>
</tr>
<tr class="odd">
<td align="left">Q31.8</td>
<td align="right">48</td>
<td align="left">Larynx atresia</td>
<td align="left">Other congenital malformations of larynx</td>
</tr>
<tr class="even">
<td align="left">Q25.3</td>
<td align="right">48</td>
<td align="left">Aneurysm of sinus of Valsalva</td>
<td align="left">Supravalvular aortic stenosis</td>
</tr>
<tr class="odd">
<td align="left">Q25.3</td>
<td align="right">48</td>
<td align="left">Supravalvular aortic stenosis</td>
<td align="left">Supravalvular aortic stenosis</td>
</tr>
<tr class="even">
<td align="left">G61.82</td>
<td align="right">48</td>
<td align="left">Multifocal motor neuropathy</td>
<td align="left">Multifocal motor neuropathy</td>
</tr>
<tr class="odd">
<td align="left">G24.1</td>
<td align="right">48</td>
<td align="left">Early-onset generalized dystonia</td>
<td align="left">Genetic torsion dystonia</td>
</tr>
<tr class="even">
<td align="left">G24.1</td>
<td align="right">48</td>
<td align="left">Partington syndrome</td>
<td align="left">Genetic torsion dystonia</td>
</tr>
<tr class="odd">
<td align="left">G24.1</td>
<td align="right">48</td>
<td align="left">Adolescent-onset dystonia of mixed type</td>
<td align="left">Genetic torsion dystonia</td>
</tr>
<tr class="even">
<td align="left">E76.01</td>
<td align="right">48</td>
<td align="left">Hurler syndrome</td>
<td align="left">Hurler’s syndrome</td>
</tr>
<tr class="odd">
<td align="left">E50.9</td>
<td align="right">48</td>
<td align="left">Keratomalacia</td>
<td align="left">Vitamin A deficiency, unspecified</td>
</tr>
<tr class="even">
<td align="left">D89.1</td>
<td align="right">48</td>
<td align="left">Cryoglobulinemia</td>
<td align="left">Cryoglobulinemia</td>
</tr>
<tr class="odd">
<td align="left">A42.9</td>
<td align="right">48</td>
<td align="left">Actinomycosis</td>
<td align="left">Actinomycosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q38.8</td>
<td align="right">47</td>
<td align="left">Palatopharyngeal incompetence</td>
<td align="left">Other congenital malformations of pharynx</td>
</tr>
<tr class="odd">
<td align="left">L12.9</td>
<td align="right">47</td>
<td align="left">Bullous pemphigoid</td>
<td align="left">Pemphigoid, unspecified</td>
</tr>
<tr class="even">
<td align="left">J84.116</td>
<td align="right">47</td>
<td align="left">Cryptogenic organizing pneumonia</td>
<td align="left">Cryptogenic organizing pneumonia</td>
</tr>
<tr class="odd">
<td align="left">J84.116</td>
<td align="right">47</td>
<td align="left">Bronchiolitis obliterans organizing pneumonia</td>
<td align="left">Cryptogenic organizing pneumonia</td>
</tr>
<tr class="even">
<td align="left">I28.8</td>
<td align="right">47</td>
<td align="left">Pulmonary vein stenosis</td>
<td align="left">Other diseases of pulmonary vessels</td>
</tr>
<tr class="odd">
<td align="left">D73.89</td>
<td align="right">47</td>
<td align="left">Wandering spleen</td>
<td align="left">Other diseases of spleen</td>
</tr>
<tr class="even">
<td align="left">D47.0</td>
<td align="right">47</td>
<td align="left">Cutaneous mastocytosis</td>
<td align="left">Histiocytic and mast cell tumors of uncertain behavior</td>
</tr>
<tr class="odd">
<td align="left">D47.0</td>
<td align="right">47</td>
<td align="left">Systemic mastocytosis</td>
<td align="left">Histiocytic and mast cell tumors of uncertain behavior</td>
</tr>
<tr class="even">
<td align="left">D47.0</td>
<td align="right">47</td>
<td align="left">Cutaneous mastocytoma</td>
<td align="left">Histiocytic and mast cell tumors of uncertain behavior</td>
</tr>
<tr class="odd">
<td align="left">D47.0</td>
<td align="right">47</td>
<td align="left">Cutaneous mastocytoma</td>
<td align="left">Histiocytic and mast cell tumors of uncertain behavior</td>
</tr>
<tr class="even">
<td align="left">Q20.0</td>
<td align="right">46</td>
<td align="left">Persistent truncus arteriosus</td>
<td align="left">Common arterial trunk</td>
</tr>
<tr class="odd">
<td align="left">E80.1</td>
<td align="right">46</td>
<td align="left">Hepatoerythropoietic porphyria</td>
<td align="left">Porphyria cutanea tarda</td>
</tr>
<tr class="even">
<td align="left">E80.1</td>
<td align="right">46</td>
<td align="left">Porphyria cutanea tarda</td>
<td align="left">Porphyria cutanea tarda</td>
</tr>
<tr class="odd">
<td align="left">D80.4</td>
<td align="right">46</td>
<td align="left">Selective IgM deficiency</td>
<td align="left">Selective deficiency of immunoglobulin M [IgM]</td>
</tr>
<tr class="even">
<td align="left">Q25.21</td>
<td align="right">45</td>
<td align="left">Aortic arch interruption</td>
<td align="left">Interruption of aortic arch</td>
</tr>
<tr class="odd">
<td align="left">P35.1</td>
<td align="right">45</td>
<td align="left">Congenital cytomegalovirus</td>
<td align="left">Congenital cytomegalovirus infection</td>
</tr>
<tr class="even">
<td align="left">G71.2</td>
<td align="right">45</td>
<td align="left">Centronuclear myopathy</td>
<td align="left">Congenital myopathies</td>
</tr>
<tr class="odd">
<td align="left">G71.2</td>
<td align="right">45</td>
<td align="left">Limb-girdle muscular dystrophy type 2H</td>
<td align="left">Congenital myopathies</td>
</tr>
<tr class="even">
<td align="left">G71.2</td>
<td align="right">45</td>
<td align="left">Tubular aggregate myopathy</td>
<td align="left">Congenital myopathies</td>
</tr>
<tr class="odd">
<td align="left">G71.2</td>
<td align="right">45</td>
<td align="left">Congenital nonprogressive myopathy with Moebius and Robin sequences</td>
<td align="left">Congenital myopathies</td>
</tr>
<tr class="even">
<td align="left">G71.2</td>
<td align="right">45</td>
<td align="left">Myopathy congenital</td>
<td align="left">Congenital myopathies</td>
</tr>
<tr class="odd">
<td align="left">G71.2</td>
<td align="right">45</td>
<td align="left">Central core disease</td>
<td align="left">Congenital myopathies</td>
</tr>
<tr class="even">
<td align="left">G71.2</td>
<td align="right">45</td>
<td align="left">Congenital fiber type disproportion</td>
<td align="left">Congenital myopathies</td>
</tr>
<tr class="odd">
<td align="left">G71.2</td>
<td align="right">45</td>
<td align="left">Multicore disease</td>
<td align="left">Congenital myopathies</td>
</tr>
<tr class="even">
<td align="left">G71.2</td>
<td align="right">45</td>
<td align="left">Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia</td>
<td align="left">Congenital myopathies</td>
</tr>
<tr class="odd">
<td align="left">G71.2</td>
<td align="right">45</td>
<td align="left">Cap myopathy</td>
<td align="left">Congenital myopathies</td>
</tr>
<tr class="even">
<td align="left">G71.2</td>
<td align="right">45</td>
<td align="left">X-linked myotubular myopathy</td>
<td align="left">Congenital myopathies</td>
</tr>
<tr class="odd">
<td align="left">G71.2</td>
<td align="right">45</td>
<td align="left">Nemaline myopathy</td>
<td align="left">Congenital myopathies</td>
</tr>
<tr class="even">
<td align="left">G71.2</td>
<td align="right">45</td>
<td align="left">Reducing body myopathy</td>
<td align="left">Congenital myopathies</td>
</tr>
<tr class="odd">
<td align="left">G71.2</td>
<td align="right">45</td>
<td align="left">Autosomal recessive centronuclear myopathy</td>
<td align="left">Congenital myopathies</td>
</tr>
<tr class="even">
<td align="left">G58.7</td>
<td align="right">45</td>
<td align="left">Mononeuritis multiplex</td>
<td align="left">Mononeuritis multiplex</td>
</tr>
<tr class="odd">
<td align="left">G44.83</td>
<td align="right">45</td>
<td align="left">Cough headache</td>
<td align="left">Primary cough headache</td>
</tr>
<tr class="even">
<td align="left">D76.1</td>
<td align="right">45</td>
<td align="left">Hemophagocytic lymphohistiocytosis</td>
<td align="left">Hemophagocytic lymphohistiocytosis</td>
</tr>
<tr class="odd">
<td align="left">D76.1</td>
<td align="right">45</td>
<td align="left">Macrophage activation syndrome</td>
<td align="left">Hemophagocytic lymphohistiocytosis</td>
</tr>
<tr class="even">
<td align="left">Q82.0</td>
<td align="right">44</td>
<td align="left">Lymphedema-distichiasis syndrome</td>
<td align="left">Hereditary lymphedema</td>
</tr>
<tr class="odd">
<td align="left">Q82.0</td>
<td align="right">44</td>
<td align="left">Congenital lymphedema</td>
<td align="left">Hereditary lymphedema</td>
</tr>
<tr class="even">
<td align="left">Q82.0</td>
<td align="right">44</td>
<td align="left">Milroy disease</td>
<td align="left">Hereditary lymphedema</td>
</tr>
<tr class="odd">
<td align="left">Q68.1</td>
<td align="right">44</td>
<td align="left">Clasped thumbs, congenital</td>
<td align="left">Congenital deformity of finger(s) and hand</td>
</tr>
<tr class="even">
<td align="left">H18.899</td>
<td align="right">44</td>
<td align="left">Iridocorneal endothelial syndrome</td>
<td align="left">Other specified disorders of cornea, unspecified eye</td>
</tr>
<tr class="odd">
<td align="left">F94.0</td>
<td align="right">44</td>
<td align="left">Elective mutism</td>
<td align="left">Selective mutism</td>
</tr>
<tr class="even">
<td align="left">F84.8</td>
<td align="right">44</td>
<td align="left">FOXG1 syndrome</td>
<td align="left">Other pervasive developmental disorders</td>
</tr>
<tr class="odd">
<td align="left">E80.20</td>
<td align="right">44</td>
<td align="left">Variegate porphyria</td>
<td align="left">Unspecified porphyria</td>
</tr>
<tr class="even">
<td align="left">E80.20</td>
<td align="right">44</td>
<td align="left">Porphyria</td>
<td align="left">Unspecified porphyria</td>
</tr>
<tr class="odd">
<td align="left">D68.1</td>
<td align="right">44</td>
<td align="left">Factor XI deficiency</td>
<td align="left">Hereditary factor XI deficiency</td>
</tr>
<tr class="even">
<td align="left">Q77.4</td>
<td align="right">43</td>
<td align="left">Hypochondroplasia</td>
<td align="left">Achondroplasia</td>
</tr>
<tr class="odd">
<td align="left">Q77.4</td>
<td align="right">43</td>
<td align="left">Achondroplasia</td>
<td align="left">Achondroplasia</td>
</tr>
<tr class="even">
<td align="left">Q77.4</td>
<td align="right">43</td>
<td align="left">Severe achondroplasia with developmental delay and acanthosis nigricans</td>
<td align="left">Achondroplasia</td>
</tr>
<tr class="odd">
<td align="left">Q64.10</td>
<td align="right">43</td>
<td align="left">Exstrophy of the bladder</td>
<td align="left">Exstrophy of urinary bladder, unspecified</td>
</tr>
<tr class="even">
<td align="left">L13.8</td>
<td align="right">43</td>
<td align="left">Linear IgA disease</td>
<td align="left">Other specified bullous disorders</td>
</tr>
<tr class="odd">
<td align="left">D61.01</td>
<td align="right">43</td>
<td align="left">Diamond-Blackfan anemia</td>
<td align="left">Constitutional (pure) red blood cell aplasia</td>
</tr>
<tr class="even">
<td align="left">D42.9</td>
<td align="right">43</td>
<td align="left">Hemangiopericytoma</td>
<td align="left">Neoplasm of uncertain behavior of meninges, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C91.50</td>
<td align="right">43</td>
<td align="left">Leukemia, T-cell, chronic</td>
<td align="left">Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">C91.50</td>
<td align="right">43</td>
<td align="left">Adult T-cell leukemia/lymphoma</td>
<td align="left">Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission</td>
</tr>
<tr class="odd">
<td align="left">O01.0</td>
<td align="right">42</td>
<td align="left">Choroideremia</td>
<td align="left">Classical hydatidiform mole</td>
</tr>
<tr class="even">
<td align="left">O01.0</td>
<td align="right">42</td>
<td align="left">Hydatidiform mole</td>
<td align="left">Classical hydatidiform mole</td>
</tr>
<tr class="odd">
<td align="left">M27.8</td>
<td align="right">42</td>
<td align="left">Cherubism</td>
<td align="left">Other specified diseases of jaws</td>
</tr>
<tr class="even">
<td align="left">M27.8</td>
<td align="right">42</td>
<td align="left">Fibrous dysplasia</td>
<td align="left">Other specified diseases of jaws</td>
</tr>
<tr class="odd">
<td align="left">J15.0</td>
<td align="right">42</td>
<td align="left">Klebsiella infection</td>
<td align="left">Pneumonia due to Klebsiella pneumoniae</td>
</tr>
<tr class="even">
<td align="left">I28.0</td>
<td align="right">42</td>
<td align="left">Pulmonary arterio-veinous fistula</td>
<td align="left">Arteriovenous fistula of pulmonary vessels</td>
</tr>
<tr class="odd">
<td align="left">I28.0</td>
<td align="right">42</td>
<td align="left">Pulmonary arteriovenous malformation</td>
<td align="left">Arteriovenous fistula of pulmonary vessels</td>
</tr>
<tr class="even">
<td align="left">G44.51</td>
<td align="right">42</td>
<td align="left">Hemicrania continua</td>
<td align="left">Hemicrania continua</td>
</tr>
<tr class="odd">
<td align="left">E71.529</td>
<td align="right">42</td>
<td align="left">X-linked adrenoleukodystrophy</td>
<td align="left">X-linked adrenoleukodystrophy, unspecified type</td>
</tr>
<tr class="even">
<td align="left">E71.529</td>
<td align="right">42</td>
<td align="left">Adrenomyeloneuropathy</td>
<td align="left">X-linked adrenoleukodystrophy, unspecified type</td>
</tr>
<tr class="odd">
<td align="left">D59.3</td>
<td align="right">42</td>
<td align="left">Hemolytic uremic syndrome</td>
<td align="left">Hemolytic-uremic syndrome</td>
</tr>
<tr class="even">
<td align="left">C85.91</td>
<td align="right">42</td>
<td align="left">Orbital lymphoma</td>
<td align="left">Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck</td>
</tr>
<tr class="odd">
<td align="left">C50.929</td>
<td align="right">42</td>
<td align="left">Breast cancer, male</td>
<td align="left">Malignant neoplasm of unspecified site of unspecified male breast</td>
</tr>
<tr class="even">
<td align="left">C50.929</td>
<td align="right">42</td>
<td align="left">Breast cancer, male</td>
<td align="left">Malignant neoplasm of unspecified site of unspecified male breast</td>
</tr>
<tr class="odd">
<td align="left">Q38.2</td>
<td align="right">41</td>
<td align="left">Macroglossia</td>
<td align="left">Macroglossia</td>
</tr>
<tr class="even">
<td align="left">L41.1</td>
<td align="right">41</td>
<td align="left">Pityriasis lichenoides chronica</td>
<td align="left">Pityriasis lichenoides chronica</td>
</tr>
<tr class="odd">
<td align="left">L41.1</td>
<td align="right">41</td>
<td align="left">Pityriasis lichenoides</td>
<td align="left">Pityriasis lichenoides chronica</td>
</tr>
<tr class="even">
<td align="left">J84.81</td>
<td align="right">41</td>
<td align="left">Lymphangioleiomyomatosis</td>
<td align="left">Lymphangioleiomyomatosis</td>
</tr>
<tr class="odd">
<td align="left">G90.09</td>
<td align="right">41</td>
<td align="left">Visceral neuropathy familial</td>
<td align="left">Other idiopathic peripheral autonomic neuropathy</td>
</tr>
<tr class="even">
<td align="left">G90.09</td>
<td align="right">41</td>
<td align="left">Paroxysmal extreme pain disorder</td>
<td align="left">Other idiopathic peripheral autonomic neuropathy</td>
</tr>
<tr class="odd">
<td align="left">G72.3</td>
<td align="right">41</td>
<td align="left">Hyperkalemic periodic paralysis</td>
<td align="left">Periodic paralysis</td>
</tr>
<tr class="even">
<td align="left">G72.3</td>
<td align="right">41</td>
<td align="left">Normokalemic periodic paralysis</td>
<td align="left">Periodic paralysis</td>
</tr>
<tr class="odd">
<td align="left">G72.3</td>
<td align="right">41</td>
<td align="left">Westphal disease</td>
<td align="left">Periodic paralysis</td>
</tr>
<tr class="even">
<td align="left">G72.3</td>
<td align="right">41</td>
<td align="left">Familial periodic paralysis</td>
<td align="left">Periodic paralysis</td>
</tr>
<tr class="odd">
<td align="left">G72.3</td>
<td align="right">41</td>
<td align="left">Hypokalemic periodic paralysis</td>
<td align="left">Periodic paralysis</td>
</tr>
<tr class="even">
<td align="left">G72.3</td>
<td align="right">41</td>
<td align="left">Thyrotoxic periodic paralysis</td>
<td align="left">Periodic paralysis</td>
</tr>
<tr class="odd">
<td align="left">D84.8</td>
<td align="right">41</td>
<td align="left">PASLI disease</td>
<td align="left">Other specified immunodeficiencies</td>
</tr>
<tr class="even">
<td align="left">A28.1</td>
<td align="right">41</td>
<td align="left">Cat scratch disease</td>
<td align="left">Cat-scratch disease</td>
</tr>
<tr class="odd">
<td align="left">Q15.8</td>
<td align="right">40</td>
<td align="left">Norrie disease</td>
<td align="left">Other specified congenital malformations of eye</td>
</tr>
<tr class="even">
<td align="left">I78.8</td>
<td align="right">40</td>
<td align="left">Systemic capillary leak syndrome</td>
<td align="left">Other diseases of capillaries</td>
</tr>
<tr class="odd">
<td align="left">I78.8</td>
<td align="right">40</td>
<td align="left">Diffuse neonatal hemangiomatosis</td>
<td align="left">Other diseases of capillaries</td>
</tr>
<tr class="even">
<td align="left">I78.8</td>
<td align="right">40</td>
<td align="left">Coffin-Lowry syndrome</td>
<td align="left">Other diseases of capillaries</td>
</tr>
<tr class="odd">
<td align="left">I78.8</td>
<td align="right">40</td>
<td align="left">Hemangiomatosis, familial pulmonary capillary</td>
<td align="left">Other diseases of capillaries</td>
</tr>
<tr class="even">
<td align="left">G31.85</td>
<td align="right">40</td>
<td align="left">Corticobasal degeneration</td>
<td align="left">Corticobasal degeneration</td>
</tr>
<tr class="odd">
<td align="left">E72.01</td>
<td align="right">40</td>
<td align="left">Cystinuria</td>
<td align="left">Cystinuria</td>
</tr>
<tr class="even">
<td align="left">C75.3</td>
<td align="right">40</td>
<td align="left">Pineal germ cell tumor</td>
<td align="left">Malignant neoplasm of pineal gland</td>
</tr>
<tr class="odd">
<td align="left">A48.1</td>
<td align="right">40</td>
<td align="left">Legionellosis</td>
<td align="left">Legionnaires’ disease</td>
</tr>
<tr class="even">
<td align="left">Q78.2</td>
<td align="right">39</td>
<td align="left">Hyperostosis corticalis generalisata, benign form of Worth with torus palatinus</td>
<td align="left">Osteopetrosis</td>
</tr>
<tr class="odd">
<td align="left">Q78.2</td>
<td align="right">39</td>
<td align="left">Osteomesopyknosis</td>
<td align="left">Osteopetrosis</td>
</tr>
<tr class="even">
<td align="left">Q78.2</td>
<td align="right">39</td>
<td align="left">Craniofacial dysostosis with diaphyseal hyperplasia</td>
<td align="left">Osteopetrosis</td>
</tr>
<tr class="odd">
<td align="left">Q78.2</td>
<td align="right">39</td>
<td align="left">Osteopathia striata cranial sclerosis</td>
<td align="left">Osteopetrosis</td>
</tr>
<tr class="even">
<td align="left">Q78.2</td>
<td align="right">39</td>
<td align="left">Osteopetrosis autosomal recessive 3</td>
<td align="left">Osteopetrosis</td>
</tr>
<tr class="odd">
<td align="left">Q78.2</td>
<td align="right">39</td>
<td align="left">Osteopetrosis</td>
<td align="left">Osteopetrosis</td>
</tr>
<tr class="even">
<td align="left">Q13.89</td>
<td align="right">39</td>
<td align="left">Anterior segment mesenchymal dysgenesis</td>
<td align="left">Other congenital malformations of anterior segment of eye</td>
</tr>
<tr class="odd">
<td align="left">M31.8</td>
<td align="right">39</td>
<td align="left">Hypocomplementemic urticarial vasculitis</td>
<td align="left">Other specified necrotizing vasculopathies</td>
</tr>
<tr class="even">
<td align="left">G46.3</td>
<td align="right">39</td>
<td align="left">Weber syndrome</td>
<td align="left">Brain stem stroke syndrome</td>
</tr>
<tr class="odd">
<td align="left">G46.3</td>
<td align="right">39</td>
<td align="left">Wallenberg syndrome</td>
<td align="left">Brain stem stroke syndrome</td>
</tr>
<tr class="even">
<td align="left">E70.30</td>
<td align="right">39</td>
<td align="left">Albinism</td>
<td align="left">Albinism, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A07.2</td>
<td align="right">39</td>
<td align="left">Cryptosporidiosis</td>
<td align="left">Cryptosporidiosis</td>
</tr>
<tr class="even">
<td align="left">Q20.8</td>
<td align="right">38</td>
<td align="left">Cor biloculare</td>
<td align="left">Other congenital malformations of cardiac chambers and connections</td>
</tr>
<tr class="odd">
<td align="left">M85.50</td>
<td align="right">38</td>
<td align="left">Aneurysmal bone cysts</td>
<td align="left">Aneurysmal bone cyst, unspecified site</td>
</tr>
<tr class="even">
<td align="left">L63.1</td>
<td align="right">38</td>
<td align="left">Alopecia universalis</td>
<td align="left">Alopecia universalis</td>
</tr>
<tr class="odd">
<td align="left">H50.69</td>
<td align="right">38</td>
<td align="left">Congenital fibrosis of extraocular muscles</td>
<td align="left">Other mechanical strabismus</td>
</tr>
<tr class="even">
<td align="left">G72.89</td>
<td align="right">38</td>
<td align="left">Myosin storage myopathy</td>
<td align="left">Other specified myopathies</td>
</tr>
<tr class="odd">
<td align="left">G72.89</td>
<td align="right">38</td>
<td align="left">Brody myopathy</td>
<td align="left">Other specified myopathies</td>
</tr>
<tr class="even">
<td align="left">G72.89</td>
<td align="right">38</td>
<td align="left">Inclusion body myopathy 2</td>
<td align="left">Other specified myopathies</td>
</tr>
<tr class="odd">
<td align="left">G72.89</td>
<td align="right">38</td>
<td align="left">Myofibrillar myopathy</td>
<td align="left">Other specified myopathies</td>
</tr>
<tr class="even">
<td align="left">G70.80</td>
<td align="right">38</td>
<td align="left">Lambert Eaton myasthenic syndrome</td>
<td align="left">Lambert-Eaton syndrome, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E76.3</td>
<td align="right">38</td>
<td align="left">Mucopolysaccharidosis</td>
<td align="left">Mucopolysaccharidosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">C79.60</td>
<td align="right">38</td>
<td align="left">Krukenberg carcinoma</td>
<td align="left">Secondary malignant neoplasm of unspecified ovary</td>
</tr>
<tr class="odd">
<td align="left">C79.60</td>
<td align="right">38</td>
<td align="left">Krukenberg carcinoma</td>
<td align="left">Secondary malignant neoplasm of unspecified ovary</td>
</tr>
<tr class="even">
<td align="left">C75.1</td>
<td align="right">38</td>
<td align="left">Pituitary cancer</td>
<td align="left">Malignant neoplasm of pituitary gland</td>
</tr>
<tr class="odd">
<td align="left">N49.3</td>
<td align="right">37</td>
<td align="left">Fournier gangrene</td>
<td align="left">Fournier gangrene</td>
</tr>
<tr class="even">
<td align="left">M60.009</td>
<td align="right">37</td>
<td align="left">Infective myositis</td>
<td align="left">Infective myositis, unspecified site</td>
</tr>
<tr class="odd">
<td align="left">E74.01</td>
<td align="right">37</td>
<td align="left">Glycogen storage disease type 1B</td>
<td align="left">von Gierke disease</td>
</tr>
<tr class="even">
<td align="left">E74.01</td>
<td align="right">37</td>
<td align="left">Glycogen storage disease type 1A</td>
<td align="left">von Gierke disease</td>
</tr>
<tr class="odd">
<td align="left">E72.09</td>
<td align="right">37</td>
<td align="left">X-linked creatine deficiency</td>
<td align="left">Other disorders of amino-acid transport</td>
</tr>
<tr class="even">
<td align="left">E72.09</td>
<td align="right">37</td>
<td align="left">Blue diaper syndrome</td>
<td align="left">Other disorders of amino-acid transport</td>
</tr>
<tr class="odd">
<td align="left">E72.09</td>
<td align="right">37</td>
<td align="left">Iminoglycinuria</td>
<td align="left">Other disorders of amino-acid transport</td>
</tr>
<tr class="even">
<td align="left">N05.5</td>
<td align="right">36</td>
<td align="left">Membranoproliferative glomerulonephritis</td>
<td align="left">Unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis</td>
</tr>
<tr class="odd">
<td align="left">L94.1</td>
<td align="right">36</td>
<td align="left">Linear scleroderma</td>
<td align="left">Linear scleroderma</td>
</tr>
<tr class="even">
<td align="left">E16.4</td>
<td align="right">36</td>
<td align="left">Zollinger-Ellison syndrome</td>
<td align="left">Increased secretion of gastrin</td>
</tr>
<tr class="odd">
<td align="left">D33.0</td>
<td align="right">36</td>
<td align="left">Dysembryoplastic neuroepithelial tumor</td>
<td align="left">Benign neoplasm of brain, supratentorial</td>
</tr>
<tr class="even">
<td align="left">D32.1</td>
<td align="right">36</td>
<td align="left">Spinal meningioma</td>
<td align="left">Benign neoplasm of spinal meninges</td>
</tr>
<tr class="odd">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Kenny-Caffey syndrome type 2</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="even">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Spondyloepimetaphyseal dysplasia Strudwick type</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="odd">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Acroosteolysis dominant type</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="even">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Frontometaphyseal dysplasia</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="odd">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Boomerang dysplasia</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="even">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Buschke Ollendorff syndrome</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="odd">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Buschke Ollendorff syndrome</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="even">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Carpotarsal osteochondromatosis</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="odd">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Desbuquois syndrome</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="even">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Dysosteosclerosis</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="odd">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Dysostosis peripheral</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="even">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Dyssegmental dysplasia Silverman-Handmaker type</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="odd">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Fibrochondrogenesis</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="even">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Geleophysic dwarfism</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="odd">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Hyperostosis corticalis generalisata</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="even">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Lenz Majewski hyperostotic dwarfism</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="odd">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Metachondromatosis</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="even">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Metaphyseal anadysplasia</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="odd">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Metatropic dysplasia</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="even">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Osteoglophonic dysplasia</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="odd">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Osteopoikilosis</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="even">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Pycnodysostosis</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="odd">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Sclerosteosis</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="even">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Spondylocarpotarsal synostosis syndrome</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="odd">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Acrodysostosis</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="even">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Infantile apnea</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="odd">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Kniest dysplasia</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="even">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Melnick-Needles syndrome</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="odd">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Atelosteogenesis type 2</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="even">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Progressive pseudorheumatoid dysplasia</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="odd">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Atelosteogenesis type 1</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="even">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Pseudodiastrophic dysplasia</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="odd">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Dyssegmental dysplasia Rolland-Desbuquois type</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="even">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Microcephalic osteodysplastic primordial dwarfism type 2</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="odd">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="even">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Kyphomelic dysplasia</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="odd">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Genochondromatosis</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="even">
<td align="left">Q78.8</td>
<td align="right">35</td>
<td align="left">Multiple epiphyseal dysplasia</td>
<td align="left">Other specified osteochondrodysplasias</td>
</tr>
<tr class="odd">
<td align="left">Q25.43</td>
<td align="right">35</td>
<td align="left">Familial thoracic aortic aneurysm and dissection</td>
<td align="left">Congenital aneurysm of aorta</td>
</tr>
<tr class="even">
<td align="left">L66.3</td>
<td align="right">35</td>
<td align="left">Dissecting cellulitis of the scalp</td>
<td align="left">Perifolliculitis capitis abscedens</td>
</tr>
<tr class="odd">
<td align="left">G12.1</td>
<td align="right">35</td>
<td align="left">Spinal muscular atrophy type 3</td>
<td align="left">Other inherited spinal muscular atrophy</td>
</tr>
<tr class="even">
<td align="left">G12.1</td>
<td align="right">35</td>
<td align="left">Spinal muscular atrophy type 4</td>
<td align="left">Other inherited spinal muscular atrophy</td>
</tr>
<tr class="odd">
<td align="left">G12.1</td>
<td align="right">35</td>
<td align="left">Spinal muscular atrophy type 2</td>
<td align="left">Other inherited spinal muscular atrophy</td>
</tr>
<tr class="even">
<td align="left">G12.1</td>
<td align="right">35</td>
<td align="left">Spinal muscular atrophy with respiratory distress 1</td>
<td align="left">Other inherited spinal muscular atrophy</td>
</tr>
<tr class="odd">
<td align="left">G12.1</td>
<td align="right">35</td>
<td align="left">Amyotrophy, neurogenic scapuloperoneal, New England type</td>
<td align="left">Other inherited spinal muscular atrophy</td>
</tr>
<tr class="even">
<td align="left">G12.1</td>
<td align="right">35</td>
<td align="left">Distal hereditary motor neuropathy</td>
<td align="left">Other inherited spinal muscular atrophy</td>
</tr>
<tr class="odd">
<td align="left">F98.21</td>
<td align="right">35</td>
<td align="left">Rumination disorder</td>
<td align="left">Rumination disorder of infancy</td>
</tr>
<tr class="even">
<td align="left">E75.25</td>
<td align="right">35</td>
<td align="left">Metachromatic leukodystrophy</td>
<td align="left">Metachromatic leukodystrophy</td>
</tr>
<tr class="odd">
<td align="left">E75.25</td>
<td align="right">35</td>
<td align="left">Metachromatic leukodystrophy due to saposin B deficiency</td>
<td align="left">Metachromatic leukodystrophy</td>
</tr>
<tr class="even">
<td align="left">E75.25</td>
<td align="right">35</td>
<td align="left">Metachromatic leukodystrophy due to saposin B deficiency</td>
<td align="left">Metachromatic leukodystrophy</td>
</tr>
<tr class="odd">
<td align="left">Q55.0</td>
<td align="right">34</td>
<td align="left">Anorchia</td>
<td align="left">Absence and aplasia of testis</td>
</tr>
<tr class="even">
<td align="left">Q55.0</td>
<td align="right">34</td>
<td align="left">Sertoli cell-only syndrome</td>
<td align="left">Absence and aplasia of testis</td>
</tr>
<tr class="odd">
<td align="left">D67</td>
<td align="right">34</td>
<td align="left">Hemophilia B</td>
<td align="left">Hereditary factor IX deficiency</td>
</tr>
<tr class="even">
<td align="left">B46.9</td>
<td align="right">34</td>
<td align="left">Zygomycosis</td>
<td align="left">Zygomycosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q44.5</td>
<td align="right">33</td>
<td align="left">Caroli disease</td>
<td align="left">Other congenital malformations of bile ducts</td>
</tr>
<tr class="even">
<td align="left">M30.1</td>
<td align="right">33</td>
<td align="left">Allergic angiitis</td>
<td align="left">Polyarteritis with lung involvement [Churg-Strauss]</td>
</tr>
<tr class="odd">
<td align="left">M30.1</td>
<td align="right">33</td>
<td align="left">Eosinophilic granulomatosis with polyangiitis</td>
<td align="left">Polyarteritis with lung involvement [Churg-Strauss]</td>
</tr>
<tr class="even">
<td align="left">K00.0</td>
<td align="right">33</td>
<td align="left">Anodontia</td>
<td align="left">Anodontia</td>
</tr>
<tr class="odd">
<td align="left">I73.1</td>
<td align="right">33</td>
<td align="left">Buerger disease</td>
<td align="left">Thromboangiitis obliterans [Buerger’s disease]</td>
</tr>
<tr class="even">
<td align="left">D64.3</td>
<td align="right">33</td>
<td align="left">Sideroblastic anemia acquired</td>
<td align="left">Other sideroblastic anemias</td>
</tr>
<tr class="odd">
<td align="left">D64.3</td>
<td align="right">33</td>
<td align="left">Sideroblastic anemia pyridoxine-responsive autosomal recessive</td>
<td align="left">Other sideroblastic anemias</td>
</tr>
<tr class="even">
<td align="left">D64.3</td>
<td align="right">33</td>
<td align="left">Sideroblastic anemia pyridoxine-responsive autosomal recessive</td>
<td align="left">Other sideroblastic anemias</td>
</tr>
<tr class="odd">
<td align="left">A86</td>
<td align="right">33</td>
<td align="left">Acute necrotizing encephalopathy</td>
<td align="left">Unspecified viral encephalitis</td>
</tr>
<tr class="even">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Gillespie syndrome</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="odd">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Hypohidrotic ectodermal dysplasia</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="even">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Johanson-Blizzard syndrome</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="odd">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Schinzel Giedion syndrome</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="even">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Facial ectodermal dysplasia</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="odd">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Jacobsen syndrome</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="even">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Cranioectodermal dysplasia</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="odd">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Weyers acrofacial dysostosis</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="even">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Alopecia epilepsy oligophrenia syndrome of Moynahan</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="odd">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Book syndrome</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="even">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Absence of fingerprints congenital milia</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="odd">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">KID syndrome</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="even">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Woolly hair hypotrichosis everted lower lip and outstanding ears</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="odd">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Periodic fever, aphthous stomatitis, pharyngitis and adenitis</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="even">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Rapp-Hodgkin syndrome</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="odd">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Ectodermal dysplasia</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="even">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Hay-Wells syndrome</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="odd">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Marshall syndrome</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="even">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Nevoid basal cell carcinoma syndrome</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="odd">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Oculodentodigital dysplasia</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="even">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Tricho-dento-osseous syndrome</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="odd">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Focal facial dermal dysplasia</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="even">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">Hypohidrotic ectodermal dysplasia with immune deficiency</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="odd">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">X-linked hypohidrotic ectodermal dysplasia</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="even">
<td align="left">Q82.4</td>
<td align="right">32</td>
<td align="left">X-linked hypohidrotic ectodermal dysplasia</td>
<td align="left">Ectodermal dysplasia (anhidrotic)</td>
</tr>
<tr class="odd">
<td align="left">Q25.72</td>
<td align="right">32</td>
<td align="left">Pulmonary arteriovenous malformation</td>
<td align="left">Congenital pulmonary arteriovenous malformation</td>
</tr>
<tr class="even">
<td align="left">L92.1</td>
<td align="right">32</td>
<td align="left">Necrobiosis lipoidica</td>
<td align="left">Necrobiosis lipoidica, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">E88.2</td>
<td align="right">32</td>
<td align="left">Encephalocraniocutaneous lipomatosis</td>
<td align="left">Lipomatosis, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">E88.2</td>
<td align="right">32</td>
<td align="left">Adiposis dolorosa</td>
<td align="left">Lipomatosis, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">E88.2</td>
<td align="right">32</td>
<td align="left">Multiple symmetric lipomatosis</td>
<td align="left">Lipomatosis, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">E88.2</td>
<td align="right">32</td>
<td align="left">Multiple symmetric lipomatosis</td>
<td align="left">Lipomatosis, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">E88.2</td>
<td align="right">32</td>
<td align="left">Familial multiple lipomatosis</td>
<td align="left">Lipomatosis, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">E77.8</td>
<td align="right">32</td>
<td align="left">Schindler disease type 1</td>
<td align="left">Other disorders of glycoprotein metabolism</td>
</tr>
<tr class="odd">
<td align="left">E77.8</td>
<td align="right">32</td>
<td align="left">PMM2-CDG (CDG-Ia)</td>
<td align="left">Other disorders of glycoprotein metabolism</td>
</tr>
<tr class="even">
<td align="left">E77.8</td>
<td align="right">32</td>
<td align="left">PMM2-CDG (CDG-Ia)</td>
<td align="left">Other disorders of glycoprotein metabolism</td>
</tr>
<tr class="odd">
<td align="left">E77.8</td>
<td align="right">32</td>
<td align="left">MGAT2-CDG (CDG-IIa)</td>
<td align="left">Other disorders of glycoprotein metabolism</td>
</tr>
<tr class="even">
<td align="left">E77.8</td>
<td align="right">32</td>
<td align="left">ALG2-CDG (CDG-Ii)</td>
<td align="left">Other disorders of glycoprotein metabolism</td>
</tr>
<tr class="odd">
<td align="left">E77.8</td>
<td align="right">32</td>
<td align="left">Congenital disorder of glycosylation type I/IIX</td>
<td align="left">Other disorders of glycoprotein metabolism</td>
</tr>
<tr class="even">
<td align="left">E77.8</td>
<td align="right">32</td>
<td align="left">Congenital disorders of glycosylation</td>
<td align="left">Other disorders of glycoprotein metabolism</td>
</tr>
<tr class="odd">
<td align="left">E77.8</td>
<td align="right">32</td>
<td align="left">COG5-CDG (CDG-IIi)</td>
<td align="left">Other disorders of glycoprotein metabolism</td>
</tr>
<tr class="even">
<td align="left">E31.21</td>
<td align="right">32</td>
<td align="left">Multiple endocrine neoplasia type 1</td>
<td align="left">Multiple endocrine neoplasia [MEN] type I</td>
</tr>
<tr class="odd">
<td align="left">E31.0</td>
<td align="right">32</td>
<td align="left">Whitaker syndrome</td>
<td align="left">Autoimmune polyglandular failure</td>
</tr>
<tr class="even">
<td align="left">E31.0</td>
<td align="right">32</td>
<td align="left">Antiphospholipid syndrome</td>
<td align="left">Autoimmune polyglandular failure</td>
</tr>
<tr class="odd">
<td align="left">E31.0</td>
<td align="right">32</td>
<td align="left">Autoimmune polyglandular syndrome type 2</td>
<td align="left">Autoimmune polyglandular failure</td>
</tr>
<tr class="even">
<td align="left">E31.0</td>
<td align="right">32</td>
<td align="left">Autoimmune polyglandular syndrome type 1</td>
<td align="left">Autoimmune polyglandular failure</td>
</tr>
<tr class="odd">
<td align="left">E31.0</td>
<td align="right">32</td>
<td align="left">Autoimmune polyglandular syndrome type 3</td>
<td align="left">Autoimmune polyglandular failure</td>
</tr>
<tr class="even">
<td align="left">Q69.1</td>
<td align="right">31</td>
<td align="left">Preaxial polydactyly type 1</td>
<td align="left">Accessory thumb(s)</td>
</tr>
<tr class="odd">
<td align="left">Q69.1</td>
<td align="right">31</td>
<td align="left">Preaxial polydactyly of fingers</td>
<td align="left">Accessory thumb(s)</td>
</tr>
<tr class="even">
<td align="left">Q62.39</td>
<td align="right">31</td>
<td align="left">Multicystic renal dysplasia, bilateral</td>
<td align="left">Other obstructive defects of renal pelvis and ureter</td>
</tr>
<tr class="odd">
<td align="left">P83.2</td>
<td align="right">31</td>
<td align="left">Fetal edema</td>
<td align="left">Hydrops fetalis not due to hemolytic disease</td>
</tr>
<tr class="even">
<td align="left">P83.2</td>
<td align="right">31</td>
<td align="left">Hydrops fetalis</td>
<td align="left">Hydrops fetalis not due to hemolytic disease</td>
</tr>
<tr class="odd">
<td align="left">I67.7</td>
<td align="right">31</td>
<td align="left">Primary angiitis of the central nervous system</td>
<td align="left">Cerebral arteritis, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">H35.51</td>
<td align="right">31</td>
<td align="left">Familial exudative vitreoretinopathy</td>
<td align="left">Vitreoretinal dystrophy</td>
</tr>
<tr class="odd">
<td align="left">H35.51</td>
<td align="right">31</td>
<td align="left">Vitreoretinal degeneration</td>
<td align="left">Vitreoretinal dystrophy</td>
</tr>
<tr class="even">
<td align="left">H35.51</td>
<td align="right">31</td>
<td align="left">Vitreoretinochoroidopathy dominant</td>
<td align="left">Vitreoretinal dystrophy</td>
</tr>
<tr class="odd">
<td align="left">H35.51</td>
<td align="right">31</td>
<td align="left">Wagner syndrome</td>
<td align="left">Vitreoretinal dystrophy</td>
</tr>
<tr class="even">
<td align="left">H35.51</td>
<td align="right">31</td>
<td align="left">Goldmann-Favre syndrome</td>
<td align="left">Vitreoretinal dystrophy</td>
</tr>
<tr class="odd">
<td align="left">G80.2</td>
<td align="right">31</td>
<td align="left">Cerebral palsy spastic hemiplegic</td>
<td align="left">Spastic hemiplegic cerebral palsy</td>
</tr>
<tr class="even">
<td align="left">E75.23</td>
<td align="right">31</td>
<td align="left">Krabbe disease</td>
<td align="left">Krabbe disease</td>
</tr>
<tr class="odd">
<td align="left">Q39.0</td>
<td align="right">30</td>
<td align="left">Esophageal atresia</td>
<td align="left">Atresia of esophagus without fistula</td>
</tr>
<tr class="even">
<td align="left">M31.7</td>
<td align="right">30</td>
<td align="left">Microscopic polyangiitis</td>
<td align="left">Microscopic polyangiitis</td>
</tr>
<tr class="odd">
<td align="left">K52.81</td>
<td align="right">30</td>
<td align="left">Eosinophilic enteropathy</td>
<td align="left">Eosinophilic gastritis or gastroenteritis</td>
</tr>
<tr class="even">
<td align="left">G12.0</td>
<td align="right">30</td>
<td align="left">Spinal muscular atrophy 1</td>
<td align="left">Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]</td>
</tr>
<tr class="odd">
<td align="left">G96.8</td>
<td align="right">29</td>
<td align="left">Spinocerebellar ataxia 3</td>
<td align="left">Other specified disorders of central nervous system</td>
</tr>
<tr class="even">
<td align="left">E75.4</td>
<td align="right">29</td>
<td align="left">Neuronal ceroid lipofuscinosis 2</td>
<td align="left">Neuronal ceroid lipofuscinosis</td>
</tr>
<tr class="odd">
<td align="left">E75.4</td>
<td align="right">29</td>
<td align="left">Northern epilepsy</td>
<td align="left">Neuronal ceroid lipofuscinosis</td>
</tr>
<tr class="even">
<td align="left">E75.4</td>
<td align="right">29</td>
<td align="left">Neuronal ceroid lipofuscinosis 3</td>
<td align="left">Neuronal ceroid lipofuscinosis</td>
</tr>
<tr class="odd">
<td align="left">E75.4</td>
<td align="right">29</td>
<td align="left">Autosomal recessive neuronal ceroid lipofuscinosis 4A</td>
<td align="left">Neuronal ceroid lipofuscinosis</td>
</tr>
<tr class="even">
<td align="left">E75.4</td>
<td align="right">29</td>
<td align="left">Ceroid storage disease</td>
<td align="left">Neuronal ceroid lipofuscinosis</td>
</tr>
<tr class="odd">
<td align="left">E75.4</td>
<td align="right">29</td>
<td align="left">Neuronal ceroid lipofuscinosis</td>
<td align="left">Neuronal ceroid lipofuscinosis</td>
</tr>
<tr class="even">
<td align="left">E75.4</td>
<td align="right">29</td>
<td align="left">Adult neuronal ceroid lipofuscinosis</td>
<td align="left">Neuronal ceroid lipofuscinosis</td>
</tr>
<tr class="odd">
<td align="left">E74.03</td>
<td align="right">29</td>
<td align="left">Glycogen storage disease type 3</td>
<td align="left">Cori disease</td>
</tr>
<tr class="even">
<td align="left">C69.90</td>
<td align="right">29</td>
<td align="left">Ocular melanoma</td>
<td align="left">Malignant neoplasm of unspecified site of unspecified eye</td>
</tr>
<tr class="odd">
<td align="left">Q91.3</td>
<td align="right">28</td>
<td align="left">Trisomy 18</td>
<td align="left">Trisomy 18, unspecified</td>
</tr>
<tr class="even">
<td align="left">M06.1</td>
<td align="right">28</td>
<td align="left">Adult-onset Still’s disease</td>
<td align="left">Adult-onset Still’s disease</td>
</tr>
<tr class="odd">
<td align="left">H55.89</td>
<td align="right">28</td>
<td align="left">Motor neuro-ophthalmic disorders</td>
<td align="left">Other irregular eye movements</td>
</tr>
<tr class="even">
<td align="left">H55.89</td>
<td align="right">28</td>
<td align="left">Ocular motility disorders</td>
<td align="left">Other irregular eye movements</td>
</tr>
<tr class="odd">
<td align="left">H47.22</td>
<td align="right">28</td>
<td align="left">Leber hereditary optic neuropathy</td>
<td align="left">Hereditary optic atrophy</td>
</tr>
<tr class="even">
<td align="left">H47.22</td>
<td align="right">28</td>
<td align="left">Leber hereditary optic neuropathy with dystonia</td>
<td align="left">Hereditary optic atrophy</td>
</tr>
<tr class="odd">
<td align="left">H47.22</td>
<td align="right">28</td>
<td align="left">Optic atrophy 1</td>
<td align="left">Hereditary optic atrophy</td>
</tr>
<tr class="even">
<td align="left">H47.22</td>
<td align="right">28</td>
<td align="left">Dominant optic atrophy</td>
<td align="left">Hereditary optic atrophy</td>
</tr>
<tr class="odd">
<td align="left">G11.1</td>
<td align="right">28</td>
<td align="left">Harding ataxia</td>
<td align="left">Early-onset cerebellar ataxia</td>
</tr>
<tr class="even">
<td align="left">G11.1</td>
<td align="right">28</td>
<td align="left">Friedreich ataxia</td>
<td align="left">Early-onset cerebellar ataxia</td>
</tr>
<tr class="odd">
<td align="left">G11.1</td>
<td align="right">28</td>
<td align="left">Dyssynergia cerebellaris myoclonica</td>
<td align="left">Early-onset cerebellar ataxia</td>
</tr>
<tr class="even">
<td align="left">G11.1</td>
<td align="right">28</td>
<td align="left">Spinocerebellar ataxia 36</td>
<td align="left">Early-onset cerebellar ataxia</td>
</tr>
<tr class="odd">
<td align="left">E74.39</td>
<td align="right">28</td>
<td align="left">Glucose-galactose malabsorption</td>
<td align="left">Other disorders of intestinal carbohydrate absorption</td>
</tr>
<tr class="even">
<td align="left">E54</td>
<td align="right">28</td>
<td align="left">Scurvy</td>
<td align="left">Ascorbic acid deficiency</td>
</tr>
<tr class="odd">
<td align="left">C90.10</td>
<td align="right">28</td>
<td align="left">Plasma cell leukemia</td>
<td align="left">Plasma cell leukemia not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">Q74.9</td>
<td align="right">27</td>
<td align="left">Multiple pterygium syndrome Escobar type</td>
<td align="left">Unspecified congenital malformation of limb(s)</td>
</tr>
<tr class="odd">
<td align="left">Q24.2</td>
<td align="right">27</td>
<td align="left">Cor triatriatum</td>
<td align="left">Cor triatriatum</td>
</tr>
<tr class="even">
<td align="left">Q24.2</td>
<td align="right">27</td>
<td align="left">Cor triatriatum dexter</td>
<td align="left">Cor triatriatum</td>
</tr>
<tr class="odd">
<td align="left">Q24.2</td>
<td align="right">27</td>
<td align="left">Cor triatriatum sinister</td>
<td align="left">Cor triatriatum</td>
</tr>
<tr class="even">
<td align="left">L44.0</td>
<td align="right">27</td>
<td align="left">Pityriasis rubra pilaris</td>
<td align="left">Pityriasis rubra pilaris</td>
</tr>
<tr class="odd">
<td align="left">J84.114</td>
<td align="right">27</td>
<td align="left">Acute intermittent porphyria</td>
<td align="left">Acute interstitial pneumonitis</td>
</tr>
<tr class="even">
<td align="left">J84.114</td>
<td align="right">27</td>
<td align="left">Idiopathic pulmonary fibrosis</td>
<td align="left">Acute interstitial pneumonitis</td>
</tr>
<tr class="odd">
<td align="left">J84.114</td>
<td align="right">27</td>
<td align="left">Acute interstitial pneumonia</td>
<td align="left">Acute interstitial pneumonitis</td>
</tr>
<tr class="even">
<td align="left">G80.4</td>
<td align="right">27</td>
<td align="left">Cerebral palsy ataxic</td>
<td align="left">Ataxic cerebral palsy</td>
</tr>
<tr class="odd">
<td align="left">F84.2</td>
<td align="right">27</td>
<td align="left">Rothmund-Thomson syndrome</td>
<td align="left">Rett’s syndrome</td>
</tr>
<tr class="even">
<td align="left">F84.2</td>
<td align="right">27</td>
<td align="left">Rett syndrome</td>
<td align="left">Rett’s syndrome</td>
</tr>
<tr class="odd">
<td align="left">D57.80</td>
<td align="right">27</td>
<td align="left">Sickle cell - hemoglobin D disease</td>
<td align="left">Other sickle-cell disorders without crisis</td>
</tr>
<tr class="even">
<td align="left">C25.4</td>
<td align="right">27</td>
<td align="left">Somatostatinoma</td>
<td align="left">Malignant neoplasm of endocrine pancreas</td>
</tr>
<tr class="odd">
<td align="left">C25.4</td>
<td align="right">27</td>
<td align="left">Pancreatic islet cell tumors</td>
<td align="left">Malignant neoplasm of endocrine pancreas</td>
</tr>
<tr class="even">
<td align="left">Q84.8</td>
<td align="right">26</td>
<td align="left">Oculocerebrocutaneous syndrome</td>
<td align="left">Other specified congenital malformations of integument</td>
</tr>
<tr class="odd">
<td align="left">Q84.8</td>
<td align="right">26</td>
<td align="left">Adrenocortical carcinoma</td>
<td align="left">Other specified congenital malformations of integument</td>
</tr>
<tr class="even">
<td align="left">Q84.8</td>
<td align="right">26</td>
<td align="left">Aplasia cutis congenita</td>
<td align="left">Other specified congenital malformations of integument</td>
</tr>
<tr class="odd">
<td align="left">Q30.0</td>
<td align="right">26</td>
<td align="left">Radial ray hypoplasia choanal atresia</td>
<td align="left">Choanal atresia</td>
</tr>
<tr class="even">
<td align="left">M34.89</td>
<td align="right">26</td>
<td align="left">Limited systemic sclerosis</td>
<td align="left">Other systemic sclerosis</td>
</tr>
<tr class="odd">
<td align="left">M34.89</td>
<td align="right">26</td>
<td align="left">Limited systemic sclerosis</td>
<td align="left">Other systemic sclerosis</td>
</tr>
<tr class="even">
<td align="left">M20.009</td>
<td align="right">26</td>
<td align="left">Thumb deformity</td>
<td align="left">Unspecified deformity of unspecified finger(s)</td>
</tr>
<tr class="odd">
<td align="left">H16.299</td>
<td align="right">26</td>
<td align="left">Vernal keratoconjunctivitis</td>
<td align="left">Other keratoconjunctivitis, unspecified eye</td>
</tr>
<tr class="even">
<td align="left">H16.299</td>
<td align="right">26</td>
<td align="left">Superior limbic keratoconjunctivitis</td>
<td align="left">Other keratoconjunctivitis, unspecified eye</td>
</tr>
<tr class="odd">
<td align="left">G31.89</td>
<td align="right">26</td>
<td align="left">Ramer Ladda syndrome</td>
<td align="left">Other specified degenerative diseases of nervous system</td>
</tr>
<tr class="even">
<td align="left">G31.89</td>
<td align="right">26</td>
<td align="left">Neuroaxonal dystrophy, infantile</td>
<td align="left">Other specified degenerative diseases of nervous system</td>
</tr>
<tr class="odd">
<td align="left">G31.89</td>
<td align="right">26</td>
<td align="left">Dentatorubral-pallidoluysian atrophy</td>
<td align="left">Other specified degenerative diseases of nervous system</td>
</tr>
<tr class="even">
<td align="left">G31.89</td>
<td align="right">26</td>
<td align="left">Fatty acid hydroxylase-associated neurodegeneration</td>
<td align="left">Other specified degenerative diseases of nervous system</td>
</tr>
<tr class="odd">
<td align="left">G31.89</td>
<td align="right">26</td>
<td align="left">PLA2G6-associated neurodegeneration</td>
<td align="left">Other specified degenerative diseases of nervous system</td>
</tr>
<tr class="even">
<td align="left">G31.89</td>
<td align="right">26</td>
<td align="left">Mitochondrial Membrane Protein-Associated Neurodegeneration</td>
<td align="left">Other specified degenerative diseases of nervous system</td>
</tr>
<tr class="odd">
<td align="left">D80.5</td>
<td align="right">26</td>
<td align="left">Immunodeficiency with hyper IgM type 1</td>
<td align="left">Immunodeficiency with increased immunoglobulin M [IgM]</td>
</tr>
<tr class="even">
<td align="left">D80.5</td>
<td align="right">26</td>
<td align="left">Immunodeficiency with hyper IgM type 1</td>
<td align="left">Immunodeficiency with increased immunoglobulin M [IgM]</td>
</tr>
<tr class="odd">
<td align="left">C86.5</td>
<td align="right">26</td>
<td align="left">Angioimmunoblastic lymphadenopathy with dysproteinemia</td>
<td align="left">Angioimmunoblastic T-cell lymphoma</td>
</tr>
<tr class="even">
<td align="left">C86.5</td>
<td align="right">26</td>
<td align="left">Angioimmunoblastic T-cell lymphoma</td>
<td align="left">Angioimmunoblastic T-cell lymphoma</td>
</tr>
<tr class="odd">
<td align="left">A31.1</td>
<td align="right">26</td>
<td align="left">Buruli ulcer</td>
<td align="left">Cutaneous mycobacterial infection</td>
</tr>
<tr class="even">
<td align="left">A31.1</td>
<td align="right">26</td>
<td align="left">Mycobacterium Marinum</td>
<td align="left">Cutaneous mycobacterial infection</td>
</tr>
<tr class="odd">
<td align="left">R29.0</td>
<td align="right">25</td>
<td align="left">Primary hypomagnesemia with secondary hypocalcemia</td>
<td align="left">Tetany</td>
</tr>
<tr class="even">
<td align="left">Q78.4</td>
<td align="right">25</td>
<td align="left">Spondyloenchondrodysplasia</td>
<td align="left">Enchondromatosis</td>
</tr>
<tr class="odd">
<td align="left">Q78.4</td>
<td align="right">25</td>
<td align="left">Maffucci syndrome</td>
<td align="left">Enchondromatosis</td>
</tr>
<tr class="even">
<td align="left">Q78.4</td>
<td align="right">25</td>
<td align="left">Ollier disease</td>
<td align="left">Enchondromatosis</td>
</tr>
<tr class="odd">
<td align="left">M86.30</td>
<td align="right">25</td>
<td align="left">Chronic recurrent multifocal osteomyelitis</td>
<td align="left">Chronic multifocal osteomyelitis, unspecified site</td>
</tr>
<tr class="even">
<td align="left">L40.1</td>
<td align="right">25</td>
<td align="left">Pustular psoriasis</td>
<td align="left">Generalized pustular psoriasis</td>
</tr>
<tr class="odd">
<td align="left">L40.1</td>
<td align="right">25</td>
<td align="left">Generalized pustular psoriasis</td>
<td align="left">Generalized pustular psoriasis</td>
</tr>
<tr class="even">
<td align="left">L40.1</td>
<td align="right">25</td>
<td align="left">Pustulosis palmaris et plantaris</td>
<td align="left">Generalized pustular psoriasis</td>
</tr>
<tr class="odd">
<td align="left">J62.8</td>
<td align="right">25</td>
<td align="left">Silicosis</td>
<td align="left">Pneumoconiosis due to other dust containing silica</td>
</tr>
<tr class="even">
<td align="left">J62.8</td>
<td align="right">25</td>
<td align="left">Silicosiderosis</td>
<td align="left">Pneumoconiosis due to other dust containing silica</td>
</tr>
<tr class="odd">
<td align="left">G71.12</td>
<td align="right">25</td>
<td align="left">Hyperkalemic periodic paralysis</td>
<td align="left">Myotonia congenita</td>
</tr>
<tr class="even">
<td align="left">G71.12</td>
<td align="right">25</td>
<td align="left">Potassium aggravated myotonia</td>
<td align="left">Myotonia congenita</td>
</tr>
<tr class="odd">
<td align="left">G71.12</td>
<td align="right">25</td>
<td align="left">Primary amebic meningoencephalitis</td>
<td align="left">Myotonia congenita</td>
</tr>
<tr class="even">
<td align="left">G71.12</td>
<td align="right">25</td>
<td align="left">Myotonia congenita</td>
<td align="left">Myotonia congenita</td>
</tr>
<tr class="odd">
<td align="left">D80.0</td>
<td align="right">25</td>
<td align="left">Immunodeficiency with hyper IgM type 1</td>
<td align="left">Hereditary hypogammaglobulinemia</td>
</tr>
<tr class="even">
<td align="left">D80.0</td>
<td align="right">25</td>
<td align="left">X-linked agammaglobulinemia</td>
<td align="left">Hereditary hypogammaglobulinemia</td>
</tr>
<tr class="odd">
<td align="left">D80.0</td>
<td align="right">25</td>
<td align="left">X-linked agammaglobulinemia</td>
<td align="left">Hereditary hypogammaglobulinemia</td>
</tr>
<tr class="even">
<td align="left">D80.0</td>
<td align="right">25</td>
<td align="left">Isolated growth hormone deficiency type 3</td>
<td align="left">Hereditary hypogammaglobulinemia</td>
</tr>
<tr class="odd">
<td align="left">D72.0</td>
<td align="right">25</td>
<td align="left">MYH9 related thrombocytopenia</td>
<td align="left">Genetic anomalies of leukocytes</td>
</tr>
<tr class="even">
<td align="left">D72.0</td>
<td align="right">25</td>
<td align="left">MYH9 related thrombocytopenia</td>
<td align="left">Genetic anomalies of leukocytes</td>
</tr>
<tr class="odd">
<td align="left">D72.0</td>
<td align="right">25</td>
<td align="left">SLC35C1-CDG (CDG-IIc)</td>
<td align="left">Genetic anomalies of leukocytes</td>
</tr>
<tr class="even">
<td align="left">D72.0</td>
<td align="right">25</td>
<td align="left">Rapp-Hodgkin syndrome</td>
<td align="left">Genetic anomalies of leukocytes</td>
</tr>
<tr class="odd">
<td align="left">D72.0</td>
<td align="right">25</td>
<td align="left">Chediak-Higashi syndrome</td>
<td align="left">Genetic anomalies of leukocytes</td>
</tr>
<tr class="even">
<td align="left">D72.0</td>
<td align="right">25</td>
<td align="left">Leukocyte adhesion deficiency type 1</td>
<td align="left">Genetic anomalies of leukocytes</td>
</tr>
<tr class="odd">
<td align="left">D72.0</td>
<td align="right">25</td>
<td align="left">Reticular dysgenesis</td>
<td align="left">Genetic anomalies of leukocytes</td>
</tr>
<tr class="even">
<td align="left">D72.0</td>
<td align="right">25</td>
<td align="left">Pelger-Huet anomaly</td>
<td align="left">Genetic anomalies of leukocytes</td>
</tr>
<tr class="odd">
<td align="left">D72.0</td>
<td align="right">25</td>
<td align="left">Linear IgA disease</td>
<td align="left">Genetic anomalies of leukocytes</td>
</tr>
<tr class="even">
<td align="left">D69.42</td>
<td align="right">25</td>
<td align="left">MYH9 related thrombocytopenia</td>
<td align="left">Congenital and hereditary thrombocytopenia purpura</td>
</tr>
<tr class="odd">
<td align="left">D69.42</td>
<td align="right">25</td>
<td align="left">Brooke-Spiegler syndrome</td>
<td align="left">Congenital and hereditary thrombocytopenia purpura</td>
</tr>
<tr class="even">
<td align="left">C92.90</td>
<td align="right">25</td>
<td align="left">Myeloid leukemia</td>
<td align="left">Myeloid leukemia, unspecified, not having achieved remission</td>
</tr>
<tr class="odd">
<td align="left">Q81.9</td>
<td align="right">24</td>
<td align="left">Pretibial epidermolysis bullosa</td>
<td align="left">Epidermolysis bullosa, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q81.9</td>
<td align="right">24</td>
<td align="left">Epidermolysis bullosa</td>
<td align="left">Epidermolysis bullosa, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q66.80</td>
<td align="right">24</td>
<td align="left">Congenital vertical talus</td>
<td align="left">Congenital vertical talus deformity, unspecified foot</td>
</tr>
<tr class="even">
<td align="left">Q13.81</td>
<td align="right">24</td>
<td align="left">Axenfeld-Rieger syndrome</td>
<td align="left">Rieger’s anomaly</td>
</tr>
<tr class="odd">
<td align="left">M34.0</td>
<td align="right">24</td>
<td align="left">Systemic scleroderma</td>
<td align="left">Progressive systemic sclerosis</td>
</tr>
<tr class="even">
<td align="left">M34.0</td>
<td align="right">24</td>
<td align="left">Diffuse cutaneous systemic sclerosis</td>
<td align="left">Progressive systemic sclerosis</td>
</tr>
<tr class="odd">
<td align="left">M34.0</td>
<td align="right">24</td>
<td align="left">Potocki-Shaffer syndrome</td>
<td align="left">Progressive systemic sclerosis</td>
</tr>
<tr class="even">
<td align="left">L59.9</td>
<td align="right">24</td>
<td align="left">UV sensitive syndrome</td>
<td align="left">Disorder of the skin and subcutaneous tissue related to radiation, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C94.6</td>
<td align="right">24</td>
<td align="left">Myelodysplastic/myeloproliferative disease</td>
<td align="left">Myelodysplastic disease, not classified</td>
</tr>
<tr class="even">
<td align="left">C94.40</td>
<td align="right">24</td>
<td align="left">Acute panmyelosis with myelofibrosis</td>
<td align="left">Acute panmyelosis with myelofibrosis not having achieved remission</td>
</tr>
<tr class="odd">
<td align="left">C72.9</td>
<td align="right">24</td>
<td align="left">Glioma</td>
<td align="left">Malignant neoplasm of central nervous system, unspecified</td>
</tr>
<tr class="even">
<td align="left">C46.9</td>
<td align="right">24</td>
<td align="left">Kaposi sarcoma</td>
<td align="left">Kaposi’s sarcoma, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C46.9</td>
<td align="right">24</td>
<td align="left">Endemic Kaposi sarcoma</td>
<td align="left">Kaposi’s sarcoma, unspecified</td>
</tr>
<tr class="even">
<td align="left">A82.9</td>
<td align="right">24</td>
<td align="left">Rabies</td>
<td align="left">Rabies, unspecified</td>
</tr>
<tr class="odd">
<td align="left">R48.1</td>
<td align="right">23</td>
<td align="left">Agnosia</td>
<td align="left">Agnosia</td>
</tr>
<tr class="even">
<td align="left">Q82.3</td>
<td align="right">23</td>
<td align="left">Hypomelanosis of Ito</td>
<td align="left">Incontinentia pigmenti</td>
</tr>
<tr class="odd">
<td align="left">Q82.3</td>
<td align="right">23</td>
<td align="left">Incontinentia pigmenti</td>
<td align="left">Incontinentia pigmenti</td>
</tr>
<tr class="even">
<td align="left">Q82.3</td>
<td align="right">23</td>
<td align="left">Nevus of Ito</td>
<td align="left">Incontinentia pigmenti</td>
</tr>
<tr class="odd">
<td align="left">Q75.1</td>
<td align="right">23</td>
<td align="left">Carpenter syndrome</td>
<td align="left">Craniofacial dysostosis</td>
</tr>
<tr class="even">
<td align="left">Q75.1</td>
<td align="right">23</td>
<td align="left">Crouzon syndrome</td>
<td align="left">Craniofacial dysostosis</td>
</tr>
<tr class="odd">
<td align="left">Q33.3</td>
<td align="right">23</td>
<td align="left">Lung agenesis</td>
<td align="left">Agenesis of lung</td>
</tr>
<tr class="even">
<td align="left">Q33.2</td>
<td align="right">23</td>
<td align="left">Pulmonary sequestration</td>
<td align="left">Sequestration of lung</td>
</tr>
<tr class="odd">
<td align="left">Q32.0</td>
<td align="right">23</td>
<td align="left">Congenital tracheomalacia</td>
<td align="left">Congenital tracheomalacia</td>
</tr>
<tr class="even">
<td align="left">J64</td>
<td align="right">23</td>
<td align="left">Coal worker’s pneumoconiosis</td>
<td align="left">Unspecified pneumoconiosis</td>
</tr>
<tr class="odd">
<td align="left">J64</td>
<td align="right">23</td>
<td align="left">Labrador lung</td>
<td align="left">Unspecified pneumoconiosis</td>
</tr>
<tr class="even">
<td align="left">H30.899</td>
<td align="right">23</td>
<td align="left">Serpiginous choroiditis</td>
<td align="left">Other chorioretinal inflammations, unspecified eye</td>
</tr>
<tr class="odd">
<td align="left">H30.899</td>
<td align="right">23</td>
<td align="left">Birdshot chorioretinopathy</td>
<td align="left">Other chorioretinal inflammations, unspecified eye</td>
</tr>
<tr class="even">
<td align="left">H30.899</td>
<td align="right">23</td>
<td align="left">Multifocal choroiditis</td>
<td align="left">Other chorioretinal inflammations, unspecified eye</td>
</tr>
<tr class="odd">
<td align="left">H18.54</td>
<td align="right">23</td>
<td align="left">Familial amyloidosis, Finnish type</td>
<td align="left">Lattice corneal dystrophy</td>
</tr>
<tr class="even">
<td align="left">H18.54</td>
<td align="right">23</td>
<td align="left">Amyloidosis corneal</td>
<td align="left">Lattice corneal dystrophy</td>
</tr>
<tr class="odd">
<td align="left">H18.54</td>
<td align="right">23</td>
<td align="left">Lattice corneal dystrophy type 1</td>
<td align="left">Lattice corneal dystrophy</td>
</tr>
<tr class="even">
<td align="left">G71.19</td>
<td align="right">23</td>
<td align="left">Hyperkalemic periodic paralysis</td>
<td align="left">Other specified myotonic disorders</td>
</tr>
<tr class="odd">
<td align="left">G71.19</td>
<td align="right">23</td>
<td align="left">Potassium aggravated myotonia</td>
<td align="left">Other specified myotonic disorders</td>
</tr>
<tr class="even">
<td align="left">G71.19</td>
<td align="right">23</td>
<td align="left">Isaacs’ syndrome</td>
<td align="left">Other specified myotonic disorders</td>
</tr>
<tr class="odd">
<td align="left">G71.19</td>
<td align="right">23</td>
<td align="left">Paramyotonia congenita</td>
<td align="left">Other specified myotonic disorders</td>
</tr>
<tr class="even">
<td align="left">G71.19</td>
<td align="right">23</td>
<td align="left">Pseudomyotonia</td>
<td align="left">Other specified myotonic disorders</td>
</tr>
<tr class="odd">
<td align="left">G71.19</td>
<td align="right">23</td>
<td align="left">Rippling muscle disease</td>
<td align="left">Other specified myotonic disorders</td>
</tr>
<tr class="even">
<td align="left">G71.19</td>
<td align="right">23</td>
<td align="left">Rippling muscle disease, 1</td>
<td align="left">Other specified myotonic disorders</td>
</tr>
<tr class="odd">
<td align="left">G71.19</td>
<td align="right">23</td>
<td align="left">Primary amebic meningoencephalitis</td>
<td align="left">Other specified myotonic disorders</td>
</tr>
<tr class="even">
<td align="left">G71.19</td>
<td align="right">23</td>
<td align="left">Autosomal recessive axonal neuropathy with neuromyotonia</td>
<td align="left">Other specified myotonic disorders</td>
</tr>
<tr class="odd">
<td align="left">E22.8</td>
<td align="right">23</td>
<td align="left">Precocious puberty, gonadotropin-dependent</td>
<td align="left">Other hyperfunction of pituitary gland</td>
</tr>
<tr class="even">
<td align="left">E20.1</td>
<td align="right">23</td>
<td align="left">Albright’s hereditary osteodystrophy</td>
<td align="left">Pseudohypoparathyroidism</td>
</tr>
<tr class="odd">
<td align="left">E20.1</td>
<td align="right">23</td>
<td align="left">Pseudohypoparathyroidism type 1A</td>
<td align="left">Pseudohypoparathyroidism</td>
</tr>
<tr class="even">
<td align="left">E20.1</td>
<td align="right">23</td>
<td align="left">Pseudopseudohypoparathyroidism</td>
<td align="left">Pseudohypoparathyroidism</td>
</tr>
<tr class="odd">
<td align="left">E20.1</td>
<td align="right">23</td>
<td align="left">Pseudohypoparathyroidism type 2</td>
<td align="left">Pseudohypoparathyroidism</td>
</tr>
<tr class="even">
<td align="left">E20.1</td>
<td align="right">23</td>
<td align="left">Pseudohypoparathyroidism</td>
<td align="left">Pseudohypoparathyroidism</td>
</tr>
<tr class="odd">
<td align="left">D13.7</td>
<td align="right">23</td>
<td align="left">Pancreatic islet cell tumors</td>
<td align="left">Benign neoplasm of endocrine pancreas</td>
</tr>
<tr class="even">
<td align="left">D13.7</td>
<td align="right">23</td>
<td align="left">Pancreatic neuroendocrine tumor</td>
<td align="left">Benign neoplasm of endocrine pancreas</td>
</tr>
<tr class="odd">
<td align="left">C96.0</td>
<td align="right">23</td>
<td align="left">Langerhans cell histiocytosis</td>
<td align="left">Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis</td>
</tr>
<tr class="even">
<td align="left">C22.2</td>
<td align="right">23</td>
<td align="left">Hepatoblastoma</td>
<td align="left">Hepatoblastoma</td>
</tr>
<tr class="odd">
<td align="left">Q52.0</td>
<td align="right">22</td>
<td align="left">Rokitansky sequence</td>
<td align="left">Congenital absence of vagina</td>
</tr>
<tr class="even">
<td align="left">Q52.0</td>
<td align="right">22</td>
<td align="left">Vagina, absence of</td>
<td align="left">Congenital absence of vagina</td>
</tr>
<tr class="odd">
<td align="left">H53.63</td>
<td align="right">22</td>
<td align="left">Oguchi disease</td>
<td align="left">Congenital night blindness</td>
</tr>
<tr class="even">
<td align="left">H18.53</td>
<td align="right">22</td>
<td align="left">Acrofacial dysostosis Catania type</td>
<td align="left">Granular corneal dystrophy</td>
</tr>
<tr class="odd">
<td align="left">H18.53</td>
<td align="right">22</td>
<td align="left">Acute cholinergic dysautonomia</td>
<td align="left">Granular corneal dystrophy</td>
</tr>
<tr class="even">
<td align="left">H18.53</td>
<td align="right">22</td>
<td align="left">Groenouw type I corneal dystrophy</td>
<td align="left">Granular corneal dystrophy</td>
</tr>
<tr class="odd">
<td align="left">E88.49</td>
<td align="right">22</td>
<td align="left">Cytochrome c oxidase deficiency</td>
<td align="left">Other mitochondrial metabolism disorders</td>
</tr>
<tr class="even">
<td align="left">E88.49</td>
<td align="right">22</td>
<td align="left">Pearson syndrome</td>
<td align="left">Other mitochondrial metabolism disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.49</td>
<td align="right">22</td>
<td align="left">Mitochondrial complex III deficiency</td>
<td align="left">Other mitochondrial metabolism disorders</td>
</tr>
<tr class="even">
<td align="left">E88.41</td>
<td align="right">22</td>
<td align="left">Mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes</td>
<td align="left">MELAS syndrome</td>
</tr>
<tr class="odd">
<td align="left">E71.311</td>
<td align="right">22</td>
<td align="left">Medium-chain acyl-coenzyme A dehydrogenase deficiency</td>
<td align="left">Medium chain acyl CoA dehydrogenase deficiency</td>
</tr>
<tr class="even">
<td align="left">D47.Z2</td>
<td align="right">22</td>
<td align="left">Angiofollicular lymph hyperplasia</td>
<td align="left">Castleman disease</td>
</tr>
<tr class="odd">
<td align="left">D47.Z2</td>
<td align="right">22</td>
<td align="left">Angiomatous lymphoid hamartoma</td>
<td align="left">Castleman disease</td>
</tr>
<tr class="even">
<td align="left">D47.Z2</td>
<td align="right">22</td>
<td align="left">Unicentric Castleman disease</td>
<td align="left">Castleman disease</td>
</tr>
<tr class="odd">
<td align="left">D47.Z2</td>
<td align="right">22</td>
<td align="left">Castleman disease</td>
<td align="left">Castleman disease</td>
</tr>
<tr class="even">
<td align="left">D37.8</td>
<td align="right">22</td>
<td align="left">Glucagonoma</td>
<td align="left">Neoplasm of uncertain behavior of other specified digestive organs</td>
</tr>
<tr class="odd">
<td align="left">D37.8</td>
<td align="right">22</td>
<td align="left">Insulinoma</td>
<td align="left">Neoplasm of uncertain behavior of other specified digestive organs</td>
</tr>
<tr class="even">
<td align="left">D37.8</td>
<td align="right">22</td>
<td align="left">Glucagonoma syndrome</td>
<td align="left">Neoplasm of uncertain behavior of other specified digestive organs</td>
</tr>
<tr class="odd">
<td align="left">A48.0</td>
<td align="right">22</td>
<td align="left">Anthrax</td>
<td align="left">Gas gangrene</td>
</tr>
<tr class="even">
<td align="left">L41.0</td>
<td align="right">21</td>
<td align="left">Febrile Ulceronecrotic Mucha-Habermann disease</td>
<td align="left">Pityriasis lichenoides et varioliformis acuta</td>
</tr>
<tr class="odd">
<td align="left">L41.0</td>
<td align="right">21</td>
<td align="left">Pityriasis lichenoides et varioliformis acuta</td>
<td align="left">Pityriasis lichenoides et varioliformis acuta</td>
</tr>
<tr class="even">
<td align="left">L41.0</td>
<td align="right">21</td>
<td align="left">Pityriasis lichenoides</td>
<td align="left">Pityriasis lichenoides et varioliformis acuta</td>
</tr>
<tr class="odd">
<td align="left">F48.1</td>
<td align="right">21</td>
<td align="left">Depersonalization disorder</td>
<td align="left">Depersonalization-derealization syndrome</td>
</tr>
<tr class="even">
<td align="left">E75.5</td>
<td align="right">21</td>
<td align="left">Chanarin-Dorfman syndrome</td>
<td align="left">Other lipid storage disorders</td>
</tr>
<tr class="odd">
<td align="left">E75.5</td>
<td align="right">21</td>
<td align="left">Salla disease</td>
<td align="left">Other lipid storage disorders</td>
</tr>
<tr class="even">
<td align="left">E75.5</td>
<td align="right">21</td>
<td align="left">Sialuria, French type</td>
<td align="left">Other lipid storage disorders</td>
</tr>
<tr class="odd">
<td align="left">E75.5</td>
<td align="right">21</td>
<td align="left">Trichohepatoenteric syndrome</td>
<td align="left">Other lipid storage disorders</td>
</tr>
<tr class="even">
<td align="left">E75.5</td>
<td align="right">21</td>
<td align="left">Cerebrotendinous xanthomatosis</td>
<td align="left">Other lipid storage disorders</td>
</tr>
<tr class="odd">
<td align="left">E75.5</td>
<td align="right">21</td>
<td align="left">Wolman disease</td>
<td align="left">Other lipid storage disorders</td>
</tr>
<tr class="even">
<td align="left">E75.5</td>
<td align="right">21</td>
<td align="left">Neutral lipid storage disease with myopathy</td>
<td align="left">Other lipid storage disorders</td>
</tr>
<tr class="odd">
<td align="left">E75.5</td>
<td align="right">21</td>
<td align="left">Free sialic acid storage disease</td>
<td align="left">Other lipid storage disorders</td>
</tr>
<tr class="even">
<td align="left">E75.5</td>
<td align="right">21</td>
<td align="left">Lysosomal acid lipase deficiency</td>
<td align="left">Other lipid storage disorders</td>
</tr>
<tr class="odd">
<td align="left">E75.5</td>
<td align="right">21</td>
<td align="left">Cholesteryl ester storage disease</td>
<td align="left">Other lipid storage disorders</td>
</tr>
<tr class="even">
<td align="left">E74.21</td>
<td align="right">21</td>
<td align="left">Galactosemia</td>
<td align="left">Galactosemia</td>
</tr>
<tr class="odd">
<td align="left">E74.21</td>
<td align="right">21</td>
<td align="left">Galactose epimerase deficiency</td>
<td align="left">Galactosemia</td>
</tr>
<tr class="even">
<td align="left">D69.41</td>
<td align="right">21</td>
<td align="left">Evans syndrome</td>
<td align="left">Evans syndrome</td>
</tr>
<tr class="odd">
<td align="left">C31.9</td>
<td align="right">21</td>
<td align="left">Sinonasal undifferentiated carcinoma</td>
<td align="left">Malignant neoplasm of accessory sinus, unspecified</td>
</tr>
<tr class="even">
<td align="left">B78.9</td>
<td align="right">21</td>
<td align="left">Strongyloidiasis</td>
<td align="left">Strongyloidiasis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A81.2</td>
<td align="right">21</td>
<td align="left">Progressive multifocal leukoencephalopathy</td>
<td align="left">Progressive multifocal leukoencephalopathy</td>
</tr>
<tr class="even">
<td align="left">A81.2</td>
<td align="right">21</td>
<td align="left">Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation</td>
<td align="left">Progressive multifocal leukoencephalopathy</td>
</tr>
<tr class="odd">
<td align="left">Q78.1</td>
<td align="right">20</td>
<td align="left">McCune-Albright syndrome</td>
<td align="left">Polyostotic fibrous dysplasia</td>
</tr>
<tr class="even">
<td align="left">Q78.1</td>
<td align="right">20</td>
<td align="left">Properdin deficiency, X-linked</td>
<td align="left">Polyostotic fibrous dysplasia</td>
</tr>
<tr class="odd">
<td align="left">Q78.1</td>
<td align="right">20</td>
<td align="left">Meconium aspiration syndrome</td>
<td align="left">Polyostotic fibrous dysplasia</td>
</tr>
<tr class="even">
<td align="left">Q64.12</td>
<td align="right">20</td>
<td align="left">Omphalocele, exstrophy of the cloaca, imperforate anus, and spinal defects complex</td>
<td align="left">Cloacal extrophy of urinary bladder</td>
</tr>
<tr class="odd">
<td align="left">Q21.8</td>
<td align="right">20</td>
<td align="left">Eisenmenger syndrome</td>
<td align="left">Other congenital malformations of cardiac septa</td>
</tr>
<tr class="even">
<td align="left">P61.0</td>
<td align="right">20</td>
<td align="left">Fetal and neonatal alloimmune thrombocytopenia</td>
<td align="left">Transient neonatal thrombocytopenia</td>
</tr>
<tr class="odd">
<td align="left">H49.9</td>
<td align="right">20</td>
<td align="left">Tolosa Hunt syndrome</td>
<td align="left">Unspecified paralytic strabismus</td>
</tr>
<tr class="even">
<td align="left">E74.04</td>
<td align="right">20</td>
<td align="left">Glycogen storage disease type 5</td>
<td align="left">McArdle disease</td>
</tr>
<tr class="odd">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">Beta ketothiolase deficiency</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">Beta ketothiolase deficiency</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">3-Hydroxyisobutyric aciduria</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">3-Hydroxyisobutyric aciduria</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">3 Methylcrotonyl-CoA carboxylase 1 deficiency</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">Valinemia</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">HMG CoA lyase deficiency</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">HMG CoA lyase deficiency</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">Leucine-sensitive hypoglycemia of infancy</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">Tiglic acidemia</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">Combined malonic and methylmalonic aciduria</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">3-methylcrotonyl-CoA carboxylase deficiency</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">HIBCH deficiency</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">C69.00</td>
<td align="right">20</td>
<td align="left">Conjunctival melanoma</td>
<td align="left">Malignant neoplasm of unspecified conjunctiva</td>
</tr>
<tr class="odd">
<td align="left">A48.3</td>
<td align="right">20</td>
<td align="left">Staphylococcal toxic shock syndrome</td>
<td align="left">Toxic shock syndrome</td>
</tr>
<tr class="even">
<td align="left">A01.00</td>
<td align="right">20</td>
<td align="left">Typhoid fever</td>
<td align="left">Typhoid fever, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q93.3</td>
<td align="right">19</td>
<td align="left">Chromosome 4p deletion</td>
<td align="left">Deletion of short arm of chromosome 4</td>
</tr>
<tr class="even">
<td align="left">Q93.3</td>
<td align="right">19</td>
<td align="left">Wolf-Hirschhorn syndrome</td>
<td align="left">Deletion of short arm of chromosome 4</td>
</tr>
<tr class="odd">
<td align="left">Q55.29</td>
<td align="right">19</td>
<td align="left">Leydig cell hypoplasia</td>
<td align="left">Other congenital malformations of testis and scrotum</td>
</tr>
<tr class="even">
<td align="left">Q43.0</td>
<td align="right">19</td>
<td align="left">Omphalomesenteric cyst</td>
<td align="left">Meckel’s diverticulum (displaced) (hypertrophic)</td>
</tr>
<tr class="odd">
<td align="left">N04.1</td>
<td align="right">19</td>
<td align="left">Focal segmental glomerulosclerosis</td>
<td align="left">Nephrotic syndrome with focal and segmental glomerular lesions</td>
</tr>
<tr class="even">
<td align="left">G21.0</td>
<td align="right">19</td>
<td align="left">Neuroleptic malignant syndrome</td>
<td align="left">Malignant neuroleptic syndrome</td>
</tr>
<tr class="odd">
<td align="left">G04.00</td>
<td align="right">19</td>
<td align="left">Acute disseminated encephalomyelitis</td>
<td align="left">Acute disseminated encephalitis and encephalomyelitis, unspecified</td>
</tr>
<tr class="even">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Gamma aminobutyric acid transaminase deficiency</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Glutamate decarboxylase deficiency</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Guanidinoacetate methyltransferase deficiency</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Homocarnosinosis</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Homocarnosinosis</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">5-oxoprolinase deficiency</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Carnosinemia</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Carnosinemia</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Hyperprolinemia type 2</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Prolidase deficiency</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Succinic semialdehyde dehydrogenase deficiency</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Aminoacylase 1 deficiency</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Glutathione synthetase deficiency</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Glutathionuria</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Hyperbetaalaninemia</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">L-arginine:glycine amidinotransferase deficiency</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.318</td>
<td align="right">19</td>
<td align="left">Beta ketothiolase deficiency</td>
<td align="left">Other disorders of fatty-acid oxidation</td>
</tr>
<tr class="odd">
<td align="left">E71.318</td>
<td align="right">19</td>
<td align="left">Mitochondrial trifunctional protein deficiency</td>
<td align="left">Other disorders of fatty-acid oxidation</td>
</tr>
<tr class="even">
<td align="left">E71.318</td>
<td align="right">19</td>
<td align="left">SCOT deficiency</td>
<td align="left">Other disorders of fatty-acid oxidation</td>
</tr>
<tr class="odd">
<td align="left">E71.318</td>
<td align="right">19</td>
<td align="left">LCHAD deficiency</td>
<td align="left">Other disorders of fatty-acid oxidation</td>
</tr>
<tr class="even">
<td align="left">E71.318</td>
<td align="right">19</td>
<td align="left">3-alpha hydroxyacyl-CoA dehydrogenase deficiency</td>
<td align="left">Other disorders of fatty-acid oxidation</td>
</tr>
<tr class="odd">
<td align="left">E71.318</td>
<td align="right">19</td>
<td align="left">2-methylbutyryl-CoA dehydrogenase deficiency</td>
<td align="left">Other disorders of fatty-acid oxidation</td>
</tr>
<tr class="even">
<td align="left">B69.0</td>
<td align="right">19</td>
<td align="left">Cysticercosis</td>
<td align="left">Cysticercosis of central nervous system</td>
</tr>
<tr class="odd">
<td align="left">B38.9</td>
<td align="right">19</td>
<td align="left">Coccidioidomycosis</td>
<td align="left">Coccidioidomycosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q65.2</td>
<td align="right">18</td>
<td align="left">Congenital diaphragmatic hernia</td>
<td align="left">Congenital dislocation of hip, unspecified</td>
</tr>
<tr class="odd">
<td align="left">M35.4</td>
<td align="right">18</td>
<td align="left">Eosinophilic fasciitis</td>
<td align="left">Diffuse (eosinophilic) fasciitis</td>
</tr>
<tr class="even">
<td align="left">I40.0</td>
<td align="right">18</td>
<td align="left">Infectious myocarditis</td>
<td align="left">Infective myocarditis</td>
</tr>
<tr class="odd">
<td align="left">E72.9</td>
<td align="right">18</td>
<td align="left">Aminoaciduria</td>
<td align="left">Disorder of amino-acid metabolism, unspecified</td>
</tr>
<tr class="even">
<td align="left">E72.9</td>
<td align="right">18</td>
<td align="left">Inborn amino acid metabolism disorder</td>
<td align="left">Disorder of amino-acid metabolism, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E16.8</td>
<td align="right">18</td>
<td align="left">WDHA syndrome</td>
<td align="left">Other specified disorders of pancreatic internal secretion</td>
</tr>
<tr class="even">
<td align="left">C96.A</td>
<td align="right">18</td>
<td align="left">Omenn syndrome</td>
<td align="left">Histiocytic sarcoma</td>
</tr>
<tr class="odd">
<td align="left">C96.A</td>
<td align="right">18</td>
<td align="left">Polymorphic reticulosis</td>
<td align="left">Histiocytic sarcoma</td>
</tr>
<tr class="even">
<td align="left">C96.A</td>
<td align="right">18</td>
<td align="left">Extranodal nasal NK/T cell lymphoma</td>
<td align="left">Histiocytic sarcoma</td>
</tr>
<tr class="odd">
<td align="left">A03.9</td>
<td align="right">18</td>
<td align="left">Shigellosis</td>
<td align="left">Shigellosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">N26.9</td>
<td align="right">17</td>
<td align="left">Nephrosclerosis</td>
<td align="left">Renal sclerosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">N04.8</td>
<td align="right">17</td>
<td align="left">Congenital nephrotic syndrome Finnish type</td>
<td align="left">Nephrotic syndrome with other morphologic changes</td>
</tr>
<tr class="even">
<td align="left">N04.8</td>
<td align="right">17</td>
<td align="left">Denys-Drash syndrome</td>
<td align="left">Nephrotic syndrome with other morphologic changes</td>
</tr>
<tr class="odd">
<td align="left">N04.8</td>
<td align="right">17</td>
<td align="left">Mohr-Tranebjaerg syndrome</td>
<td align="left">Nephrotic syndrome with other morphologic changes</td>
</tr>
<tr class="even">
<td align="left">M08.1</td>
<td align="right">17</td>
<td align="left">Juvenile spondyloarthropathy</td>
<td align="left">Juvenile ankylosing spondylitis</td>
</tr>
<tr class="odd">
<td align="left">L85.2</td>
<td align="right">17</td>
<td align="left">Palmoplantar keratoderma</td>
<td align="left">Keratosis punctata (palmaris et plantaris)</td>
</tr>
<tr class="even">
<td align="left">L10.2</td>
<td align="right">17</td>
<td align="left">Pemphigus foliaceus</td>
<td align="left">Pemphigus foliaceous</td>
</tr>
<tr class="odd">
<td align="left">I67.841</td>
<td align="right">17</td>
<td align="left">Reversible cerebral vasoconstriction syndrome</td>
<td align="left">Reversible cerebrovascular vasoconstriction syndrome</td>
</tr>
<tr class="even">
<td align="left">H49.40</td>
<td align="right">17</td>
<td align="left">Tolosa Hunt syndrome</td>
<td align="left">Progressive external ophthalmoplegia, unspecified eye</td>
</tr>
<tr class="odd">
<td align="left">H35.079</td>
<td align="right">17</td>
<td align="left">Telangiectasia macularis eruptive perstans</td>
<td align="left">Retinal telangiectasis, unspecified eye</td>
</tr>
<tr class="even">
<td align="left">H21.569</td>
<td align="right">17</td>
<td align="left">Ectopia pupillae</td>
<td align="left">Pupillary abnormality, unspecified eye</td>
</tr>
<tr class="odd">
<td align="left">D73.2</td>
<td align="right">17</td>
<td align="left">Banti’s syndrome</td>
<td align="left">Chronic congestive splenomegaly</td>
</tr>
<tr class="even">
<td align="left">D58.1</td>
<td align="right">17</td>
<td align="left">Hereditary elliptocytosis</td>
<td align="left">Hereditary elliptocytosis</td>
</tr>
<tr class="odd">
<td align="left">C84.10</td>
<td align="right">17</td>
<td align="left">Sezary syndrome</td>
<td align="left">SÃ©zary disease, unspecified site</td>
</tr>
<tr class="even">
<td align="left">B82.0</td>
<td align="right">17</td>
<td align="left">Helminthiasis</td>
<td align="left">Intestinal helminthiasis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q84.5</td>
<td align="right">16</td>
<td align="left">Pachyonychia congenita</td>
<td align="left">Enlarged and hypertrophic nails</td>
</tr>
<tr class="even">
<td align="left">Q51.818</td>
<td align="right">16</td>
<td align="left">Mullerian aplasia</td>
<td align="left">Other congenital malformations of uterus</td>
</tr>
<tr class="odd">
<td align="left">P39.1</td>
<td align="right">16</td>
<td align="left">Inclusion conjunctivitis</td>
<td align="left">Neonatal conjunctivitis and dacryocystitis</td>
</tr>
<tr class="even">
<td align="left">M72.1</td>
<td align="right">16</td>
<td align="left">Knuckle pads, leuconychia and sensorineural deafness</td>
<td align="left">Knuckle pads</td>
</tr>
<tr class="odd">
<td align="left">G83.81</td>
<td align="right">16</td>
<td align="left">Brown-Sequard syndrome</td>
<td align="left">Brown-SÃ©quard syndrome</td>
</tr>
<tr class="even">
<td align="left">G47.35</td>
<td align="right">16</td>
<td align="left">Congenital central hypoventilation syndrome</td>
<td align="left">Congenital central alveolar hypoventilation syndrome</td>
</tr>
<tr class="odd">
<td align="left">G44.81</td>
<td align="right">16</td>
<td align="left">Hypnic headache</td>
<td align="left">Hypnic headache</td>
</tr>
<tr class="even">
<td align="left">F51.11</td>
<td align="right">16</td>
<td align="left">Idiopathic hypersomnia</td>
<td align="left">Primary hypersomnia</td>
</tr>
<tr class="odd">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Dihydropyrimidine dehydrogenase deficiency</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="even">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Adenine phosphoribosyltransferase deficiency</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Adenylosuccinase deficiency</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="even">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Molybdenum cofactor deficiency</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Thiopurine S methyltranferase deficiency</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="even">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Orotic aciduria type 1</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Orotic aciduria type 1</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="even">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Xanthinuria type 1</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Xanthinuria type 1</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="even">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Dihydroxyadeninuria</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Dihydropyrimidinase deficiency</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.120</td>
<td align="right">16</td>
<td align="left">Methylmalonic acidemia with homocystinuria</td>
<td align="left">Methylmalonic acidemia</td>
</tr>
<tr class="odd">
<td align="left">E71.120</td>
<td align="right">16</td>
<td align="left">Methylmalonic acidemia</td>
<td align="left">Methylmalonic acidemia</td>
</tr>
<tr class="even">
<td align="left">E71.120</td>
<td align="right">16</td>
<td align="left">Methylmalonic acidemia with homocystinuria type cblC</td>
<td align="left">Methylmalonic acidemia</td>
</tr>
<tr class="odd">
<td align="left">E71.120</td>
<td align="right">16</td>
<td align="left">Vitamin B12-responsive methylmalonic acidemia</td>
<td align="left">Methylmalonic acidemia</td>
</tr>
<tr class="even">
<td align="left">E34.52</td>
<td align="right">16</td>
<td align="left">Partial androgen insensitivity syndrome</td>
<td align="left">Partial androgen insensitivity syndrome</td>
</tr>
<tr class="odd">
<td align="left">E07.1</td>
<td align="right">16</td>
<td align="left">Pendred syndrome</td>
<td align="left">Dyshormogenetic goiter</td>
</tr>
<tr class="even">
<td align="left">B60.13</td>
<td align="right">16</td>
<td align="left">Acanthamoeba keratitis</td>
<td align="left">Keratoconjunctivitis due to Acanthamoeba</td>
</tr>
<tr class="odd">
<td align="left">A92.0</td>
<td align="right">16</td>
<td align="left">Chikungunya</td>
<td align="left">Chikungunya virus disease</td>
</tr>
<tr class="even">
<td align="left">A06.9</td>
<td align="right">16</td>
<td align="left">Amebiasis</td>
<td align="left">Amebiasis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q91.7</td>
<td align="right">15</td>
<td align="left">Trisomy 13</td>
<td align="left">Trisomy 13, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q79.4</td>
<td align="right">15</td>
<td align="left">Prune belly syndrome</td>
<td align="left">Prune belly syndrome</td>
</tr>
<tr class="odd">
<td align="left">Q71.40</td>
<td align="right">15</td>
<td align="left">Radial ray agenesis</td>
<td align="left">Longitudinal reduction defect of unspecified radius</td>
</tr>
<tr class="even">
<td align="left">Q41.1</td>
<td align="right">15</td>
<td align="left">Atresia of small intestine</td>
<td align="left">Congenital absence, atresia and stenosis of jejunum</td>
</tr>
<tr class="odd">
<td align="left">Q41.1</td>
<td align="right">15</td>
<td align="left">Jejunal atresia</td>
<td align="left">Congenital absence, atresia and stenosis of jejunum</td>
</tr>
<tr class="even">
<td align="left">Q22.6</td>
<td align="right">15</td>
<td align="left">Hypoplastic right heart syndrome</td>
<td align="left">Hypoplastic right heart syndrome</td>
</tr>
<tr class="odd">
<td align="left">O15.9</td>
<td align="right">15</td>
<td align="left">Eclampsia</td>
<td align="left">Eclampsia, unspecified as to time period</td>
</tr>
<tr class="even">
<td align="left">I67.3</td>
<td align="right">15</td>
<td align="left">Binswanger’s disease</td>
<td align="left">Progressive vascular leukoencephalopathy</td>
</tr>
<tr class="odd">
<td align="left">G03.2</td>
<td align="right">15</td>
<td align="left">Mollaret meningitis</td>
<td align="left">Benign recurrent meningitis [Mollaret]</td>
</tr>
<tr class="even">
<td align="left">E72.51</td>
<td align="right">15</td>
<td align="left">Glycine encephalopathy</td>
<td align="left">Non-ketotic hyperglycinemia</td>
</tr>
<tr class="odd">
<td align="left">E26.81</td>
<td align="right">15</td>
<td align="left">Bartter syndrome antenatal type 1</td>
<td align="left">Bartter’s syndrome</td>
</tr>
<tr class="even">
<td align="left">E26.81</td>
<td align="right">15</td>
<td align="left">Bartter syndrome</td>
<td align="left">Bartter’s syndrome</td>
</tr>
<tr class="odd">
<td align="left">E26.81</td>
<td align="right">15</td>
<td align="left">Bartter syndrome antenatal type 2</td>
<td align="left">Bartter’s syndrome</td>
</tr>
<tr class="even">
<td align="left">E26.81</td>
<td align="right">15</td>
<td align="left">Bartter syndrome type 3</td>
<td align="left">Bartter’s syndrome</td>
</tr>
<tr class="odd">
<td align="left">E26.81</td>
<td align="right">15</td>
<td align="left">Bartter syndrome type 4</td>
<td align="left">Bartter’s syndrome</td>
</tr>
<tr class="even">
<td align="left">D58.8</td>
<td align="right">15</td>
<td align="left">Pyropoikilocytosis hereditary</td>
<td align="left">Other specified hereditary hemolytic anemias</td>
</tr>
<tr class="odd">
<td align="left">D58.8</td>
<td align="right">15</td>
<td align="left">Dehydrated hereditary stomatocytosis</td>
<td align="left">Other specified hereditary hemolytic anemias</td>
</tr>
<tr class="even">
<td align="left">D58.8</td>
<td align="right">15</td>
<td align="left">Rh deficiency syndrome</td>
<td align="left">Other specified hereditary hemolytic anemias</td>
</tr>
<tr class="odd">
<td align="left">C92.30</td>
<td align="right">15</td>
<td align="left">Myeloid sarcoma</td>
<td align="left">Myeloid sarcoma, not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">A81.00</td>
<td align="right">15</td>
<td align="left">Creutzfeldt-Jakob disease</td>
<td align="left">Creutzfeldt-Jakob disease, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A55</td>
<td align="right">15</td>
<td align="left">Lymphogranuloma venereum</td>
<td align="left">Chlamydial lymphogranuloma (venereum)</td>
</tr>
<tr class="even">
<td align="left">Q76.7</td>
<td align="right">14</td>
<td align="left">Asternia</td>
<td align="left">Congenital malformation of sternum</td>
</tr>
<tr class="odd">
<td align="left">Q16.5</td>
<td align="right">14</td>
<td align="left">Deafness with labyrinthine aplasia microtia and microdontia (LAMM)</td>
<td align="left">Congenital malformation of inner ear</td>
</tr>
<tr class="even">
<td align="left">Q04.2</td>
<td align="right">14</td>
<td align="left">Holoprosencephaly</td>
<td align="left">Holoprosencephaly</td>
</tr>
<tr class="odd">
<td align="left">Q00.0</td>
<td align="right">14</td>
<td align="left">Anencephaly</td>
<td align="left">Anencephaly</td>
</tr>
<tr class="even">
<td align="left">O01.9</td>
<td align="right">14</td>
<td align="left">Choroideremia</td>
<td align="left">Hydatidiform mole, unspecified</td>
</tr>
<tr class="odd">
<td align="left">O01.9</td>
<td align="right">14</td>
<td align="left">Gestational trophoblastic tumor</td>
<td align="left">Hydatidiform mole, unspecified</td>
</tr>
<tr class="even">
<td align="left">O01.9</td>
<td align="right">14</td>
<td align="left">Hydatidiform mole</td>
<td align="left">Hydatidiform mole, unspecified</td>
</tr>
<tr class="odd">
<td align="left">L26</td>
<td align="right">14</td>
<td align="left">Exfoliative dermatitis</td>
<td align="left">Exfoliative dermatitis</td>
</tr>
<tr class="even">
<td align="left">J84.03</td>
<td align="right">14</td>
<td align="left">Idiopathic pulmonary hemosiderosis</td>
<td align="left">Idiopathic pulmonary hemosiderosis</td>
</tr>
<tr class="odd">
<td align="left">G12.22</td>
<td align="right">14</td>
<td align="left">Riboflavin transporter deficiency</td>
<td align="left">Progressive bulbar palsy</td>
</tr>
<tr class="even">
<td align="left">G12.22</td>
<td align="right">14</td>
<td align="left">Progressive bulbar palsy</td>
<td align="left">Progressive bulbar palsy</td>
</tr>
<tr class="odd">
<td align="left">E13.69</td>
<td align="right">14</td>
<td align="left">Insulin-resistant acanthosis nigricans, type A</td>
<td align="left">Other specified diabetes mellitus with other specified complication</td>
</tr>
<tr class="even">
<td align="left">E13.69</td>
<td align="right">14</td>
<td align="left">Maternally inherited diabetes and deafness</td>
<td align="left">Other specified diabetes mellitus with other specified complication</td>
</tr>
<tr class="odd">
<td align="left">D89.82</td>
<td align="right">14</td>
<td align="left">Autoimmune lymphoproliferative syndrome</td>
<td align="left">Autoimmune lymphoproliferative syndrome [ALPS]</td>
</tr>
<tr class="even">
<td align="left">D89.3</td>
<td align="right">14</td>
<td align="left">Engraftment syndrome</td>
<td align="left">Immune reconstitution syndrome</td>
</tr>
<tr class="odd">
<td align="left">D39.0</td>
<td align="right">14</td>
<td align="left">Intravenous leiomyomatosis</td>
<td align="left">Neoplasm of uncertain behavior of uterus</td>
</tr>
<tr class="even">
<td align="left">C75.0</td>
<td align="right">14</td>
<td align="left">Parathyroid carcinoma</td>
<td align="left">Malignant neoplasm of parathyroid gland</td>
</tr>
<tr class="odd">
<td align="left">C47.9</td>
<td align="right">14</td>
<td align="left">Neurofibrosarcoma</td>
<td align="left">Malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified</td>
</tr>
<tr class="even">
<td align="left">C47.9</td>
<td align="right">14</td>
<td align="left">Malignant peripheral nerve sheath tumor</td>
<td align="left">Malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified</td>
</tr>
<tr class="odd">
<td align="left">B76.9</td>
<td align="right">14</td>
<td align="left">Cutaneous larva migrans</td>
<td align="left">Hookworm disease, unspecified</td>
</tr>
<tr class="even">
<td align="left">B76.9</td>
<td align="right">14</td>
<td align="left">Ancylostomiasis</td>
<td align="left">Hookworm disease, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q80.2</td>
<td align="right">13</td>
<td align="left">Ichthyosis linearis circumflexa</td>
<td align="left">Lamellar ichthyosis</td>
</tr>
<tr class="even">
<td align="left">Q80.2</td>
<td align="right">13</td>
<td align="left">Netherton syndrome</td>
<td align="left">Lamellar ichthyosis</td>
</tr>
<tr class="odd">
<td align="left">Q80.2</td>
<td align="right">13</td>
<td align="left">Ichthyosis lamellar, autosomal dominant</td>
<td align="left">Lamellar ichthyosis</td>
</tr>
<tr class="even">
<td align="left">Q80.2</td>
<td align="right">13</td>
<td align="left">Nonbullous congenital ichthyosiform erythroderma</td>
<td align="left">Lamellar ichthyosis</td>
</tr>
<tr class="odd">
<td align="left">Q80.2</td>
<td align="right">13</td>
<td align="left">Lamellar ichthyosis</td>
<td align="left">Lamellar ichthyosis</td>
</tr>
<tr class="even">
<td align="left">Q74.3</td>
<td align="right">13</td>
<td align="left">Arthrogryposis multiplex congenita</td>
<td align="left">Arthrogryposis multiplex congenita</td>
</tr>
<tr class="odd">
<td align="left">Q74.3</td>
<td align="right">13</td>
<td align="left">Distal arthrogryposis</td>
<td align="left">Arthrogryposis multiplex congenita</td>
</tr>
<tr class="even">
<td align="left">Q73.8</td>
<td align="right">13</td>
<td align="left">Limb reduction defect</td>
<td align="left">Other reduction defects of unspecified limb(s)</td>
</tr>
<tr class="odd">
<td align="left">Q70.4</td>
<td align="right">13</td>
<td align="left">Preaxial polydactyly type 4</td>
<td align="left">Polysyndactyly, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q64.79</td>
<td align="right">13</td>
<td align="left">Megacystis microcolon intestinal hypoperistalsis syndrome</td>
<td align="left">Other congenital malformations of bladder and urethra</td>
</tr>
<tr class="odd">
<td align="left">Q31.3</td>
<td align="right">13</td>
<td align="left">Laryngocele</td>
<td align="left">Laryngocele</td>
</tr>
<tr class="even">
<td align="left">Q04.5</td>
<td align="right">13</td>
<td align="left">Hemimegalencephaly</td>
<td align="left">Megalencephaly</td>
</tr>
<tr class="odd">
<td align="left">Q04.5</td>
<td align="right">13</td>
<td align="left">Megalencephalic leukoencephalopathy with subcortical cysts</td>
<td align="left">Megalencephaly</td>
</tr>
<tr class="even">
<td align="left">Q04.5</td>
<td align="right">13</td>
<td align="left">Macrocephaly-capillary malformation</td>
<td align="left">Megalencephaly</td>
</tr>
<tr class="odd">
<td align="left">I42.4</td>
<td align="right">13</td>
<td align="left">Endomyocardial fibroelastosis</td>
<td align="left">Endocardial fibroelastosis</td>
</tr>
<tr class="even">
<td align="left">I42.4</td>
<td align="right">13</td>
<td align="left">Endocardial fibroelastosis</td>
<td align="left">Endocardial fibroelastosis</td>
</tr>
<tr class="odd">
<td align="left">H53.51</td>
<td align="right">13</td>
<td align="left">Blue cone monochromatism</td>
<td align="left">Achromatopsia</td>
</tr>
<tr class="even">
<td align="left">G31.82</td>
<td align="right">13</td>
<td align="left">Leigh syndrome</td>
<td align="left">Leigh’s disease</td>
</tr>
<tr class="odd">
<td align="left">F84.3</td>
<td align="right">13</td>
<td align="left">Childhood disintegrative disorder</td>
<td align="left">Other childhood disintegrative disorder</td>
</tr>
<tr class="even">
<td align="left">F68.12</td>
<td align="right">13</td>
<td align="left">Munchausen by proxy syndrome</td>
<td align="left">Factitious disorder with predominantly physical signs and symptoms</td>
</tr>
<tr class="odd">
<td align="left">F10.96</td>
<td align="right">13</td>
<td align="left">Wernicke-Korsakoff syndrome</td>
<td align="left">Alcohol use, unspecified with alcohol-induced persisting amnestic disorder</td>
</tr>
<tr class="even">
<td align="left">E85.2</td>
<td align="right">13</td>
<td align="left">Primary cutaneous amyloidosis</td>
<td align="left">Heredofamilial amyloidosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E83.09</td>
<td align="right">13</td>
<td align="left">Menkes disease</td>
<td align="left">Other disorders of copper metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.4</td>
<td align="right">13</td>
<td align="left">Ornithine translocase deficiency syndrome</td>
<td align="left">Disorders of ornithine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.4</td>
<td align="right">13</td>
<td align="left">Gyrate atrophy of choroid and retina</td>
<td align="left">Disorders of ornithine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.4</td>
<td align="right">13</td>
<td align="left">Gyrate atrophy of choroid and retina</td>
<td align="left">Disorders of ornithine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.4</td>
<td align="right">13</td>
<td align="left">Ornithinemia</td>
<td align="left">Disorders of ornithine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.4</td>
<td align="right">13</td>
<td align="left">Ornithinemia</td>
<td align="left">Disorders of ornithine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.4</td>
<td align="right">13</td>
<td align="left">Ornithine transcarbamylase deficiency</td>
<td align="left">Disorders of ornithine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.4</td>
<td align="right">13</td>
<td align="left">MASS syndrome</td>
<td align="left">Disorders of ornithine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.313</td>
<td align="right">13</td>
<td align="left">Glutaric acidemia type II</td>
<td align="left">Glutaric aciduria type II</td>
</tr>
<tr class="even">
<td align="left">D82.0</td>
<td align="right">13</td>
<td align="left">Wiskott Aldrich syndrome</td>
<td align="left">Wiskott-Aldrich syndrome</td>
</tr>
<tr class="odd">
<td align="left">R48.3</td>
<td align="right">12</td>
<td align="left">Anton’s syndrome</td>
<td align="left">Visual agnosia</td>
</tr>
<tr class="even">
<td align="left">R48.3</td>
<td align="right">12</td>
<td align="left">Developmental prosopagnosia</td>
<td align="left">Visual agnosia</td>
</tr>
<tr class="odd">
<td align="left">Q55.23</td>
<td align="right">12</td>
<td align="left">Penoscrotal transposition</td>
<td align="left">Scrotal transposition</td>
</tr>
<tr class="even">
<td align="left">Q32.1</td>
<td align="right">12</td>
<td align="left">Tracheal agenesis</td>
<td align="left">Other congenital malformations of trachea</td>
</tr>
<tr class="odd">
<td align="left">Q32.1</td>
<td align="right">12</td>
<td align="left">Congenital tracheal stenosis</td>
<td align="left">Other congenital malformations of trachea</td>
</tr>
<tr class="even">
<td align="left">Q06.2</td>
<td align="right">12</td>
<td align="left">Split spinal cord malformation</td>
<td align="left">Diastematomyelia</td>
</tr>
<tr class="odd">
<td align="left">P35.2</td>
<td align="right">12</td>
<td align="left">Congenital herpes simplex</td>
<td align="left">Congenital herpesviral [herpes simplex] infection</td>
</tr>
<tr class="even">
<td align="left">N46.8</td>
<td align="right">12</td>
<td align="left">Macrozoospermia</td>
<td align="left">Other male infertility</td>
</tr>
<tr class="odd">
<td align="left">N46.8</td>
<td align="right">12</td>
<td align="left">Globozoospermia</td>
<td align="left">Other male infertility</td>
</tr>
<tr class="even">
<td align="left">N07.8</td>
<td align="right">12</td>
<td align="left">Glomerulopathy with fibronectin deposits 1</td>
<td align="left">Hereditary nephropathy, not elsewhere classified with other morphologic lesions</td>
</tr>
<tr class="odd">
<td align="left">M89.50</td>
<td align="right">12</td>
<td align="left">Torg Winchester syndrome</td>
<td align="left">Osteolysis, unspecified site</td>
</tr>
<tr class="even">
<td align="left">M89.50</td>
<td align="right">12</td>
<td align="left">Polyostotic osteolytic dysplasia, hereditary expansile</td>
<td align="left">Osteolysis, unspecified site</td>
</tr>
<tr class="odd">
<td align="left">L60.5</td>
<td align="right">12</td>
<td align="left">Yellow nail syndrome</td>
<td align="left">Yellow nail syndrome</td>
</tr>
<tr class="even">
<td align="left">L12.30</td>
<td align="right">12</td>
<td align="left">Junctional epidermolysis bullosa, non-Herlitz type</td>
<td align="left">Acquired epidermolysis bullosa, unspecified</td>
</tr>
<tr class="odd">
<td align="left">L12.30</td>
<td align="right">12</td>
<td align="left">Junctional epidermolysis bullosa</td>
<td align="left">Acquired epidermolysis bullosa, unspecified</td>
</tr>
<tr class="even">
<td align="left">L12.30</td>
<td align="right">12</td>
<td align="left">Epidermolysis bullosa acquisita</td>
<td align="left">Acquired epidermolysis bullosa, unspecified</td>
</tr>
<tr class="odd">
<td align="left">L12.30</td>
<td align="right">12</td>
<td align="left">Generalized junctional epidermolysis bullosa, non-Herlitz type</td>
<td align="left">Acquired epidermolysis bullosa, unspecified</td>
</tr>
<tr class="even">
<td align="left">G11.3</td>
<td align="right">12</td>
<td align="left">Jeune syndrome</td>
<td align="left">Cerebellar ataxia with defective DNA repair</td>
</tr>
<tr class="odd">
<td align="left">G11.3</td>
<td align="right">12</td>
<td align="left">Ataxia telangiectasia</td>
<td align="left">Cerebellar ataxia with defective DNA repair</td>
</tr>
<tr class="even">
<td align="left">D46.1</td>
<td align="right">12</td>
<td align="left">Sideroblastic anemia pyridoxine-refractory autosomal recessive</td>
<td align="left">Refractory anemia with ring sideroblasts</td>
</tr>
<tr class="odd">
<td align="left">C93.00</td>
<td align="right">12</td>
<td align="left">Acute monoblastic leukemia</td>
<td align="left">Acute monoblastic/monocytic leukemia, not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">C92.50</td>
<td align="right">12</td>
<td align="left">Acute myelomonocytic leukemia</td>
<td align="left">Acute myelomonocytic leukemia, not having achieved remission</td>
</tr>
<tr class="odd">
<td align="left">C92.50</td>
<td align="right">12</td>
<td align="left">Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)</td>
<td align="left">Acute myelomonocytic leukemia, not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">B65.9</td>
<td align="right">12</td>
<td align="left">Schistosomiasis</td>
<td align="left">Schistosomiasis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">B47.9</td>
<td align="right">12</td>
<td align="left">Mycetoma</td>
<td align="left">Mycetoma, unspecified</td>
</tr>
<tr class="even">
<td align="left">A92.5</td>
<td align="right">12</td>
<td align="left">Zika virus infection</td>
<td align="left">Zika virus disease</td>
</tr>
<tr class="odd">
<td align="left">A57</td>
<td align="right">12</td>
<td align="left">Chancroid</td>
<td align="left">Chancroid</td>
</tr>
<tr class="even">
<td align="left">A28.0</td>
<td align="right">12</td>
<td align="left">Pasteurella multocida infection</td>
<td align="left">Pasteurellosis</td>
</tr>
<tr class="odd">
<td align="left">Q97.0</td>
<td align="right">11</td>
<td align="left">47 XXX syndrome</td>
<td align="left">Karyotype 47, XXX</td>
</tr>
<tr class="even">
<td align="left">Q77.7</td>
<td align="right">11</td>
<td align="left">Opsismodysplasia</td>
<td align="left">Spondyloepiphyseal dysplasia</td>
</tr>
<tr class="odd">
<td align="left">Q77.7</td>
<td align="right">11</td>
<td align="left">Pseudoachondroplasia</td>
<td align="left">Spondyloepiphyseal dysplasia</td>
</tr>
<tr class="even">
<td align="left">Q77.7</td>
<td align="right">11</td>
<td align="left">Spondyloepimetaphyseal dysplasia Sponastrime type</td>
<td align="left">Spondyloepiphyseal dysplasia</td>
</tr>
<tr class="odd">
<td align="left">Q77.7</td>
<td align="right">11</td>
<td align="left">Spondyloepimetaphyseal dysplasia joint laxity</td>
<td align="left">Spondyloepiphyseal dysplasia</td>
</tr>
<tr class="even">
<td align="left">Q77.7</td>
<td align="right">11</td>
<td align="left">Spondyloepiphyseal dysplasia tarda X-linked</td>
<td align="left">Spondyloepiphyseal dysplasia</td>
</tr>
<tr class="odd">
<td align="left">Q77.7</td>
<td align="right">11</td>
<td align="left">Spondyloepiphyseal dysplasia congenita</td>
<td align="left">Spondyloepiphyseal dysplasia</td>
</tr>
<tr class="even">
<td align="left">Q77.7</td>
<td align="right">11</td>
<td align="left">Spondyloperipheral dysplasia</td>
<td align="left">Spondyloepiphyseal dysplasia</td>
</tr>
<tr class="odd">
<td align="left">Q77.7</td>
<td align="right">11</td>
<td align="left">Dyggve-Melchior-Clausen syndrome</td>
<td align="left">Spondyloepiphyseal dysplasia</td>
</tr>
<tr class="even">
<td align="left">Q77.7</td>
<td align="right">11</td>
<td align="left">Spondyloepiphyseal dysplasia</td>
<td align="left">Spondyloepiphyseal dysplasia</td>
</tr>
<tr class="odd">
<td align="left">Q75.4</td>
<td align="right">11</td>
<td align="left">Treacher Collins syndrome</td>
<td align="left">Mandibulofacial dysostosis</td>
</tr>
<tr class="even">
<td align="left">Q75.4</td>
<td align="right">11</td>
<td align="left">Mandibulofacial dysostosis with microcephaly</td>
<td align="left">Mandibulofacial dysostosis</td>
</tr>
<tr class="odd">
<td align="left">P59.29</td>
<td align="right">11</td>
<td align="left">Neonatal hemochromatosis</td>
<td align="left">Neonatal jaundice from other hepatocellular damage</td>
</tr>
<tr class="even">
<td align="left">M05.00</td>
<td align="right">11</td>
<td align="left">Felty’s syndrome</td>
<td align="left">Felty’s syndrome, unspecified site</td>
</tr>
<tr class="odd">
<td align="left">L98.5</td>
<td align="right">11</td>
<td align="left">Papular mucinosis</td>
<td align="left">Mucinosis of the skin</td>
</tr>
<tr class="even">
<td align="left">L98.5</td>
<td align="right">11</td>
<td align="left">Scleromyxedema</td>
<td align="left">Mucinosis of the skin</td>
</tr>
<tr class="odd">
<td align="left">H31.22</td>
<td align="right">11</td>
<td align="left">Choroidal dystrophy central areolar</td>
<td align="left">Choroidal dystrophy (central areolar) (generalized) (peripapillary)</td>
</tr>
<tr class="even">
<td align="left">H31.21</td>
<td align="right">11</td>
<td align="left">Choroideremia</td>
<td align="left">Choroideremia</td>
</tr>
<tr class="odd">
<td align="left">E76.1</td>
<td align="right">11</td>
<td align="left">Hunter-McAlpine syndrome</td>
<td align="left">Mucopolysaccharidosis, type II</td>
</tr>
<tr class="even">
<td align="left">E76.1</td>
<td align="right">11</td>
<td align="left">Mucopolysaccharidosis type II</td>
<td align="left">Mucopolysaccharidosis, type II</td>
</tr>
<tr class="odd">
<td align="left">E71.310</td>
<td align="right">11</td>
<td align="left">VLCAD deficiency</td>
<td align="left">Long chain/very long chain acyl CoA dehydrogenase deficiency</td>
</tr>
<tr class="even">
<td align="left">E71.310</td>
<td align="right">11</td>
<td align="left">Pearson syndrome</td>
<td align="left">Long chain/very long chain acyl CoA dehydrogenase deficiency</td>
</tr>
<tr class="odd">
<td align="left">E71.310</td>
<td align="right">11</td>
<td align="left">LCAD deficiency</td>
<td align="left">Long chain/very long chain acyl CoA dehydrogenase deficiency</td>
</tr>
<tr class="even">
<td align="left">E71.0</td>
<td align="right">11</td>
<td align="left">Maple syrup urine disease</td>
<td align="left">Maple-syrup-urine disease</td>
</tr>
<tr class="odd">
<td align="left">E70.320</td>
<td align="right">11</td>
<td align="left">Oculocutaneous albinism type 1</td>
<td align="left">Tyrosinase negative oculocutaneous albinism</td>
</tr>
<tr class="even">
<td align="left">E51.11</td>
<td align="right">11</td>
<td align="left">Beriberi</td>
<td align="left">Dry beriberi</td>
</tr>
<tr class="odd">
<td align="left">D55.8</td>
<td align="right">11</td>
<td align="left">Glycogen storage disease type 12</td>
<td align="left">Other anemias due to enzyme disorders</td>
</tr>
<tr class="even">
<td align="left">D51.1</td>
<td align="right">11</td>
<td align="left">Imerslund-Grasbeck syndrome</td>
<td align="left">Vitamin B12 deficiency anemia due to selective vitamin B12 malabsorption with proteinuria</td>
</tr>
<tr class="odd">
<td align="left">B26.9</td>
<td align="right">11</td>
<td align="left">Mumps</td>
<td align="left">Mumps without complication</td>
</tr>
<tr class="even">
<td align="left">A52.11</td>
<td align="right">11</td>
<td align="left">Syphilitic myelopathy</td>
<td align="left">Tabes dorsalis</td>
</tr>
<tr class="odd">
<td align="left">Q87.43</td>
<td align="right">10</td>
<td align="left">Marfanoid hypermobility syndrome</td>
<td align="left">Marfan’s syndrome with skeletal manifestation</td>
</tr>
<tr class="even">
<td align="left">Q87.43</td>
<td align="right">10</td>
<td align="left">Congenital contractural arachnodactyly</td>
<td align="left">Marfan’s syndrome with skeletal manifestation</td>
</tr>
<tr class="odd">
<td align="left">Q06.1</td>
<td align="right">10</td>
<td align="left">Spina bifida</td>
<td align="left">Hypoplasia and dysplasia of spinal cord</td>
</tr>
<tr class="even">
<td align="left">Q01.2</td>
<td align="right">10</td>
<td align="left">Chiari malformation type 3</td>
<td align="left">Occipital encephalocele</td>
</tr>
<tr class="odd">
<td align="left">L98.3</td>
<td align="right">10</td>
<td align="left">Wells syndrome</td>
<td align="left">Eosinophilic cellulitis [Wells]</td>
</tr>
<tr class="even">
<td align="left">K76.5</td>
<td align="right">10</td>
<td align="left">Hepatic veno-occlusive disease</td>
<td align="left">Hepatic veno-occlusive disease</td>
</tr>
<tr class="odd">
<td align="left">J69.1</td>
<td align="right">10</td>
<td align="left">Exogenous lipoid pneumonia</td>
<td align="left">Pneumonitis due to inhalation of oils and essences</td>
</tr>
<tr class="even">
<td align="left">I40.1</td>
<td align="right">10</td>
<td align="left">Giant cell myocarditis</td>
<td align="left">Isolated myocarditis</td>
</tr>
<tr class="odd">
<td align="left">E72.3</td>
<td align="right">10</td>
<td align="left">Saccharopinuria</td>
<td align="left">Disorders of lysine and hydroxylysine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.3</td>
<td align="right">10</td>
<td align="left">Saccharopinuria</td>
<td align="left">Disorders of lysine and hydroxylysine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.3</td>
<td align="right">10</td>
<td align="left">Hyperlysinemia</td>
<td align="left">Disorders of lysine and hydroxylysine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.3</td>
<td align="right">10</td>
<td align="left">Lysinuric protein intolerance</td>
<td align="left">Disorders of lysine and hydroxylysine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.3</td>
<td align="right">10</td>
<td align="left">D-2-hydroxyglutaric aciduria</td>
<td align="left">Disorders of lysine and hydroxylysine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.3</td>
<td align="right">10</td>
<td align="left">D-2-hydroxyglutaric aciduria</td>
<td align="left">Disorders of lysine and hydroxylysine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.3</td>
<td align="right">10</td>
<td align="left">Glutaric acidemia type I</td>
<td align="left">Disorders of lysine and hydroxylysine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.3</td>
<td align="right">10</td>
<td align="left">L-2-hydroxyglutaric aciduria</td>
<td align="left">Disorders of lysine and hydroxylysine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.3</td>
<td align="right">10</td>
<td align="left">L-2-hydroxyglutaric aciduria</td>
<td align="left">Disorders of lysine and hydroxylysine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.3</td>
<td align="right">10</td>
<td align="left">2-Hydroxyglutaric aciduria</td>
<td align="left">Disorders of lysine and hydroxylysine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E16.9</td>
<td align="right">10</td>
<td align="left">Familial hyperinsulinism</td>
<td align="left">Disorder of pancreatic internal secretion, unspecified</td>
</tr>
<tr class="even">
<td align="left">D39.2</td>
<td align="right">10</td>
<td align="left">Trophoblastic tumor placental site</td>
<td align="left">Neoplasm of uncertain behavior of placenta</td>
</tr>
<tr class="odd">
<td align="left">C44.82</td>
<td align="right">10</td>
<td align="left">Buschke Lowenstein tumor</td>
<td align="left">Squamous cell carcinoma of overlapping sites of skin</td>
</tr>
<tr class="even">
<td align="left">B83.8</td>
<td align="right">10</td>
<td align="left">Baylisascaris infection</td>
<td align="left">Other specified helminthiases</td>
</tr>
<tr class="odd">
<td align="left">B76.0</td>
<td align="right">10</td>
<td align="left">Ancylostomiasis</td>
<td align="left">Ancylostomiasis</td>
</tr>
<tr class="even">
<td align="left">B42.9</td>
<td align="right">10</td>
<td align="left">Sporotrichosis</td>
<td align="left">Sporotrichosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A99</td>
<td align="right">10</td>
<td align="left">Viral hemorrhagic fever</td>
<td align="left">Unspecified viral hemorrhagic fever</td>
</tr>
<tr class="even">
<td align="left">A99</td>
<td align="right">10</td>
<td align="left">Hemorrhagic fever</td>
<td align="left">Unspecified viral hemorrhagic fever</td>
</tr>
<tr class="odd">
<td align="left">A69.1</td>
<td align="right">10</td>
<td align="left">Acute necrotizing ulcerative gingivitis</td>
<td align="left">Other Vincent’s infections</td>
</tr>
<tr class="even">
<td align="left">Q93.4</td>
<td align="right">9</td>
<td align="left">Cri du chat syndrome</td>
<td align="left">Deletion of short arm of chromosome 5</td>
</tr>
<tr class="odd">
<td align="left">Q93.4</td>
<td align="right">9</td>
<td align="left">Chromosome 5p deletion</td>
<td align="left">Deletion of short arm of chromosome 5</td>
</tr>
<tr class="even">
<td align="left">Q81.0</td>
<td align="right">9</td>
<td align="left">Epidermolysis bullosa simplex, Dowling-Meara type</td>
<td align="left">Epidermolysis bullosa simplex</td>
</tr>
<tr class="odd">
<td align="left">Q81.0</td>
<td align="right">9</td>
<td align="left">Epidermolysis bullosa simplex, localized</td>
<td align="left">Epidermolysis bullosa simplex</td>
</tr>
<tr class="even">
<td align="left">Q81.0</td>
<td align="right">9</td>
<td align="left">Epidermolysis bullosa simplex, generalized</td>
<td align="left">Epidermolysis bullosa simplex</td>
</tr>
<tr class="odd">
<td align="left">Q81.0</td>
<td align="right">9</td>
<td align="left">Epidermolysis bullosa simplex, Ogna type</td>
<td align="left">Epidermolysis bullosa simplex</td>
</tr>
<tr class="even">
<td align="left">Q81.0</td>
<td align="right">9</td>
<td align="left">Epidermolysis bullosa simplex with mottled pigmentation</td>
<td align="left">Epidermolysis bullosa simplex</td>
</tr>
<tr class="odd">
<td align="left">Q81.0</td>
<td align="right">9</td>
<td align="left">Epidermolysis bullosa simplex</td>
<td align="left">Epidermolysis bullosa simplex</td>
</tr>
<tr class="even">
<td align="left">Q80.1</td>
<td align="right">9</td>
<td align="left">X-linked ichthyosis</td>
<td align="left">X-linked ichthyosis</td>
</tr>
<tr class="odd">
<td align="left">O43.029</td>
<td align="right">9</td>
<td align="left">Twin to twin transfusion syndrome</td>
<td align="left">Fetus-to-fetus placental transfusion syndrome, unspecified trimester</td>
</tr>
<tr class="even">
<td align="left">L74.52</td>
<td align="right">9</td>
<td align="left">Frey’s syndrome</td>
<td align="left">Secondary focal hyperhidrosis</td>
</tr>
<tr class="odd">
<td align="left">L72.12</td>
<td align="right">9</td>
<td align="left">Proliferating trichilemmal cyst</td>
<td align="left">Trichodermal cyst</td>
</tr>
<tr class="even">
<td align="left">L43.3</td>
<td align="right">9</td>
<td align="left">Actinic lichen planus</td>
<td align="left">Subacute (active) lichen planus</td>
</tr>
<tr class="odd">
<td align="left">K00.5</td>
<td align="right">9</td>
<td align="left">Lubinsky syndrome</td>
<td align="left">Hereditary disturbances in tooth structure, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">K00.5</td>
<td align="right">9</td>
<td align="left">Amelogenesis imperfecta nephrocalcinosis</td>
<td align="left">Hereditary disturbances in tooth structure, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">K00.5</td>
<td align="right">9</td>
<td align="left">Cone-rod dystrophy amelogenesis imperfecta</td>
<td align="left">Hereditary disturbances in tooth structure, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">K00.5</td>
<td align="right">9</td>
<td align="left">Dentin dysplasia, type 1</td>
<td align="left">Hereditary disturbances in tooth structure, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">K00.5</td>
<td align="right">9</td>
<td align="left">Amelogenesis imperfecta</td>
<td align="left">Hereditary disturbances in tooth structure, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">K00.5</td>
<td align="right">9</td>
<td align="left">Dentinogenesis imperfecta</td>
<td align="left">Hereditary disturbances in tooth structure, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">K00.5</td>
<td align="right">9</td>
<td align="left">Amelogenesis imperfecta hypomaturation type</td>
<td align="left">Hereditary disturbances in tooth structure, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">K00.5</td>
<td align="right">9</td>
<td align="left">Amelogenesis imperfecta pigmented hypomaturation type</td>
<td align="left">Hereditary disturbances in tooth structure, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">K00.5</td>
<td align="right">9</td>
<td align="left">Amelogenesis imperfecta hypoplastic type, IG</td>
<td align="left">Hereditary disturbances in tooth structure, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">K00.5</td>
<td align="right">9</td>
<td align="left">Dentinogenesis imperfecta type 3</td>
<td align="left">Hereditary disturbances in tooth structure, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">K00.5</td>
<td align="right">9</td>
<td align="left">Dentinogenesis imperfecta type 2</td>
<td align="left">Hereditary disturbances in tooth structure, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">K00.2</td>
<td align="right">9</td>
<td align="left">Fused mandibular incisors</td>
<td align="left">Abnormalities of size and form of teeth</td>
</tr>
<tr class="odd">
<td align="left">K00.2</td>
<td align="right">9</td>
<td align="left">Taurodontism</td>
<td align="left">Abnormalities of size and form of teeth</td>
</tr>
<tr class="even">
<td align="left">I02.9</td>
<td align="right">9</td>
<td align="left">Chorea minor</td>
<td align="left">Rheumatic chorea without heart involvement</td>
</tr>
<tr class="odd">
<td align="left">I02.9</td>
<td align="right">9</td>
<td align="left">Sydenham’s chorea</td>
<td align="left">Rheumatic chorea without heart involvement</td>
</tr>
<tr class="even">
<td align="left">G83.5</td>
<td align="right">9</td>
<td align="left">Locked-in syndrome</td>
<td align="left">Locked-in state</td>
</tr>
<tr class="odd">
<td align="left">E72.03</td>
<td align="right">9</td>
<td align="left">Lowe oculocerebrorenal syndrome</td>
<td align="left">Lowe’s syndrome</td>
</tr>
<tr class="even">
<td align="left">E71.50</td>
<td align="right">9</td>
<td align="left">Peroxisomal biogenesis disorders</td>
<td align="left">Peroxisomal disorder, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E71.41</td>
<td align="right">9</td>
<td align="left">Subacute cerebellar degeneration</td>
<td align="left">Primary carnitine deficiency</td>
</tr>
<tr class="even">
<td align="left">E71.41</td>
<td align="right">9</td>
<td align="left">Primary carnitine deficiency</td>
<td align="left">Primary carnitine deficiency</td>
</tr>
<tr class="odd">
<td align="left">E71.314</td>
<td align="right">9</td>
<td align="left">Carnitine palmitoyl transferase 1 deficiency</td>
<td align="left">Muscle carnitine palmitoyltransferase deficiency</td>
</tr>
<tr class="even">
<td align="left">E71.314</td>
<td align="right">9</td>
<td align="left">Carnitine palmitoyltransferase 2 deficiency</td>
<td align="left">Muscle carnitine palmitoyltransferase deficiency</td>
</tr>
<tr class="odd">
<td align="left">E26.89</td>
<td align="right">9</td>
<td align="left">Liddle syndrome</td>
<td align="left">Other hyperaldosteronism</td>
</tr>
<tr class="even">
<td align="left">D13.9</td>
<td align="right">9</td>
<td align="left">Littoral cell angioma of the spleen</td>
<td align="left">Benign neoplasm of ill-defined sites within the digestive system</td>
</tr>
<tr class="odd">
<td align="left">D07.4</td>
<td align="right">9</td>
<td align="left">Bowenoid papulosis</td>
<td align="left">Carcinoma in situ of penis</td>
</tr>
<tr class="even">
<td align="left">B66.4</td>
<td align="right">9</td>
<td align="left">Paragonimiasis</td>
<td align="left">Paragonimiasis</td>
</tr>
<tr class="odd">
<td align="left">B40.9</td>
<td align="right">9</td>
<td align="left">Blastomycosis</td>
<td align="left">Blastomycosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">A77.9</td>
<td align="right">9</td>
<td align="left">Spotted fever</td>
<td align="left">Spotted fever, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q84.3</td>
<td align="right">8</td>
<td align="left">Anonychia congenita</td>
<td align="left">Anonychia</td>
</tr>
<tr class="even">
<td align="left">Q56.1</td>
<td align="right">8</td>
<td align="left">5-alpha reductase deficiency</td>
<td align="left">Male pseudohermaphroditism, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q33.8</td>
<td align="right">8</td>
<td align="left">Congenital pulmonary lymphangiectasia</td>
<td align="left">Other congenital malformations of lung</td>
</tr>
<tr class="even">
<td align="left">P70.2</td>
<td align="right">8</td>
<td align="left">Transient neonatal diabetes mellitus</td>
<td align="left">Neonatal diabetes mellitus</td>
</tr>
<tr class="odd">
<td align="left">P70.2</td>
<td align="right">8</td>
<td align="left">Transient neonatal diabetes mellitus</td>
<td align="left">Neonatal diabetes mellitus</td>
</tr>
<tr class="even">
<td align="left">M36.2</td>
<td align="right">8</td>
<td align="left">Hemophilic arthropathy</td>
<td align="left">Hemophilic arthropathy</td>
</tr>
<tr class="odd">
<td align="left">L95.0</td>
<td align="right">8</td>
<td align="left">Livedoid vasculopathy</td>
<td align="left">Livedoid vasculitis</td>
</tr>
<tr class="even">
<td align="left">G71.8</td>
<td align="right">8</td>
<td align="left">Megaduodenum and/or megacystis</td>
<td align="left">Other primary disorders of muscles</td>
</tr>
<tr class="odd">
<td align="left">F63.89</td>
<td align="right">8</td>
<td align="left">Dipsogenic diabetes insipidus</td>
<td align="left">Other impulse disorders</td>
</tr>
<tr class="even">
<td align="left">E85.0</td>
<td align="right">8</td>
<td align="left">Amyloidosis familial visceral</td>
<td align="left">Non-neuropathic heredofamilial amyloidosis</td>
</tr>
<tr class="odd">
<td align="left">E71.121</td>
<td align="right">8</td>
<td align="left">Propionic acidemia</td>
<td align="left">Propionic acidemia</td>
</tr>
<tr class="even">
<td align="left">E70.8</td>
<td align="right">8</td>
<td align="left">Aromatic L-amino acid decarboxylase deficiency</td>
<td align="left">Other disorders of aromatic amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E70.8</td>
<td align="right">8</td>
<td align="left">Aromatic L-amino acid decarboxylase deficiency</td>
<td align="left">Other disorders of aromatic amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E70.8</td>
<td align="right">8</td>
<td align="left">Carnosinemia</td>
<td align="left">Other disorders of aromatic amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E70.8</td>
<td align="right">8</td>
<td align="left">Hydroxykynureninuria</td>
<td align="left">Other disorders of aromatic amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E70.331</td>
<td align="right">8</td>
<td align="left">Hermansky-Pudlak syndrome</td>
<td align="left">Hermansky-Pudlak syndrome</td>
</tr>
<tr class="odd">
<td align="left">E34.50</td>
<td align="right">8</td>
<td align="left">Androgen insensitivity syndrome</td>
<td align="left">Androgen insensitivity syndrome, unspecified</td>
</tr>
<tr class="even">
<td align="left">E24.3</td>
<td align="right">8</td>
<td align="left">Cushing’s syndrome</td>
<td align="left">Ectopic ACTH syndrome</td>
</tr>
<tr class="odd">
<td align="left">D75.0</td>
<td align="right">8</td>
<td align="left">Pseudopolycythaemia</td>
<td align="left">Familial erythrocytosis</td>
</tr>
<tr class="even">
<td align="left">D75.0</td>
<td align="right">8</td>
<td align="left">Familial erythrocytosis, 1</td>
<td align="left">Familial erythrocytosis</td>
</tr>
<tr class="odd">
<td align="left">D44.5</td>
<td align="right">8</td>
<td align="left">Pineocytoma</td>
<td align="left">Neoplasm of uncertain behavior of pineal gland</td>
</tr>
<tr class="even">
<td align="left">C86.4</td>
<td align="right">8</td>
<td align="left">Blastic plasmacytoid dendritic cell</td>
<td align="left">Blastic NK-cell lymphoma</td>
</tr>
<tr class="odd">
<td align="left">C86.0</td>
<td align="right">8</td>
<td align="left">Extranodal nasal NK/T cell lymphoma</td>
<td align="left">Extranodal NK/T-cell lymphoma, nasal type</td>
</tr>
<tr class="even">
<td align="left">B65.3</td>
<td align="right">8</td>
<td align="left">Cercarial Dermatitis</td>
<td align="left">Cercarial dermatitis</td>
</tr>
<tr class="odd">
<td align="left">B10.01</td>
<td align="right">8</td>
<td align="left">HHV-6 encephalitis</td>
<td align="left">Human herpesvirus 6 encephalitis</td>
</tr>
<tr class="even">
<td align="left">Q96.0</td>
<td align="right">7</td>
<td align="left">Genital dwarfism</td>
<td align="left">Karyotype 45, X</td>
</tr>
<tr class="odd">
<td align="left">Q96.0</td>
<td align="right">7</td>
<td align="left">Gonadal dysgenesis</td>
<td align="left">Karyotype 45, X</td>
</tr>
<tr class="even">
<td align="left">Q96.0</td>
<td align="right">7</td>
<td align="left">Turner syndrome</td>
<td align="left">Karyotype 45, X</td>
</tr>
<tr class="odd">
<td align="left">Q85.03</td>
<td align="right">7</td>
<td align="left">Schwannomatosis</td>
<td align="left">Schwannomatosis</td>
</tr>
<tr class="even">
<td align="left">Q81.2</td>
<td align="right">7</td>
<td align="left">Dominant dystrophic epidermolysis bullosa</td>
<td align="left">Epidermolysis bullosa dystrophica</td>
</tr>
<tr class="odd">
<td align="left">Q81.2</td>
<td align="right">7</td>
<td align="left">Dominant dystrophic epidermolysis bullosa</td>
<td align="left">Epidermolysis bullosa dystrophica</td>
</tr>
<tr class="even">
<td align="left">Q81.2</td>
<td align="right">7</td>
<td align="left">Dystrophic epidermolysis bullosa</td>
<td align="left">Epidermolysis bullosa dystrophica</td>
</tr>
<tr class="odd">
<td align="left">Q81.2</td>
<td align="right">7</td>
<td align="left">Recessive dystrophic epidermolysis bullosa</td>
<td align="left">Epidermolysis bullosa dystrophica</td>
</tr>
<tr class="even">
<td align="left">Q32.4</td>
<td align="right">7</td>
<td align="left">Mounier-Kuhn syndrome</td>
<td align="left">Other congenital malformations of bronchus</td>
</tr>
<tr class="odd">
<td align="left">Q32.4</td>
<td align="right">7</td>
<td align="left">Tracheobronchomegaly</td>
<td align="left">Other congenital malformations of bronchus</td>
</tr>
<tr class="even">
<td align="left">M92.70</td>
<td align="right">7</td>
<td align="left">Freiberg’s disease</td>
<td align="left">Juvenile osteochondrosis of metatarsus, unspecified foot</td>
</tr>
<tr class="odd">
<td align="left">M87.039</td>
<td align="right">7</td>
<td align="left">Kienbock’s disease</td>
<td align="left">Idiopathic aseptic necrosis of unspecified carpus</td>
</tr>
<tr class="even">
<td align="left">L68.8</td>
<td align="right">7</td>
<td align="left">Barber Say syndrome</td>
<td align="left">Other hypertrichosis</td>
</tr>
<tr class="odd">
<td align="left">L68.8</td>
<td align="right">7</td>
<td align="left">Giant platelet syndrome</td>
<td align="left">Other hypertrichosis</td>
</tr>
<tr class="even">
<td align="left">K00.4</td>
<td align="right">7</td>
<td align="left">Witkop syndrome</td>
<td align="left">Disturbances in tooth formation</td>
</tr>
<tr class="odd">
<td align="left">J66.0</td>
<td align="right">7</td>
<td align="left">Byssinosis</td>
<td align="left">Byssinosis</td>
</tr>
<tr class="even">
<td align="left">G12.8</td>
<td align="right">7</td>
<td align="left">Kennedy disease</td>
<td align="left">Other spinal muscular atrophies and related syndromes</td>
</tr>
<tr class="odd">
<td align="left">E83.32</td>
<td align="right">7</td>
<td align="left">Hypophosphatemic rickets</td>
<td align="left">Hereditary vitamin D-dependent rickets (type 1) (type 2)</td>
</tr>
<tr class="even">
<td align="left">E83.32</td>
<td align="right">7</td>
<td align="left">X-linked hypophosphatemia</td>
<td align="left">Hereditary vitamin D-dependent rickets (type 1) (type 2)</td>
</tr>
<tr class="odd">
<td align="left">E83.32</td>
<td align="right">7</td>
<td align="left">X-linked hypophosphatemia</td>
<td align="left">Hereditary vitamin D-dependent rickets (type 1) (type 2)</td>
</tr>
<tr class="even">
<td align="left">E80.29</td>
<td align="right">7</td>
<td align="left">Watson syndrome</td>
<td align="left">Other porphyria</td>
</tr>
<tr class="odd">
<td align="left">E80.29</td>
<td align="right">7</td>
<td align="left">Hereditary coproporphyria</td>
<td align="left">Other porphyria</td>
</tr>
<tr class="even">
<td align="left">E80.29</td>
<td align="right">7</td>
<td align="left">Chester porphyria</td>
<td align="left">Other porphyria</td>
</tr>
<tr class="odd">
<td align="left">E74.4</td>
<td align="right">7</td>
<td align="left">Lactate dehydrogenase deficiency</td>
<td align="left">Disorders of pyruvate metabolism and gluconeogenesis</td>
</tr>
<tr class="even">
<td align="left">E74.4</td>
<td align="right">7</td>
<td align="left">Lactate dehydrogenase deficiency</td>
<td align="left">Disorders of pyruvate metabolism and gluconeogenesis</td>
</tr>
<tr class="odd">
<td align="left">E74.4</td>
<td align="right">7</td>
<td align="left">PEPCK 1 deficiency</td>
<td align="left">Disorders of pyruvate metabolism and gluconeogenesis</td>
</tr>
<tr class="even">
<td align="left">E74.4</td>
<td align="right">7</td>
<td align="left">Pyruvate decarboxylase deficiency</td>
<td align="left">Disorders of pyruvate metabolism and gluconeogenesis</td>
</tr>
<tr class="odd">
<td align="left">E74.4</td>
<td align="right">7</td>
<td align="left">Pyruvate carboxylase deficiency</td>
<td align="left">Disorders of pyruvate metabolism and gluconeogenesis</td>
</tr>
<tr class="even">
<td align="left">E74.4</td>
<td align="right">7</td>
<td align="left">Pyruvate dehydrogenase deficiency</td>
<td align="left">Disorders of pyruvate metabolism and gluconeogenesis</td>
</tr>
<tr class="odd">
<td align="left">E72.04</td>
<td align="right">7</td>
<td align="left">Fanconi Bickel syndrome</td>
<td align="left">Cystinosis</td>
</tr>
<tr class="even">
<td align="left">E72.04</td>
<td align="right">7</td>
<td align="left">Lactate dehydrogenase A deficiency</td>
<td align="left">Cystinosis</td>
</tr>
<tr class="odd">
<td align="left">E72.04</td>
<td align="right">7</td>
<td align="left">Cystinosis</td>
<td align="left">Cystinosis</td>
</tr>
<tr class="even">
<td align="left">E72.04</td>
<td align="right">7</td>
<td align="left">Primary Fanconi syndrome</td>
<td align="left">Cystinosis</td>
</tr>
<tr class="odd">
<td align="left">E72.04</td>
<td align="right">7</td>
<td align="left">Nephropathic cystinosis</td>
<td align="left">Cystinosis</td>
</tr>
<tr class="even">
<td align="left">E71.312</td>
<td align="right">7</td>
<td align="left">Short-chain acyl-CoA dehydrogenase deficiency</td>
<td align="left">Short chain acyl CoA dehydrogenase deficiency</td>
</tr>
<tr class="odd">
<td align="left">E71.312</td>
<td align="right">7</td>
<td align="left">2-methyl-3-hydroxybutyric aciduria</td>
<td align="left">Short chain acyl CoA dehydrogenase deficiency</td>
</tr>
<tr class="even">
<td align="left">E70.321</td>
<td align="right">7</td>
<td align="left">Oculocutaneous albinism type 2</td>
<td align="left">Tyrosinase positive oculocutaneous albinism</td>
</tr>
<tr class="odd">
<td align="left">E70.321</td>
<td align="right">7</td>
<td align="left">Oculocutaneous albinism type 3</td>
<td align="left">Tyrosinase positive oculocutaneous albinism</td>
</tr>
<tr class="even">
<td align="left">E70.321</td>
<td align="right">7</td>
<td align="left">Rufous oculocutaneous albinism</td>
<td align="left">Tyrosinase positive oculocutaneous albinism</td>
</tr>
<tr class="odd">
<td align="left">E52</td>
<td align="right">7</td>
<td align="left">Pellagra</td>
<td align="left">Niacin deficiency [pellagra]</td>
</tr>
<tr class="even">
<td align="left">D81.810</td>
<td align="right">7</td>
<td align="left">Biotinidase deficiency</td>
<td align="left">Biotinidase deficiency</td>
</tr>
<tr class="odd">
<td align="left">D69.8</td>
<td align="right">7</td>
<td align="left">Pseudo-Von Willebrand disease</td>
<td align="left">Other specified hemorrhagic conditions</td>
</tr>
<tr class="even">
<td align="left">D68.311</td>
<td align="right">7</td>
<td align="left">Acquired hemophilia</td>
<td align="left">Acquired hemophilia</td>
</tr>
<tr class="odd">
<td align="left">D60.1</td>
<td align="right">7</td>
<td align="left">Transient erythroblastopenia of childhood</td>
<td align="left">Transient acquired pure red cell aplasia</td>
</tr>
<tr class="even">
<td align="left">B69.9</td>
<td align="right">7</td>
<td align="left">Cysticercosis</td>
<td align="left">Cysticercosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A90</td>
<td align="right">7</td>
<td align="left">Dengue fever</td>
<td align="left">Dengue fever [classical dengue]</td>
</tr>
<tr class="even">
<td align="left">A78</td>
<td align="right">7</td>
<td align="left">Q fever</td>
<td align="left">Q fever</td>
</tr>
<tr class="odd">
<td align="left">A32.9</td>
<td align="right">7</td>
<td align="left">Listeria infection</td>
<td align="left">Listeriosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">A07.0</td>
<td align="right">7</td>
<td align="left">Balantidiasis</td>
<td align="left">Balantidiasis</td>
</tr>
<tr class="odd">
<td align="left">Q80.3</td>
<td align="right">6</td>
<td align="left">Epidermolytic ichthyosis</td>
<td align="left">Congenital bullous ichthyosiform erythroderma</td>
</tr>
<tr class="even">
<td align="left">Q80.3</td>
<td align="right">6</td>
<td align="left">Dominant ichthyosis vulgaris</td>
<td align="left">Congenital bullous ichthyosiform erythroderma</td>
</tr>
<tr class="odd">
<td align="left">Q80.3</td>
<td align="right">6</td>
<td align="left">IBIDS syndrome</td>
<td align="left">Congenital bullous ichthyosiform erythroderma</td>
</tr>
<tr class="even">
<td align="left">Q21.4</td>
<td align="right">6</td>
<td align="left">Aortopulmonary window</td>
<td align="left">Aortopulmonary septal defect</td>
</tr>
<tr class="odd">
<td align="left">P35.0</td>
<td align="right">6</td>
<td align="left">Congenital rubella</td>
<td align="left">Congenital rubella syndrome</td>
</tr>
<tr class="even">
<td align="left">O43.90</td>
<td align="right">6</td>
<td align="left">Placenta disorder</td>
<td align="left">Unspecified placental disorder, unspecified trimester</td>
</tr>
<tr class="odd">
<td align="left">N99.83</td>
<td align="right">6</td>
<td align="left">Ovarian remnant syndrome</td>
<td align="left">Residual ovary syndrome</td>
</tr>
<tr class="even">
<td align="left">M72.8</td>
<td align="right">6</td>
<td align="left">Infantile digital fibromatosis</td>
<td align="left">Other fibroblastic disorders</td>
</tr>
<tr class="odd">
<td align="left">H18.55</td>
<td align="right">6</td>
<td align="left">Macular dystrophy, corneal type 1</td>
<td align="left">Macular corneal dystrophy</td>
</tr>
<tr class="even">
<td align="left">H18.55</td>
<td align="right">6</td>
<td align="left">Multicentric Castleman Disease</td>
<td align="left">Macular corneal dystrophy</td>
</tr>
<tr class="odd">
<td align="left">E78.72</td>
<td align="right">6</td>
<td align="left">Smith-Lemli-Opitz syndrome</td>
<td align="left">Smith-Lemli-Opitz syndrome</td>
</tr>
<tr class="even">
<td align="left">E76.219</td>
<td align="right">6</td>
<td align="left">Eccentrochondrodysplasia</td>
<td align="left">Morquio mucopolysaccharidoses, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E76.219</td>
<td align="right">6</td>
<td align="left">Mucopolysaccharidosis type IV</td>
<td align="left">Morquio mucopolysaccharidoses, unspecified</td>
</tr>
<tr class="even">
<td align="left">E70.0</td>
<td align="right">6</td>
<td align="left">Phenylketonuria</td>
<td align="left">Classical phenylketonuria</td>
</tr>
<tr class="odd">
<td align="left">E34.51</td>
<td align="right">6</td>
<td align="left">Androgen insensitivity syndrome</td>
<td align="left">Complete androgen insensitivity syndrome</td>
</tr>
<tr class="even">
<td align="left">E34.51</td>
<td align="right">6</td>
<td align="left">Complete androgen insensitivity syndrome</td>
<td align="left">Complete androgen insensitivity syndrome</td>
</tr>
<tr class="odd">
<td align="left">E31.20</td>
<td align="right">6</td>
<td align="left">Multiple endocrine neoplasia type 1</td>
<td align="left">Multiple endocrine neoplasia [MEN] syndrome, unspecified</td>
</tr>
<tr class="even">
<td align="left">C94.00</td>
<td align="right">6</td>
<td align="left">Primary effusion lymphoma</td>
<td align="left">Acute erythroid leukemia, not having achieved remission</td>
</tr>
<tr class="odd">
<td align="left">C94.00</td>
<td align="right">6</td>
<td align="left">Acute erythroid leukemia</td>
<td align="left">Acute erythroid leukemia, not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">C94.00</td>
<td align="right">6</td>
<td align="left">Di Guglielmo’s syndrome</td>
<td align="left">Acute erythroid leukemia, not having achieved remission</td>
</tr>
<tr class="odd">
<td align="left">C86.3</td>
<td align="right">6</td>
<td align="left">Subcutaneous panniculitis-like T-cell lymphoma</td>
<td align="left">Subcutaneous panniculitis-like T-cell lymphoma</td>
</tr>
<tr class="even">
<td align="left">B74.9</td>
<td align="right">6</td>
<td align="left">Lymphatic filariasis</td>
<td align="left">Filariasis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">B60.0</td>
<td align="right">6</td>
<td align="left">Babesiosis</td>
<td align="left">Babesiosis</td>
</tr>
<tr class="even">
<td align="left">A95.9</td>
<td align="right">6</td>
<td align="left">Yellow fever</td>
<td align="left">Yellow fever, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q80.8</td>
<td align="right">5</td>
<td align="left">Ichthyosis, follicular</td>
<td align="left">Other congenital ichthyosis</td>
</tr>
<tr class="even">
<td align="left">Q80.8</td>
<td align="right">5</td>
<td align="left">Ichthyosiform erythroderma, corneal involvement, deafness</td>
<td align="left">Other congenital ichthyosis</td>
</tr>
<tr class="odd">
<td align="left">Q80.8</td>
<td align="right">5</td>
<td align="left">Ichthyosis linearis circumflexa</td>
<td align="left">Other congenital ichthyosis</td>
</tr>
<tr class="even">
<td align="left">Q80.8</td>
<td align="right">5</td>
<td align="left">Ichthyosis linearis circumflexa</td>
<td align="left">Other congenital ichthyosis</td>
</tr>
<tr class="odd">
<td align="left">Q80.8</td>
<td align="right">5</td>
<td align="left">KID syndrome</td>
<td align="left">Other congenital ichthyosis</td>
</tr>
<tr class="even">
<td align="left">Q80.8</td>
<td align="right">5</td>
<td align="left">Netherton syndrome</td>
<td align="left">Other congenital ichthyosis</td>
</tr>
<tr class="odd">
<td align="left">Q80.8</td>
<td align="right">5</td>
<td align="left">Netherton syndrome</td>
<td align="left">Other congenital ichthyosis</td>
</tr>
<tr class="even">
<td align="left">Q80.8</td>
<td align="right">5</td>
<td align="left">Ichthyosis hystrix gravior</td>
<td align="left">Other congenital ichthyosis</td>
</tr>
<tr class="odd">
<td align="left">M05.20</td>
<td align="right">5</td>
<td align="left">Rheumatoid vasculitis</td>
<td align="left">Rheumatoid vasculitis with rheumatoid arthritis of unspecified site</td>
</tr>
<tr class="even">
<td align="left">L87.0</td>
<td align="right">5</td>
<td align="left">Kyrle disease</td>
<td align="left">Keratosis follicularis et parafollicularis in cutem penetrans</td>
</tr>
<tr class="odd">
<td align="left">L51.2</td>
<td align="right">5</td>
<td align="left">Toxic epidermal necrolysis</td>
<td align="left">Toxic epidermal necrolysis [Lyell]</td>
</tr>
<tr class="even">
<td align="left">G51.2</td>
<td align="right">5</td>
<td align="left">Melkersson-Rosenthal syndrome</td>
<td align="left">Melkersson’s syndrome</td>
</tr>
<tr class="odd">
<td align="left">G47.24</td>
<td align="right">5</td>
<td align="left">Non 24 hour sleep wake disorder</td>
<td align="left">Circadian rhythm sleep disorder, free running type</td>
</tr>
<tr class="even">
<td align="left">G47.13</td>
<td align="right">5</td>
<td align="left">Kleine Levin syndrome</td>
<td align="left">Recurrent hypersomnia</td>
</tr>
<tr class="odd">
<td align="left">G31.2</td>
<td align="right">5</td>
<td align="left">Subacute cerebellar degeneration</td>
<td align="left">Degeneration of nervous system due to alcohol</td>
</tr>
<tr class="even">
<td align="left">E83.89</td>
<td align="right">5</td>
<td align="left">Hypermanganesemia with dystonia polycythemia and cirrhosis</td>
<td align="left">Other disorders of mineral metabolism</td>
</tr>
<tr class="odd">
<td align="left">E80.0</td>
<td align="right">5</td>
<td align="left">Congenital erythropoietic porphyria</td>
<td align="left">Hereditary erythropoietic porphyria</td>
</tr>
<tr class="even">
<td align="left">E80.0</td>
<td align="right">5</td>
<td align="left">Erythropoietic protoporphyria</td>
<td align="left">Hereditary erythropoietic porphyria</td>
</tr>
<tr class="odd">
<td align="left">E80.0</td>
<td align="right">5</td>
<td align="left">Protoporphyria</td>
<td align="left">Hereditary erythropoietic porphyria</td>
</tr>
<tr class="even">
<td align="left">E80.0</td>
<td align="right">5</td>
<td align="left">Congenital extrahepatic portosystemic shunt</td>
<td align="left">Hereditary erythropoietic porphyria</td>
</tr>
<tr class="odd">
<td align="left">E75.249</td>
<td align="right">5</td>
<td align="left">Niemann-Pick disease type A</td>
<td align="left">Niemann-Pick disease, unspecified</td>
</tr>
<tr class="even">
<td align="left">E74.31</td>
<td align="right">5</td>
<td align="left">Congenital sucrose isomaltose malabsorption</td>
<td align="left">Sucrase-isomaltase deficiency</td>
</tr>
<tr class="odd">
<td align="left">E74.31</td>
<td align="right">5</td>
<td align="left">Congenital sucrase-isomaltase deficiency</td>
<td align="left">Sucrase-isomaltase deficiency</td>
</tr>
<tr class="even">
<td align="left">E72.23</td>
<td align="right">5</td>
<td align="left">Citrullinemia type I</td>
<td align="left">Citrullinemia</td>
</tr>
<tr class="odd">
<td align="left">E72.23</td>
<td align="right">5</td>
<td align="left">Neonatal intrahepatic cholestasis caused by citrin deficiency</td>
<td align="left">Citrullinemia</td>
</tr>
<tr class="even">
<td align="left">E72.23</td>
<td align="right">5</td>
<td align="left">Adult-onset citrullinemia type II</td>
<td align="left">Citrullinemia</td>
</tr>
<tr class="odd">
<td align="left">E72.10</td>
<td align="right">5</td>
<td align="left">Megaloblastic anemia due to dihydrofolate reductase deficiency</td>
<td align="left">Disorders of sulfur-bearing amino-acid metabolism, unspecified</td>
</tr>
<tr class="even">
<td align="left">E71.522</td>
<td align="right">5</td>
<td align="left">Adrenomyeloneuropathy</td>
<td align="left">Adrenomyeloneuropathy</td>
</tr>
<tr class="odd">
<td align="left">E71.440</td>
<td align="right">5</td>
<td align="left">Bannayan-Riley-Ruvalcaba syndrome</td>
<td align="left">Ruvalcaba-Myhre-Smith syndrome</td>
</tr>
<tr class="even">
<td align="left">E70.310</td>
<td align="right">5</td>
<td align="left">Ocular albinism type 1</td>
<td align="left">X-linked ocular albinism</td>
</tr>
<tr class="odd">
<td align="left">E23.3</td>
<td align="right">5</td>
<td align="left">Hypothalamic dysfunction</td>
<td align="left">Hypothalamic dysfunction, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">D80.8</td>
<td align="right">5</td>
<td align="left">Hyper-IgD syndrome</td>
<td align="left">Other immunodeficiencies with predominantly antibody defects</td>
</tr>
<tr class="odd">
<td align="left">D64.0</td>
<td align="right">5</td>
<td align="left">X-linked sideroblastic anemia</td>
<td align="left">Hereditary sideroblastic anemia</td>
</tr>
<tr class="even">
<td align="left">B75</td>
<td align="right">5</td>
<td align="left">Trichinosis</td>
<td align="left">Trichinellosis</td>
</tr>
<tr class="odd">
<td align="left">B68.9</td>
<td align="right">5</td>
<td align="left">Cysticercosis</td>
<td align="left">Taeniasis, unspecified</td>
</tr>
<tr class="even">
<td align="left">B58.00</td>
<td align="right">5</td>
<td align="left">Ocular toxoplasmosis</td>
<td align="left">Toxoplasma oculopathy, unspecified</td>
</tr>
<tr class="odd">
<td align="left">B06.9</td>
<td align="right">5</td>
<td align="left">Rubella</td>
<td align="left">Rubella without complication</td>
</tr>
<tr class="even">
<td align="left">B05.9</td>
<td align="right">5</td>
<td align="left">Measles</td>
<td align="left">Measles without complication</td>
</tr>
<tr class="odd">
<td align="left">A27.9</td>
<td align="right">5</td>
<td align="left">Leptospirosis</td>
<td align="left">Leptospirosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">A17.0</td>
<td align="right">5</td>
<td align="left">Tuberculous meningitis</td>
<td align="left">Tuberculous meningitis</td>
</tr>
<tr class="odd">
<td align="left">Q98.5</td>
<td align="right">4</td>
<td align="left">47, XYY syndrome</td>
<td align="left">Karyotype 47, XYY</td>
</tr>
<tr class="even">
<td align="left">Q87.5</td>
<td align="right">4</td>
<td align="left">Acromegaloid changes, cutis verticis gyrata and corneal leukoma</td>
<td align="left">Other congenital malformation syndromes with other skeletal changes</td>
</tr>
<tr class="odd">
<td align="left">Q87.5</td>
<td align="right">4</td>
<td align="left">FG syndrome</td>
<td align="left">Other congenital malformation syndromes with other skeletal changes</td>
</tr>
<tr class="even">
<td align="left">Q87.5</td>
<td align="right">4</td>
<td align="left">Mandibuloacral dysplasia with type A lipodystrophy</td>
<td align="left">Other congenital malformation syndromes with other skeletal changes</td>
</tr>
<tr class="odd">
<td align="left">Q87.5</td>
<td align="right">4</td>
<td align="left">Megaepiphyseal dwarfism</td>
<td align="left">Other congenital malformation syndromes with other skeletal changes</td>
</tr>
<tr class="even">
<td align="left">Q87.5</td>
<td align="right">4</td>
<td align="left">OSMED Syndrome</td>
<td align="left">Other congenital malformation syndromes with other skeletal changes</td>
</tr>
<tr class="odd">
<td align="left">Q87.5</td>
<td align="right">4</td>
<td align="left">Weissenbacher-Zweymuller syndrome</td>
<td align="left">Other congenital malformation syndromes with other skeletal changes</td>
</tr>
<tr class="even">
<td align="left">Q87.5</td>
<td align="right">4</td>
<td align="left">3M syndrome</td>
<td align="left">Other congenital malformation syndromes with other skeletal changes</td>
</tr>
<tr class="odd">
<td align="left">Q87.5</td>
<td align="right">4</td>
<td align="left">Antley Bixler syndrome</td>
<td align="left">Other congenital malformation syndromes with other skeletal changes</td>
</tr>
<tr class="even">
<td align="left">Q87.5</td>
<td align="right">4</td>
<td align="left">Spondylothoracic dysostosis</td>
<td align="left">Other congenital malformation syndromes with other skeletal changes</td>
</tr>
<tr class="odd">
<td align="left">Q87.5</td>
<td align="right">4</td>
<td align="left">Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia</td>
<td align="left">Other congenital malformation syndromes with other skeletal changes</td>
</tr>
<tr class="even">
<td align="left">Q87.5</td>
<td align="right">4</td>
<td align="left">Spondylocostal dysostosis 1</td>
<td align="left">Other congenital malformation syndromes with other skeletal changes</td>
</tr>
<tr class="odd">
<td align="left">Q87.5</td>
<td align="right">4</td>
<td align="left">Mandibuloacral dysplasia</td>
<td align="left">Other congenital malformation syndromes with other skeletal changes</td>
</tr>
<tr class="even">
<td align="left">Q87.5</td>
<td align="right">4</td>
<td align="left">Spondylocostal dysostosis</td>
<td align="left">Other congenital malformation syndromes with other skeletal changes</td>
</tr>
<tr class="odd">
<td align="left">Q87.5</td>
<td align="right">4</td>
<td align="left">Spondylocostal dysostosis 5</td>
<td align="left">Other congenital malformation syndromes with other skeletal changes</td>
</tr>
<tr class="even">
<td align="left">Q77.3</td>
<td align="right">4</td>
<td align="left">Chondrodysplasia punctata 2 X-linked dominant</td>
<td align="left">Chondrodysplasia punctata</td>
</tr>
<tr class="odd">
<td align="left">Q77.3</td>
<td align="right">4</td>
<td align="left">Chondrodysplasia punctata 2 X-linked dominant</td>
<td align="left">Chondrodysplasia punctata</td>
</tr>
<tr class="even">
<td align="left">Q77.3</td>
<td align="right">4</td>
<td align="left">Chondrodysplasia punctata syndrome</td>
<td align="left">Chondrodysplasia punctata</td>
</tr>
<tr class="odd">
<td align="left">Q74.8</td>
<td align="right">4</td>
<td align="left">Larsen syndrome</td>
<td align="left">Other specified congenital malformations of limb(s)</td>
</tr>
<tr class="even">
<td align="left">Q71.60</td>
<td align="right">4</td>
<td align="left">Split hand foot malformation</td>
<td align="left">Lobster-claw hand, unspecified hand</td>
</tr>
<tr class="odd">
<td align="left">Q65.82</td>
<td align="right">4</td>
<td align="left">Coxa vara, congenital</td>
<td align="left">Congenital coxa vara</td>
</tr>
<tr class="even">
<td align="left">Q55.4</td>
<td align="right">4</td>
<td align="left">Congenital bilateral absence of the vas deferens</td>
<td align="left">Other congenital malformations of vas deferens, epididymis, seminal vesicles and prostate</td>
</tr>
<tr class="odd">
<td align="left">Q42.9</td>
<td align="right">4</td>
<td align="left">Colonic atresia</td>
<td align="left">Congenital absence, atresia and stenosis of large intestine, part unspecified</td>
</tr>
<tr class="even">
<td align="left">Q18.8</td>
<td align="right">4</td>
<td align="left">Branchiooculofacial syndrome</td>
<td align="left">Other specified congenital malformations of face and neck</td>
</tr>
<tr class="odd">
<td align="left">Q18.8</td>
<td align="right">4</td>
<td align="left">Hemifacial myohyperplasia</td>
<td align="left">Other specified congenital malformations of face and neck</td>
</tr>
<tr class="even">
<td align="left">M83.8</td>
<td align="right">4</td>
<td align="left">Oncogenic osteomalacia</td>
<td align="left">Other adult osteomalacia</td>
</tr>
<tr class="odd">
<td align="left">M61.10</td>
<td align="right">4</td>
<td align="left">Fibrodysplasia ossificans progressiva</td>
<td align="left">Myositis ossificans progressiva, unspecified site</td>
</tr>
<tr class="even">
<td align="left">L75.2</td>
<td align="right">4</td>
<td align="left">Fox-Fordyce disease</td>
<td align="left">Apocrine miliaria</td>
</tr>
<tr class="odd">
<td align="left">L41.9</td>
<td align="right">4</td>
<td align="left">Parapsoriasis</td>
<td align="left">Parapsoriasis, unspecified</td>
</tr>
<tr class="even">
<td align="left">K90.81</td>
<td align="right">4</td>
<td align="left">Whipple disease</td>
<td align="left">Whipple’s disease</td>
</tr>
<tr class="odd">
<td align="left">E83.2</td>
<td align="right">4</td>
<td align="left">Acrodermatitis enteropathica</td>
<td align="left">Disorders of zinc metabolism</td>
</tr>
<tr class="even">
<td align="left">E79.2</td>
<td align="right">4</td>
<td align="left">Adenosine monophosphate deaminase 1 deficiency</td>
<td align="left">Myoadenylate deaminase deficiency</td>
</tr>
<tr class="odd">
<td align="left">E77.1</td>
<td align="right">4</td>
<td align="left">Mannosidosis, beta A, lysosomal</td>
<td align="left">Defects in glycoprotein degradation</td>
</tr>
<tr class="even">
<td align="left">E77.1</td>
<td align="right">4</td>
<td align="left">Galactosialidosis</td>
<td align="left">Defects in glycoprotein degradation</td>
</tr>
<tr class="odd">
<td align="left">E77.1</td>
<td align="right">4</td>
<td align="left">Aspartylglycosaminuria</td>
<td align="left">Defects in glycoprotein degradation</td>
</tr>
<tr class="even">
<td align="left">E77.1</td>
<td align="right">4</td>
<td align="left">Fucosidosis</td>
<td align="left">Defects in glycoprotein degradation</td>
</tr>
<tr class="odd">
<td align="left">E77.1</td>
<td align="right">4</td>
<td align="left">Fucosidosis type 1</td>
<td align="left">Defects in glycoprotein degradation</td>
</tr>
<tr class="even">
<td align="left">E77.1</td>
<td align="right">4</td>
<td align="left">Alpha-mannosidosis</td>
<td align="left">Defects in glycoprotein degradation</td>
</tr>
<tr class="odd">
<td align="left">E77.1</td>
<td align="right">4</td>
<td align="left">Sialidosis, type II</td>
<td align="left">Defects in glycoprotein degradation</td>
</tr>
<tr class="even">
<td align="left">E77.1</td>
<td align="right">4</td>
<td align="left">Sialidosis type I</td>
<td align="left">Defects in glycoprotein degradation</td>
</tr>
<tr class="odd">
<td align="left">E76.29</td>
<td align="right">4</td>
<td align="left">Mucopolysaccharidosis type VI</td>
<td align="left">Other mucopolysaccharidoses</td>
</tr>
<tr class="even">
<td align="left">E76.29</td>
<td align="right">4</td>
<td align="left">Mucopolysaccharidosis type VI</td>
<td align="left">Other mucopolysaccharidoses</td>
</tr>
<tr class="odd">
<td align="left">E76.29</td>
<td align="right">4</td>
<td align="left">Mucopolysaccharidosis type VII</td>
<td align="left">Other mucopolysaccharidoses</td>
</tr>
<tr class="even">
<td align="left">E76.210</td>
<td align="right">4</td>
<td align="left">Mucopolysaccharidosis type IVA</td>
<td align="left">Morquio A mucopolysaccharidoses</td>
</tr>
<tr class="odd">
<td align="left">E75.242</td>
<td align="right">4</td>
<td align="left">Niemann-Pick disease type C1</td>
<td align="left">Niemann-Pick disease type C</td>
</tr>
<tr class="even">
<td align="left">E75.242</td>
<td align="right">4</td>
<td align="left">Niemann-Pick disease type D</td>
<td align="left">Niemann-Pick disease type C</td>
</tr>
<tr class="odd">
<td align="left">E75.02</td>
<td align="right">4</td>
<td align="left">Tay-Sachs disease</td>
<td align="left">Tay-Sachs disease</td>
</tr>
<tr class="even">
<td align="left">E72.52</td>
<td align="right">4</td>
<td align="left">Trimethylaminuria</td>
<td align="left">Trimethylaminuria</td>
</tr>
<tr class="odd">
<td align="left">E72.19</td>
<td align="right">4</td>
<td align="left">Gamma-cystathionase deficiency</td>
<td align="left">Other disorders of sulfur-bearing amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.19</td>
<td align="right">4</td>
<td align="left">Methylcobalamin deficiency cbl G type</td>
<td align="left">Other disorders of sulfur-bearing amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.19</td>
<td align="right">4</td>
<td align="left">Sulfite oxidase deficiency</td>
<td align="left">Other disorders of sulfur-bearing amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.19</td>
<td align="right">4</td>
<td align="left">Transcobalamin 1 deficiency</td>
<td align="left">Other disorders of sulfur-bearing amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.19</td>
<td align="right">4</td>
<td align="left">Hawkinsinuria</td>
<td align="left">Other disorders of sulfur-bearing amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.19</td>
<td align="right">4</td>
<td align="left">Methionine adenosyltransferase deficiency</td>
<td align="left">Other disorders of sulfur-bearing amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.19</td>
<td align="right">4</td>
<td align="left">Glutamate formiminotransferase deficiency</td>
<td align="left">Other disorders of sulfur-bearing amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.19</td>
<td align="right">4</td>
<td align="left">Glutathione synthetase deficiency</td>
<td align="left">Other disorders of sulfur-bearing amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E70.21</td>
<td align="right">4</td>
<td align="left">Tyrosinemia type 1</td>
<td align="left">Tyrosinemia</td>
</tr>
<tr class="even">
<td align="left">E70.21</td>
<td align="right">4</td>
<td align="left">Tyrosinemia type 2</td>
<td align="left">Tyrosinemia</td>
</tr>
<tr class="odd">
<td align="left">E70.21</td>
<td align="right">4</td>
<td align="left">Tyrosinemia type 3</td>
<td align="left">Tyrosinemia</td>
</tr>
<tr class="even">
<td align="left">E31.23</td>
<td align="right">4</td>
<td align="left">Multiple endocrine neoplasia type 2B</td>
<td align="left">Multiple endocrine neoplasia [MEN] type IIB</td>
</tr>
<tr class="odd">
<td align="left">D81.4</td>
<td align="right">4</td>
<td align="left">Immune defect due to absence of thymus</td>
<td align="left">Nezelof’s syndrome</td>
</tr>
<tr class="even">
<td align="left">D35.4</td>
<td align="right">4</td>
<td align="left">Pineocytoma</td>
<td align="left">Benign neoplasm of pineal gland</td>
</tr>
<tr class="odd">
<td align="left">D14.4</td>
<td align="right">4</td>
<td align="left">Recurrent respiratory papillomatosis</td>
<td align="left">Benign neoplasm of respiratory system, unspecified</td>
</tr>
<tr class="even">
<td align="left">C96.5</td>
<td align="right">4</td>
<td align="left">Langerhans cell histiocytosis</td>
<td align="left">Multifocal and unisystemic Langerhans-cell histiocytosis</td>
</tr>
<tr class="odd">
<td align="left">C94.20</td>
<td align="right">4</td>
<td align="left">Acute megakaryoblastic leukemia</td>
<td align="left">Acute megakaryoblastic leukemia not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">B79</td>
<td align="right">4</td>
<td align="left">Trichuriasis</td>
<td align="left">Trichuriasis</td>
</tr>
<tr class="odd">
<td align="left">B70.0</td>
<td align="right">4</td>
<td align="left">Bothriocephalosis</td>
<td align="left">Diphyllobothriasis</td>
</tr>
<tr class="even">
<td align="left">B17.2</td>
<td align="right">4</td>
<td align="left">Hepatitis E</td>
<td align="left">Acute hepatitis E</td>
</tr>
<tr class="odd">
<td align="left">A98.3</td>
<td align="right">4</td>
<td align="left">Marburg hemorrhagic fever</td>
<td align="left">Marburg virus disease</td>
</tr>
<tr class="even">
<td align="left">A74.0</td>
<td align="right">4</td>
<td align="left">Inclusion conjunctivitis</td>
<td align="left">Chlamydial conjunctivitis</td>
</tr>
<tr class="odd">
<td align="left">A69.9</td>
<td align="right">4</td>
<td align="left">Spirochetes disease</td>
<td align="left">Spirochetal infection, unspecified</td>
</tr>
<tr class="even">
<td align="left">A48.8</td>
<td align="right">4</td>
<td align="left">Lemierre syndrome</td>
<td align="left">Other specified bacterial diseases</td>
</tr>
<tr class="odd">
<td align="left">Q99.1</td>
<td align="right">3</td>
<td align="left">Swyer syndrome</td>
<td align="left">46, XX true hermaphrodite</td>
</tr>
<tr class="even">
<td align="left">Q86.2</td>
<td align="right">3</td>
<td align="left">Fetal warfarin syndrome</td>
<td align="left">Dysmorphism due to warfarin</td>
</tr>
<tr class="odd">
<td align="left">Q86.2</td>
<td align="right">3</td>
<td align="left">Warfarin syndrome</td>
<td align="left">Dysmorphism due to warfarin</td>
</tr>
<tr class="even">
<td align="left">Q84.2</td>
<td align="right">3</td>
<td align="left">Burnett Schwartz Berberian syndrome</td>
<td align="left">Other congenital malformations of hair</td>
</tr>
<tr class="odd">
<td align="left">Q84.2</td>
<td align="right">3</td>
<td align="left">Hypertrichosis lanuginosa congenita</td>
<td align="left">Other congenital malformations of hair</td>
</tr>
<tr class="even">
<td align="left">Q84.2</td>
<td align="right">3</td>
<td align="left">Trichohepatoenteric syndrome</td>
<td align="left">Other congenital malformations of hair</td>
</tr>
<tr class="odd">
<td align="left">Q84.2</td>
<td align="right">3</td>
<td align="left">Ulerythema ophryogenesis</td>
<td align="left">Other congenital malformations of hair</td>
</tr>
<tr class="even">
<td align="left">Q84.2</td>
<td align="right">3</td>
<td align="left">Uncombable hair syndrome</td>
<td align="left">Other congenital malformations of hair</td>
</tr>
<tr class="odd">
<td align="left">Q84.2</td>
<td align="right">3</td>
<td align="left">Hypertrichosis universalis</td>
<td align="left">Other congenital malformations of hair</td>
</tr>
<tr class="even">
<td align="left">Q82.1</td>
<td align="right">3</td>
<td align="left">Xeroderma pigmentosum type 7</td>
<td align="left">Xeroderma pigmentosum</td>
</tr>
<tr class="odd">
<td align="left">Q82.1</td>
<td align="right">3</td>
<td align="left">Xeroderma pigmentosum</td>
<td align="left">Xeroderma pigmentosum</td>
</tr>
<tr class="even">
<td align="left">Q82.1</td>
<td align="right">3</td>
<td align="left">De Sanctis-Cacchione syndrome</td>
<td align="left">Xeroderma pigmentosum</td>
</tr>
<tr class="odd">
<td align="left">Q82.1</td>
<td align="right">3</td>
<td align="left">Xeroderma pigmentosum, type 9</td>
<td align="left">Xeroderma pigmentosum</td>
</tr>
<tr class="even">
<td align="left">Q78.3</td>
<td align="right">3</td>
<td align="left">Camurati-Engelmann disease</td>
<td align="left">Progressive diaphyseal dysplasia</td>
</tr>
<tr class="odd">
<td align="left">Q78.3</td>
<td align="right">3</td>
<td align="left">Craniodiaphyseal dysplasia</td>
<td align="left">Progressive diaphyseal dysplasia</td>
</tr>
<tr class="even">
<td align="left">Q78.3</td>
<td align="right">3</td>
<td align="left">Ghosal hematodiaphyseal dysplasia syndrome</td>
<td align="left">Progressive diaphyseal dysplasia</td>
</tr>
<tr class="odd">
<td align="left">Q77.2</td>
<td align="right">3</td>
<td align="left">Jeune syndrome</td>
<td align="left">Short rib syndrome</td>
</tr>
<tr class="even">
<td align="left">Q77.2</td>
<td align="right">3</td>
<td align="left">Short rib-polydactyly syndrome type 4</td>
<td align="left">Short rib syndrome</td>
</tr>
<tr class="odd">
<td align="left">Q77.2</td>
<td align="right">3</td>
<td align="left">Short rib-polydactyly syndrome type 2</td>
<td align="left">Short rib syndrome</td>
</tr>
<tr class="even">
<td align="left">Q77.2</td>
<td align="right">3</td>
<td align="left">Short rib-polydactyly syndrome type 1</td>
<td align="left">Short rib syndrome</td>
</tr>
<tr class="odd">
<td align="left">Q77.2</td>
<td align="right">3</td>
<td align="left">Short rib-polydactyly syndrome type 3</td>
<td align="left">Short rib syndrome</td>
</tr>
<tr class="even">
<td align="left">Q45.1</td>
<td align="right">3</td>
<td align="left">Annular pancreas</td>
<td align="left">Annular pancreas</td>
</tr>
<tr class="odd">
<td align="left">Q20.2</td>
<td align="right">3</td>
<td align="left">Double outlet left ventricle</td>
<td align="left">Double outlet left ventricle</td>
</tr>
<tr class="even">
<td align="left">M94.8X8</td>
<td align="right">3</td>
<td align="left">Tracheobronchopathia osteoplastica</td>
<td align="left">Other specified disorders of cartilage, other site</td>
</tr>
<tr class="odd">
<td align="left">M92.219</td>
<td align="right">3</td>
<td align="left">Kienbock’s disease</td>
<td align="left">Osteochondrosis (juvenile) of carpal lunate [KienbÃ¶ck], unspecified hand</td>
</tr>
<tr class="even">
<td align="left">M35.6</td>
<td align="right">3</td>
<td align="left">Nodular nonsuppurative panniculitis</td>
<td align="left">Relapsing panniculitis [Weber-Christian]</td>
</tr>
<tr class="odd">
<td align="left">M26.619</td>
<td align="right">3</td>
<td align="left">Temporomandibular ankylosis</td>
<td align="left">Adhesions and ankylosis of temporomandibular joint, unspecified side</td>
</tr>
<tr class="even">
<td align="left">K90.1</td>
<td align="right">3</td>
<td align="left">Tropical sprue</td>
<td align="left">Tropical sprue</td>
</tr>
<tr class="odd">
<td align="left">I88.8</td>
<td align="right">3</td>
<td align="left">Kikuchi disease</td>
<td align="left">Other nonspecific lymphadenitis</td>
</tr>
<tr class="even">
<td align="left">I52</td>
<td align="right">3</td>
<td align="left">Subpulmonary stenosis</td>
<td align="left">Other heart disorders in diseases classified elsewhere</td>
</tr>
<tr class="odd">
<td align="left">G23.0</td>
<td align="right">3</td>
<td align="left">Pantothenate kinase-associated neurodegeneration</td>
<td align="left">Hallervorden-Spatz disease</td>
</tr>
<tr class="even">
<td align="left">E77.0</td>
<td align="right">3</td>
<td align="left">Mucolipidosis III alpha/beta</td>
<td align="left">Defects in post-translational modification of lysosomal enzymes</td>
</tr>
<tr class="odd">
<td align="left">E76.22</td>
<td align="right">3</td>
<td align="left">Mucopolysaccharidosis type III</td>
<td align="left">Sanfilippo mucopolysaccharidoses</td>
</tr>
<tr class="even">
<td align="left">E76.22</td>
<td align="right">3</td>
<td align="left">Mucopolysaccharidosis type IIIA</td>
<td align="left">Sanfilippo mucopolysaccharidoses</td>
</tr>
<tr class="odd">
<td align="left">E76.22</td>
<td align="right">3</td>
<td align="left">Mucopolysaccharidosis type IIIB</td>
<td align="left">Sanfilippo mucopolysaccharidoses</td>
</tr>
<tr class="even">
<td align="left">E76.22</td>
<td align="right">3</td>
<td align="left">Mucopolysaccharidosis type IIIC</td>
<td align="left">Sanfilippo mucopolysaccharidoses</td>
</tr>
<tr class="odd">
<td align="left">E76.22</td>
<td align="right">3</td>
<td align="left">Mucopolysaccharidosis type IIID</td>
<td align="left">Sanfilippo mucopolysaccharidoses</td>
</tr>
<tr class="even">
<td align="left">E75.19</td>
<td align="right">3</td>
<td align="left">GM1 gangliosidosis type 3</td>
<td align="left">Other gangliosidosis</td>
</tr>
<tr class="odd">
<td align="left">E75.19</td>
<td align="right">3</td>
<td align="left">Beta-galactosidase-1 deficiency</td>
<td align="left">Other gangliosidosis</td>
</tr>
<tr class="even">
<td align="left">E75.19</td>
<td align="right">3</td>
<td align="left">GM1 gangliosidosis type 1</td>
<td align="left">Other gangliosidosis</td>
</tr>
<tr class="odd">
<td align="left">E75.19</td>
<td align="right">3</td>
<td align="left">GM1 gangliosidosis type 2</td>
<td align="left">Other gangliosidosis</td>
</tr>
<tr class="even">
<td align="left">E75.19</td>
<td align="right">3</td>
<td align="left">GM1 gangliosidosis</td>
<td align="left">Other gangliosidosis</td>
</tr>
<tr class="odd">
<td align="left">E72.59</td>
<td align="right">3</td>
<td align="left">Sarcosinemia</td>
<td align="left">Other disorders of glycine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.59</td>
<td align="right">3</td>
<td align="left">D-glycericacidemia</td>
<td align="left">Other disorders of glycine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.59</td>
<td align="right">3</td>
<td align="left">Hyperprolinemia</td>
<td align="left">Other disorders of glycine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.59</td>
<td align="right">3</td>
<td align="left">Hyperprolinemia</td>
<td align="left">Other disorders of glycine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.59</td>
<td align="right">3</td>
<td align="left">Hydroxyprolinemia</td>
<td align="left">Other disorders of glycine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.21</td>
<td align="right">3</td>
<td align="left">Arginase deficiency</td>
<td align="left">Argininemia</td>
</tr>
<tr class="odd">
<td align="left">E70.330</td>
<td align="right">3</td>
<td align="left">Chediak-Higashi syndrome</td>
<td align="left">Chediak-Higashi syndrome</td>
</tr>
<tr class="even">
<td align="left">E70.1</td>
<td align="right">3</td>
<td align="left">GTP cyclohydrolase I deficiency</td>
<td align="left">Other hyperphenylalaninemias</td>
</tr>
<tr class="odd">
<td align="left">E70.1</td>
<td align="right">3</td>
<td align="left">Maternal hyperphenylalaninemia</td>
<td align="left">Other hyperphenylalaninemias</td>
</tr>
<tr class="even">
<td align="left">E70.1</td>
<td align="right">3</td>
<td align="left">Dihydropteridine reductase deficiency</td>
<td align="left">Other hyperphenylalaninemias</td>
</tr>
<tr class="odd">
<td align="left">E70.1</td>
<td align="right">3</td>
<td align="left">Sepiapterin reductase deficiency</td>
<td align="left">Other hyperphenylalaninemias</td>
</tr>
<tr class="even">
<td align="left">D81.5</td>
<td align="right">3</td>
<td align="left">Purine nucleoside phosphorylase deficiency</td>
<td align="left">Purine nucleoside phosphorylase [PNP] deficiency</td>
</tr>
<tr class="odd">
<td align="left">D81.3</td>
<td align="right">3</td>
<td align="left">Adenosine deaminase deficiency</td>
<td align="left">Adenosine deaminase [ADA] deficiency</td>
</tr>
<tr class="even">
<td align="left">D64.4</td>
<td align="right">3</td>
<td align="left">Congenital dyserythropoietic anemia</td>
<td align="left">Congenital dyserythropoietic anemia</td>
</tr>
<tr class="odd">
<td align="left">D64.4</td>
<td align="right">3</td>
<td align="left">Congenital dyserythropoietic anemia type 1</td>
<td align="left">Congenital dyserythropoietic anemia</td>
</tr>
<tr class="even">
<td align="left">D64.4</td>
<td align="right">3</td>
<td align="left">Congenital dyserythropoietic anemia type 2</td>
<td align="left">Congenital dyserythropoietic anemia</td>
</tr>
<tr class="odd">
<td align="left">D64.4</td>
<td align="right">3</td>
<td align="left">Congenital dyserythropoietic anemia type 3</td>
<td align="left">Congenital dyserythropoietic anemia</td>
</tr>
<tr class="even">
<td align="left">D64.4</td>
<td align="right">3</td>
<td align="left">Corneal dystrophy Avellino type</td>
<td align="left">Congenital dyserythropoietic anemia</td>
</tr>
<tr class="odd">
<td align="left">C91.30</td>
<td align="right">3</td>
<td align="left">B cell prolymphocytic leukemia</td>
<td align="left">Prolymphocytic leukemia of B-cell type not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">C88.2</td>
<td align="right">3</td>
<td align="left">Gamma heavy chain disease</td>
<td align="left">Heavy chain disease</td>
</tr>
<tr class="odd">
<td align="left">B67.90</td>
<td align="right">3</td>
<td align="left">Alveolar echinococcosis</td>
<td align="left">Echinococcosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">B67.90</td>
<td align="right">3</td>
<td align="left">Hydatidosis</td>
<td align="left">Echinococcosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">B55.9</td>
<td align="right">3</td>
<td align="left">Leishmaniasis</td>
<td align="left">Leishmaniasis, unspecified</td>
</tr>
<tr class="even">
<td align="left">A71.9</td>
<td align="right">3</td>
<td align="left">Trachoma</td>
<td align="left">Trachoma, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A66.9</td>
<td align="right">3</td>
<td align="left">Yaws</td>
<td align="left">Yaws, unspecified</td>
</tr>
<tr class="even">
<td align="left">A44.0</td>
<td align="right">3</td>
<td align="left">Cat scratch disease</td>
<td align="left">Systemic bartonellosis</td>
</tr>
<tr class="odd">
<td align="left">A39.9</td>
<td align="right">3</td>
<td align="left">Neisseria meningitidis infection</td>
<td align="left">Meningococcal infection, unspecified</td>
</tr>
<tr class="even">
<td align="left">A39.9</td>
<td align="right">3</td>
<td align="left">Meningococcal infection</td>
<td align="left">Meningococcal infection, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A30.9</td>
<td align="right">3</td>
<td align="left">Hansen’s disease</td>
<td align="left">Leprosy, unspecified</td>
</tr>
<tr class="even">
<td align="left">A05.1</td>
<td align="right">3</td>
<td align="left">Botulism</td>
<td align="left">Botulism food poisoning</td>
</tr>
<tr class="odd">
<td align="left">Q96.8</td>
<td align="right">2</td>
<td align="left">Gonadal dysgenesis mixed</td>
<td align="left">Other variants of Turner’s syndrome</td>
</tr>
<tr class="even">
<td align="left">Q92.7</td>
<td align="right">2</td>
<td align="left">Triploidy</td>
<td align="left">Triploidy and polyploidy</td>
</tr>
<tr class="odd">
<td align="left">Q84.1</td>
<td align="right">2</td>
<td align="left">Monilethrix</td>
<td align="left">Congenital morphological disturbances of hair, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q84.1</td>
<td align="right">2</td>
<td align="left">Pili annulati</td>
<td align="left">Congenital morphological disturbances of hair, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q84.1</td>
<td align="right">2</td>
<td align="left">Pili torti</td>
<td align="left">Congenital morphological disturbances of hair, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q84.1</td>
<td align="right">2</td>
<td align="left">Trichostasis spinulosa</td>
<td align="left">Congenital morphological disturbances of hair, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q84.1</td>
<td align="right">2</td>
<td align="left">Woolly hair syndrome</td>
<td align="left">Congenital morphological disturbances of hair, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q84.1</td>
<td align="right">2</td>
<td align="left">Woolly hair syndrome</td>
<td align="left">Congenital morphological disturbances of hair, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">Q84.1</td>
<td align="right">2</td>
<td align="left">Woolly hair syndrome</td>
<td align="left">Congenital morphological disturbances of hair, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q77.5</td>
<td align="right">2</td>
<td align="left">Diastrophic dysplasia</td>
<td align="left">Diastrophic dysplasia</td>
</tr>
<tr class="odd">
<td align="left">Q72.50</td>
<td align="right">2</td>
<td align="left">Absence of Tibia</td>
<td align="left">Longitudinal reduction defect of unspecified tibia</td>
</tr>
<tr class="even">
<td align="left">Q71.899</td>
<td align="right">2</td>
<td align="left">Thumb deformity</td>
<td align="left">Other reduction defects of unspecified upper limb</td>
</tr>
<tr class="odd">
<td align="left">Q71.33</td>
<td align="right">2</td>
<td align="left">Acheiropody</td>
<td align="left">Congenital absence of hand and finger, bilateral</td>
</tr>
<tr class="even">
<td align="left">Q71.03</td>
<td align="right">2</td>
<td align="left">Tetra-amelia syndrome</td>
<td align="left">Congenital complete absence of upper limb, bilateral</td>
</tr>
<tr class="odd">
<td align="left">Q64.74</td>
<td align="right">2</td>
<td align="left">Duplication of urethra</td>
<td align="left">Double urethra</td>
</tr>
<tr class="even">
<td align="left">Q60.1</td>
<td align="right">2</td>
<td align="left">Potter syndrome</td>
<td align="left">Renal agenesis, bilateral</td>
</tr>
<tr class="odd">
<td align="left">Q60.1</td>
<td align="right">2</td>
<td align="left">Renal agenesis</td>
<td align="left">Renal agenesis, bilateral</td>
</tr>
<tr class="even">
<td align="left">P57.9</td>
<td align="right">2</td>
<td align="left">Kernicterus</td>
<td align="left">Kernicterus, unspecified</td>
</tr>
<tr class="odd">
<td align="left">O26.40</td>
<td align="right">2</td>
<td align="left">Pemphigoid gestationis</td>
<td align="left">Herpes gestationis, unspecified trimester</td>
</tr>
<tr class="even">
<td align="left">M85.2</td>
<td align="right">2</td>
<td align="left">Morgagni-Stewart-Morel syndrome</td>
<td align="left">Hyperostosis of skull</td>
</tr>
<tr class="odd">
<td align="left">M04.2</td>
<td align="right">2</td>
<td align="left">Chronic Infantile Neurological Cutaneous Articular syndrome</td>
<td align="left">Cryopyrin-associated periodic syndromes</td>
</tr>
<tr class="even">
<td align="left">M04.2</td>
<td align="right">2</td>
<td align="left">Marden-Walker syndrome</td>
<td align="left">Cryopyrin-associated periodic syndromes</td>
</tr>
<tr class="odd">
<td align="left">M04.2</td>
<td align="right">2</td>
<td align="left">Muckle-Wells syndrome</td>
<td align="left">Cryopyrin-associated periodic syndromes</td>
</tr>
<tr class="even">
<td align="left">M04.2</td>
<td align="right">2</td>
<td align="left">Familial cold autoinflammatory syndrome</td>
<td align="left">Cryopyrin-associated periodic syndromes</td>
</tr>
<tr class="odd">
<td align="left">M04.2</td>
<td align="right">2</td>
<td align="left">Cryopyrin-associated periodic syndrome</td>
<td align="left">Cryopyrin-associated periodic syndromes</td>
</tr>
<tr class="even">
<td align="left">L95.1</td>
<td align="right">2</td>
<td align="left">Erythema elevatum diutinum</td>
<td align="left">Erythema elevatum diutinum</td>
</tr>
<tr class="odd">
<td align="left">L90.3</td>
<td align="right">2</td>
<td align="left">Atrophoderma of Pierini and Pasini</td>
<td align="left">Atrophoderma of Pasini and Pierini</td>
</tr>
<tr class="even">
<td align="left">L85.0</td>
<td align="right">2</td>
<td align="left">Ichthyosis, acquired</td>
<td align="left">Acquired ichthyosis</td>
</tr>
<tr class="odd">
<td align="left">L66.0</td>
<td align="right">2</td>
<td align="left">Pseudopelade of Brocq</td>
<td align="left">Pseudopelade</td>
</tr>
<tr class="even">
<td align="left">J67.0</td>
<td align="right">2</td>
<td align="left">Farmer’s lung</td>
<td align="left">Farmer’s lung</td>
</tr>
<tr class="odd">
<td align="left">J63.6</td>
<td align="right">2</td>
<td align="left">Kaolin pneumoconiosis</td>
<td align="left">Pneumoconiosis due to other specified inorganic dusts</td>
</tr>
<tr class="even">
<td align="left">J63.6</td>
<td align="right">2</td>
<td align="left">Baritosis</td>
<td align="left">Pneumoconiosis due to other specified inorganic dusts</td>
</tr>
<tr class="odd">
<td align="left">J63.4</td>
<td align="right">2</td>
<td align="left">Siderosis</td>
<td align="left">Siderosis</td>
</tr>
<tr class="even">
<td align="left">J16.0</td>
<td align="right">2</td>
<td align="left">Psittacosis</td>
<td align="left">Chlamydial pneumonia</td>
</tr>
<tr class="odd">
<td align="left">I23.3</td>
<td align="right">2</td>
<td align="left">Cardiac rupture</td>
<td align="left">Rupture of cardiac wall without hemopericardium as current complication following acute myocardial infarction</td>
</tr>
<tr class="even">
<td align="left">H83.19</td>
<td align="right">2</td>
<td align="left">Perilymphatic fistula</td>
<td align="left">Labyrinthine fistula, unspecified ear</td>
</tr>
<tr class="odd">
<td align="left">G90.1</td>
<td align="right">2</td>
<td align="left">Familial dysautonomia</td>
<td align="left">Familial dysautonomia [Riley-Day]</td>
</tr>
<tr class="even">
<td align="left">G60.1</td>
<td align="right">2</td>
<td align="left">Refsum disease, infantile form</td>
<td align="left">Refsum’s disease</td>
</tr>
<tr class="odd">
<td align="left">G60.1</td>
<td align="right">2</td>
<td align="left">Refsum disease</td>
<td align="left">Refsum’s disease</td>
</tr>
<tr class="even">
<td align="left">G13.1</td>
<td align="right">2</td>
<td align="left">Limbic encephalitis</td>
<td align="left">Other systemic atrophy primarily affecting central nervous system in neoplastic disease</td>
</tr>
<tr class="odd">
<td align="left">E85.1</td>
<td align="right">2</td>
<td align="left">Familial transthyretin amyloidosis</td>
<td align="left">Neuropathic heredofamilial amyloidosis</td>
</tr>
<tr class="even">
<td align="left">E85.1</td>
<td align="right">2</td>
<td align="left">Hereditary amyloidosis</td>
<td align="left">Neuropathic heredofamilial amyloidosis</td>
</tr>
<tr class="odd">
<td align="left">E85.1</td>
<td align="right">2</td>
<td align="left">Amyloid neuropathy</td>
<td align="left">Neuropathic heredofamilial amyloidosis</td>
</tr>
<tr class="even">
<td align="left">E80.5</td>
<td align="right">2</td>
<td align="left">Crigler Najjar syndrome, type 1</td>
<td align="left">Crigler-Najjar syndrome</td>
</tr>
<tr class="odd">
<td align="left">E80.5</td>
<td align="right">2</td>
<td align="left">Crigler Najjar syndrome, type 2</td>
<td align="left">Crigler-Najjar syndrome</td>
</tr>
<tr class="even">
<td align="left">E79.1</td>
<td align="right">2</td>
<td align="left">Hypoxanthine guanine phosphoribosyltransferase deficiency</td>
<td align="left">Lesch-Nyhan syndrome</td>
</tr>
<tr class="odd">
<td align="left">E79.1</td>
<td align="right">2</td>
<td align="left">Hereditary hyperuricemia</td>
<td align="left">Lesch-Nyhan syndrome</td>
</tr>
<tr class="even">
<td align="left">E79.1</td>
<td align="right">2</td>
<td align="left">Lesch Nyhan syndrome</td>
<td align="left">Lesch-Nyhan syndrome</td>
</tr>
<tr class="odd">
<td align="left">E76.02</td>
<td align="right">2</td>
<td align="left">HurlerÎ“ÃÃ´Scheie syndrome</td>
<td align="left">Hurler-Scheie syndrome</td>
</tr>
<tr class="even">
<td align="left">E74.29</td>
<td align="right">2</td>
<td align="left">Galactokinase deficiency</td>
<td align="left">Other disorders of galactose metabolism</td>
</tr>
<tr class="odd">
<td align="left">E74.12</td>
<td align="right">2</td>
<td align="left">Hereditary fructose intolerance</td>
<td align="left">Hereditary fructose intolerance</td>
</tr>
<tr class="even">
<td align="left">E72.29</td>
<td align="right">2</td>
<td align="left">N-acetylglutamate synthase deficiency</td>
<td align="left">Other disorders of urea cycle metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.29</td>
<td align="right">2</td>
<td align="left">Carbamoyl phosphate synthetase 1 deficiency</td>
<td align="left">Other disorders of urea cycle metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.02</td>
<td align="right">2</td>
<td align="left">Hartnup disease</td>
<td align="left">Hartnup’s disease</td>
</tr>
<tr class="odd">
<td align="left">E71.528</td>
<td align="right">2</td>
<td align="left">Pseudoneonatal adrenoleukodystrophy</td>
<td align="left">Other X-linked adrenoleukodystrophy</td>
</tr>
<tr class="even">
<td align="left">E71.39</td>
<td align="right">2</td>
<td align="left">Carnitine-acylcarnitine translocase deficiency</td>
<td align="left">Other disorders of fatty-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.39</td>
<td align="right">2</td>
<td align="left">Malonyl-CoA decarboxylase deficiency</td>
<td align="left">Other disorders of fatty-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.39</td>
<td align="right">2</td>
<td align="left">Malonyl-CoA decarboxylase deficiency</td>
<td align="left">Other disorders of fatty-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.39</td>
<td align="right">2</td>
<td align="left">Acetyl-carnitine deficiency</td>
<td align="left">Other disorders of fatty-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.39</td>
<td align="right">2</td>
<td align="left">Multicentric Castleman Disease</td>
<td align="left">Other disorders of fatty-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.39</td>
<td align="right">2</td>
<td align="left">Multicentric Castleman Disease</td>
<td align="left">Other disorders of fatty-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.39</td>
<td align="right">2</td>
<td align="left">2,4-Dienoyl-CoA reductase deficiency</td>
<td align="left">Other disorders of fatty-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.39</td>
<td align="right">2</td>
<td align="left">HIBCH deficiency</td>
<td align="left">Other disorders of fatty-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.110</td>
<td align="right">2</td>
<td align="left">Isovaleric acidemia</td>
<td align="left">Isovaleric acidemia</td>
</tr>
<tr class="odd">
<td align="left">E70.29</td>
<td align="right">2</td>
<td align="left">Dopamine beta hydroxylase deficiency</td>
<td align="left">Other disorders of tyrosine metabolism</td>
</tr>
<tr class="even">
<td align="left">E70.29</td>
<td align="right">2</td>
<td align="left">Alkaptonuria</td>
<td align="left">Other disorders of tyrosine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E70.29</td>
<td align="right">2</td>
<td align="left">Ochronosis</td>
<td align="left">Other disorders of tyrosine metabolism</td>
</tr>
<tr class="even">
<td align="left">E70.29</td>
<td align="right">2</td>
<td align="left">Tyrosinemia type 3</td>
<td align="left">Other disorders of tyrosine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E70.29</td>
<td align="right">2</td>
<td align="left">Exogenous ochronosis</td>
<td align="left">Other disorders of tyrosine metabolism</td>
</tr>
<tr class="even">
<td align="left">E70.29</td>
<td align="right">2</td>
<td align="left">Exogenous ochronosis</td>
<td align="left">Other disorders of tyrosine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E26.02</td>
<td align="right">2</td>
<td align="left">Familial hyperaldosteronism type 2</td>
<td align="left">Glucocorticoid-remediable aldosteronism</td>
</tr>
<tr class="even">
<td align="left">E26.02</td>
<td align="right">2</td>
<td align="left">Glucocorticoid-remediable aldosteronism</td>
<td align="left">Glucocorticoid-remediable aldosteronism</td>
</tr>
<tr class="odd">
<td align="left">E26.02</td>
<td align="right">2</td>
<td align="left">Familial hyperaldosteronism type III</td>
<td align="left">Glucocorticoid-remediable aldosteronism</td>
</tr>
<tr class="even">
<td align="left">D81.818</td>
<td align="right">2</td>
<td align="left">Holocarboxylase synthetase deficiency</td>
<td align="left">Other biotin-dependent carboxylase deficiency</td>
</tr>
<tr class="odd">
<td align="left">D81.818</td>
<td align="right">2</td>
<td align="left">Multiple carboxylase deficiency</td>
<td align="left">Other biotin-dependent carboxylase deficiency</td>
</tr>
<tr class="even">
<td align="left">D48.4</td>
<td align="right">2</td>
<td align="left">Disseminated peritoneal leiomyomatosis</td>
<td align="left">Neoplasm of uncertain behavior of peritoneum</td>
</tr>
<tr class="odd">
<td align="left">C93.30</td>
<td align="right">2</td>
<td align="left">Juvenile myelomonocytic leukemia</td>
<td align="left">Juvenile myelomonocytic leukemia, not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">C88.8</td>
<td align="right">2</td>
<td align="left">Light chain deposition disease</td>
<td align="left">Other malignant immunoproliferative diseases</td>
</tr>
<tr class="odd">
<td align="left">C86.2</td>
<td align="right">2</td>
<td align="left">Enteropathy-associated T-cell lymphoma</td>
<td align="left">Enteropathy-type (intestinal) T-cell lymphoma</td>
</tr>
<tr class="even">
<td align="left">C26.1</td>
<td align="right">2</td>
<td align="left">Splenic neoplasm</td>
<td align="left">Malignant neoplasm of spleen</td>
</tr>
<tr class="odd">
<td align="left">B65.1</td>
<td align="right">2</td>
<td align="left">Schistosomiasis</td>
<td align="left">Schistosomiasis due to Schistosoma mansoni [intestinal schistosomiasis]</td>
</tr>
<tr class="even">
<td align="left">B41.9</td>
<td align="right">2</td>
<td align="left">Paracoccidioidomycosis</td>
<td align="left">Paracoccidioidomycosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A92.30</td>
<td align="right">2</td>
<td align="left">West nile virus</td>
<td align="left">West Nile virus infection, unspecified</td>
</tr>
<tr class="even">
<td align="left">A83.5</td>
<td align="right">2</td>
<td align="left">California encephalitis</td>
<td align="left">California encephalitis</td>
</tr>
<tr class="odd">
<td align="left">A83.5</td>
<td align="right">2</td>
<td align="left">La Crosse encephalitis</td>
<td align="left">California encephalitis</td>
</tr>
<tr class="even">
<td align="left">A81.83</td>
<td align="right">2</td>
<td align="left">Fatal familial insomnia</td>
<td align="left">Fatal familial insomnia</td>
</tr>
<tr class="odd">
<td align="left">A75.2</td>
<td align="right">2</td>
<td align="left">Typhus</td>
<td align="left">Typhus fever due to Rickettsia typhi</td>
</tr>
<tr class="even">
<td align="left">A65</td>
<td align="right">2</td>
<td align="left">Bejel</td>
<td align="left">Nonvenereal syphilis</td>
</tr>
<tr class="odd">
<td align="left">A39.4</td>
<td align="right">2</td>
<td align="left">Meningococcemia</td>
<td align="left">Meningococcemia, unspecified</td>
</tr>
<tr class="even">
<td align="left">A36.9</td>
<td align="right">2</td>
<td align="left">Diphtheria</td>
<td align="left">Diphtheria, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A23.9</td>
<td align="right">2</td>
<td align="left">Brucellosis</td>
<td align="left">Brucellosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q98.8</td>
<td align="right">1</td>
<td align="left">48,XXYY syndrome</td>
<td align="left">Other specified sex chromosome abnormalities, male phenotype</td>
</tr>
<tr class="odd">
<td align="left">Q98.1</td>
<td align="right">1</td>
<td align="left">48,XXXY syndrome</td>
<td align="left">Klinefelter syndrome, male with more than two X chromosomes</td>
</tr>
<tr class="even">
<td align="left">Q98.1</td>
<td align="right">1</td>
<td align="left">49,XXXXY syndrome</td>
<td align="left">Klinefelter syndrome, male with more than two X chromosomes</td>
</tr>
<tr class="odd">
<td align="left">Q93.2</td>
<td align="right">1</td>
<td align="left">Ring chromosome 20</td>
<td align="left">Chromosome replaced with ring, dicentric or isochromosome</td>
</tr>
<tr class="even">
<td align="left">Q93.2</td>
<td align="right">1</td>
<td align="left">Ring chromosome 14</td>
<td align="left">Chromosome replaced with ring, dicentric or isochromosome</td>
</tr>
<tr class="odd">
<td align="left">Q87.82</td>
<td align="right">1</td>
<td align="left">Arterial tortuosity syndrome</td>
<td align="left">Arterial tortuosity syndrome</td>
</tr>
<tr class="even">
<td align="left">Q81.8</td>
<td align="right">1</td>
<td align="left">Epidermolysis bullosa simplex, localized</td>
<td align="left">Other epidermolysis bullosa</td>
</tr>
<tr class="odd">
<td align="left">Q81.8</td>
<td align="right">1</td>
<td align="left">Junctional epidermolysis bullosa</td>
<td align="left">Other epidermolysis bullosa</td>
</tr>
<tr class="even">
<td align="left">Q81.8</td>
<td align="right">1</td>
<td align="left">Junctional epidermolysis bullosa</td>
<td align="left">Other epidermolysis bullosa</td>
</tr>
<tr class="odd">
<td align="left">Q81.8</td>
<td align="right">1</td>
<td align="left">Generalized junctional epidermolysis bullosa, non-Herlitz type</td>
<td align="left">Other epidermolysis bullosa</td>
</tr>
<tr class="even">
<td align="left">Q81.8</td>
<td align="right">1</td>
<td align="left">Generalized junctional epidermolysis bullosa, non-Herlitz type</td>
<td align="left">Other epidermolysis bullosa</td>
</tr>
<tr class="odd">
<td align="left">Q77.8</td>
<td align="right">1</td>
<td align="left">Acromesomelic dysplasia</td>
<td align="left">Other osteochondrodysplasia with defects of growth of tubular bones and spine</td>
</tr>
<tr class="even">
<td align="left">Q77.8</td>
<td align="right">1</td>
<td align="left">Acromicric dysplasia</td>
<td align="left">Other osteochondrodysplasia with defects of growth of tubular bones and spine</td>
</tr>
<tr class="odd">
<td align="left">Q77.8</td>
<td align="right">1</td>
<td align="left">Schneckenbecken dysplasia</td>
<td align="left">Other osteochondrodysplasia with defects of growth of tubular bones and spine</td>
</tr>
<tr class="even">
<td align="left">Q77.8</td>
<td align="right">1</td>
<td align="left">Acromesomelic dysplasia Hunter Thompson type</td>
<td align="left">Other osteochondrodysplasia with defects of growth of tubular bones and spine</td>
</tr>
<tr class="odd">
<td align="left">Q77.8</td>
<td align="right">1</td>
<td align="left">Acromesomelic dysplasia Maroteaux type</td>
<td align="left">Other osteochondrodysplasia with defects of growth of tubular bones and spine</td>
</tr>
<tr class="even">
<td align="left">Q77.8</td>
<td align="right">1</td>
<td align="left">Leri Weill dyschondrosteosis</td>
<td align="left">Other osteochondrodysplasia with defects of growth of tubular bones and spine</td>
</tr>
<tr class="odd">
<td align="left">Q77.8</td>
<td align="right">1</td>
<td align="left">Langer mesomelic dysplasia</td>
<td align="left">Other osteochondrodysplasia with defects of growth of tubular bones and spine</td>
</tr>
<tr class="even">
<td align="left">Q77.8</td>
<td align="right">1</td>
<td align="left">Epiphyseal dysplasia multiple with early-onset diabetes mellitus</td>
<td align="left">Other osteochondrodysplasia with defects of growth of tubular bones and spine</td>
</tr>
<tr class="odd">
<td align="left">Q77.8</td>
<td align="right">1</td>
<td align="left">Astley-Kendall syndrome</td>
<td align="left">Other osteochondrodysplasia with defects of growth of tubular bones and spine</td>
</tr>
<tr class="even">
<td align="left">Q77.0</td>
<td align="right">1</td>
<td align="left">Achondrogenesis type 1A</td>
<td align="left">Achondrogenesis</td>
</tr>
<tr class="odd">
<td align="left">Q77.0</td>
<td align="right">1</td>
<td align="left">Achondrogenesis type 1B</td>
<td align="left">Achondrogenesis</td>
</tr>
<tr class="even">
<td align="left">Q77.0</td>
<td align="right">1</td>
<td align="left">Achondrogenesis</td>
<td align="left">Achondrogenesis</td>
</tr>
<tr class="odd">
<td align="left">Q77.0</td>
<td align="right">1</td>
<td align="left">Achondrogenesis type 2</td>
<td align="left">Achondrogenesis</td>
</tr>
<tr class="even">
<td align="left">Q73.1</td>
<td align="right">1</td>
<td align="left">Roberts syndrome</td>
<td align="left">Phocomelia, unspecified limb(s)</td>
</tr>
<tr class="odd">
<td align="left">Q73.1</td>
<td align="right">1</td>
<td align="left">Phocomelia</td>
<td align="left">Phocomelia, unspecified limb(s)</td>
</tr>
<tr class="even">
<td align="left">Q24.1</td>
<td align="right">1</td>
<td align="left">Isolated levocardia</td>
<td align="left">Levocardia</td>
</tr>
<tr class="odd">
<td align="left">O69.3XX0</td>
<td align="right">1</td>
<td align="left">Limb-body wall complex</td>
<td align="left">Labor and delivery complicated by short cord, not applicable or unspecified</td>
</tr>
<tr class="even">
<td align="left">N05.0</td>
<td align="right">1</td>
<td align="left">Minimal change disease</td>
<td align="left">Unspecified nephritic syndrome with minor glomerular abnormality</td>
</tr>
<tr class="odd">
<td align="left">M93.839</td>
<td align="right">1</td>
<td align="left">Kienbock’s disease</td>
<td align="left">Other specified osteochondropathies, unspecified forearm</td>
</tr>
<tr class="even">
<td align="left">M31.2</td>
<td align="right">1</td>
<td align="left">Midline lethal granuloma</td>
<td align="left">Lethal midline granuloma</td>
</tr>
<tr class="odd">
<td align="left">M31.2</td>
<td align="right">1</td>
<td align="left">Extranodal nasal NK/T cell lymphoma</td>
<td align="left">Lethal midline granuloma</td>
</tr>
<tr class="even">
<td align="left">L94.6</td>
<td align="right">1</td>
<td align="left">Ainhum</td>
<td align="left">Ainhum</td>
</tr>
<tr class="odd">
<td align="left">L92.8</td>
<td align="right">1</td>
<td align="left">Granulomatous slack skin disease</td>
<td align="left">Other granulomatous disorders of the skin and subcutaneous tissue</td>
</tr>
<tr class="even">
<td align="left">L87.2</td>
<td align="right">1</td>
<td align="left">Elastosis perforans serpiginosa</td>
<td align="left">Elastosis perforans serpiginosa</td>
</tr>
<tr class="odd">
<td align="left">L75.1</td>
<td align="right">1</td>
<td align="left">Chromhidrosis</td>
<td align="left">Chromhidrosis</td>
</tr>
<tr class="even">
<td align="left">L72.2</td>
<td align="right">1</td>
<td align="left">Steatocystoma multiplex</td>
<td align="left">Steatocystoma multiplex</td>
</tr>
<tr class="odd">
<td align="left">L66.8</td>
<td align="right">1</td>
<td align="left">Central centrifugal cicatricial alopecia</td>
<td align="left">Other cicatricial alopecia</td>
</tr>
<tr class="even">
<td align="left">L66.4</td>
<td align="right">1</td>
<td align="left">Atrophoderma vermiculata</td>
<td align="left">Folliculitis ulerythematosa reticulata</td>
</tr>
<tr class="odd">
<td align="left">L50.4</td>
<td align="right">1</td>
<td align="left">Vibratory urticaria</td>
<td align="left">Vibratory urticaria</td>
</tr>
<tr class="even">
<td align="left">L41.4</td>
<td align="right">1</td>
<td align="left">Parapsoriasis</td>
<td align="left">Large plaque parapsoriasis</td>
</tr>
<tr class="odd">
<td align="left">L10.3</td>
<td align="right">1</td>
<td align="left">Pemphigus and fogo selvagem</td>
<td align="left">Brazilian pemphigus [fogo selvagem]</td>
</tr>
<tr class="even">
<td align="left">K13.5</td>
<td align="right">1</td>
<td align="left">Oral submucous fibrosis</td>
<td align="left">Oral submucous fibrosis</td>
</tr>
<tr class="odd">
<td align="left">K04.2</td>
<td align="right">1</td>
<td align="left">Dentin dysplasia, coronal</td>
<td align="left">Pulp degeneration</td>
</tr>
<tr class="even">
<td align="left">K03.4</td>
<td align="right">1</td>
<td align="left">Hypercementosis</td>
<td align="left">Hypercementosis</td>
</tr>
<tr class="odd">
<td align="left">J63.2</td>
<td align="right">1</td>
<td align="left">Beryllium disease</td>
<td align="left">Berylliosis</td>
</tr>
<tr class="even">
<td align="left">J12.81</td>
<td align="right">1</td>
<td align="left">SARS</td>
<td align="left">Pneumonia due to SARS-associated coronavirus</td>
</tr>
<tr class="odd">
<td align="left">H53.55</td>
<td align="right">1</td>
<td align="left">Carotid body tumor</td>
<td align="left">Tritanomaly</td>
</tr>
<tr class="even">
<td align="left">H31.29</td>
<td align="right">1</td>
<td align="left">Bietti crystalline corneoretinal dystrophy</td>
<td align="left">Other hereditary choroidal dystrophy</td>
</tr>
<tr class="odd">
<td align="left">H31.23</td>
<td align="right">1</td>
<td align="left">Gyrate atrophy of choroid and retina</td>
<td align="left">Gyrate atrophy, choroid</td>
</tr>
<tr class="even">
<td align="left">G93.7</td>
<td align="right">1</td>
<td align="left">Reye syndrome</td>
<td align="left">Reye’s syndrome</td>
</tr>
<tr class="odd">
<td align="left">G70.2</td>
<td align="right">1</td>
<td align="left">Amyotonia congenita</td>
<td align="left">Congenital and developmental myasthenia</td>
</tr>
<tr class="even">
<td align="left">G70.2</td>
<td align="right">1</td>
<td align="left">Congenital myasthenic syndrome with episodic apnea</td>
<td align="left">Congenital and developmental myasthenia</td>
</tr>
<tr class="odd">
<td align="left">G70.2</td>
<td align="right">1</td>
<td align="left">Congenital myasthenic syndrome</td>
<td align="left">Congenital and developmental myasthenia</td>
</tr>
<tr class="even">
<td align="left">G37.0</td>
<td align="right">1</td>
<td align="left">Alpers syndrome</td>
<td align="left">Diffuse sclerosis of central nervous system</td>
</tr>
<tr class="odd">
<td align="left">G37.0</td>
<td align="right">1</td>
<td align="left">Tumefactive multiple sclerosis</td>
<td align="left">Diffuse sclerosis of central nervous system</td>
</tr>
<tr class="even">
<td align="left">G31.81</td>
<td align="right">1</td>
<td align="left">Alpers syndrome</td>
<td align="left">Alpers disease</td>
</tr>
<tr class="odd">
<td align="left">E85.3</td>
<td align="right">1</td>
<td align="left">Amyloidosis AA</td>
<td align="left">Secondary systemic amyloidosis</td>
</tr>
<tr class="even">
<td align="left">E85.3</td>
<td align="right">1</td>
<td align="left">Amyloidosis Beta2M</td>
<td align="left">Secondary systemic amyloidosis</td>
</tr>
<tr class="odd">
<td align="left">E78.81</td>
<td align="right">1</td>
<td align="left">Multicentric reticulohistiocytosis</td>
<td align="left">Lipoid dermatoarthritis</td>
</tr>
<tr class="even">
<td align="left">E76.03</td>
<td align="right">1</td>
<td align="left">Scheie syndrome</td>
<td align="left">Scheie’s syndrome</td>
</tr>
<tr class="odd">
<td align="left">E75.241</td>
<td align="right">1</td>
<td align="left">Niemann-Pick disease type B</td>
<td align="left">Niemann-Pick disease type B</td>
</tr>
<tr class="even">
<td align="left">E75.01</td>
<td align="right">1</td>
<td align="left">Sandhoff disease</td>
<td align="left">Sandhoff disease</td>
</tr>
<tr class="odd">
<td align="left">E74.19</td>
<td align="right">1</td>
<td align="left">Acquired fructose intolerance</td>
<td align="left">Other disorders of fructose metabolism</td>
</tr>
<tr class="even">
<td align="left">E74.19</td>
<td align="right">1</td>
<td align="left">Fructose-1,6-bisphosphatase deficiency</td>
<td align="left">Other disorders of fructose metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.510</td>
<td align="right">1</td>
<td align="left">Zellweger syndrome</td>
<td align="left">Zellweger syndrome</td>
</tr>
<tr class="even">
<td align="left">E71.111</td>
<td align="right">1</td>
<td align="left">OPA3 defect</td>
<td align="left">3-methylglutaconic aciduria</td>
</tr>
<tr class="odd">
<td align="left">E71.111</td>
<td align="right">1</td>
<td align="left">3-methylglutaconyl-CoA hydratase deficiency (AUH defect)</td>
<td align="left">3-methylglutaconic aciduria</td>
</tr>
<tr class="even">
<td align="left">E71.111</td>
<td align="right">1</td>
<td align="left">MEGDEL syndrome</td>
<td align="left">3-methylglutaconic aciduria</td>
</tr>
<tr class="odd">
<td align="left">E71.111</td>
<td align="right">1</td>
<td align="left">DCMA syndrome</td>
<td align="left">3-methylglutaconic aciduria</td>
</tr>
<tr class="even">
<td align="left">E70.39</td>
<td align="right">1</td>
<td align="left">Piebaldism</td>
<td align="left">Other specified albinism</td>
</tr>
<tr class="odd">
<td align="left">E70.39</td>
<td align="right">1</td>
<td align="left">Tietz syndrome</td>
<td align="left">Other specified albinism</td>
</tr>
<tr class="even">
<td align="left">E70.39</td>
<td align="right">1</td>
<td align="left">Griscelli syndrome</td>
<td align="left">Other specified albinism</td>
</tr>
<tr class="odd">
<td align="left">E59</td>
<td align="right">1</td>
<td align="left">Keshan disease</td>
<td align="left">Dietary selenium deficiency</td>
</tr>
<tr class="even">
<td align="left">E25.8</td>
<td align="right">1</td>
<td align="left">Aromatase deficiency</td>
<td align="left">Other adrenogenital disorders</td>
</tr>
<tr class="odd">
<td align="left">E25.8</td>
<td align="right">1</td>
<td align="left">Achard Thiers syndrome</td>
<td align="left">Other adrenogenital disorders</td>
</tr>
<tr class="even">
<td align="left">E24.1</td>
<td align="right">1</td>
<td align="left">Nelson syndrome</td>
<td align="left">Nelson’s syndrome</td>
</tr>
<tr class="odd">
<td align="left">D89.40</td>
<td align="right">1</td>
<td align="left">Mast cell activation syndrome</td>
<td align="left">Mast cell activation, unspecified</td>
</tr>
<tr class="even">
<td align="left">D81.89</td>
<td align="right">1</td>
<td align="left">X-linked severe combined immunodeficiency</td>
<td align="left">Other combined immunodeficiencies</td>
</tr>
<tr class="odd">
<td align="left">D81.89</td>
<td align="right">1</td>
<td align="left">WHIM syndrome</td>
<td align="left">Other combined immunodeficiencies</td>
</tr>
<tr class="even">
<td align="left">D81.6</td>
<td align="right">1</td>
<td align="left">Bare lymphocyte syndrome</td>
<td align="left">Major histocompatibility complex class I deficiency</td>
</tr>
<tr class="odd">
<td align="left">D74.0</td>
<td align="right">1</td>
<td align="left">Hereditary methemoglobinemia</td>
<td align="left">Congenital methemoglobinemia</td>
</tr>
<tr class="even">
<td align="left">D74.0</td>
<td align="right">1</td>
<td align="left">Dihydrolipoamide dehydrogenase deficiency</td>
<td align="left">Congenital methemoglobinemia</td>
</tr>
<tr class="odd">
<td align="left">D74.0</td>
<td align="right">1</td>
<td align="left">NADH cytochrome B5 reductase deficiency</td>
<td align="left">Congenital methemoglobinemia</td>
</tr>
<tr class="even">
<td align="left">D74.0</td>
<td align="right">1</td>
<td align="left">Methemoglobinemia, beta-globin type</td>
<td align="left">Congenital methemoglobinemia</td>
</tr>
<tr class="odd">
<td align="left">C96.4</td>
<td align="right">1</td>
<td align="left">Langerhans cell sarcoma</td>
<td align="left">Sarcoma of dendritic cells (accessory cells)</td>
</tr>
<tr class="even">
<td align="left">C92.Z0</td>
<td align="right">1</td>
<td align="left">Chronic myeloid leukemia</td>
<td align="left">Other myeloid leukemia not having achieved remission</td>
</tr>
<tr class="odd">
<td align="left">C92.A0</td>
<td align="right">1</td>
<td align="left">AML with myelodysplasia-related features</td>
<td align="left">Acute myeloid leukemia with multilineage dysplasia, not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">C22.3</td>
<td align="right">1</td>
<td align="left">Angiosarcoma of the liver</td>
<td align="left">Angiosarcoma of liver</td>
</tr>
<tr class="odd">
<td align="left">B88.1</td>
<td align="right">1</td>
<td align="left">Tungiasis</td>
<td align="left">Tungiasis [sandflea infestation]</td>
</tr>
<tr class="even">
<td align="left">B87.0</td>
<td align="right">1</td>
<td align="left">Creeping myiasis</td>
<td align="left">Cutaneous myiasis</td>
</tr>
<tr class="odd">
<td align="left">B83.2</td>
<td align="right">1</td>
<td align="left">Angiostrongyliasis</td>
<td align="left">Angiostrongyliasis due to Parastrongylus cantonensis</td>
</tr>
<tr class="even">
<td align="left">B74.4</td>
<td align="right">1</td>
<td align="left">Acanthocheilonemiasis</td>
<td align="left">Mansonelliasis</td>
</tr>
<tr class="odd">
<td align="left">B74.4</td>
<td align="right">1</td>
<td align="left">Acanthocheilonemiasis</td>
<td align="left">Mansonelliasis</td>
</tr>
<tr class="even">
<td align="left">B74.4</td>
<td align="right">1</td>
<td align="left">Mansonelliasis</td>
<td align="left">Mansonelliasis</td>
</tr>
<tr class="odd">
<td align="left">B74.3</td>
<td align="right">1</td>
<td align="left">Loiasis</td>
<td align="left">Loiasis</td>
</tr>
<tr class="even">
<td align="left">B74.0</td>
<td align="right">1</td>
<td align="left">Lymphatic filariasis</td>
<td align="left">Filariasis due to Wuchereria bancrofti</td>
</tr>
<tr class="odd">
<td align="left">B71.0</td>
<td align="right">1</td>
<td align="left">Hymenolepiasis</td>
<td align="left">Hymenolepiasis</td>
</tr>
<tr class="even">
<td align="left">B66.3</td>
<td align="right">1</td>
<td align="left">Fascioliasis</td>
<td align="left">Fascioliasis</td>
</tr>
<tr class="odd">
<td align="left">B43.9</td>
<td align="right">1</td>
<td align="left">Chromoblastomycosis</td>
<td align="left">Chromomycosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">B04</td>
<td align="right">1</td>
<td align="left">Monkeypox</td>
<td align="left">Monkeypox</td>
</tr>
<tr class="odd">
<td align="left">A92.31</td>
<td align="right">1</td>
<td align="left">West nile encephalitis</td>
<td align="left">West Nile virus infection with encephalitis</td>
</tr>
<tr class="even">
<td align="left">A85.8</td>
<td align="right">1</td>
<td align="left">Encephalitis lethargica</td>
<td align="left">Other specified viral encephalitis</td>
</tr>
<tr class="odd">
<td align="left">A83.1</td>
<td align="right">1</td>
<td align="left">Western equine encephalitis</td>
<td align="left">Western equine encephalitis</td>
</tr>
<tr class="even">
<td align="left">A77.49</td>
<td align="right">1</td>
<td align="left">Human granulocytic ehrlichiosis</td>
<td align="left">Other ehrlichiosis</td>
</tr>
<tr class="odd">
<td align="left">A75.9</td>
<td align="right">1</td>
<td align="left">Typhus</td>
<td align="left">Typhus fever, unspecified</td>
</tr>
<tr class="even">
<td align="left">A58</td>
<td align="right">1</td>
<td align="left">Granuloma Inguinale</td>
<td align="left">Granuloma inguinale</td>
</tr>
<tr class="odd">
<td align="left">A52.13</td>
<td align="right">1</td>
<td align="left">Syphilitic aseptic meningitis</td>
<td align="left">Late syphilitic meningitis</td>
</tr>
<tr class="even">
<td align="left">A25.9</td>
<td align="right">1</td>
<td align="left">Rat bite fever</td>
<td align="left">Rat-bite fever, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A24.0</td>
<td align="right">1</td>
<td align="left">Glanders</td>
<td align="left">Glanders</td>
</tr>
<tr class="even">
<td align="left">A21.9</td>
<td align="right">1</td>
<td align="left">Tularemia</td>
<td align="left">Tularemia, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A05.0</td>
<td align="right">1</td>
<td align="left">Staphylococcal food poisoning</td>
<td align="left">Foodborne staphylococcal intoxication</td>
</tr>
<tr class="even">
<td align="left">A00.9</td>
<td align="right">1</td>
<td align="left">Cholera</td>
<td align="left">Cholera, unspecified</td>
</tr>
</tbody>
</table>
</div>
<div id="frequency-table-of-icd-10-codes-that-each-only-map-to-exactly-1-rare-disease" class="section level3">
<h3>Frequency Table of ICD-10 Codes that Each Only Map to Exactly 1 Rare Disease</h3>
<p>Here, we specifically looked at only ICD-10 codes that uniquely mapped to exactly one “rare” disease in our mapping files.</p>
<p>Number of ICD-10 Codes: <strong>1029</strong></p>
<p>Total Number of Patients: <strong>934264</strong></p>
<table>
<thead>
<tr class="header">
<th align="left">ICD-10 Code</th>
<th align="right">Frequency</th>
<th align="left">Rare Disease Name</th>
<th align="left">ICD Code Description</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">E11.9</td>
<td align="right">78370</td>
<td align="left">Maturity-onset diabetes of the young, type 2</td>
<td align="left">Type 2 diabetes mellitus without complications</td>
</tr>
<tr class="even">
<td align="left">E55.9</td>
<td align="right">67357</td>
<td align="left">Rickets</td>
<td align="left">Vitamin D deficiency, unspecified</td>
</tr>
<tr class="odd">
<td align="left">F32.9</td>
<td align="right">63921</td>
<td align="left">Mal de debarquement</td>
<td align="left">Major depressive disorder, single episode, unspecified</td>
</tr>
<tr class="even">
<td align="left">R42</td>
<td align="right">48568</td>
<td align="left">Dysequilibrium syndrome</td>
<td align="left">Dizziness and giddiness</td>
</tr>
<tr class="odd">
<td align="left">E78.00</td>
<td align="right">46355</td>
<td align="left">Hyperlipoproteinemia type 2</td>
<td align="left">Pure hypercholesterolemia, unspecified</td>
</tr>
<tr class="even">
<td align="left">B97.89</td>
<td align="right">29781</td>
<td align="left">Togaviridae disease</td>
<td align="left">Other viral agents as the cause of diseases classified elsewhere</td>
</tr>
<tr class="odd">
<td align="left">R06.00</td>
<td align="right">25025</td>
<td align="left">Paraneoplastic Neurologic Disorders</td>
<td align="left">Dyspnea, unspecified</td>
</tr>
<tr class="even">
<td align="left">J44.9</td>
<td align="right">23648</td>
<td align="left">Bronchiolitis obliterans</td>
<td align="left">Chronic obstructive pulmonary disease, unspecified</td>
</tr>
<tr class="odd">
<td align="left">K52.9</td>
<td align="right">20685</td>
<td align="left">WDHA syndrome</td>
<td align="left">Noninfective gastroenteritis and colitis, unspecified</td>
</tr>
<tr class="even">
<td align="left">D48.5</td>
<td align="right">18678</td>
<td align="left">Dermatofibrosarcoma protuberans</td>
<td align="left">Neoplasm of uncertain behavior of skin</td>
</tr>
<tr class="odd">
<td align="left">M85.80</td>
<td align="right">16522</td>
<td align="left">Melorheostosis</td>
<td align="left">Other specified disorders of bone density and structure, unspecified site</td>
</tr>
<tr class="even">
<td align="left">E53.8</td>
<td align="right">16024</td>
<td align="left">Biotinidase deficiency</td>
<td align="left">Deficiency of other specified B group vitamins</td>
</tr>
<tr class="odd">
<td align="left">D50.9</td>
<td align="right">14805</td>
<td align="left">Iron-refractory iron deficiency anemia</td>
<td align="left">Iron deficiency anemia, unspecified</td>
</tr>
<tr class="even">
<td align="left">M62.81</td>
<td align="right">12278</td>
<td align="left">Neuropathy ataxia retinitis pigmentosa syndrome</td>
<td align="left">Muscle weakness (generalized)</td>
</tr>
<tr class="odd">
<td align="left">I63.9</td>
<td align="right">11807</td>
<td align="left">Neonatal stroke</td>
<td align="left">Cerebral infarction, unspecified</td>
</tr>
<tr class="even">
<td align="left">M72.2</td>
<td align="right">11148</td>
<td align="left">Ledderhose disease</td>
<td align="left">Plantar fascial fibromatosis</td>
</tr>
<tr class="odd">
<td align="left">E87.5</td>
<td align="right">10605</td>
<td align="left">Gordon syndrome</td>
<td align="left">Hyperkalemia</td>
</tr>
<tr class="even">
<td align="left">L08.9</td>
<td align="right">10432</td>
<td align="left">Erosive pustular dermatosis of the scalp</td>
<td align="left">Local infection of the skin and subcutaneous tissue, unspecified</td>
</tr>
<tr class="odd">
<td align="left">F98.8</td>
<td align="right">8735</td>
<td align="left">Psychosocial short stature</td>
<td align="left">Other specified behavioral and emotional disorders with onset usually occurring in childhood and adolescence</td>
</tr>
<tr class="even">
<td align="left">K58.9</td>
<td align="right">7800</td>
<td align="left">Ichthyosis bullosa of Siemens</td>
<td align="left">Irritable bowel syndrome without diarrhea</td>
</tr>
<tr class="odd">
<td align="left">H53.8</td>
<td align="right">7657</td>
<td align="left">Bradyopsia</td>
<td align="left">Other visual disturbances</td>
</tr>
<tr class="even">
<td align="left">I47.1</td>
<td align="right">7305</td>
<td align="left">His bundle tachycardia</td>
<td align="left">Supraventricular tachycardia</td>
</tr>
<tr class="odd">
<td align="left">M53.3</td>
<td align="right">7125</td>
<td align="left">Coccygodynia</td>
<td align="left">Sacrococcygeal disorders, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">E78.1</td>
<td align="right">7041</td>
<td align="left">Hyperlipoproteinemia type 4</td>
<td align="left">Pure hyperglyceridemia</td>
</tr>
<tr class="odd">
<td align="left">E83.42</td>
<td align="right">6761</td>
<td align="left">Primary hypomagnesemia with secondary hypocalcemia</td>
<td align="left">Hypomagnesemia</td>
</tr>
<tr class="even">
<td align="left">R33.9</td>
<td align="right">5974</td>
<td align="left">Fowler’s syndrome</td>
<td align="left">Retention of urine, unspecified</td>
</tr>
<tr class="odd">
<td align="left">L29.8</td>
<td align="right">5920</td>
<td align="left">Aquagenic pruritus</td>
<td align="left">Other pruritus</td>
</tr>
<tr class="even">
<td align="left">R06.89</td>
<td align="right">5625</td>
<td align="left">Congenital central hypoventilation syndrome</td>
<td align="left">Other abnormalities of breathing</td>
</tr>
<tr class="odd">
<td align="left">E83.52</td>
<td align="right">5433</td>
<td align="left">Familial hypocalciuric hypercalcemia</td>
<td align="left">Hypercalcemia</td>
</tr>
<tr class="even">
<td align="left">D50.8</td>
<td align="right">5173</td>
<td align="left">Hypochromic microcytic anemia with iron overload</td>
<td align="left">Other iron deficiency anemias</td>
</tr>
<tr class="odd">
<td align="left">G45.9</td>
<td align="right">5107</td>
<td align="left">Aganglionosis, total intestinal</td>
<td align="left">Transient cerebral ischemic attack, unspecified</td>
</tr>
<tr class="even">
<td align="left">K76.0</td>
<td align="right">4828</td>
<td align="left">Visceral steatosis</td>
<td align="left">Fatty (change of) liver, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">B37.9</td>
<td align="right">4824</td>
<td align="left">Candidiasis familial chronic mucocutaneous, autosomal recessive</td>
<td align="left">Candidiasis, unspecified</td>
</tr>
<tr class="even">
<td align="left">H81.10</td>
<td align="right">4798</td>
<td align="left">Benign paroxysmal positional vertigo</td>
<td align="left">Benign paroxysmal vertigo, unspecified ear</td>
</tr>
<tr class="odd">
<td align="left">J98.8</td>
<td align="right">4762</td>
<td align="left">Ciliary dyskinesia with excessively long cilia</td>
<td align="left">Other specified respiratory disorders</td>
</tr>
<tr class="even">
<td align="left">E10.9</td>
<td align="right">4635</td>
<td align="left">Insulin autoimmune syndrome</td>
<td align="left">Type 1 diabetes mellitus without complications</td>
</tr>
<tr class="odd">
<td align="left">M94.0</td>
<td align="right">4624</td>
<td align="left">Tietze syndrome</td>
<td align="left">Chondrocostal junction syndrome [Tietze]</td>
</tr>
<tr class="even">
<td align="left">R62.50</td>
<td align="right">4040</td>
<td align="left">GRACILE syndrome</td>
<td align="left">Unspecified lack of expected normal physiological development in childhood</td>
</tr>
<tr class="odd">
<td align="left">I21.3</td>
<td align="right">3629</td>
<td align="left">Mesenteric artery ischemia</td>
<td align="left">ST elevation (STEMI) myocardial infarction of unspecified site</td>
</tr>
<tr class="even">
<td align="left">L81.9</td>
<td align="right">3566</td>
<td align="left">Hypomelanotic disorder</td>
<td align="left">Disorder of pigmentation, unspecified</td>
</tr>
<tr class="odd">
<td align="left">I49.5</td>
<td align="right">3554</td>
<td align="left">Hypoparathyroidism-intellectual disability-dysmorphism syndrome</td>
<td align="left">Sick sinus syndrome</td>
</tr>
<tr class="even">
<td align="left">K62.89</td>
<td align="right">3542</td>
<td align="left">Cronkhite-Canada disease</td>
<td align="left">Other specified diseases of anus and rectum</td>
</tr>
<tr class="odd">
<td align="left">E46</td>
<td align="right">3221</td>
<td align="left">Paracoccidioidomycosis</td>
<td align="left">Unspecified protein-calorie malnutrition</td>
</tr>
<tr class="even">
<td align="left">D49.6</td>
<td align="right">3208</td>
<td align="left">Acoustic neuroma</td>
<td align="left">Neoplasm of unspecified behavior of brain</td>
</tr>
<tr class="odd">
<td align="left">I71.4</td>
<td align="right">3075</td>
<td align="left">Abdominal aortic aneurysm</td>
<td align="left">Abdominal aortic aneurysm, without rupture</td>
</tr>
<tr class="even">
<td align="left">L50.8</td>
<td align="right">3005</td>
<td align="left">Aquagenic urticaria</td>
<td align="left">Other urticaria</td>
</tr>
<tr class="odd">
<td align="left">F80.9</td>
<td align="right">2979</td>
<td align="left">Developmental dysphasia familial</td>
<td align="left">Developmental disorder of speech and language, unspecified</td>
</tr>
<tr class="even">
<td align="left">H50.00</td>
<td align="right">2913</td>
<td align="left">Esotropia</td>
<td align="left">Unspecified esotropia</td>
</tr>
<tr class="odd">
<td align="left">J38.3</td>
<td align="right">2888</td>
<td align="left">Spasmodic dysphonia</td>
<td align="left">Other diseases of vocal cords</td>
</tr>
<tr class="even">
<td align="left">B86</td>
<td align="right">2812</td>
<td align="left">Crusted scabies</td>
<td align="left">Scabies</td>
</tr>
<tr class="odd">
<td align="left">I86.8</td>
<td align="right">2758</td>
<td align="left">Orbital varix</td>
<td align="left">Varicose veins of other specified sites</td>
</tr>
<tr class="even">
<td align="left">K13.79</td>
<td align="right">2676</td>
<td align="left">Palatopharyngeal incompetence</td>
<td align="left">Other lesions of oral mucosa</td>
</tr>
<tr class="odd">
<td align="left">H20.9</td>
<td align="right">2654</td>
<td align="left">Anterior uveitis</td>
<td align="left">Unspecified iridocyclitis</td>
</tr>
<tr class="even">
<td align="left">R82.99</td>
<td align="right">2554</td>
<td align="left">Hydroxykynureninuria</td>
<td align="left">Other abnormal findings in urine</td>
</tr>
<tr class="odd">
<td align="left">J21.9</td>
<td align="right">2513</td>
<td align="left">Diffuse panbronchiolitis</td>
<td align="left">Acute bronchiolitis, unspecified</td>
</tr>
<tr class="even">
<td align="left">N28.1</td>
<td align="right">2461</td>
<td align="left">Maturity-onset diabetes of the young, type 5</td>
<td align="left">Cyst of kidney, acquired</td>
</tr>
<tr class="odd">
<td align="left">K56.69</td>
<td align="right">2445</td>
<td align="left">Superior mesenteric artery syndrome</td>
<td align="left">Other intestinal obstruction</td>
</tr>
<tr class="even">
<td align="left">L28.2</td>
<td align="right">2399</td>
<td align="left">Papular urticaria</td>
<td align="left">Other prurigo</td>
</tr>
<tr class="odd">
<td align="left">N62</td>
<td align="right">2392</td>
<td align="left">Gigantomastia</td>
<td align="left">Hypertrophy of breast</td>
</tr>
<tr class="even">
<td align="left">B20</td>
<td align="right">2370</td>
<td align="left">AIDS Dementia Complex</td>
<td align="left">Human immunodeficiency virus [HIV] disease</td>
</tr>
<tr class="odd">
<td align="left">C44.91</td>
<td align="right">2365</td>
<td align="left">Nevoid basal cell carcinoma syndrome</td>
<td align="left">Basal cell carcinoma of skin, unspecified</td>
</tr>
<tr class="even">
<td align="left">K12.0</td>
<td align="right">2361</td>
<td align="left">Aphthous stomatitis</td>
<td align="left">Recurrent oral aphthae</td>
</tr>
<tr class="odd">
<td align="left">M43.6</td>
<td align="right">2346</td>
<td align="left">Sandifer syndrome</td>
<td align="left">Torticollis</td>
</tr>
<tr class="even">
<td align="left">I34.1</td>
<td align="right">2346</td>
<td align="left">Mitral valve prolapse, familial, X-linked</td>
<td align="left">Nonrheumatic mitral (valve) prolapse</td>
</tr>
<tr class="odd">
<td align="left">M62.89</td>
<td align="right">2325</td>
<td align="left">Kocher-Debre-Semelaigne syndrome</td>
<td align="left">Other specified disorders of muscle</td>
</tr>
<tr class="even">
<td align="left">K76.89</td>
<td align="right">2324</td>
<td align="left">Nodular regenerative hyperplasia</td>
<td align="left">Other specified diseases of liver</td>
</tr>
<tr class="odd">
<td align="left">K13.0</td>
<td align="right">2273</td>
<td align="left">Cheilitis glandularis</td>
<td align="left">Diseases of lips</td>
</tr>
<tr class="even">
<td align="left">M89.8X9</td>
<td align="right">2264</td>
<td align="left">Gorham’s disease</td>
<td align="left">Other specified disorders of bone, unspecified site</td>
</tr>
<tr class="odd">
<td align="left">J96.90</td>
<td align="right">2249</td>
<td align="left">Congenital central hypoventilation syndrome</td>
<td align="left">Respiratory failure, unspecified, unspecified whether with hypoxia or hypercapnia</td>
</tr>
<tr class="even">
<td align="left">A74.9</td>
<td align="right">2239</td>
<td align="left">Psittacosis</td>
<td align="left">Chlamydial infection, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E06.3</td>
<td align="right">2220</td>
<td align="left">Lymphomatous thyroiditis</td>
<td align="left">Autoimmune thyroiditis</td>
</tr>
<tr class="even">
<td align="left">F45.8</td>
<td align="right">2214</td>
<td align="left">Gardner-Diamond syndrome</td>
<td align="left">Other somatoform disorders</td>
</tr>
<tr class="odd">
<td align="left">K22.70</td>
<td align="right">2117</td>
<td align="left">Congenital lobar emphysema</td>
<td align="left">Barrett’s esophagus without dysplasia</td>
</tr>
<tr class="even">
<td align="left">G91.9</td>
<td align="right">2098</td>
<td align="left">Hydrocephalus</td>
<td align="left">Hydrocephalus, unspecified</td>
</tr>
<tr class="odd">
<td align="left">B35.0</td>
<td align="right">2089</td>
<td align="left">Kerion celsi</td>
<td align="left">Tinea barbae and tinea capitis</td>
</tr>
<tr class="even">
<td align="left">Q21.0</td>
<td align="right">2083</td>
<td align="left">Ventricular septal defects</td>
<td align="left">Ventricular septal defect</td>
</tr>
<tr class="odd">
<td align="left">C90.00</td>
<td align="right">2046</td>
<td align="left">Multiple myeloma</td>
<td align="left">Multiple myeloma not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">R58</td>
<td align="right">2020</td>
<td align="left">Greenberg dysplasia</td>
<td align="left">Hemorrhage, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">E83.51</td>
<td align="right">2020</td>
<td align="left">Hypocalcemia, autosomal dominant</td>
<td align="left">Hypocalcemia</td>
</tr>
<tr class="even">
<td align="left">M86.9</td>
<td align="right">1970</td>
<td align="left">Osteomyelitis</td>
<td align="left">Osteomyelitis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D17.9</td>
<td align="right">1964</td>
<td align="left">Lipoblastoma</td>
<td align="left">Benign lipomatous neoplasm, unspecified</td>
</tr>
<tr class="even">
<td align="left">I67.1</td>
<td align="right">1949</td>
<td align="left">Vein of Galen aneurysm</td>
<td align="left">Cerebral aneurysm, nonruptured</td>
</tr>
<tr class="odd">
<td align="left">L85.8</td>
<td align="right">1918</td>
<td align="left">Muir-Torre syndrome</td>
<td align="left">Other specified epidermal thickening</td>
</tr>
<tr class="even">
<td align="left">B07.8</td>
<td align="right">1873</td>
<td align="left">Epidermodysplasia verruciformis</td>
<td align="left">Other viral warts</td>
</tr>
<tr class="odd">
<td align="left">D49.2</td>
<td align="right">1855</td>
<td align="left">Lymph Node Neoplasm</td>
<td align="left">Neoplasm of unspecified behavior of bone, soft tissue, and skin</td>
</tr>
<tr class="even">
<td align="left">G51.0</td>
<td align="right">1775</td>
<td align="left">Bell’s palsy</td>
<td align="left">Bell’s palsy</td>
</tr>
<tr class="odd">
<td align="left">O99.89</td>
<td align="right">1745</td>
<td align="left">Chiari-Frommel syndrome</td>
<td align="left">Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium</td>
</tr>
<tr class="even">
<td align="left">D47.3</td>
<td align="right">1735</td>
<td align="left">Essential thrombocythemia</td>
<td align="left">Essential (hemorrhagic) thrombocythemia</td>
</tr>
<tr class="odd">
<td align="left">K75.81</td>
<td align="right">1710</td>
<td align="left">Visceral steatosis</td>
<td align="left">Nonalcoholic steatohepatitis (NASH)</td>
</tr>
<tr class="even">
<td align="left">K91.2</td>
<td align="right">1694</td>
<td align="left">Short bowel syndrome</td>
<td align="left">Postsurgical malabsorption, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">M35.00</td>
<td align="right">1693</td>
<td align="left">Acute febrile neutrophilic dermatosis</td>
<td align="left">Sicca syndrome, unspecified</td>
</tr>
<tr class="even">
<td align="left">C54.1</td>
<td align="right">1691</td>
<td align="left">Endometrial stromal sarcoma</td>
<td align="left">Malignant neoplasm of endometrium</td>
</tr>
<tr class="odd">
<td align="left">Q65.89</td>
<td align="right">1604</td>
<td align="left">Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy</td>
<td align="left">Other specified congenital deformities of hip</td>
</tr>
<tr class="even">
<td align="left">D75.1</td>
<td align="right">1600</td>
<td align="left">Pseudopolycythaemia</td>
<td align="left">Secondary polycythemia</td>
</tr>
<tr class="odd">
<td align="left">G80.9</td>
<td align="right">1550</td>
<td align="left">Cerebral palsy</td>
<td align="left">Cerebral palsy, unspecified</td>
</tr>
<tr class="even">
<td align="left">D32.9</td>
<td align="right">1536</td>
<td align="left">Meningioma</td>
<td align="left">Benign neoplasm of meninges, unspecified</td>
</tr>
<tr class="odd">
<td align="left">L60.3</td>
<td align="right">1532</td>
<td align="left">Twenty-nail dystrophy</td>
<td align="left">Nail dystrophy</td>
</tr>
<tr class="even">
<td align="left">K72.90</td>
<td align="right">1517</td>
<td align="left">Hepatic encephalopathy</td>
<td align="left">Hepatic failure, unspecified without coma</td>
</tr>
<tr class="odd">
<td align="left">Q24.9</td>
<td align="right">1403</td>
<td align="left">Cardiofaciocutaneous syndrome</td>
<td align="left">Congenital malformation of heart, unspecified</td>
</tr>
<tr class="even">
<td align="left">G50.0</td>
<td align="right">1388</td>
<td align="left">Trigeminal neuralgia</td>
<td align="left">Trigeminal neuralgia</td>
</tr>
<tr class="odd">
<td align="left">K20.9</td>
<td align="right">1386</td>
<td align="left">Crohn’s disease of the esophagus</td>
<td align="left">Esophagitis, unspecified</td>
</tr>
<tr class="even">
<td align="left">G93.2</td>
<td align="right">1371</td>
<td align="left">Pseudotumor cerebri</td>
<td align="left">Benign intracranial hypertension</td>
</tr>
<tr class="odd">
<td align="left">F79</td>
<td align="right">1364</td>
<td align="left">Blepharophimosis intellectual disability syndromes</td>
<td align="left">Unspecified intellectual disabilities</td>
</tr>
<tr class="even">
<td align="left">B25.9</td>
<td align="right">1353</td>
<td align="left">Cytomegalic inclusion disease</td>
<td align="left">Cytomegaloviral disease, unspecified</td>
</tr>
<tr class="odd">
<td align="left">I49.1</td>
<td align="right">1346</td>
<td align="left">Gianotti Crosti syndrome</td>
<td align="left">Atrial premature depolarization</td>
</tr>
<tr class="even">
<td align="left">G72.9</td>
<td align="right">1311</td>
<td align="left">Intestinal pseudo-obstruction</td>
<td align="left">Myopathy, unspecified</td>
</tr>
<tr class="odd">
<td align="left">K74.69</td>
<td align="right">1280</td>
<td align="left">Scalp ear nipple syndrome</td>
<td align="left">Other cirrhosis of liver</td>
</tr>
<tr class="even">
<td align="left">N13.5</td>
<td align="right">1271</td>
<td align="left">Retroperitoneal fibrosis</td>
<td align="left">Crossing vessel and stricture of ureter without hydronephrosis</td>
</tr>
<tr class="odd">
<td align="left">M26.609</td>
<td align="right">1262</td>
<td align="left">Transient myeloproliferative syndrome</td>
<td align="left">Unspecified temporomandibular joint disorder, unspecified side</td>
</tr>
<tr class="even">
<td align="left">K11.20</td>
<td align="right">1255</td>
<td align="left">Sialadenitis</td>
<td align="left">Sialoadenitis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C85.89</td>
<td align="right">1210</td>
<td align="left">Primary central nervous system lymphoma</td>
<td align="left">Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites</td>
</tr>
<tr class="even">
<td align="left">M54.89</td>
<td align="right">1187</td>
<td align="left">Eagle syndrome</td>
<td align="left">Other dorsalgia</td>
</tr>
<tr class="odd">
<td align="left">F80.0</td>
<td align="right">1170</td>
<td align="left">Childhood apraxia of speech</td>
<td align="left">Phonological disorder</td>
</tr>
<tr class="even">
<td align="left">M35.3</td>
<td align="right">1161</td>
<td align="left">Rhizomelic pseudopolyarthritis</td>
<td align="left">Polymyalgia rheumatica</td>
</tr>
<tr class="odd">
<td align="left">K86.1</td>
<td align="right">1134</td>
<td align="left">Hereditary pancreatitis</td>
<td align="left">Other chronic pancreatitis</td>
</tr>
<tr class="even">
<td align="left">L56.5</td>
<td align="right">1120</td>
<td align="left">Disseminated superficial actinic porokeratosis</td>
<td align="left">Disseminated superficial actinic porokeratosis (DSAP)</td>
</tr>
<tr class="odd">
<td align="left">I71.9</td>
<td align="right">1120</td>
<td align="left">Triple A syndrome</td>
<td align="left">Aortic aneurysm of unspecified site, without rupture</td>
</tr>
<tr class="even">
<td align="left">N39.8</td>
<td align="right">1117</td>
<td align="left">Loin pain hematuria syndrome</td>
<td align="left">Other specified disorders of urinary system</td>
</tr>
<tr class="odd">
<td align="left">I27.0</td>
<td align="right">1115</td>
<td align="left">Pulmonary arterial hypertension</td>
<td align="left">Primary pulmonary hypertension</td>
</tr>
<tr class="even">
<td align="left">Q25.0</td>
<td align="right">1107</td>
<td align="left">Patent ductus arteriosus</td>
<td align="left">Patent ductus arteriosus</td>
</tr>
<tr class="odd">
<td align="left">D84.9</td>
<td align="right">1050</td>
<td align="left">Immunodeficiency with thymoma</td>
<td align="left">Immunodeficiency, unspecified</td>
</tr>
<tr class="even">
<td align="left">I42.2</td>
<td align="right">1041</td>
<td align="left">Familial hypertrophic cardiomyopathy</td>
<td align="left">Other hypertrophic cardiomyopathy</td>
</tr>
<tr class="odd">
<td align="left">R16.1</td>
<td align="right">1034</td>
<td align="left">Splenomegaly</td>
<td align="left">Splenomegaly, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">L81.0</td>
<td align="right">1031</td>
<td align="left">Lichen planus pigmentosus</td>
<td align="left">Postinflammatory hyperpigmentation</td>
</tr>
<tr class="odd">
<td align="left">K83.8</td>
<td align="right">1026</td>
<td align="left">Benign recurrent intrahepatic cholestasis</td>
<td align="left">Other specified diseases of biliary tract</td>
</tr>
<tr class="even">
<td align="left">C15.9</td>
<td align="right">1004</td>
<td align="left">Esophageal cancer</td>
<td align="left">Malignant neoplasm of esophagus, unspecified</td>
</tr>
<tr class="odd">
<td align="left">H02.30</td>
<td align="right">980</td>
<td align="left">Ascher Syndrome</td>
<td align="left">Blepharochalasis unspecified eye, unspecified eyelid</td>
</tr>
<tr class="even">
<td align="left">N87.9</td>
<td align="right">977</td>
<td align="left">Cervical intraepithelial neoplasia</td>
<td align="left">Dysplasia of cervix uteri, unspecified</td>
</tr>
<tr class="odd">
<td align="left">R25.3</td>
<td align="right">975</td>
<td align="left">Cramp-fasciculation syndrome</td>
<td align="left">Fasciculation</td>
</tr>
<tr class="even">
<td align="left">L90.0</td>
<td align="right">970</td>
<td align="left">Lichen sclerosus</td>
<td align="left">Lichen sclerosus et atrophicus</td>
</tr>
<tr class="odd">
<td align="left">A49.8</td>
<td align="right">946</td>
<td align="left">Vibrio vulnificus infection</td>
<td align="left">Other bacterial infections of unspecified site</td>
</tr>
<tr class="even">
<td align="left">K63.9</td>
<td align="right">942</td>
<td align="left">Autoimmune enteropathy</td>
<td align="left">Disease of intestine, unspecified</td>
</tr>
<tr class="odd">
<td align="left">I15.0</td>
<td align="right">941</td>
<td align="left">Spondylometaphyseal dysplasia with dentinogenesis imperfecta</td>
<td align="left">Renovascular hypertension</td>
</tr>
<tr class="even">
<td align="left">A31.0</td>
<td align="right">894</td>
<td align="left">Mycobacterium Kansasii</td>
<td align="left">Pulmonary mycobacterial infection</td>
</tr>
<tr class="odd">
<td align="left">D48.0</td>
<td align="right">867</td>
<td align="left">Giant cell tumor of bone</td>
<td align="left">Neoplasm of uncertain behavior of bone and articular cartilage</td>
</tr>
<tr class="even">
<td align="left">H46.9</td>
<td align="right">860</td>
<td align="left">Optic neuritis</td>
<td align="left">Unspecified optic neuritis</td>
</tr>
<tr class="odd">
<td align="left">D46.9</td>
<td align="right">860</td>
<td align="left">Myelodysplastic syndromes</td>
<td align="left">Myelodysplastic syndrome, unspecified</td>
</tr>
<tr class="even">
<td align="left">G54.0</td>
<td align="right">859</td>
<td align="left">Thoracic outlet syndrome</td>
<td align="left">Brachial plexus disorders</td>
</tr>
<tr class="odd">
<td align="left">N94.3</td>
<td align="right">858</td>
<td align="left">Polydactyly myopia syndrome</td>
<td align="left">Premenstrual tension syndrome</td>
</tr>
<tr class="even">
<td align="left">K14.8</td>
<td align="right">855</td>
<td align="left">Macroglossia</td>
<td align="left">Other diseases of tongue</td>
</tr>
<tr class="odd">
<td align="left">J39.2</td>
<td align="right">842</td>
<td align="left">Oral pharyngeal disorders</td>
<td align="left">Other diseases of pharynx</td>
</tr>
<tr class="even">
<td align="left">P96.89</td>
<td align="right">832</td>
<td align="left">Neonatal systemic lupus erythematosus</td>
<td align="left">Other specified conditions originating in the perinatal period</td>
</tr>
<tr class="odd">
<td align="left">K83.0</td>
<td align="right">825</td>
<td align="left">Primary sclerosing cholangitis</td>
<td align="left">Cholangitis</td>
</tr>
<tr class="even">
<td align="left">N64.89</td>
<td align="right">818</td>
<td align="left">Galactocele</td>
<td align="left">Other specified disorders of breast</td>
</tr>
<tr class="odd">
<td align="left">Q66.6</td>
<td align="right">811</td>
<td align="left">Congenital vertical talus</td>
<td align="left">Other congenital valgus deformities of feet</td>
</tr>
<tr class="even">
<td align="left">C44.90</td>
<td align="right">798</td>
<td align="left">Muir-Torre syndrome</td>
<td align="left">Unspecified malignant neoplasm of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">K82.8</td>
<td align="right">782</td>
<td align="left">Rokitansky-Aschoff sinuses of the gallbladder</td>
<td align="left">Other specified diseases of gallbladder</td>
</tr>
<tr class="even">
<td align="left">H51.8</td>
<td align="right">777</td>
<td align="left">Ocular neuromyotonia</td>
<td align="left">Other specified disorders of binocular movement</td>
</tr>
<tr class="odd">
<td align="left">Q67.3</td>
<td align="right">764</td>
<td align="left">Plagiocephaly</td>
<td align="left">Plagiocephaly</td>
</tr>
<tr class="even">
<td align="left">G12.21</td>
<td align="right">748</td>
<td align="left">Amyotrophic lateral sclerosis</td>
<td align="left">Amyotrophic lateral sclerosis</td>
</tr>
<tr class="odd">
<td align="left">Q99.9</td>
<td align="right">746</td>
<td align="left">Ulnar-mammary syndrome</td>
<td align="left">Chromosomal abnormality, unspecified</td>
</tr>
<tr class="even">
<td align="left">K20.0</td>
<td align="right">745</td>
<td align="left">Eosinophilic enteropathy</td>
<td align="left">Eosinophilic esophagitis</td>
</tr>
<tr class="odd">
<td align="left">H47.10</td>
<td align="right">740</td>
<td align="left">Papilledema</td>
<td align="left">Unspecified papilledema</td>
</tr>
<tr class="even">
<td align="left">E11.39</td>
<td align="right">740</td>
<td align="left">Wolfram syndrome</td>
<td align="left">Type 2 diabetes mellitus with other diabetic ophthalmic complication</td>
</tr>
<tr class="odd">
<td align="left">Z15.01</td>
<td align="right">717</td>
<td align="left">Li-Fraumeni syndrome</td>
<td align="left">Genetic susceptibility to malignant neoplasm of breast</td>
</tr>
<tr class="even">
<td align="left">J39.8</td>
<td align="right">706</td>
<td align="left">Tracheobronchopathia osteoplastica</td>
<td align="left">Other specified diseases of upper respiratory tract</td>
</tr>
<tr class="odd">
<td align="left">E22.1</td>
<td align="right">706</td>
<td align="left">Galactorrhoea-Hyperprolactinaemia</td>
<td align="left">Hyperprolactinemia</td>
</tr>
<tr class="even">
<td align="left">I85.00</td>
<td align="right">705</td>
<td align="left">Esophageal varices</td>
<td align="left">Esophageal varices without bleeding</td>
</tr>
<tr class="odd">
<td align="left">G47.31</td>
<td align="right">704</td>
<td align="left">Idiopathic alveolar hypoventilation syndrome</td>
<td align="left">Primary central sleep apnea</td>
</tr>
<tr class="even">
<td align="left">A31.9</td>
<td align="right">700</td>
<td align="left">Atypical mycobacteriosis, familial</td>
<td align="left">Mycobacterial infection, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D3A.8</td>
<td align="right">695</td>
<td align="left">Carcinoid tumor</td>
<td align="left">Other benign neuroendocrine tumors</td>
</tr>
<tr class="even">
<td align="left">I27.89</td>
<td align="right">686</td>
<td align="left">Eisenmenger syndrome</td>
<td align="left">Other specified pulmonary heart diseases</td>
</tr>
<tr class="odd">
<td align="left">K90.9</td>
<td align="right">685</td>
<td align="left">Hereditary folate malabsorption</td>
<td align="left">Intestinal malabsorption, unspecified</td>
</tr>
<tr class="even">
<td align="left">R77.8</td>
<td align="right">678</td>
<td align="left">Hyperferritinemia cataract syndrome</td>
<td align="left">Other specified abnormalities of plasma proteins</td>
</tr>
<tr class="odd">
<td align="left">D33.3</td>
<td align="right">675</td>
<td align="left">Acoustic neuroma</td>
<td align="left">Benign neoplasm of cranial nerves</td>
</tr>
<tr class="even">
<td align="left">L53.9</td>
<td align="right">665</td>
<td align="left">Exfoliative dermatitis</td>
<td align="left">Erythematous condition, unspecified</td>
</tr>
<tr class="odd">
<td align="left">M00.9</td>
<td align="right">660</td>
<td align="left">Infectious arthritis</td>
<td align="left">Pyogenic arthritis, unspecified</td>
</tr>
<tr class="even">
<td align="left">K14.6</td>
<td align="right">657</td>
<td align="left">Glossodynia</td>
<td align="left">Glossodynia</td>
</tr>
<tr class="odd">
<td align="left">L65.8</td>
<td align="right">649</td>
<td align="left">Loose anagen hair syndrome</td>
<td align="left">Other specified nonscarring hair loss</td>
</tr>
<tr class="even">
<td align="left">K75.4</td>
<td align="right">642</td>
<td align="left">Autoimmune hepatitis</td>
<td align="left">Autoimmune hepatitis</td>
</tr>
<tr class="odd">
<td align="left">D69.2</td>
<td align="right">628</td>
<td align="left">Gardner-Diamond syndrome</td>
<td align="left">Other nonthrombocytopenic purpura</td>
</tr>
<tr class="even">
<td align="left">Q25.6</td>
<td align="right">625</td>
<td align="left">Pulmonary supravalvular stenosis</td>
<td align="left">Stenosis of pulmonary artery</td>
</tr>
<tr class="odd">
<td align="left">Q10.3</td>
<td align="right">620</td>
<td align="left">Ankyloblepharon filiforme adnatum cleft palate</td>
<td align="left">Other congenital malformations of eyelid</td>
</tr>
<tr class="even">
<td align="left">C16.9</td>
<td align="right">620</td>
<td align="left">Stomach cancer</td>
<td align="left">Malignant neoplasm of stomach, unspecified</td>
</tr>
<tr class="odd">
<td align="left">J38.00</td>
<td align="right">618</td>
<td align="left">Vocal cord dysfunction familial</td>
<td align="left">Paralysis of vocal cords and larynx, unspecified</td>
</tr>
<tr class="even">
<td align="left">F60.3</td>
<td align="right">617</td>
<td align="left">Bronchopulmonary dysplasia</td>
<td align="left">Borderline personality disorder</td>
</tr>
<tr class="odd">
<td align="left">E27.0</td>
<td align="right">616</td>
<td align="left">Hyperadrenalism</td>
<td align="left">Other adrenocortical overactivity</td>
</tr>
<tr class="even">
<td align="left">G81.90</td>
<td align="right">603</td>
<td align="left">Alternating hemiplegia of childhood</td>
<td align="left">Hemiplegia, unspecified affecting unspecified side</td>
</tr>
<tr class="odd">
<td align="left">L21.1</td>
<td align="right">583</td>
<td align="left">Leiner disease</td>
<td align="left">Seborrheic infantile dermatitis</td>
</tr>
<tr class="even">
<td align="left">A49.1</td>
<td align="right">580</td>
<td align="left">Streptococcal Group A invasive disease</td>
<td align="left">Streptococcal infection, unspecified site</td>
</tr>
<tr class="odd">
<td align="left">L71.8</td>
<td align="right">572</td>
<td align="left">Granulomatous rosacea</td>
<td align="left">Other rosacea</td>
</tr>
<tr class="even">
<td align="left">M21.869</td>
<td align="right">565</td>
<td align="left">Absence of Tibia</td>
<td align="left">Other specified acquired deformities of unspecified lower leg</td>
</tr>
<tr class="odd">
<td align="left">C22.8</td>
<td align="right">555</td>
<td align="left">Primary liver cancer</td>
<td align="left">Malignant neoplasm of liver, primary, unspecified as to type</td>
</tr>
<tr class="even">
<td align="left">J98.59</td>
<td align="right">553</td>
<td align="left">Fibrosing mediastinitis</td>
<td align="left">Other diseases of mediastinum, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">M47.9</td>
<td align="right">544</td>
<td align="left">Spondylarthropathy</td>
<td align="left">Spondylosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">E84.9</td>
<td align="right">541</td>
<td align="left">Cystic fibrosis</td>
<td align="left">Cystic fibrosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">G24.5</td>
<td align="right">540</td>
<td align="left">Benign essential blepharospasm</td>
<td align="left">Blepharospasm</td>
</tr>
<tr class="even">
<td align="left">G40.901</td>
<td align="right">536</td>
<td align="left">Status epilepticus</td>
<td align="left">Epilepsy, unspecified, not intractable, with status epilepticus</td>
</tr>
<tr class="odd">
<td align="left">G24.3</td>
<td align="right">536</td>
<td align="left">Cervical dystonia</td>
<td align="left">Spasmodic torticollis</td>
</tr>
<tr class="even">
<td align="left">E78.01</td>
<td align="right">535</td>
<td align="left">Hyperlipoproteinemia type 2</td>
<td align="left">Familial hypercholesterolemia</td>
</tr>
<tr class="odd">
<td align="left">C91.00</td>
<td align="right">533</td>
<td align="left">Acute lymphoblastic leukemia</td>
<td align="left">Acute lymphoblastic leukemia not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">L56.8</td>
<td align="right">521</td>
<td align="left">Actinic cheilitis</td>
<td align="left">Other specified acute skin changes due to ultraviolet radiation</td>
</tr>
<tr class="odd">
<td align="left">M33.90</td>
<td align="right">510</td>
<td align="left">Dermatomyositis</td>
<td align="left">Dermatopolymyositis, unspecified, organ involvement unspecified</td>
</tr>
<tr class="even">
<td align="left">Q21.3</td>
<td align="right">503</td>
<td align="left">Tetralogy of Fallot</td>
<td align="left">Tetralogy of Fallot</td>
</tr>
<tr class="odd">
<td align="left">M31.6</td>
<td align="right">503</td>
<td align="left">Giant cell arteritis</td>
<td align="left">Other giant cell arteritis</td>
</tr>
<tr class="even">
<td align="left">I33.0</td>
<td align="right">500</td>
<td align="left">Infective endocarditis</td>
<td align="left">Acute and subacute infective endocarditis</td>
</tr>
<tr class="odd">
<td align="left">L81.3</td>
<td align="right">492</td>
<td align="left">Watson syndrome</td>
<td align="left">CafÃ© au lait spots</td>
</tr>
<tr class="even">
<td align="left">C84.00</td>
<td align="right">490</td>
<td align="left">Mycosis fungoides</td>
<td align="left">Mycosis fungoides, unspecified site</td>
</tr>
<tr class="odd">
<td align="left">A53.9</td>
<td align="right">486</td>
<td align="left">Treponema infection</td>
<td align="left">Syphilis, unspecified</td>
</tr>
<tr class="even">
<td align="left">R44.1</td>
<td align="right">478</td>
<td align="left">Charles Bonnet syndrome</td>
<td align="left">Visual hallucinations</td>
</tr>
<tr class="odd">
<td align="left">G47.419</td>
<td align="right">476</td>
<td align="left">Narcolepsy</td>
<td align="left">Narcolepsy without cataplexy</td>
</tr>
<tr class="even">
<td align="left">R48.2</td>
<td align="right">473</td>
<td align="left">Apraxia</td>
<td align="left">Apraxia</td>
</tr>
<tr class="odd">
<td align="left">Q31.5</td>
<td align="right">470</td>
<td align="left">Laryngomalacia</td>
<td align="left">Congenital laryngomalacia</td>
</tr>
<tr class="even">
<td align="left">G44.52</td>
<td align="right">467</td>
<td align="left">New daily-persistent headache</td>
<td align="left">New daily persistent headache (NDPH)</td>
</tr>
<tr class="odd">
<td align="left">D3A.00</td>
<td align="right">465</td>
<td align="left">Carcinoid tumor</td>
<td align="left">Benign carcinoid tumor of unspecified site</td>
</tr>
<tr class="even">
<td align="left">D56.3</td>
<td align="right">457</td>
<td align="left">Beta-thalassemia</td>
<td align="left">Thalassemia minor</td>
</tr>
<tr class="odd">
<td align="left">L28.1</td>
<td align="right">454</td>
<td align="left">Prurigo nodularis</td>
<td align="left">Prurigo nodularis</td>
</tr>
<tr class="even">
<td align="left">H35.00</td>
<td align="right">452</td>
<td align="left">Acute zonal occult outer retinopathy</td>
<td align="left">Unspecified background retinopathy</td>
</tr>
<tr class="odd">
<td align="left">I95.0</td>
<td align="right">450</td>
<td align="left">Pure autonomic failure</td>
<td align="left">Idiopathic hypotension</td>
</tr>
<tr class="even">
<td align="left">R23.1</td>
<td align="right">438</td>
<td align="left">Sneddon syndrome</td>
<td align="left">Pallor</td>
</tr>
<tr class="odd">
<td align="left">J80</td>
<td align="right">438</td>
<td align="left">Acute respiratory distress syndrome</td>
<td align="left">Acute respiratory distress syndrome</td>
</tr>
<tr class="even">
<td align="left">L50.3</td>
<td align="right">435</td>
<td align="left">Familial dermographism</td>
<td align="left">Dermatographic urticaria</td>
</tr>
<tr class="odd">
<td align="left">O00.90</td>
<td align="right">434</td>
<td align="left">Ectopic pregnancy</td>
<td align="left">Unspecified ectopic pregnancy without intrauterine pregnancy</td>
</tr>
<tr class="even">
<td align="left">F80.81</td>
<td align="right">431</td>
<td align="left">Cluttering</td>
<td align="left">Childhood onset fluency disorder</td>
</tr>
<tr class="odd">
<td align="left">D89.813</td>
<td align="right">424</td>
<td align="left">Homologous wasting disease</td>
<td align="left">Graft-versus-host disease, unspecified</td>
</tr>
<tr class="even">
<td align="left">F44.5</td>
<td align="right">417</td>
<td align="left">Dissociative seizures</td>
<td align="left">Conversion disorder with seizures or convulsions</td>
</tr>
<tr class="odd">
<td align="left">A77.0</td>
<td align="right">416</td>
<td align="left">Rocky mountain spotted fever</td>
<td align="left">Spotted fever due to Rickettsia rickettsii</td>
</tr>
<tr class="even">
<td align="left">K74.3</td>
<td align="right">412</td>
<td align="left">Primary biliary cholangitis</td>
<td align="left">Primary biliary cirrhosis</td>
</tr>
<tr class="odd">
<td align="left">I83.10</td>
<td align="right">410</td>
<td align="left">Lipodermatosclerosis</td>
<td align="left">Varicose veins of unspecified lower extremity with inflammation</td>
</tr>
<tr class="even">
<td align="left">G98.8</td>
<td align="right">410</td>
<td align="left">Allan-Herndon-Dudley syndrome</td>
<td align="left">Other disorders of nervous system</td>
</tr>
<tr class="odd">
<td align="left">R43.0</td>
<td align="right">385</td>
<td align="left">Congenital anosmia</td>
<td align="left">Anosmia</td>
</tr>
<tr class="even">
<td align="left">Q85.00</td>
<td align="right">382</td>
<td align="left">Neurofibromatosis</td>
<td align="left">Neurofibromatosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q24.5</td>
<td align="right">381</td>
<td align="left">Coronary arteries congenital malformation</td>
<td align="left">Malformation of coronary vessels</td>
</tr>
<tr class="even">
<td align="left">L43.9</td>
<td align="right">381</td>
<td align="left">Linear lichen planus</td>
<td align="left">Lichen planus, unspecified</td>
</tr>
<tr class="odd">
<td align="left">G45.3</td>
<td align="right">367</td>
<td align="left">Amaurosis fugax</td>
<td align="left">Amaurosis fugax</td>
</tr>
<tr class="even">
<td align="left">I99.9</td>
<td align="right">365</td>
<td align="left">Hereditary angiopathy with nephropathy, aneurysms, and muscle cramps syndrome</td>
<td align="left">Unspecified disorder of circulatory system</td>
</tr>
<tr class="odd">
<td align="left">M35.1</td>
<td align="right">364</td>
<td align="left">Mixed connective tissue disease</td>
<td align="left">Other overlap syndromes</td>
</tr>
<tr class="even">
<td align="left">N80.0</td>
<td align="right">363</td>
<td align="left">Adenomyosis</td>
<td align="left">Endometriosis of uterus</td>
</tr>
<tr class="odd">
<td align="left">D49.9</td>
<td align="right">363</td>
<td align="left">Paraneoplastic cerebellar degeneration</td>
<td align="left">Neoplasm of unspecified behavior of unspecified site</td>
</tr>
<tr class="even">
<td align="left">C32.9</td>
<td align="right">363</td>
<td align="left">Laryngeal cancer</td>
<td align="left">Malignant neoplasm of larynx, unspecified</td>
</tr>
<tr class="odd">
<td align="left">G25.89</td>
<td align="right">362</td>
<td align="left">Biotin-thiamine-responsive basal ganglia disease</td>
<td align="left">Other specified extrapyramidal and movement disorders</td>
</tr>
<tr class="even">
<td align="left">D57.20</td>
<td align="right">362</td>
<td align="left">Hemoglobin SC disease</td>
<td align="left">Sickle-cell/Hb-C disease without crisis</td>
</tr>
<tr class="odd">
<td align="left">G96.0</td>
<td align="right">360</td>
<td align="left">Cerebrospinal fluid leak</td>
<td align="left">Cerebrospinal fluid leak</td>
</tr>
<tr class="even">
<td align="left">B02.30</td>
<td align="right">359</td>
<td align="left">Herpes zoster ophthalmicus</td>
<td align="left">Zoster ocular disease, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q20.3</td>
<td align="right">358</td>
<td align="left">Transposition of the great arteries</td>
<td align="left">Discordant ventriculoarterial connection</td>
</tr>
<tr class="even">
<td align="left">P00.2</td>
<td align="right">352</td>
<td align="left">TORCH syndrome</td>
<td align="left">Newborn affected by maternal infectious and parasitic diseases</td>
</tr>
<tr class="odd">
<td align="left">D49.89</td>
<td align="right">352</td>
<td align="left">Heart tumor</td>
<td align="left">Neoplasm of unspecified behavior of other specified sites</td>
</tr>
<tr class="even">
<td align="left">D24.9</td>
<td align="right">346</td>
<td align="left">Florid papillomatosis of the nipple</td>
<td align="left">Benign neoplasm of unspecified breast</td>
</tr>
<tr class="odd">
<td align="left">E75.21</td>
<td align="right">345</td>
<td align="left">Fabry disease</td>
<td align="left">Fabry (-Anderson) disease</td>
</tr>
<tr class="even">
<td align="left">I80.8</td>
<td align="right">344</td>
<td align="left">Mondor disease</td>
<td align="left">Phlebitis and thrombophlebitis of other sites</td>
</tr>
<tr class="odd">
<td align="left">F06.30</td>
<td align="right">339</td>
<td align="left">Organic mood syndrome</td>
<td align="left">Mood disorder due to known physiological condition, unspecified</td>
</tr>
<tr class="even">
<td align="left">G61.81</td>
<td align="right">338</td>
<td align="left">Chronic inflammatory demyelinating polyneuropathy</td>
<td align="left">Chronic inflammatory demyelinating polyneuritis</td>
</tr>
<tr class="odd">
<td align="left">L92.0</td>
<td align="right">334</td>
<td align="left">Granuloma annulare</td>
<td align="left">Granuloma annulare</td>
</tr>
<tr class="even">
<td align="left">L85.9</td>
<td align="right">332</td>
<td align="left">Tylosis</td>
<td align="left">Epidermal thickening, unspecified</td>
</tr>
<tr class="odd">
<td align="left">K11.8</td>
<td align="right">332</td>
<td align="left">Mikulicz disease</td>
<td align="left">Other diseases of salivary glands</td>
</tr>
<tr class="even">
<td align="left">C21.0</td>
<td align="right">329</td>
<td align="left">Anal cancer</td>
<td align="left">Malignant neoplasm of anus, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C84.A0</td>
<td align="right">327</td>
<td align="left">Cutaneous T-cell lymphoma</td>
<td align="left">Cutaneous T-cell lymphoma, unspecified, unspecified site</td>
</tr>
<tr class="even">
<td align="left">K51.20</td>
<td align="right">326</td>
<td align="left">Ulcerative proctitis</td>
<td align="left">Ulcerative (chronic) proctitis without complications</td>
</tr>
<tr class="odd">
<td align="left">H55.01</td>
<td align="right">325</td>
<td align="left">Nystagmus 1, congenital, X- linked</td>
<td align="left">Congenital nystagmus</td>
</tr>
<tr class="even">
<td align="left">G80.1</td>
<td align="right">325</td>
<td align="left">Spastic diplegia cerebral palsy</td>
<td align="left">Spastic diplegic cerebral palsy</td>
</tr>
<tr class="odd">
<td align="left">D45</td>
<td align="right">325</td>
<td align="left">Polycythemia vera</td>
<td align="left">Polycythemia vera</td>
</tr>
<tr class="even">
<td align="left">Q12.0</td>
<td align="right">324</td>
<td align="left">Cerulean cataract</td>
<td align="left">Congenital cataract</td>
</tr>
<tr class="odd">
<td align="left">M32.14</td>
<td align="right">310</td>
<td align="left">Lupus nephritis</td>
<td align="left">Glomerular disease in systemic lupus erythematosus</td>
</tr>
<tr class="even">
<td align="left">C85.10</td>
<td align="right">310</td>
<td align="left">B-cell lymphoma</td>
<td align="left">Unspecified B-cell lymphoma, unspecified site</td>
</tr>
<tr class="odd">
<td align="left">P22.0</td>
<td align="right">307</td>
<td align="left">Respiratory distress syndrome, infant</td>
<td align="left">Respiratory distress syndrome of newborn</td>
</tr>
<tr class="even">
<td align="left">E72.20</td>
<td align="right">302</td>
<td align="left">Urea cycle disorders</td>
<td align="left">Disorder of urea cycle metabolism, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C02.9</td>
<td align="right">299</td>
<td align="left">Tongue cancer</td>
<td align="left">Malignant neoplasm of tongue, unspecified</td>
</tr>
<tr class="even">
<td align="left">J67.9</td>
<td align="right">297</td>
<td align="left">Hypersensitivity pneumonitis</td>
<td align="left">Hypersensitivity pneumonitis due to unspecified organic dust</td>
</tr>
<tr class="odd">
<td align="left">M53.9</td>
<td align="right">296</td>
<td align="left">Spondylarthropathy</td>
<td align="left">Dorsopathy, unspecified</td>
</tr>
<tr class="even">
<td align="left">E80.4</td>
<td align="right">296</td>
<td align="left">Congenital nonhemolytic jaundice</td>
<td align="left">Gilbert syndrome</td>
</tr>
<tr class="odd">
<td align="left">D83.9</td>
<td align="right">296</td>
<td align="left">Common variable immunodeficiency</td>
<td align="left">Common variable immunodeficiency, unspecified</td>
</tr>
<tr class="even">
<td align="left">G57.00</td>
<td align="right">291</td>
<td align="left">Piriformis syndrome</td>
<td align="left">Lesion of sciatic nerve, unspecified lower limb</td>
</tr>
<tr class="odd">
<td align="left">Q35.9</td>
<td align="right">288</td>
<td align="left">Cleft palate lateral synechia syndrome</td>
<td align="left">Cleft palate, unspecified</td>
</tr>
<tr class="even">
<td align="left">F44.9</td>
<td align="right">284</td>
<td align="left">Conversion disorder</td>
<td align="left">Dissociative and conversion disorder, unspecified</td>
</tr>
<tr class="odd">
<td align="left">P22.9</td>
<td align="right">283</td>
<td align="left">Respiratory distress syndrome, infant</td>
<td align="left">Respiratory distress of newborn, unspecified</td>
</tr>
<tr class="even">
<td align="left">I45.5</td>
<td align="right">283</td>
<td align="left">Progressive familial heart block type 2</td>
<td align="left">Other specified heart block</td>
</tr>
<tr class="odd">
<td align="left">B08.3</td>
<td align="right">283</td>
<td align="left">Parvovirus antenatal infection</td>
<td align="left">Erythema infectiosum [fifth disease]</td>
</tr>
<tr class="even">
<td align="left">R25.8</td>
<td align="right">282</td>
<td align="left">Athetosis</td>
<td align="left">Other abnormal involuntary movements</td>
</tr>
<tr class="odd">
<td align="left">D75.82</td>
<td align="right">281</td>
<td align="left">Heparin-induced thrombocytopenia</td>
<td align="left">Heparin induced thrombocytopenia (HIT)</td>
</tr>
<tr class="even">
<td align="left">G80.0</td>
<td align="right">278</td>
<td align="left">Cerebral palsy spastic quadriplegic</td>
<td align="left">Spastic quadriplegic cerebral palsy</td>
</tr>
<tr class="odd">
<td align="left">E20.9</td>
<td align="right">278</td>
<td align="left">Hypoparathyroidism</td>
<td align="left">Hypoparathyroidism, unspecified</td>
</tr>
<tr class="even">
<td align="left">E88.01</td>
<td align="right">272</td>
<td align="left">Alpha-1 antitrypsin deficiency</td>
<td align="left">Alpha-1-antitrypsin deficiency</td>
</tr>
<tr class="odd">
<td align="left">G58.8</td>
<td align="right">265</td>
<td align="left">Pudendal Neuralgia</td>
<td align="left">Other specified mononeuropathies</td>
</tr>
<tr class="even">
<td align="left">M62.50</td>
<td align="right">263</td>
<td align="left">Muscular atrophy ataxia retinitis pigmentosa and diabetes mellitus</td>
<td align="left">Muscle wasting and atrophy, not elsewhere classified, unspecified site</td>
</tr>
<tr class="odd">
<td align="left">C71.6</td>
<td align="right">262</td>
<td align="left">Medulloblastoma</td>
<td align="left">Malignant neoplasm of cerebellum</td>
</tr>
<tr class="even">
<td align="left">P91.60</td>
<td align="right">261</td>
<td align="left">Hyper IgE syndrome</td>
<td align="left">Hypoxic ischemic encephalopathy [HIE], unspecified</td>
</tr>
<tr class="odd">
<td align="left">G31.09</td>
<td align="right">258</td>
<td align="left">Semantic dementia</td>
<td align="left">Other frontotemporal dementia</td>
</tr>
<tr class="even">
<td align="left">L93.2</td>
<td align="right">255</td>
<td align="left">Lupus erythematosus tumidus</td>
<td align="left">Other local lupus erythematosus</td>
</tr>
<tr class="odd">
<td align="left">Q55.69</td>
<td align="right">251</td>
<td align="left">Diphallia</td>
<td align="left">Other congenital malformation of penis</td>
</tr>
<tr class="even">
<td align="left">N64.3</td>
<td align="right">250</td>
<td align="left">Ahumada Del Castillo syndrome</td>
<td align="left">Galactorrhea not associated with childbirth</td>
</tr>
<tr class="odd">
<td align="left">D03.9</td>
<td align="right">246</td>
<td align="left">Lentigo maligna melanoma</td>
<td align="left">Melanoma in situ, unspecified</td>
</tr>
<tr class="even">
<td align="left">B37.7</td>
<td align="right">244</td>
<td align="left">Systemic candidiasis</td>
<td align="left">Candidal sepsis</td>
</tr>
<tr class="odd">
<td align="left">Q82.2</td>
<td align="right">242</td>
<td align="left">Mastocytosis</td>
<td align="left">Mastocytosis</td>
</tr>
<tr class="even">
<td align="left">G31.9</td>
<td align="right">241</td>
<td align="left">Cerebellar degeneration</td>
<td align="left">Degenerative disease of nervous system, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D61.9</td>
<td align="right">238</td>
<td align="left">Aplastic anemia</td>
<td align="left">Aplastic anemia, unspecified</td>
</tr>
<tr class="even">
<td align="left">G90.3</td>
<td align="right">237</td>
<td align="left">Multiple system atrophy</td>
<td align="left">Multi-system degeneration of the autonomic nervous system</td>
</tr>
<tr class="odd">
<td align="left">N05.1</td>
<td align="right">236</td>
<td align="left">Focal segmental glomerulosclerosis</td>
<td align="left">Unspecified nephritic syndrome with focal and segmental glomerular lesions</td>
</tr>
<tr class="even">
<td align="left">G89.0</td>
<td align="right">236</td>
<td align="left">Central pain syndrome</td>
<td align="left">Central pain syndrome</td>
</tr>
<tr class="odd">
<td align="left">G45.4</td>
<td align="right">236</td>
<td align="left">Transient global amnesia</td>
<td align="left">Transient global amnesia</td>
</tr>
<tr class="even">
<td align="left">E27.1</td>
<td align="right">236</td>
<td align="left">Addison’s disease</td>
<td align="left">Primary adrenocortical insufficiency</td>
</tr>
<tr class="odd">
<td align="left">C51.9</td>
<td align="right">233</td>
<td align="left">Vulvar cancer</td>
<td align="left">Malignant neoplasm of vulva, unspecified</td>
</tr>
<tr class="even">
<td align="left">I20.1</td>
<td align="right">231</td>
<td align="left">Prinzmetal’s variant angina</td>
<td align="left">Angina pectoris with documented spasm</td>
</tr>
<tr class="odd">
<td align="left">E05.80</td>
<td align="right">231</td>
<td align="left">Focal dermal hypoplasia</td>
<td align="left">Other thyrotoxicosis without thyrotoxic crisis or storm</td>
</tr>
<tr class="even">
<td align="left">M31.30</td>
<td align="right">230</td>
<td align="left">Granulomatosis with polyangiitis</td>
<td align="left">Wegener’s granulomatosis without renal involvement</td>
</tr>
<tr class="odd">
<td align="left">I89.8</td>
<td align="right">230</td>
<td align="left">Chylous ascites</td>
<td align="left">Other specified noninfective disorders of lymphatic vessels and lymph nodes</td>
</tr>
<tr class="even">
<td align="left">P84</td>
<td align="right">229</td>
<td align="left">Asphyxia neonatorum</td>
<td align="left">Other problems with newborn</td>
</tr>
<tr class="odd">
<td align="left">M30.3</td>
<td align="right">227</td>
<td align="left">Kawasaki disease</td>
<td align="left">Mucocutaneous lymph node syndrome [Kawasaki]</td>
</tr>
<tr class="even">
<td align="left">H81.90</td>
<td align="right">224</td>
<td align="left">Benign paroxysmal positional vertigo</td>
<td align="left">Unspecified disorder of vestibular function, unspecified ear</td>
</tr>
<tr class="odd">
<td align="left">Q24.4</td>
<td align="right">223</td>
<td align="left">Subvalvular aortic stenosis</td>
<td align="left">Congenital subaortic stenosis</td>
</tr>
<tr class="even">
<td align="left">G37.3</td>
<td align="right">223</td>
<td align="left">Transverse myelitis</td>
<td align="left">Acute transverse myelitis in demyelinating disease of central nervous system</td>
</tr>
<tr class="odd">
<td align="left">G11.9</td>
<td align="right">223</td>
<td align="left">Hereditary ataxia</td>
<td align="left">Hereditary ataxia, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q07.9</td>
<td align="right">220</td>
<td align="left">Muscle eye brain disease</td>
<td align="left">Congenital malformation of nervous system, unspecified</td>
</tr>
<tr class="odd">
<td align="left">G47.11</td>
<td align="right">220</td>
<td align="left">Idiopathic hypersomnia</td>
<td align="left">Idiopathic hypersomnia with long sleep time</td>
</tr>
<tr class="even">
<td align="left">D58.9</td>
<td align="right">213</td>
<td align="left">Congenital hemolytic anemia</td>
<td align="left">Hereditary hemolytic anemia, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D43.2</td>
<td align="right">212</td>
<td align="left">Subependymal giant cell astrocytoma</td>
<td align="left">Neoplasm of uncertain behavior of brain, unspecified</td>
</tr>
<tr class="even">
<td align="left">G51.4</td>
<td align="right">210</td>
<td align="left">Morvan’s fibrillary chorea</td>
<td align="left">Facial myokymia</td>
</tr>
<tr class="odd">
<td align="left">Q14.1</td>
<td align="right">208</td>
<td align="left">Juvenile retinoschisis</td>
<td align="left">Congenital malformation of retina</td>
</tr>
<tr class="even">
<td align="left">J94.8</td>
<td align="right">208</td>
<td align="left">Chylothorax, congenital</td>
<td align="left">Other specified pleural conditions</td>
</tr>
<tr class="odd">
<td align="left">Q45.3</td>
<td align="right">205</td>
<td align="left">Accessory pancreas</td>
<td align="left">Other congenital malformations of pancreas and pancreatic duct</td>
</tr>
<tr class="even">
<td align="left">O90.3</td>
<td align="right">204</td>
<td align="left">Peripartum cardiomyopathy</td>
<td align="left">Peripartum cardiomyopathy</td>
</tr>
<tr class="odd">
<td align="left">D89.811</td>
<td align="right">203</td>
<td align="left">Chronic graft versus host disease</td>
<td align="left">Chronic graft-versus-host disease</td>
</tr>
<tr class="even">
<td align="left">I51.81</td>
<td align="right">198</td>
<td align="left">Broken heart syndrome</td>
<td align="left">Takotsubo syndrome</td>
</tr>
<tr class="odd">
<td align="left">N02.8</td>
<td align="right">195</td>
<td align="left">IgA nephropathy</td>
<td align="left">Recurrent and persistent hematuria with other morphologic changes</td>
</tr>
<tr class="even">
<td align="left">C45.9</td>
<td align="right">194</td>
<td align="left">Malignant mesothelioma</td>
<td align="left">Mesothelioma, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D89.2</td>
<td align="right">192</td>
<td align="left">Cryofibrinogenemia</td>
<td align="left">Hypergammaglobulinemia, unspecified</td>
</tr>
<tr class="even">
<td align="left">C18.1</td>
<td align="right">189</td>
<td align="left">Adenocarcinoma of the appendix</td>
<td align="left">Malignant neoplasm of appendix</td>
</tr>
<tr class="odd">
<td align="left">C88.4</td>
<td align="right">188</td>
<td align="left">Marginal zone lymphoma</td>
<td align="left">Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]</td>
</tr>
<tr class="even">
<td align="left">C06.9</td>
<td align="right">187</td>
<td align="left">Oral cancer</td>
<td align="left">Malignant neoplasm of mouth, unspecified</td>
</tr>
<tr class="odd">
<td align="left">H93.299</td>
<td align="right">186</td>
<td align="left">Auditory neuropathy</td>
<td align="left">Other abnormal auditory perceptions, unspecified ear</td>
</tr>
<tr class="even">
<td align="left">G47.411</td>
<td align="right">185</td>
<td align="left">Narcolepsy</td>
<td align="left">Narcolepsy with cataplexy</td>
</tr>
<tr class="odd">
<td align="left">D53.1</td>
<td align="right">185</td>
<td align="left">Thiamine responsive megaloblastic anemia syndrome</td>
<td align="left">Other megaloblastic anemias, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">D89.810</td>
<td align="right">184</td>
<td align="left">Acute graft versus host disease</td>
<td align="left">Acute graft-versus-host disease</td>
</tr>
<tr class="odd">
<td align="left">D70.8</td>
<td align="right">183</td>
<td align="left">Neutropenia chronic familial</td>
<td align="left">Other neutropenia</td>
</tr>
<tr class="even">
<td align="left">Q67.7</td>
<td align="right">181</td>
<td align="left">Pectus carinatum</td>
<td align="left">Pectus carinatum</td>
</tr>
<tr class="odd">
<td align="left">Z88.8</td>
<td align="right">180</td>
<td align="left">Pseudocholinesterase deficiency</td>
<td align="left">Allergy status to other drugs, medicaments and biological substances status</td>
</tr>
<tr class="even">
<td align="left">Q27.8</td>
<td align="right">175</td>
<td align="left">Aberrant subclavian artery</td>
<td align="left">Other specified congenital malformations of peripheral vascular system</td>
</tr>
<tr class="odd">
<td align="left">E10.69</td>
<td align="right">175</td>
<td align="left">Immunodysregulation, polyendocrinopathy and enteropathy X-linked</td>
<td align="left">Type 1 diabetes mellitus with other specified complication</td>
</tr>
<tr class="even">
<td align="left">B25.8</td>
<td align="right">173</td>
<td align="left">Cytomegalovirus retinitis</td>
<td align="left">Other cytomegaloviral diseases</td>
</tr>
<tr class="odd">
<td align="left">Q03.9</td>
<td align="right">172</td>
<td align="left">Hydrocephalus due to congenital stenosis of aqueduct of sylvius</td>
<td align="left">Congenital hydrocephalus, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q20.1</td>
<td align="right">170</td>
<td align="left">Double outlet right ventricle</td>
<td align="left">Double outlet right ventricle</td>
</tr>
<tr class="odd">
<td align="left">D75.81</td>
<td align="right">168</td>
<td align="left">Myelofibrosis</td>
<td align="left">Myelofibrosis</td>
</tr>
<tr class="even">
<td align="left">N32.1</td>
<td align="right">167</td>
<td align="left">Enterovesical fistula</td>
<td align="left">Vesicointestinal fistula</td>
</tr>
<tr class="odd">
<td align="left">G51.8</td>
<td align="right">166</td>
<td align="left">Progressive hemifacial atrophy</td>
<td align="left">Other disorders of facial nerve</td>
</tr>
<tr class="even">
<td align="left">E53.1</td>
<td align="right">163</td>
<td align="left">Pyridoxine deficiency</td>
<td align="left">Pyridoxine deficiency</td>
</tr>
<tr class="odd">
<td align="left">G92</td>
<td align="right">162</td>
<td align="left">Neurotoxicity syndromes</td>
<td align="left">Toxic encephalopathy</td>
</tr>
<tr class="even">
<td align="left">Q04.9</td>
<td align="right">159</td>
<td align="left">Cerebro-costo-mandibular syndrome</td>
<td align="left">Congenital malformation of brain, unspecified</td>
</tr>
<tr class="odd">
<td align="left">K14.1</td>
<td align="right">159</td>
<td align="left">Geographic tongue</td>
<td align="left">Geographic tongue</td>
</tr>
<tr class="even">
<td align="left">P28.89</td>
<td align="right">158</td>
<td align="left">Laryngomalacia</td>
<td align="left">Other specified respiratory conditions of newborn</td>
</tr>
<tr class="odd">
<td align="left">F84.9</td>
<td align="right">156</td>
<td align="left">Camurati-Engelmann disease</td>
<td align="left">Pervasive developmental disorder, unspecified</td>
</tr>
<tr class="even">
<td align="left">B59</td>
<td align="right">154</td>
<td align="left">Pneumocystosis</td>
<td align="left">Pneumocystosis</td>
</tr>
<tr class="odd">
<td align="left">Q23.4</td>
<td align="right">153</td>
<td align="left">Hypoplastic left heart syndrome</td>
<td align="left">Hypoplastic left heart syndrome</td>
</tr>
<tr class="even">
<td align="left">M02.30</td>
<td align="right">153</td>
<td align="left">Reactive arthritis</td>
<td align="left">Reiter’s disease, unspecified site</td>
</tr>
<tr class="odd">
<td align="left">G90.2</td>
<td align="right">153</td>
<td align="left">Horner’s syndrome</td>
<td align="left">Horner’s syndrome</td>
</tr>
<tr class="even">
<td align="left">C71.0</td>
<td align="right">153</td>
<td align="left">Supratentorial primitive neuroectodermal tumor</td>
<td align="left">Malignant neoplasm of cerebrum, except lobes and ventricles</td>
</tr>
<tr class="odd">
<td align="left">C23</td>
<td align="right">153</td>
<td align="left">Gallbladder cancer</td>
<td align="left">Malignant neoplasm of gallbladder</td>
</tr>
<tr class="even">
<td align="left">G57.10</td>
<td align="right">152</td>
<td align="left">Meralgia paresthetica</td>
<td align="left">Meralgia paresthetica, unspecified lower limb</td>
</tr>
<tr class="odd">
<td align="left">G24.4</td>
<td align="right">152</td>
<td align="left">Meige syndrome</td>
<td align="left">Idiopathic orofacial dystonia</td>
</tr>
<tr class="even">
<td align="left">D82.1</td>
<td align="right">150</td>
<td align="left">22q11.2 deletion syndrome</td>
<td align="left">Di George’s syndrome</td>
</tr>
<tr class="odd">
<td align="left">D56.9</td>
<td align="right">150</td>
<td align="left">Thalassemia</td>
<td align="left">Thalassemia, unspecified</td>
</tr>
<tr class="even">
<td align="left">F44.4</td>
<td align="right">149</td>
<td align="left">Camptocormism</td>
<td align="left">Conversion disorder with motor symptom or deficit</td>
</tr>
<tr class="odd">
<td align="left">L50.2</td>
<td align="right">148</td>
<td align="left">Cold urticaria</td>
<td align="left">Urticaria due to cold and heat</td>
</tr>
<tr class="even">
<td align="left">D55.0</td>
<td align="right">147</td>
<td align="left">Glucose-6-phosphate dehydrogenase deficiency</td>
<td align="left">Anemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency</td>
</tr>
<tr class="odd">
<td align="left">D59.9</td>
<td align="right">146</td>
<td align="left">Hemoglobinemia</td>
<td align="left">Acquired hemolytic anemia, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q20.4</td>
<td align="right">145</td>
<td align="left">Single ventricular heart</td>
<td align="left">Double inlet ventricle</td>
</tr>
<tr class="odd">
<td align="left">B54</td>
<td align="right">145</td>
<td align="left">Malaria</td>
<td align="left">Unspecified malaria</td>
</tr>
<tr class="even">
<td align="left">Q89.01</td>
<td align="right">144</td>
<td align="left">Ivemark syndrome</td>
<td align="left">Asplenia (congenital)</td>
</tr>
<tr class="odd">
<td align="left">G83.4</td>
<td align="right">144</td>
<td align="left">Cauda equina syndrome</td>
<td align="left">Cauda equina syndrome</td>
</tr>
<tr class="even">
<td align="left">Q93.81</td>
<td align="right">142</td>
<td align="left">22q11.2 deletion syndrome</td>
<td align="left">Velo-cardio-facial syndrome</td>
</tr>
<tr class="odd">
<td align="left">K59.4</td>
<td align="right">142</td>
<td align="left">Levator syndrome</td>
<td align="left">Anal spasm</td>
</tr>
<tr class="even">
<td align="left">N15.9</td>
<td align="right">141</td>
<td align="left">BK-virus nephropathy</td>
<td align="left">Renal tubulo-interstitial disease, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q69.9</td>
<td align="right">140</td>
<td align="left">Polydactyly</td>
<td align="left">Polydactyly, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q68.0</td>
<td align="right">140</td>
<td align="left">Congenital torticollis</td>
<td align="left">Congenital deformity of sternocleidomastoid muscle</td>
</tr>
<tr class="odd">
<td align="left">J86.0</td>
<td align="right">140</td>
<td align="left">Tracheoesophageal fistula</td>
<td align="left">Pyothorax with fistula</td>
</tr>
<tr class="even">
<td align="left">H21.9</td>
<td align="right">140</td>
<td align="left">Uveal diseases</td>
<td align="left">Unspecified disorder of iris and ciliary body</td>
</tr>
<tr class="odd">
<td align="left">C88.0</td>
<td align="right">140</td>
<td align="left">Waldenstrom macroglobulinemia</td>
<td align="left">WaldenstrÃ¶m macroglobulinemia</td>
</tr>
<tr class="even">
<td align="left">C48.0</td>
<td align="right">140</td>
<td align="left">Retroperitoneal liposarcoma</td>
<td align="left">Malignant neoplasm of retroperitoneum</td>
</tr>
<tr class="odd">
<td align="left">N48.30</td>
<td align="right">139</td>
<td align="left">Priapism</td>
<td align="left">Priapism, unspecified</td>
</tr>
<tr class="even">
<td align="left">L66.1</td>
<td align="right">139</td>
<td align="left">Lichen planopilaris</td>
<td align="left">Lichen planopilaris</td>
</tr>
<tr class="odd">
<td align="left">E34.0</td>
<td align="right">139</td>
<td align="left">Carcinoid syndrome</td>
<td align="left">Carcinoid syndrome</td>
</tr>
<tr class="even">
<td align="left">L12.0</td>
<td align="right">137</td>
<td align="left">Bullous pemphigoid</td>
<td align="left">Bullous pemphigoid</td>
</tr>
<tr class="odd">
<td align="left">J61</td>
<td align="right">137</td>
<td align="left">Asbestosis</td>
<td align="left">Pneumoconiosis due to asbestos and other mineral fibers</td>
</tr>
<tr class="even">
<td align="left">J15.7</td>
<td align="right">137</td>
<td align="left">Mycoplasmal pneumonia</td>
<td align="left">Pneumonia due to Mycoplasma pneumoniae</td>
</tr>
<tr class="odd">
<td align="left">Q43.3</td>
<td align="right">135</td>
<td align="left">Chilaiditi syndrome</td>
<td align="left">Congenital malformations of intestinal fixation</td>
</tr>
<tr class="even">
<td align="left">P05.9</td>
<td align="right">135</td>
<td align="left">IMAGe syndrome</td>
<td align="left">Newborn affected by slow intrauterine growth, unspecified</td>
</tr>
<tr class="odd">
<td align="left">M35.2</td>
<td align="right">135</td>
<td align="left">BehâÂºet disease</td>
<td align="left">BehÃ§et’s disease</td>
</tr>
<tr class="even">
<td align="left">G14</td>
<td align="right">135</td>
<td align="left">Post Polio syndrome</td>
<td align="left">Postpolio syndrome</td>
</tr>
<tr class="odd">
<td align="left">D81.9</td>
<td align="right">135</td>
<td align="left">Severe combined immunodeficiency</td>
<td align="left">Combined immunodeficiency, unspecified</td>
</tr>
<tr class="even">
<td align="left">C90.30</td>
<td align="right">133</td>
<td align="left">Anaplastic plasmacytoma</td>
<td align="left">Solitary plasmacytoma not having achieved remission</td>
</tr>
<tr class="odd">
<td align="left">G44.84</td>
<td align="right">132</td>
<td align="left">Exertional headache</td>
<td align="left">Primary exertional headache</td>
</tr>
<tr class="even">
<td align="left">D13.2</td>
<td align="right">132</td>
<td align="left">Paragangliomas 1</td>
<td align="left">Benign neoplasm of duodenum</td>
</tr>
<tr class="odd">
<td align="left">H53.60</td>
<td align="right">129</td>
<td align="left">Keratomalacia</td>
<td align="left">Unspecified night blindness</td>
</tr>
<tr class="even">
<td align="left">D14.1</td>
<td align="right">129</td>
<td align="left">Laryngeal papillomatosis</td>
<td align="left">Benign neoplasm of larynx</td>
</tr>
<tr class="odd">
<td align="left">J03.80</td>
<td align="right">127</td>
<td align="left">Lemierre syndrome</td>
<td align="left">Acute tonsillitis due to other specified organisms</td>
</tr>
<tr class="even">
<td align="left">D04.9</td>
<td align="right">127</td>
<td align="left">Bowen’s disease</td>
<td align="left">Carcinoma in situ of skin, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q72.899</td>
<td align="right">126</td>
<td align="left">Congenital short femur</td>
<td align="left">Other reduction defects of unspecified lower limb</td>
</tr>
<tr class="even">
<td align="left">M31.1</td>
<td align="right">124</td>
<td align="left">Thrombotic thrombocytopenic purpura, acquired</td>
<td align="left">Thrombotic microangiopathy</td>
</tr>
<tr class="odd">
<td align="left">D58.0</td>
<td align="right">123</td>
<td align="left">Hereditary spherocytosis</td>
<td align="left">Hereditary spherocytosis</td>
</tr>
<tr class="even">
<td align="left">D11.9</td>
<td align="right">123</td>
<td align="left">Warthin tumor</td>
<td align="left">Benign neoplasm of major salivary gland, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q22.5</td>
<td align="right">121</td>
<td align="left">Ebstein’s anomaly</td>
<td align="left">Ebstein’s anomaly</td>
</tr>
<tr class="even">
<td align="left">M72.6</td>
<td align="right">120</td>
<td align="left">Necrotizing fasciitis</td>
<td align="left">Necrotizing fasciitis</td>
</tr>
<tr class="odd">
<td align="left">L40.3</td>
<td align="right">119</td>
<td align="left">Pustulosis palmaris et plantaris</td>
<td align="left">Pustulosis palmaris et plantaris</td>
</tr>
<tr class="even">
<td align="left">K31.819</td>
<td align="right">119</td>
<td align="left">Watermelon stomach</td>
<td align="left">Angiodysplasia of stomach and duodenum without bleeding</td>
</tr>
<tr class="odd">
<td align="left">K31.5</td>
<td align="right">118</td>
<td align="left">Duodenal atresia</td>
<td align="left">Obstruction of duodenum</td>
</tr>
<tr class="even">
<td align="left">Q84.6</td>
<td align="right">117</td>
<td align="left">Hereditary koilonychia</td>
<td align="left">Other congenital malformations of nails</td>
</tr>
<tr class="odd">
<td align="left">D44.4</td>
<td align="right">116</td>
<td align="left">Craniopharyngioma</td>
<td align="left">Neoplasm of uncertain behavior of craniopharyngeal duct</td>
</tr>
<tr class="even">
<td align="left">B44.81</td>
<td align="right">116</td>
<td align="left">Allergic bronchopulmonary aspergillosis</td>
<td align="left">Allergic bronchopulmonary aspergillosis</td>
</tr>
<tr class="odd">
<td align="left">A46</td>
<td align="right">116</td>
<td align="left">Erysipelas</td>
<td align="left">Erysipelas</td>
</tr>
<tr class="even">
<td align="left">P29.3</td>
<td align="right">115</td>
<td align="left">Alveolar capillary dysplasia</td>
<td align="left">Persistent fetal circulation</td>
</tr>
<tr class="odd">
<td align="left">Q14.2</td>
<td align="right">114</td>
<td align="left">Coloboma of optic nerve</td>
<td align="left">Congenital malformation of optic disc</td>
</tr>
<tr class="even">
<td align="left">L11.1</td>
<td align="right">114</td>
<td align="left">Grover’s disease</td>
<td align="left">Transient acantholytic dermatosis [Grover]</td>
</tr>
<tr class="odd">
<td align="left">L98.6</td>
<td align="right">112</td>
<td align="left">Lymphocytic infiltrate of Jessner</td>
<td align="left">Other infiltrative disorders of the skin and subcutaneous tissue</td>
</tr>
<tr class="even">
<td align="left">K22.6</td>
<td align="right">112</td>
<td align="left">Mallory-Weiss syndrome</td>
<td align="left">Gastro-esophageal laceration-hemorrhage syndrome</td>
</tr>
<tr class="odd">
<td align="left">D56.1</td>
<td align="right">110</td>
<td align="left">Beta-thalassemia</td>
<td align="left">Beta thalassemia</td>
</tr>
<tr class="even">
<td align="left">M42.00</td>
<td align="right">108</td>
<td align="left">Scheuermann disease</td>
<td align="left">Juvenile osteochondrosis of spine, site unspecified</td>
</tr>
<tr class="odd">
<td align="left">I70.8</td>
<td align="right">108</td>
<td align="left">Retinopathy, arteriosclerotic</td>
<td align="left">Atherosclerosis of other arteries</td>
</tr>
<tr class="even">
<td align="left">C74.90</td>
<td align="right">108</td>
<td align="left">Neuroblastoma</td>
<td align="left">Malignant neoplasm of unspecified part of unspecified adrenal gland</td>
</tr>
<tr class="odd">
<td align="left">C52</td>
<td align="right">105</td>
<td align="left">Vaginal cancer</td>
<td align="left">Malignant neoplasm of vagina</td>
</tr>
<tr class="even">
<td align="left">C10.9</td>
<td align="right">105</td>
<td align="left">Oropharyngeal cancer, adult</td>
<td align="left">Malignant neoplasm of oropharynx, unspecified</td>
</tr>
<tr class="odd">
<td align="left">G00.9</td>
<td align="right">104</td>
<td align="left">Bacterial meningitis</td>
<td align="left">Bacterial meningitis, unspecified</td>
</tr>
<tr class="even">
<td align="left">D73.5</td>
<td align="right">104</td>
<td align="left">Splenic infarcts</td>
<td align="left">Infarction of spleen</td>
</tr>
<tr class="odd">
<td align="left">Q26.8</td>
<td align="right">103</td>
<td align="left">Pulmonary venous return anomaly</td>
<td align="left">Other congenital malformations of great veins</td>
</tr>
<tr class="even">
<td align="left">G23.1</td>
<td align="right">103</td>
<td align="left">Progressive supranuclear palsy</td>
<td align="left">Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]</td>
</tr>
<tr class="odd">
<td align="left">K76.7</td>
<td align="right">102</td>
<td align="left">Hepatorenal syndrome</td>
<td align="left">Hepatorenal syndrome</td>
</tr>
<tr class="even">
<td align="left">M83.9</td>
<td align="right">101</td>
<td align="left">Osteomalacia</td>
<td align="left">Adult osteomalacia, unspecified</td>
</tr>
<tr class="odd">
<td align="left">G72.41</td>
<td align="right">101</td>
<td align="left">Inclusion body myositis</td>
<td align="left">Inclusion body myositis [IBM]</td>
</tr>
<tr class="even">
<td align="left">L01.02</td>
<td align="right">100</td>
<td align="left">Eosinophilic pustular folliculitis</td>
<td align="left">Bockhart’s impetigo</td>
</tr>
<tr class="odd">
<td align="left">E51.9</td>
<td align="right">100</td>
<td align="left">Beriberi</td>
<td align="left">Thiamine deficiency, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q42.3</td>
<td align="right">99</td>
<td align="left">Imperforate anus</td>
<td align="left">Congenital absence, atresia and stenosis of anus without fistula</td>
</tr>
<tr class="odd">
<td align="left">Q22.4</td>
<td align="right">98</td>
<td align="left">Tricuspid atresia</td>
<td align="left">Congenital tricuspid stenosis</td>
</tr>
<tr class="even">
<td align="left">Q30.2</td>
<td align="right">97</td>
<td align="left">Bifid nose</td>
<td align="left">Fissured, notched and cleft nose</td>
</tr>
<tr class="odd">
<td align="left">D56.0</td>
<td align="right">97</td>
<td align="left">Alpha-thalassemia</td>
<td align="left">Alpha thalassemia</td>
</tr>
<tr class="even">
<td align="left">P91.2</td>
<td align="right">96</td>
<td align="left">Periventricular leukomalacia</td>
<td align="left">Neonatal cerebral leukomalacia</td>
</tr>
<tr class="odd">
<td align="left">L40.4</td>
<td align="right">96</td>
<td align="left">Guttate psoriasis</td>
<td align="left">Guttate psoriasis</td>
</tr>
<tr class="even">
<td align="left">I67.5</td>
<td align="right">96</td>
<td align="left">Moyamoya disease</td>
<td align="left">Moyamoya disease</td>
</tr>
<tr class="odd">
<td align="left">G04.91</td>
<td align="right">96</td>
<td align="left">Myelitis</td>
<td align="left">Myelitis, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q79.0</td>
<td align="right">95</td>
<td align="left">Congenital diaphragmatic hernia</td>
<td align="left">Congenital diaphragmatic hernia</td>
</tr>
<tr class="odd">
<td align="left">G54.8</td>
<td align="right">95</td>
<td align="left">Tarlov cysts</td>
<td align="left">Other nerve root and plexus disorders</td>
</tr>
<tr class="even">
<td align="left">F81.2</td>
<td align="right">95</td>
<td align="left">Gerstmann syndrome</td>
<td align="left">Mathematics disorder</td>
</tr>
<tr class="odd">
<td align="left">C24.9</td>
<td align="right">95</td>
<td align="left">Biliary tract cancer</td>
<td align="left">Malignant neoplasm of biliary tract, unspecified</td>
</tr>
<tr class="even">
<td align="left">K55.30</td>
<td align="right">94</td>
<td align="left">Necrotizing enterocolitis</td>
<td align="left">Necrotizing enterocolitis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D3A.098</td>
<td align="right">94</td>
<td align="left">VIPoma</td>
<td align="left">Benign carcinoid tumors of other sites</td>
</tr>
<tr class="even">
<td align="left">D30.00</td>
<td align="right">94</td>
<td align="left">Renal oncocytoma</td>
<td align="left">Benign neoplasm of unspecified kidney</td>
</tr>
<tr class="odd">
<td align="left">C68.0</td>
<td align="right">94</td>
<td align="left">Urethral cancer</td>
<td align="left">Malignant neoplasm of urethra</td>
</tr>
<tr class="even">
<td align="left">N85.6</td>
<td align="right">93</td>
<td align="left">Asherman’s syndrome</td>
<td align="left">Intrauterine synechiae</td>
</tr>
<tr class="odd">
<td align="left">L81.5</td>
<td align="right">93</td>
<td align="left">Hypomelanotic disorder</td>
<td align="left">Leukoderma, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">K22.3</td>
<td align="right">93</td>
<td align="left">Boerhaave syndrome</td>
<td align="left">Perforation of esophagus</td>
</tr>
<tr class="odd">
<td align="left">H71.90</td>
<td align="right">93</td>
<td align="left">Cholesteatoma</td>
<td align="left">Unspecified cholesteatoma, unspecified ear</td>
</tr>
<tr class="even">
<td align="left">A41.4</td>
<td align="right">93</td>
<td align="left">Clostridium perfringens infection</td>
<td align="left">Sepsis due to anaerobes</td>
</tr>
<tr class="odd">
<td align="left">Q13.1</td>
<td align="right">92</td>
<td align="left">Aniridia</td>
<td align="left">Absence of iris</td>
</tr>
<tr class="even">
<td align="left">L13.0</td>
<td align="right">92</td>
<td align="left">Dermatitis herpetiformis</td>
<td align="left">Dermatitis herpetiformis</td>
</tr>
<tr class="odd">
<td align="left">I25.41</td>
<td align="right">92</td>
<td align="left">Coronary artery aneurysm</td>
<td align="left">Coronary artery aneurysm</td>
</tr>
<tr class="even">
<td align="left">D43.4</td>
<td align="right">92</td>
<td align="left">Sacrococcygeal Teratoma</td>
<td align="left">Neoplasm of uncertain behavior of spinal cord</td>
</tr>
<tr class="odd">
<td align="left">I51.4</td>
<td align="right">91</td>
<td align="left">Myocarditis</td>
<td align="left">Myocarditis, unspecified</td>
</tr>
<tr class="even">
<td align="left">G44.53</td>
<td align="right">91</td>
<td align="left">Thunderclap headache</td>
<td align="left">Primary thunderclap headache</td>
</tr>
<tr class="odd">
<td align="left">A31.8</td>
<td align="right">91</td>
<td align="left">Mycobacterium Avium Complex</td>
<td align="left">Other mycobacterial infections</td>
</tr>
<tr class="even">
<td align="left">J82</td>
<td align="right">90</td>
<td align="left">Pneumonia, eosinophilic</td>
<td align="left">Pulmonary eosinophilia, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">D80.9</td>
<td align="right">90</td>
<td align="left">Primary agammaglobulinemia</td>
<td align="left">Immunodeficiency with predominantly antibody defects, unspecified</td>
</tr>
<tr class="even">
<td align="left">G57.50</td>
<td align="right">89</td>
<td align="left">Tarsal tunnel syndrome</td>
<td align="left">Tarsal tunnel syndrome, unspecified lower limb</td>
</tr>
<tr class="odd">
<td align="left">F63.9</td>
<td align="right">89</td>
<td align="left">I cell disease</td>
<td align="left">Impulse disorder, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q55.62</td>
<td align="right">88</td>
<td align="left">Penis agenesis</td>
<td align="left">Hypoplasia of penis</td>
</tr>
<tr class="odd">
<td align="left">D14.0</td>
<td align="right">88</td>
<td align="left">Endolymphatic sac tumor</td>
<td align="left">Benign neoplasm of middle ear, nasal cavity and accessory sinuses</td>
</tr>
<tr class="even">
<td align="left">Q44.6</td>
<td align="right">87</td>
<td align="left">Polycystic liver disease</td>
<td align="left">Cystic disease of liver</td>
</tr>
<tr class="odd">
<td align="left">M33.00</td>
<td align="right">87</td>
<td align="left">Juvenile dermatomyositis</td>
<td align="left">Juvenile dermatopolymyositis, organ involvement unspecified</td>
</tr>
<tr class="even">
<td align="left">C93.10</td>
<td align="right">87</td>
<td align="left">Chronic myelomonocytic leukemia</td>
<td align="left">Chronic myelomonocytic leukemia not having achieved remission</td>
</tr>
<tr class="odd">
<td align="left">A43.9</td>
<td align="right">87</td>
<td align="left">Nocardiosis</td>
<td align="left">Nocardiosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q26.2</td>
<td align="right">86</td>
<td align="left">Pulmonary venous return anomaly</td>
<td align="left">Total anomalous pulmonary venous connection</td>
</tr>
<tr class="odd">
<td align="left">D61.3</td>
<td align="right">86</td>
<td align="left">Aplastic anemia</td>
<td align="left">Idiopathic aplastic anemia</td>
</tr>
<tr class="even">
<td align="left">Q03.1</td>
<td align="right">85</td>
<td align="left">Dandy-Walker complex</td>
<td align="left">Atresia of foramina of Magendie and Luschka</td>
</tr>
<tr class="odd">
<td align="left">M65.20</td>
<td align="right">85</td>
<td align="left">Synovial Chondromatosis</td>
<td align="left">Calcific tendinitis, unspecified site</td>
</tr>
<tr class="even">
<td align="left">L81.6</td>
<td align="right">85</td>
<td align="left">Alezzandrini syndrome</td>
<td align="left">Other disorders of diminished melanin formation</td>
</tr>
<tr class="odd">
<td align="left">C11.9</td>
<td align="right">85</td>
<td align="left">Nasopharyngeal carcinoma</td>
<td align="left">Malignant neoplasm of nasopharynx, unspecified</td>
</tr>
<tr class="even">
<td align="left">N08</td>
<td align="right">84</td>
<td align="left">Glomerulonephritis</td>
<td align="left">Glomerular disorders in diseases classified elsewhere</td>
</tr>
<tr class="odd">
<td align="left">J60</td>
<td align="right">84</td>
<td align="left">Coal worker’s pneumoconiosis</td>
<td align="left">Coalworker’s pneumoconiosis</td>
</tr>
<tr class="even">
<td align="left">C91.Z0</td>
<td align="right">84</td>
<td align="left">Large granular lymphocyte leukemia</td>
<td align="left">Other lymphoid leukemia not having achieved remission</td>
</tr>
<tr class="odd">
<td align="left">Q61.9</td>
<td align="right">83</td>
<td align="left">Meckel syndrome</td>
<td align="left">Cystic kidney disease, unspecified</td>
</tr>
<tr class="even">
<td align="left">F07.0</td>
<td align="right">83</td>
<td align="left">Kluver Bucy syndrome</td>
<td align="left">Personality change due to known physiological condition</td>
</tr>
<tr class="odd">
<td align="left">D59.6</td>
<td align="right">83</td>
<td align="left">Paroxysmal cold hemoglobinuria</td>
<td align="left">Hemoglobinuria due to hemolysis from other external causes</td>
</tr>
<tr class="even">
<td align="left">M08.20</td>
<td align="right">82</td>
<td align="left">Systemic onset juvenile idiopathic arthritis</td>
<td align="left">Juvenile rheumatoid arthritis with systemic onset, unspecified site</td>
</tr>
<tr class="odd">
<td align="left">Q24.0</td>
<td align="right">81</td>
<td align="left">Dextrocardia</td>
<td align="left">Dextrocardia</td>
</tr>
<tr class="even">
<td align="left">I78.0</td>
<td align="right">81</td>
<td align="left">Hereditary hemorrhagic telangiectasia</td>
<td align="left">Hereditary hemorrhagic telangiectasia</td>
</tr>
<tr class="odd">
<td align="left">B02.21</td>
<td align="right">81</td>
<td align="left">Herpes zoster oticus</td>
<td align="left">Postherpetic geniculate ganglionitis</td>
</tr>
<tr class="even">
<td align="left">Q64.4</td>
<td align="right">80</td>
<td align="left">Urachal cyst</td>
<td align="left">Malformation of urachus</td>
</tr>
<tr class="odd">
<td align="left">L88</td>
<td align="right">80</td>
<td align="left">Pyoderma gangrenosum</td>
<td align="left">Pyoderma gangrenosum</td>
</tr>
<tr class="even">
<td align="left">E55.0</td>
<td align="right">80</td>
<td align="left">Rickets</td>
<td align="left">Rickets, active</td>
</tr>
<tr class="odd">
<td align="left">C91.40</td>
<td align="right">79</td>
<td align="left">Hairy cell leukemia</td>
<td align="left">Hairy cell leukemia not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">C08.9</td>
<td align="right">79</td>
<td align="left">Polymorphous low-grade adenocarcinoma</td>
<td align="left">Malignant neoplasm of major salivary gland, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q43.1</td>
<td align="right">78</td>
<td align="left">Hirschsprung’s disease</td>
<td align="left">Hirschsprung’s disease</td>
</tr>
<tr class="even">
<td align="left">K65.4</td>
<td align="right">78</td>
<td align="left">Sclerosing mesenteritis</td>
<td align="left">Sclerosing mesenteritis</td>
</tr>
<tr class="odd">
<td align="left">N30.80</td>
<td align="right">77</td>
<td align="left">Eosinophilic cystitis</td>
<td align="left">Other cystitis without hematuria</td>
</tr>
<tr class="even">
<td align="left">L93.1</td>
<td align="right">77</td>
<td align="left">Cutaneous lupus erythematosus</td>
<td align="left">Subacute cutaneous lupus erythematosus</td>
</tr>
<tr class="odd">
<td align="left">E24.0</td>
<td align="right">77</td>
<td align="left">ACTH-secreting pituitary adenoma</td>
<td align="left">Pituitary-dependent Cushing’s disease</td>
</tr>
<tr class="even">
<td align="left">D59.4</td>
<td align="right">77</td>
<td align="left">Thrombotic thrombocytopenic purpura, congenital</td>
<td align="left">Other nonautoimmune hemolytic anemias</td>
</tr>
<tr class="odd">
<td align="left">B45.9</td>
<td align="right">77</td>
<td align="left">Cryptococcosis</td>
<td align="left">Cryptococcosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">I73.81</td>
<td align="right">76</td>
<td align="left">Erythromelalgia</td>
<td align="left">Erythromelalgia</td>
</tr>
<tr class="odd">
<td align="left">G54.5</td>
<td align="right">76</td>
<td align="left">Parsonage Turner syndrome</td>
<td align="left">Neuralgic amyotrophy</td>
</tr>
<tr class="even">
<td align="left">N46.01</td>
<td align="right">74</td>
<td align="left">Spermatogenesis arrest</td>
<td align="left">Organic azoospermia</td>
</tr>
<tr class="odd">
<td align="left">O26.86</td>
<td align="right">71</td>
<td align="left">Pruritic urticarial papules plaques of pregnancy</td>
<td align="left">Pruritic urticarial papules and plaques of pregnancy (PUPPP)</td>
</tr>
<tr class="even">
<td align="left">G52.1</td>
<td align="right">71</td>
<td align="left">Glossopharyngeal neuralgia</td>
<td align="left">Disorders of glossopharyngeal nerve</td>
</tr>
<tr class="odd">
<td align="left">Q24.6</td>
<td align="right">70</td>
<td align="left">Congenital heart block</td>
<td align="left">Congenital heart block</td>
</tr>
<tr class="even">
<td align="left">N94.810</td>
<td align="right">70</td>
<td align="left">Vulvar Vestibulitis Syndrome</td>
<td align="left">Vulvar vestibulitis</td>
</tr>
<tr class="odd">
<td align="left">D59.5</td>
<td align="right">70</td>
<td align="left">Paroxysmal nocturnal hemoglobinuria</td>
<td align="left">Paroxysmal nocturnal hemoglobinuria [Marchiafava-Micheli]</td>
</tr>
<tr class="even">
<td align="left">Q78.6</td>
<td align="right">69</td>
<td align="left">Hereditary multiple osteochondromas</td>
<td align="left">Multiple congenital exostoses</td>
</tr>
<tr class="odd">
<td align="left">M94.1</td>
<td align="right">69</td>
<td align="left">Relapsing polychondritis</td>
<td align="left">Relapsing polychondritis</td>
</tr>
<tr class="even">
<td align="left">C4A.9</td>
<td align="right">69</td>
<td align="left">Merkel cell carcinoma</td>
<td align="left">Merkel cell carcinoma, unspecified</td>
</tr>
<tr class="odd">
<td align="left">P08.0</td>
<td align="right">68</td>
<td align="left">Fetal macrosomia</td>
<td align="left">Exceptionally large newborn baby</td>
</tr>
<tr class="even">
<td align="left">C30.0</td>
<td align="right">68</td>
<td align="left">Olfactory neuroblastoma</td>
<td align="left">Malignant neoplasm of nasal cavity</td>
</tr>
<tr class="odd">
<td align="left">Q79.3</td>
<td align="right">67</td>
<td align="left">Gastroschisis</td>
<td align="left">Gastroschisis</td>
</tr>
<tr class="even">
<td align="left">Q78.9</td>
<td align="right">67</td>
<td align="left">Chondrodystrophy</td>
<td align="left">Osteochondrodysplasia, unspecified</td>
</tr>
<tr class="odd">
<td align="left">L10.9</td>
<td align="right">66</td>
<td align="left">Pemphigus</td>
<td align="left">Pemphigus, unspecified</td>
</tr>
<tr class="even">
<td align="left">L56.4</td>
<td align="right">65</td>
<td align="left">Hydroa vacciniforme</td>
<td align="left">Polymorphous light eruption</td>
</tr>
<tr class="odd">
<td align="left">I77.4</td>
<td align="right">65</td>
<td align="left">Celiac artery compression syndrome</td>
<td align="left">Celiac artery compression syndrome</td>
</tr>
<tr class="even">
<td align="left">D80.6</td>
<td align="right">65</td>
<td align="left">Specific antibody deficiency</td>
<td align="left">Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia</td>
</tr>
<tr class="odd">
<td align="left">Q85.02</td>
<td align="right">63</td>
<td align="left">Neurofibromatosis type 2</td>
<td align="left">Neurofibromatosis, type 2</td>
</tr>
<tr class="even">
<td align="left">Q64.2</td>
<td align="right">63</td>
<td align="left">Posterior urethral valves</td>
<td align="left">Congenital posterior urethral valves</td>
</tr>
<tr class="odd">
<td align="left">Q38.0</td>
<td align="right">63</td>
<td align="left">Van der Woude syndrome</td>
<td align="left">Congenital malformations of lips, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">C49.10</td>
<td align="right">63</td>
<td align="left">Stewart Treves syndrome</td>
<td align="left">Malignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulder</td>
</tr>
<tr class="odd">
<td align="left">B48.8</td>
<td align="right">63</td>
<td align="left">Phaeohyphomycosis</td>
<td align="left">Other specified mycoses</td>
</tr>
<tr class="even">
<td align="left">A80.9</td>
<td align="right">63</td>
<td align="left">Poliomyelitis</td>
<td align="left">Acute poliomyelitis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">G40.301</td>
<td align="right">62</td>
<td align="left">Status epilepticus</td>
<td align="left">Generalized idiopathic epilepsy and epileptic syndromes, not intractable, with status epilepticus</td>
</tr>
<tr class="even">
<td align="left">Q63.8</td>
<td align="right">61</td>
<td align="left">AREDYLD</td>
<td align="left">Other specified congenital malformations of kidney</td>
</tr>
<tr class="odd">
<td align="left">J43.0</td>
<td align="right">61</td>
<td align="left">Swyer-James syndrome</td>
<td align="left">Unilateral pulmonary emphysema [MacLeod’s syndrome]</td>
</tr>
<tr class="even">
<td align="left">I68.0</td>
<td align="right">61</td>
<td align="left">Hereditary cerebral hemorrhage with amyloidosis</td>
<td align="left">Cerebral amyloid angiopathy</td>
</tr>
<tr class="odd">
<td align="left">H21.239</td>
<td align="right">61</td>
<td align="left">Pigment-dispersion syndrome</td>
<td align="left">Degeneration of iris (pigmentary), unspecified eye</td>
</tr>
<tr class="even">
<td align="left">A77.40</td>
<td align="right">61</td>
<td align="left">Ehrlichiosis</td>
<td align="left">Ehrlichiosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">N25.0</td>
<td align="right">60</td>
<td align="left">Renal rickets</td>
<td align="left">Renal osteodystrophy</td>
</tr>
<tr class="even">
<td align="left">Q60.2</td>
<td align="right">59</td>
<td align="left">Renal agenesis</td>
<td align="left">Renal agenesis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q32.2</td>
<td align="right">59</td>
<td align="left">Tracheobronchomalacia</td>
<td align="left">Congenital bronchomalacia</td>
</tr>
<tr class="even">
<td align="left">D70.0</td>
<td align="right">59</td>
<td align="left">Severe congenital neutropenia autosomal recessive 3</td>
<td align="left">Congenital agranulocytosis</td>
</tr>
<tr class="odd">
<td align="left">C69.20</td>
<td align="right">59</td>
<td align="left">Melanoma-associated retinopathy</td>
<td align="left">Malignant neoplasm of unspecified retina</td>
</tr>
<tr class="even">
<td align="left">E83.31</td>
<td align="right">58</td>
<td align="left">Hypophosphatemic rickets</td>
<td align="left">Familial hypophosphatemia</td>
</tr>
<tr class="odd">
<td align="left">O26.619</td>
<td align="right">57</td>
<td align="left">Intrahepatic cholestasis of pregnancy</td>
<td align="left">Liver and biliary tract disorders in pregnancy, unspecified trimester</td>
</tr>
<tr class="even">
<td align="left">E70.329</td>
<td align="right">57</td>
<td align="left">Oculocutaneous albinism</td>
<td align="left">Oculocutaneous albinism, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C83.70</td>
<td align="right">57</td>
<td align="left">Burkitt lymphoma</td>
<td align="left">Burkitt lymphoma, unspecified site</td>
</tr>
<tr class="even">
<td align="left">M26.213</td>
<td align="right">56</td>
<td align="left">Prognathism mandibular</td>
<td align="left">Malocclusion, Angle’s class III</td>
</tr>
<tr class="odd">
<td align="left">Q38.3</td>
<td align="right">55</td>
<td align="left">Cleft tongue</td>
<td align="left">Other congenital malformations of tongue</td>
</tr>
<tr class="even">
<td align="left">M31.4</td>
<td align="right">55</td>
<td align="left">Takayasu arteritis</td>
<td align="left">Aortic arch syndrome [Takayasu]</td>
</tr>
<tr class="odd">
<td align="left">G83.89</td>
<td align="right">55</td>
<td align="left">Alternating hemiplegia of childhood</td>
<td align="left">Other specified paralytic syndromes</td>
</tr>
<tr class="even">
<td align="left">D50.1</td>
<td align="right">55</td>
<td align="left">Plummer Vinson syndrome</td>
<td align="left">Sideropenic dysphagia</td>
</tr>
<tr class="odd">
<td align="left">K06.1</td>
<td align="right">54</td>
<td align="left">Gingival fibromatosis, 1</td>
<td align="left">Gingival enlargement</td>
</tr>
<tr class="even">
<td align="left">Q75.8</td>
<td align="right">53</td>
<td align="left">Frontonasal dysplasia</td>
<td align="left">Other specified congenital malformations of skull and face bones</td>
</tr>
<tr class="odd">
<td align="left">N25.1</td>
<td align="right">53</td>
<td align="left">Nephrogenic diabetes insipidus</td>
<td align="left">Nephrogenic diabetes insipidus</td>
</tr>
<tr class="even">
<td align="left">C13.9</td>
<td align="right">53</td>
<td align="left">Hypopharyngeal cancer</td>
<td align="left">Malignant neoplasm of hypopharynx, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A35</td>
<td align="right">53</td>
<td align="left">Tetanus</td>
<td align="left">Other tetanus</td>
</tr>
<tr class="even">
<td align="left">L40.54</td>
<td align="right">52</td>
<td align="left">Psoriatic juvenile idiopathic arthritis</td>
<td align="left">Psoriatic juvenile arthropathy</td>
</tr>
<tr class="odd">
<td align="left">I42.3</td>
<td align="right">52</td>
<td align="left">Endomyocardial fibrosis</td>
<td align="left">Endomyocardial (eosinophilic) disease</td>
</tr>
<tr class="even">
<td align="left">D47.4</td>
<td align="right">52</td>
<td align="left">Myelofibrosis</td>
<td align="left">Osteomyelofibrosis</td>
</tr>
<tr class="odd">
<td align="left">C96.2</td>
<td align="right">52</td>
<td align="left">Miles-Carpenter x-linked mental retardation syndrome</td>
<td align="left">Malignant mast cell tumor</td>
</tr>
<tr class="even">
<td align="left">Q28.8</td>
<td align="right">51</td>
<td align="left">Patent ductus venosus</td>
<td align="left">Other specified congenital malformations of circulatory system</td>
</tr>
<tr class="odd">
<td align="left">G80.3</td>
<td align="right">51</td>
<td align="left">Cerebral palsy athetoid</td>
<td align="left">Athetoid cerebral palsy</td>
</tr>
<tr class="even">
<td align="left">D36.7</td>
<td align="right">51</td>
<td align="left">Perineurioma</td>
<td align="left">Benign neoplasm of other specified sites</td>
</tr>
<tr class="odd">
<td align="left">Q76.1</td>
<td align="right">50</td>
<td align="left">Klippel Feil syndrome</td>
<td align="left">Klippel-Feil syndrome</td>
</tr>
<tr class="even">
<td align="left">Q14.8</td>
<td align="right">50</td>
<td align="left">Retinochoroidal coloboma</td>
<td align="left">Other congenital malformations of posterior segment of eye</td>
</tr>
<tr class="odd">
<td align="left">L66.2</td>
<td align="right">50</td>
<td align="left">Quinquaud’s decalvans folliculitis</td>
<td align="left">Folliculitis decalvans</td>
</tr>
<tr class="even">
<td align="left">D82.4</td>
<td align="right">50</td>
<td align="left">Hyper IgE syndrome</td>
<td align="left">Hyperimmunoglobulin E [IgE] syndrome</td>
</tr>
<tr class="odd">
<td align="left">A52.3</td>
<td align="right">50</td>
<td align="left">Neurosyphilis</td>
<td align="left">Neurosyphilis, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q86.0</td>
<td align="right">49</td>
<td align="left">Fetal Alcohol Spectrum Disorders</td>
<td align="left">Fetal alcohol syndrome (dysmorphic)</td>
</tr>
<tr class="odd">
<td align="left">N03.2</td>
<td align="right">49</td>
<td align="left">Membranous nephropathy</td>
<td align="left">Chronic nephritic syndrome with diffuse membranous glomerulonephritis</td>
</tr>
<tr class="even">
<td align="left">M92.9</td>
<td align="right">49</td>
<td align="left">Osteochondrosis</td>
<td align="left">Juvenile osteochondrosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">L10.0</td>
<td align="right">49</td>
<td align="left">Pemphigus vulgaris</td>
<td align="left">Pemphigus vulgaris</td>
</tr>
<tr class="even">
<td align="left">K55.8</td>
<td align="right">49</td>
<td align="left">Superior mesenteric artery syndrome</td>
<td align="left">Other vascular disorders of intestine</td>
</tr>
<tr class="odd">
<td align="left">I82.0</td>
<td align="right">49</td>
<td align="left">Budd-Chiari syndrome</td>
<td align="left">Budd-Chiari syndrome</td>
</tr>
<tr class="even">
<td align="left">G90.8</td>
<td align="right">49</td>
<td align="left">Crisponi syndrome</td>
<td align="left">Other disorders of autonomic nervous system</td>
</tr>
<tr class="odd">
<td align="left">E83.01</td>
<td align="right">49</td>
<td align="left">Wilson disease</td>
<td align="left">Wilson’s disease</td>
</tr>
<tr class="even">
<td align="left">D46.C</td>
<td align="right">49</td>
<td align="left">5q- syndrome</td>
<td align="left">Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality</td>
</tr>
<tr class="odd">
<td align="left">C86.6</td>
<td align="right">49</td>
<td align="left">Lymphomatoid papulosis</td>
<td align="left">Primary cutaneous CD30-positive T-cell proliferations</td>
</tr>
<tr class="even">
<td align="left">B00.4</td>
<td align="right">49</td>
<td align="left">Herpes simplex encephalitis</td>
<td align="left">Herpesviral encephalitis</td>
</tr>
<tr class="odd">
<td align="left">Q44.4</td>
<td align="right">48</td>
<td align="left">Bile duct cysts</td>
<td align="left">Choledochal cyst</td>
</tr>
<tr class="even">
<td align="left">G61.82</td>
<td align="right">48</td>
<td align="left">Multifocal motor neuropathy</td>
<td align="left">Multifocal motor neuropathy</td>
</tr>
<tr class="odd">
<td align="left">E76.01</td>
<td align="right">48</td>
<td align="left">Hurler syndrome</td>
<td align="left">Hurler’s syndrome</td>
</tr>
<tr class="even">
<td align="left">E50.9</td>
<td align="right">48</td>
<td align="left">Keratomalacia</td>
<td align="left">Vitamin A deficiency, unspecified</td>
</tr>
<tr class="odd">
<td align="left">D89.1</td>
<td align="right">48</td>
<td align="left">Cryoglobulinemia</td>
<td align="left">Cryoglobulinemia</td>
</tr>
<tr class="even">
<td align="left">A42.9</td>
<td align="right">48</td>
<td align="left">Actinomycosis</td>
<td align="left">Actinomycosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q38.8</td>
<td align="right">47</td>
<td align="left">Palatopharyngeal incompetence</td>
<td align="left">Other congenital malformations of pharynx</td>
</tr>
<tr class="even">
<td align="left">L12.9</td>
<td align="right">47</td>
<td align="left">Bullous pemphigoid</td>
<td align="left">Pemphigoid, unspecified</td>
</tr>
<tr class="odd">
<td align="left">I28.8</td>
<td align="right">47</td>
<td align="left">Pulmonary vein stenosis</td>
<td align="left">Other diseases of pulmonary vessels</td>
</tr>
<tr class="even">
<td align="left">D73.89</td>
<td align="right">47</td>
<td align="left">Wandering spleen</td>
<td align="left">Other diseases of spleen</td>
</tr>
<tr class="odd">
<td align="left">Q20.0</td>
<td align="right">46</td>
<td align="left">Persistent truncus arteriosus</td>
<td align="left">Common arterial trunk</td>
</tr>
<tr class="even">
<td align="left">D80.4</td>
<td align="right">46</td>
<td align="left">Selective IgM deficiency</td>
<td align="left">Selective deficiency of immunoglobulin M [IgM]</td>
</tr>
<tr class="odd">
<td align="left">Q25.21</td>
<td align="right">45</td>
<td align="left">Aortic arch interruption</td>
<td align="left">Interruption of aortic arch</td>
</tr>
<tr class="even">
<td align="left">P35.1</td>
<td align="right">45</td>
<td align="left">Congenital cytomegalovirus</td>
<td align="left">Congenital cytomegalovirus infection</td>
</tr>
<tr class="odd">
<td align="left">G58.7</td>
<td align="right">45</td>
<td align="left">Mononeuritis multiplex</td>
<td align="left">Mononeuritis multiplex</td>
</tr>
<tr class="even">
<td align="left">G44.83</td>
<td align="right">45</td>
<td align="left">Cough headache</td>
<td align="left">Primary cough headache</td>
</tr>
<tr class="odd">
<td align="left">Q68.1</td>
<td align="right">44</td>
<td align="left">Clasped thumbs, congenital</td>
<td align="left">Congenital deformity of finger(s) and hand</td>
</tr>
<tr class="even">
<td align="left">H18.899</td>
<td align="right">44</td>
<td align="left">Iridocorneal endothelial syndrome</td>
<td align="left">Other specified disorders of cornea, unspecified eye</td>
</tr>
<tr class="odd">
<td align="left">F94.0</td>
<td align="right">44</td>
<td align="left">Elective mutism</td>
<td align="left">Selective mutism</td>
</tr>
<tr class="even">
<td align="left">F84.8</td>
<td align="right">44</td>
<td align="left">FOXG1 syndrome</td>
<td align="left">Other pervasive developmental disorders</td>
</tr>
<tr class="odd">
<td align="left">D68.1</td>
<td align="right">44</td>
<td align="left">Factor XI deficiency</td>
<td align="left">Hereditary factor XI deficiency</td>
</tr>
<tr class="even">
<td align="left">Q64.10</td>
<td align="right">43</td>
<td align="left">Exstrophy of the bladder</td>
<td align="left">Exstrophy of urinary bladder, unspecified</td>
</tr>
<tr class="odd">
<td align="left">L13.8</td>
<td align="right">43</td>
<td align="left">Linear IgA disease</td>
<td align="left">Other specified bullous disorders</td>
</tr>
<tr class="even">
<td align="left">D61.01</td>
<td align="right">43</td>
<td align="left">Diamond-Blackfan anemia</td>
<td align="left">Constitutional (pure) red blood cell aplasia</td>
</tr>
<tr class="odd">
<td align="left">D42.9</td>
<td align="right">43</td>
<td align="left">Hemangiopericytoma</td>
<td align="left">Neoplasm of uncertain behavior of meninges, unspecified</td>
</tr>
<tr class="even">
<td align="left">J15.0</td>
<td align="right">42</td>
<td align="left">Klebsiella infection</td>
<td align="left">Pneumonia due to Klebsiella pneumoniae</td>
</tr>
<tr class="odd">
<td align="left">G44.51</td>
<td align="right">42</td>
<td align="left">Hemicrania continua</td>
<td align="left">Hemicrania continua</td>
</tr>
<tr class="even">
<td align="left">D59.3</td>
<td align="right">42</td>
<td align="left">Hemolytic uremic syndrome</td>
<td align="left">Hemolytic-uremic syndrome</td>
</tr>
<tr class="odd">
<td align="left">C85.91</td>
<td align="right">42</td>
<td align="left">Orbital lymphoma</td>
<td align="left">Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck</td>
</tr>
<tr class="even">
<td align="left">C50.929</td>
<td align="right">42</td>
<td align="left">Breast cancer, male</td>
<td align="left">Malignant neoplasm of unspecified site of unspecified male breast</td>
</tr>
<tr class="odd">
<td align="left">Q38.2</td>
<td align="right">41</td>
<td align="left">Macroglossia</td>
<td align="left">Macroglossia</td>
</tr>
<tr class="even">
<td align="left">J84.81</td>
<td align="right">41</td>
<td align="left">Lymphangioleiomyomatosis</td>
<td align="left">Lymphangioleiomyomatosis</td>
</tr>
<tr class="odd">
<td align="left">D84.8</td>
<td align="right">41</td>
<td align="left">PASLI disease</td>
<td align="left">Other specified immunodeficiencies</td>
</tr>
<tr class="even">
<td align="left">A28.1</td>
<td align="right">41</td>
<td align="left">Cat scratch disease</td>
<td align="left">Cat-scratch disease</td>
</tr>
<tr class="odd">
<td align="left">Q15.8</td>
<td align="right">40</td>
<td align="left">Norrie disease</td>
<td align="left">Other specified congenital malformations of eye</td>
</tr>
<tr class="even">
<td align="left">G31.85</td>
<td align="right">40</td>
<td align="left">Corticobasal degeneration</td>
<td align="left">Corticobasal degeneration</td>
</tr>
<tr class="odd">
<td align="left">E72.01</td>
<td align="right">40</td>
<td align="left">Cystinuria</td>
<td align="left">Cystinuria</td>
</tr>
<tr class="even">
<td align="left">C75.3</td>
<td align="right">40</td>
<td align="left">Pineal germ cell tumor</td>
<td align="left">Malignant neoplasm of pineal gland</td>
</tr>
<tr class="odd">
<td align="left">A48.1</td>
<td align="right">40</td>
<td align="left">Legionellosis</td>
<td align="left">Legionnaires’ disease</td>
</tr>
<tr class="even">
<td align="left">Q13.89</td>
<td align="right">39</td>
<td align="left">Anterior segment mesenchymal dysgenesis</td>
<td align="left">Other congenital malformations of anterior segment of eye</td>
</tr>
<tr class="odd">
<td align="left">M31.8</td>
<td align="right">39</td>
<td align="left">Hypocomplementemic urticarial vasculitis</td>
<td align="left">Other specified necrotizing vasculopathies</td>
</tr>
<tr class="even">
<td align="left">E70.30</td>
<td align="right">39</td>
<td align="left">Albinism</td>
<td align="left">Albinism, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A07.2</td>
<td align="right">39</td>
<td align="left">Cryptosporidiosis</td>
<td align="left">Cryptosporidiosis</td>
</tr>
<tr class="even">
<td align="left">Q20.8</td>
<td align="right">38</td>
<td align="left">Cor biloculare</td>
<td align="left">Other congenital malformations of cardiac chambers and connections</td>
</tr>
<tr class="odd">
<td align="left">M85.50</td>
<td align="right">38</td>
<td align="left">Aneurysmal bone cysts</td>
<td align="left">Aneurysmal bone cyst, unspecified site</td>
</tr>
<tr class="even">
<td align="left">L63.1</td>
<td align="right">38</td>
<td align="left">Alopecia universalis</td>
<td align="left">Alopecia universalis</td>
</tr>
<tr class="odd">
<td align="left">H50.69</td>
<td align="right">38</td>
<td align="left">Congenital fibrosis of extraocular muscles</td>
<td align="left">Other mechanical strabismus</td>
</tr>
<tr class="even">
<td align="left">G70.80</td>
<td align="right">38</td>
<td align="left">Lambert Eaton myasthenic syndrome</td>
<td align="left">Lambert-Eaton syndrome, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E76.3</td>
<td align="right">38</td>
<td align="left">Mucopolysaccharidosis</td>
<td align="left">Mucopolysaccharidosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">C79.60</td>
<td align="right">38</td>
<td align="left">Krukenberg carcinoma</td>
<td align="left">Secondary malignant neoplasm of unspecified ovary</td>
</tr>
<tr class="odd">
<td align="left">C75.1</td>
<td align="right">38</td>
<td align="left">Pituitary cancer</td>
<td align="left">Malignant neoplasm of pituitary gland</td>
</tr>
<tr class="even">
<td align="left">N49.3</td>
<td align="right">37</td>
<td align="left">Fournier gangrene</td>
<td align="left">Fournier gangrene</td>
</tr>
<tr class="odd">
<td align="left">M60.009</td>
<td align="right">37</td>
<td align="left">Infective myositis</td>
<td align="left">Infective myositis, unspecified site</td>
</tr>
<tr class="even">
<td align="left">N05.5</td>
<td align="right">36</td>
<td align="left">Membranoproliferative glomerulonephritis</td>
<td align="left">Unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis</td>
</tr>
<tr class="odd">
<td align="left">L94.1</td>
<td align="right">36</td>
<td align="left">Linear scleroderma</td>
<td align="left">Linear scleroderma</td>
</tr>
<tr class="even">
<td align="left">E16.4</td>
<td align="right">36</td>
<td align="left">Zollinger-Ellison syndrome</td>
<td align="left">Increased secretion of gastrin</td>
</tr>
<tr class="odd">
<td align="left">D33.0</td>
<td align="right">36</td>
<td align="left">Dysembryoplastic neuroepithelial tumor</td>
<td align="left">Benign neoplasm of brain, supratentorial</td>
</tr>
<tr class="even">
<td align="left">D32.1</td>
<td align="right">36</td>
<td align="left">Spinal meningioma</td>
<td align="left">Benign neoplasm of spinal meninges</td>
</tr>
<tr class="odd">
<td align="left">Q25.43</td>
<td align="right">35</td>
<td align="left">Familial thoracic aortic aneurysm and dissection</td>
<td align="left">Congenital aneurysm of aorta</td>
</tr>
<tr class="even">
<td align="left">L66.3</td>
<td align="right">35</td>
<td align="left">Dissecting cellulitis of the scalp</td>
<td align="left">Perifolliculitis capitis abscedens</td>
</tr>
<tr class="odd">
<td align="left">F98.21</td>
<td align="right">35</td>
<td align="left">Rumination disorder</td>
<td align="left">Rumination disorder of infancy</td>
</tr>
<tr class="even">
<td align="left">D67</td>
<td align="right">34</td>
<td align="left">Hemophilia B</td>
<td align="left">Hereditary factor IX deficiency</td>
</tr>
<tr class="odd">
<td align="left">B46.9</td>
<td align="right">34</td>
<td align="left">Zygomycosis</td>
<td align="left">Zygomycosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q44.5</td>
<td align="right">33</td>
<td align="left">Caroli disease</td>
<td align="left">Other congenital malformations of bile ducts</td>
</tr>
<tr class="odd">
<td align="left">K00.0</td>
<td align="right">33</td>
<td align="left">Anodontia</td>
<td align="left">Anodontia</td>
</tr>
<tr class="even">
<td align="left">I73.1</td>
<td align="right">33</td>
<td align="left">Buerger disease</td>
<td align="left">Thromboangiitis obliterans [Buerger’s disease]</td>
</tr>
<tr class="odd">
<td align="left">A86</td>
<td align="right">33</td>
<td align="left">Acute necrotizing encephalopathy</td>
<td align="left">Unspecified viral encephalitis</td>
</tr>
<tr class="even">
<td align="left">Q25.72</td>
<td align="right">32</td>
<td align="left">Pulmonary arteriovenous malformation</td>
<td align="left">Congenital pulmonary arteriovenous malformation</td>
</tr>
<tr class="odd">
<td align="left">L92.1</td>
<td align="right">32</td>
<td align="left">Necrobiosis lipoidica</td>
<td align="left">Necrobiosis lipoidica, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">E31.21</td>
<td align="right">32</td>
<td align="left">Multiple endocrine neoplasia type 1</td>
<td align="left">Multiple endocrine neoplasia [MEN] type I</td>
</tr>
<tr class="odd">
<td align="left">Q62.39</td>
<td align="right">31</td>
<td align="left">Multicystic renal dysplasia, bilateral</td>
<td align="left">Other obstructive defects of renal pelvis and ureter</td>
</tr>
<tr class="even">
<td align="left">I67.7</td>
<td align="right">31</td>
<td align="left">Primary angiitis of the central nervous system</td>
<td align="left">Cerebral arteritis, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">G80.2</td>
<td align="right">31</td>
<td align="left">Cerebral palsy spastic hemiplegic</td>
<td align="left">Spastic hemiplegic cerebral palsy</td>
</tr>
<tr class="even">
<td align="left">E75.23</td>
<td align="right">31</td>
<td align="left">Krabbe disease</td>
<td align="left">Krabbe disease</td>
</tr>
<tr class="odd">
<td align="left">Q39.0</td>
<td align="right">30</td>
<td align="left">Esophageal atresia</td>
<td align="left">Atresia of esophagus without fistula</td>
</tr>
<tr class="even">
<td align="left">M31.7</td>
<td align="right">30</td>
<td align="left">Microscopic polyangiitis</td>
<td align="left">Microscopic polyangiitis</td>
</tr>
<tr class="odd">
<td align="left">K52.81</td>
<td align="right">30</td>
<td align="left">Eosinophilic enteropathy</td>
<td align="left">Eosinophilic gastritis or gastroenteritis</td>
</tr>
<tr class="even">
<td align="left">G12.0</td>
<td align="right">30</td>
<td align="left">Spinal muscular atrophy 1</td>
<td align="left">Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]</td>
</tr>
<tr class="odd">
<td align="left">G96.8</td>
<td align="right">29</td>
<td align="left">Spinocerebellar ataxia 3</td>
<td align="left">Other specified disorders of central nervous system</td>
</tr>
<tr class="even">
<td align="left">E74.03</td>
<td align="right">29</td>
<td align="left">Glycogen storage disease type 3</td>
<td align="left">Cori disease</td>
</tr>
<tr class="odd">
<td align="left">C69.90</td>
<td align="right">29</td>
<td align="left">Ocular melanoma</td>
<td align="left">Malignant neoplasm of unspecified site of unspecified eye</td>
</tr>
<tr class="even">
<td align="left">Q91.3</td>
<td align="right">28</td>
<td align="left">Trisomy 18</td>
<td align="left">Trisomy 18, unspecified</td>
</tr>
<tr class="odd">
<td align="left">M06.1</td>
<td align="right">28</td>
<td align="left">Adult-onset Still’s disease</td>
<td align="left">Adult-onset Still’s disease</td>
</tr>
<tr class="even">
<td align="left">E74.39</td>
<td align="right">28</td>
<td align="left">Glucose-galactose malabsorption</td>
<td align="left">Other disorders of intestinal carbohydrate absorption</td>
</tr>
<tr class="odd">
<td align="left">E54</td>
<td align="right">28</td>
<td align="left">Scurvy</td>
<td align="left">Ascorbic acid deficiency</td>
</tr>
<tr class="even">
<td align="left">C90.10</td>
<td align="right">28</td>
<td align="left">Plasma cell leukemia</td>
<td align="left">Plasma cell leukemia not having achieved remission</td>
</tr>
<tr class="odd">
<td align="left">Q74.9</td>
<td align="right">27</td>
<td align="left">Multiple pterygium syndrome Escobar type</td>
<td align="left">Unspecified congenital malformation of limb(s)</td>
</tr>
<tr class="even">
<td align="left">L44.0</td>
<td align="right">27</td>
<td align="left">Pityriasis rubra pilaris</td>
<td align="left">Pityriasis rubra pilaris</td>
</tr>
<tr class="odd">
<td align="left">G80.4</td>
<td align="right">27</td>
<td align="left">Cerebral palsy ataxic</td>
<td align="left">Ataxic cerebral palsy</td>
</tr>
<tr class="even">
<td align="left">D57.80</td>
<td align="right">27</td>
<td align="left">Sickle cell - hemoglobin D disease</td>
<td align="left">Other sickle-cell disorders without crisis</td>
</tr>
<tr class="odd">
<td align="left">Q30.0</td>
<td align="right">26</td>
<td align="left">Radial ray hypoplasia choanal atresia</td>
<td align="left">Choanal atresia</td>
</tr>
<tr class="even">
<td align="left">M34.89</td>
<td align="right">26</td>
<td align="left">Limited systemic sclerosis</td>
<td align="left">Other systemic sclerosis</td>
</tr>
<tr class="odd">
<td align="left">M20.009</td>
<td align="right">26</td>
<td align="left">Thumb deformity</td>
<td align="left">Unspecified deformity of unspecified finger(s)</td>
</tr>
<tr class="even">
<td align="left">D80.5</td>
<td align="right">26</td>
<td align="left">Immunodeficiency with hyper IgM type 1</td>
<td align="left">Immunodeficiency with increased immunoglobulin M [IgM]</td>
</tr>
<tr class="odd">
<td align="left">R29.0</td>
<td align="right">25</td>
<td align="left">Primary hypomagnesemia with secondary hypocalcemia</td>
<td align="left">Tetany</td>
</tr>
<tr class="even">
<td align="left">M86.30</td>
<td align="right">25</td>
<td align="left">Chronic recurrent multifocal osteomyelitis</td>
<td align="left">Chronic multifocal osteomyelitis, unspecified site</td>
</tr>
<tr class="odd">
<td align="left">C92.90</td>
<td align="right">25</td>
<td align="left">Myeloid leukemia</td>
<td align="left">Myeloid leukemia, unspecified, not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">Q66.80</td>
<td align="right">24</td>
<td align="left">Congenital vertical talus</td>
<td align="left">Congenital vertical talus deformity, unspecified foot</td>
</tr>
<tr class="odd">
<td align="left">Q13.81</td>
<td align="right">24</td>
<td align="left">Axenfeld-Rieger syndrome</td>
<td align="left">Rieger’s anomaly</td>
</tr>
<tr class="even">
<td align="left">L59.9</td>
<td align="right">24</td>
<td align="left">UV sensitive syndrome</td>
<td align="left">Disorder of the skin and subcutaneous tissue related to radiation, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C94.6</td>
<td align="right">24</td>
<td align="left">Myelodysplastic/myeloproliferative disease</td>
<td align="left">Myelodysplastic disease, not classified</td>
</tr>
<tr class="even">
<td align="left">C94.40</td>
<td align="right">24</td>
<td align="left">Acute panmyelosis with myelofibrosis</td>
<td align="left">Acute panmyelosis with myelofibrosis not having achieved remission</td>
</tr>
<tr class="odd">
<td align="left">C72.9</td>
<td align="right">24</td>
<td align="left">Glioma</td>
<td align="left">Malignant neoplasm of central nervous system, unspecified</td>
</tr>
<tr class="even">
<td align="left">A82.9</td>
<td align="right">24</td>
<td align="left">Rabies</td>
<td align="left">Rabies, unspecified</td>
</tr>
<tr class="odd">
<td align="left">R48.1</td>
<td align="right">23</td>
<td align="left">Agnosia</td>
<td align="left">Agnosia</td>
</tr>
<tr class="even">
<td align="left">Q33.3</td>
<td align="right">23</td>
<td align="left">Lung agenesis</td>
<td align="left">Agenesis of lung</td>
</tr>
<tr class="odd">
<td align="left">Q33.2</td>
<td align="right">23</td>
<td align="left">Pulmonary sequestration</td>
<td align="left">Sequestration of lung</td>
</tr>
<tr class="even">
<td align="left">Q32.0</td>
<td align="right">23</td>
<td align="left">Congenital tracheomalacia</td>
<td align="left">Congenital tracheomalacia</td>
</tr>
<tr class="odd">
<td align="left">E22.8</td>
<td align="right">23</td>
<td align="left">Precocious puberty, gonadotropin-dependent</td>
<td align="left">Other hyperfunction of pituitary gland</td>
</tr>
<tr class="even">
<td align="left">C96.0</td>
<td align="right">23</td>
<td align="left">Langerhans cell histiocytosis</td>
<td align="left">Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis</td>
</tr>
<tr class="odd">
<td align="left">C22.2</td>
<td align="right">23</td>
<td align="left">Hepatoblastoma</td>
<td align="left">Hepatoblastoma</td>
</tr>
<tr class="even">
<td align="left">H53.63</td>
<td align="right">22</td>
<td align="left">Oguchi disease</td>
<td align="left">Congenital night blindness</td>
</tr>
<tr class="odd">
<td align="left">E88.41</td>
<td align="right">22</td>
<td align="left">Mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes</td>
<td align="left">MELAS syndrome</td>
</tr>
<tr class="even">
<td align="left">E71.311</td>
<td align="right">22</td>
<td align="left">Medium-chain acyl-coenzyme A dehydrogenase deficiency</td>
<td align="left">Medium chain acyl CoA dehydrogenase deficiency</td>
</tr>
<tr class="odd">
<td align="left">A48.0</td>
<td align="right">22</td>
<td align="left">Anthrax</td>
<td align="left">Gas gangrene</td>
</tr>
<tr class="even">
<td align="left">F48.1</td>
<td align="right">21</td>
<td align="left">Depersonalization disorder</td>
<td align="left">Depersonalization-derealization syndrome</td>
</tr>
<tr class="odd">
<td align="left">D69.41</td>
<td align="right">21</td>
<td align="left">Evans syndrome</td>
<td align="left">Evans syndrome</td>
</tr>
<tr class="even">
<td align="left">C31.9</td>
<td align="right">21</td>
<td align="left">Sinonasal undifferentiated carcinoma</td>
<td align="left">Malignant neoplasm of accessory sinus, unspecified</td>
</tr>
<tr class="odd">
<td align="left">B78.9</td>
<td align="right">21</td>
<td align="left">Strongyloidiasis</td>
<td align="left">Strongyloidiasis, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q64.12</td>
<td align="right">20</td>
<td align="left">Omphalocele, exstrophy of the cloaca, imperforate anus, and spinal defects complex</td>
<td align="left">Cloacal extrophy of urinary bladder</td>
</tr>
<tr class="odd">
<td align="left">Q21.8</td>
<td align="right">20</td>
<td align="left">Eisenmenger syndrome</td>
<td align="left">Other congenital malformations of cardiac septa</td>
</tr>
<tr class="even">
<td align="left">P61.0</td>
<td align="right">20</td>
<td align="left">Fetal and neonatal alloimmune thrombocytopenia</td>
<td align="left">Transient neonatal thrombocytopenia</td>
</tr>
<tr class="odd">
<td align="left">H49.9</td>
<td align="right">20</td>
<td align="left">Tolosa Hunt syndrome</td>
<td align="left">Unspecified paralytic strabismus</td>
</tr>
<tr class="even">
<td align="left">E74.04</td>
<td align="right">20</td>
<td align="left">Glycogen storage disease type 5</td>
<td align="left">McArdle disease</td>
</tr>
<tr class="odd">
<td align="left">C69.00</td>
<td align="right">20</td>
<td align="left">Conjunctival melanoma</td>
<td align="left">Malignant neoplasm of unspecified conjunctiva</td>
</tr>
<tr class="even">
<td align="left">A48.3</td>
<td align="right">20</td>
<td align="left">Staphylococcal toxic shock syndrome</td>
<td align="left">Toxic shock syndrome</td>
</tr>
<tr class="odd">
<td align="left">A01.00</td>
<td align="right">20</td>
<td align="left">Typhoid fever</td>
<td align="left">Typhoid fever, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q55.29</td>
<td align="right">19</td>
<td align="left">Leydig cell hypoplasia</td>
<td align="left">Other congenital malformations of testis and scrotum</td>
</tr>
<tr class="odd">
<td align="left">Q43.0</td>
<td align="right">19</td>
<td align="left">Omphalomesenteric cyst</td>
<td align="left">Meckel’s diverticulum (displaced) (hypertrophic)</td>
</tr>
<tr class="even">
<td align="left">N04.1</td>
<td align="right">19</td>
<td align="left">Focal segmental glomerulosclerosis</td>
<td align="left">Nephrotic syndrome with focal and segmental glomerular lesions</td>
</tr>
<tr class="odd">
<td align="left">G21.0</td>
<td align="right">19</td>
<td align="left">Neuroleptic malignant syndrome</td>
<td align="left">Malignant neuroleptic syndrome</td>
</tr>
<tr class="even">
<td align="left">G04.00</td>
<td align="right">19</td>
<td align="left">Acute disseminated encephalomyelitis</td>
<td align="left">Acute disseminated encephalitis and encephalomyelitis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">B69.0</td>
<td align="right">19</td>
<td align="left">Cysticercosis</td>
<td align="left">Cysticercosis of central nervous system</td>
</tr>
<tr class="even">
<td align="left">B38.9</td>
<td align="right">19</td>
<td align="left">Coccidioidomycosis</td>
<td align="left">Coccidioidomycosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q65.2</td>
<td align="right">18</td>
<td align="left">Congenital diaphragmatic hernia</td>
<td align="left">Congenital dislocation of hip, unspecified</td>
</tr>
<tr class="even">
<td align="left">M35.4</td>
<td align="right">18</td>
<td align="left">Eosinophilic fasciitis</td>
<td align="left">Diffuse (eosinophilic) fasciitis</td>
</tr>
<tr class="odd">
<td align="left">I40.0</td>
<td align="right">18</td>
<td align="left">Infectious myocarditis</td>
<td align="left">Infective myocarditis</td>
</tr>
<tr class="even">
<td align="left">E16.8</td>
<td align="right">18</td>
<td align="left">WDHA syndrome</td>
<td align="left">Other specified disorders of pancreatic internal secretion</td>
</tr>
<tr class="odd">
<td align="left">A03.9</td>
<td align="right">18</td>
<td align="left">Shigellosis</td>
<td align="left">Shigellosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">N26.9</td>
<td align="right">17</td>
<td align="left">Nephrosclerosis</td>
<td align="left">Renal sclerosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">M08.1</td>
<td align="right">17</td>
<td align="left">Juvenile spondyloarthropathy</td>
<td align="left">Juvenile ankylosing spondylitis</td>
</tr>
<tr class="even">
<td align="left">L85.2</td>
<td align="right">17</td>
<td align="left">Palmoplantar keratoderma</td>
<td align="left">Keratosis punctata (palmaris et plantaris)</td>
</tr>
<tr class="odd">
<td align="left">L10.2</td>
<td align="right">17</td>
<td align="left">Pemphigus foliaceus</td>
<td align="left">Pemphigus foliaceous</td>
</tr>
<tr class="even">
<td align="left">I67.841</td>
<td align="right">17</td>
<td align="left">Reversible cerebral vasoconstriction syndrome</td>
<td align="left">Reversible cerebrovascular vasoconstriction syndrome</td>
</tr>
<tr class="odd">
<td align="left">H49.40</td>
<td align="right">17</td>
<td align="left">Tolosa Hunt syndrome</td>
<td align="left">Progressive external ophthalmoplegia, unspecified eye</td>
</tr>
<tr class="even">
<td align="left">H35.079</td>
<td align="right">17</td>
<td align="left">Telangiectasia macularis eruptive perstans</td>
<td align="left">Retinal telangiectasis, unspecified eye</td>
</tr>
<tr class="odd">
<td align="left">H21.569</td>
<td align="right">17</td>
<td align="left">Ectopia pupillae</td>
<td align="left">Pupillary abnormality, unspecified eye</td>
</tr>
<tr class="even">
<td align="left">D73.2</td>
<td align="right">17</td>
<td align="left">Banti’s syndrome</td>
<td align="left">Chronic congestive splenomegaly</td>
</tr>
<tr class="odd">
<td align="left">D58.1</td>
<td align="right">17</td>
<td align="left">Hereditary elliptocytosis</td>
<td align="left">Hereditary elliptocytosis</td>
</tr>
<tr class="even">
<td align="left">C84.10</td>
<td align="right">17</td>
<td align="left">Sezary syndrome</td>
<td align="left">SÃ©zary disease, unspecified site</td>
</tr>
<tr class="odd">
<td align="left">B82.0</td>
<td align="right">17</td>
<td align="left">Helminthiasis</td>
<td align="left">Intestinal helminthiasis, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q84.5</td>
<td align="right">16</td>
<td align="left">Pachyonychia congenita</td>
<td align="left">Enlarged and hypertrophic nails</td>
</tr>
<tr class="odd">
<td align="left">Q51.818</td>
<td align="right">16</td>
<td align="left">Mullerian aplasia</td>
<td align="left">Other congenital malformations of uterus</td>
</tr>
<tr class="even">
<td align="left">P39.1</td>
<td align="right">16</td>
<td align="left">Inclusion conjunctivitis</td>
<td align="left">Neonatal conjunctivitis and dacryocystitis</td>
</tr>
<tr class="odd">
<td align="left">M72.1</td>
<td align="right">16</td>
<td align="left">Knuckle pads, leuconychia and sensorineural deafness</td>
<td align="left">Knuckle pads</td>
</tr>
<tr class="even">
<td align="left">G83.81</td>
<td align="right">16</td>
<td align="left">Brown-Sequard syndrome</td>
<td align="left">Brown-SÃ©quard syndrome</td>
</tr>
<tr class="odd">
<td align="left">G47.35</td>
<td align="right">16</td>
<td align="left">Congenital central hypoventilation syndrome</td>
<td align="left">Congenital central alveolar hypoventilation syndrome</td>
</tr>
<tr class="even">
<td align="left">G44.81</td>
<td align="right">16</td>
<td align="left">Hypnic headache</td>
<td align="left">Hypnic headache</td>
</tr>
<tr class="odd">
<td align="left">F51.11</td>
<td align="right">16</td>
<td align="left">Idiopathic hypersomnia</td>
<td align="left">Primary hypersomnia</td>
</tr>
<tr class="even">
<td align="left">E34.52</td>
<td align="right">16</td>
<td align="left">Partial androgen insensitivity syndrome</td>
<td align="left">Partial androgen insensitivity syndrome</td>
</tr>
<tr class="odd">
<td align="left">E07.1</td>
<td align="right">16</td>
<td align="left">Pendred syndrome</td>
<td align="left">Dyshormogenetic goiter</td>
</tr>
<tr class="even">
<td align="left">B60.13</td>
<td align="right">16</td>
<td align="left">Acanthamoeba keratitis</td>
<td align="left">Keratoconjunctivitis due to Acanthamoeba</td>
</tr>
<tr class="odd">
<td align="left">A92.0</td>
<td align="right">16</td>
<td align="left">Chikungunya</td>
<td align="left">Chikungunya virus disease</td>
</tr>
<tr class="even">
<td align="left">A06.9</td>
<td align="right">16</td>
<td align="left">Amebiasis</td>
<td align="left">Amebiasis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">Q91.7</td>
<td align="right">15</td>
<td align="left">Trisomy 13</td>
<td align="left">Trisomy 13, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q79.4</td>
<td align="right">15</td>
<td align="left">Prune belly syndrome</td>
<td align="left">Prune belly syndrome</td>
</tr>
<tr class="odd">
<td align="left">Q71.40</td>
<td align="right">15</td>
<td align="left">Radial ray agenesis</td>
<td align="left">Longitudinal reduction defect of unspecified radius</td>
</tr>
<tr class="even">
<td align="left">Q22.6</td>
<td align="right">15</td>
<td align="left">Hypoplastic right heart syndrome</td>
<td align="left">Hypoplastic right heart syndrome</td>
</tr>
<tr class="odd">
<td align="left">O15.9</td>
<td align="right">15</td>
<td align="left">Eclampsia</td>
<td align="left">Eclampsia, unspecified as to time period</td>
</tr>
<tr class="even">
<td align="left">I67.3</td>
<td align="right">15</td>
<td align="left">Binswanger’s disease</td>
<td align="left">Progressive vascular leukoencephalopathy</td>
</tr>
<tr class="odd">
<td align="left">G03.2</td>
<td align="right">15</td>
<td align="left">Mollaret meningitis</td>
<td align="left">Benign recurrent meningitis [Mollaret]</td>
</tr>
<tr class="even">
<td align="left">E72.51</td>
<td align="right">15</td>
<td align="left">Glycine encephalopathy</td>
<td align="left">Non-ketotic hyperglycinemia</td>
</tr>
<tr class="odd">
<td align="left">C92.30</td>
<td align="right">15</td>
<td align="left">Myeloid sarcoma</td>
<td align="left">Myeloid sarcoma, not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">A81.00</td>
<td align="right">15</td>
<td align="left">Creutzfeldt-Jakob disease</td>
<td align="left">Creutzfeldt-Jakob disease, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A55</td>
<td align="right">15</td>
<td align="left">Lymphogranuloma venereum</td>
<td align="left">Chlamydial lymphogranuloma (venereum)</td>
</tr>
<tr class="even">
<td align="left">Q76.7</td>
<td align="right">14</td>
<td align="left">Asternia</td>
<td align="left">Congenital malformation of sternum</td>
</tr>
<tr class="odd">
<td align="left">Q16.5</td>
<td align="right">14</td>
<td align="left">Deafness with labyrinthine aplasia microtia and microdontia (LAMM)</td>
<td align="left">Congenital malformation of inner ear</td>
</tr>
<tr class="even">
<td align="left">Q04.2</td>
<td align="right">14</td>
<td align="left">Holoprosencephaly</td>
<td align="left">Holoprosencephaly</td>
</tr>
<tr class="odd">
<td align="left">Q00.0</td>
<td align="right">14</td>
<td align="left">Anencephaly</td>
<td align="left">Anencephaly</td>
</tr>
<tr class="even">
<td align="left">L26</td>
<td align="right">14</td>
<td align="left">Exfoliative dermatitis</td>
<td align="left">Exfoliative dermatitis</td>
</tr>
<tr class="odd">
<td align="left">J84.03</td>
<td align="right">14</td>
<td align="left">Idiopathic pulmonary hemosiderosis</td>
<td align="left">Idiopathic pulmonary hemosiderosis</td>
</tr>
<tr class="even">
<td align="left">D89.82</td>
<td align="right">14</td>
<td align="left">Autoimmune lymphoproliferative syndrome</td>
<td align="left">Autoimmune lymphoproliferative syndrome [ALPS]</td>
</tr>
<tr class="odd">
<td align="left">D89.3</td>
<td align="right">14</td>
<td align="left">Engraftment syndrome</td>
<td align="left">Immune reconstitution syndrome</td>
</tr>
<tr class="even">
<td align="left">D39.0</td>
<td align="right">14</td>
<td align="left">Intravenous leiomyomatosis</td>
<td align="left">Neoplasm of uncertain behavior of uterus</td>
</tr>
<tr class="odd">
<td align="left">C75.0</td>
<td align="right">14</td>
<td align="left">Parathyroid carcinoma</td>
<td align="left">Malignant neoplasm of parathyroid gland</td>
</tr>
<tr class="even">
<td align="left">Q73.8</td>
<td align="right">13</td>
<td align="left">Limb reduction defect</td>
<td align="left">Other reduction defects of unspecified limb(s)</td>
</tr>
<tr class="odd">
<td align="left">Q70.4</td>
<td align="right">13</td>
<td align="left">Preaxial polydactyly type 4</td>
<td align="left">Polysyndactyly, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q64.79</td>
<td align="right">13</td>
<td align="left">Megacystis microcolon intestinal hypoperistalsis syndrome</td>
<td align="left">Other congenital malformations of bladder and urethra</td>
</tr>
<tr class="odd">
<td align="left">Q31.3</td>
<td align="right">13</td>
<td align="left">Laryngocele</td>
<td align="left">Laryngocele</td>
</tr>
<tr class="even">
<td align="left">H53.51</td>
<td align="right">13</td>
<td align="left">Blue cone monochromatism</td>
<td align="left">Achromatopsia</td>
</tr>
<tr class="odd">
<td align="left">G31.82</td>
<td align="right">13</td>
<td align="left">Leigh syndrome</td>
<td align="left">Leigh’s disease</td>
</tr>
<tr class="even">
<td align="left">F84.3</td>
<td align="right">13</td>
<td align="left">Childhood disintegrative disorder</td>
<td align="left">Other childhood disintegrative disorder</td>
</tr>
<tr class="odd">
<td align="left">F68.12</td>
<td align="right">13</td>
<td align="left">Munchausen by proxy syndrome</td>
<td align="left">Factitious disorder with predominantly physical signs and symptoms</td>
</tr>
<tr class="even">
<td align="left">F10.96</td>
<td align="right">13</td>
<td align="left">Wernicke-Korsakoff syndrome</td>
<td align="left">Alcohol use, unspecified with alcohol-induced persisting amnestic disorder</td>
</tr>
<tr class="odd">
<td align="left">E85.2</td>
<td align="right">13</td>
<td align="left">Primary cutaneous amyloidosis</td>
<td align="left">Heredofamilial amyloidosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">E83.09</td>
<td align="right">13</td>
<td align="left">Menkes disease</td>
<td align="left">Other disorders of copper metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.313</td>
<td align="right">13</td>
<td align="left">Glutaric acidemia type II</td>
<td align="left">Glutaric aciduria type II</td>
</tr>
<tr class="even">
<td align="left">D82.0</td>
<td align="right">13</td>
<td align="left">Wiskott Aldrich syndrome</td>
<td align="left">Wiskott-Aldrich syndrome</td>
</tr>
<tr class="odd">
<td align="left">Q55.23</td>
<td align="right">12</td>
<td align="left">Penoscrotal transposition</td>
<td align="left">Scrotal transposition</td>
</tr>
<tr class="even">
<td align="left">Q06.2</td>
<td align="right">12</td>
<td align="left">Split spinal cord malformation</td>
<td align="left">Diastematomyelia</td>
</tr>
<tr class="odd">
<td align="left">P35.2</td>
<td align="right">12</td>
<td align="left">Congenital herpes simplex</td>
<td align="left">Congenital herpesviral [herpes simplex] infection</td>
</tr>
<tr class="even">
<td align="left">N07.8</td>
<td align="right">12</td>
<td align="left">Glomerulopathy with fibronectin deposits 1</td>
<td align="left">Hereditary nephropathy, not elsewhere classified with other morphologic lesions</td>
</tr>
<tr class="odd">
<td align="left">L60.5</td>
<td align="right">12</td>
<td align="left">Yellow nail syndrome</td>
<td align="left">Yellow nail syndrome</td>
</tr>
<tr class="even">
<td align="left">D46.1</td>
<td align="right">12</td>
<td align="left">Sideroblastic anemia pyridoxine-refractory autosomal recessive</td>
<td align="left">Refractory anemia with ring sideroblasts</td>
</tr>
<tr class="odd">
<td align="left">C93.00</td>
<td align="right">12</td>
<td align="left">Acute monoblastic leukemia</td>
<td align="left">Acute monoblastic/monocytic leukemia, not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">B65.9</td>
<td align="right">12</td>
<td align="left">Schistosomiasis</td>
<td align="left">Schistosomiasis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">B47.9</td>
<td align="right">12</td>
<td align="left">Mycetoma</td>
<td align="left">Mycetoma, unspecified</td>
</tr>
<tr class="even">
<td align="left">A92.5</td>
<td align="right">12</td>
<td align="left">Zika virus infection</td>
<td align="left">Zika virus disease</td>
</tr>
<tr class="odd">
<td align="left">A57</td>
<td align="right">12</td>
<td align="left">Chancroid</td>
<td align="left">Chancroid</td>
</tr>
<tr class="even">
<td align="left">A28.0</td>
<td align="right">12</td>
<td align="left">Pasteurella multocida infection</td>
<td align="left">Pasteurellosis</td>
</tr>
<tr class="odd">
<td align="left">Q97.0</td>
<td align="right">11</td>
<td align="left">47 XXX syndrome</td>
<td align="left">Karyotype 47, XXX</td>
</tr>
<tr class="even">
<td align="left">P59.29</td>
<td align="right">11</td>
<td align="left">Neonatal hemochromatosis</td>
<td align="left">Neonatal jaundice from other hepatocellular damage</td>
</tr>
<tr class="odd">
<td align="left">M05.00</td>
<td align="right">11</td>
<td align="left">Felty’s syndrome</td>
<td align="left">Felty’s syndrome, unspecified site</td>
</tr>
<tr class="even">
<td align="left">H31.22</td>
<td align="right">11</td>
<td align="left">Choroidal dystrophy central areolar</td>
<td align="left">Choroidal dystrophy (central areolar) (generalized) (peripapillary)</td>
</tr>
<tr class="odd">
<td align="left">H31.21</td>
<td align="right">11</td>
<td align="left">Choroideremia</td>
<td align="left">Choroideremia</td>
</tr>
<tr class="even">
<td align="left">E71.0</td>
<td align="right">11</td>
<td align="left">Maple syrup urine disease</td>
<td align="left">Maple-syrup-urine disease</td>
</tr>
<tr class="odd">
<td align="left">E70.320</td>
<td align="right">11</td>
<td align="left">Oculocutaneous albinism type 1</td>
<td align="left">Tyrosinase negative oculocutaneous albinism</td>
</tr>
<tr class="even">
<td align="left">E51.11</td>
<td align="right">11</td>
<td align="left">Beriberi</td>
<td align="left">Dry beriberi</td>
</tr>
<tr class="odd">
<td align="left">D55.8</td>
<td align="right">11</td>
<td align="left">Glycogen storage disease type 12</td>
<td align="left">Other anemias due to enzyme disorders</td>
</tr>
<tr class="even">
<td align="left">D51.1</td>
<td align="right">11</td>
<td align="left">Imerslund-Grasbeck syndrome</td>
<td align="left">Vitamin B12 deficiency anemia due to selective vitamin B12 malabsorption with proteinuria</td>
</tr>
<tr class="odd">
<td align="left">B26.9</td>
<td align="right">11</td>
<td align="left">Mumps</td>
<td align="left">Mumps without complication</td>
</tr>
<tr class="even">
<td align="left">A52.11</td>
<td align="right">11</td>
<td align="left">Syphilitic myelopathy</td>
<td align="left">Tabes dorsalis</td>
</tr>
<tr class="odd">
<td align="left">Q06.1</td>
<td align="right">10</td>
<td align="left">Spina bifida</td>
<td align="left">Hypoplasia and dysplasia of spinal cord</td>
</tr>
<tr class="even">
<td align="left">Q01.2</td>
<td align="right">10</td>
<td align="left">Chiari malformation type 3</td>
<td align="left">Occipital encephalocele</td>
</tr>
<tr class="odd">
<td align="left">L98.3</td>
<td align="right">10</td>
<td align="left">Wells syndrome</td>
<td align="left">Eosinophilic cellulitis [Wells]</td>
</tr>
<tr class="even">
<td align="left">K76.5</td>
<td align="right">10</td>
<td align="left">Hepatic veno-occlusive disease</td>
<td align="left">Hepatic veno-occlusive disease</td>
</tr>
<tr class="odd">
<td align="left">J69.1</td>
<td align="right">10</td>
<td align="left">Exogenous lipoid pneumonia</td>
<td align="left">Pneumonitis due to inhalation of oils and essences</td>
</tr>
<tr class="even">
<td align="left">I40.1</td>
<td align="right">10</td>
<td align="left">Giant cell myocarditis</td>
<td align="left">Isolated myocarditis</td>
</tr>
<tr class="odd">
<td align="left">E16.9</td>
<td align="right">10</td>
<td align="left">Familial hyperinsulinism</td>
<td align="left">Disorder of pancreatic internal secretion, unspecified</td>
</tr>
<tr class="even">
<td align="left">D39.2</td>
<td align="right">10</td>
<td align="left">Trophoblastic tumor placental site</td>
<td align="left">Neoplasm of uncertain behavior of placenta</td>
</tr>
<tr class="odd">
<td align="left">C44.82</td>
<td align="right">10</td>
<td align="left">Buschke Lowenstein tumor</td>
<td align="left">Squamous cell carcinoma of overlapping sites of skin</td>
</tr>
<tr class="even">
<td align="left">B83.8</td>
<td align="right">10</td>
<td align="left">Baylisascaris infection</td>
<td align="left">Other specified helminthiases</td>
</tr>
<tr class="odd">
<td align="left">B76.0</td>
<td align="right">10</td>
<td align="left">Ancylostomiasis</td>
<td align="left">Ancylostomiasis</td>
</tr>
<tr class="even">
<td align="left">B42.9</td>
<td align="right">10</td>
<td align="left">Sporotrichosis</td>
<td align="left">Sporotrichosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A69.1</td>
<td align="right">10</td>
<td align="left">Acute necrotizing ulcerative gingivitis</td>
<td align="left">Other Vincent’s infections</td>
</tr>
<tr class="even">
<td align="left">Q80.1</td>
<td align="right">9</td>
<td align="left">X-linked ichthyosis</td>
<td align="left">X-linked ichthyosis</td>
</tr>
<tr class="odd">
<td align="left">O43.029</td>
<td align="right">9</td>
<td align="left">Twin to twin transfusion syndrome</td>
<td align="left">Fetus-to-fetus placental transfusion syndrome, unspecified trimester</td>
</tr>
<tr class="even">
<td align="left">L74.52</td>
<td align="right">9</td>
<td align="left">Frey’s syndrome</td>
<td align="left">Secondary focal hyperhidrosis</td>
</tr>
<tr class="odd">
<td align="left">L72.12</td>
<td align="right">9</td>
<td align="left">Proliferating trichilemmal cyst</td>
<td align="left">Trichodermal cyst</td>
</tr>
<tr class="even">
<td align="left">L43.3</td>
<td align="right">9</td>
<td align="left">Actinic lichen planus</td>
<td align="left">Subacute (active) lichen planus</td>
</tr>
<tr class="odd">
<td align="left">G83.5</td>
<td align="right">9</td>
<td align="left">Locked-in syndrome</td>
<td align="left">Locked-in state</td>
</tr>
<tr class="even">
<td align="left">E72.03</td>
<td align="right">9</td>
<td align="left">Lowe oculocerebrorenal syndrome</td>
<td align="left">Lowe’s syndrome</td>
</tr>
<tr class="odd">
<td align="left">E71.50</td>
<td align="right">9</td>
<td align="left">Peroxisomal biogenesis disorders</td>
<td align="left">Peroxisomal disorder, unspecified</td>
</tr>
<tr class="even">
<td align="left">E26.89</td>
<td align="right">9</td>
<td align="left">Liddle syndrome</td>
<td align="left">Other hyperaldosteronism</td>
</tr>
<tr class="odd">
<td align="left">D13.9</td>
<td align="right">9</td>
<td align="left">Littoral cell angioma of the spleen</td>
<td align="left">Benign neoplasm of ill-defined sites within the digestive system</td>
</tr>
<tr class="even">
<td align="left">D07.4</td>
<td align="right">9</td>
<td align="left">Bowenoid papulosis</td>
<td align="left">Carcinoma in situ of penis</td>
</tr>
<tr class="odd">
<td align="left">B66.4</td>
<td align="right">9</td>
<td align="left">Paragonimiasis</td>
<td align="left">Paragonimiasis</td>
</tr>
<tr class="even">
<td align="left">B40.9</td>
<td align="right">9</td>
<td align="left">Blastomycosis</td>
<td align="left">Blastomycosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A77.9</td>
<td align="right">9</td>
<td align="left">Spotted fever</td>
<td align="left">Spotted fever, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q84.3</td>
<td align="right">8</td>
<td align="left">Anonychia congenita</td>
<td align="left">Anonychia</td>
</tr>
<tr class="odd">
<td align="left">Q56.1</td>
<td align="right">8</td>
<td align="left">5-alpha reductase deficiency</td>
<td align="left">Male pseudohermaphroditism, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">Q33.8</td>
<td align="right">8</td>
<td align="left">Congenital pulmonary lymphangiectasia</td>
<td align="left">Other congenital malformations of lung</td>
</tr>
<tr class="odd">
<td align="left">P70.2</td>
<td align="right">8</td>
<td align="left">Transient neonatal diabetes mellitus</td>
<td align="left">Neonatal diabetes mellitus</td>
</tr>
<tr class="even">
<td align="left">M36.2</td>
<td align="right">8</td>
<td align="left">Hemophilic arthropathy</td>
<td align="left">Hemophilic arthropathy</td>
</tr>
<tr class="odd">
<td align="left">L95.0</td>
<td align="right">8</td>
<td align="left">Livedoid vasculopathy</td>
<td align="left">Livedoid vasculitis</td>
</tr>
<tr class="even">
<td align="left">G71.8</td>
<td align="right">8</td>
<td align="left">Megaduodenum and/or megacystis</td>
<td align="left">Other primary disorders of muscles</td>
</tr>
<tr class="odd">
<td align="left">F63.89</td>
<td align="right">8</td>
<td align="left">Dipsogenic diabetes insipidus</td>
<td align="left">Other impulse disorders</td>
</tr>
<tr class="even">
<td align="left">E85.0</td>
<td align="right">8</td>
<td align="left">Amyloidosis familial visceral</td>
<td align="left">Non-neuropathic heredofamilial amyloidosis</td>
</tr>
<tr class="odd">
<td align="left">E71.121</td>
<td align="right">8</td>
<td align="left">Propionic acidemia</td>
<td align="left">Propionic acidemia</td>
</tr>
<tr class="even">
<td align="left">E70.331</td>
<td align="right">8</td>
<td align="left">Hermansky-Pudlak syndrome</td>
<td align="left">Hermansky-Pudlak syndrome</td>
</tr>
<tr class="odd">
<td align="left">E34.50</td>
<td align="right">8</td>
<td align="left">Androgen insensitivity syndrome</td>
<td align="left">Androgen insensitivity syndrome, unspecified</td>
</tr>
<tr class="even">
<td align="left">E24.3</td>
<td align="right">8</td>
<td align="left">Cushing’s syndrome</td>
<td align="left">Ectopic ACTH syndrome</td>
</tr>
<tr class="odd">
<td align="left">D44.5</td>
<td align="right">8</td>
<td align="left">Pineocytoma</td>
<td align="left">Neoplasm of uncertain behavior of pineal gland</td>
</tr>
<tr class="even">
<td align="left">C86.4</td>
<td align="right">8</td>
<td align="left">Blastic plasmacytoid dendritic cell</td>
<td align="left">Blastic NK-cell lymphoma</td>
</tr>
<tr class="odd">
<td align="left">C86.0</td>
<td align="right">8</td>
<td align="left">Extranodal nasal NK/T cell lymphoma</td>
<td align="left">Extranodal NK/T-cell lymphoma, nasal type</td>
</tr>
<tr class="even">
<td align="left">B65.3</td>
<td align="right">8</td>
<td align="left">Cercarial Dermatitis</td>
<td align="left">Cercarial dermatitis</td>
</tr>
<tr class="odd">
<td align="left">B10.01</td>
<td align="right">8</td>
<td align="left">HHV-6 encephalitis</td>
<td align="left">Human herpesvirus 6 encephalitis</td>
</tr>
<tr class="even">
<td align="left">Q85.03</td>
<td align="right">7</td>
<td align="left">Schwannomatosis</td>
<td align="left">Schwannomatosis</td>
</tr>
<tr class="odd">
<td align="left">M92.70</td>
<td align="right">7</td>
<td align="left">Freiberg’s disease</td>
<td align="left">Juvenile osteochondrosis of metatarsus, unspecified foot</td>
</tr>
<tr class="even">
<td align="left">M87.039</td>
<td align="right">7</td>
<td align="left">Kienbock’s disease</td>
<td align="left">Idiopathic aseptic necrosis of unspecified carpus</td>
</tr>
<tr class="odd">
<td align="left">K00.4</td>
<td align="right">7</td>
<td align="left">Witkop syndrome</td>
<td align="left">Disturbances in tooth formation</td>
</tr>
<tr class="even">
<td align="left">J66.0</td>
<td align="right">7</td>
<td align="left">Byssinosis</td>
<td align="left">Byssinosis</td>
</tr>
<tr class="odd">
<td align="left">G12.8</td>
<td align="right">7</td>
<td align="left">Kennedy disease</td>
<td align="left">Other spinal muscular atrophies and related syndromes</td>
</tr>
<tr class="even">
<td align="left">E52</td>
<td align="right">7</td>
<td align="left">Pellagra</td>
<td align="left">Niacin deficiency [pellagra]</td>
</tr>
<tr class="odd">
<td align="left">D81.810</td>
<td align="right">7</td>
<td align="left">Biotinidase deficiency</td>
<td align="left">Biotinidase deficiency</td>
</tr>
<tr class="even">
<td align="left">D69.8</td>
<td align="right">7</td>
<td align="left">Pseudo-Von Willebrand disease</td>
<td align="left">Other specified hemorrhagic conditions</td>
</tr>
<tr class="odd">
<td align="left">D68.311</td>
<td align="right">7</td>
<td align="left">Acquired hemophilia</td>
<td align="left">Acquired hemophilia</td>
</tr>
<tr class="even">
<td align="left">D60.1</td>
<td align="right">7</td>
<td align="left">Transient erythroblastopenia of childhood</td>
<td align="left">Transient acquired pure red cell aplasia</td>
</tr>
<tr class="odd">
<td align="left">B69.9</td>
<td align="right">7</td>
<td align="left">Cysticercosis</td>
<td align="left">Cysticercosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">A90</td>
<td align="right">7</td>
<td align="left">Dengue fever</td>
<td align="left">Dengue fever [classical dengue]</td>
</tr>
<tr class="odd">
<td align="left">A78</td>
<td align="right">7</td>
<td align="left">Q fever</td>
<td align="left">Q fever</td>
</tr>
<tr class="even">
<td align="left">A32.9</td>
<td align="right">7</td>
<td align="left">Listeria infection</td>
<td align="left">Listeriosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A07.0</td>
<td align="right">7</td>
<td align="left">Balantidiasis</td>
<td align="left">Balantidiasis</td>
</tr>
<tr class="even">
<td align="left">Q21.4</td>
<td align="right">6</td>
<td align="left">Aortopulmonary window</td>
<td align="left">Aortopulmonary septal defect</td>
</tr>
<tr class="odd">
<td align="left">P35.0</td>
<td align="right">6</td>
<td align="left">Congenital rubella</td>
<td align="left">Congenital rubella syndrome</td>
</tr>
<tr class="even">
<td align="left">O43.90</td>
<td align="right">6</td>
<td align="left">Placenta disorder</td>
<td align="left">Unspecified placental disorder, unspecified trimester</td>
</tr>
<tr class="odd">
<td align="left">N99.83</td>
<td align="right">6</td>
<td align="left">Ovarian remnant syndrome</td>
<td align="left">Residual ovary syndrome</td>
</tr>
<tr class="even">
<td align="left">M72.8</td>
<td align="right">6</td>
<td align="left">Infantile digital fibromatosis</td>
<td align="left">Other fibroblastic disorders</td>
</tr>
<tr class="odd">
<td align="left">E78.72</td>
<td align="right">6</td>
<td align="left">Smith-Lemli-Opitz syndrome</td>
<td align="left">Smith-Lemli-Opitz syndrome</td>
</tr>
<tr class="even">
<td align="left">E70.0</td>
<td align="right">6</td>
<td align="left">Phenylketonuria</td>
<td align="left">Classical phenylketonuria</td>
</tr>
<tr class="odd">
<td align="left">E31.20</td>
<td align="right">6</td>
<td align="left">Multiple endocrine neoplasia type 1</td>
<td align="left">Multiple endocrine neoplasia [MEN] syndrome, unspecified</td>
</tr>
<tr class="even">
<td align="left">C86.3</td>
<td align="right">6</td>
<td align="left">Subcutaneous panniculitis-like T-cell lymphoma</td>
<td align="left">Subcutaneous panniculitis-like T-cell lymphoma</td>
</tr>
<tr class="odd">
<td align="left">B74.9</td>
<td align="right">6</td>
<td align="left">Lymphatic filariasis</td>
<td align="left">Filariasis, unspecified</td>
</tr>
<tr class="even">
<td align="left">B60.0</td>
<td align="right">6</td>
<td align="left">Babesiosis</td>
<td align="left">Babesiosis</td>
</tr>
<tr class="odd">
<td align="left">A95.9</td>
<td align="right">6</td>
<td align="left">Yellow fever</td>
<td align="left">Yellow fever, unspecified</td>
</tr>
<tr class="even">
<td align="left">M05.20</td>
<td align="right">5</td>
<td align="left">Rheumatoid vasculitis</td>
<td align="left">Rheumatoid vasculitis with rheumatoid arthritis of unspecified site</td>
</tr>
<tr class="odd">
<td align="left">L87.0</td>
<td align="right">5</td>
<td align="left">Kyrle disease</td>
<td align="left">Keratosis follicularis et parafollicularis in cutem penetrans</td>
</tr>
<tr class="even">
<td align="left">L51.2</td>
<td align="right">5</td>
<td align="left">Toxic epidermal necrolysis</td>
<td align="left">Toxic epidermal necrolysis [Lyell]</td>
</tr>
<tr class="odd">
<td align="left">G51.2</td>
<td align="right">5</td>
<td align="left">Melkersson-Rosenthal syndrome</td>
<td align="left">Melkersson’s syndrome</td>
</tr>
<tr class="even">
<td align="left">G47.24</td>
<td align="right">5</td>
<td align="left">Non 24 hour sleep wake disorder</td>
<td align="left">Circadian rhythm sleep disorder, free running type</td>
</tr>
<tr class="odd">
<td align="left">G47.13</td>
<td align="right">5</td>
<td align="left">Kleine Levin syndrome</td>
<td align="left">Recurrent hypersomnia</td>
</tr>
<tr class="even">
<td align="left">G31.2</td>
<td align="right">5</td>
<td align="left">Subacute cerebellar degeneration</td>
<td align="left">Degeneration of nervous system due to alcohol</td>
</tr>
<tr class="odd">
<td align="left">E83.89</td>
<td align="right">5</td>
<td align="left">Hypermanganesemia with dystonia polycythemia and cirrhosis</td>
<td align="left">Other disorders of mineral metabolism</td>
</tr>
<tr class="even">
<td align="left">E75.249</td>
<td align="right">5</td>
<td align="left">Niemann-Pick disease type A</td>
<td align="left">Niemann-Pick disease, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E72.10</td>
<td align="right">5</td>
<td align="left">Megaloblastic anemia due to dihydrofolate reductase deficiency</td>
<td align="left">Disorders of sulfur-bearing amino-acid metabolism, unspecified</td>
</tr>
<tr class="even">
<td align="left">E71.522</td>
<td align="right">5</td>
<td align="left">Adrenomyeloneuropathy</td>
<td align="left">Adrenomyeloneuropathy</td>
</tr>
<tr class="odd">
<td align="left">E71.440</td>
<td align="right">5</td>
<td align="left">Bannayan-Riley-Ruvalcaba syndrome</td>
<td align="left">Ruvalcaba-Myhre-Smith syndrome</td>
</tr>
<tr class="even">
<td align="left">E70.310</td>
<td align="right">5</td>
<td align="left">Ocular albinism type 1</td>
<td align="left">X-linked ocular albinism</td>
</tr>
<tr class="odd">
<td align="left">E23.3</td>
<td align="right">5</td>
<td align="left">Hypothalamic dysfunction</td>
<td align="left">Hypothalamic dysfunction, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">D80.8</td>
<td align="right">5</td>
<td align="left">Hyper-IgD syndrome</td>
<td align="left">Other immunodeficiencies with predominantly antibody defects</td>
</tr>
<tr class="odd">
<td align="left">D64.0</td>
<td align="right">5</td>
<td align="left">X-linked sideroblastic anemia</td>
<td align="left">Hereditary sideroblastic anemia</td>
</tr>
<tr class="even">
<td align="left">B75</td>
<td align="right">5</td>
<td align="left">Trichinosis</td>
<td align="left">Trichinellosis</td>
</tr>
<tr class="odd">
<td align="left">B68.9</td>
<td align="right">5</td>
<td align="left">Cysticercosis</td>
<td align="left">Taeniasis, unspecified</td>
</tr>
<tr class="even">
<td align="left">B58.00</td>
<td align="right">5</td>
<td align="left">Ocular toxoplasmosis</td>
<td align="left">Toxoplasma oculopathy, unspecified</td>
</tr>
<tr class="odd">
<td align="left">B06.9</td>
<td align="right">5</td>
<td align="left">Rubella</td>
<td align="left">Rubella without complication</td>
</tr>
<tr class="even">
<td align="left">B05.9</td>
<td align="right">5</td>
<td align="left">Measles</td>
<td align="left">Measles without complication</td>
</tr>
<tr class="odd">
<td align="left">A27.9</td>
<td align="right">5</td>
<td align="left">Leptospirosis</td>
<td align="left">Leptospirosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">A17.0</td>
<td align="right">5</td>
<td align="left">Tuberculous meningitis</td>
<td align="left">Tuberculous meningitis</td>
</tr>
<tr class="odd">
<td align="left">Q98.5</td>
<td align="right">4</td>
<td align="left">47, XYY syndrome</td>
<td align="left">Karyotype 47, XYY</td>
</tr>
<tr class="even">
<td align="left">Q74.8</td>
<td align="right">4</td>
<td align="left">Larsen syndrome</td>
<td align="left">Other specified congenital malformations of limb(s)</td>
</tr>
<tr class="odd">
<td align="left">Q71.60</td>
<td align="right">4</td>
<td align="left">Split hand foot malformation</td>
<td align="left">Lobster-claw hand, unspecified hand</td>
</tr>
<tr class="even">
<td align="left">Q65.82</td>
<td align="right">4</td>
<td align="left">Coxa vara, congenital</td>
<td align="left">Congenital coxa vara</td>
</tr>
<tr class="odd">
<td align="left">Q55.4</td>
<td align="right">4</td>
<td align="left">Congenital bilateral absence of the vas deferens</td>
<td align="left">Other congenital malformations of vas deferens, epididymis, seminal vesicles and prostate</td>
</tr>
<tr class="even">
<td align="left">Q42.9</td>
<td align="right">4</td>
<td align="left">Colonic atresia</td>
<td align="left">Congenital absence, atresia and stenosis of large intestine, part unspecified</td>
</tr>
<tr class="odd">
<td align="left">M83.8</td>
<td align="right">4</td>
<td align="left">Oncogenic osteomalacia</td>
<td align="left">Other adult osteomalacia</td>
</tr>
<tr class="even">
<td align="left">M61.10</td>
<td align="right">4</td>
<td align="left">Fibrodysplasia ossificans progressiva</td>
<td align="left">Myositis ossificans progressiva, unspecified site</td>
</tr>
<tr class="odd">
<td align="left">L75.2</td>
<td align="right">4</td>
<td align="left">Fox-Fordyce disease</td>
<td align="left">Apocrine miliaria</td>
</tr>
<tr class="even">
<td align="left">L41.9</td>
<td align="right">4</td>
<td align="left">Parapsoriasis</td>
<td align="left">Parapsoriasis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">K90.81</td>
<td align="right">4</td>
<td align="left">Whipple disease</td>
<td align="left">Whipple’s disease</td>
</tr>
<tr class="even">
<td align="left">E83.2</td>
<td align="right">4</td>
<td align="left">Acrodermatitis enteropathica</td>
<td align="left">Disorders of zinc metabolism</td>
</tr>
<tr class="odd">
<td align="left">E79.2</td>
<td align="right">4</td>
<td align="left">Adenosine monophosphate deaminase 1 deficiency</td>
<td align="left">Myoadenylate deaminase deficiency</td>
</tr>
<tr class="even">
<td align="left">E76.210</td>
<td align="right">4</td>
<td align="left">Mucopolysaccharidosis type IVA</td>
<td align="left">Morquio A mucopolysaccharidoses</td>
</tr>
<tr class="odd">
<td align="left">E75.02</td>
<td align="right">4</td>
<td align="left">Tay-Sachs disease</td>
<td align="left">Tay-Sachs disease</td>
</tr>
<tr class="even">
<td align="left">E72.52</td>
<td align="right">4</td>
<td align="left">Trimethylaminuria</td>
<td align="left">Trimethylaminuria</td>
</tr>
<tr class="odd">
<td align="left">E31.23</td>
<td align="right">4</td>
<td align="left">Multiple endocrine neoplasia type 2B</td>
<td align="left">Multiple endocrine neoplasia [MEN] type IIB</td>
</tr>
<tr class="even">
<td align="left">D81.4</td>
<td align="right">4</td>
<td align="left">Immune defect due to absence of thymus</td>
<td align="left">Nezelof’s syndrome</td>
</tr>
<tr class="odd">
<td align="left">D35.4</td>
<td align="right">4</td>
<td align="left">Pineocytoma</td>
<td align="left">Benign neoplasm of pineal gland</td>
</tr>
<tr class="even">
<td align="left">D14.4</td>
<td align="right">4</td>
<td align="left">Recurrent respiratory papillomatosis</td>
<td align="left">Benign neoplasm of respiratory system, unspecified</td>
</tr>
<tr class="odd">
<td align="left">C96.5</td>
<td align="right">4</td>
<td align="left">Langerhans cell histiocytosis</td>
<td align="left">Multifocal and unisystemic Langerhans-cell histiocytosis</td>
</tr>
<tr class="even">
<td align="left">C94.20</td>
<td align="right">4</td>
<td align="left">Acute megakaryoblastic leukemia</td>
<td align="left">Acute megakaryoblastic leukemia not having achieved remission</td>
</tr>
<tr class="odd">
<td align="left">B79</td>
<td align="right">4</td>
<td align="left">Trichuriasis</td>
<td align="left">Trichuriasis</td>
</tr>
<tr class="even">
<td align="left">B70.0</td>
<td align="right">4</td>
<td align="left">Bothriocephalosis</td>
<td align="left">Diphyllobothriasis</td>
</tr>
<tr class="odd">
<td align="left">B17.2</td>
<td align="right">4</td>
<td align="left">Hepatitis E</td>
<td align="left">Acute hepatitis E</td>
</tr>
<tr class="even">
<td align="left">A98.3</td>
<td align="right">4</td>
<td align="left">Marburg hemorrhagic fever</td>
<td align="left">Marburg virus disease</td>
</tr>
<tr class="odd">
<td align="left">A74.0</td>
<td align="right">4</td>
<td align="left">Inclusion conjunctivitis</td>
<td align="left">Chlamydial conjunctivitis</td>
</tr>
<tr class="even">
<td align="left">A69.9</td>
<td align="right">4</td>
<td align="left">Spirochetes disease</td>
<td align="left">Spirochetal infection, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A48.8</td>
<td align="right">4</td>
<td align="left">Lemierre syndrome</td>
<td align="left">Other specified bacterial diseases</td>
</tr>
<tr class="even">
<td align="left">Q99.1</td>
<td align="right">3</td>
<td align="left">Swyer syndrome</td>
<td align="left">46, XX true hermaphrodite</td>
</tr>
<tr class="odd">
<td align="left">Q45.1</td>
<td align="right">3</td>
<td align="left">Annular pancreas</td>
<td align="left">Annular pancreas</td>
</tr>
<tr class="even">
<td align="left">Q20.2</td>
<td align="right">3</td>
<td align="left">Double outlet left ventricle</td>
<td align="left">Double outlet left ventricle</td>
</tr>
<tr class="odd">
<td align="left">M94.8X8</td>
<td align="right">3</td>
<td align="left">Tracheobronchopathia osteoplastica</td>
<td align="left">Other specified disorders of cartilage, other site</td>
</tr>
<tr class="even">
<td align="left">M92.219</td>
<td align="right">3</td>
<td align="left">Kienbock’s disease</td>
<td align="left">Osteochondrosis (juvenile) of carpal lunate [KienbÃ¶ck], unspecified hand</td>
</tr>
<tr class="odd">
<td align="left">M35.6</td>
<td align="right">3</td>
<td align="left">Nodular nonsuppurative panniculitis</td>
<td align="left">Relapsing panniculitis [Weber-Christian]</td>
</tr>
<tr class="even">
<td align="left">M26.619</td>
<td align="right">3</td>
<td align="left">Temporomandibular ankylosis</td>
<td align="left">Adhesions and ankylosis of temporomandibular joint, unspecified side</td>
</tr>
<tr class="odd">
<td align="left">K90.1</td>
<td align="right">3</td>
<td align="left">Tropical sprue</td>
<td align="left">Tropical sprue</td>
</tr>
<tr class="even">
<td align="left">I88.8</td>
<td align="right">3</td>
<td align="left">Kikuchi disease</td>
<td align="left">Other nonspecific lymphadenitis</td>
</tr>
<tr class="odd">
<td align="left">I52</td>
<td align="right">3</td>
<td align="left">Subpulmonary stenosis</td>
<td align="left">Other heart disorders in diseases classified elsewhere</td>
</tr>
<tr class="even">
<td align="left">G23.0</td>
<td align="right">3</td>
<td align="left">Pantothenate kinase-associated neurodegeneration</td>
<td align="left">Hallervorden-Spatz disease</td>
</tr>
<tr class="odd">
<td align="left">E77.0</td>
<td align="right">3</td>
<td align="left">Mucolipidosis III alpha/beta</td>
<td align="left">Defects in post-translational modification of lysosomal enzymes</td>
</tr>
<tr class="even">
<td align="left">E72.21</td>
<td align="right">3</td>
<td align="left">Arginase deficiency</td>
<td align="left">Argininemia</td>
</tr>
<tr class="odd">
<td align="left">E70.330</td>
<td align="right">3</td>
<td align="left">Chediak-Higashi syndrome</td>
<td align="left">Chediak-Higashi syndrome</td>
</tr>
<tr class="even">
<td align="left">D81.5</td>
<td align="right">3</td>
<td align="left">Purine nucleoside phosphorylase deficiency</td>
<td align="left">Purine nucleoside phosphorylase [PNP] deficiency</td>
</tr>
<tr class="odd">
<td align="left">D81.3</td>
<td align="right">3</td>
<td align="left">Adenosine deaminase deficiency</td>
<td align="left">Adenosine deaminase [ADA] deficiency</td>
</tr>
<tr class="even">
<td align="left">C91.30</td>
<td align="right">3</td>
<td align="left">B cell prolymphocytic leukemia</td>
<td align="left">Prolymphocytic leukemia of B-cell type not having achieved remission</td>
</tr>
<tr class="odd">
<td align="left">C88.2</td>
<td align="right">3</td>
<td align="left">Gamma heavy chain disease</td>
<td align="left">Heavy chain disease</td>
</tr>
<tr class="even">
<td align="left">B55.9</td>
<td align="right">3</td>
<td align="left">Leishmaniasis</td>
<td align="left">Leishmaniasis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A71.9</td>
<td align="right">3</td>
<td align="left">Trachoma</td>
<td align="left">Trachoma, unspecified</td>
</tr>
<tr class="even">
<td align="left">A66.9</td>
<td align="right">3</td>
<td align="left">Yaws</td>
<td align="left">Yaws, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A44.0</td>
<td align="right">3</td>
<td align="left">Cat scratch disease</td>
<td align="left">Systemic bartonellosis</td>
</tr>
<tr class="even">
<td align="left">A30.9</td>
<td align="right">3</td>
<td align="left">Hansen’s disease</td>
<td align="left">Leprosy, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A05.1</td>
<td align="right">3</td>
<td align="left">Botulism</td>
<td align="left">Botulism food poisoning</td>
</tr>
<tr class="even">
<td align="left">Q96.8</td>
<td align="right">2</td>
<td align="left">Gonadal dysgenesis mixed</td>
<td align="left">Other variants of Turner’s syndrome</td>
</tr>
<tr class="odd">
<td align="left">Q92.7</td>
<td align="right">2</td>
<td align="left">Triploidy</td>
<td align="left">Triploidy and polyploidy</td>
</tr>
<tr class="even">
<td align="left">Q77.5</td>
<td align="right">2</td>
<td align="left">Diastrophic dysplasia</td>
<td align="left">Diastrophic dysplasia</td>
</tr>
<tr class="odd">
<td align="left">Q72.50</td>
<td align="right">2</td>
<td align="left">Absence of Tibia</td>
<td align="left">Longitudinal reduction defect of unspecified tibia</td>
</tr>
<tr class="even">
<td align="left">Q71.899</td>
<td align="right">2</td>
<td align="left">Thumb deformity</td>
<td align="left">Other reduction defects of unspecified upper limb</td>
</tr>
<tr class="odd">
<td align="left">Q71.33</td>
<td align="right">2</td>
<td align="left">Acheiropody</td>
<td align="left">Congenital absence of hand and finger, bilateral</td>
</tr>
<tr class="even">
<td align="left">Q71.03</td>
<td align="right">2</td>
<td align="left">Tetra-amelia syndrome</td>
<td align="left">Congenital complete absence of upper limb, bilateral</td>
</tr>
<tr class="odd">
<td align="left">Q64.74</td>
<td align="right">2</td>
<td align="left">Duplication of urethra</td>
<td align="left">Double urethra</td>
</tr>
<tr class="even">
<td align="left">P57.9</td>
<td align="right">2</td>
<td align="left">Kernicterus</td>
<td align="left">Kernicterus, unspecified</td>
</tr>
<tr class="odd">
<td align="left">O26.40</td>
<td align="right">2</td>
<td align="left">Pemphigoid gestationis</td>
<td align="left">Herpes gestationis, unspecified trimester</td>
</tr>
<tr class="even">
<td align="left">M85.2</td>
<td align="right">2</td>
<td align="left">Morgagni-Stewart-Morel syndrome</td>
<td align="left">Hyperostosis of skull</td>
</tr>
<tr class="odd">
<td align="left">L95.1</td>
<td align="right">2</td>
<td align="left">Erythema elevatum diutinum</td>
<td align="left">Erythema elevatum diutinum</td>
</tr>
<tr class="even">
<td align="left">L90.3</td>
<td align="right">2</td>
<td align="left">Atrophoderma of Pierini and Pasini</td>
<td align="left">Atrophoderma of Pasini and Pierini</td>
</tr>
<tr class="odd">
<td align="left">L85.0</td>
<td align="right">2</td>
<td align="left">Ichthyosis, acquired</td>
<td align="left">Acquired ichthyosis</td>
</tr>
<tr class="even">
<td align="left">L66.0</td>
<td align="right">2</td>
<td align="left">Pseudopelade of Brocq</td>
<td align="left">Pseudopelade</td>
</tr>
<tr class="odd">
<td align="left">J67.0</td>
<td align="right">2</td>
<td align="left">Farmer’s lung</td>
<td align="left">Farmer’s lung</td>
</tr>
<tr class="even">
<td align="left">J63.4</td>
<td align="right">2</td>
<td align="left">Siderosis</td>
<td align="left">Siderosis</td>
</tr>
<tr class="odd">
<td align="left">J16.0</td>
<td align="right">2</td>
<td align="left">Psittacosis</td>
<td align="left">Chlamydial pneumonia</td>
</tr>
<tr class="even">
<td align="left">I23.3</td>
<td align="right">2</td>
<td align="left">Cardiac rupture</td>
<td align="left">Rupture of cardiac wall without hemopericardium as current complication following acute myocardial infarction</td>
</tr>
<tr class="odd">
<td align="left">H83.19</td>
<td align="right">2</td>
<td align="left">Perilymphatic fistula</td>
<td align="left">Labyrinthine fistula, unspecified ear</td>
</tr>
<tr class="even">
<td align="left">G90.1</td>
<td align="right">2</td>
<td align="left">Familial dysautonomia</td>
<td align="left">Familial dysautonomia [Riley-Day]</td>
</tr>
<tr class="odd">
<td align="left">G13.1</td>
<td align="right">2</td>
<td align="left">Limbic encephalitis</td>
<td align="left">Other systemic atrophy primarily affecting central nervous system in neoplastic disease</td>
</tr>
<tr class="even">
<td align="left">E76.02</td>
<td align="right">2</td>
<td align="left">HurlerÎ“ÃÃ´Scheie syndrome</td>
<td align="left">Hurler-Scheie syndrome</td>
</tr>
<tr class="odd">
<td align="left">E74.29</td>
<td align="right">2</td>
<td align="left">Galactokinase deficiency</td>
<td align="left">Other disorders of galactose metabolism</td>
</tr>
<tr class="even">
<td align="left">E74.12</td>
<td align="right">2</td>
<td align="left">Hereditary fructose intolerance</td>
<td align="left">Hereditary fructose intolerance</td>
</tr>
<tr class="odd">
<td align="left">E72.02</td>
<td align="right">2</td>
<td align="left">Hartnup disease</td>
<td align="left">Hartnup’s disease</td>
</tr>
<tr class="even">
<td align="left">E71.528</td>
<td align="right">2</td>
<td align="left">Pseudoneonatal adrenoleukodystrophy</td>
<td align="left">Other X-linked adrenoleukodystrophy</td>
</tr>
<tr class="odd">
<td align="left">E71.110</td>
<td align="right">2</td>
<td align="left">Isovaleric acidemia</td>
<td align="left">Isovaleric acidemia</td>
</tr>
<tr class="even">
<td align="left">D48.4</td>
<td align="right">2</td>
<td align="left">Disseminated peritoneal leiomyomatosis</td>
<td align="left">Neoplasm of uncertain behavior of peritoneum</td>
</tr>
<tr class="odd">
<td align="left">C93.30</td>
<td align="right">2</td>
<td align="left">Juvenile myelomonocytic leukemia</td>
<td align="left">Juvenile myelomonocytic leukemia, not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">C88.8</td>
<td align="right">2</td>
<td align="left">Light chain deposition disease</td>
<td align="left">Other malignant immunoproliferative diseases</td>
</tr>
<tr class="odd">
<td align="left">C86.2</td>
<td align="right">2</td>
<td align="left">Enteropathy-associated T-cell lymphoma</td>
<td align="left">Enteropathy-type (intestinal) T-cell lymphoma</td>
</tr>
<tr class="even">
<td align="left">C26.1</td>
<td align="right">2</td>
<td align="left">Splenic neoplasm</td>
<td align="left">Malignant neoplasm of spleen</td>
</tr>
<tr class="odd">
<td align="left">B65.1</td>
<td align="right">2</td>
<td align="left">Schistosomiasis</td>
<td align="left">Schistosomiasis due to Schistosoma mansoni [intestinal schistosomiasis]</td>
</tr>
<tr class="even">
<td align="left">B41.9</td>
<td align="right">2</td>
<td align="left">Paracoccidioidomycosis</td>
<td align="left">Paracoccidioidomycosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A92.30</td>
<td align="right">2</td>
<td align="left">West nile virus</td>
<td align="left">West Nile virus infection, unspecified</td>
</tr>
<tr class="even">
<td align="left">A81.83</td>
<td align="right">2</td>
<td align="left">Fatal familial insomnia</td>
<td align="left">Fatal familial insomnia</td>
</tr>
<tr class="odd">
<td align="left">A75.2</td>
<td align="right">2</td>
<td align="left">Typhus</td>
<td align="left">Typhus fever due to Rickettsia typhi</td>
</tr>
<tr class="even">
<td align="left">A65</td>
<td align="right">2</td>
<td align="left">Bejel</td>
<td align="left">Nonvenereal syphilis</td>
</tr>
<tr class="odd">
<td align="left">A39.4</td>
<td align="right">2</td>
<td align="left">Meningococcemia</td>
<td align="left">Meningococcemia, unspecified</td>
</tr>
<tr class="even">
<td align="left">A36.9</td>
<td align="right">2</td>
<td align="left">Diphtheria</td>
<td align="left">Diphtheria, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A23.9</td>
<td align="right">2</td>
<td align="left">Brucellosis</td>
<td align="left">Brucellosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">Q98.8</td>
<td align="right">1</td>
<td align="left">48,XXYY syndrome</td>
<td align="left">Other specified sex chromosome abnormalities, male phenotype</td>
</tr>
<tr class="odd">
<td align="left">Q87.82</td>
<td align="right">1</td>
<td align="left">Arterial tortuosity syndrome</td>
<td align="left">Arterial tortuosity syndrome</td>
</tr>
<tr class="even">
<td align="left">Q24.1</td>
<td align="right">1</td>
<td align="left">Isolated levocardia</td>
<td align="left">Levocardia</td>
</tr>
<tr class="odd">
<td align="left">O69.3XX0</td>
<td align="right">1</td>
<td align="left">Limb-body wall complex</td>
<td align="left">Labor and delivery complicated by short cord, not applicable or unspecified</td>
</tr>
<tr class="even">
<td align="left">N05.0</td>
<td align="right">1</td>
<td align="left">Minimal change disease</td>
<td align="left">Unspecified nephritic syndrome with minor glomerular abnormality</td>
</tr>
<tr class="odd">
<td align="left">M93.839</td>
<td align="right">1</td>
<td align="left">Kienbock’s disease</td>
<td align="left">Other specified osteochondropathies, unspecified forearm</td>
</tr>
<tr class="even">
<td align="left">L94.6</td>
<td align="right">1</td>
<td align="left">Ainhum</td>
<td align="left">Ainhum</td>
</tr>
<tr class="odd">
<td align="left">L92.8</td>
<td align="right">1</td>
<td align="left">Granulomatous slack skin disease</td>
<td align="left">Other granulomatous disorders of the skin and subcutaneous tissue</td>
</tr>
<tr class="even">
<td align="left">L87.2</td>
<td align="right">1</td>
<td align="left">Elastosis perforans serpiginosa</td>
<td align="left">Elastosis perforans serpiginosa</td>
</tr>
<tr class="odd">
<td align="left">L75.1</td>
<td align="right">1</td>
<td align="left">Chromhidrosis</td>
<td align="left">Chromhidrosis</td>
</tr>
<tr class="even">
<td align="left">L72.2</td>
<td align="right">1</td>
<td align="left">Steatocystoma multiplex</td>
<td align="left">Steatocystoma multiplex</td>
</tr>
<tr class="odd">
<td align="left">L66.8</td>
<td align="right">1</td>
<td align="left">Central centrifugal cicatricial alopecia</td>
<td align="left">Other cicatricial alopecia</td>
</tr>
<tr class="even">
<td align="left">L66.4</td>
<td align="right">1</td>
<td align="left">Atrophoderma vermiculata</td>
<td align="left">Folliculitis ulerythematosa reticulata</td>
</tr>
<tr class="odd">
<td align="left">L50.4</td>
<td align="right">1</td>
<td align="left">Vibratory urticaria</td>
<td align="left">Vibratory urticaria</td>
</tr>
<tr class="even">
<td align="left">L41.4</td>
<td align="right">1</td>
<td align="left">Parapsoriasis</td>
<td align="left">Large plaque parapsoriasis</td>
</tr>
<tr class="odd">
<td align="left">L10.3</td>
<td align="right">1</td>
<td align="left">Pemphigus and fogo selvagem</td>
<td align="left">Brazilian pemphigus [fogo selvagem]</td>
</tr>
<tr class="even">
<td align="left">K13.5</td>
<td align="right">1</td>
<td align="left">Oral submucous fibrosis</td>
<td align="left">Oral submucous fibrosis</td>
</tr>
<tr class="odd">
<td align="left">K04.2</td>
<td align="right">1</td>
<td align="left">Dentin dysplasia, coronal</td>
<td align="left">Pulp degeneration</td>
</tr>
<tr class="even">
<td align="left">K03.4</td>
<td align="right">1</td>
<td align="left">Hypercementosis</td>
<td align="left">Hypercementosis</td>
</tr>
<tr class="odd">
<td align="left">J63.2</td>
<td align="right">1</td>
<td align="left">Beryllium disease</td>
<td align="left">Berylliosis</td>
</tr>
<tr class="even">
<td align="left">J12.81</td>
<td align="right">1</td>
<td align="left">SARS</td>
<td align="left">Pneumonia due to SARS-associated coronavirus</td>
</tr>
<tr class="odd">
<td align="left">H53.55</td>
<td align="right">1</td>
<td align="left">Carotid body tumor</td>
<td align="left">Tritanomaly</td>
</tr>
<tr class="even">
<td align="left">H31.29</td>
<td align="right">1</td>
<td align="left">Bietti crystalline corneoretinal dystrophy</td>
<td align="left">Other hereditary choroidal dystrophy</td>
</tr>
<tr class="odd">
<td align="left">H31.23</td>
<td align="right">1</td>
<td align="left">Gyrate atrophy of choroid and retina</td>
<td align="left">Gyrate atrophy, choroid</td>
</tr>
<tr class="even">
<td align="left">G93.7</td>
<td align="right">1</td>
<td align="left">Reye syndrome</td>
<td align="left">Reye’s syndrome</td>
</tr>
<tr class="odd">
<td align="left">G31.81</td>
<td align="right">1</td>
<td align="left">Alpers syndrome</td>
<td align="left">Alpers disease</td>
</tr>
<tr class="even">
<td align="left">E78.81</td>
<td align="right">1</td>
<td align="left">Multicentric reticulohistiocytosis</td>
<td align="left">Lipoid dermatoarthritis</td>
</tr>
<tr class="odd">
<td align="left">E76.03</td>
<td align="right">1</td>
<td align="left">Scheie syndrome</td>
<td align="left">Scheie’s syndrome</td>
</tr>
<tr class="even">
<td align="left">E75.241</td>
<td align="right">1</td>
<td align="left">Niemann-Pick disease type B</td>
<td align="left">Niemann-Pick disease type B</td>
</tr>
<tr class="odd">
<td align="left">E75.01</td>
<td align="right">1</td>
<td align="left">Sandhoff disease</td>
<td align="left">Sandhoff disease</td>
</tr>
<tr class="even">
<td align="left">E71.510</td>
<td align="right">1</td>
<td align="left">Zellweger syndrome</td>
<td align="left">Zellweger syndrome</td>
</tr>
<tr class="odd">
<td align="left">E59</td>
<td align="right">1</td>
<td align="left">Keshan disease</td>
<td align="left">Dietary selenium deficiency</td>
</tr>
<tr class="even">
<td align="left">E24.1</td>
<td align="right">1</td>
<td align="left">Nelson syndrome</td>
<td align="left">Nelson’s syndrome</td>
</tr>
<tr class="odd">
<td align="left">D89.40</td>
<td align="right">1</td>
<td align="left">Mast cell activation syndrome</td>
<td align="left">Mast cell activation, unspecified</td>
</tr>
<tr class="even">
<td align="left">D81.6</td>
<td align="right">1</td>
<td align="left">Bare lymphocyte syndrome</td>
<td align="left">Major histocompatibility complex class I deficiency</td>
</tr>
<tr class="odd">
<td align="left">C96.4</td>
<td align="right">1</td>
<td align="left">Langerhans cell sarcoma</td>
<td align="left">Sarcoma of dendritic cells (accessory cells)</td>
</tr>
<tr class="even">
<td align="left">C92.Z0</td>
<td align="right">1</td>
<td align="left">Chronic myeloid leukemia</td>
<td align="left">Other myeloid leukemia not having achieved remission</td>
</tr>
<tr class="odd">
<td align="left">C92.A0</td>
<td align="right">1</td>
<td align="left">AML with myelodysplasia-related features</td>
<td align="left">Acute myeloid leukemia with multilineage dysplasia, not having achieved remission</td>
</tr>
<tr class="even">
<td align="left">C22.3</td>
<td align="right">1</td>
<td align="left">Angiosarcoma of the liver</td>
<td align="left">Angiosarcoma of liver</td>
</tr>
<tr class="odd">
<td align="left">B88.1</td>
<td align="right">1</td>
<td align="left">Tungiasis</td>
<td align="left">Tungiasis [sandflea infestation]</td>
</tr>
<tr class="even">
<td align="left">B87.0</td>
<td align="right">1</td>
<td align="left">Creeping myiasis</td>
<td align="left">Cutaneous myiasis</td>
</tr>
<tr class="odd">
<td align="left">B83.2</td>
<td align="right">1</td>
<td align="left">Angiostrongyliasis</td>
<td align="left">Angiostrongyliasis due to Parastrongylus cantonensis</td>
</tr>
<tr class="even">
<td align="left">B74.3</td>
<td align="right">1</td>
<td align="left">Loiasis</td>
<td align="left">Loiasis</td>
</tr>
<tr class="odd">
<td align="left">B74.0</td>
<td align="right">1</td>
<td align="left">Lymphatic filariasis</td>
<td align="left">Filariasis due to Wuchereria bancrofti</td>
</tr>
<tr class="even">
<td align="left">B71.0</td>
<td align="right">1</td>
<td align="left">Hymenolepiasis</td>
<td align="left">Hymenolepiasis</td>
</tr>
<tr class="odd">
<td align="left">B66.3</td>
<td align="right">1</td>
<td align="left">Fascioliasis</td>
<td align="left">Fascioliasis</td>
</tr>
<tr class="even">
<td align="left">B43.9</td>
<td align="right">1</td>
<td align="left">Chromoblastomycosis</td>
<td align="left">Chromomycosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">B04</td>
<td align="right">1</td>
<td align="left">Monkeypox</td>
<td align="left">Monkeypox</td>
</tr>
<tr class="even">
<td align="left">A92.31</td>
<td align="right">1</td>
<td align="left">West nile encephalitis</td>
<td align="left">West Nile virus infection with encephalitis</td>
</tr>
<tr class="odd">
<td align="left">A85.8</td>
<td align="right">1</td>
<td align="left">Encephalitis lethargica</td>
<td align="left">Other specified viral encephalitis</td>
</tr>
<tr class="even">
<td align="left">A83.1</td>
<td align="right">1</td>
<td align="left">Western equine encephalitis</td>
<td align="left">Western equine encephalitis</td>
</tr>
<tr class="odd">
<td align="left">A77.49</td>
<td align="right">1</td>
<td align="left">Human granulocytic ehrlichiosis</td>
<td align="left">Other ehrlichiosis</td>
</tr>
<tr class="even">
<td align="left">A75.9</td>
<td align="right">1</td>
<td align="left">Typhus</td>
<td align="left">Typhus fever, unspecified</td>
</tr>
<tr class="odd">
<td align="left">A58</td>
<td align="right">1</td>
<td align="left">Granuloma Inguinale</td>
<td align="left">Granuloma inguinale</td>
</tr>
<tr class="even">
<td align="left">A52.13</td>
<td align="right">1</td>
<td align="left">Syphilitic aseptic meningitis</td>
<td align="left">Late syphilitic meningitis</td>
</tr>
<tr class="odd">
<td align="left">A25.9</td>
<td align="right">1</td>
<td align="left">Rat bite fever</td>
<td align="left">Rat-bite fever, unspecified</td>
</tr>
<tr class="even">
<td align="left">A24.0</td>
<td align="right">1</td>
<td align="left">Glanders</td>
<td align="left">Glanders</td>
</tr>
<tr class="odd">
<td align="left">A21.9</td>
<td align="right">1</td>
<td align="left">Tularemia</td>
<td align="left">Tularemia, unspecified</td>
</tr>
<tr class="even">
<td align="left">A05.0</td>
<td align="right">1</td>
<td align="left">Staphylococcal food poisoning</td>
<td align="left">Foodborne staphylococcal intoxication</td>
</tr>
<tr class="odd">
<td align="left">A00.9</td>
<td align="right">1</td>
<td align="left">Cholera</td>
<td align="left">Cholera, unspecified</td>
</tr>
</tbody>
</table>
</div>
<div id="frequency-table-with-all-icd-10-codes-for-rare-metabolic-diseases" class="section level3">
<h3>Frequency Table with All ICD-10 Codes for Rare Metabolic Diseases</h3>
<p>This table shows the frequency of all rare metabolic disease ICD-10 codes from our rare disease file (from the National Library of Medicine). We also include the ICD-10 code description as well as the name of the rare metabolic disease it maps to in our mapping file.</p>
<p>Number of ICD-10 Codes: <strong>429</strong></p>
<p>Total Number of Patients: <strong>231182</strong></p>
<table>
<thead>
<tr class="header">
<th align="left">ICD-10 Code</th>
<th align="right">Frequency</th>
<th align="left">Rare Disease Name</th>
<th align="left">ICD Code Description</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">E78.00</td>
<td align="right">46355</td>
<td align="left">Hyperlipoproteinemia type 2</td>
<td align="left">Pure hypercholesterolemia, unspecified</td>
</tr>
<tr class="even">
<td align="left">E78.2</td>
<td align="right">42956</td>
<td align="left">Hyperlipidemia type 3</td>
<td align="left">Mixed hyperlipidemia</td>
</tr>
<tr class="odd">
<td align="left">E78.2</td>
<td align="right">42956</td>
<td align="left">Xanthoma disseminatum</td>
<td align="left">Mixed hyperlipidemia</td>
</tr>
<tr class="even">
<td align="left">E87.5</td>
<td align="right">10605</td>
<td align="left">Gordon syndrome</td>
<td align="left">Hyperkalemia</td>
</tr>
<tr class="odd">
<td align="left">E78.1</td>
<td align="right">7041</td>
<td align="left">Hyperlipoproteinemia type 4</td>
<td align="left">Pure hyperglyceridemia</td>
</tr>
<tr class="even">
<td align="left">E83.42</td>
<td align="right">6761</td>
<td align="left">Primary hypomagnesemia with secondary hypocalcemia</td>
<td align="left">Hypomagnesemia</td>
</tr>
<tr class="odd">
<td align="left">E83.52</td>
<td align="right">5433</td>
<td align="left">Familial hypocalciuric hypercalcemia</td>
<td align="left">Hypercalcemia</td>
</tr>
<tr class="even">
<td align="left">E88.81</td>
<td align="right">4269</td>
<td align="left">Insulin-resistance type B</td>
<td align="left">Metabolic syndrome</td>
</tr>
<tr class="odd">
<td align="left">E88.81</td>
<td align="right">4269</td>
<td align="left">Abdominal obesity metabolic syndrome</td>
<td align="left">Metabolic syndrome</td>
</tr>
<tr class="even">
<td align="left">E80.6</td>
<td align="right">3459</td>
<td align="left">Rotor syndrome</td>
<td align="left">Other disorders of bilirubin metabolism</td>
</tr>
<tr class="odd">
<td align="left">E80.6</td>
<td align="right">3459</td>
<td align="left">Dubin-Johnson syndrome</td>
<td align="left">Other disorders of bilirubin metabolism</td>
</tr>
<tr class="even">
<td align="left">E83.51</td>
<td align="right">2020</td>
<td align="left">Hypocalcemia, autosomal dominant</td>
<td align="left">Hypocalcemia</td>
</tr>
<tr class="odd">
<td align="left">E88.09</td>
<td align="right">1763</td>
<td align="left">Pseudocholinesterase deficiency</td>
<td align="left">Other disorders of plasma-protein metabolism, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">E88.09</td>
<td align="right">1763</td>
<td align="left">Pseudocholinesterase deficiency</td>
<td align="left">Other disorders of plasma-protein metabolism, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">E88.09</td>
<td align="right">1763</td>
<td align="left">Atransferrinemia</td>
<td align="left">Other disorders of plasma-protein metabolism, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">E88.09</td>
<td align="right">1763</td>
<td align="left">Congenital analbuminemia</td>
<td align="left">Other disorders of plasma-protein metabolism, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">E78.6</td>
<td align="right">1704</td>
<td align="left">Abetalipoproteinemia</td>
<td align="left">Lipoprotein deficiency</td>
</tr>
<tr class="even">
<td align="left">E78.6</td>
<td align="right">1704</td>
<td align="left">Familial HDL deficiency</td>
<td align="left">Lipoprotein deficiency</td>
</tr>
<tr class="odd">
<td align="left">E78.6</td>
<td align="right">1704</td>
<td align="left">Familial hypobetalipoproteinemia</td>
<td align="left">Lipoprotein deficiency</td>
</tr>
<tr class="even">
<td align="left">E78.6</td>
<td align="right">1704</td>
<td align="left">Chorea-acanthocytosis</td>
<td align="left">Lipoprotein deficiency</td>
</tr>
<tr class="odd">
<td align="left">E78.6</td>
<td align="right">1704</td>
<td align="left">Familial LCAT deficiency</td>
<td align="left">Lipoprotein deficiency</td>
</tr>
<tr class="even">
<td align="left">E78.6</td>
<td align="right">1704</td>
<td align="left">Fish-eye disease</td>
<td align="left">Lipoprotein deficiency</td>
</tr>
<tr class="odd">
<td align="left">E78.6</td>
<td align="right">1704</td>
<td align="left">Tangier disease</td>
<td align="left">Lipoprotein deficiency</td>
</tr>
<tr class="even">
<td align="left">E78.6</td>
<td align="right">1704</td>
<td align="left">Hypolipoproteinemia</td>
<td align="left">Lipoprotein deficiency</td>
</tr>
<tr class="odd">
<td align="left">E78.6</td>
<td align="right">1704</td>
<td align="left">Neuroacanthocytosis</td>
<td align="left">Lipoprotein deficiency</td>
</tr>
<tr class="even">
<td align="left">E83.39</td>
<td align="right">942</td>
<td align="left">Hypophosphatasia</td>
<td align="left">Other disorders of phosphorus metabolism</td>
</tr>
<tr class="odd">
<td align="left">E83.39</td>
<td align="right">942</td>
<td align="left">Childhood hypophosphatasia</td>
<td align="left">Other disorders of phosphorus metabolism</td>
</tr>
<tr class="even">
<td align="left">E78.89</td>
<td align="right">749</td>
<td align="left">Lipoid proteinosis of Urbach and Wiethe</td>
<td align="left">Other lipoprotein metabolism disorders</td>
</tr>
<tr class="odd">
<td align="left">E78.89</td>
<td align="right">749</td>
<td align="left">Farber’s disease</td>
<td align="left">Other lipoprotein metabolism disorders</td>
</tr>
<tr class="even">
<td align="left">E78.89</td>
<td align="right">749</td>
<td align="left">Sitosterolemia</td>
<td align="left">Other lipoprotein metabolism disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.1</td>
<td align="right">558</td>
<td align="left">Familial partial lipodystrophy type 2</td>
<td align="left">Lipodystrophy, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">E88.1</td>
<td align="right">558</td>
<td align="left">Familial partial lipodystrophy type 2</td>
<td align="left">Lipodystrophy, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">E88.1</td>
<td align="right">558</td>
<td align="left">Familial partial lipodystrophy type 2</td>
<td align="left">Lipodystrophy, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">E88.1</td>
<td align="right">558</td>
<td align="left">Congenital generalized lipodystrophy type 2</td>
<td align="left">Lipodystrophy, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">E88.1</td>
<td align="right">558</td>
<td align="left">Congenital generalized lipodystrophy type 2</td>
<td align="left">Lipodystrophy, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">E88.1</td>
<td align="right">558</td>
<td align="left">Familial partial lipodystrophy</td>
<td align="left">Lipodystrophy, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">E88.1</td>
<td align="right">558</td>
<td align="left">Acquired generalized lipodystrophy</td>
<td align="left">Lipodystrophy, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">E88.1</td>
<td align="right">558</td>
<td align="left">Acquired generalized lipodystrophy</td>
<td align="left">Lipodystrophy, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">E84.9</td>
<td align="right">541</td>
<td align="left">Cystic fibrosis</td>
<td align="left">Cystic fibrosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">E78.01</td>
<td align="right">535</td>
<td align="left">Hyperlipoproteinemia type 2</td>
<td align="left">Familial hypercholesterolemia</td>
</tr>
<tr class="odd">
<td align="left">E72.53</td>
<td align="right">490</td>
<td align="left">Primary hyperoxaluria type 1</td>
<td align="left">Hyperoxaluria</td>
</tr>
<tr class="even">
<td align="left">E72.53</td>
<td align="right">490</td>
<td align="left">Primary hyperoxaluria type 2</td>
<td align="left">Hyperoxaluria</td>
</tr>
<tr class="odd">
<td align="left">E83.19</td>
<td align="right">451</td>
<td align="left">Hemosiderosis</td>
<td align="left">Other disorders of iron metabolism</td>
</tr>
<tr class="even">
<td align="left">E83.19</td>
<td align="right">451</td>
<td align="left">Aceruloplasminemia</td>
<td align="left">Other disorders of iron metabolism</td>
</tr>
<tr class="odd">
<td align="left">E74.02</td>
<td align="right">392</td>
<td align="left">Adrenomyodystrophy</td>
<td align="left">Pompe disease</td>
</tr>
<tr class="even">
<td align="left">E74.02</td>
<td align="right">392</td>
<td align="left">Glycogen storage disease type 2</td>
<td align="left">Pompe disease</td>
</tr>
<tr class="odd">
<td align="left">E75.21</td>
<td align="right">345</td>
<td align="left">Fabry disease</td>
<td align="left">Fabry (-Anderson) disease</td>
</tr>
<tr class="even">
<td align="left">E72.20</td>
<td align="right">302</td>
<td align="left">Urea cycle disorders</td>
<td align="left">Disorder of urea cycle metabolism, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E80.4</td>
<td align="right">296</td>
<td align="left">Congenital nonhemolytic jaundice</td>
<td align="left">Gilbert syndrome</td>
</tr>
<tr class="even">
<td align="left">E88.01</td>
<td align="right">272</td>
<td align="left">Alpha-1 antitrypsin deficiency</td>
<td align="left">Alpha-1-antitrypsin deficiency</td>
</tr>
<tr class="odd">
<td align="left">E72.11</td>
<td align="right">241</td>
<td align="left">Homocystinuria due to CBS deficiency</td>
<td align="left">Homocystinuria</td>
</tr>
<tr class="even">
<td align="left">E72.11</td>
<td align="right">241</td>
<td align="left">Homocystinuria</td>
<td align="left">Homocystinuria</td>
</tr>
<tr class="odd">
<td align="left">E85.4</td>
<td align="right">240</td>
<td align="left">Primary cutaneous amyloidosis</td>
<td align="left">Organ-limited amyloidosis</td>
</tr>
<tr class="even">
<td align="left">E85.4</td>
<td align="right">240</td>
<td align="left">Primary cutaneous amyloidosis</td>
<td align="left">Organ-limited amyloidosis</td>
</tr>
<tr class="odd">
<td align="left">E85.4</td>
<td align="right">240</td>
<td align="left">Primary cutaneous amyloidosis</td>
<td align="left">Organ-limited amyloidosis</td>
</tr>
<tr class="even">
<td align="left">E85.4</td>
<td align="right">240</td>
<td align="left">Primary cutaneous amyloidosis</td>
<td align="left">Organ-limited amyloidosis</td>
</tr>
<tr class="odd">
<td align="left">E85.4</td>
<td align="right">240</td>
<td align="left">Amyloidosis corneal</td>
<td align="left">Organ-limited amyloidosis</td>
</tr>
<tr class="even">
<td align="left">E85.8</td>
<td align="right">213</td>
<td align="left">AL amyloidosis</td>
<td align="left">Other amyloidosis</td>
</tr>
<tr class="odd">
<td align="left">E85.8</td>
<td align="right">213</td>
<td align="left">Amyloidosis AA</td>
<td align="left">Other amyloidosis</td>
</tr>
<tr class="even">
<td align="left">E83.59</td>
<td align="right">212</td>
<td align="left">Calciphylaxis</td>
<td align="left">Other disorders of calcium metabolism</td>
</tr>
<tr class="odd">
<td align="left">E83.59</td>
<td align="right">212</td>
<td align="left">Nephrocalcinosis</td>
<td align="left">Other disorders of calcium metabolism</td>
</tr>
<tr class="even">
<td align="left">E78.3</td>
<td align="right">180</td>
<td align="left">Hyperlipoproteinemia type 5</td>
<td align="left">Hyperchylomicronemia</td>
</tr>
<tr class="odd">
<td align="left">E78.3</td>
<td align="right">180</td>
<td align="left">Chylomicron retention disease</td>
<td align="left">Hyperchylomicronemia</td>
</tr>
<tr class="even">
<td align="left">E78.3</td>
<td align="right">180</td>
<td align="left">Familial lipoprotein lipase deficiency</td>
<td align="left">Hyperchylomicronemia</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Infantile free sialic acid storage disease</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">17-alpha-hydroxylase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Gordon syndrome</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Gordon syndrome</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Tyrosinemia type 1</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Hyperphenylalaninemia due to dehydratase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Tyrosinemia type 2</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Methylmalonyl-Coenzyme A mutase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Phosphoribosylpyrophosphate synthetase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Pseudohypoaldosteronism type 2</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Pseudohypoaldosteronism type 2</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Salla disease</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">SCOT deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Sialuria, French type</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Sialuria, French type</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Mitochondrial complex II deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">17-beta hydroxysteroid dehydrogenase 3 deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">3 Methylcrotonyl-CoA carboxylase 1 deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Fumarase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Fumarase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Multiple symmetric lipomatosis</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Prolidase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Prolidase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Prolidase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Prolidase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Pseudocholinesterase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Pyruvate kinase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Rowley-Rosenberg syndrome</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Acetyl CoA acetyltransferase 2 deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Pseudoxanthoma elasticum</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Cortisone reductase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Isobutyryl-CoA dehydrogenase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Transaldolase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Cerebral folate deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Free sialic acid storage disease</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">3-methylcrotonyl-CoA carboxylase deficiency</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Aromatase excess syndrome</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="even">
<td align="left">E88.89</td>
<td align="right">163</td>
<td align="left">Hereditary folate malabsorption</td>
<td align="left">Other specified metabolic disorders</td>
</tr>
<tr class="odd">
<td align="left">E83.118</td>
<td align="right">123</td>
<td align="left">Bantu siderosis</td>
<td align="left">Other hemochromatosis</td>
</tr>
<tr class="even">
<td align="left">E83.118</td>
<td align="right">123</td>
<td align="left">Hemochromatosis type 2</td>
<td align="left">Other hemochromatosis</td>
</tr>
<tr class="odd">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">Pentosuria</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="even">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">Diphosphoglycerate mutase deficiency of erythrocyte</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="odd">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">Glucosephosphate isomerase deficiency</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="even">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">Glyceraldehyde-3-phosphate dehydrogenase deficiency</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="odd">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">Hyperglycerolemia</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="even">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">Alpha-mannosidosis</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="odd">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">Phosphoglycerate kinase deficiency</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="even">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">Renal glycosuria</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="odd">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">ALG6-CDG (CDG-Ic)</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="even">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">ALG6-CDG (CDG-Ic)</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="odd">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">ALG12-CDG (CDG-Ig)</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="even">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">Phosphoglycerate mutase deficiency</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="odd">
<td align="left">E74.8</td>
<td align="right">98</td>
<td align="left">Trehalase deficiency</td>
<td align="left">Other specified disorders of carbohydrate metabolism</td>
</tr>
<tr class="even">
<td align="left">E75.29</td>
<td align="right">62</td>
<td align="left">Metachromatic leukodystrophy</td>
<td align="left">Other sphingolipidosis</td>
</tr>
<tr class="odd">
<td align="left">E75.29</td>
<td align="right">62</td>
<td align="left">Pelizaeus-Merzbacher disease</td>
<td align="left">Other sphingolipidosis</td>
</tr>
<tr class="even">
<td align="left">E75.29</td>
<td align="right">62</td>
<td align="left">Multiple sulfatase deficiency</td>
<td align="left">Other sphingolipidosis</td>
</tr>
<tr class="odd">
<td align="left">E75.29</td>
<td align="right">62</td>
<td align="left">Canavan disease</td>
<td align="left">Other sphingolipidosis</td>
</tr>
<tr class="even">
<td align="left">E75.29</td>
<td align="right">62</td>
<td align="left">Leukodystrophy</td>
<td align="left">Other sphingolipidosis</td>
</tr>
<tr class="odd">
<td align="left">E83.31</td>
<td align="right">58</td>
<td align="left">Hypophosphatemic rickets</td>
<td align="left">Familial hypophosphatemia</td>
</tr>
<tr class="even">
<td align="left">E70.329</td>
<td align="right">57</td>
<td align="left">Oculocutaneous albinism</td>
<td align="left">Oculocutaneous albinism, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E75.22</td>
<td align="right">51</td>
<td align="left">Gaucher disease type 1</td>
<td align="left">Gaucher disease</td>
</tr>
<tr class="even">
<td align="left">E75.22</td>
<td align="right">51</td>
<td align="left">Gaucher disease type 2</td>
<td align="left">Gaucher disease</td>
</tr>
<tr class="odd">
<td align="left">E75.22</td>
<td align="right">51</td>
<td align="left">Gaucher disease type 3</td>
<td align="left">Gaucher disease</td>
</tr>
<tr class="even">
<td align="left">E75.22</td>
<td align="right">51</td>
<td align="left">Gaucher disease</td>
<td align="left">Gaucher disease</td>
</tr>
<tr class="odd">
<td align="left">E83.01</td>
<td align="right">49</td>
<td align="left">Wilson disease</td>
<td align="left">Wilson’s disease</td>
</tr>
<tr class="even">
<td align="left">E74.09</td>
<td align="right">49</td>
<td align="left">Fanconi Bickel syndrome</td>
<td align="left">Other glycogen storage disease</td>
</tr>
<tr class="odd">
<td align="left">E74.09</td>
<td align="right">49</td>
<td align="left">Glycogen storage disease type 4</td>
<td align="left">Other glycogen storage disease</td>
</tr>
<tr class="even">
<td align="left">E74.09</td>
<td align="right">49</td>
<td align="left">Lactate dehydrogenase A deficiency</td>
<td align="left">Other glycogen storage disease</td>
</tr>
<tr class="odd">
<td align="left">E74.09</td>
<td align="right">49</td>
<td align="left">Glycogen storage disease type 7</td>
<td align="left">Other glycogen storage disease</td>
</tr>
<tr class="even">
<td align="left">E74.09</td>
<td align="right">49</td>
<td align="left">Glycogen storage disease type 6</td>
<td align="left">Other glycogen storage disease</td>
</tr>
<tr class="odd">
<td align="left">E74.09</td>
<td align="right">49</td>
<td align="left">Glycogen storage disease 8</td>
<td align="left">Other glycogen storage disease</td>
</tr>
<tr class="even">
<td align="left">E74.09</td>
<td align="right">49</td>
<td align="left">Glycogen storage disease 8</td>
<td align="left">Other glycogen storage disease</td>
</tr>
<tr class="odd">
<td align="left">E74.09</td>
<td align="right">49</td>
<td align="left">Primary Fanconi syndrome</td>
<td align="left">Other glycogen storage disease</td>
</tr>
<tr class="even">
<td align="left">E74.09</td>
<td align="right">49</td>
<td align="left">Danon disease</td>
<td align="left">Other glycogen storage disease</td>
</tr>
<tr class="odd">
<td align="left">E74.09</td>
<td align="right">49</td>
<td align="left">Phosphoglycerate mutase deficiency</td>
<td align="left">Other glycogen storage disease</td>
</tr>
<tr class="even">
<td align="left">E76.01</td>
<td align="right">48</td>
<td align="left">Hurler syndrome</td>
<td align="left">Hurler’s syndrome</td>
</tr>
<tr class="odd">
<td align="left">E80.1</td>
<td align="right">46</td>
<td align="left">Hepatoerythropoietic porphyria</td>
<td align="left">Porphyria cutanea tarda</td>
</tr>
<tr class="even">
<td align="left">E80.1</td>
<td align="right">46</td>
<td align="left">Porphyria cutanea tarda</td>
<td align="left">Porphyria cutanea tarda</td>
</tr>
<tr class="odd">
<td align="left">E80.20</td>
<td align="right">44</td>
<td align="left">Variegate porphyria</td>
<td align="left">Unspecified porphyria</td>
</tr>
<tr class="even">
<td align="left">E80.20</td>
<td align="right">44</td>
<td align="left">Porphyria</td>
<td align="left">Unspecified porphyria</td>
</tr>
<tr class="odd">
<td align="left">E71.529</td>
<td align="right">42</td>
<td align="left">X-linked adrenoleukodystrophy</td>
<td align="left">X-linked adrenoleukodystrophy, unspecified type</td>
</tr>
<tr class="even">
<td align="left">E71.529</td>
<td align="right">42</td>
<td align="left">Adrenomyeloneuropathy</td>
<td align="left">X-linked adrenoleukodystrophy, unspecified type</td>
</tr>
<tr class="odd">
<td align="left">E72.01</td>
<td align="right">40</td>
<td align="left">Cystinuria</td>
<td align="left">Cystinuria</td>
</tr>
<tr class="even">
<td align="left">E70.30</td>
<td align="right">39</td>
<td align="left">Albinism</td>
<td align="left">Albinism, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E76.3</td>
<td align="right">38</td>
<td align="left">Mucopolysaccharidosis</td>
<td align="left">Mucopolysaccharidosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">E74.01</td>
<td align="right">37</td>
<td align="left">Glycogen storage disease type 1B</td>
<td align="left">von Gierke disease</td>
</tr>
<tr class="odd">
<td align="left">E74.01</td>
<td align="right">37</td>
<td align="left">Glycogen storage disease type 1A</td>
<td align="left">von Gierke disease</td>
</tr>
<tr class="even">
<td align="left">E72.09</td>
<td align="right">37</td>
<td align="left">X-linked creatine deficiency</td>
<td align="left">Other disorders of amino-acid transport</td>
</tr>
<tr class="odd">
<td align="left">E72.09</td>
<td align="right">37</td>
<td align="left">Blue diaper syndrome</td>
<td align="left">Other disorders of amino-acid transport</td>
</tr>
<tr class="even">
<td align="left">E72.09</td>
<td align="right">37</td>
<td align="left">Iminoglycinuria</td>
<td align="left">Other disorders of amino-acid transport</td>
</tr>
<tr class="odd">
<td align="left">E75.25</td>
<td align="right">35</td>
<td align="left">Metachromatic leukodystrophy</td>
<td align="left">Metachromatic leukodystrophy</td>
</tr>
<tr class="even">
<td align="left">E75.25</td>
<td align="right">35</td>
<td align="left">Metachromatic leukodystrophy due to saposin B deficiency</td>
<td align="left">Metachromatic leukodystrophy</td>
</tr>
<tr class="odd">
<td align="left">E75.25</td>
<td align="right">35</td>
<td align="left">Metachromatic leukodystrophy due to saposin B deficiency</td>
<td align="left">Metachromatic leukodystrophy</td>
</tr>
<tr class="even">
<td align="left">E88.2</td>
<td align="right">32</td>
<td align="left">Encephalocraniocutaneous lipomatosis</td>
<td align="left">Lipomatosis, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">E88.2</td>
<td align="right">32</td>
<td align="left">Adiposis dolorosa</td>
<td align="left">Lipomatosis, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">E88.2</td>
<td align="right">32</td>
<td align="left">Multiple symmetric lipomatosis</td>
<td align="left">Lipomatosis, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">E88.2</td>
<td align="right">32</td>
<td align="left">Multiple symmetric lipomatosis</td>
<td align="left">Lipomatosis, not elsewhere classified</td>
</tr>
<tr class="even">
<td align="left">E88.2</td>
<td align="right">32</td>
<td align="left">Familial multiple lipomatosis</td>
<td align="left">Lipomatosis, not elsewhere classified</td>
</tr>
<tr class="odd">
<td align="left">E77.8</td>
<td align="right">32</td>
<td align="left">Schindler disease type 1</td>
<td align="left">Other disorders of glycoprotein metabolism</td>
</tr>
<tr class="even">
<td align="left">E77.8</td>
<td align="right">32</td>
<td align="left">PMM2-CDG (CDG-Ia)</td>
<td align="left">Other disorders of glycoprotein metabolism</td>
</tr>
<tr class="odd">
<td align="left">E77.8</td>
<td align="right">32</td>
<td align="left">PMM2-CDG (CDG-Ia)</td>
<td align="left">Other disorders of glycoprotein metabolism</td>
</tr>
<tr class="even">
<td align="left">E77.8</td>
<td align="right">32</td>
<td align="left">MGAT2-CDG (CDG-IIa)</td>
<td align="left">Other disorders of glycoprotein metabolism</td>
</tr>
<tr class="odd">
<td align="left">E77.8</td>
<td align="right">32</td>
<td align="left">ALG2-CDG (CDG-Ii)</td>
<td align="left">Other disorders of glycoprotein metabolism</td>
</tr>
<tr class="even">
<td align="left">E77.8</td>
<td align="right">32</td>
<td align="left">Congenital disorder of glycosylation type I/IIX</td>
<td align="left">Other disorders of glycoprotein metabolism</td>
</tr>
<tr class="odd">
<td align="left">E77.8</td>
<td align="right">32</td>
<td align="left">Congenital disorders of glycosylation</td>
<td align="left">Other disorders of glycoprotein metabolism</td>
</tr>
<tr class="even">
<td align="left">E77.8</td>
<td align="right">32</td>
<td align="left">COG5-CDG (CDG-IIi)</td>
<td align="left">Other disorders of glycoprotein metabolism</td>
</tr>
<tr class="odd">
<td align="left">E75.23</td>
<td align="right">31</td>
<td align="left">Krabbe disease</td>
<td align="left">Krabbe disease</td>
</tr>
<tr class="even">
<td align="left">E75.4</td>
<td align="right">29</td>
<td align="left">Neuronal ceroid lipofuscinosis 2</td>
<td align="left">Neuronal ceroid lipofuscinosis</td>
</tr>
<tr class="odd">
<td align="left">E75.4</td>
<td align="right">29</td>
<td align="left">Northern epilepsy</td>
<td align="left">Neuronal ceroid lipofuscinosis</td>
</tr>
<tr class="even">
<td align="left">E75.4</td>
<td align="right">29</td>
<td align="left">Neuronal ceroid lipofuscinosis 3</td>
<td align="left">Neuronal ceroid lipofuscinosis</td>
</tr>
<tr class="odd">
<td align="left">E75.4</td>
<td align="right">29</td>
<td align="left">Autosomal recessive neuronal ceroid lipofuscinosis 4A</td>
<td align="left">Neuronal ceroid lipofuscinosis</td>
</tr>
<tr class="even">
<td align="left">E75.4</td>
<td align="right">29</td>
<td align="left">Ceroid storage disease</td>
<td align="left">Neuronal ceroid lipofuscinosis</td>
</tr>
<tr class="odd">
<td align="left">E75.4</td>
<td align="right">29</td>
<td align="left">Neuronal ceroid lipofuscinosis</td>
<td align="left">Neuronal ceroid lipofuscinosis</td>
</tr>
<tr class="even">
<td align="left">E75.4</td>
<td align="right">29</td>
<td align="left">Adult neuronal ceroid lipofuscinosis</td>
<td align="left">Neuronal ceroid lipofuscinosis</td>
</tr>
<tr class="odd">
<td align="left">E74.03</td>
<td align="right">29</td>
<td align="left">Glycogen storage disease type 3</td>
<td align="left">Cori disease</td>
</tr>
<tr class="even">
<td align="left">E74.39</td>
<td align="right">28</td>
<td align="left">Glucose-galactose malabsorption</td>
<td align="left">Other disorders of intestinal carbohydrate absorption</td>
</tr>
<tr class="odd">
<td align="left">E88.49</td>
<td align="right">22</td>
<td align="left">Cytochrome c oxidase deficiency</td>
<td align="left">Other mitochondrial metabolism disorders</td>
</tr>
<tr class="even">
<td align="left">E88.49</td>
<td align="right">22</td>
<td align="left">Pearson syndrome</td>
<td align="left">Other mitochondrial metabolism disorders</td>
</tr>
<tr class="odd">
<td align="left">E88.49</td>
<td align="right">22</td>
<td align="left">Mitochondrial complex III deficiency</td>
<td align="left">Other mitochondrial metabolism disorders</td>
</tr>
<tr class="even">
<td align="left">E88.41</td>
<td align="right">22</td>
<td align="left">Mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes</td>
<td align="left">MELAS syndrome</td>
</tr>
<tr class="odd">
<td align="left">E71.311</td>
<td align="right">22</td>
<td align="left">Medium-chain acyl-coenzyme A dehydrogenase deficiency</td>
<td align="left">Medium chain acyl CoA dehydrogenase deficiency</td>
</tr>
<tr class="even">
<td align="left">E75.5</td>
<td align="right">21</td>
<td align="left">Chanarin-Dorfman syndrome</td>
<td align="left">Other lipid storage disorders</td>
</tr>
<tr class="odd">
<td align="left">E75.5</td>
<td align="right">21</td>
<td align="left">Salla disease</td>
<td align="left">Other lipid storage disorders</td>
</tr>
<tr class="even">
<td align="left">E75.5</td>
<td align="right">21</td>
<td align="left">Sialuria, French type</td>
<td align="left">Other lipid storage disorders</td>
</tr>
<tr class="odd">
<td align="left">E75.5</td>
<td align="right">21</td>
<td align="left">Trichohepatoenteric syndrome</td>
<td align="left">Other lipid storage disorders</td>
</tr>
<tr class="even">
<td align="left">E75.5</td>
<td align="right">21</td>
<td align="left">Cerebrotendinous xanthomatosis</td>
<td align="left">Other lipid storage disorders</td>
</tr>
<tr class="odd">
<td align="left">E75.5</td>
<td align="right">21</td>
<td align="left">Wolman disease</td>
<td align="left">Other lipid storage disorders</td>
</tr>
<tr class="even">
<td align="left">E75.5</td>
<td align="right">21</td>
<td align="left">Neutral lipid storage disease with myopathy</td>
<td align="left">Other lipid storage disorders</td>
</tr>
<tr class="odd">
<td align="left">E75.5</td>
<td align="right">21</td>
<td align="left">Free sialic acid storage disease</td>
<td align="left">Other lipid storage disorders</td>
</tr>
<tr class="even">
<td align="left">E75.5</td>
<td align="right">21</td>
<td align="left">Lysosomal acid lipase deficiency</td>
<td align="left">Other lipid storage disorders</td>
</tr>
<tr class="odd">
<td align="left">E75.5</td>
<td align="right">21</td>
<td align="left">Cholesteryl ester storage disease</td>
<td align="left">Other lipid storage disorders</td>
</tr>
<tr class="even">
<td align="left">E74.21</td>
<td align="right">21</td>
<td align="left">Galactosemia</td>
<td align="left">Galactosemia</td>
</tr>
<tr class="odd">
<td align="left">E74.21</td>
<td align="right">21</td>
<td align="left">Galactose epimerase deficiency</td>
<td align="left">Galactosemia</td>
</tr>
<tr class="even">
<td align="left">E74.04</td>
<td align="right">20</td>
<td align="left">Glycogen storage disease type 5</td>
<td align="left">McArdle disease</td>
</tr>
<tr class="odd">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">Beta ketothiolase deficiency</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">Beta ketothiolase deficiency</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">3-Hydroxyisobutyric aciduria</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">3-Hydroxyisobutyric aciduria</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">3 Methylcrotonyl-CoA carboxylase 1 deficiency</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">Valinemia</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">HMG CoA lyase deficiency</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">HMG CoA lyase deficiency</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">Leucine-sensitive hypoglycemia of infancy</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">Tiglic acidemia</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">Combined malonic and methylmalonic aciduria</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">3-methylcrotonyl-CoA carboxylase deficiency</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.19</td>
<td align="right">20</td>
<td align="left">HIBCH deficiency</td>
<td align="left">Other disorders of branched-chain amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Gamma aminobutyric acid transaminase deficiency</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Glutamate decarboxylase deficiency</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Guanidinoacetate methyltransferase deficiency</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Homocarnosinosis</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Homocarnosinosis</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">5-oxoprolinase deficiency</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Carnosinemia</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Carnosinemia</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Hyperprolinemia type 2</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Prolidase deficiency</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Succinic semialdehyde dehydrogenase deficiency</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Aminoacylase 1 deficiency</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Glutathione synthetase deficiency</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Glutathionuria</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">Hyperbetaalaninemia</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.8</td>
<td align="right">19</td>
<td align="left">L-arginine:glycine amidinotransferase deficiency</td>
<td align="left">Other specified disorders of amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.318</td>
<td align="right">19</td>
<td align="left">Beta ketothiolase deficiency</td>
<td align="left">Other disorders of fatty-acid oxidation</td>
</tr>
<tr class="odd">
<td align="left">E71.318</td>
<td align="right">19</td>
<td align="left">Mitochondrial trifunctional protein deficiency</td>
<td align="left">Other disorders of fatty-acid oxidation</td>
</tr>
<tr class="even">
<td align="left">E71.318</td>
<td align="right">19</td>
<td align="left">SCOT deficiency</td>
<td align="left">Other disorders of fatty-acid oxidation</td>
</tr>
<tr class="odd">
<td align="left">E71.318</td>
<td align="right">19</td>
<td align="left">LCHAD deficiency</td>
<td align="left">Other disorders of fatty-acid oxidation</td>
</tr>
<tr class="even">
<td align="left">E71.318</td>
<td align="right">19</td>
<td align="left">3-alpha hydroxyacyl-CoA dehydrogenase deficiency</td>
<td align="left">Other disorders of fatty-acid oxidation</td>
</tr>
<tr class="odd">
<td align="left">E71.318</td>
<td align="right">19</td>
<td align="left">2-methylbutyryl-CoA dehydrogenase deficiency</td>
<td align="left">Other disorders of fatty-acid oxidation</td>
</tr>
<tr class="even">
<td align="left">E72.9</td>
<td align="right">18</td>
<td align="left">Aminoaciduria</td>
<td align="left">Disorder of amino-acid metabolism, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E72.9</td>
<td align="right">18</td>
<td align="left">Inborn amino acid metabolism disorder</td>
<td align="left">Disorder of amino-acid metabolism, unspecified</td>
</tr>
<tr class="even">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Dihydropyrimidine dehydrogenase deficiency</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Adenine phosphoribosyltransferase deficiency</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="even">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Adenylosuccinase deficiency</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Molybdenum cofactor deficiency</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="even">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Thiopurine S methyltranferase deficiency</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Orotic aciduria type 1</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="even">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Orotic aciduria type 1</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Xanthinuria type 1</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="even">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Xanthinuria type 1</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Dihydroxyadeninuria</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="even">
<td align="left">E79.8</td>
<td align="right">16</td>
<td align="left">Dihydropyrimidinase deficiency</td>
<td align="left">Other disorders of purine and pyrimidine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.120</td>
<td align="right">16</td>
<td align="left">Methylmalonic acidemia with homocystinuria</td>
<td align="left">Methylmalonic acidemia</td>
</tr>
<tr class="even">
<td align="left">E71.120</td>
<td align="right">16</td>
<td align="left">Methylmalonic acidemia</td>
<td align="left">Methylmalonic acidemia</td>
</tr>
<tr class="odd">
<td align="left">E71.120</td>
<td align="right">16</td>
<td align="left">Methylmalonic acidemia with homocystinuria type cblC</td>
<td align="left">Methylmalonic acidemia</td>
</tr>
<tr class="even">
<td align="left">E71.120</td>
<td align="right">16</td>
<td align="left">Vitamin B12-responsive methylmalonic acidemia</td>
<td align="left">Methylmalonic acidemia</td>
</tr>
<tr class="odd">
<td align="left">E72.51</td>
<td align="right">15</td>
<td align="left">Glycine encephalopathy</td>
<td align="left">Non-ketotic hyperglycinemia</td>
</tr>
<tr class="even">
<td align="left">E85.2</td>
<td align="right">13</td>
<td align="left">Primary cutaneous amyloidosis</td>
<td align="left">Heredofamilial amyloidosis, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E83.09</td>
<td align="right">13</td>
<td align="left">Menkes disease</td>
<td align="left">Other disorders of copper metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.4</td>
<td align="right">13</td>
<td align="left">Ornithine translocase deficiency syndrome</td>
<td align="left">Disorders of ornithine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.4</td>
<td align="right">13</td>
<td align="left">Gyrate atrophy of choroid and retina</td>
<td align="left">Disorders of ornithine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.4</td>
<td align="right">13</td>
<td align="left">Gyrate atrophy of choroid and retina</td>
<td align="left">Disorders of ornithine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.4</td>
<td align="right">13</td>
<td align="left">Ornithinemia</td>
<td align="left">Disorders of ornithine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.4</td>
<td align="right">13</td>
<td align="left">Ornithinemia</td>
<td align="left">Disorders of ornithine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.4</td>
<td align="right">13</td>
<td align="left">Ornithine transcarbamylase deficiency</td>
<td align="left">Disorders of ornithine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.4</td>
<td align="right">13</td>
<td align="left">MASS syndrome</td>
<td align="left">Disorders of ornithine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.313</td>
<td align="right">13</td>
<td align="left">Glutaric acidemia type II</td>
<td align="left">Glutaric aciduria type II</td>
</tr>
<tr class="even">
<td align="left">E76.1</td>
<td align="right">11</td>
<td align="left">Hunter-McAlpine syndrome</td>
<td align="left">Mucopolysaccharidosis, type II</td>
</tr>
<tr class="odd">
<td align="left">E76.1</td>
<td align="right">11</td>
<td align="left">Mucopolysaccharidosis type II</td>
<td align="left">Mucopolysaccharidosis, type II</td>
</tr>
<tr class="even">
<td align="left">E71.310</td>
<td align="right">11</td>
<td align="left">VLCAD deficiency</td>
<td align="left">Long chain/very long chain acyl CoA dehydrogenase deficiency</td>
</tr>
<tr class="odd">
<td align="left">E71.310</td>
<td align="right">11</td>
<td align="left">Pearson syndrome</td>
<td align="left">Long chain/very long chain acyl CoA dehydrogenase deficiency</td>
</tr>
<tr class="even">
<td align="left">E71.310</td>
<td align="right">11</td>
<td align="left">LCAD deficiency</td>
<td align="left">Long chain/very long chain acyl CoA dehydrogenase deficiency</td>
</tr>
<tr class="odd">
<td align="left">E71.0</td>
<td align="right">11</td>
<td align="left">Maple syrup urine disease</td>
<td align="left">Maple-syrup-urine disease</td>
</tr>
<tr class="even">
<td align="left">E70.320</td>
<td align="right">11</td>
<td align="left">Oculocutaneous albinism type 1</td>
<td align="left">Tyrosinase negative oculocutaneous albinism</td>
</tr>
<tr class="odd">
<td align="left">E72.3</td>
<td align="right">10</td>
<td align="left">Saccharopinuria</td>
<td align="left">Disorders of lysine and hydroxylysine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.3</td>
<td align="right">10</td>
<td align="left">Saccharopinuria</td>
<td align="left">Disorders of lysine and hydroxylysine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.3</td>
<td align="right">10</td>
<td align="left">Hyperlysinemia</td>
<td align="left">Disorders of lysine and hydroxylysine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.3</td>
<td align="right">10</td>
<td align="left">Lysinuric protein intolerance</td>
<td align="left">Disorders of lysine and hydroxylysine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.3</td>
<td align="right">10</td>
<td align="left">D-2-hydroxyglutaric aciduria</td>
<td align="left">Disorders of lysine and hydroxylysine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.3</td>
<td align="right">10</td>
<td align="left">D-2-hydroxyglutaric aciduria</td>
<td align="left">Disorders of lysine and hydroxylysine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.3</td>
<td align="right">10</td>
<td align="left">Glutaric acidemia type I</td>
<td align="left">Disorders of lysine and hydroxylysine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.3</td>
<td align="right">10</td>
<td align="left">L-2-hydroxyglutaric aciduria</td>
<td align="left">Disorders of lysine and hydroxylysine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.3</td>
<td align="right">10</td>
<td align="left">L-2-hydroxyglutaric aciduria</td>
<td align="left">Disorders of lysine and hydroxylysine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.3</td>
<td align="right">10</td>
<td align="left">2-Hydroxyglutaric aciduria</td>
<td align="left">Disorders of lysine and hydroxylysine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.03</td>
<td align="right">9</td>
<td align="left">Lowe oculocerebrorenal syndrome</td>
<td align="left">Lowe’s syndrome</td>
</tr>
<tr class="even">
<td align="left">E71.50</td>
<td align="right">9</td>
<td align="left">Peroxisomal biogenesis disorders</td>
<td align="left">Peroxisomal disorder, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E71.41</td>
<td align="right">9</td>
<td align="left">Subacute cerebellar degeneration</td>
<td align="left">Primary carnitine deficiency</td>
</tr>
<tr class="even">
<td align="left">E71.41</td>
<td align="right">9</td>
<td align="left">Primary carnitine deficiency</td>
<td align="left">Primary carnitine deficiency</td>
</tr>
<tr class="odd">
<td align="left">E71.314</td>
<td align="right">9</td>
<td align="left">Carnitine palmitoyl transferase 1 deficiency</td>
<td align="left">Muscle carnitine palmitoyltransferase deficiency</td>
</tr>
<tr class="even">
<td align="left">E71.314</td>
<td align="right">9</td>
<td align="left">Carnitine palmitoyltransferase 2 deficiency</td>
<td align="left">Muscle carnitine palmitoyltransferase deficiency</td>
</tr>
<tr class="odd">
<td align="left">E85.0</td>
<td align="right">8</td>
<td align="left">Amyloidosis familial visceral</td>
<td align="left">Non-neuropathic heredofamilial amyloidosis</td>
</tr>
<tr class="even">
<td align="left">E71.121</td>
<td align="right">8</td>
<td align="left">Propionic acidemia</td>
<td align="left">Propionic acidemia</td>
</tr>
<tr class="odd">
<td align="left">E70.8</td>
<td align="right">8</td>
<td align="left">Aromatic L-amino acid decarboxylase deficiency</td>
<td align="left">Other disorders of aromatic amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E70.8</td>
<td align="right">8</td>
<td align="left">Aromatic L-amino acid decarboxylase deficiency</td>
<td align="left">Other disorders of aromatic amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E70.8</td>
<td align="right">8</td>
<td align="left">Carnosinemia</td>
<td align="left">Other disorders of aromatic amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E70.8</td>
<td align="right">8</td>
<td align="left">Hydroxykynureninuria</td>
<td align="left">Other disorders of aromatic amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E70.331</td>
<td align="right">8</td>
<td align="left">Hermansky-Pudlak syndrome</td>
<td align="left">Hermansky-Pudlak syndrome</td>
</tr>
<tr class="even">
<td align="left">E83.32</td>
<td align="right">7</td>
<td align="left">Hypophosphatemic rickets</td>
<td align="left">Hereditary vitamin D-dependent rickets (type 1) (type 2)</td>
</tr>
<tr class="odd">
<td align="left">E83.32</td>
<td align="right">7</td>
<td align="left">X-linked hypophosphatemia</td>
<td align="left">Hereditary vitamin D-dependent rickets (type 1) (type 2)</td>
</tr>
<tr class="even">
<td align="left">E83.32</td>
<td align="right">7</td>
<td align="left">X-linked hypophosphatemia</td>
<td align="left">Hereditary vitamin D-dependent rickets (type 1) (type 2)</td>
</tr>
<tr class="odd">
<td align="left">E80.29</td>
<td align="right">7</td>
<td align="left">Watson syndrome</td>
<td align="left">Other porphyria</td>
</tr>
<tr class="even">
<td align="left">E80.29</td>
<td align="right">7</td>
<td align="left">Hereditary coproporphyria</td>
<td align="left">Other porphyria</td>
</tr>
<tr class="odd">
<td align="left">E80.29</td>
<td align="right">7</td>
<td align="left">Chester porphyria</td>
<td align="left">Other porphyria</td>
</tr>
<tr class="even">
<td align="left">E74.4</td>
<td align="right">7</td>
<td align="left">Lactate dehydrogenase deficiency</td>
<td align="left">Disorders of pyruvate metabolism and gluconeogenesis</td>
</tr>
<tr class="odd">
<td align="left">E74.4</td>
<td align="right">7</td>
<td align="left">Lactate dehydrogenase deficiency</td>
<td align="left">Disorders of pyruvate metabolism and gluconeogenesis</td>
</tr>
<tr class="even">
<td align="left">E74.4</td>
<td align="right">7</td>
<td align="left">PEPCK 1 deficiency</td>
<td align="left">Disorders of pyruvate metabolism and gluconeogenesis</td>
</tr>
<tr class="odd">
<td align="left">E74.4</td>
<td align="right">7</td>
<td align="left">Pyruvate decarboxylase deficiency</td>
<td align="left">Disorders of pyruvate metabolism and gluconeogenesis</td>
</tr>
<tr class="even">
<td align="left">E74.4</td>
<td align="right">7</td>
<td align="left">Pyruvate carboxylase deficiency</td>
<td align="left">Disorders of pyruvate metabolism and gluconeogenesis</td>
</tr>
<tr class="odd">
<td align="left">E74.4</td>
<td align="right">7</td>
<td align="left">Pyruvate dehydrogenase deficiency</td>
<td align="left">Disorders of pyruvate metabolism and gluconeogenesis</td>
</tr>
<tr class="even">
<td align="left">E72.04</td>
<td align="right">7</td>
<td align="left">Fanconi Bickel syndrome</td>
<td align="left">Cystinosis</td>
</tr>
<tr class="odd">
<td align="left">E72.04</td>
<td align="right">7</td>
<td align="left">Lactate dehydrogenase A deficiency</td>
<td align="left">Cystinosis</td>
</tr>
<tr class="even">
<td align="left">E72.04</td>
<td align="right">7</td>
<td align="left">Cystinosis</td>
<td align="left">Cystinosis</td>
</tr>
<tr class="odd">
<td align="left">E72.04</td>
<td align="right">7</td>
<td align="left">Primary Fanconi syndrome</td>
<td align="left">Cystinosis</td>
</tr>
<tr class="even">
<td align="left">E72.04</td>
<td align="right">7</td>
<td align="left">Nephropathic cystinosis</td>
<td align="left">Cystinosis</td>
</tr>
<tr class="odd">
<td align="left">E71.312</td>
<td align="right">7</td>
<td align="left">Short-chain acyl-CoA dehydrogenase deficiency</td>
<td align="left">Short chain acyl CoA dehydrogenase deficiency</td>
</tr>
<tr class="even">
<td align="left">E71.312</td>
<td align="right">7</td>
<td align="left">2-methyl-3-hydroxybutyric aciduria</td>
<td align="left">Short chain acyl CoA dehydrogenase deficiency</td>
</tr>
<tr class="odd">
<td align="left">E70.321</td>
<td align="right">7</td>
<td align="left">Oculocutaneous albinism type 2</td>
<td align="left">Tyrosinase positive oculocutaneous albinism</td>
</tr>
<tr class="even">
<td align="left">E70.321</td>
<td align="right">7</td>
<td align="left">Oculocutaneous albinism type 3</td>
<td align="left">Tyrosinase positive oculocutaneous albinism</td>
</tr>
<tr class="odd">
<td align="left">E70.321</td>
<td align="right">7</td>
<td align="left">Rufous oculocutaneous albinism</td>
<td align="left">Tyrosinase positive oculocutaneous albinism</td>
</tr>
<tr class="even">
<td align="left">E78.72</td>
<td align="right">6</td>
<td align="left">Smith-Lemli-Opitz syndrome</td>
<td align="left">Smith-Lemli-Opitz syndrome</td>
</tr>
<tr class="odd">
<td align="left">E76.219</td>
<td align="right">6</td>
<td align="left">Eccentrochondrodysplasia</td>
<td align="left">Morquio mucopolysaccharidoses, unspecified</td>
</tr>
<tr class="even">
<td align="left">E76.219</td>
<td align="right">6</td>
<td align="left">Mucopolysaccharidosis type IV</td>
<td align="left">Morquio mucopolysaccharidoses, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E70.0</td>
<td align="right">6</td>
<td align="left">Phenylketonuria</td>
<td align="left">Classical phenylketonuria</td>
</tr>
<tr class="even">
<td align="left">E83.89</td>
<td align="right">5</td>
<td align="left">Hypermanganesemia with dystonia polycythemia and cirrhosis</td>
<td align="left">Other disorders of mineral metabolism</td>
</tr>
<tr class="odd">
<td align="left">E80.0</td>
<td align="right">5</td>
<td align="left">Congenital erythropoietic porphyria</td>
<td align="left">Hereditary erythropoietic porphyria</td>
</tr>
<tr class="even">
<td align="left">E80.0</td>
<td align="right">5</td>
<td align="left">Erythropoietic protoporphyria</td>
<td align="left">Hereditary erythropoietic porphyria</td>
</tr>
<tr class="odd">
<td align="left">E80.0</td>
<td align="right">5</td>
<td align="left">Protoporphyria</td>
<td align="left">Hereditary erythropoietic porphyria</td>
</tr>
<tr class="even">
<td align="left">E80.0</td>
<td align="right">5</td>
<td align="left">Congenital extrahepatic portosystemic shunt</td>
<td align="left">Hereditary erythropoietic porphyria</td>
</tr>
<tr class="odd">
<td align="left">E75.249</td>
<td align="right">5</td>
<td align="left">Niemann-Pick disease type A</td>
<td align="left">Niemann-Pick disease, unspecified</td>
</tr>
<tr class="even">
<td align="left">E74.31</td>
<td align="right">5</td>
<td align="left">Congenital sucrose isomaltose malabsorption</td>
<td align="left">Sucrase-isomaltase deficiency</td>
</tr>
<tr class="odd">
<td align="left">E74.31</td>
<td align="right">5</td>
<td align="left">Congenital sucrase-isomaltase deficiency</td>
<td align="left">Sucrase-isomaltase deficiency</td>
</tr>
<tr class="even">
<td align="left">E72.23</td>
<td align="right">5</td>
<td align="left">Citrullinemia type I</td>
<td align="left">Citrullinemia</td>
</tr>
<tr class="odd">
<td align="left">E72.23</td>
<td align="right">5</td>
<td align="left">Neonatal intrahepatic cholestasis caused by citrin deficiency</td>
<td align="left">Citrullinemia</td>
</tr>
<tr class="even">
<td align="left">E72.23</td>
<td align="right">5</td>
<td align="left">Adult-onset citrullinemia type II</td>
<td align="left">Citrullinemia</td>
</tr>
<tr class="odd">
<td align="left">E72.10</td>
<td align="right">5</td>
<td align="left">Megaloblastic anemia due to dihydrofolate reductase deficiency</td>
<td align="left">Disorders of sulfur-bearing amino-acid metabolism, unspecified</td>
</tr>
<tr class="even">
<td align="left">E71.522</td>
<td align="right">5</td>
<td align="left">Adrenomyeloneuropathy</td>
<td align="left">Adrenomyeloneuropathy</td>
</tr>
<tr class="odd">
<td align="left">E71.440</td>
<td align="right">5</td>
<td align="left">Bannayan-Riley-Ruvalcaba syndrome</td>
<td align="left">Ruvalcaba-Myhre-Smith syndrome</td>
</tr>
<tr class="even">
<td align="left">E70.310</td>
<td align="right">5</td>
<td align="left">Ocular albinism type 1</td>
<td align="left">X-linked ocular albinism</td>
</tr>
<tr class="odd">
<td align="left">E83.2</td>
<td align="right">4</td>
<td align="left">Acrodermatitis enteropathica</td>
<td align="left">Disorders of zinc metabolism</td>
</tr>
<tr class="even">
<td align="left">E79.2</td>
<td align="right">4</td>
<td align="left">Adenosine monophosphate deaminase 1 deficiency</td>
<td align="left">Myoadenylate deaminase deficiency</td>
</tr>
<tr class="odd">
<td align="left">E77.1</td>
<td align="right">4</td>
<td align="left">Mannosidosis, beta A, lysosomal</td>
<td align="left">Defects in glycoprotein degradation</td>
</tr>
<tr class="even">
<td align="left">E77.1</td>
<td align="right">4</td>
<td align="left">Galactosialidosis</td>
<td align="left">Defects in glycoprotein degradation</td>
</tr>
<tr class="odd">
<td align="left">E77.1</td>
<td align="right">4</td>
<td align="left">Aspartylglycosaminuria</td>
<td align="left">Defects in glycoprotein degradation</td>
</tr>
<tr class="even">
<td align="left">E77.1</td>
<td align="right">4</td>
<td align="left">Fucosidosis</td>
<td align="left">Defects in glycoprotein degradation</td>
</tr>
<tr class="odd">
<td align="left">E77.1</td>
<td align="right">4</td>
<td align="left">Fucosidosis type 1</td>
<td align="left">Defects in glycoprotein degradation</td>
</tr>
<tr class="even">
<td align="left">E77.1</td>
<td align="right">4</td>
<td align="left">Alpha-mannosidosis</td>
<td align="left">Defects in glycoprotein degradation</td>
</tr>
<tr class="odd">
<td align="left">E77.1</td>
<td align="right">4</td>
<td align="left">Sialidosis, type II</td>
<td align="left">Defects in glycoprotein degradation</td>
</tr>
<tr class="even">
<td align="left">E77.1</td>
<td align="right">4</td>
<td align="left">Sialidosis type I</td>
<td align="left">Defects in glycoprotein degradation</td>
</tr>
<tr class="odd">
<td align="left">E76.29</td>
<td align="right">4</td>
<td align="left">Mucopolysaccharidosis type VI</td>
<td align="left">Other mucopolysaccharidoses</td>
</tr>
<tr class="even">
<td align="left">E76.29</td>
<td align="right">4</td>
<td align="left">Mucopolysaccharidosis type VI</td>
<td align="left">Other mucopolysaccharidoses</td>
</tr>
<tr class="odd">
<td align="left">E76.29</td>
<td align="right">4</td>
<td align="left">Mucopolysaccharidosis type VII</td>
<td align="left">Other mucopolysaccharidoses</td>
</tr>
<tr class="even">
<td align="left">E76.210</td>
<td align="right">4</td>
<td align="left">Mucopolysaccharidosis type IVA</td>
<td align="left">Morquio A mucopolysaccharidoses</td>
</tr>
<tr class="odd">
<td align="left">E75.242</td>
<td align="right">4</td>
<td align="left">Niemann-Pick disease type C1</td>
<td align="left">Niemann-Pick disease type C</td>
</tr>
<tr class="even">
<td align="left">E75.242</td>
<td align="right">4</td>
<td align="left">Niemann-Pick disease type D</td>
<td align="left">Niemann-Pick disease type C</td>
</tr>
<tr class="odd">
<td align="left">E75.02</td>
<td align="right">4</td>
<td align="left">Tay-Sachs disease</td>
<td align="left">Tay-Sachs disease</td>
</tr>
<tr class="even">
<td align="left">E72.52</td>
<td align="right">4</td>
<td align="left">Trimethylaminuria</td>
<td align="left">Trimethylaminuria</td>
</tr>
<tr class="odd">
<td align="left">E72.19</td>
<td align="right">4</td>
<td align="left">Gamma-cystathionase deficiency</td>
<td align="left">Other disorders of sulfur-bearing amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.19</td>
<td align="right">4</td>
<td align="left">Methylcobalamin deficiency cbl G type</td>
<td align="left">Other disorders of sulfur-bearing amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.19</td>
<td align="right">4</td>
<td align="left">Sulfite oxidase deficiency</td>
<td align="left">Other disorders of sulfur-bearing amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.19</td>
<td align="right">4</td>
<td align="left">Transcobalamin 1 deficiency</td>
<td align="left">Other disorders of sulfur-bearing amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.19</td>
<td align="right">4</td>
<td align="left">Hawkinsinuria</td>
<td align="left">Other disorders of sulfur-bearing amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.19</td>
<td align="right">4</td>
<td align="left">Methionine adenosyltransferase deficiency</td>
<td align="left">Other disorders of sulfur-bearing amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.19</td>
<td align="right">4</td>
<td align="left">Glutamate formiminotransferase deficiency</td>
<td align="left">Other disorders of sulfur-bearing amino-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.19</td>
<td align="right">4</td>
<td align="left">Glutathione synthetase deficiency</td>
<td align="left">Other disorders of sulfur-bearing amino-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E70.21</td>
<td align="right">4</td>
<td align="left">Tyrosinemia type 1</td>
<td align="left">Tyrosinemia</td>
</tr>
<tr class="even">
<td align="left">E70.21</td>
<td align="right">4</td>
<td align="left">Tyrosinemia type 2</td>
<td align="left">Tyrosinemia</td>
</tr>
<tr class="odd">
<td align="left">E70.21</td>
<td align="right">4</td>
<td align="left">Tyrosinemia type 3</td>
<td align="left">Tyrosinemia</td>
</tr>
<tr class="even">
<td align="left">E77.0</td>
<td align="right">3</td>
<td align="left">Mucolipidosis III alpha/beta</td>
<td align="left">Defects in post-translational modification of lysosomal enzymes</td>
</tr>
<tr class="odd">
<td align="left">E76.22</td>
<td align="right">3</td>
<td align="left">Mucopolysaccharidosis type III</td>
<td align="left">Sanfilippo mucopolysaccharidoses</td>
</tr>
<tr class="even">
<td align="left">E76.22</td>
<td align="right">3</td>
<td align="left">Mucopolysaccharidosis type IIIA</td>
<td align="left">Sanfilippo mucopolysaccharidoses</td>
</tr>
<tr class="odd">
<td align="left">E76.22</td>
<td align="right">3</td>
<td align="left">Mucopolysaccharidosis type IIIB</td>
<td align="left">Sanfilippo mucopolysaccharidoses</td>
</tr>
<tr class="even">
<td align="left">E76.22</td>
<td align="right">3</td>
<td align="left">Mucopolysaccharidosis type IIIC</td>
<td align="left">Sanfilippo mucopolysaccharidoses</td>
</tr>
<tr class="odd">
<td align="left">E76.22</td>
<td align="right">3</td>
<td align="left">Mucopolysaccharidosis type IIID</td>
<td align="left">Sanfilippo mucopolysaccharidoses</td>
</tr>
<tr class="even">
<td align="left">E75.19</td>
<td align="right">3</td>
<td align="left">GM1 gangliosidosis type 3</td>
<td align="left">Other gangliosidosis</td>
</tr>
<tr class="odd">
<td align="left">E75.19</td>
<td align="right">3</td>
<td align="left">Beta-galactosidase-1 deficiency</td>
<td align="left">Other gangliosidosis</td>
</tr>
<tr class="even">
<td align="left">E75.19</td>
<td align="right">3</td>
<td align="left">GM1 gangliosidosis type 1</td>
<td align="left">Other gangliosidosis</td>
</tr>
<tr class="odd">
<td align="left">E75.19</td>
<td align="right">3</td>
<td align="left">GM1 gangliosidosis type 2</td>
<td align="left">Other gangliosidosis</td>
</tr>
<tr class="even">
<td align="left">E75.19</td>
<td align="right">3</td>
<td align="left">GM1 gangliosidosis</td>
<td align="left">Other gangliosidosis</td>
</tr>
<tr class="odd">
<td align="left">E72.59</td>
<td align="right">3</td>
<td align="left">Sarcosinemia</td>
<td align="left">Other disorders of glycine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.59</td>
<td align="right">3</td>
<td align="left">D-glycericacidemia</td>
<td align="left">Other disorders of glycine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.59</td>
<td align="right">3</td>
<td align="left">Hyperprolinemia</td>
<td align="left">Other disorders of glycine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.59</td>
<td align="right">3</td>
<td align="left">Hyperprolinemia</td>
<td align="left">Other disorders of glycine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.59</td>
<td align="right">3</td>
<td align="left">Hydroxyprolinemia</td>
<td align="left">Other disorders of glycine metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.21</td>
<td align="right">3</td>
<td align="left">Arginase deficiency</td>
<td align="left">Argininemia</td>
</tr>
<tr class="odd">
<td align="left">E70.330</td>
<td align="right">3</td>
<td align="left">Chediak-Higashi syndrome</td>
<td align="left">Chediak-Higashi syndrome</td>
</tr>
<tr class="even">
<td align="left">E70.1</td>
<td align="right">3</td>
<td align="left">GTP cyclohydrolase I deficiency</td>
<td align="left">Other hyperphenylalaninemias</td>
</tr>
<tr class="odd">
<td align="left">E70.1</td>
<td align="right">3</td>
<td align="left">Maternal hyperphenylalaninemia</td>
<td align="left">Other hyperphenylalaninemias</td>
</tr>
<tr class="even">
<td align="left">E70.1</td>
<td align="right">3</td>
<td align="left">Dihydropteridine reductase deficiency</td>
<td align="left">Other hyperphenylalaninemias</td>
</tr>
<tr class="odd">
<td align="left">E70.1</td>
<td align="right">3</td>
<td align="left">Sepiapterin reductase deficiency</td>
<td align="left">Other hyperphenylalaninemias</td>
</tr>
<tr class="even">
<td align="left">E85.1</td>
<td align="right">2</td>
<td align="left">Familial transthyretin amyloidosis</td>
<td align="left">Neuropathic heredofamilial amyloidosis</td>
</tr>
<tr class="odd">
<td align="left">E85.1</td>
<td align="right">2</td>
<td align="left">Hereditary amyloidosis</td>
<td align="left">Neuropathic heredofamilial amyloidosis</td>
</tr>
<tr class="even">
<td align="left">E85.1</td>
<td align="right">2</td>
<td align="left">Amyloid neuropathy</td>
<td align="left">Neuropathic heredofamilial amyloidosis</td>
</tr>
<tr class="odd">
<td align="left">E80.5</td>
<td align="right">2</td>
<td align="left">Crigler Najjar syndrome, type 1</td>
<td align="left">Crigler-Najjar syndrome</td>
</tr>
<tr class="even">
<td align="left">E80.5</td>
<td align="right">2</td>
<td align="left">Crigler Najjar syndrome, type 2</td>
<td align="left">Crigler-Najjar syndrome</td>
</tr>
<tr class="odd">
<td align="left">E79.1</td>
<td align="right">2</td>
<td align="left">Hypoxanthine guanine phosphoribosyltransferase deficiency</td>
<td align="left">Lesch-Nyhan syndrome</td>
</tr>
<tr class="even">
<td align="left">E79.1</td>
<td align="right">2</td>
<td align="left">Hereditary hyperuricemia</td>
<td align="left">Lesch-Nyhan syndrome</td>
</tr>
<tr class="odd">
<td align="left">E79.1</td>
<td align="right">2</td>
<td align="left">Lesch Nyhan syndrome</td>
<td align="left">Lesch-Nyhan syndrome</td>
</tr>
<tr class="even">
<td align="left">E76.02</td>
<td align="right">2</td>
<td align="left">HurlerÎ“ÃÃ´Scheie syndrome</td>
<td align="left">Hurler-Scheie syndrome</td>
</tr>
<tr class="odd">
<td align="left">E74.29</td>
<td align="right">2</td>
<td align="left">Galactokinase deficiency</td>
<td align="left">Other disorders of galactose metabolism</td>
</tr>
<tr class="even">
<td align="left">E74.12</td>
<td align="right">2</td>
<td align="left">Hereditary fructose intolerance</td>
<td align="left">Hereditary fructose intolerance</td>
</tr>
<tr class="odd">
<td align="left">E72.29</td>
<td align="right">2</td>
<td align="left">N-acetylglutamate synthase deficiency</td>
<td align="left">Other disorders of urea cycle metabolism</td>
</tr>
<tr class="even">
<td align="left">E72.29</td>
<td align="right">2</td>
<td align="left">Carbamoyl phosphate synthetase 1 deficiency</td>
<td align="left">Other disorders of urea cycle metabolism</td>
</tr>
<tr class="odd">
<td align="left">E72.02</td>
<td align="right">2</td>
<td align="left">Hartnup disease</td>
<td align="left">Hartnup’s disease</td>
</tr>
<tr class="even">
<td align="left">E71.528</td>
<td align="right">2</td>
<td align="left">Pseudoneonatal adrenoleukodystrophy</td>
<td align="left">Other X-linked adrenoleukodystrophy</td>
</tr>
<tr class="odd">
<td align="left">E71.39</td>
<td align="right">2</td>
<td align="left">Carnitine-acylcarnitine translocase deficiency</td>
<td align="left">Other disorders of fatty-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.39</td>
<td align="right">2</td>
<td align="left">Malonyl-CoA decarboxylase deficiency</td>
<td align="left">Other disorders of fatty-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.39</td>
<td align="right">2</td>
<td align="left">Malonyl-CoA decarboxylase deficiency</td>
<td align="left">Other disorders of fatty-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.39</td>
<td align="right">2</td>
<td align="left">Acetyl-carnitine deficiency</td>
<td align="left">Other disorders of fatty-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.39</td>
<td align="right">2</td>
<td align="left">Multicentric Castleman Disease</td>
<td align="left">Other disorders of fatty-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.39</td>
<td align="right">2</td>
<td align="left">Multicentric Castleman Disease</td>
<td align="left">Other disorders of fatty-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.39</td>
<td align="right">2</td>
<td align="left">2,4-Dienoyl-CoA reductase deficiency</td>
<td align="left">Other disorders of fatty-acid metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.39</td>
<td align="right">2</td>
<td align="left">HIBCH deficiency</td>
<td align="left">Other disorders of fatty-acid metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.110</td>
<td align="right">2</td>
<td align="left">Isovaleric acidemia</td>
<td align="left">Isovaleric acidemia</td>
</tr>
<tr class="even">
<td align="left">E70.29</td>
<td align="right">2</td>
<td align="left">Dopamine beta hydroxylase deficiency</td>
<td align="left">Other disorders of tyrosine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E70.29</td>
<td align="right">2</td>
<td align="left">Alkaptonuria</td>
<td align="left">Other disorders of tyrosine metabolism</td>
</tr>
<tr class="even">
<td align="left">E70.29</td>
<td align="right">2</td>
<td align="left">Ochronosis</td>
<td align="left">Other disorders of tyrosine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E70.29</td>
<td align="right">2</td>
<td align="left">Tyrosinemia type 3</td>
<td align="left">Other disorders of tyrosine metabolism</td>
</tr>
<tr class="even">
<td align="left">E70.29</td>
<td align="right">2</td>
<td align="left">Exogenous ochronosis</td>
<td align="left">Other disorders of tyrosine metabolism</td>
</tr>
<tr class="odd">
<td align="left">E70.29</td>
<td align="right">2</td>
<td align="left">Exogenous ochronosis</td>
<td align="left">Other disorders of tyrosine metabolism</td>
</tr>
<tr class="even">
<td align="left">E85.3</td>
<td align="right">1</td>
<td align="left">Amyloidosis AA</td>
<td align="left">Secondary systemic amyloidosis</td>
</tr>
<tr class="odd">
<td align="left">E85.3</td>
<td align="right">1</td>
<td align="left">Amyloidosis Beta2M</td>
<td align="left">Secondary systemic amyloidosis</td>
</tr>
<tr class="even">
<td align="left">E78.81</td>
<td align="right">1</td>
<td align="left">Multicentric reticulohistiocytosis</td>
<td align="left">Lipoid dermatoarthritis</td>
</tr>
<tr class="odd">
<td align="left">E76.03</td>
<td align="right">1</td>
<td align="left">Scheie syndrome</td>
<td align="left">Scheie’s syndrome</td>
</tr>
<tr class="even">
<td align="left">E75.241</td>
<td align="right">1</td>
<td align="left">Niemann-Pick disease type B</td>
<td align="left">Niemann-Pick disease type B</td>
</tr>
<tr class="odd">
<td align="left">E75.01</td>
<td align="right">1</td>
<td align="left">Sandhoff disease</td>
<td align="left">Sandhoff disease</td>
</tr>
<tr class="even">
<td align="left">E74.19</td>
<td align="right">1</td>
<td align="left">Acquired fructose intolerance</td>
<td align="left">Other disorders of fructose metabolism</td>
</tr>
<tr class="odd">
<td align="left">E74.19</td>
<td align="right">1</td>
<td align="left">Fructose-1,6-bisphosphatase deficiency</td>
<td align="left">Other disorders of fructose metabolism</td>
</tr>
<tr class="even">
<td align="left">E71.510</td>
<td align="right">1</td>
<td align="left">Zellweger syndrome</td>
<td align="left">Zellweger syndrome</td>
</tr>
<tr class="odd">
<td align="left">E71.111</td>
<td align="right">1</td>
<td align="left">OPA3 defect</td>
<td align="left">3-methylglutaconic aciduria</td>
</tr>
<tr class="even">
<td align="left">E71.111</td>
<td align="right">1</td>
<td align="left">3-methylglutaconyl-CoA hydratase deficiency (AUH defect)</td>
<td align="left">3-methylglutaconic aciduria</td>
</tr>
<tr class="odd">
<td align="left">E71.111</td>
<td align="right">1</td>
<td align="left">MEGDEL syndrome</td>
<td align="left">3-methylglutaconic aciduria</td>
</tr>
<tr class="even">
<td align="left">E71.111</td>
<td align="right">1</td>
<td align="left">DCMA syndrome</td>
<td align="left">3-methylglutaconic aciduria</td>
</tr>
<tr class="odd">
<td align="left">E70.39</td>
<td align="right">1</td>
<td align="left">Piebaldism</td>
<td align="left">Other specified albinism</td>
</tr>
<tr class="even">
<td align="left">E70.39</td>
<td align="right">1</td>
<td align="left">Tietz syndrome</td>
<td align="left">Other specified albinism</td>
</tr>
<tr class="odd">
<td align="left">E70.39</td>
<td align="right">1</td>
<td align="left">Griscelli syndrome</td>
<td align="left">Other specified albinism</td>
</tr>
</tbody>
</table>
</div>
<div id="frequency-table-of-icd-10-codes-that-each-only-map-to-exactly-1-rare-metabolic-disease" class="section level3">
<h3>Frequency Table of ICD-10 Codes that Each Only Map to Exactly 1 Rare Metabolic Disease</h3>
<p>Here, we specifically looked at only ICD-10 codes that uniquely mapped to exactly one “rare” metabolic disease in our mapping files.</p>
<p>Number of ICD-10 Codes: <strong>63</strong></p>
<p>Total Number of Patients: <strong>81193</strong></p>
<table>
<thead>
<tr class="header">
<th align="left">ICD-10 Code</th>
<th align="right">Frequency</th>
<th align="left">Rare Disease Name</th>
<th align="left">ICD Code Description</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">E78.00</td>
<td align="right">46355</td>
<td align="left">Hyperlipoproteinemia type 2</td>
<td align="left">Pure hypercholesterolemia, unspecified</td>
</tr>
<tr class="even">
<td align="left">E87.5</td>
<td align="right">10605</td>
<td align="left">Gordon syndrome</td>
<td align="left">Hyperkalemia</td>
</tr>
<tr class="odd">
<td align="left">E78.1</td>
<td align="right">7041</td>
<td align="left">Hyperlipoproteinemia type 4</td>
<td align="left">Pure hyperglyceridemia</td>
</tr>
<tr class="even">
<td align="left">E83.42</td>
<td align="right">6761</td>
<td align="left">Primary hypomagnesemia with secondary hypocalcemia</td>
<td align="left">Hypomagnesemia</td>
</tr>
<tr class="odd">
<td align="left">E83.52</td>
<td align="right">5433</td>
<td align="left">Familial hypocalciuric hypercalcemia</td>
<td align="left">Hypercalcemia</td>
</tr>
<tr class="even">
<td align="left">E83.51</td>
<td align="right">2020</td>
<td align="left">Hypocalcemia, autosomal dominant</td>
<td align="left">Hypocalcemia</td>
</tr>
<tr class="odd">
<td align="left">E84.9</td>
<td align="right">541</td>
<td align="left">Cystic fibrosis</td>
<td align="left">Cystic fibrosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">E78.01</td>
<td align="right">535</td>
<td align="left">Hyperlipoproteinemia type 2</td>
<td align="left">Familial hypercholesterolemia</td>
</tr>
<tr class="odd">
<td align="left">E75.21</td>
<td align="right">345</td>
<td align="left">Fabry disease</td>
<td align="left">Fabry (-Anderson) disease</td>
</tr>
<tr class="even">
<td align="left">E72.20</td>
<td align="right">302</td>
<td align="left">Urea cycle disorders</td>
<td align="left">Disorder of urea cycle metabolism, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E80.4</td>
<td align="right">296</td>
<td align="left">Congenital nonhemolytic jaundice</td>
<td align="left">Gilbert syndrome</td>
</tr>
<tr class="even">
<td align="left">E88.01</td>
<td align="right">272</td>
<td align="left">Alpha-1 antitrypsin deficiency</td>
<td align="left">Alpha-1-antitrypsin deficiency</td>
</tr>
<tr class="odd">
<td align="left">E83.31</td>
<td align="right">58</td>
<td align="left">Hypophosphatemic rickets</td>
<td align="left">Familial hypophosphatemia</td>
</tr>
<tr class="even">
<td align="left">E70.329</td>
<td align="right">57</td>
<td align="left">Oculocutaneous albinism</td>
<td align="left">Oculocutaneous albinism, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E83.01</td>
<td align="right">49</td>
<td align="left">Wilson disease</td>
<td align="left">Wilson’s disease</td>
</tr>
<tr class="even">
<td align="left">E76.01</td>
<td align="right">48</td>
<td align="left">Hurler syndrome</td>
<td align="left">Hurler’s syndrome</td>
</tr>
<tr class="odd">
<td align="left">E72.01</td>
<td align="right">40</td>
<td align="left">Cystinuria</td>
<td align="left">Cystinuria</td>
</tr>
<tr class="even">
<td align="left">E70.30</td>
<td align="right">39</td>
<td align="left">Albinism</td>
<td align="left">Albinism, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E76.3</td>
<td align="right">38</td>
<td align="left">Mucopolysaccharidosis</td>
<td align="left">Mucopolysaccharidosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">E75.23</td>
<td align="right">31</td>
<td align="left">Krabbe disease</td>
<td align="left">Krabbe disease</td>
</tr>
<tr class="odd">
<td align="left">E74.03</td>
<td align="right">29</td>
<td align="left">Glycogen storage disease type 3</td>
<td align="left">Cori disease</td>
</tr>
<tr class="even">
<td align="left">E74.39</td>
<td align="right">28</td>
<td align="left">Glucose-galactose malabsorption</td>
<td align="left">Other disorders of intestinal carbohydrate absorption</td>
</tr>
<tr class="odd">
<td align="left">E88.41</td>
<td align="right">22</td>
<td align="left">Mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes</td>
<td align="left">MELAS syndrome</td>
</tr>
<tr class="even">
<td align="left">E71.311</td>
<td align="right">22</td>
<td align="left">Medium-chain acyl-coenzyme A dehydrogenase deficiency</td>
<td align="left">Medium chain acyl CoA dehydrogenase deficiency</td>
</tr>
<tr class="odd">
<td align="left">E74.04</td>
<td align="right">20</td>
<td align="left">Glycogen storage disease type 5</td>
<td align="left">McArdle disease</td>
</tr>
<tr class="even">
<td align="left">E72.51</td>
<td align="right">15</td>
<td align="left">Glycine encephalopathy</td>
<td align="left">Non-ketotic hyperglycinemia</td>
</tr>
<tr class="odd">
<td align="left">E85.2</td>
<td align="right">13</td>
<td align="left">Primary cutaneous amyloidosis</td>
<td align="left">Heredofamilial amyloidosis, unspecified</td>
</tr>
<tr class="even">
<td align="left">E83.09</td>
<td align="right">13</td>
<td align="left">Menkes disease</td>
<td align="left">Other disorders of copper metabolism</td>
</tr>
<tr class="odd">
<td align="left">E71.313</td>
<td align="right">13</td>
<td align="left">Glutaric acidemia type II</td>
<td align="left">Glutaric aciduria type II</td>
</tr>
<tr class="even">
<td align="left">E71.0</td>
<td align="right">11</td>
<td align="left">Maple syrup urine disease</td>
<td align="left">Maple-syrup-urine disease</td>
</tr>
<tr class="odd">
<td align="left">E70.320</td>
<td align="right">11</td>
<td align="left">Oculocutaneous albinism type 1</td>
<td align="left">Tyrosinase negative oculocutaneous albinism</td>
</tr>
<tr class="even">
<td align="left">E72.03</td>
<td align="right">9</td>
<td align="left">Lowe oculocerebrorenal syndrome</td>
<td align="left">Lowe’s syndrome</td>
</tr>
<tr class="odd">
<td align="left">E71.50</td>
<td align="right">9</td>
<td align="left">Peroxisomal biogenesis disorders</td>
<td align="left">Peroxisomal disorder, unspecified</td>
</tr>
<tr class="even">
<td align="left">E85.0</td>
<td align="right">8</td>
<td align="left">Amyloidosis familial visceral</td>
<td align="left">Non-neuropathic heredofamilial amyloidosis</td>
</tr>
<tr class="odd">
<td align="left">E71.121</td>
<td align="right">8</td>
<td align="left">Propionic acidemia</td>
<td align="left">Propionic acidemia</td>
</tr>
<tr class="even">
<td align="left">E70.331</td>
<td align="right">8</td>
<td align="left">Hermansky-Pudlak syndrome</td>
<td align="left">Hermansky-Pudlak syndrome</td>
</tr>
<tr class="odd">
<td align="left">E78.72</td>
<td align="right">6</td>
<td align="left">Smith-Lemli-Opitz syndrome</td>
<td align="left">Smith-Lemli-Opitz syndrome</td>
</tr>
<tr class="even">
<td align="left">E70.0</td>
<td align="right">6</td>
<td align="left">Phenylketonuria</td>
<td align="left">Classical phenylketonuria</td>
</tr>
<tr class="odd">
<td align="left">E83.89</td>
<td align="right">5</td>
<td align="left">Hypermanganesemia with dystonia polycythemia and cirrhosis</td>
<td align="left">Other disorders of mineral metabolism</td>
</tr>
<tr class="even">
<td align="left">E75.249</td>
<td align="right">5</td>
<td align="left">Niemann-Pick disease type A</td>
<td align="left">Niemann-Pick disease, unspecified</td>
</tr>
<tr class="odd">
<td align="left">E72.10</td>
<td align="right">5</td>
<td align="left">Megaloblastic anemia due to dihydrofolate reductase deficiency</td>
<td align="left">Disorders of sulfur-bearing amino-acid metabolism, unspecified</td>
</tr>
<tr class="even">
<td align="left">E71.522</td>
<td align="right">5</td>
<td align="left">Adrenomyeloneuropathy</td>
<td align="left">Adrenomyeloneuropathy</td>
</tr>
<tr class="odd">
<td align="left">E71.440</td>
<td align="right">5</td>
<td align="left">Bannayan-Riley-Ruvalcaba syndrome</td>
<td align="left">Ruvalcaba-Myhre-Smith syndrome</td>
</tr>
<tr class="even">
<td align="left">E70.310</td>
<td align="right">5</td>
<td align="left">Ocular albinism type 1</td>
<td align="left">X-linked ocular albinism</td>
</tr>
<tr class="odd">
<td align="left">E83.2</td>
<td align="right">4</td>
<td align="left">Acrodermatitis enteropathica</td>
<td align="left">Disorders of zinc metabolism</td>
</tr>
<tr class="even">
<td align="left">E79.2</td>
<td align="right">4</td>
<td align="left">Adenosine monophosphate deaminase 1 deficiency</td>
<td align="left">Myoadenylate deaminase deficiency</td>
</tr>
<tr class="odd">
<td align="left">E76.210</td>
<td align="right">4</td>
<td align="left">Mucopolysaccharidosis type IVA</td>
<td align="left">Morquio A mucopolysaccharidoses</td>
</tr>
<tr class="even">
<td align="left">E75.02</td>
<td align="right">4</td>
<td align="left">Tay-Sachs disease</td>
<td align="left">Tay-Sachs disease</td>
</tr>
<tr class="odd">
<td align="left">E72.52</td>
<td align="right">4</td>
<td align="left">Trimethylaminuria</td>
<td align="left">Trimethylaminuria</td>
</tr>
<tr class="even">
<td align="left">E77.0</td>
<td align="right">3</td>
<td align="left">Mucolipidosis III alpha/beta</td>
<td align="left">Defects in post-translational modification of lysosomal enzymes</td>
</tr>
<tr class="odd">
<td align="left">E72.21</td>
<td align="right">3</td>
<td align="left">Arginase deficiency</td>
<td align="left">Argininemia</td>
</tr>
<tr class="even">
<td align="left">E70.330</td>
<td align="right">3</td>
<td align="left">Chediak-Higashi syndrome</td>
<td align="left">Chediak-Higashi syndrome</td>
</tr>
<tr class="odd">
<td align="left">E76.02</td>
<td align="right">2</td>
<td align="left">HurlerÎ“ÃÃ´Scheie syndrome</td>
<td align="left">Hurler-Scheie syndrome</td>
</tr>
<tr class="even">
<td align="left">E74.29</td>
<td align="right">2</td>
<td align="left">Galactokinase deficiency</td>
<td align="left">Other disorders of galactose metabolism</td>
</tr>
<tr class="odd">
<td align="left">E74.12</td>
<td align="right">2</td>
<td align="left">Hereditary fructose intolerance</td>
<td align="left">Hereditary fructose intolerance</td>
</tr>
<tr class="even">
<td align="left">E72.02</td>
<td align="right">2</td>
<td align="left">Hartnup disease</td>
<td align="left">Hartnup’s disease</td>
</tr>
<tr class="odd">
<td align="left">E71.528</td>
<td align="right">2</td>
<td align="left">Pseudoneonatal adrenoleukodystrophy</td>
<td align="left">Other X-linked adrenoleukodystrophy</td>
</tr>
<tr class="even">
<td align="left">E71.110</td>
<td align="right">2</td>
<td align="left">Isovaleric acidemia</td>
<td align="left">Isovaleric acidemia</td>
</tr>
<tr class="odd">
<td align="left">E78.81</td>
<td align="right">1</td>
<td align="left">Multicentric reticulohistiocytosis</td>
<td align="left">Lipoid dermatoarthritis</td>
</tr>
<tr class="even">
<td align="left">E76.03</td>
<td align="right">1</td>
<td align="left">Scheie syndrome</td>
<td align="left">Scheie’s syndrome</td>
</tr>
<tr class="odd">
<td align="left">E75.241</td>
<td align="right">1</td>
<td align="left">Niemann-Pick disease type B</td>
<td align="left">Niemann-Pick disease type B</td>
</tr>
<tr class="even">
<td align="left">E75.01</td>
<td align="right">1</td>
<td align="left">Sandhoff disease</td>
<td align="left">Sandhoff disease</td>
</tr>
<tr class="odd">
<td align="left">E71.510</td>
<td align="right">1</td>
<td align="left">Zellweger syndrome</td>
<td align="left">Zellweger syndrome</td>
</tr>
</tbody>
</table>
<p><span class="math inline">\(\hspace{4ex} _\blacksquare\)</span></p>
</div>




</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.header').parent('thead').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
